Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
their	their	PRP$	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
to	to	TO	B-PP	O
hormone	hormone	NN	B-NP	O
action	action	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
study	study	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
decreased	decrease	VBN	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
(	(	(	O	O
GR	GR	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
hypercholesterolemic	hypercholesterolemic	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
elevated	elevate	VBN	I-NP	O
level	level	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	B-cell_type
with	with	IN	B-PP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
GR	GR	NN	I-NP	B-protein
number	number	NN	I-NP	O
,	,	,	O	O
dexamethasone	dexamethasone	NN	B-NP	O
inhibited	inhibit	VBD	B-VP	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	I-NP	O
-thymidine	-thymidine	NN	I-NP	O
and	and	CC	O	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
-acetate	-acetate	NN	I-NP	O
incorporation	incorporation	NN	I-NP	O
into	into	IN	B-PP	O
DNA	DNA	NN	B-NP	O
and	and	CC	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
manner	manner	NN	I-NP	O
as	as	IN	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
hand	hand	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
decreased	decrease	VBN	I-NP	O
GR	GR	NN	I-NP	B-protein
number	number	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
less	less	RBR	I-NP	O
efficient	efficient	JJ	I-NP	O
dexamethasone	dexamethasone	NN	I-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
incorporation	incorporation	NN	I-NP	O
of	of	IN	B-PP	O
labeled	label	VBN	B-NP	O
compounds	compound	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
to	to	TO	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
changed	change	VBD	B-VP	O
only	only	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
of	of	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
level	level	NN	I-NP	O
.	.	.	O	O

[	[	(	O	O
1	1	CD	B-NP	B-protein
,	,	,	O	I-protein
25-Dihydroxyvitamin	25-Dihydroxyvitamin	NN	B-NP	I-protein
D3	D3	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
T-	T-	NN	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
B-lymphocyte	B-lymphocyte	NN	I-NP	I-cell_type
count	count	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
glomerulonephritis	glomerulonephritis	NN	B-NP	O
]	]	)	O	O

Content	Content	NN	B-NP	O
of	of	IN	B-PP	O
receptors	receptor	NNS	B-NP	O
to	to	TO	B-PP	O
hormonal	hormonal	JJ	B-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
vitamin	vitamin	NN	B-NP	O
D3	D3	NN	I-NP	O
,	,	,	O	O
1.25	1.25	CD	B-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
,	,	,	O	O
constituted	constitute	VBD	B-VP	O
27.3	27.3	CD	B-NP	O
fmole/mg	fmole/mg	NN	I-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
in	in	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
peripheric	peripheric	JJ	B-NP	O
blood	blood	NN	I-NP	O
of	of	IN	B-PP	O
children	child	NNS	B-NP	O
with	with	IN	B-PP	O
glomerulonephritis	glomerulonephritis	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
and	and	CC	I-NP	O
ionized	ionize	VBN	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
Ca2+	Ca2+	NN	B-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
2.04	2.04	CD	B-NP	O
mmole/L	mmole/L	NN	I-NP	O
and	and	CC	O	O
1.09	1.09	CD	B-NP	O
mmole/L	mmole/L	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
parathormone	parathormone	NN	B-NP	O
(	(	(	O	O
PTH	PTH	NN	B-NP	O
)	)	)	O	O
by	by	IN	B-PP	O
36	36	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
distinct	distinct	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
25	25	CD	B-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
D	D	NN	B-NP	O
concentration	concentration	NN	I-NP	O
(	(	(	O	O
lower	low	JJR	B-NP	O
than	than	IN	I-NP	O
1.25	1.25	CD	I-NP	O
ng/ml	ng/ml	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
;	;	:	O	O
content	content	NN	B-NP	O
of	of	IN	B-PP	O
cAMP	cAMP	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
in	in	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
by	by	IN	B-PP	O
33	33	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
content	content	NN	I-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
1.5-fold	1.5-fold	RB	B-ADVP	O
in	in	IN	B-PP	O
peripheric	peripheric	JJ	B-NP	O
blood	blood	NN	I-NP	O
.	.	.	O	O

Treatment	Treatment	NN	B-NP	O
with	with	IN	B-PP	O
I-hydroxyvitamin	I-hydroxyvitamin	NN	B-NP	O
D3	D3	NN	I-NP	O
(	(	(	O	O
1-1.5	1-1.5	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
within	within	IN	B-PP	O
4	4	CD	B-NP	O
weeks	week	NNS	I-NP	O
)	)	)	O	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
normalization	normalization	NN	B-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
and	and	CC	I-NP	O
ionized	ionize	VBN	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
Ca2+	Ca2+	NN	B-NP	O
and	and	CC	B-PP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
D	D	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
PTH	PTH	NN	I-NP	O
content	content	NN	I-NP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
.	.	.	O	O

Concentration	Concentration	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
receptors	receptor	NNS	I-NP	O
to	to	TO	B-PP	O
1.25	1.25	CD	B-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
39.7	39.7	CD	I-NP	O
fmole/mg	fmole/mg	NN	I-NP	O
after	after	IN	B-PP	O
I	I	NN	B-NP	O
week	week	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
level	level	NN	I-NP	O
24.8	24.8	CD	I-NP	O
fmole/mg	fmole/mg	NN	I-NP	O
within	within	IN	B-PP	O
4	4	CD	B-NP	O
weeks	week	NNS	I-NP	O
;	;	:	O	O
simultaneous	simultaneous	JJ	B-NP	O
alteration	alteration	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cAMP	cAMP	NN	I-NP	O
content	content	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
.	.	.	O	O

Treatment	Treatment	NN	B-NP	O
with	with	IN	B-PP	O
1-	1-	NN	B-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
D3	D3	NN	B-NP	O
normalized	normalize	VBD	B-VP	O
also	also	RB	B-ADVP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
content	content	NN	I-NP	O
in	in	IN	B-PP	O
peripheric	peripheric	JJ	B-NP	O
blood	blood	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
data	datum	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
under	under	IN	B-PP	O
conditions	condition	NNS	B-NP	O
of	of	IN	B-PP	O
glomerulonephritis	glomerulonephritis	NN	B-NP	O
only	only	RB	B-NP	O
high	high	JJ	I-NP	O
content	content	NN	I-NP	O
of	of	IN	B-PP	O
receptors	receptor	NNS	B-NP	O
to	to	TO	B-PP	O
1.25	1.25	CD	B-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
in	in	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
enabled	enable	VBD	B-VP	O
to	to	TO	I-VP	O
perform	perform	VB	I-VP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hormone	hormone	NN	I-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

Tumor	Tumor	NN	B-NP	O
and	and	CC	I-NP	O
serum	serum	NN	I-NP	B-protein
beta-2-microglobulin	beta-2-microglobulin	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
women	woman	NNS	B-NP	O
with	with	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
whether	whether	IN	B-SBAR	O
the	the	DT	B-NP	O
tumor	tumor	NN	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
beta-2-microglobulin	beta-2-microglobulin	NN	B-NP	B-protein
(	(	(	O	O
beta	beta	SYM	B-NP	B-protein
2-M	2-M	NN	I-NP	I-protein
)	)	)	O	O
could	could	MD	B-VP	O
serve	serve	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
marker	marker	NN	I-NP	O
of	of	IN	B-PP	O
tumor	tumor	NN	B-NP	O
biologic	biologic	JJ	I-NP	O
behavior	behavior	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
authors	author	NNS	I-NP	O
studied	study	VBD	B-VP	O
specimens	specimen	NNS	B-NP	O
of	of	IN	B-PP	O
breast	breast	NN	B-NP	O
carcinomas	carcinoma	NNS	I-NP	O
from	from	IN	B-PP	O
60	60	CD	B-NP	O
consecutive	consecutive	JJ	I-NP	O
female	female	JJ	I-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Presence	Presence	NN	B-NP	O
of	of	IN	B-PP	O
beta	beta	SYM	B-NP	B-protein
2-M	2-M	NN	I-NP	I-protein
was	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
by	by	IN	B-PP	O
immunohistochemistry	immunohistochemistry	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
correlations	correlation	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
tumor	tumor	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
2-M	2-M	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
several	several	JJ	B-NP	O
histologic	histologic	JJ	I-NP	O
attributes	attribute	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
type	type	NN	B-NP	O
,	,	,	O	O
histologic	histologic	JJ	B-NP	O
and	and	CC	I-NP	O
nuclear	nuclear	JJ	I-NP	O
grades	grade	NNS	I-NP	O
,	,	,	O	O
mitotic	mitotic	JJ	B-NP	O
index	index	NN	I-NP	O
,	,	,	O	O
necrosis	necrosis	NN	B-NP	O
,	,	,	O	O
vascular	vascular	JJ	B-NP	O
invasion	invasion	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
lymphocytic	lymphocytic	JJ	B-NP	O
infiltration	infiltration	NN	I-NP	O
.	.	.	O	O

Likewise	Likewise	RB	B-ADVP	O
,	,	,	O	O
beta	beta	NN	B-NP	B-protein
2-M	2-M	NN	I-NP	I-protein
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
markers	marker	NNS	B-NP	O
of	of	IN	B-PP	O
disease	disease	NN	B-NP	O
extension	extension	NN	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
TNM	TNM	NN	B-NP	B-protein
,	,	,	O	O
(	(	(	O	O
UICC	UICC	NN	B-NP	O
,	,	,	O	O
classification	classification	NN	B-NP	O
of	of	IN	B-PP	O
malignant	malignant	JJ	B-NP	O
tumors	tumor	NNS	I-NP	O
)	)	)	O	O
staging	stag	VBG	B-VP	O
and	and	CC	O	O
axillary	axillary	JJ	B-NP	O
lymph	lymph	NN	I-NP	O
node	node	NN	I-NP	O
involvement	involvement	NN	I-NP	O
or	or	CC	B-PP	O
with	with	IN	B-PP	O
estrogen	estrogen	NN	B-NP	O
,	,	,	O	O
progesterone	progesterone	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
levels	level	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
significantly	significantly	RB	I-NP	O
positive	positive	JJ	I-NP	O
association	association	NN	I-NP	O
between	between	IN	B-PP	O
tumor	tumor	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
2-M	2-M	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
lymphocytic	lymphocytic	JJ	B-NP	O
infiltration	infiltration	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
tumor	tumor	NN	I-NP	O
tissue	tissue	NN	I-NP	O
.	.	.	O	O

Beta	Beta	SYM	O	O
2-M	2-M	NN	B-NP	O
serum	serum	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
enzyme-linked	enzyme-linked	JJ	I-NP	O
immunosorbent	immunosorbent	JJ	I-NP	O
assay	assay	NN	I-NP	O
in	in	IN	B-PP	O
samples	sample	NNS	B-NP	O
from	from	IN	B-PP	O
22	22	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
above	above	JJ	I-NP	O
women	woman	NNS	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
values	value	NNS	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
obtained	obtain	VBN	I-VP	O
in	in	IN	B-PP	O
women	woman	NNS	B-NP	O
with	with	IN	B-PP	O
larger	large	JJR	B-NP	O
(	(	(	I-NP	O
T4	T4	NN	I-NP	O
)	)	)	I-NP	O
primary	primary	JJ	I-NP	O
tumors	tumor	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
authors	author	NNS	I-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
detect	detect	VB	I-VP	O
any	any	DT	B-NP	O
statistical	statistical	JJ	I-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
beta	beta	SYM	B-NP	B-protein
2-M	2-M	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
tumor	tumor	NN	I-NP	O
with	with	IN	B-PP	O
serum	serum	NN	B-NP	O
levels	level	NNS	I-NP	O
or	or	CC	B-PP	O
between	between	IN	B-PP	O
serum	serum	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
2-M	2-M	NN	I-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
above	above	JJ	I-NP	O
histologic	histologic	NN	I-NP	O
,	,	,	O	O
laboratory	laboratory	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
clinical	clinical	JJ	B-NP	O
factors	factor	NNS	I-NP	O
.	.	.	O	O

[	[	(	O	O
Preliminary	Preliminary	JJ	B-NP	O
observation	observation	NN	I-NP	O
of	of	IN	B-PP	O
level	level	NN	B-NP	O
free-form	free-form	JJ	I-NP	O
E	E	NN	I-NP	O
receptor	receptor	NN	I-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
serum	serum	NN	B-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
childbearing-aged	childbearing-aged	JJ	I-NP	O
and	and	CC	I-NP	O
pregnant	pregnant	JJ	I-NP	O
women	woman	NNS	I-NP	O
]	]	)	O	O

In	In	IN	B-PP	O
137	137	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
childbearing-aged	childbearing-aged	JJ	B-NP	O
and	and	CC	I-NP	O
pregnant	pregnant	JJ	I-NP	O
women	woman	NNS	I-NP	O
,	,	,	O	O
free	free	JJ	B-NP	O
form	form	NN	I-NP	O
E	E	NN	I-NP	O
receptor	receptor	NN	I-NP	O
levels	level	NNS	I-NP	O
(	(	(	O	O
sE	sE	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
serum	serum	NN	B-NP	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
by	by	IN	B-PP	O
ELISA	ELISA	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
sE	sE	NN	B-NP	B-protein
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
trimester	trimester	NN	I-NP	O
,	,	,	O	O
slightly	slightly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
trimester	trimester	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
recovered	recover	VBD	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
third	third	JJ	I-NP	O
trimester	trimester	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
level	level	NN	I-NP	O
remained	remain	VBD	B-VP	O
lower	low	JJR	B-ADJP	O
in	in	IN	B-PP	O
29	29	CD	B-NP	O
PIH	PIH	NN	I-NP	O
women	woman	NNS	I-NP	O
but	but	CC	O	O
appeared	appear	VBD	B-VP	O
higher	high	JJR	B-ADVP	O
in	in	IN	B-PP	O
overdue	overdue	JJ	B-NP	O
pregnancies	pregnancy	NNS	I-NP	O
as	as	IN	B-PP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
3rd	3rd	NN	I-NP	O
trimester	trimester	NN	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
a	a	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
function	function	NN	I-NP	O
and	and	CC	I-NP	O
pregnancy	pregnancy	NN	I-NP	O
.	.	.	O	O

Kappa	Kappa	NN	B-NP	B-protein
B-specific	B-specific	JJ	I-NP	I-protein
DNA	DNA	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
:	:	:	O	O
role	role	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-DNA
interleukin-2	interleukin-2	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
.	.	.	O	O

Transcriptional	Transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
interleukin-2	interleukin-2	NN	I-NP	I-DNA
(	(	(	O	I-DNA
IL-2	IL-2	NN	B-NP	I-DNA
)	)	)	O	I-DNA
gene	gene	NN	B-NP	I-DNA
,	,	,	O	O
like	like	IN	B-PP	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
receptor	receptor	NN	I-NP	I-DNA
alpha	alpha	NN	I-NP	I-DNA
(	(	(	O	I-DNA
IL-2R	IL-2R	NN	B-NP	I-DNA
alpha	alpha	NN	I-NP	I-DNA
)	)	)	O	I-DNA
gene	gene	NN	B-NP	I-DNA
and	and	CC	O	O
the	the	DT	B-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
human	human	JJ	I-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
HIV-1	HIV-1	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
is	be	VBZ	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
modulated	modulate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
kappa	kappa	NN	I-NP	B-DNA
B-like	B-like	JJ	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
.	.	.	O	O

Mutation	Mutation	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
kappa	kappa	NN	I-NP	B-DNA
B	B	NN	I-NP	I-DNA
core	core	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
identified	identify	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
(	(	(	O	O
-206	-206	CD	B-NP	B-DNA
to	to	TO	O	I-DNA
-195	-195	CD	B-NP	I-DNA
)	)	)	O	O
partially	partially	RB	B-ADVP	O
inhibits	inhibit	VBZ	B-VP	O
both	both	CC	O	O
mitogen-	mitogen-	NN	B-NP	B-protein
and	and	CC	O	O
HTLV-I	HTLV-I	NN	B-NP	O
Tax-mediated	Tax-mediated	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
transcription	transcription	NN	I-NP	B-DNA
unit	unit	NN	I-NP	I-DNA
and	and	CC	O	O
blocks	block	VBZ	B-VP	O
the	the	DT	B-NP	O
specific	specific	JJ	I-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
inducible	inducible	JJ	I-NP	O
cellular	cellular	JJ	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

These	These	DT	B-NP	O
kappa	kappa	NN	I-NP	B-protein
B-specific	B-specific	JJ	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
(	(	(	O	O
80	80	CD	B-NP	O
to	to	TO	I-NP	O
90	90	CD	I-NP	O
and	and	CC	I-NP	O
50	50	CD	I-NP	O
to	to	TO	I-NP	O
55	55	CD	I-NP	O
kilodaltons	kilodalton	NNS	I-NP	O
)	)	)	O	O
similarly	similarly	RB	B-ADVP	O
interact	interact	VBP	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	B-DNA
kappa	kappa	NN	I-NP	I-DNA
B	B	NN	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
IL-2R	IL-2R	NN	I-NP	B-DNA
alpha	alpha	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
kappa	kappa	NN	I-NP	B-protein
B-specific	B-specific	JJ	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
coordinate	coordinate	JJ	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
growth	growth	NN	I-NP	B-DNA
factor-growth	factor-growth	NN	I-NP	I-DNA
factor	factor	NN	I-NP	I-DNA
receptor	receptor	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
system	system	NN	I-NP	O
that	that	WDT	B-NP	O
controls	control	VBZ	B-VP	O
T	T	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
proliferation	proliferation	NN	I-NP	O
.	.	.	O	O

Novel	Novel	JJ	B-NP	O
region	region	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
V	V	NN	I-NP	B-DNA
kappa	kappa	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
tissue	tissue	NN	B-NP	O
and	and	CC	O	O
stage-specific	stage-specific	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
lymphoid	lymphoid	JJ	I-NP	I-cell_type
neoplasms	neoplasm	NNS	I-NP	I-cell_type
.	.	.	O	O

Immunoglobulin	Immunoglobulin	NN	B-NP	B-protein
gene-specific	gene-specific	JJ	I-NP	I-protein
transacting	transact	VBG	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
lymphoid	lymphoid	JJ	B-NP	O
tissue-specific	tissue-specific	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
factors	factor	NNS	I-NP	O
in	in	IN	B-PP	O
B-cell	B-cell	NN	B-NP	B-cell_type
differentiation	differentiation	NN	I-NP	O
and	and	CC	O	O
stage-specific	stage-specific	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
genes	gene	NNS	I-NP	O
is	be	VBZ	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
not	not	RB	O	O
fully	fully	RB	B-VP	O
understood	understand	VBN	I-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
used	use	VBN	I-VP	O
a	a	DT	B-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
lymphoid	lymphoid	JJ	I-NP	O
neoplasia	neoplasia	NN	I-NP	O
to	to	TO	B-VP	O
address	address	VB	I-VP	O
this	this	DT	B-NP	O
question	question	NN	I-NP	O
.	.	.	O	O

Different	Different	JJ	B-NP	O
fragments	fragment	NNS	I-NP	O
of	of	IN	B-PP	O
unrearranged	unrearranged	JJ	B-NP	O
human	human	JJ	I-NP	O
variable	variable	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-DNA
kappa	kappa	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
(	(	(	O	O
V	V	NN	B-NP	O
kappa	kappa	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
cell-free	cell-free	JJ	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
transcription	transcription	NN	I-NP	O
and	and	CC	I-NP	O
DNA	DNA	NN	I-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
.	.	.	O	O

Previously	Previously	RB	B-NP	O
described	describe	VBN	I-NP	O
enhancement	enhancement	NN	I-NP	O
of	of	IN	B-PP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
transcription	transcription	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
only	only	RB	I-VP	O
seen	see	VBN	I-VP	O
with	with	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
B-cell	B-cell	NN	B-NP	B-cell_type
neoplasms	neoplasm	NNS	I-NP	I-cell_type
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
late	late	JJ	I-NP	O
stages	stage	NNS	I-NP	O
of	of	IN	B-PP	O
B-cell	B-cell	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
actions	action	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
factor	factor	NN	I-NP	O
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
within	within	IN	B-PP	O
the	the	DT	B-NP	O
V	V	NN	I-NP	B-DNA
kappa	kappa	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

This	This	DT	B-NP	O
region	region	NN	I-NP	O
is	be	VBZ	B-VP	O
located	located	JJ	B-ADJP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
920	920	CD	I-NP	B-DNA
bp	bp	NN	I-NP	I-DNA
fragment	fragment	NN	I-NP	I-DNA
located	located	JJ	I-NP	I-DNA
210	210	CD	I-NP	I-DNA
bp	bp	NN	I-NP	I-DNA
upstream	upstream	RB	B-ADVP	I-DNA
from	from	IN	B-PP	O
the	the	DT	B-NP	O
coding	cod	VBG	I-NP	O
region	region	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
fragment	fragment	NN	I-NP	O
represents	represent	VBZ	B-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
novel	novel	JJ	I-NP	O
DNA	DNA	NN	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
,	,	,	O	O
which	which	WDT	B-NP	O
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
stage-	stage-	NN	I-NP	O
and	and	CC	O	O
tissue-specific	tissue-specific	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

[	[	(	O	O
Determination	Determination	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
to	to	TO	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
]	]	)	O	O

A	A	DT	B-NP	O
modified	modify	VBN	I-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
determination	determination	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
suggested	suggest	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
principal	principal	JJ	I-NP	O
distinction	distinction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
method	method	NN	I-NP	O
is	be	VBZ	B-VP	O
standardization	standardization	NN	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
lymphocyte	lymphocyte	NN	I-NP	O
count	count	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
sample	sample	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
mln	mln	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
labeled	label	VBN	I-NP	O
hormone	hormone	NN	I-NP	O
concentration	concentration	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
modification	modification	NN	I-NP	O
saves	save	VBZ	B-VP	O
time	time	NN	B-NP	O
and	and	CC	I-NP	O
money	money	NN	I-NP	O
,	,	,	O	O
limits	limit	VBZ	B-VP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
variations	variation	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
makes	make	VBZ	B-VP	O
use	use	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
lesser	less	JJR	I-NP	O
volume	volume	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
.	.	.	O	O

Examinations	Examination	NNS	B-NP	O
of	of	IN	B-PP	O
70	70	CD	B-NP	O
children	child	NNS	I-NP	O
aged	age	VBN	B-ADJP	O
4	4	CD	B-NP	O
to	to	TO	B-PP	O
15	15	CD	B-NP	O
suffering	suffer	VBG	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
nephrotic	nephrotic	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
glomerulonephritis	glomerulonephritis	NN	B-NP	O
have	have	VBP	B-VP	O
made	make	VBN	I-VP	O
it	it	PRP	B-NP	O
possible	possible	JJ	B-ADJP	O
to	to	TO	B-VP	O
distinguish	distinguish	VB	I-VP	O
two	two	CD	B-NP	O
groups	group	NNS	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
:	:	:	O	O
with	with	IN	B-PP	O
relatively	relatively	RB	B-NP	O
high	high	JJ	I-NP	O
values	value	NNS	I-NP	O
of	of	IN	B-PP	O
specific	specific	JJ	B-NP	O
binding	binding	NN	I-NP	O
X	X	NN	I-NP	O
=	=	SYM	B-VP	O
6820.1	6820.1	CD	B-NP	O
+/-	+/-	SYM	B-NP	O
530.0	530.0	CD	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
30	30	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.95	0.95	CD	B-NP	O
,	,	,	O	O
t	t	NN	B-NP	O
=	=	JJ	B-VP	O
2.04	2.04	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
this	this	DT	B-NP	O
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
hormone	hormone	NN	B-NP	O
-sensitive	-sensitive	JJ	I-NP	O
glomerulonephritis	glomerulonephritis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
with	with	IN	B-PP	O
relatively	relatively	RB	B-NP	O
low	low	JJ	I-NP	O
values	value	NNS	I-NP	O
of	of	IN	B-PP	O
specific	specific	JJ	B-NP	O
binding	binding	NN	I-NP	O
X	X	NN	I-NP	O
=	=	SYM	B-VP	O
1815.2	1815.2	CD	B-NP	O
+/-	+/-	SYM	B-NP	O
302.8	302.8	CD	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
40	40	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.95	0.95	CD	B-NP	O
,	,	,	O	O
t	t	NN	B-NP	O
=	=	JJ	B-VP	O
1.96	1.96	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
that	that	WDT	B-NP	O
corresponds	correspond	VBZ	B-VP	O
to	to	TO	B-PP	O
hormone	hormone	NN	B-NP	O
-resistant	-resistant	JJ	I-NP	O
glomerulonephritis	glomerulonephritis	NN	I-NP	O
.	.	.	O	O

Dynamic	Dynamic	JJ	B-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
not	not	RB	I-VP	O
shown	show	VBN	I-VP	O
any	any	DT	B-NP	O
statistically	statistically	RB	I-NP	O
significant	significant	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
specific	specific	JJ	I-NP	O
binding	binding	NN	I-NP	O
values	value	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
permit	permit	VBP	B-VP	O
regarding	regard	VBG	I-VP	O
the	the	DT	B-NP	O
specific	specific	JJ	I-NP	O
binding	binding	NN	I-NP	O
value	value	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
prognostic	prognostic	JJ	I-NP	O
criterion	criterion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
assessment	assessment	NN	I-NP	O
of	of	IN	B-PP	O
corticosteroid	corticosteroid	NN	B-NP	O
therapy	therapy	NN	I-NP	O
;	;	:	O	O
this	this	DT	B-NP	O
allows	allow	VBZ	B-VP	O
a	a	DT	B-NP	O
wide	wide	JJ	I-NP	O
employment	employment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
described	describe	VBN	I-NP	O
method	method	NN	I-NP	O
in	in	IN	B-PP	O
practical	practical	JJ	B-NP	O
nephrology	nephrology	NN	I-NP	O
.	.	.	O	O

Octamer-binding	Octamer-binding	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
from	from	IN	B-PP	O
B	B	NN	B-NP	O
or	or	CC	O	O
HeLa	HeLa	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
stimulate	stimulate	VBP	B-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	B-DNA
heavy-chain	heavy-chain	JJ	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
B-cell	B-cell	NN	I-NP	O
-type	-type	JJ	I-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	B-DNA
(	(	(	I-NP	I-DNA
Ig	Ig	NN	I-NP	I-DNA
)	)	)	I-NP	I-DNA
heavy-chain	heavy-chain	JJ	I-NP	I-DNA
and	and	CC	I-NP	I-DNA
light-chain	light-chain	JJ	I-NP	I-DNA
promoters	promoter	NNS	I-NP	I-DNA
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
octanucleotide	octanucleotide	NN	I-NP	B-DNA
(	(	(	O	I-DNA
OCTA	OCTA	NN	B-NP	I-DNA
)	)	)	O	I-DNA
element	element	NN	B-NP	I-DNA
,	,	,	O	O
ATGCAAAT	ATGCAAAT	NN	B-NP	O
,	,	,	O	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
RNA	RNA	NN	I-NP	B-DNA
polymerase	polymerase	NN	I-NP	I-DNA
II	II	CD	B-NP	I-DNA
promoters	promoter	NNS	I-NP	I-DNA
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
snRNA	snRNA	NN	B-NP	B-DNA
and	and	CC	I-NP	I-DNA
histone	histone	NN	I-NP	I-DNA
H2B	H2B	NN	I-NP	I-DNA
promoters	promoter	NNS	I-NP	I-DNA
.	.	.	O	O

Two	Two	CD	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
bind	bind	VBP	B-VP	O
specifically	specifically	RB	B-ADVP	O
and	and	CC	O	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
OCTA	OCTA	NN	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

NF-A1	NF-A1	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
types	type	NNS	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
NF-A2	NF-A2	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
essentially	essentially	RB	I-VP	O
confined	confine	VBN	I-VP	O
to	to	TO	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
NF-A2	NF-A2	NN	B-NP	B-protein
activates	activate	VBZ	B-VP	O
cell-type-specific	cell-type-specific	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ig	Ig	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
and	and	CC	I-NP	O
NF-A1	NF-A1	NN	I-NP	B-protein
mediates	mediate	VBZ	B-VP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
responses	response	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
OCTA	OCTA	NN	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
.	.	.	O	O

Extracts	Extract	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
B-cell	B-cell	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
,	,	,	O	O
BJA-B	BJA-B	NN	B-NP	B-cell_line
,	,	,	O	O
contain	contain	VBP	B-VP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
NF-A2	NF-A2	NN	B-NP	B-protein
and	and	CC	O	O
specifically	specifically	RB	B-VP	O
transcribe	transcribe	VBP	I-VP	O
Ig	Ig	NN	B-NP	B-DNA
promoters	promoter	NNS	I-NP	I-DNA
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
extracts	extract	NNS	B-NP	O
from	from	IN	B-PP	O
HeLa	HeLa	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
transcribed	transcribe	VBD	B-VP	O
the	the	DT	B-NP	O
Ig	Ig	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
poorly	poorly	RB	B-ADVP	O
.	.	.	O	O

Surprisingly	Surprisingly	RB	B-ADVP	O
,	,	,	O	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
either	either	CC	B-NP	O
affinity-enriched	affinity-enriched	JJ	I-NP	O
NF-A2	NF-A2	NN	I-NP	B-protein
or	or	CC	I-NP	O
NF-A1	NF-A1	NN	I-NP	B-protein
to	to	TO	B-PP	O
either	either	CC	O	O
a	a	DT	B-NP	O
HeLa	HeLa	NN	I-NP	O
extract	extract	NN	I-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
partially	partially	RB	I-NP	O
purified	purify	VBN	I-NP	O
reaction	reaction	NN	I-NP	O
system	system	NN	I-NP	O
specifically	specifically	RB	B-ADVP	O
stimulates	stimulate	VBZ	B-VP	O
the	the	DT	B-NP	O
Ig	Ig	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

This	This	DT	B-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
constitutive	constitutive	JJ	I-NP	B-protein
OCTA-binding	OCTA-binding	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
NF-A1	NF-A1	NN	I-NP	B-protein
can	can	MD	B-VP	O
activate	activate	VB	I-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ig	Ig	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
and	and	CC	O	O
that	that	IN	B-SBAR	O
B-cell	B-cell	NN	B-NP	B-cell_type
-specific	-specific	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
promoter	promoter	NN	I-NP	B-DNA
,	,	,	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
partially	partially	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
quantitative	quantitative	JJ	I-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
OCTA-binding	OCTA-binding	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

Because	Because	IN	B-SBAR	O
NF-A1	NF-A1	NN	B-NP	B-protein
can	can	MD	B-VP	O
stimulate	stimulate	VB	I-VP	O
Ig	Ig	NN	B-NP	B-protein
transcription	transcription	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
inability	inability	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
factor	factor	NN	I-NP	O
to	to	TO	B-VP	O
activate	activate	VB	I-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
the	the	DT	B-NP	O
Ig	Ig	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
to	to	TO	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
degree	degree	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
snRNA	snRNA	NN	I-NP	B-DNA
promoters	promoter	NNS	I-NP	I-DNA
probably	probably	RB	B-ADVP	O
reflects	reflect	VBZ	B-VP	O
a	a	DT	B-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
OCTA	OCTA	NN	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
in	in	IN	B-PP	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
promoters	promoter	NNS	B-NP	B-DNA
.	.	.	O	O

Identification	Identification	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	B-protein
regulator	regulator	NN	I-NP	I-protein
of	of	IN	B-PP	O
early	early	JJ	B-NP	B-DNA
T	T	NN	I-NP	I-DNA
cell	cell	NN	I-NP	I-DNA
activation	activation	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

Molecules	Molecule	NNS	B-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
antigen	antigen	NN	I-NP	O
receptor-dependent	receptor-dependent	JJ	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
early	early	JJ	B-NP	B-DNA
T	T	NN	I-NP	I-DNA
cell	cell	NN	I-NP	I-DNA
activation	activation	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
functional	functional	JJ	B-NP	O
sequences	sequence	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-DNA
cell	cell	NN	I-NP	I-DNA
activation-specific	activation-specific	JJ	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
of	of	IN	B-PP	O
interleukin-2	interleukin-2	NN	B-NP	B-protein
(	(	(	O	O
IL-2	IL-2	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

One	One	CD	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
forms	form	VBZ	B-VP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
,	,	,	O	O
NFAT-1	NFAT-1	NN	B-NP	B-protein
,	,	,	O	O
specifically	specifically	RB	B-ADVP	O
with	with	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
of	of	IN	B-PP	O
activated	activate	VBN	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

This	This	DT	B-NP	O
complex	complex	NN	I-NP	O
appeared	appear	VBD	B-VP	O
10	10	CD	B-NP	O
to	to	TO	I-NP	O
25	25	CD	I-NP	O
minutes	minute	NNS	I-NP	O
before	before	IN	B-SBAR	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

Studies	Study	NNS	B-NP	O
with	with	IN	B-PP	O
inhibitors	inhibitor	NNS	B-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
synthesis	synthesis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
activator	activator	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
in	in	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
corresponds	correspond	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
appearance	appearance	NN	B-NP	O
of	of	IN	B-PP	O
NFAT-1	NFAT-1	NN	B-NP	B-protein
.	.	.	O	O

NFAT-1	NFAT-1	NN	B-NP	B-protein
,	,	,	O	O
or	or	CC	O	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
similar	similar	JJ	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
bound	bind	VBD	B-VP	O
functional	functional	JJ	B-NP	O
sequences	sequence	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
long	long	JJ	I-NP	B-DNA
terminal	terminal	JJ	I-NP	I-DNA
repeat	repeat	NN	I-NP	I-DNA
(	(	(	O	O
LTR	LTR	NN	B-NP	B-DNA
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
LTR	LTR	NN	I-NP	B-DNA
of	of	IN	B-PP	O
this	this	DT	B-NP	O
virus	virus	NN	I-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
stimulated	stimulate	VBN	I-VP	O
during	during	IN	B-PP	O
early	early	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
binding	bind	VBG	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
for	for	IN	B-PP	O
this	this	DT	B-NP	O
complex	complex	NN	I-NP	O
activated	activate	VBD	B-VP	O
a	a	DT	B-NP	O
linked	link	VBN	I-NP	O
promoter	promoter	NN	I-NP	O
after	after	IN	B-PP	O
transfection	transfection	NN	B-NP	O
into	into	IN	B-PP	O
antigen	antigen	NN	B-NP	B-cell_type
receptor-activated	receptor-activated	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
but	but	CC	B-CONJP	O
not	not	RB	I-CONJP	O
other	other	JJ	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
characteristics	characteristic	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
NFAT-1	NFAT-1	NN	B-NP	B-protein
transmits	transmit	VBZ	B-VP	O
signals	signal	NNS	B-NP	O
initiated	initiate	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-protein
cell	cell	NN	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

Characterization	Characterization	NN	B-NP	O
of	of	IN	B-PP	O
thyroid	thyroid	NN	B-NP	B-protein
hormone	hormone	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
IM-9	IM-9	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Although	Although	IN	B-SBAR	O
putatively	putatively	RB	B-ADVP	O
identified	identify	VBN	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
10	10	CD	I-NP	O
years	year	NNS	I-NP	O
ago	ago	IN	B-ADVP	O
,	,	,	O	O
thyroid	thyroid	NN	B-NP	B-protein
hormone	hormone	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
remain	remain	VBP	B-VP	O
poorly	poorly	RB	B-ADJP	O
characterized	characterize	VBN	I-ADJP	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
first	first	JJ	I-NP	O
step	step	NN	I-NP	O
towards	towards	IN	B-PP	O
understanding	understand	VBG	B-VP	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
thyroid	thyroid	NN	B-NP	O
hormone	hormone	NN	I-NP	O
action	action	NN	I-NP	O
in	in	IN	B-PP	O
man	man	NN	B-NP	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
characterized	characterize	VBN	I-VP	O
T3	T3	NN	B-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
nuclei	nucleus	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-cell_line
lymphoblastoid	lymphoblastoid	JJ	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
,	,	,	O	O
IM-9	IM-9	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

In	In	IN	B-PP	O
whole	whole	JJ	B-NP	O
cell	cell	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
at	at	IN	B-PP	O
37	37	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-NP	O
,	,	,	I-NP	O
nuclear	nuclear	JJ	I-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
[	[	(	O	O
125I	125I	NN	B-NP	O
]	]	)	I-NP	O
T3	T3	NN	I-NP	O
was	be	VBD	B-VP	O
saturable	saturable	JJ	B-ADJP	O
(	(	(	O	O
Kd	Kd	NN	B-NP	O
34	34	CD	I-NP	O
+/-	+/-	SYM	I-NP	O
6	6	CD	I-NP	O
pmol/l	pmol/l	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
of	of	IN	B-PP	O
finite	finite	JJ	B-NP	O
capacity	capacity	NN	I-NP	O
(	(	(	O	O
approximately	approximately	RB	B-ADJP	O
equal	equal	JJ	I-ADJP	O
to	to	TO	B-PP	O
350	350	CD	B-NP	O
sites/cell	sites/cell	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
binding	bind	VBG	I-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
extracted	extract	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
pellet	pellet	NN	I-NP	O
by	by	IN	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
0.4	0.4	CD	B-NP	O
mol/l	mol/l	NN	I-NP	O
KCl	KCl	NN	I-NP	O
and	and	CC	I-NP	O
sonication	sonication	NN	I-NP	O
.	.	.	O	O

Separation	Separation	NN	B-NP	O
of	of	IN	B-PP	O
bound	bind	VBN	B-VP	O
from	from	IN	B-PP	O
free	free	JJ	B-NP	O
[	[	(	I-NP	O
125I	125I	NN	I-NP	O
]	]	)	I-NP	O
T3	T3	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
extracts	extract	NNS	I-NP	O
was	be	VBD	B-VP	O
achieved	achieve	VBN	I-VP	O
using	use	VBG	I-VP	O
the	the	DT	B-NP	O
calcium	calcium	NN	I-NP	O
phosphate	phosphate	NN	I-NP	O
matrix	matrix	NN	I-NP	O
,	,	,	O	O
hydroxyapatite	hydroxyapatite	NN	B-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
0.3	0.3	CD	B-NP	O
ml	ml	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
150	150	CD	I-NP	O
g/l	g/l	NN	I-NP	O
slurry	slurry	NN	I-NP	O
.	.	.	O	O

Rectilinear	Rectilinear	NNP	B-NP	O
Scatchard	Scatchard	NNP	I-NP	O
plots	plot	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
only	only	RB	B-ADVP	O
when	when	WRB	I-ADVP	O
the	the	DT	B-NP	O
hydroxyapatite	hydroxyapatite	NN	I-NP	O
was	be	VBD	B-VP	O
washed	wash	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
buffer	buffer	NN	I-NP	O
containing	contain	VBG	B-VP	O
0.5	0.5	CD	B-NP	O
%	%	NN	I-NP	O
Triton	Triton	NN	I-NP	O
X-100	X-100	NN	I-NP	O
.	.	.	O	O

Under	Under	IN	B-PP	O
these	these	DT	B-NP	O
conditions	condition	NNS	I-NP	O
T3	T3	NN	I-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
extracts	extract	NNS	I-NP	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
22.4	22.4	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
8.6	8.6	CD	I-NP	O
fmol/mg	fmol/mg	NN	I-NP	O
protein	protein	NN	I-NP	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
affinity	affinity	NN	I-NP	O
of	of	IN	B-PP	O
(	(	(	O	O
Kd	Kd	NN	B-NP	O
,	,	,	O	O
room	room	NN	B-NP	O
temperature	temperature	NN	I-NP	O
)	)	)	O	O
140	140	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
10	10	CD	I-NP	O
pmol/l	pmol/l	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
same	same	JJ	I-NP	O
assay	assay	NN	I-NP	O
system	system	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
hierarchy	hierarchy	NN	I-NP	O
of	of	IN	B-PP	O
affinities	affinity	NNS	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
natural	natural	JJ	B-NP	O
and	and	CC	I-NP	O
synthetic	synthetic	JJ	I-NP	O
analogues	analogue	NNS	I-NP	O
.	.	.	O	O

Calling	Call	VBG	B-VP	O
T3	T3	NN	B-NP	O
100	100	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
order	order	NN	I-NP	O
of	of	IN	B-PP	O
potencies	potency	NNS	B-NP	O
observed	observe	VBN	B-VP	O
was	be	VBD	B-VP	O
:	:	:	O	O
Triac	Triac	NN	B-NP	O
,	,	,	O	O
500	500	CD	B-NP	O
;	;	:	O	O
3	3	CD	B-NP	O
,	,	,	I-NP	O
5-diiodo-3'-isopropylthyronine	5-diiodo-3'-isopropylthyronine	CD	I-NP	O
,	,	,	I-NP	O
89	89	CD	I-NP	O
;	;	:	O	O
T4	T4	NN	B-NP	O
,	,	,	O	O
32	32	CD	B-NP	O
;	;	:	O	O
3	3	CD	B-NP	O
,	,	,	O	O
5-dimethyl-3'isopropylthyronine	5-dimethyl-3'isopropylthyronine	CD	B-NP	O
2	2	CD	I-NP	O
;	;	:	O	O
3	3	CD	B-NP	O
,	,	,	O	O
5-T2	5-T2	NN	B-NP	O
,	,	,	O	O
0.7	0.7	CD	B-NP	O
,	,	,	O	O
rT3	rT3	NN	B-NP	O
,	,	,	O	O
0.4	0.4	CD	B-NP	O
;	;	:	O	O
3'5'-T2	3'5'-T2	NN	B-NP	O
,	,	,	O	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
0.01	0.01	CD	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
T3	T3	NN	I-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
IM-9	IM-9	NN	I-NP	O
lymphocyte	lymphocyte	NN	I-NP	O
nuclei	nucleus	NNS	I-NP	O
and	and	CC	I-NP	O
extracts	extract	NNS	I-NP	O
thereof	thereof	RB	B-ADVP	O
are	be	VBP	B-VP	O
thyroid	thyroid	JJ	B-NP	B-protein
hormone	hormone	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
.	.	.	O	O

These	These	DT	B-NP	O
cells	cell	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
useful	useful	JJ	I-NP	O
tool	tool	NN	I-NP	O
to	to	TO	B-VP	O
increase	increase	VB	I-VP	O
our	our	PRP$	B-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-protein
T3	T3	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein

Definition	Definition	NN	B-NP	O
of	of	IN	B-PP	O
T-cell	T-cell	NN	B-NP	O
specific	specific	JJ	I-NP	O
DNA-binding	DNA-binding	JJ	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
interact	interact	VBP	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
3'-silencer	3'-silencer	NN	I-NP	B-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CD4+	CD4+	JJ	I-NP	B-DNA
T-cell	T-cell	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
Rpt-1	Rpt-1	NN	I-NP	B-protein
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
3	3	CD	I-NP	O
'	'	SYM	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CD4+	CD4+	JJ	I-NP	B-DNA
T-cell	T-cell	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
Rpt-1	Rpt-1	NN	I-NP	B-protein
(	(	(	O	O
encoding	encode	VBG	B-VP	O
regulatory	regulatory	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
T-lymphocyte	T-lymphocyte	NN	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
definition	definition	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
silencer	silencer	NN	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
that	that	WDT	B-NP	O
inhibits	inhibit	VBZ	B-VP	O
heterologous	heterologous	JJ	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
certain	certain	JJ	B-NP	O
CD4+	CD4+	JJ	I-NP	B-cell_line
T-cell	T-cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
but	but	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
B-cell	B-cell	NN	B-NP	B-cell_line
or	or	CC	O	I-cell_line
non-lymphoid	non-lymphoid	JJ	B-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
.	.	.	O	O

Functional	Functional	JJ	B-NP	O
silencer	silencer	NN	I-NP	O
activity	activity	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
silencer-DNA-protein	silencer-DNA-protein	JJ	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
in	in	IN	B-PP	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
with	with	IN	B-PP	O
T-cell	T-cell	NN	B-NP	O
extracts	extract	NNS	I-NP	O
.	.	.	O	O

Formation	Formation	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
complex	complex	NN	I-NP	O
was	be	VBD	B-VP	O
selectively	selectively	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
in	in	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	O
containing	contain	VBG	B-VP	O
a	a	DT	B-NP	O
silencer	silencer	NN	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
discuss	discuss	VBP	B-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
that	that	IN	B-SBAR	O
DNA-binding	DNA-binding	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
may	may	MD	B-VP	O
coregulate	coregulate	VB	I-VP	O
HIV-1	HIV-1	NN	B-NP	O
and	and	CC	I-NP	O
Rpt-1	Rpt-1	NN	I-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
through	through	IN	B-PP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	B-DNA
silencer	silencer	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
.	.	.	O	O

Congenital	Congenital	JJ	B-NP	O
immunodeficiencies	immunodeficiency	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
absence	absence	NN	B-NP	O
of	of	IN	B-PP	O
HLA	HLA	NN	B-NP	B-protein
class	class	NN	I-NP	I-protein
II	II	CD	B-NP	I-protein
antigens	antigen	NNS	I-NP	I-protein
on	on	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
result	result	VBP	B-VP	O
from	from	IN	B-PP	O
distinct	distinct	JJ	B-NP	O
mutations	mutation	NNS	I-NP	O
in	in	IN	B-PP	O
trans-acting	trans-acting	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

Coordinate	Coordinate	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
HLA	HLA	NN	B-NP	B-DNA
class	class	NN	I-NP	I-DNA
II	II	CD	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
during	during	IN	B-PP	O
development	development	NN	B-NP	O
and	and	CC	I-NP	O
coinduction	coinduction	NN	I-NP	O
of	of	IN	B-PP	O
class	class	NN	B-NP	B-DNA
II	II	CD	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
by	by	IN	B-PP	O
soluble	soluble	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
common	common	JJ	B-NP	B-protein
trans-acting	trans-acting	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
control	control	NN	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
genes	gene	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
B-lymphoblastoid	B-lymphoblastoid	JJ	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
two	two	CD	B-NP	O
independent	independent	JJ	I-NP	O
class	class	NN	I-NP	O
II-deficient	II-deficient	JJ	I-NP	O
bare	bare	JJ	I-NP	O
lymphocyte	lymphocyte	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
observed	observe	VBD	B-VP	O
a	a	DT	B-NP	O
drastic	drastic	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
transcription	transcription	NN	B-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
class	class	NN	I-NP	B-DNA
II	II	CD	B-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

When	When	WRB	B-ADVP	O
these	these	DT	B-NP	O
cell	cell	NN	I-NP	B-cell_line
lines	line	NNS	I-NP	I-cell_line
are	be	VBP	B-VP	O
fused	fuse	VBN	I-VP	O
,	,	,	O	O
class	class	NN	B-NP	B-DNA
II	II	CD	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
are	be	VBP	B-VP	O
reexpressed	reexpresse	VBN	I-VP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
immunodeficiencies	immunodeficiency	NNS	B-NP	O
in	in	IN	B-PP	O
bare	bare	JJ	B-NP	O
lymphocyte	lymphocyte	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
patients	patient	NNS	I-NP	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
distinct	distinct	JJ	I-NP	O
mutations	mutation	NNS	I-NP	O
.	.	.	O	O

Further	Further	JJ	B-NP	O
studies	study	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
genes	gene	NNS	B-NP	O
governing	govern	VBG	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
class	class	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
antigens	antigen	NNS	I-NP	I-protein
fall	fall	VBP	B-VP	O
into	into	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
three	three	CD	I-NP	O
complementation	complementation	NN	I-NP	O
groups	group	NNS	I-NP	O
;	;	:	O	O
two	two	CD	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
were	be	VBD	B-VP	O
previously	previously	RB	B-ADJP	O
unidentified	unidentified	JJ	I-ADJP	O
in	in	IN	B-PP	O
mutant	mutant	JJ	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
generated	generate	VBN	B-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
identification	identification	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
discrete	discrete	JJ	I-NP	O
complexes	complex	NNS	I-NP	O
,	,	,	O	O
NFX1.1	NFX1.1	NN	B-NP	B-protein
and	and	CC	I-NP	O
NFX1.2	NFX1.2	NN	I-NP	B-protein
,	,	,	O	O
that	that	WDT	B-NP	O
bind	bind	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
DRA	DRA	NN	I-NP	B-DNA
X	X	NN	I-NP	I-DNA
consensus	consensus	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
.	.	.	O	O

Though	Though	IN	B-SBAR	O
the	the	DT	B-NP	O
mutation	mutation	NN	I-NP	O
in	in	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
one	one	CD	I-NP	O
mutant	mutant	JJ	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
generated	generate	VBN	B-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
(	(	(	O	O
RJ2.2.5	RJ2.2.5	NN	B-NP	B-cell_line
)	)	)	O	O
affects	affect	VBZ	B-VP	O
products	product	NNS	B-NP	O
functioning	function	VBG	B-VP	O
via	via	IN	B-PP	O
interaction	interaction	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
X	X	NN	I-NP	B-DNA
box	box	NN	I-NP	I-DNA
,	,	,	O	O
clear	clear	JJ	B-NP	O
alterations	alteration	NNS	I-NP	O
in	in	IN	B-PP	O
either	either	CC	O	O
NFX1.1	NFX1.1	NN	B-NP	B-protein
or	or	CC	I-NP	O
NFX1.2	NFX1.2	NN	I-NP	B-protein
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mutant	mutant	JJ	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
.	.	.	O	O

In	In	FW	B-NP	O
vivo	vivo	FW	I-NP	O
responsiveness	responsiveness	NN	I-NP	O
to	to	TO	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
content	content	NN	I-NP	O
in	in	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
humans	human	NNS	I-NP	O
.	.	.	O	O

Dexamethasone	Dexamethasone	NN	B-NP	O
loading	loading	NN	I-NP	O
tests	test	NNS	I-NP	O
(	(	(	O	O
0.1	0.1	CD	B-NP	O
mg	mg	NN	I-NP	O
dexamethasone/kg	dexamethasone/kg	NN	I-NP	O
,	,	,	O	O
iv	iv	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
in	in	IN	B-PP	O
18	18	CD	B-NP	O
normal	normal	JJ	I-NP	O
males	male	NNS	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
individual	individual	JJ	I-NP	O
responsiveness	responsiveness	NN	I-NP	O
to	to	TO	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
inter-individual	inter-individual	JJ	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
increase	increase	NN	B-NP	O
in	in	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
polymorphonuclear	polymorphonuclear	JJ	I-NP	I-cell_type
leukocyte	leukocyte	NN	I-NP	I-cell_type
count	count	NN	I-NP	O
,	,	,	O	O
decrease	decrease	NN	B-NP	O
in	in	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
lymphocyte	lymphocyte	NN	I-NP	I-cell_type
count	count	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
increase	increase	NN	B-NP	O
in	in	IN	B-PP	O
plasma	plasma	NN	B-NP	O
free	free	JJ	I-NP	O
fatty	fatty	JJ	I-NP	O
acids	acid	NNS	I-NP	O
levels	level	NNS	I-NP	O
after	after	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
injection	injection	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
maximum	maximum	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
polymorphonuclear	polymorphonuclear	JJ	B-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
the	the	DT	B-NP	O
maximum	maximum	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
0.7514	0.7514	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.0003	0.0003	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Simultaneous	Simultaneous	JJ	B-NP	O
measurements	measurement	NNS	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
content	content	NN	I-NP	O
by	by	IN	B-PP	O
whole-cell	whole-cell	JJ	B-NP	O
assay	assay	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
content	content	NN	I-NP	O
in	in	IN	B-PP	O
polymorphonuclear	polymorphonuclear	JJ	B-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
linearly	linearly	RB	B-ADVP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
corresponding	corresponding	JJ	I-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
0.9482	0.9482	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.0001	0.0001	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
significant	significant	JJ	B-NP	O
correlations	correlation	NNS	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
maximum	maximum	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
polymorphonuclear	polymorphonuclear	JJ	B-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
content	content	NN	I-NP	O
in	in	IN	B-PP	O
polymorphonuclear	polymorphonuclear	JJ	B-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
0.7239	0.7239	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.0007	0.0007	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
maximum	maximum	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
content	content	NN	I-NP	O
in	in	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
0.7703	0.7703	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.0002	0.0002	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
individual	individual	JJ	B-NP	O
differences	difference	NNS	I-NP	O
are	be	VBP	B-VP	O
preserved	preserve	VBN	I-VP	O
both	both	CC	B-PP	O
in	in	IN	I-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
responsiveness	responsiveness	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
content	content	NN	I-NP	O
in	in	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
humans	human	NNS	I-NP	O
.	.	.	O	O

Estradiol	Estradiol	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cytosol	cytosol	NN	I-NP	O
of	of	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
hepatitis	hepatitis	NN	B-NP	O
B	B	NN	I-NP	O
virus	virus	NN	I-NP	O
carriers	carrier	NNS	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
interferon-alpha	interferon-alpha	NN	B-NP	B-protein
.	.	.	O	O

Estradiol	Estradiol	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cytosol	cytosol	NN	I-NP	O
of	of	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
interferon-alpha	interferon-alpha	NN	B-NP	B-protein
(	(	(	O	O
IFN-alpha	IFN-alpha	NN	B-NP	B-protein
)	)	)	O	O
on	on	IN	B-PP	O
estradiol	estradiol	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
asymptomatic	asymptomatic	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
B	B	NN	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
HBV	HBV	NN	B-NP	O
)	)	)	O	O
carriers	carrier	NNS	B-NP	O
,	,	,	O	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
B	B	NN	I-NP	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
estradiol	estradiol	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cytosol	cytosol	NN	I-NP	O
of	of	IN	B-PP	O
mononuclear	mononuclear	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
in	in	IN	B-PP	O
asymptomatic	asymptomatic	JJ	B-NP	O
HBV	HBV	NN	I-NP	O
carriers	carrier	NNS	I-NP	O
and	and	CC	O	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
B	B	NN	I-NP	O
,	,	,	O	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
low	low	JJ	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
cytosol	cytosol	NN	B-NP	B-protein
estradiol	estradiol	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
B	B	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
IFN-alpha	IFN-alpha	NN	B-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
B	B	NN	I-NP	O
were	be	VBD	B-VP	O
incubated	incubate	VBN	I-VP	O
with	with	IN	B-PP	O
IFN-alpha	IFN-alpha	NN	B-NP	B-protein
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
cytosol	cytosol	NN	B-NP	B-protein
estradiol	estradiol	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
also	also	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
by	by	IN	B-PP	O
increasing	increase	VBG	B-VP	O
the	the	DT	B-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
IFN-alpha	IFN-alpha	NN	B-NP	B-protein
.	.	.	O	O

We	We	PRP	B-NP	O
previously	previously	RB	B-ADVP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
response	response	NN	I-NP	O
of	of	IN	B-PP	O
mononuclear	mononuclear	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
estrogen	estrogen	NN	B-NP	O
is	be	VBZ	B-VP	O
impaired	impaired	JJ	B-ADJP	O
in	in	IN	B-PP	O
HBV	HBV	NN	B-NP	O
carriers	carrier	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
our	our	PRP$	B-NP	O
present	present	JJ	I-NP	O
results	result	NNS	I-NP	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
estradiol	estradiol	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cytosol	cytosol	NN	I-NP	O
of	of	IN	B-PP	O
mononuclear	mononuclear	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Association	Association	NN	B-NP	O
of	of	IN	B-PP	O
increased	increase	VBN	B-NP	O
lytic	lytic	JJ	I-NP	O
effector	effector	NN	I-NP	O
cell	cell	NN	I-NP	O
function	function	NN	I-NP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
estrogen	estrogen	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
tumor-bearing	tumor-bearing	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

Tumor-bearing	Tumor-bearing	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
were	be	VBD	B-VP	O
assayed	assay	VBN	I-VP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
natural	natural	JJ	I-NP	B-cell_type
killer	killer	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
NK	NK	NN	B-NP	I-cell_type
)	)	)	O	I-cell_type
cell	cell	NN	B-NP	I-cell_type
activity	activity	NN	I-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
activated	activate	VBN	B-NP	B-cell_type
cytotoxic	cytotoxic	JJ	I-NP	I-cell_type
T-cells	T-cell	NNS	I-NP	I-cell_type
,	,	,	O	O
as	as	IN	B-SBAR	O
assessed	assess	VBN	B-VP	O
by	by	IN	B-PP	O
lectin-dependent	lectin-dependent	JJ	B-NP	O
cellular	cellular	JJ	I-NP	O
cytotoxicity	cytotoxicity	NN	I-NP	O
(	(	(	O	O
LDCC	LDCC	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Tumor-bearing	Tumor-bearing	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
NK	NK	NN	B-NP	O
activity	activity	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
LDCC	LDCC	NN	B-NP	B-cell_line
,	,	,	O	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
control	control	NN	I-NP	O
individuals	individual	NNS	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
enhanced	enhance	VBN	I-NP	O
NK	NK	NN	I-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
activity	activity	NN	I-NP	O
and	and	CC	I-NP	O
LDCC	LDCC	NN	I-NP	B-protein
were	be	VBD	B-VP	O
closely	closely	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
(	(	(	O	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
31	31	CD	I-NP	O
fmol/mg	fmol/mg	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
estrogen	estrogen	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
ER	ER	NN	B-NP	B-protein
)	)	)	O	O
content	content	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
clinical	clinical	JJ	I-NP	O
or	or	CC	I-NP	O
histologic	histologic	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
either	either	CC	O	O
parameter	parameter	NN	B-NP	O
of	of	IN	B-PP	O
cytotoxic	cytotoxic	JJ	B-NP	B-cell_type
effector	effector	NN	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
function	function	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
found	find	VBN	I-VP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
ER	ER	NN	B-NP	B-protein
levels	level	NNS	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
31	31	CD	B-NP	O
fmol/mg	fmol/mg	NN	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
cytotoxic	cytotoxic	JJ	I-NP	B-cell_type
effector	effector	NN	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
function	function	NN	I-NP	O
in	in	IN	B-PP	O
tumor-bearing	tumor-bearing	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

Properties	Property	NNS	B-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
Epstein-Barr	Epstein-Barr	JJ	B-NP	B-cell_type
virus-transformed	virus-transformed	JJ	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
familial	familial	JJ	B-NP	O
cortisol	cortisol	NN	I-NP	O
resistance	resistance	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
a	a	DT	B-NP	O
previous	previous	JJ	I-NP	O
report	report	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
familial	familial	JJ	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
resistance	resistance	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
reduced	reduce	VBN	B-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
(	(	(	O	O
GR	GR	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
decreased	decrease	VBN	B-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
in	in	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
cultured	culture	VBN	B-NP	B-cell_type
fibroblasts	fibroblast	NNS	I-NP	I-cell_type
but	but	CC	O	O
normal	normal	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
of	of	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
in	in	IN	B-PP	O
both	both	DT	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
these	these	DT	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
son	son	NN	I-NP	O
and	and	CC	I-NP	O
daughter	daughter	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
were	be	VBD	B-VP	O
transformed	transform	VBN	I-VP	O
with	with	IN	B-PP	O
Epstein-Barr	Epstein-Barr	JJ	B-NP	O
virus	virus	NN	I-NP	O
.	.	.	O	O

Reduced	Reduce	VBN	B-NP	O
numbers	number	NNS	I-NP	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
of	of	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Epstein-Barr	Epstein-Barr	JJ	I-NP	B-cell_type
virus-transformed	virus-transformed	JJ	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
both	both	DT	B-NP	O
patients	patient	NNS	I-NP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
son	son	NN	I-NP	O
and	and	CC	I-NP	O
daughter	daughter	NN	I-NP	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
numbers	number	NNS	B-NP	O
and	and	CC	O	O
affinity	affinity	NN	B-NP	O
of	of	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
thermal	thermal	JJ	I-NP	O
stability	stability	NN	I-NP	O
of	of	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
and	and	CC	O	O
thermal	thermal	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
cytosolic	cytosolic	JJ	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
both	both	DT	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
percentages	percentage	NNS	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
bound	bind	VBN	I-NP	O
GR	GR	NN	I-NP	B-protein
were	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
in	in	IN	B-PP	O
both	both	CC	O	O
patients	patient	NNS	B-NP	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
controls	control	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
absolute	absolute	JJ	I-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
bound	bind	VBN	I-NP	O
GR	GR	NN	I-NP	B-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
about	about	RB	B-NP	O
one-half	one-half	JJ	I-NP	O
that	that	DT	I-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
abnormal	abnormal	JJ	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
(	(	(	O	O
reduced	reduce	VBN	B-VP	O
numbers	number	NNS	B-NP	O
of	of	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
)	)	)	O	O
were	be	VBD	B-VP	O
preserved	preserve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
transformed	transform	VBN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
from	from	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Octamer	Octamer	NN	B-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
1	1	CD	B-NP	I-protein
and	and	CC	I-NP	I-protein
2	2	CD	I-NP	I-protein
each	each	DT	B-NP	O
bind	bind	VBP	B-VP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
different	different	JJ	I-NP	O
functional	functional	JJ	I-NP	O
elements	element	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	B-DNA
heavy-chain	heavy-chain	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

Immunoglobulin	Immunoglobulin	NN	B-NP	B-DNA
heavy-chain	heavy-chain	JJ	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
contain	contain	VBP	B-VP	O
two	two	CD	B-NP	O
conserved	conserve	VBN	I-NP	O
sequence	sequence	NN	I-NP	O
elements	element	NNS	I-NP	O
5	5	CD	B-NP	O
'	'	SYM	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
initiation	initiation	NN	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
octamer	octamer	NN	I-NP	O
ATGCAAAT	ATGCAAAT	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
heptamer	heptamer	NN	I-NP	B-DNA
CTCATGA	CTCATGA	NN	I-NP	I-DNA
.	.	.	O	O

Both	Both	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
elements	element	NNS	I-NP	B-DNA
are	be	VBP	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
normal	normal	JJ	B-NP	O
cell-specific	cell-specific	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
demonstrates	demonstrate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
both	both	CC	O	O
the	the	DT	B-NP	O
ubiquitous	ubiquitous	JJ	I-NP	O
and	and	CC	I-NP	O
lymphoid-cell-specific	lymphoid-cell-specific	JJ	I-NP	B-protein
octamer	octamer	NN	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
(	(	(	O	O
OTF-1	OTF-1	NN	B-NP	B-protein
and	and	CC	O	O
OTF-2	OTF-2	NN	B-NP	B-protein
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
)	)	)	O	O
interact	interact	VBP	B-VP	O
specifically	specifically	RB	B-ADVP	O
with	with	IN	B-PP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
conserved	conserve	VBN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
,	,	,	O	O
forming	form	VBG	B-VP	O
either	either	CC	O	O
homo-	homo-	JJ	B-NP	O
or	or	CC	I-NP	O
heterodimeric	heterodimeric	JJ	I-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
surprising	surprising	JJ	B-ADJP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
the	the	DT	B-NP	O
heptamer	heptamer	NN	I-NP	O
and	and	CC	I-NP	O
octamer	octamer	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
motifs	motif	NNS	I-NP	I-DNA
bear	bear	VBP	B-VP	O
no	no	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
similarity	similarity	NN	I-NP	O
to	to	TO	B-PP	O
each	each	DT	B-NP	O
other	other	JJ	I-NP	O
.	.	.	O	O

Binding	Binding	NN	B-NP	O
of	of	IN	B-PP	O
either	either	DT	B-NP	O
factor	factor	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
octamer	octamer	NN	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
occurred	occur	VBD	B-VP	O
independently	independently	RB	B-ADVP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
OTF	OTF	NN	B-NP	B-protein
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
heptamer	heptamer	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
require	require	VB	I-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
intact	intact	JJ	I-NP	O
octamer	octamer	NN	I-NP	B-DNA
motif	motif	NN	I-NP	I-DNA
and	and	CC	O	O
occurred	occur	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
spacing	spacing	NN	I-NP	O
of	of	IN	B-PP	O
either	either	CC	B-NP	O
2	2	CD	I-NP	O
or	or	CC	I-NP	O
14	14	CD	I-NP	O
base	base	NN	I-NP	O
pairs	pair	NNS	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
elements	element	NNS	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
coordinate	coordinate	JJ	B-NP	O
binding	binding	NN	I-NP	O
resulting	result	VBG	B-VP	O
from	from	IN	B-PP	O
protein-protein	protein-protein	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
degeneracy	degeneracy	NN	I-NP	O
in	in	IN	B-PP	O
sequences	sequence	NNS	B-NP	O
recognized	recognize	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
OTFs	OTF	NNS	I-NP	B-protein
may	may	MD	B-VP	O
be	be	VB	I-VP	O
important	important	JJ	B-ADJP	O
in	in	IN	B-PP	O
widening	widen	VBG	B-VP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
over	over	IN	B-PP	O
which	which	WDT	B-NP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
modulated	modulate	VBN	I-VP	O
and	and	CC	O	O
in	in	IN	B-PP	O
establishing	establish	VBG	B-VP	O
cell	cell	NN	B-NP	O
type	type	NN	I-NP	O
specificity	specificity	NN	I-NP	O
.	.	.	O	O

Identification	Identification	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
lymphoid	lymphoid	JJ	I-NP	O
specific	specific	JJ	I-NP	O
octamer	octamer	NN	I-NP	B-protein
binding	binding	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	O
OTF-2B	OTF-2B	NN	B-NP	B-protein
)	)	)	O	O
by	by	IN	B-PP	O
proteolytic	proteolytic	JJ	B-NP	O
clipping	clipping	NN	I-NP	O
bandshift	bandshift	NN	I-NP	O
assay	assay	NN	I-NP	O
(	(	(	O	O
PCBA	PCBA	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
octamer	octamer	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
ATGCAAAT	ATGCAAAT	NN	I-NP	O
is	be	VBZ	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
promoters	promoter	NNS	I-NP	B-DNA
of	of	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-DNA
(	(	(	I-NP	I-DNA
Ig	Ig	NN	I-NP	I-DNA
)	)	)	I-NP	I-DNA
heavy	heavy	JJ	I-NP	I-DNA
and	and	CC	I-NP	I-DNA
light	light	JJ	I-NP	I-DNA
chain	chain	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
heavy	heavy	JJ	I-NP	B-DNA
chain	chain	NN	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
and	and	CC	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
determinant	determinant	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
type	type	NN	I-NP	O
specific	specific	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
Ig	Ig	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

An	An	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
paradox	paradox	NN	I-NP	O
is	be	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
serves	serve	VBZ	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
upstream	upstream	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
or	or	CC	I-NP	O
enhancer	enhancer	NN	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
in	in	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
housekeeping	housekeeping	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
the	the	DT	B-NP	O
histone	histone	NN	I-NP	B-DNA
H2B	H2B	NN	I-NP	I-DNA
and	and	CC	O	I-DNA
U	U	NN	B-NP	I-DNA
snRNA	snRNA	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
differential	differential	JJ	I-NP	O
usage	usage	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
motif	motif	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
different	different	JJ	B-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
octamer	octamer	NN	B-NP	B-protein
binding	binding	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
.	.	.	O	O

One	One	CD	B-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
kd	kd	NN	I-NP	O
,	,	,	O	O
designated	designate	VBN	B-VP	O
OTF-1	OTF-1	NN	B-NP	B-protein
,	,	,	O	O
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
and	and	CC	O	O
may	may	MD	B-VP	O
exert	exert	VB	I-VP	O
its	its	PRP$	B-NP	O
activating	activate	VBG	I-NP	O
function	function	NN	I-NP	O
only	only	RB	O	O
when	when	WRB	B-ADVP	O
it	it	PRP	B-NP	O
can	can	MD	B-VP	O
interact	interact	VB	I-VP	O
with	with	IN	B-PP	O
additional	additional	JJ	B-NP	O
adjacent	adjacent	JJ	I-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
lymphoid	lymphoid	JJ	I-NP	O
cell	cell	NN	I-NP	O
specific	specific	JJ	I-NP	O
octamer	octamer	NN	I-NP	B-protein
binding	binding	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
of	of	IN	B-PP	O
60	60	CD	B-NP	B-protein
kd	kd	NN	I-NP	I-protein
(	(	(	O	O
OTF-2A	OTF-2A	NN	B-NP	B-protein
)	)	)	O	O
specifically	specifically	RB	B-ADVP	O
stimulates	stimulate	VBZ	B-VP	O
Ig	Ig	NN	B-NP	B-DNA
promoters	promoter	NNS	I-NP	I-DNA
which	which	WDT	B-NP	O
consist	consist	VBP	B-VP	O
essentially	essentially	RB	B-ADVP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
TATA-box	TATA-box	NN	I-NP	B-DNA
and	and	CC	O	O
an	an	DT	B-NP	O
octamer	octamer	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
it	it	PRP	B-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
present	present	VBP	B-VP	O
evidence	evidence	NN	B-NP	O
for	for	IN	B-PP	O
yet	yet	RB	B-NP	O
another	another	DT	I-NP	O
B	B	NN	I-NP	O
cell	cell	NN	I-NP	O
specific	specific	JJ	I-NP	O
octamer	octamer	NN	I-NP	B-protein
binding	binding	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
of	of	IN	B-PP	O
75	75	CD	B-NP	B-protein
kd	kd	NN	I-NP	I-protein
(	(	(	O	O
OTF-2B	OTF-2B	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

From	From	IN	B-PP	O
several	several	JJ	B-NP	O
findings	finding	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
OTF-2B	OTF-2B	NN	B-NP	B-protein
(	(	(	O	O
but	but	CC	O	O
not	not	RB	O	O
OTF-2A	OTF-2A	NN	B-NP	B-protein
)	)	)	O	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
lymphocyte	lymphocyte	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
respond	respond	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
IgH	IgH	NN	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
,	,	,	O	O
we	we	PRP	B-NP	O
propose	propose	VBP	B-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
novel	novel	JJ	I-NP	O
octamer	octamer	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
long	long	JJ	I-NP	O
range	range	NN	I-NP	O
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
IgH	IgH	NN	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
used	use	VBN	I-VP	O
the	the	DT	B-NP	O
proteolytic	proteolytic	JJ	I-NP	O
clipping	clipping	NN	I-NP	O
bandshift	bandshift	NN	I-NP	O
assay	assay	NN	I-NP	O
(	(	(	O	O
PCBA	PCBA	NN	B-NP	O
)	)	)	O	O
technique	technique	NN	B-NP	O
to	to	TO	B-VP	O
distinguish	distinguish	VB	I-VP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
different	different	JJ	I-NP	O
forms	form	NNS	I-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

This	This	DT	B-NP	O
analysis	analysis	NN	I-NP	O
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
75	75	CD	I-NP	O
kd-species	kd-specy	NNS	I-NP	O
OTF-2B	OTF-2B	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
closely	closely	RB	B-ADJP	O
related	related	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
60	60	CD	I-NP	O
kd	kd	NN	I-NP	O
species	specie	NNS	I-NP	O
OTF-2A	OTF-2A	NN	I-NP	B-protein
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
interleukin	interleukin	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
-induced	-induced	JJ	I-NP	O
proliferation	proliferation	NN	I-NP	O
of	of	IN	B-PP	O
cloned	clone	VBN	B-NP	B-cell_type
murine	murine	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
.	.	.	O	O

Possible	Possible	JJ	B-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
to	to	TO	B-VP	O
inhibit	inhibit	VB	I-VP	O
interleukin	interleukin	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
(	(	(	O	O
IL	IL	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
)	)	)	I-NP	O
-induced	-induced	JJ	I-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
proliferation	proliferation	NN	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
cytotoxic	cytotoxic	JJ	I-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
(	(	(	O	O
CTL	CTL	NN	B-NP	B-cell_type
)	)	)	O	O
clones	clone	NNS	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
studied	study	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
complete	complete	JJ	I-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
by	by	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
(	(	(	O	O
Dx	Dx	NN	B-NP	O
)	)	)	O	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
observed	observe	VBN	I-VP	O
when	when	WRB	B-ADVP	O
IL	IL	NN	B-NP	B-cell_line
2-depleted	2-depleted	JJ	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
of	of	IN	B-PP	O
CTL	CTL	NN	B-NP	B-cell_type
were	be	VBD	B-VP	O
either	either	RB	I-VP	O
incubated	incubate	VBN	I-VP	O
for	for	IN	B-PP	O
6	6	CD	B-NP	O
h	h	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
hormone	hormone	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
IL	IL	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
or	or	CC	O	O
treated	treat	VBN	B-VP	O
simultaneously	simultaneously	RB	B-ADVP	O
with	with	IN	B-PP	O
Dx	Dx	NN	B-NP	B-protein
and	and	CC	O	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
IL	IL	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
and	and	CC	O	O
affinity	affinity	NN	B-NP	O
of	of	IN	B-PP	O
IL	IL	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
after	after	IN	B-PP	O
6	6	CD	B-NP	O
h	h	NN	I-NP	O
incubation	incubation	NN	I-NP	O
with	with	IN	B-PP	O
Dx	Dx	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
order	order	NN	I-NP	O
of	of	IN	B-PP	O
potency	potency	NN	B-NP	O
observed	observe	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
steroids	steroid	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
was	be	VBD	B-VP	O
mediated	mediate	VBN	I-VP	O
through	through	IN	B-PP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
hormones	hormone	NNS	I-NP	O
possibly	possibly	RB	B-ADVP	O
involves	involve	VBZ	B-VP	O
the	the	DT	B-NP	O
synthesis	synthesis	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
since	since	IN	B-SBAR	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
cycloheximide	cycloheximide	NN	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
incubation	incubation	NN	I-NP	O
with	with	IN	B-PP	O
Dx	Dx	NN	B-NP	O
prevented	prevent	VBD	B-VP	O
the	the	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
supernatant	supernatant	JJ	B-ADJP	O
from	from	IN	B-PP	O
Dx-treated	Dx-treated	JJ	B-NP	B-cell_type
CTL	CTL	NN	I-NP	I-cell_type
contained	contain	VBD	B-VP	O
a	a	DT	B-NP	O
nondialyzable	nondialyzable	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
which	which	WDT	B-NP	O
inhibited	inhibit	VBD	B-VP	O
DNA	DNA	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
and	and	CC	O	O
cell	cell	NN	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
CTL	CTL	NN	B-NP	B-cell_line
clones	clone	NNS	I-NP	I-cell_line
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
IL	IL	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Blocking	Blocking	NN	B-NP	O
of	of	IN	B-PP	O
IL	IL	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
synthesis	synthesis	NN	I-NP	O
and	and	CC	O	O
IL	IL	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
formation	formation	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
proposed	propose	VBN	I-VP	O
as	as	IN	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
of	of	IN	B-PP	O
glucocorticoid-induced	glucocorticoid-induced	JJ	B-NP	O
immunosuppression	immunosuppression	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
hormones	hormone	NNS	I-NP	O
may	may	MD	B-VP	O
also	also	RB	I-VP	O
affect	affect	VB	I-VP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
proliferation	proliferation	NN	I-NP	O
by	by	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
IL	IL	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
activity	activity	NN	I-NP	O
.	.	.	O	O

Identification	Identification	NN	B-NP	O
and	and	CC	I-NP	O
purification	purification	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	B-protein
immunoglobulin-enhancer-binding	immunoglobulin-enhancer-binding	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
)	)	)	O	O
that	that	WDT	B-NP	O
activates	activate	VBZ	B-VP	O
transcription	transcription	NN	B-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
immunodeficiency	immunodeficiency	NN	I-NP	I-DNA
virus	virus	NN	I-NP	I-DNA
type	type	NN	I-NP	I-DNA
1	1	CD	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
enhancer-binding	enhancer-binding	JJ	I-NP	O
factor	factor	NN	I-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
found	find	VBN	I-VP	O
only	only	RB	B-ADVP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
that	that	WDT	B-NP	O
transcribe	transcribe	VBP	B-VP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-DNA
light	light	JJ	I-NP	I-DNA
chain	chain	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
,	,	,	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
purified	purify	VBN	I-VP	O
from	from	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
of	of	IN	B-PP	O
Namalwa	Namalwa	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
human	human	JJ	B-NP	B-cell_line
Burkitt	Burkitt	NN	I-NP	I-cell_line
lymphoma	lymphoma	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
)	)	)	O	O
by	by	IN	B-PP	O
sequence-specific	sequence-specific	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
affinity	affinity	NN	I-NP	O
chromatography	chromatography	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
purified	purify	VBN	I-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
51-kDa	51-kDa	JJ	I-NP	B-protein
polypeptide	polypeptide	NN	I-NP	I-protein
by	by	IN	B-PP	O
UV-crosslinking	UV-crosslinking	NN	B-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O

``	``	``	O	O
Footprint	Footprint	NNP	B-NP	O
''	''	''	O	O
and	and	CC	O	O
methylation-interference	methylation-interference	NN	B-NP	O
analyses	analysis	NNS	I-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
purified	purify	VBN	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
specific	specific	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
kappa	kappa	NN	I-NP	B-DNA
light	light	JJ	I-NP	I-DNA
chain	chain	NN	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
purified	purify	VBN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
activated	activate	VBN	B-VP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
immunodeficiency	immunodeficiency	NN	I-NP	I-DNA
virus	virus	NN	I-NP	I-DNA
type	type	NN	I-NP	I-DNA
I	I	CD	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
by	by	IN	B-PP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
upstream	upstream	JJ	I-NP	B-DNA
NF-kappa	NF-kappa	NN	I-NP	I-DNA
B-binding	B-binding	JJ	I-NP	I-DNA
site	site	NN	I-NP	I-DNA

Lymphocyte	Lymphocyte	NN	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
binding	binding	NN	I-NP	O
in	in	IN	B-PP	O
depression	depression	NN	B-NP	O
:	:	:	O	O
normal	normal	JJ	B-NP	O
values	value	NNS	I-NP	O
following	follow	VBG	B-PP	O
recovery	recovery	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
sites	site	NNS	I-NP	O
in	in	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
plasma	plasma	NN	B-NP	O
cortisol	cortisol	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
in	in	IN	B-PP	O
20	20	CD	B-NP	O
patients	patient	NNS	I-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
recovered	recover	VBN	I-VP	O
from	from	IN	B-PP	O
major	major	JJ	B-NP	O
depressive	depressive	JJ	I-NP	O
disorder	disorder	NN	I-NP	O
and	and	CC	O	O
20	20	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
control	control	NN	I-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
sites	site	NNS	I-NP	O
in	in	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
the	the	DT	B-NP	O
recovered	recover	VBN	I-NP	O
depressed	depressed	JJ	I-NP	O
group	group	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
significantly	significantly	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
from	from	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
mean	mean	JJ	I-NP	O
plasma	plasma	NN	I-NP	O
cortisol	cortisol	NN	I-NP	O
concentration	concentration	NN	I-NP	O
in	in	IN	B-PP	O
recovered	recover	VBN	B-NP	O
depressives	depressive	NNS	I-NP	O
was	be	VBD	B-VP	O
higher	high	JJR	B-ADJP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
control	control	NN	B-NP	O
subjects	subject	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
difference	difference	NN	I-NP	O
only	only	RB	B-VP	O
just	just	RB	I-VP	O
reached	reach	VBD	I-VP	O
significance	significance	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
shows	show	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
numbers	number	NNS	I-NP	O
which	which	WDT	B-NP	O
occurs	occur	VBZ	B-VP	O
during	during	IN	B-PP	O
acute	acute	JJ	B-NP	O
depressive	depressive	JJ	I-NP	O
illness	illness	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
persist	persist	VB	I-VP	O
on	on	IN	B-PP	O
recovery	recovery	NN	B-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
state-dependent	state-dependent	JJ	B-ADJP	O
.	.	.	O	O

Identification	Identification	NN	B-NP	O
and	and	CC	I-NP	O
purification	purification	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	B-protein
lymphoid-specific	lymphoid-specific	JJ	I-NP	I-protein
octamer-binding	octamer-binding	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	O
OTF-2	OTF-2	NN	B-NP	B-protein
)	)	)	O	O
that	that	WDT	B-NP	O
activates	activate	VBZ	B-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
octamer	octamer	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
5'-ATGCAAAT	5'-ATGCAAAT	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
either	either	CC	O	O
orientation	orientation	NN	B-NP	O
,	,	,	O	O
serves	serve	VBZ	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
upstream	upstream	JJ	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
in	in	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
promoters	promoter	NNS	B-NP	B-DNA
and	and	CC	O	O
also	also	RB	B-VP	O
occurs	occur	VBZ	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
modular	modular	JJ	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
of	of	IN	B-PP	O
particular	particular	JJ	B-NP	O
interest	interest	NN	I-NP	O
in	in	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
since	since	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upstream	upstream	JJ	I-NP	B-DNA
regions	region	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
all	all	DT	B-NP	O
heavy	heavy	JJ	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
light	light	JJ	I-NP	I-DNA
chain	chain	NN	I-NP	I-DNA
promoters	promoter	NNS	I-NP	I-DNA
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
heavy	heavy	JJ	I-NP	B-DNA
chain	chain	NN	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
,	,	,	O	O
both	both	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
cell-specific	cell-specific	JJ	B-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
here	here	RB	B-ADVP	O
the	the	DT	B-NP	O
chromatographic	chromatographic	JJ	I-NP	O
separation	separation	NN	I-NP	O
of	of	IN	B-PP	O
ubiquitous	ubiquitous	JJ	B-NP	O
and	and	CC	I-NP	O
B	B	NN	I-NP	B-protein
cell-specific	cell-specific	JJ	I-NP	I-protein
octamer-binding	octamer-binding	JJ	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
B	B	NN	I-NP	B-protein
cell	cell	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
was	be	VBD	B-VP	O
purified	purify	VBN	I-VP	O
to	to	TO	B-PP	O
homogeneity	homogeneity	NN	B-NP	O
using	use	VBG	B-VP	O
affinity	affinity	NN	B-NP	O
chromatography	chromatography	NN	I-NP	O
and	and	CC	O	O
consists	consist	VBZ	B-VP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
peptides	peptide	NNS	I-NP	O
of	of	IN	B-PP	O
62	62	CD	B-NP	O
,	,	,	I-NP	O
61	61	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
58.5	58.5	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
1.5	1.5	CD	I-NP	O
kd	kd	NN	I-NP	O
.	.	.	O	O

Each	Each	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
polypeptides	polypeptide	NNS	I-NP	O
was	be	VBD	B-VP	O
renatured	renature	VBN	I-VP	O
after	after	IN	B-PP	O
SDS-PAGE	SDS-PAGE	NN	B-NP	O
and	and	CC	O	O
shown	show	VBN	B-VP	O
to	to	TO	I-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
octamer	octamer	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
specific	specific	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pure	pure	JJ	I-NP	B-protein
B	B	NN	I-NP	I-protein
cell-specific	cell-specific	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
was	be	VBD	B-VP	O
indistinguishable	indistinguishable	JJ	B-ADJP	O
from	from	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
affinity-purified	affinity-purified	JJ	I-NP	B-protein
ubiquitous	ubiquitous	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
.	.	.	O	O

This	This	DT	B-NP	O
B	B	NN	I-NP	B-protein
cell-specific	cell-specific	JJ	I-NP	I-protein
octamer-binding	octamer-binding	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
in	in	IN	B-PP	O
pure	pure	JJ	B-NP	O
form	form	NN	I-NP	O
,	,	,	O	O
activated	activate	VBD	B-VP	O
transcription	transcription	NN	B-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
kappa	kappa	NN	I-NP	B-DNA
light	light	JJ	I-NP	I-DNA
chain	chain	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
thus	thus	RB	B-ADVP	O
demonstrating	demonstrate	VBG	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
indeed	indeed	RB	B-ADVP	O
a	a	DT	B-NP	O
B	B	NN	I-NP	B-protein
cell-specific	cell-specific	JJ	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
for	for	IN	B-PP	O
this	this	DT	B-NP	O
gene	gene	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ubiquitous	ubiquitous	JJ	I-NP	O
and	and	CC	I-NP	O
B	B	NN	I-NP	B-protein
cell-specific	cell-specific	JJ	I-NP	I-protein
octamer-binding	octamer-binding	JJ	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
,	,	,	O	O
we	we	PRP	B-NP	O
identified	identify	VBD	B-VP	O
several	several	JJ	B-NP	O
additional	additional	JJ	I-NP	O
proteins	protein	NNS	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
-specific	-specific	JJ	B-ADJP	O
,	,	,	O	O
that	that	WDT	B-NP	O
interact	interact	VBP	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
kappa	kappa	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

Decreased	Decrease	VBN	B-NP	O
deoxyribonucleic	deoxyribonucleic	JJ	I-NP	O
acid	acid	NN	I-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid-receptor	glucocorticoid-receptor	NN	B-NP	B-protein
complex	complex	NN	I-NP	I-protein
in	in	IN	B-PP	O
cultured	culture	VBN	B-NP	B-cell_line
skin	skin	NN	I-NP	I-cell_line
fibroblasts	fibroblast	NNS	I-NP	I-cell_line
from	from	IN	B-PP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
resistance	resistance	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
syndrome	syndrome	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
resistance	resistance	NN	I-NP	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
27-yr-old	27-yr-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
initially	initially	RB	B-ADVP	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
as	as	IN	B-PP	O
having	have	VBG	B-VP	O
Cushing	Cushing	NN	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
findings	finding	NNS	I-NP	O
of	of	IN	B-PP	O
high	high	JJ	B-NP	O
plasma	plasma	NN	I-NP	O
ACTH	ACTH	NN	I-NP	O
and	and	CC	I-NP	O
serum	serum	NN	I-NP	O
cortisol	cortisol	NN	I-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
urinary	urinary	JJ	I-NP	O
cortisol	cortisol	NN	I-NP	O
secretion	secretion	NN	I-NP	O
,	,	,	O	O
resistance	resistance	NN	B-NP	O
to	to	TO	B-PP	O
adrenal	adrenal	JJ	B-NP	O
suppression	suppression	NN	I-NP	O
with	with	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
adrenal	adrenal	JJ	I-NP	O
hyperplasia	hyperplasia	NN	I-NP	O
by	by	IN	B-PP	O
computed	compute	VBN	B-NP	O
tomography	tomography	NN	I-NP	O
and	and	CC	I-NP	O
scintigraphy	scintigraphy	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
adrenal	adrenal	JJ	I-NP	O
glands	gland	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
or	or	CC	I-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
Cushing	Cushing	NNP	B-NP	O
's	's	POS	B-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
a	a	DT	B-NP	O
5-yr	5-yr	JJ	I-NP	O
follow-up	follow-up	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
developed	develop	VBD	B-VP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
hypercortisolism	hypercortisolism	NN	B-NP	O
persisted	persist	VBD	B-VP	O
.	.	.	O	O

End-organ	End-organ	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
cortisol	cortisol	NN	B-NP	O
was	be	VBD	B-VP	O
suspected	suspect	VBN	I-VP	O
.	.	.	O	O

To	To	TO	B-VP	O
explain	explain	VB	I-VP	O
the	the	DT	B-NP	O
end-organ	end-organ	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
cortisol	cortisol	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
(	(	(	O	O
GR	GR	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
cultured	culture	VBN	B-NP	B-cell_line
skin	skin	NN	I-NP	I-cell_line
fibroblasts	fibroblast	NNS	I-NP	I-cell_line
from	from	IN	B-PP	O
a	a	DT	B-NP	O
forearm	forearm	NN	I-NP	O
skin	skin	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
were	be	VBD	B-VP	O
characterized	characterize	VBN	I-VP	O
and	and	CC	O	O
compared	compare	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
similar	similar	JJ	B-NP	O
studies	study	NNS	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
GR	GR	NN	I-NP	B-protein
in	in	IN	B-PP	O
whole	whole	JJ	B-NP	O
cell	cell	NN	I-NP	O
assays	assay	NNS	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
dissociation	dissociation	NN	I-NP	O
constant	constant	NN	I-NP	O
(	(	(	O	O
Kd	Kd	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
cytosol	cytosol	NN	I-NP	O
of	of	IN	B-PP	O
cultured	culture	VBN	B-NP	B-cell_line
skin	skin	NN	I-NP	I-cell_line
fibroblasts	fibroblast	NNS	I-NP	I-cell_line
from	from	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
binding	binding	NN	B-NP	O
capacity	capacity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
thermal	thermal	JJ	I-NP	O
stability	stability	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
sedimentation	sedimentation	NN	I-NP	O
coefficient	coefficient	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
sucrose	sucrose	NN	I-NP	O
density	density	NN	I-NP	O
gradient	gradient	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
receptors	receptor	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cytosol	cytosol	NN	I-NP	O
of	of	IN	B-PP	O
cultured	culture	VBN	B-NP	B-cell_line
skin	skin	NN	I-NP	I-cell_line
fibroblasts	fibroblast	NNS	I-NP	I-cell_line
from	from	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
were	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
.	.	.	O	O

GR	GR	NN	B-NP	B-protein
complex	complex	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
,	,	,	O	O
analyzed	analyze	VBN	B-VP	O
by	by	IN	B-PP	O
DEAE-cellulose	DEAE-cellulose	NN	B-NP	O
chromatography	chromatography	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

DNA	DNA	NN	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
GR	GR	NN	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
after	after	IN	B-PP	O
temperature-induced	temperature-induced	JJ	B-NP	O
activation	activation	NN	I-NP	O
was	be	VBD	B-VP	O
lower	low	JJR	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

Nuclear	Nuclear	JJ	B-NP	O
translocation	translocation	NN	I-NP	O
of	of	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
from	from	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
slightly	slightly	RB	B-ADJP	O
decreased	decrease	VBN	I-ADJP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
resistance	resistance	NN	I-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
affinity	affinity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
for	for	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
GR	GR	NN	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
to	to	TO	B-PP	O
DNA	DNA	NN	B-NP	O
.	.	.	O	O

Granulocyte-macrophage	Granulocyte-macrophage	JJ	B-NP	B-protein
colony-stimulating	colony-stimulating	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
.	.	.	O	O

Sensitive	Sensitive	JJ	B-NP	O
and	and	CC	I-NP	O
receptor-mediated	receptor-mediated	JJ	I-NP	O
regulation	regulation	NN	I-NP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
25-dihydroxyvitamin	25-dihydroxyvitamin	NN	B-NP	O
D3	D3	NN	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
1	1	CD	B-NP	O
,	,	,	O	O
25-dihydroxyvitamin	25-dihydroxyvitamin	NN	B-NP	O
D3	D3	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
[	[	(	O	O
OH	OH	NN	B-NP	O
]	]	)	O	O
2D3	2D3	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
hormonally	hormonally	RB	I-NP	O
active	active	JJ	I-NP	O
metabolite	metabolite	NN	I-NP	O
of	of	IN	B-PP	O
vitamin	vitamin	NN	B-NP	O
D3	D3	NN	I-NP	O
,	,	,	O	O
modulates	modulate	VBZ	B-VP	O
sensitively	sensitively	RB	B-ADVP	O
and	and	CC	I-ADVP	O
specifically	specifically	RB	I-ADVP	O
both	both	CC	O	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	O
and	and	CC	I-NP	O
messenger	messenger	NN	I-NP	O
RNA	RNA	NN	I-NP	O
accumulation	accumulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
multilineage	multilineage	JJ	I-NP	B-protein
growth	growth	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
granulocyte-macrophage	granulocyte-macrophage	JJ	B-NP	I-protein
colony-stimulating	colony-stimulating	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
GM-CSF	GM-CSF	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
GM-CSF	GM-CSF	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
normal	normal	JJ	I-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
mitogen-activated	mitogen-activated	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
a	a	DT	B-NP	O
line	line	NN	I-NP	O
(	(	(	O	O
S-LB1	S-LB1	NN	B-NP	B-cell_line
)	)	)	O	O
transformed	transform	VBN	B-VP	O
with	with	IN	B-PP	O
human	human	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
lymphotropic	lymphotropic	JJ	I-NP	O
virus	virus	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
HTLV-1	HTLV-1	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
cells	cell	NNS	B-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
HTLV-1	HTLV-1	NN	I-NP	B-cell_line
transformed	transform	VBD	B-VP	I-cell_line
T	T	NN	B-NP	I-cell_line
lymphocyte	lymphocyte	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
(	(	(	O	O
Ab-VDR	Ab-VDR	NN	B-NP	O
)	)	)	O	O
established	establish	VBN	B-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
vitamin	vitamin	NN	B-NP	O
D-resistant	D-resistant	JJ	I-NP	O
rickets	ricket	NNS	I-NP	O
type	type	NN	I-NP	O
II	II	CD	I-NP	O
with	with	IN	B-PP	O
undetectable	undetectable	JJ	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
cellular	cellular	JJ	I-NP	O
receptors	receptor	NNS	I-NP	O
are	be	VBP	B-VP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
GM-CSF	GM-CSF	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
can	can	MD	B-VP	O
occur	occur	VB	I-VP	O
independently	independently	RB	B-ADVP	O
of	of	IN	B-PP	O
interleukin	interleukin	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
regulation	regulation	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
probably	probably	RB	I-VP	O
mediated	mediate	VBN	I-VP	O
through	through	IN	B-PP	O
cellular	cellular	JJ	B-NP	B-protein
1	1	CD	I-NP	I-protein
,	,	,	I-NP	I-protein
25	25	CD	I-NP	I-protein
(	(	(	O	I-protein
OH	OH	NN	B-NP	I-protein
)	)	)	O	I-protein
2D3	2D3	NN	B-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
.	.	.	O	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
important	important	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
physiology	physiology	NN	I-NP	O
of	of	IN	B-PP	O
hematopoiesis	hematopoiesis	NN	B-NP	O
.	.	.	O	O

Altered	Altered	JJ	B-NP	O
interaction	interaction	NN	I-NP	O
between	between	IN	B-PP	O
triiodothyronine	triiodothyronine	NN	B-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
absence	absence	NN	B-NP	O
of	of	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
proposed	propose	VBN	I-NP	O
mechanism	mechanism	NN	I-NP	O
for	for	IN	B-PP	O
increased	increase	VBN	B-NP	O
thyrotropin	thyrotropin	NN	I-NP	O
secretion	secretion	NN	I-NP	O
in	in	IN	B-PP	O
corticosteroid	corticosteroid	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
states	state	NNS	I-NP	O
.	.	.	O	O

Thyroid	Thyroid	JJ	B-NP	O
hormones	hormone	NNS	I-NP	O
occasionally	occasionally	RB	B-ADVP	O
appear	appear	VBP	B-VP	O
less	less	RBR	B-ADJP	O
effective	effective	JJ	I-ADJP	O
when	when	WRB	B-ADVP	O
administered	administer	VBN	B-VP	O
alone	alone	RB	B-ADVP	O
to	to	TO	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
panhypopituitarism	panhypopituitarism	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
manifestations	manifestation	NNS	B-NP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
hypothyroidism	hypothyroidism	NN	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
suffering	suffer	VBG	B-VP	O
from	from	IN	B-PP	O
untreated	untreated	JJ	B-NP	O
Addison	Addison	NN	I-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
latter	latter	JJ	I-NP	O
condition	condition	NN	I-NP	O
,	,	,	O	O
thyrotropin	thyrotropin	NN	B-NP	O
secretion	secretion	NN	I-NP	O
is	be	VBZ	B-VP	O
increased	increase	VBN	I-VP	O
:	:	:	O	O
this	this	DT	B-NP	O
occurs	occur	VBZ	B-VP	O
already	already	RB	B-ADVP	O
after	after	IN	B-PP	O
as	as	RB	B-NP	O
little	little	JJ	I-NP	O
as	as	IN	I-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
temporary	temporary	JJ	B-NP	O
withdrawal	withdrawal	NN	I-NP	O
of	of	IN	B-PP	O
therapy	therapy	NN	B-NP	O
with	with	IN	B-PP	O
substitution	substitution	NN	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
corticosteroids	corticosteroid	NNS	B-NP	O
while	while	IN	B-SBAR	O
circulating	circulate	VBG	B-VP	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
thyroid	thyroid	JJ	B-NP	O
hormones	hormone	NNS	I-NP	O
remain	remain	VBP	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
in	in	IN	B-PP	O
interaction	interaction	NN	B-NP	O
between	between	IN	B-PP	O
triiodothyronine	triiodothyronine	NN	B-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
circulating	circulate	VBG	B-VP	B-cell_type
lymphocytes	lymphocyte	NNS	B-NP	I-cell_type
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
or	or	CC	I-NP	O
secondary	secondary	JJ	I-NP	O
adrenocortical	adrenocortical	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
affinity	affinity	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
receptors	receptor	NNS	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
decreased	decrease	VBN	I-VP	O
,	,	,	O	O
by	by	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
average	average	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
treatments	treatment	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
change	change	NN	I-NP	O
was	be	VBD	B-VP	O
promptly	promptly	RB	I-VP	O
corrected	correct	VBN	I-VP	O
upon	upon	IN	B-PP	O
resumption	resumption	NN	B-NP	O
of	of	IN	B-PP	O
therapy	therapy	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
binding	bind	VBG	B-NP	B-protein
sites	site	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
not	not	RB	O	O
significantly	significantly	RB	B-ADJP	O
modified	modify	VBN	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
on	on	IN	B-PP	O
thyroid	thyroid	NN	B-NP	B-protein
hormone	hormone	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
discussed	discuss	VBN	B-VP	O
here	here	RB	B-ADVP	O
might	might	MD	B-VP	O
account	account	VB	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
observations	observation	NNS	I-NP	O
mentioned	mention	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
by	by	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
natural	natural	JJ	I-NP	I-cell_type
killer	killer	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
NK	NK	NN	B-NP	I-cell_type
)	)	)	O	I-cell_type
cell	cell	NN	B-NP	I-cell_type
activity	activity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
natural	natural	JJ	I-NP	O
killer	killer	NN	I-NP	O
(	(	(	O	O
NK	NK	NN	B-NP	O
)	)	)	O	O
activity	activity	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	B-ADJP	I-cell_type
(	(	(	O	I-cell_type
PBM	PBM	NN	B-NP	I-cell_type
)	)	)	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
direct	direct	JJ	I-NP	O
4-h	4-h	JJ	I-NP	O
51Cr-release	51Cr-release	NN	I-NP	O
assay	assay	NN	I-NP	O
and	and	CC	O	O
K	K	NN	B-NP	B-cell_line
562	562	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
as	as	IN	B-PP	O
a	a	DT	B-NP	O
target	target	NN	I-NP	O
.	.	.	O	O

Preincubation	Preincubation	NN	B-NP	O
for	for	IN	B-PP	O
20	20	CD	B-NP	O
h	h	NN	I-NP	O
of	of	IN	B-PP	O
PBM	PBM	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
drawn	draw	VBN	B-VP	O
from	from	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
donors	donor	NNS	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
X	X	SYM	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
-8	-8	CD	B-NP	O
)	)	)	O	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
X	X	SYM	O	O
10	10	CD	O	O
(	(	(	O	O
-5	-5	CD	B-NP	O
)	)	)	O	O
M	M	NN	B-NP	O
cortisol	cortisol	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
of	of	IN	B-PP	O
NK	NK	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
activity	activity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
magnitude	magnitude	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
suppression	suppression	NN	I-NP	O
was	be	VBD	B-VP	O
directly	directly	RB	B-ADJP	O
related	relate	VBN	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
steroid	steroid	NN	I-NP	O
concentration	concentration	NN	I-NP	O
and	and	CC	O	O
inversely	inversely	RB	B-ADJP	O
related	related	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
effector	effector	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Cortisol	Cortisol	NN	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
minimize	minimize	VB	I-VP	O
the	the	DT	B-NP	O
enhancement	enhancement	NN	I-NP	O
of	of	IN	B-PP	O
NK	NK	NN	B-NP	O
cytotoxicity	cytotoxicity	NN	I-NP	O
obtainable	obtainable	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
immune	immune	JJ	B-NP	B-protein
interferon	interferon	NN	I-NP	I-protein
(	(	(	O	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

A	A	DT	B-NP	O
significantly	significantly	RB	I-NP	O
higher	high	JJR	I-NP	O
suppression	suppression	NN	I-NP	O
was	be	VBD	B-VP	O
achieved	achieve	VBN	I-VP	O
after	after	IN	B-PP	O
sequential	sequential	JJ	B-NP	O
exposure	exposure	NN	I-NP	O
of	of	IN	B-PP	O
PBM	PBM	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
cortisol	cortisol	NN	B-NP	O
and	and	CC	O	O
equimolar	equimolar	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
prostaglandin	prostaglandin	NN	B-NP	B-protein
E2	E2	NN	I-NP	I-protein
(	(	(	O	O
PgE2	PgE2	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
concomitant	concomitant	JJ	I-NP	O
incubation	incubation	NN	I-NP	O
with	with	IN	B-PP	O
theophylline	theophylline	NN	B-NP	O
and	and	CC	I-NP	O
isobutyl-methylxanthine	isobutyl-methylxanthine	NN	I-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
enhance	enhance	VB	I-VP	O
the	the	DT	B-NP	O
cortisol-induced	cortisol-induced	JJ	I-NP	O
suppression	suppression	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
PgE2-dependent	PgE2-dependent	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
significantly	significantly	RB	B-VP	O
increased	increase	VBD	I-VP	O
after	after	IN	B-PP	O
exposure	exposure	NN	B-NP	O
of	of	IN	B-PP	O
PBM	PBM	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
methyl-xanthines	methyl-xanthine	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
was	be	VBD	B-VP	O
partially	partially	RB	B-VP	O
or	or	CC	I-VP	O
totally	totally	RB	I-VP	O
prevented	prevent	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
concomitant	concomitant	JJ	I-NP	O
incubation	incubation	NN	I-NP	O
with	with	IN	B-PP	O
equimolar	equimolar	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
11-deoxycortisol	11-deoxycortisol	NN	B-NP	O
and	and	CC	I-NP	O
RU	RU	NN	I-NP	O
486	486	CD	I-NP	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
of	of	IN	I-PP	O
progesterone	progesterone	NN	B-NP	O
.	.	.	O	O

Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
NK	NK	NN	B-NP	B-protein
effectors	effector	NNS	I-NP	I-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
monoclonal	monoclonal	JJ	I-NP	B-protein
anti-human	anti-human	JJ	I-NP	I-protein
corticosteroid-binding	corticosteroid-binding	JJ	I-NP	I-protein
globulin	globulin	NN	I-NP	I-protein
(	(	(	O	I-protein
CBG	CBG	NN	B-NP	I-protein
)	)	)	O	I-protein
antibody	antibody	NN	B-NP	I-protein
produced	produce	VBD	B-VP	O
an	an	DT	B-NP	O
enhancement	enhancement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
spontaneous	spontaneous	JJ	I-NP	O
NK	NK	NN	I-NP	O
activity	activity	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
partial	partial	JJ	I-NP	O
suppression	suppression	NN	I-NP	O
of	of	IN	B-PP	O
cortisol-mediated	cortisol-mediated	JJ	B-NP	O
effects	effect	NNS	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
endogenous	endogenous	JJ	B-NP	O
glucocorticoids	glucocorticoid	NNS	I-NP	O
play	play	VBP	B-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
NK	NK	NN	B-NP	O
cell-mediated	cell-mediated	JJ	I-NP	O
cytotoxicity	cytotoxicity	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
was	be	VBD	B-VP	O
additive	additive	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
PgE2	PgE2	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
changed	change	VBN	I-VP	O
by	by	IN	B-PP	O
phosphodiesterase	phosphodiesterase	NN	B-NP	B-protein
inhibitors	inhibitor	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
conceivable	conceivable	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
hormone	hormone	NN	I-NP	O
acts	act	VBZ	B-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
level	level	NN	I-NP	O
different	different	JJ	B-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
adenylate	adenylate	NN	I-NP	B-protein
cyclase	cyclase	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
phosphodiesterase	phosphodiesterase	NN	I-NP	B-protein
system	system	NN	I-NP	O
.	.	.	O	O

Data	Datum	NNS	B-NP	O
obtained	obtain	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
antiglucocorticoids	antiglucocorticoid	NNS	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
anti-CBG	anti-CBG	JJ	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
are	be	VBP	B-VP	O
compatible	compatible	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
both	both	DT	B-NP	O
of	of	IN	B-PP	O
high-affinity	high-affinity	JJ	B-NP	B-protein
glucocorticoid	glucocorticoid	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
and	and	CC	B-PP	O
of	of	IN	B-PP	O
CBG	CBG	NN	B-NP	B-protein
in	in	IN	B-PP	O
mediating	mediate	VBG	B-VP	O
cortisol	cortisol	NN	B-NP	O
action	action	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
NK	NK	NN	I-NP	O
cell	cell	NN	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

Interaction	Interaction	NN	B-NP	O
of	of	IN	B-PP	O
cell-type-specific	cell-type-specific	JJ	B-NP	B-protein
nuclear	nuclear	JJ	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
with	with	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-DNA
VH	VH	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
.	.	.	O	O

All	All	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
murine	murine	JJ	I-NP	I-DNA
immunoglobulin	immunoglobulin	NN	I-NP	I-DNA
heavy	heavy	JJ	I-NP	I-DNA
chain	chain	NN	I-NP	I-DNA
variable	variable	JJ	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
(	(	(	O	I-DNA
VH	VH	NN	B-NP	I-DNA
)	)	)	O	I-DNA
genes	gene	NNS	B-NP	I-DNA
contain	contain	VBP	B-VP	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
ATGCAAAT	ATGCAAAT	NN	I-NP	O
approximately	approximately	RB	B-NP	O
70	70	CD	I-NP	B-DNA
nucleotides	nucleotide	NNS	I-NP	I-DNA
5	5	CD	I-NP	I-DNA
'	'	SYM	B-NP	I-DNA
from	from	IN	B-PP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
initiation	initiation	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
octanucleotide	octanucleotide	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
reverse	reverse	JJ	B-NP	O
orientation	orientation	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
light	light	JJ	I-NP	B-DNA
chain	chain	NN	I-NP	I-DNA
variable	variable	JJ	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
(	(	(	O	I-DNA
VL	VL	NN	B-NP	I-DNA
)	)	)	O	I-DNA
genes	gene	NNS	B-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	B-DNA
heavy	heavy	JJ	I-NP	I-DNA
chain	chain	NN	I-NP	I-DNA
transcriptional	transcriptional	JJ	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
.	.	.	O	O

Transfection	Transfection	NN	B-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
established	establish	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
octamer	octamer	NN	I-NP	B-DNA
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lymphoid-specific	lymphoid-specific	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

Octamer-containing	Octamer-containing	JJ	B-NP	B-DNA
fragments	fragment	NNS	I-NP	I-DNA
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
to	to	TO	I-VP	O
bind	bind	VB	I-VP	O
a	a	DT	B-NP	O
factor	factor	NN	I-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
identical	identical	JJ	B-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	CC	O	O
B	B	NN	B-NP	O
lymphoid	lymphoid	JJ	I-NP	O
and	and	CC	I-NP	O
non-lymphoid	non-lymphoid	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
establish	establish	VBP	B-VP	O
that	that	IN	B-SBAR	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
from	from	IN	B-PP	O
distinct	distinct	JJ	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
differ	differ	VBP	B-VP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
interact	interact	VB	I-VP	O
with	with	IN	B-PP	O
octamer-containing	octamer-containing	JJ	B-NP	B-DNA
fragments	fragment	NNS	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
also	also	RB	I-VP	O
detected	detect	VBN	I-VP	O
a	a	DT	B-NP	O
DNA-protein	DNA-protein	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cell-type	cell-type	JJ	I-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
determined	determine	VBN	I-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
sequence	sequence	NN	I-NP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
octamer	octamer	NN	I-NP	B-DNA
participates	participate	VBZ	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

Preferential	Preferential	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
HTLV-I	HTLV-I	NN	B-NP	B-DNA
LTR	LTR	NN	I-NP	I-DNA
in	in	IN	B-PP	O
cell-free	cell-free	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-protein
T	T	NN	I-NP	I-protein
cells	cell	NNS	I-NP	I-protein
producing	produce	VBG	B-VP	I-protein
HTLV-I	HTLV-I	NN	B-NP	I-protein
viral	viral	JJ	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
promoters	promoter	NNS	I-NP	B-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
adenovirus	adenovirus	NN	I-NP	B-DNA
2	2	CD	I-NP	I-DNA
major	major	JJ	I-NP	I-DNA
late	late	JJ	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
,	,	,	O	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	B-DNA
beta-globin	beta-globin	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
,	,	,	O	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	B-DNA
immunoglobulin	immunoglobulin	NN	I-NP	I-DNA
VH	VH	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
and	and	CC	O	O
the	the	DT	B-NP	O
LTR	LTR	NN	I-NP	B-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
T-lymphotropic	T-lymphotropic	JJ	I-NP	O
retrovirus	retrovirus	NN	I-NP	O
type	type	NN	I-NP	O
I	I	CD	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
transcription	transcription	NN	I-NP	O
activities	activity	NNS	I-NP	O
in	in	IN	B-PP	O
cell-free	cell-free	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
of	of	IN	B-PP	O
four	four	CD	B-NP	O
cell	cell	NN	I-NP	B-cell_line
lines	line	NNS	I-NP	I-cell_line
;	;	:	O	O
HeLa	HeLa	NN	B-NP	O
,	,	,	O	O
CESS	CESS	NN	B-NP	O
(	(	(	O	O
Epstein-Barr	Epstein-Barr	JJ	B-NP	B-cell_line
virus-transformed	virus-transformed	JJ	I-NP	I-cell_line
human	human	JJ	I-NP	I-cell_line
B	B	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
)	)	)	O	O
,	,	,	O	O
MT-1	MT-1	NN	B-NP	B-cell_line
(	(	(	O	O
HTLV-I-infected	HTLV-I-infected	JJ	B-NP	B-cell_line
human	human	JJ	I-NP	I-cell_line
T	T	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
without	without	IN	B-PP	O
viral	viral	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
synthesis	synthesis	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
MT-2	MT-2	NN	B-NP	B-cell_line
(	(	(	O	O
HTLV-I-infected	HTLV-I-infected	JJ	B-NP	B-cell_line
human	human	JJ	I-NP	I-cell_line
T	T	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
producing	produce	VBG	B-VP	O
viral	viral	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
)	)	)	O	O
.	.	.	O	O

LTR	LTR	NN	B-NP	B-DNA
was	be	VBD	B-VP	O
preferentially	preferentially	RB	I-VP	O
transcribed	transcribe	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
extracts	extract	NNS	I-NP	O
of	of	IN	B-PP	O
MT-2	MT-2	NN	B-NP	B-protein
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
three	three	CD	I-NP	O
genes	gene	NNS	I-NP	O
were	be	VBD	B-VP	O
transcribed	transcribe	VBN	I-VP	O
with	with	IN	B-PP	O
relatively	relatively	RB	B-NP	O
constant	constant	JJ	I-NP	O
efficiencies	efficiency	NNS	I-NP	O
in	in	IN	B-PP	O
different	different	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
agree	agree	VBP	B-VP	O
well	well	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
previous	previous	JJ	I-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
studies	study	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
HTLV-I	HTLV-I	NN	B-NP	B-DNA
LTR	LTR	NN	I-NP	I-DNA
.	.	.	O	O

Mixing	Mixing	NN	B-NP	O
of	of	IN	B-PP	O
HeLa	HeLa	NN	B-NP	B-cell_line
and	and	CC	I-NP	O
MT-2	MT-2	NN	I-NP	O
extracts	extract	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
LTR-specific	LTR-specific	JJ	I-NP	O
stimulating	stimulating	NN	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
MT-2	MT-2	NN	B-NP	O
extracts	extract	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
that	that	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
conserved	conserve	VBN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
motif	motif	NN	I-NP	I-DNA
in	in	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	B-DNA
control	control	NN	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

Trans-acting	Trans-acting	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
mediate	mediate	VBP	B-VP	O
B-cell	B-cell	NN	B-NP	O
specific	specific	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
postulated	postulate	VBN	I-VP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
exogenously	exogenously	RB	B-NP	O
introduced	introduce	VBN	I-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	O
gene	gene	NN	I-NP	O
recombinants	recombinant	NNS	I-NP	O
in	in	IN	B-PP	O
lymphoid	lymphoid	JJ	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
non-lymphoid	non-lymphoid	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Two	Two	CD	B-NP	O
B-cell-specific	B-cell-specific	JJ	I-NP	O
,	,	,	I-NP	O
cis-acting	cis-acting	JJ	I-NP	B-DNA
transcriptional	transcriptional	JJ	I-NP	I-DNA
regulatory	regulatory	JJ	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

One	One	CD	B-NP	O
element	element	NN	I-NP	O
is	be	VBZ	B-VP	O
located	locate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
intron	intron	NN	I-NP	B-DNA
between	between	IN	B-PP	O
the	the	DT	B-NP	O
variable	variable	JJ	I-NP	B-DNA
(	(	(	O	I-DNA
V	V	NN	B-NP	I-DNA
)	)	)	O	I-DNA
and	and	CC	O	I-DNA
constant	constant	JJ	B-NP	I-DNA
(	(	(	O	I-DNA
C	C	NN	B-NP	I-DNA
)	)	)	O	I-DNA
regions	region	NNS	B-NP	I-DNA
of	of	IN	B-PP	O
both	both	CC	B-NP	O
heavy	heavy	JJ	I-NP	B-DNA
and	and	CC	O	I-DNA
kappa	kappa	NN	B-NP	I-DNA
light-chain	light-chain	JJ	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
and	and	CC	O	O
acts	act	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
second	second	JJ	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
found	find	VBN	I-VP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
both	both	CC	B-NP	O
heavy	heavy	JJ	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
kappa	kappa	NN	I-NP	I-DNA
light-chain	light-chain	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
promoters	promoter	NNS	I-NP	I-DNA
.	.	.	O	O

This	This	DT	B-NP	O
element	element	NN	I-NP	O
directs	direct	VBZ	B-VP	O
lymphoid-specific	lymphoid-specific	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
even	even	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	I-PP	O
presence	presence	NN	I-PP	O
of	of	IN	I-PP	O
viral	viral	JJ	B-NP	B-DNA
enhancers	enhancer	NNS	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
sought	seek	VBN	I-VP	O
nuclear	nuclear	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
might	might	MD	B-VP	O
bind	bind	VB	I-VP	O
specifically	specifically	RB	B-ADVP	O
to	to	TO	B-PP	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
regulatory	regulatory	JJ	I-NP	B-DNA
elements	element	NNS	I-NP	I-DNA
by	by	IN	B-PP	O
application	application	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
modified	modify	VBN	I-NP	O
gel	gel	NN	I-NP	O
electrophoresis	electrophoresis	NN	I-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
here	here	RB	B-ADVP	O
the	the	DT	B-NP	O
identification	identification	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	B-protein
B-cell	B-cell	NN	I-NP	I-protein
nuclear	nuclear	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
IgNF-A	IgNF-A	NN	B-NP	B-protein
)	)	)	O	O
that	that	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
DNA	DNA	NN	B-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upstream	upstream	JJ	I-NP	B-DNA
regions	region	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	B-DNA
heavy	heavy	NN	I-NP	I-DNA
and	and	CC	O	I-DNA
kappa	kappa	NN	B-NP	I-DNA
light-chain	light-chain	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
promoters	promoter	NNS	I-NP	I-DNA
and	and	CC	O	O
also	also	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	B-DNA
heavy-chain	heavy-chain	JJ	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
.	.	.	O	O

This	This	DT	B-NP	O
sequence-specific	sequence-specific	JJ	I-NP	O
binding	binding	NN	I-NP	O
is	be	VBZ	B-VP	O
probably	probably	RB	I-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	O
conserved	conserve	VBN	I-NP	O
sequence	sequence	NN	I-NP	O
motif	motif	NN	I-NP	O
,	,	,	O	O
ATTTGCAT	ATTTGCAT	NN	B-NP	O
,	,	,	O	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
three	three	CD	I-NP	O
transcriptional	transcriptional	JJ	I-NP	B-DNA
elements	element	NNS	I-NP	I-DNA
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
factor	factor	NN	I-NP	O
showing	show	VBG	B-VP	O
similar	similar	JJ	B-NP	O
binding	binding	NN	I-NP	O
specificity	specificity	NN	I-NP	O
to	to	TO	B-PP	O
IgNF-A	IgNF-A	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
HeLa	HeLa	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
new	new	JJ	I-NP	O
world	world	NN	I-NP	O
primates	primate	NNS	I-NP	O
as	as	IN	B-PP	O
animal	animal	NN	B-NP	O
models	model	NNS	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
resistance	resistance	NN	I-NP	O
.	.	.	O	O

Many	Many	JJ	B-NP	O
New	New	JJ	I-NP	O
World	World	NN	I-NP	O
primate	primate	JJ	I-NP	O
species	specie	NNS	I-NP	O
have	have	VBP	B-VP	O
greatly	greatly	RB	I-VP	O
increased	increase	VBN	I-VP	O
plasma	plasma	NN	B-NP	O
cortisol	cortisol	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
,	,	,	O	O
decreased	decrease	VBN	B-NP	O
plasma	plasma	NN	I-NP	O
cortisol	cortisol	NN	I-NP	O
binding	binding	NN	I-NP	O
globulin	globulin	NN	I-NP	O
capacity	capacity	NN	I-NP	O
and	and	CC	O	O
affinity	affinity	NN	B-NP	O
,	,	,	O	O
marked	marked	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hypothalamic-pituitary-adrenal	hypothalamic-pituitary-adrenal	JJ	I-NP	O
axis	axis	NN	I-NP	O
to	to	TO	B-PP	O
suppression	suppression	NN	B-NP	O
by	by	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
biological	biological	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
excess	excess	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
primates	primate	NNS	I-NP	O
also	also	RB	B-ADVP	O
have	have	VBP	B-VP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
circulating	circulate	VBG	B-VP	O
progesterone	progesterone	NN	B-NP	O
,	,	,	O	O
estrogen	estrogen	NN	B-NP	O
,	,	,	O	O
mineralocorticoid	mineralocorticoid	NN	B-NP	O
,	,	,	O	O
androgen	androgen	NN	B-NP	O
and	and	CC	O	O
vitamin	vitamin	NN	B-NP	O
D	D	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
target	target	NN	I-NP	O
tissues	tissue	NNS	I-NP	O
that	that	WDT	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
examined	examine	VBN	I-VP	O
(	(	(	O	O
circulating	circulate	VBG	B-VP	B-cell_type
mononuclear	mononuclear	JJ	B-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
cultured	culture	VBN	B-NP	B-cell_line
skin	skin	NN	I-NP	I-cell_line
fibroblasts	fibroblast	NNS	I-NP	I-cell_line
)	)	)	O	O
have	have	VBP	B-VP	O
normal	normal	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
affinity	affinity	NN	I-NP	O
for	for	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
.	.	.	O	O

Transformation	Transformation	NN	B-NP	O
of	of	IN	B-PP	O
B-lymphocytes	B-lymphocyte	NNS	B-NP	B-cell_type
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Epstein-Barr	Epstein-Barr	JJ	I-NP	O
virus	virus	NN	I-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
induction	induction	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
observed	observe	VBN	B-VP	O
with	with	IN	B-PP	O
cells	cell	NNS	B-NP	O
from	from	IN	B-PP	O
Old	Old	NNP	B-NP	O
World	World	NNP	I-NP	O
primates	primate	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
receptor	receptor	NN	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
affinity	affinity	NN	I-NP	O
for	for	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
low	low	JJ	I-NP	O
affinity	affinity	NN	I-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
specific	specific	JJ	B-NP	O
bound	bind	VBN	I-NP	O
ligand	ligand	NN	I-NP	O
during	during	IN	B-PP	O
thermal	thermal	JJ	B-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

Meroreceptor	Meroreceptor	NN	B-NP	O
generation	generation	NN	I-NP	O
is	be	VBZ	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
,	,	,	O	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
SDS-PAGE	SDS-PAGE	NN	B-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
Old	Old	NNP	B-NP	O
World	World	NNP	I-NP	O
primates	primate	NNS	I-NP	O
(	(	(	O	O
approximately	approximately	RB	B-NP	O
92	92	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
pattern	pattern	NN	I-NP	O
per	per	FW	B-ADVP	O
se	se	FW	I-ADVP	O
,	,	,	O	O
examined	examine	VBN	B-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
by	by	IN	B-PP	O
heating	heat	VBG	B-VP	O
cytosol	cytosol	NN	B-NP	O
and	and	CC	O	O
performing	perform	VBG	B-VP	O
phosphocellulose	phosphocellulose	NN	B-NP	O
chromatography	chromatography	NN	I-NP	O
,	,	,	O	O
appears	appear	VBZ	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ratios	ratio	NNS	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
to	to	TO	B-PP	O
cytosolic	cytosolic	JJ	B-NP	B-protein
hormone-receptor-complexes	hormone-receptor-complex	NNS	I-NP	I-protein
and	and	CC	B-PP	O
of	of	IN	B-PP	O
cytosolic	cytosolic	JJ	B-NP	B-protein
activated	activate	VBN	B-VP	I-protein
to	to	TO	B-PP	I-protein
unactivated	unactivated	JJ	B-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
in	in	IN	B-PP	O
intact	intact	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
Old	Old	NNP	B-NP	O
World	World	NNP	I-NP	O
primates	primate	NNS	I-NP	O
.	.	.	O	O

Results	Result	NNS	B-NP	O
from	from	IN	B-PP	O
mixing	mix	VBG	B-NP	O
studies	study	NNS	I-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
support	support	VB	I-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
binding	binding	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
or	or	CC	O	O
a	a	DT	B-NP	O
deficient	deficient	JJ	I-NP	O
cytosolic	cytosolic	JJ	I-NP	O
positive	positive	JJ	I-NP	O
modifier	modifier	NN	I-NP	O
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
binding	binding	NN	B-NP	O
underlies	underlie	VBZ	B-VP	O
the	the	DT	B-NP	O
findings	finding	NNS	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
primates	primate	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
New	New	NNP	I-NP	O
World	World	NN	I-NP	O
primates	primate	NNS	I-NP	O
,	,	,	O	O
unlike	unlike	IN	B-PP	O
men	man	NNS	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
syndrome	syndrome	NN	I-NP	O
of	of	IN	B-PP	O
primary	primary	JJ	B-NP	O
cortisol	cortisol	NN	I-NP	O
resistance	resistance	NN	I-NP	O
,	,	,	O	O
have	have	VBP	B-VP	O
compensated	compensate	VBN	I-VP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
condition	condition	NN	I-NP	O
with	with	IN	B-PP	O
intra-adrenal	intra-adrenal	JJ	B-NP	O
and	and	CC	I-NP	O
mineralocorticoid	mineralocorticoid	NN	I-NP	O
receptor	receptor	NN	I-NP	O
adaptations	adaptation	NNS	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
unlike	unlike	IN	B-PP	O
Old	Old	NNP	B-NP	O
World	World	NNP	I-NP	O
primates	primate	NNS	I-NP	O
,	,	,	O	O
cortisol	cortisol	NN	B-NP	O
in	in	IN	B-PP	O
New	New	JJ	B-NP	O
World	World	NN	I-NP	O
primates	primate	NNS	I-NP	O
has	have	VBZ	B-VP	O
only	only	RB	B-NP	O
weak	weak	JJ	I-NP	O
sodium-retaining	sodium-retaining	JJ	I-NP	O
potency	potency	NN	I-NP	O
because	because	IN	B-SBAR	O
the	the	DT	B-NP	O
aldosterone	aldosterone	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
affinity	affinity	NN	I-NP	O
for	for	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
common	common	JJ	I-NP	O
element	element	NN	I-NP	O
that	that	WDT	B-NP	O
would	would	MD	B-VP	O
explain	explain	VB	I-VP	O
the	the	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
six	six	CD	B-NP	O
steroid	steroid	NN	I-NP	O
hormones	hormone	NNS	I-NP	O
in	in	IN	B-PP	O
New	New	JJ	B-NP	O
World	World	NN	I-NP	O
primates	primate	NNS	I-NP	O

Acetylation	Acetylation	NN	B-NP	O
and	and	CC	I-NP	O
modulation	modulation	NN	I-NP	O
of	of	IN	B-PP	O
erythroid	erythroid	JJ	B-NP	B-protein
Kruppel-like	Kruppel-like	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
EKLF	EKLF	NN	B-NP	B-protein
)	)	)	O	O
activity	activity	NN	B-NP	O
by	by	IN	B-PP	O
interaction	interaction	NN	B-NP	O
with	with	IN	B-PP	O
histone	histone	NN	B-NP	B-protein
acetyltransferases	acetyltransferas	NNS	I-NP	I-protein
.	.	.	O	O

Erythroid	Erythroid	JJ	B-NP	B-protein
Kruppel-like	Kruppel-like	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
EKLF	EKLF	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
red	red	JJ	I-NP	B-protein
cell-specific	cell-specific	JJ	I-NP	I-protein
transcriptional	transcriptional	JJ	I-NP	I-protein
activator	activator	NN	I-NP	I-protein
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
crucial	crucial	JJ	B-ADJP	O
for	for	IN	B-PP	O
consolidating	consolidate	VBG	B-VP	O
the	the	DT	B-NP	O
switch	switch	NN	I-NP	O
to	to	TO	B-PP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
adult	adult	JJ	B-NP	O
beta-globin	beta-globin	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
during	during	IN	B-PP	O
erythroid	erythroid	JJ	B-NP	O
ontogeny	ontogeny	NN	I-NP	O
.	.	.	O	O

EKLF	EKLF	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
integrity	integrity	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chromatin	chromatin	NN	I-NP	B-DNA
structure	structure	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
beta-like	beta-like	JJ	I-NP	B-DNA
globin	globin	NN	I-NP	I-DNA
locus	locus	NN	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
interacts	interact	VBZ	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
positive-acting	positive-acting	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

We	We	PRP	B-NP	O
find	find	VBP	B-VP	O
that	that	IN	B-SBAR	O
EKLF	EKLF	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
acetylated	acetylate	VBN	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
interacts	interact	VBZ	B-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
with	with	IN	B-PP	O
CBP	CBP	NN	B-NP	B-protein
,	,	,	O	O
p300	p300	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
P/CAF	P/CAF	NN	B-NP	B-protein
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
its	its	PRP$	B-NP	O
interactions	interaction	NNS	I-NP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
histone	histone	NN	I-NP	B-protein
acetyltransferases	acetyltransferas	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
not	not	RB	O	O
equivalent	equivalent	JJ	B-ADJP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
CBP	CBP	NN	B-NP	B-protein
and	and	CC	I-NP	O
p300	p300	NN	I-NP	B-protein
,	,	,	B-NP	O
but	but	CC	I-NP	O
not	not	RB	I-NP	O
P/CAF	P/CAF	NN	B-NP	B-protein
,	,	,	O	O
utilize	utilize	VBP	B-VP	O
EKLF	EKLF	NN	B-NP	B-protein
as	as	IN	B-PP	O
a	a	DT	B-NP	O
substrate	substrate	NN	I-NP	O
for	for	IN	B-PP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
acetylation	acetylation	NN	I-NP	O
within	within	IN	B-PP	O
its	its	PRP$	B-NP	O
trans-activation	trans-activation	NN	I-NP	B-protein
region	region	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
functional	functional	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
interactions	interaction	NNS	I-NP	O
are	be	VBP	B-VP	O
that	that	IN	B-SBAR	O
CBP	CBP	NN	B-NP	B-protein
and	and	CC	I-NP	O
p300	p300	NN	I-NP	B-protein
,	,	,	B-NP	O
but	but	CC	I-NP	O
not	not	RB	I-NP	O
P/CAF	P/CAF	NN	B-NP	B-protein
,	,	,	O	O
enhance	enhance	VBP	B-VP	O
EKLF	EKLF	NN	B-NP	B-protein
's	's	POS	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
beta-globin	beta-globin	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
in	in	IN	B-PP	O
erythroid	erythroid	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
establish	establish	VBP	B-VP	O
EKLF	EKLF	NN	B-NP	B-protein
as	as	IN	B-PP	O
a	a	DT	B-NP	O
tissue-specific	tissue-specific	JJ	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
that	that	WDT	B-NP	O
undergoes	undergo	VBZ	B-VP	O
post-translational	post-translational	JJ	B-NP	O
acetylation	acetylation	NN	I-NP	O
and	and	CC	O	O
suggest	suggest	VBP	B-VP	O
a	a	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
EKLF	EKLF	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
alter	alter	VB	I-VP	O
chromatin	chromatin	NN	B-NP	B-DNA
structure	structure	NN	I-NP	O
and	and	CC	O	O
induce	induce	VB	B-VP	O
beta-globin	beta-globin	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
beta-like	beta-like	JJ	I-NP	B-DNA
globin	globin	NN	I-NP	I-DNA
cluster	cluster	NN	I-NP	I-DNA
.	.	.	O	O

Recognition	Recognition	NN	B-NP	O
of	of	IN	B-PP	O
herpes	herpes	NN	B-NP	B-protein
simplex	simplex	NN	I-NP	I-protein
virus	virus	NN	I-NP	I-protein
type	type	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
tegument	tegument	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
by	by	IN	B-PP	O
CD4	CD4	NN	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
infiltrating	infiltrate	VBG	B-VP	O
human	human	JJ	B-NP	O
genital	genital	JJ	I-NP	O
herpes	herpes	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
local	local	JJ	I-NP	O
cellular	cellular	JJ	I-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
herpes	herpes	NN	B-NP	O
simplex	simplex	NN	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
HSV	HSV	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
HSV	HSV	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
antiviral	antiviral	JJ	I-NP	O
functions	function	NNS	I-NP	O
of	of	IN	B-PP	O
infiltrating	infiltrate	VBG	B-VP	B-cell_type
CD4-bearing	CD4-bearing	JJ	B-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
may	may	MD	B-VP	O
include	include	VB	I-VP	O
cytotoxicity	cytotoxicity	NN	B-NP	O
,	,	,	O	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
viral	viral	JJ	B-NP	O
growth	growth	NN	I-NP	O
,	,	,	O	O
lymphokine	lymphokine	NN	B-NP	B-protein
secretion	secretion	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
support	support	NN	B-NP	O
of	of	IN	B-PP	O
humoral	humoral	JJ	B-NP	O
and	and	CC	I-NP	O
CD8	CD8	NN	I-NP	B-protein
responses	response	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
antigens	antigen	NNS	I-NP	O
recognized	recognize	VBN	B-VP	O
by	by	IN	B-PP	O
many	many	JJ	B-NP	O
HSV-specific	HSV-specific	JJ	I-NP	B-cell_type
CD4	CD4	NN	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
localizing	localize	VBG	B-VP	O
to	to	TO	B-PP	O
genital	genital	JJ	B-NP	O
HSV-2	HSV-2	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
are	be	VBP	B-VP	O
unknown	unknown	JJ	B-ADJP	O
.	.	.	O	O

T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
recognizing	recognize	VBG	B-VP	O
antigens	antigen	NNS	B-NP	O
encoded	encode	VBN	B-VP	O
within	within	IN	B-PP	O
map	map	NN	B-NP	O
units	unit	NNS	I-NP	O
0.67	0.67	CD	B-NP	O
to	to	TO	B-PP	O
0.73	0.73	CD	B-NP	O
of	of	IN	B-PP	O
HSV	HSV	NN	B-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
are	be	VBP	B-VP	O
frequently	frequently	RB	I-VP	O
recovered	recover	VBN	I-VP	O
from	from	IN	B-PP	O
herpetic	herpetic	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

Expression	Expression	NN	B-NP	O
cloning	cloning	NN	I-NP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
now	now	RB	B-ADVP	O
shows	show	VBZ	B-VP	O
that	that	IN	B-SBAR	O
tegument	tegument	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
VP22	VP22	NN	I-NP	B-protein
and	and	CC	O	O
the	the	DT	B-NP	O
viral	viral	JJ	I-NP	B-protein
dUTPase	dUTPase	NN	I-NP	I-protein
,	,	,	O	O
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
genes	gene	NNS	B-NP	O
UL49	UL49	NN	I-NP	B-DNA
and	and	CC	I-NP	O
UL50	UL50	NN	I-NP	B-protein
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
are	be	VBP	B-VP	O
T-cell	T-cell	NN	B-NP	B-protein
antigens	antigen	NNS	I-NP	I-protein
.	.	.	O	O

Separate	Separate	JJ	B-NP	O
epitopes	epitope	NNS	I-NP	B-protein
in	in	IN	B-PP	O
VP22	VP22	NN	B-NP	B-protein
were	be	VBD	B-VP	O
defined	define	VBN	I-VP	O
for	for	IN	B-PP	O
T-cell	T-cell	NN	B-NP	B-cell_line
clones	clone	NNS	I-NP	I-cell_line
from	from	IN	B-PP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Reactivity	Reactivity	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
tegument	tegument	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
UL21	UL21	NN	B-NP	B-protein
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

Three	Three	CD	B-NP	O
new	new	JJ	I-NP	O
epitopes	epitope	NNS	I-NP	B-protein
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
VP16	VP16	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
tegument	tegument	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
VP22	VP22	NN	B-NP	B-protein
.	.	.	O	O

Some	Some	DT	B-NP	O
tegument-specific	tegument-specific	JJ	I-NP	B-cell_line
CD4	CD4	NN	I-NP	I-cell_line
T-cell	T-cell	NN	I-NP	I-cell_line
clones	clone	NNS	I-NP	I-cell_line
exhibited	exhibit	VBD	B-VP	O
cytotoxic	cytotoxic	JJ	B-NP	O
activity	activity	NN	I-NP	O
against	against	IN	B-PP	O
HSV-infected	HSV-infected	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
herpes	herpes	NN	B-NP	B-protein
simplex	simplex	NN	I-NP	I-protein
tegument	tegument	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
processed	process	VBN	I-VP	O
for	for	IN	B-PP	O
antigen	antigen	NN	B-NP	O
presentation	presentation	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
possible	possible	JJ	B-NP	O
candidate	candidate	NN	I-NP	O
compounds	compound	NNS	I-NP	O
for	for	IN	B-PP	O
herpes	herpes	NN	B-NP	O
simplex	simplex	NN	I-NP	O
vaccines	vaccine	NNS	I-NP	O
.	.	.	O	O

Fibrinogen	Fibrinogen	NN	B-NP	B-protein
activates	activate	VBZ	B-VP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
mononuclear	mononuclear	JJ	B-NP	B-cell_type
phagocytes	phagocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Adhesion	Adhesion	NN	B-NP	O
to	to	TO	B-PP	O
extracellular	extracellular	JJ	B-NP	O
matrices	matrix	NNS	I-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
modulate	modulate	VB	I-VP	O
leukocyte	leukocyte	NN	B-NP	O
activation	activation	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
fully	fully	RB	I-VP	O
understood	understand	VBN	I-VP	O
.	.	.	O	O

Mononuclear	Mononuclear	JJ	B-NP	B-cell_type
phagocytes	phagocyte	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
exposed	expose	VBN	I-VP	O
to	to	TO	B-PP	O
fibrinous	fibrinous	JJ	B-NP	O
provisional	provisional	JJ	I-NP	O
matrix	matrix	NN	I-NP	O
throughout	throughout	IN	B-PP	O
migration	migration	NN	B-NP	O
into	into	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	O
foci	focus	NNS	I-NP	O
,	,	,	O	O
so	so	RB	O	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
undertaken	undertake	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
fibrinogen	fibrinogen	NN	B-NP	B-protein
triggers	trigger	VBZ	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

U937	U937	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
differentiated	differentiate	VBN	B-VP	O
with	with	IN	B-PP	O
PMA	PMA	NN	B-NP	O
in	in	IN	B-PP	O
nonadherent	nonadherent	JJ	B-NP	B-cell_line
culture	culture	NN	I-NP	I-cell_line
were	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
express	express	VB	I-VP	O
two	two	CD	B-NP	O
fibrinogen-binding	fibrinogen-binding	JJ	I-NP	B-protein
integrins	integrin	NNS	I-NP	I-protein
,	,	,	O	O
predominately	predominately	RB	B-NP	O
CD11b/CD18	CD11b/CD18	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
lesser	less	JJR	I-NP	O
extent	extent	NN	I-NP	O
,	,	,	I-NP	O
CD11c/CD18	CD11c/CD18	NN	I-NP	B-protein
.	.	.	O	O

Cells	Cell	NNS	B-NP	O
stimulated	stimulate	VBN	B-VP	O
with	with	IN	B-PP	O
fibrinogen	fibrinogen	NN	B-NP	B-protein
(	(	(	O	O
10-100	10-100	CD	B-NP	O
microg/ml	microg/ml	NN	I-NP	O
)	)	)	O	O
/Mn2+	/Mn2+	NN	B-NP	O
(	(	(	O	O
50	50	CD	B-NP	O
microM	microM	NN	I-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
h	h	NN	I-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
by	by	IN	B-PP	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
,	,	,	O	O
minimal	minimal	JJ	B-ADJP	O
in	in	IN	B-PP	O
unstimulated	unstimulated	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
was	be	VBD	B-VP	O
substantially	substantially	RB	I-VP	O
up-regulated	up-regulate	VBN	I-VP	O
by	by	IN	B-PP	O
fibrinogen	fibrinogen	NN	B-NP	B-protein
.	.	.	O	O

Fibrinogen	Fibrinogen	NN	B-NP	B-protein
also	also	RB	B-ADVP	O
caused	cause	VBD	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
SP1	SP1	NN	B-NP	B-protein
or	or	CC	O	O
cAMP	cAMP	NN	B-NP	B-protein
response	response	NN	I-NP	I-protein
element-binding	element-binding	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	I-protein
CREB	CREB	NN	B-NP	I-protein
)	)	)	O	I-protein
factors	factor	NNS	B-NP	I-protein
.	.	.	O	O

Blocking	Block	VBG	B-VP	O
mAbs	mAb	NNS	B-NP	B-protein
against	against	IN	B-PP	O
CD18	CD18	NN	B-NP	B-protein
and	and	CC	I-NP	O
CD11b	CD11b	NN	I-NP	B-protein
abrogated	abrogate	VBD	B-VP	O
fibrinogen	fibrinogen	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
,	,	,	O	O
U937	U937	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
transfected	transfecte	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
plasmid	plasmid	NN	I-NP	B-DNA
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
HIV-1	HIV-1	NN	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
(	(	(	O	O
bearing	bear	VBG	B-VP	O
two	two	CD	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-DNA
B	B	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
)	)	)	O	O
coupled	couple	VBN	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
chloramphenicol	chloramphenicol	NN	I-NP	B-DNA
acetyltransferase	acetyltransferase	NN	I-NP	I-DNA
(	(	(	O	I-DNA
CAT	CAT	NN	B-NP	I-DNA
)	)	)	O	I-DNA
reporter	reporter	NN	B-NP	I-DNA
.	.	.	O	O

Cells	Cell	NNS	B-NP	O
were	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
stimulated	stimulate	VBN	I-VP	O
with	with	IN	B-PP	O
1	1	LS	O	O
)	)	)	O	O
PMA	PMA	NN	B-NP	O
for	for	IN	B-PP	O
24	24	CD	B-NP	O
h	h	NN	I-NP	O
,	,	,	O	O
inducing	induce	VBG	B-VP	O
CAT	CAT	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
by	by	IN	B-PP	O
2.6-fold	2.6-fold	JJ	B-ADJP	O
,	,	,	O	O
2	2	LS	B-LST	O
)	)	)	O	O
fibrinogen	fibrinogen	NN	B-NP	B-protein
/Mn2+	/Mn2+	NN	I-NP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
h	h	NN	I-NP	O
,	,	,	O	O
inducing	induce	VBG	B-VP	O
CAT	CAT	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
by	by	IN	B-PP	O
3.2-fold	3.2-fold	JJ	B-ADJP	O
,	,	,	O	O
or	or	CC	O	O
3	3	LS	B-LST	O
)	)	)	O	O
costimulation	costimulation	NN	B-NP	O
with	with	IN	B-PP	O
fibrinogen	fibrinogen	NN	B-NP	B-protein
and	and	CC	I-NP	O
PMA	PMA	NN	I-NP	O
,	,	,	O	O
inducing	induce	VBG	B-VP	O
5.7-fold	5.7-fold	JJ	B-ADJP	O
the	the	DT	B-NP	O
CAT	CAT	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
PMA	PMA	NN	B-NP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
contact	contact	NN	B-NP	O
with	with	IN	B-PP	O
fibrinogen-derived	fibrinogen-derived	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
may	may	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
mononuclear	mononuclear	JJ	B-NP	B-cell_type
phagocyte	phagocyte	NN	I-NP	I-cell_type
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
signaling	signaling	NN	B-NP	O
through	through	IN	B-PP	O
CD11b/CD18	CD11b/CD18	NN	B-NP	B-protein
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
selective	selective	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	B-protein
regulatory	regulatory	JJ	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
,	,	,	O	O
including	include	VBG	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
monocytes	monocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
B	B	NN	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
lupus	lupus	NN	B-NP	O
express	express	VBP	B-VP	O
estrogen	estrogen	NN	B-NP	B-RNA
receptor	receptor	NN	I-NP	I-RNA
transcripts	transcript	NNS	I-NP	I-RNA
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

OBJECTIVE	OBJECTIVE	NN	B-NP	O
:	:	:	O	O
To	To	TO	B-VP	O
identify	identify	VB	I-VP	O
and	and	CC	I-VP	O
characterize	characterize	VB	I-VP	O
estrogen	estrogen	NN	B-NP	B-RNA
receptor	receptor	NN	I-NP	I-RNA
(	(	(	O	I-RNA
ER	ER	NN	B-NP	I-RNA
)	)	)	O	I-RNA
transcripts	transcript	NNS	B-NP	I-RNA
expressed	express	VBN	B-VP	O
in	in	IN	B-PP	O
immune	immune	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
lupus	lupus	NN	I-NP	O
erythematosus	erythematosus	NN	I-NP	O
(	(	(	O	O
SLE	SLE	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
healthy	healthy	JJ	B-NP	O
donors	donor	NNS	I-NP	O
.	.	.	O	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
Peripheral	Peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
prepared	prepare	VBN	I-VP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
SLE	SLE	NN	B-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
6	6	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
healthy	healthy	JJ	B-NP	O
donors	donor	NNS	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
8	8	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
separated	separate	VBN	I-VP	O
into	into	IN	B-PP	O
CD4	CD4	NN	B-NP	B-protein
and	and	CC	I-NP	O
CD8	CD8	NN	I-NP	B-protein
.	.	.	O	O

Some	Some	DT	B-NP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	B-NP	I-cell_type
were	be	VBD	B-VP	O
stimulated	stimulate	VBN	I-VP	O
with	with	IN	B-PP	O
estradiol	estradiol	NN	B-NP	O
,	,	,	O	O
PMA	PMA	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
ionomycin	ionomycin	NN	B-NP	O
.	.	.	O	O

Epstein-Barr	Epstein-Barr	JJ	B-NP	B-cell_line
virus-transformed	virus-transformed	JJ	I-NP	I-cell_line
B	B	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
7	7	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
B	B	NN	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
hybridomas	hybridoma	NNS	I-NP	I-cell_line
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
2	2	CD	B-NP	O
)	)	)	O	O
established	establish	VBN	B-VP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
SLE	SLE	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
healthy	healthy	JJ	I-NP	O
individual	individual	NN	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
B	B	NN	I-NP	O
cell	cell	NN	I-NP	O
source	source	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
cells	cell	NNS	I-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
for	for	IN	B-PP	O
ER	ER	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
by	by	IN	B-PP	O
reverse	reverse	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
nested	nest	VBD	B-VP	O
polymerase	polymerase	NN	B-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
.	.	.	O	O

Amplified	Amplify	VBN	B-NP	O
cDNA	cDNA	NN	I-NP	B-DNA
were	be	VBD	B-VP	O
sequenced	sequence	VBN	I-VP	O
by	by	IN	B-PP	O
standard	standard	JJ	B-NP	O
methods	method	NNS	I-NP	O
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
all	all	DT	B-NP	O
cells	cell	NNS	I-NP	O
tested	test	VBN	B-VP	O
,	,	,	O	O
ER	ER	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
was	be	VBD	B-VP	O
expressed	express	VBN	I-VP	O
without	without	IN	B-PP	O
prior	prior	JJ	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

Partial	Partial	JJ	B-NP	O
sequences	sequence	NNS	I-NP	O
from	from	IN	B-PP	O
exons	exon	NNS	B-NP	B-DNA
1-8	1-8	CD	B-NP	I-DNA
were	be	VBD	B-VP	O
nearly	nearly	RB	B-ADJP	O
identical	identical	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
published	publish	VBN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-RNA
ER	ER	NN	I-NP	I-RNA
mRNA	mRNA	NN	I-NP	I-RNA
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
notable	notable	JJ	I-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ER	ER	NN	I-NP	B-RNA
transcripts	transcript	NNS	I-NP	I-RNA
between	between	IN	B-PP	O
patients	patient	NNS	B-NP	O
and	and	CC	O	O
healthy	healthy	JJ	B-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

Variant	Variant	JJ	B-NP	O
receptor	receptor	NN	I-NP	O
transcripts	transcript	NNS	I-NP	O
lacking	lack	VBG	B-VP	O
exon	exon	NN	B-NP	B-DNA
5	5	CD	I-NP	I-DNA
or	or	CC	O	O
exon	exon	NN	B-NP	B-DNA
7	7	CD	I-NP	I-DNA
,	,	,	O	O
which	which	WDT	B-NP	O
encodes	encode	VBZ	B-VP	O
the	the	DT	B-NP	O
hormone	hormone	NN	I-NP	B-protein
binding	binding	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
,	,	,	O	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

Precise	Precise	JJ	B-NP	O
deletion	deletion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
exons	exon	NNS	I-NP	B-DNA
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
they	they	PRP	B-NP	O
are	be	VBP	B-VP	O
alternatively	alternatively	RB	I-VP	B-RNA
spliced	splice	VBN	I-VP	I-RNA
transcripts	transcript	NNS	B-NP	I-RNA
.	.	.	O	O

Whether	Whether	IN	B-SBAR	O
the	the	DT	B-NP	O
detected	detect	VBN	I-NP	O
transcripts	transcript	NNS	I-NP	O
are	be	VBP	B-VP	O
translated	translate	VBN	I-VP	O
into	into	IN	B-PP	O
functional	functional	JJ	B-NP	O
receptor	receptor	NN	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
remains	remain	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
determined	determine	VBN	I-VP	O
.	.	.	O	O

In	In	FW	B-NP	O
vitro	vitro	FW	I-NP	O
stimulation	stimulation	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
ER	ER	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
expression	expression	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
variants	variant	NNS	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
correlate	correlate	VB	I-VP	O
with	with	IN	B-PP	O
disease	disease	NN	B-NP	O
activity	activity	NN	I-NP	O
or	or	CC	I-NP	O
medication	medication	NN	I-NP	O
.	.	.	O	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
Monocytes	Monocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
express	express	VBP	B-VP	O
transcripts	transcript	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
wild	wild	JJ	I-NP	B-protein
type	type	NN	I-NP	I-protein
ER	ER	NN	I-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
hormone	hormone	NN	I-NP	B-protein
binding	binding	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
variants	variant	NNS	I-NP	I-protein
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

DNA	DNA	NN	B-NP	O
damaging	damaging	NN	I-NP	O
agents	agent	NNS	I-NP	O
induce	induce	VBP	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
Fas	Fas	NN	B-NP	B-protein
ligand	ligand	NN	I-NP	I-protein
and	and	CC	O	O
subsequent	subsequent	JJ	B-NP	O
apoptosis	apoptosis	NN	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
via	via	IN	B-PP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
and	and	CC	O	O
AP-1	AP-1	NN	B-NP	B-protein
.	.	.	O	O

Apoptosis	Apoptosis	NN	B-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
DNA	DNA	NN	B-NP	O
damage	damage	NN	I-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
stresses	stress	NNS	I-NP	O
can	can	MD	B-VP	O
proceed	proceed	VB	I-VP	O
via	via	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
Fas	Fas	NN	B-NP	B-protein
ligand	ligand	NN	I-NP	I-protein
(	(	(	O	O
FasL	FasL	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
ligation	ligation	NN	B-NP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
receptor	receptor	NN	I-NP	O
,	,	,	O	O
Fas	Fas	NN	B-NP	B-protein
(	(	(	O	O
CD95	CD95	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
that	that	IN	B-SBAR	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
and	and	CC	O	O
AP-1	AP-1	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
crucially	crucially	RB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
FasL	FasL	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
etoposide	etoposide	NN	B-NP	O
,	,	,	O	O
teniposide	teniposide	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
UV	UV	NN	B-NP	O
irradiation	irradiation	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
nondegradable	nondegradable	JJ	I-NP	O
mutant	mutant	NN	I-NP	O
of	of	IN	B-PP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
blocked	block	VBD	B-VP	O
both	both	CC	O	O
FasL	FasL	NN	B-NP	B-protein
expression	expression	NN	B-NP	O
and	and	CC	O	O
apoptosis	apoptosis	NN	B-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
DNA	DNA	NN	B-NP	O
damage	damage	NN	I-NP	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
Fas	Fas	NN	B-NP	B-protein
ligation	ligation	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
stimuli	stimulus	NNS	I-NP	O
also	also	RB	B-ADVP	O
induced	induce	VBD	B-VP	O
the	the	DT	B-NP	O
stress-activated	stress-activated	JJ	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
pathway	pathway	NN	I-NP	O
(	(	(	O	O
SAPK/JNK	SAPK/JNK	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
maximal	maximal	JJ	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
1.2	1.2	CD	I-NP	O
kb	kb	NN	I-NP	O
FasL	FasL	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
responded	respond	VBD	B-VP	O
to	to	TO	B-PP	O
DNA	DNA	NN	B-NP	O
damage	damage	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
coexpression	coexpression	NN	B-NP	O
with	with	IN	B-PP	O
p65	p65	NN	B-NP	B-protein
Rel	Rel	NN	I-NP	I-protein
or	or	CC	I-NP	O
Fos/Jun	Fos/Jun	NN	I-NP	B-protein
.	.	.	O	O

Mutations	Mutation	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
relevant	relevant	JJ	I-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
and	and	CC	O	O
AP-1	AP-1	NN	B-NP	B-DNA
binding	binding	NN	B-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
eliminated	eliminate	VBD	B-VP	O
these	these	DT	B-NP	O
responses	response	NNS	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
and	and	CC	O	O
AP-1	AP-1	NN	B-NP	B-protein
contributes	contribute	VBZ	B-VP	O
to	to	TO	B-PP	O
stress-induced	stress-induced	JJ	B-NP	O
apoptosis	apoptosis	NN	I-NP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
FasL	FasL	NN	B-NP	B-protein
.	.	.	O	O

A	A	DT	B-NP	O
small	small	JJ	I-NP	O
,	,	,	I-NP	O
nonpeptidyl	nonpeptidyl	JJ	I-NP	O
mimic	mimic	NN	I-NP	O
of	of	IN	B-PP	O
granulocyte-colony-stimulating	granulocyte-colony-stimulating	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
[	[	(	O	O
see	see	VB	B-VP	O
commetns	commetn	NNS	B-NP	O
]	]	)	O	O

A	A	DT	B-NP	O
nonpeptidyl	nonpeptidyl	JJ	I-NP	O
small	small	JJ	I-NP	O
molecule	molecule	NN	I-NP	O
SB	SB	NN	I-NP	O
247464	247464	CD	I-NP	O
,	,	,	O	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
activating	activate	VBG	B-VP	O
granulocyte-colony-stimulating	granulocyte-colony-stimulating	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
G-CSF	G-CSF	NN	B-NP	B-protein
)	)	)	O	O
signal	signal	NN	B-NP	O
transduction	transduction	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
high-throughput	high-throughput	JJ	I-NP	O
assay	assay	NN	I-NP	O
in	in	IN	B-PP	O
cultured	culture	VBN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Like	Like	IN	B-PP	O
G-CSF	G-CSF	NN	B-NP	B-protein
,	,	,	O	O
SB	SB	NN	B-NP	O
247464	247464	CD	I-NP	O
induced	induce	VBD	B-VP	O
tyrosine	tyrosine	NN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	B-protein
signaling	signaling	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
and	and	CC	O	O
stimulated	stimulate	VBN	B-VP	O
primary	primary	JJ	B-NP	B-cell_type
murine	murine	JJ	I-NP	I-cell_type
bone	bone	NN	I-NP	I-cell_type
marrow	marrow	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-VP	O
form	form	VB	I-VP	O
granulocytic	granulocytic	JJ	B-NP	B-cell_type
colonies	colony	NNS	I-NP	I-cell_type
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

It	It	PRP	B-NP	O
also	also	RB	B-ADVP	O
elevated	elevate	VBD	B-VP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
neutrophil	neutrophil	NN	I-NP	I-cell_type
counts	count	NNS	I-NP	O
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
extracellular	extracellular	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	B-protein
G-CSF	G-CSF	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
was	be	VBD	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
SB	SB	NN	B-NP	O
247464	247464	CD	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
compound	compound	NN	I-NP	O
acts	act	VBZ	B-VP	O
by	by	IN	B-PP	O
oligomerizing	oligomerize	VBG	B-VP	B-protein
receptor	receptor	NN	B-NP	I-protein
chains	chain	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
molecule	molecule	NN	I-NP	O
can	can	MD	B-VP	O
activate	activate	VB	I-VP	O
a	a	DT	B-NP	O
receptor	receptor	NN	I-NP	O
that	that	WDT	B-NP	O
normally	normally	RB	B-ADVP	O
binds	bind	VBZ	B-VP	O
a	a	DT	B-NP	O
relatively	relatively	RB	I-NP	O
large	large	JJ	I-NP	O
protein	protein	NN	I-NP	O
ligand	ligand	NN	I-NP	O
.	.	.	O	O

Minimal	Minimal	JJ	B-NP	O
residual	residual	JJ	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
myelogenous	myelogenous	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
with	with	IN	B-PP	O
PML/RAR	PML/RAR	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
or	or	CC	O	O
AML1/ETO	AML1/ETO	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
and	and	CC	O	O
phenotypic	phenotypic	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
possible	possible	JJ	B-NP	O
T	T	NN	I-NP	O
and	and	CC	I-NP	O
natural	natural	JJ	I-NP	B-cell_type
killer	killer	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
bone	bone	NN	B-NP	O
marrow	marrow	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
studied	study	VBD	B-VP	O
minimal	minimal	JJ	B-NP	O
residual	residual	JJ	I-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
MRD	MRD	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
myeloid	myeloid	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
AML	AML	NN	B-NP	O
)	)	)	O	O
who	who	WP	B-NP	O
have	have	VBP	B-VP	O
PML/RAR	PML/RAR	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
or	or	CC	I-NP	O
AML1/ETO	AML1/ETO	NN	I-NP	B-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
phenotypic	phenotypic	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
lymphocyte	lymphocyte	NN	B-NP	B-cell_type
subsets	subset	NNS	I-NP	I-cell_type
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
antitumor	antitumor	NN	B-NP	O
immunity	immunity	NN	I-NP	O
.	.	.	O	O

Eight	Eight	CD	B-NP	O
patients	patient	NNS	I-NP	O
in	in	IN	B-PP	O
long-term	long-term	JJ	O	O
(	(	(	O	O
LT	LT	JJ	B-ADJP	O
;	;	:	O	O
3	3	CD	B-NP	O
to	to	TO	I-NP	O
15	15	CD	I-NP	O
years	year	NNS	I-NP	O
)	)	)	O	O
and	and	CC	O	O
15	15	CD	B-NP	O
patients	patient	NNS	I-NP	O
in	in	IN	B-PP	O
short-term	short-term	JJ	O	O
(	(	(	O	O
ST	ST	JJ	B-ADJP	O
;	;	:	O	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
3	3	CD	I-NP	O
years	year	NNS	I-NP	O
)	)	)	O	O
remission	remission	NN	B-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
the	the	DT	B-NP	O
reverse	reverse	JJ	I-NP	O
transcription-polymerase	transcription-polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
(	(	(	O	O
RT	RT	NN	B-NP	O
)	)	)	O	O
assay	assay	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
limit	limit	NN	I-NP	O
of	of	IN	B-PP	O
detection	detection	NN	B-NP	O
was	be	VBD	B-VP	O
10	10	CD	B-NP	O
(	(	(	O	O
-5	-5	CD	B-NP	O
)	)	)	O	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
(	(	(	O	O
-6	-6	CD	B-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
PML/RAR	PML/RAR	NN	B-NP	B-RNA
alpha	alpha	NN	I-NP	I-RNA
transcript	transcript	NN	I-NP	I-RNA
and	and	CC	O	O
10	10	CD	B-NP	O
(	(	(	O	O
-4	-4	CD	B-NP	O
)	)	)	O	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
(	(	(	O	O
-5	-5	CD	B-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
AML1/ETO	AML1/ETO	NN	I-NP	B-RNA
transcript	transcript	NN	I-NP	I-RNA
.	.	.	O	O

Simultaneously	Simultaneously	RB	B-ADVP	O
,	,	,	O	O
T	T	NN	B-NP	B-cell_type
lymphocyte	lymphocyte	NN	I-NP	I-cell_type
subsets	subset	NNS	I-NP	I-cell_type
and	and	CC	O	O
NK	NK	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
the	the	DT	B-NP	O
peripheral	peripheral	JJ	I-NP	O
blood	blood	NN	I-NP	O
(	(	(	O	O
PB	PB	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
bone	bone	NN	B-NP	O
marrow	marrow	NN	I-NP	O
(	(	(	O	O
BM	BM	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
by	by	IN	B-PP	O
flow	flow	NN	B-NP	O
cytometric	cytometric	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O

Four	Four	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
eight	eight	CD	I-NP	O
patients	patient	NNS	I-NP	O
in	in	IN	B-PP	O
LT	LT	NN	B-NP	B-protein
and	and	CC	O	I-protein
7	7	CD	B-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
15	15	CD	I-NP	O
patients	patient	NNS	I-NP	O
in	in	IN	B-PP	O
ST	ST	JJ	B-NP	O
remission	remission	NN	I-NP	O
were	be	VBD	B-VP	O
MRD-positive	MRD-positive	JJ	B-ADJP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
all	all	DT	B-NP	O
MRD-positive	MRD-positive	JJ	I-NP	O
patients	patient	NNS	I-NP	O
in	in	IN	B-PP	O
LT	LT	NN	B-NP	O
remission	remission	NN	I-NP	O
are	be	VBP	B-VP	O
still	still	RB	B-ADVP	O
until	until	IN	B-PP	O
now	now	RB	B-NP	O
event-free	event-free	JJ	B-ADJP	O
,	,	,	O	O
3	3	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
7	7	CD	I-NP	O
MRD-positive	MRD-positive	JJ	I-NP	O
(	(	(	O	O
MRD+	MRD+	JJ	B-ADJP	O
)	)	)	O	O
patients	patient	NNS	B-NP	O
in	in	IN	B-PP	O
ST	ST	JJ	B-NP	O
remission	remission	NN	I-NP	O
soon	soon	RB	B-ADVP	O
relapsed	relapse	VBD	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
total	total	JJ	I-NP	O
populations	population	NNS	I-NP	O
of	of	IN	B-PP	O
CD4	CD4	NN	B-NP	B-protein
+	+	SYM	B-NP	O
,	,	,	O	O
CD8	CD8	NN	B-NP	B-protein
+	+	SYM	B-NP	O
and	and	CC	O	O
CD56	CD56	NN	B-NP	B-protein
+	+	SYM	O	O
[	[	(	O	O
possible	possible	JJ	B-NP	O
T-cell	T-cell	NN	I-NP	O
and	and	CC	O	O
natural	natural	JJ	B-NP	B-cell_type
killer	killer	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
T/NK	T/NK	NN	B-NP	I-cell_type
)	)	)	O	I-cell_type
populations	population	NNS	B-NP	I-cell_type
]	]	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
BM	BM	NN	I-NP	O
of	of	IN	B-PP	O
ST	ST	JJ	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
MRD+/LT	MRD+/LT	NN	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	JJR	B-NP	O
.01	.01	CD	I-NP	O
)	)	)	O	O
low	low	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
CD8+	CD8+	JJ	I-NP	B-cell_type
CD28+	CD28+	JJ	I-NP	I-cell_type
population	population	NN	I-NP	I-cell_type
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
tendency	tendency	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	JJR	B-NP	O
.01-.02	.01-.02	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
T/NK	T/NK	NN	I-NP	B-cell_type
subsets	subset	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
the	the	DT	B-NP	O
BM	BM	NN	I-NP	O
of	of	IN	B-PP	O
MRD-negative	MRD-negative	JJ	O	O
(	(	(	O	O
MRD-	MRD-	JJ	B-ADJP	O
)	)	)	O	O
LT	LT	NN	B-NP	O
(	(	(	O	O
MRD-/LT	MRD-/LT	JJ	O	O
)	)	)	O	O
patients	patient	NNS	B-NP	O
showed	show	VBD	B-VP	O
similar	similar	JJ	B-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
as	as	IN	B-PP	O
normal	normal	JJ	B-NP	O
volunteers	volunteer	NNS	I-NP	O
.	.	.	O	O

Basically	Basically	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
percentage	percentage	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CD4+	CD4+	JJ	I-NP	B-cell_type
,	,	,	I-NP	I-cell_type
CD8+	CD8+	JJ	I-NP	I-cell_type
and	and	CC	I-NP	I-cell_type
CD56+	CD56+	JJ	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
populations	population	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
the	the	DT	B-NP	O
BM	BM	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
and	and	CC	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
order	order	NN	I-NP	O
:	:	:	O	O
MRD-/LT	MRD-/LT	JJ	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
volunteers	volunteer	NNS	I-NP	O
,	,	,	O	O
MRD+/LT	MRD+/LT	JJ	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
MRD+	MRD+	JJ	B-NP	O
or	or	CC	I-NP	O
-/ST	-/ST	JJ	I-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
percentages	percentage	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
T/NK-cell	T/NK-cell	NN	I-NP	B-cell_type
subsets	subset	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
the	the	DT	B-NP	O
PB	PB	NN	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	B-ADJP	O
significantly	significantly	RB	I-ADJP	O
different	different	JJ	I-ADJP	O
among	among	IN	B-PP	O
these	these	DT	B-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
difference	difference	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
T/NK-cell	T/NK-cell	NN	I-NP	O
phenotype	phenotype	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
BM	BM	NN	I-NP	O
may	may	MD	B-VP	O
strongly	strongly	RB	I-VP	O
influence	influence	VB	I-VP	O
clinical	clinical	JJ	B-NP	O
and	and	CC	I-NP	O
molecular	molecular	JJ	I-NP	O
remission	remission	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
still	still	RB	B-ADVP	O
remain	remain	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
confirmed	confirm	VBN	I-VP	O
by	by	IN	B-PP	O
further	further	JJ	B-NP	O
studies	study	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	O
anti-tumor	anti-tumor	JJ	I-NP	O
immunity	immunity	NN	I-NP	O
of	of	IN	B-PP	O
T/NK	T/NK	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
AML	AML	NN	B-NP	O
in	in	IN	B-PP	O
remission	remission	NN	B-NP	O
.	.	.	O	O

Mycobacterium	Mycobacterium	NN	B-NP	O
tuberculosis	tuberculosis	NN	I-NP	O
mannose-capped	mannose-capped	JJ	I-NP	O
lipoarabinomannan	lipoarabinomannan	NN	I-NP	O
can	can	MD	B-VP	O
induce	induce	VB	I-VP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-DNA
immunodeficiency	immunodeficiency	NN	I-NP	I-DNA
virus	virus	NN	I-NP	I-DNA
type	type	NN	I-NP	I-DNA
1	1	CD	I-NP	I-DNA
long	long	JJ	I-NP	I-DNA
terminal	terminal	JJ	I-NP	I-DNA
repeat	repeat	NN	I-NP	I-DNA
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Tuberculosis	Tuberculosis	NN	B-NP	O
has	have	VBZ	B-VP	O
emerged	emerge	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
epidemic	epidemic	JJ	I-NP	O
,	,	,	O	O
extended	extend	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
large	large	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
individuals	individual	NNS	B-NP	O
infected	infect	VBN	B-VP	O
with	with	IN	B-PP	O
human	human	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
HIV-1	HIV-1	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
major	major	JJ	I-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
the	the	DT	B-NP	O
mycobacterial	mycobacterial	JJ	I-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
wall	wall	NN	I-NP	O
component	component	NN	I-NP	O
mannose-capped	mannose-capped	JJ	I-NP	O
lipoarabinomannan	lipoarabinomannan	NN	I-NP	O
(	(	(	O	O
ManLAM	ManLAM	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
Mycobacterium	Mycobacterium	NN	B-NP	O
tuberculosis	tuberculosis	NN	I-NP	O
(	(	(	O	O
M.	M.	NN	B-NP	O
tuberculosis	tuberculosis	NN	I-NP	O
)	)	)	O	O
could	could	MD	B-VP	O
activate	activate	VB	I-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
cell	cell	NN	I-NP	O
culture	culture	NN	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
experiments	experiment	NNS	I-NP	O
are	be	VBP	B-VP	O
of	of	IN	B-PP	O
prime	prime	JJ	B-NP	O
importance	importance	NN	I-NP	O
considering	consider	VBG	B-VP	O
that	that	IN	B-SBAR	O
CD4	CD4	NN	B-NP	B-protein
-expressing	-expressing	JJ	I-NP	O
T	T	NN	I-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O
represent	represent	VBP	B-VP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
virus	virus	NN	I-NP	O
reservoir	reservoir	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
peripheral	peripheral	JJ	I-NP	O
blood	blood	NN	I-NP	O
of	of	IN	B-PP	O
infected	infected	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
the	the	DT	B-NP	O
1G5	1G5	NN	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
harbouring	harbour	VBG	B-VP	O
the	the	DT	B-NP	O
luciferase	luciferase	NN	I-NP	B-DNA
reporter	reporter	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
under	under	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HIV-1	HIV-1	NN	I-NP	B-DNA
LTR	LTR	NN	I-NP	I-DNA
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
first	first	RB	I-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
culture	culture	NN	B-NP	O
protein	protein	NN	I-NP	O
filtrates	filtrate	NNS	I-NP	O
(	(	(	O	O
CFP	CFP	NN	B-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
M.	M.	FW	B-NP	O
tuberculosis	tuberculosis	FW	I-NP	O
or	or	CC	O	O
purified	purify	VBN	B-NP	O
ManLAM	ManLAM	NN	I-NP	O
could	could	MD	B-VP	O
activate	activate	VB	I-VP	O
HIV-1	HIV-1	NN	B-NP	B-DNA
LTR-dependent	LTR-dependent	JJ	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
unlike	unlike	IN	B-PP	O
similarly	similarly	RB	B-NP	O
prepared	prepare	VBN	I-NP	O
CFP	CFP	NN	I-NP	O
extracts	extract	NNS	I-NP	O
devoid	devoid	JJ	B-ADJP	O
of	of	IN	B-PP	O
ManLAM	ManLAM	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
implication	implication	NN	I-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	B-protein
tyrosine	tyrosine	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
protein	protein	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
A	A	NN	I-NP	I-protein
and/or	and/or	CC	O	O
protein	protein	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
C	C	NN	I-NP	I-protein
was	be	VBD	B-VP	O
highlighted	highlight	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
abrogation	abrogation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ManLAM-mediated	ManLAM-mediated	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	B-DNA
LTR-driven	LTR-driven	JJ	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
using	use	VBG	B-VP	O
herbimycin	herbimycin	NN	B-NP	O
A	A	NN	I-NP	O
and	and	CC	I-NP	O
H7	H7	NN	I-NP	B-protein
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
determined	determine	VBN	I-VP	O
,	,	,	O	O
using	use	VBG	B-VP	O
electrophoresis	electrophoresis	NN	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
,	,	,	O	O
that	that	IN	B-SBAR	O
M.	M.	FW	B-NP	O
tuberculosis	tuberculosis	FW	I-NP	O
ManLAM	ManLAM	NN	I-NP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
translocation	translocation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
.	.	.	O	O

M.	M.	FW	B-NP	O
tuberculosis	tuberculosis	FW	I-NP	O
ManLAM	ManLAM	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
clear	clear	JJ	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
luciferase	luciferase	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
placed	place	VBN	B-VP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
wild-type	wild-type	JJ	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
the	the	DT	B-NP	O
kappaB-mutated	kappaB-mutated	JJ	I-NP	O
,	,	,	I-NP	O
HIV-1	HIV-1	NN	I-NP	B-DNA
LTR	LTR	NN	I-NP	I-DNA
region	region	NN	I-NP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
ManLAM-mediated	ManLAM-mediated	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	B-DNA
LTR	LTR	NN	I-NP	I-DNA
transcription	transcription	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
autocrine	autocrine	JJ	I-NP	O
or	or	CC	I-NP	O
paracrine	paracrine	JJ	I-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
endogenous	endogenous	JJ	B-NP	B-protein
TNF-alpha	TNF-alpha	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
M.	M.	NN	B-NP	O
tuberculosis	tuberculosis	NN	I-NP	O
can	can	MD	B-VP	O
upregulate	upregulate	VB	I-VP	O
HIV-1	HIV-1	NN	B-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
could	could	MD	B-VP	O
thus	thus	RB	I-VP	O
have	have	VB	I-VP	O
the	the	DT	B-NP	O
potential	potential	NN	I-NP	O
to	to	TO	B-VP	O
influence	influence	VB	I-VP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Human	Human	JJ	B-NP	B-DNA
immunodeficiency	immunodeficiency	NN	I-NP	I-DNA
virus	virus	NN	I-NP	I-DNA
type	type	NN	I-NP	I-DNA
1	1	CD	I-NP	I-DNA
long	long	JJ	I-NP	I-DNA
terminal	terminal	JJ	I-NP	I-DNA
repeat	repeat	NN	I-NP	I-DNA
quasispecies	quasispecy	NNS	I-NP	I-DNA
differ	differ	VBP	B-VP	O
in	in	IN	B-PP	O
basal	basal	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
recruitment	recruitment	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
glial	glial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
generation	generation	NN	I-NP	O
of	of	IN	B-PP	O
genomic	genomic	JJ	B-NP	O
diversity	diversity	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
has	have	VBZ	B-VP	O
the	the	DT	B-NP	O
potential	potential	NN	I-NP	O
to	to	TO	B-VP	O
affect	affect	VB	I-VP	O
all	all	DT	B-NP	O
aspects	aspect	NNS	I-NP	O
of	of	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	O
replication	replication	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proviral	proviral	JJ	I-NP	B-DNA
genome	genome	NN	I-NP	I-DNA
.	.	.	O	O

To	To	TO	B-VP	O
gain	gain	VB	I-VP	O
a	a	DT	B-NP	O
better	good	JJR	I-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
impact	impact	NN	I-NP	O
of	of	IN	B-PP	O
long	long	JJ	B-NP	B-DNA
terminal	terminal	JJ	I-NP	I-DNA
repeat	repeat	NN	I-NP	I-DNA
(	(	(	O	O
LTR	LTR	NN	B-NP	B-DNA
)	)	)	O	O
sequence	sequence	NN	B-NP	O
diversity	diversity	NN	I-NP	O
on	on	IN	B-PP	O
LTR-directed	LTR-directed	JJ	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
central	central	JJ	I-NP	O
nervous	nervous	JJ	I-NP	O
system	system	NN	I-NP	O
(	(	(	O	O
CNS	CNS	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
immune	immune	JJ	B-NP	O
system	system	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
amplified	amplify	VBD	B-VP	O
and	and	CC	O	O
cloned	clone	VBN	B-NP	O
LTRs	LTR	NNS	I-NP	B-DNA
from	from	IN	B-PP	O
proviral	proviral	JJ	B-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
in	in	IN	B-PP	O
HIV-1-infected	HIV-1-infected	JJ	B-NP	O
peripheral	peripheral	JJ	I-NP	O
blood	blood	NN	I-NP	O
.	.	.	O	O

Sequence	Sequence	NN	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
nineteen	nineteen	CD	B-NP	O
LTRs	LTR	NNS	I-NP	B-DNA
cloned	clone	VBN	B-VP	O
from	from	IN	B-PP	O
2	2	CD	B-NP	O
adult	adult	JJ	I-NP	O
and	and	CC	O	O
3	3	CD	B-NP	O
pediatric	pediatric	JJ	I-NP	O
patients	patient	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
average	average	NN	I-NP	O
of	of	IN	B-PP	O
33	33	CD	B-NP	O
nucleotide	nucleotide	NN	I-NP	O
changes	change	NNS	I-NP	O
(	(	(	O	O
with	with	IN	B-PP	O
respect	respect	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
LAI	LAI	NN	I-NP	B-DNA
LTR	LTR	NN	I-NP	I-DNA
)	)	)	O	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
455-bp	455-bp	JJ	I-NP	B-DNA
U3	U3	NN	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
.	.	.	O	O

Transient	Transient	JJ	B-NP	O
expression	expression	NN	I-NP	O
analyses	analysis	NNS	I-NP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
of	of	IN	B-PP	O
neuroglial	neuroglial	JJ	B-NP	O
and	and	CC	I-NP	O
lymphocytic	lymphocytic	JJ	I-NP	O
origin	origin	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
LTRs	LTR	NNS	I-NP	B-DNA
had	have	VBD	B-VP	O
activities	activity	NNS	B-NP	O
which	which	WDT	B-NP	O
varied	vary	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
LAI	LAI	NN	I-NP	B-DNA
LTR	LTR	NN	I-NP	I-DNA
in	in	IN	B-PP	O
U-373	U-373	NN	B-NP	B-cell_line
MG	MG	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
(	(	(	O	O
an	an	DT	B-NP	O
astrocytoma	astrocytoma	NN	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
)	)	)	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
in	in	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
(	(	(	O	O
a	a	DT	B-NP	O
CD4-positive	CD4-positive	JJ	I-NP	B-cell_line
lymphocyte	lymphocyte	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
)	)	)	O	O
.	.	.	O	O

While	While	IN	B-SBAR	O
LTRs	LTR	NNS	B-NP	B-DNA
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
activities	activity	NNS	I-NP	O
in	in	IN	B-PP	O
U-373	U-373	NN	B-NP	B-cell_line
MG	MG	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
also	also	RB	B-ADVP	O
yielded	yield	VBD	B-VP	O
high	high	JJ	B-NP	O
activities	activity	NNS	I-NP	O
in	in	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
the	the	DT	B-NP	O
LTRs	LTR	NNS	I-NP	B-DNA
were	be	VBD	B-VP	O
generally	generally	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
active	active	JJ	I-ADJP	O
in	in	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
LAI	LAI	NN	I-NP	B-DNA
LTR	LTR	NN	I-NP	I-DNA
.	.	.	O	O

Differences	Difference	NNS	B-NP	O
in	in	IN	B-PP	O
LTR	LTR	NN	B-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
also	also	RB	B-ADVP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
differences	difference	NNS	B-NP	O
in	in	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
recruitment	recruitment	NN	I-NP	O
to	to	TO	B-PP	O
cis-acting	cis-acting	JJ	B-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
within	within	IN	B-PP	O
the	the	DT	B-NP	O
U3	U3	NN	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
LTR	LTR	NN	I-NP	B-DNA
,	,	,	O	O
as	as	IN	B-SBAR	O
demonstrated	demonstrate	VBN	B-VP	O
by	by	IN	B-PP	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
particular	particular	JJ	B-NP	O
,	,	,	O	O
naturally	naturally	RB	B-VP	O
occurring	occur	VBG	I-VP	O
sequence	sequence	NN	B-NP	O
variation	variation	NN	I-NP	O
impacted	impact	VBD	B-VP	O
transcription	transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
activating	activate	VBG	I-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
/	/	SYM	B-NP	O
cAMP	cAMP	NN	I-NP	O
response	response	NN	I-NP	O
element	element	NN	I-NP	O
binding	binding	NN	I-NP	O
(	(	(	O	O
ATF	ATF	NN	B-NP	B-protein
/	/	SYM	B-NP	O
CREB	CREB	NN	I-NP	B-protein
)	)	)	O	O
binding	binding	NN	B-NP	O
site	site	NN	I-NP	O
(	(	(	O	O
located	located	JJ	B-ADJP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
LEF-1	LEF-1	NN	I-NP	B-protein
and	and	CC	O	O
distal	distal	JJ	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
transcription	transcription	NN	I-NP	O
factor	factor	NN	I-NP	O
binding	binding	NN	I-NP	O
sites	site	NNS	I-NP	O
)	)	)	O	O
that	that	WDT	B-NP	O
we	we	PRP	B-NP	O
identified	identify	VBD	B-VP	O
in	in	IN	B-PP	O
previous	previous	JJ	B-NP	O
studies	study	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HIV-1	HIV-1	NN	I-NP	B-DNA
LTR	LTR	NN	I-NP	I-DNA
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
LTR	LTR	NN	B-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
changes	change	NNS	I-NP	O
can	can	MD	B-VP	O
significantly	significantly	RB	I-VP	O
affect	affect	VB	I-VP	O
basal	basal	JJ	B-NP	O
LTR	LTR	NN	I-NP	B-DNA
function	function	NN	I-NP	O
and	and	CC	O	O
transcription	transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
recruitment	recruitment	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
,	,	,	O	O
in	in	IN	B-PP	O
turn	turn	NN	B-NP	O
,	,	,	O	O
alter	alter	VBP	B-VP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
viral	viral	JJ	B-NP	O
replication	replication	NN	I-NP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
of	of	IN	B-PP	O
CNS	CNS	NN	B-NP	B-protein
and	and	CC	O	O
immune	immune	JJ	B-NP	O
system	system	NN	I-NP	O
origin	origin	NN	I-NP	O
.	.	.	O	O

HMG	HMG	NN	B-NP	B-protein
box	box	NN	I-NP	I-protein
containing	contain	VBG	B-VP	O
transcription	transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
lymphocyte	lymphocyte	NN	B-NP	B-cell_type
differentiation	differentiation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
identification	identification	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mammalian	mammalian	JJ	I-NP	B-DNA
sex-determining	sex-determining	JJ	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
Sry	Sry	NN	I-NP	I-DNA
has	have	VBZ	B-VP	O
led	lead	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
discovery	discovery	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
related	related	JJ	B-NP	O
(	(	(	O	O
'	'	``	O	O
HMG	HMG	NN	B-NP	B-protein
box	box	NN	I-NP	I-protein
'	'	''	O	O
)	)	)	O	O
transcription	transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
control	control	VBP	B-VP	O
developmental	developmental	JJ	B-NP	O
events	event	NNS	I-NP	O
in	in	IN	B-PP	O
yeast	yeast	NN	B-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
elegans	elegans	NNP	I-NP	O
,	,	,	O	O
Drosophila	Drosophila	NNP	B-NP	O
and	and	CC	O	O
vertebrates	vertebrate	NNS	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
lymphocyte	lymphocyte	NN	B-NP	B-cell_type
differentiation	differentiation	NN	I-NP	O
,	,	,	O	O
several	several	JJ	B-NP	O
HMG	HMG	NN	I-NP	B-protein
box	box	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
play	play	VBP	B-VP	O
a	a	DT	B-NP	O
decisive	decisive	JJ	I-NP	O
role	role	NN	I-NP	O
.	.	.	O	O

Sox-4	Sox-4	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
very	very	RB	B-NP	O
early	early	JJ	I-NP	O
B-cell	B-cell	NN	I-NP	O
differentiation	differentiation	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
TCF-1	TCF-1	NN	B-NP	B-protein
/	/	SYM	B-NP	O
LEF-1	LEF-1	NN	I-NP	B-protein
play	play	VBP	B-VP	O
a	a	DT	B-NP	O
crucial	crucial	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
early	early	JJ	B-NP	O
thymocyte	thymocyte	NN	I-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

TCF/LEF	TCF/LEF	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
have	have	VBP	B-VP	O
recently	recently	RB	I-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
constitute	constitute	VB	I-VP	O
a	a	DT	B-NP	O
downstream	downstream	JJ	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Wingless/Wnt	Wingless/Wnt	NN	I-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
pathway	pathway	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
flies	fly	NNS	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
pathway	pathway	NN	I-NP	O
controls	control	VBZ	B-VP	O
segment	segment	NN	B-NP	O
polarity	polarity	NN	I-NP	O
;	;	:	O	O
in	in	IN	B-PP	O
Xenopus	Xenopus	NN	B-NP	O
it	it	PRP	B-NP	O
controls	control	VBZ	B-VP	O
the	the	DT	B-NP	O
definition	definition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
body	body	NN	I-NP	O
axis	axis	NN	I-NP	O
.	.	.	O	O

Deregulation	Deregulation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pathway	pathway	NN	I-NP	O
occurs	occur	VBZ	B-VP	O
in	in	IN	B-PP	O
several	several	JJ	B-NP	O
human	human	JJ	I-NP	O
tumors	tumor	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
insights	insight	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
events	event	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
TCF/LEF	TCF/LEF	NN	B-NP	B-protein
function	function	NN	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
organisms	organism	NNS	I-NP	O
may	may	MD	B-VP	O
eventually	eventually	RB	I-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
HMG	HMG	NN	I-NP	B-protein
box	box	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
in	in	IN	B-PP	O
lymphoid	lymphoid	JJ	B-NP	O
development	development	NN	I-NP	O

Transcriptional	Transcriptional	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
by	by	IN	B-PP	O
C/EBP	C/EBP	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
and	and	CC	O	I-protein
-beta	-beta	NN	B-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
MRP14	MRP14	NN	I-NP	B-protein
myeloid	myeloid	JJ	I-NP	I-protein
calcium	calcium	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

Transcriptional	Transcriptional	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
myeloid	myeloid	JJ	I-NP	B-protein
calcium	calcium	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
,	,	,	O	O
MRP14	MRP14	NN	B-NP	B-protein
,	,	,	O	O
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
monocytic	monocytic	JJ	I-NP	I-cell_line
leukemia	leukemia	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
MRP14	MRP14	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
monoblastic	monoblastic	JJ	B-NP	B-cell_line
ML-1	ML-1	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
promonocytic	promonocytic	JJ	B-NP	B-cell_line
U-937	U-937	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
or	or	CC	O	O
promyelocytic	promyelocytic	JJ	B-NP	B-cell_line
HL-60	HL-60	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
hand	hand	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
was	be	VBD	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
monocytic	monocytic	JJ	B-NP	B-cell_line
THP-1	THP-1	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
HL-60	HL-60	NN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
25-dihydroxyvitamin	25-dihydroxyvitamin	NN	B-NP	O
D3	D3	NN	I-NP	O
(	(	(	O	O
VD3	VD3	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
MRP14	MRP14	NN	B-NP	B-protein
in	in	IN	B-PP	O
VD3-treated	VD3-treated	JJ	B-NP	B-cell_line
HL-60	HL-60	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
was	be	VBD	B-VP	O
two-fold	two-fold	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
THP-1	THP-1	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Among	Among	IN	B-PP	O
several	several	JJ	B-NP	O
known	known	JJ	I-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
binding	binding	NN	I-NP	O
motifs	motif	NNS	I-NP	O
,	,	,	O	O
nuclear	nuclear	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
VD3-treated	VD3-treated	JJ	B-NP	B-cell_line
HL-60	HL-60	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
and	and	CC	O	O
THP-1	THP-1	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
bound	bind	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCAAT/enhancer	CCAAT/enhancer	NN	I-NP	B-protein
binding	binding	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	O
C/EBP	C/EBP	NN	B-NP	O
)	)	)	O	O
-binding	-binding	JJ	B-NP	O
motif	motif	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
located	located	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upstream	upstream	JJ	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MRP14	MRP14	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
(	(	(	O	O
-81	-81	CD	B-NP	B-DNA
)	)	)	O	O
,	,	,	O	O
as	as	IN	B-SBAR	O
evidenced	evidence	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
competitive	competitive	JJ	I-NP	O
gel	gel	NN	I-NP	O
mobility-shift	mobility-shift	NN	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
antibody	antibody	NN	I-NP	O
for	for	IN	B-PP	O
C/EBP	C/EBP	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
super-shifted	super-shifte	VBD	B-VP	O
the	the	DT	B-NP	O
nucleoprotein	nucleoprotein	NN	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
in	in	IN	B-PP	O
THP-1	THP-1	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
but	but	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
the	the	DT	B-NP	O
VD3-treated	VD3-treated	JJ	I-NP	B-cell_line
HL-60	HL-60	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
whereas	whereas	IN	O	O
an	an	DT	B-NP	O
antibody	antibody	NN	I-NP	O
for	for	IN	B-PP	O
C/EBP	C/EBP	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
blocked	block	VBD	B-VP	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
complex	complex	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HL-60	HL-60	NN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
but	but	CC	B-PP	O
not	not	RB	B-PP	O
with	with	IN	I-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
THP-1	THP-1	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

An	An	DT	B-NP	O
anti-C/EBP	anti-C/EBP	JJ	I-NP	B-protein
delta	delta	NN	I-NP	I-protein
antibody	antibody	NN	I-NP	I-protein
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
complex	complex	NN	I-NP	O
in	in	IN	B-PP	O
either	either	DT	B-NP	O
cell	cell	NN	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
C/EBP	C/EBP	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
and	and	CC	O	I-protein
-beta	-beta	NN	B-NP	I-protein
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
C/EBP	C/EBP	NN	I-NP	B-DNA
motif	motif	NN	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
C/EBP	C/EBP	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
bound	bind	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
motif	motif	NN	I-NP	O
in	in	IN	B-PP	O
THP-1	THP-1	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
and	and	CC	O	O
C/EBP	C/EBP	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
bound	bind	VBD	B-VP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
VD3-treated	VD3-treated	JJ	I-NP	B-cell_line
HL-60	HL-60	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
C/EBP	C/EBP	NN	I-NP	B-DNA
motif	motif	NN	I-NP	I-DNA
,	,	,	O	O
we	we	PRP	B-NP	O
transfected	transfecte	VBD	B-VP	O
several	several	JJ	B-NP	O
constructed	construct	VBN	I-NP	O
luciferase	luciferase	NN	I-NP	B-DNA
reporter	reporter	NN	I-NP	I-DNA
DNAs	DNA	NNS	I-NP	I-DNA
into	into	IN	B-PP	O
HL-60	HL-60	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
and	and	CC	O	O
THP-1	THP-1	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
luciferase	luciferase	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
C/EBP	C/EBP	NN	I-NP	B-DNA
motif	motif	NN	I-NP	I-DNA
in	in	IN	B-PP	O
HL-60	HL-60	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
by	by	IN	B-PP	O
VD3	VD3	NN	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
C/EBP	C/EBP	NN	I-NP	B-DNA
motif	motif	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MRP14	MRP14	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
to	to	TO	I-VP	O
function	function	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
in	in	IN	B-PP	O
VD3-treated	VD3-treated	JJ	B-NP	B-cell_line
HL-60	HL-60	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
and	and	CC	O	O
THP-1	THP-1	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
by	by	IN	B-PP	O
the	the	DT	B-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
C/EBP	C/EBP	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
VD3-untreated	VD3-untreated	JJ	B-NP	B-cell_line
HL-60	HL-60	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
by	by	IN	B-PP	O
immunoblotting	immunoblotting	NN	B-NP	O
,	,	,	O	O
VD3	VD3	NN	B-NP	O
activated	activate	VBD	B-VP	O
C/EBP	C/EBP	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
motif	motif	NN	I-NP	O
,	,	,	O	O
probably	probably	RB	B-ADVP	O
through	through	IN	B-PP	O
post-translational	post-translational	JJ	B-NP	O
modification	modification	NN	I-NP	O
.	.	.	O	O

Patients	Patient	NNS	B-NP	O
with	with	IN	B-PP	O
high-risk	high-risk	JJ	B-NP	O
myelodysplastic	myelodysplastic	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
can	can	MD	B-VP	O
have	have	VB	I-VP	O
polyclonal	polyclonal	JJ	B-NP	O
or	or	CC	I-NP	O
clonal	clonal	JJ	I-NP	O
haemopoiesis	haemopoiesis	NN	I-NP	O
in	in	IN	B-PP	O
complete	complete	JJ	B-NP	O
haematological	haematological	JJ	I-NP	O
remission	remission	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
clonality	clonality	NN	I-NP	O
of	of	IN	B-PP	O
mature	mature	JJ	B-NP	O
peripheral	peripheral	JJ	I-NP	O
blood-derived	blood-derived	JJ	I-NP	O
myeloid	myeloid	JJ	I-NP	O
and	and	CC	I-NP	O
lymphoid	lymphoid	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
bone	bone	NN	B-NP	B-cell_type
marrow	marrow	NN	I-NP	I-cell_type
haemopoietic	haemopoietic	JJ	I-NP	I-cell_type
progenitors	progenitor	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
18	18	CD	B-NP	O
females	female	NNS	I-NP	O
with	with	IN	B-PP	O
myelodysplasia	myelodysplasia	NN	B-NP	O
(	(	(	O	O
MDS	MDS	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
five	five	CD	B-NP	O
refractory	refractory	JJ	I-NP	O
anaemia	anaemia	NN	I-NP	O
,	,	,	O	O
RA	RA	NN	B-NP	O
;	;	:	O	O
one	one	CD	B-NP	O
RA	RA	NN	I-NP	O
with	with	IN	B-PP	O
ringed	ringed	JJ	B-NP	B-cell_type
sideroblasts	sideroblast	NNS	I-NP	I-cell_type
,	,	,	O	O
RARS	RARS	NN	B-NP	B-protein
;	;	:	O	O
three	three	CD	B-NP	O
chronic	chronic	JJ	I-NP	O
myelomonocytic	myelomonocytic	JJ	I-NP	O
leukaemia	leukaemia	NN	I-NP	O
,	,	,	O	O
CMML	CMML	NN	B-NP	O
;	;	:	O	O
four	four	CD	B-NP	O
RA	RA	NN	I-NP	O
with	with	IN	B-PP	O
excess	excess	NN	B-NP	O
of	of	IN	B-PP	O
blasts	blast	NNS	B-NP	B-cell_type
,	,	,	O	O
RAEB	RAEB	NN	B-NP	B-protein
;	;	:	O	O
five	five	CD	B-NP	O
RAEB	RAEB	NN	I-NP	B-protein
in	in	IN	B-PP	O
transformation	transformation	NN	B-NP	O
,	,	,	O	O
RAEB-t	RAEB-t	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
by	by	IN	B-PP	O
X-chromosome	X-chromosome	NN	B-NP	B-DNA
inactivation	inactivation	NN	I-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-protein
androgen-receptor	androgen-receptor	NN	I-NP	I-protein
(	(	(	O	O
HUMARA	HUMARA	NN	B-NP	B-DNA
)	)	)	O	O
assay	assay	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
analysed	analyse	VBD	B-VP	O
the	the	DT	B-NP	O
clonal	clonal	JJ	I-NP	O
patterns	pattern	NNS	I-NP	O
of	of	IN	B-PP	O
highly	highly	RB	B-NP	B-cell_type
purified	purify	VBN	I-NP	I-cell_type
immature	immature	JJ	I-NP	I-cell_type
CD34+	CD34+	JJ	I-NP	I-cell_type
38-	38-	CD	I-NP	I-cell_type
and	and	CC	O	I-cell_type
committed	commit	VBN	B-VP	I-cell_type
CD34+	CD34+	JJ	B-NP	I-cell_type
38+	38+	JJ	I-NP	I-cell_type
marrow-derived	marrow-derived	JJ	I-NP	I-cell_type
progenitors	progenitor	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
CD16+	CD16+	JJ	B-NP	B-cell_type
14-	14-	JJ	I-NP	I-cell_type
granulocytes	granulocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
CD14+	CD14+	JJ	B-NP	B-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
CD3+	CD3+	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
and	and	CC	I-NP	I-cell_type
CD19+	CD19+	JJ	I-NP	I-cell_type
B	B	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
blood	blood	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
high-risk	high-risk	JJ	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
RAEB	RAEB	NN	B-NP	B-protein
,	,	,	I-NP	O
RAEB-t	RAEB-t	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
clonality	clonality	NN	B-NP	O
analysis	analysis	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
intensive	intensive	JJ	B-NP	O
remission-induction	remission-induction	NN	I-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
except	except	IN	B-PP	O
one	one	CD	B-NP	O
with	with	IN	B-PP	O
RA	RA	NN	B-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
predominance	predominance	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
clone	clone	NN	I-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
granulocytes	granulocyte	NNS	I-NP	B-cell_type
and	and	CC	I-NP	O
monocytes	monocyte	NNS	I-NP	B-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
same	same	JJ	I-NP	O
clonal	clonal	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
CD34+	CD34+	JJ	B-NP	B-cell_type
progenitor	progenitor	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
CD3+	CD3+	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
polyclonal	polyclonal	JJ	B-ADJP	O
or	or	CC	I-ADJP	O
oligoclonal	oligoclonal	JJ	I-ADJP	O
in	in	IN	B-PP	O
14/18	14/18	CD	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

X-chromosome	X-chromosome	NN	B-NP	B-DNA
inactivation	inactivation	NN	I-NP	O
patterns	pattern	NNS	I-NP	O
of	of	IN	B-PP	O
CD19+	CD19+	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
highly	highly	RB	B-ADJP	O
concordant	concordant	JJ	I-ADJP	O
with	with	IN	B-PP	O
CD3+	CD3+	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
except	except	IN	B-PP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
one	one	CD	B-NP	O
RA	RA	NN	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
CMML	CMML	NN	I-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
monoclonal	monoclonal	JJ	B-NP	B-protein
B	B	NN	I-NP	I-protein
and	and	CC	O	O
polyclonal	polyclonal	JJ	B-NP	O
T	T	NN	I-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
suggesting	suggest	VBG	B-VP	O
a	a	DT	B-NP	O
clonal	clonal	JJ	I-NP	O
mutation	mutation	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
progenitor	progenitor	NN	I-NP	O
common	common	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
myeloid	myeloid	JJ	I-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
B-lymphoid	B-lymphoid	JJ	I-NP	I-cell_type
lineages	lineage	NNS	I-NP	I-cell_type
or	or	CC	O	O
the	the	DT	B-NP	O
coexistence	coexistence	NN	I-NP	O
of	of	IN	B-PP	O
MDS	MDS	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
B-cell	B-cell	NN	I-NP	O
disorder	disorder	NN	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
particular	particular	JJ	I-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
high-dose	high-dose	JJ	B-NP	O
non-myeloablative	non-myeloablative	JJ	I-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
,	,	,	O	O
polyclonal	polyclonal	JJ	B-NP	O
haemopoiesis	haemopoiesis	NN	I-NP	O
was	be	VBD	B-VP	O
reinstalled	reinstall	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mature	mature	JJ	I-NP	B-cell_type
myeloid	myeloid	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
immature	immature	JJ	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
committed	commit	VBN	I-NP	I-cell_type
marrow	marrow	NN	I-NP	I-cell_type
progenitors	progenitor	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
three	three	CD	B-NP	O
of	of	IN	I-NP	O
four	four	CD	I-NP	O
patients	patient	NNS	I-NP	O
achieving	achieve	VBG	B-VP	O
complete	complete	JJ	B-NP	O
haematological	haematological	JJ	I-NP	O
remission	remission	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
we	we	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
most	most	JJS	B-NP	O
haematological	haematological	JJ	I-NP	O
remissions	remission	NNS	I-NP	O
in	in	IN	B-PP	O
MDS	MDS	NN	B-NP	O
are	be	VBP	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
restoration	restoration	NN	B-NP	O
of	of	IN	B-PP	O
polyclonal	polyclonal	JJ	B-NP	O
haemopoiesis	haemopoiesis	NN	I-NP	O
.	.	.	O	O

Prominent	Prominent	JJ	B-NP	O
sex	sex	NN	I-NP	O
steroid	steroid	NN	I-NP	O
metabolism	metabolism	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Steroid	Steroid	NN	B-NP	O
metabolism	metabolism	NN	I-NP	O
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
in	in	IN	B-PP	O
cultured	culture	VBN	B-NP	B-cell_line
human	human	JJ	I-NP	I-cell_line
B-lymphoblastoid	B-lymphoblastoid	JJ	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
(	(	(	O	O
B-LCL	B-LCL	NN	B-NP	B-cell_line
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
peripheral	peripheral	JJ	B-NP	O
blood	blood	NN	I-NP	O
T	T	NN	I-NP	O
and	and	CC	I-NP	O
B	B	NN	I-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

Gene	Gene	NN	B-NP	O
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
by	by	IN	B-PP	O
reverse-transcription	reverse-transcription	NN	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
amplification	amplification	NN	I-NP	O
(	(	(	O	O
RT-PCR	RT-PCR	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Appropriate	Appropriate	JJ	B-NP	O
sized	sized	JJ	I-NP	O
transcripts	transcript	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
cultured	culture	VBN	I-NP	O
and	and	CC	I-NP	O
fresh	fresh	JJ	I-NP	O
peripheral	peripheral	JJ	I-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
for	for	IN	B-PP	O
CYP11A	CYP11A	NN	B-NP	B-protein
,	,	,	O	O
CYP17	CYP17	NN	B-NP	B-protein
,	,	,	O	O
HSD11L	HSD11L	NN	B-NP	B-protein
(	(	(	O	O
11beta-hydroxysteroid	11beta-hydroxysteroid	JJ	B-NP	B-protein
dehydrogenase	dehydrogenase	NN	I-NP	I-protein
I	I	CD	I-NP	I-protein
)	)	)	O	O
,	,	,	O	O
HSD17B1	HSD17B1	NN	B-NP	B-protein
(	(	(	O	O
17beta-hydroxysteroid	17beta-hydroxysteroid	NN	B-NP	B-protein
dehydrogenase	dehydrogenase	NN	I-NP	I-protein
type	type	NN	I-NP	I-protein
I	I	CD	I-NP	I-protein
)	)	)	O	O
and	and	CC	O	O
SRD5A1	SRD5A1	NN	B-NP	B-protein
(	(	(	O	O
5alpha-reductase	5alpha-reductase	NN	B-NP	O
I	I	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

B-LCL	B-LCL	NN	B-NP	B-cell_line
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
T	T	NN	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
expressed	express	VBD	B-VP	O
CYP11B	CYP11B	NN	B-NP	B-protein
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
minimal	minimal	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
HSD3B1	HSD3B1	NN	B-NP	B-protein
and	and	CC	O	O
HSD3B2	HSD3B2	NN	B-NP	B-protein
(	(	(	O	O
3beta-hydroxysteroid	3beta-hydroxysteroid	NN	B-NP	O
dehydrogenase	dehydrogenase	NN	I-NP	O
I	I	CD	B-NP	O
and	and	CC	I-NP	O
II	II	CD	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
B-LCL	B-LCL	NN	B-NP	B-cell_line
and	and	CC	O	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	B-NP	I-cell_type
.	.	.	O	O

Transcripts	Transcript	NNS	B-NP	O
for	for	IN	B-PP	O
CYP19	CYP19	NN	B-NP	B-protein
and	and	CC	I-NP	O
HSD11K	HSD11K	NN	I-NP	B-protein
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
detected	detect	VBN	I-VP	O
.	.	.	O	O

Corresponding	Correspond	VBG	B-VP	O
enzymatic	enzymatic	JJ	B-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
detectable	detectable	JJ	B-ADJP	O
only	only	RB	B-ADVP	O
for	for	IN	B-PP	O
17-hydroxysteroid	17-hydroxysteroid	JJ	B-NP	B-protein
dehydrogenase	dehydrogenase	NN	I-NP	I-protein
and	and	CC	I-NP	O
5alpha-reductase	5alpha-reductase	NN	I-NP	B-protein
,	,	,	O	O
respectively	respectively	RB	B-VP	O
producing	produce	VBG	I-VP	O
testosterone	testosterone	NN	B-NP	O
and	and	CC	I-NP	O
5alpha-dihydrotestosterone	5alpha-dihydrotestosterone	NN	I-NP	O
.	.	.	O	O

Steroid	Steroid	NN	B-NP	O
identities	identity	NNS	I-NP	O
were	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
by	by	IN	B-PP	O
gas	gas	NN	B-NP	O
chromatography/mass	chromatography/mass	NN	I-NP	O
spectrometry	spectrometry	NN	I-NP	O
(	(	(	O	O
GC/MS	GC/MS	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

One	One	CD	B-NP	O
metabolite	metabolite	NN	I-NP	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
deoxycorticosterone	deoxycorticosterone	NN	B-NP	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
GC/MS	GC/MS	NN	B-NP	B-protein
as	as	IN	B-PP	O
6alpha-hydroxypregnanolone	6alpha-hydroxypregnanolone	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
sex	sex	NN	B-NP	O
hormone	hormone	NN	I-NP	O
metabolism	metabolism	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
androgen	androgen	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
,	,	,	O	O
occurs	occur	VBZ	B-VP	O
in	in	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
and	and	CC	O	O
may	may	MD	B-VP	O
modulate	modulate	VB	I-VP	O
immune	immune	JJ	B-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Human	Human	JJ	B-NP	B-cell_type
white	white	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
hair	hair	NN	B-NP	O
follicles	follicle	NNS	I-NP	O
are	be	VBP	B-VP	O
good	good	JJ	B-NP	O
sources	source	NNS	I-NP	O
of	of	IN	B-PP	O
mRNA	mRNA	NN	B-NP	B-RNA
for	for	IN	B-PP	O
the	the	DT	B-NP	O
pterin	pterin	NN	I-NP	B-protein
carbinolamine	carbinolamine	NN	I-NP	I-protein
dehydratase/dimerization	dehydratase/dimerization	NN	I-NP	I-protein
cofactor	cofactor	NN	I-NP	I-protein
of	of	IN	B-PP	O
HNF1	HNF1	NN	B-NP	B-protein
for	for	IN	B-PP	O
mutation	mutation	NN	B-NP	O
detection	detection	NN	I-NP	O
.	.	.	O	O

Pterin	Pterin	NN	B-NP	B-protein
carbinolamine	carbinolamine	NN	I-NP	I-protein
dehydratase/dimerization	dehydratase/dimerization	NN	I-NP	I-protein
cofactor	cofactor	NN	I-NP	I-protein
of	of	IN	B-PP	O
HNF1	HNF1	NN	B-NP	B-protein
(	(	(	O	O
PCD/DCoH	PCD/DCoH	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
that	that	WDT	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
dual	dual	JJ	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
pterin	pterin	NN	I-NP	B-protein
4alpha-carbinolamine	4alpha-carbinolamine	NN	I-NP	I-protein
dehydratase	dehydratase	NN	I-NP	I-protein
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regeneration	regeneration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cofactor	cofactor	NN	I-NP	B-protein
tetrahydrobiopterin	tetrahydrobiopterin	NN	I-NP	I-protein
during	during	IN	B-PP	O
the	the	DT	B-NP	O
phenylalanine	phenylalanine	NN	I-NP	O
hydroxylase-	hydroxylase-	NN	I-NP	O
catalyzed	catalyze	VBD	B-VP	O
hydroxylation	hydroxylation	NN	B-NP	O
of	of	IN	B-PP	O
phenylalanine	phenylalanine	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
dimerization	dimerization	NN	I-NP	B-protein
cofactor	cofactor	NN	I-NP	I-protein
of	of	IN	B-PP	O
HNF1	HNF1	NN	B-NP	B-protein
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
activate	activate	VB	I-VP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
HNF1	HNF1	NN	B-NP	B-protein
.	.	.	O	O

Deficiencies	Deficiency	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
dual	dual	JJ	I-NP	B-protein
functional	functional	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
result	result	VBP	B-VP	O
in	in	IN	B-PP	O
hyperphenylalaninemia	hyperphenylalaninemia	NN	B-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
time	time	NN	I-NP	O
that	that	IN	B-ADVP	O
the	the	DT	B-NP	O
PCD/DCoH	PCD/DCoH	NN	I-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
white	white	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
hair	hair	NN	B-NP	O
follicles	follicle	NNS	I-NP	O
.	.	.	O	O

Taking	Take	VBG	B-VP	O
advantage	advantage	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
finding	finding	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
sensitive	sensitive	JJ	I-NP	O
,	,	,	I-NP	O
rapid	rapid	JJ	I-NP	O
and	and	CC	I-NP	O
convenient	convenient	JJ	I-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
screening	screening	NN	B-NP	O
mutations	mutation	NNS	I-NP	O
occurring	occur	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
coding	cod	VBG	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
gene	gene	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
described	describe	VBN	I-VP	O
.	.	.	O	O

Copyright	Copyright	NN	B-NP	O
1998	1998	CD	I-NP	O
Academic	Academic	NNP	I-NP	O
Press	Press	NNP	I-NP	O
.	.	.	O	O

Biochemical	Biochemical	JJ	B-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NF-Y	NF-Y	NN	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
during	during	IN	B-PP	O
B	B	NN	B-NP	O
lymphocyte	lymphocyte	NN	I-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
NF-Y	NF-Y	NN	B-NP	B-protein
,	,	,	O	O
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
tissue-specific	tissue-specific	JJ	B-NP	B-DNA
major	major	JJ	I-NP	I-DNA
histocompatibility	histocompatibility	NN	I-NP	I-DNA
complex	complex	NN	I-NP	I-DNA
class	class	NN	I-NP	I-DNA
II	II	CD	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
transcription	transcription	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
the	the	DT	B-NP	O
biochemical	biochemical	JJ	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
heterotrimeric	heterotrimeric	JJ	I-NP	B-protein
NF-Y	NF-Y	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
characterized	characterize	VBN	I-VP	O
during	during	IN	B-PP	O
stage-specific	stage-specific	JJ	B-NP	O
B-cell	B-cell	NN	I-NP	O
development	development	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
several	several	JJ	B-NP	O
class	class	NN	I-NP	B-cell_line
II-	II-	NN	I-NP	I-cell_line
mutant	mutant	JJ	I-NP	I-cell_line
B-cell	B-cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
which	which	WDT	B-NP	O
represent	represent	VBP	B-VP	O
distinct	distinct	JJ	B-NP	O
bare	bare	JJ	I-NP	O
lymphocyte	lymphocyte	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
class	class	NN	I-NP	O
II	II	CD	I-NP	O
genetic	genetic	JJ	I-NP	O
complementation	complementation	NN	I-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
NF-Y	NF-Y	NN	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
class	class	NN	B-NP	B-cell_line
II+	II+	JJ	I-NP	I-cell_line
mature	mature	JJ	I-NP	I-cell_line
B-cells	B-cell	NNS	I-NP	I-cell_line
bound	bind	VBD	B-VP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
to	to	TO	B-PP	O
anion	anion	NN	B-NP	B-protein
exchangers	exchanger	NNS	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
eluted	elute	VBD	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
intact	intact	JJ	I-NP	B-protein
trimeric	trimeric	JJ	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
,	,	,	O	O
whereas	whereas	IN	O	O
,	,	,	O	O
NF-Y	NF-Y	NN	B-NP	B-protein
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
class	class	NN	B-NP	B-cell_line
II-	II-	NN	I-NP	I-cell_line
plasma	plasma	NN	I-NP	I-cell_line
B-cells	B-cell	NNS	I-NP	I-cell_line
,	,	,	B-PP	O
and	and	CC	I-PP	O
from	from	IN	B-PP	O
bare	bare	JJ	B-NP	B-cell_line
lymphocyte	lymphocyte	NN	I-NP	I-cell_line
syndrome	syndrome	NN	I-NP	I-cell_line
group	group	NN	I-NP	I-cell_line
II	II	CD	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
RJ2.2.5	RJ2.2.5	NN	B-NP	B-cell_line
and	and	CC	I-NP	O
RM3	RM3	NN	I-NP	B-protein
,	,	,	O	O
dissociated	dissociate	VBN	B-VP	O
into	into	IN	B-PP	O
discrete	discrete	JJ	B-NP	O
NF-YA	NF-YA	NN	I-NP	O
and	and	CC	I-NP	O
NF-YB	NF-YB	NN	I-NP	B-protein
:	:	SYM	I-NP	O
C	C	NN	I-NP	O
subunit	subunit	NN	I-NP	O
fractions	fraction	NNS	I-NP	O
.	.	.	O	O

Recombination	Recombination	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MPC11	MPC11	NN	I-NP	O
plasma	plasma	NN	I-NP	O
B-cell	B-cell	NN	I-NP	O
derived	derive	VBN	I-NP	O
NF-Y	NF-Y	NN	I-NP	B-protein
A	A	NN	I-NP	O
:	:	:	O	O
B	B	NN	B-NP	O
:	:	:	O	O
C	C	NN	B-NP	O
complex	complex	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	B-protein
molecular	molecular	JJ	I-NP	I-protein
mass	mass	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
fraction	fraction	NN	I-NP	O
,	,	,	O	O
NF-Y-associated	NF-Y-associated	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
(	(	(	O	O
YAFs	YAF	NNS	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
mature	mature	JJ	B-NP	O
A20	A20	NN	I-NP	O
B-cell	B-cell	NN	I-NP	O
nuclei	nucleus	NNS	I-NP	O
,	,	,	O	O
conferred	confer	VBD	B-VP	O
high	high	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
anion	anion	NN	I-NP	O
exchange	exchange	NN	I-NP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
NF-Y	NF-Y	NN	B-NP	B-protein
as	as	IN	B-PP	O
an	an	DT	B-NP	O
intact	intact	JJ	I-NP	B-protein
trimeric	trimeric	JJ	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
.	.	.	O	O

Recombination	Recombination	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
native	native	JJ	I-NP	O
NF-YA	NF-YA	NN	I-NP	O
:	:	:	O	O
B	B	NN	B-NP	O
:	:	:	O	O
C	C	NN	B-NP	O
complex	complex	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	B-protein
cofactor	cofactor	NN	I-NP	I-protein
,	,	,	O	O
PC4	PC4	NN	B-NP	B-protein
,	,	,	O	O
likewise	likewise	RB	B-ADVP	O
conferred	confer	VBD	B-VP	O
high	high	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
NF-Y	NF-Y	NN	I-NP	B-protein
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
anion	anion	NN	B-NP	B-protein
exchangers	exchanger	NNS	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
stabilized	stabilize	VBD	B-VP	O
NF-Y	NF-Y	NN	B-NP	B-protein
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
CCAAT-box	CCAAT-box	NN	B-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
motifs	motif	NNS	I-NP	I-DNA
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

Interaction	Interaction	NN	B-NP	O
between	between	IN	B-PP	O
PC4	PC4	NN	B-NP	B-protein
and	and	CC	I-NP	O
NF-Y	NF-Y	NN	I-NP	B-protein
was	be	VBD	B-VP	O
mapped	map	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
C-terminal	C-terminal	JJ	I-NP	B-protein
region	region	NN	I-NP	I-protein
of	of	IN	B-PP	O
PC4	PC4	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
subunit	subunit	NN	I-NP	O
interaction	interaction	NN	I-NP	O
subdomain	subdomain	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
highly	highly	RB	I-NP	O
conserved	conserve	VBN	I-NP	O
DNA	DNA	NN	I-NP	B-protein
binding-subunit	binding-subunit	NN	I-NP	I-protein
interaction	interaction	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
(	(	(	O	O
DBD	DBD	NN	B-NP	B-protein
)	)	)	O	O
of	of	IN	B-PP	O
NF-YA	NF-YA	NN	B-NP	B-protein
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
class	class	NN	B-NP	O
II+	II+	JJ	I-NP	O
mature	mature	JJ	I-NP	O
B-cells	B-cell	NNS	I-NP	O
NF-Y	NF-Y	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	B-protein
cofactor	cofactor	NN	I-NP	I-protein
,	,	,	O	O
PC4	PC4	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
NF-Y-mediated	NF-Y-mediated	JJ	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
class	class	NN	B-NP	B-DNA
II	II	CD	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

Arrest	Arrest	NN	B-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
lymphocyte	lymphocyte	NN	I-NP	I-cell_type
terminal	terminal	JJ	I-NP	O
differentiation	differentiation	NN	I-NP	O
by	by	IN	B-PP	O
CD40	CD40	NN	B-NP	B-protein
signaling	signaling	NN	I-NP	O
:	:	:	O	O
mechanism	mechanism	NN	B-NP	O
for	for	IN	B-PP	O
lack	lack	NN	B-NP	O
of	of	IN	B-PP	O
antibody-secreting	antibody-secreting	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
germinal	germinal	JJ	B-NP	O
centers	center	NNS	I-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
extensive	extensive	JJ	B-NP	O
research	research	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
CD40	CD40	NN	B-NP	B-protein
signaling	signaling	NN	I-NP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
terminal	terminal	JJ	I-NP	O
differentiation	differentiation	NN	I-NP	O
remains	remain	VBZ	B-VP	O
controversial	controversial	JJ	B-ADJP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
CD40	CD40	NN	B-NP	B-protein
engagement	engagement	NN	I-NP	O
arrests	arrest	VBZ	B-VP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
differentiation	differentiation	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
plasma	plasma	NN	B-NP	O
cell	cell	NN	I-NP	O
formation	formation	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
arrest	arrest	NN	I-NP	O
is	be	VBZ	B-VP	O
manifested	manifest	VBN	I-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
level	level	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
mRNA	mRNA	NN	B-NP	B-RNA
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
secretory	secretory	JJ	B-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	B-protein
gene	gene	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
mu	mu	NN	B-NP	O
(	(	(	O	O
s	s	NNS	B-NP	O
)	)	)	O	O
and	and	CC	O	O
J	J	NN	B-NP	B-protein
chain	chain	NN	I-NP	I-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	B-protein
regulator	regulator	NN	I-NP	I-protein
BLIMP-1	BLIMP-1	NN	I-NP	I-protein
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
differentiation	differentiation	NN	I-NP	O
by	by	IN	B-PP	O
CD40	CD40	NN	B-NP	B-protein
engagement	engagement	NN	I-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
overcome	overcome	VBN	I-VP	O
by	by	IN	B-PP	O
either	either	CC	B-NP	O
mitogens	mitogen	NNS	I-NP	B-protein
or	or	CC	I-NP	O
cytokines	cytokine	NNS	I-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
reversed	reverse	VBN	I-VP	O
by	by	IN	B-PP	O
antibodies	antibody	NNS	B-NP	B-protein
that	that	WDT	B-NP	O
interfere	interfere	VBP	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
CD40	CD40	NN	I-NP	B-protein
/	/	SYM	B-NP	O
gp39	gp39	NN	I-NP	B-protein
interaction	interaction	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
secretory	secretory	JJ	B-NP	B-protein
immunoglobulin	immunoglobulin	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
produced	produce	VBN	I-VP	O
by	by	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
actively	actively	RB	I-VP	O
engaged	engage	VBN	I-VP	O
by	by	IN	B-PP	O
gp39-expressing	gp39-expressing	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

A	A	DT	B-NP	O
positively	positively	RB	I-NP	O
charged	charge	VBN	I-NP	O
alpha-lipoic	alpha-lipoic	JJ	I-NP	O
acid	acid	NN	I-NP	O
analogue	analogue	NN	I-NP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
cellular	cellular	JJ	I-NP	O
uptake	uptake	NN	I-NP	O
and	and	CC	O	O
more	more	RBR	B-NP	O
potent	potent	JJ	I-NP	O
immunomodulatory	immunomodulatory	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

alpha-Lipoic	alpha-Lipoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
LA	LA	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
taken	take	VBN	I-VP	O
up	up	RP	B-PRT	O
by	by	IN	B-PP	O
cells	cell	NNS	B-NP	O
and	and	CC	O	O
reduced	reduce	VBN	B-VP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
potent	potent	JJ	I-NP	O
dithiol	dithiol	NN	I-NP	O
form	form	NN	I-NP	O
,	,	,	O	O
dihydrolipoate	dihydrolipoate	NN	B-NP	O
(	(	(	O	O
DHLA	DHLA	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
much	much	JJ	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
rapidly	rapidly	RB	I-VP	O
effluxed	effluxe	VBN	I-VP	O
out	out	RP	B-PRT	O
from	from	IN	B-PP	O
cells	cell	NNS	B-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
improve	improve	VB	I-VP	O
retention	retention	NN	B-NP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
LA	LA	NN	I-NP	B-protein
molecule	molecule	NN	I-NP	I-protein
was	be	VBD	B-VP	O
modified	modify	VBN	I-VP	O
to	to	TO	I-VP	O
confer	confer	VB	I-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
charge	charge	NN	I-NP	O
at	at	IN	B-PP	O
physiological	physiological	JJ	B-NP	O
pH	pH	NN	I-NP	O
.	.	.	O	O

N	N	NN	B-NP	O
,	,	,	O	O
N-dimethyl	N-dimethyl	NN	B-NP	O
,	,	,	O	O
N'-2-amidoethyl-lipoate	N'-2-amidoethyl-lipoate	NN	B-NP	O
was	be	VBD	B-VP	O
synthesized	synthesize	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
protonated	protonated	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
new	new	JJ	I-NP	O
molecule	molecule	NN	I-NP	O
is	be	VBZ	B-VP	O
referred	refer	VBN	I-VP	O
to	to	TO	B-PP	O
as	as	IN	B-PP	O
LA-Plus	LA-Plus	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
uptake	uptake	NN	I-NP	O
of	of	IN	B-PP	O
LA-Plus	LA-Plus	NN	B-NP	O
by	by	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
Wurzburg	Wurzburg	NN	I-NP	I-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
was	be	VBD	B-VP	O
higher	high	JJR	B-ADJP	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
LA	LA	NN	B-NP	O
.	.	.	O	O

Several-fold	Several-fold	RB	B-NP	O
higher	high	JJR	I-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
DHLA-Plus	DHLA-Plus	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
corresponding	correspond	VBG	I-NP	O
reduced	reduce	VBN	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
LA-Plus	LA-Plus	NN	B-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
LA-Plus	LA-Plus	JJ	B-NP	B-cell_line
treated	treat	VBN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
DHLA	DHLA	NN	B-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
LA	LA	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
100	100	CD	B-NP	O
microM	microM	NN	I-NP	O
,	,	,	O	O
LA	LA	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	O	O
but	but	CC	O	O
LA-Plus	LA-Plus	NN	B-NP	O
inhibited	inhibit	VBD	B-VP	O
H2O2	H2O2	NN	B-NP	O
induced	induced	JJ	I-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
and	and	CC	O	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
directed	direct	VBD	B-VP	O
IL-2	IL-2	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

Both	Both	CC	O	O
LA	LA	NN	B-NP	O
and	and	CC	I-NP	O
LA-Plus	LA-Plus	NN	I-NP	O
synergised	synergise	VBN	B-VP	O
with	with	IN	B-PP	O
selenium	selenium	NN	B-NP	O
in	in	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
H2O2	H2O2	NN	B-NP	O
induced	induce	VBD	B-VP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
150	150	CD	B-NP	O
microM	microM	NN	I-NP	O
LA-Plus	LA-Plus	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
LA	LA	NN	B-NP	O
,	,	,	O	O
inhibited	inhibit	VBD	B-VP	O
TNFalpha	TNFalpha	NN	B-NP	B-protein
induced	induced	JJ	I-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
5	5	CD	B-NP	O
microM	microM	NN	I-NP	O
LA-Plus	LA-Plus	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
LA	LA	NN	B-NP	O
,	,	,	O	O
protected	protect	VBD	B-VP	O
against	against	IN	B-PP	O
both	both	CC	B-NP	O
spontaneous	spontaneous	JJ	I-NP	O
and	and	CC	I-NP	O
etoposide	etoposide	NN	I-NP	O
induced	induce	VBD	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
in	in	IN	B-PP	O
rat	rat	NN	B-NP	B-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

LA-Plus	LA-Plus	NN	B-NP	O
is	be	VBZ	B-VP	O
thus	thus	RB	B-ADVP	O
an	an	DT	B-NP	O
improved	improved	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
LA	LA	NN	B-NP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
potential	potential	NN	I-NP	O
.	.	.	O	O

Copyright	Copyright	NN	B-NP	O
1998	1998	CD	I-NP	O
Academic	Academic	NNP	I-NP	O
Press	Press	NNP	I-NP	O
.	.	.	O	O

Carrier	Carri	JJR	B-NP	O
identification	identification	NN	I-NP	O
in	in	IN	B-PP	O
X-linked	X-linked	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

OBJECTIVE	OBJECTIVE	NN	B-NP	O
:	:	:	O	O
Carrier	Carri	JJR	B-NP	O
identification	identification	NN	I-NP	O
in	in	IN	B-PP	O
X-linked	X-linked	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
disorders	disorder	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
based	base	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
demonstration	demonstration	NN	I-NP	O
of	of	IN	B-PP	O
non-random	non-random	JJ	B-NP	O
X	X	NN	I-NP	O
inactivation	inactivation	NN	I-NP	O
(	(	(	O	O
NRXI	NRXI	NN	B-NP	B-DNA
)	)	)	O	O
in	in	IN	B-PP	O
affected	affect	VBN	B-NP	O
blood	blood	NN	I-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
lineages	lineage	NNS	I-NP	I-cell_type
when	when	WRB	B-ADVP	O
growth	growth	NN	B-NP	O
is	be	VBZ	B-VP	O
impaired	impair	VBN	I-VP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
expressing	express	VBG	B-VP	O
the	the	DT	B-NP	O
abnormal	abnormal	JJ	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
utility	utility	NN	I-NP	O
of	of	IN	B-PP	O
seeking	seek	VBG	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
NRXI	NRXI	NN	B-NP	B-protein
to	to	TO	B-VP	O
test	test	VB	I-VP	O
the	the	DT	B-NP	O
carrier	carrier	NN	I-NP	O
status	status	NN	I-NP	O
of	of	IN	B-PP	O
women	woman	NNS	B-NP	O
in	in	IN	B-PP	O
families	family	NNS	B-NP	O
affected	affect	VBN	B-VP	O
by	by	IN	B-PP	O
X-linked	X-linked	JJ	B-NP	O
severe	severe	JJ	I-NP	O
combined	combined	JJ	I-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
(	(	(	O	O
XSCID	XSCID	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
X-linked	X-linked	JJ	B-NP	O
hypogammaglobulinaemia	hypogammaglobulinaemia	NN	I-NP	O
(	(	(	O	O
XLH	XLH	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
as	as	IN	B-PP	O
carriers	carrier	NNS	B-NP	O
the	the	DT	B-NP	O
mothers	mother	NNS	I-NP	O
of	of	IN	B-PP	O
boys	boy	NNS	B-NP	O
with	with	IN	B-PP	O
SCID	SCID	NN	B-NP	O
or	or	CC	I-NP	O
hypogammaglobulinaemia	hypogammaglobulinaemia	NN	I-NP	O
whose	whose	WP$	B-NP	O
phenotype	phenotype	NN	I-NP	O
suggested	suggest	VBD	B-VP	O
X-linkage	X-linkage	NN	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
infer	infer	VB	I-VP	O
X-linkage	X-linkage	NN	B-NP	O
in	in	IN	B-PP	O
boys	boy	NNS	B-NP	O
with	with	IN	B-PP	O
SCID	SCID	NN	B-NP	O
or	or	CC	I-NP	O
hypogammaglobulinaemia	hypogammaglobulinaemia	NN	I-NP	O
whose	whose	WP$	B-NP	O
disease	disease	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
clearly	clearly	RB	B-ADJP	O
X-linked	X-linked	JJ	I-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
either	either	CC	B-PP	O
of	of	IN	B-PP	O
family	family	NN	B-NP	O
history	history	NN	I-NP	O
or	or	CC	O	O
clinical	clinical	JJ	B-NP	O
and	and	CC	I-NP	O
immunological	immunological	JJ	I-NP	O
characteristics	characteristic	NNS	I-NP	O
.	.	.	O	O

METHODOLOGY	METHODOLOGY	NN	B-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction-based	reaction-based	JJ	I-NP	O
method	method	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
amplify	amplify	VB	I-VP	O
a	a	DT	B-NP	O
polymorphic	polymorphic	JJ	I-NP	B-DNA
CAG	CAG	NN	I-NP	I-DNA
repeat	repeat	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	B-DNA
exon	exon	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
androgen	androgen	NN	I-NP	B-DNA
receptor	receptor	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
after	after	IN	B-PP	O
selective	selective	JJ	B-NP	O
digestion	digestion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
active	active	JJ	I-NP	O
X	X	NN	I-NP	B-DNA
chromosome	chromosome	NN	I-NP	I-DNA
with	with	IN	B-PP	O
a	a	DT	B-NP	O
methylation-sensitive	methylation-sensitive	JJ	I-NP	B-protein
enzyme	enzyme	NN	I-NP	I-protein
,	,	,	O	O
HpaII	HpaII	NN	B-NP	O
to	to	TO	B-VP	O
distinguish	distinguish	VB	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
paternal	paternal	JJ	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
maternal	maternal	JJ	I-NP	I-DNA
alleles	allele	NNS	I-NP	I-DNA
and	and	CC	O	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
their	their	PRP$	B-NP	O
methylation	methylation	NN	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Heterozygosity	Heterozygosity	NN	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
24	24	CD	B-NP	O
of	of	IN	B-PP	O
31	31	CD	B-NP	O
female	female	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
(	(	(	O	O
77	77	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

As	As	IN	B-SBAR	O
anticipated	anticipate	VBN	B-VP	O
,	,	,	O	O
NRXI	NRXI	NNP	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
demonstrated	demonstrate	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
lymphoid	lymphoid	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
studied	study	VBN	B-VP	O
from	from	IN	B-PP	O
obligate	obligate	JJ	B-NP	O
carriers	carrier	NNS	I-NP	O
of	of	IN	B-PP	O
XSCID	XSCID	NN	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
obligate	obligate	JJ	I-NP	O
carrier	carrier	NN	I-NP	O
of	of	IN	B-PP	O
XLH	XLH	NN	B-NP	B-protein
but	but	CC	B-PP	O
not	not	RB	B-PP	O
on	on	IN	I-PP	O
a	a	DT	B-NP	O
carrier	carrier	NN	I-NP	O
of	of	IN	B-PP	O
X-linked	X-linked	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
with	with	IN	B-PP	O
hyper-IgM	hyper-IgM	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
finding	finding	NN	I-NP	O
of	of	IN	B-PP	O
NRXI	NRXI	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mother	mother	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
boy	boy	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
SCID	SCID	NN	I-NP	B-cell_line
variant	variant	NN	I-NP	I-cell_line
showed	show	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
carrier	carrier	NN	I-NP	O
of	of	IN	B-PP	O
XSCID	XSCID	NN	B-NP	O
and	and	CC	O	O
establishes	establish	VBZ	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
son	son	NN	I-NP	O
has	have	VBZ	B-VP	O
XSCID	XSCID	NN	B-NP	O
,	,	,	O	O
not	not	RB	O	O
otherwise	otherwise	RB	B-ADJP	O
evident	evident	JJ	I-ADJP	O
from	from	IN	B-PP	O
available	available	JJ	B-NP	O
data	datum	NNS	I-NP	O
.	.	.	O	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
PCR	PCR	NN	I-NP	O
assay	assay	NN	I-NP	O
provides	provide	VBZ	B-VP	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
carrier	carrier	NN	B-NP	O
detection	detection	NN	I-NP	O
of	of	IN	B-PP	O
X-linked	X-linked	JJ	B-NP	O
immunodeficiencies	immunodeficiency	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
allowed	allow	VBN	I-VP	O
us	us	PRP	B-NP	O
to	to	TO	B-VP	O
expand	expand	VB	I-VP	O
the	the	DT	B-NP	O
phenotype	phenotype	NN	I-NP	O
of	of	IN	B-PP	O
XSCID	XSCID	NN	B-NP	O

Leukocyte-endothelial	Leukocyte-endothelial	JJ	B-NP	O
interaction	interaction	NN	I-NP	O
is	be	VBZ	B-VP	O
augmented	augment	VBN	I-VP	O
by	by	IN	B-PP	O
high	high	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
and	and	CC	O	O
hyperglycemia	hyperglycemia	NN	B-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
NF-kB-dependent	NF-kB-dependent	JJ	I-NP	O
fashion	fashion	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
addressed	address	VBD	B-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
hyperglycemia	hyperglycemia	NN	B-NP	O
in	in	IN	B-PP	O
leukocyte-endothelium	leukocyte-endothelium	JJ	B-NP	O
interaction	interaction	NN	I-NP	O
under	under	IN	B-PP	O
flow	flow	NN	B-NP	O
conditions	condition	NNS	I-NP	O
by	by	IN	B-PP	O
exposing	expose	VBG	B-VP	O
human	human	JJ	B-NP	B-cell_type
umbilical	umbilical	JJ	I-NP	I-cell_type
vein	vein	NN	I-NP	I-cell_type
endothelial	endothelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
for	for	IN	B-PP	O
24	24	CD	B-NP	O
h	h	NN	I-NP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-ADJP	O
(	(	(	O	O
5	5	CD	B-NP	O
mM	mM	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
high	high	JJ	B-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
glucose	glucose	NN	B-NP	O
(	(	(	O	O
30	30	CD	B-NP	O
mM	mM	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
advanced	advance	VBD	B-VP	O
glycosylation	glycosylation	NN	B-NP	B-protein
end	end	NN	I-NP	I-protein
product-albumin	product-albumin	NN	I-NP	I-protein
(	(	(	O	O
100	100	CD	B-NP	O
microg/ml	microg/ml	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
or	or	CC	O	O
hyperglycemic	hyperglycemic	JJ	B-ADJP	O
(	(	(	O	O
174-316	174-316	CD	B-NP	O
mg/dl	mg/dl	NN	I-NP	O
)	)	)	O	O
sera	serum	NNS	B-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
and	and	CC	O	O
abnormal	abnormal	JJ	B-NP	O
hemoglobin	hemoglobin	NN	I-NP	O
A1c	A1c	NN	I-NP	O
(	(	(	O	O
8.1+/-1.4	8.1+/-1.4	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
incubation	incubation	NN	B-NP	O
endothelial	endothelial	JJ	I-NP	O
cells	cell	NNS	I-NP	O
were	be	VBD	B-VP	O
perfused	perfuse	VBN	I-VP	O
with	with	IN	B-PP	O
total	total	JJ	B-NP	O
leukocyte	leukocyte	NN	I-NP	O
suspension	suspension	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
parallel	parallel	JJ	I-NP	O
plate	plate	NN	I-NP	O
flow	flow	NN	I-NP	O
chamber	chamber	NN	I-NP	O
under	under	IN	B-PP	O
laminar	laminar	JJ	B-NP	O
flow	flow	NN	I-NP	O
(	(	(	O	O
1.5	1.5	CD	B-NP	O
dyn/cm2	dyn/cm2	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Rolling	Rolling	NN	B-NP	O
and	and	CC	O	O
adherent	adherent	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
digital	digital	JJ	B-NP	O
image	image	NN	I-NP	O
processing	processing	NN	I-NP	O
.	.	.	O	O

Results	Result	NNS	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
30	30	CD	B-NP	O
mM	mM	NN	I-NP	O
glucose	glucose	NN	I-NP	O
significantly	significantly	RB	B-ADVP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.01	0.01	CD	B-NP	O
)	)	)	O	O
increased	increase	VBD	B-VP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
adherent	adherent	JJ	B-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
endothelial	endothelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
respect	respect	NN	B-NP	O
to	to	TO	B-PP	O
control	control	NN	B-NP	O
(	(	(	O	O
5	5	CD	B-NP	O
mM	mM	NN	I-NP	O
glucose	glucose	NN	I-NP	O
;	;	:	O	O
151+/-19	151+/-19	CD	B-NP	O
versus	versus	IN	I-NP	O
33+/-8	33+/-8	CD	I-NP	O
cells/mm2	cells/mm2	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

A	A	DT	B-NP	O
similar	similar	JJ	I-NP	O
response	response	NN	I-NP	O
was	be	VBD	B-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
endothelial	endothelial	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
with	with	IN	B-PP	O
IL-1beta	IL-1beta	NN	B-NP	B-protein
,	,	,	O	O
here	here	RB	B-ADVP	O
used	use	VBN	B-VP	O
as	as	IN	B-PP	O
positive	positive	JJ	B-NP	O
control	control	NN	I-NP	O
(	(	(	O	O
195+/-20	195+/-20	CD	B-NP	O
cells/mm2	cells/mm2	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
rolling	roll	VBG	B-VP	B-cell_type
cells	cell	NNS	B-NP	I-cell_type
on	on	IN	B-PP	O
endothelial	endothelial	JJ	B-NP	O
surface	surface	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
high	high	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

Stable	Stable	JJ	B-NP	O
adhesion	adhesion	NN	I-NP	O
of	of	IN	B-PP	O
leukocytes	leukocyte	NNS	B-NP	B-cell_type
to	to	TO	B-PP	O
glucose-treated	glucose-treated	JJ	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
to	to	TO	B-PP	O
IL-1beta-stimulated	IL-1beta-stimulated	JJ	B-NP	B-cell_line
endothelial	endothelial	JJ	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
was	be	VBD	B-VP	O
preceded	precede	VBN	I-VP	O
by	by	IN	B-PP	O
short	short	JJ	B-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
leukocytes	leukocyte	NNS	B-NP	B-cell_type
with	with	IN	B-PP	O
the	the	DT	B-NP	O
endothelial	endothelial	JJ	I-NP	O
surface	surface	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
distance	distance	NN	I-NP	O
travelled	travel	VBN	B-VP	O
by	by	IN	B-PP	O
leukocytes	leukocyte	NNS	B-NP	B-cell_type
before	before	IN	B-PP	O
arrest	arrest	NN	B-NP	O
on	on	IN	B-PP	O
30	30	CD	B-NP	O
mM	mM	NN	I-NP	O
glucose	glucose	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
on	on	IN	B-PP	O
IL-1beta-treated	IL-1beta-treated	JJ	B-NP	B-cell_line
endothelial	endothelial	JJ	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
0.01	0.01	CD	I-NP	O
)	)	)	O	O
higher	high	JJR	B-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
observed	observe	VBN	B-VP	O
for	for	IN	B-PP	O
leukocytes	leukocyte	NNS	B-NP	B-cell_type
adhering	adhere	VBG	B-VP	O
on	on	IN	B-PP	O
control	control	NN	B-NP	O
endothelium	endothelium	NN	I-NP	O
(	(	(	O	O
30	30	CD	B-NP	O
mM	mM	NN	I-NP	O
glucose	glucose	NN	I-NP	O
:	:	:	O	O
76.7+/-3.5	76.7+/-3.5	CD	B-NP	O
;	;	:	O	O
IL1beta	IL1beta	NN	B-NP	B-protein
:	:	:	O	O
69.7+/-4	69.7+/-4	CD	B-NP	O
versus	versus	IN	I-NP	O
5	5	CD	I-NP	O
mM	mM	NN	I-NP	O
glucose	glucose	NN	I-NP	O
:	:	:	O	O
21.5+/-5	21.5+/-5	CD	B-NP	O
microm	microm	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Functional	Functional	JJ	B-NP	O
blocking	blocking	NN	I-NP	O
of	of	IN	B-PP	O
E-selectin	E-selectin	NN	B-NP	B-protein
,	,	,	O	O
intercellular	intercellular	JJ	B-NP	B-protein
cell	cell	NN	I-NP	I-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
vascular	vascular	JJ	B-NP	B-protein
cell	cell	NN	I-NP	I-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
on	on	IN	B-PP	O
endothelial	endothelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
the	the	DT	B-NP	O
corresponding	correspond	VBG	I-NP	O
mouse	mouse	NN	I-NP	B-protein
mAb	mAb	NN	I-NP	I-protein
significantly	significantly	RB	B-ADVP	O
inhibited	inhibit	VBD	B-VP	O
glucose-induced	glucose-induced	JJ	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
leukocyte	leukocyte	NN	B-NP	O
adhesion	adhesion	NN	I-NP	O
(	(	(	O	O
67+/-16	67+/-16	CD	B-NP	O
,	,	,	I-NP	O
83+/-12	83+/-12	CD	I-NP	O
,	,	,	I-NP	O
62+/-8	62+/-8	CD	I-NP	O
versus	versus	IN	I-NP	O
144+/-21	144+/-21	CD	I-NP	O
cells/	cells/	NNS	I-NP	O
mm2	mm2	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Confocal	Confocal	JJ	B-NP	O
fluorescence	fluorescence	NN	I-NP	O
microscopy	microscopy	NN	I-NP	O
studies	study	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
30	30	CD	B-NP	O
mM	mM	NN	I-NP	O
glucose	glucose	NN	I-NP	O
induced	induce	VBD	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
endothelial	endothelial	JJ	B-NP	O
surface	surface	NN	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
E-selectin	E-selectin	NN	B-NP	B-protein
,	,	,	O	O
intercellular	intercellular	JJ	B-NP	B-protein
cell	cell	NN	I-NP	I-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
vascular	vascular	JJ	B-NP	B-protein
cell	cell	NN	I-NP	I-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
.	.	.	O	O

Electrophoretic	Electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assay	assay	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
umbilical	umbilical	JJ	I-NP	I-cell_type
vein	vein	NN	I-NP	I-cell_type
endothelial	endothelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
HUVEC	HUVEC	NNS	B-NP	B-cell_line
)	)	)	O	O
exposed	expose	VBN	B-VP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
mM	mM	NN	I-NP	O
glucose	glucose	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
intense	intense	JJ	I-NP	O
NF-kB	NF-kB	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
HUVEC	HUVEC	NNS	B-NP	B-cell_line
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
high	high	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
NF-kB	NF-kB	NN	I-NP	B-protein
inhibitors	inhibitor	NNS	I-NP	O
pyrrolidinedithiocarbamate	pyrrolidinedithiocarbamate	NN	I-NP	O
(	(	(	O	O
100	100	CD	B-NP	O
microM	microM	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
tosyl-phe-chloromethylketone	tosyl-phe-chloromethylketone	NN	B-NP	O
(	(	(	O	O
25	25	CD	B-NP	O
microM	microM	NN	I-NP	O
)	)	)	O	O
significantly	significantly	RB	B-VP	O
reduced	reduce	VBD	I-VP	O
(	(	(	O	O
P	P	NN	O	O
<	<	SYM	O	O
0.05	0.05	CD	O	O
)	)	)	O	O
leukocyte	leukocyte	NN	B-NP	O
adhesion	adhesion	NN	I-NP	O
in	in	IN	B-PP	O
respect	respect	NN	B-NP	O
to	to	TO	B-PP	O
HUVEC	HUVEC	NN	B-NP	B-cell_line
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
glucose	glucose	NN	B-NP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

A	A	DT	O	O
significant	significant	JJ	O	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.01	0.01	CD	O	O
)	)	)	O	O
inhibitory	inhibitory	JJ	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
glucose-induced	glucose-induced	JJ	B-NP	O
leukocyte	leukocyte	NN	I-NP	O
adhesion	adhesion	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
after	after	IN	B-PP	O
blocking	block	VBG	B-VP	O
protein	protein	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
C	C	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
with	with	IN	B-PP	O
staurosporine	staurosporine	NN	B-NP	O
(	(	(	O	O
5	5	CD	B-NP	O
nM	nM	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
HUVEC	HUVEC	NNS	B-NP	B-cell_type
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
specific	specific	JJ	B-NP	O
antisense	antisense	JJ	I-NP	O
oligodesoxynucleotides	oligodesoxynucleotide	NNS	I-NP	O
against	against	IN	B-PP	O
PKCalpha	PKCalpha	NN	B-NP	B-protein
and	and	CC	I-NP	O
PKCepsilon	PKCepsilon	NN	I-NP	B-protein
isoforms	isoform	NNS	I-NP	I-protein
before	before	IN	B-PP	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
mM	mM	NN	I-NP	O
glucose	glucose	NN	I-NP	O
,	,	,	O	O
a	a	DT	O	O
significant	significant	JJ	O	O
(	(	(	O	O
P	P	NN	O	O
<	<	SYM	O	O
0.05	0.05	CD	O	O
)	)	)	O	O
reduction	reduction	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
adhesion	adhesion	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
seen	see	VBN	I-VP	O
.	.	.	O	O

Advanced	Advance	VBN	B-NP	O
glycosylation	glycosylation	NN	I-NP	B-protein
end	end	NN	I-NP	I-protein
product-albumin	product-albumin	NN	I-NP	I-protein
significantly	significantly	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
adhering	adhering	JJ	B-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
respect	respect	NN	B-NP	O
to	to	TO	B-PP	O
native	native	JJ	B-NP	O
albumin	albumin	NN	I-NP	O
used	use	VBN	B-VP	O
as	as	IN	B-PP	O
control	control	NN	B-NP	O
(	(	(	O	O
110+/-16	110+/-16	CD	B-NP	O
versus	versus	IN	B-PP	O
66+/-7	66+/-7	CD	B-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
0.01	0.01	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

Sera	Sera	NN	B-NP	O
from	from	IN	B-PP	O
diabetic	diabetic	JJ	B-NP	O
patients	patient	NNS	I-NP	O
significantly	significantly	RB	B-ADVP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.01	0.01	CD	B-NP	O
)	)	)	O	O
enhanced	enhance	VBD	B-VP	O
leukocyte	leukocyte	NN	B-NP	O
adhesion	adhesion	NN	I-NP	O
as	as	IN	B-PP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
controls	control	NNS	B-NP	O
,	,	,	O	O
despite	despite	IN	B-PP	O
normal	normal	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
IL-1beta	IL-1beta	NN	B-NP	B-protein
and	and	CC	I-NP	O
TNFalpha	TNFalpha	NN	I-NP	B-protein
in	in	IN	B-PP	O
these	these	DT	B-NP	O
sera	serum	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
high	high	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
concentration	concentration	NN	I-NP	O
and	and	CC	I-NP	O
hyperglycemia	hyperglycemia	NN	I-NP	O
promote	promote	VBP	B-VP	O
leukocyte	leukocyte	NN	B-NP	O
adhesion	adhesion	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
endothelium	endothelium	NN	I-NP	O
through	through	IN	B-PP	O
upregulation	upregulation	NN	B-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
surface	surface	NN	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
adhesive	adhesive	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
,	,	,	O	O
possibly	possibly	RB	B-ADVP	O
depending	depend	VBG	B-PP	O
on	on	IN	B-PP	O
NF-kB	NF-kB	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

Ikaros	Ikaros	NN	B-NP	B-protein
in	in	IN	B-PP	O
hemopoietic	hemopoietic	JJ	B-NP	O
lineage	lineage	NN	I-NP	O
determination	determination	NN	I-NP	O
and	and	CC	I-NP	O
homeostasis	homeostasis	NN	I-NP	O
.	.	.	O	O

Studies	Study	NNS	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
that	that	WDT	B-NP	O
control	control	VBP	B-VP	O
hemopoietic	hemopoietic	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
have	have	VBP	B-VP	O
focused	focus	VBN	I-VP	O
on	on	IN	B-PP	O
signaling	signaling	NN	B-NP	O
cascades	cascade	NNS	I-NP	O
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	O
effectors	effector	NNS	I-NP	O
that	that	WDT	B-NP	O
drive	drive	VBP	B-VP	O
this	this	DT	B-NP	O
complex	complex	JJ	I-NP	O
developmental	developmental	JJ	I-NP	O
system	system	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
regulated	regulated	JJ	I-NP	O
fashion	fashion	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
review	review	VBP	B-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
Ikaros	Ikaros	NN	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
founding	founding	JJ	I-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
unique	unique	JJ	I-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
zinc	zinc	NN	B-NP	B-protein
finger	finger	NN	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
this	this	DT	B-NP	O
developmental	developmental	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

Studies	Study	NNS	B-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
Ikaros	Ikaros	NN	I-NP	B-protein
null	null	JJ	I-NP	O
mutation	mutation	NN	I-NP	O
have	have	VBP	B-VP	O
revealed	reveal	VBN	I-VP	O
an	an	DT	B-NP	O
essential	essential	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
factor	factor	NN	I-NP	O
in	in	IN	B-PP	O
lymphoid	lymphoid	JJ	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
fate	fate	NN	I-NP	O
determination	determination	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
subsequent	subsequent	JJ	B-NP	O
branch	branch	NN	I-NP	O
points	point	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
differentiation	differentiation	NN	I-NP	O
pathway	pathway	NN	I-NP	O
.	.	.	O	O

Differences	Difference	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
phenotypes	phenotype	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
null	null	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
negative	negative	JJ	I-NP	O
(	(	(	O	O
DN	DN	JJ	B-ADJP	O
)	)	)	O	O
Ikaros	Ikaros	NN	B-NP	O
mutation	mutation	NN	I-NP	O
provide	provide	VBP	B-VP	O
insight	insight	NN	B-NP	O
into	into	IN	B-PP	O
a	a	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	O
network	network	NN	I-NP	O
through	through	IN	B-PP	O
which	which	WDT	B-NP	O
Ikaros	Ikaros	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
exert	exert	VBP	B-VP	O
their	their	PRP$	B-NP	O
effects	effect	NNS	I-NP	O
in	in	IN	B-PP	O
development	development	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
a	a	DT	B-NP	O
comparative	comparative	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hemopoietic	hemopoietic	JJ	I-NP	B-cell_type
stem	stem	NN	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
and	and	CC	I-NP	O
precursor	precursor	NN	I-NP	O
compartment	compartment	NN	I-NP	O
resulting	result	VBG	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
Ikaros	Ikaros	NN	I-NP	O
mutations	mutation	NNS	I-NP	O
reveals	reveal	VBZ	B-VP	O
a	a	DT	B-NP	O
profound	profound	JJ	I-NP	O
yet	yet	CC	O	O
not	not	RB	O	O
absolute	absolute	JJ	B-NP	O
requirement	requirement	NN	I-NP	O
for	for	IN	B-PP	O
Ikaros	Ikaros	NN	B-NP	B-protein

Induction	Induction	NN	B-NP	O
of	of	IN	B-PP	O
early	early	JJ	B-NP	B-protein
B	B	NN	I-NP	I-protein
cell	cell	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
EBF	EBF	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
B	B	NN	I-NP	B-DNA
lineage	lineage	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
by	by	IN	B-PP	O
the	the	DT	B-NP	O
basic	basic	JJ	I-NP	B-protein
helix-loop-helix	helix-loop-helix	JJ	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
E12	E12	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
E2A	E2A	NN	I-NP	B-DNA
and	and	CC	O	I-DNA
early	early	JJ	B-NP	I-DNA
B	B	NN	I-NP	I-DNA
cell	cell	NN	I-NP	I-DNA
factor	factor	NN	I-NP	I-DNA
(	(	(	O	I-DNA
EBF	EBF	NN	B-NP	I-DNA
)	)	)	O	I-DNA
genes	gene	NNS	B-NP	I-DNA
are	be	VBP	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
proper	proper	JJ	I-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
lineage	lineage	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
E2A-	E2A-	NN	B-NP	O
and	and	CC	O	O
EBF-deficient	EBF-deficient	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
has	have	VBZ	B-VP	O
made	make	VBN	I-VP	O
it	it	PRP	B-NP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
function	function	NN	I-NP	O
or	or	CC	I-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
these	these	DT	B-NP	O
proteins	protein	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
identification	identification	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
model	model	NN	I-NP	O
system	system	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
E2A	E2A	NN	B-NP	B-protein
and	and	CC	I-NP	O
EBF	EBF	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
B	B	NN	I-NP	O
lineage	lineage	NN	I-NP	O
traits	trait	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
studied	study	VBN	I-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
conversion	conversion	NN	I-NP	O
of	of	IN	B-PP	O
70Z/3	70Z/3	NN	B-NP	B-protein
pre-B	pre-B	JJ	I-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O
to	to	TO	B-PP	O
cells	cell	NNS	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
macrophage-like	macrophage-like	JJ	I-NP	O
phenotype	phenotype	NN	I-NP	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
E2A	E2A	NN	B-NP	B-protein
and	and	CC	I-NP	O
EBF	EBF	NN	I-NP	B-protein
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
ectopic	ectopic	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
E2A	E2A	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
E12	E12	NN	I-NP	B-protein
in	in	IN	B-PP	O
this	this	DT	B-NP	O
macrophage	macrophage	NN	I-NP	O
line	line	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
many	many	JJ	B-NP	O
B	B	NN	I-NP	B-DNA
lineage	lineage	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
,	,	,	O	O
including	include	VBG	B-PP	O
EBF	EBF	NN	B-NP	B-protein
,	,	,	O	O
IL7Ralpha	IL7Ralpha	NN	B-NP	B-protein
,	,	,	O	O
lambda5	lambda5	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
Rag-1	Rag-1	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
kappa	kappa	NN	B-NP	B-protein
light	light	JJ	I-NP	I-protein
chain	chain	NN	I-NP	I-protein
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
mitogen	mitogen	NN	B-NP	B-protein
.	.	.	O	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
EBF	EBF	NN	B-NP	B-protein
may	may	MD	B-VP	O
be	be	VB	I-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
critical	critical	JJ	I-NP	O
functions	function	NNS	I-NP	O
of	of	IN	B-PP	O
E12	E12	NN	B-NP	B-protein
in	in	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
the	the	DT	B-NP	O
B	B	NN	I-NP	O
lineage	lineage	NN	I-NP	O
phenotype	phenotype	NN	I-NP	O
since	since	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
EBF	EBF	NN	B-NP	B-protein
alone	alone	RB	B-ADVP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
subset	subset	NN	I-NP	O
of	of	IN	B-PP	O
E12	E12	NN	B-NP	B-protein
-inducible	-inducible	JJ	I-NP	O
traits	trait	NNS	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
data	datum	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
macrophage	macrophage	NN	I-NP	O
line	line	NN	I-NP	O
,	,	,	O	O
E12	E12	NN	B-NP	B-protein
induces	induce	VBZ	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
EBF	EBF	NN	B-NP	B-protein
and	and	CC	O	O
together	together	RB	B-ADVP	O
these	these	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
coordinately	coordinately	RB	B-ADVP	O
regulate	regulate	VBP	B-VP	O
numerous	numerous	JJ	B-NP	O
B	B	NN	I-NP	B-DNA
lineage-associated	lineage-associated	JJ	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

Activation-induced	Activation-induced	JJ	B-NP	O
down-regulation	down-regulation	NN	I-NP	O
of	of	IN	B-PP	O
retinoid	retinoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
RXRalpha	RXRalpha	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Role	Role	NN	B-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
regulation	regulation	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
5.4-kilobase	5.4-kilobase	NN	I-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
,	,	,	O	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
down-regulated	down-regulate	VBN	I-VP	O
after	after	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
PBMCs	PBMC	NNS	B-NP	B-cell_type
)	)	)	O	O
with	with	IN	B-PP	O
various	various	JJ	B-NP	O
T	T	NN	I-NP	O
cell-activating	cell-activating	JJ	I-NP	O
agents	agent	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
using	use	VBG	I-VP	O
an	an	DT	B-NP	O
mRNA	mRNA	NN	I-NP	B-RNA
differential	differential	JJ	I-NP	O
display	display	NN	I-NP	O
method	method	NN	I-NP	O
.	.	.	O	O

Nucleotide	Nucleotide	NN	B-NP	O
sequence	sequence	NN	I-NP	O
analysis	analysis	NN	I-NP	O
identified	identify	VBD	B-VP	O
the	the	DT	B-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
end	end	NN	I-NP	I-DNA
of	of	IN	B-PP	O
this	this	DT	B-NP	O
RNA	RNA	NN	I-NP	O
as	as	IN	B-SBAR	O
human	human	JJ	B-NP	B-RNA
retinoid	retinoid	NN	I-NP	I-RNA
receptor	receptor	NN	I-NP	I-RNA
RXRalpha	RXRalpha	NN	I-NP	I-RNA
mRNA	mRNA	NN	I-NP	I-RNA
.	.	.	O	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
nucleotide	nucleotide	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
of	of	IN	B-PP	O
3.6	3.6	CD	B-NP	O
kilobases	kilobas	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
RNA	RNA	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
represents	represent	VBZ	B-VP	O
the	the	DT	B-NP	O
3	3	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
end	end	NN	I-NP	I-DNA
of	of	IN	B-PP	O
RXRalpha	RXRalpha	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
,	,	,	O	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
previously	previously	RB	I-VP	O
described	describe	VBN	I-VP	O
.	.	.	O	O

Activated	Activate	VBN	B-NP	O
PBMCs	PBMC	NNS	I-NP	B-cell_type
also	also	RB	B-ADVP	O
expressed	express	VBD	B-VP	O
lower	low	JJR	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
RXRalpha	RXRalpha	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
assay	assay	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
activation-induced	activation-induced	JJ	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
RXRalpha	RXRalpha	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
and	and	CC	O	O
protein	protein	NN	B-NP	O
expression	expression	NN	I-NP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
protein	protein	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
present	present	VBP	B-VP	O
evidence	evidence	NN	B-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
transition	transition	NN	I-NP	O
from	from	IN	B-PP	O
G0/G1	G0/G1	NN	B-NP	O
to	to	TO	B-PP	O
S	S	NN	B-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
down-regulation	down-regulation	NN	I-NP	O
of	of	IN	B-PP	O
RXRalpha	RXRalpha	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
inhibitors	inhibitor	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
block	block	VBP	B-VP	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
in	in	IN	B-PP	O
G1	G1	NN	B-NP	O
phase	phase	NN	I-NP	O
,	,	,	O	O
prevent	prevent	VBP	B-VP	O
this	this	DT	B-NP	O
down-regulation	down-regulation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
RXRalpha	RXRalpha	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
regulated	regulate	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
post-transcriptional	post-transcriptional	JJ	I-NP	O
level	level	NN	I-NP	O
and	and	CC	O	O
involved	involve	VBD	B-VP	O
new	new	JJ	B-NP	O
protein	protein	NN	I-NP	O
synthesis	synthesis	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
observations	observation	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
RXRalpha	RXRalpha	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
coupled	couple	VBN	I-VP	O
to	to	TO	B-PP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
progression	progression	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
tight	tight	JJ	B-NP	O
regulatory	regulatory	JJ	I-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
RXRalpha	RXRalpha	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
transition	transition	NN	I-NP	O
from	from	IN	B-PP	O
G0/G1	G0/G1	NN	B-NP	O
to	to	TO	B-PP	O
S	S	NN	B-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
.	.	.	O	O

Epidemiology	Epidemiology	NN	B-NP	O
and	and	CC	I-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
AIDS-related	AIDS-related	JJ	B-NP	O
lymphomas	lymphoma	NNS	I-NP	O
.	.	.	O	O

Among	Among	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
congenital	congenital	JJ	B-NP	O
and	and	CC	I-NP	O
acquired	acquire	VBN	I-NP	O
immunodeficiencies	immunodeficiency	NNS	I-NP	O
,	,	,	O	O
non-Hodgkin	non-Hodgkin	JJ	B-NP	O
's	's	POS	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
(	(	(	O	O
NHLs	NHL	NNS	B-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
tumors	tumor	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
immune	immune	JJ	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
HIV	HIV	NN	B-NP	O
)	)	)	O	O
infection	infection	NN	B-NP	O
,	,	,	O	O
as	as	RB	B-NP	O
many	many	JJ	I-NP	O
as	as	IN	I-NP	O
10	10	CD	I-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
20	20	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
people	people	NNS	B-NP	O
ultimately	ultimately	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
NHLs	NHL	NNS	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
tumors	tumor	NNS	I-NP	O
are	be	VBP	B-VP	O
clinically	clinically	RB	B-ADJP	O
aggressive	aggressive	JJ	I-ADJP	O
,	,	,	O	O
frequently	frequently	RB	B-ADVP	O
involve	involve	VBP	B-VP	O
extranodal	extranodal	JJ	B-NP	O
sites	site	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
often	often	RB	B-VP	O
exhibit	exhibit	VBP	I-VP	O
unique	unique	JJ	B-NP	O
features	feature	NNS	I-NP	O
that	that	WDT	B-NP	O
distinguish	distinguish	VBP	B-VP	O
them	them	PRP	B-NP	O
from	from	IN	B-PP	O
NHL	NHL	NN	B-NP	O
arising	arise	VBG	B-VP	O
in	in	IN	B-PP	O
individuals	individual	NNS	B-NP	O
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
immunosuppression	immunosuppression	NN	B-NP	O
.	.	.	O	O

Important	Important	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
HIV-associated	HIV-associated	JJ	B-NP	O
NHL	NHL	NN	I-NP	O
are	be	VBP	B-VP	O
cytokines	cytokine	NNS	B-NP	B-protein
and	and	CC	O	O
other	other	JJ	B-NP	O
factors	factor	NNS	I-NP	O
that	that	WDT	B-NP	O
induce	induce	VBP	B-VP	O
B-cell	B-cell	NN	B-NP	B-cell_type
proliferation	proliferation	NN	I-NP	O
and	and	CC	O	O
increase	increase	VB	B-VP	O
the	the	DT	B-NP	O
likelihood	likelihood	NN	I-NP	O
of	of	IN	B-PP	O
mutations	mutation	NNS	B-NP	O
of	of	IN	B-PP	O
c-myc	c-myc	NN	B-NP	B-DNA
,	,	,	O	O
bcl-6	bcl-6	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
other	other	JJ	B-NP	O
tumor-suppressor	tumor-suppressor	JJ	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
with	with	IN	B-PP	O
carcinogenic	carcinogenic	JJ	B-NP	O
potential	potential	NN	I-NP	O
.	.	.	O	O

Specific	Specific	JJ	B-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
HIV-associated	HIV-associated	JJ	B-NP	O
NHL	NHL	NN	I-NP	O
are	be	VBP	B-VP	O
linked	link	VBN	I-VP	O
to	to	TO	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
Epstein-Barr	Epstein-Barr	JJ	B-NP	B-protein
virus	virus	NN	I-NP	I-protein
(	(	(	O	I-protein
EBV	EBV	NN	B-NP	I-protein
)	)	)	O	I-protein
-latent	-latent	JJ	B-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
;	;	:	O	O
the	the	DT	B-NP	O
newly	newly	RB	I-NP	O
described	describe	VBN	I-NP	O
DNA	DNA	NN	I-NP	O
virus	virus	NN	I-NP	O
,	,	,	O	O
Karposi	Karposi	NNP	B-NP	O
's	's	POS	B-NP	O
sarcoma-associated	sarcoma-associated	JJ	I-NP	O
herpesvirus/human	herpesvirus/human	JJ	I-NP	O
herpesvirus-8	herpesvirus-8	NN	I-NP	O
(	(	(	O	O
KSHV/HHV-8	KSHV/HHV-8	NN	B-NP	O
)	)	)	O	O
;	;	:	O	O
and	and	CC	O	O
perhaps	perhaps	RB	B-ADVP	O
HIV	HIV	NN	B-NP	O
.	.	.	O	O

Elucidation	Elucidation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
factors	factor	NNS	I-NP	O
that	that	WDT	B-NP	O
contribute	contribute	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
NHL	NHL	NN	B-NP	O
among	among	IN	B-PP	O
patients	patient	NNS	B-NP	O
infected	infect	VBN	B-VP	O
with	with	IN	B-PP	O
HIV	HIV	NN	B-NP	O
provides	provide	VBZ	B-VP	O
insights	insight	NNS	B-NP	O
into	into	IN	B-PP	O
important	important	JJ	B-NP	O
elements	element	NNS	I-NP	O
of	of	IN	B-PP	O
lymphomagenesis	lymphomagenesis	NN	B-NP	O
.	.	.	O	O

Matrix	Matrix	NN	B-NP	B-protein
metalloproteinase	metalloproteinase	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
:	:	:	O	O
an	an	DT	B-NP	O
immunohistochemical	immunohistochemical	JJ	I-NP	O
study	study	NN	I-NP	O
including	include	VBG	B-PP	O
correlation	correlation	NN	B-NP	O
with	with	IN	B-PP	O
cathepsin	cathepsin	NN	B-NP	B-protein
D	D	NN	I-NP	I-protein
,	,	,	O	O
type	type	NN	B-NP	B-protein
IV	IV	CD	I-NP	I-protein
collagen	collagen	NN	I-NP	I-protein
,	,	,	O	O
laminin	laminin	NN	B-NP	B-protein
,	,	,	O	O
fibronectin	fibronectin	NN	B-NP	B-protein
,	,	,	O	O
EGFR	EGFR	NN	B-NP	B-protein
,	,	,	O	O
c-erbB-2	c-erbB-2	NN	B-NP	B-protein
oncoprotein	oncoprotein	NN	I-NP	I-protein
,	,	,	O	O
p53	p53	NN	B-NP	B-protein
,	,	,	O	O
steroid	steroid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
status	status	NN	I-NP	O
and	and	CC	O	O
proliferative	proliferative	JJ	B-NP	O
indices	index	NNS	I-NP	O
.	.	.	O	O

Matrix	Matrix	NN	B-NP	B-protein
metalloproteinase	metalloproteinase	NN	I-NP	I-protein
s	s	NNS	I-NP	I-protein
(	(	(	O	O
MMPs	MMP	NNS	B-NP	B-protein
)	)	)	O	O
are	be	VBP	B-VP	O
a	a	DT	B-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
both	both	CC	B-NP	O
normal	normal	JJ	I-NP	O
connective	connective	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
matrix	matrix	NN	I-NP	O
remodelling	remodelling	NN	I-NP	O
and	and	CC	O	O
accelerated	accelerate	VBD	B-VP	O
breakdown	breakdown	NN	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
tumour	tumour	NN	B-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
current	current	JJ	I-NP	O
study	study	NN	I-NP	O
aimed	aim	VBD	B-VP	O
to	to	TO	I-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
immunohistochemical	immunohistochemical	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
matrix	matrix	NN	B-NP	B-protein
metalloproteinase	metalloproteinase	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
(	(	(	O	O
MMP-3	MMP-3	NN	B-NP	B-protein
,	,	,	O	O
stromelysin-1	stromelysin-1	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
correlation	correlation	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
Basement	Basement	NN	B-NP	B-protein
Membrane	Membrane	NN	I-NP	I-protein
(	(	(	O	I-protein
BM	BM	NN	B-NP	I-protein
)	)	)	O	I-protein
antigen	antigen	NN	B-NP	I-protein
(	(	(	O	O
type	type	NN	B-NP	B-protein
IV	IV	CD	I-NP	I-protein
collagen	collagen	NN	I-NP	I-protein
,	,	,	O	O
laminin	laminin	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
fibronectin	fibronectin	NN	B-NP	B-protein
,	,	,	O	O
cathepsin	cathepsin	NN	B-NP	B-protein
D	D	NN	I-NP	I-protein
,	,	,	O	O
p53	p53	NN	B-NP	B-protein
,	,	,	O	O
c-erbB-2	c-erbB-2	NN	B-NP	B-protein
,	,	,	O	O
proliferative	proliferative	JJ	B-NP	O
activity	activity	NN	I-NP	O
(	(	(	O	O
Ki-67	Ki-67	NN	B-NP	B-protein
,	,	,	O	O
PCNA	PCNA	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
steroid	steroid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
content	content	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
conventional	conventional	JJ	I-NP	O
clinicopathological	clinicopathological	JJ	I-NP	O
parameters	parameter	NNS	I-NP	O
in	in	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
frozen	frozen	NN	B-NP	O
and	and	CC	I-NP	O
paraffin	paraffin	NN	I-NP	O
sections	section	NNS	I-NP	O
from	from	IN	B-PP	O
84	84	CD	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
specimens	specimen	NNS	I-NP	O
by	by	IN	B-PP	O
immunohistochemistry	immunohistochemistry	NN	B-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
monoclonal	monoclonal	JJ	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
MMP-3	MMP-3	NN	I-NP	B-protein
(	(	(	O	O
Ab-1	Ab-1	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Stromelysin-1	Stromelysin-1	NN	B-NP	B-protein
(	(	(	O	O
ST1	ST1	NN	B-NP	B-protein
)	)	)	O	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
about	about	RB	B-NP	O
10	10	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
epithelial	epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
groups	group	NNS	I-NP	O
(	(	(	O	O
cases	case	NNS	B-NP	O
of	of	IN	B-PP	O
fibrocystic	fibrocystic	JJ	B-NP	O
and	and	CC	I-NP	O
benign	benign	JJ	I-NP	O
proliferative	proliferative	JJ	I-NP	O
breast	breast	NN	I-NP	O
disease	disease	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
while	while	IN	B-SBAR	O
expression	expression	NN	B-NP	O
(	(	(	O	O
>	>	JJR	B-NP	O
10	10	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
89.7	89.7	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
tumours	tumour	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
ST1	ST1	NN	B-NP	B-protein
in	in	IN	B-PP	O
carcinoma	carcinoma	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
strongly	strongly	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
its	its	PRP$	B-NP	O
presence	presence	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
stroma	stroma	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

A	A	DT	B-NP	O
significantly	significantly	RB	I-NP	O
positive	positive	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
ST1	ST1	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
p53	p53	NN	B-NP	B-protein
tumour	tumour	NN	I-NP	I-protein
suppressor	suppressor	NN	I-NP	I-protein
gene	gene	NN	I-NP	I-protein
product	product	NN	I-NP	I-protein
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.004	0.004	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
relationship	relationship	NN	I-NP	O
with	with	IN	B-PP	O
c-erbB-2	c-erbB-2	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
and	and	CC	O	O
progesterone	progesterone	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
status	status	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
indicated	indicate	VBN	I-VP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
ST1	ST1	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
tissue	tissue	NN	I-NP	O
is	be	VBZ	B-VP	O
irrespective	irrespective	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
extracellular	extracellular	JJ	I-NP	B-protein
matrix	matrix	NN	I-NP	I-protein
component	component	NN	I-NP	I-protein
,	,	,	O	O
the	the	DT	B-NP	O
proteolytic	proteolytic	JJ	I-NP	O
enzyme	enzyme	NN	I-NP	O
cathepsin	cathepsin	NN	I-NP	O
D	D	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tumour	tumour	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
new	new	JJ	I-NP	O
prognostic	prognostic	JJ	I-NP	O
marker	marker	NN	I-NP	O
in	in	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

Use	Use	NN	B-NP	O
of	of	IN	B-PP	O
transfected	transfecte	VBN	B-NP	B-cell_line
liver	liver	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
potential	potential	JJ	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
of	of	IN	B-PP	O
alcohol-induced	alcohol-induced	JJ	B-NP	O
liver	liver	NN	I-NP	O
injury	injury	NN	I-NP	O
[	[	(	O	O
see	see	VB	B-VP	O
comments	comment	NNS	B-NP	O
]	]	)	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
increased	increase	VBN	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proinflammatory	proinflammatory	JJ	I-NP	B-protein
cytokine	cytokine	NN	I-NP	I-protein
,	,	,	O	O
tumor	tumor	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
TNF	TNF	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
alcoholic	alcoholic	JJ	B-NP	O
liver	liver	NN	I-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
ALD	ALD	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Hepatic	Hepatic	JJ	B-NP	O
neutrophil	neutrophil	NN	I-NP	O
infiltration	infiltration	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
principal	principal	JJ	I-NP	O
injurious	injurious	JJ	I-NP	O
manifestation	manifestation	NN	I-NP	O
of	of	IN	B-PP	O
ALD	ALD	NN	B-NP	O
.	.	.	O	O

TNF	TNF	NN	B-NP	B-protein
can	can	MD	B-VP	O
induce	induce	VB	I-VP	O
cellular	cellular	JJ	B-NP	O
oxidative	oxidative	JJ	I-NP	O
injury	injury	NN	I-NP	O
directly	directly	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
indirectly	indirectly	RB	B-ADVP	O
by	by	IN	B-PP	O
inducing	induce	VBG	B-VP	O
neutrophil	neutrophil	NN	B-NP	O
chemotactic	chemotactic	JJ	I-NP	O
factor	factor	NN	I-NP	O
(	(	(	O	O
IL-8	IL-8	NN	B-NP	B-protein
)	)	)	O	O
production	production	NN	B-NP	O
by	by	IN	B-PP	O
hepatocytes	hepatocyte	NNS	B-NP	B-cell_type
.	.	.	O	O

IL-8	IL-8	NN	B-NP	B-protein
activates	activate	VBZ	B-VP	O
and	and	CC	O	O
chemotactically	chemotactically	RB	B-VP	O
attracts	attract	VBZ	I-VP	O
neutrophils	neutrophil	NNS	B-NP	B-cell_type
to	to	TO	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
where	where	WRB	B-ADVP	O
they	they	PRP	B-NP	O
release	release	VBP	B-VP	O
oxidizing	oxidize	VBG	I-VP	O
substances	substance	NNS	B-NP	O
.	.	.	O	O

Patients	Patient	NNS	B-NP	O
with	with	IN	B-PP	O
ALD	ALD	NN	B-NP	O
also	also	RB	B-ADVP	O
have	have	VBP	B-VP	O
decreased	decrease	VBN	I-VP	O
protective	protective	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
for	for	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
oxidative	oxidative	JJ	I-NP	O
injury	injury	NN	I-NP	O
.	.	.	O	O

Manganous	Manganous	JJ	B-NP	B-protein
superoxide	superoxide	NN	I-NP	I-protein
dismutase	dismutase	NN	I-NP	I-protein
(	(	(	O	O
MnSOD	MnSOD	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
antioxidant	antioxidant	JJ	I-NP	B-protein
protective	protective	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
objectives	objective	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
investigate	investigate	VB	I-VP	O
mechanisms	mechanism	NNS	B-NP	O
for	for	IN	B-PP	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
injurious	injurious	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
IL-8	IL-8	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
protective	protective	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
MnSOD	MnSOD	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
HepG2	HepG2	NN	I-NP	B-cell_line
human	human	JJ	I-NP	I-cell_line
hepatoma	hepatoma	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
experiments	experiment	NNS	B-NP	O
,	,	,	O	O
IL-8	IL-8	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
reporter	reporter	NN	I-NP	I-DNA
constructs	construct	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
transiently	transiently	RB	I-VP	O
transfect	transfect	VB	I-VP	O
a	a	DT	B-NP	O
derivative	derivative	JJ	I-NP	O
(	(	(	O	O
MVh2E1-9	MVh2E1-9	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HepG2	HepG2	NN	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
which	which	WDT	B-NP	O
expresses	express	VBZ	B-VP	O
P-4502E1	P-4502E1	NN	B-NP	B-protein
and	and	CC	O	O
metabolizes	metabolize	VBZ	B-VP	O
ethanol	ethanol	NN	B-NP	O
.	.	.	O	O

Inactivation	Inactivation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
and	and	CC	I-NP	O
3'NF-IL-6	3'NF-IL-6	NN	I-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
decreased	decrease	VBD	B-VP	O
IL-8	IL-8	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
transcriptional	transcriptional	JJ	I-NP	O
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
TNF	TNF	NN	B-NP	B-protein
while	while	IN	B-SBAR	O
inactivation	inactivation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
5'NF-IL-6	5'NF-IL-6	NN	I-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
increased	increase	VBD	B-VP	O
IL-8	IL-8	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
TNF	TNF	NN	B-NP	B-protein
.	.	.	O	O

This	This	DT	B-NP	O
system	system	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
useful	useful	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
ethanol	ethanol	NN	B-NP	O
on	on	IN	B-PP	O
TNF	TNF	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
hepatocyte	hepatocyte	NN	I-NP	O
IL-8	IL-8	NN	I-NP	B-protein
production	production	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
experiments	experiment	NNS	B-NP	O
,	,	,	O	O
HepG2	HepG2	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
in	in	IN	B-PP	O
25	25	CD	B-NP	O
to	to	TO	I-NP	O
100	100	CD	I-NP	O
mmol	mmol	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
ethanol	ethanol	NN	B-NP	O
.	.	.	O	O

Both	Both	CC	O	O
TNF	TNF	NN	B-NP	B-protein
and	and	CC	I-NP	O
ethanol	ethanol	NN	I-NP	O
increased	increase	VBD	B-VP	O
HepG2	HepG2	NN	B-NP	O
cell	cell	NN	I-NP	O
MnSOD	MnSOD	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
short-term	short-term	JJ	B-NP	B-cell_line
(	(	(	O	I-cell_line
72	72	CD	B-NP	I-cell_line
hr	hr	NN	I-NP	I-cell_line
)	)	)	O	I-cell_line
cultures	culture	NNS	B-NP	I-cell_line
with	with	IN	B-PP	O
ethanol	ethanol	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
after	after	IN	B-PP	O
long-term	long-term	JJ	B-ADJP	B-cell_line
(	(	(	O	I-cell_line
10	10	CD	B-NP	I-cell_line
weeks	week	NNS	I-NP	I-cell_line
)	)	)	O	I-cell_line
culture	culture	NN	B-NP	I-cell_line
with	with	IN	B-PP	O
ethanol	ethanol	NN	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
MnSOD	MnSOD	NN	B-NP	B-protein
by	by	IN	B-PP	O
ethanol	ethanol	NN	B-NP	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
diminished	diminish	VBN	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
MnSOD	MnSOD	NN	B-NP	B-protein
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
TNF	TNF	NN	B-NP	B-protein
.	.	.	O	O

Further	Further	JJ	B-NP	O
studies	study	NNS	I-NP	O
are	be	VBP	B-VP	O
needed	need	VBN	I-VP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
diminished	diminish	VBN	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
MnSOD	MnSOD	NN	B-NP	B-protein
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
ethanol	ethanol	NN	I-NP	O
culture	culture	NN	I-NP	O
on	on	IN	B-PP	O
HepG2	HepG2	NN	B-NP	O
cell	cell	NN	I-NP	O
susceptibility	susceptibility	NN	I-NP	O
to	to	TO	B-PP	O
TNF	TNF	NN	B-NP	B-protein
cytotoxicity	cytotoxicity	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
transfected	transfecte	VBN	B-NP	B-cell_line
liver	liver	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
can	can	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
mechanisms	mechanism	NNS	B-NP	O
for	for	IN	B-PP	O
increased	increase	VBN	B-NP	O
injurious	injurious	JJ	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
protective	protective	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
alcoholic	alcoholic	JJ	B-NP	O
liver	liver	NN	I-NP	O
injury	injury	NN	I-NP	O
.	.	.	O	O

Tissue	Tissue	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
transcription	transcription	NN	I-NP	O
driven	drive	VBN	B-VP	O
by	by	IN	B-PP	O
Egr-1	Egr-1	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
murine	murine	JJ	B-NP	B-protein
pulmonary	pulmonary	JJ	I-NP	I-protein
fibrin	fibrin	NN	I-NP	I-protein
deposition	deposition	NN	I-NP	O
in	in	IN	B-PP	O
hypoxia	hypoxia	NN	B-NP	O
.	.	.	O	O

Local	Local	JJ	B-NP	O
hypoxemia	hypoxemia	NN	I-NP	O
and	and	CC	I-NP	O
stasis	stasis	NN	I-NP	O
trigger	trigger	NN	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
previously	previously	RB	B-ADVP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
murine	murine	JJ	I-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
normobaric	normobaric	JJ	B-NP	O
hypoxia	hypoxia	NN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
fibrin	fibrin	NN	I-NP	O
deposition	deposition	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
tissue	tissue	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
especially	especially	RB	B-ADVP	O
in	in	IN	B-PP	O
oxygen-deprived	oxygen-deprived	JJ	B-NP	B-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
phagocytes	phagocyte	NNS	I-NP	I-cell_type
(	(	(	O	O
MPs	MP	NNS	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

We	We	PRP	B-NP	O
now	now	RB	B-ADVP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
transcription	transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
early-growth-response	early-growth-response	JJ	I-NP	I-protein
gene	gene	NN	I-NP	I-protein
product	product	NN	I-NP	I-protein
(	(	(	O	O
Egr-1	Egr-1	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
rapidly	rapidly	RB	I-VP	O
activated	activate	VBN	I-VP	O
in	in	IN	B-PP	O
hypoxia	hypoxia	NN	B-NP	O
,	,	,	O	O
both	both	CC	O	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
transcription	transcription	NN	B-NP	O
and	and	CC	O	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
tissue	tissue	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
in	in	IN	B-PP	O
hypoxic	hypoxic	JJ	B-NP	O
lung	lung	NN	I-NP	O
.	.	.	O	O

MPs	MP	NNS	B-NP	O
and	and	CC	O	O
HeLa	HeLa	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
subjected	subject	VBN	B-VP	O
to	to	TO	B-PP	O
hypoxia	hypoxia	NN	B-NP	O
(	(	(	O	O
pO2	pO2	NN	B-NP	O
approximately	approximately	RB	B-NP	O
13	13	CD	I-NP	O
torr	torr	NN	I-NP	O
)	)	)	O	O
had	have	VBD	B-VP	O
increased	increase	VBN	I-VP	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
tissue	tissue	NN	B-NP	B-RNA
factor	factor	NN	I-NP	I-RNA
transcripts	transcript	NNS	I-NP	I-RNA
(	(	(	O	O
approximately	approximately	RB	B-NP	O
18-fold	18-fold	JJ	I-NP	O
)	)	)	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
(	(	(	O	O
approximately	approximately	RB	B-ADVP	O
15-fold	15-fold	RB	B-ADVP	O
)	)	)	O	O
,	,	,	O	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
run-on	run-on	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O

Gel-shift	Gel-shift	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
from	from	IN	B-PP	O
hypoxic	hypoxic	JJ	B-NP	O
MPs	MP	NNS	I-NP	O
and	and	CC	O	O
HeLa	HeLa	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
demonstrated	demonstrate	VBD	B-VP	O
increased	increase	VBN	B-NP	O
DNA-binding	DNA-binding	JJ	I-NP	O
activity	activity	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
serum	serum	NN	I-NP	B-DNA
response	response	NN	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
(	(	(	O	O
SRR	SRR	NN	B-NP	B-DNA
;	;	:	O	I-DNA
-111/+14	-111/+14	CD	B-NP	I-DNA
bp	bp	NN	I-NP	I-DNA
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tissue	tissue	NN	I-NP	B-DNA
factor	factor	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
at	at	IN	B-PP	O
Egr-1	Egr-1	NN	B-NP	B-DNA
motifs	motif	NNS	I-NP	I-DNA
.	.	.	O	O

Using	Use	VBG	B-VP	O
32P-labeled	32P-labeled	JJ	B-NP	O
Egr	Egr	NN	I-NP	O
consensus	consensus	NN	I-NP	O
oligonucleotide	oligonucleotide	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
observed	observe	VBD	B-VP	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
DNA-binding	DNA-binding	JJ	B-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
from	from	IN	B-PP	O
hypoxic	hypoxic	JJ	B-NP	O
lung	lung	NN	I-NP	O
and	and	CC	I-NP	O
HeLa	HeLa	NN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
because	because	IN	B-PP	O
of	of	IN	I-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
Egr-1	Egr-1	NN	B-NP	B-protein
,	,	,	O	O
by	by	IN	B-PP	O
means	mean	NNS	B-NP	O
of	of	IN	B-PP	O
supershift	supershift	NN	B-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O

Transient	Transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
of	of	IN	B-PP	O
HeLa	HeLa	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
with	with	IN	B-PP	O
chimeric	chimeric	JJ	B-NP	B-DNA
plasmids	plasmid	NNS	I-NP	I-DNA
containing	contain	VBG	B-VP	O
wild-type	wild-type	JJ	B-NP	O
or	or	CC	I-NP	O
mutant	mutant	JJ	I-NP	O
SRR	SRR	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
tissue	tissue	NN	I-NP	B-DNA
factor	factor	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
intact	intact	JJ	B-NP	O
Sp1	Sp1	NN	I-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
are	be	VBP	B-VP	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
basal	basal	JJ	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
activity	activity	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
integrity	integrity	NN	I-NP	O
of	of	IN	B-PP	O
Egr-1	Egr-1	NN	B-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
was	be	VBD	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
hypoxia-enhanced	hypoxia-enhanced	JJ	B-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
central	central	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
Egr-1	Egr-1	NN	B-NP	B-protein
in	in	IN	B-PP	O
hypoxia-mediated	hypoxia-mediated	JJ	B-NP	O
tissue	tissue	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
by	by	IN	B-PP	O
experiments	experiment	NNS	B-NP	O
with	with	IN	B-PP	O
homozygous	homozygous	JJ	B-NP	O
Egr-1	Egr-1	NN	I-NP	B-protein
null	null	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
;	;	:	O	O
wild-type	wild-type	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
subjected	subject	VBN	B-VP	O
to	to	TO	B-PP	O
oxygen	oxygen	NN	B-NP	O
deprivation	deprivation	NN	I-NP	O
expressed	express	VBD	B-VP	O
tissue	tissue	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
and	and	CC	O	O
showed	show	VBD	B-VP	O
fibrin	fibrin	NN	B-NP	O
deposition	deposition	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
hypoxic	hypoxic	JJ	B-NP	O
homozygous	homozygous	JJ	I-NP	O
Egr-1	Egr-1	NN	I-NP	B-protein
null	null	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
displayed	display	VBD	B-VP	O
neither	neither	CC	O	O
tissue	tissue	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
nor	nor	CC	O	O
fibrin	fibrin	NN	B-NP	B-protein
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
delineate	delineate	VBP	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
biology	biology	NN	I-NP	O
for	for	IN	B-PP	O
hypoxia-induced	hypoxia-induced	JJ	B-NP	O
fibrin	fibrin	NN	I-NP	O
deposition	deposition	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
oxygen	oxygen	NN	B-NP	O
deprivation-induced	deprivation-induced	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
Egr-1	Egr-1	NN	B-NP	B-protein
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
tissue	tissue	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
unexpected	unexpected	JJ	I-NP	O
and	and	CC	I-NP	O
central	central	JJ	I-NP	O
role	role	NN	I-NP	O
.	.	.	O	O

Kinetics	Kinetic	NNS	B-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-protein
and	and	CC	I-NP	O
NFAT	NFAT	NN	I-NP	B-protein
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
interleukin-2-dependent	interleukin-2-dependent	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
lymphoblasts	lymphoblast	NNS	I-NP	I-cell_type
stimulated	stimulate	VBN	B-VP	O
via	via	IN	B-PP	O
T-cell	T-cell	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
respond	respond	VBP	B-VP	O
to	to	TO	B-PP	O
mitogenic	mitogenic	JJ	B-NP	O
or	or	CC	I-NP	O
antigenic	antigenic	JJ	I-NP	O
stimulation	stimulation	NN	I-NP	O
by	by	IN	B-PP	O
proliferation	proliferation	NN	B-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
turning	turn	VBG	B-VP	O
on	on	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
analysed	analyse	VBN	I-VP	O
the	the	DT	B-NP	O
kinetics	kinetic	NNS	I-NP	O
and	and	CC	I-NP	O
nature	nature	NN	I-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-protein
production	production	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood-derived	blood-derived	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
lymphoblasts	lymphoblast	NNS	I-NP	I-cell_type
stimulated	stimulate	VBN	B-VP	O
with	with	IN	B-PP	O
anti-CD3	anti-CD3	JJ	B-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
or	or	CC	O	O
Lens	Lens	NNP	B-NP	O
culinaris	culinaris	NN	I-NP	O
lectin	lectin	NN	I-NP	O
(	(	(	O	O
LCL	LCL	NN	B-NP	B-cell_line
)	)	)	O	O
.	.	.	O	O

T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
purified	purify	VBN	I-VP	O
from	from	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
PBMC	PBMC	NN	B-NP	B-cell_type
)	)	)	O	O
and	and	CC	O	O
primarily	primarily	RB	B-VP	O
activated	activate	VBN	I-VP	O
with	with	IN	B-PP	O
anti-CD3	anti-CD3	JJ	B-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
and	and	CC	O	O
cultured	culture	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
interleukin-2	interleukin-2	NN	B-NP	B-protein
(	(	(	O	O
IL-2	IL-2	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Anti-CD3-restimulated	Anti-CD3-restimulated	JJ	B-NP	B-protein
T	T	NN	I-NP	I-protein
cells	cell	NNS	I-NP	I-protein
(	(	(	O	O
mainly	mainly	RB	B-ADJP	O
CD8+	CD8+	JJ	I-ADJP	O
)	)	)	O	O
produced	produce	VBD	B-VP	O
IL-2	IL-2	NN	B-NP	B-protein
,	,	,	O	O
interferon-gamma	interferon-gamma	NN	B-NP	B-protein
(	(	(	O	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
tumour	tumour	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor-alpha	factor-alpha	NN	I-NP	I-protein
(	(	(	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
low	low	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
IL-4	IL-4	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-10	IL-10	NN	I-NP	B-protein
transcripts	transcript	NNS	I-NP	O
and	and	CC	I-NP	O
proteins	protein	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
IL-6	IL-6	NN	I-NP	B-protein
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
LCL-stimulated	LCL-stimulated	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
the	the	DT	B-NP	O
cytokine	cytokine	NN	I-NP	B-protein
production	production	NN	I-NP	O
pattern	pattern	NN	I-NP	O
was	be	VBD	B-VP	O
very	very	RB	B-ADJP	O
similar	similar	JJ	I-ADJP	O
.	.	.	O	O

Steady-state	Steady-state	JJ	B-NP	O
mRNA	mRNA	NN	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
,	,	,	O	O
IL-10	IL-10	NN	B-NP	B-protein
and	and	CC	I-NP	O
IFN-gamma	IFN-gamma	NN	I-NP	B-protein
peaked	peak	VBD	B-VP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
anti-CD3	anti-CD3	JJ	B-NP	B-protein
stimulation	stimulation	NN	I-NP	O
and	and	CC	O	O
declined	decline	VBD	B-VP	O
rapidly	rapidly	RB	B-ADVP	O
thereafter	thereafter	RB	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
kinetics	kinetic	NNS	I-NP	O
of	of	IN	B-PP	O
TNF-alpha	TNF-alpha	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
faster	fast	JJR	B-ADJP	O
,	,	,	O	O
being	be	VBG	B-VP	O
at	at	IN	B-PP	O
its	its	PRP$	B-NP	O
peak	peak	JJ	I-NP	O
level	level	NN	I-NP	O
1	1	CD	I-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
.	.	.	O	O

Anti-CD3-stimulated	Anti-CD3-stimulated	JJ	B-NP	O
IL-2	IL-2	NN	I-NP	B-protein
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
down-regulated	down-regulate	VBN	I-VP	O
by	by	IN	B-PP	O
protein	protein	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
IL-10	IL-10	NN	B-NP	B-protein
,	,	,	I-NP	O
IFN-gamma	IFN-gamma	NN	I-NP	B-protein
and	and	CC	I-NP	O
TNF-alpha	TNF-alpha	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
readily	readily	RB	I-VP	O
induced	induce	VBN	I-VP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
ongoing	ongoing	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
synthesis	synthesis	NN	I-NP	O
.	.	.	O	O

T-cell	T-cell	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
stimulation	stimulation	NN	I-NP	O
also	also	RB	B-ADVP	O
induced	induce	VBD	B-VP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
rapid	rapid	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
c-jun	c-jun	NN	B-NP	B-DNA
,	,	,	O	O
c-fos	c-fos	NN	B-NP	B-DNA
and	and	CC	O	O
NFATc1	NFATc1	NN	B-NP	B-DNA
(	(	(	O	I-DNA
NFATc	NFATc	NN	B-NP	I-DNA
)	)	)	O	I-DNA
genes	gene	NNS	B-NP	I-DNA
,	,	,	O	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	B-protein
products	product	NNS	I-NP	I-protein
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
conclusion	conclusion	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
cytokines	cytokine	NNS	I-NP	B-protein
synthesized	synthesize	VBN	B-VP	O
by	by	IN	B-PP	O
IL-2-dependent	IL-2-dependent	JJ	B-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
predominantly	predominantly	RB	B-ADVP	O
IL-2	IL-2	NN	B-NP	B-protein
,	,	,	I-NP	O
IFN-gamma	IFN-gamma	NN	I-NP	B-protein
and	and	CC	I-NP	O
TNF-alpha	TNF-alpha	NN	I-NP	B-protein
.	.	.	O	O

An	An	DT	B-NP	O
animal	animal	NN	I-NP	O
model	model	NN	I-NP	O
to	to	TO	B-VP	O
study	study	VB	I-VP	O
local	local	JJ	B-NP	O
oxidation	oxidation	NN	I-NP	O
of	of	IN	B-PP	O
LDL	LDL	NN	B-NP	B-protein
and	and	CC	O	O
its	its	PRP$	B-NP	O
biological	biological	JJ	I-NP	O
effects	effect	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
arterial	arterial	JJ	I-NP	O
wall	wall	NN	I-NP	O
.	.	.	O	O

Oxidized	Oxidize	VBN	B-NP	B-protein
LDL	LDL	NN	I-NP	I-protein
(	(	(	O	O
oxLDL	oxLDL	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
atherosclerotic	atherosclerotic	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
believed	believe	VBN	I-VP	O
to	to	TO	I-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
key	key	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
atherogenesis	atherogenesis	NN	B-NP	O
.	.	.	O	O

Mainly	Mainly	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
culture	culture	NN	I-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
oxLDL	oxLDL	NN	B-NP	B-protein
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
produce	produce	VB	I-VP	O
many	many	JJ	B-NP	O
biological	biological	JJ	I-NP	O
effects	effect	NNS	I-NP	O
that	that	WDT	B-NP	O
influence	influence	VBP	B-VP	O
the	the	DT	B-NP	O
atherosclerotic	atherosclerotic	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
study	study	VB	I-VP	O
LDL	LDL	NN	B-NP	B-protein
oxidation	oxidation	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
established	establish	VBN	I-VP	O
a	a	DT	B-NP	O
model	model	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
Sprague-Dawley	Sprague-Dawley	JJ	B-NP	O
rats	rat	NNS	I-NP	O
are	be	VBP	B-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
injection	injection	NN	I-NP	O
of	of	IN	B-PP	O
unmodified	unmodified	JJ	B-NP	O
human	human	JJ	I-NP	O
LDL	LDL	NN	I-NP	O
(	(	(	O	O
>	>	SYM	B-NP	O
or	or	CC	O	O
=	=	SYM	B-VP	O
4	4	CD	B-NP	O
mg/kg	mg/kg	NN	I-NP	O
body	body	NN	I-NP	O
weight	weight	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Within	Within	IN	B-PP	O
6	6	CD	B-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
accumulation	accumulation	NN	I-NP	O
of	of	IN	B-PP	O
apolipoprotein	apolipoprotein	NN	B-NP	O
B	B	NN	I-NP	O
and	and	CC	O	O
epitopes	epitope	NNS	B-NP	O
present	present	JJ	B-ADJP	O
on	on	IN	B-PP	O
oxLDL	oxLDL	NN	B-NP	B-protein
are	be	VBP	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
arterial	arterial	JJ	I-NP	O
endothelium	endothelium	NN	I-NP	O
and	and	CC	I-NP	O
media	medium	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
oxLDL	oxLDL	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
nuclear	nuclear	JJ	I-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
endothelium	endothelium	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
endothelial	endothelial	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
intercellular	intercellular	JJ	B-NP	B-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
.	.	.	O	O

Injection	Injection	NN	B-NP	O
of	of	IN	B-PP	O
LDL	LDL	NN	B-NP	B-protein
enriched	enrich	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
antioxidant	antioxidant	JJ	I-NP	O
probucol	probucol	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
arterial	arterial	JJ	B-NP	O
accumulation	accumulation	NN	I-NP	O
of	of	IN	B-PP	O
apolipoprotein	apolipoprotein	NN	B-NP	O
B	B	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
oxLDL-specific	oxLDL-specific	JJ	B-NP	B-protein
epitopes	epitope	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
at	at	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
simple	simple	JJ	I-NP	O
model	model	NN	I-NP	O
has	have	VBZ	B-VP	O
the	the	DT	B-NP	O
potential	potential	NN	I-NP	O
to	to	TO	B-VP	O
analyze	analyze	VB	I-VP	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
behind	behind	IN	B-ADVP	O
and	and	CC	O	O
biological	biological	JJ	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
LDL	LDL	NN	B-NP	B-protein
oxidation	oxidation	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

Molecular	Molecular	JJ	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
of	of	IN	B-PP	O
promoter	promoter	NN	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gp34	gp34	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
trans-activated	trans-activate	VBN	I-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
oncoprotein	oncoprotein	NN	I-NP	B-protein
Tax	Tax	NN	I-NP	B-protein
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
leukemia	leukemia	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
I	I	CD	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gp34	gp34	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Tax	Tax	NN	I-NP	B-protein
oncoprotein	oncoprotein	NN	I-NP	I-protein
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
leukemia	leukemia	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
I	I	CD	I-NP	O
(	(	(	O	O
HTLV-I	HTLV-I	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

gp34	gp34	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
type	type	NN	I-NP	B-protein
II	II	CD	I-NP	I-protein
transmembrane	transmembrane	JJ	I-NP	I-protein
molecule	molecule	NN	I-NP	I-protein
belonging	belong	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
tumor	tumor	NN	I-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
family	family	NN	I-NP	I-protein
and	and	CC	O	O
is	be	VBZ	B-VP	O
constitutively	constitutively	RB	I-VP	O
expressed	express	VBN	I-VP	O
on	on	IN	B-PP	O
HTLV-I-producing	HTLV-I-producing	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
but	but	CC	B-NP	O
not	not	RB	I-NP	O
normal	normal	JJ	I-NP	B-cell_type
resting	rest	VBG	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	B-DNA
regulatory	regulatory	JJ	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gp34	gp34	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
HTLV-I	HTLV-I	NN	B-NP	B-protein
Tax	Tax	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
Jurkat	Jurkat	NN	I-NP	I-cell_line
,	,	,	O	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
endogenous	endogenous	JJ	B-NP	O
gp34	gp34	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
Tax	Tax	NN	B-NP	B-protein
.	.	.	O	O

Sequence	Sequence	NN	B-NP	O
analysis	analysis	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
two	two	CD	B-NP	O
NF-kappaB-like	NF-kappaB-like	JJ	I-NP	B-DNA
elements	element	NNS	I-NP	I-DNA
(	(	(	O	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
2	2	CD	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
.	.	.	O	O

Both	Both	DT	B-NP	O
NF-kappaB-like	NF-kappaB-like	JJ	I-NP	B-DNA
elements	element	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
or	or	CC	O	O
its	its	PRP$	B-NP	O
related	related	JJ	I-NP	O
factor	factor	NN	I-NP	O
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
Tax	Tax	NN	I-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
.	.	.	O	O

Chloramphenicol	Chloramphenicol	NN	B-NP	B-protein
acetyltransferase	acetyltransferase	NN	I-NP	I-protein
assays	assay	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
NF-kappaB-like	NF-kappaB-like	JJ	B-NP	B-DNA
element	element	NN	I-NP	I-DNA
1	1	CD	I-NP	I-DNA
was	be	VBD	B-VP	O
Tax	Tax	NN	B-NP	B-protein
-responsive	-responsive	JJ	B-ADJP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
lower	low	JJR	B-ADJP	O
than	than	IN	B-PP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
native	native	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

NF-kappaB	NF-kappaB	NN	B-NP	B-protein
-like	-like	JJ	I-NP	O
element	element	NN	I-NP	O
2	2	CD	I-NP	O
elevated	elevated	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
activity	activity	NN	I-NP	O
when	when	WRB	B-ADVP	O
combined	combine	VBN	B-VP	O
with	with	IN	B-PP	O
NF-kappaB-like	NF-kappaB-like	JJ	B-NP	B-DNA
element	element	NN	I-NP	I-DNA
1	1	CD	I-NP	I-DNA
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
cooperative	cooperative	JJ	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
elements	element	NNS	I-NP	O
for	for	IN	B-PP	O
maximum	maximum	NN	B-NP	O
promoter	promoter	NN	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

Unlike	Unlike	IN	B-PP	O
typical	typical	JJ	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-DNA
elements	element	NNS	I-NP	I-DNA
,	,	,	O	O
the	the	DT	B-NP	O
NF-kappaB-like	NF-kappaB-like	JJ	I-NP	B-DNA
elements	element	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
gp34	gp34	NN	B-NP	B-protein
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
with	with	IN	B-PP	O
phorbol	phorbol	NN	B-NP	O
ester	ester	NN	I-NP	O
despite	despite	IN	B-PP	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
-like	-like	JJ	I-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

Chloramphenicol	Chloramphenicol	NN	B-NP	B-protein
acetyltransferase	acetyltransferase	NN	I-NP	I-protein
reporter	reporter	NN	I-NP	O
assays	assay	NNS	I-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
upstream	upstream	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NF-kappaB-like	NF-kappaB-like	JJ	I-NP	B-DNA
elements	element	NNS	I-NP	I-DNA
identified	identify	VBD	B-VP	O
an	an	DT	B-NP	O
upstream	upstream	JJ	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
that	that	WDT	B-NP	O
reduced	reduce	VBD	B-VP	O
transcription	transcription	NN	B-NP	O
from	from	IN	B-PP	O
cognate	cognate	JJ	B-NP	O
and	and	CC	I-NP	O
noncognate	noncognate	JJ	I-NP	B-DNA
core	core	NN	I-NP	I-DNA
promoters	promoter	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
a	a	DT	B-NP	O
Tax-independent	Tax-independent	JJ	I-NP	O
manner	manner	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
imply	imply	VBP	B-VP	O
complex	complex	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gp34	gp34	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
and	and	CC	O	O
suggest	suggest	VBP	B-VP	O
implication	implication	NN	B-NP	O
of	of	IN	B-PP	O
gp34	gp34	NN	B-NP	B-protein
in	in	IN	B-PP	O
proliferation	proliferation	NN	B-NP	O
of	of	IN	B-PP	O
HTLV-I	HTLV-I	NN	B-NP	B-cell_type
infected	infected	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

beta-Amyloid	beta-Amyloid	JJ	B-NP	B-protein
fibrils	fibril	NNS	I-NP	I-protein
activate	activate	VBP	B-VP	O
parallel	parallel	JJ	B-NP	O
mitogen-activated	mitogen-activated	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
pathways	pathway	NNS	I-NP	O
in	in	IN	B-PP	O
microglia	microglia	NN	B-NP	B-cell_type
and	and	CC	I-NP	O
THP1	THP1	NN	I-NP	B-cell_line
monocytes	monocyte	NNS	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
senile	senile	JJ	I-NP	O
plaques	plaque	NNS	I-NP	O
of	of	IN	B-PP	O
Alzheimer	Alzheimer	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
are	be	VBP	B-VP	O
foci	focus	NNS	B-NP	O
of	of	IN	B-PP	O
local	local	JJ	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
responses	response	NNS	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
evidenced	evidence	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	B-protein
phase	phase	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
and	and	CC	O	O
oxidative	oxidative	JJ	B-NP	O
damage	damage	NN	I-NP	O
.	.	.	O	O

Fibrillar	Fibrillar	JJ	B-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
beta-amyloid	beta-amyloid	NN	B-NP	O
(	(	(	O	O
Abeta	Abeta	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
constituents	constituent	NNS	I-NP	O
of	of	IN	B-PP	O
senile	senile	JJ	B-NP	O
plaques	plaque	NNS	I-NP	O
,	,	,	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
activate	activate	VB	I-VP	O
tyrosine	tyrosine	NN	B-NP	O
kinase-dependent	kinase-dependent	JJ	I-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
cascades	cascade	NNS	I-NP	O
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	O
responses	response	NNS	I-NP	O
in	in	IN	B-PP	O
microglia	microglia	NNS	B-NP	B-cell_type
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
downstream	downstream	JJ	I-NP	O
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
mediating	mediate	VBG	B-VP	O
Abeta	Abeta	NN	B-NP	O
-induced	-induced	JJ	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
events	event	NNS	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
well	well	RB	I-VP	O
characterized	characterize	VBN	I-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
that	that	IN	B-SBAR	O
exposure	exposure	NN	B-NP	O
of	of	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
rat	rat	NN	I-NP	I-cell_type
microglia	microglia	NNS	I-NP	I-cell_type
and	and	CC	O	O
human	human	JJ	B-NP	B-cell_type
THP1	THP1	NN	I-NP	I-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
fibrillar	fibrillar	JJ	B-NP	B-protein
Abeta	Abeta	NN	I-NP	I-protein
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
tyrosine	tyrosine	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
-dependent	-dependent	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
parallel	parallel	JJ	I-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
cascades	cascade	NNS	I-NP	O
involving	involve	VBG	B-VP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mitogen-activated	mitogen-activated	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	I-protein
MAPK	MAPK	NN	B-NP	I-protein
)	)	)	O	I-protein
superfamily	superfamily	NN	B-NP	I-protein
.	.	.	O	O

Abeta	Abeta	NN	B-NP	O
stimulated	stimulate	VBD	B-VP	O
the	the	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
,	,	,	I-NP	O
transient	transient	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
extracellular	extracellular	JJ	B-NP	B-protein
signal-regulated	signal-regulated	JJ	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
(	(	(	O	O
ERK1	ERK1	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
ERK2	ERK2	NN	B-NP	B-protein
in	in	IN	B-PP	O
microglia	microglia	NN	B-NP	B-cell_type
and	and	CC	I-NP	O
ERK2	ERK2	NN	I-NP	B-protein
in	in	IN	B-PP	O
THP1	THP1	NN	B-NP	B-cell_line
monocytes	monocyte	NNS	I-NP	I-cell_line
.	.	.	O	O

A	A	DT	B-NP	O
second	second	JJ	I-NP	O
superfamily	superfamily	NN	I-NP	O
member	member	NN	I-NP	O
,	,	,	O	O
p38	p38	NN	B-NP	B-protein
MAPK	MAPK	NN	I-NP	I-protein
,	,	,	O	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
activated	activate	VBN	I-VP	O
with	with	IN	B-PP	O
similar	similar	JJ	B-NP	O
kinetics	kinetic	NNS	I-NP	O
.	.	.	O	O

Scavenger	Scavenger	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
and	and	CC	O	O
receptor	receptor	NN	B-NP	O
for	for	IN	B-PP	O
advanced	advance	VBN	B-NP	O
glycated	glycate	VBN	I-NP	O
end	end	NN	I-NP	O
products	product	NNS	I-NP	O
(	(	(	O	O
RAGE	RAGE	NN	B-NP	O
)	)	)	O	O
ligands	ligand	NNS	B-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
activate	activate	VB	I-VP	O
ERK	ERK	NN	B-NP	B-protein
and	and	CC	I-NP	O
p38	p38	NN	I-NP	B-protein
MAPK	MAPK	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
significant	significant	JJ	B-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
protein	protein	NN	B-NP	O
tyrosine	tyrosine	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
,	,	,	O	O
demonstrating	demonstrate	VBG	B-VP	O
that	that	IN	B-SBAR	O
scavenger	scavenger	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
and	and	CC	O	O
RAGE	RAGE	NN	B-NP	B-protein
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
linked	link	VBN	I-VP	O
to	to	TO	B-PP	O
these	these	DT	B-NP	O
pathways	pathway	NNS	I-NP	O
.	.	.	O	O

Importantly	Importantly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
stress-activated	stress-activated	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinases	kinase	NNS	I-NP	I-protein
(	(	(	O	O
SAPKs	SAPK	NNS	B-NP	B-protein
)	)	)	O	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
significantly	significantly	RB	I-VP	O
activated	activate	VBN	I-VP	O
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
Abeta	Abeta	NN	B-NP	B-protein
.	.	.	O	O

Downstream	Downstream	JJ	B-NP	O
effectors	effector	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MAPK	MAPK	NN	I-NP	B-protein
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
cascades	cascade	NNS	I-NP	O
include	include	VBP	B-VP	O
MAPKAP	MAPKAP	NN	B-NP	B-protein
kinases	kinase	NNS	I-NP	I-protein
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
RSK1	RSK1	NN	B-NP	B-protein
and	and	CC	I-NP	O
RSK2	RSK2	NN	I-NP	B-protein
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
transcription	transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

Exposure	Exposure	NN	B-NP	O
of	of	IN	B-PP	O
microglia	microglia	NN	B-NP	B-cell_type
and	and	CC	I-NP	O
THP1	THP1	NN	I-NP	B-cell_line
monocytes	monocyte	NNS	I-NP	I-cell_line
to	to	TO	B-PP	O
Abeta	Abeta	NN	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
RSK1	RSK1	NN	B-NP	B-protein
and	and	CC	O	O
RSK2	RSK2	NN	B-NP	B-protein
and	and	CC	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
cAMP	cAMP	NN	B-NP	B-protein
response	response	NN	I-NP	I-protein
element-binding	element-binding	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
at	at	IN	B-PP	O
Ser133	Ser133	NN	B-NP	O
,	,	,	O	O
providing	provide	VBG	B-VP	O
a	a	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
for	for	IN	B-PP	O
Abeta	Abeta	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O

Regulation	Regulation	NN	B-NP	O
of	of	IN	B-PP	O
cellular	cellular	JJ	B-NP	B-protein
retinoic	retinoic	JJ	I-NP	I-protein
acid	acid	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	O
CRABP	CRABP	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
)	)	)	O	O
during	during	IN	B-PP	O
human	human	JJ	B-NP	O
monocyte	monocyte	NN	I-NP	O
differentiation	differentiation	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

Cellular	Cellular	JJ	B-NP	B-protein
retinoic	retinoic	JJ	I-NP	I-protein
acid	acid	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
(	(	(	O	O
CRABP	CRABP	NN	B-NP	B-protein
)	)	)	O	O
are	be	VBP	B-VP	O
low	low	JJ	B-NP	B-protein
molecular	molecular	JJ	I-NP	I-protein
weight	weight	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
whose	whose	WP$	B-NP	O
precise	precise	JJ	I-NP	O
function	function	NN	I-NP	O
remains	remain	VBZ	B-VP	O
unknown	unknown	JJ	B-ADJP	O
.	.	.	O	O

They	They	PRP	B-NP	O
bind	bind	VBP	B-VP	O
retinoids	retinoid	NNS	B-NP	O
and	and	CC	O	O
may	may	MD	B-VP	O
thereby	thereby	RB	I-VP	O
modulate	modulate	VB	I-VP	O
the	the	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	O
steady-state	steady-state	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
retinoids	retinoid	NNS	B-NP	O
.	.	.	O	O

Whereas	Whereas	IN	B-SBAR	O
CRABP	CRABP	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
is	be	VBZ	B-VP	O
ubiquitously	ubiquitously	RB	I-VP	O
expressed	express	VBN	I-VP	O
,	,	,	O	O
CRABP	CRABP	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
is	be	VBZ	B-VP	O
mainly	mainly	RB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
various	various	JJ	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
skin	skin	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
representative	representative	JJ	B-NP	O
difference	difference	NN	I-NP	O
analysis	analysis	NN	I-NP	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
CRABP	CRABP	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
strongly	strongly	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
monocyte-derived	monocyte-derived	JJ	I-NP	I-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
(	(	(	O	O
MAC	MAC	NN	B-NP	O
)	)	)	O	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
freshly	freshly	RB	B-NP	B-cell_type
isolated	isolate	VBN	I-NP	I-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
(	(	(	O	O
MO	MO	NN	B-NP	B-cell_type
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
CRABP	CRABP	NN	I-NP	B-RNA
II	II	CD	I-NP	I-RNA
mRNA	mRNA	NN	I-NP	I-RNA
was	be	VBD	B-VP	O
gradually	gradually	RB	I-VP	O
upregulated	upregulate	VBN	I-VP	O
during	during	IN	B-PP	O
differentiation	differentiation	NN	B-NP	O
from	from	IN	B-PP	O
MO	MO	NN	B-NP	B-cell_type
to	to	TO	B-PP	O
MAC	MAC	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
serum	serum	NN	I-NP	O
.	.	.	O	O

Adherence	Adherence	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
MO	MO	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
,	,	,	O	O
induced	induce	VBD	B-VP	O
CRABP	CRABP	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
expression	expression	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
(	(	(	O	O
-7	-7	CD	B-NP	O
)	)	)	O	O
M	M	NN	B-NP	O
retinoic	retinoic	JJ	I-NP	O
acid	acid	NN	I-NP	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
upregulation	upregulation	NN	I-NP	O
of	of	IN	B-PP	O
CRABP	CRABP	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
expression	expression	NN	I-NP	O
during	during	IN	B-PP	O
MO/MAC	MO/MAC	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
MO	MO	NN	B-NP	B-cell_type
can	can	MD	B-VP	O
differentiate	differentiate	VB	I-VP	O
along	along	IN	B-PP	O
the	the	DT	B-NP	O
classical	classical	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
to	to	TO	B-PP	O
MAC	MAC	NN	B-NP	B-protein
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
to	to	TO	B-PP	O
dendritic	dendritic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
we	we	PRP	B-NP	O
analyzed	analyze	VBD	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
CRABP	CRABP	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
in	in	IN	B-PP	O
MO-derived	MO-derived	JJ	B-NP	B-cell_type
dendritic	dendritic	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
cultured	culture	VBN	B-VP	O
with	with	IN	B-PP	O
10	10	CD	B-NP	O
%	%	NN	I-NP	O
FCS	FCS	NN	I-NP	O
,	,	,	O	O
IL-4	IL-4	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
GM-CSF	GM-CSF	NN	B-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
MAC	MAC	NN	B-NP	B-protein
,	,	,	O	O
MO-derived	MO-derived	JJ	B-NP	B-cell_type
dendritic	dendritic	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
extremely	extremely	RB	I-NP	O
low	low	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
CRABP	CRABP	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
.	.	.	O	O

From	From	IN	B-PP	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
we	we	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
availability	availability	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
metabolism	metabolism	NN	I-NP	O
of	of	IN	B-PP	O
retinoids	retinoid	NNS	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
different	different	JJ	B-ADJP	O
in	in	IN	B-PP	O
MAC	MAC	NN	B-NP	B-protein
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
MO	MO	NN	B-NP	B-cell_type
and	and	CC	O	O
dendritic	dendritic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
(	(	(	B-LST	O
2	2	LS	I-LST	O
)	)	)	O	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
may	may	MD	B-VP	O
influence	influence	VB	I-VP	O
differentiation	differentiation	NN	B-NP	O
and	and	CC	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
those	those	DT	B-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

Transcription	Transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
B-cell-specific	B-cell-specific	JJ	I-NP	I-protein
activator	activator	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	O
BSAP	BSAP	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
differentially	differentially	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	B-PP	O
in	in	IN	B-PP	O
subsets	subset	NNS	B-NP	O
of	of	IN	B-PP	O
B-cell	B-cell	NN	B-NP	B-cell_type
lymphomas	lymphoma	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
paired	paired	JJ	I-NP	B-DNA
box	box	NN	I-NP	I-DNA
containing	contain	VBG	B-VP	O
gene	gene	NN	B-NP	O
PAX-5	PAX-5	NN	I-NP	B-DNA
encodes	encode	VBZ	B-VP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
BSAP	BSAP	NN	I-NP	B-protein
(	(	(	O	O
B-cell-specific	B-cell-specific	JJ	B-NP	B-protein
activator	activator	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
key	key	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
B-lymphocyte	B-lymphocyte	NN	B-NP	B-cell_type
development	development	NN	I-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
its	its	PRP$	B-NP	O
known	known	JJ	I-NP	O
involvement	involvement	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
rare	rare	JJ	I-NP	O
subtype	subtype	NN	I-NP	O
of	of	IN	B-PP	O
non-Hodgkin	non-Hodgkin	JJ	B-NP	O
's	's	POS	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
(	(	(	O	O
NHL	NHL	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
detailed	detailed	JJ	I-NP	O
examination	examination	NN	I-NP	O
of	of	IN	B-PP	O
BSAP	BSAP	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
NHL	NHL	NN	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
previously	previously	RB	I-VP	O
reported	report	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
analyzed	analyze	VBD	B-VP	O
normal	normal	JJ	B-NP	O
and	and	CC	I-NP	O
malignant	malignant	JJ	I-NP	O
lymphoid	lymphoid	JJ	I-NP	O
tissues	tissue	NNS	I-NP	O
and	and	CC	O	O
cell	cell	NN	B-NP	O
lines	line	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
102	102	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
B-cell	B-cell	NN	B-NP	O
NHL	NHL	NN	I-NP	O
,	,	,	O	O
23	23	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
T-	T-	NN	B-NP	O
and	and	CC	I-NP	O
null-cell	null-cell	NN	I-NP	O
NHL	NHL	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
18	18	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
Hodgkin	Hodgkin	NN	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
lymphoid	lymphoid	JJ	I-NP	O
tissues	tissue	NNS	I-NP	O
showed	show	VBD	B-VP	O
strong	strong	JJ	B-NP	O
nuclear	nuclear	JJ	I-NP	O
BSAP	BSAP	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
mantle	mantle	NN	B-NP	B-cell_type
zone	zone	NN	I-NP	I-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
less	less	RBR	B-NP	O
intense	intense	JJ	I-NP	O
reactivity	reactivity	NN	I-NP	O
in	in	IN	B-PP	O
follicular	follicular	JJ	B-NP	B-cell_type
center	center	NN	I-NP	I-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
T-cell-rich	T-cell-rich	JJ	I-NP	O
zones	zone	NNS	I-NP	O
.	.	.	O	O

Monocytoid	Monocytoid	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
showed	show	VBD	B-VP	O
weak	weak	JJ	B-NP	O
expression	expression	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
plasma	plasma	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
extrafollicular	extrafollicular	JJ	B-NP	B-cell_type
large	large	JJ	I-NP	I-cell_type
transformed	transform	VBN	I-NP	I-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
the	the	DT	B-NP	O
102	102	CD	I-NP	O
B-cell	B-cell	NN	I-NP	O
NHLs	NHL	NNS	I-NP	O
,	,	,	O	O
83	83	CD	B-NP	O
(	(	(	O	O
81	81	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
demonstrated	demonstrate	VBD	B-VP	O
BSAP	BSAP	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
13	13	CD	I-NP	O
(	(	(	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
B-cell	B-cell	NN	B-NP	O
chronic	chronic	JJ	I-NP	O
lymphocytic	lymphocytic	JJ	I-NP	O
leukemias	leukemia	NNS	I-NP	O
(	(	(	O	O
B-CLLs	B-CLL	NNS	B-NP	B-cell_line
)	)	)	O	O
,	,	,	O	O
21	21	CD	B-NP	O
of	of	IN	B-PP	O
(	(	(	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
mantle	mantle	NN	B-NP	O
cells	cell	NNS	I-NP	O
(	(	(	O	O
MCLs	MCL	NNS	B-NP	B-cell_line
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
20	20	CD	B-NP	O
of	of	IN	B-PP	O
21	21	CD	B-NP	O
(	(	(	O	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
follicular	follicular	JJ	B-NP	O
lymphomas	lymphoma	NNS	I-NP	O
(	(	(	O	O
FLs	FL	NNS	B-NP	B-protein
)	)	)	O	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

Moderate	Moderate	JJ	B-NP	O
staining	staining	NN	I-NP	O
intensities	intensity	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
most	most	JJS	B-NP	O
B-CLL	B-CLL	NN	I-NP	B-cell_line
and	and	CC	I-NP	O
FL	FL	NN	I-NP	O
cases	case	NNS	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
most	most	JJS	B-NP	O
MCLs	MCL	NNS	I-NP	B-cell_type
showed	show	VBD	B-VP	O
strong	strong	JJ	B-NP	O
reactions	reaction	NNS	I-NP	O
,	,	,	O	O
paralleling	parallel	VBG	B-VP	O
the	the	DT	B-NP	O
strong	strong	JJ	I-NP	O
reactivity	reactivity	NN	I-NP	O
of	of	IN	B-PP	O
nonmalignant	nonmalignant	JJ	B-NP	B-cell_type
mantle	mantle	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Eight	Eight	CD	B-NP	O
of	of	IN	B-PP	O
12	12	CD	B-NP	O
(	(	(	O	O
67	67	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
marginal	marginal	JJ	B-NP	O
zone	zone	NN	I-NP	O
lymphoma	lymphoma	NN	I-NP	O
cases	case	NNS	I-NP	O
showed	show	VBD	B-VP	O
negative	negative	JJ	B-NP	O
or	or	CC	I-NP	O
low	low	JJ	I-NP	O
BSAP	BSAP	NN	I-NP	B-protein
levels	level	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
17	17	CD	B-NP	O
of	of	IN	B-PP	O
24	24	CD	B-NP	O
(	(	(	O	O
71	71	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
large	large	JJ	B-NP	O
B-cell	B-cell	NN	I-NP	B-cell_type
lymphomas	lymphoma	NNS	I-NP	I-cell_type
displayed	display	VBD	B-VP	O
moderate	moderate	JJ	B-ADJP	O
to	to	TO	B-PP	O
strong	strong	JJ	B-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O

None	None	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
23	23	CD	I-NP	O
T-	T-	NN	I-NP	O
and	and	CC	I-NP	O
null-cell	null-cell	NN	I-NP	O
lymphomas	lymphoma	NNS	I-NP	O
reacted	react	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
BSAP	BSAP	NN	I-NP	B-protein
antisera	antiserum	NNS	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
in	in	IN	B-PP	O
Hodgkin	Hodgkin	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
(	(	(	O	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
nodular	nodular	JJ	B-NP	O
lymphocytic	lymphocytic	JJ	I-NP	O
predominance	predominance	NN	I-NP	O
and	and	CC	O	O
5	5	CD	B-NP	O
of	of	IN	B-PP	O
14	14	CD	B-NP	O
(	(	(	O	O
36	36	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
classical	classical	JJ	B-NP	O
cases	case	NNS	I-NP	O
showed	show	VBD	B-VP	O
weak	weak	JJ	B-NP	O
nuclear	nuclear	JJ	I-NP	O
or	or	CC	I-NP	O
nucleolar	nucleolar	JJ	I-NP	O
BSAP	BSAP	NN	I-NP	O
reactions	reaction	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tumor	tumor	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Western	Western	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
52-kD	52-kD	JJ	I-NP	B-protein
BSAP	BSAP	NN	I-NP	I-protein
band	band	NN	I-NP	I-protein
in	in	IN	B-PP	O
B-cell	B-cell	NN	B-NP	B-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	B-PP	O
but	but	CC	I-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
non-B-cell	non-B-cell	JJ	B-NP	B-cell_line
or	or	CC	I-NP	I-cell_line
plasma	plasma	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
.	.	.	O	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
BSAP	BSAP	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
largely	largely	RB	B-ADJP	O
restricted	restricted	JJ	I-ADJP	O
to	to	TO	B-PP	O
lymphomas	lymphoma	NNS	B-NP	O
of	of	IN	B-PP	O
B-cell	B-cell	NN	B-NP	B-cell_type
lineage	lineage	NN	I-NP	I-cell_type
and	and	CC	O	O
that	that	IN	B-SBAR	O
BSAP	BSAP	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
varies	vary	VBZ	B-VP	O
in	in	IN	B-PP	O
B-cell	B-cell	NN	B-NP	B-cell_type
subsets	subset	NNS	I-NP	I-cell_type
and	and	CC	I-NP	O
subtypes	subtype	NNS	I-NP	O
of	of	IN	B-PP	O
B-cell	B-cell	NN	B-NP	O
NHL	NHL	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
high	high	JJ	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
BSAP	BSAP	NN	B-NP	B-protein
,	,	,	O	O
especially	especially	RB	B-ADVP	O
those	those	DT	B-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
large-cell	large-cell	JJ	B-NP	O
lymphomas	lymphoma	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
follicular	follicular	JJ	I-NP	B-cell_type
lymphomas	lymphoma	NNS	I-NP	I-cell_type
,	,	,	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
consequence	consequence	NN	I-NP	O
of	of	IN	B-PP	O
deregulated	deregulate	VBN	B-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
and	and	CC	O	O
suggest	suggest	VBP	B-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
PAX-5	PAX-5	NN	B-NP	B-protein
in	in	IN	B-PP	O
certain	certain	JJ	B-NP	O
B-cell	B-cell	NN	I-NP	O
malignancies	malignancy	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
US	US	NNP	I-NP	O
government	government	NN	I-NP	O
work	work	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
restrictions	restriction	NNS	I-NP	O
on	on	IN	B-PP	O
its	its	PRP$	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

Mitogen	Mitogen	NN	B-NP	B-protein
and	and	CC	I-NP	O
growth	growth	NN	I-NP	O
factor-induced	factor-induced	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
STAT-like	STAT-like	JJ	I-NP	B-protein
molecule	molecule	NN	I-NP	I-protein
in	in	IN	B-PP	O
channel	channel	NN	B-NP	B-cell_type
catfish	catfish	NN	I-NP	I-cell_type
lymphoid	lymphoid	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

This	This	DT	B-NP	O
article	article	NN	I-NP	O
describes	describe	VBZ	B-VP	O
the	the	DT	B-NP	O
identification	identification	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	O
STAT	STAT	NN	I-NP	B-protein
molecule	molecule	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
channel	channel	NN	I-NP	O
catfish	catfish	NN	I-NP	O
(	(	(	O	O
Ictalurus	Ictalurus	NN	B-NP	O
punctatus	punctatus	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
report	report	NN	I-NP	O
of	of	IN	B-PP	O
such	such	JJ	B-NP	O
a	a	DT	I-NP	O
molecule	molecule	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
'lower	'low	JJR	I-NP	O
'	'	POS	B-NP	O
vertebrate	vertebrate	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
monoclonal	monoclonal	JJ	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
against	against	IN	B-PP	O
human	human	JJ	B-NP	O
STAT6	STAT6	NN	I-NP	B-protein
recognizes	recognize	VBZ	B-VP	O
an	an	DT	B-NP	O
approximately	approximately	RB	I-NP	O
100	100	CD	I-NP	B-protein
kDa	kDa	NN	I-NP	I-protein
molecule	molecule	NN	I-NP	I-protein
that	that	WDT	B-NP	O
becomes	become	VBZ	B-VP	O
activated	activate	VBN	I-VP	O
and	and	CC	O	O
translocates	translocate	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
nucleus	nucleus	NN	I-NP	O
upon	upon	IN	B-PP	O
both	both	CC	O	O
growth	growth	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
and	and	CC	O	O
mitogen	mitogen	NN	B-NP	B-protein
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
catfish	catfish	NN	B-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

This	This	DT	B-NP	O
presumed	presumed	JJ	I-NP	O
catfish	catfish	NN	I-NP	O
STAT	STAT	NN	I-NP	B-protein
binds	bind	VBZ	B-VP	O
the	the	DT	B-NP	O
mammalian	mammalian	JJ	I-NP	B-DNA
interferon-gamma	interferon-gamma	NN	I-NP	I-DNA
activation	activation	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
,	,	,	O	O
a	a	DT	B-NP	O
known	known	JJ	I-NP	O
motif	motif	NN	I-NP	O
of	of	IN	B-PP	O
mammalian	mammalian	JJ	B-NP	O
STAT	STAT	NN	I-NP	O
binding	binding	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
shown	show	VBN	B-VP	O
by	by	IN	B-PP	O
electromobility	electromobility	NN	B-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
.	.	.	O	O

Purification	Purification	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proteins	protein	NNS	I-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
DNA	DNA	NN	I-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
confirms	confirm	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
catfish	catfish	NN	I-NP	B-protein
reactive	reactive	JJ	I-NP	I-protein
molecule	molecule	NN	I-NP	I-protein
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
interferon-gamma	interferon-gamma	NN	I-NP	B-DNA
activation	activation	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
STAT	STAT	NN	B-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
highly	highly	RB	I-VP	O
conserved	conserve	VBN	I-VP	O
in	in	IN	B-PP	O
vertebrate	vertebrate	NN	B-NP	O
evolution	evolution	NN	I-NP	O
.	.	.	O	O

Isolation	Isolation	NN	B-NP	O
and	and	CC	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
T	T	NN	I-NP	B-protein
cell	cell	NN	I-NP	I-protein
clone	clone	NN	I-NP	I-protein
variant	variant	NN	I-NP	I-protein
exhibiting	exhibit	VBG	B-VP	I-protein
constitutively	constitutively	RB	B-NP	I-protein
phosphorylated	phosphorylate	VBN	I-NP	I-protein
Ser133	Ser133	NN	I-NP	I-protein
cAMP	cAMP	NN	I-NP	I-protein
response	response	NN	I-NP	I-protein
element-binding	element-binding	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
driving	drive	VBG	B-VP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
proliferation	proliferation	NN	I-NP	O
,	,	,	O	O
IL-2	IL-2	NN	B-NP	B-protein
stimulates	stimulate	VBZ	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
program	program	NN	I-NP	O
of	of	IN	B-PP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
that	that	WDT	B-NP	O
includes	include	VBZ	B-VP	O
proliferating	proliferate	VBG	B-NP	O
cell	cell	NN	I-NP	O
nuclear	nuclear	JJ	I-NP	O
antigen	antigen	NN	I-NP	O
(	(	(	O	O
PCNA	PCNA	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
requisite	requisite	JJ	I-NP	B-protein
processivity	processivity	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
for	for	IN	B-PP	O
DNA	DNA	NN	B-NP	B-protein
polymerase	polymerase	NN	I-NP	I-protein
delta	delta	NN	I-NP	I-protein
.	.	.	O	O

PCNA	PCNA	NN	B-NP	O
transcription	transcription	NN	I-NP	O
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
through	through	IN	B-PP	O
tandem	tandem	JJ	B-NP	B-DNA
CRE	CRE	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	B-DNA
and	and	CC	I-NP	O
CRE	CRE	NN	I-NP	B-protein
binding	binding	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
;	;	:	O	O
IL-2	IL-2	NN	B-NP	B-protein
stimulates	stimulate	VBZ	B-VP	O
CREB	CREB	NN	B-NP	B-protein
phosphorylation	phosphorylation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
resting	rest	VBG	I-NP	B-cell_type
cloned	clone	VBN	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
lymphocyte	lymphocyte	NN	I-NP	I-cell_type
,	,	,	O	O
L2	L2	NN	B-NP	B-DNA
.	.	.	O	O

After	After	IN	B-PP	O
culturing	culture	VBG	B-VP	O
L2	L2	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
for	for	IN	B-PP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
91	91	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
consistently	consistently	RB	B-ADVP	O
isolate	isolate	VBP	B-VP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
variant	variant	NN	I-NP	O
that	that	WDT	B-NP	O
exhibits	exhibit	VBZ	B-VP	O
constitutive	constitutive	JJ	B-NP	O
CREB	CREB	NN	I-NP	B-protein
phosphorylation	phosphorylation	NN	I-NP	O
.	.	.	O	O

L2	L2	NN	B-NP	B-DNA
and	and	CC	I-NP	O
L2	L2	NN	I-NP	B-cell_line
variant	variant	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
responsiveness	responsiveness	NN	I-NP	O
and	and	CC	O	O
rapamycin	rapamycin	NN	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
with	with	IN	B-PP	O
respect	respect	NN	B-NP	O
to	to	TO	B-PP	O
specific	specific	JJ	B-NP	O
kinase	kinase	NN	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
PCNA	PCNA	NN	B-NP	B-protein
expression	expression	NN	B-NP	O
and	and	CC	O	O
proliferation	proliferation	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
L2	L2	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
IL-2	IL-2	NN	B-NP	B-protein
stimulated	stimulate	VBN	B-VP	O
and	and	CC	O	O
rapamycin	rapamycin	NN	B-NP	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
cAMP-independent	cAMP-independent	JJ	B-NP	O
CREB	CREB	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
,	,	,	O	O
PCNA	PCNA	NN	B-NP	B-protein
expression	expression	NN	B-NP	O
and	and	CC	O	O
proliferation	proliferation	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
L2	L2	NN	B-NP	B-cell_line
variant	variant	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
CREB	CREB	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
constitutively	constitutively	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
;	;	:	O	O
IL-2	IL-2	NN	B-NP	B-protein
stimulated	stimulate	VBN	B-VP	O
and	and	CC	O	O
rapamycin	rapamycin	NN	B-NP	O
blocked	block	VBD	B-VP	O
PCNA	PCNA	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
proliferation	proliferation	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
IL-2	IL-2	NN	B-NP	B-protein
induces	induce	VBZ	B-VP	O
a	a	DT	B-NP	O
rapamycin-sensitive	rapamycin-sensitive	JJ	I-NP	O
,	,	,	I-NP	O
cAMP-independent	cAMP-independent	JJ	I-NP	O
CREB	CREB	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
L2	L2	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
phosphorylation	phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
CREB	CREB	NN	B-NP	B-protein
alone	alone	RB	B-ADVP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
drive	drive	VB	I-VP	O
PCNA	PCNA	NN	B-NP	B-protein
expression	expression	NN	B-NP	O
and	and	CC	O	O
L2	L2	NN	B-NP	O
cell	cell	NN	I-NP	O
proliferation	proliferation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
.	.	.	O	O

Serotonin	Serotonin	NN	B-NP	O
derivative	derivative	NN	I-NP	O
,	,	,	O	O
N-	N-	NN	B-NP	B-protein
(	(	(	O	I-protein
p-coumaroyl	p-coumaroyl	NN	B-NP	I-protein
)	)	)	O	I-protein
serotonin	serotonin	NN	B-NP	I-protein
,	,	,	O	O
inhibits	inhibit	VBZ	B-VP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
,	,	,	O	O
IL-1alpha	IL-1alpha	NN	B-NP	B-protein
,	,	,	O	O
IL-1beta	IL-1beta	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
IL-6	IL-6	NN	B-NP	B-protein
by	by	IN	B-PP	O
endotoxin-stimulated	endotoxin-stimulated	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
reported	report	VBN	I-VP	O
that	that	IN	B-SBAR	O
N-	N-	NN	B-NP	B-protein
(	(	(	O	I-protein
p-coumaroyl	p-coumaroyl	NN	B-NP	I-protein
)	)	)	O	I-protein
serotonin	serotonin	NN	B-NP	I-protein
(	(	(	O	O
CS	CS	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
derivatives	derivative	NNS	I-NP	O
with	with	IN	B-PP	O
antioxidative	antioxidative	JJ	B-NP	O
activity	activity	NN	I-NP	O
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
safflower	safflow	JJR	B-NP	O
seeds	seed	NNS	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
reactive	reactive	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
species	specie	NNS	I-NP	O
(	(	(	O	O
ROS	ROS	NNS	B-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
signaling	signaling	NN	I-NP	O
of	of	IN	B-PP	O
lipopolysaccharide	lipopolysaccharide	NN	B-NP	O
(	(	(	O	O
LPS	LPS	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
we	we	PRP	B-NP	O
examined	examine	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
CS	CS	NN	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
suppressive	suppressive	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	B-protein
cytokine	cytokine	NN	I-NP	I-protein
generation	generation	NN	I-NP	O
from	from	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
monocyte	monocyte	NN	I-NP	I-cell_type
s	s	NNS	I-NP	I-cell_type
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

CS	CS	NNS	B-NP	O
at	at	IN	B-PP	O
50-200	50-200	CD	B-NP	O
microM	microM	NN	I-NP	O
reduced	reduce	VBD	B-VP	O
tumor	tumor	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
TNF	TNF	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
interleukin-1	interleukin-1	NN	B-NP	B-protein
(	(	(	O	O
IL-1	IL-1	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
IL-6	IL-6	NN	B-NP	B-protein
activities	activity	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
culture	culture	NN	I-NP	O
supernatants	supernatant	NNS	I-NP	O
from	from	IN	B-PP	O
LPS-stimulated	LPS-stimulated	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
without	without	IN	B-PP	O
cytotoxicity	cytotoxicity	NN	B-NP	O
.	.	.	O	O

ELISA	ELISA	NN	B-NP	O
assay	assay	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
,	,	,	O	O
IL-1alpha	IL-1alpha	NN	B-NP	B-protein
,	,	,	O	O
IL-1beta	IL-1beta	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
IL-6	IL-6	NN	B-NP	B-protein
was	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
CS	CS	NN	B-NP	O
.	.	.	O	O

Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
LPS-induced	LPS-induced	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
cytokine	cytokine	NN	I-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
in	in	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
was	be	VBD	B-VP	O
suppressed	suppress	VBN	I-VP	O
by	by	IN	B-PP	O
CS	CS	NN	B-NP	O
.	.	.	O	O

NF-kappaB	NF-kappaB	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
CS	CS	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
CS	CS	NN	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
suppressive	suppressive	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
proinflammatory	proinflammatory	JJ	B-NP	B-protein
cytokine	cytokine	NN	I-NP	I-protein
production	production	NN	I-NP	O
from	from	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
effect	effect	NN	I-NP	O
is	be	VBZ	B-VP	O
based	base	VBN	I-VP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
suppression	suppression	NN	I-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
expression	expression	NN	I-NP	O
through	through	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

Elevated	Elevated	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
differentiation	differentiation	NN	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
factor	factor	NN	I-NP	O
nm23	nm23	NN	I-NP	O
mRNA	mRNA	NN	I-NP	O
in	in	IN	B-PP	O
monoblastic	monoblastic	JJ	B-NP	O
crisis	crisis	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
myelogenous	myelogenous	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
.	.	.	O	O

Differentiation	Differentiation	NN	B-NP	B-DNA
inhibitory	inhibitory	JJ	I-NP	I-DNA
factor	factor	NN	I-NP	I-DNA
nm23	nm23	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
high	high	JJ	B-NP	O
quantities	quantity	NNS	I-NP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
myelogenous	myelogenous	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
AML	AML	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
monocytic	monocytic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
AML-M5	AML-M5	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
suggested	suggest	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
prognostic	prognostic	JJ	I-NP	O
factor	factor	NN	I-NP	O
in	in	IN	B-PP	O
AML-M5	AML-M5	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
an	an	DT	B-NP	O
example	example	NN	I-NP	O
of	of	IN	B-PP	O
elevated	elevate	VBN	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
nm23	nm23	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
in	in	IN	B-PP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
myelogenous	myelogenous	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
CML	CML	NN	B-NP	O
)	)	)	O	O
who	who	WP	B-NP	O
developed	develop	VBD	B-VP	O
monoblastic	monoblastic	JJ	B-NP	O
crisis	crisis	NN	I-NP	O
.	.	.	O	O

Relative	Relative	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
nm23-H1	nm23-H1	NN	B-NP	B-RNA
and	and	CC	O	I-RNA
-H2	-H2	NN	B-NP	I-RNA
mRNA	mRNA	NN	I-NP	I-RNA
extracted	extract	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
peripheral	peripheral	JJ	I-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
bone	bone	NN	B-NP	B-cell_type
marrow	marrow	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
by	by	IN	B-PP	O
quantitative	quantitative	JJ	B-NP	O
reverse	reverse	JJ	I-NP	B-protein
transcriptase	transcriptase	NN	I-NP	I-protein
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
nm23-H1	nm23-H1	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
in	in	IN	B-PP	O
CML	CML	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
at	at	IN	B-PP	O
the	the	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
phase	phase	NN	I-NP	O
was	be	VBD	B-VP	O
as	as	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
as	as	IN	B-PP	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
bone	bone	NN	B-NP	B-cell_type
marrow	marrow	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
volunteers	volunteer	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mRNA	mRNA	NN	I-NP	B-RNA
level	level	NN	I-NP	O
of	of	IN	B-PP	O
nm23-H2	nm23-H2	NN	B-NP	B-protein
was	be	VBD	B-VP	O
slightly	slightly	RB	B-ADVP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
blastic	blastic	JJ	B-NP	O
crisis	crisis	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
nm23-H1	nm23-H1	NN	B-NP	B-protein
and	and	CC	O	O
-H2	-H2	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
to	to	TO	B-PP	O
about	about	RB	B-NP	O
three	three	CD	I-NP	O
to	to	TO	I-NP	O
nine	nine	CD	I-NP	O
times	time	NNS	I-NP	O
of	of	IN	B-PP	O
that	that	DT	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
phase	phase	NN	I-NP	O
.	.	.	O	O

Proliferated	Proliferate	VBN	B-NP	O
blastic	blastic	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
non-specific	non-specific	JJ	B-NP	O
esterase	esterase	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
serum	serum	NN	I-NP	B-protein
lysozyme	lysozyme	NN	I-NP	I-protein
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
and	and	CC	O	O
diagnosed	diagnose	VBN	B-VP	O
as	as	IN	B-PP	O
monoblastic	monoblastic	JJ	B-NP	O
crisis	crisis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
combined	combine	VBN	I-VP	O
chemotherapy	chemotherapy	NN	B-NP	O
but	but	CC	O	O
response	response	NN	B-NP	O
was	be	VBD	B-VP	O
partial	partial	JJ	B-ADJP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
are	be	VBP	B-VP	O
compatible	compatible	JJ	B-ADJP	O
with	with	IN	B-PP	O
our	our	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
report	report	NN	I-NP	O
that	that	IN	B-SBAR	O
nm23	nm23	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
overexpressed	overexpresse	VBN	I-VP	O
in	in	IN	B-PP	O
monocytic	monocytic	JJ	B-NP	O
leukemia	leukemia	NN	I-NP	O
.	.	.	O	O

Increased	Increase	VBN	B-NP	O
transcription	transcription	NN	I-NP	O
decreases	decrease	VBZ	B-VP	O
the	the	DT	B-NP	O
spontaneous	spontaneous	JJ	I-NP	O
mutation	mutation	NN	I-NP	O
rate	rate	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
thymidine	thymidine	NN	I-NP	B-DNA
kinase	kinase	NN	I-NP	I-DNA
locus	locus	NN	I-NP	I-DNA
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Transcription	Transcription	NN	B-NP	O
increases	increase	VBZ	B-VP	O
DNA	DNA	NN	B-NP	O
repair	repair	NN	I-NP	O
efficiency	efficiency	NN	I-NP	O
and	and	CC	O	O
modulates	modulate	VBZ	B-VP	O
the	the	DT	B-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
certain	certain	JJ	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
damage	damage	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
transcription	transcription	NN	I-NP	O
level	level	NN	I-NP	O
stimulates	stimulate	VBZ	B-VP	O
spontaneous	spontaneous	JJ	B-NP	O
mutation	mutation	NN	I-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
yeast	yeast	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
explored	explore	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
transcription	transcription	NN	B-NP	O
level	level	NN	I-NP	O
affects	affect	VBZ	B-VP	O
spontaneous	spontaneous	JJ	B-NP	O
mutation	mutation	NN	I-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
first	first	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
two	two	CD	B-NP	O
thymidine	thymidine	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
tk	tk	NN	B-NP	O
)	)	)	O	O
inducible	inducible	JJ	B-NP	O
human	human	JJ	I-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
Gal4-Estrogen	Gal4-Estrogen	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
system	system	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
our	our	PRP$	B-NP	O
TK6i-G3	TK6i-G3	NN	I-NP	O
and	and	CC	I-NP	O
G9	G9	NN	I-NP	B-cell_line
tk	tk	NN	I-NP	I-cell_line
heterozygous	heterozygous	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
the	the	DT	B-NP	O
active	active	JJ	I-NP	B-DNA
tk	tk	NN	I-NP	I-DNA
allele	allele	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
linked	link	VBN	I-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
inducible	inducible	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
.	.	.	O	O

Tk	Tk	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
is	be	VBZ	B-VP	O
induced	induce	VBN	I-VP	O
following	follow	VBG	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
estrogen	estrogen	NN	B-NP	O
.	.	.	O	O

Spontaneous	Spontaneous	JJ	B-NP	O
mutation	mutation	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
after	after	IN	B-PP	O
induction	induction	NN	B-NP	O
in	in	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
report	report	NN	I-NP	O
in	in	IN	B-PP	O
yeast	yeast	NN	B-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
humans	human	NNS	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
evolved	evolve	VBN	I-VP	O
different	different	JJ	B-NP	O
or	or	CC	I-NP	O
additional	additional	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
to	to	TO	B-VP	O
deal	deal	VB	I-VP	O
with	with	IN	B-PP	O
transcription	transcription	NN	B-NP	O
related	related	JJ	I-NP	O
spontaneous	spontaneous	JJ	I-NP	O
mutagenesis	mutagenesis	NN	I-NP	O
.	.	.	O	O

Copyright	Copyright	NN	B-NP	O
1998	1998	CD	I-NP	O
Elsevier	Elsevier	NNP	I-NP	O
Science	Science	NNP	I-NP	O
B.V	B.V	NNP	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
rights	right	NNS	I-NP	O
reserved	reserve	VBN	B-VP	O
.	.	.	O	O

Mutation	Mutation	NN	B-NP	O
of	of	IN	B-PP	O
BCL-6	BCL-6	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
the	the	DT	B-NP	O
process	process	NN	I-NP	O
of	of	IN	B-PP	O
somatic	somatic	JJ	B-NP	O
hypermutation	hypermutation	NN	I-NP	O
of	of	IN	B-PP	O
Ig	Ig	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

Immunoglobulin	Immunoglobulin	NN	B-NP	B-DNA
(	(	(	O	I-DNA
Ig	Ig	NN	B-NP	I-DNA
)	)	)	O	I-DNA
genes	gene	NNS	B-NP	I-DNA
are	be	VBP	B-VP	O
hypermutated	hypermutate	VBN	I-VP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
precursors	precursor	NNS	I-NP	O
to	to	TO	B-PP	O
memory	memory	NN	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
mutations	mutation	NNS	I-NP	O
are	be	VBP	B-VP	O
linked	link	VBN	I-VP	O
to	to	TO	B-PP	O
transcription	transcription	NN	B-NP	O
initiation	initiation	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
non-Ig	non-Ig	JJ	B-NP	B-DNA
promoters	promoter	NNS	I-NP	I-DNA
are	be	VBP	B-VP	O
permissible	permissible	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
mutation	mutation	NN	I-NP	O
process	process	NN	I-NP	O
;	;	:	O	O
thus	thus	RB	B-ADVP	O
,	,	,	O	O
other	other	JJ	B-NP	O
genes	gene	NNS	I-NP	O
expressed	express	VBN	B-VP	O
in	in	IN	B-PP	O
mutating	mutate	VBG	B-VP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
may	may	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
subject	subject	JJ	B-ADJP	O
to	to	TO	B-PP	O
somatic	somatic	JJ	B-NP	O
hypermutation	hypermutation	NN	I-NP	O
.	.	.	O	O

Significant	Significant	JJ	B-NP	O
mutations	mutation	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
c-MYC	c-MYC	NN	B-NP	B-protein
,	,	,	O	O
S14	S14	NN	B-NP	B-protein
,	,	,	O	O
or	or	CC	O	O
alpha-fetoprotein	alpha-fetoprotein	NN	B-NP	B-DNA
(	(	(	O	I-DNA
AFP	AFP	NN	B-NP	I-DNA
)	)	)	O	I-DNA
genes	gene	NNS	B-NP	I-DNA
,	,	,	O	O
but	but	CC	O	O
BCL-6	BCL-6	NN	B-NP	B-protein
was	be	VBD	B-VP	O
highly	highly	RB	B-ADJP	O
mutated	mutated	JJ	I-ADJP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
memory	memory	NN	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mutation	mutation	NN	I-NP	O
pattern	pattern	NN	I-NP	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
Ig	Ig	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

CD28-mediated	CD28-mediated	JJ	B-NP	O
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
CD45RA+	CD45RA+	JJ	B-NP	O
and	and	CC	I-NP	O
CD45RO+	CD45RO+	JJ	I-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
:	:	:	O	O
enhanced	enhance	VBN	B-VP	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
reactive	reactive	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
intermediates	intermediate	NNS	I-NP	O
and	and	CC	O	O
c-Rel	c-Rel	NN	B-NP	B-protein
nuclear	nuclear	JJ	I-NP	O
translocation	translocation	NN	I-NP	O
in	in	IN	B-PP	O
CD45RA+	CD45RA+	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
analyzed	analyze	VBN	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
complete	complete	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
(	(	(	O	O
anti-CD3	anti-CD3	NN	B-NP	B-protein
plus	plus	CC	O	O
anti-CD28	anti-CD28	NN	B-NP	B-protein
)	)	)	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
in	in	IN	B-PP	O
CD45RA+	CD45RA+	JJ	O	O
(	(	(	O	O
naive	naive	JJ	B-ADJP	O
)	)	)	O	O
and	and	CC	O	O
CD45RO+	CD45RO+	JJ	B-NP	B-cell_type
(	(	(	O	I-cell_type
memory/effector	memory/effector	NN	B-NP	I-cell_type
)	)	)	O	I-cell_type
T	T	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Long	Long	JJ	B-NP	O
exposure	exposure	NN	I-NP	O
(	(	(	O	O
24	24	CD	B-NP	O
h	h	NN	I-NP	O
)	)	)	O	O
induced	induce	VBD	B-VP	O
stronger	strong	JJR	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
in	in	IN	B-PP	O
CD45RA+	CD45RA+	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
than	than	IN	B-PP	O
in	in	IN	B-PP	O
CD45RO+	CD45RO+	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
c-Rel	c-Rel	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
after	after	IN	B-SBAR	O
anti-CD3+anti-CD28	anti-CD3+anti-CD28	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
c-Rel	c-Rel	NN	B-NP	B-protein
was	be	VBD	B-VP	O
higher	high	JJR	B-ADJP	O
in	in	IN	B-PP	O
CD45RA+	CD45RA+	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	B-protein
inhibitor	inhibitor	NN	I-NP	I-protein
IkappaBalpha	IkappaBalpha	NN	I-NP	B-protein
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
anti-CD3+anti-CD28	anti-CD3+anti-CD28	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
induced	induce	VBD	B-VP	O
a	a	DT	B-NP	O
long-lasting	long-lasting	JJ	I-NP	O
degradation	degradation	NN	I-NP	O
in	in	IN	B-PP	O
CD45RA+	CD45RA+	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
but	but	CC	B-PP	O
in	in	IN	B-PP	O
CD45RO+	CD45RO+	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
the	the	DT	B-NP	O
degradation	degradation	NN	I-NP	O
process	process	NN	I-NP	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
rapid	rapid	JJ	I-ADJP	O
.	.	.	O	O

Because	Because	IN	B-SBAR	O
the	the	DT	B-NP	O
CD28	CD28	NN	I-NP	B-protein
costimulus	costimulus	NN	I-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
induce	induce	VB	I-VP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
reactive	reactive	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
intermediates	intermediate	NNS	I-NP	O
(	(	(	O	O
ROIs	ROI	NNS	B-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	O
ROI	ROI	NN	I-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
CD45RA+	CD45RA+	JJ	B-NP	O
and	and	CC	I-NP	O
CD45RO+	CD45RO+	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
by	by	IN	B-PP	O
flow	flow	NN	B-NP	O
cytometry	cytometry	NN	I-NP	O
.	.	.	O	O

ROIs	ROI	NNS	B-NP	O
were	be	VBD	B-VP	O
produced	produce	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
more	more	RBR	B-ADVP	O
strongly	strongly	RB	I-ADVP	O
in	in	IN	B-PP	O
CD45RA+	CD45RA+	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
data	datum	NNS	I-NP	O
presented	present	VBN	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
further	further	RB	B-ADVP	O
emphasize	emphasize	VBP	B-VP	O
the	the	DT	B-NP	O
differences	difference	NNS	I-NP	O
between	between	IN	B-PP	O
CD45RA+	CD45RA+	JJ	B-NP	O
and	and	CC	I-NP	O
CD45RO+	CD45RO+	JJ	I-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
ROI-dependent	ROI-dependent	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
.	.	.	O	O

Non-Hodgkin	Non-Hodgkin	JJ	B-NP	O
's	's	POS	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
involving	involve	VBG	B-VP	O
bilateral	bilateral	JJ	B-NP	O
breasts	breast	NNS	I-NP	O
[	[	(	O	O
see	see	VB	B-VP	O
comments	comment	NNS	B-NP	O
]	]	)	O	O

We	We	PRP	B-NP	O
describe	describe	VBP	B-VP	O
here	here	RB	B-ADVP	O
two	two	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
diffuse	diffuse	JJ	B-NP	O
large	large	JJ	I-NP	O
cell	cell	NN	I-NP	O
type	type	NN	I-NP	O
non-Hodgkin	non-Hodgkin	JJ	B-NP	O
's	's	POS	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
affecting	affect	VBG	B-VP	O
the	the	DT	B-NP	O
bilateral	bilateral	JJ	I-NP	O
breasts	breast	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
contralateral	contralateral	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
case	case	NN	I-NP	O
appeared	appear	VBD	B-VP	O
17	17	CD	B-NP	O
months	month	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
mastectomy	mastectomy	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
bilateral	bilateral	JJ	I-NP	O
tumors	tumor	NNS	I-NP	O
occurred	occur	VBD	B-VP	O
concurrently	concurrently	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
patient	patient	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
pregnant	pregnant	JJ	B-ADJP	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
widespread	widespread	JJ	B-NP	O
dissemination	dissemination	NN	I-NP	O
at	at	IN	B-PP	O
initial	initial	JJ	B-NP	O
presentation	presentation	NN	I-NP	O
.	.	.	O	O

Lymphoma	Lymphoma	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
both	both	DT	B-NP	O
cases	case	NNS	I-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
mature	mature	JJ	I-NP	O
B-cell	B-cell	NN	I-NP	O
immunophenotype	immunophenotype	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
rearrangements	rearrangement	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
BCL6	BCL6	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

Both	Both	DT	B-NP	O
patients	patient	NNS	I-NP	O
developed	develop	VBD	B-VP	O
progressive	progressive	JJ	B-NP	O
disease	disease	NN	I-NP	O
despite	despite	IN	B-PP	O
chemo-radiotherapy	chemo-radiotherapy	NN	B-NP	O
and	and	CC	O	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
leukemic	leukemic	JJ	B-NP	O
manifestations	manifestation	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
pathological	pathological	JJ	I-NP	O
features	feature	NNS	I-NP	O
of	of	IN	B-PP	O
lymphomas	lymphoma	NNS	B-NP	O
of	of	IN	B-PP	O
mucosa-associated	mucosa-associated	JJ	B-NP	O
lymphoid	lymphoid	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
origin	origin	NN	I-NP	O

Biochemical	Biochemical	JJ	B-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
MIP-1	MIP-1	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
nuclear	nuclear	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

A	A	DT	B-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
hematopoietic	hematopoietic	JJ	B-NP	B-protein
specific	specific	JJ	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
,	,	,	O	O
MIP-1	MIP-1	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
nuclear	nuclear	JJ	I-NP	O
protein	protein	NN	I-NP	O
(	(	(	O	O
MNP	MNP	NN	B-NP	B-protein
)	)	)	O	O
family	family	NN	B-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
recently	recently	RB	I-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

They	They	PRP	B-NP	O
are	be	VBP	B-VP	O
intimately	intimately	RB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
huMIP-1	huMIP-1	NN	I-NP	B-DNA
alpha	alpha	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
in	in	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
T-cells	T-cell	NNS	B-NP	B-cell_type
,	,	,	O	O
and	and	CC	O	O
transformed	transform	VBN	B-NP	B-cell_line
B-cells	B-cell	NNS	I-NP	I-cell_line
.	.	.	O	O

One	One	CD	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O
(	(	(	O	O
MNP-1	MNP-1	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
promoter	promoter	NN	B-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
and	and	CC	I-NP	O
B-cells	B-cell	NNS	I-NP	B-cell_type
,	,	,	O	O
while	while	IN	B-SBAR	O
another	another	DT	B-NP	O
(	(	(	O	O
MNP-2	MNP-2	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
full	full	JJ	B-NP	O
promotor	promotor	NN	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
T-cells	T-cell	NNS	B-NP	B-cell_type
.	.	.	O	O

A	A	DT	B-NP	O
third	third	JJ	I-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O
(	(	(	O	O
MNP-3	MNP-3	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
PMA	PMA	NN	B-NP	B-cell_line
induced	induced	JJ	I-NP	I-cell_line
HL60	HL60	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
and	and	CC	O	O
probably	probably	RB	B-VP	O
has	have	VBZ	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
monocyte	monocyte	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
communication	communication	NN	I-NP	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
by	by	IN	B-PP	O
two	two	CD	B-NP	O
techniques	technique	NNS	I-NP	O
that	that	IN	B-NP	O
MNP-1	MNP-1	NN	B-NP	B-protein
and	and	CC	I-NP	O
MNP-2	MNP-2	NN	I-NP	B-protein
are	be	VBP	B-VP	O
distinct	distinct	JJ	B-NP	O
but	but	CC	I-NP	O
related	related	JJ	I-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
we	we	PRP	B-NP	O
present	present	VBP	B-VP	O
further	further	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
to	to	TO	B-VP	O
show	show	VB	I-VP	O
that	that	IN	B-SBAR	O
MNP-1	MNP-1	NN	B-NP	B-protein
acts	act	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
heterodimer	heterodimer	NN	I-NP	B-protein
.	.	.	O	O

Bcl-3	Bcl-3	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	O
translocation	translocation	NN	I-NP	O
are	be	VBP	B-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
granulocyte-macrophage	granulocyte-macrophage	JJ	B-NP	B-protein
colony-stimulating	colony-stimulating	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
and	and	CC	I-NP	O
erythropoietin	erythropoietin	NN	I-NP	B-protein
in	in	IN	B-PP	O
proliferating	proliferate	VBG	B-VP	B-cell_type
human	human	JJ	B-NP	I-cell_type
erythroid	erythroid	JJ	I-NP	I-cell_type
precursors	precursor	NNS	I-NP	I-cell_type
.	.	.	O	O

Bcl-3	Bcl-3	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
proto-oncogene	proto-oncogene	NN	I-NP	B-DNA
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
chromosomal	chromosomal	JJ	I-NP	O
translocation	translocation	NN	I-NP	O
t	t	NN	I-NP	O
(	(	(	O	O
14	14	CD	B-NP	O
;	;	:	O	O
19	19	CD	B-NP	O
)	)	)	O	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
lymphocytic	lymphocytic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
shares	share	VBZ	B-VP	O
structural	structural	JJ	B-NP	O
similarities	similarity	NNS	I-NP	O
with	with	IN	B-PP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IkappaB	IkappaB	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
of	of	IN	B-PP	O
proteins	protein	NNS	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
,	,	,	O	O
involvement	involvement	NN	B-NP	O
of	of	IN	B-PP	O
Bcl-3	Bcl-3	NN	B-NP	B-protein
in	in	IN	B-PP	O
hematopoietic	hematopoietic	JJ	B-NP	O
growth	growth	NN	I-NP	O
factor-stimulated	factor-stimulated	JJ	I-NP	O
erythroid	erythroid	JJ	I-NP	O
proliferation	proliferation	NN	I-NP	O
and	and	CC	O	O
differentiation	differentiation	NN	B-NP	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
TF-1	TF-1	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
an	an	DT	B-NP	O
erythroleukemia	erythroleukemia	NN	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
,	,	,	O	O
granulocyte-macrophage	granulocyte-macrophage	JJ	B-NP	B-protein
colony-stimulating	colony-stimulating	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
GM-CSF	GM-CSF	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
erythropoietin	erythropoietin	NN	B-NP	B-protein
(	(	(	O	O
Epo	Epo	NN	B-NP	B-protein
)	)	)	O	O
greatly	greatly	RB	B-VP	O
enhanced	enhance	VBD	I-VP	O
Bcl-3	Bcl-3	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
at	at	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	O
and	and	CC	I-NP	O
mRNA	mRNA	NN	I-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
association	association	NN	B-NP	O
with	with	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
of	of	IN	B-PP	O
proliferation	proliferation	NN	B-NP	O
.	.	.	O	O

Bcl-3	Bcl-3	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
highly	highly	RB	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
early	early	JJ	B-NP	B-cell_line
burst-forming	burst-forming	JJ	I-NP	I-cell_line
unit-erythroid	unit-erythroid	JJ	I-NP	I-cell_line
(	(	(	O	I-cell_line
BFU-E	BFU-E	NN	B-NP	I-cell_line
)	)	)	O	I-cell_line
-derived	-derived	JJ	B-NP	I-cell_line
erythroid	erythroid	JJ	I-NP	I-cell_line
precursors	precursor	NNS	I-NP	I-cell_line
(	(	(	O	O
day	day	NN	B-NP	O
7	7	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
decreased	decrease	VBN	B-VP	O
during	during	IN	B-PP	O
maturation	maturation	NN	B-NP	O
(	(	(	O	O
days	day	NNS	B-NP	O
10	10	CD	B-NP	O
and	and	CC	I-NP	O
14	14	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
Bcl-3	Bcl-3	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
erythroid	erythroid	JJ	I-NP	O
proliferation	proliferation	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
these	these	DT	B-NP	O
hematopoietic	hematopoietic	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
Bcl-3	Bcl-3	NN	B-NP	B-protein
was	be	VBD	B-VP	O
hyperphosphorylated	hyperphosphorylate	VBN	I-VP	O
.	.	.	O	O

GM-CSF	GM-CSF	NN	B-NP	B-protein
and	and	CC	I-NP	O
Epo	Epo	NN	I-NP	B-protein
modulated	modulate	VBD	B-VP	O
the	the	DT	B-NP	O
subcellular	subcellular	JJ	I-NP	O
localization	localization	NN	I-NP	O
of	of	IN	B-PP	O
Bcl-3	Bcl-3	NN	B-NP	B-protein
.	.	.	O	O

Upon	Upon	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
of	of	IN	B-PP	O
TF-1	TF-1	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
with	with	IN	B-PP	O
GM-CSF	GM-CSF	NN	B-NP	B-protein
or	or	CC	I-NP	O
Epo	Epo	NN	I-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
translocation	translocation	NN	I-NP	O
of	of	IN	B-PP	O
Bcl-3	Bcl-3	NN	B-NP	B-protein
was	be	VBD	B-VP	O
dramatically	dramatically	RB	I-VP	O
enhanced	enhance	VBN	I-VP	O
.	.	.	O	O

Overexpression	Overexpression	NN	B-NP	O
of	of	IN	B-PP	O
Bcl-3	Bcl-3	NN	B-NP	B-protein
in	in	IN	B-PP	O
TF-1	TF-1	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
by	by	IN	B-PP	O
transient	transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
p50	p50	NN	B-NP	B-protein
or	or	CC	O	O
p52	p52	NN	B-NP	B-protein
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
significant	significant	JJ	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
immunodeficiency	immunodeficiency	NN	I-NP	I-DNA
virus-type	virus-type	NN	I-NP	I-DNA
1	1	CD	I-NP	I-DNA
(	(	(	O	I-DNA
HIV-1	HIV-1	NN	B-NP	I-DNA
)	)	)	O	I-DNA
kappaB-TATA-luceriferase	kappaB-TATA-luceriferase	NN	B-NP	I-DNA
reporter	reporter	NN	I-NP	I-DNA
plasmid	plasmid	NN	I-NP	I-DNA
,	,	,	O	O
demonstrating	demonstrate	VBG	B-VP	O
that	that	IN	B-SBAR	O
Bcl-3	Bcl-3	NN	B-NP	B-protein
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
transactivation	transactivation	NN	B-NP	O
of	of	IN	B-PP	O
kappaB-containing	kappaB-containing	JJ	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
erythroid	erythroid	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Stimulation	Stimulation	NN	B-NP	O
with	with	IN	B-PP	O
GM-CSF	GM-CSF	NN	B-NP	B-protein
enhanced	enhance	VBD	B-VP	O
c-myb	c-myb	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

Bcl-3	Bcl-3	NN	B-NP	B-protein
in	in	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
of	of	IN	B-PP	O
TF-1	TF-1	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
bound	bind	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
kappaB	kappaB	NN	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
c-myb	c-myb	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
NF-kappaB2/p52	NF-kappaB2/p52	NN	B-NP	B-protein
and	and	CC	O	O
this	this	DT	B-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
enhanced	enhance	VBN	I-VP	O
by	by	IN	B-PP	O
GM-CSF	GM-CSF	NN	B-NP	B-protein
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
cotransfection	cotransfection	NN	B-NP	O
of	of	IN	B-PP	O
Bcl-3	Bcl-3	NN	B-NP	B-protein
with	with	IN	B-PP	O
p52	p52	NN	B-NP	B-protein
or	or	CC	I-NP	O
p50	p50	NN	I-NP	B-protein
in	in	IN	B-PP	O
TF-1	TF-1	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
significant	significant	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
c-myb	c-myb	NN	I-NP	B-DNA
kappaB-TATA-luceriferase	kappaB-TATA-luceriferase	NN	I-NP	I-DNA
reporter	reporter	NN	I-NP	I-DNA
plasmid	plasmid	NN	I-NP	I-DNA
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
Bcl-3	Bcl-3	NN	B-NP	B-protein
may	may	MD	B-VP	O
participate	participate	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
certain	certain	JJ	B-NP	O
kappaB-containing	kappaB-containing	JJ	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
hematopoiesis	hematopoiesis	NN	B-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
c-myb	c-myb	NN	B-NP	B-DNA
.	.	.	O	O

Copyright	Copyright	NN	B-NP	O
1998	1998	CD	I-NP	O
by	by	IN	B-PP	O
The	The	NNP	B-NP	O
American	American	NNP	I-NP	O
Society	Society	NNP	I-NP	O
of	of	IN	B-PP	O
Hematology	Hematology	NNP	B-NP	O
.	.	.	O	O

5-Lipoxygenase	5-Lipoxygenase	NN	B-NP	B-protein
compartmentalization	compartmentalization	NN	I-NP	O
in	in	IN	B-PP	O
granulocytic	granulocytic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
modulated	modulate	VBN	I-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
internal	internal	JJ	I-NP	B-DNA
bipartite	bipartite	JJ	I-NP	I-DNA
nuclear	nuclear	JJ	I-NP	I-DNA
localizing	localize	VBG	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
formation	formation	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
basic	basic	JJ	B-NP	B-protein
amino	amino	NN	I-NP	I-protein
acids	acid	NNS	I-NP	I-protein
spanning	span	VBG	B-VP	I-protein
residues	residue	NNS	B-NP	I-protein
639-656	639-656	CD	B-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
5-lipoxygenase	5-lipoxygenase	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
resembles	resemble	VBZ	B-VP	O
a	a	DT	B-NP	O
consensus	consensus	NN	I-NP	B-DNA
bipartite	bipartite	JJ	I-NP	I-DNA
nuclear	nuclear	JJ	I-NP	I-DNA
localizing	localize	VBG	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
.	.	.	O	O

A	A	DT	B-NP	O
synthetic	synthetic	JJ	I-NP	O
peptide	peptide	NN	I-NP	O
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Kaposi	Kaposi	NNP	I-NP	B-DNA
fibroblast	fibroblast	NN	I-NP	I-DNA
growth	growth	NN	I-NP	I-DNA
factor	factor	NN	I-NP	I-DNA
signal	signal	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
fused	fuse	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
5-lipoxygenase639-656	5-lipoxygenase639-656	CD	I-NP	B-DNA
bipartite	bipartite	JJ	I-NP	I-DNA
nuclear	nuclear	JJ	I-NP	I-DNA
localizing	localizing	JJ	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
prominent	prominent	JJ	I-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
5-lipoxygenase	5-lipoxygenase	NN	B-NP	B-protein
catalysis	catalysis	NN	I-NP	O
in	in	IN	B-PP	O
granulocytic	granulocytic	JJ	B-NP	B-cell_line
HL-60	HL-60	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
activated	activate	VBN	B-VP	O
by	by	IN	B-PP	O
calcium	calcium	NN	B-NP	O
ionophor	ionophor	NN	I-NP	O
A23187	A23187	NN	I-NP	O
.	.	.	O	O

Recombinant	Recombinant	JJ	B-NP	B-protein
5-lipoxygenase	5-lipoxygenase	NN	I-NP	I-protein
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
peptide	peptide	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
peptide	peptide	NN	I-NP	O
also	also	RB	B-ADVP	O
inhibited	inhibit	VBD	B-VP	O
redistribution	redistribution	NN	B-NP	O
of	of	IN	B-PP	O
5-lipoxygenase	5-lipoxygenase	NN	B-NP	B-protein
from	from	IN	B-PP	O
the	the	DT	B-NP	O
cytosol	cytosol	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
membrane	membrane	NN	I-NP	O
of	of	IN	B-PP	O
HL-60	HL-60	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
stimulated	stimulate	VBN	B-VP	O
by	by	IN	B-PP	O
A23187	A23187	NN	B-NP	O
.	.	.	O	O

5-Lipoxygenase	5-Lipoxygenase	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
kappaB	kappaB	NN	I-NP	I-protein
(	(	(	O	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
)	)	)	O	O
p65	p65	NN	B-NP	O
subunit	subunit	NN	I-NP	O
immunoprecipitate	immunoprecipitate	NN	I-NP	O
fractions	fraction	NNS	I-NP	O
prepared	prepare	VBN	B-VP	O
from	from	IN	B-PP	O
HL-60	HL-60	NN	B-NP	O
cell	cell	NN	I-NP	O
lysates	lysate	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
5-lipoxygenase	5-lipoxygenase	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
coimmunoprecipitated	coimmunoprecipitate	VBN	B-VP	O
by	by	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
antiserum	antiserum	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
following	follow	VBG	B-PP	O
A23187	A23187	NN	B-NP	O
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
cells	cell	NNS	B-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
agents	agent	NNS	B-NP	O
that	that	WDT	B-NP	O
block	block	VBP	B-VP	O
5-lipoxygenase	5-lipoxygenase	NN	B-NP	B-protein
translocation	translocation	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
nucleus	nucleus	NN	I-NP	O
,	,	,	O	O
5-lipoxygenase	5-lipoxygenase	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
appearing	appear	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
immunoprecipitate	immunoprecipitate	NN	I-NP	O
was	be	VBD	B-VP	O
diminished	diminish	VBN	I-VP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
implicate	implicate	VBP	B-VP	O
an	an	DT	B-NP	O
internal	internal	JJ	I-NP	B-DNA
bipartite	bipartite	JJ	I-NP	I-DNA
nuclear	nuclear	JJ	I-NP	I-DNA
localizing	localize	VBG	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
as	as	IN	B-PP	O
a	a	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
that	that	WDT	B-NP	O
modulates	modulate	VBZ	B-VP	O
5-lipoxygenase	5-lipoxygenase	NN	B-NP	B-protein
redistribution	redistribution	NN	I-NP	O
and	and	CC	I-NP	O
catalysis	catalysis	NN	I-NP	O
in	in	IN	B-PP	O
granulocytic	granulocytic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
our	our	PRP$	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
molecular	molecular	JJ	B-NP	O
determinants	determinant	NNS	I-NP	O
which	which	WDT	B-NP	O
govern	govern	VBP	B-VP	O
5-lipoxygenase	5-lipoxygenase	NN	B-NP	B-protein
and	and	CC	I-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
redistribution	redistribution	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
nucleus	nucleus	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
coordinately	coordinately	RB	I-VP	O
controlled	control	VBN	I-VP	O
in	in	IN	B-PP	O
granulocytic	granulocytic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Copyright	Copyright	NN	B-NP	O
1998	1998	CD	I-NP	O
Academic	Academic	NNP	I-NP	O
Press	Press	NNP	I-NP	O
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
CD28/CD3-mediated	CD28/CD3-mediated	JJ	B-NP	O
costimulation	costimulation	NN	I-NP	O
of	of	IN	B-PP	O
naive	naive	JJ	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
memory	memory	NN	I-NP	I-cell_type
human	human	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
incorporation	incorporation	NN	I-NP	O
of	of	IN	B-PP	O
polyclonal	polyclonal	JJ	B-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
specific	specific	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
activator	activator	NN	I-NP	B-protein
protein-1	protein-1	NN	I-NP	I-protein
transcriptional	transcriptional	JJ	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
.	.	.	O	O

A	A	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
indirect	indirect	JJ	B-NP	O
methods	method	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
utilized	utilize	VBN	I-VP	O
in	in	IN	B-PP	O
demonstrating	demonstrate	VBG	B-VP	O
activator	activator	NN	B-NP	B-protein
protein-1	protein-1	NN	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
function	function	NN	I-NP	O
in	in	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
activity	activity	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
no	no	DT	B-NP	O
direct	direct	JJ	I-NP	O
demonstration	demonstration	NN	I-NP	O
that	that	IN	B-NP	O
activator	activator	NN	B-NP	B-protein
protein-1	protein-1	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
CD28-dependent	CD28-dependent	JJ	B-NP	O
costimulation	costimulation	NN	I-NP	O
of	of	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
transcription	transcription	NN	I-NP	O
in	in	IN	B-PP	O
freshly	freshly	RB	B-NP	O
isolated	isolate	VBN	I-NP	O
naive	naive	JJ	I-NP	O
and	and	CC	I-NP	O
memory	memory	NN	I-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

To	To	TO	B-VP	O
address	address	VB	I-VP	O
this	this	DT	B-NP	O
issue	issue	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
method	method	NN	I-NP	O
of	of	IN	B-PP	O
scrape	scrape	NN	B-NP	O
loading	loading	NN	I-NP	O
was	be	VBD	B-VP	O
applied	apply	VBN	I-VP	O
to	to	TO	B-PP	O
purified	purify	VBN	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Since	Since	IN	B-SBAR	O
scrape	scrape	NN	B-NP	O
loading	loading	NN	I-NP	O
relies	rely	VBZ	B-VP	O
on	on	IN	B-PP	O
adherent	adherent	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
human	human	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
(	(	(	I-NP	I-cell_type
PB-T	PB-T	NN	I-NP	I-cell_type
)	)	)	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
immobilized	immobilize	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
nonspecific	nonspecific	JJ	I-NP	O
cell	cell	NN	I-NP	O
attachment	attachment	NN	I-NP	O
factor	factor	NN	I-NP	O
poly-L-lysine	poly-L-lysine	NN	I-NP	O
.	.	.	O	O

Cells	Cell	NNS	B-NP	O
scraped	scrap	VBD	B-VP	O
off	off	RP	B-PRT	O
poly-L-lysine	poly-L-lysine	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
Ig	Ig	NN	B-NP	B-protein
FITC	FITC	NN	I-NP	I-protein
efficiently	efficiently	RB	B-ADVP	O
incorporated	incorporate	VBD	B-VP	O
Ig	Ig	NN	B-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
relatively	relatively	RB	B-NP	O
uniform	uniform	JJ	I-NP	O
fluorescence	fluorescence	NN	I-NP	O
.	.	.	O	O

T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
retained	retain	VBD	B-VP	O
their	their	PRP$	B-NP	O
physical	physical	JJ	I-NP	O
parameters	parameter	NNS	I-NP	O
as	as	IN	B-SBAR	O
measured	measure	VBN	B-VP	O
by	by	IN	B-PP	O
forward	forward	JJ	B-NP	O
and	and	CC	I-NP	O
side	side	NN	I-NP	O
light	light	NN	I-NP	O
scatter	scatter	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
functional	functional	JJ	B-NP	O
activity	activity	NN	I-NP	O
as	as	IN	B-SBAR	O
measured	measure	VBN	B-VP	O
by	by	IN	B-PP	O
costimulation	costimulation	NN	B-NP	O
of	of	IN	B-PP	O
proliferation	proliferation	NN	B-NP	O
and	and	CC	O	O
IL-2	IL-2	NN	B-NP	B-protein
production	production	NN	I-NP	O
after	after	IN	B-PP	O
being	be	VBG	B-VP	O
scraped	scrap	VBN	I-VP	O
off	off	RP	B-PRT	O
this	this	DT	B-NP	O
substrate	substrate	NN	I-NP	O
.	.	.	O	O

CD28/CD3-costimulated	CD28/CD3-costimulated	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
produced	produce	VBD	B-VP	O
intracellular	intracellular	JJ	B-NP	O
IL-2	IL-2	NN	I-NP	B-protein
from	from	IN	B-PP	O
all	all	DT	B-NP	O
subsets	subset	NNS	I-NP	O
measured	measure	VBN	B-VP	O
(	(	(	O	O
CD4+	CD4+	JJ	B-NP	B-protein
,	,	,	I-NP	O
CD4-	CD4-	JJ	I-NP	O
,	,	,	I-NP	O
CD45RO+	CD45RO+	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
CD45RO-	CD45RO-	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

IL-2	IL-2	NN	B-NP	B-protein
production	production	NN	I-NP	O
and	and	CC	O	O
intracellular	intracellular	JJ	B-NP	O
accumulation	accumulation	NN	I-NP	O
in	in	IN	B-PP	O
nonscraped	nonscraped	JJ	B-NP	B-cell_type
PB-T	PB-T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
activated	activate	VBN	B-VP	O
with	with	IN	B-PP	O
CD28/CD3	CD28/CD3	NN	B-NP	O
coligation	coligation	NN	I-NP	O
were	be	VBD	B-VP	O
skewed	skew	VBN	I-VP	O
favoring	favor	VBG	B-VP	O
CD45RO+	CD45RO+	JJ	B-NP	O
and	and	CC	I-NP	O
CD4+	CD4+	JJ	I-NP	B-cell_type
subsets	subset	NNS	I-NP	I-cell_type
,	,	,	O	O
as	as	IN	B-SBAR	O
was	be	VBD	B-VP	O
IL-2	IL-2	NN	B-NP	B-protein
production	production	NN	I-NP	O
in	in	IN	B-PP	O
scraped	scrap	VBN	B-NP	B-cell_line
PB-T	PB-T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	O
incorporation	incorporation	NN	I-NP	O
of	of	IN	B-PP	O
Abs	Ab	NNS	B-NP	B-protein
specific	specific	JJ	B-ADJP	O
for	for	IN	B-PP	O
c-Fos	c-Fos	NN	B-NP	B-protein
and	and	CC	I-NP	O
c-Jun	c-Jun	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
members	member	NNS	I-NP	I-protein
by	by	IN	B-PP	O
scrape	scrape	NN	B-NP	O
loading	loading	NN	I-NP	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
and	and	CC	I-NP	O
intracellular	intracellular	JJ	I-NP	O
accumulation	accumulation	NN	I-NP	O
of	of	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
within	within	IN	B-PP	O
6	6	CD	B-NP	O
h	h	NN	I-NP	O
of	of	IN	B-PP	O
costimulation	costimulation	NN	B-NP	O
with	with	IN	B-PP	O
PMA/ionomycin	PMA/ionomycin	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
costimulation	costimulation	NN	B-NP	O
by	by	IN	B-PP	O
CD28	CD28	NN	B-NP	B-protein
and	and	CC	I-NP	O
CD3	CD3	NN	I-NP	B-protein
ligation	ligation	NN	I-NP	O
.	.	.	O	O

Scrape	Scrape	NN	B-NP	O
loading	loading	NN	I-NP	O
thus	thus	RB	B-ADVP	O
provides	provide	VBZ	B-VP	O
an	an	DT	B-NP	O
efficient	efficient	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
for	for	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
incorporation	incorporation	NN	I-NP	O
of	of	IN	B-PP	O
macromolecules	macromolecule	NNS	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
direct	direct	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
that	that	IN	B-SBAR	O
c-Fos	c-Fos	NN	B-NP	B-protein
and	and	CC	I-NP	O
c-Jun	c-Jun	NN	I-NP	B-protein
are	be	VBP	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
within	within	IN	B-PP	O
its	its	PRP$	B-NP	O
correct	correct	JJ	I-NP	O
chromosomal	chromosomal	JJ	I-NP	O
context	context	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
resting	rest	VBG	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
lymphocyte	lymphocyte	NN	I-NP	I-cell_type
subpopulations	subpopulation	NNS	I-NP	I-cell_type
.	.	.	O	O

Differential	Differential	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
Nur77	Nur77	NN	B-NP	B-protein
family	family	NN	I-NP	I-protein
members	member	NNS	I-NP	I-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
T-lymphotropic	T-lymphotropic	JJ	I-NP	I-cell_type
virus	virus	NN	I-NP	I-cell_type
type	type	NN	I-NP	I-cell_type
1-infected	1-infected	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
:	:	:	O	O
transactivation	transactivation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TR3/nur77	TR3/nur77	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
by	by	IN	B-PP	O
Tax	Tax	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

We	We	PRP	B-NP	O
analyzed	analyze	VBD	B-VP	O
the	the	DT	B-NP	O
differential	differential	JJ	I-NP	O
expression	expression	NN	I-NP	O
and	and	CC	O	O
regulation	regulation	NN	B-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Nur77	Nur77	NN	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
family	family	NN	I-NP	I-protein
by	by	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-protein
T-lymphotropic	T-lymphotropic	JJ	I-NP	I-protein
virus	virus	NN	I-NP	I-protein
type	type	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
(	(	(	O	I-protein
HTLV-1	HTLV-1	NN	B-NP	I-protein
)	)	)	O	I-protein
Tax	Tax	NN	B-NP	I-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
HTLV-1-infected	HTLV-1-infected	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
Tax-expressing	Tax-expressing	JJ	B-NP	B-cell_line
JPX-9	JPX-9	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
TR3/nur77	TR3/nur77	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
highly	highly	RB	I-VP	O
expressed	express	VBN	I-VP	O
,	,	,	O	O
whereas	whereas	IN	O	O
neither	neither	CC	O	O
NOR-1	NOR-1	NN	B-NP	B-protein
nor	nor	CC	O	O
NOT	NOT	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
detectable	detectable	JJ	B-ADJP	O
.	.	.	O	O

Transient	Transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
analysis	analysis	NN	I-NP	O
further	further	RBR	B-ADVP	O
confirmed	confirm	VBD	B-VP	O
the	the	DT	B-NP	O
Tax	Tax	NN	I-NP	B-protein
transactivation	transactivation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TR3/nur77	TR3/nur77	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
but	but	CC	B-NP	O
not	not	RB	I-NP	O
the	the	DT	B-NP	O
NOR-1	NOR-1	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
in	in	IN	B-PP	O
different	different	JJ	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
luciferase	luciferase	NN	I-NP	B-DNA
reporter	reporter	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
driven	drive	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
NGFI-B	NGFI-B	NN	I-NP	B-protein
(	(	(	O	O
rat	rat	NN	B-NP	O
homolog	homolog	NN	I-NP	O
of	of	IN	B-PP	O
TR3/Nur77	TR3/Nur77	NN	B-NP	O
)	)	)	O	O
response	response	NN	B-NP	O
element	element	NN	I-NP	O
(	(	(	O	O
NBRE	NBRE	NN	B-NP	B-DNA
)	)	)	O	O
provided	provide	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
that	that	IN	B-SBAR	O
Tax	Tax	NN	B-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
transactivation	transactivation	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

Cotransfection	Cotransfection	NN	B-NP	O
assays	assay	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
TR3/nur77	TR3/nur77	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
or	or	CC	O	O
the	the	DT	B-NP	O
NBRE	NBRE	NN	I-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
motif	motif	NN	I-NP	I-DNA
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
Tax	Tax	NN	B-NP	B-protein
mutants	mutant	NNS	I-NP	I-protein
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
Tax	Tax	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
TR3/nur77	TR3/nur77	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
CREB/ATF-related	CREB/ATF-related	JJ	B-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

Negative	Negative	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
heat	heat	NN	I-NP	O
shock	shock	NN	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
response	response	NN	I-NP	O
by	by	IN	B-PP	O
HSBP1	HSBP1	NN	B-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
stress	stress	NN	B-NP	O
,	,	,	O	O
heat	heat	NN	B-NP	B-protein
shock	shock	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
(	(	(	O	O
HSF1	HSF1	NN	B-NP	B-protein
)	)	)	O	O
acquires	acquire	VBZ	B-VP	O
rapid	rapid	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
and	and	CC	O	O
transient	transient	JJ	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
while	while	IN	B-SBAR	O
undergoing	undergo	VBG	B-VP	O
conformational	conformational	JJ	B-NP	O
transition	transition	NN	I-NP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
inert	inert	JJ	I-NP	B-protein
non-DNA-binding	non-DNA-binding	JJ	I-NP	I-protein
monomer	monomer	NN	I-NP	I-protein
to	to	TO	B-PP	O
active	active	JJ	B-NP	O
functional	functional	JJ	I-NP	O
trimers	trimer	NNS	I-NP	O
.	.	.	O	O

Attenuation	Attenuation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inducible	inducible	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
response	response	NN	I-NP	O
occurs	occur	VBZ	B-VP	O
during	during	IN	B-PP	O
heat	heat	NN	B-NP	O
shock	shock	NN	I-NP	O
or	or	CC	B-PP	O
upon	upon	IN	B-PP	O
recovery	recovery	NN	B-NP	O
at	at	IN	B-PP	O
non-stress	non-stress	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
and	and	CC	O	O
involves	involve	VBZ	B-VP	O
dissociation	dissociation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HSF1	HSF1	NN	I-NP	B-protein
trimer	trimer	NN	I-NP	O
and	and	CC	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
activity	activity	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
used	use	VBN	I-VP	O
the	the	DT	B-NP	O
hydrophobic	hydrophobic	JJ	I-NP	B-DNA
repeats	repeat	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HSF1	HSF1	NN	I-NP	B-protein
trimerization	trimerization	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
yeast	yeast	NN	I-NP	O
two-hybrid	two-hybrid	JJ	I-NP	O
protein	protein	NN	I-NP	O
interaction	interaction	NN	I-NP	O
assay	assay	NN	I-NP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
heat	heat	NN	B-NP	B-protein
shock	shock	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
(	(	(	O	O
HSBP1	HSBP1	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
,	,	,	I-NP	O
conserved	conserve	VBN	I-NP	O
,	,	,	I-NP	O
76-amino-acid	76-amino-acid	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
that	that	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
two	two	CD	B-NP	O
extended	extend	VBN	I-NP	O
arrays	array	NNS	I-NP	O
of	of	IN	B-PP	O
hydrophobic	hydrophobic	JJ	B-NP	B-protein
repeats	repeat	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
interact	interact	VBP	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
HSF1	HSF1	NN	I-NP	B-protein
heptad	heptad	NN	I-NP	O
repeats	repeat	NNS	I-NP	O
.	.	.	O	O

HSBP1	HSBP1	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
nuclear-localized	nuclear-localized	JJ	B-ADJP	O
and	and	CC	O	O
interacts	interact	VBZ	B-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
active	active	JJ	I-NP	O
trimeric	trimeric	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
HSF1	HSF1	NN	B-NP	B-protein
that	that	WDT	B-NP	O
appears	appear	VBZ	B-VP	O
during	during	IN	B-PP	O
heat	heat	NN	B-NP	O
shock	shock	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
attenuation	attenuation	NN	B-NP	O
of	of	IN	B-PP	O
HSF1	HSF1	NN	B-NP	B-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
inert	inert	JJ	I-NP	B-protein
monomer	monomer	NN	I-NP	I-protein
,	,	,	O	O
HSBP1	HSBP1	NN	B-NP	B-protein
associates	associate	VBZ	B-VP	O
with	with	IN	B-PP	O
Hsp70	Hsp70	NN	B-NP	B-protein
.	.	.	O	O

HSBP1	HSBP1	NN	B-NP	B-protein
negatively	negatively	RB	B-ADVP	O
affects	affect	VBZ	B-VP	O
HSF1	HSF1	NN	B-NP	B-protein
DNA-binding	DNA-binding	JJ	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
HSBP1	HSBP1	NN	B-NP	B-protein
in	in	IN	B-PP	O
mammalian	mammalian	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
represses	repress	VBZ	B-VP	O
the	the	DT	B-NP	O
transactivation	transactivation	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
HSF1	HSF1	NN	B-NP	B-protein
.	.	.	O	O

To	To	TO	B-VP	O
establish	establish	VB	I-VP	O
a	a	DT	B-NP	O
biological	biological	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
HSBP1	HSBP1	NN	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
homologous	homologous	JJ	I-NP	B-protein
Caenorhabditis	Caenorhabditis	NN	I-NP	I-protein
elegans	elegan	NNS	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
was	be	VBD	B-VP	O
overexpressed	overexpresse	VBN	I-VP	O
in	in	IN	B-PP	O
body	body	NN	B-NP	B-cell_type
wall	wall	NN	I-NP	I-cell_type
muscle	muscle	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
block	block	VB	I-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
heat	heat	NN	I-NP	O
shock	shock	NN	I-NP	O
response	response	NN	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
heat	heat	NN	I-NP	B-DNA
shock	shock	NN	I-NP	I-DNA
promoter-reporter	promoter-reporter	NN	I-NP	I-DNA
construct	construct	NN	I-NP	I-DNA
.	.	.	O	O

Alteration	Alteration	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
HSBP1	HSBP1	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
C.	C.	NNP	B-NP	O
elegans	elegans	NNP	I-NP	O
has	have	VBZ	B-VP	O
severe	severe	JJ	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
survival	survival	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
animals	animal	NNS	I-NP	O
after	after	IN	B-PP	O
thermal	thermal	JJ	B-NP	O
and	and	CC	I-NP	O
chemical	chemical	JJ	I-NP	O
stress	stress	NN	I-NP	O
,	,	,	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
HSBP1	HSBP1	NN	B-NP	B-protein
as	as	IN	B-PP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
regulator	regulator	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
heat	heat	NN	I-NP	O
shock	shock	NN	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Long-range	Long-range	JJ	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
.	.	.	O	O

Most	Most	JJS	B-NP	O
studies	study	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
have	have	VBP	B-VP	O
involved	involve	VBN	I-VP	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
proximal	proximal	JJ	B-NP	B-DNA
promoters	promoter	NNS	I-NP	I-DNA
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
work	work	NN	I-NP	O
has	have	VBZ	B-VP	O
identified	identify	VBN	I-VP	O
distal	distal	JJ	B-NP	B-DNA
elements	element	NNS	I-NP	I-DNA
that	that	WDT	B-NP	O
mediate	mediate	VBP	B-VP	O
long-range	long-range	JJ	B-NP	B-DNA
cytokine	cytokine	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
regulation	regulation	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
implicated	implicate	VBN	I-VP	O
chromatin	chromatin	NN	B-NP	B-DNA
reorganization	reorganization	NN	I-NP	O
in	in	IN	B-PP	O
regulation	regulation	NN	B-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
loci	locus	NNS	I-NP	I-DNA
.	.	.	O	O

These	These	DT	B-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
begun	begin	VBN	I-VP	O
to	to	TO	I-VP	O
elucidate	elucidate	VB	I-VP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
cell-specificity	cell-specificity	NN	B-NP	O
and	and	CC	O	O
high-level	high-level	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

A	A	DT	B-NP	O
signaling	signaling	NN	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
of	of	IN	B-PP	O
Ca2+-calmodulin-dependent	Ca2+-calmodulin-dependent	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
IV	IV	CD	B-NP	I-protein
and	and	CC	O	O
protein	protein	NN	B-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
2A	2A	NN	I-NP	I-protein
[	[	(	O	O
see	see	VB	B-VP	O
comments	comment	NNS	B-NP	O
]	]	)	O	O

Stimulation	Stimulation	NN	B-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
calcium	calcium	NN	I-NP	O
concentration	concentration	NN	I-NP	O
(	(	(	O	O
[	[	(	O	O
Ca2+	Ca2+	NN	B-NP	O
]	]	)	I-NP	O
i	i	NN	I-NP	O
)	)	)	O	O
that	that	WDT	B-NP	O
parallels	parallel	VBZ	B-VP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
Ca2+-calmodulin-dependent	Ca2+-calmodulin-dependent	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
IV	IV	CD	I-NP	I-protein
(	(	(	O	O
CaMKIV	CaMKIV	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
enzyme	enzyme	NN	I-NP	I-protein
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
phosphorylate	phosphorylate	VB	I-VP	O
and	and	CC	I-VP	O
activate	activate	VB	I-VP	O
the	the	DT	B-NP	O
cyclic	cyclic	JJ	I-NP	B-protein
adenosine	adenosine	NN	I-NP	I-protein
monophosphate	monophosphate	NN	I-NP	I-protein
(	(	(	O	I-protein
cAMP	cAMP	NN	B-NP	I-protein
)	)	)	O	I-protein
response	response	NN	B-NP	I-protein
element-binding	element-binding	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	O
CREB	CREB	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
inactivation	inactivation	NN	B-NP	O
of	of	IN	B-PP	O
CaMKIV	CaMKIV	NN	B-NP	B-protein
occurs	occur	VBZ	B-VP	O
despite	despite	IN	B-PP	O
the	the	DT	B-NP	O
sustained	sustained	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
[	[	(	B-NP	O
Ca2+	Ca2+	NN	I-NP	O
]	]	)	I-NP	O
i	i	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
stable	stable	JJ	I-NP	O
and	and	CC	I-NP	O
stoichiometric	stoichiometric	JJ	I-NP	O
complex	complex	NN	I-NP	O
of	of	IN	B-PP	O
CaMKIV	CaMKIV	NN	B-NP	B-protein
with	with	IN	B-PP	O
protein	protein	NN	B-NP	B-protein
serine-threonine	serine-threonine	NN	I-NP	I-protein
phosphatase	phosphatase	NN	I-NP	I-protein
2A	2A	NN	I-NP	I-protein
(	(	(	O	O
PP2A	PP2A	NN	B-NP	B-protein
)	)	)	O	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
PP2A	PP2A	NN	B-NP	B-protein
dephosphorylates	dephosphorylate	VBZ	B-VP	O
CaMKIV	CaMKIV	NN	B-NP	B-protein
and	and	CC	O	O
functions	function	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
regulator	regulator	NN	I-NP	O
of	of	IN	B-PP	O
CaMKIV	CaMKIV	NN	B-NP	B-protein
signaling	signaling	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
PP2A	PP2A	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
by	by	IN	B-PP	O
small	small	JJ	B-NP	B-protein
t	t	NN	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
enhanced	enhance	VBD	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
CREB	CREB	NN	B-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
by	by	IN	B-PP	O
CaMKIV	CaMKIV	NN	B-NP	B-protein
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
reveal	reveal	VBP	B-VP	O
an	an	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	O
signaling	signaling	NN	I-NP	O
mechanism	mechanism	NN	I-NP	O
whereby	whereby	WRB	B-ADVP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	B-protein
serine-threonine	serine-threonine	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
CaMKIV	CaMKIV	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
tightly	tightly	RB	I-NP	O
associated	associate	VBN	I-NP	O
protein	protein	NN	I-NP	B-protein
serine-threonine	serine-threonine	NN	I-NP	I-protein
phosphatase	phosphatase	NN	I-NP	I-protein
(	(	(	O	O
PP2A	PP2A	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Hypoxia	Hypoxia	NN	B-NP	O
down-regulates	down-regulate	VBZ	B-VP	O
MCP-1	MCP-1	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
:	:	:	O	O
implications	implication	NNS	B-NP	O
for	for	IN	B-PP	O
macrophage	macrophage	NN	B-NP	O
distribution	distribution	NN	I-NP	O
in	in	IN	B-PP	O
tumors	tumor	NNS	B-NP	O
.	.	.	O	O

Monocyte	Monocyte	NN	B-NP	B-protein
chemoattractant	chemoattractant	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
(	(	(	O	O
MCP-1	MCP-1	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
macrophage	macrophage	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
ovarian	ovarian	JJ	I-NP	O
carcinomas	carcinoma	NNS	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
MCP-1	MCP-1	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
predominantly	predominantly	RB	I-VP	O
expressed	express	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
tumor	tumor	NN	I-NP	O
parenchyma	parenchyma	NN	I-NP	O
,	,	,	O	O
macrophages	macrophage	NNS	B-NP	B-cell_type
accumulate	accumulate	VBP	B-VP	O
at	at	IN	B-PP	O
highest	high	JJS	B-NP	O
density	density	NN	I-NP	O
in	in	IN	B-PP	O
necrotic	necrotic	JJ	B-NP	B-protein
regions	region	NNS	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
tensions	tension	NNS	I-NP	O
.	.	.	O	O

Tumor	Tumor	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
(	(	(	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
)	)	)	O	O
can	can	MD	B-VP	O
stimulate	stimulate	VB	I-VP	O
MCP-1	MCP-1	NN	B-NP	B-protein
production	production	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
present	present	JJ	B-ADJP	O
within	within	IN	B-PP	O
ovarian	ovarian	JJ	B-NP	O
carcinomas	carcinoma	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
investigated	investigate	VBN	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
hypoxia	hypoxia	NN	B-NP	O
both	both	CC	B-PP	O
on	on	IN	B-PP	O
MCP-1	MCP-1	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
ovarian	ovarian	JJ	B-NP	B-cell_line
cancer	cancer	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
and	and	CC	O	O
monocyte	monocyte	NN	B-NP	O
migration	migration	NN	I-NP	O
.	.	.	O	O

Hypoxia	Hypoxia	NN	B-NP	O
down-regulated	down-regulate	VBD	B-VP	O
TNF-alpha-induced	TNF-alpha-induced	JJ	B-NP	O
MCP-1	MCP-1	NN	I-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
and	and	CC	O	O
protein	protein	NN	B-NP	O
production	production	NN	I-NP	O
by	by	IN	B-PP	O
ovarian	ovarian	JJ	B-NP	B-cell_type
cancer	cancer	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
was	be	VBD	B-VP	O
mimicked	mimic	VBN	I-VP	O
by	by	IN	B-PP	O
cobalt	cobalt	NN	B-NP	O
chloride	chloride	NN	I-NP	O
and	and	CC	I-NP	O
desferrioxamine	desferrioxamine	NN	I-NP	O
,	,	,	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
oxygen-sensing	oxygen-sensing	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
.	.	.	O	O

Unlike	Unlike	IN	B-PP	O
antioxidants	antioxidant	NNS	B-NP	O
,	,	,	O	O
hypoxia	hypoxia	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
inhibit	inhibit	VB	I-VP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
KB	KB	NN	I-NP	I-protein
mobilization	mobilization	NN	I-NP	O
.	.	.	O	O

Monocyte	Monocyte	NN	B-NP	O
migration	migration	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
MCP-1	MCP-1	NN	B-NP	B-protein
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
diminished	diminish	VBN	I-VP	O
under	under	IN	B-PP	O
hypoxic	hypoxic	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
.	.	.	O	O

Down-regulation	Down-regulation	NN	B-NP	O
of	of	IN	B-PP	O
MCP-1	MCP-1	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
monocyte	monocyte	NN	B-NP	O
migration	migration	NN	I-NP	O
are	be	VBP	B-VP	O
independent	independent	JJ	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
hypoxia	hypoxia	NN	B-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
macrophages	macrophage	NNS	B-NP	B-cell_type
within	within	IN	B-PP	O
ovarian	ovarian	JJ	B-NP	O
tumors	tumor	NNS	I-NP	O
.	.	.	O	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
inflammatory	inflammatory	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
disease	disease	NN	I-NP	O
[	[	(	O	O
see	see	VB	B-VP	O
comments	comment	NNS	B-NP	O
]	]	)	O	O

BACKGROUND	BACKGROUND	NN	B-NP	O
:	:	:	O	O
Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
pro-inflammatory	pro-inflammatory	JJ	B-NP	B-protein
cytokines	cytokine	NNS	I-NP	I-protein
is	be	VBZ	B-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
intestinal	intestinal	JJ	I-NP	O
lamina	lamina	NN	I-NP	O
propria	propria	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
IBD	IBD	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Nuclear	Nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
(	(	(	O	O
NF	NF	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
)	)	)	O	O
controls	control	VBZ	B-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
inflammation	inflammation	NN	B-NP	O
genes	gene	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
activation	activation	NN	B-NP	O
,	,	,	O	O
NF	NF	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
rapidly	rapidly	RB	I-VP	O
released	release	VBN	I-VP	O
from	from	IN	B-PP	O
its	its	PRP$	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	B-protein
inhibitor	inhibitor	NN	I-NP	I-protein
(	(	(	O	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
)	)	)	O	O
,	,	,	O	O
transmigrates	transmigrate	VBZ	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
nucleus	nucleus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
DNA	DNA	NN	B-NP	B-DNA
response	response	NN	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
gene	gene	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
regions	region	NNS	I-NP	I-DNA
.	.	.	O	O

AIMS	AIMS	NNS	B-NP	O
:	:	:	O	O
To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
whether	whether	IN	B-SBAR	O
increased	increase	VBN	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
NF	NF	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
in	in	IN	B-PP	O
IBD	IBD	NN	B-NP	O
and	and	CC	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
down-regulated	down-regulate	VBN	I-VP	O
by	by	IN	B-PP	O
anti-inflammatory	anti-inflammatory	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
NF	NF	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
western	western	JJ	B-NP	O
blot	blot	NN	I-NP	O
assessment	assessment	NN	I-NP	O
and	and	CC	O	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assay	assay	NN	I-NP	O
in	in	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
of	of	IN	B-PP	O
colonic	colonic	JJ	B-NP	O
biopsy	biopsy	NN	I-NP	O
samples	sample	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
lamina	lamina	NN	B-NP	B-cell_type
propria	propria	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Nuclear	Nuclear	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
NF	NF	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
p65	p65	NN	I-NP	I-protein
are	be	VBP	B-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
lamina	lamina	NN	B-NP	O
propria	propria	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
specimens	specimen	NNS	I-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
Crohn	Crohn	NN	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
comparison	comparison	NN	B-NP	O
with	with	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
ulcerative	ulcerative	JJ	B-NP	O
colitis	colitis	NN	I-NP	O
and	and	CC	I-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

Increased	Increase	VBN	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
NF	NF	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
lamina	lamina	NN	B-NP	B-cell_type
propria	propria	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
active	active	JJ	B-NP	O
IBD	IBD	NN	I-NP	O
.	.	.	O	O

Corticosteroids	Corticosteroid	NNS	B-NP	O
strongly	strongly	RB	B-VP	O
inhibit	inhibit	VBP	I-VP	O
intestinal	intestinal	JJ	B-NP	O
NF	NF	NN	I-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
IBD	IBD	NN	B-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
by	by	IN	B-PP	O
stabilising	stabilise	VBG	B-VP	O
the	the	DT	B-NP	O
cytosolic	cytosolic	JJ	I-NP	B-protein
inhibitor	inhibitor	NN	I-NP	I-protein
I	I	NN	I-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
against	against	IN	B-PP	O
activation	activation	NN	B-NP	O
induced	induce	VBN	I-NP	O
degradation	degradation	NN	I-NP	O
.	.	.	O	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
both	both	DT	B-NP	O
IBDs	IBD	NNS	I-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
particularly	particularly	RB	B-ADVP	O
Crohn	Crohn	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
NF	NF	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
may	may	MD	B-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
NF	NF	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
may	may	MD	B-VP	O
represent	represent	VB	I-VP	O
a	a	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
steroids	steroid	NNS	B-NP	O
exert	exert	VBP	B-VP	O
an	an	DT	B-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	O
effect	effect	NN	I-NP	O
in	in	IN	B-PP	O
IBD	IBD	NN	B-NP	O

Insufficient	Insufficient	JJ	B-NP	O
glycemic	glycemic	JJ	I-NP	O
control	control	NN	I-NP	O
increases	increase	VBZ	B-VP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor-kappa	factor-kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
type	type	NN	B-NP	O
1	1	CD	I-NP	O
diabetes	diabetes	NN	I-NP	O
.	.	.	O	O

OBJECTIVE	OBJECTIVE	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
redox-sensitive	redox-sensitive	JJ	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
nuclear	nuclear	JJ	I-NP	B-protein
factor-kappa	factor-kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
(	(	(	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
believed	believe	VBN	I-VP	O
to	to	TO	I-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
late	late	JJ	B-NP	O
diabetic	diabetic	JJ	I-NP	O
complications	complication	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
unknown	unknown	JJ	B-ADJP	O
whether	whether	IN	B-SBAR	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
influenced	influence	VBN	I-VP	O
by	by	IN	B-PP	O
glycemic	glycemic	JJ	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

RESEARCH	RESEARCH	NN	B-NP	O
DESIGN	DESIGN	NN	I-NP	O
AND	AND	CC	B-NP	O
METHODS	METHODS	NNS	I-NP	O
:	:	:	O	O
To	To	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
activated	activate	VBN	I-VP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
insufficient	insufficient	JJ	B-NP	O
glycemic	glycemic	JJ	I-NP	O
control	control	NN	I-NP	O
(	(	(	O	O
HbA1c	HbA1c	NN	B-NP	O
>	>	SYM	O	O
10	10	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
we	we	PRP	B-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
tissue	tissue	NN	I-NP	O
culture-independent	culture-independent	JJ	I-NP	O
electrophoretic	electrophoretic	JJ	I-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assay	assay	NN	I-NP	O
(	(	(	O	O
EMSA	EMSA	NN	B-NP	O
)	)	)	O	O
-based	-based	JJ	B-NP	O
semiquantitative	semiquantitative	JJ	I-NP	O
detection	detection	NN	I-NP	O
system	system	NN	I-NP	O
that	that	WDT	B-NP	O
allowed	allow	VBD	B-VP	O
us	us	PRP	B-NP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
ex	ex	NN	B-NP	O
vivo-isolated	vivo-isolated	JJ	I-NP	O
peripheral	peripheral	JJ	I-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
PBMCs	PBMC	NNS	B-NP	B-cell_type
)	)	)	O	O
.	.	.	O	O

We	We	PRP	B-NP	O
included	include	VBD	B-VP	O
43	43	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
type	type	NN	B-NP	O
1	1	CD	I-NP	O
diabetes	diabetes	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
cross-sectional	cross-sectional	JJ	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
of	of	IN	B-PP	O
those	those	DT	B-NP	O
received	receive	VBD	B-VP	O
the	the	DT	B-NP	O
antioxidant	antioxidant	JJ	I-NP	O
thioctic	thioctic	JJ	I-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
600	600	CD	B-NP	O
mg/day	mg/day	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Monocytes	Monocyte	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
HbA1c	HbA1c	NN	B-NP	O
levels	level	NNS	I-NP	O
>	>	SYM	B-NP	O
10	10	CD	B-NP	O
%	%	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
higher	high	JJR	I-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
EMSA	EMSA	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
stronger	strong	JJR	I-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
staining	staining	NN	I-NP	O
in	in	IN	B-PP	O
immunohistochemistry	immunohistochemistry	NN	B-NP	O
than	than	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
HbA1c	HbA1c	NN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
6-8	6-8	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
plasmatic	plasmatic	JJ	B-NP	O
markers	marker	NNS	I-NP	O
of	of	IN	B-PP	O
lipid	lipid	NN	B-NP	O
peroxidation	peroxidation	NN	I-NP	O
.	.	.	O	O

Treatment	Treatment	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
antioxidant	antioxidant	JJ	I-NP	O
thioctic	thioctic	JJ	I-NP	O
acid	acid	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
Hyperglycemia	Hyperglycemia	NN	B-NP	O
induces	induce	VBZ	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
in	in	IN	B-PP	O
ex	ex	NN	B-NP	O
vivo-isolated	vivo-isolated	JJ	I-NP	O
PBMCs	PBMC	NNS	I-NP	B-cell_type
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
type	type	NN	B-NP	O
1	1	CD	I-NP	O
diabetes	diabetes	NN	I-NP	O
.	.	.	O	O

NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
is	be	VBZ	B-VP	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
partially	partially	RB	B-ADJP	O
dependent	dependent	JJ	I-ADJP	O
on	on	IN	B-PP	O
oxidative	oxidative	JJ	B-NP	O
stress	stress	NN	I-NP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
the	the	DT	B-NP	O
antioxidant	antioxidant	JJ	I-NP	O
thioctic	thioctic	JJ	I-NP	O
acid	acid	NN	I-NP	O
significantly	significantly	RB	B-ADVP	O
lowered	lower	VBD	B-VP	O
the	the	DT	B-NP	O
extent	extent	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

Synergistic	Synergistic	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
MAP	MAP	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
ERK1/2	ERK1/2	NN	B-NP	B-protein
)	)	)	O	O
by	by	IN	B-PP	O
erythropoietin	erythropoietin	NN	B-NP	B-protein
and	and	CC	I-NP	O
stem	stem	NN	I-NP	B-protein
cell	cell	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
expanded	expand	VBN	B-NP	O
erythropoiesis	erythropoiesis	NN	I-NP	O
.	.	.	O	O

Stem	Stem	NN	B-NP	B-protein
cell	cell	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
SCF	SCF	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
erythropoietin	erythropoietin	NN	B-NP	B-protein
(	(	(	O	O
EPO	EPO	NN	B-NP	B-protein
)	)	)	O	O
work	work	NN	B-NP	O
synergistically	synergistically	RB	B-ADVP	O
to	to	TO	B-VP	O
support	support	VB	I-VP	O
erythropoiesis	erythropoiesis	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
synergism	synergism	NN	I-NP	O
is	be	VBZ	B-VP	O
unknown	unknown	JJ	B-ADJP	O
.	.	.	O	O

By	By	IN	B-PP	O
using	use	VBG	B-VP	O
purified	purify	VBN	B-NP	B-cell_line
human	human	JJ	I-NP	I-cell_line
erythroid	erythroid	JJ	I-NP	I-cell_line
colony-forming	colony-forming	JJ	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
(	(	(	O	O
ECFC	ECFC	NN	B-NP	B-cell_type
)	)	)	O	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
SCF	SCF	NN	B-NP	B-protein
and	and	CC	I-NP	O
EPO	EPO	NN	I-NP	B-protein
synergistically	synergistically	RB	B-ADVP	O
activate	activate	VBP	B-VP	O
MAP	MAP	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
MAPK	MAPK	NN	B-NP	B-protein
,	,	,	O	O
ERK1/2	ERK1/2	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
correlates	correlate	VBZ	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
growth	growth	NN	I-NP	O
and	and	CC	O	O
thus	thus	RB	B-VP	O
may	may	MD	I-VP	O
be	be	VB	I-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
synergistic	synergistic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
.	.	.	O	O

Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
with	with	IN	B-PP	O
PD98059	PD98059	NN	B-NP	O
and	and	CC	I-NP	O
wortmannin	wortmannin	NN	I-NP	O
,	,	,	O	O
inhibitors	inhibitor	NNS	B-NP	O
of	of	IN	B-PP	O
MEK	MEK	NN	B-NP	B-protein
and	and	CC	I-NP	O
PI-3	PI-3	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
synergistic	synergistic	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
MAPK	MAPK	NN	B-NP	B-protein
and	and	CC	O	O
also	also	RB	B-ADVP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
growth	growth	NN	I-NP	O
,	,	,	O	O
further	further	RB	B-VP	O
supporting	support	VBG	I-VP	O
this	this	DT	B-NP	O
conclusion	conclusion	NN	I-NP	O
.	.	.	O	O

Wortmannin	Wortmannin	NN	B-NP	O
only	only	RB	B-ADVP	O
inhibits	inhibit	VBZ	B-VP	O
MAPK	MAPK	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
EPO	EPO	NN	B-NP	B-protein
but	but	CC	B-CONJP	O
not	not	RB	I-CONJP	O
that	that	DT	B-NP	O
by	by	IN	B-PP	O
SCF	SCF	NN	B-NP	B-protein
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
SCF	SCF	NN	B-NP	B-protein
and	and	CC	I-NP	O
EPO	EPO	NN	I-NP	B-protein
may	may	MD	B-VP	O
activate	activate	VB	I-VP	O
MAPK	MAPK	NN	B-NP	B-protein
through	through	IN	B-PP	O
different	different	JJ	B-NP	O
pathways	pathway	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
would	would	MD	B-VP	O
facilitate	facilitate	VB	I-VP	O
synergy	synergy	NN	B-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
EPO	EPO	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
SCF	SCF	NN	B-NP	B-protein
,	,	,	O	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
STAT5	STAT5	NN	B-NP	B-protein
,	,	,	O	O
whereas	whereas	IN	O	O
SCF	SCF	NN	B-NP	B-protein
and	and	CC	I-NP	O
wortmannin	wortmannin	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
EPO	EPO	NN	I-NP	B-protein
-induced	-induced	JJ	I-NP	O
STAT5	STAT5	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
STAT5	STAT5	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
synergistic	synergistic	JJ	I-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
SCF	SCF	NN	B-NP	B-protein
and	and	CC	I-NP	O
EPO	EPO	NN	I-NP	B-protein
.	.	.	O	O

Together	Together	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
synergistic	synergistic	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
MAPK	MAPK	NN	B-NP	B-protein
by	by	IN	B-PP	O
SCF	SCF	NN	B-NP	B-protein
and	and	CC	I-NP	O
EPO	EPO	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
expanded	expand	VBN	B-NP	O
erythropoiesis	erythropoiesis	NN	I-NP	O
.	.	.	O	O

Copyright	Copyright	NN	B-NP	O
1998	1998	CD	I-NP	O
by	by	IN	B-PP	O
The	The	NNP	B-NP	O
American	American	NNP	I-NP	O
Society	Society	NNP	I-NP	O
of	of	IN	B-PP	O
Hematology	Hematology	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
and	and	CC	I-NP	O
phenotypic	phenotypic	JJ	I-NP	O
profile	profile	NN	I-NP	O
of	of	IN	B-PP	O
primary	primary	JJ	B-NP	O
central	central	JJ	I-NP	O
nervous	nervous	JJ	I-NP	O
system	system	NN	I-NP	O
lymphoma	lymphoma	NN	I-NP	O
identifies	identify	VBZ	B-VP	O
distinct	distinct	JJ	B-NP	O
categories	category	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
histogenetic	histogenetic	JJ	B-NP	O
derivation	derivation	NN	I-NP	O
from	from	IN	B-PP	O
germinal	germinal	JJ	B-NP	B-cell_type
center-related	center-related	JJ	I-NP	I-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Primary	Primary	JJ	B-NP	O
central	central	JJ	I-NP	O
nervous	nervous	JJ	I-NP	O
system	system	NN	I-NP	O
lymphoma	lymphoma	NN	I-NP	O
(	(	(	O	O
PCNSL	PCNSL	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
morbidity	morbidity	NN	B-NP	O
and	and	CC	I-NP	O
mortality	mortality	NN	I-NP	O
among	among	IN	B-PP	O
human	human	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
HIV	HIV	NN	B-NP	O
)	)	)	O	O
-infected	-infected	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
precise	precise	JJ	I-NP	O
histogenetic	histogenetic	JJ	I-NP	O
derivation	derivation	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
PCNSL	PCNSL	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
poorly	poorly	RB	I-VP	O
understood	understand	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
an	an	DT	B-NP	O
attempt	attempt	NN	I-NP	O
to	to	TO	B-VP	O
clarify	clarify	VB	I-VP	O
the	the	DT	B-NP	O
histogenesis	histogenesis	NN	I-NP	O
and	and	CC	I-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
lymphomas	lymphoma	NNS	I-NP	O
,	,	,	O	O
49	49	CD	B-NP	O
PCNSL	PCNSL	NN	I-NP	O
(	(	(	O	O
26	26	CD	B-NP	O
acquired	acquire	VBN	I-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
[	[	(	I-NP	O
AIDS	AIDS	NN	I-NP	O
]	]	)	I-NP	O
-related	-related	JJ	I-NP	O
and	and	CC	O	O
23	23	CD	B-NP	O
AIDS-unrelated	AIDS-unrelated	JJ	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
for	for	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
biologic	biologic	JJ	I-NP	O
markers	marker	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
bear	bear	VB	I-VP	O
histogenetic	histogenetic	JJ	B-NP	O
and	and	CC	I-NP	O
pathogenetic	pathogenetic	JJ	I-NP	O
significance	significance	NN	I-NP	O
for	for	IN	B-PP	O
mature	mature	JJ	B-NP	B-cell_type
B-cell	B-cell	NN	I-NP	I-cell_type
neoplasms	neoplasm	NNS	I-NP	I-cell_type
.	.	.	O	O

PCNSL	PCNSL	NN	B-NP	B-protein
associated	associate	VBN	B-VP	O
frequently	frequently	RB	B-ADVP	O
(	(	(	O	O
50.0	50.0	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
mutations	mutation	NNS	B-NP	O
of	of	IN	B-PP	O
BCL-6	BCL-6	NN	B-NP	B-DNA
5	5	CD	I-NP	I-DNA
'	'	SYM	I-NP	I-DNA
noncoding	noncoding	JJ	I-NP	I-DNA
regions	region	NNS	I-NP	I-DNA
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
regarded	regard	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
marker	marker	NN	I-NP	O
of	of	IN	B-PP	O
B-cell	B-cell	NN	B-NP	O
transition	transition	NN	I-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
germinal	germinal	JJ	I-NP	O
center	center	NN	I-NP	O
(	(	(	O	O
GC	GC	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
BCL-6	BCL-6	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
restricted	restricted	JJ	B-ADJP	O
to	to	TO	B-PP	O
GC	GC	NN	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
throughout	throughout	IN	B-PP	O
physiologic	physiologic	JJ	B-NP	O
B-cell	B-cell	NN	I-NP	O
maturation	maturation	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
AIDS-unrelated	AIDS-unrelated	JJ	I-NP	O
PCNSL	PCNSL	NN	I-NP	O
and	and	CC	O	O
in	in	IN	B-PP	O
56.2	56.2	CD	B-NP	O
%	%	NN	I-NP	O
AIDS-related	AIDS-related	JJ	I-NP	O
cases	case	NNS	I-NP	O
.	.	.	O	O

Notably	Notably	RB	B-ADVP	O
,	,	,	O	O
among	among	IN	B-PP	O
AIDS-related	AIDS-related	JJ	B-NP	O
PCNSL	PCNSL	NN	I-NP	O
,	,	,	O	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
BCL-6	BCL-6	NN	B-NP	B-protein
was	be	VBD	B-VP	O
mutually	mutually	RB	B-ADJP	O
exclusive	exclusive	JJ	I-ADJP	O
with	with	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
Epstein-Barr	Epstein-Barr	JJ	B-NP	B-protein
virus	virus	NN	I-NP	I-protein
(	(	(	O	I-protein
EBV	EBV	NN	B-NP	I-protein
)	)	)	O	I-protein
-encoded	-encoded	JJ	B-NP	I-protein
latent	latent	JJ	I-NP	I-protein
membrane	membrane	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	O
LMP	LMP	NN	B-NP	O
)	)	)	O	O
-1	-1	CD	B-NP	O
and	and	CC	O	O
,	,	,	O	O
with	with	IN	B-PP	O
few	few	JJ	B-NP	O
exceptions	exception	NNS	I-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
of	of	IN	B-PP	O
BCL-2	BCL-2	NN	B-NP	B-protein
.	.	.	O	O

All	All	DT	B-NP	O
but	but	IN	I-NP	O
one	one	CD	I-NP	O
PCNSL	PCNSL	NN	I-NP	B-protein
expressed	express	VBD	B-VP	O
hMSH2	hMSH2	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
among	among	IN	B-PP	O
mature	mature	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
selectively	selectively	RB	B-ADVP	O
stains	stain	VBZ	B-VP	O
GC	GC	NN	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
PCNSL	PCNSL	NN	B-NP	B-protein
may	may	MD	B-VP	O
be	be	VB	I-VP	O
frequently	frequently	RB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
GC	GC	NN	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
segregated	segregate	VBN	I-VP	O
into	into	IN	B-PP	O
two	two	CD	B-NP	O
major	major	JJ	I-NP	O
biologic	biologic	JJ	I-NP	O
categories	category	NNS	I-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
BCL-6	BCL-6	NN	B-NP	B-protein
,	,	,	O	O
LMP-1	LMP-1	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
BCL-2	BCL-2	NN	B-NP	B-protein
.	.	.	O	O

BCL-6	BCL-6	NN	B-NP	B-protein
(	(	(	O	O
+	+	SYM	B-NP	O
)	)	)	O	O
/	/	SYM	B-NP	O
LMP-1	LMP-1	NN	I-NP	B-protein
(	(	(	O	O
-	-	SYM	B-NP	O
)	)	)	O	O
/	/	SYM	B-NP	O
BCL-2	BCL-2	NN	I-NP	B-protein
(	(	(	O	O
-	-	SYM	O	O
)	)	)	O	O
PCNSL	PCNSL	NN	B-NP	O
occur	occur	VBP	B-VP	O
both	both	CC	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
HIV	HIV	NN	B-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
consistently	consistently	RB	B-VP	O
display	display	VBP	I-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
noncleaved	noncleaved	JJ	I-NP	O
cell	cell	NN	I-NP	O
morphology	morphology	NN	I-NP	O
.	.	.	O	O

Conversely	Conversely	RB	B-ADVP	O
,	,	,	O	O
BCL-6	BCL-6	NN	B-NP	B-protein
(	(	(	O	O
-	-	SYM	B-NP	O
)	)	)	O	O
/	/	SYM	B-NP	O
LMP-1	LMP-1	NN	I-NP	B-protein
(	(	(	O	O
+	+	SYM	B-NP	O
)	)	)	O	O
/	/	SYM	B-NP	O
BCL-2	BCL-2	NN	I-NP	B-protein
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
PCNSL	PCNSL	NN	B-NP	O
are	be	VBP	B-VP	O
restricted	restricted	JJ	B-ADJP	O
to	to	TO	B-PP	O
HIV-infected	HIV-infected	JJ	B-NP	O
hosts	host	NNS	I-NP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
represented	represent	VBN	I-VP	O
by	by	IN	B-PP	O
lymphomas	lymphoma	NNS	B-NP	O
with	with	IN	B-PP	O
immunoblastic	immunoblastic	JJ	B-NP	O
features	feature	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
are	be	VBP	B-VP	O
relevant	relevant	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
and	and	CC	I-NP	O
histogenesis	histogenesis	NN	I-NP	O
of	of	IN	B-PP	O
PCNSL	PCNSL	NN	B-NP	B-protein
and	and	CC	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
helpful	helpful	JJ	B-ADJP	O
to	to	TO	B-VP	O
segregate	segregate	VB	I-VP	O
distinct	distinct	JJ	B-NP	O
biologic	biologic	JJ	I-NP	O
and	and	CC	I-NP	O
prognostic	prognostic	JJ	I-NP	O
categories	category	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
lymphomas	lymphoma	NNS	I-NP	O
.	.	.	O	O

Copyright	Copyright	NN	B-NP	O
1998	1998	CD	I-NP	O
by	by	IN	B-PP	O
The	The	NNP	B-NP	O
American	American	NNP	I-NP	O
Society	Society	NNP	I-NP	O
of	of	IN	B-PP	O
Hematology	Hematology	NNP	B-NP	O
.	.	.	O	O

Antioxidant	Antioxidant	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
phorbol	phorbol	NN	B-NP	O
ester-induced	ester-induced	JJ	I-NP	O
adhesion	adhesion	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
Jurkat	Jurkat	NN	I-NP	I-cell_line
T-cells	T-cell	NNS	I-NP	I-cell_line
to	to	TO	B-PP	O
endothelial	endothelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Regulation	Regulation	NN	B-NP	O
of	of	IN	B-PP	O
adhesion	adhesion	NN	B-NP	B-protein
molecule	molecule	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
function	function	NN	B-NP	O
by	by	IN	B-PP	O
reactive	reactive	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
species	specie	NNS	I-NP	O
via	via	IN	B-PP	O
specific	specific	JJ	B-NP	O
redox	redox	NN	I-NP	O
sensitive	sensitive	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
clinically	clinically	RB	B-NP	O
safe	safe	JJ	I-NP	O
antioxidants	antioxidant	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
adhesion	adhesion	NN	B-NP	B-protein
molecule	molecule	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
endothelial	endothelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
ECV	ECV	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
adherence	adherence	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
Jurkat	Jurkat	NN	I-NP	I-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
to	to	TO	B-PP	O
ECV	ECV	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
thiol	thiol	NN	I-NP	O
antioxidant	antioxidant	NN	I-NP	O
,	,	,	O	O
alpha-lipoate	alpha-lipoate	NN	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
clinically	clinically	RB	B-NP	O
relevant	relevant	JJ	I-NP	O
doses	dose	NNS	I-NP	O
down-regulated	down-regulate	VBD	B-VP	O
phorbol	phorbol	NN	B-NP	O
12-myristate	12-myristate	NN	I-NP	O
13-acetate	13-acetate	NN	I-NP	O
(	(	(	O	O
PMA	PMA	NN	B-NP	O
)	)	)	O	O
-induced	-induced	JJ	B-NP	O
adhesion	adhesion	NN	I-NP	B-protein
molecule	molecule	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
cell-cell	cell-cell	JJ	B-NP	O
adhesion	adhesion	NN	I-NP	O
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
PMA-induced	PMA-induced	JJ	B-NP	O
ICAM-1	ICAM-1	NN	I-NP	B-protein
and	and	CC	I-NP	O
VCAM-1	VCAM-1	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
PMA-induced	PMA-induced	JJ	B-NP	O
adhesion	adhesion	NN	I-NP	O
of	of	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
T-cells	T-cell	NNS	I-NP	I-cell_line
to	to	TO	B-PP	O
ECV	ECV	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
alpha-lipoate	alpha-lipoate	NN	B-NP	O
was	be	VBD	B-VP	O
dose	dose	NN	B-NP	O
dependent	dependent	JJ	B-ADJP	O
(	(	(	O	O
50-250	50-250	CD	B-NP	O
microM	microM	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
ICAM-1	ICAM-1	NN	B-NP	B-protein
(	(	(	O	O
p	p	NN	B-NP	O
<	<	JJR	B-NP	O
.01	.01	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
VCAM-1	VCAM-1	NN	B-NP	B-protein
(	(	(	O	O
p	p	NN	B-NP	O
<	<	JJR	B-NP	O
.01	.01	CD	I-NP	O
)	)	)	O	O
expression	expression	NN	B-NP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
pretreated	pretreate	VBN	B-VP	O
with	with	IN	B-PP	O
100	100	CD	B-NP	O
microM	microM	NN	I-NP	O
alpha-lipoate	alpha-lipoate	NN	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
PMA-activated	PMA-activated	JJ	B-NP	B-cell_type
untreated	untreated	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
PMA-induced	PMA-induced	JJ	B-NP	B-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule	molecule	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
cell-cell	cell-cell	JJ	B-NP	O
adhesion	adhesion	NN	I-NP	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
pronounced	pronounced	JJ	I-ADJP	O
when	when	WRB	B-ADVP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
antioxidants	antioxidant	NNS	B-NP	O
,	,	,	I-NP	O
alpha-lipoate	alpha-lipoate	NN	I-NP	O
and	and	CC	I-NP	O
alpha-tocopherol	alpha-tocopherol	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
either	either	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
antioxidant	antioxidant	NN	I-NP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
adhesion	adhesion	NN	B-NP	B-protein
molecule	molecule	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
function	function	NN	B-NP	O
by	by	IN	B-PP	O
low	low	JJ	B-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
antioxidants	antioxidant	NNS	B-NP	O
investigated	investigate	VBN	B-VP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
appear	appear	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
regulated	regulated	JJ	B-ADJP	O
or	or	CC	O	O
transcription	transcription	NN	B-ADJP	O
dependent	dependent	JJ	I-ADJP	O
because	because	IN	B-SBAR	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mRNA	mRNA	NN	I-NP	B-RNA
response	response	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

Protein	Protein	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
C	C	NN	I-NP	I-protein
(	(	(	O	O
PKC	PKC	NN	B-NP	B-protein
)	)	)	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
suggested	suggest	VBN	I-VP	O
to	to	TO	I-VP	O
regulate	regulate	VB	I-VP	O
PMA-induced	PMA-induced	JJ	B-NP	B-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule	molecule	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
by	by	IN	B-PP	O
post-transcriptional	post-transcriptional	JJ	B-NP	O
stabilization	stabilization	NN	I-NP	O
of	of	IN	B-PP	O
adhesion	adhesion	NN	B-NP	B-RNA
molecule	molecule	NN	I-NP	I-RNA
mRNA	mRNA	NN	I-NP	I-RNA
.	.	.	O	O

Alpha-lipoate	Alpha-lipoate	JJ	B-NP	O
pretreatment	pretreatment	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
influence	influence	VB	I-VP	O
the	the	DT	B-NP	O
response	response	NN	I-NP	O
of	of	IN	B-PP	O
PKC	PKC	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
to	to	TO	B-PP	O
PMA	PMA	NN	B-NP	O
.	.	.	O	O

Oxidants	Oxidant	NNS	B-NP	O
are	be	VBP	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
adhesion	adhesion	NN	I-NP	O
processes	process	NNS	I-NP	O
.	.	.	O	O

Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
ECV	ECV	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
with	with	IN	B-PP	O
PMA	PMA	NN	B-NP	O
induced	induce	VBD	B-VP	O
generation	generation	NN	B-NP	O
of	of	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
oxidants	oxidant	NNS	I-NP	O
.	.	.	O	O

Alpha-lipoate	Alpha-lipoate	NN	B-NP	O
(	(	(	O	O
100	100	CD	B-NP	O
or	or	CC	I-NP	O
250	250	CD	I-NP	O
microM	microM	NN	I-NP	O
)	)	)	O	O
treatment	treatment	NN	B-NP	O
decreased	decrease	VBD	B-VP	O
PMA-induced	PMA-induced	JJ	B-NP	O
generation	generation	NN	I-NP	O
of	of	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
oxidants	oxidant	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
low	low	JJ	B-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
alpha-lipaote	alpha-lipaote	NN	B-NP	O
alone	alone	RB	B-ADVP	O
or	or	CC	O	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
with	with	IN	B-PP	O
alpha-tocopherol	alpha-tocopherol	NN	B-NP	O
on	on	IN	B-PP	O
agonist-induced	agonist-induced	JJ	B-NP	O
adhesion	adhesion	NN	I-NP	O
processes	process	NNS	I-NP	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
of	of	IN	B-PP	O
potential	potential	JJ	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
value	value	NN	I-NP	O
.	.	.	O	O

Binding	Binding	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
CD4	CD4	NN	B-NP	B-protein
and	and	CC	I-NP	O
CXCR4	CXCR4	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
differentially	differentially	RB	B-ADVP	O
regulates	regulate	VBZ	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
and	and	CC	O	O
activates	activate	VBZ	B-VP	O
the	the	DT	B-NP	O
MEK	MEK	NN	I-NP	B-protein
/ERK	/ERK	NN	I-NP	B-protein
signaling	signaling	NN	I-NP	O
pathway	pathway	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
previously	previously	RB	I-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
binding	binding	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
HIV-1	HIV-1	NN	B-NP	O
)	)	)	O	O
virions	virion	NNS	B-NP	O
to	to	TO	B-PP	O
CD4	CD4	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
stimulates	stimulate	VBZ	B-VP	O
association	association	NN	B-NP	O
of	of	IN	B-PP	O
Lck	Lck	NN	B-NP	B-protein
with	with	IN	B-PP	O
Raf-1	Raf-1	NN	B-NP	B-protein
and	and	CC	O	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
Raf-1	Raf-1	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
in	in	IN	B-PP	O
a	a	DT	B-NP	O
Ras-independent	Ras-independent	JJ	I-NP	O
manner	manner	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
HIV-1	HIV-1	NN	B-NP	B-protein
envelope	envelope	NN	I-NP	I-protein
glycoproteins	glycoprotein	NNS	I-NP	I-protein
of	of	IN	B-PP	O
both	both	CC	B-NP	O
T-cell-tropic	T-cell-tropic	JJ	I-NP	O
and	and	CC	I-NP	O
macrophagetropic	macrophagetropic	JJ	I-NP	O
strains	strain	NNS	I-NP	O
rapidly	rapidly	RB	B-ADVP	O
activate	activate	VBP	B-VP	O
the	the	DT	B-NP	O
ERK/mitogen-activated	ERK/mitogen-activated	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	I-protein
MAP	MAP	NN	B-NP	I-protein
)	)	)	O	I-protein
kinase	kinase	NN	B-NP	I-protein
pathway	pathway	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
(	(	(	O	O
AP-1	AP-1	NN	B-NP	B-protein
,	,	,	O	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
C/EBP	C/EBP	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
stimulate	stimulate	VBP	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-protein
and	and	CC	I-NP	O
chemokine	chemokine	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
signaling	signaling	NN	I-NP	O
pathway	pathway	NN	I-NP	O
requires	require	VBZ	B-VP	O
functional	functional	JJ	B-NP	O
CD4	CD4	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
and	and	CC	O	O
is	be	VBZ	B-VP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
CXCR4	CXCR4	NN	B-NP	B-protein
.	.	.	O	O

Binding	Binding	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
natural	natural	JJ	I-NP	B-protein
ligand	ligand	NN	I-NP	I-protein
stromal	stromal	JJ	I-NP	I-protein
cell-derived	cell-derived	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
(	(	(	O	O
SDF-1	SDF-1	NN	B-NP	B-protein
)	)	)	O	O
to	to	TO	B-PP	O
CXCR4	CXCR4	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
inhibits	inhibit	VBZ	B-VP	O
entry	entry	NN	B-NP	O
of	of	IN	B-PP	O
T-cell-tropic	T-cell-tropic	JJ	B-NP	O
HIV-1	HIV-1	NN	I-NP	O
,	,	,	O	O
activates	activate	VBZ	B-VP	O
also	also	RB	B-ADVP	O
the	the	DT	B-NP	O
ERK/	ERK/	NN	I-NP	B-protein
MAP	MAP	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
pathway	pathway	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
SDF-1	SDF-1	NN	B-NP	B-protein
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
CD4-mediated	CD4-mediated	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-protein
and	and	CC	I-NP	O
chemokine	chemokine	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
provide	provide	VBP	B-VP	O
firm	firm	JJ	B-NP	O
molecular	molecular	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
that	that	IN	B-SBAR	O
binding	binding	NN	B-NP	O
of	of	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	B-protein
envelope	envelope	NN	I-NP	I-protein
glycoproteins	glycoprotein	NNS	I-NP	I-protein
to	to	TO	B-PP	O
CD4	CD4	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
initiates	initiate	VBZ	B-VP	O
a	a	DT	B-NP	O
signaling	signaling	NN	I-NP	O
pathway	pathway	NN	I-NP	O
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
chemokine	chemokine	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
that	that	WDT	B-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
aberrant	aberrant	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
and	and	CC	O	O
may	may	MD	B-VP	O
contribute	contribute	VB	I-VP	O
significantly	significantly	RB	B-ADVP	O
to	to	TO	B-PP	O
HIV-1	HIV-1	NN	B-NP	O
replication	replication	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
to	to	TO	B-PP	O
deregulation	deregulation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
immune	immune	JJ	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

Antigen	Antigen	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
signaling	signaling	NN	I-NP	O
induces	induce	VBZ	B-VP	O
MAP	MAP	NN	B-NP	O
kinase-mediated	kinase-mediated	JJ	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
and	and	CC	I-NP	O
degradation	degradation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
BCL-6	BCL-6	NN	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
bcl-6	bcl-6	NN	I-NP	B-DNA
proto-oncogene	proto-oncogene	NN	I-NP	I-DNA
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
POZ/zinc	POZ/zinc	NN	I-NP	B-protein
finger	finger	NN	I-NP	I-protein
transcriptional	transcriptional	JJ	I-NP	I-protein
repressor	repressor	NN	I-NP	I-protein
expressed	express	VBN	B-VP	O
in	in	IN	B-PP	O
germinal	germinal	JJ	B-NP	B-cell_type
center	center	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
GC	GC	NN	B-NP	I-cell_type
)	)	)	O	I-cell_type
B	B	NN	B-NP	I-cell_type
and	and	CC	O	I-cell_type
T	T	NN	B-NP	I-cell_type
cells	cell	NNS	B-NP	I-cell_type
and	and	CC	O	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
GC	GC	NN	B-NP	O
formation	formation	NN	I-NP	O
and	and	CC	O	O
antibody	antibody	NN	B-NP	O
affinity	affinity	NN	I-NP	O
maturation	maturation	NN	I-NP	O
.	.	.	O	O

Deregulation	Deregulation	NN	B-NP	O
of	of	IN	B-PP	O
bcl-6	bcl-6	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
by	by	IN	B-PP	O
chromosomal	chromosomal	JJ	B-NP	O
rearrangements	rearrangement	NNS	I-NP	O
and	and	CC	O	O
point	point	NN	B-NP	O
mutations	mutation	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bcl-6	bcl-6	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
are	be	VBP	B-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
B-cell	B-cell	NN	B-NP	B-cell_type
lymphoma	lymphoma	NN	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
signals	signal	NNS	I-NP	O
regulating	regulate	VBG	B-VP	O
bcl-6	bcl-6	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
known	know	VBN	I-VP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
antigen	antigen	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
BCL-6	BCL-6	NN	B-NP	B-protein
phosphorylation	phosphorylation	NN	I-NP	O
by	by	IN	B-PP	O
mitogen-activated	mitogen-activated	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
MAPK	MAPK	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Phosphorylation	Phosphorylation	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
turn	turn	NN	B-NP	O
,	,	,	O	O
targets	target	VBZ	B-VP	O
BCL-6	BCL-6	NN	B-NP	B-protein
for	for	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
degradation	degradation	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
ubiquitin	ubiquitin	NN	I-NP	B-protein
/	/	SYM	B-NP	O
proteasome	proteasome	NN	I-NP	B-protein
pathway	pathway	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
BCL-6	BCL-6	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
directly	directly	RB	I-VP	O
controlled	control	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
antigen	antigen	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
via	via	IN	B-PP	O
MAPK	MAPK	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
signaling	signaling	NN	I-NP	O
pathway	pathway	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
crucial	crucial	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
B-cell	B-cell	NN	B-NP	B-cell_type
differentiation	differentiation	NN	I-NP	O
and	and	CC	O	O
antibody	antibody	NN	B-NP	O
response	response	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
implications	implication	NNS	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
POZ/zinc	POZ/zinc	NN	I-NP	B-protein
finger	finger	NN	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
other	other	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
.	.	.	O	O

Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
differentially	differentially	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	I-NP	O
tissues	tissue	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
immune	immune	JJ	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

Cytosolic	Cytosolic	JJ	B-NP	B-protein
glucocorticoid	glucocorticoid	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
GR	GR	NN	B-NP	B-protein
)	)	)	O	O
binding	binding	NN	B-NP	O
studies	study	NNS	I-NP	O
on	on	IN	B-PP	O
immune	immune	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
thymus	thymus	NN	I-NP	O
exhibits	exhibit	VBZ	B-VP	O
three	three	CD	B-NP	O
to	to	TO	I-NP	O
four	four	CD	I-NP	O
times	time	NNS	I-NP	O
higher	high	JJR	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
than	than	IN	B-PP	O
the	the	DT	B-NP	O
spleen	spleen	NN	I-NP	O
.	.	.	O	O

High	High	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
are	be	VBP	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
exquisite	exquisite	JJ	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
thymus	thymus	NN	I-NP	O
to	to	TO	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
exposure	exposure	NN	I-NP	O
.	.	.	O	O

Nevertheless	Nevertheless	RB	B-ADVP	O
,	,	,	O	O
whole	whole	JJ	B-NP	O
cell	cell	NN	I-NP	O
binding	binding	NN	I-NP	O
studies	study	NNS	I-NP	O
reveal	reveal	VBP	B-VP	O
similar	similar	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
in	in	IN	B-PP	O
immature	immature	JJ	B-NP	B-cell_type
thymic	thymic	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
more	more	RBR	B-NP	O
mature	mature	JJ	I-NP	O
,	,	,	I-NP	O
splenic	splenic	JJ	I-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
whole	whole	JJ	B-NP	O
cell	cell	NN	I-NP	O
binding	binding	NN	I-NP	O
techniques	technique	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
neutrophils	neutrophil	NNS	B-NP	B-cell_type
(	(	(	O	O
which	which	WDT	B-NP	O
represent	represent	VBP	B-VP	O
roughly	roughly	RB	B-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
splenic	splenic	JJ	B-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
)	)	)	O	O
exhibit	exhibit	VBP	B-VP	O
higher	high	JJR	B-NP	O
GR	GR	NN	I-NP	B-protein
than	than	IN	B-SBAR	O
both	both	CC	O	O
T	T	NN	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
B	B	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
further	further	RB	B-ADVP	O
contradicting	contradict	VBG	B-VP	O
results	result	NNS	B-NP	O
from	from	IN	B-PP	O
cytosolic	cytosolic	JJ	B-NP	O
binding	binding	NN	I-NP	O
studies	study	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
address	address	VB	I-VP	O
these	these	DT	B-NP	O
inconsistencies	inconsistency	NNS	I-NP	O
,	,	,	O	O
GR	GR	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
in	in	IN	B-PP	O
immune	immune	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
tissues	tissue	NNS	B-NP	O
using	use	VBG	B-VP	O
cytosolic	cytosolic	JJ	B-NP	O
radioligand	radioligand	NN	I-NP	O
binding	binding	NN	I-NP	O
.	.	.	O	O

Western	Western	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
immunocytochemistry	immunocytochemistry	NN	B-NP	O
.	.	.	O	O

Consistent	Consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
previous	previous	JJ	B-NP	O
cytosolic	cytosolic	JJ	I-NP	O
receptor	receptor	NN	I-NP	O
binding	binding	NN	I-NP	O
studies	study	NNS	I-NP	O
on	on	IN	B-PP	O
immune	immune	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
homogenates	homogenate	NNS	I-NP	O
,	,	,	O	O
thymic	thymic	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
higher	high	JJR	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
than	than	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
spleen	spleen	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
neutrophils	neutrophil	NNS	B-NP	B-cell_type
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
fewer	few	JJR	B-NP	O
GR	GR	NN	I-NP	B-protein
than	than	IN	B-SBAR	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
and	and	CC	I-NP	O
monocytes	monocyte	NNS	I-NP	B-cell_type
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
a	a	DT	B-NP	O
meaningful	meaningful	JJ	I-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
receptor	receptor	NN	B-NP	O
expression	expression	NN	I-NP	O
and	and	CC	O	O
known	know	VBN	B-VP	O
sensitivity	sensitivity	NN	B-NP	O
to	to	TO	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
.	.	.	O	O

Functional	Functional	JJ	B-NP	O
replacement	replacement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	B-DNA
E2A	E2A	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
with	with	IN	B-PP	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
HEB	HEB	NN	I-NP	I-DNA
cDNA	cDNA	NN	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
mammalian	mammalian	JJ	I-NP	O
E2A	E2A	NN	I-NP	B-protein
,	,	,	O	O
HEB	HEB	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
E2-2	E2-2	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
encode	encode	VBP	B-VP	O
a	a	DT	B-NP	O
unique	unique	JJ	I-NP	O
class	class	NN	I-NP	O
of	of	IN	B-PP	O
basic	basic	JJ	B-NP	B-protein
helix-loop-helix	helix-loop-helix	JJ	I-NP	I-protein
(	(	(	O	I-protein
bHLH	bHLH	JJ	B-ADJP	I-protein
)	)	)	O	I-protein
transcription	transcription	NN	B-NP	I-protein
factors	factor	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
evolutionarily	evolutionarily	RB	I-VP	O
conserved	conserve	VBN	I-VP	O
and	and	CC	O	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
embryonic	embryonic	JJ	B-NP	O
and	and	CC	I-NP	O
postnatal	postnatal	JJ	I-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
the	the	DT	B-NP	O
structural	structural	JJ	I-NP	O
and	and	CC	I-NP	O
functional	functional	JJ	I-NP	O
similarities	similarity	NNS	I-NP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	B-protein
products	product	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
well	well	RB	I-VP	O
demonstrated	demonstrate	VBN	I-VP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
clear	clear	JJ	B-ADJP	O
why	why	WRB	B-ADVP	O
deletion	deletion	NN	B-NP	O
of	of	IN	B-PP	O
E2A	E2A	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
HEB	HEB	NN	B-NP	B-protein
or	or	CC	I-NP	O
E2-2	E2-2	NN	I-NP	B-protein
,	,	,	O	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
complete	complete	JJ	I-NP	O
arrest	arrest	NN	I-NP	O
in	in	IN	B-PP	O
B-lymphocyte	B-lymphocyte	NN	B-NP	B-cell_type
development	development	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
understand	understand	VB	I-VP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	O
specificity	specificity	NN	I-NP	O
between	between	IN	B-PP	O
E2A	E2A	NN	B-NP	B-protein
and	and	CC	I-NP	O
HEB	HEB	NN	I-NP	B-protein
/	/	SYM	B-NP	O
E2-2	E2-2	NN	I-NP	B-protein
in	in	IN	B-PP	O
mammalian	mammalian	JJ	B-NP	O
development	development	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
generated	generate	VBD	B-VP	O
and	and	CC	I-VP	O
tested	test	VBD	I-VP	O
a	a	DT	B-NP	O
panel	panel	NN	I-NP	O
of	of	IN	B-PP	O
E2A	E2A	NN	B-NP	B-protein
knockin	knockin	NN	I-NP	O
mutations	mutation	NNS	I-NP	O
including	include	VBG	B-PP	O
subtle	subtle	JJ	B-NP	O
mutations	mutation	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
E12	E12	NN	I-NP	B-protein
and	and	CC	I-NP	O
E47	E47	NN	I-NP	B-DNA
exons	exon	NNS	I-NP	I-DNA
and	and	CC	O	O
substitution	substitution	NN	B-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
E12	E12	NN	B-NP	B-protein
and	and	CC	O	O
E47	E47	NN	B-NP	B-protein
exons	exon	NNS	I-NP	I-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
HEB	HEB	NN	I-NP	I-DNA
cDNA	cDNA	NN	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
find	find	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
alternatively	alternatively	RB	I-NP	O
spliced	splice	VBN	I-NP	O
E12	E12	NN	I-NP	B-protein
and	and	CC	I-NP	O
E47	E47	NN	I-NP	B-protein
bHLH	bHLH	JJ	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
E2A	E2A	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
play	play	VBP	B-VP	O
similar	similar	JJ	B-NP	O
and	and	CC	I-NP	O
additive	additive	JJ	I-NP	O
roles	role	NNS	I-NP	O
in	in	IN	B-PP	O
supporting	support	VBG	B-VP	O
B	B	NN	B-NP	O
lymphopoiesis	lymphopoiesis	NN	I-NP	O
.	.	.	O	O

Further	Further	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
find	find	VBP	B-VP	O
that	that	IN	B-SBAR	O
HEB	HEB	NN	B-NP	B-protein
driven	drive	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
endogenous	endogenous	JJ	I-NP	B-DNA
E2A	E2A	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
can	can	MD	B-VP	O
functionally	functionally	RB	I-VP	O
replace	replace	VB	I-VP	O
E2A	E2A	NN	B-NP	B-protein
in	in	IN	B-PP	O
supporting	support	VBG	B-VP	O
B-cell	B-cell	NN	B-NP	O
commitment	commitment	NN	I-NP	O
and	and	CC	O	O
differentiation	differentiation	NN	B-NP	O
toward	toward	IN	B-PP	O
completion	completion	NN	B-NP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
postnatal	postnatal	JJ	I-NP	O
lethality	lethality	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
E2A	E2A	NN	B-NP	B-protein
disruption	disruption	NN	I-NP	O
is	be	VBZ	B-VP	O
fully	fully	RB	I-VP	O
rescued	rescue	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
HEB	HEB	NN	B-NP	B-protein
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	O
divergence	divergence	NN	I-NP	O
among	among	IN	B-PP	O
E12	E12	NN	B-NP	B-protein
,	,	,	O	O
E47	E47	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
HEB	HEB	NN	B-NP	B-protein
in	in	IN	B-PP	O
different	different	JJ	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
is	be	VBZ	B-VP	O
partially	partially	RB	I-VP	O
defined	define	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O

Biased	Bias	VBN	B-NP	O
dependency	dependency	NN	I-NP	O
of	of	IN	B-PP	O
CD80	CD80	NN	B-NP	B-protein
versus	versus	CC	I-NP	O
CD86	CD86	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
regulating	regulate	VBG	B-VP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
IL-2	IL-2	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
signals	signal	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
by	by	IN	B-PP	O
ligation	ligation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TCR	TCR	NN	I-NP	B-protein
,	,	,	O	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
need	need	VBP	B-VP	O
additional	additional	JJ	B-NP	O
,	,	,	I-NP	O
co-stimulatory	co-stimulatory	JJ	I-NP	O
signals	signal	NNS	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
activated	activate	VBN	I-VP	O
.	.	.	O	O

One	One	CD	B-NP	O
such	such	JJ	I-NP	O
co-stimulatory	co-stimulatory	JJ	I-NP	O
signal	signal	NN	I-NP	O
is	be	VBZ	B-VP	O
delivered	deliver	VBN	I-VP	O
when	when	WRB	B-ADVP	O
CD28	CD28	NN	B-NP	B-protein
on	on	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
CD80	CD80	NN	B-NP	B-protein
or	or	CC	I-NP	O
CD86	CD86	NN	I-NP	B-protein
on	on	IN	B-PP	O
antigen-presenting	antigen-presenting	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
APC	APC	NN	B-NP	B-cell_type
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
analyzed	analyze	VBD	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
CD80	CD80	NN	B-NP	B-protein
and	and	CC	I-NP	O
CD86	CD86	NN	I-NP	B-protein
to	to	TO	B-VP	O
co-stimulate	co-stimulate	VB	I-VP	O
human	human	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
activated	activate	VBN	B-VP	O
by	by	IN	B-PP	O
superantigen	superantigen	NN	B-NP	B-protein
.	.	.	O	O

Using	Use	VBG	B-VP	O
the	the	DT	B-NP	O
Raji	Raji	NN	I-NP	O
B	B	NN	I-NP	O
cell	cell	NN	I-NP	O
lymphoma	lymphoma	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
express	express	VBP	B-VP	O
similar	similar	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
CD80	CD80	NN	B-NP	B-protein
and	and	CC	I-NP	O
CD86	CD86	NN	I-NP	B-protein
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
T	T	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
proliferation	proliferation	NN	I-NP	O
was	be	VBD	B-VP	O
mainly	mainly	RB	I-VP	O
co-stimulated	co-stimulate	VBN	I-VP	O
by	by	IN	B-PP	O
CD80	CD80	NN	B-NP	B-protein
.	.	.	O	O

To	To	TO	B-VP	O
further	further	RB	I-VP	O
characterize	characterize	VB	I-VP	O
the	the	DT	B-NP	O
consequences	consequence	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
biased	biased	JJ	I-NP	O
co-stimulatory	co-stimulatory	JJ	I-NP	O
dependency	dependency	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
employed	employ	VBD	B-VP	O
a	a	DT	B-NP	O
well-defined	well-defined	JJ	I-NP	O
system	system	NN	I-NP	O
of	of	IN	B-PP	O
transfected	transfecte	VBN	B-NP	B-cell_line
CHO	CHO	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
expressing	express	VBG	B-VP	O
human	human	JJ	B-NP	B-protein
MHC	MHC	NN	I-NP	I-protein
class	class	NN	I-NP	I-protein
II	II	CD	I-NP	I-protein
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
CD80	CD80	NN	B-NP	B-protein
,	,	,	I-NP	O
CD86	CD86	NN	I-NP	B-protein
or	or	CC	I-NP	O
CD80	CD80	NN	I-NP	B-protein
and	and	CC	I-NP	O
CD86	CD86	NN	I-NP	B-protein
.	.	.	O	O

Proliferation	Proliferation	NN	B-NP	O
of	of	IN	B-PP	O
freshly	freshly	RB	B-NP	O
prepared	prepare	VBN	I-NP	O
CD4+	CD4+	JJ	I-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
required	require	VBD	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
either	either	CC	O	O
CD80	CD80	NN	B-NP	B-protein
or	or	CC	I-NP	O
CD86	CD86	NN	I-NP	B-protein
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
IL-2	IL-2	NN	B-NP	B-protein
production	production	NN	I-NP	O
reached	reach	VBD	B-VP	O
only	only	RB	B-NP	O
suboptimal	suboptimal	JJ	I-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	I-PP	O
presence	presence	NN	I-PP	O
of	of	IN	I-PP	O
CD86	CD86	NN	B-NP	B-protein
but	but	CC	O	O
optimal	optimal	JJ	B-NP	O
levels	level	NNS	I-NP	O
with	with	IN	B-PP	O
CD80	CD80	NN	B-NP	B-protein
.	.	.	O	O

To	To	TO	B-VP	O
analyze	analyze	VB	I-VP	O
IL-2	IL-2	NN	B-NP	B-protein
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
CD80	CD80	NN	B-NP	B-protein
and	and	CC	O	O
CD86	CD86	NN	B-NP	B-protein
co-stimulated	co-stimulated	JJ	I-NP	O
T	T	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
we	we	PRP	B-NP	O
used	use	VBD	B-VP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
transfected	transfecte	VBN	B-VP	O
with	with	IN	B-PP	O
luciferase	luciferase	NN	B-NP	B-DNA
reporter	reporter	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
constructs	construct	NNS	I-NP	I-DNA
.	.	.	O	O

CD80	CD80	NN	B-NP	B-protein
induced	induce	VBD	B-VP	O
higher	high	JJR	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
-enhancer	-enhancer	NN	I-NP	I-DNA
activity	activity	NN	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
CD86	CD86	NN	B-NP	B-protein
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
regulating	regulate	VBG	B-VP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter-enhancer	promoter-enhancer	JJ	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
including	include	VBG	B-PP	O
activation	activation	NN	B-NP	O
protein-1	protein-1	NN	I-NP	O
,	,	,	O	O
CD28	CD28	NN	B-NP	B-DNA
response	response	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
kappaB	kappaB	NN	I-NP	I-protein
were	be	VBD	B-VP	O
4-8	4-8	CD	B-ADJP	O
times	time	NNS	I-ADJP	O
higher	high	JJR	I-ADJP	O
after	after	IN	B-PP	O
CD80	CD80	NN	B-NP	B-protein
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
CD86	CD86	NN	B-NP	B-protein
ligation	ligation	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
eventual	eventual	JJ	I-NP	O
appearance	appearance	NN	I-NP	O
of	of	IN	B-PP	O
CD80	CD80	NN	B-NP	B-protein
on	on	IN	B-PP	O
recently	recently	RB	B-NP	O
activated	activate	VBN	I-NP	O
CD86+	CD86+	JJ	I-NP	O
APC	APC	NN	I-NP	O
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
superinduction	superinduction	NN	I-NP	O
of	of	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
production	production	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
support	support	VB	I-VP	O
vigorous	vigorous	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
proliferation	proliferation	NN	I-NP	O
.	.	.	O	O

Duplication	Duplication	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
DR3	DR3	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
on	on	IN	B-PP	O
human	human	JJ	B-NP	B-DNA
chromosome	chromosome	NN	I-NP	I-DNA
1p36	1p36	NN	I-NP	I-DNA
and	and	CC	O	O
its	its	PRP$	B-NP	O
deletion	deletion	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
neuroblastoma	neuroblastoma	NN	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
DR3	DR3	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
,	,	,	O	O
whose	whose	WP$	B-NP	O
product	product	NN	I-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
known	know	VBN	I-VP	O
as	as	IN	B-PP	O
Wsl-1/APO-3/TRAMP/LARD	Wsl-1/APO-3/TRAMP/LARD	NN	B-NP	O
,	,	,	O	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
tumor	tumor	NN	I-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor-related	factor-related	JJ	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
primarily	primarily	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
surface	surface	NN	I-NP	O
of	of	IN	B-PP	O
thymocytes	thymocyte	NNS	B-NP	B-cell_type
and	and	CC	I-NP	O
lymphocytes	lymphocyte	NNS	I-NP	B-cell_type
.	.	.	O	O

DR3	DR3	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
inducing	induce	VBG	B-VP	O
both	both	CC	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
activation	activation	NN	B-NP	O
and	and	CC	O	O
apoptosis	apoptosis	NN	B-NP	O
when	when	WRB	B-ADVP	O
overexpressed	overexpresse	VBN	B-VP	O
in	in	IN	B-PP	O
mammalian	mammalian	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
although	although	IN	B-SBAR	O
its	its	PRP$	B-NP	O
ligand	ligand	NN	I-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
yet	yet	RB	I-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
here	here	RB	B-ADVP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
DR3	DR3	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
locus	locus	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
tandemly	tandemly	RB	I-VP	O
duplicated	duplicate	VBN	I-VP	O
on	on	IN	B-PP	O
human	human	JJ	B-NP	O
chromosome	chromosome	NN	I-NP	O
band	band	NN	I-NP	O
1p36.2-p36.3	1p36.2-p36.3	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
genes	gene	NNS	I-NP	O
are	be	VBP	B-VP	O
hemizygously	hemizygously	RB	I-VP	O
deleted	delete	VBN	I-VP	O
and/or	and/or	CC	O	O
translocated	translocate	VBN	B-VP	O
to	to	TO	B-PP	O
another	another	DT	B-NP	O
chromosome	chromosome	NN	I-NP	B-DNA
in	in	IN	B-PP	O
neuroblastoma	neuroblastoma	NN	B-NP	B-cell_line
(	(	(	O	I-cell_line
NB	NB	NN	B-NP	I-cell_line
)	)	)	O	I-cell_line
cell	cell	NN	B-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
with	with	IN	B-PP	O
amplified	amplify	VBN	B-NP	O
MYCN	MYCN	NN	I-NP	B-protein
.	.	.	O	O

Duplication	Duplication	NN	B-NP	O
of	of	IN	B-PP	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
a	a	DT	B-NP	O
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
DR3	DR3	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
,	,	,	O	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
extracellular	extracellular	JJ	I-NP	O
and	and	CC	I-NP	O
transmembrane	transmembrane	NN	I-NP	B-protein
regions	region	NNS	I-NP	I-protein
but	but	CC	B-NP	O
not	not	RB	I-NP	O
the	the	DT	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
,	,	,	O	O
was	be	VBD	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
by	by	IN	B-PP	O
both	both	CC	O	O
fluorescence	fluorescence	NN	B-NP	O
in	in	FW	B-NP	O
situ	situ	FW	I-NP	O
hybridization	hybridization	NN	I-NP	O
and	and	CC	O	O
genomic	genomic	JJ	B-NP	O
Southern	Southern	JJ	I-NP	O
blotting	blotting	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
most	most	JJS	B-NP	O
NB	NB	NN	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
both	both	CC	O	O
the	the	DT	B-NP	O
DR3	DR3	NN	I-NP	B-protein
and	and	CC	O	O
the	the	DT	B-NP	O
DR3L	DR3L	NN	I-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
are	be	VBP	B-VP	O
simultaneously	simultaneously	RB	I-VP	O
deleted	delete	VBN	I-VP	O
and/or	and/or	CC	O	O
translocated	translocate	VBN	B-VP	O
to	to	TO	B-PP	O
another	another	DT	B-NP	O
chromosome	chromosome	NN	I-NP	B-DNA
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
DR3/	DR3/	NN	B-NP	O
Wsl-1	Wsl-1	NN	I-NP	O
protein	protein	NN	I-NP	O
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
quite	quite	RB	B-ADJP	O
variable	variable	JJ	I-ADJP	O
among	among	IN	B-PP	O
these	these	DT	B-NP	O
NB	NB	NN	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
with	with	IN	B-PP	O
very	very	RB	B-NP	O
low	low	JJ	I-NP	O
or	or	CC	I-NP	O
undetectable	undetectable	JJ	I-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
7	7	CD	B-NP	O
of	of	IN	B-PP	O
17	17	CD	B-NP	O
NB	NB	NN	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line

Differential	Differential	JJ	B-NP	O
protection	protection	NN	I-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
and	and	CC	I-NP	O
malignant	malignant	JJ	I-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
myeloid	myeloid	JJ	I-NP	I-cell_type
progenitors	progenitor	NNS	I-NP	I-cell_type
(	(	(	O	O
CFU-GM	CFU-GM	NN	B-NP	B-protein
)	)	)	O	O
from	from	IN	B-PP	O
Ara-C	Ara-C	NN	B-NP	O
toxicity	toxicity	NN	I-NP	O
using	use	VBG	B-VP	O
cycloheximide	cycloheximide	NN	B-NP	O
.	.	.	O	O

Cycloheximide	Cycloheximide	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
reversible	reversible	JJ	I-NP	O
protein	protein	NN	I-NP	O
synthesis	synthesis	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
block	block	VB	I-VP	O
DNA	DNA	NN	B-NP	O
replication	replication	NN	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
preventing	prevent	VBG	B-VP	O
synthesis	synthesis	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
labile	labile	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
animal	animal	NN	B-NP	O
systems	system	NNS	I-NP	O
,	,	,	O	O
cycloheximide	cycloheximide	NN	B-NP	O
protects	protect	VBZ	B-VP	O
normal	normal	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
cytotoxic	cytotoxic	JJ	B-NP	O
S-phase	S-phase	NN	I-NP	O
specific	specific	JJ	I-NP	O
agents	agent	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
cytosine	cytosine	NN	B-NP	O
arabinoside	arabinoside	NN	I-NP	O
(	(	(	O	O
Ara-C	Ara-C	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Malignant	Malignant	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
appear	appear	VBP	B-VP	O
not	not	RB	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
susceptible	susceptible	JJ	B-ADJP	O
to	to	TO	B-PP	O
cycloheximide-induced	cycloheximide-induced	JJ	B-NP	O
cycle	cycle	NN	I-NP	O
arrest	arrest	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
subsequently	subsequently	RB	B-ADVP	O
,	,	,	O	O
may	may	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
protected	protect	VBN	I-VP	O
from	from	IN	B-PP	O
Ara-C	Ara-C	NN	B-NP	O
cytotoxicity	cytotoxicity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
cycloheximide	cycloheximide	NN	B-NP	O
on	on	IN	B-PP	O
granulocyte/macrophage	granulocyte/macrophage	JJ	B-NP	B-cell_type
progenitors	progenitor	NNS	I-NP	I-cell_type
(	(	(	O	O
CFU-GM	CFU-GM	NN	B-NP	B-protein
)	)	)	O	O
after	after	IN	B-PP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
Ara-C	Ara-C	NN	I-NP	O
exposure	exposure	NN	I-NP	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
using	use	VBG	B-VP	O
normal	normal	JJ	B-NP	O
human	human	JJ	I-NP	O
bone	bone	NN	I-NP	O
marrow	marrow	NN	I-NP	O
,	,	,	O	O
malignant	malignant	JJ	B-NP	B-cell_type
progenitors	progenitor	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
myelogenous	myelogenous	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
CML	CML	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
clonogenic	clonogenic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-cell_line
acute	acute	JJ	I-NP	I-cell_line
nonlymphocytic	nonlymphocytic	JJ	I-NP	I-cell_line
leukemia	leukemia	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
HL-60	HL-60	NN	B-NP	B-cell_line
and	and	CC	O	O
KG-1	KG-1	NN	B-NP	B-cell_line
.	.	.	O	O

Mononuclear	Mononuclear	JJ	B-NP	B-cell_type
or	or	CC	I-NP	I-cell_type
clonogenic	clonogenic	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
incubated	incubate	VBN	I-VP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
hour	hour	NN	I-NP	O
with	with	IN	B-PP	O
cycloheximide	cycloheximide	NN	B-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
or	or	CC	I-NP	O
17	17	CD	I-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
Ara-C	Ara-C	NN	B-NP	O
before	before	IN	B-PP	O
being	be	VBG	B-VP	O
plated	plat	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
methylcellulose	methylcellulose	NN	I-NP	O
culture	culture	NN	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

CFU-GM	CFU-GM	NN	B-NP	O
survival	survival	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
increase	increase	VB	I-VP	O
if	if	IN	B-SBAR	O
normal	normal	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
cycloheximide	cycloheximide	NN	B-NP	O
before	before	IN	B-PP	O
Ara-C	Ara-C	NN	B-NP	O
exposure	exposure	NN	I-NP	O
.	.	.	O	O

Similar	Similar	JJ	B-NP	O
cycloheximide	cycloheximide	NN	I-NP	O
pretreatment	pretreatment	NN	I-NP	O
of	of	IN	B-PP	O
CML	CML	NN	B-NP	B-cell_type
progenitors	progenitor	NNS	I-NP	I-cell_type
and	and	CC	O	O
clonogenic	clonogenic	JJ	B-NP	O
HL-60	HL-60	NN	I-NP	O
and	and	CC	I-NP	O
KG-1	KG-1	NN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
protect	protect	VB	I-VP	O
CFU-GM	CFU-GM	NN	B-NP	B-protein
from	from	IN	B-PP	O
Ara-C-induced	Ara-C-induced	JJ	B-NP	O
cytotoxicity	cytotoxicity	NN	I-NP	O
.	.	.	O	O

Primary	Primary	JJ	B-NP	O
cortisol	cortisol	NN	I-NP	O
resistance	resistance	NN	I-NP	O
accompanied	accompany	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
two	two	CD	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
family	family	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
report	report	NN	I-NP	O
describes	describe	VBZ	B-VP	O
studies	study	NNS	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
man	man	NN	I-NP	O
suspected	suspect	VBN	B-VP	O
of	of	IN	B-PP	O
having	have	VBG	B-VP	O
primary	primary	JJ	B-NP	O
cortisol	cortisol	NN	I-NP	O
resistance	resistance	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
conclusion	conclusion	NN	I-NP	O
is	be	VBZ	B-VP	O
based	base	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
high	high	JJ	I-NP	O
plasma	plasma	NN	I-NP	O
cortisol	cortisol	NN	I-NP	O
levels	level	NNS	I-NP	O
and	and	CC	O	O
high	high	JJ	B-NP	O
24-h	24-h	JJ	I-NP	O
urinary	urinary	JJ	I-NP	O
17-hydroxycorticosteroid	17-hydroxycorticosteroid	NN	I-NP	O
and	and	CC	O	O
cortisol	cortisol	NN	B-NP	O
excretion	excretion	NN	I-NP	O
,	,	,	O	O
plus	plus	CC	O	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
manifestations	manifestation	NNS	I-NP	O
of	of	IN	B-PP	O
Cushing	Cushing	NNP	B-NP	O
's	's	POS	B-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

Among	Among	IN	B-PP	O
family	family	NN	B-NP	O
members	member	NNS	I-NP	O
tested	test	VBN	B-VP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
mother	mother	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
hypercortisolemia	hypercortisolemia	NN	B-NP	O
.	.	.	O	O

Both	Both	CC	O	O
mother	mother	NN	B-NP	O
and	and	CC	I-NP	O
son	son	NN	I-NP	O
had	have	VBD	B-VP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
unbound	unbound	JJ	B-NP	O
plasma	plasma	NN	I-NP	O
cortisol	cortisol	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
their	their	PRP$	B-NP	O
plasma	plasma	NN	I-NP	O
ACTH	ACTH	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

Both	Both	DT	B-NP	O
were	be	VBD	B-VP	O
partially	partially	RB	B-ADJP	O
resistant	resistant	JJ	I-ADJP	O
to	to	TO	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
adrenal	adrenal	JJ	I-NP	O
suppression	suppression	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
both	both	DT	B-NP	O
had	have	VBD	B-VP	O
mild	mild	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
without	without	IN	B-PP	O
hypokalemia	hypokalemia	NN	B-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
study	study	VB	I-VP	O
this	this	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
end-organ	end-organ	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
cortisol	cortisol	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Using	Use	VBG	B-VP	O
whole	whole	JJ	B-NP	O
cell	cell	NN	I-NP	O
assays	assay	NNS	I-NP	O
,	,	,	O	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
both	both	DT	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
reduced	reduce	VBN	I-VP	O
total	total	JJ	B-NP	O
binding	binding	NN	I-NP	O
capacity	capacity	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
family	family	NN	I-NP	O
,	,	,	O	O
have	have	VBP	B-VP	O
primary	primary	JJ	B-NP	O
cortisol	cortisol	NN	I-NP	O
resistance	resistance	NN	I-NP	O
accompanied	accompany	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
reduced	reduce	VBN	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
.	.	.	O	O

[	[	(	O	O
Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
and	and	CC	O	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
polychemotherapy	polychemotherapy	NN	B-NP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
lymphatic	lymphatic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
]	]	)	O	O

Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
GR	GR	NN	B-NP	B-protein
)	)	)	O	O
levels	level	NNS	B-NP	O
were	be	VBD	B-VP	O
quantified	quantify	VBN	I-VP	O
in	in	IN	B-PP	O
leukemic	leukemic	JJ	B-NP	B-cell_type
blasts	blast	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
blood	blood	NN	I-NP	O
of	of	IN	B-PP	O
86	86	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
lymphoblastic	lymphoblastic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
subsequent	subsequent	JJ	I-NP	O
achievement	achievement	NN	I-NP	O
of	of	IN	B-PP	O
complete	complete	JJ	B-NP	O
remission	remission	NN	I-NP	O
after	after	IN	B-PP	O
combination	combination	NN	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
was	be	VBD	B-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
receptor	receptor	NN	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

Forty-seven	Forty-seven	CD	B-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
leukemic	leukemic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
containing	contain	VBG	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
6	6	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
receptor	receptor	NN	I-NP	O
sites	site	NNS	I-NP	O
and	and	CC	O	O
22	22	CD	B-NP	O
of	of	IN	B-PP	O
36	36	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
cells	cell	NNS	B-NP	O
containing	contain	VBG	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
6	6	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
receptor	receptor	NN	I-NP	O
sites	site	NNS	I-NP	O
achieved	achieve	VBD	B-VP	O
remission	remission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
leukemic	leukemic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
may	may	MD	B-VP	O
predict	predict	VB	I-VP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
combination	combination	NN	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
lymphoblastic	lymphoblastic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
.	.	.	O	O

Specific	Specific	JJ	B-NP	O
uptake	uptake	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
25-dihydroxycholecalciferol	25-dihydroxycholecalciferol	NN	B-NP	O
by	by	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
chronic	chronic	JJ	I-NP	I-cell_type
myeloid	myeloid	JJ	I-NP	I-cell_type
leukemia	leukemia	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
examined	examine	VBN	I-VP	O
mononuclear	mononuclear	JJ	B-NP	O
cell	cell	NN	I-NP	O
preparations	preparation	NNS	I-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
myeloid	myeloid	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
[	[	(	O	O
CML	CML	NN	B-NP	O
]	]	)	O	O
for	for	IN	B-PP	O
binding	binding	NN	B-NP	O
of	of	IN	B-PP	O
and	and	CC	O	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
25-dihydroxycholecalciferol	25-dihydroxycholecalciferol	NN	B-NP	O
[	[	(	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
25-	25-	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
]	]	)	O	O
.	.	.	O	O

Whole	Whole	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
specifically	specifically	RB	B-ADVP	O
took	take	VBD	B-VP	O
up	up	RP	B-PRT	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	O	O
-1	-1	CD	B-NP	O
,	,	,	O	O
25-	25-	CD	B-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
(	(	(	O	O
Kd	Kd	NN	B-NP	O
3.6	3.6	CD	I-NP	O
X	X	SYM	B-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
-11	-11	CD	B-NP	O
)	)	)	O	O
M	M	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
low	low	JJ	B-NP	O
capacity	capacity	NN	I-NP	O
.	.	.	O	O

Subcellular	Subcellular	JJ	B-NP	O
fractionation	fractionation	NN	I-NP	O
of	of	IN	B-PP	O
labeled	label	VBN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
binding	binding	NN	B-NP	O
was	be	VBD	B-VP	O
restricted	restricted	JJ	B-ADJP	O
to	to	TO	B-PP	O
cytosols	cytosol	NNS	B-NP	O
and	and	CC	I-NP	O
nuclei	nucleus	NNS	I-NP	O
.	.	.	O	O

Sucrose	Sucrose	NN	B-NP	O
gradient	gradient	NN	I-NP	O
centrifugation	centrifugation	NN	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
preincubated	preincubate	VBN	B-VP	O
with	with	IN	B-PP	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	O	O
-1	-1	CD	B-NP	O
,	,	,	O	O
25-	25-	CD	B-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
3.6S	3.6S	NN	I-NP	O
peak	peak	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
totally	totally	RB	I-VP	O
displaced	displace	VBN	I-VP	O
with	with	IN	B-PP	O
100-fold	100-fold	JJ	B-NP	O
excess	excess	JJ	I-NP	O
nonradioactive	nonradioactive	JJ	I-NP	O
hormone	hormone	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
were	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
demonstrate	demonstrate	VB	I-VP	O
specific	specific	JJ	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25-	25-	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
by	by	IN	B-PP	O
postlabeling	postlabele	VBG	B-VP	O
standard	standard	JJ	B-NP	O
cytosol	cytosol	NN	I-NP	O
preparations	preparation	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
cytosols	cytosol	NNS	B-NP	O
prepared	prepare	VBN	B-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
mixture	mixture	NN	I-NP	O
of	of	IN	B-PP	O
CML	CML	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25-	25-	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
receptor-positive	receptor-positive	JJ	I-NP	O
T47D	T47D	NN	I-NP	O
(	(	(	O	O
human	human	JJ	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
)	)	)	I-NP	O
cells	cell	NNS	I-NP	O
had	have	VBD	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
10	10	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
measured	measure	VBN	B-VP	O
in	in	IN	B-PP	O
T47D	T47D	NN	B-NP	O
cytosol	cytosol	NN	I-NP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
binding	binding	NN	B-NP	O
in	in	IN	B-PP	O
T47D	T47D	NN	B-NP	O
cytosols	cytosol	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
receptors	receptor	NNS	I-NP	O
were	be	VBD	B-VP	O
occupied	occupy	VBN	I-VP	O
with	with	IN	B-PP	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	O	O
-1	-1	CD	B-NP	O
,	,	,	O	O
25-	25-	CD	B-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CML	CML	NN	I-NP	O
cytosols	cytosol	NNS	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
CML	CML	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
contain	contain	VB	I-VP	O
both	both	CC	O	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25-	25-	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
unknown	unknown	JJ	I-NP	O
substance	substance	NN	I-NP	O
which	which	WDT	B-NP	O
prevents	prevent	VBZ	B-VP	O
its	its	PRP$	B-NP	O
detection	detection	NN	I-NP	O
following	follow	VBG	B-PP	O
the	the	DT	B-NP	O
preparation	preparation	NN	I-NP	O
of	of	IN	B-PP	O
cytosol	cytosol	NN	B-NP	O
.	.	.	O	O

Cells	Cell	NNS	B-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
CML	CML	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
phase	phase	NN	I-NP	O
specifically	specifically	RB	B-ADVP	O
bound	bind	VBD	B-VP	O
more	more	RBR	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
25-	25-	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
[	[	(	O	O
18.0	18.0	CD	B-NP	O
+/-	+/-	CC	I-NP	O
3.2	3.2	CD	I-NP	O
(	(	(	O	O
S.E.	S.E.	NN	B-NP	O
)	)	)	O	O
fmol/10	fmol/10	NN	B-NP	O
(	(	(	O	O
7	7	CD	B-NP	O
)	)	)	O	O
cells	cell	NNS	B-NP	O
]	]	)	O	O
than	than	IN	B-SBAR	O
did	do	VBD	O	O
those	those	DT	B-NP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
myeloid	myeloid	JJ	I-NP	O
transformation	transformation	NN	I-NP	O
[	[	(	O	O
7.2	7.2	CD	B-NP	O
+/-	+/-	CC	I-NP	O
1.5	1.5	CD	I-NP	O
]	]	)	O	O
or	or	CC	O	O
than	than	IN	B-SBAR	O
did	do	VBD	O	O
cells	cell	NNS	B-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
myeloid	myeloid	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
[	[	(	O	O
2.6	2.6	CD	B-NP	O
+/-	+/-	CC	I-NP	O
0.8	0.8	CD	I-NP	O
]	]	)	O	O
.	.	.	O	O

Only	Only	RB	B-NP	O
cells	cell	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
responded	respond	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25-	25-	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
by	by	IN	B-PP	O
differentiating	differentiate	VBG	B-VP	O
along	along	IN	B-PP	O
the	the	DT	B-NP	O
monocyte-macrophage	monocyte-macrophage	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
differentiation-induction	differentiation-induction	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25-	25-	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
depend	depend	VB	I-VP	O
on	on	IN	B-PP	O
adequate	adequate	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
receptor	receptor	NN	B-NP	B-protein
and	and	CC	O	O
that	that	IN	B-SBAR	O
intact	intact	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
rather	rather	RB	B-PP	O
than	than	IN	I-PP	O
cytosol	cytosol	NN	B-NP	O
preparations	preparation	NNS	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
studied	study	VBN	I-VP	O
before	before	IN	B-PP	O
cells	cell	NNS	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
particular	particular	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
are	be	VBP	B-VP	O
designated	designate	VBN	I-VP	O
as	as	IN	B-PP	O
receptor	receptor	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
position	position	NN	I-NP	O
on	on	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
binding	binding	NN	I-NP	O
by	by	IN	B-PP	O
mouse	mouse	NN	B-NP	B-cell_line
and	and	CC	O	I-cell_line
human	human	JJ	B-NP	I-cell_line
lymphoid	lymphoid	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
:	:	:	O	O
correlation	correlation	NN	B-NP	O
between	between	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
binding	binding	NN	I-NP	O
during	during	IN	B-PP	O
S	S	NN	B-NP	O
phase	phase	NN	I-NP	O
and	and	CC	O	O
dexamethasone	dexamethasone	NN	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
determined	determine	VBD	B-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
position	position	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
specifically	specifically	RB	I-VP	O
bound	bind	VBN	I-VP	O
by	by	IN	B-PP	O
mouse	mouse	NN	B-NP	O
and	and	CC	O	O
human	human	JJ	B-NP	B-cell_line
lymphoid	lymphoid	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
.	.	.	O	O

Cell	Cell	NN	B-NP	B-cell_line
lines	line	NNS	I-NP	I-cell_line
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
either	either	CC	O	O
sensitive	sensitive	JJ	B-ADJP	O
or	or	CC	I-ADJP	O
resistant	resistant	JJ	I-ADJP	O
to	to	TO	B-PP	O
growth	growth	NN	B-NP	O
inhibition	inhibition	NN	I-NP	O
by	by	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
.	.	.	O	O

Exponentially	Exponentially	RB	B-NP	O
growing	grow	VBG	I-NP	O
cells	cell	NNS	I-NP	O
were	be	VBD	B-VP	O
separated	separate	VBN	I-VP	O
by	by	IN	B-PP	O
centrifugal	centrifugal	JJ	B-NP	O
elutriation	elutriation	NN	I-NP	O
into	into	IN	B-PP	O
fractions	fraction	NNS	B-NP	O
that	that	WDT	B-NP	O
corresponded	correspond	VBD	B-VP	O
to	to	TO	B-PP	O
different	different	JJ	B-NP	O
positions	position	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
phase	phase	NN	I-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
each	each	DT	B-NP	O
fraction	fraction	NN	I-NP	O
was	be	VBD	B-VP	O
estimated	estimate	VBN	I-VP	O
by	by	IN	B-PP	O
flow	flow	NN	B-NP	O
cytometry	cytometry	NN	I-NP	O
and	and	CC	I-NP	O
autoradiography	autoradiography	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
bound	bind	VBN	B-VP	O
per	per	IN	B-PP	O
cell	cell	NN	B-NP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
fraction	fraction	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
whole	whole	JJ	I-NP	O
cell	cell	NN	I-NP	O
binding	binding	NN	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
three	three	CD	B-NP	O
dexamethasone-sensitive	dexamethasone-sensitive	JJ	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
(	(	(	O	O
two	two	CD	B-NP	O
mouse	mouse	NN	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
human	human	JJ	I-NP	O
)	)	)	O	O
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
bound	bind	VBN	B-VP	O
per	per	IN	B-PP	O
cell	cell	NN	B-NP	O
increased	increase	VBD	B-VP	O
2-4-fold	2-4-fold	RB	B-ADVP	O
between	between	IN	B-PP	O
G1	G1	NN	B-NP	O
phase	phase	NN	I-NP	O
and	and	CC	O	O
S	S	NN	B-NP	O
phase	phase	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	B-VP	O
decreased	decrease	VBD	I-VP	O
during	during	IN	B-PP	O
G2/M	G2/M	NN	B-NP	O
phase	phase	NN	I-NP	O
.	.	.	O	O

Results	Result	NNS	B-NP	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
bound	bind	VBN	B-VP	O
per	per	IN	B-PP	O
milligram	milligram	NN	B-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
.	.	.	O	O

Binding	Binding	NN	B-NP	O
affinity	affinity	NN	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
during	during	IN	B-PP	O
G1	G1	NN	B-NP	O
phase	phase	NN	I-NP	O
and	and	CC	O	O
S	S	NN	B-NP	O
phase	phase	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
bound	bind	VBN	B-NP	O
dexamethasone	dexamethasone	NN	I-NP	O
that	that	WDT	B-NP	O
translocated	translocate	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
nucleus	nucleus	NN	I-NP	O
was	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
during	during	IN	B-PP	O
S	S	NN	B-NP	O
phase	phase	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
bound	bind	VBN	B-VP	O
per	per	IN	B-PP	O
cell	cell	NN	B-NP	O
by	by	IN	B-PP	O
three	three	CD	B-NP	O
dexamethasone-resistant	dexamethasone-resistant	JJ	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
(	(	(	O	O
two	two	CD	B-NP	O
mouse	mouse	NN	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
human	human	JJ	I-NP	O
)	)	)	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
increase	increase	VB	I-VP	O
during	during	IN	B-PP	O
S	S	NN	B-NP	O
phase	phase	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
binding	binding	NN	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
simply	simply	RB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
cell	cell	NN	B-NP	O
protein	protein	NN	I-NP	O
or	or	CC	O	O
cell	cell	NN	B-NP	O
volume	volume	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
binding	binding	NN	I-NP	O
during	during	IN	B-PP	O
S	S	NN	B-NP	O
phase	phase	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
to	to	TO	B-VP	O
inhibit	inhibit	VB	I-VP	O
cell	cell	NN	B-NP	O
growth	growth	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
failure	failure	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
binding	binding	NN	I-NP	O
to	to	TO	B-VP	O
increase	increase	VB	I-VP	O
during	during	IN	B-PP	O
S	S	NN	B-NP	O
phase	phase	NN	I-NP	O
might	might	MD	B-VP	O
represent	represent	VB	I-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
resistance	resistance	NN	I-NP	O
in	in	IN	B-PP	O
lymphoid	lymphoid	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Presence	Presence	NN	B-NP	O
and	and	CC	I-NP	O
steroid	steroid	NN	I-NP	O
inducibility	inducibility	NN	I-NP	O
of	of	IN	B-PP	O
glutamine	glutamine	NN	B-NP	B-protein
synthetase	synthetase	NN	I-NP	I-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
leukemic	leukemic	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Glutamine	Glutamine	NN	B-NP	B-protein
synthetase	synthetase	NN	I-NP	I-protein
(	(	(	O	O
EC	EC	NN	B-NP	O
6.3.1.2	6.3.1.2	NN	I-NP	O
;	;	:	O	O
GS	GS	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
lymphoblasts	lymphoblast	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
lymphoblastic	lymphoblastic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
ALL	ALL	NN	B-NP	O
)	)	)	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
16	16	CD	B-NP	O
out	out	IN	I-NP	O
of	of	IN	I-NP	O
20	20	CD	I-NP	O
ALL	ALL	NN	I-NP	O
patients	patient	NNS	I-NP	O
studied	study	VBD	B-VP	O
exposure	exposure	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
to	to	TO	B-PP	O
physiological	physiological	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
increased	increase	VBN	B-NP	O
enzyme	enzyme	NN	I-NP	O
activity	activity	NN	I-NP	O
above	above	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
increase	increase	NN	I-NP	O
was	be	VBD	B-VP	O
specific	specific	JJ	B-ADJP	O
for	for	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
ligands	ligand	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
direct	direct	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
magnitude	magnitude	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid-mediated	glucocorticoid-mediated	JJ	B-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
GS	GS	NN	B-NP	O
activity	activity	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
specific	specific	JJ	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
assayed	assay	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
cell	cell	NN	I-NP	O
specimen	specimen	NN	I-NP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
basal	basal	JJ	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
enzyme	enzyme	NN	I-NP	B-protein
measured	measure	VBN	B-VP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
correlated	correlate	VBD	B-VP	O
negatively	negatively	RB	B-ADVP	O
with	with	IN	B-PP	O
receptor	receptor	NN	B-NP	O
density	density	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
suggested	suggest	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
steroid-inducible	steroid-inducible	JJ	B-NP	B-protein
GS	GS	NN	I-NP	I-protein
in	in	IN	B-PP	O
ALL	ALL	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
may	may	MD	B-VP	O
prove	prove	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
marker	marker	NN	I-NP	O
for	for	IN	B-PP	O
functional	functional	JJ	B-NP	O
receptor	receptor	NN	I-NP	O
sites	site	NNS	I-NP	O
.	.	.	O	O

Binding	Binding	NN	B-NP	O
of	of	IN	B-PP	O
progestins	progestin	NNS	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

Correlation	Correlation	NN	B-NP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
glucocorticoid-like	glucocorticoid-like	JJ	I-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
functions	function	NNS	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

A	A	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
physiological	physiological	JJ	B-NP	O
and	and	CC	I-NP	O
synthetic	synthetic	JJ	I-NP	O
progestins	progestin	NNS	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
compete	compete	VB	I-VP	O
with	with	IN	B-PP	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
dexamethasone	dexamethasone	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
their	their	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
elicit	elicit	VB	I-VP	O
glucocorticoid-like	glucocorticoid-like	JJ	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
reference	reference	NN	I-NP	O
compound	compound	NN	I-NP	O
dexamethasone	dexamethasone	NN	I-NP	O
(	(	(	O	O
relative	relative	JJ	B-NP	O
receptor	receptor	NN	I-NP	O
binding	binding	NN	I-NP	O
affinity	affinity	NN	I-NP	O
defined	define	VBN	B-VP	O
as	as	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
two	two	CD	B-NP	O
potent	potent	JJ	I-NP	O
synthetic	synthetic	JJ	I-NP	O
progestins	progestin	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
pregnane-type	pregnane-type	JJ	I-NP	O
structure	structure	NN	I-NP	O
,	,	,	O	O
megestrol	megestrol	NN	B-NP	O
acetate	acetate	NN	I-NP	O
and	and	CC	O	O
medroxyprogesterone	medroxyprogesterone	NN	B-NP	O
acetate	acetate	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
display	display	VB	I-VP	O
a	a	DT	B-NP	O
considerable	considerable	JJ	I-NP	O
binding	binding	NN	I-NP	O
affinity	affinity	NN	I-NP	O
towards	towards	IN	B-PP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
(	(	(	O	O
46	46	CD	B-NP	O
and	and	CC	I-NP	O
42	42	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
relative	relative	JJ	I-NP	O
binding	binding	NN	I-NP	O
affinity	affinity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
naturally	naturally	RB	I-NP	O
occurring	occur	VBG	I-NP	O
ligand	ligand	NN	I-NP	O
,	,	,	O	O
cortisol	cortisol	NN	B-NP	O
,	,	,	O	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
was	be	VBD	B-VP	O
clearly	clearly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
(	(	(	O	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
effective	effective	JJ	I-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
medroxyprogesterone	medroxyprogesterone	NN	B-NP	O
acetate	acetate	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
was	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
by	by	IN	B-PP	O
direct	direct	JJ	B-NP	O
binding	binding	NN	I-NP	O
studies	study	NNS	I-NP	O
utilizing	utilize	VBG	B-VP	O
a	a	DT	B-NP	O
tritiated	tritiate	VBN	I-NP	O
derivative	derivative	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
steroid	steroid	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
progesterone	progesterone	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
as	as	IN	B-SBAR	O
judged	judge	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
competition	competition	NN	B-NP	O
experiments	experiment	NNS	I-NP	O
where	where	WRB	B-ADVP	O
a	a	DT	B-NP	O
progesterone	progesterone	NN	I-NP	O
receptor-specific	receptor-specific	JJ	I-NP	O
ligand	ligand	NN	I-NP	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	O	O
Org	Org	NNP	B-NP	O
2058	2058	CD	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
.	.	.	O	O

Medroxyprogesterone	Medroxyprogesterone	NN	B-NP	O
acetate	acetate	NN	I-NP	O
and	and	CC	I-NP	O
megestrol	megestrol	NN	I-NP	O
acetate	acetate	NN	I-NP	O
also	also	RB	B-ADVP	O
induced	induce	VBD	B-VP	O
glucocorticoid-like	glucocorticoid-like	JJ	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
lymphocyte	lymphocyte	NN	I-NP	O
functions	function	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
included	include	VBD	B-VP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proliferative	proliferative	JJ	I-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
T-cell	T-cell	NN	I-NP	B-protein
mitogens	mitogen	NNS	I-NP	I-protein
concanavalin	concanavalin	NN	I-NP	O
A	A	NN	I-NP	O
and	and	CC	O	O
phytohaemagglutinin	phytohaemagglutinin	NN	B-NP	B-protein
and	and	CC	O	O
an	an	DT	B-NP	O
enhanced	enhance	VBN	I-NP	O
accumulation	accumulation	NN	I-NP	O
of	of	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-cell_type
secreting	secreting	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
pokeweed	pokeweed	NN	B-NP	B-cell_line
mitogen-stimulated	mitogen-stimulated	JJ	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
progestin	progestin	NN	I-NP	O
effect	effect	NN	I-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
mediated	mediate	VBN	I-VP	O
through	through	IN	B-PP	O
a	a	DT	B-NP	O
radiosensitive	radiosensitive	JJ	I-NP	O
(	(	(	O	O
suppressor	suppressor	NN	B-NP	O
)	)	)	O	O
subpopulation	subpopulation	NN	B-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
synthetic	synthetic	JJ	I-NP	O
progestins	progestin	NNS	I-NP	O
related	relate	VBN	B-VP	O
structurally	structurally	RB	B-ADVP	O
to	to	TO	B-PP	O
19-nortestosterone	19-nortestosterone	NN	B-NP	O
,	,	,	I-NP	O
norethisterone	norethisterone	NN	I-NP	O
and	and	CC	I-NP	O
d-norgestrel	d-norgestrel	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
virtually	virtually	RB	B-ADJP	O
devoid	devoid	JJ	I-ADJP	O
of	of	IN	B-PP	O
binding	binding	NN	B-NP	O
affinity	affinity	NN	I-NP	O
towards	towards	IN	B-PP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
nor	nor	CC	O	O
did	do	VBD	O	O
they	they	PRP	B-NP	O
measurably	measurably	RB	B-ADVP	O
influence	influence	VB	B-VP	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
lymphocyte	lymphocyte	NN	I-NP	O
functions	function	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
studies	study	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
certain	certain	JJ	B-NP	O
progestins	progestin	NNS	I-NP	O
in	in	IN	B-PP	O
common	common	JJ	B-NP	O
clinical	clinical	JJ	I-NP	O
use	use	NN	I-NP	O
probably	probably	RB	B-ADVP	O
possess	possess	VBP	B-VP	O
inherent	inherent	JJ	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
activity	activity	NN	I-NP	O
and	and	CC	O	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
side	side	JJ	B-NP	O
effects	effect	NNS	I-NP	O
attributable	attributable	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
character	character	NN	I-NP	O
(	(	(	O	O
e.g.	e.g.	FW	B-NP	O
suppression	suppression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pituitary-adrenal	pituitary-adrenal	JJ	I-NP	O
axis	axis	NN	I-NP	O
)	)	)	O	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
expected	expect	VBN	I-VP	O
when	when	WRB	B-ADVP	O
these	these	DT	B-NP	O
compounds	compound	NNS	I-NP	O
are	be	VBP	B-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
pharmacological	pharmacological	JJ	B-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

Metabolic	Metabolic	JJ	B-NP	O
and	and	CC	I-NP	O
ultrastructural	ultrastructural	JJ	I-NP	O
aspects	aspect	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
lysis	lysis	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	B-cell_type
lymphocytic	lymphocytic	JJ	I-NP	I-cell_type
leukemia	leukemia	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
.	.	.	O	O

Human	Human	JJ	B-NP	B-cell_line
chronic	chronic	JJ	I-NP	I-cell_line
lymphocytic	lymphocytic	JJ	I-NP	I-cell_line
leukemia	leukemia	NN	I-NP	I-cell_line
(	(	(	O	I-cell_line
CLL	CLL	NN	B-NP	I-cell_line
)	)	)	O	I-cell_line
cells	cell	NNS	B-NP	I-cell_line
like	like	IN	B-PP	O
prothymocytes	prothymocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
immunoactivated	immunoactivated	JJ	B-NP	B-cell_type
T-lymphocytes	T-lymphocyte	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
readily	readily	RB	I-VP	O
lysed	lyse	VBN	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
by	by	IN	B-PP	O
pharmacological	pharmacological	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
cortisol	cortisol	NN	B-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
and	and	CC	I-NP	O
thymocytes	thymocyte	NNS	I-NP	B-cell_type
are	be	VBP	B-VP	O
unaffected	unaffected	JJ	B-ADJP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
hormone	hormone	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
metabolic	metabolic	JJ	B-NP	O
and	and	CC	I-NP	O
ultrastructural	ultrastructural	JJ	I-NP	O
aspects	aspect	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cortisol-induced	cortisol-induced	JJ	I-NP	O
killing	killing	NN	I-NP	O
process	process	NN	I-NP	O
of	of	IN	B-PP	O
CLL	CLL	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
are	be	VBP	B-VP	O
recorded	record	VBN	I-VP	O
.	.	.	O	O

In	In	FW	B-NP	O
vitro	vitro	FW	I-NP	O
lysis	lysis	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
temperature	temperature	NN	B-NP	O
dependent	dependent	JJ	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
only	only	RB	B-ADVP	O
after	after	IN	B-PP	O
6	6	CD	B-NP	O
to	to	TO	I-NP	O
8	8	CD	I-NP	O
hr	hr	NN	I-NP	O
incubation	incubation	NN	I-NP	O
with	with	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
by	by	IN	B-PP	O
means	mean	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
trypan	trypan	NN	I-NP	O
blue	blue	JJ	I-NP	O
exclusion	exclusion	NN	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
30	30	CD	B-NP	O
min	min	NN	I-NP	O
of	of	IN	B-PP	O
incubation	incubation	NN	B-NP	O
with	with	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
at	at	IN	B-PP	O
either	either	CC	B-NP	O
37	37	CD	I-NP	O
degrees	degree	NNS	I-NP	O
or	or	CC	O	O
4	4	CD	B-NP	O
degrees	degree	NNS	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
removal	removal	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hormone	hormone	NN	I-NP	O
was	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
the	the	DT	B-NP	O
lytic	lytic	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

Ultrastructural	Ultrastructural	JJ	B-NP	O
studies	study	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
sequential	sequential	JJ	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cytoplasm	cytoplasm	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
swelling	swelling	NN	B-NP	O
of	of	IN	B-PP	O
mitochondria	mitochondrion	NNS	B-NP	O
and	and	CC	O	O
cytoplasmic	cytoplasmic	JJ	B-NP	O
decompartmentalization	decompartmentalization	NN	I-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
surface	surface	NN	B-NP	O
microvilli	microvilli	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
appearance	appearance	NN	I-NP	O
of	of	IN	B-PP	O
``	``	``	O	O
holes	hole	NNS	B-NP	O
''	''	''	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
membrane	membrane	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
subsequent	subsequent	JJ	B-NP	O
condensation	condensation	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
chromatin	chromatin	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
large	large	JJ	I-NP	O
holes	hole	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
membrane	membrane	NN	I-NP	O
appearing	appear	VBG	B-VP	O
after	after	IN	B-SBAR	O
6	6	CD	B-NP	O
hr	hr	NN	I-NP	O
of	of	IN	B-PP	O
incubation	incubation	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
hormone	hormone	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
cause	cause	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
penetration	penetration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
viable	viable	JJ	I-NP	O
stain	stain	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
dead	dead	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
as	as	IN	B-SBAR	O
seen	see	VBN	B-VP	O
by	by	IN	B-PP	O
light	light	JJ	B-NP	O
microscopy	microscopy	NN	I-NP	O
.	.	.	O	O

Addition	Addition	NN	B-NP	O
of	of	IN	B-PP	O
metabolic	metabolic	JJ	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
including	include	VBG	B-PP	O
actinomycin	actinomycin	NN	B-NP	O
D	D	NN	I-NP	O
,	,	,	O	O
puromycin	puromycin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
cycloheximide	cycloheximide	NN	B-NP	O
following	follow	VBG	B-PP	O
administration	administration	NN	B-NP	O
of	of	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
lysis	lysis	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
excess	excess	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
antagonist	antagonist	NN	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
cortexolone	cortexolone	NN	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
inhibit	inhibit	VB	I-VP	O
the	the	DT	B-NP	O
cortisol-induced	cortisol-induced	JJ	I-NP	O
cytolysis	cytolysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CLL	CLL	NN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
suggested	suggest	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
glucocorticoid-induced	glucocorticoid-induced	JJ	I-NP	O
lysis	lysis	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
CLL	CLL	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
is	be	VBZ	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
phenomenon	phenomenon	NN	I-NP	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
rat	rat	NN	B-NP	O
or	or	CC	O	O
murine	murine	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
interaction	interaction	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
steroid	steroid	NN	I-NP	B-protein
molecule	molecule	NN	I-NP	I-protein
with	with	IN	B-PP	O
the	the	DT	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
resulting	result	VBG	I-NP	O
complex	complex	NN	I-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
activate	activate	VB	I-VP	O
specific	specific	JJ	B-NP	O
gene	gene	NN	I-NP	O
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
the	the	DT	B-NP	O
products	product	NNS	I-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
eventually	eventually	RB	B-ADVP	O
cause	cause	VBP	B-VP	O
cytolysis	cytolysis	NN	B-NP	O
.	.	.	O	O

Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
lymphoid	lymphoid	JJ	B-NP	O
tumors	tumor	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
numbers	number	NNS	I-NP	O
seen	see	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
various	various	JJ	I-NP	O
subclasses	subclass	NNS	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
lymphatic	lymphatic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
ALL	ALL	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

This	This	DT	B-NP	O
variability	variability	NN	I-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
explained	explain	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
known	known	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
active	active	JJ	B-NP	O
cell	cell	NN	I-NP	O
proliferation	proliferation	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
receptors	receptor	NNS	B-NP	B-protein
,	,	,	O	O
since	since	IN	B-SBAR	O
the	the	DT	B-NP	O
tumors	tumor	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
growth	growth	NN	I-NP	O
fraction	fraction	NN	I-NP	O
(	(	(	O	O
i.e.	i.e.	FW	B-NP	O
,	,	,	O	O
Burkitt	Burkitt	NN	B-NP	O
's	's	POS	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
and	and	CC	I-NP	O
T-cell	T-cell	NN	I-NP	O
leukemia	leukemia	NN	I-NP	O
)	)	)	O	O
tend	tend	VBP	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
lower	low	JJR	B-NP	O
average	average	JJ	I-NP	O
receptor	receptor	NN	I-NP	O
numbers	number	NNS	I-NP	O
than	than	IN	B-SBAR	O
do	do	VBP	O	O
tumors	tumor	NNS	B-NP	O
with	with	IN	B-PP	O
lower	low	JJR	B-NP	O
growth	growth	NN	I-NP	O
fractions	fraction	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
common	common	JJ	B-NP	O
ALL	ALL	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
specimens	specimen	NNS	I-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
lymphatic	lymphatic	JJ	B-NP	O
leukemia	leukemia	NN	I-NP	O
have	have	VBP	B-VP	O
some	some	DT	B-NP	O
measurable	measurable	JJ	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
;	;	:	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
resistance	resistance	NN	I-NP	O
seen	see	VBN	B-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
explained	explain	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
receptors	receptor	NNS	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
our	our	PRP$	B-NP	O
hands	hand	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
receptor	receptor	NN	B-NP	O
level	level	NN	I-NP	O
and	and	CC	I-NP	O
prognosis	prognosis	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
models	model	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
proposed	propose	VBN	I-VP	O
that	that	IN	B-SBAR	O
perhaps	perhaps	RB	B-ADVP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	B-cell_line
receptor	receptor	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
(	(	(	O	O
i.e.	i.e.	FW	B-NP	O
,	,	,	O	O
common	common	JJ	B-NP	O
ALL	ALL	NN	I-NP	O
of	of	IN	B-PP	O
childhood	childhood	NN	B-NP	O
)	)	)	O	O
have	have	VBP	B-VP	O
relative	relative	JJ	B-NP	O
stability	stability	NN	I-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
genetic	genetic	JJ	I-NP	O
material	material	NN	I-NP	O
making	make	VBG	B-VP	O
glucocorticoid-resistant	glucocorticoid-resistant	JJ	B-NP	O
mutations	mutation	NNS	I-NP	O
less	less	RBR	B-ADJP	O
likely	likely	JJ	I-ADJP	O
to	to	TO	B-VP	O
occur	occur	VB	I-VP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
low-receptor	low-receptor	JJ	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
(	(	(	O	O
i.e.	i.e.	FW	B-NP	O
,	,	,	O	O
T-cell	T-cell	NN	B-NP	O
leukemia	leukemia	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

This	This	DT	B-NP	O
greater	great	JJR	I-NP	O
genetic	genetic	JJ	I-NP	O
variability	variability	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
low-receptor	low-receptor	JJ	I-NP	B-cell_line
lines	line	NNS	I-NP	I-cell_line
could	could	MD	B-VP	O
account	account	VB	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
earlier	early	JJR	I-NP	O
emergence	emergence	NN	I-NP	O
of	of	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
resistance	resistance	NN	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

[	[	(	O	O
Tumor	Tumor	NN	B-NP	O
histology	histology	NN	I-NP	O
and	and	CC	O	O
steroid	steroid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
breast	breast	NN	B-NP	O
carcinoma	carcinoma	NN	I-NP	O
]	]	)	O	O

In	In	IN	B-PP	O
Specimens	Specimens	NNP	B-NP	O
of	of	IN	B-PP	O
115	115	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
4	4	CD	B-NP	O
tumorparameters	tumorparameter	NNS	I-NP	O
(	(	(	O	O
tumorsize	tumorsize	NN	B-NP	O
,	,	,	O	O
tumorboder	tumorboder	NN	B-NP	O
,	,	,	O	O
nucleargrade	nucleargrade	NN	B-NP	O
,	,	,	O	O
lymphocytic	lymphocytic	JJ	B-NP	O
stromal	stromal	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
)	)	)	O	O
3	3	CD	B-NP	O
features	feature	NNS	I-NP	O
of	of	IN	B-PP	O
regional	regional	JJ	B-NP	O
lymphnodes	lymphnode	NNS	I-NP	O
(	(	(	O	O
sinushistiocytosis	sinushistiocytosis	NN	B-NP	O
,	,	,	O	O
T-cellreaction	T-cellreaction	NN	B-NP	O
,	,	,	O	O
lymphnode	lymphnode	NN	B-NP	B-protein
metastases	metastasis	NNS	I-NP	I-protein
)	)	)	O	O
and	and	CC	O	O
estrogen	estrogen	NN	B-NP	O
and	and	CC	I-NP	O
progesteron	progesteron	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
strong	strong	JJ	I-NP	O
sinushistiocytosis	sinushistiocytosis	NN	I-NP	O
and	and	CC	I-NP	O
T-cellreaction	T-cellreaction	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
verified	verify	VBN	I-VP	O
mainly	mainly	RB	B-ADVP	O
in	in	IN	B-PP	O
metastases	metastasis	NNS	B-NP	O
in	in	IN	B-PP	O
free	free	JJ	B-NP	O
lymphnodes	lymphnode	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
steroid	steroid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
content	content	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
correlate	correlate	VB	I-VP	O
with	with	IN	B-PP	O
histological	histological	JJ	B-NP	O
parameters	parameter	NNS	I-NP	O

Aldosterone-receptor	Aldosterone-receptor	JJ	B-NP	O
deficiency	deficiency	NN	I-NP	O
in	in	IN	B-PP	O
pseudohypoaldosteronism	pseudohypoaldosteronism	NN	B-NP	O
.	.	.	O	O

Pseudohypoaldosteronism	Pseudohypoaldosteronism	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
syndrome	syndrome	NN	I-NP	O
characterized	characterize	VBN	B-VP	O
by	by	IN	B-PP	O
salt	salt	NN	B-NP	O
wasting	wasting	NN	I-NP	O
and	and	CC	O	O
failure	failure	NN	B-NP	O
to	to	TO	B-VP	O
thrive	thrive	VB	I-VP	O
,	,	,	O	O
usually	usually	RB	B-ADVP	O
presents	present	VBZ	B-VP	O
in	in	IN	B-PP	O
infancy	infancy	NN	B-NP	O
as	as	IN	B-PP	O
high	high	JJ	B-NP	O
urinary	urinary	JJ	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
sodium	sodium	NN	B-NP	O
despite	despite	IN	B-PP	O
hyponatremia	hyponatremia	NN	B-NP	O
,	,	,	O	O
hyperkalemia	hyperkalemia	NN	B-NP	O
,	,	,	O	O
hyperreninemia	hyperreninemia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
elevated	elevated	JJ	B-NP	O
aldosterone	aldosterone	NN	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
investigated	investigate	VBN	I-VP	O
this	this	DT	B-NP	O
syndrome	syndrome	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
abnormal	abnormal	JJ	B-NP	O
Type	Type	NN	I-NP	O
I	I	CD	I-NP	O
or	or	CC	O	O
``	``	``	B-NP	B-protein
mineralocorticoid-like	mineralocorticoid-like	JJ	I-NP	I-protein
''	''	''	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
have	have	VBP	B-VP	O
intrinsic	intrinsic	JJ	B-NP	O
steroid	steroid	NN	I-NP	O
specificity	specificity	NN	I-NP	O
indistinguishable	indistinguishable	JJ	B-ADJP	O
from	from	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	B-protein
mineralocorticoid	mineralocorticoid	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
and	and	CC	O	O
are	be	VBP	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
many	many	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
and	and	CC	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
mononuclear	mononuclear	JJ	B-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
studied	study	VBN	I-VP	O
three	three	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
pseudohypoaldosteronism	pseudohypoaldosteronism	NN	B-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
28-year-old	28-year-old	JJ	I-NP	O
index	index	NN	I-NP	O
case	case	NN	I-NP	O
in	in	IN	B-PP	O
Melbourne	Melbourne	NN	B-NP	O
(	(	(	O	O
Patient	Patient	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
)	)	)	O	O
and	and	CC	O	O
two	two	CD	B-NP	O
siblings	sibling	NNS	I-NP	O
in	in	IN	B-PP	O
Munich	Munich	NNP	B-NP	O
,	,	,	O	O
eight	eight	CD	B-NP	O
and	and	CC	I-NP	O
two	two	CD	I-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
(	(	(	O	O
Patients	Patient	NNS	B-NP	O
2	2	CD	B-NP	O
and	and	CC	I-NP	O
3	3	CD	I-NP	O
)	)	)	O	O
;	;	:	O	O
clinically	clinically	RB	B-ADVP	O
,	,	,	O	O
Patient	Patient	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
less	less	RBR	I-NP	O
severe	severe	JJ	I-NP	O
case	case	NN	I-NP	O
than	than	IN	B-PP	O
his	his	PRP$	B-NP	O
sister	sister	NN	I-NP	O
.	.	.	O	O

Percoll-separated	Percoll-separated	JJ	B-NP	B-cell_type
control	control	NN	I-NP	I-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
bound	bind	VBN	B-VP	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	I-NP	O
aldosterone	aldosterone	NN	I-NP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
(	(	(	O	O
Kd	Kd	NN	B-NP	O
approximately	approximately	RB	B-NP	O
3	3	CD	I-NP	O
nM	nM	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
limited	limit	VBN	B-NP	O
capacity	capacity	NN	I-NP	O
(	(	(	O	O
150	150	CD	B-NP	B-DNA
to	to	TO	I-NP	I-DNA
600	600	CD	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
per	per	IN	B-PP	O
cell	cell	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

On	On	IN	B-PP	O
repeated	repeat	VBN	B-NP	O
examination	examination	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
[	[	(	I-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
aldosterone	aldosterone	NN	I-NP	O
binding	binding	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
Patients	Patient	NNS	B-NP	B-protein
1	1	CD	I-NP	I-protein
and	and	CC	I-NP	I-protein
2	2	CD	I-NP	I-protein
;	;	:	O	O
in	in	IN	B-PP	O
Patient	Patient	NN	B-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
62	62	CD	B-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
per	per	IN	B-PP	O
cell	cell	NN	B-NP	O
,	,	,	O	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
2	2	CD	I-NP	O
S.D.	S.D.	NNP	I-NP	O
below	below	IN	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Levels	Level	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
parents	parent	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Munich	Munich	JJ	I-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
first	first	JJ	B-NP	O
cousins	cousin	NNS	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

It	It	PRP	B-NP	O
appears	appear	VBZ	B-VP	O
that	that	IN	B-SBAR	O
pseudohypoaldosteronism	pseudohypoaldosteronism	NN	B-NP	O
is	be	VBZ	B-VP	O
caused	cause	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
Type	Type	NN	I-NP	B-protein
I	I	CD	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
defect	defect	NN	I-NP	O
,	,	,	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
defect	defect	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
complete	complete	JJ	B-ADJP	O
or	or	CC	I-ADJP	O
partial	partial	JJ	I-ADJP	O
,	,	,	O	O
that	that	DT	B-NP	O
transmission	transmission	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
autosomal	autosomal	JJ	B-ADJP	O
recessive	recessive	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
pseudohypoaldosteronism	pseudohypoaldosteronism	NN	B-NP	O
may	may	MD	B-VP	O
indicate	indicate	VB	I-VP	O
physiologic	physiologic	JJ	B-NP	O
roles	role	NNS	I-NP	O
for	for	IN	B-PP	O
Type	Type	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
nonepithelial	nonepithelial	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
.	.	.	O	O

Glucocorticoid	Glucocorticoid	NN	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
urokinase-like	urokinase-like	JJ	B-NP	B-protein
plasminogen	plasminogen	NN	I-NP	I-protein
activators	activator	NNS	I-NP	I-protein
in	in	IN	B-PP	O
cultured	culture	VBN	B-NP	B-cell_line
human	human	JJ	I-NP	I-cell_line
lymphoblasts	lymphoblast	NNS	I-NP	I-cell_line
.	.	.	O	O

Two	Two	CD	B-NP	O
human	human	JJ	I-NP	B-cell_line
lymphoblast	lymphoblast	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
LICR-LON-HMy2	LICR-LON-HMy2	NN	B-NP	O
(	(	(	O	O
HMy2	HMy2	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
)	)	)	O	O
and	and	CC	O	O
GM4672A	GM4672A	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
are	be	VBP	B-VP	O
moderately	moderately	RB	B-ADVP	O
growth	growth	NN	B-NP	O
inhibited	inhibit	VBN	B-VP	O
by	by	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
,	,	,	O	O
4-pregnadien-9-fluoro-16	4-pregnadien-9-fluoro-16	CD	B-NP	O
alpha-methyl-11	alpha-methyl-11	NN	I-NP	O
beta	beta	SYM	B-NP	O
,	,	,	O	O
17	17	CD	B-NP	O
alpha	alpha	SYM	B-NP	O
,	,	,	O	O
21-triol-3	21-triol-3	CD	B-NP	O
,	,	,	O	O
20-dione	20-dione	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
Dex	Dex	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Both	Both	DT	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
secrete	secrete	VBP	B-VP	O
a	a	DT	B-NP	O
urokinase	urokinase	NN	I-NP	O
(	(	(	O	O
UK	UK	NN	B-NP	O
)	)	)	O	O
-like	-like	JJ	B-NP	O
plasminogen	plasminogen	NN	I-NP	O
activator	activator	NN	I-NP	O
(	(	(	O	O
PA	PA	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
HMy2	HMy2	NN	B-NP	B-protein
and	and	CC	O	O
GM4672A	GM4672A	NN	B-NP	O
cells	cell	NNS	I-NP	O
with	with	IN	B-PP	O
Dex	Dex	NN	B-NP	O
for	for	IN	B-PP	O
1-4	1-4	CD	B-NP	O
days	day	NNS	I-NP	O
inhibits	inhibit	VBZ	B-VP	O
extracellular	extracellular	JJ	B-NP	O
PA	PA	NN	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
concentration-dependent	concentration-dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
,	,	,	O	O
being	be	VBG	B-VP	O
half-maximal	half-maximal	JJ	B-ADJP	O
at	at	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
X	X	SYM	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
-9	-9	CD	B-NP	O
)	)	)	O	O
M	M	NN	B-NP	O
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
PA	PA	NN	B-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
is	be	VBZ	B-VP	O
specific	specific	JJ	B-ADJP	O
for	for	IN	B-PP	O
active	active	JJ	B-NP	O
glucocorticoids	glucocorticoid	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
specificity	specificity	NN	I-NP	O
parallels	parallel	VBZ	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
various	various	JJ	B-NP	O
steroids	steroid	NNS	I-NP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
.	.	.	O	O

HMy2	HMy2	NN	B-NP	O
cell	cell	NN	I-NP	O
PA	PA	NN	I-NP	O
is	be	VBZ	B-VP	O
fully	fully	RB	B-ADJP	O
suppressible	suppressible	JJ	I-ADJP	O
by	by	IN	B-PP	O
Dex	Dex	NN	B-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
one	one	CD	I-NP	O
third	third	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
activator	activator	NN	I-NP	O
expressed	express	VBN	B-VP	O
by	by	IN	B-PP	O
GM4672A	GM4672A	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
is	be	VBZ	B-VP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
inhibition	inhibition	NN	I-NP	O
.	.	.	O	O

Mixing	Mix	VBG	B-VP	O
experiments	experiment	NNS	B-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
UK	UK	NNP	I-NP	O
standard	standard	NN	I-NP	O
and	and	CC	O	O
conditioned	condition	VBN	B-NP	O
media	medium	NNS	I-NP	O
from	from	IN	B-PP	O
Dex-treated	Dex-treated	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
suggest	suggest	VBP	B-VP	O
an	an	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid-inducible	glucocorticoid-inducible	JJ	B-NP	B-protein
inhibitors	inhibitor	NNS	I-NP	I-protein
to	to	TO	B-PP	O
UK	UK	NN	B-NP	B-protein
or	or	CC	I-NP	O
plasmin	plasmin	NN	I-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
conditioned	condition	VBN	B-NP	O
media	medium	NNS	I-NP	O
from	from	IN	B-PP	O
Dex-treated	Dex-treated	JJ	B-NP	B-cell_line
GM4672A	GM4672A	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
inhibits	inhibit	VBZ	B-VP	O
a	a	DT	B-NP	O
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
homologous	homologous	JJ	I-NP	O
cellular	cellular	JJ	I-NP	O
activator	activator	NN	I-NP	O
in	in	IN	B-PP	O
conditioned	condition	VBN	B-NP	O
media	medium	NNS	I-NP	O
from	from	IN	B-PP	O
control	control	NN	B-NP	B-cell_line
GM4672A	GM4672A	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
low	low	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
glucocorticoid-inducible	glucocorticoid-inducible	JJ	B-NP	B-protein
inhibitors	inhibitor	NNS	I-NP	I-protein
may	may	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
,	,	,	O	O
but	but	CC	O	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
fully	fully	RB	I-VP	O
account	account	VB	I-VP	O
for	for	IN	B-PP	O
,	,	,	O	O
Dex	Dex	NN	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
GM4672A	GM4672A	NN	B-NP	B-protein
PA	PA	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
.	.	.	O	O

Glucocorticoid-inducible	Glucocorticoid-inducible	JJ	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
in	in	IN	B-PP	O
HMy2	HMy2	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
are	be	VBP	B-VP	O
either	either	RB	B-ADVP	O
totally	totally	RB	B-ADJP	O
absent	absent	JJ	I-ADJP	O
or	or	CC	O	O
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
at	at	IN	B-PP	O
undetectable	undetectable	JJ	B-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
regulation	regulation	NN	B-NP	O
of	of	IN	B-PP	O
UK-like	UK-like	JJ	B-NP	O
PAs	PA	NNS	I-NP	O
in	in	IN	B-PP	O
HMy2	HMy2	NN	B-NP	B-cell_line
and	and	CC	I-NP	I-cell_line
GM4672A	GM4672A	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
differs	differ	VBZ	B-VP	O
with	with	IN	B-PP	O
respect	respect	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
extent	extent	NN	I-NP	O
to	to	TO	B-PP	O
which	which	WDT	B-NP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
inhibit	inhibit	VBP	B-VP	O
constitutively	constitutively	RB	B-NP	O
expressed	express	VBN	I-NP	O
activator	activator	NN	I-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
contribution	contribution	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid-inducible	glucocorticoid-inducible	JJ	B-NP	B-protein
inhibitors	inhibitor	NNS	I-NP	I-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	O
process	process	NN	I-NP	O
in	in	IN	B-PP	O
GM4672A	GM4672A	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Characterization	Characterization	NN	B-NP	O
of	of	IN	B-PP	O
aldosterone	aldosterone	NN	B-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
circulating	circulate	VBG	B-VP	B-cell_type
human	human	JJ	B-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Aldosterone	Aldosterone	NN	B-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
characterized	characterize	VBN	I-VP	O
after	after	IN	B-PP	O
separation	separation	NN	B-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
from	from	IN	B-PP	O
blood	blood	NN	B-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
Percoll	Percoll	NNP	I-NP	O
gradient	gradient	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
washing	washing	NN	B-NP	O
and	and	CC	I-NP	O
resuspension	resuspension	NN	I-NP	O
in	in	IN	B-PP	O
RPMI-1640	RPMI-1640	NN	B-NP	B-cell_line
medium	medium	NN	I-NP	I-cell_line
,	,	,	O	I-cell_line
cells	cell	NNS	B-NP	I-cell_line
were	be	VBD	B-VP	O
incubated	incubate	VBN	I-VP	O
at	at	IN	B-PP	O
37	37	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
with	with	IN	B-PP	O
different	different	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	I-NP	O
aldosterone	aldosterone	NN	I-NP	O
plus	plus	CC	O	O
a	a	DT	B-NP	O
100-fold	100-fold	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
RU-26988	RU-26988	NN	B-NP	O
(	(	(	O	O
11	11	CD	B-NP	O
alpha	alpha	SYM	O	O
,	,	,	O	O
17	17	CD	B-NP	O
alpha-dihydroxy-17	alpha-dihydroxy-17	NN	I-NP	O
beta-propynylandrost-1	beta-propynylandrost-1	NN	I-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
,	,	,	O	O
6-trien-3-one	6-trien-3-one	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
with	with	IN	B-PP	O
or	or	CC	B-PP	O
without	without	IN	B-PP	O
an	an	DT	B-NP	O
excess	excess	NN	I-NP	O
of	of	IN	B-PP	O
unlabeled	unlabeled	JJ	B-NP	O
aldosterone	aldosterone	NN	I-NP	O
.	.	.	O	O

Aldosterone	Aldosterone	NN	B-NP	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
class	class	NN	I-NP	O
of	of	IN	B-PP	O
receptors	receptor	NNS	B-NP	B-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
affinity	affinity	NN	I-NP	O
of	of	IN	B-PP	O
2.7	2.7	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
0.5	0.5	CD	I-NP	O
nM	nM	NN	I-NP	O
(	(	(	O	O
means	mean	VBZ	B-VP	O
+/-	+/-	SYM	B-NP	O
SD	SD	NN	I-NP	O
,	,	,	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
14	14	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
capacity	capacity	NN	I-NP	O
of	of	IN	B-PP	O
290	290	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
108	108	CD	I-NP	O
sites/cell	sites/cell	NNS	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
14	14	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
specificity	specificity	NN	I-NP	O
data	datum	NNS	I-NP	O
show	show	VBP	B-VP	O
a	a	DT	B-NP	O
hierarchy	hierarchy	NN	I-NP	O
of	of	IN	B-PP	O
affinity	affinity	NN	B-NP	O
of	of	IN	B-PP	O
desoxycorticosterone	desoxycorticosterone	NN	B-NP	O
=	=	SYM	B-VP	O
corticosterone	corticosterone	NN	B-NP	O
=	=	SYM	B-VP	O
aldosterone	aldosterone	NN	B-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
hydrocortisone	hydrocortisone	NN	B-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
mononuclear	mononuclear	JJ	B-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
could	could	MD	B-VP	O
be	be	VB	I-VP	O
useful	useful	JJ	B-ADJP	O
for	for	IN	B-PP	O
studying	study	VBG	B-VP	O
the	the	DT	B-NP	O
physiological	physiological	JJ	I-NP	O
significance	significance	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
mineralocorticoid	mineralocorticoid	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
and	and	CC	O	O
their	their	PRP$	B-NP	O
regulation	regulation	NN	I-NP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
.	.	.	O	O

Mineralocorticoid	Mineralocorticoid	NN	B-NP	O
and	and	CC	I-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
circulating	circulate	VBG	B-VP	B-cell_type
mononuclear	mononuclear	JJ	B-NP	I-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
hyperaldosteronism	hyperaldosteronism	NN	I-NP	O
.	.	.	O	O

Mineralocorticoid	Mineralocorticoid	NN	B-NP	O
and	and	CC	I-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
in	in	IN	B-PP	O
circulating	circulate	VBG	B-VP	B-cell_type
mononuclear	mononuclear	JJ	B-NP	I-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
5	5	CD	B-NP	O
patients	patient	NNS	I-NP	O
affected	affect	VBN	B-VP	O
by	by	IN	B-PP	O
Conn	Conn	NNP	B-NP	O
's	's	POS	B-NP	O
syndrome	syndrome	NN	I-NP	O
(	(	(	O	O
3	3	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
adrenal	adrenal	JJ	I-NP	O
hyperplasia	hyperplasia	NN	I-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
adenoma	adenoma	NN	B-NP	O
plus	plus	CC	O	O
unilateral	unilateral	JJ	B-NP	O
hyperplasia	hyperplasia	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
binding	bind	VBG	I-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
per	per	IN	B-PP	O
cell	cell	NN	B-NP	O
resulted	result	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
(	(	(	O	O
189	189	CD	B-NP	O
+/-	+/-	CC	I-NP	O
114	114	CD	I-NP	O
,	,	,	O	O
mean	mean	NN	B-NP	O
+/-	+/-	SYM	I-NP	O
SD	SD	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
controls	control	NNS	I-NP	O
(	(	(	O	O
298	298	CD	B-NP	O
+/-	+/-	CC	I-NP	O
105	105	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
affinity	affinity	NN	I-NP	O
of	of	IN	B-PP	O
aldosterone	aldosterone	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
not	not	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
control	control	NN	I-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
capacity	capacity	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
affinity	affinity	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
for	for	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
ranged	range	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
values	value	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
down-regulation	down-regulation	NN	I-NP	O
of	of	IN	B-PP	O
mineralocorticoid	mineralocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
.	.	.	O	O

Short-term	Short-term	JJ	B-NP	O
and	and	CC	I-NP	O
long-term	long-term	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
estrogen	estrogen	NN	B-NP	O
on	on	IN	B-PP	O
lymphoid	lymphoid	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
and	and	CC	O	O
lymphoid	lymphoid	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
some	some	DT	B-NP	O
remarks	remark	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
significance	significance	NN	I-NP	O
for	for	IN	B-PP	O
carcinogenesis	carcinogenesis	NN	B-NP	O
.	.	.	O	O

Estrogens	Estrogen	NNS	B-NP	O
have	have	VBP	B-VP	O
long	long	RB	I-VP	O
been	be	VBN	I-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
the	the	DT	B-NP	O
immune	immune	JJ	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
immune	immune	JJ	B-NP	O
responses	response	NNS	I-NP	O
between	between	IN	B-PP	O
males	male	NNS	B-NP	O
and	and	CC	I-NP	O
females	female	NNS	I-NP	O
is	be	VBZ	B-VP	O
well-known	well-known	JJ	B-ADJP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
pronounced	pronounced	JJ	I-NP	O
thymic	thymic	JJ	I-NP	O
involution	involution	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
exogenous	exogenous	JJ	B-NP	O
estrogens	estrogen	NNS	I-NP	O
.	.	.	O	O

Estrogens	Estrogen	NNS	B-NP	O
stimulate	stimulate	VBP	B-VP	O
some	some	DT	B-NP	O
aspects	aspect	NNS	I-NP	O
of	of	IN	B-PP	O
macrophage	macrophage	NN	B-NP	B-cell_type
activity	activity	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
depending	depend	VBG	B-PP	O
on	on	IN	B-PP	O
dose	dose	NN	B-NP	O
and	and	CC	I-NP	O
mitogen	mitogen	NN	I-NP	O
,	,	,	O	O
inhibit	inhibit	VBP	B-VP	O
or	or	CC	I-VP	O
stimulate	stimulate	VBP	I-VP	O
lymphocyte	lymphocyte	NN	B-NP	O
proliferative	proliferative	JJ	I-NP	O
response	response	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

Another	Another	DT	B-NP	O
example	example	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
estrogen	estrogen	NN	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
delayed	delay	VBN	I-NP	O
type	type	NN	I-NP	O
hypersensitivity	hypersensitivity	NN	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
broad	broad	JJ	I-NP	O
review	review	NN	I-NP	O
is	be	VBZ	B-VP	O
given	give	VBN	I-VP	O
of	of	IN	B-PP	O
such	such	JJ	B-NP	O
estrogen	estrogen	NN	I-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
lymphoid	lymphoid	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
and	and	CC	O	O
immune	immune	JJ	B-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Most	Most	JJS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
studies	study	NNS	I-NP	O
published	publish	VBN	B-VP	O
so	so	RB	B-ADVP	O
far	far	RB	I-ADVP	O
are	be	VBP	B-VP	O
phenomenological	phenomenological	JJ	B-ADJP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
recent	recent	JJ	I-NP	O
description	description	NN	I-NP	O
of	of	IN	B-PP	O
estrogen	estrogen	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
thymus	thymus	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
lymphocyte	lymphocyte	NN	I-NP	B-cell_type
subpopulations	subpopulation	NNS	I-NP	I-cell_type
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
deeper	deep	JJR	I-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
regulating	regulate	VBG	B-VP	B-protein
factors	factor	NNS	B-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
immune	immune	JJ	I-NP	O
system	system	NN	I-NP	O
,	,	,	O	O
open	open	VB	B-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
detailed	detailed	JJ	I-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
estrogen	estrogen	NN	I-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
interference	interference	NN	B-NP	O
.	.	.	O	O

Estrogen	Estrogen	NN	B-NP	O
effects	effect	NNS	I-NP	O
in	in	IN	B-PP	O
adults	adult	NNS	B-NP	O
are	be	VBP	B-VP	O
reversible	reversible	JJ	B-ADJP	O
.	.	.	O	O

After	After	IN	B-PP	O
treating	treat	VBG	B-VP	O
neonatal	neonatal	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
synthetic	synthetic	JJ	I-NP	O
estrogen	estrogen	NN	I-NP	O
diethylstilbestrol	diethylstilbestrol	NN	I-NP	O
(	(	(	O	O
DES	DES	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
disturbances	disturbance	NNS	B-NP	O
are	be	VBP	B-VP	O
induced	induce	VBN	I-VP	O
in	in	IN	B-PP	O
lymphocyte	lymphocyte	NN	B-NP	B-cell_type
populations	population	NNS	I-NP	I-cell_type
and	and	CC	O	O
lymphocyte	lymphocyte	NN	B-NP	O
functions	function	NNS	I-NP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
permanent	permanent	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
irreversible	irreversible	JJ	I-ADJP	O
.	.	.	O	O

Lymphocytes	Lymphocyte	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
adult	adult	JJ	B-NP	O
,	,	,	I-NP	O
neonatally	neonatally	RB	I-NP	O
DES-treated	DES-treated	JJ	I-NP	O
female	female	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
reduced	reduce	VBN	I-NP	O
mitogen	mitogen	NN	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
ConA	ConA	NN	B-NP	O
and	and	CC	O	O
LPS	LPS	NN	B-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
and	and	CC	I-NP	O
B	B	NN	I-NP	B-protein
cell	cell	NN	I-NP	I-protein
mitogen	mitogen	NN	I-NP	I-protein
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
delayed	delay	VBN	I-NP	O
type	type	NN	I-NP	O
hypersensitivity	hypersensitivity	NN	I-NP	O
response	response	NN	I-NP	O
is	be	VBZ	B-VP	O
depressed	depress	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
detailed	detailed	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
decreased	decrease	VBN	I-NP	O
T	T	NN	I-NP	O
helper	helper	NN	I-NP	O
cell	cell	NN	I-NP	O
population	population	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
Natural	Natural	JJ	B-NP	B-cell_type
Killer	Killer	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
permanently	permanently	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
and	and	CC	O	O
this	this	DT	B-NP	O
functional	functional	JJ	I-NP	O
impairment	impairment	NN	I-NP	O
is	be	VBZ	B-VP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
decreased	decrease	VBN	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
turn	turn	NN	B-NP	O
determined	determine	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bone	bone	NN	I-NP	O
marrow	marrow	NN	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
same	same	JJ	I-NP	O
animals	animal	NNS	I-NP	O
have	have	VBP	B-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
to	to	TO	B-PP	O
chemical	chemical	JJ	B-NP	O
carcinogens	carcinogen	NNS	I-NP	O
(	(	(	O	O
methylcholanthrene	methylcholanthrene	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
they	they	PRP	B-NP	O
spontaneously	spontaneously	RB	B-VP	O
develop	develop	VBP	I-VP	O
epithelial	epithelial	JJ	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
uterine	uterine	JJ	I-NP	O
cervix	cervix	NN	I-NP	O
which	which	WDT	B-NP	O
morphologically	morphologically	RB	B-ADVP	O
are	be	VBP	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
adenocarcinoma	adenocarcinoma	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
association	association	NN	I-NP	O
between	between	IN	B-PP	O
estrogen-associated	estrogen-associated	JJ	B-NP	O
malignancy	malignancy	NN	I-NP	O
and	and	CC	I-NP	O
estrogen	estrogen	NN	I-NP	O
effects	effect	NNS	I-NP	O
in	in	IN	B-PP	O
lymphocyte	lymphocyte	NN	B-NP	O
functions	function	NNS	I-NP	O
deserves	deserve	VBZ	B-VP	O
further	further	JJ	B-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

Drugs	Drug	NNS	B-NP	O
affecting	affect	VBG	B-VP	O
the	the	DT	B-NP	O
hormonal	hormonal	JJ	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
leukaemic	leukaemic	JJ	I-NP	I-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
leucocytes	leucocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
authors	author	NNS	I-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
behaviour	behaviour	NN	I-NP	O
of	of	IN	B-PP	O
steroid	steroid	NN	B-NP	O
hormone	hormone	NN	I-NP	O
uptake	uptake	NN	I-NP	O
in	in	IN	B-PP	O
leukaemic	leukaemic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
CML	CML	NN	B-NP	O
,	,	,	O	O
CLL	CLL	NN	B-NP	O
,	,	,	O	O
AML	AML	NN	B-NP	O
,	,	,	O	O
ALL	ALL	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
in	in	IN	B-PP	O
basal	basal	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
and	and	CC	B-PP	O
after	after	IN	B-PP	O
incubation	incubation	NN	B-NP	O
with	with	IN	B-PP	O
drugs	drug	NNS	B-NP	O
which	which	WDT	B-NP	O
modify	modify	VBP	B-VP	O
the	the	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
cAMP	cAMP	NN	B-NP	O
,	,	,	I-NP	O
PGE	PGE	NN	I-NP	O
and	and	CC	I-NP	O
PGF	PGF	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
in	in	IN	B-PP	O
leukaemic	leukaemic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
an	an	DT	B-NP	O
alteration	alteration	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
incorporation	incorporation	NN	I-NP	O
of	of	IN	B-PP	O
steroid	steroid	NN	B-NP	O
hormones	hormone	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
alteration	alteration	NN	I-NP	O
was	be	VBD	B-VP	O
scarcely	scarcely	RB	I-VP	O
modified	modify	VBN	I-VP	O
by	by	IN	B-PP	O
incubation	incubation	NN	B-NP	O
with	with	IN	B-PP	O
theophylline	theophylline	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
increases	increase	VBZ	B-VP	O
cellular	cellular	JJ	B-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
cAMP	cAMP	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
hand	hand	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
moderately	moderately	RB	I-VP	O
counteracted	counteract	VBN	I-VP	O
by	by	IN	B-PP	O
thioproline	thioproline	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
evidently	evidently	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
flurbiprofen	flurbiprofen	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
also	also	RB	B-ADVP	O
reduced	reduce	VBD	B-VP	O
cellular	cellular	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
prostaglandins	prostaglandin	NNS	B-NP	O
,	,	,	O	O
particularly	particularly	RB	B-NP	O
PGE2	PGE2	NN	I-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
exception	exception	NN	I-NP	O
of	of	IN	B-PP	O
PGF2	PGF2	NN	B-NP	B-protein
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
poor	poor	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Differences	Difference	NNS	B-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
behavior	behavior	NN	I-NP	O
of	of	IN	B-PP	O
hormonal	hormonal	JJ	B-NP	O
uptake	uptake	NN	I-NP	O
of	of	IN	B-PP	O
CML	CML	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
AML	AML	NN	B-NP	O
,	,	,	O	O
CLL	CLL	NN	B-NP	O
and	and	CC	O	O
ALL	ALL	NN	B-NP	O
peripheral	peripheral	JJ	I-NP	O
leucocytes	leucocyte	NNS	I-NP	O
.	.	.	O	O

Human	Human	JJ	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
and	and	CC	O	O
impaired	impaired	JJ	B-NP	O
NK	NK	NN	I-NP	O
cell	cell	NN	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
advances	advance	NNS	I-NP	O
in	in	IN	B-PP	O
tumor	tumor	NN	B-NP	O
immunology	immunology	NN	I-NP	O
have	have	VBP	B-VP	O
led	lead	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
discovery	discovery	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
lymphoid	lymphoid	JJ	I-NP	O
cell	cell	NN	I-NP	O
with	with	IN	B-PP	O
unique	unique	JJ	B-NP	O
antitumor	antitumor	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

Natural	Natural	JJ	B-NP	B-cell_type
killer	killer	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
NK	NK	NN	B-NP	I-cell_type
)	)	)	O	I-cell_type
cells	cell	NNS	B-NP	I-cell_type
form	form	VBP	B-VP	O
an	an	DT	B-NP	O
antitumor	antitumor	JJ	I-NP	O
surveillance	surveillance	NN	I-NP	O
system	system	NN	I-NP	O
and	and	CC	O	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
vital	vital	JJ	B-ADJP	O
in	in	IN	B-PP	O
preventing	prevent	VBG	B-VP	O
tumor	tumor	NN	B-NP	O
growth	growth	NN	I-NP	O
and	and	CC	O	O
metastasis	metastasis	NN	B-NP	O
in	in	IN	B-PP	O
animal	animal	NN	B-NP	O
models	model	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
studied	study	VBD	B-VP	O
NK	NK	NN	B-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
benign	benign	JJ	B-NP	O
and	and	CC	I-NP	O
malignant	malignant	JJ	I-NP	O
breast	breast	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
chromium-51	chromium-51	NN	I-NP	O
release	release	NN	I-NP	O
microtiter	microtiter	NN	I-NP	O
cytotoxicity	cytotoxicity	NN	I-NP	O
assay	assay	NN	I-NP	O
with	with	IN	B-PP	O
K562	K562	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
as	as	IN	B-PP	O
targets	target	NNS	B-NP	O
.	.	.	O	O

Compared	Compare	VBN	B-PP	O
with	with	IN	B-PP	O
benign	benign	JJ	B-NP	O
controls	control	NNS	I-NP	O
,	,	,	O	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
malignancies	malignancy	NNS	B-NP	O
had	have	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
depressed	depressed	JJ	I-NP	O
NK	NK	NN	I-NP	O
-mediated	-mediated	JJ	I-NP	O
lysis	lysis	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.01	0.01	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
lysis	lysis	NN	B-NP	O
in	in	IN	B-PP	O
those	those	DT	B-NP	O
with	with	IN	B-PP	O
advanced	advance	VBN	B-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
stages	stage	NNS	B-NP	O
II	II	CD	I-NP	O
,	,	,	I-NP	O
III	III	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
IV	IV	CD	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
less	less	JJR	I-ADJP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
those	those	DT	B-NP	O
with	with	IN	B-PP	O
limited	limited	JJ	B-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
stage	stage	NN	B-NP	O
I	I	CD	I-NP	O
)	)	)	O	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.01	0.01	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

NK	NK	NN	B-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
to	to	TO	B-PP	O
estrogen	estrogen	NN	B-NP	O
or	or	CC	I-NP	O
progesterone	progesterone	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
states	state	NNS	I-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
correlation	correlation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
depressed	depressed	JJ	I-NP	O
natural	natural	JJ	I-NP	O
killer	killer	NN	I-NP	O
activity	activity	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
extent	extent	NN	I-NP	O
of	of	IN	B-PP	O
tumor	tumor	NN	B-NP	O
spread	spread	NN	I-NP	O
supports	support	VBZ	B-VP	O
the	the	DT	B-NP	O
concept	concept	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
NK	NK	NN	I-NP	O
cell	cell	NN	I-NP	O
immune	immune	JJ	I-NP	O
surveillance	surveillance	NN	I-NP	O
system	system	NN	I-NP	O
in	in	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
and	and	CC	O	O
emphasizes	emphasize	VBZ	B-VP	O
its	its	PRP$	B-NP	O
importance	importance	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
malignancy	malignancy	NN	I-NP	O
.	.	.	O	O

Immunosuppressive	Immunosuppressive	JJ	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
serum	serum	NN	B-NP	O
progesterone	progesterone	NN	I-NP	O
during	during	IN	B-PP	O
pregnancy	pregnancy	NN	B-NP	O
depends	depend	VBZ	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
progesterone	progesterone	NN	I-NP	O
binding	binding	NN	I-NP	O
capacity	capacity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	B-cell_type
.	.	.	O	O

Cytotoxic	Cytotoxic	JJ	B-NP	O
activity	activity	NN	I-NP	O
and	and	CC	O	O
progesterone	progesterone	NN	B-NP	O
binding	binding	NN	I-NP	O
capacity	capacity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	B-cell_type
,	,	,	O	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
serum	serum	NN	B-NP	O
progesterone	progesterone	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
in	in	IN	B-PP	O
women	woman	NNS	B-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
pregnancy	pregnancy	NN	I-NP	O
or	or	CC	B-PP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
threatened	threaten	VBN	B-NP	O
abortion	abortion	NN	I-NP	O
or	or	CC	O	O
threatened	threaten	VBD	B-VP	O
premature	premature	JJ	B-NP	O
labour	labour	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	B-cell_type
of	of	IN	B-PP	O
women	woman	NNS	B-NP	O
with	with	IN	B-PP	O
threatened	threaten	VBN	B-NP	O
abortion	abortion	NN	I-NP	O
or	or	CC	O	O
threatened	threaten	VBD	B-VP	O
premature	premature	JJ	B-NP	O
labour	labour	NN	I-NP	O
showed	show	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
higher	high	JJR	I-NP	O
cytotoxic	cytotoxic	JJ	I-NP	O
activity	activity	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
significantly	significantly	RB	B-NP	O
lower	low	JJR	I-NP	O
progesterone	progesterone	NN	I-NP	O
binding	binding	NN	I-NP	O
capacity	capacity	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
than	than	IN	B-SBAR	O
did	do	VBD	O	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
healthy	healthy	JJ	I-NP	O
pregnant	pregnant	JJ	I-NP	O
women	woman	NNS	I-NP	O
.	.	.	O	O

Significant	Significant	JJ	B-NP	O
inverse	inverse	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
progesterone	progesterone	NN	B-NP	O
binding	binding	NN	I-NP	O
capacity	capacity	NN	I-NP	O
and	and	CC	O	O
cytotoxic	cytotoxic	JJ	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	B-cell_type
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
progesterone	progesterone	NN	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pregnancy	pregnancy	NN	I-NP	O
serum	serum	NN	I-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
no	no	DT	B-NP	O
influence	influence	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
two	two	CD	I-NP	O
parameters	parameter	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
findings	finding	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
intact	intact	JJ	B-NP	O
progesterone	progesterone	NN	I-NP	O
binding	binding	NN	I-NP	O
capacity	capacity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	B-cell_type
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
essential	essential	JJ	I-NP	O
factor	factor	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
manifestation	manifestation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
blocking	block	VBG	I-NP	O
effect	effect	NN	I-NP	O
exerted	exert	VBN	B-VP	O
by	by	IN	B-PP	O
pregnancy	pregnancy	NN	B-NP	O
serum	serum	NN	I-NP	O
on	on	IN	B-PP	O
lymphocyte	lymphocyte	NN	B-NP	O
cytotoxicity	cytotoxicity	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

Serum	Serum	NN	B-NP	O
sex	sex	NN	I-NP	O
steroid	steroid	NN	I-NP	O
and	and	CC	O	O
peptide	peptide	NN	B-NP	O
hormone	hormone	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
endometrial	endometrial	JJ	B-NP	O
estrogen	estrogen	NN	I-NP	O
and	and	CC	I-NP	O
progestin	progestin	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
levels	level	NNS	I-NP	O
during	during	IN	B-PP	O
administration	administration	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-protein
leukocyte	leukocyte	NN	I-NP	I-protein
interferon	interferon	NN	I-NP	I-protein
.	.	.	O	O

Five	Five	CD	B-NP	O
normally	normally	RB	I-NP	O
cycling	cycle	VBG	I-NP	O
healthy	healthy	JJ	B-NP	O
women	woman	NNS	I-NP	O
were	be	VBD	B-VP	O
given	give	VBN	I-VP	O
daily	daily	JJ	B-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
injections	injection	NNS	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
leukocyte	leukocyte	NN	I-NP	I-cell_type
interferon	interferon	NN	I-NP	O
(	(	(	O	O
3	3	CD	B-NP	O
X	X	SYM	O	O
10	10	CD	B-NP	O
(	(	(	O	O
6	6	CD	B-NP	O
)	)	)	O	O
units/day	units/day	NN	B-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
3rd	3rd	NN	I-NP	O
through	through	IN	B-PP	O
23rd	23rd	JJ	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
menstrual	menstrual	JJ	I-NP	O
cycle	cycle	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
serum	serum	NN	B-NP	O
steroid	steroid	NN	I-NP	O
and	and	CC	O	O
peptide	peptide	NN	B-NP	O
hormone	hormone	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
monitored	monitor	VBN	B-VP	O
at	at	IN	B-PP	O
3-day	3-day	JJ	B-NP	O
intervals	interval	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
preceding	precede	VBG	I-NP	O
control	control	NN	I-NP	O
cycle	cycle	NN	I-NP	O
.	.	.	O	O

Concentrations	Concentration	NNS	B-NP	O
of	of	IN	B-PP	O
cytosol	cytosol	NN	B-NP	O
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	B-protein
estrogen	estrogen	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
(	(	(	O	O
ERC	ERC	NN	B-NP	B-protein
and	and	CC	I-NP	O
ERN	ERN	NN	I-NP	B-protein
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
)	)	)	O	O
and	and	CC	O	O
progestin	progestin	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
(	(	(	O	O
PRC	PRC	NN	B-NP	B-protein
and	and	CC	O	O
PRN	PRN	NN	B-NP	B-protein
)	)	)	O	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
measured	measure	VBN	I-VP	O
from	from	IN	B-PP	O
endometrial	endometrial	JJ	B-NP	O
biopsies	biopsy	NNS	I-NP	O
taken	take	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
24th	24th	JJ	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
and	and	CC	I-NP	O
treatment	treatment	NN	I-NP	O
cycle	cycle	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
extensive	extensive	JJ	I-NP	O
monitoring	monitoring	NN	I-NP	O
of	of	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
chemical	chemical	NN	I-NP	O
and	and	CC	O	O
hematological	hematological	JJ	B-NP	O
tests	test	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	B-cell_type
samples	sample	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
.	.	.	O	O

Serum	Serum	NN	B-NP	O
estradiol	estradiol	NN	I-NP	O
and	and	CC	O	O
progesterone	progesterone	NN	B-NP	O
concentrations	concentration	NNS	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
cycle	cycle	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
interferon	interferon	NN	B-NP	B-protein
interacts	interact	VBZ	B-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
FSH	FSH	NN	B-NP	O
and	and	CC	I-NP	O
LH	LH	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
serum	serum	NN	I-NP	O
peptide	peptide	NN	I-NP	O
hormone	hormone	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
measured	measure	VBN	B-VP	O
(	(	(	O	O
FSH	FSH	NN	B-NP	O
,	,	,	O	O
LH	LH	NN	B-NP	O
,	,	,	O	O
prolactin	prolactin	NN	B-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
,	,	,	O	O
growth	growth	NN	B-NP	O
hormone	hormone	NN	I-NP	O
and	and	CC	O	O
TSH	TSH	NN	B-NP	O
)	)	)	O	O
;	;	:	O	O
neither	neither	CC	O	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
endometrial	endometrial	JJ	B-NP	O
ERC	ERC	NN	I-NP	O
,	,	,	I-NP	O
ERN	ERN	NN	I-NP	B-protein
,	,	,	I-NP	O
PRC	PRC	NN	I-NP	B-protein
and	and	CC	I-NP	O
PRN	PRN	NN	I-NP	O
affected	affect	VBN	B-VP	O
by	by	IN	B-PP	O
interferon	interferon	NN	B-NP	B-protein
administration	administration	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
expected	expect	VBN	B-VP	O
,	,	,	O	O
interferon	interferon	NN	B-NP	O
administration	administration	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
leukocyte	leukocyte	NN	I-NP	O
counts	count	NNS	I-NP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
an	an	DT	B-NP	O
increasing	increase	VBG	I-NP	O
tendency	tendency	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
serum	serum	NN	B-NP	B-protein
alkaline	alkaline	NN	I-NP	I-protein
phosphatase	phosphatase	NN	I-NP	I-protein
and	and	CC	I-NP	O
gamma-glutamyltransferase	gamma-glutamyltransferase	NN	I-NP	B-protein
during	during	IN	B-PP	O
the	the	DT	B-NP	O
interferon	interferon	NN	I-NP	O
therapy	therapy	NN	I-NP	O
shows	show	VBZ	B-VP	O
that	that	IN	B-SBAR	O
interferon	interferon	NN	B-NP	B-protein
may	may	MD	B-VP	O
slightly	slightly	RB	I-VP	O
interfere	interfere	VB	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
interferon	interferon	NN	B-NP	B-protein
treatment	treatment	NN	I-NP	O
may	may	MD	B-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
hormone-dependent	hormone-dependent	JJ	B-NP	O
neoplasms	neoplasm	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
production	production	NN	B-NP	O
and/or	and/or	CC	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
circulating	circulate	VBG	B-VP	O
hormonal	hormonal	JJ	B-NP	O
compounds	compound	NNS	I-NP	O
.	.	.	O	O

[	[	(	B-NP	O
Glucocorticoid	Glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
level	level	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
different	different	JJ	B-NP	O
acute	acute	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
]	]	)	O	O

Content	Content	NN	B-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
cytosol	cytosol	NN	B-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
concentration	concentration	NN	B-NP	O
of	of	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
and	and	CC	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
leukocytes	leukocyte	NNS	B-NP	B-cell_type
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
20	20	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
impairments	impairment	NNS	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Content	Content	NN	B-NP	O
of	of	IN	B-PP	O
receptors	receptor	NNS	B-NP	B-protein
in	in	IN	B-PP	O
cytosol	cytosol	NN	B-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
using	use	VBG	B-VP	O
3H-triamcinolone	3H-triamcinolone	JJ	B-NP	O
acetonide	acetonide	NN	I-NP	O
.	.	.	O	O

Distinct	Distinct	JJ	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
amount	amount	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
leukocyte	leukocyte	NN	I-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
poisoning	poisoning	NN	B-NP	O
by	by	IN	B-PP	O
dichlorethane	dichlorethane	NN	B-NP	O
and	and	CC	O	O
hypnotic	hypnotic	JJ	B-NP	O
drugs	drug	NNS	I-NP	O
under	under	IN	B-PP	O
conditions	condition	NNS	B-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
acute	acute	JJ	B-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
content	content	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
leukocyte	leukocyte	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
altered	alter	VBN	I-VP	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
controls	control	NNS	B-NP	O
.	.	.	O	O

Concentration	Concentration	NN	B-NP	O
of	of	IN	B-PP	O
endogenous	endogenous	JJ	B-NP	O
cortisol	cortisol	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
of	of	IN	B-PP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
except	except	IN	B-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
acetate	acetate	NN	B-NP	O
intoxication	intoxication	NN	I-NP	O
.	.	.	O	O

Reverse	Reverse	JJ	B-NP	O
correlation	correlation	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
between	between	IN	B-PP	O
concentration	concentration	NN	B-NP	O
of	of	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
and	and	CC	I-NP	O
content	content	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
leukocytes	leukocyte	NNS	B-NP	B-cell_type
.	.	.	O	O

But	But	CC	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
the	the	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
content	content	NN	B-NP	O
of	of	IN	B-PP	O
leukocyte	leukocyte	NN	B-NP	B-protein
glucocorticoid	glucocorticoid	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
observed	observe	VBN	I-VP	O
although	although	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
concentration	concentration	NN	I-NP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
immunological	immunological	JJ	B-NP	O
processes	process	NNS	I-NP	O
under	under	IN	B-PP	O
conditions	condition	NNS	B-NP	O
of	of	IN	B-PP	O
purulent	purulent	JJ	B-NP	O
complications	complication	NNS	I-NP	O
and	and	CC	O	O
possibility	possibility	NN	B-NP	O
to	to	TO	B-VP	O
regulate	regulate	VB	I-VP	O
the	the	DT	B-NP	O
metabolism	metabolism	NN	I-NP	O
in	in	IN	B-PP	O
leukocytes	leukocyte	NNS	B-NP	B-cell_type

Therapeutic	Therapeutic	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
suppress	suppress	VBP	B-VP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
without	without	IN	B-PP	O
impairing	impair	VBG	B-VP	O
their	their	PRP$	B-NP	O
responsiveness	responsiveness	NN	I-NP	O
to	to	TO	B-PP	O
gamma	gamma	NN	B-NP	B-protein
interferon	interferon	NN	I-NP	I-protein
.	.	.	O	O

By	By	IN	B-PP	O
exposing	expose	VBG	B-VP	O
human	human	JJ	B-NP	B-cell_type
blood-derived	blood-derived	JJ	I-NP	I-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
and	and	CC	O	O
alveolar	alveolar	JJ	B-NP	B-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
to	to	TO	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
showed	show	VBD	B-VP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
studies	study	NNS	I-NP	O
that	that	IN	B-NP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
markedly	markedly	RB	B-ADVP	O
suppress	suppress	VBP	B-VP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
macrophages	macrophage	NNS	B-NP	B-cell_type
but	but	CC	B-NP	O
not	not	RB	I-NP	O
macrophage	macrophage	NN	B-NP	O
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
lymphokines	lymphokine	NNS	B-NP	B-protein
.	.	.	O	O

As	As	RB	B-NP	O
little	little	JJ	I-NP	O
as	as	IN	I-NP	O
2.5	2.5	CD	I-NP	O
X	X	SYM	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
-8	-8	CD	B-NP	O
)	)	)	O	O
mol/liter	mol/liter	NN	B-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
prevented	prevent	VBD	B-VP	O
macrophages	macrophage	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
germination	germination	NN	B-NP	O
of	of	IN	B-PP	O
Aspergillus	Aspergillus	NN	B-NP	O
spores	spore	NNS	I-NP	O
or	or	CC	B-PP	O
from	from	IN	B-PP	O
eliminating	eliminate	VBG	B-VP	O
ingested	ingest	VBN	B-NP	O
bacteria	bacteria	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
Listeria	Listeria	NNP	B-NP	O
,	,	,	O	O
Nocardia	Nocardia	NNP	B-NP	O
,	,	,	O	O
or	or	CC	O	O
Salmonella	Salmonella	NNP	B-NP	O
.	.	.	O	O

Damage	Damage	NN	B-NP	O
to	to	TO	B-PP	O
macrophage	macrophage	NN	B-NP	O
function	function	NN	I-NP	O
was	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
progesterone	progesterone	NN	B-NP	O
and	and	CC	O	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
receptor-mediated	receptor-mediated	JJ	B-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
accordance	accordance	NN	B-NP	O
with	with	IN	B-PP	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
observations	observation	NNS	I-NP	O
,	,	,	O	O
dexamethasone	dexamethasone	NN	B-NP	O
required	require	VBD	B-VP	O
24-36	24-36	CD	B-NP	O
h	h	NN	I-NP	O
to	to	TO	B-VP	O
suppress	suppress	VB	I-VP	O
antimicrobial	antimicrobial	JJ	B-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
interfered	interfere	VBD	B-VP	O
with	with	IN	B-PP	O
base-line	base-line	NN	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
macrophages	macrophage	NNS	B-NP	B-cell_type
,	,	,	O	O
dexamethasone	dexamethasone	NN	B-NP	O
concentrations	concentration	NNS	I-NP	O
comparable	comparable	JJ	B-ADJP	O
to	to	TO	B-PP	O
drug	drug	NN	B-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
macrophage	macrophage	NN	B-NP	B-cell_type
activation	activation	NN	I-NP	O
.	.	.	O	O

Proliferating	Proliferate	VBG	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
gamma-interferon	gamma-interferon	NN	B-NP	B-protein
thus	thus	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
phagocytes	phagocyte	NNS	B-NP	B-cell_type
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
over	over	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
control	control	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Macrophage	Macrophage	NN	B-NP	O
activation	activation	NN	I-NP	O
and	and	CC	O	O
correction	correction	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
dexamethasone	dexamethasone	NN	I-NP	O
effect	effect	NN	I-NP	O
by	by	IN	B-PP	O
gamma-interferon	gamma-interferon	NN	B-NP	B-protein
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
was	be	VBD	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
pathogen	pathogen	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
lymphokine	lymphokine	NN	I-NP	B-protein
enhanced	enhance	VBD	B-VP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone-treated	dexamethasone-treated	JJ	B-NP	B-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
against	against	IN	B-PP	O
Listeria	Listeria	NNP	B-NP	O
and	and	CC	I-NP	O
Salmonella	Salmonella	NNP	I-NP	O
but	but	CC	B-PP	O
not	not	RB	B-NP	O
against	against	IN	B-PP	O
Aspergillus	Aspergillus	NNP	B-NP	O
or	or	CC	I-NP	O
Nocardia	Nocardia	NNP	I-NP	O
.	.	.	O	O

Dexamethasone-induced	Dexamethasone-induced	JJ	B-NP	O
damage	damage	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
parallels	parallel	NNS	I-NP	O
observations	observation	NNS	I-NP	O
that	that	IN	B-NP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
render	render	VBP	B-VP	O
laboratory	laboratory	NN	B-NP	O
animals	animal	NNS	I-NP	O
susceptible	susceptible	JJ	B-ADJP	O
to	to	TO	B-PP	O
listeriosis	listeriosis	NN	B-NP	O
and	and	CC	I-NP	O
aspergillosis	aspergillosis	NN	I-NP	O
by	by	IN	B-PP	O
damaging	damage	VBG	B-VP	B-cell_type
resident	resident	JJ	B-NP	I-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
.	.	.	O	O

Suppression	Suppression	NN	B-NP	O
of	of	IN	B-PP	O
macrophage	macrophage	NN	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
should	should	MD	B-VP	O
thus	thus	RB	I-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
when	when	WRB	B-ADVP	O
treating	treat	VBG	B-VP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
;	;	:	O	O
its	its	PRP$	B-NP	O
prevention	prevention	NN	I-NP	O
by	by	IN	B-PP	O
gamma-interferon	gamma-interferon	NN	B-NP	B-protein
might	might	MD	B-VP	O
be	be	VB	I-VP	O
beneficial	beneficial	JJ	B-ADJP	O
for	for	IN	B-PP	O
some	some	DT	B-NP	O
but	but	CC	I-NP	O
not	not	RB	I-NP	O
all	all	DT	B-NP	O
pathogens	pathogen	NNS	I-NP	O
.	.	.	O	O

Interleukin	Interleukin	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
Tac	Tac	NN	B-NP	B-protein
antigen	antigen	NN	I-NP	I-protein
)	)	)	O	O
expression	expression	NN	B-NP	O
in	in	IN	B-PP	O
HTLV-I-associated	HTLV-I-associated	JJ	B-NP	O
adult	adult	JJ	I-NP	O
T-cell	T-cell	NN	I-NP	O
leukemia	leukemia	NN	I-NP	O
.	.	.	O	O

Interleukin-2	Interleukin-2	NN	B-NP	B-protein
(	(	(	O	O
IL-2	IL-2	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
lymphokine	lymphokine	NN	I-NP	B-protein
synthesized	synthesize	VBN	B-VP	O
by	by	IN	B-PP	O
some	some	DT	B-NP	O
T-cells	T-cell	NNS	I-NP	B-cell_type
following	follow	VBG	B-PP	O
activation	activation	NN	B-NP	O
.	.	.	O	O

Resting	Rest	VBG	B-NP	B-cell_type
T-cells	T-cell	NNS	I-NP	I-cell_type
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
express	express	VB	I-VP	O
IL-2	IL-2	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
,	,	,	O	O
but	but	CC	O	O
receptors	receptor	NNS	B-NP	O
are	be	VBP	B-VP	O
rapidly	rapidly	RB	I-VP	O
expressed	express	VBN	I-VP	O
on	on	IN	B-PP	O
T-cells	T-cell	NNS	B-NP	B-cell_type
following	follow	VBG	B-PP	O
interaction	interaction	NN	B-NP	O
of	of	IN	B-PP	O
antigens	antigen	NNS	B-NP	B-protein
,	,	,	O	O
mitogens	mitogen	NNS	B-NP	B-protein
,	,	,	O	O
or	or	CC	O	O
monoclonal	monoclonal	JJ	B-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
with	with	IN	B-PP	O
the	the	DT	B-NP	O
antigen-specific	antigen-specific	JJ	I-NP	B-protein
T-cell	T-cell	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
.	.	.	O	O

Using	Use	VBG	B-VP	O
anti-Tac	anti-Tac	JJ	B-ADJP	O
,	,	,	O	O
a	a	DT	B-NP	O
monoclonal	monoclonal	JJ	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
that	that	WDT	B-NP	O
recognizes	recognize	VBZ	B-VP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
,	,	,	O	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
purified	purify	VBN	I-VP	O
and	and	CC	O	O
shown	show	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
Mr	Mr	NN	I-NP	O
33	33	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
peptide	peptide	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
posttranslationally	posttranslationally	RB	I-VP	O
glycosylated	glycosylate	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
Mr	Mr	NN	I-NP	B-protein
55	55	CD	I-NP	I-protein
,	,	,	I-NP	I-protein
000	000	CD	I-NP	I-protein
mature	mature	JJ	I-NP	I-protein
form	form	NN	I-NP	I-protein
.	.	.	O	O

Normal	Normal	JJ	B-NP	B-cell_type
resting	rest	VBG	I-NP	I-cell_type
T-cells	T-cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
most	most	RBS	B-NP	O
leukemic	leukemic	JJ	I-NP	B-cell_type
T-cell	T-cell	NN	I-NP	I-cell_type
populations	population	NNS	I-NP	I-cell_type
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
express	express	VB	I-VP	O
IL-2	IL-2	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
leukemic	leukemic	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
the	the	DT	B-NP	O
11	11	CD	I-NP	O
patients	patient	NNS	I-NP	O
examined	examine	VBN	B-VP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
human	human	JJ	B-NP	O
T-cell	T-cell	NN	I-NP	O
lymphotropic	lymphotropic	JJ	I-NP	O
virus-associated	virus-associated	JJ	I-NP	O
adult	adult	JJ	I-NP	O
T-cell	T-cell	NN	I-NP	O
leukemia	leukemia	NN	I-NP	O
expressed	express	VBD	B-VP	O
the	the	DT	B-NP	O
Tac	Tac	NNP	I-NP	B-protein
antigen	antigen	NN	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
T-cell	T-cell	NN	I-NP	I-cell_type
lymphotropic	lymphotropic	JJ	I-NP	I-cell_type
virus-I	virus-I	NN	I-NP	I-cell_type
infected	infected	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
the	the	DT	B-NP	O
Mr	Mr	NN	I-NP	B-protein
42	42	CD	I-NP	I-protein
,	,	,	I-NP	I-protein
000	000	CD	I-NP	I-protein
long	long	JJ	I-NP	I-protein
open	open	JJ	I-NP	I-protein
reading	reading	NN	I-NP	I-protein
frame	frame	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
encoded	encode	VBN	B-VP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
pX	pX	NN	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
this	this	DT	B-NP	O
virus	virus	NN	I-NP	O
may	may	MD	B-VP	O
act	act	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
transacting	transact	VBG	I-NP	O
transcriptional	transcriptional	JJ	I-NP	B-protein
activator	activator	NN	I-NP	I-protein
that	that	WDT	B-NP	O
induces	induce	VBZ	B-VP	O
IL-2	IL-2	NN	B-NP	B-DNA
receptor	receptor	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
transcription	transcription	NN	I-NP	O
,	,	,	O	O
thus	thus	RB	B-ADVP	O
providing	provide	VBG	B-VP	O
an	an	DT	B-NP	O
explanation	explanation	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
constant	constant	JJ	I-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
with	with	IN	B-PP	O
adult	adult	JJ	B-NP	O
T-cell	T-cell	NN	I-NP	O
lymphotropic	lymphotropic	JJ	I-NP	O
virus-I	virus-I	NN	I-NP	O
infection	infection	NN	I-NP	O
of	of	IN	B-PP	O
lymphoid	lymphoid	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
constant	constant	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
large	large	JJ	B-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
aberrant	aberrant	JJ	B-ADJP	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
uncontrolled	uncontrolled	JJ	I-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
adult	adult	JJ	B-NP	B-cell_type
T-cell	T-cell	NN	I-NP	I-cell_type
leukemia	leukemia	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Two	Two	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
Tac-positive	Tac-positive	JJ	B-NP	O
adult	adult	JJ	I-NP	O
T-cell	T-cell	NN	I-NP	O
leukemia	leukemia	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
anti-Tac	anti-Tac	NN	I-NP	B-protein
.	.	.	O	O

One	One	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
6-	6-	CD	B-NP	O
and	and	CC	O	O
3-mo	3-mo	JJ	B-NP	O
remissions	remission	NNS	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
leukemia	leukemia	NN	I-NP	O
following	follow	VBG	B-PP	O
two	two	CD	B-NP	O
courses	course	NNS	I-NP	O
of	of	IN	B-PP	O
therapy	therapy	NN	B-NP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
monoclonal	monoclonal	JJ	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
directed	direct	VBN	B-VP	O
toward	toward	IN	B-PP	O
this	this	DT	B-NP	O
growth	growth	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

Lymphocyte	Lymphocyte	NN	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
binding	binding	NN	I-NP	O
in	in	IN	B-PP	O
depressed	depressed	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
hypercortisolemia	hypercortisolemia	NN	B-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
elevated	elevate	VBN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
serum	serum	NN	B-NP	O
and	and	CC	O	O
urinary	urinary	JJ	B-NP	O
cortisol	cortisol	NN	I-NP	O
,	,	,	O	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
depressive	depressive	JJ	B-NP	O
illness	illness	NN	I-NP	O
manifest	manifest	NN	I-NP	O
none	none	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
stigmata	stigmata	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
excess	excess	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
hypercortisolemia	hypercortisolemia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
effects	effect	NNS	I-NP	O
suggests	suggest	VBZ	B-VP	O
a	a	DT	B-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
hormone	hormone	NN	B-NP	O
resistance	resistance	NN	I-NP	O
and	and	CC	O	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
alterations	alteration	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

Earlier	Early	JJR	B-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
small	small	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
cause	cause	VBP	B-VP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
binding	binding	NN	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

White	White	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
depressed	depressed	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
hypercortisolemia	hypercortisolemia	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
expected	expect	VBN	I-VP	O
to	to	TO	I-VP	O
show	show	VB	I-VP	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
receptor	receptor	NN	B-NP	O
concentration	concentration	NN	I-NP	O
if	if	IN	B-SBAR	O
peripheral	peripheral	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
are	be	VBP	B-VP	O
adequately	adequately	RB	I-VP	O
exposed	expose	VBN	I-VP	O
to	to	TO	B-PP	O
and	and	CC	O	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hormone	hormone	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
we	we	PRP	B-NP	O
compared	compare	VBD	B-VP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	I-NP	O
dexamethasone	dexamethasone	NN	I-NP	O
to	to	TO	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
normal	normal	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
and	and	CC	O	O
depressed	depressed	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
hypercortisolemia	hypercortisolemia	NN	B-NP	O
.	.	.	O	O

Lymphocytes	Lymphocyte	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
normal	normal	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
mean	mean	JJ	I-NP	O
receptor	receptor	NN	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
10.2	10.2	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
0.66	0.66	CD	I-NP	O
fm/10	fm/10	NN	I-NP	O
(	(	(	O	O
6	6	CD	B-NP	O
)	)	)	O	O
cells	cell	NNS	B-NP	O
(	(	(	O	O
S.E.M.	S.E.M.	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
dissociation	dissociation	NN	I-NP	O
constant	constant	NN	I-NP	O
of	of	IN	B-PP	O
4.8	4.8	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
0.47	0.47	CD	I-NP	O
nM	nM	NN	I-NP	O
.	.	.	O	O

Lymphocytes	Lymphocyte	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
depressed	depressed	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
abnormal	abnormal	JJ	B-NP	O
0800	0800	CD	I-NP	O
h	h	NN	I-NP	O
serum	serum	NN	I-NP	O
cortisol	cortisol	NN	I-NP	O
after	after	IN	B-SBAR	O
dexamethasone	dexamethasone	NN	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
mean	mean	JJ	I-NP	O
receptor	receptor	NN	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
8.8	8.8	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
0.75	0.75	CD	I-NP	O
fm/10	fm/10	NN	I-NP	O
(	(	(	O	O
6	6	CD	B-NP	O
)	)	)	O	O
cells	cell	NNS	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
significantly	significantly	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
from	from	IN	B-PP	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
normal	normal	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
or	or	CC	B-PP	O
from	from	IN	B-PP	O
depressed	depressed	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
post-dexamethasone	post-dexamethasone	JJ	I-NP	O
cortisol	cortisol	NN	I-NP	O
levels	level	NNS	I-NP	O
(	(	(	O	O
9.4	9.4	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
0.95	0.95	CD	I-NP	O
fm/10	fm/10	NN	I-NP	O
(	(	(	O	O
6	6	CD	B-NP	O
)	)	)	I-NP	O
cells	cell	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

Lymphocytes	Lymphocyte	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
depressed	depressed	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
urinary	urinary	JJ	I-NP	O
free	free	JJ	I-NP	O
cortisol	cortisol	NN	I-NP	O
excretion	excretion	NN	I-NP	O
(	(	(	O	O
UFC	UFC	NN	B-NP	O
)	)	)	O	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-NP	O
receptor	receptor	NN	I-NP	O
concentration	concentration	NN	I-NP	O
and	and	CC	O	O
binding	binding	NN	B-NP	O
affinity	affinity	NN	I-NP	O
for	for	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
lymphocyte	lymphocyte	NN	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
concentration	concentration	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
excess	excess	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
that	that	IN	B-SBAR	O
hypercortisolemia	hypercortisolemia	NN	B-NP	O
in	in	IN	B-PP	O
depressive	depressive	JJ	B-NP	O
illness	illness	NN	I-NP	O
represents	represent	VBZ	B-VP	O
a	a	DT	B-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
resistance	resistance	NN	I-NP	O
.	.	.	O	O

Structure	Structure	NN	B-NP	O
and	and	CC	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
hormone	hormone	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
which	which	WDT	B-NP	O
possesses	possess	VBZ	B-VP	O
three	three	CD	B-NP	O
distinct	distinct	JJ	I-NP	O
domains	domain	NNS	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
that	that	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
agonist	agonist	NN	B-NP	O
and	and	CC	I-NP	O
antagonist	antagonist	NN	I-NP	O
steroids	steroid	NNS	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
that	that	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
DNA	DNA	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
one	one	CD	B-NP	O
that	that	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
anti-receptor	anti-receptor	JJ	B-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
and	and	CC	O	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
modulation	modulation	NN	I-NP	O
of	of	IN	B-PP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
intact	intact	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
receptor	receptor	NN	B-NP	O
number	number	NN	I-NP	O
,	,	,	O	O
affinity	affinity	NN	B-NP	O
and	and	CC	I-NP	O
activity	activity	NN	I-NP	O
can	can	MD	B-VP	O
change	change	VB	I-VP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
factors	factor	NNS	B-NP	O
that	that	WDT	B-NP	O
bind	bind	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
that	that	WDT	B-NP	O
act	act	VBP	B-VP	O
indirectly	indirectly	RB	B-ADVP	O
through	through	IN	B-PP	O
ill-defined	ill-defined	JJ	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
include	include	VB	I-VP	O
resumption	resumption	NN	B-NP	O
or	or	CC	I-NP	O
arrest	arrest	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
cycling	cycling	NN	I-NP	O
and	and	CC	O	O
variations	variation	NNS	B-NP	O
in	in	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
calcium	calcium	NN	I-NP	O
ion	ion	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
.	.	.	O	O

Some	Some	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
factors	factor	NNS	I-NP	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
exert	exert	VB	I-VP	O
their	their	PRP$	B-NP	O
effect	effect	NN	I-NP	O
by	by	IN	B-PP	O
controlling	control	VBG	B-VP	O
critical	critical	JJ	B-NP	O
receptor	receptor	NN	I-NP	O
properties	property	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
ATP-dependent	ATP-dependent	JJ	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
,	,	,	O	O
integrity	integrity	NN	B-NP	O
of	of	IN	B-PP	O
thiol	thiol	NN	B-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
exposure	exposure	NN	B-NP	O
of	of	IN	B-PP	O
key	key	JJ	B-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
residues	residue	NNS	I-NP	O
.	.	.	O	O

Glucocorticoid	Glucocorticoid	NN	B-NP	O
agonists	agonist	NNS	I-NP	O
promote	promote	VBP	B-VP	O
the	the	DT	B-NP	O
'transformation	'transformation	NN	I-NP	O
'	'	''	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
DNA-binding	DNA-binding	JJ	I-NP	B-protein
state	state	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
competent	competent	JJ	B-ADJP	O
for	for	IN	B-PP	O
modulating	modulate	VBG	B-VP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O

Glucocorticoid	Glucocorticoid	NN	B-NP	O
antagonists	antagonist	NNS	I-NP	O
are	be	VBP	B-VP	O
steroids	steroid	NNS	B-NP	O
that	that	WDT	B-NP	O
interact	interact	VBP	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
but	but	CC	O	O
either	either	CC	O	O
fail	fail	VBP	B-VP	O
to	to	TO	I-VP	O
produce	produce	VB	I-VP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
complex	complex	NN	I-NP	O
or	or	CC	O	O
produce	produce	VB	B-VP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	B-protein
but	but	CC	I-NP	I-protein
inefficient	inefficient	JJ	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
.	.	.	O	O

Although	Although	IN	B-SBAR	O
substituent	substituent	JJ	B-NP	O
groups	group	NNS	I-NP	O
that	that	WDT	B-NP	O
confer	confer	VBP	B-VP	O
agonist	agonist	NN	B-NP	O
or	or	CC	I-NP	O
antagonist	antagonist	NN	I-NP	O
activity	activity	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
steroid	steroid	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
determinants	determinant	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
difference	difference	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
level	level	NN	I-NP	O
remain	remain	VBP	B-VP	O
unknown	unknown	JJ	B-ADJP	O
.	.	.	O	O

Most	Most	JJS	B-ADVP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
data	datum	NNS	I-NP	O
on	on	IN	B-PP	O
receptor	receptor	NN	B-NP	O
regulation	regulation	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
accommodated	accommodate	VBN	I-VP	O
by	by	IN	B-PP	O
postulating	postulate	VBG	B-VP	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	O
cycle	cycle	NN	I-NP	O
that	that	WDT	B-NP	O
involves	involve	VBZ	B-VP	O
five	five	CD	B-NP	O
states	state	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
active	active	JJ	I-NP	B-protein
free	free	JJ	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
phosphorylated	phosphorylate	VBN	I-VP	O
,	,	,	O	O
reduced	reduce	VBN	B-VP	O
,	,	,	O	O
and	and	CC	O	O
presumably	presumably	RB	B-ADJP	O
oligomeric	oligomeric	JJ	I-ADJP	O
(	(	(	O	O
state	state	NN	B-NP	B-protein
A	A	NN	I-NP	I-protein
)	)	)	O	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
binding	binding	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
agonist	agonist	NN	I-NP	O
(	(	(	O	O
state	state	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
)	)	)	O	O
,	,	,	O	O
it	it	PRP	B-NP	O
can	can	MD	B-VP	O
become	become	VB	I-VP	O
transformed	transform	VBN	I-VP	O
by	by	IN	B-PP	O
dissociation	dissociation	NN	B-NP	O
into	into	IN	B-PP	O
its	its	PRP$	B-NP	O
subunits	subunit	NNS	I-NP	O
and	and	CC	I-NP	O
dephosphorylation	dephosphorylation	NN	I-NP	O
(	(	(	O	O
state	state	NN	B-NP	O
C	C	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
transformed	transform	VBN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
then	then	RB	B-ADVP	O
interacts	interact	VBZ	B-VP	O
with	with	IN	B-PP	O
chromatin	chromatin	NN	B-NP	B-DNA
(	(	(	O	O
state	state	NN	B-NP	O
D	D	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Dissociation	Dissociation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
steroid	steroid	NN	I-NP	O
and	and	CC	I-NP	O
oxidation	oxidation	NN	I-NP	O
of	of	IN	B-PP	O
receptor	receptor	NN	B-NP	O
thiol	thiol	NN	I-NP	O
group	group	NN	I-NP	O
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
lead	lead	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
inactive	inactive	JJ	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
form	form	NN	I-NP	O
(	(	(	O	O
state	state	NN	B-NP	O
E	E	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Reduction	Reduction	NN	B-NP	O
and	and	CC	I-NP	O
rephosphorylation	rephosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
enable	enable	NN	I-NP	O
it	it	PRP	B-NP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
steroids	steroid	NNS	B-NP	O
again	again	RB	B-ADVP	O
so	so	IN	B-SBAR	O
that	that	IN	I-SBAR	O
the	the	DT	B-NP	O
cycle	cycle	NN	I-NP	O
is	be	VBZ	B-VP	O
closed	close	VBN	I-VP	O
.	.	.	O	O

Thermodynamics	Thermodynamic	NNS	B-NP	O
of	of	IN	B-PP	O
steroid	steroid	NN	B-NP	O
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-protein
glucocorticoid	glucocorticoid	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
thermodynamics	thermodynamic	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
with	with	IN	B-PP	O
their	their	PRP$	B-NP	O
receptor	receptor	NN	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
cytosol	cytosol	NN	B-NP	O
from	from	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
lymphoblastoid	lymphoblastoid	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
affinity	affinity	NN	I-NP	O
constants	constant	NNS	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
and	and	CC	O	O
cortisol	cortisol	NN	B-NP	O
between	between	IN	B-PP	O
0	0	CD	B-NP	O
degree	degree	NN	I-NP	O
and	and	CC	O	O
25	25	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	NN	I-NP	O
were	be	VBD	B-VP	O
calculated	calculate	VBN	I-VP	O
by	by	IN	B-PP	O
curve-fitting	curve-fitting	JJ	B-NP	O
from	from	IN	B-PP	O
time-course	time-course	NN	B-NP	O
and	and	CC	I-NP	O
equilibrium	equilibrium	NN	I-NP	O
kinetics	kinetic	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
data	datum	NNS	I-NP	O
were	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
simple	simple	JJ	I-NP	O
reversible	reversible	JJ	I-NP	O
bimolecular	bimolecular	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
.	.	.	O	O

Arrhenius	Arrhenius	NNP	B-NP	O
and	and	CC	I-NP	O
Va	Va	NNP	I-NP	O
n't	n't	RB	O	O
Hoff	Hoff	NNP	B-NP	O
plots	plot	NNS	I-NP	O
were	be	VBD	B-VP	O
curvilinear	curvilinear	JJ	B-ADJP	O
for	for	IN	B-PP	O
both	both	DT	B-NP	O
steroids	steroid	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
equilibrium	equilibrium	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
solution	solution	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
equation	equation	NN	I-NP	B-protein
delta	delta	SYM	B-NP	I-protein
G	G	NN	I-NP	I-protein
=	=	SYM	B-VP	O
delta	delta	SYM	B-NP	O
H	H	NN	I-NP	O
-	-	HYPH	I-NP	O
T	T	NN	I-NP	B-protein
X	X	NN	I-NP	I-protein
delta	delta	NN	I-NP	I-protein
S	S	NN	I-NP	I-protein
(	(	(	O	O
eqn.	eqn.	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
)	)	)	O	O
was	be	VBD	B-VP	O
(	(	(	O	O
in	in	IN	B-PP	O
kJ	kJ	NN	B-NP	O
X	X	SYM	B-NP	O
mol-1	mol-1	NN	I-NP	O
)	)	)	O	O
-47	-47	CD	B-NP	O
=	=	SYM	B-VP	O
36	36	CD	B-NP	O
-	-	HYPH	I-NP	O
83	83	CD	I-NP	O
(	(	(	O	O
dexamethasone	dexamethasone	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
-42	-42	CD	B-NP	O
=	=	SYM	B-VP	O
-9	-9	CD	B-NP	O
-	-	HYPH	I-NP	O
33	33	CD	I-NP	O
(	(	(	O	O
cortisol	cortisol	NN	B-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
0	0	CD	B-NP	O
degree	degree	NN	I-NP	O
C	C	NN	I-NP	O
.	.	.	O	O

Enthalpy	Enthalpy	NN	B-NP	O
and	and	CC	I-NP	O
entropy	entropy	NN	I-NP	O
changes	change	NNS	I-NP	O
decreased	decrease	VBD	B-VP	O
quasi-linearly	quasi-linearly	RB	B-ADVP	O
with	with	IN	B-PP	O
temperature	temperature	NN	B-NP	O
such	such	JJ	B-NP	O
that	that	IN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
25	25	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
respective	respective	JJ	I-NP	O
values	value	NNS	I-NP	O
were	be	VBD	B-VP	O
-50	-50	CD	B-NP	O
=	=	SYM	B-VP	O
-75	-75	CD	B-NP	O
+	+	SYM	I-NP	O
25	25	CD	I-NP	O
and	and	CC	I-NP	O
-43	-43	CD	I-NP	O
=	=	SYM	B-VP	O
-48	-48	CD	B-NP	O
+	+	SYM	B-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
for	for	IN	B-PP	O
both	both	DT	B-NP	O
steroids	steroid	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
interaction	interaction	NN	I-NP	O
was	be	VBD	B-VP	O
entropy-driven	entropy-driven	JJ	B-ADJP	O
at	at	IN	B-PP	O
low	low	JJ	B-NP	O
temperature	temperature	NN	I-NP	O
and	and	CC	O	O
became	become	VBD	B-VP	O
entirely	entirely	RB	B-ADJP	O
enthalpy-driven	enthalpy-driven	JJ	I-ADJP	O
at	at	IN	B-PP	O
20	20	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
.	.	.	O	O

Thermodynamic	Thermodynamic	JJ	B-NP	O
values	value	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
transition	transition	NN	I-NP	O
state	state	NN	I-NP	O
were	be	VBD	B-VP	O
calculated	calculate	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
constants	constant	NNS	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
forward	forward	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
,	,	,	O	O
eqn.	eqn.	FW	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
gave	give	VBD	B-VP	O
45	45	CD	B-NP	O
=	=	SYM	B-VP	O
84	84	CD	B-NP	O
-	-	HYPH	I-NP	O
39	39	CD	I-NP	O
(	(	(	O	O
dexamethasone	dexamethasone	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
46	46	CD	B-NP	O
=	=	SYM	B-VP	O
60	60	CD	B-NP	O
-	-	HYPH	I-NP	O
14	14	CD	I-NP	O
(	(	(	O	O
cortisol	cortisol	NN	B-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
0	0	CD	B-NP	O
degree	degree	NN	I-NP	O
C	C	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
44	44	CD	B-NP	O
=	=	SYM	B-VP	O
24	24	CD	B-NP	O
+	+	SYM	I-NP	O
20	20	CD	I-NP	O
(	(	(	O	O
dexamethasone	dexamethasone	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
46	46	CD	B-NP	O
=	=	SYM	B-VP	O
28	28	CD	B-NP	O
+	+	SYM	B-NP	O
18	18	CD	I-NP	O
(	(	(	O	O
cortisol	cortisol	NN	B-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
25	25	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
fit	fit	VBP	B-VP	O
quite	quite	RB	B-ADVP	O
well	well	RB	I-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
two-step	two-step	JJ	I-NP	O
model	model	NN	I-NP	O
[	[	(	O	O
Ross	Ross	NNP	B-NP	O
&	&	CC	I-NP	O
Subramanian	Subramanian	NNP	I-NP	O
(	(	(	O	O
1981	1981	CD	B-NP	O
)	)	)	O	O
Biochemistry	Biochemistry	NNP	B-NP	O
20	20	CD	I-NP	O
,	,	,	I-NP	O
3096-3102	3096-3102	CD	I-NP	O
]	]	)	O	O
proposed	propose	VBN	B-VP	O
for	for	IN	B-PP	O
ligand-protein	ligand-protein	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
involves	involve	VBZ	B-VP	O
a	a	DT	B-NP	O
partial	partial	JJ	I-NP	O
immobilization	immobilization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
reacting	react	VBG	I-NP	O
species	specie	NNS	I-NP	O
governed	govern	VBN	B-VP	O
by	by	IN	B-PP	O
hydrophobic	hydrophobic	JJ	B-NP	O
forces	force	NNS	I-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
stabilization	stabilization	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
complex	complex	NN	I-NP	O
by	by	IN	B-PP	O
short-range	short-range	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
model	model	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transition-state	transition-state	JJ	I-NP	O
thermodynamics	thermodynamic	NNS	I-NP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
conclusion	conclusion	NN	I-NP	O
that	that	IN	B-SBAR	O
no	no	DT	B-NP	O
more	more	JJR	I-NP	O
than	than	IN	I-NP	O
half	half	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
steroid	steroid	NN	I-NP	O
molecular	molecular	JJ	I-NP	O
area	area	NN	I-NP	O
is	be	VBZ	B-VP	O
engaged	engage	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

Cell	Cell	NN	B-NP	O
cycle-related	cycle-related	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
number	number	NN	B-NP	O
of	of	IN	B-PP	O
T-lymphocyte	T-lymphocyte	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
for	for	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
and	and	CC	I-NP	O
insulin	insulin	NN	I-NP	B-protein
.	.	.	O	O

Enriched	Enrich	VBN	B-NP	O
human	human	JJ	I-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
T-lymphocytes	T-lymphocyte	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
stimulated	stimulate	VBN	I-VP	O
with	with	IN	B-PP	O
PHA	PHA	NN	B-NP	B-protein
and	and	CC	O	O
examined	examine	VBN	B-VP	O
for	for	IN	B-PP	O
variations	variation	NNS	B-NP	O
in	in	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
and	and	CC	O	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
(	(	(	O	I-protein
dexamethasone	dexamethasone	NN	B-NP	I-protein
)	)	)	O	I-protein
receptor	receptor	NN	B-NP	I-protein
numbers	number	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
phases	phase	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
.	.	.	O	O

Cells	Cell	NNS	B-NP	O
in	in	IN	B-PP	O
G0	G0	NN	B-NP	O
,	,	,	I-NP	O
G1a	G1a	NN	I-NP	B-protein
and	and	CC	I-NP	O
G1b	G1b	NN	I-NP	O
phases	phase	NNS	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
the	the	DT	B-NP	O
G1a	G1a	NN	I-NP	B-protein
-	-	HYPH	I-NP	O
G1b	G1b	NN	I-NP	O
transition	transition	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
Interleukin	Interleukin	NN	I-NP	B-protein
2	2	CD	I-NP	I-protein
dependent	dependent	JJ	I-NP	O
event	event	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
quantitated	quantitate	VBN	I-VP	O
by	by	IN	B-PP	O
flow	flow	NN	B-NP	O
cytometry	cytometry	NN	I-NP	O
.	.	.	O	O

Few	Few	JJ	B-NP	O
but	but	CC	I-NP	O
significant	significant	JJ	I-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
(	(	(	O	O
2700/cell	2700/cell	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
insulin	insulin	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
(	(	(	O	O
-1/cell	-1/cell	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
resting	resting	NN	I-NP	O
(	(	(	O	O
G0	G0	NN	B-NP	O
)	)	)	O	O
phase	phase	NN	B-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
cells	cell	NNS	B-NP	O
entered	enter	VBD	B-VP	O
the	the	DT	B-NP	O
G1a	G1a	NN	I-NP	O
phase	phase	NN	I-NP	O
the	the	DT	B-NP	O
specific	specific	JJ	I-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
increased	increase	VBD	B-VP	O
and	and	CC	O	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
took	take	VBD	B-VP	O
place	place	NN	B-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
specific	specific	JJ	I-NP	O
binding	binding	NN	I-NP	O
further	further	RBR	B-ADVP	O
increased	increase	VBD	B-VP	O
as	as	IN	B-SBAR	O
T-cells	T-cell	NNS	B-NP	B-cell_type
entered	enter	VBD	B-VP	O
the	the	DT	B-NP	O
G1b	G1b	NN	I-NP	O
phase	phase	NN	I-NP	O
(	(	(	O	O
as	as	IN	B-SBAR	O
measured	measure	VBN	B-VP	O
at	at	IN	B-PP	O
44	44	CD	B-NP	O
h	h	NN	I-NP	O
of	of	IN	B-PP	O
incubation	incubation	NN	B-NP	O
and	and	CC	O	O
using	use	VBG	B-VP	O
hydroxyurea-treated	hydroxyurea-treated	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
specific	specific	JJ	I-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
took	take	VBD	B-VP	O
place	place	NN	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
period	period	NN	I-NP	O
16	16	CD	I-NP	O
-	-	HYPH	I-NP	O
20	20	CD	I-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
.	.	.	O	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
these	these	DT	B-NP	O
findings	finding	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
both	both	CC	O	O
receptor	receptor	NN	B-NP	O
types	type	NNS	I-NP	O
(	(	(	O	O
cell	cell	NN	B-NP	O
membrane	membrane	NN	I-NP	O
and	and	CC	O	O
cytoplasmic	cytoplasmic	JJ	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
)	)	)	O	O
are	be	VBP	B-VP	O
being	be	VBG	I-VP	O
formed	form	VBN	I-VP	O
and	and	CC	O	O
increased	increase	VBN	B-VP	O
at	at	IN	B-PP	O
G1	G1	NN	B-NP	O
phase	phase	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
cell	cell	NN	B-NP	O
proliferation	proliferation	NN	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
G1	G1	NN	B-NP	O
phase	phase	NN	I-NP	O
in	in	IN	B-PP	O
immunoregulation	immunoregulation	NN	B-NP	O
.	.	.	O	O

Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
and	and	CC	O	O
cortico-sensitivity	cortico-sensitivity	NN	B-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	B-cell_line
clonal	clonal	JJ	I-NP	I-cell_line
monocytic	monocytic	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
,	,	,	O	O
CM-SM	CM-SM	NN	B-NP	B-cell_line
.	.	.	O	O

CM-SM	CM-SM	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
clonal	clonal	JJ	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
precursor	precursor	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
phagocytes	phagocyte	NNS	I-NP	I-cell_type
inducible	inducible	JJ	B-ADJP	O
to	to	TO	B-PP	O
macrophage	macrophage	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
tumor	tumor	NN	I-NP	O
promoter	promoter	NN	I-NP	O
phorbol	phorbol	NN	I-NP	O
ester	ester	NN	I-NP	O
12-O-tetradecanoyl-phorbol-13-acetate	12-O-tetradecanoyl-phorbol-13-acetate	NN	I-NP	O
(	(	(	O	O
TPA	TPA	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Untreated	Untreated	JJ	B-NP	B-cell_line
CM-SM	CM-SM	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
contain	contain	VBP	B-VP	O
single	single	JJ	B-NP	O
class	class	NN	I-NP	O
,	,	,	O	O
high-affinity	high-affinity	NN	B-NP	O
(	(	(	O	O
KD	KD	NN	B-NP	O
=	=	SYM	B-VP	O
4.0	4.0	CD	B-NP	O
X	X	SYM	O	O
10	10	CD	B-NP	O
(	(	(	O	O
-9	-9	CD	B-NP	O
)	)	)	O	O
M	M	NN	B-NP	O
)	)	)	O	O
glucocorticoid-specific	glucocorticoid-specific	JJ	B-NP	O
receptor	receptor	NN	I-NP	O
sites	site	NNS	I-NP	O
(	(	(	O	O
approximately	approximately	RB	B-NP	O
60	60	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
per	per	IN	B-PP	O
cell	cell	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
as	as	IN	B-SBAR	O
measured	measure	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
whole	whole	JJ	I-NP	O
cell	cell	NN	I-NP	O
assay	assay	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
37	37	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	NN	I-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	O	O
triamcinolone	triamcinolone	NN	B-NP	O
acetonide	acetonide	NN	I-NP	O
(	(	(	O	O
TA	TA	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Exposure	Exposure	NN	B-NP	O
of	of	IN	B-PP	O
CM-SM	CM-SM	NN	B-NP	B-protein
to	to	TO	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
(	(	(	O	O
DEX	DEX	NN	B-NP	O
)	)	)	O	O
produced	produce	VBD	B-VP	O
a	a	DT	B-NP	O
progressive	progressive	JJ	I-NP	O
,	,	,	I-NP	O
dose-	dose-	NN	I-NP	O
and	and	CC	I-NP	O
time-related	time-related	JJ	I-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
CM-SM	CM-SM	NN	B-NP	O
cell	cell	NN	I-NP	O
growth	growth	NN	I-NP	O
,	,	,	O	O
saturation	saturation	NN	B-NP	O
density	density	NN	I-NP	O
,	,	,	O	O
morphology	morphology	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
functional	functional	JJ	B-NP	O
properties	property	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
half-maximal	half-maximal	JJ	B-NP	O
effects	effect	NNS	I-NP	O
at	at	IN	B-PP	O
about	about	RB	B-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
-9	-9	CD	B-NP	O
)	)	)	O	O
M	M	NN	B-NP	O
for	for	IN	B-PP	O
DEX	DEX	NN	B-NP	O
.	.	.	O	O

TA-receptor	TA-receptor	NN	B-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
rapidly	rapidly	RB	B-ADVP	O
decreased	decrease	VBD	B-VP	O
(	(	(	O	O
about	about	RB	B-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
after	after	IN	B-PP	O
DEX	DEX	NN	B-NP	O
treatment	treatment	NN	I-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
steroid	steroid	NN	B-NP	O
specificity	specificity	NN	I-NP	O
and	and	CC	O	O
affinity	affinity	NN	B-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
in	in	IN	B-PP	O
culture	culture	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
saturating	saturating	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
(	(	(	O	O
3.6	3.6	CD	B-NP	O
X	X	SYM	O	O
10	10	CD	B-NP	O
(	(	(	O	O
-8	-8	CD	B-NP	O
)	)	)	O	O
M	M	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
hormone	hormone	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
reached	reach	VBD	B-VP	O
a	a	DT	B-NP	O
saturation	saturation	NN	I-NP	O
density	density	NN	I-NP	O
of	of	IN	B-PP	O
about	about	IN	B-NP	O
9.0	9.0	CD	I-NP	O
X	X	SYM	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
6	6	CD	B-NP	O
)	)	)	O	O
viable	viable	JJ	B-NP	O
cells/ml	cells/ml	NNS	I-NP	O
(	(	(	O	O
about	about	RB	B-NP	O
4.0	4.0	CD	I-NP	O
X	X	SYM	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
6	6	CD	B-NP	O
)	)	)	O	O
viable	viable	JJ	B-NP	O
cells/ml	cells/ml	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
controls	control	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
modal	modal	JJ	I-NP	O
volume	volume	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
resulting	result	VBG	I-NP	O
cell	cell	NN	I-NP	O
population	population	NN	I-NP	O
was	be	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
60	60	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
volume	volume	NN	I-NP	O
of	of	IN	B-PP	O
untreated	untreated	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

DEX-treated	DEX-treated	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
appeared	appear	VBD	B-VP	O
less	less	RBR	B-ADJP	O
differentiated	differentiate	VBN	I-ADJP	O
than	than	IN	B-PP	O
controls	control	NNS	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
assessed	assess	VBN	B-VP	O
by	by	IN	B-PP	O
combined	combine	VBN	B-NP	O
morphologic	morphologic	JJ	I-NP	O
,	,	,	I-NP	O
antigenic	antigenic	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
cytoenzymatic	cytoenzymatic	JJ	B-NP	O
analyses	analysis	NNS	I-NP	O
.	.	.	O	O

DEX	DEX	NN	B-NP	O
almost	almost	RB	B-ADVP	O
completely	completely	RB	I-ADVP	O
inhibited	inhibit	VBD	B-VP	O
TPA	TPA	NN	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
macrophage	macrophage	NN	I-NP	O
functions	function	NNS	I-NP	O
:	:	:	O	O
adherency	adherency	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
culture	culture	NN	I-NP	O
plate	plate	NN	I-NP	O
,	,	,	O	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
lysosomal	lysosomal	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
,	,	,	O	O
Fc	Fc	NN	B-NP	B-protein
and	and	CC	I-NP	O
C3	C3	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
stimulation	stimulation	NN	B-NP	O
of	of	IN	B-PP	O
phagocytosis	phagocytosis	NN	B-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
DEX	DEX	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
passages	passage	NNS	I-NP	O
,	,	,	O	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
state	state	NN	I-NP	O
apparently	apparently	RB	B-ADJP	O
identical	identical	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
untreated	untreated	JJ	I-NP	O
controls	control	NNS	I-NP	O
and	and	CC	O	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
induced	induce	VBN	I-VP	O
to	to	TO	B-PP	O
macrophage	macrophage	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
TPA	TPA	NN	B-NP	O
.	.	.	O	O

Acute	Acute	JJ	B-NP	O
lymphoblastic	lymphoblastic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
:	:	:	O	O
current	current	JJ	B-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
controversies	controversy	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
future	future	JJ	B-NP	O
perspective	perspective	NN	I-NP	O
.	.	.	O	O

Disease-free	Disease-free	JJ	B-NP	O
survival	survival	NN	I-NP	O
(	(	(	O	O
DFS	DFS	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
childhood	childhood	NN	B-NP	O
ALL	ALL	NN	I-NP	O
is	be	VBZ	B-VP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
survival	survival	NN	B-NP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
,	,	,	I-NP	O
average	average	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
poor	poor	JJ	B-NP	O
prognostic	prognostic	JJ	I-NP	O
groups	group	NNS	I-NP	O
defined	define	VBN	B-VP	O
by	by	IN	B-PP	O
initial	initial	JJ	B-NP	O
WBC	WBC	NN	I-NP	O
and	and	CC	I-NP	O
age	age	NN	I-NP	O
is	be	VBZ	B-VP	O
90	90	CD	B-NP	O
,	,	,	I-NP	O
60	60	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

Additional	Additional	JJ	B-NP	O
immunological	immunological	JJ	I-NP	O
,	,	,	I-NP	O
morphological	morphological	JJ	I-NP	O
,	,	,	I-NP	O
biochemical	biochemical	JJ	I-NP	O
,	,	,	I-NP	O
cytokinetic	cytokinetic	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
cytogenetic	cytogenetic	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
,	,	,	O	O
illustrating	illustrate	VBG	B-VP	O
the	the	DT	B-NP	O
heterogeneity	heterogeneity	NN	I-NP	O
of	of	IN	B-PP	O
ALL	ALL	NN	B-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
derivation	derivation	NN	I-NP	O
from	from	IN	B-PP	O
malignant	malignant	JJ	B-NP	B-cell_line
clones	clone	NNS	I-NP	I-cell_line
at	at	IN	B-PP	O
various	various	JJ	B-NP	O
stages	stage	NNS	I-NP	O
of	of	IN	B-PP	O
differentiation	differentiation	NN	B-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
varying	vary	VBG	B-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
proliferation	proliferation	NN	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
biologic	biologic	JJ	B-NP	O
importance	importance	NN	I-NP	O
,	,	,	O	O
these	these	DT	B-NP	O
factors	factor	NNS	I-NP	O
may	may	MD	B-VP	O
refine	refine	VB	I-VP	O
further	further	RBR	B-ADVP	O
the	the	DT	B-NP	O
characteristic	characteristic	JJ	I-NP	O
features	feature	NNS	I-NP	O
of	of	IN	B-PP	O
clinically-determined	clinically-determined	JJ	B-NP	O
prognostic	prognostic	JJ	I-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

Multivariate	Multivariate	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
large	large	JJ	B-NP	O
prospective	prospective	JJ	I-NP	O
trials	trial	NNS	I-NP	O
with	with	IN	B-PP	O
homogeneous	homogeneous	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
required	require	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
independent	independent	JJ	I-NP	O
prognostic	prognostic	JJ	I-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
factors	factor	NNS	I-NP	O
.	.	.	O	O

Current	Current	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
strategies	strategy	NNS	I-NP	O
in	in	IN	B-PP	O
ALL	ALL	NN	B-NP	O
include	include	VBP	B-VP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
tailoring	tailor	VBG	B-VP	O
therapy	therapy	NN	B-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
intensity	intensity	NN	I-NP	O
to	to	TO	B-PP	O
prognostic	prognostic	JJ	B-NP	O
groups	group	NNS	I-NP	O
;	;	:	O	O
(	(	(	B-LST	O
2	2	LS	I-LST	O
)	)	)	O	O
multiple-drug	multiple-drug	JJ	B-NP	O
combinations	combination	NNS	I-NP	O
in	in	IN	B-PP	O
induction	induction	NN	B-NP	O
;	;	:	O	O
(	(	(	B-LST	O
3	3	LS	I-LST	O
)	)	)	O	O
early	early	JJ	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
intrathecal	intrathecal	JJ	O	O
(	(	(	O	O
IT	IT	JJ	B-ADJP	O
)	)	)	O	O
methotrexate	methotrexate	NN	B-NP	O
(	(	(	O	O
MTX	MTX	NN	B-NP	B-protein
)	)	)	O	O
;	;	:	O	O
(	(	(	B-LST	O
4	4	LS	I-LST	O
)	)	)	O	O
CNS	CNS	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
with	with	IN	B-PP	O
IT	IT	NN	B-NP	B-protein
MTX	MTX	NN	I-NP	I-protein
alone	alone	RB	B-ADVP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
prognosis	prognosis	NN	I-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
combined	combined	JJ	B-NP	O
cranial	cranial	JJ	I-NP	O
radiation	radiation	NN	I-NP	O
(	(	(	O	O
CXRT	CXRT	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
1800	1800	CD	B-NP	O
rads	rad	NNS	I-NP	O
plus	plus	CC	O	O
IT	IT	NN	B-NP	B-protein
MTX	MTX	NN	I-NP	I-protein
,	,	,	O	O
in	in	IN	B-PP	O
average	average	JJ	B-NP	O
and	and	CC	I-NP	O
poor	poor	JJ	I-NP	O
prognosis	prognosis	NN	I-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Current	Current	JJ	B-NP	O
studies	study	NNS	I-NP	O
show	show	VBP	B-VP	O
a	a	DT	B-NP	O
CNS	CNS	NN	I-NP	B-protein
relapse	relapse	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
prognostic	prognostic	JJ	I-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

Late	Late	JJ	B-NP	O
neuropsychological	neuropsychological	JJ	I-NP	O
defects	defect	NNS	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
cranial	cranial	JJ	B-NP	O
XRT	XRT	NN	I-NP	O
and	and	CC	I-NP	O
IT	IT	NN	I-NP	B-protein
MTX	MTX	NN	I-NP	I-protein
have	have	VBP	B-VP	O
prompted	prompt	VBN	I-VP	O
programs	program	NNS	B-NP	O
designed	design	VBN	B-VP	O
to	to	TO	I-VP	O
reduce	reduce	VB	I-VP	O
the	the	DT	B-NP	O
potential	potential	JJ	I-NP	O
late	late	JJ	I-NP	O
toxicity	toxicity	NN	I-NP	O
of	of	IN	B-PP	O
CNS	CNS	NN	B-NP	B-protein
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

More	More	RBR	B-ADJP	O
pronounced	pronounced	JJ	I-ADJP	O
in	in	IN	B-PP	O
younger	young	JJR	B-NP	O
children	child	NNS	I-NP	O
,	,	,	O	O
these	these	DT	B-NP	O
abnormalities	abnormality	NNS	I-NP	O
include	include	VBP	B-VP	O
decreased	decrease	VBN	B-NP	O
IQ	IQ	NN	I-NP	O
,	,	,	O	O
visual-motor	visual-motor	JJ	B-NP	O
incoordination	incoordination	NN	I-NP	O
,	,	,	O	O
poor	poor	JJ	B-NP	O
performance	performance	NN	I-NP	O
in	in	IN	B-PP	O
mathematics	mathematic	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
memory	memory	NN	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

Until	Until	IN	B-PP	O
1980	1980	CD	B-NP	O
,	,	,	O	O
more	more	RBR	B-NP	O
intensive	intensive	JJ	I-NP	O
induction	induction	NN	I-NP	O
,	,	,	O	O
consolidation	consolidation	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
maintenance	maintenance	NN	B-NP	O
therapy	therapy	NN	I-NP	O
had	have	VBD	B-VP	O
failed	fail	VBN	I-VP	O
to	to	TO	I-VP	O
prolong	prolong	VB	I-VP	O
DFS	DFS	NN	B-NP	B-protein
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
poor	poor	JJ	I-NP	O
prognosis	prognosis	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
West	West	NNP	B-NP	O
Germany	Germany	NNP	I-NP	O
(	(	(	O	O
Berlin-Frankfurt-Muenster	Berlin-Frankfurt-Muenster	NNP	B-NP	O
protocol	protocol	NN	I-NP	O
)	)	)	O	O
a	a	DT	B-NP	O
70	70	CD	I-NP	O
to	to	TO	I-NP	O
75	75	CD	I-NP	O
%	%	NN	I-NP	O
DFS	DFS	NN	I-NP	O
is	be	VBZ	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
patients	patient	NNS	I-NP	O
regardless	regardless	RB	B-ADVP	O
of	of	IN	B-PP	O
initial	initial	JJ	B-NP	O
WBC	WBC	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
effective	effective	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
will	will	MD	B-VP	O
override	override	VB	I-VP	O
prognostic	prognostic	JJ	B-NP	O
factors	factor	NNS	I-NP	O
.	.	.	O	O

Ultra-high-dose	Ultra-high-dose	JJ	B-NP	O
MTX	MTX	NN	I-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
cranial	cranial	JJ	B-NP	O
radiation	radiation	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
showing	show	VBG	I-VP	O
promise	promise	NN	B-NP	O
in	in	IN	B-PP	O
poor	poor	JJ	B-NP	O
prognosis	prognosis	NN	I-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
issues	issue	NNS	I-NP	O
include	include	VBP	B-VP	O
the	the	DT	B-NP	O
optimal	optimal	JJ	I-NP	O
duration	duration	NN	I-NP	O
of	of	IN	B-PP	O
therapy	therapy	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
testicular	testicular	JJ	B-NP	O
biopsies	biopsy	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
prophylactic	prophylactic	JJ	B-NP	O
testicular	testicular	JJ	I-NP	O
radiation	radiation	NN	I-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
studies	study	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
prognostic	prognostic	JJ	B-NP	O
factors	factor	NNS	I-NP	O
lose	lose	VBP	B-VP	O
their	their	PRP$	B-NP	O
significance	significance	NN	I-NP	O
after	after	IN	B-PP	O
2	2	CD	B-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
continuous	continuous	JJ	B-NP	O
complete	complete	JJ	I-NP	O
remission	remission	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
2	2	CD	B-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
maintenance	maintenance	NN	B-NP	O
therapy	therapy	NN	I-NP	O
is	be	VBZ	B-VP	O
adequate	adequate	JJ	B-ADJP	O
.	.	.	O	O

Bilateral	Bilateral	JJ	B-NP	O
open-wedge	open-wedge	JJ	I-NP	O
testicular	testicular	JJ	I-NP	O
biopsies	biopsy	NNS	I-NP	O
have	have	VBP	B-VP	O
identified	identify	VBN	I-VP	O
occult	occult	JJ	B-NP	O
testicular	testicular	JJ	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
8	8	CD	B-NP	O
to	to	TO	I-NP	O
10	10	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
males	male	NNS	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
unified	unified	JJ	I-NP	O
approach	approach	NN	I-NP	O
to	to	TO	B-PP	O
children	child	NNS	B-NP	O
with	with	IN	B-PP	O
leukemia/lymphoma	leukemia/lymphoma	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
group	group	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
particularly	particularly	RB	I-NP	O
poor	poor	JJ	I-NP	O
prognosis	prognosis	NN	I-NP	O
,	,	,	O	O
utilizing	utilize	VBG	B-VP	O
NHL-type	NHL-type	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
more	more	RBR	B-ADJP	O
effective	effective	JJ	I-ADJP	O
than	than	IN	B-PP	O
conventional	conventional	JJ	B-NP	O
ALL	ALL	NN	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

(	(	(	O	O
ABSTRACT	ABSTRACT	NN	B-NP	O
TRUNCATED	TRUNCATED	VBN	B-VP	O
AT	AT	IN	B-PP	O
400	400	CD	B-NP	O
WORDS	WORDS	NNS	I-NP	O
)	)	)	O	O

Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
and	and	CC	O	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
to	to	TO	B-PP	O
steroid	steroid	NN	B-NP	O
hormones	hormone	NNS	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
lymphoproliferative	lymphoproliferative	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
and	and	CC	O	O
myeloid	myeloid	JJ	B-NP	O
leukemia	leukemia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
GR	GR	NN	B-NP	B-protein
)	)	)	O	O
quantitation	quantitation	NN	B-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
whole-cell	whole-cell	JJ	I-NP	O
assay	assay	NN	I-NP	O
and/or	and/or	CC	I-NP	O
cytosol	cytosol	NN	I-NP	O
technique	technique	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
to	to	TO	B-PP	O
steroids	steroid	NNS	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
assessed	assess	VBN	I-VP	O
in	in	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
normal	normal	JJ	B-NP	O
donors	donor	NNS	I-NP	O
and	and	CC	O	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
lymphatic	lymphatic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
CLL	CLL	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
acute	acute	JJ	B-NP	O
lymphoblastic	lymphoblastic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
ALL	ALL	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
lymphosarcoma	lymphosarcoma	NN	B-NP	O
cell	cell	NN	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
LSCL	LSCL	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
acute	acute	JJ	B-NP	O
nonlymphatic	nonlymphatic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
ANLL	ANLL	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
myeloid	myeloid	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
CML	CML	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Within	Within	IN	B-PP	O
the	the	DT	B-NP	O
lymphoproliferative	lymphoproliferative	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
,	,	,	O	O
ALL	ALL	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
exhibited	exhibit	VBD	B-VP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
GR	GR	NN	I-NP	B-protein
concentration	concentration	NN	I-NP	O
(	(	(	O	O
regardless	regardless	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
method	method	NN	I-NP	O
used	use	VBN	B-VP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
spontaneous	spontaneous	JJ	B-NP	O
[	[	(	I-NP	O
3H	3H	NN	I-NP	O
]	]	)	O	O
thymidine	thymidine	NN	B-NP	O
(	(	(	O	O
[	[	(	O	O
3H	3H	NN	O	O
]	]	)	O	O
TdR	TdR	NN	B-NP	O
)	)	)	O	O
uptake	uptake	NN	B-NP	O
by	by	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
significant	significant	JJ	I-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
concentration	concentration	NN	I-NP	O
(	(	(	O	O
whole-cell	whole-cell	JJ	B-NP	O
assay	assay	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
to	to	TO	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
found	find	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
contrary	contrary	NN	I-NP	O
,	,	,	O	O
CLL	CLL	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
presented	present	VBD	B-VP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
to	to	TO	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
in	in	IN	B-PP	O
PHA-stimulated	PHA-stimulated	JJ	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
.	.	.	O	O

Cells	Cell	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
only	only	JJ	I-NP	O
two	two	CD	I-NP	O
ALL	ALL	NN	I-NP	O
patients	patient	NNS	I-NP	O
who	who	WP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
undergo	undergo	VB	I-VP	O
a	a	DT	B-NP	O
remission	remission	NN	I-NP	O
after	after	IN	B-PP	O
glucocorticoid-inclusive	glucocorticoid-inclusive	JJ	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
had	have	VBD	B-VP	O
both	both	CC	O	O
the	the	DT	B-NP	O
lowest	low	JJS	I-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
to	to	TO	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
lowest	low	JJS	I-NP	O
GR	GR	NN	I-NP	B-protein
concentration	concentration	NN	I-NP	O
with	with	IN	B-PP	O
whole-cell	whole-cell	JJ	B-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

Concerning	Concern	VBG	B-VP	O
myeloid	myeloid	JJ	B-NP	O
leukemia	leukemia	NN	I-NP	O
,	,	,	O	O
ANLL	ANLL	NN	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
GR	GR	NN	B-NP	B-protein
concentrations	concentration	NNS	I-NP	O
slightly	slightly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ALL	ALL	NN	I-NP	O
group	group	NN	I-NP	O
but	but	CC	O	O
exhibited	exhibit	VBD	B-VP	O
the	the	DT	B-NP	O
lowest	low	JJS	I-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
spontaneous	spontaneous	JJ	B-NP	O
[	[	(	I-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
TdR	TdR	NN	I-NP	O
uptake	uptake	NN	I-NP	O
by	by	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
(	(	(	O	O
stimulatory	stimulatory	JJ	B-NP	O
effects	effect	NNS	I-NP	O
occurred	occur	VBD	B-VP	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
cases	case	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

CML	CML	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
exhibited	exhibit	VBD	B-VP	O
an	an	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
degree	degree	NN	I-NP	O
by	by	IN	B-PP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
glucocorticoids	glucocorticoid	NNS	I-NP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
ANLL	ANLL	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
but	but	CC	O	O
not	not	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
from	from	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
lymphoproliferative	lymphoproliferative	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
clear	clear	JJ	I-NP	O
relationship	relationship	NN	I-NP	O
among	among	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
pattern	pattern	NN	I-NP	O
,	,	,	O	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
cell	cell	NN	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
to	to	TO	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
clinicohematologic	clinicohematologic	JJ	B-NP	O
parameters	parameter	NNS	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
myeloid	myeloid	JJ	B-NP	O
leukemia-bearing	leukemia-bearing	JJ	I-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
and	and	CC	O	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
corticosensitivity	corticosensitivity	NN	I-NP	O
of	of	IN	B-PP	O
peanut-positive	peanut-positive	JJ	B-NP	O
and	and	CC	I-NP	O
peanut-negative	peanut-negative	JJ	I-NP	O
human	human	JJ	I-NP	O
thymocyte	thymocyte	NN	I-NP	O
subpopulations	subpopulation	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
6	6	CD	B-NP	O
human	human	JJ	I-NP	O
thymus	thymus	NN	I-NP	O
glands	gland	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
immature	immature	JJ	I-NP	B-cell_type
subset	subset	NN	I-NP	I-cell_type
of	of	IN	B-PP	O
thymocytes	thymocyte	NNS	B-NP	B-cell_type
was	be	VBD	B-VP	O
separated	separate	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
more	more	RBR	I-NP	O
mature	mature	JJ	I-NP	O
one	one	CD	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
differential	differential	JJ	B-NP	O
peanut	peanut	NN	I-NP	O
lectin	lectin	NN	I-NP	O
agglutination	agglutination	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
2	2	CD	I-NP	O
cell	cell	NN	I-NP	O
subpopulations	subpopulation	NNS	I-NP	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
for	for	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
content	content	NN	I-NP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
whole	whole	JJ	I-NP	O
cell	cell	NN	I-NP	O
assay	assay	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
(	(	(	O	O
3H	3H	NN	B-NP	O
)	)	)	O	O
-triamcinolone	-triamcinolone	JJ	B-NP	O
acetonide	acetonide	NN	I-NP	O
as	as	IN	B-PP	O
tracer	tracer	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
unagglutinated	unagglutinated	JJ	I-NP	B-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
(	(	(	O	O
peanut	peanut	NN	B-NP	O
negative	negative	JJ	I-NP	O
)	)	)	O	O
contained	contain	VBD	B-VP	O
about	about	RB	B-NP	O
2	2	CD	I-NP	O
times	time	NNS	I-NP	O
more	more	JJR	I-NP	O
receptor	receptor	NN	I-NP	O
sites	site	NNS	I-NP	O
per	per	IN	B-PP	O
cell	cell	NN	B-NP	O
than	than	IN	B-SBAR	O
agglutinated	agglutinate	VBN	B-VP	O
(	(	(	O	O
peanut	peanut	NN	B-NP	O
positive	positive	JJ	B-ADJP	O
)	)	)	O	O
ones	one	NNS	B-NP	O
(	(	(	O	O
7650	7650	CD	B-NP	O
+/-	+/-	CC	I-NP	O
1550	1550	CD	I-NP	O
S.D.	S.D.	NNP	I-NP	O
verus	verus	CC	O	O
3195	3195	CD	B-NP	O
+/-	+/-	CC	I-NP	O
896	896	CD	I-NP	O
S.D.	S.D.	NNP	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
affinity	affinity	NN	I-NP	O
for	for	IN	B-PP	O
steroid	steroid	NN	B-NP	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
cell	cell	NN	I-NP	B-cell_type
subsets	subset	NNS	I-NP	I-cell_type
,	,	,	O	O
as	as	IN	B-SBAR	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
stereospecificity	stereospecificity	NN	I-NP	O
for	for	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
time-course	time-course	NN	I-NP	O
of	of	IN	B-PP	O
steroid-receptor	steroid-receptor	JJ	B-NP	O
association	association	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
cytoplasmic	cytoplasmic	JJ	B-ADJP	O
to	to	TO	B-PP	O
nuclear	nuclear	JJ	B-NP	O
translocation	translocation	NN	I-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
the	the	DT	B-NP	O
greater	great	JJR	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
sites	site	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
peanut-negative	peanut-negative	JJ	I-NP	O
thymocyte	thymocyte	NN	I-NP	O
subpopulation	subpopulation	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
differ	differ	VB	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
peanut-positive	peanut-positive	JJ	I-NP	O
one	one	CD	I-NP	O
in	in	IN	B-PP	O
its	its	PRP$	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
triamcinolone	triamcinolone	NN	B-NP	O
acetonide	acetonide	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
measurements	measurement	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
incorporation	incorporation	NN	I-NP	O
of	of	IN	B-PP	O
radiolabeled	radiolabele	VBN	B-NP	O
precursors	precursor	NNS	I-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
and	and	CC	I-NP	O
DNA	DNA	NN	I-NP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
peanut-negative	peanut-negative	JJ	I-NP	O
subset	subset	NN	I-NP	O
appeared	appear	VBD	B-VP	O
more	more	RBR	B-ADJP	O
resistant	resistant	JJ	I-ADJP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
steroid-induced	steroid-induced	JJ	I-NP	O
cell	cell	NN	I-NP	O
lysis	lysis	NN	I-NP	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
peanut-positive	peanut-positive	JJ	I-NP	O
one	one	CD	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
our	our	PRP$	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
density	density	NN	I-NP	O
and	and	CC	I-NP	O
corticosensitivity	corticosensitivity	NN	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
directly	directly	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
sites	site	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
immunologic	immunologic	JJ	B-NP	O
maturation	maturation	NN	I-NP	O

Defective	Defective	JJ	B-NP	O
binding	binding	NN	I-NP	O
and	and	CC	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	B-protein
,	,	,	O	I-protein
25-dihydroxyvitamin	25-dihydroxyvitamin	NN	B-NP	I-protein
D3	D3	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
end-organ	end-organ	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
25-dihydroxyvitamin	25-dihydroxyvitamin	NN	B-NP	O
D	D	NN	I-NP	O
.	.	.	O	O

Lectin-induced	Lectin-induced	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
synthesis	synthesis	NN	I-NP	O
by	by	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
17	17	CD	B-NP	O
normal	normal	JJ	I-NP	O
donors	donor	NNS	I-NP	O
was	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
(	(	(	O	O
40-60	40-60	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
25-dihydroxyvitamin	25-dihydroxyvitamin	NN	B-NP	O
D3	D3	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
[	[	(	O	O
OH	OH	NN	B-NP	O
]	]	)	O	O
2D3	2D3	NN	B-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
physiological	physiological	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
(	(	(	O	O
10	10	CD	B-NP	O
(	(	(	O	O
-10	-10	CD	B-NP	O
)	)	)	O	O
-10	-10	CD	B-NP	O
(	(	(	O	O
-9	-9	CD	B-NP	O
)	)	)	O	O
M	M	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	B-cell_type
acquire	acquire	VBP	B-VP	O
specific	specific	JJ	B-NP	O
receptors	receptor	NNS	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
upon	upon	IN	B-PP	O
activation	activation	NN	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
lectins	lectin	NNS	I-NP	B-protein
.	.	.	O	O

This	This	DT	B-NP	O
process	process	NN	I-NP	O
precedes	precede	VBZ	B-VP	O
the	the	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
studied	study	VBD	B-VP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
six	six	CD	B-NP	O
patients	patient	NNS	I-NP	O
from	from	IN	B-PP	O
four	four	CD	B-NP	O
different	different	JJ	I-NP	O
kindreds	kindred	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
syndrome	syndrome	NN	I-NP	O
of	of	IN	B-PP	O
hereditary	hereditary	JJ	B-NP	O
end-organ	end-organ	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D	2D	NN	B-NP	O
(	(	(	O	O
the	the	DT	B-NP	O
so-called	so-called	JJ	I-NP	O
vitamin	vitamin	NN	I-NP	O
D-dependent	D-dependent	JJ	I-NP	O
rickets	ricket	NNS	I-NP	O
type	type	NN	I-NP	O
II	II	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
five	five	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
three	three	CD	B-NP	O
kindreds	kindred	NNS	I-NP	O
)	)	)	O	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
acquire	acquire	VB	I-VP	O
receptors	receptor	NNS	B-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
upon	upon	IN	B-PP	O
phytohemagglutinin-induced	phytohemagglutinin-induced	JJ	B-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
the	the	DT	B-NP	O
mitogenic	mitogenic	JJ	I-NP	O
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
patients	patient	NNS	I-NP	O
'	'	POS	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	B-cell_type
by	by	IN	B-PP	O
phytohemagglutinin	phytohemagglutinin	NN	B-NP	B-protein
and	and	CC	I-NP	O
concanavalin	concanavalin	NN	I-NP	O
A	A	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
.	.	.	O	O

Activated	Activate	VBN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
the	the	DT	B-NP	O
sixth	sixth	JJ	I-NP	O
patient	patient	NN	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
fourth	fourth	JJ	I-NP	O
kindred	kindred	NN	I-NP	O
exhibited	exhibit	VBD	B-VP	O
normal	normal	JJ	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
but	but	CC	O	O
the	the	DT	B-NP	O
hormone	hormone	NN	I-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
inhibit	inhibit	VB	I-VP	O
the	the	DT	B-NP	O
mitogenic	mitogenic	JJ	I-NP	O
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
similar	similar	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
vitamin	vitamin	NN	I-NP	O
D	D	NN	I-NP	O
effector	effector	NN	I-NP	O
system	system	NN	I-NP	O
was	be	VBD	B-VP	O
previously	previously	RB	I-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
fibroblasts	fibroblast	NNS	B-NP	B-cell_type
cultured	culture	VBN	B-VP	O
from	from	IN	B-PP	O
skin	skin	NN	B-NP	O
biopsies	biopsy	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
conclusions	conclusion	NNS	I-NP	O
from	from	IN	B-PP	O
these	these	DT	B-NP	O
findings	finding	NNS	I-NP	O
are	be	VBP	B-VP	O
:	:	:	O	O
(	(	(	B-LST	O
a	a	LS	I-LST	O
)	)	)	O	O
the	the	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
mitogenic	mitogenic	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
specific	specific	JJ	B-NP	O
functional	functional	JJ	I-NP	O
receptors	receptor	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hormone	hormone	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
(	(	(	B-LST	O
b	b	LS	I-LST	O
)	)	)	O	O
the	the	DT	B-NP	O
receptors	receptor	NNS	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
in	in	IN	B-PP	O
mononuclear	mononuclear	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
probably	probably	RB	I-VP	O
controlled	control	VBN	I-VP	O
genetically	genetically	RB	B-ADVP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
effector	effector	NN	I-NP	O
system	system	NN	I-NP	O
in	in	IN	B-PP	O
well-characterized	well-characterized	JJ	B-NP	O
target	target	NN	I-NP	O
organs	organ	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hormone	hormone	NN	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
intestine	intestine	NN	B-NP	O
and	and	CC	I-NP	O
kidney	kidney	NN	I-NP	O
.	.	.	O	O

Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
of	of	IN	B-PP	O
mononuclear	mononuclear	JJ	B-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
myasthenia	myasthenia	NN	B-NP	O
gravis	gravis	NN	I-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
to	to	TO	I-VP	O
analyse	analyse	VB	I-VP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
GR	GR	NN	B-NP	B-protein
)	)	)	O	O
binding	binding	NN	B-NP	O
in	in	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
(	(	(	O	O
MNL	MNL	NNS	B-NP	B-cell_type
)	)	)	O	O
from	from	IN	B-PP	O
39	39	CD	B-NP	O
myasthenia	myasthenia	NN	I-NP	O
gravis	gravis	NN	I-NP	O
(	(	(	O	O
MG	MG	NN	B-NP	O
)	)	)	O	O
patients	patient	NNS	B-NP	O
(	(	(	O	O
unoperated	unoperated	JJ	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
13	13	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
thymectomized	thymectomize	VBN	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
14	14	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
patients	patient	NNS	B-NP	O
receiving	receive	VBG	B-VP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
:	:	:	O	O
thymectomized	thymectomize	VBN	B-VP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
11	11	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
unoperated	unoperated	JJ	B-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
6	6	CD	B-NP	O
]	]	)	O	O
.	.	.	O	O

A	A	DT	B-NP	O
whole	whole	JJ	I-NP	O
cell	cell	NN	I-NP	O
binding	binding	NN	I-NP	O
assay	assay	NN	I-NP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
(	(	(	O	O
H	H	NN	B-NP	O
)	)	)	O	O
dexamethasone	dexamethasone	NN	B-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
.	.	.	O	O

GR	GR	NN	B-NP	B-protein
mean	mean	NN	I-NP	O
values	value	NNS	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MNL	MNL	NN	I-NP	B-cell_type
of	of	IN	B-PP	O
MG	MG	NN	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
thymectomized	thymectomize	VBN	B-VP	O
or	or	CC	O	O
not	not	RB	O	O
)	)	)	O	O
not	not	RB	O	O
receiving	receive	VBG	B-VP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MNL	MNL	NN	I-NP	B-cell_type
of	of	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
donors	donor	NNS	I-NP	O
.	.	.	O	O

Affinity	Affinity	NN	B-NP	O
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

Sex	Sex	NN	B-NP	B-protein
,	,	,	O	O
age	age	NN	B-NP	O
or	or	CC	O	O
clinical	clinical	JJ	B-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
illness	illness	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
influence	influence	VB	I-VP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
patients	patient	NNS	B-NP	O
receiving	receive	VBG	B-VP	O
prednisone	prednisone	NN	B-NP	O
(	(	(	O	O
Pd	Pd	NN	B-NP	O
)	)	)	O	O
the	the	DT	B-NP	O
GR	GR	NN	I-NP	B-protein
values	value	NNS	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
MG	MG	NN	B-NP	O
patients	patient	NNS	I-NP	O
without	without	IN	B-PP	O
Pd	Pd	NN	B-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
Pd	Pd	NN	B-NP	O
dose	dose	NN	I-NP	O
or	or	CC	O	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
administration	administration	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
receptor	receptor	NN	B-NP	O
binding	binding	NN	I-NP	O
between	between	IN	B-PP	O
normal	normal	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
and	and	CC	O	O
MG	MG	NN	B-NP	O
patients	patient	NNS	I-NP	O
receiving	receive	VBG	B-VP	O
Pd	Pd	NN	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
.	.	.	O	O

Immunological	Immunological	JJ	B-NP	O
interference	interference	NN	I-NP	O
of	of	IN	B-PP	O
high	high	JJ	B-NP	O
dose	dose	NN	I-NP	O
corticosteroids	corticosteroid	NNS	I-NP	O
.	.	.	O	O

High-dose	High-dose	JJ	B-NP	O
corticosteroids	corticosteroid	NNS	I-NP	O
(	(	(	O	O
HDC	HDC	NN	B-NP	B-cell_type
)	)	)	O	O
will	will	MD	B-VP	O
influence	influence	VB	I-VP	O
cellular	cellular	JJ	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
humoral	humoral	JJ	B-NP	O
participants	participant	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
lymphoid	lymphoid	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
will	will	MD	B-VP	O
decrease	decrease	VB	I-VP	O
in	in	IN	B-PP	O
size	size	NN	B-NP	O
and	and	CC	I-NP	O
weight	weight	NN	I-NP	O
after	after	IN	B-PP	O
prolonged	prolonged	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
HDC	HDC	NN	B-NP	B-cell_type
.	.	.	O	O

Lymphocyte	Lymphocyte	NN	B-NP	O
functions	function	NNS	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
impaired	impair	VBN	I-VP	O
.	.	.	O	O

Reduced	Reduce	VBN	B-NP	O
synthesis	synthesis	NN	I-NP	O
of	of	IN	B-PP	O
B-	B-	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
T-lymphocytes	T-lymphocyte	NNS	B-NP	B-cell_type
will	will	MD	B-VP	O
be	be	VB	I-VP	O
seen	see	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
B-cell	B-cell	NN	B-NP	B-cell_type
function	function	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
observed	observe	VBN	I-VP	O
both	both	CC	O	O
as	as	IN	B-SBAR	O
decreased	decrease	VBN	B-NP	O
serum	serum	NN	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
immunoglobulins	immunoglobulin	NNS	B-NP	B-protein
and	and	CC	B-PP	O
as	as	IN	B-PP	O
impaired	impaired	JJ	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
antibodies	antibody	NNS	B-NP	B-protein
and	and	CC	O	O
complement	complement	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
surface	surface	NN	I-NP	O
.	.	.	O	O

Reduced	Reduce	VBN	B-NP	O
T-cell	T-cell	NN	I-NP	O
function	function	NN	I-NP	O
indicated	indicate	VBN	B-VP	O
by	by	IN	B-PP	O
impaired	impaired	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
by	by	IN	B-PP	O
PHA	PHA	NN	B-NP	B-protein
and	and	CC	I-NP	O
porkweed	porkweed	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
by	by	IN	B-PP	O
impaired	impaired	JJ	B-NP	O
lymphokinin	lymphokinin	NN	I-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
leukocyte	leukocyte	NN	B-NP	O
migration	migration	NN	I-NP	O
inhibition	inhibition	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
.	.	.	O	O

Reduced	Reduce	VBN	B-NP	O
lymphocyte	lymphocyte	NN	I-NP	O
adherence	adherence	NN	I-NP	O
to	to	TO	B-PP	O
antigen	antigen	NN	B-NP	O
and	and	CC	O	O
suppressed	suppress	VBD	B-VP	O
lymphocyte	lymphocyte	NN	B-NP	O
reaction	reaction	NN	I-NP	O
have	have	VBP	B-VP	O
also	also	RB	I-VP	O
been	be	VBN	I-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

Humoral	Humoral	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
chemotaxis	chemotaxis	NN	B-NP	O
,	,	,	O	O
opsonisation	opsonisation	NN	B-NP	O
,	,	,	O	O
phagocytosis	phagocytosis	NN	B-NP	O
,	,	,	O	O
vascular	vascular	JJ	B-NP	O
permeability	permeability	NN	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
leakage	leakage	NN	B-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
and	and	CC	I-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
factors	factor	NNS	B-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
lysis	lysis	NN	B-NP	O
of	of	IN	B-PP	O
antigens	antigen	NNS	B-NP	B-protein
are	be	VBP	B-VP	O
impaired	impaired	JJ	B-ADJP	O
.	.	.	O	O

This	This	DT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
explained	explain	VBN	I-VP	O
partly	partly	RB	B-ADVP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
observed	observe	VBN	I-NP	O
reduced	reduce	VBN	I-NP	O
complement	complement	NN	I-NP	O
activation	activation	NN	I-NP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
alternative	alternative	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
classical	classical	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
in	in	IN	B-PP	O
association	association	NN	B-NP	O
with	with	IN	B-PP	O
HDC	HDC	NN	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

Acute	Acute	JJ	B-NP	O
processes	process	NNS	I-NP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
vascular	vascular	JJ	I-NP	O
permeability	permeability	NN	I-NP	O
and	and	CC	I-NP	O
accumulation	accumulation	NN	I-NP	O
of	of	IN	B-PP	O
leukocytes	leukocyte	NNS	B-NP	B-cell_type
as	as	IN	B-PP	O
impairing	impair	VBG	B-VP	B-protein
factors	factor	NNS	B-NP	I-protein
could	could	MD	B-VP	O
be	be	VB	I-VP	O
influenced	influence	VBN	I-VP	O
beneficially	beneficially	RB	B-ADVP	O
by	by	IN	B-PP	O
HDC	HDC	NN	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
positive	positive	JJ	I-NP	O
effect	effect	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
septic	septic	JJ	B-NP	O
shock	shock	NN	I-NP	O
or	or	CC	I-NP	O
rejection	rejection	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
transplant	transplant	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
sepsis	sepsis	NN	B-NP	O
or	or	CC	I-NP	O
rejection	rejection	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
rapidly	rapidly	RB	B-ADVP	O
reversed	reverse	VBD	B-VP	O
,	,	,	O	O
complications	complication	NNS	B-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
multisystem	multisystem	JJ	B-NP	O
organ	organ	NN	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
bacteremia	bacteremia	NN	B-NP	O
are	be	VBP	B-VP	O
prone	prone	JJ	B-ADJP	O
to	to	TO	B-VP	O
appear	appear	VB	I-VP	O
.	.	.	O	O

Identification	Identification	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-protein
leukemic	leukemic	JJ	I-NP	I-protein
glucocorticoid	glucocorticoid	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
using	use	VBG	B-VP	O
affinity	affinity	NN	B-NP	O
labeling	labeling	NN	I-NP	O
and	and	CC	O	O
anti-human	anti-human	JJ	B-NP	B-protein
glucocorticoid	glucocorticoid	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
antibodies	antibody	NNS	I-NP	I-protein
.	.	.	O	O

Antisera	Antiserum	NNS	B-NP	O
raised	raise	VBN	B-VP	O
against	against	IN	B-PP	O
human	human	JJ	B-NP	B-protein
lymphoid	lymphoid	JJ	I-NP	I-protein
glucocorticoid	glucocorticoid	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
affinity	affinity	NN	I-NP	O
label	label	NN	I-NP	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	O	O
dexamethasone	dexamethasone	NN	B-NP	O
21-mesylate	21-mesylate	NN	I-NP	O
[	[	(	O	O
(	(	(	O	O
3H	3H	NN	B-NP	O
]	]	)	O	O
DM	DM	NN	B-NP	O
)	)	)	O	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-cell_line
B-lymphoblastoid	B-lymphoblastoid	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
IM-9	IM-9	NN	I-NP	B-cell_line
and	and	CC	O	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-cell_line
T-cell	T-cell	NN	I-NP	I-cell_line
leukemic	leukemic	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
CEM-C7	CEM-C7	NN	I-NP	B-cell_line
.	.	.	O	O

Antisera	Antiserum	NNS	B-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
following	follow	VBG	B-PP	O
immunization	immunization	NN	B-NP	O
of	of	IN	B-PP	O
New	New	NNP	B-NP	O
Zealand	Zealand	NNP	I-NP	O
White	White	NNP	I-NP	O
rabbits	rabbit	NNS	I-NP	O
with	with	IN	B-PP	O
[	[	(	O	O
3H	3H	NN	O	O
]	]	)	O	O
triamcinolone	triamcinolone	NN	B-NP	O
acetonide	acetonide	NN	I-NP	O
[	[	(	O	O
(	(	(	O	O
3H	3H	NN	B-NP	O
]	]	)	O	O
TA	TA	NN	B-NP	O
)	)	)	O	O
-glucocorticoid	-glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
partially	partially	RB	B-VP	O
purified	purify	VBN	I-VP	O
by	by	IN	B-PP	O
two-stage	two-stage	JJ	B-NP	O
DNA-cellulose	DNA-cellulose	JJ	I-NP	O
chromatography	chromatography	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
anti-human	anti-human	JJ	B-NP	B-protein
glucocorticoid	glucocorticoid	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
antibodies	antibody	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
verified	verify	VBN	I-VP	O
by	by	IN	B-PP	O
:	:	:	O	O
(	(	(	B-LST	O
a	a	LS	I-LST	O
)	)	)	O	O
adsorption	adsorption	NN	B-NP	O
of	of	IN	B-PP	O
[	[	(	O	B-protein
3H	3H	NN	B-NP	I-protein
]	]	)	I-NP	I-protein
TA-receptor-antibody	TA-receptor-antibody	NN	I-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
to	to	TO	B-PP	O
Protein	Protein	NN	B-NP	B-protein
A	A	NN	I-NP	I-protein
;	;	:	O	O
(	(	(	B-LST	O
b	b	LS	I-LST	O
)	)	)	O	O
a	a	DT	B-NP	O
shift	shift	NN	I-NP	O
to	to	TO	B-PP	O
higher	high	JJR	B-NP	O
apparent	apparent	JJ	I-NP	O
molecular	molecular	JJ	I-NP	O
weight	weight	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
elution	elution	NN	I-NP	O
position	position	NN	I-NP	O
from	from	IN	B-PP	O
Sephacryl	Sephacryl	NN	B-NP	O
S300	S300	NN	I-NP	O
of	of	IN	B-PP	O
[	[	(	O	B-protein
3H	3H	NN	B-NP	I-protein
]	]	)	I-NP	I-protein
TA-receptor	TA-receptor	NN	I-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
incubated	incubate	VBN	B-VP	O
with	with	IN	B-PP	O
immune	immune	JJ	B-NP	O
serum	serum	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
(	(	(	B-LST	O
c	c	LS	I-LST	O
)	)	)	O	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
immune	immune	JJ	B-NP	O
serum	serum	NN	I-NP	O
to	to	TO	B-VP	O
displace	displace	VB	I-VP	O
[	[	(	O	B-protein
3H	3H	NN	B-NP	I-protein
]	]	)	O	I-protein
TA-receptor	TA-receptor	NN	B-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
on	on	IN	B-PP	O
sucrose	sucrose	NN	B-NP	O
gradients	gradient	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
antibodies	antibody	NNS	I-NP	B-protein
also	also	RB	B-ADVP	O
recognized	recognize	VBD	B-VP	O
rat	rat	NN	B-NP	O
liver	liver	NN	I-NP	O
and	and	CC	O	O
murine	murine	JJ	B-NP	O
S49	S49	NN	I-NP	O
cell	cell	NN	I-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
.	.	.	O	O

Sodium	Sodium	NN	B-NP	O
dodecyl	dodecyl	NN	I-NP	O
sulfate-polyacrylamide	sulfate-polyacrylamide	NN	I-NP	O
gel	gel	NN	I-NP	O
electrophoresis	electrophoresis	NN	I-NP	O
of	of	IN	B-PP	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
DM-labeled	DM-labeled	JJ	I-NP	O
IM-9	IM-9	NN	I-NP	O
cytosol	cytosol	NN	I-NP	O
identified	identify	VBD	B-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
competable	competable	JJ	I-NP	O
band	band	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
90	90	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
,	,	,	I-NP	O
three	three	CD	I-NP	O
minor	minor	JJ	I-NP	B-protein
competable	competable	JJ	I-NP	I-protein
components	component	NNS	I-NP	I-protein
with	with	IN	B-PP	O
molecular	molecular	JJ	B-NP	O
weights	weight	NNS	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
78	78	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
,	,	,	O	O
approximately	approximately	RB	B-NP	O
51	51	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
approximately	approximately	RB	B-NP	O
38	38	CD	I-NP	O
,	,	,	I-NP	O
500	500	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
21	21	CD	I-NP	O
other	other	JJ	I-NP	O
noncompetable	noncompetable	JJ	I-NP	B-protein
components	component	NNS	I-NP	I-protein
.	.	.	O	O

Following	Follow	VBG	B-NP	O
immunoprecipitation	immunoprecipitation	NN	I-NP	O
of	of	IN	B-PP	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
DM-labeled	DM-labeled	JJ	I-NP	O
cytosol	cytosol	NN	I-NP	O
with	with	IN	B-PP	O
immune	immune	JJ	B-NP	O
serum	serum	NN	I-NP	O
,	,	,	O	O
only	only	RB	B-NP	O
the	the	DT	I-NP	O
Mr	Mr	NN	I-NP	O
90	90	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
and	and	CC	I-NP	O
78	78	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
components	component	NNS	I-NP	O
were	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
.	.	.	O	O

Sodium	Sodium	NN	B-NP	O
dodecyl	dodecyl	NN	I-NP	O
sulfate-polyacrylamide	sulfate-polyacrylamide	NN	I-NP	O
gel	gel	NN	I-NP	O
electrophoresis	electrophoresis	NN	I-NP	O
of	of	IN	B-PP	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
DM-labeled	DM-labeled	JJ	I-NP	O
CEM-C7	CEM-C7	NN	I-NP	O
cytosol	cytosol	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
larger	large	JJR	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
[	[	(	B-NP	B-protein
3H	3H	NN	I-NP	I-protein
]	]	)	I-NP	I-protein
DM-labeled	DM-labeled	JJ	I-NP	I-protein
components	component	NNS	I-NP	I-protein
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
after	after	IN	B-PP	O
immunoprecipitation	immunoprecipitation	NN	B-NP	O
of	of	IN	B-PP	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
DM-labeled	DM-labeled	JJ	I-NP	O
CEM-C7	CEM-C7	NN	I-NP	O
cytosol	cytosol	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
predominant	predominant	JJ	I-NP	O
competable	competable	JJ	I-NP	O
component	component	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
90	90	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
was	be	VBD	B-VP	O
easily	easily	RB	I-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
component	component	NN	I-NP	O
was	be	VBD	B-VP	O
markedly	markedly	RB	I-VP	O
diminished	diminish	VBN	I-VP	O
when	when	WRB	B-ADVP	O
cytosols	cytosol	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-cell_line
receptor-deficient	receptor-deficient	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
ICR-27	ICR-27	NN	I-NP	B-cell_line
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
affinity	affinity	NN	B-NP	O
labeling	labeling	NN	I-NP	O
and	and	CC	O	O
anti-human	anti-human	JJ	B-NP	B-protein
glucocorticoid	glucocorticoid	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
antibodies	antibody	NNS	I-NP	I-protein
is	be	VBZ	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
providing	provide	VBG	B-VP	O
direct	direct	JJ	B-NP	O
physical	physical	JJ	I-NP	O
identification	identification	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-protein
lymphoid	lymphoid	JJ	I-NP	I-protein
glucocorticoid	glucocorticoid	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
.	.	.	O	O

Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
thymosin	thymosin	NN	B-NP	O
on	on	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
and	and	CC	O	O
glucocorticoid	glucocorticoid	NN	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Incubation	Incubation	NN	B-NP	O
with	with	IN	B-PP	O
thymosin	thymosin	NN	B-NP	B-protein
fraction	fraction	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
,	,	,	O	O
(	(	(	O	O
TMS	TMS	NNP	B-NP	O
F5	F5	NNP	I-NP	O
at	at	IN	B-PP	O
300	300	CD	B-NP	O
micrograms/ml	micrograms/ml	NN	I-NP	O
)	)	)	O	O
a	a	DT	B-NP	O
partially	partially	RB	I-NP	O
purified	purify	VBN	I-NP	B-protein
thymic	thymic	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
reduced	reduce	VBD	B-VP	O
the	the	DT	B-NP	O
steroid	steroid	NN	I-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
infant	infant	NN	I-NP	I-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
9.6	9.6	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
2.1	2.1	CD	I-NP	O
fmole/ml	fmole/ml	NN	I-NP	O
to	to	TO	B-PP	O
5.0	5.0	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
2.0	2.0	CD	I-NP	O
fmole/ml	fmole/ml	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
infant	infant	NN	I-NP	I-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
2	2	CD	B-NP	O
,	,	,	I-NP	O
146	146	CD	I-NP	O
+/-	+/-	CC	I-NP	O
726	726	CD	I-NP	O
(	(	(	O	O
s.d.	s.d.	NN	B-NP	O
)	)	)	O	O
sites	site	NNS	B-NP	O
per	per	IN	B-PP	O
cell	cell	NN	B-NP	O
with	with	IN	B-PP	O
dissociation	dissociation	NN	B-NP	O
constant	constant	NN	I-NP	O
of	of	IN	B-PP	O
1.4	1.4	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
0.6	0.6	CD	I-NP	O
X	X	SYM	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
-8	-8	CD	B-NP	O
)	)	)	O	O
M	M	NN	B-NP	O
.	.	.	O	O

TMS	TMS	NN	B-NP	B-protein
F5	F5	NN	I-NP	I-protein
also	also	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
the	the	DT	B-NP	O
resistance	resistance	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cytolytic	cytolytic	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
(	(	(	O	O
2.5	2.5	CD	B-NP	O
X	X	SYM	O	O
10	10	CD	B-NP	O
(	(	(	O	O
-8	-8	CD	B-NP	O
)	)	)	O	O
M	M	NN	B-NP	O
)	)	)	O	O
to	to	TO	B-PP	O
168.6	168.6	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
30.2	30.2	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
control	control	NN	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.01	0.01	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
animals	animal	NNS	B-NP	O
,	,	,	O	O
medullary	medullary	JJ	B-NP	O
and	and	CC	I-NP	O
peripheral	peripheral	JJ	I-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
more	more	RBR	B-ADJP	O
resistant	resistant	JJ	I-ADJP	O
to	to	TO	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
than	than	IN	B-PP	O
immature	immature	JJ	B-NP	B-cell_type
thymic	thymic	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
thymosin	thymosin	NN	B-NP	O
can	can	MD	B-VP	O
induce	induce	VB	I-VP	O
changes	change	NNS	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
differentiation	differentiation	NN	B-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

These	These	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
results	result	NNS	I-NP	O
are	be	VBP	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
physiological	physiological	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
thymosin	thymosin	NN	B-NP	B-protein
in	in	IN	B-PP	O
intrathymic	intrathymic	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
maturation	maturation	NN	I-NP	O
in	in	IN	B-PP	O
man	man	NN	B-NP	O
.	.	.	O	O

Incubation	Incubation	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	B-cell_line
malignant	malignant	JJ	I-NP	I-cell_line
thymus	thymus	NN	I-NP	I-cell_line
derived	derive	VBN	I-NP	I-cell_line
T	T	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
(	(	(	O	O
MOLT	MOLT	NN	B-NP	B-cell_line
3	3	CD	I-NP	I-cell_line
)	)	)	O	O
with	with	IN	B-PP	O
TMS	TMS	NN	B-NP	B-protein
F5	F5	NN	I-NP	I-protein
also	also	RB	B-ADVP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
steroid	steroid	NN	B-NP	B-protein
binding	binding	NN	I-NP	I-protein
sites	site	NNS	I-NP	I-protein
to	to	TO	B-PP	O
44.2	44.2	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
15.3	15.3	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
control	control	NN	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
but	but	CC	O	O
TMS	TMS	NN	B-NP	B-protein
F5	F5	NN	I-NP	I-protein
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
significantly	significantly	RB	I-VP	O
reduce	reduce	VB	I-VP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
MOLT	MOLT	NN	B-NP	B-cell_line
3	3	CD	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Specific	Specific	JJ	B-NP	O
high-affinity	high-affinity	JJ	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
for	for	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
25-dihydroxyvitamin	25-dihydroxyvitamin	NN	B-NP	O
D3	D3	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
:	:	:	O	O
presence	presence	NN	B-NP	O
in	in	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
induction	induction	NN	B-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
following	follow	VBG	B-PP	O
activation	activation	NN	B-NP	O
.	.	.	O	O

Human	Human	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
have	have	VBP	B-VP	O
high	high	JJ	B-NP	B-DNA
affinity	affinity	NN	I-NP	I-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
for	for	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25-	25-	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
(	(	(	O	O
Kd	Kd	NN	B-NP	O
0.14	0.14	CD	I-NP	O
nM	nM	NN	I-NP	O
,	,	,	O	O
sedimentation	sedimentation	NN	B-NP	O
coefficient	coefficient	JJ	I-NP	O
3.7S	3.7S	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Resting	Rest	VBG	B-VP	B-cell_type
human	human	JJ	B-NP	I-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
demonstrable	demonstrable	JJ	I-NP	B-protein
1	1	CD	I-NP	I-protein
,	,	,	I-NP	I-protein
25-	25-	CD	I-NP	I-protein
(	(	(	O	I-protein
OH	OH	NN	B-NP	I-protein
)	)	)	O	I-protein
2D3	2D3	NN	B-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

After	After	IN	B-PP	O
activation	activation	NN	B-NP	O
with	with	IN	B-PP	O
phytohemagglutinin	phytohemagglutinin	NN	B-NP	B-protein
the	the	DT	B-NP	O
T	T	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
exhibit	exhibit	VBP	B-VP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
within	within	IN	B-PP	O
24	24	CD	B-NP	O
h	h	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
blocked	block	VBN	I-VP	O
by	by	IN	B-PP	O
cycloheximide	cycloheximide	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
receptor	receptor	NN	I-NP	O
in	in	IN	B-PP	O
activated	activate	VBN	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
sedimentation	sedimentation	NN	I-NP	O
coefficient	coefficient	NN	I-NP	O
of	of	IN	B-PP	O
3.7S	3.7S	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
affinity	affinity	NN	I-NP	O
(	(	(	O	O
Kd	Kd	NN	B-NP	O
0.10	0.10	CD	I-NP	O
nM	nM	NN	I-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
ligand	ligand	NN	I-NP	O
.	.	.	O	O

Effects	Effect	NNS	B-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
excess	excess	NN	I-NP	O
in	in	IN	B-PP	O
man	man	NN	B-NP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	O
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
circulating	circulate	VBG	B-VP	B-cell_type
cells	cell	NNS	B-NP	I-cell_type
:	:	:	O	O
differences	difference	NNS	B-NP	O
between	between	IN	B-PP	O
endogenous	endogenous	JJ	B-NP	O
and	and	CC	I-NP	O
exogenous	exogenous	JJ	I-NP	O
hypercorticism	hypercorticism	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
measured	measure	VBD	B-VP	O
[	[	(	O	O
125I	125I	NN	B-NP	O
]	]	)	I-NP	O
insulin	insulin	NN	I-NP	O
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
circulating	circulate	VBG	B-VP	B-cell_type
monocytes	monocyte	NNS	B-NP	I-cell_type
or	or	CC	I-NP	O
erythrocytes	erythrocyte	NNS	I-NP	B-cell_type
from	from	IN	B-PP	O
16	16	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
excess	excess	NN	I-NP	O
,	,	,	O	O
9	9	CD	B-NP	O
chronically	chronically	RB	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
and	and	CC	O	O
7	7	CD	B-NP	O
with	with	IN	B-PP	O
adrenocortical	adrenocortical	JJ	B-NP	O
hyperfunction	hyperfunction	NN	I-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
[	[	(	B-LST	O
125I	125I	LS	I-LST	O
]	]	)	O	O
insulin	insulin	NN	B-NP	O
binding	binding	NN	I-NP	O
was	be	VBD	B-VP	O
iincreased	iincrease	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
binding	binding	NN	B-NP	O
data	datum	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
increased	increase	VBN	B-NP	O
binding	binding	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
ncrease	ncrease	NN	I-NP	O
in	in	IN	B-PP	O
receptor	receptor	NN	B-NP	O
concentration	concentration	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
adrenocortical	adrenocortical	JJ	B-NP	O
hyperfunction	hyperfunction	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
receptor	receptor	NN	B-NP	O
affinity	affinity	NN	I-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
erythrocytes	erythrocyte	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
adrenocortical	adrenocortical	JJ	B-NP	O
hyperfunction	hyperfunction	NN	I-NP	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
receptor	receptor	NN	B-NP	O
affinity	affinity	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
receptor	receptor	NN	B-NP	O
concentration	concentration	NN	I-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
that	that	IN	I-SBAR	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
[	[	(	O	B-protein
125I	125I	NN	B-NP	I-protein
]	]	)	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
disparity	disparity	NN	I-NP	O
of	of	IN	B-PP	O
results	result	NNS	B-NP	O
between	between	IN	B-PP	O
endogenous	endogenous	JJ	B-NP	O
and	and	CC	I-NP	O
exogenous	exogenous	JJ	I-NP	O
hypercorticism	hypercorticism	NN	I-NP	O
,	,	,	O	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
studies	study	NNS	I-NP	O
and	and	CC	O	O
previous	previous	JJ	B-NP	O
studies	study	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
excess	excess	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
insulin	insulin	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
are	be	VBP	B-VP	O
extremely	extremely	RB	B-ADJP	O
complex	complex	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
wide-ranging	wide-ranging	JJ	I-ADJP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
condition	condition	NN	I-NP	O
,	,	,	O	O
extrapolations	extrapolation	NNS	B-NP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
from	from	IN	B-PP	O
data	datum	NNS	B-NP	O
with	with	IN	B-PP	O
circulating	circulate	VBG	B-VP	B-cell_type
cells	cell	NNS	B-NP	I-cell_type
to	to	TO	B-PP	O
liver	liver	NN	B-NP	O
and	and	CC	I-NP	O
muscle	muscle	NN	I-NP	O
may	may	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
appropriate	appropriate	JJ	B-ADJP	O
.	.	.	O	O

Reduced	Reduce	VBN	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
cellular	cellular	JJ	B-NP	B-protein
glucocorticoid	glucocorticoid	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
anorexia	anorexia	NN	B-NP	O
nervosa	nervosa	NN	I-NP	O
.	.	.	O	O

Specific	Specific	JJ	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
in	in	IN	B-PP	O
circulating	circulate	VBG	B-VP	B-cell_type
mononuclear	mononuclear	JJ	B-NP	I-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
12	12	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
anorexia	anorexia	NN	B-NP	O
nervosa	nervosa	NN	I-NP	O
and	and	CC	O	O
21	21	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
control	control	NN	I-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

Cells	Cell	NNS	B-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
contain	contain	VB	I-VP	O
a	a	DT	O	O
significantly	significantly	RB	O	O
(	(	(	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.01	0.01	CD	B-NP	O
)	)	)	O	O
lower	low	JJR	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
3830	3830	CD	B-NP	O
+/-	+/-	CC	I-NP	O
210	210	CD	I-NP	O
sites/cell	sites/cell	NNS	I-NP	O
,	,	,	O	O
mean	mean	NN	B-NP	O
+/-	+/-	SYM	I-NP	O
SE	SE	NN	I-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
from	from	IN	B-PP	O
controls	control	NNS	B-NP	O
(	(	(	O	O
4930	4930	CD	B-NP	O
+/-	+/-	CC	I-NP	O
250	250	CD	I-NP	O
sites/cell	sites/cell	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

A	A	DT	B-NP	O
partial	partial	JJ	I-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
defect	defect	NN	I-NP	O
may	may	MD	B-VP	O
well	well	RB	I-VP	O
explain	explain	VB	I-VP	O
the	the	DT	B-NP	O
abnormal	abnormal	JJ	I-NP	O
cortisol	cortisol	NN	I-NP	O
metabolism	metabolism	NN	I-NP	O
and	and	CC	I-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
resistance	resistance	NN	I-NP	O
commonly	commonly	RB	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
anorexia	anorexia	NN	B-NP	O
nervosa	nervosa	NN	I-NP	O
.	.	.	O	O

Regulation	Regulation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
well	well	RB	I-VP	O
established	establish	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
factors	factor	NNS	B-NP	O
affecting	affect	VBG	B-VP	O
its	its	PRP$	B-NP	O
regulation	regulation	NN	I-NP	O
have	have	VBP	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
described	describe	VBN	I-VP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
a	a	DT	B-NP	O
competitive	competitive	JJ	I-NP	O
binding	binding	NN	I-NP	O
whole	whole	JJ	I-NP	O
cell	cell	NN	I-NP	O
assay	assay	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
examined	examine	VBN	I-VP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
-dexamethasone	-dexamethasone	NN	I-NP	O
at	at	IN	B-PP	O
24	24	CD	B-NP	O
and	and	CC	I-NP	O
37	37	CD	I-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
in	in	IN	B-PP	O
untreated	untreated	JJ	B-NP	O
normal	normal	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
taking	take	VBG	B-VP	O
various	various	JJ	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
preparations	preparation	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
24	24	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-NP	O
normal	normal	JJ	I-NP	O
human	human	JJ	I-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O
had	have	VBD	B-VP	O
6000	6000	CD	B-NP	O
binding	bind	VBG	I-NP	O
sites/cell	sites/cell	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
dissociation	dissociation	NN	I-NP	O
constant	constant	NN	I-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
x	x	NN	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
-9	-9	CD	B-NP	O
)	)	)	O	O
M	M	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
37.5	37.5	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
cortisone	cortisone	NN	B-NP	O
acetate	acetate	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
binding	bind	VBG	B-NP	O
sites	site	NNS	I-NP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
binding	binding	NN	B-NP	O
affinity	affinity	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
binding	bind	VBG	B-NP	B-protein
sites	site	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
before	before	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
diminished	diminish	VBN	I-NP	O
number	number	NN	I-NP	O
persisted	persist	VBD	B-VP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
after	after	IN	B-PP	O
discontinuation	discontinuation	NN	B-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

Lymphocytes	Lymphocyte	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
hospitalized	hospitalize	VBN	B-NP	O
patients	patient	NNS	I-NP	O
taking	take	VBG	B-VP	O
40-60	40-60	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
daily	daily	RB	B-ADVP	O
demonstrated	demonstrate	VBD	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
number	number	NN	B-NP	O
of	of	IN	B-PP	O
binding	bind	VBG	B-NP	B-protein
sites	site	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
taking	take	VBG	B-VP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
binding	binding	NN	B-NP	O
assays	assay	NNS	I-NP	O
were	be	VBD	B-VP	O
carried	carry	VBN	I-VP	O
out	out	RP	B-PRT	O
at	at	IN	B-PP	O
physiologic	physiologic	JJ	B-NP	O
temperature	temperature	NN	I-NP	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
number	number	NN	B-NP	O
of	of	IN	B-PP	O
binding	bind	VBG	B-NP	O
sites	site	NNS	I-NP	O
after	after	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
administration	administration	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
two-fold	two-fold	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
binding	binding	NN	B-NP	O
affinity	affinity	NN	I-NP	O
.	.	.	O	O

Glucocorticoid	Glucocorticoid	NN	B-NP	O
administration	administration	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
time-dependent	time-dependent	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
lymphocyte	lymphocyte	NN	B-NP	B-protein
glucocorticoid	glucocorticoid	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
sites	site	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
type	type	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
administered	administer	VBN	B-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
demonstration	demonstration	NN	I-NP	O
that	that	IN	B-NP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
modulate	modulate	VBP	B-VP	O
their	their	PRP$	B-NP	O
own	own	JJ	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
man	man	NN	B-NP	O
.	.	.	O	O

Immunoglobulin	Immunoglobulin	NN	B-NP	O
localization	localization	NN	I-NP	O
in	in	IN	B-PP	O
benign	benign	JJ	B-NP	O
and	and	CC	I-NP	O
malignant	malignant	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
mammary	mammary	JJ	I-NP	O
gland	gland	NN	I-NP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
direct	direct	JJ	B-NP	O
imunofluorescence	imunofluorescence	NN	I-NP	O
,	,	,	O	O
lesions	lesion	NNS	B-NP	O
from	from	IN	B-PP	O
266	266	CD	B-NP	O
human	human	JJ	I-NP	O
breast	breast	NN	I-NP	O
specimens	specimen	NNS	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
IgA	IgA	NN	B-NP	B-protein
,	,	,	O	O
IgM	IgM	NN	B-NP	B-protein
,	,	,	O	O
or	or	CC	O	O
IgG	IgG	NN	B-NP	B-protein
localization	localization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
lesions	lesion	NNS	I-NP	B-DNA
included	include	VBD	B-VP	I-DNA
benign	benign	JJ	B-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
from	from	IN	B-PP	O
66	66	CD	B-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
mastectomy	mastectomy	NN	I-NP	O
specimens	specimen	NNS	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
simultaneous	simultaneous	JJ	B-NP	O
breast	breast	NN	I-NP	O
malignancy	malignancy	NN	I-NP	O
was	be	VBD	B-VP	O
documented	document	VBN	I-VP	O
,	,	,	O	O
primary	primary	JJ	B-NP	O
breast	breast	NN	I-NP	O
carcinomas	carcinoma	NNS	I-NP	O
from	from	IN	B-PP	O
153	153	CD	B-NP	O
mastectomy	mastectomy	NN	I-NP	O
specimens	specimen	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
47	47	CD	B-NP	O
biopsies	biopsy	NNS	I-NP	O
containing	contain	VBG	B-VP	O
metastatic	metastatic	JJ	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
statistically	statistically	RB	I-NP	O
significant	significant	JJ	I-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
IgA	IgA	NN	B-NP	B-protein
and	and	CC	I-NP	O
IgM	IgM	NN	I-NP	B-protein
with	with	IN	B-PP	O
benign	benign	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
was	be	VBD	B-VP	O
contrasted	contrast	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
IgG	IgG	NN	B-NP	B-protein
with	with	IN	B-PP	O
malignant	malignant	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
both	both	CC	O	O
primary	primary	JJ	B-NP	O
and	and	CC	I-NP	O
metastatic	metastatic	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
,	,	,	O	O
IgG	IgG	NN	B-NP	B-protein
localization	localization	NN	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
estrogen-receptor-poor	estrogen-receptor-poor	JJ	B-NP	O
primary	primary	JJ	I-NP	O
cancers	cancer	NNS	I-NP	O
as	as	IN	B-PP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
estrogen-receptor-rich	estrogen-receptor-rich	JJ	B-NP	O
primary	primary	JJ	I-NP	O
cancers	cancer	NNS	I-NP	O
.	.	.	O	O

Among	Among	IN	B-PP	O
primary	primary	JJ	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
IgG	IgG	NN	B-NP	B-protein
localization	localization	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
tumor	tumor	NN	I-NP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
relative	relative	JJ	B-NP	O
lymphopenia	lymphopenia	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
shorter	short	JJR	I-NP	O
disease-free	disease-free	JJ	I-NP	O
interval	interval	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
in	in	IN	B-PP	O
association	association	NN	B-NP	O
with	with	IN	B-PP	O
IgG	IgG	NN	B-NP	B-protein
localization	localization	NN	I-NP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
metastatic	metastatic	JJ	I-NP	O
breast	breast	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
statistically	statistically	RB	I-NP	O
significant	significant	JJ	I-NP	O
association	association	NN	I-NP	O
between	between	IN	B-PP	O
stage	stage	NN	B-NP	O
of	of	IN	B-PP	O
disease	disease	NN	B-NP	O
and	and	CC	O	O
immunoglobulin	immunoglobulin	NN	B-NP	B-protein
presence	presence	NN	I-NP	O
was	be	VBD	B-VP	O
demonstrable	demonstrable	JJ	B-ADJP	O
.	.	.	O	O

Moderate-to-severe	Moderate-to-severe	JJ	B-NP	O
intraductal	intraductal	JJ	I-NP	O
epithelial	epithelial	JJ	I-NP	O
hyperplasias	hyperplasia	NNS	I-NP	O
were	be	VBD	B-VP	O
more	more	RBR	I-VP	O
often	often	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	O
G	G	NN	I-NP	O
localization	localization	NN	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
other	other	JJ	B-NP	O
benign	benign	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O

Correlation	Correlation	NN	B-NP	O
of	of	IN	B-PP	O
steroid	steroid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
with	with	IN	B-PP	O
histologic	histologic	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
in	in	IN	B-PP	O
mammary	mammary	JJ	B-NP	O
carcinoma	carcinoma	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
Singapore	Singapore	NNP	I-NP	O
experience	experience	NN	I-NP	O
.	.	.	O	O

Cancer	Cancer	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
breast	breast	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
in	in	IN	B-PP	O
females	female	NNS	B-NP	O
in	in	IN	B-PP	O
Singapore	Singapore	NNP	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
20.7	20.7	CD	B-NP	O
per	per	IN	B-PP	O
100	100	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
per	per	IN	B-PP	O
year	year	NN	B-NP	O
(	(	(	O	O
1977	1977	CD	B-NP	O
estimate	estimate	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
predicted	predict	VBN	I-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
to	to	TO	B-PP	O
29.8	29.8	CD	B-NP	O
per	per	IN	B-PP	O
100	100	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
women	woman	NNS	I-NP	O
per	per	IN	B-PP	O
year	year	NN	B-NP	O
by	by	IN	B-PP	O
1995	1995	CD	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
detailed	detailed	JJ	I-NP	O
histopathologic	histopathologic	JJ	I-NP	O
review	review	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
primary	primary	JJ	I-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
tumors	tumor	NNS	I-NP	O
analyzed	analyze	VBN	B-VP	O
for	for	IN	B-PP	O
estrogen	estrogen	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	I-NP	O
ER	ER	NN	I-NP	B-protein
)	)	)	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
carried	carry	VBN	I-VP	O
out	out	RP	B-PRT	O
and	and	CC	O	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
morphologic	morphologic	JJ	B-NP	O
features	feature	NNS	I-NP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
ER	ER	NN	B-NP	B-protein
results	result	NNS	I-NP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
any	any	DT	B-NP	O
factors	factor	NNS	I-NP	O
that	that	WDT	B-NP	O
will	will	MD	B-VP	O
improve	improve	VB	I-VP	O
the	the	DT	B-NP	O
management	management	NN	I-NP	O
and	and	CC	I-NP	O
prognosis	prognosis	NN	I-NP	O
for	for	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

Cytosol	Cytosol	NN	B-NP	O
was	be	VBD	B-VP	O
incubated	incubate	VBN	I-VP	O
with	with	IN	B-PP	O
3H-estradiol	3H-estradiol	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
and	and	CC	I-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
cold	cold	JJ	B-NP	O
diethylstilbestrol	diethylstilbestrol	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
bound	bind	VBD	B-VP	O
and	and	CC	O	O
free	free	JJ	B-NP	O
hormone	hormone	NN	I-NP	O
were	be	VBD	B-VP	O
separated	separate	VBN	I-VP	O
by	by	IN	B-PP	O
Dextran-coated	Dextran-coated	JJ	B-NP	O
charcoal	charcoal	NN	I-NP	O
method	method	NN	I-NP	O
.	.	.	O	O

Tumors	Tumor	NNS	B-NP	O
binding	bind	VBG	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
5	5	CD	I-NP	O
fmol/mg	fmol/mg	NN	I-NP	O
cytosol	cytosol	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
were	be	VBD	B-VP	O
classified	classify	VBN	I-VP	O
as	as	IN	B-PP	O
ER	ER	NN	B-NP	B-protein
-positive	-positive	JJ	B-ADJP	O
.	.	.	O	O

Progesterone	Progesterone	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
PR	PR	NN	B-NP	B-protein
)	)	)	O	O
level	level	NN	B-NP	O
was	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
specimens	specimen	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
method	method	NN	I-NP	O
.	.	.	O	O

Most	Most	JJS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
Chinese	Chinese	JJ	B-ADJP	O
(	(	(	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Three	Three	CD	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
Malays	Malay	NNS	B-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
was	be	VBD	B-VP	O
Indian	Indian	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
one	one	CD	B-NP	O
was	be	VBD	B-VP	O
European	European	JJ	B-ADJP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
series	series	NN	I-NP	O
.	.	.	O	O

Results	Result	NNS	B-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
strong	strong	JJ	B-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
ER	ER	NN	B-NP	B-protein
level	level	NN	I-NP	O
,	,	,	O	O
age	age	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
histologic	histologic	JJ	B-NP	O
grade	grade	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tumors	tumor	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
correlation	correlation	NN	I-NP	O
existed	exist	VBD	B-VP	O
between	between	IN	B-PP	O
absence	absence	NN	B-NP	O
or	or	CC	I-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
lymph	lymph	NN	B-NP	B-protein
node	node	NN	I-NP	I-protein
metastases	metastasis	NNS	I-NP	I-protein
and	and	CC	O	O
ER	ER	NN	B-NP	B-protein
.	.	.	O	O

Although	Although	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
trend	trend	NN	I-NP	O
for	for	IN	B-PP	O
ER	ER	NN	B-NP	B-protein
-positive	-positive	JJ	I-NP	O
tumors	tumor	NNS	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
low-grade	low-grade	JJ	I-NP	O
lymphocytic	lymphocytic	JJ	I-NP	O
infiltration	infiltration	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
difference	difference	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
statistically	statistically	RB	B-ADJP	O
significant	significant	JJ	I-ADJP	O
.	.	.	O	O

Mononuclear	Mononuclear	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
infiltrating	infiltrate	VBG	B-VP	O
human	human	JJ	B-NP	O
mammary	mammary	JJ	I-NP	O
carcinomas	carcinoma	NNS	I-NP	O
:	:	:	O	O
immunohistochemical	immunohistochemical	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
with	with	IN	B-PP	O
monoclonal	monoclonal	JJ	B-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
.	.	.	O	O

Breast	Breast	NN	B-NP	O
carcinomas	carcinoma	NNS	I-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
immunoperoxidase	immunoperoxidase	NN	I-NP	O
technique	technique	NN	I-NP	O
using	use	VBG	B-VP	O
antisera	antiserum	NNS	B-NP	O
specific	specific	JJ	B-ADJP	O
for	for	IN	B-PP	O
lymphocyte	lymphocyte	NN	B-NP	B-cell_type
subsets	subset	NNS	I-NP	I-cell_type
,	,	,	O	O
monocytes	monocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
NK	NK	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
major	major	JJ	B-NP	B-protein
histocompatibility	histocompatibility	NN	I-NP	I-protein
antigens	antigen	NNS	I-NP	I-protein
(	(	(	O	O
HLA-A	HLA-A	NN	B-NP	B-protein
,	,	,	O	O
-B	-B	NN	B-NP	B-protein
,	,	,	O	O
-C	-C	NN	B-NP	B-protein
;	;	:	O	O
Ia-like	Ia-like	JJ	B-ADJP	O
)	)	)	O	O
.	.	.	O	O

Sixty-four	Sixty-four	CD	B-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
moderate	moderate	JJ	I-NP	O
or	or	CC	I-NP	O
strong	strong	JJ	I-NP	O
mononuclear	mononuclear	JJ	I-NP	O
cell	cell	NN	I-NP	O
infiltration	infiltration	NN	I-NP	O
,	,	,	O	O
77	77	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
without	without	IN	B-PP	O
mononuclear	mononuclear	JJ	B-NP	O
cell	cell	NN	I-NP	O
infiltration	infiltration	NN	I-NP	O
had	have	VBD	B-VP	O
receptors	receptor	NNS	B-NP	O
for	for	IN	B-PP	O
estrogens	estrogen	NNS	B-NP	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
51	51	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
infiltration	infiltration	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
infiltrating	infiltrate	VBG	I-NP	O
mononuclear	mononuclear	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
;	;	:	O	O
generally	generally	RB	B-ADVP	O
the	the	DT	B-NP	O
OKT8	OKT8	NN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
predominant	predominant	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
Leu	Leu	NN	I-NP	O
3A/OKT8	3A/OKT8	NN	I-NP	O
cell	cell	NN	I-NP	O
ratio	ratio	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
histological	histological	JJ	B-NP	O
type	type	NN	I-NP	O
,	,	,	O	O
tumor	tumor	NN	B-NP	O
size	size	NN	I-NP	O
,	,	,	O	O
age	age	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
or	or	CC	I-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
metastases	metastasis	NNS	B-NP	O
.	.	.	O	O

Some	Some	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
Ia	Ia	NN	I-NP	B-protein
antigen	antigen	NN	I-NP	I-protein
and	and	CC	O	O
were	be	VBD	B-VP	O
thus	thus	RB	I-VP	O
probably	probably	RB	I-VP	O
activated	activate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
B	B	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
either	either	CC	O	O
absent	absent	JJ	B-ADJP	O
or	or	CC	O	O
less	less	RBR	B-ADJP	O
numerous	numerous	JJ	I-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
relation	relation	NN	I-NP	O
between	between	IN	B-PP	O
their	their	PRP$	B-NP	O
distribution	distribution	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
various	various	JJ	I-NP	O
parameters	parameter	NNS	I-NP	O
studied	study	VBN	B-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
few	few	JJ	I-NP	O
monocytes	monocyte	NNS	I-NP	B-cell_type
were	be	VBD	B-VP	O
heterogeneous	heterogeneous	JJ	B-ADJP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
markers	marker	NNS	I-NP	O
(	(	(	O	O
OKM	OKM	NN	B-NP	O
I	I	CD	I-NP	O
and	and	CC	O	O
acid	acid	NN	B-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
6	6	CD	B-NP	O
cases	case	NNS	I-NP	O
only	only	RB	B-ADVP	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
strong	strong	JJ	I-NP	O
infiltration	infiltration	NN	I-NP	O
of	of	IN	B-PP	O
mononuclear	mononuclear	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
acid	acid	NN	B-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
natural	natural	JJ	I-NP	B-cell_type
killer	killer	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
low	low	JJ	B-ADJP	O
.	.	.	O	O

Only	Only	RB	B-NP	O
a	a	DT	I-NP	O
few	few	JJ	I-NP	O
mononuclear	mononuclear	JJ	I-NP	B-cell_type
infiltrating	infiltrating	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
had	have	VBD	B-VP	O
receptors	receptor	NNS	B-NP	O
for	for	IN	B-PP	O
transferrin	transferrin	NN	B-NP	B-protein
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
infiltration	infiltration	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
HLA	HLA	NN	B-NP	B-protein
class-I	class-I	NN	I-NP	I-protein
antigens	antigen	NNS	I-NP	I-protein
on	on	IN	B-PP	O
tumor	tumor	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
s	s	NNS	I-NP	I-cell_type
.	.	.	O	O

Some	Some	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
antisera	antiserum	NNS	I-NP	O
specific	specific	JJ	B-ADJP	O
for	for	IN	B-PP	O
lymphocyte	lymphocyte	NN	B-NP	B-cell_type
subsets	subset	NNS	I-NP	I-cell_type
also	also	RB	B-ADVP	O
stained	stain	VBD	B-VP	O
the	the	DT	B-NP	O
breast	breast	NN	I-NP	B-cell_type
carcinoma	carcinoma	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
great	great	JJ	I-NP	O
variations	variation	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
subsets	subset	NNS	I-NP	O
of	of	IN	B-PP	O
mononuclear	mononuclear	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
breast	breast	NN	B-NP	O
carcinomas	carcinoma	NNS	I-NP	O
may	may	MD	B-VP	O
correspond	correspond	VB	I-VP	O
to	to	TO	B-PP	O
various	various	JJ	B-NP	O
systems	system	NNS	I-NP	O
of	of	IN	B-PP	O
defense	defense	NN	B-NP	O
against	against	IN	B-PP	O
neoplasm	neoplasm	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
male	male	JJ	B-NP	O
pseudohermaphroditism	pseudohermaphroditism	NN	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
androgen	androgen	NN	I-NP	O
receptor	receptor	NN	I-NP	O
binding	binding	NN	I-NP	O
and	and	CC	O	O
47	47	CD	B-NP	O
,	,	,	O	O
XYY	XYY	NN	B-NP	O
karyotype	karyotype	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
male	male	JJ	B-NP	O
pseudohermaphroditism	pseudohermaphroditism	NN	I-NP	O
with	with	IN	B-PP	O
47	47	CD	B-NP	O
,	,	,	O	O
XYY	XYY	NN	B-NP	O
karyotype	karyotype	NN	I-NP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
and	and	CC	O	O
cutaneous	cutaneous	JJ	B-NP	B-cell_type
fibroblasts	fibroblast	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
described	describe	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
plasma	plasma	NN	I-NP	O
testosterone	testosterone	NN	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
HCG	HCG	NN	B-NP	O
stimulation	stimulation	NN	I-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	B-ADVP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
range	range	NN	I-NP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
occasions	occasion	NNS	I-NP	O
suggesting	suggest	VBG	B-VP	O
a	a	DT	B-NP	O
deficit	deficit	NN	I-NP	O
of	of	IN	B-PP	O
gonadal	gonadal	JJ	B-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
receptors	receptor	NNS	I-NP	O
for	for	IN	B-PP	O
dihydrotestosterone	dihydrotestosterone	NN	B-NP	O
in	in	IN	B-PP	O
fibroblasts	fibroblast	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
genital	genital	JJ	B-NP	O
and	and	CC	I-NP	O
nongenital	nongenital	JJ	I-NP	O
skin	skin	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
receptors	receptor	NNS	B-NP	O
in	in	IN	B-PP	O
genital	genital	JJ	B-NP	O
skin	skin	NN	I-NP	O
;	;	:	O	O
5-alpha-reductase	5-alpha-reductase	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
fibroblasts	fibroblast	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genital	genital	JJ	I-NP	O
skin	skin	NN	I-NP	O
was	be	VBD	B-VP	O
low	low	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
plasma	plasma	NN	I-NP	O
relationship	relationship	NN	I-NP	O
testosterone/dihydrotestosterone	testosterone/dihydrotestosterone	NN	I-NP	O
under	under	IN	B-PP	O
HCG	HCG	NN	B-NP	O
stimulation	stimulation	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
diagnostic	diagnostic	JJ	I-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
complete	complete	JJ	I-NP	O
testicular	testicular	JJ	I-NP	O
feminization	feminization	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
for	for	IN	B-PP	O
dihydrotestosterone	dihydrotestosterone	NN	B-NP	O
is	be	VBZ	B-VP	O
commented	comment	VBN	I-VP	O
on	on	IN	B-PP	O
.	.	.	O	O

1	1	CD	B-NP	O
,	,	,	O	O
25-Dihydroxyvitamin	25-Dihydroxyvitamin	NN	B-NP	O
D3	D3	NN	I-NP	O
inhibits	inhibit	VBZ	B-VP	O
antigen-induced	antigen-induced	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
proliferative	proliferative	JJ	I-NP	O
response	response	NN	I-NP	O
of	of	IN	B-PP	O
murine	murine	JJ	B-NP	B-cell_type
spleen	spleen	NN	I-NP	I-cell_type
and	and	CC	I-NP	I-cell_type
thymus	thymus	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
antigen	antigen	NN	B-NP	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
to	to	TO	I-PP	O
lectin	lectin	NN	B-NP	B-protein
was	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
active	active	JJ	I-NP	O
metabolite	metabolite	NN	I-NP	O
of	of	IN	B-PP	O
vitamin	vitamin	NN	B-NP	O
D3	D3	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25-	25-	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
directly	directly	RB	I-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25-	25-	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
on	on	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
complicating	complicate	VBG	I-NP	O
interactions	interaction	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
utilized	utilize	VBD	B-VP	O
a	a	DT	B-NP	O
panel	panel	NN	I-NP	O
of	of	IN	B-PP	O
cloned	clone	VBN	B-NP	B-cell_line
Ia-restricted	Ia-restricted	JJ	I-NP	I-cell_line
T	T	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
hybridomas	hybridoma	NNS	I-NP	I-cell_line
that	that	WDT	B-NP	O
secrete	secrete	VBP	B-VP	O
IL	IL	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
on	on	IN	B-PP	O
activation	activation	NN	B-NP	O
by	by	IN	B-PP	O
cloned	clone	VBN	B-NP	B-cell_line
Ia-bearing	Ia-bearing	JJ	I-NP	I-cell_line
stimulator	stimulator	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
(	(	(	O	O
TA3	TA3	NN	B-NP	B-protein
)	)	)	O	O
or	or	CC	O	O
when	when	WRB	B-ADVP	O
stimulated	stimulate	VBN	B-VP	O
by	by	IN	B-PP	O
mitogen	mitogen	NN	B-NP	B-protein
.	.	.	O	O

Physiologic	Physiologic	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25-	25-	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
(	(	(	O	O
0.01	0.01	CD	B-NP	O
to	to	TO	O	O
0.1	0.1	CD	B-NP	O
nm	nm	NN	I-NP	O
)	)	)	O	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
antigen-induced	antigen-induced	JJ	I-NP	O
secretion	secretion	NN	I-NP	O
of	of	IN	B-PP	O
IL	IL	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
by	by	IN	B-PP	O
several	several	JJ	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
T	T	NN	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
hybridomas	hybridoma	NNS	I-NP	I-cell_line
.	.	.	O	O

This	This	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
was	be	VBD	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
free	free	JJ	I-NP	O
hormone	hormone	NN	I-NP	O
and	and	CC	O	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
overcome	overcome	VBN	I-VP	O
by	by	IN	B-PP	O
increasing	increase	VBG	B-VP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
Ia-bearing	Ia-bearing	JJ	B-NP	B-cell_line
stimulator	stimulator	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
used	use	VBN	B-VP	O
.	.	.	O	O

Pretreatment	Pretreatment	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-cell_line
hybridoma	hybridoma	NN	I-NP	I-cell_line
but	but	CC	B-CONJP	O
not	not	RB	I-CONJP	O
the	the	DT	B-NP	O
TA3	TA3	NN	I-NP	B-cell_line
stimulator	stimulator	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
with	with	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25-	25-	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
activation	activation	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
are	be	VBP	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
finding	finding	NN	I-NP	O
that	that	IN	B-SBAR	O
specific	specific	JJ	B-NP	O
1	1	CD	I-NP	B-protein
,	,	,	I-NP	I-protein
25-	25-	CD	I-NP	I-protein
(	(	(	O	I-protein
OH	OH	NN	B-NP	I-protein
)	)	)	O	I-protein
2D3	2D3	NN	B-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
hybridomas	hybridoma	NNS	I-NP	I-cell_line
but	but	CC	O	O
are	be	VBP	B-VP	O
lacking	lack	VBG	I-VP	O
in	in	IN	B-PP	O
TA3	TA3	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

1	1	CD	B-NP	O
,	,	,	I-NP	O
25-	25-	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
failed	fail	VBD	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
to	to	TO	B-VP	O
inhibit	inhibit	VB	I-VP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
hybridomas	hybridoma	NNS	I-NP	I-cell_line
by	by	IN	B-PP	O
lectin	lectin	NN	B-NP	B-protein
or	or	CC	B-PP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
anti-Thy-1	anti-Thy-1	JJ	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
25-	25-	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
interfering	interfere	VBG	I-VP	O
with	with	IN	B-PP	O
early	early	JJ	B-NP	O
events	event	NNS	I-NP	O
of	of	IN	B-PP	O
antigen-induced	antigen-induced	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
,	,	,	O	O
perhaps	perhaps	RB	B-ADVP	O
by	by	IN	B-PP	O
hindering	hinder	VBG	B-VP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
recognition	recognition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
relevant	relevant	JJ	I-NP	B-protein
antigen	antigen	NN	I-NP	I-protein
on	on	IN	B-PP	O
stimulator	stimulator	NN	B-NP	O
cell	cell	NN	I-NP	O
surfaces	surface	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
system	system	NN	I-NP	O
should	should	MD	B-VP	O
prove	prove	VB	I-VP	O
useful	useful	JJ	B-ADJP	O
in	in	IN	B-PP	O
studying	study	VBG	B-VP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
25-	25-	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
acts	act	VBZ	B-VP	O
to	to	TO	I-VP	O
inhibit	inhibit	VB	I-VP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
and	and	CC	O	O
subsequent	subsequent	JJ	B-NP	O
IL	IL	NN	I-NP	B-protein
2	2	CD	I-NP	I-protein
production	production	NN	I-NP	O
.	.	.	O	O

Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
and	and	CC	O	O
steroid	steroid	JJ	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
and	and	CC	I-NP	O
neoplastic	neoplastic	JJ	I-NP	O
human	human	JJ	I-NP	O
lymphoid	lymphoid	JJ	I-NP	O
tissues	tissue	NNS	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
review	review	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
determination	determination	NN	I-NP	O
of	of	IN	B-PP	O
estrogen	estrogen	NN	B-NP	O
and	and	CC	O	O
progesterone	progesterone	NN	B-NP	B-protein
receptors	receptor	NNS	B-NP	I-protein
in	in	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
useful	useful	JJ	B-ADJP	O
in	in	IN	B-PP	O
predicting	predict	VBG	B-VP	O
the	the	DT	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
endocrine	endocrine	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
their	their	PRP$	B-NP	O
well-known	well-known	JJ	I-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
lymphoid	lymphoid	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
,	,	,	O	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
used	use	VBN	I-VP	O
widely	widely	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
leukemia	leukemia	NN	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
these	these	DT	B-NP	O
facts	fact	NNS	I-NP	O
,	,	,	O	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
10	10	CD	I-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
several	several	JJ	B-NP	O
investigators	investigator	NNS	I-NP	O
have	have	VBP	B-VP	O
measured	measure	VBN	I-VP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
and	and	CC	I-NP	O
neoplastic	neoplastic	JJ	I-NP	O
lymphoid	lymphoid	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
whether	whether	IN	B-SBAR	O
their	their	PRP$	B-NP	O
number	number	NN	I-NP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
responsiveness	responsiveness	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
or	or	CC	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
clear	clear	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
established	establish	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
and	and	CC	I-NP	O
neoplastic	neoplastic	JJ	I-NP	O
lymphoid	lymphoid	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
attempts	attempt	VBZ	B-VP	O
to	to	TO	I-VP	O
correlate	correlate	VB	I-VP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
lymphocytic	lymphocytic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
to	to	TO	B-PP	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
steroid	steroid	NN	I-NP	O
responsiveness	responsiveness	NN	I-NP	O
and	and	CC	O	O
immunological	immunological	JJ	B-NP	O
type	type	NN	I-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
whole-cell-binding	whole-cell-binding	JJ	I-NP	O
assay	assay	NN	I-NP	O
for	for	IN	B-PP	O
receptor	receptor	NN	B-NP	O
determination	determination	NN	I-NP	O
and	and	CC	O	O
selecting	select	VBG	B-VP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
age	age	NN	B-NP	O
and	and	CC	I-NP	O
immunological	immunological	JJ	I-NP	O
criteria	criterion	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
more	more	RBR	B-ADJP	O
successful	successful	JJ	I-ADJP	O
.	.	.	O	O

[	[	(	O	O
Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
]	]	)	O	O

Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
(	(	(	O	I-protein
GC	GC	NN	B-NP	I-protein
)	)	)	O	I-protein
receptors	receptor	NNS	B-NP	I-protein
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
intact	intact	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
11	11	CD	B-NP	O
donors	donor	NNS	I-NP	O
.	.	.	O	O

GC	GC	NN	B-NP	O
binding	binding	NN	I-NP	O
parameters	parameter	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
highly	highly	RB	B-ADJP	O
reproducible	reproducible	JJ	I-ADJP	O
in	in	IN	B-PP	O
repeated	repeat	VBN	B-NP	O
experiments	experiment	NNS	I-NP	O
with	with	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
GC	GC	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
donors	donor	NNS	B-NP	B-cell_type
'	'	POS	B-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
could	could	MD	B-VP	O
be	be	VB	I-VP	O
distributed	distribute	VBN	I-VP	O
into	into	IN	B-PP	O
two	two	CD	B-NP	O
different	different	JJ	I-NP	O
classes	class	NNS	I-NP	O
similarly	similarly	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
pattern	pattern	NN	I-NP	O
seen	see	VBN	B-VP	O
in	in	IN	B-PP	O
skin	skin	NN	B-NP	B-cell_type
fibroblasts	fibroblast	NNS	I-NP	I-cell_type
.	.	.	O	O

Human	Human	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
an	an	DT	B-NP	O
adequate	adequate	JJ	I-NP	O
object	object	NN	I-NP	O
for	for	IN	B-PP	O
studying	study	VBG	B-VP	O
genetically	genetically	RB	B-NP	O
determined	determine	VBN	I-NP	O
variability	variability	NN	I-NP	O
of	of	IN	B-PP	O
GC	GC	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
and	and	CC	O	O
its	its	PRP$	B-NP	O
clinical	clinical	JJ	I-NP	O
importance	importance	NN	I-NP	O
.	.	.	O	O

Specific	Specific	JJ	B-NP	O
estrogen	estrogen	NN	I-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
lymphoid	lymphoid	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
thymic	thymic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
estrogen	estrogen	NN	B-NP	O
in	in	IN	B-PP	O
preparations	preparation	NNS	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
by	by	IN	B-PP	O
splenic	splenic	JJ	B-NP	O
and	and	CC	I-NP	O
thymic	thymic	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
by	by	IN	B-PP	O
three	three	CD	B-NP	O
different	different	JJ	I-NP	O
approaches	approach	NNS	I-NP	O
(	(	(	O	O
Dextran-coated	Dextran-coated	JJ	B-NP	O
charcoal	charcoal	NN	I-NP	O
method	method	NN	I-NP	O
,	,	,	O	O
whole	whole	JJ	B-NP	O
cell	cell	NN	I-NP	O
assay	assay	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
gel	gel	NN	B-NP	O
filtration	filtration	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
sepharose	sepharose	NN	I-NP	O
4B	4B	NN	I-NP	O
column	column	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Scatchard	Scatchard	NNP	B-NP	O
's	's	POS	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	O	O
-moxestrol	-moxestrol	NN	B-NP	O
(	(	(	O	O
R2858	R2858	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
-estradiol	-estradiol	NN	I-NP	O
binding	binding	NN	I-NP	O
proves	prove	VBZ	B-VP	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
class	class	NN	I-NP	O
of	of	IN	B-PP	O
receptor	receptor	NN	B-NP	O
sites	site	NNS	I-NP	O
having	have	VBG	B-VP	O
a	a	DT	B-NP	O
dissociation	dissociation	NN	I-NP	O
constant	constant	NN	I-NP	O
of	of	IN	B-PP	O
0.18-2.4	0.18-2.4	CD	B-NP	O
X	X	SYM	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
-9	-9	CD	B-NP	O
)	)	)	O	O
M	M	NN	B-NP	O
.	.	.	O	O

Physicochemical	Physicochemical	JJ	B-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
binder	binder	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
binding	binding	NN	B-NP	O
capacity	capacity	NN	I-NP	O
and	and	CC	O	O
steroid	steroid	NN	B-NP	O
specificity	specificity	NN	I-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
quite	quite	RB	B-ADJP	O
similar	similar	JJ	I-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
reported	report	VBN	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
thymus	thymus	NN	I-NP	O
of	of	IN	B-PP	O
small	small	JJ	B-NP	O
mammalian	mammalian	JJ	I-NP	O
species	specie	NNS	I-NP	O
or	or	CC	O	O
human	human	JJ	B-NP	O
thymoma	thymoma	NN	I-NP	O
.	.	.	O	O

Administration	Administration	NN	B-NP	O
of	of	IN	B-PP	O
fibroblast	fibroblast	NN	B-NP	B-protein
interferon	interferon	NN	I-NP	I-protein
to	to	TO	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
advanced	advance	VBN	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
:	:	:	O	O
possible	possible	JJ	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
skin	skin	NN	B-NP	O
metastasis	metastasis	NN	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
hormone	hormone	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
.	.	.	O	O

Eleven	Eleven	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
metastasized	metastasize	VBN	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
received	receive	VBD	B-VP	O
8	8	CD	B-NP	O
intramuscular	intramuscular	JJ	I-NP	O
injections	injection	NNS	I-NP	O
of	of	IN	B-PP	O
6	6	CD	B-NP	O
x	x	SYM	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
6	6	CD	B-NP	O
)	)	)	O	O
units	unit	NNS	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-protein
fibroblast	fibroblast	NN	I-NP	I-protein
interferon	interferon	NN	I-NP	I-protein
over	over	IN	B-PP	O
a	a	DT	B-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
injections	injection	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
cause	cause	VB	I-VP	O
local	local	JJ	B-NP	O
irritation	irritation	NN	I-NP	O
or	or	CC	I-NP	O
inflammation	inflammation	NN	I-NP	O
.	.	.	O	O

Fever	Fever	NNP	B-NP	O
occurred	occur	VBD	B-VP	O
in	in	IN	B-PP	O
only	only	RB	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
11	11	CD	I-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
several	several	JJ	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
metastases	metastasis	NNS	B-NP	O
were	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
,	,	,	O	O
only	only	RB	B-NP	O
skin	skin	NN	I-NP	O
nodules	nodule	NNS	I-NP	O
consistently	consistently	RB	B-ADVP	O
(	(	(	O	O
10	10	CD	B-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
11	11	CD	B-NP	O
patients	patient	NNS	I-NP	O
)	)	)	O	O
exhibited	exhibit	VBD	B-VP	O
changes	change	NNS	B-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
regimen	regimen	NN	I-NP	O
:	:	:	O	O
either	either	CC	O	O
a	a	DT	B-NP	O
simple	simple	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
size	size	NN	B-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
nodules	nodule	NNS	I-NP	O
or	or	CC	O	O
central	central	JJ	B-NP	O
necrosis	necrosis	NN	I-NP	O
accompanied	accompany	VBN	B-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
.	.	.	O	O

NK-activity	NK-activity	NN	B-NP	O
of	of	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
increased	increase	VBN	I-VP	O
after	after	IN	B-PP	O
administration	administration	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
dose	dose	NN	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
subsequent	subsequent	JJ	B-NP	O
injections	injection	NNS	I-NP	O
was	be	VBD	B-VP	O
less	less	RBR	B-ADJP	O
clear	clear	JJ	I-ADJP	O
.	.	.	O	O

Receptors	Receptor	NNS	B-NP	O
for	for	IN	B-PP	O
estrogens	estrogen	NNS	B-NP	O
and	and	CC	I-NP	O
progestogens	progestogen	NNS	I-NP	O
were	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
tumor	tumor	NN	I-NP	O
biopsies	biopsy	NNS	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
out	out	IN	I-NP	O
of	of	IN	I-NP	O
2	2	CD	I-NP	O
and	and	CC	I-NP	O
5	5	CD	I-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
6	6	CD	B-NP	O
patients	patient	NNS	I-NP	O
tested	test	VBN	B-VP	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

Decreased	Decrease	VBN	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
binding	binding	NN	I-NP	O
in	in	IN	B-PP	O
adrenal	adrenal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
,	,	,	O	O
we	we	PRP	B-NP	O
examine	examine	VBP	B-VP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	I-NP	O
dexamethasone	dexamethasone	NN	I-NP	O
to	to	TO	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
and	and	CC	O	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
adrenal	adrenal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
replacement	replacement	NN	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
a	a	DT	B-NP	O
whole	whole	JJ	I-NP	O
cell	cell	NN	I-NP	O
competitive	competitive	JJ	I-NP	O
binding	binding	NN	I-NP	O
assay	assay	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
human	human	JJ	I-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O
had	have	VBD	B-VP	O
5977	5977	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
1487	1487	CD	I-NP	O
(	(	(	O	O
mean	mean	NN	B-NP	O
+/-	+/-	SYM	O	O
SD	SD	NN	B-NP	O
)	)	)	O	O
binding	binding	NN	B-NP	O
sites/cell	sites/cell	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
dissociation	dissociation	NN	I-NP	O
constant	constant	NN	I-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
2	2	CD	I-NP	O
nM	nM	NN	I-NP	O
.	.	.	O	O

Lymphocytes	Lymphocyte	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
untreated	untreated	JJ	B-NP	O
adrenal	adrenal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
had	have	VBD	B-VP	O
fewer	few	JJR	B-NP	O
binding	bind	VBG	I-NP	O
sites	site	NNS	I-NP	O
(	(	(	O	O
3364	3364	CD	B-NP	O
+/-322	+/-322	CC	O	O
)	)	)	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
2-fold	2-fold	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
binding	binding	NN	B-NP	O
affinity	affinity	NN	I-NP	O
(	(	(	O	O
5.4	5.4	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
0.9	0.9	CD	I-NP	O
mM	mM	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
conventional	conventional	JJ	B-NP	O
replacement	replacement	NN	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
cortisone	cortisone	NN	B-NP	O
acetate	acetate	NN	I-NP	O
for	for	IN	B-PP	O
6	6	CD	B-NP	O
months	month	NNS	I-NP	O
caused	cause	VBD	B-VP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
receptor	receptor	NN	B-NP	O
number	number	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
binding	binding	NN	B-NP	O
affinity	affinity	NN	I-NP	O
toward	toward	IN	B-PP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

After	After	IN	B-PP	O
long	long	JJ	B-NP	O
term	term	NN	I-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
replacement	replacement	NN	I-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
binding	bind	VBG	B-NP	O
parameters	parameter	NNS	I-NP	O
were	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
before	before	IN	B-PP	O
treatment	treatment	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
physiological	physiological	JJ	I-NP	O
implications	implication	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
decreased	decrease	VBN	I-NP	O
receptor	receptor	NN	I-NP	O
number	number	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBD	B-VP	O
binding	binding	NN	B-NP	O
affinity	affinity	NN	I-NP	O
in	in	IN	B-PP	O
adrenal	adrenal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
remain	remain	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
elucidated	elucidate	VBN	I-VP	O
.	.	.	O	O

Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
concentrations	concentration	NNS	I-NP	O
and	and	CC	O	O
terminal	terminal	JJ	B-NP	B-protein
transferase	transferase	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
as	as	IN	B-PP	O
indicators	indicator	NNS	B-NP	O
of	of	IN	B-PP	O
prognosis	prognosis	NN	B-NP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
non-lymphocytic	non-lymphocytic	JJ	I-NP	O
leukaemia	leukaemia	NN	I-NP	O
.	.	.	O	O

Activity	Activity	NN	B-NP	O
of	of	IN	B-PP	O
terminal	terminal	JJ	B-NP	B-protein
deoxynucleotidyl	deoxynucleotidyl	NN	I-NP	I-protein
transferase	transferase	NN	I-NP	I-protein
(	(	(	O	O
TdT	TdT	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
adenosine	adenosine	NN	B-NP	B-protein
deaminase	deaminase	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
5'nucleotidase	5'nucleotidase	NN	B-NP	B-protein
and	and	CC	O	O
the	the	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
(	(	(	O	I-protein
dexamethasone	dexamethasone	NN	B-NP	I-protein
)	)	)	O	I-protein
receptor	receptor	NN	B-NP	I-protein
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
in	in	IN	B-PP	O
25	25	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
non-lymphocytic	non-lymphocytic	JJ	I-NP	O
leukaemia	leukaemia	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
protocol	protocol	NN	I-NP	O
.	.	.	O	O

Increased	Increase	VBN	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
TdT	TdT	NN	B-NP	O
(	(	(	O	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
0.1	0.1	CD	I-NP	O
unit/microgram	unit/microgram	NN	I-NP	O
DNA	DNA	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
11	11	CD	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
higher	high	JJR	B-NP	O
remission	remission	NN	I-NP	O
and	and	CC	I-NP	O
survival	survival	NN	I-NP	O
rates	rate	NNS	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.06	0.06	CD	B-NP	O
)	)	)	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
TdT	TdT	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
leukaemic	leukaemic	JJ	I-NP	B-cell_type
blast	blast	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
ranged	range	VBD	B-VP	O
from	from	IN	B-PP	O
0	0	CD	B-NP	O
to	to	TO	I-NP	O
0.94	0.94	CD	I-NP	O
fmol/microgram	fmol/microgram	NN	I-NP	O
DNA	DNA	NN	I-NP	O
.	.	.	O	O

Thirteen	Thirteen	CD	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
blast	blast	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
a	a	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
concentration	concentration	NN	I-NP	O
over	over	IN	B-PP	O
0.22	0.22	CD	B-NP	O
fmol/microgram	fmol/microgram	NN	I-NP	O
DNA	DNA	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
increased	increase	VBN	I-VP	O
remission	remission	NN	B-NP	O
and	and	CC	I-NP	O
survival	survival	NN	I-NP	O
rates	rate	NNS	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.006	0.006	CD	B-NP	O
)	)	)	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
those	those	DT	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
receptor	receptor	NN	I-NP	O
concentration	concentration	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
finding	finding	NN	I-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
explained	explain	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
sensitivity	sensitivity	NN	B-NP	O
to	to	TO	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
since	since	IN	B-PP	O
these	these	DT	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O

Adenosine	Adenosine	NN	B-NP	B-protein
deaminase	deaminase	NN	I-NP	I-protein
and	and	CC	I-NP	O
5'nucleotidase	5'nucleotidase	NN	I-NP	O
activities	activity	NNS	I-NP	O
both	both	DT	O	O
varied	vary	VBD	B-VP	O
within	within	IN	B-PP	O
two	two	CD	B-NP	O
orders	order	NNS	I-NP	O
of	of	IN	B-PP	O
magnitude	magnitude	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
correlation	correlation	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
activities	activity	NNS	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
enzymes	enzyme	NNS	I-NP	B-protein
and	and	CC	O	O
remission	remission	NN	B-NP	O
or	or	CC	I-NP	O
survival	survival	NN	I-NP	O
rate	rate	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
measurements	measurement	NNS	B-NP	O
of	of	IN	B-PP	O
TdT	TdT	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
concentration	concentration	NN	I-NP	O
yield	yield	NN	I-NP	O
valuable	valuable	JJ	I-NP	O
prognostic	prognostic	JJ	I-NP	O
information	information	NN	I-NP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
non-lymphocytic	non-lymphocytic	JJ	I-NP	O
leukaemia	leukaemia	NN	I-NP	O

[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	O	O
cortivazol	cortivazol	NN	B-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
unique	unique	JJ	I-NP	O
high	high	JJ	I-NP	O
affinity	affinity	NN	I-NP	O
ligand	ligand	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

Cortivazol	Cortivazol	NN	B-NP	O
(	(	(	O	O
CVZ	CVZ	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
deacylcortivazol	deacylcortivazol	NN	B-NP	O
(	(	(	O	O
DAC	DAC	NN	B-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
pyrazolosteroids	pyrazolosteroid	NNS	B-NP	O
with	with	IN	B-PP	O
potent	potent	JJ	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
previous	previous	JJ	B-NP	O
work	work	NN	I-NP	O
we	we	PRP	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
DAC	DAC	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
40-fold	40-fold	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
potent	potent	JJ	I-ADJP	O
than	than	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
(	(	(	O	O
DEX	DEX	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
lysing	lyse	VBG	B-VP	B-cell_type
leukemic	leukemic	JJ	B-NP	I-cell_type
lymphoblasts	lymphoblast	NNS	I-NP	I-cell_type
.	.	.	O	O

To	To	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
interaction	interaction	NN	I-NP	O
between	between	IN	B-PP	O
these	these	DT	B-NP	O
atypical	atypical	JJ	I-NP	O
steroids	steroid	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
,	,	,	O	O
we	we	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	I-NP	O
CVZ	CVZ	NN	I-NP	O
to	to	TO	B-PP	O
cytosol	cytosol	NN	B-NP	O
from	from	IN	B-PP	O
glucocorticoid-sensitive	glucocorticoid-sensitive	JJ	B-NP	O
and	and	CC	I-NP	O
-resistant	-resistant	JJ	I-NP	B-cell_line
variants	variant	NNS	I-NP	I-cell_line
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-cell_line
leukemic	leukemic	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
CEM	CEM	NN	I-NP	I-cell_line
C7	C7	NN	I-NP	I-cell_line
.	.	.	O	O

In	In	IN	B-PP	O
glucocorticoid-sensitive	glucocorticoid-sensitive	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	I-NP	O
CVZ	CVZ	NN	I-NP	O
causes	cause	VBZ	B-VP	O
a	a	DT	B-NP	O
2-fold	2-fold	JJ	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
glutamine	glutamine	NN	B-NP	B-protein
synthetase	synthetase	NN	I-NP	I-protein
and	and	CC	O	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
4.6	4.6	CD	I-NP	O
S	S	NN	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
high	high	JJ	B-NP	O
salt	salt	NN	I-NP	O
sucrose	sucrose	NN	I-NP	O
gradients	gradient	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
DEAE-cellulose	DEAE-cellulose	NN	B-NP	O
chromatography	chromatography	NN	I-NP	O
,	,	,	O	O
[	[	(	O	B-protein
3H	3H	NN	B-NP	I-protein
]	]	)	O	I-protein
CVZ-receptor	CVZ-receptor	NN	B-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
show	show	VBP	B-VP	O
a	a	DT	B-NP	O
shift	shift	NN	I-NP	O
from	from	IN	B-PP	O
high	high	JJ	B-NP	O
(	(	(	O	O
0.25	0.25	CD	B-NP	O
M	M	NN	I-NP	O
KP	KP	NN	I-NP	O
)	)	)	O	O
to	to	TO	B-PP	O
low	low	JJ	B-NP	O
salt	salt	NN	I-NP	O
(	(	(	O	O
0.09	0.09	CD	B-NP	O
M	M	NN	I-NP	O
KP	KP	NN	I-NP	O
)	)	)	O	O
eluting	elute	VBG	B-VP	O
forms	form	NNS	B-NP	O
upon	upon	IN	B-PP	O
activation	activation	NN	B-NP	O
.	.	.	O	O

CVZ	CVZ	NN	B-NP	O
competes	compete	NNS	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
97	97	CD	I-NP	B-protein
,	,	,	O	I-protein
000-dalton	000-dalton	JJ	B-NP	I-protein
protein	protein	NN	I-NP	I-protein
labeled	label	VBN	B-VP	O
by	by	IN	B-PP	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
dexamethasone	dexamethasone	NN	I-NP	O
mesylate	mesylate	NN	I-NP	O
.	.	.	O	O

Scatchard	Scatchard	NN	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
CVZ	CVZ	NN	I-NP	O
in	in	IN	B-PP	O
glucocorticoid-sensitive	glucocorticoid-sensitive	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
curvilinear	curvilinear	JJ	I-NP	O
plot	plot	NN	I-NP	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
into	into	IN	B-PP	O
high	high	JJ	B-NP	O
(	(	(	O	O
0.4	0.4	CD	B-NP	O
nM	nM	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
low	low	JJ	B-ADJP	O
(	(	(	O	O
11	11	CD	B-NP	O
nM	nM	NN	I-NP	O
)	)	)	O	O
affinity	affinity	NN	B-NP	O
components	component	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
receptor	receptor	NN	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	B-DNA
affinity	affinity	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
(	(	(	O	O
0.30	0.30	CD	B-NP	O
pmol/mg	pmol/mg	NN	I-NP	O
protein	protein	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
twice	twice	RB	I-NP	O
that	that	DT	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	B-DNA
affinity	affinity	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
(	(	(	O	O
0.14	0.14	CD	B-NP	O
pmol/mg	pmol/mg	NN	I-NP	O
protein	protein	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Dissociation	Dissociation	NN	B-NP	O
experiments	experiment	NNS	I-NP	O
with	with	IN	B-PP	O
dilution	dilution	NN	B-NP	O
and/or	and/or	CC	O	O
excess	excess	JJ	B-NP	O
unlabeled	unlabeled	JJ	I-NP	O
CVZ	CVZ	NN	I-NP	O
supported	support	VBD	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
independent	independent	JJ	B-NP	O
sites	site	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	I-NP	O
DEX	DEX	NN	I-NP	O
to	to	TO	B-PP	O
C7	C7	NN	B-NP	O
cytosol	cytosol	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
class	class	NN	I-NP	O
of	of	IN	B-PP	O
binding	bind	VBG	B-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
(	(	(	O	O
Kd	Kd	NN	B-NP	O
=	=	SYM	B-VP	O
1.9	1.9	CD	B-NP	O
nM	nM	NN	I-NP	O
;	;	:	O	O
receptor	receptor	NN	B-NP	O
concentration	concentration	NN	I-NP	O
,	,	,	O	O
0.46	0.46	CD	B-NP	O
pmol/mg	pmol/mg	NN	I-NP	O
protein	protein	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Examination	Examination	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	I-NP	O
CVZ	CVZ	NN	I-NP	O
using	use	VBG	B-VP	O
10	10	CD	B-NP	O
(	(	(	O	O
-5	-5	CD	B-NP	O
)	)	)	O	O
M	M	NN	B-NP	O
DEX	DEX	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
competing	compete	VBG	I-NP	O
ligand	ligand	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
DEX	DEX	NN	B-NP	O
binds	bind	VBZ	B-VP	O
only	only	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	B-DNA
affinity	affinity	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
detected	detect	VBN	B-VP	O
by	by	IN	B-PP	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
CVZ	CVZ	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
cytosol	cytosol	NN	B-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
glucocorticoid-resistant	glucocorticoid-resistant	JJ	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
with	with	IN	B-PP	O
virtually	virtually	RB	B-NP	O
no	no	DT	I-NP	O
[	[	(	I-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
DEX	DEX	NN	I-NP	O
binding	binding	NN	I-NP	O
,	,	,	O	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	I-NP	O
CVZ	CVZ	NN	I-NP	O
detected	detect	VBD	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
high	high	JJ	I-NP	O
affinity	affinity	NN	I-NP	O
binding	binding	NN	I-NP	O
site	site	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
in	in	IN	B-PP	O
dissociation	dissociation	NN	B-NP	O
constant	constant	NN	I-NP	O
(	(	(	O	O
0.8	0.8	CD	B-NP	O
nM	nM	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
receptor	receptor	NN	B-NP	O
concentration	concentration	NN	I-NP	O
(	(	(	O	O
0.13	0.13	CD	B-NP	O
pmol/mg	pmol/mg	NN	I-NP	O
protein	protein	NN	I-NP	O
)	)	)	O	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	B-DNA
affinity	affinity	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
detected	detect	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
glucocorticoid-sensitive	glucocorticoid-sensitive	JJ	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
C7	C7	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
controlled	control	VBN	I-NP	O
pore	pore	NN	I-NP	O
glass	glass	NN	I-NP	O
bead	bead	NN	I-NP	O
assay	assay	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
measurement	measurement	NN	I-NP	O
of	of	IN	B-PP	O
cytoplasmic	cytoplasmic	JJ	B-NP	O
and	and	CC	I-NP	O
nuclear	nuclear	JJ	I-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
.	.	.	O	O

An	An	DT	B-NP	O
assay	assay	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
quantitation	quantitation	NN	I-NP	O
of	of	IN	B-PP	O
cytoplasmic	cytoplasmic	JJ	B-NP	O
and	and	CC	I-NP	O
nuclear	nuclear	JJ	I-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
lymphoid	lymphoid	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
developed	develop	VBN	I-VP	O
using	use	VBG	B-VP	O
controlled	control	VBN	B-NP	O
pore	pore	NN	I-NP	O
glass	glass	NN	I-NP	O
(	(	(	O	O
CPG	CPG	NN	B-NP	O
)	)	)	O	O
beads	bead	VBZ	B-VP	O
.	.	.	O	O

Soluble	Soluble	JJ	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
--	--	:	O	I-protein
3H-steroid	3H-steroid	JJ	B-NP	I-protein
complex	complex	NN	I-NP	I-protein
(	(	(	O	O
cytosol	cytosol	NN	B-NP	O
or	or	CC	O	O
nuclear	nuclear	JJ	B-NP	O
extract	extract	NN	I-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
adsorbed	adsorb	VBN	I-VP	O
quantitatively	quantitatively	RB	B-ADVP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
crevasses	crevasse	NNS	I-NP	O
of	of	IN	B-PP	O
porous	porous	JJ	B-NP	O
glass	glass	NN	I-NP	O
beads	bead	NNS	I-NP	O
.	.	.	O	O

Excess	Excess	JJ	B-NP	O
labeled	label	VBN	I-NP	O
steroid	steroid	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
most	most	JJS	B-NP	O
non-specifically	non-specifically	RB	I-NP	O
bound	bind	VBN	I-NP	O
steroid	steroid	NN	I-NP	O
is	be	VBZ	B-VP	O
easily	easily	RB	I-VP	O
washed	wash	VBN	I-VP	O
away	away	RB	B-ADVP	O
,	,	,	O	O
leaving	leave	VBG	B-VP	O
the	the	DT	B-NP	O
hormone-receptor	hormone-receptor	NN	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
retained	retain	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
beads	bead	NNS	I-NP	O
.	.	.	O	O

Bound	Bound	NN	B-NP	O
3H-steroid	3H-steroid	NN	I-NP	O
is	be	VBZ	B-VP	O
eluted	elute	VBN	I-VP	O
with	with	IN	B-PP	O
ethanol	ethanol	NN	B-NP	O
and	and	CC	O	O
measured	measure	VBN	B-VP	O
for	for	IN	B-PP	O
radioactivity	radioactivity	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
procedure	procedure	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
simple	simple	JJ	B-ADJP	O
,	,	,	O	O
rapid	rapid	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
highly	highly	RB	B-ADJP	O
reproducible	reproducible	JJ	I-ADJP	O
is	be	VBZ	B-VP	O
carried	carry	VBN	I-VP	O
out	out	RP	B-PRT	O
using	use	VBG	B-VP	O
frozen	freeze	VBN	B-NP	O
samples	sample	NNS	I-NP	O
(	(	(	O	O
stable	stable	JJ	B-ADJP	O
for	for	IN	B-PP	O
many	many	JJ	B-NP	O
months	month	NNS	I-NP	O
)	)	)	O	O
containing	contain	VBG	B-VP	O
as	as	RB	B-ADJP	O
few	few	JJ	I-ADJP	O
as	as	IN	B-PP	O
1	1	CD	B-NP	O
X	X	SYM	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
7	7	CD	B-NP	O
)	)	)	O	O
cells	cell	NNS	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
comparison	comparison	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CPG	CPG	NN	I-NP	O
assay	assay	NN	I-NP	O
to	to	TO	B-VP	O
dextran	dextran	VB	I-VP	O
coated	coated	JJ	B-NP	O
charcoal	charcoal	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
whole	whole	JJ	I-NP	O
cell	cell	NN	I-NP	O
assay	assay	NN	I-NP	O
demonstrates	demonstrate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
CPG	CPG	NN	B-NP	B-protein
and	and	CC	O	O
dextran	dextran	NN	B-NP	O
coated	coated	JJ	I-NP	O
charcoal	charcoal	NN	I-NP	O
give	give	VBP	B-VP	O
equivalent	equivalent	JJ	B-NP	O
measurements	measurement	NNS	I-NP	O
of	of	IN	B-PP	O
cytosolic	cytosolic	JJ	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
concentration	concentration	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
CPG	CPG	NN	I-NP	B-DNA
and	and	CC	I-NP	O
whole	whole	JJ	I-NP	O
cell	cell	NN	I-NP	O
assays	assay	NNS	I-NP	O
provide	provide	VBP	B-VP	O
equivalent	equivalent	JJ	B-NP	O
values	value	NNS	I-NP	O
for	for	IN	B-PP	O
total	total	JJ	B-NP	O
receptor	receptor	NN	I-NP	O
content	content	NN	I-NP	O
.	.	.	O	O

Plasmacytoid	Plasmacytoid	JJ	B-NP	O
blast	blast	NN	I-NP	O
crisis	crisis	NN	I-NP	O
in	in	IN	B-PP	O
B-cell	B-cell	NN	B-NP	O
chronic	chronic	JJ	I-NP	O
lymphocytic	lymphocytic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
:	:	:	O	O
effect	effect	NN	B-NP	O
of	of	IN	B-PP	O
estradiol	estradiol	NN	B-NP	O
on	on	IN	B-PP	O
growth	growth	NN	B-NP	O
and	and	CC	O	O
differentiation	differentiation	NN	B-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

Evolution	Evolution	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
lymphocytic	lymphocytic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
CLL	CLL	NN	B-NP	O
)	)	)	O	O
into	into	IN	B-PP	O
blast	blast	NN	B-NP	O
crisis	crisis	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
three	three	CD	B-NP	O
unusual	unusual	JJ	I-NP	O
features	feature	NNS	I-NP	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
the	the	DT	B-NP	O
phenotype	phenotype	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
emerging	emerge	VBG	I-NP	O
blast	blast	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
that	that	IN	B-SBAR	O
of	of	IN	B-PP	O
pre-plasmacytoid	pre-plasmacytoid	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
as	as	IN	B-SBAR	O
shown	show	VBN	B-VP	O
by	by	IN	B-PP	O
plasma	plasma	NN	B-NP	O
cell	cell	NN	I-NP	O
morphology	morphology	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
immunological	immunological	JJ	I-NP	O
phenotype	phenotype	NN	I-NP	O
corresponding	correspond	VBG	B-VP	O
partially	partially	RB	B-ADVP	O
with	with	IN	B-PP	O
CLL-	CLL-	NN	B-NP	O
or	or	CC	O	O
intermediate	intermediate	JJ	B-NP	B-cell_type
B-cells	B-cell	NNS	I-NP	I-cell_type
,	,	,	O	O
partially	partially	RB	B-ADVP	O
with	with	IN	B-PP	O
plasma	plasma	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
terminal	terminal	JJ	B-NP	B-protein
transferase	transferase	NN	I-NP	I-protein
-	-	HYPH	B-ADJP	O
,	,	,	O	O
common	common	JJ	B-NP	O
acute	acute	JJ	I-NP	B-protein
lymphocytic	lymphocytic	JJ	I-NP	I-protein
leukemia	leukemia	NN	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
-	-	HYPH	B-ADJP	O
,	,	,	O	O
Ia+	Ia+	NN	B-NP	B-protein
,	,	,	O	O
surface	surface	NN	B-NP	B-protein
immunoglobulin	immunoglobulin	NN	I-NP	I-protein
heavy	heavy	JJ	I-NP	I-protein
chains	chain	NNS	I-NP	I-protein
-	-	HYPH	B-ADJP	O
,	,	,	O	O
surface	surface	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
light	light	JJ	I-NP	I-protein
chains	chain	NNS	I-NP	I-protein
+	+	SYM	B-NP	O
,	,	,	O	O
intracytoplasmic	intracytoplasmic	JJ	B-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	O
A+	A+	JJ	I-NP	O
and	and	CC	I-NP	O
G+	G+	JJ	I-NP	O
,	,	,	I-NP	O
BA-1+	BA-1+	JJ	I-NP	O
,	,	,	I-NP	O
polyclonal	polyclonal	JJ	I-NP	O
gammaglobulin	gammaglobulin	NN	I-NP	O
production	production	NN	I-NP	O
)	)	)	O	O
;	;	:	O	O
(	(	(	B-LST	O
2	2	LS	I-LST	O
)	)	)	O	O
cytogenetic	cytogenetic	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
spontaneous	spontaneous	JJ	B-NP	O
metaphases	metaphase	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
typical	typical	JJ	I-NP	O
CLL	CLL	NN	I-NP	O
abnormality	abnormality	NN	I-NP	O
,	,	,	O	O
trisomy	trisomy	NN	B-NP	O
12	12	CD	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
translocation	translocation	NN	I-NP	O
between	between	IN	B-PP	O
chromosomes	chromosome	NNS	B-NP	B-DNA
14	14	CD	B-NP	I-DNA
and	and	CC	I-NP	O
17	17	CD	I-NP	O
was	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
presumptive	presumptive	JJ	I-NP	O
breakpoint	breakpoint	NN	I-NP	O
on	on	IN	B-PP	O
chromosome	chromosome	NN	B-NP	B-DNA
14	14	CD	I-NP	I-DNA
(	(	(	O	O
q12-3	q12-3	NN	B-NP	O
)	)	)	O	O
never	never	RB	B-VP	O
described	describe	VBN	I-VP	O
before	before	IN	B-PP	O
(	(	(	O	O
commonly	commonly	RB	B-NP	O
q32	q32	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
(	(	(	B-LST	O
3	3	LS	I-LST	O
)	)	)	O	O
the	the	DT	B-NP	O
progression	progression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
striking	striking	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
transformed	transform	VBN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
of	of	IN	B-PP	O
specific	specific	JJ	B-NP	O
binding	bind	VBG	I-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
for	for	IN	B-PP	O
estradiol	estradiol	NN	B-NP	O
(	(	(	O	O
E2	E2	NN	B-NP	O
)	)	)	O	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
actual	actual	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
total	total	JJ	B-NP	O
cellular	cellular	JJ	I-NP	O
receptor	receptor	NN	I-NP	O
proteins	protein	NNS	I-NP	O
and	and	CC	O	O
not	not	RB	B-PP	O
to	to	TO	I-PP	O
a	a	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
receptor	receptor	NN	B-NP	O
affinity	affinity	NN	I-NP	O
for	for	IN	B-PP	O
E2	E2	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
functional	functional	JJ	I-NP	O
status	status	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
steroid	steroid	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
by	by	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
transfer	transfer	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	B-protein
hormone-receptor	hormone-receptor	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
upon	upon	IN	B-PP	O
temperature	temperature	NN	B-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
the	the	DT	B-NP	O
rise	rise	NN	I-NP	O
in	in	IN	B-PP	O
E2-receptor	E2-receptor	NN	B-NP	O
display	display	NN	I-NP	O
paralleled	parallel	VBD	B-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
proliferative	proliferative	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
maturation	maturation	NN	I-NP	O
status	status	NN	I-NP	O
the	the	DT	B-NP	O
question	question	NN	I-NP	O
was	be	VBD	B-VP	O
raised	raise	VBN	I-VP	O
as	as	IN	B-PP	O
to	to	TO	B-PP	O
whether	whether	IN	B-SBAR	O
the	the	DT	B-NP	O
E2-receptor	E2-receptor	NN	I-NP	B-protein
should	should	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
physiological	physiological	JJ	I-NP	O
marker	marker	NN	I-NP	O
of	of	IN	B-PP	O
growth	growth	NN	B-NP	O
rate	rate	NN	I-NP	O
or	or	CC	B-PP	O
of	of	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
.	.	.	O	O

Exposure	Exposure	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blast	blast	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
E2	E2	NN	B-NP	B-protein
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
cessation	cessation	NN	B-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
growth	growth	NN	I-NP	O
following	follow	VBG	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
one	one	CD	I-NP	O
mitosis	mitosis	NN	I-NP	O
after	after	IN	B-PP	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inducer	inducer	NN	I-NP	O
as	as	IN	B-SBAR	O
seen	see	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
replacement	replacement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
large	large	JJ	I-NP	B-cell_type
blasts	blast	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
small	small	JJ	B-NP	B-cell_type
CLL-like	CLL-like	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
without	without	IN	B-PP	O
definite	definite	JJ	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
alteration	alteration	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
differentiation	differentiation	NN	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
suggests	suggest	VBZ	B-VP	O
the	the	DT	B-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
E2-receptor	E2-receptor	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
with	with	IN	B-PP	O
control	control	NN	B-NP	O
of	of	IN	B-PP	O
growth	growth	NN	B-NP	O
rather	rather	RB	B-CONJP	O
than	than	IN	I-CONJP	O
cell	cell	NN	B-NP	O
maturation	maturation	NN	I-NP	O
.	.	.	O	O

Multiple	Multiple	JJ	B-NP	O
forms	form	NNS	I-NP	O
and	and	CC	I-NP	O
fragments	fragment	NNS	I-NP	O
of	of	IN	B-PP	O
cytosolic	cytosolic	JJ	B-NP	B-protein
glucocorticoid	glucocorticoid	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
from	from	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
leukemic	leukemic	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
normal	normal	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Therapy	Therapy	NN	B-NP	O
with	with	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
is	be	VBZ	B-VP	O
generally	generally	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
effective	effective	JJ	I-ADJP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
lymphoblastic	lymphoblastic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
other	other	JJ	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
leukemia	leukemia	NN	I-NP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
have	have	VBP	B-VP	O
not	not	RB	I-VP	O
revealed	reveal	VBN	I-VP	O
any	any	DT	B-NP	O
consistent	consistent	JJ	I-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
responsiveness	responsiveness	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
or	or	CC	I-NP	O
cytosolic	cytosolic	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid-binding	glucocorticoid-binding	JJ	B-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
objectives	objective	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
intrinsic	intrinsic	JJ	B-NP	O
structural	structural	JJ	I-NP	O
differences	difference	NNS	I-NP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
various	various	JJ	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
leukemic	leukemic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
normal	normal	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
endogenous	endogenous	JJ	B-NP	B-protein
peptidases	peptidase	NNS	I-NP	I-protein
in	in	IN	B-PP	O
receptor	receptor	NN	B-NP	O
degradation	degradation	NN	I-NP	O
.	.	.	O	O

Cytosols	Cytosol	NNS	B-NP	O
were	be	VBD	B-VP	O
prepared	prepare	VBN	I-VP	O
from	from	IN	B-PP	O
fresh	fresh	JJ	B-NP	O
or	or	CC	I-NP	O
rapidly	rapidly	RB	I-NP	O
frozen	freeze	VBN	I-NP	O
leukocytes	leukocyte	NNS	I-NP	B-cell_type
from	from	IN	B-PP	O
6	6	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
adults	adult	NNS	I-NP	O
and	and	CC	O	O
35	35	CD	B-NP	O
high-risk	high-risk	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
median	median	JJ	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
,	,	,	O	O
150	150	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
cells/microliter	cells/microliter	NNS	I-NP	O
;	;	:	O	O
median	median	JJ	B-NP	O
age	age	NN	I-NP	O
,	,	,	O	O
13	13	CD	B-NP	O
years	year	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

Receptors	Receptor	NNS	B-NP	O
were	be	VBD	B-VP	O
labeled	label	VBN	I-VP	O
with	with	IN	B-PP	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
triamcinolone	triamcinolone	NN	I-NP	O
acetonide	acetonide	NN	I-NP	O
and	and	CC	O	O
quantitated	quantitate	VBN	B-VP	O
by	by	IN	B-PP	O
charcoal-dextran	charcoal-dextran	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
or	or	CC	I-NP	O
Sephadex	Sephadex	NN	I-NP	O
LH-20	LH-20	NN	I-NP	O
chromatography	chromatography	NN	I-NP	O
.	.	.	O	O

Mean	Mean	JJ	B-NP	O
and	and	CC	I-NP	O
median	median	JJ	I-NP	O
cytosolic	cytosolic	JJ	I-NP	O
receptor	receptor	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
in	in	IN	B-PP	O
12	12	CD	B-NP	O
acute	acute	JJ	I-NP	O
lymphoblastic	lymphoblastic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
specimens	specimen	NNS	I-NP	O
lacking	lack	VBG	B-VP	O
the	the	DT	B-NP	O
standard	standard	JJ	I-NP	O
B-cell	B-cell	NN	I-NP	O
or	or	CC	I-NP	O
T-cell	T-cell	NN	I-NP	B-protein
markers	marker	NNS	I-NP	I-protein
(	(	(	O	O
``	``	``	O	B-cell_type
null	null	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
''	''	''	O	O
)	)	)	O	O
were	be	VBD	B-VP	O
approximately	approximately	RB	B-ADVP	O
4-fold	4-fold	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
23	23	CD	B-NP	O
other	other	JJ	I-NP	O
leukemic	leukemic	JJ	I-NP	O
cell	cell	NN	I-NP	O
specimens	specimen	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
other	other	JJ	I-NP	O
consistent	consistent	JJ	I-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
receptor	receptor	NN	B-NP	O
content	content	NN	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

Agarose	Agarose	NN	B-NP	O
filtration	filtration	NN	I-NP	O
and	and	CC	I-NP	O
ultracentrifugation	ultracentrifugation	NN	I-NP	O
in	in	IN	B-PP	O
hypotonic	hypotonic	JJ	B-NP	O
buffers	buffer	NNS	I-NP	O
containing	contain	VBG	B-VP	O
20	20	CD	B-NP	O
mM	mM	NN	I-NP	O
Na2MoO4	Na2MoO4	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
complexes	complex	NNS	B-NP	O
of	of	IN	B-PP	O
similar	similar	JJ	B-NP	O
size	size	NN	I-NP	O
and	and	CC	I-NP	O
shape	shape	NN	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
specimens	specimen	NNS	I-NP	O
tested	test	VBN	B-VP	O
and	and	CC	O	O
two	two	CD	B-NP	O
established	establish	VBN	I-NP	O
leukemic	leukemic	JJ	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
.	.	.	O	O

They	They	PRP	B-NP	O
had	have	VBD	B-VP	O
Stokes	Stokes	NNP	B-NP	O
radii	radius	NNS	I-NP	O
(	(	(	O	O
Rs	R	NNS	B-NP	B-protein
)	)	)	O	O
of	of	IN	B-PP	O
8.1	8.1	CD	B-NP	O
+/-	+/-	CC	I-NP	O
0.5	0.5	CD	I-NP	O
(	(	(	O	O
S.D.	S.D.	NN	B-NP	O
)	)	)	O	O
nm	nm	NN	B-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
50	50	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
sedimentation	sedimentation	NN	B-NP	O
coefficients	coefficient	NNS	I-NP	O
of	of	IN	B-PP	O
9.5	9.5	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
0.3S	0.3S	NN	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
40	40	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
molecular	molecular	JJ	B-NP	O
weights	weight	NNS	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
330	330	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
axial	axial	JJ	B-NP	O
ratios	ratio	NNS	I-NP	O
(	(	(	O	O
a/b	a/b	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
hypertonic	hypertonic	JJ	B-NP	O
,	,	,	I-NP	O
molybdate-free	molybdate-free	JJ	I-NP	O
buffer	buffer	NN	I-NP	O
,	,	,	O	O
these	these	DT	B-NP	O
oligomeric	oligomeric	JJ	I-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
dissociated	dissociate	VBN	I-VP	O
into	into	IN	B-PP	O
subunits	subunit	NNS	B-NP	O
with	with	IN	B-PP	O
Rs	R	NNS	B-NP	B-protein
of	of	IN	B-PP	O
5.9	5.9	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
0.3	0.3	CD	I-NP	O
nm	nm	NN	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
12	12	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
a/b	a/b	NN	B-NP	O
of	of	IN	B-PP	O
11	11	CD	B-NP	O
to	to	TO	B-PP	O
12	12	CD	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
observed	observe	VBN	B-VP	O
previously	previously	RB	B-ADVP	O
for	for	IN	B-PP	O
other	other	JJ	B-NP	O
receptors	receptor	NNS	I-NP	O
.	.	.	O	O

Fragmentation	Fragmentation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oligomer	oligomer	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
subunit	subunit	NN	I-NP	O
was	be	VBD	B-VP	O
evident	evident	JJ	B-ADJP	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
cytosols	cytosol	NNS	I-NP	O
.	.	.	O	O

High	High	JJ	B-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
peptidases	peptidase	NNS	B-NP	O
of	of	IN	B-PP	O
various	various	JJ	B-NP	O
specificities	specificity	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
leukemic	leukemic	JJ	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
cytosols	cytosol	NNS	I-NP	O
,	,	,	O	O
as	as	IN	B-PP	O
in	in	IN	B-PP	O
other	other	JJ	B-NP	O
cytosols	cytosol	NNS	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
fluorometric	fluorometric	JJ	B-NP	O
assays	assay	NNS	I-NP	O
with	with	IN	B-PP	O
derivatives	derivative	NNS	B-NP	O
of	of	IN	B-PP	O
7-amino-4-methylcoumarin	7-amino-4-methylcoumarin	NN	B-NP	B-protein
.	.	.	O	O

Receptor	Receptor	NN	B-NP	O
cleavage	cleavage	NN	I-NP	O
by	by	IN	B-PP	O
these	these	DT	B-NP	O
and	and	CC	I-NP	O
other	other	JJ	I-NP	O
endogenous	endogenous	JJ	I-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
may	may	MD	B-VP	O
account	account	VB	I-VP	O
for	for	IN	B-PP	O
previous	previous	JJ	B-NP	O
observations	observation	NNS	I-NP	O
of	of	IN	B-PP	O
``	``	``	B-NP	B-protein
abnormal	abnormal	JJ	I-NP	I-protein
''	''	''	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
cytosols	cytosol	NNS	B-NP	O
from	from	IN	B-PP	O
some	some	DT	B-NP	O
leukemic	leukemic	JJ	I-NP	O
specimens	specimen	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
intrinsic	intrinsic	JJ	B-NP	O
structural	structural	JJ	I-NP	O
defects	defect	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
receptors	receptor	NNS	I-NP	O
are	be	VBP	B-VP	O
unlikely	unlikely	JJ	B-NP	O
explanations	explanation	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
unresponsiveness	unresponsiveness	NN	I-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
leukemia	leukemia	NN	B-NP	O
to	to	TO	B-PP	O
steroid	steroid	NN	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
number	number	NN	I-NP	O
and	and	CC	O	O
intracellular	intracellular	JJ	B-NP	O
water	water	NN	I-NP	O
space	space	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
elucidate	elucidate	VB	I-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
cell	cell	NN	B-NP	O
water	water	NN	I-NP	O
content	content	NN	I-NP	O
and	and	CC	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
,	,	,	O	O
eleven	eleven	CD	B-NP	O
normal	normal	JJ	I-NP	O
and	and	CC	I-NP	O
malignant	malignant	JJ	I-NP	O
lymphoid	lymphoid	JJ	I-NP	O
or	or	CC	I-NP	O
myelomonocytic	myelomonocytic	JJ	I-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
types	type	NNS	I-NP	I-cell_type
originating	originate	VBG	B-VP	O
from	from	IN	B-PP	O
mouse	mouse	NN	B-NP	O
,	,	,	O	O
rat	rat	NN	B-NP	O
and	and	CC	O	O
man	man	NN	B-NP	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
water	water	NN	I-NP	O
space	space	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
with	with	IN	B-PP	O
3H2O	3H2O	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
number	number	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
whole-cell	whole-cell	JJ	I-NP	O
binding	binding	NN	I-NP	O
assay	assay	NN	I-NP	O
with	with	IN	B-PP	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
dexamethasone	dexamethasone	NN	I-NP	O
at	at	IN	B-PP	O
30	30	CD	B-NP	O
and	and	CC	I-NP	O
37	37	CD	I-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	O
water	water	NN	I-NP	O
phase	phase	NN	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
(	(	(	O	O
around	around	IN	B-NP	O
40	40	CD	I-NP	O
nmol/l	nmol/l	NN	I-NP	O
cell	cell	NN	I-NP	O
water	water	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
dependence	dependence	NN	I-NP	O
of	of	IN	B-PP	O
receptor	receptor	NN	B-NP	O
affinity	affinity	NN	I-NP	O
on	on	IN	B-PP	O
temperature	temperature	NN	B-NP	O
were	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
and	and	CC	I-NP	O
malignant	malignant	JJ	I-NP	O
rodent	rodent	NN	I-NP	O
and	and	CC	O	O
human	human	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
comparisons	comparison	NNS	B-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
levels	level	NNS	I-NP	O
are	be	VBP	B-VP	O
best	best	RB	I-VP	O
made	make	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
concentrations	concentration	NNS	I-NP	O
.	.	.	O	O

Covalent	Covalent	JJ	B-NP	O
labeling	labeling	NN	I-NP	O
of	of	IN	B-PP	O
rat	rat	NN	B-NP	B-cell_type
thymocyte	thymocyte	NN	I-NP	I-cell_type
and	and	CC	O	O
human	human	JJ	B-NP	O
lymphoid	lymphoid	JJ	I-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

Lymphoid	Lymphoid	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
contain	contain	VBP	B-VP	O
specific	specific	JJ	B-NP	O
receptors	receptor	NNS	I-NP	O
for	for	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
used	use	VBN	I-VP	O
[	[	(	O	O
3H	3H	NN	O	O
]	]	)	O	O
dexamethasone-21-mesylate	dexamethasone-21-mesylate	NN	B-NP	O
to	to	TO	B-VP	O
label	label	VB	I-VP	O
covalently	covalently	RB	B-ADVP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
rat	rat	NN	B-NP	B-cell_type
thymic	thymic	JJ	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
and	and	CC	B-PP	O
in	in	IN	B-PP	O
neoplastic	neoplastic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
lymphoblastic	lymphoblastic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
and	and	CC	O	O
malignant	malignant	JJ	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
covalently	covalently	RB	I-NP	O
labeled	label	VBN	I-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
polyacrylamide	polyacrylamide	NN	B-NP	O
gel	gel	NN	I-NP	O
electrophoresis	electrophoresis	NN	I-NP	O
(	(	(	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
0.1	0.1	CD	B-NP	O
%	%	NN	I-NP	O
sodium	sodium	NN	I-NP	O
dodecyl	dodecyl	NN	I-NP	O
sulfate	sulfate	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
cytosolic	cytosolic	JJ	B-NP	O
fractions	fraction	NNS	I-NP	O
prepared	prepare	VBN	B-VP	O
from	from	IN	B-PP	O
rat	rat	NN	B-NP	B-cell_type
thymic	thymic	JJ	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	I-NP	O
-dexamethasone-21-mesylate	-dexamethasone-21-mesylate	NN	I-NP	O
labels	label	VBZ	B-VP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
(	(	(	O	O
Mr	Mr	NN	B-NP	B-protein
approximately	approximately	RB	B-ADJP	O
equal	equal	JJ	I-ADJP	O
to	to	TO	B-PP	O
95	95	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
)	)	)	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
by	by	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
criteria	criterion	NNS	I-NP	O
:	:	:	O	O
(	(	(	B-LST	O
a	a	LS	I-LST	O
)	)	)	O	O
labeling	labeling	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
moiety	moiety	NN	I-NP	O
is	be	VBZ	B-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
100-fold	100-fold	JJ	I-NP	O
molar	molar	JJ	I-NP	O
excess	excess	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
and	and	CC	I-NP	O
triamcinolone	triamcinolone	NN	I-NP	O
acetonide	acetonide	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
(	(	(	B-LST	O
b	b	LS	I-LST	O
)	)	)	O	O
the	the	DT	B-NP	O
covalently	covalently	RB	I-NP	O
labeled	label	VBN	I-NP	O
Mr	Mr	NN	I-NP	B-protein
approximately	approximately	RB	B-ADJP	O
equal	equal	JJ	I-ADJP	O
to	to	TO	B-PP	O
95	95	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
protein	protein	NN	I-NP	O
is	be	VBZ	B-VP	O
activated	activate	VBN	I-VP	O
(	(	(	O	O
by	by	IN	B-PP	O
heating	heat	VBG	B-VP	O
at	at	IN	B-PP	O
20	20	CD	B-NP	O
degrees	degree	NNS	I-NP	O
for	for	IN	B-PP	O
30	30	CD	B-NP	O
min	min	NN	I-NP	O
)	)	)	O	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
form	form	NN	I-NP	O
that	that	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
DNA-cellulose	DNA-cellulose	NN	B-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
intact	intact	JJ	B-NP	B-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	I-NP	O
dexamethasone-21-mesylate	dexamethasone-21-mesylate	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
Mr	Mr	NN	I-NP	B-protein
approximately	approximately	RB	B-ADJP	O
equal	equal	JJ	I-ADJP	O
to	to	TO	B-PP	O
95	95	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
moiety	moiety	NN	I-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
labeled	label	VBN	I-VP	O
covalently	covalently	RB	B-ADVP	O
.	.	.	O	O

Approximately	Approximately	RB	B-NP	O
35	35	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
can	can	MD	B-VP	O
be	be	VB	I-VP	O
labeled	label	VBN	I-VP	O
covalently	covalently	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
intact	intact	JJ	B-NP	B-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
100	100	CD	B-NP	O
nM	nM	NN	I-NP	O
[	[	(	I-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
dexamethasone-21-mesylate	dexamethasone-21-mesylate	NN	I-NP	O
for	for	IN	B-PP	O
30	30	CD	B-NP	O
min	min	NN	I-NP	O
at	at	IN	B-PP	O
4	4	CD	B-NP	O
degrees	degree	NNS	I-NP	O
.	.	.	O	O

Neoplastic	Neoplastic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
acute	acute	JJ	B-NP	O
lymphoblastic	lymphoblastic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
and	and	CC	O	O
malignant	malignant	JJ	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
dexamethasone-21-mesylate	dexamethasone-21-mesylate	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
all	all	DT	B-NP	O
samples	sample	NNS	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
Mr	Mr	NN	I-NP	B-protein
approximately	approximately	RB	B-ADJP	O
equal	equal	JJ	I-ADJP	O
to	to	TO	B-PP	O
95	95	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
moiety	moiety	NN	I-NP	O
was	be	VBD	B-VP	O
labeled	label	VBN	I-VP	O
covalently	covalently	RB	B-ADVP	O
;	;	:	O	O
labeling	labeling	NN	B-NP	O
was	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
excess	excess	JJ	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
.	.	.	O	O

Smaller	Small	JJR	B-NP	O
moieties	moiety	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
competition	competition	NN	B-NP	O
experiments	experiment	NNS	I-NP	O
;	;	:	O	O
these	these	DT	B-NP	O
may	may	MD	B-VP	O
represent	represent	VB	I-VP	O
proteolytic	proteolytic	JJ	B-NP	B-protein
fragments	fragment	NNS	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Mr	Mr	NN	I-NP	B-protein
approximately	approximately	RB	B-ADJP	O
equal	equal	JJ	I-ADJP	O
to	to	TO	B-PP	O
95	95	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
receptor	receptor	NN	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
rat	rat	NN	B-NP	O
and	and	CC	O	O
human	human	JJ	B-NP	B-cell_type
lymphoid	lymphoid	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	I-NP	O
dexamethasone-21-mesylate	dexamethasone-21-mesylate	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
label	label	VB	I-VP	O
covalently	covalently	RB	B-ADVP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
cytosol	cytosol	NN	B-NP	O
oestrogen	oestrogen	NN	I-NP	O
and	and	CC	O	O
progesterone	progesterone	NN	B-NP	B-protein
receptors	receptor	NNS	B-NP	I-protein
with	with	IN	B-PP	O
histological	histological	JJ	B-NP	O
features	feature	NNS	I-NP	O
of	of	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
and	and	CC	O	O
early	early	JJ	B-NP	O
recurrence	recurrence	NN	I-NP	O
of	of	IN	B-PP	O
disease	disease	NN	B-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
hundred	hundred	CD	I-NP	O
and	and	CC	I-NP	O
eighty-eight	eighty-eight	CD	I-NP	O
primary	primary	JJ	I-NP	O
breast	breast	NN	I-NP	O
tumours	tumour	NNS	I-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
or	or	CC	I-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
oestrogen	oestrogen	NN	B-NP	O
(	(	(	O	O
REc	REc	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
progesterone	progesterone	NN	B-NP	B-protein
(	(	(	O	I-protein
RPc	RPc	NN	B-NP	I-protein
)	)	)	O	I-protein
receptors	receptor	NNS	B-NP	I-protein
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
has	have	VBZ	B-VP	O
shown	show	VBN	I-VP	O
a	a	DT	B-NP	O
relative	relative	JJ	I-NP	O
interdependence	interdependence	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
steroid	steroid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
status	status	NN	I-NP	O
of	of	IN	B-PP	O
primary	primary	JJ	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
prognostic	prognostic	JJ	I-NP	O
variables	variable	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
histological	histological	JJ	B-NP	O
grade	grade	NN	I-NP	O
,	,	,	O	O
lymphocytic	lymphocytic	JJ	B-NP	O
infiltration	infiltration	NN	I-NP	O
and	and	CC	I-NP	O
tumour	tumour	NN	I-NP	O
elastosis	elastosis	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
significant	significant	JJ	B-NP	O
associations	association	NNS	I-NP	O
between	between	IN	B-PP	O
epithelial	epithelial	JJ	B-NP	O
cellularity	cellularity	NN	I-NP	O
,	,	,	O	O
stromal	stromal	JJ	B-NP	O
fibrosis	fibrosis	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
REc	REc	NN	B-NP	B-protein
in	in	IN	B-PP	O
those	those	DT	B-NP	O
tumours	tumour	NNS	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
was	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

Cellularity	Cellularity	NN	B-NP	O
and	and	CC	I-NP	O
fibrosis	fibrosis	NN	I-NP	O
were	be	VBD	B-VP	O
unrelated	unrelated	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
or	or	CC	I-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
oestrogen	oestrogen	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

By	By	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
neither	neither	CC	O	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
or	or	CC	I-NP	O
absence	absence	NN	I-NP	O
nor	nor	CC	O	O
the	the	DT	B-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
RPc	RPc	NN	B-NP	B-protein
could	could	MD	B-VP	O
be	be	VB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
cellularity	cellularity	NN	B-NP	O
or	or	CC	I-NP	O
fibrosis	fibrosis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
REc	REc	NN	B-NP	B-protein
and	and	CC	I-NP	O
RPc	RPc	NN	I-NP	O
analysis	analysis	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
indicator	indicator	NN	I-NP	O
of	of	IN	B-PP	O
prognosis	prognosis	NN	B-NP	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
sub-group	sub-group	NN	I-NP	O
of	of	IN	B-PP	O
175	175	CD	B-NP	O
patients	patient	NNS	I-NP	O
receiving	receive	VBG	B-VP	O
no	no	DT	B-NP	O
additional	additional	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
following	follow	VBG	I-NP	O
mastectomy	mastectomy	NN	I-NP	O
.	.	.	O	O

Overall	Overall	JJ	B-NP	O
relapse-free	relapse-free	JJ	I-NP	O
survival	survival	NN	I-NP	O
(	(	(	O	O
RFS	RFS	NN	B-NP	B-protein
)	)	)	O	O
was	be	VBD	B-VP	O
no	no	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
for	for	IN	B-PP	O
those	those	DT	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
receptors	receptor	NNS	B-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
without	without	IN	B-PP	O
them	them	PRP	B-NP	O
(	(	(	O	O
REc	REc	NN	B-NP	O
P	P	NN	I-NP	O
=	=	SYM	B-VP	O
0.11	0.11	CD	B-NP	O
,	,	,	O	O
RPc	RPc	NN	B-NP	O
P	P	NN	I-NP	O
=	=	SYM	B-VP	O
0.7	0.7	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
RFS	RFS	NN	B-NP	B-protein
of	of	IN	B-PP	O
receptor	receptor	NN	B-NP	O
positive	positive	JJ	I-NP	O
and	and	CC	I-NP	O
negative	negative	JJ	I-NP	O
tumours	tumour	NNS	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
axillary	axillary	JJ	I-NP	O
node	node	NN	I-NP	O
status	status	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
into	into	IN	B-PP	O
account	account	NN	B-NP	O
.	.	.	O	O

Clinical	Clinical	JJ	B-NP	O
implications	implication	NNS	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
leukemia	leukemia	NN	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	B-cell_type
lymphoid	lymphoid	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
contain	contain	VBP	B-VP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

A	A	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
stimuli	stimulus	NNS	B-NP	O
that	that	WDT	B-NP	O
activate	activate	VBP	B-VP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
also	also	RB	B-ADVP	O
induce	induce	VBP	B-VP	O
increases	increase	NNS	B-NP	O
in	in	IN	B-PP	O
receptor	receptor	NN	B-NP	O
concentration	concentration	NN	I-NP	O
.	.	.	O	O

Similar	Similar	JJ	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
can	can	MD	B-VP	O
be	be	VB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
lymphoid	lymphoid	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
lymphoblastic	lymphoblastic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
ALL	ALL	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Absence	Absence	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
usually	usually	RB	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
treated	treat	VBN	B-NP	O
patients	patient	NNS	I-NP	O
)	)	)	O	O
predicts	predict	VBZ	B-VP	O
lack	lack	NN	B-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
responsiveness	responsiveness	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
our	our	PRP$	B-NP	O
hands	hand	NNS	I-NP	O
,	,	,	O	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
levels	level	NNS	I-NP	O
correlate	correlate	VBP	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
duration	duration	NN	I-NP	O
of	of	IN	B-PP	O
complete	complete	JJ	B-NP	O
remission	remission	NN	I-NP	O
in	in	IN	B-PP	O
ALL	ALL	NN	B-NP	O
(	(	(	O	O
though	though	IN	B-SBAR	O
not	not	RB	O	O
in	in	IN	B-PP	O
other	other	JJ	B-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
leukemia	leukemia	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

This	This	DT	B-NP	O
association	association	NN	I-NP	O
is	be	VBZ	B-VP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
type	type	NN	I-NP	O
,	,	,	O	O
age	age	NN	B-NP	O
,	,	,	O	O
sex	sex	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
initial	initial	JJ	B-NP	O
leukocyte	leukocyte	NN	I-NP	O
count	count	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
receptor	receptor	NN	B-NP	B-protein
shows	show	VBZ	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
aggressiveness	aggressiveness	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tumor	tumor	NN	I-NP	O
(	(	(	O	O
null-cell	null-cell	JJ	B-NP	O
leukemia	leukemia	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
T-cell	T-cell	NN	B-NP	O
leukemia	leukemia	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
Burkitt	Burkitt	NN	B-NP	O
's	's	POS	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Corticosteroid-mediated	Corticosteroid-mediated	JJ	B-NP	O
immunoregulation	immunoregulation	NN	I-NP	O
in	in	IN	B-PP	O
man	man	NN	B-NP	O
.	.	.	O	O

Glucocorticoids	Glucocorticoid	NNS	B-NP	O
have	have	VBP	B-VP	O
profound	profound	JJ	B-NP	O
and	and	CC	I-NP	O
complex	complex	JJ	I-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
precise	precise	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
corticosteroid-induced	corticosteroid-induced	JJ	I-NP	O
immunoregulation	immunoregulation	NN	I-NP	O
in	in	IN	B-PP	O
man	man	NN	B-NP	O
have	have	VBP	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
precisely	precisely	RB	B-ADJP	O
defined	define	VBN	I-ADJP	O
.	.	.	O	O

Intracytoplasmic	Intracytoplasmic	JJ	B-NP	B-protein
corticosteroid-specific	corticosteroid-specific	JJ	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
common	common	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
for	for	IN	B-PP	O
steroid-induced	steroid-induced	JJ	B-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
variations	variation	NNS	B-NP	O
of	of	IN	B-PP	O
receptor	receptor	NN	B-NP	O
parameters	parameter	NNS	I-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
account	account	VB	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
multifaceted	multifaceted	JJ	I-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
immune	immune	JJ	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

Human	Human	JJ	B-ADJP	B-cell_type
circulating	circulate	VBG	B-VP	I-cell_type
mononuclear	mononuclear	JJ	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
redistribute	redistribute	VBP	B-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
intravascular	intravascular	JJ	I-NP	O
compartment	compartment	NN	I-NP	O
following	follow	VBG	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
corticosteroids	corticosteroid	NNS	B-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
certain	certain	JJ	B-NP	O
components	component	NNS	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
redistribution	redistribution	NN	I-NP	O
phenomenon	phenomenon	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
well-characterized	well-characterized	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
compartmental	compartmental	JJ	I-NP	O
cellular	cellular	JJ	I-NP	O
shift	shift	NN	I-NP	O
with	with	IN	B-PP	O
respect	respect	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
of	of	IN	B-PP	O
corticosteroid-induced	corticosteroid-induced	JJ	B-NP	O
immunoregulation	immunoregulation	NN	I-NP	O
are	be	VBP	B-VP	O
less	less	RBR	B-ADJP	O
well-defined	well-defined	JJ	I-ADJP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
observations	observation	NNS	I-NP	O
that	that	IN	B-NP	O
activated	activate	VBN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
may	may	MD	B-VP	O
be	be	VB	I-VP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
lytic	lytic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
under	under	IN	B-PP	O
certain	certain	JJ	B-NP	O
situations	situation	NNS	I-NP	O
the	the	DT	B-NP	O
elimination	elimination	NN	I-NP	O
of	of	IN	B-PP	O
selected	select	VBN	B-NP	O
subsets	subset	NNS	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
relevant	relevant	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
corticosteroid-mediated	corticosteroid-mediated	JJ	B-NP	O
immunoregulation	immunoregulation	NN	I-NP	O
in	in	IN	B-PP	O
man	man	NN	B-NP	O
.	.	.	O	O

Corticosteroid-mediated	Corticosteroid-mediated	JJ	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
monocyte	monocyte	NN	B-NP	O
function	function	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
drug-induced	drug-induced	JJ	B-NP	O
immunoregulation	immunoregulation	NN	I-NP	O
in	in	IN	B-PP	O
monocyte-dependent	monocyte-dependent	JJ	B-NP	O
responses	response	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
some	some	DT	B-NP	O
experimental	experimental	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
,	,	,	O	O
corticosteroids	corticosteroid	NNS	B-NP	O
inhibit	inhibit	VBP	B-VP	O
Interleukin	Interleukin	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
production	production	NN	I-NP	O
by	by	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
immunoregulatory	immunoregulatory	JJ	I-NP	B-protein
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
corticosteroids	corticosteroid	NNS	B-NP	O
on	on	IN	B-PP	O
lymphocyte	lymphocyte	NN	B-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
are	be	VBP	B-VP	O
complex	complex	JJ	B-ADJP	O
.	.	.	O	O

In	In	FW	B-NP	O
vitro	vitro	FW	I-NP	O
corticosteroids	corticosteroid	NNS	I-NP	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
selectively	selectively	RB	I-VP	O
affect	affect	VB	I-VP	O
early	early	JJ	B-NP	O
immunoregulatory	immunoregulatory	JJ	I-NP	O
events	event	NNS	I-NP	O
as	as	IN	B-SBAR	O
opposed	oppose	VBN	B-VP	O
to	to	TO	B-PP	O
altering	alter	VBG	B-VP	O
an	an	DT	B-NP	O
established	established	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Multiple	Multiple	JJ	B-NP	O
sites	site	NNS	I-NP	O
of	of	IN	B-PP	O
steroid-induced	steroid-induced	JJ	B-NP	O
modulations	modulation	NNS	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
B	B	NN	I-NP	O
cell	cell	NN	I-NP	O
responses	response	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
defined	define	VBN	I-VP	O
.	.	.	O	O

Human	Human	JJ	B-NP	B-cell_line
lymphoid	lymphoid	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
and	and	CC	I-NP	O
glucocorticoids	glucocorticoid	NNS	I-NP	O
:	:	:	O	O
II	II	CD	B-NP	O
.	.	.	O	O

Whole	Whole	JJ	B-NP	O
cell	cell	NN	I-NP	O
and	and	CC	O	O
cytoplasmic	cytoplasmic	JJ	B-NP	O
binding	binding	NN	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
lymphoblastoid	lymphoblastoid	JJ	B-NP	O
,	,	,	I-NP	O
leukaemia	leukaemia	NN	I-NP	O
and	and	CC	I-NP	O
lymphoma	lymphoma	NN	I-NP	O
lines	line	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
binding	binding	NN	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
18	18	CD	B-NP	O
human	human	JJ	I-NP	B-cell_line
lymphoid	lymphoid	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
(	(	(	O	O
HLCL	HLCL	NN	B-NP	B-cell_line
)	)	)	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
steroid	steroid	NN	B-NP	O
binding	binding	NN	I-NP	O
was	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
with	with	IN	B-PP	O
various	various	JJ	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
agonists	agonist	NNS	I-NP	O
and	and	CC	I-NP	O
antagonists	antagonist	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
gradation	gradation	NN	I-NP	O
in	in	IN	B-PP	O
whole	whole	JJ	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
and	and	CC	I-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
binding	binding	NN	I-NP	O
capacity	capacity	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
types	type	NNS	I-NP	O
:	:	:	O	O
lymphoblastoid	lymphoblastoid	JJ	B-ADJP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
lymphoma	lymphoma	NN	B-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
leukaemia	leukaemia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
of	of	IN	B-PP	O
leukaemia	leukaemia	NN	B-NP	O
and	and	CC	O	O
lymphoblastoid	lymphoblastoid	JJ	B-NP	B-cell_line
lines	line	NNS	I-NP	I-cell_line
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
contain	contain	VB	I-VP	O
both	both	CC	O	O
proteinaceous	proteinaceous	JJ	B-NP	O
and	and	CC	I-NP	O
phospholipid	phospholipid	NN	I-NP	B-protein
components	component	NNS	I-NP	I-protein
.	.	.	O	O

Cytoplasmic	Cytoplasmic	JJ	B-NP	B-protein
steroid-receptor	steroid-receptor	NN	I-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
exhibited	exhibit	VBD	B-VP	O
a	a	DT	B-NP	O
wide	wide	JJ	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
sedimentation	sedimentation	NN	B-NP	O
coefficients	coefficient	NNS	I-NP	O
(	(	(	O	O
8.5-11.3S	8.5-11.3S	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
low	low	JJ	B-NP	O
ionic	ionic	JJ	I-NP	O
strength	strength	NN	I-NP	O
buffer	buffer	NN	I-NP	O
but	but	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
correlation	correlation	NN	I-NP	O
with	with	IN	B-PP	O
cell	cell	NN	B-NP	O
line	line	NN	I-NP	O
type	type	NN	I-NP	O
or	or	CC	I-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
.	.	.	O	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
complexes	complex	NNS	I-NP	O
by	by	IN	B-PP	O
heat	heat	NN	B-NP	O
(	(	(	O	O
37	37	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	NN	I-NP	O
)	)	)	O	O
or	or	CC	O	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-PP	O
high	high	JJ	B-NP	O
ionic	ionic	JJ	I-NP	O
strength	strength	NN	I-NP	O
buffer	buffer	NN	I-NP	O
(	(	(	O	O
0.3	0.3	CD	B-NP	O
M	M	NN	I-NP	O
NaCl	NaCl	NN	I-NP	O
)	)	)	O	O
induced	induce	VBD	B-VP	O
nuclear	nuclear	JJ	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
steroid	steroid	NN	B-NP	O
but	but	CC	O	O
only	only	JJ	B-NP	O
complexes	complex	NNS	I-NP	O
in	in	IN	B-PP	O
high	high	JJ	B-NP	O
ionic	ionic	JJ	I-NP	O
strength	strength	NN	I-NP	O
buffer	buffer	NN	I-NP	O
manifested	manifest	VBD	B-VP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
sedimentation	sedimentation	NN	B-NP	O
coefficient	coefficient	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
correlation	correlation	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
or	or	CC	I-NP	O
nature	nature	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
binding	binding	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
cytolethal	cytolethal	JJ	I-NP	O
or	or	CC	I-NP	O
cytostatic	cytostatic	JJ	I-NP	O
responsiveness	responsiveness	NN	I-NP	O
of	of	IN	B-PP	O
HLCL	HLCL	NN	B-NP	B-cell_line
to	to	TO	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
treatment	treatment	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
cytolethal	cytolethal	JJ	B-NP	O
effects	effect	NNS	I-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
ascribed	ascribe	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
failure	failure	NN	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
up	up	RP	B-PRT	O
and	and	CC	O	O
bind	bind	VBP	B-VP	O
steroid	steroid	NN	B-NP	O
or	or	CC	B-PP	O
to	to	TO	B-PP	O
significant	significant	JJ	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
cytoplasmic	cytoplasmic	JJ	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
present	present	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
achieve	achieve	VBP	B-VP	O
cytolethal	cytolethal	JJ	B-NP	O
responses	response	NNS	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
lymphoid	lymphoid	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type

CD28	CD28	NN	B-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
CD45RA+	CD45RA+	JJ	B-NP	O
and	and	CC	I-NP	O
CD45RO+	CD45RO+	JJ	I-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
:	:	:	O	O
enhanced	enhance	VBN	B-VP	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
reactive	reactive	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
intermediates	intermediate	NNS	I-NP	O
and	and	CC	O	O
c-Rel	c-Rel	NN	B-NP	B-protein
nuclear	nuclear	JJ	I-NP	O
translocation	translocation	NN	I-NP	O
in	in	IN	B-PP	O
CD45RA+	CD45RA+	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
analyzed	analyze	VBN	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
complete	complete	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
(	(	(	O	O
anti-CD3	anti-CD3	NN	B-NP	B-protein
plus	plus	CC	O	O
anti-CD28	anti-CD28	NN	B-NP	B-protein
)	)	)	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
in	in	IN	B-PP	O
CD45RA+	CD45RA+	JJ	O	O
(	(	(	O	O
naive	naive	JJ	B-ADJP	O
)	)	)	O	O
and	and	CC	O	O
CD45RO+	CD45RO+	JJ	B-NP	B-cell_type
(	(	(	O	I-cell_type
memory/effector	memory/effector	NN	B-NP	I-cell_type
)	)	)	O	I-cell_type
T	T	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Long	Long	JJ	B-NP	O
exposure	exposure	NN	I-NP	O
(	(	(	O	O
24	24	CD	B-NP	O
h	h	NN	I-NP	O
)	)	)	O	O
induced	induce	VBD	B-VP	O
stronger	strong	JJR	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
in	in	IN	B-PP	O
CD45RA+	CD45RA+	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
than	than	IN	B-PP	O
in	in	IN	B-PP	O
CD45RO+	CD45RO+	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
c-Rel	c-Rel	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
after	after	IN	B-SBAR	O
anti-CD3+anti-CD28	anti-CD3+anti-CD28	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
c-Rel	c-Rel	NN	B-NP	B-protein
was	be	VBD	B-VP	O
higher	high	JJR	B-ADJP	O
in	in	IN	B-PP	O
CD45RA+	CD45RA+	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	B-protein
inhibitor	inhibitor	NN	I-NP	I-protein
IkappaBalpha	IkappaBalpha	NN	I-NP	B-protein
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
anti-CD3+anti-CD28	anti-CD3+anti-CD28	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
induced	induce	VBD	B-VP	O
a	a	DT	B-NP	O
long-lasting	long-lasting	JJ	I-NP	O
degradation	degradation	NN	I-NP	O
in	in	IN	B-PP	O
CD45RA+	CD45RA+	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
but	but	CC	B-PP	O
in	in	IN	B-PP	O
CD45RO+	CD45RO+	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
the	the	DT	B-NP	O
degradation	degradation	NN	I-NP	O
process	process	NN	I-NP	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
rapid	rapid	JJ	I-ADJP	O
.	.	.	O	O

Because	Because	IN	B-SBAR	O
the	the	DT	B-NP	O
CD28	CD28	NN	I-NP	B-protein
costimulus	costimulus	NN	I-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
induce	induce	VB	I-VP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
reactive	reactive	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
intermediates	intermediate	NNS	I-NP	O
(	(	(	O	O
ROIs	ROI	NNS	B-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	O
ROI	ROI	NN	I-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
CD45RA+	CD45RA+	JJ	B-NP	O
and	and	CC	I-NP	O
CD45RO+	CD45RO+	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
by	by	IN	B-PP	O
flow	flow	NN	B-NP	O
cytometry	cytometry	NN	I-NP	O
.	.	.	O	O

ROIs	ROI	NNS	B-NP	O
were	be	VBD	B-VP	O
produced	produce	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
more	more	RBR	B-ADVP	O
strongly	strongly	RB	I-ADVP	O
in	in	IN	B-PP	O
CD45RA+	CD45RA+	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
data	datum	NNS	I-NP	O
presented	present	VBN	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
further	further	RB	B-ADVP	O
emphasize	emphasize	VBP	B-VP	O
the	the	DT	B-NP	O
differences	difference	NNS	I-NP	O
between	between	IN	B-PP	O
CD45RA+	CD45RA+	JJ	B-NP	O
and	and	CC	I-NP	O
CD45RO+	CD45RO+	JJ	I-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
ROI-dependent	ROI-dependent	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
.	.	.	O	O

Ikaros	Ikaros	NN	B-NP	B-protein
in	in	IN	B-PP	O
hemopoietic	hemopoietic	JJ	B-NP	O
lineage	lineage	NN	I-NP	O
determination	determination	NN	I-NP	O
and	and	CC	I-NP	O
homeostasis	homeostasis	NN	I-NP	O
.	.	.	O	O

Studies	Study	NNS	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
that	that	WDT	B-NP	O
control	control	VBP	B-VP	O
hemopoietic	hemopoietic	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
have	have	VBP	B-VP	O
focused	focus	VBN	I-VP	O
on	on	IN	B-PP	O
signaling	signaling	NN	B-NP	O
cascades	cascade	NNS	I-NP	O
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	O
effectors	effector	NNS	I-NP	O
that	that	WDT	B-NP	O
drive	drive	VBP	B-VP	O
this	this	DT	B-NP	O
complex	complex	JJ	I-NP	O
developmental	developmental	JJ	I-NP	O
system	system	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
regulated	regulated	JJ	I-NP	O
fashion	fashion	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
review	review	VBP	B-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
Ikaros	Ikaros	NN	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
founding	founding	JJ	I-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
unique	unique	JJ	I-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
zinc	zinc	NN	B-NP	B-protein
finger	finger	NN	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
this	this	DT	B-NP	O
developmental	developmental	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

Studies	Study	NNS	B-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
Ikaros	Ikaros	NN	I-NP	B-protein
null	null	JJ	I-NP	O
mutation	mutation	NN	I-NP	O
have	have	VBP	B-VP	O
revealed	reveal	VBN	I-VP	O
an	an	DT	B-NP	O
essential	essential	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
factor	factor	NN	I-NP	O
in	in	IN	B-PP	O
lymphoid	lymphoid	JJ	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
fate	fate	NN	I-NP	O
determination	determination	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
subsequent	subsequent	JJ	B-NP	O
branch	branch	NN	I-NP	O
points	point	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
differentiation	differentiation	NN	I-NP	O
pathway	pathway	NN	I-NP	O
.	.	.	O	O

Differences	Difference	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
phenotypes	phenotype	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
null	null	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
negative	negative	JJ	I-NP	O
(	(	(	O	O
DN	DN	JJ	B-ADJP	O
)	)	)	O	O
Ikaros	Ikaros	NN	B-NP	O
mutation	mutation	NN	I-NP	O
provide	provide	VBP	B-VP	O
insight	insight	NN	B-NP	O
into	into	IN	B-PP	O
a	a	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	O
network	network	NN	I-NP	O
through	through	IN	B-PP	O
which	which	WDT	B-NP	O
Ikaros	Ikaros	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
exert	exert	VBP	B-VP	O
their	their	PRP$	B-NP	O
effects	effect	NNS	I-NP	O
in	in	IN	B-PP	O
development	development	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
a	a	DT	B-NP	O
comparative	comparative	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hemopoietic	hemopoietic	JJ	I-NP	B-cell_type
stem	stem	NN	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
and	and	CC	I-NP	O
precursor	precursor	NN	I-NP	O
compartment	compartment	NN	I-NP	O
resulting	result	VBG	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
Ikaros	Ikaros	NN	I-NP	O
mutations	mutation	NNS	I-NP	O
reveals	reveal	VBZ	B-VP	O
a	a	DT	B-NP	O
profound	profound	JJ	I-NP	O
yet	yet	CC	O	O
not	not	RB	O	O
absolute	absolute	JJ	B-NP	O
requirement	requirement	NN	I-NP	O
for	for	IN	B-PP	O
Ikaros	Ikaros	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
and	and	CC	I-NP	O
differentiation	differentiation	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
populations	population	NNS	I-NP	O
.	.	.	O	O

Overexpression	Overexpression	NN	B-NP	O
of	of	IN	B-PP	O
p65	p65	NN	B-NP	B-protein
and	and	CC	I-NP	O
c-Jun	c-Jun	NN	I-NP	B-protein
substitutes	substitute	NNS	I-NP	O
for	for	IN	B-PP	O
B7-1	B7-1	NN	B-NP	B-protein
costimulation	costimulation	NN	I-NP	O
by	by	IN	B-PP	O
targeting	target	VBG	B-VP	O
the	the	DT	B-NP	O
CD28RE	CD28RE	NN	I-NP	B-DNA
within	within	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
Rel	Rel	NN	B-NP	B-protein
and	and	CC	O	O
activation	activation	NN	B-NP	O
protein-1	protein-1	NN	I-NP	O
(	(	(	O	O
AP-1	AP-1	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
B7-1-	B7-1-	NN	B-NP	B-protein
and	and	CC	O	O
leukocyte	leukocyte	NN	B-NP	B-protein
function-associated	function-associated	JJ	I-NP	I-protein
Ag-3	Ag-3	NN	I-NP	I-protein
(	(	(	O	O
LFA.	LFA.	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
)	)	)	O	O
-costimulated	-costimulated	JJ	B-NP	O
T	T	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
evaluated	evaluate	VBN	I-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
c-Jun	c-Jun	NN	B-NP	B-protein
but	but	CC	B-NP	O
not	not	RB	I-NP	O
c-Fos	c-Fos	NN	B-NP	B-protein
increases	increase	VBZ	B-VP	O
IL-2	IL-2	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
both	both	CC	O	O
B7-1-	B7-1-	NN	B-NP	B-protein
and	and	CC	O	O
LFA-3-costimulated	LFA-3-costimulated	JJ	B-NP	B-cell_line
Jurkat	Jurkat	NN	I-NP	I-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Cotransfection	Cotransfection	NN	B-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
c-Jun	c-Jun	NN	B-NP	B-protein
and	and	CC	O	O
c-Fos	c-Fos	NN	B-NP	B-protein
substitutes	substitute	NNS	I-NP	O
for	for	IN	B-PP	O
B7-1	B7-1	NN	B-NP	B-protein
costimulation	costimulation	NN	I-NP	O
in	in	IN	B-PP	O
driving	drive	VBG	B-VP	O
an	an	DT	B-NP	O
activation	activation	NN	I-NP	O
protein-1	protein-1	NN	I-NP	O
response	response	NN	I-NP	O
element	element	NN	I-NP	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
for	for	IN	I-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

Overexpression	Overexpression	NN	B-NP	O
of	of	IN	B-PP	O
Rel	Rel	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
p65-expressing	p65-expressing	JJ	B-NP	B-cell_line
Jurkat	Jurkat	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
transcribed	transcribe	VBN	B-VP	O
equally	equally	RB	B-ADVP	O
well	well	RB	I-ADVP	O
a	a	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-DNA
factor	factor	NN	I-NP	I-DNA
kappabeta	kappabeta	NN	I-NP	I-DNA
reporter	reporter	NN	I-NP	I-DNA
construct	construct	NN	I-NP	I-DNA
when	when	WRB	B-ADVP	O
costimulated	costimulate	VBN	B-VP	O
with	with	IN	B-PP	O
B7-1	B7-1	NN	B-NP	B-protein
or	or	CC	I-NP	O
LFA-3	LFA-3	NN	I-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
or	or	CC	O	O
CD28	CD28	NN	B-NP	B-DNA
response	response	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
(	(	(	O	O
CD28RE	CD28RE	NN	B-NP	B-DNA
)	)	)	O	O
-driven	-driven	JJ	B-NP	O
reporters	reporter	NNS	I-NP	O
was	be	VBD	B-VP	O
superior	superior	JJ	B-ADJP	O
in	in	IN	B-PP	O
B7-1-costimulated	B7-1-costimulated	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Combined	Combine	VBN	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
c-Jun	c-Jun	NN	B-NP	B-protein
and	and	CC	I-NP	O
p65	p65	NN	I-NP	B-protein
induced	induce	VBD	B-VP	O
vigorous	vigorous	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-DNA
promoter-	promoter-	NN	I-NP	I-DNA
and	and	CC	O	O
CD28RE-driven	CD28RE-driven	JJ	B-NP	B-DNA
reporter	reporter	NN	I-NP	I-DNA
constructs	construct	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
both	both	CC	O	O
LFA-3-	LFA-3-	NN	B-NP	B-protein
and	and	CC	O	O
B7-1-costimulated	B7-1-costimulated	JJ	B-NP	B-cell_line
Jurkat	Jurkat	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Mutating	Mutate	VBG	B-VP	O
the	the	DT	B-NP	O
CD28RE	CD28RE	NN	I-NP	B-DNA
but	but	CC	B-NP	O
not	not	RB	I-NP	O
the	the	DT	B-NP	O
upstream	upstream	JJ	I-NP	B-DNA
nuclear	nuclear	JJ	I-NP	I-DNA
factor	factor	NN	I-NP	I-DNA
kappabeta-binding	kappabeta-binding	JJ	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
reduced	reduce	VBD	B-VP	O
B7-1	B7-1	NN	B-NP	B-protein
-driven	-driven	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
>	>	SYM	B-NP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
implicates	implicate	VBZ	B-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CD28RE	CD28RE	NN	I-NP	B-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
integration	integration	NN	I-NP	O
of	of	IN	B-PP	O
p65	p65	NN	B-NP	B-protein
/	/	SYM	B-VP	O
c-Jun	c-Jun	NN	B-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
transition	transition	NN	I-NP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
autocrine	autocrine	JJ	I-NP	O
LFA-3	LFA-3	NN	I-NP	B-protein
-driven	-driven	JJ	I-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
B7	B7	NN	I-NP	B-protein
--	--	:	O	O
induced	induce	VBD	B-VP	O
paracrine	paracrine	JJ	B-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
involves	involve	VBZ	B-VP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
c-Jun	c-Jun	NN	B-NP	B-protein
and	and	CC	I-NP	O
p65	p65	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
target	target	VBP	B-VP	O
the	the	DT	B-NP	O
CD28RE	CD28RE	NN	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

Defects	Defect	NNS	B-NP	O
in	in	IN	B-PP	O
actin-cap	actin-cap	NN	B-NP	O
formation	formation	NN	I-NP	O
in	in	IN	B-PP	O
Vav-deficient	Vav-deficient	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
implicate	implicate	VBP	B-VP	O
an	an	DT	B-NP	O
actin	actin	NN	I-NP	B-protein
requirement	requirement	NN	I-NP	O
for	for	IN	B-PP	O
lymphocyte	lymphocyte	NN	B-NP	B-cell_type
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
.	.	.	O	O

BACKGROUND	BACKGROUND	NN	B-NP	O
:	:	:	O	O
Antigen-receptor	Antigen-receptor	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
on	on	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
result	result	VBP	B-VP	O
in	in	IN	B-PP	O
local	local	JJ	B-NP	O
clustering	clustering	NN	I-NP	O
of	of	IN	B-PP	O
actin	actin	NN	B-NP	B-protein
,	,	,	O	O
receptors	receptor	NNS	B-NP	O
and	and	CC	O	O
signaling	signal	VBG	B-VP	B-protein
molecules	molecule	NNS	B-NP	I-protein
into	into	IN	B-PP	O
an	an	DT	B-NP	O
asymmetric	asymmetric	JJ	I-NP	O
membrane	membrane	NN	I-NP	O
structure	structure	NN	I-NP	O
termed	term	VBN	B-VP	O
a	a	DT	B-NP	O
cap	cap	NN	I-NP	B-protein
.	.	.	O	O

Although	Although	IN	B-SBAR	O
actin	actin	NN	B-NP	B-protein
polymerization	polymerization	NN	I-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
required	require	VBN	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
underlying	underlie	VBG	B-VP	O
cap	cap	NN	B-NP	O
formation	formation	NN	I-NP	O
are	be	VBP	B-VP	O
unclear	unclear	JJ	B-ADJP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
studied	study	VBN	I-VP	O
the	the	DT	B-NP	O
events	event	NNS	I-NP	O
underlying	underlie	VBG	B-VP	O
cap	cap	NN	B-NP	O
formation	formation	NN	I-NP	O
using	use	VBG	B-VP	O
mice	mouse	NNS	B-NP	O
bearing	bear	VBG	B-VP	O
a	a	DT	B-NP	O
null	null	JJ	I-NP	O
mutation	mutation	NN	I-NP	O
in	in	IN	B-PP	O
vav	vav	NN	B-NP	B-protein
(	(	(	O	O
vav	vav	NN	B-NP	B-protein
-/-	-/-	SYM	B-ADJP	O
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
gene	gene	NN	I-NP	O
that	that	WDT	B-NP	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
guanine-nucleotide	guanine-nucleotide	JJ	I-NP	B-protein
exchange	exchange	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
for	for	IN	B-PP	O
the	the	DT	B-NP	O
GTPase	GTPase	NN	I-NP	B-protein
Rac	Rac	NN	I-NP	I-protein
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Lymphocytes	Lymphocyte	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
vav	vav	NN	B-NP	B-protein
-/-	-/-	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
form	form	VB	I-VP	O
T-cell	T-cell	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
caps	cap	NNS	I-NP	I-protein
following	follow	VBG	B-PP	O
activation	activation	NN	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
defective	defective	JJ	I-NP	O
actin	actin	NN	I-NP	O
cytoskeleton	cytoskeleton	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
vav-/-	vav-/-	JJ	I-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
deficient	deficient	JJ	B-ADJP	O
in	in	IN	B-PP	O
interleukin-2	interleukin-2	NN	B-NP	B-protein
(	(	(	O	O
IL-2	IL-2	NN	B-NP	B-protein
)	)	)	O	O
production	production	NN	B-NP	O
and	and	CC	I-NP	O
proliferation	proliferation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
peak	peak	NN	I-NP	O
of	of	IN	B-PP	O
Ca2+	Ca2+	NN	B-NP	O
mobilization	mobilization	NN	I-NP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
although	although	IN	B-SBAR	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
duration	duration	NN	I-NP	O
.	.	.	O	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
Jun	Jun	NN	B-NP	B-protein
N-terminal	N-terminal	JJ	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
or	or	CC	O	O
stress-activated	stress-activated	JJ	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
JNK	JNK	NN	B-NP	B-protein
or	or	CC	O	O
SAPK	SAPK	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
mitogen-activated	mitogen-activated	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
MAPK	MAPK	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
NF-ATc1	NF-ATc1	NN	I-NP	B-protein
and	and	CC	I-NP	O
egr-1	egr-1	NN	I-NP	O
genes	gene	NNS	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
the	the	DT	B-NP	O
reduced	reduce	VBN	I-NP	O
Ca2+	Ca2+	NN	I-NP	O
mobilization	mobilization	NN	I-NP	O
,	,	,	O	O
translocation	translocation	NN	B-NP	O
of	of	IN	B-PP	O
cytoplasmic	cytoplasmic	JJ	B-NP	B-protein
NF-ATc	NF-ATc	NN	I-NP	I-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
nucleus	nucleus	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
reflecting	reflect	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
Ca2+	Ca2+	NN	B-NP	O
in	in	IN	B-PP	O
vav-/-	vav-/-	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
activate	activate	VB	I-VP	O
calcineurin	calcineurin	NN	B-NP	B-protein
.	.	.	O	O

Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
with	with	IN	B-PP	O
cytochalasin	cytochalasin	NN	B-NP	O
D	D	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
blocks	block	VBZ	B-VP	O
actin	actin	NN	B-NP	B-protein
polymerization	polymerization	NN	I-NP	O
,	,	,	O	O
inhibited	inhibit	VBD	B-VP	O
cap	cap	NN	B-NP	O
formation	formation	NN	I-NP	O
and	and	CC	O	O
produced	produce	VBD	B-VP	O
defects	defect	NNS	B-NP	O
in	in	IN	B-PP	O
signaling	signaling	NN	B-NP	O
and	and	CC	O	O
IL-2	IL-2	NN	B-NP	B-protein
transcriptional	transcriptional	JJ	I-NP	O
induction	induction	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
antigen-receptor	antigen-receptor	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
nearly	nearly	RB	B-ADJP	O
identical	identical	JJ	I-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
seen	see	VBN	B-VP	O
in	in	IN	B-PP	O
vav-/-	vav-/-	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
transfection	transfection	NN	B-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
either	either	CC	B-NP	O
constitutively	constitutively	RB	I-NP	O
active	active	JJ	I-NP	O
Vav	Vav	NN	I-NP	B-protein
or	or	CC	I-NP	O
Rac	Rac	NN	I-NP	B-protein
could	could	MD	B-VP	O
complement	complement	VB	I-VP	O
constitutively	constitutively	RB	B-NP	O
active	active	JJ	I-NP	O
calcineurin	calcineurin	NN	I-NP	B-protein
to	to	TO	B-VP	O
activate	activate	VB	I-VP	O
NF-AT-dependent	NF-AT-dependent	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
.	.	.	O	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
Vav	Vav	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
cap	cap	NN	B-NP	O
formation	formation	NN	I-NP	O
in	in	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
cap	cap	NN	B-NP	O
formation	formation	NN	I-NP	O
,	,	,	O	O
IL-2	IL-2	NN	B-NP	B-protein
production	production	NN	I-NP	O
and	and	CC	I-NP	O
proliferation	proliferation	NN	I-NP	O
supports	support	VBZ	B-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
an	an	DT	B-NP	O
actin-dependent	actin-dependent	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
specialized	specialize	VBN	B-NP	O
growth	growth	NN	I-NP	O
regulatory	regulatory	JJ	I-NP	O
signals	signal	NNS	I-NP	O
.	.	.	O	O

CD14	CD14	NN	B-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
endothelial	endothelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
Bacteroides	Bacteroide	NNS	B-NP	O
fragilis	fragili	VBZ	B-VP	O
outer	outer	JJ	B-NP	O
membrane	membrane	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
studied	study	VBD	B-VP	O
the	the	DT	B-NP	O
capacity	capacity	NN	I-NP	O
of	of	IN	B-PP	O
isolated	isolate	VBN	B-NP	O
Bacteriodes	Bacteriode	NNS	I-NP	O
fragilis	fragili	VBZ	B-VP	O
outer	outer	JJ	B-NP	O
membrane	membrane	NN	I-NP	O
,	,	,	O	O
B.	B.	NNP	B-NP	O
fragilis	fragilis	NN	I-NP	O
NCTC9343	NCTC9343	NN	I-NP	O
lipopolysaccharide	lipopolysaccharide	NN	I-NP	O
(	(	(	O	O
LPS	LPS	NN	B-NP	O
;	;	:	O	O
endotoxin	endotoxin	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
B.	B.	NNP	B-NP	O
fragilis	fragilis	NN	I-NP	O
NCTC9343	NCTC9343	NN	I-NP	O
capsular	capsular	JJ	I-NP	O
polysaccharides	polysaccharide	NNS	I-NP	O
to	to	TO	B-VP	O
activate	activate	VB	I-VP	O
human	human	JJ	B-NP	B-cell_type
umbilical	umbilical	JJ	I-NP	I-cell_type
vein	vein	NN	I-NP	I-cell_type
endothelial	endothelial	JJ	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
(	(	(	O	O
HUVEC	HUVEC	NN	B-NP	B-cell_line
)	)	)	O	O
monolayers	monolayer	NNS	B-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
assess	assess	VB	I-VP	O
HUVEC	HUVEC	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
,	,	,	O	O
E-selectin	E-selectin	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
by	by	IN	B-PP	O
enzyme-linked	enzyme-linked	JJ	B-NP	O
immunosorbent	immunosorbent	JJ	I-NP	O
assay	assay	NN	I-NP	O
(	(	(	O	O
ELISA	ELISA	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
for	for	IN	B-PP	O
E-selectin-specific	E-selectin-specific	JJ	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
,	,	,	O	O
and	and	CC	O	O
electrophoretic	electrophoretic	JJ	B-NP	O
gel	gel	NN	I-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assay	assay	NN	I-NP	O
(	(	(	O	O
EMSA	EMSA	NN	B-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
,	,	,	O	O
a	a	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
E-selectin	E-selectin	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
activation	activation	NN	I-NP	O
.	.	.	O	O

Exposure	Exposure	NN	B-NP	O
of	of	IN	B-PP	O
HUVECs	HUVEC	NNS	B-NP	B-cell_line
to	to	TO	B-PP	O
B.	B.	NNP	B-NP	O
fragilis	fragilis	NN	I-NP	O
outer	outer	JJ	I-NP	O
membrane	membrane	NN	I-NP	O
fractions	fraction	NNS	I-NP	O
,	,	,	O	O
separated	separate	VBN	B-VP	O
from	from	IN	B-PP	O
other	other	JJ	B-NP	O
components	component	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
B.	B.	NNP	I-NP	O
fragilis	fragilis	NN	I-NP	O
cell	cell	NN	I-NP	O
wall	wall	NN	I-NP	O
by	by	IN	B-PP	O
isopycnic	isopycnic	JJ	B-NP	O
,	,	,	I-NP	O
sucrose	sucrose	NN	I-NP	O
gradient	gradient	NN	I-NP	O
centrifugation	centrifugation	NN	I-NP	O
,	,	,	O	O
significantly	significantly	RB	B-VP	O
increased	increase	VBD	I-VP	O
surface	surface	NN	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
E-selectin	E-selectin	NN	B-NP	B-protein
and	and	CC	O	O
induced	induce	VBD	B-VP	O
functional	functional	JJ	B-NP	O
endothelial	endothelial	JJ	I-NP	O
cell	cell	NN	I-NP	O
-dependent	-dependent	JJ	I-NP	O
leukocyte	leukocyte	NN	I-NP	O
adhesion	adhesion	NN	I-NP	O
.	.	.	O	O

B.	B.	NNP	B-NP	O
fragilis	fragili	VBZ	B-VP	O
outer	outer	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
induced	induce	VBD	B-VP	O
translocation	translocation	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
to	to	TO	B-PP	O
HUVEC	HUVEC	NN	B-NP	B-cell_line
nuclei	nucleus	NNS	I-NP	O
and	and	CC	O	O
accumulation	accumulation	NN	B-NP	O
of	of	IN	B-PP	O
E-selectin	E-selectin	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
in	in	IN	B-PP	O
HUVEC	HUVEC	NN	B-NP	B-cell_type
cytoplasm	cytoplasm	NN	I-NP	O
.	.	.	O	O

E-selectin	E-selectin	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
B.	B.	NNP	B-NP	O
fragilis	fragili	VBZ	B-VP	O
outer	outer	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
blocked	block	VBN	I-VP	O
by	by	IN	B-PP	O
polymixin	polymixin	NN	B-NP	O
B	B	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
E-selectin	E-selectin	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
outer	outer	JJ	B-NP	O
membrane	membrane	NN	I-NP	O
fractions	fraction	NNS	I-NP	O
purified	purify	VBN	B-VP	O
from	from	IN	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
was	be	VBD	B-VP	O
competitively	competitively	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
polymixin	polymixin	NN	B-NP	O
B	B	NN	I-NP	O
.	.	.	O	O

Neither	Neither	CC	O	O
purified	purify	VBN	B-NP	O
B.	B.	NNP	I-NP	O
fragilis	fragilis	NN	I-NP	O
LPS	LPS	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
prominent	prominent	JJ	I-NP	O
constituent	constituent	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
outer	outer	JJ	I-NP	O
membrane	membrane	NN	I-NP	O
,	,	,	O	O
nor	nor	CC	O	O
purified	purify	VBN	O	O
B.	B.	NNP	B-NP	O
fragilis	fragili	VBZ	B-VP	O
capsular	capsular	JJ	B-NP	O
polysaccharides	polysaccharide	NNS	I-NP	O
induced	induce	VBD	B-VP	O
HUVEC	HUVEC	NN	B-NP	B-cell_type
activation	activation	NN	I-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
different	different	JJ	I-NP	O
monoclonal	monoclonal	JJ	I-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
directed	direct	VBN	B-VP	O
against	against	IN	B-PP	O
human	human	JJ	B-NP	B-protein
CD14	CD14	NN	I-NP	I-protein
completely	completely	RB	B-ADVP	O
inhibited	inhibit	VBD	B-VP	O
B.	B.	NNP	B-NP	O
fragilis	fragilis	NN	I-NP	O
outer	outer	JJ	I-NP	O
membrane-induced	membrane-induced	JJ	I-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
,	,	,	O	O
E-selectin	E-selectin	NN	B-NP	B-protein
transcription	transcription	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
E-selectin	E-selectin	NN	B-NP	B-protein
surface	surface	NN	I-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
outer	outer	JJ	I-NP	O
membrane	membrane	NN	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
B.	B.	NNP	I-NP	O
fragilis	fragilis	NN	I-NP	O
cell	cell	NN	I-NP	O
wall	wall	NN	I-NP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
proinflammatory	proinflammatory	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
LPS	LPS	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
induces	induce	VBZ	B-VP	O
human	human	JJ	B-NP	B-cell_type
endothelial	endothelial	JJ	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
soluble	soluble	JJ	I-NP	O
CD14	CD14	NN	I-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
.	.	.	O	O

NF-kappaB	NF-kappaB	NN	B-NP	B-protein
protects	protect	VBZ	B-VP	O
HIV-1-infected	HIV-1-infected	JJ	B-NP	B-cell_type
myeloid	myeloid	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
.	.	.	O	O

HIV-1	HIV-1	NN	B-NP	O
infection	infection	NN	I-NP	O
of	of	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
monocytic	monocytic	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
myeloid	myeloid	JJ	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
sustained	sustained	JJ	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

Recently	Recently	RB	B-ADVP	O
,	,	,	O	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
induction	induction	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
protecting	protect	VBG	B-VP	O
cells	cell	NNS	B-NP	O
from	from	IN	B-PP	O
programmed	program	VBN	B-NP	O
cell	cell	NN	I-NP	O
death	death	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
sought	seek	VBD	B-VP	O
to	to	TO	I-VP	O
investigate	investigate	VB	I-VP	O
whether	whether	IN	B-SBAR	O
constitutive	constitutive	JJ	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
chronically	chronically	RB	B-NP	O
HIV-1-infected	HIV-1-infected	JJ	I-NP	O
promonocytic	promonocytic	JJ	I-NP	O
U937	U937	NN	I-NP	O
(	(	(	O	O
U9-IIIB	U9-IIIB	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
myeloblastic	myeloblastic	JJ	B-NP	B-cell_line
PLB-985	PLB-985	NN	I-NP	I-cell_line
(	(	(	O	I-cell_line
PLB-IIIB	PLB-IIIB	NN	B-NP	I-cell_line
)	)	)	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
affects	affect	VBZ	B-VP	O
apoptotic	apoptotic	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
.	.	.	O	O

TNFalpha	TNFalpha	NN	B-NP	B-protein
and	and	CC	I-NP	O
cycloheximide	cycloheximide	NN	I-NP	O
caused	cause	VBD	B-VP	O
infected	infected	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-VP	O
undergo	undergo	VB	I-VP	O
apoptosis	apoptosis	NN	B-NP	O
more	more	RBR	B-ADVP	O
rapidly	rapidly	RB	I-ADVP	O
than	than	IN	B-PP	O
parental	parental	JJ	B-NP	O
U937	U937	NN	I-NP	O
and	and	CC	I-NP	O
PLB-985	PLB-985	NN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
TNFalpha	TNFalpha	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
antioxidant	antioxidant	JJ	I-NP	O
N-acetylcysteine	N-acetylcysteine	NN	I-NP	O
(	(	(	O	O
NAC	NAC	NN	B-NP	O
)	)	)	O	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
increased	increase	VBN	B-NP	O
apoptosis	apoptosis	NN	I-NP	O
in	in	IN	B-PP	O
both	both	CC	O	O
U937	U937	NN	B-NP	B-cell_line
and	and	CC	I-NP	O
U9-IIIB	U9-IIIB	NN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
while	while	IN	B-SBAR	O
preactivation	preactivation	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
with	with	IN	B-PP	O
the	the	DT	B-NP	O
non-apoptotic	non-apoptotic	JJ	I-NP	O
inducer	inducer	NN	I-NP	O
IL-1beta	IL-1beta	NN	I-NP	B-protein
caused	cause	VBD	B-VP	O
a	a	DT	B-NP	O
relative	relative	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
constitutive	constitutive	JJ	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
U9-IIIB	U9-IIIB	NN	B-NP	B-cell_line
and	and	CC	I-NP	O
PLB-IIIB	PLB-IIIB	NN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
also	also	RB	B-ADVP	O
induced	induce	VBD	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
protects	protect	VBZ	B-VP	O
cells	cell	NNS	B-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
persistent	persistent	JJ	I-NP	O
apoptotic	apoptotic	JJ	I-NP	O
signal	signal	NN	I-NP	O
.	.	.	O	O

TNFalpha	TNFalpha	NN	B-NP	B-protein
plus	plus	CC	I-NP	O
NAC	NAC	NN	I-NP	O
treatment	treatment	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
marked	marked	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
Bcl-2	Bcl-2	NN	B-NP	B-protein
protein	protein	NN	I-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
HIV-1-infected	HIV-1-infected	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
coupled	couple	VBN	B-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
Bax	Bax	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
uninfected	uninfected	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
susceptibility	susceptibility	NN	B-NP	O
to	to	TO	B-PP	O
TNFalpha	TNFalpha	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
apoptosis	apoptosis	NN	I-NP	O
may	may	MD	B-VP	O
relate	relate	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
relative	relative	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
Bcl-2	Bcl-2	NN	B-NP	B-protein
and	and	CC	I-NP	O
Bax	Bax	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
protective	protective	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
in	in	IN	B-PP	O
blocking	block	VBG	B-VP	O
TNFalpha-	TNFalpha-	NN	B-NP	B-protein
and	and	CC	O	O
HIV-1-induced	HIV-1-induced	JJ	B-NP	O
apoptosis	apoptosis	NN	I-NP	O
was	be	VBD	B-VP	O
supported	support	VBN	I-VP	O
by	by	IN	B-PP	O
studies	study	NNS	B-NP	O
in	in	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
engineered	engineer	VBN	B-VP	O
to	to	TO	B-VP	O
express	express	VB	I-VP	O
IkappaB	IkappaB	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
repressor	repressor	NN	I-NP	I-protein
mutants	mutant	NNS	I-NP	I-protein
(	(	(	O	O
TD-IkappaB	TD-IkappaB	NN	B-NP	O
)	)	)	O	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
tetracycline-responsive	tetracycline-responsive	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

Cells	Cell	NNS	B-NP	O
underwent	undergo	VBD	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
TNFalpha	TNFalpha	NN	B-NP	B-protein
only	only	RB	B-ADVP	O
when	when	WRB	I-ADVP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
was	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
TD-IkappaB	TD-IkappaB	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
U9-IIIB	U9-IIIB	NN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
TNFalpha	TNFalpha	NN	B-NP	B-protein
treatment	treatment	NN	I-NP	O
also	also	RB	B-ADVP	O
induced	induce	VBD	B-VP	O
a	a	DT	B-NP	O
marked	marked	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
Bcl-2	Bcl-2	NN	B-NP	B-protein
protein	protein	NN	I-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
TD-IkappaB	TD-IkappaB	NN	B-NP	B-cell_line
expressing	express	VBG	B-VP	I-cell_line
cells	cell	NNS	B-NP	I-cell_line
.	.	.	O	O

These	These	DT	B-NP	O
experiments	experiment	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
apoptotic	apoptotic	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
is	be	VBZ	B-VP	O
perturbed	perturb	VBN	I-VP	O
in	in	IN	B-PP	O
HIV-1-infected	HIV-1-infected	JJ	B-NP	B-cell_type
U9-IIIB	U9-IIIB	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
protective	protective	JJ	I-NP	O
role	role	NN	I-NP	O
against	against	IN	B-PP	O
HIV-1-induced	HIV-1-induced	JJ	B-NP	O
apoptosis	apoptosis	NN	I-NP	O
in	in	IN	B-PP	O
myeloid	myeloid	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Human	Human	JJ	B-NP	B-cell_type
normal	normal	JJ	I-NP	I-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
B-lymphocytes	B-lymphocyte	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
deficient	deficient	JJ	B-ADJP	O
in	in	IN	B-PP	O
DNA-dependent	DNA-dependent	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
variant	variant	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ku86	Ku86	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
heterodimeric	heterodimeric	JJ	I-NP	B-protein
Ku	Ku	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
comprises	comprise	VBZ	B-VP	O
a	a	DT	B-NP	O
86	86	CD	I-NP	O
kDa	kDa	NN	I-NP	O
(	(	(	O	O
Ku86	Ku86	NN	B-NP	O
)	)	)	O	O
amd	amd	VBD	B-VP	O
a	a	DT	B-NP	O
70	70	CD	I-NP	B-protein
kDa	kDa	NN	I-NP	I-protein
(	(	(	O	I-protein
Ku70	Ku70	NN	B-NP	I-protein
)	)	)	O	I-protein
subunits	subunit	NNS	B-NP	I-protein
,	,	,	O	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
abundant	abundant	JJ	I-NP	B-protein
nuclear	nuclear	JJ	I-NP	I-protein
DNA-binding	DNA-binding	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
which	which	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
to	to	TO	B-PP	O
DNA	DNA	NN	B-NP	B-protein
termini	terminus	NNS	I-NP	I-protein
without	without	IN	B-PP	O
sequence	sequence	NN	B-NP	O
specificity	specificity	NN	I-NP	O
.	.	.	O	O

Ku	Ku	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
DNA-targeting	DNA-targeting	JJ	I-NP	B-protein
component	component	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
large	large	JJ	I-NP	B-protein
catalytic	catalytic	JJ	I-NP	I-protein
sub-unit	sub-unit	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
DNA-dependent	DNA-dependent	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
(	(	(	O	O
DNA-PK	DNA-PK	NN	B-NP	B-protein
[	[	(	O	O
CS	CS	NN	B-NP	O
]	]	)	O	O
)	)	)	O	O
,	,	,	O	O
that	that	WDT	B-NP	O
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
mammalian	mammalian	JJ	B-NP	O
double-strand	double-strand	JJ	I-NP	O
break	break	NN	I-NP	O
repair	repair	NN	I-NP	O
and	and	CC	O	O
lymphoid	lymphoid	JJ	B-NP	O
V	V	NN	I-NP	O
(	(	(	O	O
D	D	NN	B-NP	O
)	)	)	O	O
J	J	NN	B-NP	O
recombination	recombination	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
using	use	VBG	B-VP	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
Ku	Ku	NN	I-NP	B-protein
x	x	SYM	B-NP	I-protein
DNA	DNA	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
usually	usually	RB	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
cell	cell	NN	B-NP	O
line	line	NN	I-NP	O
extracts	extract	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
complex	complex	NN	I-NP	O
with	with	IN	B-PP	O
faster	fast	JJR	B-NP	O
electrophoretic	electrophoretic	JJ	I-NP	O
mobility	mobility	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
(	(	(	O	O
PBL	PBL	NNS	B-NP	B-cell_type
)	)	)	O	O
extracts	extract	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
faster	fast	JJR	I-NP	B-protein
migrating	migrate	VBG	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
was	be	VBD	B-VP	O
restricted	restricted	JJ	B-ADJP	O
to	to	TO	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
among	among	IN	B-PP	O
the	the	DT	B-NP	O
circulating	circulate	VBG	I-NP	O
lymphocyte	lymphocyte	NN	I-NP	O
population	population	NN	I-NP	O
.	.	.	O	O

Western	Western	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
express	express	VBP	B-VP	O
a	a	DT	B-NP	O
variant	variant	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ku86	Ku86	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
molecular	molecular	JJ	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
69	69	CD	B-NP	B-protein
kDa	kDa	NN	I-NP	I-protein
,	,	,	B-NP	O
and	and	CC	I-NP	O
not	not	RB	I-NP	O
the	the	DT	B-NP	O
86	86	CD	I-NP	B-protein
kDa-	kDa-	NN	I-NP	I-protein
full-length	full-length	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
heterodimer	heterodimer	NN	I-NP	B-protein
Ku70/variant-Ku86	Ku70/variant-Ku86	NN	I-NP	I-protein
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
DNA-ends	DNA-end	NNS	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
altered	altered	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ku	Ku	NN	I-NP	B-protein
heterodimer	heterodimer	NN	I-NP	I-protein
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
decreased	decrease	VBN	I-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
recruit	recruit	VB	I-VP	O
the	the	DT	B-NP	O
catalytic	catalytic	JJ	I-NP	B-protein
component	component	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
complex	complex	NN	I-NP	O
,	,	,	O	O
DNA-PK	DNA-PK	NN	B-NP	B-protein
(	(	(	O	I-protein
CS	CS	NN	B-NP	I-protein
)	)	)	O	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
contributes	contribute	VBZ	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
detectable	detectable	JJ	B-NP	O
DNA-PK	DNA-PK	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
provide	provide	VBP	B-VP	O
a	a	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
increased	increase	VBN	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
ionizing	ionize	VBG	B-VP	O
radiation	radiation	NN	B-NP	O
and	and	CC	O	O
identify	identify	VBP	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
regulation	regulation	NN	B-NP	O
of	of	IN	B-PP	O
DNA-PK	DNA-PK	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
that	that	WDT	B-NP	O
operates	operate	VBZ	B-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

Co-stimulation	Co-stimulation	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
and	and	CC	O	O
anti-CD3	anti-CD3	JJ	B-NP	B-protein
monoclonal	monoclonal	JJ	I-NP	I-protein
antibodies	antibody	NNS	I-NP	I-protein
induces	induce	VBZ	B-VP	O
phosphorylation	phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
CREB	CREB	NN	B-NP	B-protein
.	.	.	O	O

Phosphorylation	Phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cAMP-response	cAMP-response	JJ	I-NP	B-protein
element	element	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
CREB	CREB	NN	I-NP	B-protein
within	within	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
of	of	IN	B-PP	O
CD2	CD2	NN	B-NP	B-protein
but	but	CC	B-NP	O
not	not	RB	I-NP	O
CD3	CD3	NN	B-NP	B-protein
cross-linking	cross-linking	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
PBMC	PBMC	NN	I-NP	B-cell_type
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
demonstrated	demonstrate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
P-CREB	P-CREB	NN	B-NP	B-protein
following	follow	VBG	B-PP	O
CD3	CD3	NN	B-NP	B-protein
cross-linking	cross-linking	NN	I-NP	O
was	be	VBD	B-VP	O
unexpected	unexpected	JJ	B-ADJP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
other	other	JJ	B-NP	O
laboratories	laboratory	NNS	I-NP	O
reported	report	VBD	B-VP	O
increased	increase	VBN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
CREB	CREB	NN	B-NP	B-protein
following	follow	VBG	B-PP	O
CD3	CD3	NN	B-NP	B-protein
cross-linking	cross-linking	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Jurkat	Jurkat	NN	I-NP	B-cell_line
lymphocyte	lymphocyte	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

Due	Due	JJ	B-PP	O
to	to	TO	I-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
T-cells	T-cell	NNS	I-NP	I-cell_line
being	be	VBG	B-VP	O
IL-2-independent	IL-2-independent	JJ	B-ADJP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
postulated	postulate	VBN	I-VP	O
that	that	IN	B-SBAR	O
IL-2	IL-2	NN	B-NP	B-protein
might	might	MD	B-VP	O
provide	provide	VB	I-VP	O
a	a	DT	B-NP	O
necessary	necessary	JJ	I-NP	O
co-stimulus	co-stimulus	NN	I-NP	O
for	for	IN	B-PP	O
phosphorylation	phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
CREB	CREB	NN	B-NP	B-protein
in	in	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
P-CREB	P-CREB	NN	B-NP	B-protein
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
following	follow	VBG	B-PP	O
co-stimulation	co-stimulation	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
PBMC	PBMC	NN	I-NP	B-cell_type
through	through	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-protein
and	and	CC	I-NP	O
CD2	CD2	NN	I-NP	B-protein
or	or	CC	I-NP	O
CD3	CD3	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
.	.	.	O	O

IL-2	IL-2	NN	B-NP	B-protein
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
further	further	RBR	I-VP	O
augment	augment	VB	I-VP	O
phosphorylation	phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
CREB	CREB	NN	B-NP	B-protein
following	follow	VBG	B-PP	O
CD2	CD2	NN	B-NP	B-protein
cross-linking	cross-linking	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
neither	neither	CC	O	O
IL-2	IL-2	NN	B-NP	B-protein
nor	nor	CC	I-NP	O
CD3	CD3	NN	I-NP	B-protein
cross-linking	cross-linking	NN	I-NP	O
alone	alone	RB	B-ADVP	O
induced	induce	VBD	B-VP	O
P-CREB	P-CREB	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
4.5-fold	4.5-fold	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
phosphorylation	phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
CREB	CREB	NN	B-NP	B-protein
within	within	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
of	of	IN	B-PP	O
IL-2/CD3	IL-2/CD3	NN	B-NP	O
co-stimulation	co-stimulation	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

Phosphorylation	Phosphorylation	NN	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
cAMP	cAMP	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
PKA	PKA	NN	B-NP	B-protein
signaling	signaling	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
P-CREB	P-CREB	NN	B-NP	B-protein
.	.	.	O	O

Consistent	Consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
signal	signal	NN	B-NP	O
transduction	transduction	NN	I-NP	O
through	through	IN	B-PP	O
p56lck	p56lck	NN	B-NP	B-protein
or	or	CC	I-NP	O
p59fyn	p59fyn	NN	I-NP	B-protein
,	,	,	O	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
PTK	PTK	NN	B-NP	B-protein
signaling	signaling	NN	I-NP	O
reduced	reduce	VBD	B-VP	O
phosphorylation	phosphorylation	NN	B-NP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
inhibiting	inhibit	VBG	B-VP	O
PKC	PKC	NN	B-NP	B-protein
signaling	signaling	NN	I-NP	O
with	with	IN	B-PP	O
calphostin	calphostin	NN	B-NP	O
C	C	NN	I-NP	O
further	further	RBR	B-ADVP	O
increased	increase	VBD	B-VP	O
P-CREB	P-CREB	NN	B-NP	B-protein
levels	level	NNS	I-NP	O
3-fold	3-fold	RB	B-ADVP	O
over	over	IN	B-PP	O
that	that	DT	B-NP	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
IL-2/CD3	IL-2/CD3	NN	B-NP	B-cell_line
co-stimulated	co-stimulated	JJ	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
not	not	RB	B-VP	O
pretreated	pretreate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
PKC	PKC	NN	I-NP	B-protein
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
previous	previous	JJ	B-NP	O
studies	study	NNS	I-NP	O
performed	perform	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
exogenous	exogenous	JJ	B-NP	O
IL-2	IL-2	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
binding	binding	NN	B-NP	O
of	of	IN	B-PP	O
CREB	CREB	NN	B-NP	B-protein
to	to	TO	B-PP	O
a	a	DT	B-NP	O
32P-labeled	32P-labeled	JJ	I-NP	B-DNA
oligonucleotide	oligonucleotide	NN	I-NP	I-DNA
probe	probe	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
by	by	IN	B-PP	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-protein
and	and	CC	I-NP	O
CD3	CD3	NN	I-NP	B-protein
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
provide	provide	VBP	B-VP	O
a	a	DT	B-NP	O
necessary	necessary	JJ	I-NP	O
and	and	CC	I-NP	O
co-operative	co-operative	JJ	I-NP	O
stimulus	stimulus	NN	I-NP	O
promoting	promote	VBG	B-VP	O
phosphorylation	phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
CREB	CREB	NN	B-NP	B-protein
following	follow	VBG	B-PP	O
receptor	receptor	NN	B-NP	O
cross-linking	cross-linking	NN	I-NP	O
.	.	.	O	O

HIV-1	HIV-1	NN	B-NP	O
infection	infection	NN	I-NP	O
induces	induce	VBZ	B-VP	O
a	a	DT	B-NP	O
selective	selective	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
STAT5	STAT5	NN	B-NP	B-protein
protein	protein	NN	I-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O

HIV-1	HIV-1	NN	B-NP	O
infection	infection	NN	I-NP	O
is	be	VBZ	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
qualitative	qualitative	JJ	B-NP	O
and	and	CC	I-NP	O
quantitative	quantitative	JJ	I-NP	O
defects	defect	NNS	I-NP	O
in	in	IN	B-PP	O
CD4+	CD4+	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Loss	Loss	NN	B-NP	O
of	of	IN	B-PP	O
immune	immune	JJ	B-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
HIV	HIV	NN	B-NP	O
patients	patient	NNS	I-NP	O
is	be	VBZ	B-VP	O
usually	usually	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
profound	profound	JJ	I-NP	O
dysregulation	dysregulation	NN	I-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-protein
production	production	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
whether	whether	IN	B-SBAR	O
cytokine	cytokine	NN	B-NP	B-protein
signaling	signaling	NN	I-NP	O
defects	defect	NNS	I-NP	O
occur	occur	VBP	B-VP	O
during	during	IN	B-PP	O
HIV	HIV	NN	B-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
PHA	PHA	NN	B-NP	B-cell_line
blasts	blast	NNS	I-NP	I-cell_line
from	from	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
human	human	JJ	I-NP	O
donors	donor	NNS	I-NP	O
were	be	VBD	B-VP	O
infected	infect	VBN	I-VP	O
with	with	IN	B-PP	O
two	two	CD	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	O
and	and	CC	O	O
screened	screen	VBD	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
STAT	STAT	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
used	use	VBN	B-VP	O
in	in	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-protein
signaling	signaling	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
selective	selective	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
STAT5B	STAT5B	NN	B-NP	B-protein
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
8	8	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
infection	infection	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
BZ167	BZ167	NN	I-NP	O
dual-tropic	dual-tropic	JJ	I-NP	O
HIV	HIV	NN	I-NP	O
isolate	isolate	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Ba-L	Ba-L	NN	I-NP	O
,	,	,	O	O
M-tropic	M-tropic	JJ	B-NP	O
strain	strain	NN	I-NP	O
.	.	.	O	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
these	these	DT	B-NP	O
findings	finding	NNS	I-NP	O
,	,	,	O	O
purified	purify	VBN	B-NP	O
T	T	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
HIV-infected	HIV-infected	JJ	B-NP	O
patients	patient	NNS	I-NP	O
in	in	IN	B-PP	O
different	different	JJ	B-NP	O
stages	stage	NNS	I-NP	O
of	of	IN	B-PP	O
disease	disease	NN	B-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
STAT	STAT	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
;	;	:	O	O
decreases	decrease	VBZ	B-VP	O
in	in	IN	B-PP	O
STAT5A	STAT5A	NN	B-NP	B-protein
,	,	,	O	O
STAT5B	STAT5B	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
STAT1alpha	STAT1alpha	NN	B-NP	B-protein
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
STATs	STAT	NNS	B-NP	B-protein
seen	see	VBN	B-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
after	after	IN	B-PP	O
HIV	HIV	NN	B-NP	O
infection	infection	NN	I-NP	O
may	may	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
function	function	NN	I-NP	O
in	in	IN	B-PP	O
HIV	HIV	NN	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Transcription	Transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
regulate	regulate	VBP	B-VP	O
monocyte	monocyte	NN	B-NP	B-cell_type
/	/	SYM	B-VP	O
macrophage	macrophage	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
cells	cell	NNS	I-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
organism	organism	NN	I-NP	O
contain	contain	VBP	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
genetic	genetic	JJ	I-NP	O
information	information	NN	I-NP	O
,	,	,	O	O
differences	difference	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
phenotype	phenotype	NN	I-NP	O
arise	arise	VBP	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
lineage-specific	lineage-specific	JJ	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

During	During	IN	B-PP	O
myelopoiesis	myelopoiesis	NN	B-NP	O
,	,	,	O	O
external	external	JJ	B-NP	O
differentiating	differentiate	VBG	I-NP	O
signals	signal	NNS	I-NP	O
regulate	regulate	VBP	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
combined	combined	JJ	I-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
subsequently	subsequently	RB	B-ADVP	O
determines	determine	VBZ	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
myeloid-specific	myeloid-specific	JJ	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
and	and	CC	O	O
the	the	DT	B-NP	O
generation	generation	NN	I-NP	O
of	of	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
macrophages	macrophage	NNS	B-NP	B-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
particular	particular	JJ	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
PU.1	PU.1	NN	I-NP	B-protein
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
review	review	VBP	B-VP	O
the	the	DT	B-NP	O
contribution	contribution	NN	I-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
macrophage	macrophage	NN	B-NP	O
development	development	NN	I-NP	O

Transcription	Transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
LKLF	LKLF	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-PP	O
program	program	NN	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
quiescence	quiescence	NN	I-NP	O
via	via	IN	B-PP	O
a	a	DT	B-NP	O
c-Myc	c-Myc	NN	I-NP	B-protein
--	--	:	O	O
dependent	dependent	JJ	B-NP	O
pathway	pathway	NN	I-NP	O
.	.	.	O	O

T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
circulate	circulate	VBP	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
quiescent	quiescent	JJ	I-NP	O
state	state	NN	I-NP	O
until	until	IN	B-SBAR	O
they	they	PRP	B-NP	O
encounter	encounter	VBP	B-VP	O
cognate	cognate	JJ	B-NP	B-protein
antigen	antigen	NN	I-NP	I-protein
bound	bind	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
surface	surface	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
antigen-presenting	antigen-presenting	JJ	I-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
pathways	pathway	NNS	I-NP	O
that	that	WDT	B-NP	O
regulate	regulate	VBP	B-VP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
quiescence	quiescence	NN	I-NP	O
remain	remain	VBP	B-VP	O
largely	largely	RB	B-ADJP	O
unknown	unknown	JJ	I-ADJP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
forced	force	VBN	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	B-protein
Kruppel-like	Kruppel-like	JJ	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
LKLF	LKLF	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
is	be	VBZ	B-VP	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
program	program	VB	I-VP	O
a	a	DT	B-NP	O
quiescent	quiescent	JJ	I-NP	O
phenotype	phenotype	NN	I-NP	O
characterized	characterize	VBN	B-VP	O
by	by	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
proliferation	proliferation	NN	I-NP	O
,	,	,	O	O
reduced	reduce	VBD	B-VP	O
cell	cell	NN	B-NP	O
size	size	NN	I-NP	O
and	and	CC	O	O
protein	protein	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
surface	surface	NN	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
activation	activation	NN	B-NP	O
markers	marker	NNS	I-NP	O
.	.	.	O	O

Conversely	Conversely	RB	B-ADVP	O
,	,	,	O	O
LKLF-deficient	LKLF-deficient	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
produced	produce	VBN	B-VP	O
by	by	IN	B-PP	O
gene	gene	NN	B-NP	O
targeting	targeting	NN	I-NP	O
showed	show	VBD	B-VP	O
increased	increase	VBN	B-NP	O
proliferation	proliferation	NN	I-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
cell	cell	NN	B-NP	O
size	size	NN	I-NP	O
and	and	CC	O	O
enhanced	enhance	VBN	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
surface	surface	NN	B-NP	B-protein
activation	activation	NN	I-NP	I-protein
markers	marker	NNS	I-NP	I-protein
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

LKLF	LKLF	NN	B-NP	B-protein
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
function	function	VB	I-VP	O
,	,	,	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
decreasing	decrease	VBG	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proto-oncogene	proto-oncogene	NN	I-NP	B-DNA
encoding	encode	VBG	B-VP	O
c-Myc	c-Myc	NN	B-NP	B-protein
.	.	.	O	O

Forced	Force	VBN	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
LKLF	LKLF	NN	B-NP	B-protein
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
markedly	markedly	RB	B-NP	O
decreased	decrease	VBN	I-NP	O
c-Myc	c-Myc	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
many	many	JJ	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
LKLF	LKLF	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
were	be	VBD	B-VP	O
mimicked	mimic	VBN	I-VP	O
by	by	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
dominant-negative	dominant-negative	JJ	I-NP	B-protein
MadMyc	MadMyc	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
and	and	CC	O	O
rescued	rescue	VBN	B-VP	O
by	by	IN	B-PP	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
c-Myc	c-Myc	NN	B-NP	B-protein
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
LKLF	LKLF	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
both	both	CC	O	O
necessary	necessary	JJ	B-NP	O
and	and	CC	I-NP	O
sufficient	sufficient	JJ	I-NP	O
to	to	TO	B-PP	O
program	program	NN	B-NP	O
quiescence	quiescence	NN	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
functions	function	NNS	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
negatively	negatively	RB	B-ADVP	O
regulating	regulate	VBG	B-VP	O
a	a	DT	B-NP	O
c-Myc	c-Myc	NN	I-NP	B-protein
--	--	:	O	O
dependent	dependent	JJ	B-NP	O
pathway	pathway	NN	I-NP	O
.	.	.	O	O

HTLV-1	HTLV-1	NN	B-NP	B-protein
p12	p12	NN	I-NP	I-protein
(	(	(	O	I-protein
I	I	NN	B-NP	I-protein
)	)	)	O	I-protein
protein	protein	NN	B-NP	I-protein
enhances	enhance	VBZ	B-VP	O
STAT5	STAT5	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
and	and	CC	O	O
decreases	decrease	VBZ	B-VP	O
the	the	DT	B-NP	O
interleukin-2	interleukin-2	NN	I-NP	B-protein
requirement	requirement	NN	I-NP	O
for	for	IN	B-PP	O
proliferation	proliferation	NN	B-NP	O
of	of	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
p12	p12	NN	I-NP	B-protein
(	(	(	O	I-protein
I	I	NN	B-NP	I-protein
)	)	)	O	I-protein
protein	protein	NN	B-NP	I-protein
,	,	,	O	O
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
pX	pX	NN	I-NP	B-protein
open	open	JJ	I-NP	I-protein
reading	reading	NN	I-NP	I-protein
frame	frame	NN	I-NP	I-protein
I	I	CD	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
T-lymphotropic	T-lymphotropic	JJ	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
HTLV-1	HTLV-1	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
hydrophobic	hydrophobic	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
that	that	WDT	B-NP	O
localizes	localize	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
endoplasmic	endoplasmic	JJ	I-NP	O
reticulum	reticulum	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Golgi	Golgi	NNP	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
p12	p12	NN	B-NP	B-protein
(	(	(	O	I-protein
I	I	NN	B-NP	I-protein
)	)	)	O	I-protein
contains	contain	VBZ	B-VP	O
4	4	CD	B-NP	O
minimal	minimal	JJ	I-NP	O
proline-rich	proline-rich	JJ	I-NP	O
,	,	,	I-NP	O
src	src	NN	I-NP	B-DNA
homology	homology	NN	I-NP	I-DNA
3-binding	3-binding	JJ	I-NP	I-DNA
motifs	motif	NNS	I-NP	I-DNA
(	(	(	O	O
PXXP	PXXP	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
characteristic	characteristic	JJ	I-NP	O
commonly	commonly	RB	I-NP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
proteins	protein	NNS	B-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
signaling	signaling	NN	B-NP	O
pathways	pathway	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
known	know	VBN	I-VP	O
whether	whether	IN	B-SBAR	O
p12	p12	NN	B-NP	B-protein
(	(	(	O	I-protein
I	I	NN	B-NP	I-protein
)	)	)	O	I-protein
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
modulating	modulate	VBG	B-VP	O
intracellular	intracellular	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
p12	p12	NN	B-NP	B-protein
(	(	(	O	I-protein
I	I	NN	B-NP	I-protein
)	)	)	O	I-protein
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
interleukin-2	interleukin-2	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	I-protein
IL-2R	IL-2R	NN	B-NP	I-protein
)	)	)	O	I-protein
beta	beta	NN	B-NP	I-protein
chain	chain	NN	I-NP	I-protein
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
recruitment	recruitment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Jak1	Jak1	NN	I-NP	B-protein
and	and	CC	I-NP	O
Jak3	Jak3	NN	I-NP	B-protein
kinases	kinase	NNS	I-NP	I-protein
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
interaction	interaction	NN	I-NP	O
,	,	,	O	O
p12	p12	NN	B-NP	B-protein
(	(	(	O	I-protein
I	I	NN	B-NP	I-protein
)	)	)	O	I-protein
increases	increase	VBZ	B-VP	O
signal	signal	NN	B-NP	B-protein
transducers	transducer	NNS	I-NP	I-protein
and	and	CC	I-NP	I-protein
activators	activator	NNS	I-NP	I-protein
of	of	IN	B-PP	I-protein
transcription	transcription	NN	B-NP	I-protein
5	5	CD	I-NP	I-protein
(	(	(	O	O
STAT5	STAT5	NN	B-NP	B-protein
)	)	)	O	O
DNA	DNA	NN	B-NP	O
binding	binding	NN	I-NP	O
and	and	CC	O	O
transcriptional	transcriptional	JJ	B-NP	O
activity	activity	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
effect	effect	NN	I-NP	O
depends	depend	VBZ	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
IL-2R	IL-2R	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
and	and	CC	O	O
gamma	gamma	NN	B-NP	B-protein
(	(	(	O	I-protein
c	c	NN	B-NP	I-protein
)	)	)	O	I-protein
chains	chain	NNS	B-NP	I-protein
and	and	CC	I-NP	O
Jak3	Jak3	NN	I-NP	B-protein
.	.	.	O	O

Transduction	Transduction	NN	B-NP	O
of	of	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
PBMCs	PBMC	NNS	B-NP	B-cell_type
)	)	)	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
immunodeficiency	immunodeficiency	NN	I-NP	I-DNA
virus	virus	NN	I-NP	I-DNA
type	type	NN	I-NP	I-DNA
1-based	1-based	JJ	I-NP	I-DNA
retroviral	retroviral	JJ	I-NP	I-DNA
vector	vector	NN	I-NP	I-DNA
expressing	express	VBG	B-VP	O
p12	p12	NN	B-NP	B-protein
(	(	(	O	I-protein
I	I	NN	B-NP	I-protein
)	)	)	O	I-protein
also	also	RB	B-ADVP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
increased	increase	VBN	B-NP	O
STAT5	STAT5	NN	I-NP	B-protein
phosphorylation	phosphorylation	NN	I-NP	O
and	and	CC	O	O
DNA	DNA	NN	B-NP	O
binding	binding	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
p12	p12	NN	B-NP	B-protein
(	(	(	O	I-protein
I	I	NN	B-NP	I-protein
)	)	)	O	I-protein
could	could	MD	B-VP	O
increase	increase	VB	I-VP	O
proliferation	proliferation	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
PBMCs	PBMC	NNS	I-NP	B-cell_type
only	only	RB	B-ADVP	O
after	after	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
of	of	IN	B-PP	O
T-cell	T-cell	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
by	by	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
alphaCD3	alphaCD3	NN	B-NP	B-protein
and	and	CC	I-NP	O
alphaCD28	alphaCD28	NN	I-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
proliferative	proliferative	JJ	I-NP	O
advantage	advantage	NN	I-NP	O
of	of	IN	B-PP	O
p12	p12	NN	B-NP	O
(	(	(	I-NP	O
I	I	NN	I-NP	O
)	)	)	I-NP	O
-transduced	-transduced	JJ	I-NP	O
PBMCs	PBMC	NNS	I-NP	B-cell_type
was	be	VBD	B-VP	O
evident	evident	JJ	B-ADJP	O
mainly	mainly	RB	B-ADVP	O
at	at	IN	B-PP	O
low	low	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
.	.	.	O	O

Together	Together	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
p12	p12	NN	B-NP	B-protein
(	(	(	O	I-protein
I	I	NN	B-NP	I-protein
)	)	)	O	I-protein
may	may	MD	B-VP	O
confer	confer	VB	I-VP	O
a	a	DT	B-NP	O
proliferative	proliferative	JJ	I-NP	O
advantage	advantage	NN	I-NP	O
on	on	IN	B-PP	O
HTLV-1-infected	HTLV-1-infected	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
the	the	DT	I-PP	O
presence	presence	NN	I-PP	O
of	of	IN	I-PP	O
suboptimal	suboptimal	JJ	B-NP	O
antigen	antigen	NN	I-NP	O
stimulation	stimulation	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
event	event	NN	I-NP	O
may	may	MD	B-VP	O
account	account	VB	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
clonal	clonal	JJ	I-NP	O
proliferation	proliferation	NN	I-NP	O
of	of	IN	B-PP	O
infected	infected	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

(	(	(	O	O
Blood.	Blood.	NNP	B-NP	O
2001	2001	CD	I-NP	O
;	;	:	O	O
98	98	CD	B-NP	O
:	:	:	O	O
823-829	823-829	CD	B-NP	O
)	)	)	O	O

Single	Single	JJ	B-NP	O
dose	dose	NN	I-NP	O
intranasal	intranasal	JJ	I-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
retinal	retinal	JJ	B-NP	B-protein
autoantigen	autoantigen	NN	I-NP	I-protein
generates	generate	VBZ	B-VP	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
accumulation	accumulation	NN	I-NP	O
and	and	CC	O	O
cell	cell	NN	B-NP	O
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
draining	drain	VBG	B-VP	O
lymph	lymph	NN	B-NP	O
node	node	NN	I-NP	O
and	and	CC	I-NP	O
spleen	spleen	NN	I-NP	O
:	:	:	O	O
implications	implication	NNS	B-NP	O
for	for	IN	B-PP	O
tolerance	tolerance	NN	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

BACKGROUND/AIMS	BACKGROUND/AIMS	NN	B-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
single	single	JJ	I-NP	O
intranasal	intranasal	JJ	I-NP	O
delivery	delivery	NN	I-NP	O
of	of	IN	B-PP	O
retinal	retinal	JJ	B-NP	B-protein
autoantigen	autoantigen	NN	I-NP	I-protein
suppresses	suppress	VBZ	B-VP	O
effectively	effectively	RB	B-NP	O
experimental	experimental	JJ	I-NP	O
autoimmune	autoimmune	JJ	I-NP	O
uveoretinitis	uveoretinitis	NN	I-NP	O
(	(	(	O	O
EAU	EAU	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

To	To	TO	B-PP	O
further	further	RB	B-NP	O
unravel	unravel	JJ	I-NP	O
underlying	underlie	VBG	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
the	the	DT	B-NP	O
authors	author	NNS	I-NP	O
wished	wish	VBD	B-VP	O
to	to	TO	I-VP	O
determine	determine	VB	I-VP	O
,	,	,	O	O
firstly	firstly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
kinetics	kinetic	NNS	I-NP	O
of	of	IN	B-PP	O
antigen	antigen	NN	B-NP	O
delivery	delivery	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
secondly	secondly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
cellular	cellular	JJ	I-NP	O
responses	response	NNS	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
stages	stage	NNS	I-NP	O
of	of	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
mucosal	mucosal	JJ	I-NP	O
tolerance	tolerance	NN	I-NP	O
induction	induction	NN	I-NP	O
.	.	.	O	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
Flow	Flow	NN	B-NP	O
cytometry	cytometry	NN	I-NP	O
,	,	,	O	O
cell	cell	NN	B-NP	O
proliferation	proliferation	NN	I-NP	O
assays	assay	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
microscopy	microscopy	NN	B-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
track	track	VB	I-VP	O
antigen	antigen	NN	B-NP	O
following	follow	VBG	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
,	,	,	I-NP	O
intranasal	intranasal	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Alexa-488	Alexa-488	NN	B-NP	B-protein
labelled	labelled	JJ	I-NP	I-protein
retinal	retinal	JJ	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
accumulation	accumulation	NN	I-NP	O
of	of	IN	B-PP	O
antigen	antigen	NN	B-NP	O
within	within	IN	B-PP	O
both	both	CC	O	O
superficial	superficial	JJ	B-NP	O
cervical	cervical	JJ	I-NP	O
lymph	lymph	NN	I-NP	O
nodes	node	NNS	I-NP	O
(	(	(	O	O
SCLN	SCLN	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
spleen	spleen	NN	B-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
after	after	IN	B-PP	O
30	30	CD	B-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

Significant	Significant	JJ	B-NP	O
proliferative	proliferative	JJ	I-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
IRBP	IRBP	NN	B-NP	B-protein
were	be	VBD	B-VP	O
elicited	elicit	VBN	I-VP	O
by	by	IN	B-PP	O
48	48	CD	B-NP	O
hours	hour	NNS	I-NP	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
systemic	systemic	JJ	B-NP	O
priming	priming	NN	I-NP	O
of	of	IN	B-PP	O
naive	naive	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
retinal	retinal	JJ	B-NP	B-protein
antigen	antigen	NN	I-NP	I-protein
had	have	VBD	B-VP	O
occurred	occur	VBN	I-VP	O
.	.	.	O	O

Cell	Cell	NN	B-NP	O
activation	activation	NN	I-NP	O
was	be	VBD	B-VP	O
further	further	RBR	I-VP	O
confirmed	confirm	VBN	I-VP	O
by	by	IN	B-PP	O
immunoprecipitation	immunoprecipitation	NN	B-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
phosphorylation	phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
STAT4	STAT4	NN	B-NP	B-protein
but	but	CC	B-NP	O
not	not	RB	I-NP	O
STAT6	STAT6	NN	B-NP	B-protein
in	in	IN	B-PP	O
both	both	DT	B-NP	O
lymph	lymph	NN	I-NP	O
nodes	node	NNS	I-NP	O
and	and	CC	I-NP	O
spleen	spleen	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
at	at	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
STAT4	STAT4	NN	B-NP	B-protein
heterodimerisation	heterodimerisation	NN	I-NP	O
with	with	IN	B-PP	O
STAT	STAT	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
was	be	VBD	B-VP	O
only	only	RB	I-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
spleen	spleen	NN	B-NP	O
.	.	.	O	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
results	result	NNS	I-NP	O
provide	provide	VBP	B-VP	O
novel	novel	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
that	that	IN	B-SBAR	O
following	follow	VBG	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
intranasal	intranasal	JJ	I-NP	O
application	application	NN	I-NP	O
rapid	rapid	JJ	I-NP	O
transfer	transfer	NN	I-NP	O
of	of	IN	B-PP	O
antigen	antigen	NN	B-NP	O
occurs	occur	VBZ	B-VP	O
.	.	.	O	O

Resulting	Result	VBG	B-VP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
proliferation	proliferation	NN	I-NP	O
develops	develop	VBZ	B-VP	O
consequent	consequent	JJ	B-ADJP	O
to	to	TO	B-PP	O
differential	differential	JJ	B-NP	O
cell	cell	NN	I-NP	O
signalling	signalling	NN	I-NP	O
in	in	IN	B-PP	O
SCLN	SCLN	NN	B-NP	B-protein
and	and	CC	I-NP	O
spleen	spleen	NN	I-NP	O
.	.	.	O	O

Further	Further	JJ	B-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
underlying	underlie	VBG	I-NP	O
cellular	cellular	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
particular	particular	JJ	B-ADJP	O
as	as	IN	B-SBAR	O
is	be	VBZ	B-VP	O
inferred	infer	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
the	the	DT	B-NP	O
contribution	contribution	NN	I-NP	O
of	of	IN	B-PP	O
local	local	JJ	B-NP	O
versus	versus	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
tolerance	tolerance	NN	I-NP	O
induction	induction	NN	I-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
assist	assist	VB	I-VP	O
in	in	IN	B-PP	O
strategies	strategy	NNS	B-NP	O
to	to	TO	B-VP	O
clinically	clinically	RB	I-VP	O
apply	apply	VB	I-VP	O
mucosal	mucosal	JJ	B-NP	O
tolerance	tolerance	NN	I-NP	O
therapy	therapy	NN	I-NP	O
successfully	successfully	RB	B-ADVP	O
.	.	.	O	O

Regulation	Regulation	NN	B-NP	O
of	of	IN	B-PP	O
interleukin	interleukin	NN	B-NP	B-protein
(	(	(	O	I-protein
IL	IL	NN	B-NP	I-protein
)	)	)	O	I-protein
-18	-18	CD	B-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
chain	chain	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
on	on	IN	B-PP	O
CD4	CD4	NN	B-NP	B-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
T	T	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
during	during	IN	B-PP	O
T	T	NN	B-NP	O
helper	helper	NN	I-NP	O
(	(	(	O	O
Th	Th	NN	B-NP	O
)	)	)	O	O
1/Th2	1/Th2	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
.	.	.	O	O

Critical	Critical	JJ	B-NP	O
downregulatory	downregulatory	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
IL-4	IL-4	NN	B-NP	B-protein
.	.	.	O	O

Interleukin	Interleukin	NN	B-NP	B-protein
(	(	(	O	I-protein
IL	IL	NN	B-NP	I-protein
)	)	)	O	I-protein
-18	-18	CD	B-NP	I-protein
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
well	well	RB	I-VP	O
characterized	characterize	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
costimulatory	costimulatory	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
for	for	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
IL-12-mediated	IL-12-mediated	JJ	B-NP	B-protein
interferon	interferon	NN	I-NP	I-protein
(	(	(	O	I-protein
IFN	IFN	NN	B-NP	I-protein
)	)	)	O	I-protein
-gamma	-gamma	NN	B-NP	I-protein
production	production	NN	I-NP	O
by	by	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
helper	helper	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
Th	Th	NN	B-NP	I-cell_type
)	)	)	O	I-cell_type
1	1	CD	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
but	but	CC	O	O
also	also	RB	B-ADVP	O
can	can	MD	B-VP	O
induce	induce	VB	I-VP	O
IL-4	IL-4	NN	B-NP	B-protein
production	production	NN	I-NP	O
and	and	CC	O	O
thus	thus	RB	B-VP	O
facilitate	facilitate	VB	I-VP	O
the	the	DT	B-NP	O
differentiation	differentiation	NN	I-NP	O
of	of	IN	B-PP	O
Th2	Th2	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

To	To	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
IL-18	IL-18	NN	B-NP	B-protein
might	might	MD	B-VP	O
regulate	regulate	VB	I-VP	O
these	these	DT	B-NP	O
diametrically	diametrically	RB	I-NP	O
distinct	distinct	JJ	I-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
analyzed	analyze	VBN	I-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
cytokines	cytokine	NNS	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
IL-18	IL-18	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
chain	chain	NN	I-NP	I-protein
(	(	(	O	O
IL-18Ralpha	IL-18Ralpha	NN	B-NP	B-protein
)	)	)	O	O
expression	expression	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
CD4	CD4	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
T	T	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
constitutively	constitutively	RB	B-ADVP	O
expressed	express	VBD	B-VP	O
the	the	DT	B-NP	O
IL-18Ralpha	IL-18Ralpha	NN	I-NP	B-protein
.	.	.	O	O

Upon	Upon	IN	B-PP	O
antigen	antigen	NN	B-NP	O
stimulation	stimulation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
IL-12	IL-12	NN	B-NP	B-protein
,	,	,	O	O
marked	marked	JJ	B-NP	O
enhancement	enhancement	NN	I-NP	O
of	of	IN	B-PP	O
IL-18Ralpha	IL-18Ralpha	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

IL-12	IL-12	NN	B-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
upregulation	upregulation	NN	I-NP	O
of	of	IN	B-PP	O
IL-18Ralpha	IL-18Ralpha	NN	B-NP	B-protein
required	require	VBD	B-VP	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
.	.	.	O	O

Activated	Activate	VBN	B-NP	B-cell_type
CD4	CD4	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
T	T	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
that	that	WDT	B-NP	O
expressed	express	VBD	B-VP	O
low	low	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
IL-18Ralpha	IL-18Ralpha	NN	B-NP	B-protein
could	could	MD	B-VP	O
produce	produce	VB	I-VP	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
when	when	WRB	B-ADVP	O
stimulated	stimulate	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
IL-12	IL-12	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-18	IL-18	NN	I-NP	B-protein
,	,	,	O	O
while	while	IN	B-SBAR	O
CD4	CD4	NN	B-NP	B-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
cells	cell	NNS	B-NP	I-cell_type
which	which	WDT	B-NP	O
expressed	express	VBD	B-VP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
IL-18Ralpha	IL-18Ralpha	NN	B-NP	B-protein
could	could	MD	B-VP	O
respond	respond	VB	I-VP	O
to	to	TO	B-PP	O
IL-18	IL-18	NN	B-NP	B-protein
alone	alone	RB	B-ADVP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
stimulation	stimulation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	I-PP	O
presence	presence	NN	I-PP	O
of	of	IN	I-PP	O
IL-4	IL-4	NN	B-NP	B-protein
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
downregulation	downregulation	NN	I-NP	O
of	of	IN	B-PP	O
IL-18Ralpha	IL-18Ralpha	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

Both	Both	CC	O	O
IL-4	IL-4	NN	B-NP	B-protein
(	(	(	O	O
-/	-/	SYM	B-NP	O
)	)	)	O	O
-	-	HYPH	O	O
and	and	CC	O	O
signal	signal	NN	B-NP	B-protein
transducer	transducer	NN	I-NP	I-protein
and	and	CC	O	I-protein
activator	activator	NN	B-NP	I-protein
of	of	IN	B-PP	I-protein
transcription	transcription	NN	B-NP	I-protein
(	(	(	O	I-protein
Stat	Stat	NN	B-NP	I-protein
)	)	)	O	I-protein
6	6	CD	B-NP	I-protein
(	(	(	O	O
-/	-/	SYM	B-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
T	T	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
expressed	express	VBD	B-VP	O
higher	high	JJR	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
IL-18Ralpha	IL-18Ralpha	NN	B-NP	B-protein
after	after	IN	B-PP	O
TCR	TCR	NN	B-NP	B-protein
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
activated	activate	VBN	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
Stat6	Stat6	NN	B-NP	B-protein
(	(	(	O	O
-/	-/	SYM	B-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
mice	mouse	NNS	I-NP	O
produced	produce	VBD	B-VP	O
more	more	JJR	B-NP	O
IFN-gamma	IFN-gamma	NN	I-NP	B-protein
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
IL-18	IL-18	NN	B-NP	B-protein
than	than	IN	B-PP	O
wild-type	wild-type	JJ	B-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
positive/negative	positive/negative	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-18Ralpha	IL-18Ralpha	NN	I-NP	B-protein
by	by	IN	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
inductive	inductive	JJ	I-NP	O
cytokines	cytokine	NNS	I-NP	B-protein
(	(	(	O	O
IL-12	IL-12	NN	B-NP	B-protein
and	and	CC	O	O
IL-4	IL-4	NN	B-NP	B-protein
)	)	)	O	O
determines	determine	VBZ	B-VP	O
the	the	DT	B-NP	O
capacity	capacity	NN	I-NP	O
of	of	IN	B-PP	O
IL-18	IL-18	NN	B-NP	B-protein
to	to	TO	B-VP	O
polarize	polarize	VB	I-VP	O
an	an	DT	B-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Glucocorticoid-regulated	Glucocorticoid-regulated	JJ	B-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

Glucocorticoids	Glucocorticoid	NNS	B-NP	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
effective	effective	JJ	I-NP	O
antiinflammatory	antiinflammatory	JJ	I-NP	O
drugs	drug	NNS	I-NP	O
used	use	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
asthma	asthma	NN	B-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
act	act	VBP	B-VP	O
by	by	IN	B-PP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
receptor	receptor	NN	I-NP	O
(	(	(	O	O
GR	GR	NN	B-NP	B-protein
)	)	)	O	O
that	that	WDT	B-NP	O
,	,	,	O	O
upon	upon	IN	B-PP	O
activation	activation	NN	B-NP	O
,	,	,	O	O
translocates	translocate	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
nucleus	nucleus	NN	I-NP	O
and	and	CC	O	O
either	either	CC	O	O
increases	increase	NNS	B-NP	O
(	(	(	O	O
transactivates	transactivate	NNS	B-NP	O
)	)	)	O	O
or	or	CC	O	O
decreases	decrease	VBZ	B-NP	O
(	(	(	O	O
transrepresses	transrepresse	VBZ	O	O
)	)	)	O	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
pro-inflammatory	pro-inflammatory	JJ	B-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
activator	activator	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	I-protein
AP	AP	NN	B-NP	I-protein
)	)	)	O	I-protein
-1	-1	CD	B-NP	I-protein
,	,	,	O	O
signal	signal	NN	B-NP	O
transducers	transducer	NNS	I-NP	O
and	and	CC	O	O
activators	activator	NNS	B-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
(	(	(	O	O
STATs	STAT	NNS	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
of	of	IN	B-PP	I-protein
activated	activate	VBN	B-NP	I-protein
T	T	NN	I-NP	I-protein
cells	cell	NNS	I-NP	I-protein
(	(	(	O	O
NFAT	NFAT	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	I-protein
NF	NF	NN	B-NP	I-protein
)	)	)	O	I-protein
-kappa	-kappa	NN	B-NP	I-protein
B	B	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
.	.	.	O	O

Acetylation	Acetylation	NN	B-NP	O
of	of	IN	B-PP	O
histones	histone	NNS	B-NP	B-protein
allows	allow	VBZ	B-VP	O
unwinding	unwinding	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
local	local	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
structure	structure	NN	I-NP	O
and	and	CC	O	O
enables	enable	VBZ	B-VP	O
RNA	RNA	NN	B-NP	B-protein
polymerase	polymerase	NN	I-NP	I-protein
II	II	CD	I-NP	I-protein
to	to	TO	B-VP	O
enhance	enhance	VB	I-VP	O
gene	gene	NN	B-NP	O
transcription	transcription	NN	I-NP	O
.	.	.	O	O

Histone	Histone	NN	B-NP	O
acetylation	acetylation	NN	I-NP	O
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
balance	balance	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
histone	histone	NN	B-NP	B-protein
acetyltransferases	acetyltransferas	NNS	I-NP	I-protein
(	(	(	O	O
HATs	HAT	NNS	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
histone	histone	NN	B-NP	B-protein
deacetylases	deacetylas	NNS	I-NP	I-protein
(	(	(	O	O
HDACs	HDAC	NNS	B-NP	B-cell_type
)	)	)	O	O
.	.	.	O	O

GR	GR	NN	B-NP	B-protein
acts	act	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
direct	direct	JJ	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	O
B-induced	B-induced	JJ	I-NP	O
HAT	HAT	NN	I-NP	O
activity	activity	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
by	by	IN	B-PP	O
recruiting	recruit	VBG	B-VP	O
HDAC2	HDAC2	NN	B-NP	B-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B/HAT	B/HAT	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
.	.	.	O	O

A	A	DT	B-NP	O
sub-group	sub-group	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
glucocorticoid-insensitive	glucocorticoid-insensitive	JJ	B-NP	O
asthma	asthma	NN	I-NP	O
have	have	VBP	B-VP	O
an	an	DT	B-NP	O
inability	inability	NN	I-NP	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
histone	histone	NN	B-NP	O
acetylation	acetylation	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
suggesting	suggest	VBG	B-VP	O
reduced	reduce	VBN	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
GR-specific	GR-specific	JJ	I-NP	B-protein
HAT	HAT	NN	I-NP	I-protein
.	.	.	O	O

This	This	DT	B-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
pharmacological	pharmacological	JJ	B-NP	O
manipulation	manipulation	NN	I-NP	O
of	of	IN	B-PP	O
specific	specific	JJ	B-NP	O
histone	histone	NN	I-NP	O
acetylation	acetylation	NN	I-NP	O
status	status	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
potentially	potentially	RB	I-NP	O
useful	useful	JJ	I-NP	O
approach	approach	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

Identification	Identification	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
precise	precise	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
activated	activate	VBN	B-NP	O
GR	GR	NN	I-NP	B-protein
recruits	recruit	VBZ	B-VP	O
HDAC2	HDAC2	NN	B-NP	B-protein
may	may	MD	B-VP	O
reveal	reveal	VB	I-VP	O
new	new	JJ	B-NP	O
targets	target	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
drugs	drug	NNS	B-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
dissociate	dissociate	VB	I-VP	O
the	the	DT	B-NP	O
antiinflammatory	antiinflammatory	JJ	I-NP	O
actions	action	NNS	I-NP	O
of	of	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
from	from	IN	B-PP	O
their	their	PRP$	B-NP	O
side	side	NN	I-NP	O
effects	effect	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
largely	largely	RB	B-ADVP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
gene	gene	NN	B-NP	O
induction	induction	NN	I-NP	O
.	.	.	O	O

Copyright	Copyright	NN	B-NP	O
Academic	Academic	NNP	I-NP	O
Press	Press	NNP	I-NP	O
.	.	.	O	O

Differential	Differential	JJ	B-NP	O
ultraviolet-B-induced	ultraviolet-B-induced	JJ	I-NP	O
immunomodulation	immunomodulation	NN	I-NP	O
in	in	IN	B-PP	O
XPA	XPA	NN	B-NP	O
,	,	,	O	O
XPC	XPC	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
CSB	CSB	NN	B-NP	B-protein
DNA	DNA	NN	I-NP	O
repair-deficient	repair-deficient	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

Ultraviolet	Ultraviolet	NN	B-NP	O
B	B	NN	I-NP	O
irradiation	irradiation	NN	I-NP	O
has	have	VBZ	B-VP	O
serious	serious	JJ	B-NP	O
consequences	consequence	NNS	I-NP	O
for	for	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
immunity	immunity	NN	I-NP	O
and	and	CC	O	O
can	can	MD	B-VP	O
suppress	suppress	VB	I-VP	O
the	the	DT	B-NP	O
rejection	rejection	NN	I-NP	O
of	of	IN	B-PP	O
skin	skin	NN	B-NP	O
tumors	tumor	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
infectious	infectious	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

DNA	DNA	NN	B-NP	O
damage	damage	NN	I-NP	O
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
crucial	crucial	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
immunomodulatory	immunomodulatory	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
ultraviolet	ultraviolet	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
,	,	,	O	O
as	as	IN	B-SBAR	O
impaired	impaired	JJ	B-NP	O
repair	repair	NN	I-NP	O
of	of	IN	B-PP	O
ultraviolet-B-induced	ultraviolet-B-induced	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
damage	damage	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
cause	cause	VB	I-VP	O
suppression	suppression	NN	B-NP	O
of	of	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
immunity	immunity	NN	I-NP	O
.	.	.	O	O

Ultraviolet-B-induced	Ultraviolet-B-induced	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
damage	damage	NN	I-NP	O
is	be	VBZ	B-VP	O
repaired	repair	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
nucleotide	nucleotide	NN	I-NP	O
excision	excision	NN	I-NP	O
repair	repair	NN	I-NP	O
mechanism	mechanism	NN	I-NP	O
very	very	RB	B-ADVP	O
efficiently	efficiently	RB	I-ADVP	O
.	.	.	O	O

Nucleotide	Nucleotide	NN	B-NP	O
excision	excision	NN	I-NP	O
repair	repair	NN	I-NP	O
comprises	comprise	VBZ	B-VP	O
two	two	CD	B-NP	O
subpathways	subpathway	NNS	I-NP	O
:	:	:	O	O
transcription-coupled	transcription-coupled	JJ	B-NP	O
and	and	CC	I-NP	O
global	global	JJ	I-NP	O
genome	genome	NN	I-NP	O
repair	repair	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
the	the	DT	B-NP	O
immunologic	immunologic	JJ	I-NP	O
consequences	consequence	NNS	I-NP	O
of	of	IN	B-PP	O
specific	specific	JJ	B-NP	O
nucleotide	nucleotide	NN	I-NP	O
excision	excision	NN	I-NP	O
repair	repair	NN	I-NP	O
defects	defect	NNS	I-NP	O
in	in	IN	B-PP	O
three	three	CD	B-NP	O
mouse	mouse	NN	I-NP	O
models	model	NNS	I-NP	O
,	,	,	O	O
XPA	XPA	NN	B-NP	B-protein
,	,	,	O	O
XPC	XPC	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
CSB	CSB	NN	B-NP	B-protein
mutant	mutant	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

XPA	XPA	NN	B-NP	O
mice	mouse	NNS	I-NP	O
carry	carry	VBP	B-VP	O
a	a	DT	B-NP	O
total	total	JJ	I-NP	O
nucleotide	nucleotide	NN	I-NP	O
excision	excision	NN	I-NP	O
repair	repair	NN	I-NP	O
defect	defect	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
XPC	XPC	NN	B-NP	B-cell_type
and	and	CC	I-NP	O
CSB	CSB	NN	I-NP	O
mice	mouse	NNS	I-NP	O
only	only	RB	B-ADVP	O
lack	lack	VBP	B-VP	O
global	global	JJ	B-NP	B-DNA
genome	genome	NN	I-NP	I-DNA
and	and	CC	O	O
transcription-coupled	transcription-coupled	JJ	B-NP	O
nucleotide	nucleotide	NN	I-NP	O
excision	excision	NN	I-NP	O
repair	repair	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
data	datum	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
cellular	cellular	JJ	B-NP	O
immune	immune	JJ	I-NP	O
parameters	parameter	NNS	I-NP	O
in	in	IN	B-PP	O
XPA	XPA	NN	B-NP	O
,	,	,	O	O
XPC	XPC	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
CSB	CSB	NN	B-NP	B-protein
mice	mouse	NNS	I-NP	O
are	be	VBP	B-VP	O
normal	normal	JJ	B-ADJP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
their	their	PRP$	B-NP	O
wild-type	wild-type	JJ	I-NP	O
(	(	(	O	O
control	control	NN	B-NP	O
)	)	)	O	O
littermates	littermate	NNS	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
may	may	MD	B-VP	O
indicate	indicate	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
reported	report	VBN	I-NP	O
altered	altered	JJ	I-NP	O
cellular	cellular	JJ	I-NP	O
responses	response	NNS	I-NP	O
in	in	IN	B-PP	O
xeroderma	xeroderma	NN	B-NP	O
pigmentosum	pigmentosum	NN	I-NP	O
patients	patient	NNS	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	O	O
constitutive	constitutive	JJ	B-ADJP	O
but	but	CC	O	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADVP	O
to	to	TO	B-PP	O
external	external	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
ultraviolet	ultraviolet	JJ	B-NP	O
B	B	NN	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-VP	O
ultraviolet	ultraviolet	VB	I-VP	O
B	B	NN	B-NP	O
,	,	,	O	O
only	only	RB	B-NP	O
XPA	XPA	NN	I-NP	O
mice	mouse	NNS	I-NP	O
are	be	VBP	B-VP	O
very	very	RB	B-ADJP	O
sensitive	sensitive	JJ	I-ADJP	O
to	to	TO	B-PP	O
ultraviolet-B-induced	ultraviolet-B-induced	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
Th1-mediated	Th1-mediated	JJ	B-NP	O
contact	contact	NN	I-NP	O
hypersensitivity	hypersensitivity	NN	I-NP	O
responses	response	NNS	I-NP	O
and	and	CC	O	O
interferon-gamma	interferon-gamma	NN	B-NP	B-protein
production	production	NN	I-NP	O
in	in	IN	B-PP	O
skin	skin	NN	B-NP	O
draining	drain	VBG	B-VP	O
lymph	lymph	NN	B-NP	O
nodes	node	NNS	I-NP	O
.	.	.	O	O

Lipopolysaccharide-stimulated	Lipopolysaccharide-stimulated	JJ	B-NP	O
tumor	tumor	NN	I-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
and	and	CC	O	O
interleukin-10	interleukin-10	NN	B-NP	B-protein
production	production	NN	I-NP	O
are	be	VBP	B-VP	O
significantly	significantly	RB	I-VP	O
augmented	augment	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	CC	O	O
XPA	XPA	NN	B-NP	B-DNA
and	and	CC	I-NP	O
CSB	CSB	NN	I-NP	O
mice	mouse	NNS	I-NP	O
after	after	IN	B-PP	O
ultraviolet	ultraviolet	NN	B-NP	O
B	B	NN	I-NP	O
exposure	exposure	NN	I-NP	O
.	.	.	O	O

Lymph	Lymph	NN	B-NP	O
node	node	NN	I-NP	O
cell	cell	NN	I-NP	O
numbers	number	NNS	I-NP	O
were	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
very	very	RB	B-ADVP	O
significantly	significantly	RB	I-ADVP	O
in	in	IN	B-PP	O
XPA	XPA	NN	B-NP	B-DNA
,	,	,	O	O
mildly	mildly	RB	B-VP	O
increased	increase	VBD	I-VP	O
in	in	IN	B-PP	O
CSB	CSB	NNP	B-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
XPC	XPC	NN	B-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-NP	O
XPC	XPC	NN	I-NP	O
mice	mouse	NNS	I-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
exhibit	exhibit	VB	I-VP	O
any	any	DT	B-NP	O
indication	indication	NN	I-NP	O
of	of	IN	B-PP	O
enhanced	enhance	VBN	B-NP	O
ultraviolet	ultraviolet	NN	I-NP	O
B	B	NN	I-NP	O
susceptibility	susceptibility	NN	I-NP	O
with	with	IN	B-PP	O
regard	regard	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
immune	immune	JJ	I-NP	O
parameters	parameter	NNS	I-NP	O
analyzed	analyze	VBN	B-VP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
both	both	CC	O	O
global	global	JJ	B-NP	O
genome	genome	NN	I-NP	O
repair	repair	NN	I-NP	O
and	and	CC	O	O
transcription-coupled	transcription-coupled	JJ	B-NP	O
repair	repair	NN	I-NP	O
are	be	VBP	B-VP	O
needed	need	VBN	I-VP	O
to	to	TO	B-VP	O
prevent	prevent	VB	I-VP	O
immunomodulation	immunomodulation	NN	B-NP	O
by	by	IN	B-PP	O
ultraviolet	ultraviolet	NN	B-NP	O
B	B	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
transcription-coupled	transcription-coupled	JJ	B-NP	O
repair	repair	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
repair	repair	NN	I-NP	O
subpathway	subpathway	NN	I-NP	O
of	of	IN	B-PP	O
nucleotide	nucleotide	NN	B-NP	O
excision	excision	NN	I-NP	O
repair	repair	NN	I-NP	O
that	that	WDT	B-NP	O
prevents	prevent	VBZ	B-VP	O
the	the	DT	B-NP	O
acute	acute	JJ	I-NP	O
ultraviolet-B-induced	ultraviolet-B-induced	JJ	I-NP	O
effects	effect	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
erythema	erythema	NN	B-NP	O
.	.	.	O	O

Biomechanical	Biomechanical	JJ	B-NP	O
strain	strain	NN	I-NP	O
induces	induce	VBZ	B-VP	O
class	class	NN	B-NP	O
a	a	DT	B-NP	O
scavenger	scavenger	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
monocyte/macrophages	monocyte/macrophage	NNS	I-NP	I-cell_type
and	and	CC	O	O
THP-1	THP-1	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
:	:	:	O	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
increased	increase	VBN	B-NP	O
atherosclerosis	atherosclerosis	NN	I-NP	O
in	in	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
.	.	.	O	O

BACKGROUND	BACKGROUND	NN	B-NP	O
:	:	:	O	O
Although	Although	IN	B-SBAR	O
hypertension	hypertension	NN	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
risk	risk	NN	I-NP	O
factor	factor	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
atherosclerosis	atherosclerosis	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
interaction	interaction	NN	I-NP	O
are	be	VBP	B-VP	O
incompletely	incompletely	RB	I-VP	O
described	describe	VBN	I-VP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
suggested	suggest	VBN	I-VP	O
that	that	IN	B-SBAR	O
biomechanical	biomechanical	JJ	B-NP	O
strain	strain	NN	I-NP	O
regulates	regulate	VBZ	B-VP	O
macrophage	macrophage	NN	B-NP	O
phenotype	phenotype	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
tested	test	VBD	B-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
biomechanical	biomechanical	JJ	B-NP	O
strain	strain	NN	I-NP	O
can	can	MD	B-VP	O
induce	induce	VB	I-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
class	class	NN	I-NP	B-protein
A	A	NN	I-NP	I-protein
scavenger	scavenger	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
SRA	SRA	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
lipoprotein	lipoprotein	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
in	in	IN	B-PP	O
atherogenesis	atherogenesis	NN	B-NP	O
.	.	.	O	O

METHODS	METHODS	NNS	B-NP	O
AND	AND	CC	I-NP	O
RESULTS	RESULTS	NNS	I-NP	O
:	:	:	O	O
Human	Human	JJ	B-NP	B-cell_type
monocyte/macrophages	monocyte/macrophage	NNS	I-NP	I-cell_type
or	or	CC	O	O
THP-1	THP-1	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
device	device	NN	I-NP	O
that	that	WDT	B-NP	O
imposes	impose	VBZ	B-VP	O
uniform	uniform	JJ	B-NP	O
biaxial	biaxial	JJ	I-NP	O
cyclic	cyclic	JJ	I-NP	O
1-Hz	1-Hz	NN	I-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
0	0	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
3	3	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
SRA	SRA	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
.	.	.	O	O

Mechanical	Mechanical	JJ	B-NP	O
strains	strain	NNS	I-NP	O
induced	induce	VBD	B-VP	O
SRA	SRA	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
(	(	(	O	O
3.5+/-0.6-fold	3.5+/-0.6-fold	RB	B-ADVP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
%	%	NN	I-NP	O
strain	strain	NN	I-NP	O
for	for	IN	B-PP	O
48	48	CD	B-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
0.01	0.01	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
SRA	SRA	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
in	in	IN	B-PP	O
THP-1	THP-1	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
in	in	IN	B-PP	O
an	an	DT	B-NP	O
amplitude-dependent	amplitude-dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
induction	induction	NN	I-NP	O
was	be	VBD	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
augmented	augmented	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
class	class	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
scavenger	scavenger	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
CD36	CD36	NN	I-NP	O
(	(	(	O	O
2.8+/-0.3-fold	2.8+/-0.3-fold	JJ	B-ADJP	O
,	,	,	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
0.001	0.001	CD	I-NP	O
)	)	)	O	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
by	by	IN	I-PP	O
increased	increase	VBN	B-NP	O
peroxisome	peroxisome	NN	I-NP	B-protein
proliferator-activated	proliferator-activated	JJ	I-NP	I-protein
receptor-gamma	receptor-gamma	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
this	this	DT	B-NP	O
effect	effect	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
,	,	,	O	O
apolipoprotein	apolipoprotein	NN	B-NP	O
E	E	NN	I-NP	O
(	(	(	O	O
-/-	-/-	JJ	O	O
)	)	)	O	O
mice	mouse	NNS	B-NP	O
were	be	VBD	B-VP	O
randomly	randomly	RB	I-VP	O
assigned	assign	VBN	I-VP	O
to	to	TO	I-VP	O
receive	receive	VB	I-VP	O
standard	standard	JJ	B-NP	O
chow	chow	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
high-cholesterol	high-cholesterol	JJ	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
a	a	DT	B-NP	O
high-cholesterol	high-cholesterol	JJ	I-NP	O
diet	diet	NN	I-NP	O
with	with	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
angiotensin	angiotensin	NN	B-NP	O
II	II	CD	I-NP	O
infusion	infusion	NN	I-NP	O
for	for	IN	B-PP	O
8	8	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Immunohistochemistry	Immunohistochemistry	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
among	among	IN	B-PP	O
macrophages	macrophage	NNS	B-NP	B-cell_type
in	in	IN	B-PP	O
atherosclerotic	atherosclerotic	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
aorta	aorta	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
macrophages	macrophage	NNS	B-NP	B-cell_type
with	with	IN	B-PP	O
SRA	SRA	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
highest	high	JJS	B-ADJP	O
in	in	IN	B-PP	O
hypertensive	hypertensive	JJ	B-NP	O
animals	animal	NNS	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
high-cholesterol	high-cholesterol	NN	I-NP	O
diet	diet	NN	I-NP	O
(	(	(	O	O
43.9+/-0.7	43.9+/-0.7	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
versus	versus	IN	B-ADVP	O
12.0+/-2.0	12.0+/-2.0	CD	B-NP	O
%	%	NN	I-NP	O
for	for	IN	B-PP	O
normotensive	normotensive	JJ	B-NP	O
animals	animal	NNS	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
high-cholesterol	high-cholesterol	JJ	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
4.7+/-4.7	4.7+/-4.7	CD	B-NP	O
%	%	NN	I-NP	O
for	for	IN	B-PP	O
animals	animal	NNS	B-NP	O
on	on	IN	B-PP	O
standard	standard	JJ	B-NP	O
chow	chow	NN	I-NP	O
;	;	:	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
0.001	0.001	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
Biomechanical	Biomechanical	JJ	B-NP	O
strain	strain	NN	I-NP	O
induces	induce	VBZ	B-VP	O
SRA	SRA	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
by	by	IN	B-PP	O
monocyte/macrophages	monocyte/macrophage	NNS	B-NP	B-cell_type
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
for	for	IN	B-PP	O
promotion	promotion	NN	B-NP	O
of	of	IN	B-PP	O
atherosclerosis	atherosclerosis	NN	B-NP	O
in	in	IN	B-PP	O
hypertensive	hypertensive	JJ	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

High	High	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
induces	induce	VBZ	B-VP	O
MCP-1	MCP-1	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
partly	partly	RB	B-ADVP	O
via	via	IN	B-PP	O
tyrosine	tyrosine	NN	B-NP	B-protein
kinase-AP-1	kinase-AP-1	NN	I-NP	I-protein
pathway	pathway	NN	I-NP	O
in	in	IN	B-PP	O
peritoneal	peritoneal	JJ	B-NP	B-cell_type
mesothelial	mesothelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

BACKGROUND	BACKGROUND	NN	B-NP	O
:	:	:	O	O
High	High	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
in	in	IN	B-PP	O
peritoneal	peritoneal	JJ	B-NP	O
dialysis	dialysis	NN	I-NP	O
solutions	solution	NNS	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
peritoneal	peritoneal	JJ	B-NP	O
fibrosis	fibrosis	NN	I-NP	O
in	in	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
ambulatory	ambulatory	JJ	I-NP	O
peritoneal	peritoneal	JJ	I-NP	O
dialysis	dialysis	NN	I-NP	O
(	(	(	O	O
CAPD	CAPD	NN	B-NP	O
)	)	)	O	O
patients	patient	NNS	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	O	O
very	very	RB	B-ADJP	O
clear	clear	JJ	I-ADJP	O
.	.	.	O	O

Peritoneal	Peritoneal	JJ	B-NP	B-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
seem	seem	VBP	B-VP	O
to	to	TO	I-VP	O
participate	participate	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
process	process	NN	I-NP	O
of	of	IN	B-PP	O
peritoneal	peritoneal	JJ	B-NP	O
fibrosis	fibrosis	NN	I-NP	O
and	and	CC	I-NP	O
monocyte	monocyte	NN	I-NP	B-protein
chemoattractant	chemoattractant	NN	I-NP	I-protein
protein-1	protein-1	NN	I-NP	I-protein
(	(	(	O	O
MCP-1	MCP-1	NN	B-NP	B-protein
)	)	)	O	O
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
key	key	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
recruitment	recruitment	NN	I-NP	O
of	of	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
toward	toward	IN	B-PP	O
the	the	DT	B-NP	O
peritoneal	peritoneal	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
little	little	JJ	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
high	high	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
on	on	IN	B-PP	O
MCP-1	MCP-1	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
pathway	pathway	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
peritoneal	peritoneal	JJ	I-NP	I-cell_type
mesothelial	mesothelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
Mesothelial	Mesothelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
with	with	IN	B-PP	O
glucose	glucose	NN	B-NP	O
(	(	(	O	O
5	5	CD	B-NP	O
to	to	TO	O	O
100	100	CD	B-NP	O
mmol/L	mmol/L	NN	I-NP	O
)	)	)	O	O
or	or	CC	O	O
mannitol	mannitol	NN	B-NP	O
chronically	chronically	RB	B-ADVP	O
for	for	IN	B-PP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
seven	seven	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

MCP-1	MCP-1	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
mRNA	mRNA	NN	B-NP	B-RNA
and	and	CC	I-NP	O
protein	protein	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
by	by	IN	B-PP	O
Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
and	and	CC	O	O
enzyme-linked	enzyme-linked	JJ	B-NP	O
immunosorbent	immunosorbent	JJ	I-NP	O
assay	assay	NN	I-NP	O
(	(	(	O	O
ELISA	ELISA	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Chemotactic	Chemotactic	JJ	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
high-glucose-conditioned	high-glucose-conditioned	JJ	B-NP	O
culture	culture	NN	I-NP	O
supernatant	supernatant	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
by	by	IN	B-PP	O
chemotactic	chemotactic	JJ	B-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
roles	role	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
activator	activator	NN	B-NP	B-protein
protein-1	protein-1	NN	I-NP	I-protein
(	(	(	O	O
AP-1	AP-1	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
(	(	(	O	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assay	assay	NN	I-NP	O
(	(	(	O	O
EMSA	EMSA	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Glucose	Glucose	NN	B-NP	O
induced	induce	VBD	B-VP	O
MCP-1	MCP-1	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
time-	time-	NN	I-NP	O
and	and	CC	I-NP	O
dose-dependent	dose-dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
.	.	.	O	O

MCP-1	MCP-1	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
in	in	IN	B-PP	O
cell	cell	NN	B-NP	O
culture	culture	NN	I-NP	O
supernant	supernant	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
increased	increase	VBN	I-VP	O
.	.	.	O	O

Equivalent	Equivalent	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
mannitol	mannitol	NN	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

High-glucose-conditioned	High-glucose-conditioned	JJ	B-NP	O
supernatant	supernatant	NN	I-NP	O
possessed	possess	VBD	B-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
chemotactic	chemotactic	JJ	I-NP	O
activity	activity	NN	I-NP	O
for	for	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
neutralized	neutralize	VBN	I-VP	O
by	by	IN	B-PP	O
anti-MCP-1	anti-MCP-1	JJ	B-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
.	.	.	O	O

EMSA	EMSA	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
glucose	glucose	NN	B-NP	O
increased	increase	VBD	B-VP	O
the	the	DT	B-NP	O
AP-1	AP-1	NN	I-NP	B-protein
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
time-	time-	NN	I-NP	O
and	and	CC	I-NP	O
dose-dependent	dose-dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
,	,	,	B-NP	O
but	but	CC	I-NP	O
not	not	RB	I-NP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
.	.	.	O	O

Curcumin	Curcumin	NN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
of	of	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-protein
,	,	,	O	O
dose-dependently	dose-dependently	RB	B-ADVP	O
suppressed	suppress	VBD	B-VP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
MCP-1	MCP-1	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
by	by	IN	B-PP	O
high	high	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
.	.	.	O	O

Tyrosine	Tyrosine	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
inhibitors	inhibitor	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
genistein	genistein	NN	B-NP	O
(	(	(	O	O
12.5	12.5	CD	B-NP	O
to	to	TO	I-NP	O
50	50	CD	I-NP	O
micromol/L	micromol/L	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
herbimycin	herbimycin	NN	B-NP	O
A	A	NN	I-NP	O
(	(	(	O	O
0.1	0.1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
micromol/L	micromol/L	NN	I-NP	O
)	)	)	O	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
high-glucose-induced	high-glucose-induced	JJ	I-NP	O
MCP-1	MCP-1	NN	I-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
dose-dependent	dose-dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
also	also	RB	B-VP	O
suppressed	suppress	VBD	I-VP	O
the	the	DT	B-NP	O
high-glucose-induced	high-glucose-induced	JJ	I-NP	O
AP-1	AP-1	NN	I-NP	B-protein
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
:	:	:	O	O
High	High	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
induced	induce	VBD	B-VP	O
mesothelial	mesothelial	JJ	B-NP	O
MCP-1	MCP-1	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
partly	partly	RB	B-ADVP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
tyrosine	tyrosine	NN	I-NP	B-protein
kinase-	kinase-	NN	I-NP	I-protein
AP-1	AP-1	NN	I-NP	B-protein
pathway	pathway	NN	I-NP	O
.	.	.	O	O

Signal	Signal	NN	B-NP	O
thresholds	threshold	NNS	I-NP	O
and	and	CC	O	O
modular	modular	JJ	B-NP	O
synergy	synergy	NN	I-NP	O
during	during	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
costimulatory	costimulatory	JJ	B-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
analyzed	analyze	VBD	B-VP	O
intracellular	intracellular	JJ	B-NP	O
pathways	pathway	NNS	I-NP	O
modulating	modulate	VBG	B-VP	O
surface	surface	NN	B-NP	O
densities	density	NNS	I-NP	O
of	of	IN	B-PP	O
CD80	CD80	NN	B-NP	B-protein
and	and	CC	I-NP	O
CD86	CD86	NN	I-NP	B-protein
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
activated	activate	VBN	B-VP	O
through	through	IN	B-PP	O
ligation	ligation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ag	Ag	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
adhesion	adhesion	NN	I-NP	B-protein
molecule	molecule	NN	I-NP	I-protein
CD54	CD54	NN	I-NP	B-protein
.	.	.	O	O

Whereas	Whereas	IN	B-SBAR	O
B	B	NN	B-NP	B-protein
cell	cell	NN	I-NP	I-protein
Ag	Ag	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
BCR	BCR	NN	B-NP	B-protein
)	)	)	O	O
cross-linking	cross-linking	NN	B-NP	O
alone	alone	RB	B-ADVP	O
stimulated	stimulate	VBD	B-VP	O
increased	increase	VBN	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
CD86	CD86	NN	B-NP	B-protein
,	,	,	O	O
up-regulation	up-regulation	NN	B-NP	O
of	of	IN	B-PP	O
CD80	CD80	NN	B-NP	B-protein
required	require	VBD	B-VP	O
dual	dual	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
with	with	IN	B-PP	O
anti-IgM	anti-IgM	JJ	B-NP	B-protein
and	and	CC	I-NP	O
anti-CD54	anti-CD54	JJ	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
principal	principal	JJ	I-NP	O
downstream	downstream	JJ	I-NP	O
component	component	NN	I-NP	O
contributed	contribute	VBN	B-VP	O
by	by	IN	B-PP	O
BCR	BCR	NN	B-NP	B-protein
signaling	signaling	NN	I-NP	O
,	,	,	O	O
toward	toward	IN	B-PP	O
both	both	CC	O	O
CD80	CD80	NN	B-NP	B-protein
and	and	CC	O	O
CD86	CD86	NN	B-NP	B-protein
induction	induction	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
free	free	JJ	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	O
Ca	Ca	NN	I-NP	O
(	(	(	O	O
2+	2+	JJ	B-ADVP	O
)	)	)	O	O
,	,	,	O	O
recruited	recruit	VBN	B-VP	O
by	by	IN	B-PP	O
way	way	NN	B-NP	O
of	of	IN	B-PP	O
capacitative	capacitative	JJ	B-NP	O
influx	influx	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
alone	alone	RB	B-ADVP	O
was	be	VBD	B-VP	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
generate	generate	VB	I-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
CD86	CD86	NN	B-NP	B-protein
levels	level	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
CD80	CD80	NN	B-NP	B-protein
enhancement	enhancement	NN	I-NP	O
required	require	VBD	B-VP	O
the	the	DT	B-NP	O
concerted	concerted	JJ	I-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
intracellular	intracellular	JJ	B-NP	O
Ca	Ca	NN	I-NP	O
(	(	(	O	O
2+	2+	JJ	O	O
)	)	)	O	O
concentration	concentration	NN	B-NP	O
and	and	CC	O	O
CD54-initiated	CD54-initiated	JJ	B-NP	O
pathways	pathway	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
nexus	nexus	NN	I-NP	O
between	between	IN	B-PP	O
anti-IgM	anti-IgM	JJ	B-NP	B-protein
and	and	CC	I-NP	O
anti-CD54	anti-CD54	JJ	I-NP	B-protein
stimulation	stimulation	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
CD80	CD80	NN	B-NP	B-protein
regulation	regulation	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
to	to	TO	I-VP	O
involve	involve	VB	I-VP	O
a	a	DT	B-NP	O
self-propagating	self-propagating	JJ	I-NP	O
process	process	NN	I-NP	O
of	of	IN	B-PP	O
sequential	sequential	JJ	B-NP	O
synergy	synergy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
first	first	JJ	I-NP	O
step	step	NN	I-NP	O
involved	involve	VBD	B-VP	O
amplified	amplify	VBN	B-NP	O
accumulation	accumulation	NN	I-NP	O
of	of	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
cAMP	cAMP	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
cross-talk	cross-talk	NN	B-NP	O
between	between	IN	B-PP	O
BCR	BCR	NN	B-NP	B-protein
-mobilized	-mobilized	JJ	I-NP	O
Ca	Ca	NN	I-NP	O
(	(	(	O	O
2+	2+	JJ	B-ADJP	O
)	)	)	O	O
and	and	CC	O	O
CD54-derived	CD54-derived	JJ	B-NP	O
signals	signal	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
then	then	RB	B-ADVP	O
facilitated	facilitate	VBD	B-VP	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
synergistic	synergistic	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
between	between	IN	B-PP	O
Ca	Ca	NN	B-NP	O
(	(	(	O	O
2+	2+	JJ	B-ADJP	O
)	)	)	O	O
and	and	CC	O	O
cAMP	cAMP	NN	B-NP	O
,	,	,	O	O
culminating	culminate	VBG	B-VP	O
in	in	IN	B-PP	O
CD80	CD80	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
findings	finding	NNS	I-NP	O
of	of	IN	B-PP	O
distinct	distinct	JJ	B-NP	O
signal	signal	NN	I-NP	B-protein
transducer	transducer	NN	I-NP	I-protein
requirements	requirement	NNS	I-NP	I-protein
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
added	add	VBN	I-NP	O
consequences	consequence	NNS	I-NP	O
of	of	IN	B-PP	O
cross-talk	cross-talk	NN	B-NP	O
,	,	,	O	O
offers	offer	VBZ	B-VP	O
an	an	DT	B-NP	O
explanation	explanation	NN	I-NP	O
for	for	IN	B-PP	O
variable	variable	JJ	B-NP	O
modulation	modulation	NN	I-NP	O
of	of	IN	B-PP	O
costimulatory	costimulatory	JJ	B-NP	B-protein
molecule	molecule	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
diverse	diverse	JJ	B-NP	O
physiological	physiological	JJ	I-NP	O
stimuli	stimulus	NNS	I-NP	O
.	.	.	O	O

Importantly	Importantly	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
also	also	RB	B-ADVP	O
reveal	reveal	VBP	B-VP	O
how	how	WRB	B-ADVP	O
concentration	concentration	NN	B-NP	O
threshold	threshold	NN	I-NP	O
barriers	barrier	NNS	I-NP	O
for	for	IN	B-PP	O
recruitment	recruitment	NN	B-NP	O
of	of	IN	B-PP	O
individual	individual	JJ	B-NP	O
second	second	JJ	I-NP	O
messengers	messenger	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
overcome	overcome	VBN	I-VP	O
by	by	IN	B-PP	O
constructive	constructive	JJ	B-NP	O
convergence	convergence	NN	I-NP	O
of	of	IN	B-PP	O
signaling	signaling	NN	B-NP	O
modules	module	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
Epstein-Barr	Epstein-Barr	JJ	B-NP	O
virus	virus	NN	I-NP	O
in	in	IN	B-PP	O
neoplastic	neoplastic	JJ	B-NP	O
transformation	transformation	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
review	review	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
focus	focus	VBP	B-VP	O
on	on	IN	B-PP	O
new	new	JJ	B-NP	O
data	datum	NNS	I-NP	O
from	from	IN	B-PP	O
basic	basic	JJ	B-NP	O
,	,	,	I-NP	O
translational	translational	JJ	I-NP	O
and	and	CC	I-NP	O
clinical	clinical	JJ	I-NP	O
research	research	NN	I-NP	O
relating	relate	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Epstein-Barr	Epstein-Barr	JJ	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
EBV	EBV	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Beside	Beside	IN	B-PP	O
its	its	PRP$	B-NP	O
well-known	well-known	JJ	I-NP	O
tropism	tropism	NN	I-NP	O
for	for	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
epithelial	epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
EBV	EBV	NN	B-NP	O
also	also	RB	B-ADVP	O
infects	infect	VBZ	B-VP	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
monocytes	monocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
granulocytes	granulocyte	NNS	B-NP	B-cell_type
.	.	.	O	O

After	After	IN	B-PP	O
primary	primary	JJ	B-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
EBV	EBV	NN	B-NP	O
persists	persist	VBZ	B-VP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
life	life	NN	I-NP	O
span	span	NN	I-NP	O
in	in	IN	B-PP	O
resting	rest	VBG	B-NP	B-cell_type
memory	memory	NN	I-NP	I-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
from	from	IN	B-PP	O
where	where	WRB	B-ADVP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
reactivated	reactivate	VBN	I-VP	O
upon	upon	IN	B-PP	O
breakdown	breakdown	NN	B-NP	O
of	of	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
immunity	immunity	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
process	process	NN	I-NP	O
of	of	IN	B-PP	O
neoplastic	neoplastic	JJ	B-NP	O
transformation	transformation	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
EBV-encoded	EBV-encoded	JJ	I-NP	B-DNA
latent	latent	JJ	I-NP	I-DNA
membrane	membrane	NN	I-NP	I-DNA
protein	protein	NN	I-NP	I-DNA
1	1	CD	I-NP	I-DNA
(	(	(	O	I-DNA
LMP1	LMP1	NN	B-NP	I-DNA
)	)	)	O	I-DNA
oncogene	oncogene	NN	B-NP	I-DNA
represents	represent	VBZ	B-VP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
driving	drive	VBG	I-NP	O
force	force	NN	I-NP	O
.	.	.	O	O

LMP1	LMP1	NN	B-NP	B-protein
acts	act	VBZ	B-VP	O
like	like	IN	B-PP	O
a	a	DT	B-NP	O
constitutively	constitutively	RB	I-NP	B-protein
activated	activate	VBN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tumor	tumor	NN	I-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
family	family	NN	I-NP	I-protein
and	and	CC	O	O
allows	allow	VBZ	B-VP	O
the	the	DT	B-NP	O
amplification	amplification	NN	I-NP	O
or	or	CC	I-NP	O
bypassing	bypassing	NN	I-NP	O
of	of	IN	B-PP	O
physiological	physiological	JJ	B-NP	O
regulatory	regulatory	JJ	I-NP	O
signals	signal	NNS	I-NP	O
through	through	IN	B-PP	O
direct	direct	JJ	B-NP	O
and	and	CC	I-NP	O
indirect	indirect	JJ	I-NP	O
interactions	interaction	NNS	I-NP	O
with	with	IN	B-PP	O
proteins	protein	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tumor	tumor	NN	I-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
receptor-associated	receptor-associated	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	I-protein
TRAF	TRAF	NN	B-NP	I-protein
)	)	)	O	I-protein
family	family	NN	B-NP	I-protein
.	.	.	O	O

TRAF2	TRAF2	NN	B-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
,	,	,	O	O
AP-1	AP-1	NN	B-NP	B-protein
induction	induction	NN	I-NP	O
and	and	CC	I-NP	O
JAK3	JAK3	NN	I-NP	B-protein
/	/	SYM	B-NP	O
STAT	STAT	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
may	may	MD	B-VP	O
result	result	VB	I-VP	O
in	in	IN	B-PP	O
sustained	sustained	JJ	B-NP	O
proliferation	proliferation	NN	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
lymphoma	lymphoma	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
LMP1	LMP1	NN	B-NP	B-protein
to	to	TO	B-VP	O
suppress	suppress	VB	I-VP	O
germinal	germinal	JJ	B-NP	O
center	center	NN	I-NP	O
formation	formation	NN	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
capacity	capacity	NN	I-NP	O
to	to	TO	B-VP	O
mediate	mediate	VB	I-VP	O
its	its	PRP$	B-NP	O
own	own	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activation	activation	NN	I-NP	O
shed	shed	VBD	B-VP	O
new	new	JJ	B-NP	O
light	light	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
EBV-associated	EBV-associated	JJ	B-NP	O
latency	latency	NN	I-NP	O
type	type	NN	I-NP	O
II	II	CD	I-NP	O
lymphoproliferations	lymphoproliferation	NNS	I-NP	O
like	like	IN	B-PP	O
Hodgkin	Hodgkin	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
angioimmunoblastic	angioimmunoblastic	JJ	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
carboxy	carboxy	NN	I-NP	B-protein
terminus	terminus	NN	I-NP	I-protein
of	of	IN	B-PP	O
LMP1	LMP1	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
a	a	DT	B-NP	O
reliable	reliable	JJ	I-NP	O
marker	marker	NN	I-NP	O
for	for	IN	B-PP	O
individual	individual	JJ	B-NP	O
EBV	EBV	NN	I-NP	O
strain	strain	NN	I-NP	O
identification	identification	NN	I-NP	O
and	and	CC	O	O
thus	thus	RB	B-VP	O
offers	offer	VBZ	I-VP	O
new	new	JJ	B-NP	O
possibilities	possibility	NNS	I-NP	O
in	in	IN	B-PP	O
tracing	trace	VBG	B-VP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
events	event	NNS	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	I-VP	O
posttransplant	posttransplant	VB	I-VP	O
lymphoproliferative	lymphoproliferative	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O
(	(	(	O	O
PTLDs	PTLD	NNS	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Cytotoxic	Cytotoxic	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
directed	direct	VBN	B-VP	O
against	against	IN	B-PP	O
well-characterized	well-characterized	JJ	B-NP	O
epitopes	epitope	NNS	I-NP	O
of	of	IN	B-PP	O
EBV	EBV	NN	B-NP	B-DNA
latency	latency	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
represent	represent	VBP	B-VP	O
an	an	DT	B-NP	O
already	already	RB	I-NP	O
successful	successful	JJ	I-NP	O
and	and	CC	I-NP	O
promising	promising	JJ	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
approach	approach	NN	I-NP	O
to	to	TO	B-PP	O
EBV-associated	EBV-associated	JJ	B-NP	O
lymphomas	lymphoma	NNS	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
particular	particular	JJ	B-NP	O
PTLDs	PTLD	NNS	I-NP	O

Interferon-alpha	Interferon-alpha	NN	B-NP	B-protein
drives	drive	VBZ	B-VP	O
T	T	NN	B-NP	O
cell-mediated	cell-mediated	JJ	I-NP	O
immunopathology	immunopathology	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
intestine	intestine	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
interferon	interferon	NN	B-NP	B-protein
(	(	(	O	I-protein
IFN	IFN	NN	B-NP	I-protein
)	)	)	O	I-protein
-alpha	-alpha	NN	B-NP	I-protein
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
autoimmunity	autoimmunity	NN	B-NP	O
and	and	CC	I-NP	O
exacerbate	exacerbate	NN	I-NP	O
Th1	Th1	NN	I-NP	O
diseases	disease	NNS	I-NP	O
is	be	VBZ	B-VP	O
well	well	RB	B-ADJP	O
known	know	VBN	I-ADJP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
recently	recently	RB	I-VP	O
described	describe	VBN	I-VP	O
enhanced	enhance	VBN	I-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
IFN-alpha	IFN-alpha	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mucosa	mucosa	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
celiac	celiac	JJ	B-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
CD	CD	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
gluten-sensitive	gluten-sensitive	JJ	I-NP	O
Th1-mediated	Th1-mediated	JJ	I-NP	O
enteropathy	enteropathy	NN	I-NP	O
,	,	,	O	O
characterized	characterize	VBN	B-VP	O
by	by	IN	B-PP	O
villous	villous	JJ	B-NP	O
atrophy	atrophy	NN	I-NP	O
and	and	CC	I-NP	O
crypt	crypt	NN	I-NP	O
cell	cell	NN	I-NP	O
hyperplasia	hyperplasia	NN	I-NP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
studies	study	NNS	I-NP	O
from	from	IN	B-PP	O
this	this	DT	B-NP	O
laboratory	laboratory	NN	I-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
explant	explant	NN	B-NP	O
cultures	culture	NNS	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
fetal	fetal	JJ	I-NP	O
gut	gut	NN	I-NP	O
can	can	MD	B-VP	O
also	also	RB	I-VP	O
result	result	VB	I-VP	O
in	in	IN	B-PP	O
villous	villous	JJ	B-NP	O
atrophy	atrophy	NN	I-NP	O
and	and	CC	I-NP	O
crypt	crypt	NN	I-NP	O
cell	cell	NN	I-NP	O
hyperplasia	hyperplasia	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
examined	examine	VBN	B-NP	O
changes	change	NNS	I-NP	O
that	that	WDT	B-NP	O
take	take	VBP	B-VP	O
place	place	NN	B-NP	O
in	in	IN	B-PP	O
explant	explant	NN	B-NP	O
cultures	culture	NNS	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
fetal	fetal	JJ	I-NP	O
gut	gut	NN	I-NP	O
after	after	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
anti-CD3	anti-CD3	NN	B-NP	B-protein
and/or	and/or	CC	I-NP	O
IFN-alpha	IFN-alpha	NN	I-NP	B-protein
.	.	.	O	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
anti-CD3	anti-CD3	NN	B-NP	B-protein
alone	alone	RB	B-ADVP	O
elicits	elicit	VBZ	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
IFN-gamma	IFN-gamma	NN	I-NP	B-protein
and	and	CC	I-NP	O
TNF-alpha	TNF-alpha	NN	I-NP	B-protein
response	response	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
tissue	tissue	NN	I-NP	O
injury	injury	NN	I-NP	O
.	.	.	O	O

Similarly	Similarly	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
changes	change	NNS	I-NP	O
are	be	VBP	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
explants	explant	NNS	B-NP	O
cultured	culture	VBN	B-VP	O
with	with	IN	B-PP	O
IFN-alpha	IFN-alpha	NN	B-NP	B-protein
alone	alone	RB	B-ADVP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
IFN-alpha	IFN-alpha	NN	B-NP	B-protein
with	with	IN	B-PP	O
anti-CD3	anti-CD3	NN	B-NP	B-protein
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
enhanced	enhance	VBN	B-NP	O
Th1	Th1	NN	I-NP	O
response	response	NN	I-NP	O
and	and	CC	I-NP	O
crypt	crypt	NN	I-NP	O
cell	cell	NN	I-NP	O
hyperplasia	hyperplasia	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
enhanced	enhance	VBN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
STAT1	STAT1	NN	B-NP	B-protein
,	,	,	O	O
STAT3	STAT3	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
Fyn	Fyn	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
Src	Src	NN	I-NP	B-protein
homology	homology	NN	I-NP	I-protein
tyrosine	tyrosine	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
interacts	interact	VBZ	B-VP	O
with	with	IN	B-PP	O
both	both	CC	O	O
TCR	TCR	NN	B-NP	B-protein
and	and	CC	O	O
IFN-alpha	IFN-alpha	NN	B-NP	B-protein
signal	signal	NN	I-NP	O
components	component	NNS	I-NP	O
.	.	.	O	O

Together	Together	RB	B-ADVP	O
these	these	DT	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
IFN-alpha	IFN-alpha	NN	B-NP	B-protein
can	can	MD	B-VP	O
facilitate	facilitate	VB	I-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
Th1-reactive	Th1-reactive	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
the	the	DT	B-NP	O
gut	gut	NN	I-NP	O
and	and	CC	I-NP	O
drive	drive	NN	I-NP	O
immunopathology	immunopathology	NN	I-NP	O
.	.	.	O	O

Suppression	Suppression	NN	B-NP	O
of	of	IN	B-PP	O
tumor	tumor	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
production	production	NN	I-NP	O
by	by	IN	B-PP	O
cAMP	cAMP	NN	B-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
:	:	:	O	O
dissociation	dissociation	NN	B-NP	O
with	with	IN	B-PP	O
mRNA	mRNA	NN	B-NP	O
level	level	NN	I-NP	O
and	and	CC	O	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
interleukin-10	interleukin-10	NN	B-NP	B-protein
.	.	.	O	O

BACKGROUND	BACKGROUND	NN	B-NP	O
:	:	:	O	O
Elevation	Elevation	NN	B-NP	O
of	of	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
cAMP	cAMP	NN	I-NP	O
inhibits	inhibit	VBZ	B-VP	O
lipopolysaccharide	lipopolysaccharide	NN	B-NP	O
(	(	(	O	O
LPS	LPS	NN	B-NP	O
)	)	)	O	O
-stimulated	-stimulated	JJ	B-NP	O
tumor	tumor	NN	I-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
(	(	(	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
)	)	)	O	O
production	production	NN	B-NP	O
and	and	CC	O	O
increases	increase	VBZ	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
interleukin	interleukin	NN	B-NP	B-protein
(	(	(	O	I-protein
IL	IL	NN	B-NP	I-protein
)	)	)	O	I-protein
-10	-10	CD	B-NP	I-protein
in	in	IN	B-PP	O
mononuclear	mononuclear	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

TNF-alpha	TNF-alpha	NN	B-NP	B-protein
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
obligates	obligate	VBZ	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
kappaB	kappaB	NN	I-NP	I-protein
(	(	(	O	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Exogenous	Exogenous	JJ	B-NP	O
IL-10	IL-10	NN	I-NP	B-protein
inhibits	inhibit	VBZ	B-VP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
in	in	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
thus	thus	RB	B-VP	O
attenuates	attenuate	VBZ	I-VP	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
production	production	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
endogenous	endogenous	JJ	B-NP	O
IL-10	IL-10	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
and	and	CC	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
production	production	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
cAMP	cAMP	NN	B-NP	O
.	.	.	O	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
Human	Human	JJ	B-NP	B-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
stimulated	stimulate	VBN	I-VP	O
with	with	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O
LPS	LPS	NN	I-NP	O
(	(	(	O	O
100	100	CD	B-NP	O
ng/ml	ng/ml	NN	I-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
and	and	CC	I-PP	O
without	without	IN	I-PP	O
forskolin	forskolin	NN	B-NP	O
(	(	(	O	O
FSK	FSK	NN	B-NP	B-protein
,	,	,	O	O
50	50	CD	B-NP	O
microM	microM	NN	I-NP	O
)	)	)	O	O
or	or	CC	O	O
dibutyryl	dibutyryl	NN	B-NP	O
cyclic	cyclic	JJ	I-NP	O
AMP	AMP	NN	I-NP	O
(	(	(	O	O
dbcAMP	dbcAMP	NN	B-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
microM	microM	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Cytokine	Cytokine	NN	B-NP	B-protein
(	(	(	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
and	and	CC	O	O
IL-10	IL-10	NN	B-NP	B-protein
)	)	)	O	O
release	release	NN	B-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
by	by	IN	B-PP	O
immunoassay	immunoassay	NN	B-NP	O
.	.	.	O	O

TNF-alpha	TNF-alpha	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
by	by	IN	B-PP	O
reverse	reverse	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
by	by	IN	B-PP	O
gel	gel	NN	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
cAMP-elevating	cAMP-elevating	JJ	B-NP	O
agents	agent	NNS	I-NP	O
inhibited	inhibit	VBD	B-VP	O
LPS-stimulated	LPS-stimulated	JJ	B-NP	O
TNF-alpha	TNF-alpha	NN	I-NP	B-protein
release	release	NN	I-NP	O
(	(	(	O	O
0.77	0.77	CD	B-NP	O
+/-	+/-	CC	I-NP	O
0.13	0.13	CD	I-NP	O
ng/10	ng/10	CD	I-NP	O
(	(	(	O	O
6	6	CD	B-NP	O
)	)	)	O	O
cells	cell	NNS	B-NP	O
in	in	IN	B-PP	O
LPS	LPS	NN	B-NP	O
+	+	CC	I-NP	O
dbcAMP	dbcAMP	NN	I-NP	O
and	and	CC	O	O
0.68	0.68	CD	B-NP	O
+/-	+/-	CC	I-NP	O
0.19	0.19	CD	I-NP	O
ng/10	ng/10	CD	I-NP	O
(	(	(	O	O
6	6	CD	B-NP	O
)	)	)	O	O
cells	cell	NNS	B-NP	O
in	in	IN	B-PP	O
LPS	LPS	NN	B-NP	O
+	+	SYM	B-NP	O
FSK	FSK	NN	I-NP	B-protein
,	,	,	O	O
both	both	DT	B-NP	O
P	P	NN	I-NP	O
<	<	JJR	B-NP	O
0.05	0.05	CD	I-NP	O
vs	vs	IN	B-PP	O
1.61	1.61	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
0.34	0.34	CD	I-NP	O
ng/10	ng/10	CD	I-NP	O
(	(	(	O	O
6	6	CD	B-NP	O
)	)	)	O	O
cells	cell	NNS	B-NP	O
in	in	IN	B-PP	O
LPS	LPS	NN	B-NP	O
alone	alone	RB	B-ADVP	O
)	)	)	O	O
.	.	.	O	O

Conversely	Conversely	RB	B-ADVP	O
,	,	,	O	O
cAMP	cAMP	NN	B-NP	O
enhanced	enhance	VBD	B-VP	O
LPS-stimulated	LPS-stimulated	JJ	B-NP	O
IL-10	IL-10	NN	I-NP	B-protein
release	release	NN	I-NP	O
(	(	(	O	O
100	100	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
21.5	21.5	CD	I-NP	O
pg/10	pg/10	NN	I-NP	O
(	(	(	O	O
6	6	CD	B-NP	O
)	)	)	O	O
cells	cell	NNS	B-NP	O
in	in	IN	B-PP	O
LPS	LPS	NN	B-NP	O
+	+	CC	I-NP	O
dbcAMP	dbcAMP	NN	I-NP	O
and	and	CC	O	O
110	110	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
25.2	25.2	CD	I-NP	O
pg/10	pg/10	NN	I-NP	O
(	(	(	O	O
6	6	CD	B-NP	O
)	)	)	O	O
cells	cell	NNS	B-NP	O
in	in	IN	B-PP	O
LPS	LPS	NN	B-NP	O
+	+	SYM	B-NP	O
FSK	FSK	NN	I-NP	B-protein
,	,	,	O	O
both	both	DT	B-NP	O
P	P	NN	I-NP	O
<	<	JJR	B-NP	O
0.05	0.05	CD	I-NP	O
vs	vs	IN	B-PP	O
53.3	53.3	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
12.8	12.8	CD	I-NP	O
pg/10	pg/10	NN	I-NP	O
(	(	(	O	O
6	6	CD	B-NP	O
)	)	)	O	O
cells	cell	NNS	B-NP	O
in	in	IN	B-PP	O
LPS	LPS	NN	B-NP	O
alone	alone	RB	B-ADVP	O
)	)	)	O	O
.	.	.	O	O

Neither	Neither	CC	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
expression	expression	NN	I-NP	O
nor	nor	CC	O	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
stimulated	stimulate	VBN	B-VP	O
by	by	IN	B-PP	O
LPS	LPS	NN	B-NP	O
was	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
cAMP-elevating	cAMP-elevating	JJ	I-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O

Neutralization	Neutralization	NN	B-NP	O
of	of	IN	B-PP	O
IL-10	IL-10	NN	B-NP	B-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
antibody	antibody	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
attenuate	attenuate	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
cAMP-elevating	cAMP-elevating	JJ	B-NP	O
agents	agent	NNS	I-NP	O
on	on	IN	B-PP	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
production	production	NN	I-NP	O
.	.	.	O	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
cAMP	cAMP	NN	B-NP	O
inhibits	inhibit	VBZ	B-VP	O
LPS-stimulated	LPS-stimulated	JJ	B-NP	O
TNF-alpha	TNF-alpha	NN	I-NP	B-protein
production	production	NN	I-NP	O
through	through	IN	B-PP	O
a	a	DT	B-NP	O
posttranscriptional	posttranscriptional	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
endogenous	endogenous	JJ	B-NP	O
IL-10	IL-10	NN	I-NP	B-protein
.	.	.	O	O

Copyright	Copyright	NN	B-NP	O
2001	2001	CD	I-NP	O
Academic	Academic	NNP	I-NP	O
Press	Press	NNP	I-NP	O
.	.	.	O	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
p21	p21	NN	I-NP	B-DNA
(	(	(	O	I-DNA
CIP1/WAF1	CIP1/WAF1	NN	B-NP	I-DNA
)	)	)	O	I-DNA
promoter	promoter	NN	B-NP	I-DNA
by	by	IN	B-PP	O
bone	bone	NN	B-NP	B-protein
morphogenetic	morphogenetic	JJ	I-NP	I-protein
protein-2	protein-2	NN	I-NP	I-protein
in	in	IN	B-PP	O
mouse	mouse	NN	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
lineage	lineage	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

BMPs	BMP	NNS	B-NP	O
exert	exert	VBP	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
growth	growth	NN	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
various	various	JJ	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
previously	previously	RB	I-VP	O
reported	report	VBN	I-VP	O
that	that	IN	B-SBAR	O
BMP-2	BMP-2	NN	B-NP	B-protein
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
HS-72	HS-72	NN	B-NP	B-cell_line
mouse	mouse	NN	I-NP	I-cell_line
hybridoma	hybridoma	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
by	by	IN	B-PP	O
inducing	induce	VBG	B-VP	O
p21	p21	NN	B-NP	B-protein
(	(	(	O	I-protein
CIP1/WAF1	CIP1/WAF1	NN	B-NP	I-protein
)	)	)	O	I-protein
expression	expression	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
BMP-2	BMP-2	NN	B-NP	B-protein
activated	activate	VBD	B-VP	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	B-DNA
p21	p21	NN	I-NP	I-DNA
(	(	(	O	I-DNA
CIP1/WAF1	CIP1/WAF1	NN	B-NP	I-DNA
)	)	)	O	I-DNA
promoter	promoter	NN	B-NP	I-DNA
in	in	IN	B-PP	O
HS-72	HS-72	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
29-base	29-base	JJ	I-NP	B-DNA
pair	pair	NN	I-NP	I-DNA
(	(	(	O	I-DNA
b	b	NN	B-NP	I-DNA
)	)	)	O	I-DNA
region	region	NN	B-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	B-DNA
(	(	(	O	O
-1928/-1900	-1928/-1900	CD	B-NP	O
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
TATA	TATA	NN	I-NP	B-DNA
box	box	NN	I-NP	I-DNA
)	)	)	O	O
,	,	,	O	O
conserved	conserve	VBN	B-VP	O
between	between	IN	B-PP	O
mice	mouse	NNS	B-NP	O
and	and	CC	I-NP	O
humans	human	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
responsive	responsive	JJ	B-ADJP	O
to	to	TO	B-PP	O
BMP-2	BMP-2	NN	B-NP	B-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
Smad1	Smad1	NN	B-NP	B-protein
,	,	,	O	O
Smad4	Smad4	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
constitutively	constitutively	RB	B-NP	O
active	active	JJ	I-NP	O
mutants	mutant	NNS	I-NP	O
of	of	IN	B-PP	O
BMP	BMP	NN	B-NP	B-protein
type	type	NN	I-NP	I-protein
I	I	CD	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
an	an	DT	B-NP	O
oligonucleotide	oligonucleotide	NN	I-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
29-b	29-b	JJ	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
Smad4	Smad4	NN	B-NP	B-protein
and	and	CC	O	O
phosphorylated	phosphorylate	VBN	B-NP	O
Smad1	Smad1	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
extract	extract	NN	I-NP	O
of	of	IN	B-PP	O
BMP-2	BMP-2	NN	B-NP	B-cell_line
-stimulated	-stimulated	JJ	I-NP	I-cell_line
HS-72	HS-72	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
BMP-2	BMP-2	NN	B-NP	B-protein
might	might	MD	B-VP	O
activate	activate	VB	I-VP	O
p21	p21	NN	B-NP	O
(	(	(	O	O
CIP1/WAF1	CIP1/WAF1	NN	B-NP	O
)	)	)	O	O
transcription	transcription	NN	B-NP	O
by	by	IN	B-PP	O
inducing	induce	VBG	B-VP	O
a	a	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
Smad4	Smad4	NN	B-NP	B-protein
and	and	CC	I-NP	O
Smad1	Smad1	NN	I-NP	B-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
29-b	29-b	JJ	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
in	in	IN	B-PP	O
HS-72	HS-72	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Dendritic	Dendritic	JJ	B-NP	O
cell	cell	NN	I-NP	O
development	development	NN	I-NP	O
from	from	IN	B-PP	O
common	common	JJ	B-NP	B-cell_type
myeloid	myeloid	JJ	I-NP	I-cell_type
progenitors	progenitor	NNS	I-NP	I-cell_type
.	.	.	O	O

Dendritic	Dendritic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
DCs	DC	NNS	B-NP	B-cell_type
)	)	)	O	O
are	be	VBP	B-VP	O
professional	professional	JJ	B-NP	B-cell_type
antigen-presenting	antigen-presenting	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
which	which	WDT	B-NP	O
both	both	DT	B-NP	O
initiate	initiate	VBP	B-VP	O
adaptive	adaptive	JJ	B-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
and	and	CC	O	O
control	control	NN	B-NP	O
tolerance	tolerance	NN	I-NP	O
to	to	TO	B-PP	O
self-antigens	self-antigen	NNS	B-NP	B-protein
.	.	.	O	O

It	It	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
suggested	suggest	VBN	I-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
different	different	JJ	I-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
responder	responder	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
depend	depend	VBP	B-VP	O
on	on	IN	B-PP	O
subsets	subset	NNS	B-NP	O
of	of	IN	B-PP	O
DCs	DC	NNS	B-NP	B-cell_type
arising	arise	VBG	B-VP	O
from	from	IN	B-PP	O
either	either	CC	B-NP	O
myeloid	myeloid	JJ	I-NP	O
or	or	CC	I-NP	O
lymphoid	lymphoid	JJ	I-NP	O
hematopoietic	hematopoietic	JJ	I-NP	O
origins	origin	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
model	model	NN	I-NP	O
,	,	,	O	O
CD8	CD8	NN	B-NP	B-protein
alpha+	alpha+	SYM	B-VP	O
Mac-1-	Mac-1-	NN	B-NP	O
DCs	DC	NNS	I-NP	B-cell_type
are	be	VBP	B-VP	O
supposed	suppose	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
of	of	IN	B-PP	O
lymphoid	lymphoid	JJ	B-NP	B-cell_type
while	while	IN	B-SBAR	I-cell_type
CD8	CD8	NN	B-NP	I-cell_type
alpha-	alpha-	NN	I-NP	I-cell_type
Mac-1+	Mac-1+	JJ	I-NP	I-cell_type
DCs	DC	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
supposed	suppose	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
of	of	IN	B-PP	O
myeloid	myeloid	JJ	B-NP	B-protein
origin	origin	NN	I-NP	I-protein
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
summarize	summarize	VBP	B-VP	O
our	our	PRP$	B-NP	O
findings	finding	NNS	I-NP	O
that	that	IN	B-SBAR	O
both	both	CC	O	O
CD8	CD8	NN	B-NP	B-protein
alpha+	alpha+	SYM	B-NP	O
and	and	CC	O	O
CD8	CD8	NN	B-NP	B-cell_type
alpha-	alpha-	NN	I-NP	I-cell_type
DCs	DC	NNS	I-NP	I-cell_type
can	can	MD	B-VP	O
arise	arise	VB	I-VP	O
from	from	IN	B-PP	O
clonogenic	clonogenic	JJ	B-NP	B-cell_type
common	common	JJ	I-NP	I-cell_type
myeloid	myeloid	JJ	I-NP	I-cell_type
progenitors	progenitor	NNS	I-NP	I-cell_type
(	(	(	O	O
CMPs	CMP	NNS	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
both	both	CC	O	O
thymus	thymus	NN	B-NP	O
and	and	CC	I-NP	O
spleen	spleen	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-NP	O
CD8	CD8	NN	I-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
DCs	DC	NNS	I-NP	B-cell_type
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
indicate	indicate	VB	I-VP	O
a	a	DT	B-NP	O
lymphoid	lymphoid	JJ	I-NP	O
origin	origin	NN	I-NP	O
and	and	CC	I-NP	O
differences	difference	NNS	I-NP	O
among	among	IN	B-PP	O
CD8	CD8	NN	B-NP	B-protein
alpha+	alpha+	SYM	B-NP	O
and	and	CC	O	O
CD8	CD8	NN	B-NP	B-cell_type
alpha-	alpha-	NN	I-NP	I-cell_type
DCs	DC	NNS	I-NP	I-cell_type
might	might	MD	B-VP	O
rather	rather	RB	I-VP	O
reflect	reflect	VB	I-VP	O
maturation	maturation	NN	B-NP	O
status	status	NN	I-NP	O
than	than	IN	B-PP	O
ontogeny	ontogeny	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
transplantation	transplantation	NN	B-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
seems	seem	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
DCs	DC	NNS	I-NP	B-cell_type
in	in	IN	B-PP	O
secondary	secondary	JJ	B-NP	O
lymphoid	lymphoid	JJ	I-NP	O
organs	organ	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
substantial	substantial	JJ	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
thymic	thymic	JJ	B-NP	B-cell_type
DCs	DC	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
myeloid-derived	myeloid-derived	JJ	B-ADJP	O
.	.	.	O	O

Macrophage	Macrophage	NN	B-NP	O
stimulation	stimulation	NN	I-NP	O
with	with	IN	B-PP	O
Murabutide	Murabutide	NNP	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
HIV-suppressive	HIV-suppressive	JJ	I-NP	O
muramyl	muramyl	NN	I-NP	O
peptide	peptide	NN	I-NP	O
derivative	derivative	NN	I-NP	O
,	,	,	O	O
selectively	selectively	RB	B-VP	O
activates	activate	VBZ	I-VP	O
extracellular	extracellular	JJ	B-NP	B-protein
signal-regulated	signal-regulated	JJ	I-NP	I-protein
kinases	kinase	NNS	I-NP	I-protein
1	1	CD	I-NP	I-protein
and	and	CC	I-NP	I-protein
2	2	CD	I-NP	I-protein
,	,	,	I-NP	O
C/EBPbeta	C/EBPbeta	NN	I-NP	B-protein
and	and	CC	I-NP	O
STAT1	STAT1	NN	I-NP	B-protein
:	:	:	O	O
role	role	NN	B-NP	O
of	of	IN	B-PP	O
CD14	CD14	NN	B-NP	B-protein
and	and	CC	O	O
Toll-like	Toll-like	JJ	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
2	2	CD	B-NP	I-protein
and	and	CC	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
smallest	small	JJS	I-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
peptidoglycans	peptidoglycan	NNS	I-NP	O
known	know	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
endowed	endow	VBN	I-VP	O
with	with	IN	B-PP	O
biological	biological	JJ	B-NP	O
activities	activity	NNS	I-NP	O
is	be	VBZ	B-VP	O
muramyl	muramyl	NN	B-NP	O
dipeptide	dipeptide	NN	I-NP	O
(	(	(	O	O
MDP	MDP	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

A	A	DT	B-NP	O
clinically	clinically	RB	I-NP	O
acceptable	acceptable	JJ	I-NP	O
synthetic	synthetic	JJ	I-NP	O
derivative	derivative	NN	I-NP	O
of	of	IN	B-PP	O
MDP	MDP	NN	B-NP	O
,	,	,	O	O
namely	namely	RB	B-ADVP	O
murabutide	murabutide	NN	B-NP	O
(	(	(	O	O
MB	MB	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
present	present	VB	I-VP	O
interesting	interesting	JJ	B-NP	O
pharmacological	pharmacological	JJ	I-NP	O
properties	property	NNS	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
suppress	suppress	VB	I-VP	O
HIV-1	HIV-1	NN	B-NP	O
replication	replication	NN	I-NP	O
in	in	IN	B-PP	O
monocyte-derived	monocyte-derived	JJ	B-NP	B-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
(	(	(	O	O
MDM	MDM	NN	B-NP	B-cell_type
)	)	)	O	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
addressed	address	VBN	I-VP	O
the	the	DT	B-NP	O
signaling	signaling	NN	I-NP	O
events	event	NNS	I-NP	O
activated	activate	VBN	B-VP	O
in	in	IN	B-PP	O
MDM	MDM	NN	B-NP	B-cell_type
following	follow	VBG	B-PP	O
stimulation	stimulation	NN	B-NP	O
with	with	IN	B-PP	O
either	either	CC	O	O
MB	MB	NN	B-NP	B-protein
or	or	CC	O	O
the	the	DT	B-NP	O
potent	potent	JJ	I-NP	O
immunostimulant	immunostimulant	JJ	I-NP	O
LPS	LPS	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
examined	examine	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
signaling	signaling	NN	B-NP	O
by	by	IN	B-PP	O
muramyl	muramyl	NN	B-NP	O
peptides	peptide	NNS	I-NP	O
involves	involve	VBZ	B-VP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	B-protein
surface	surface	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
,	,	,	O	O
including	include	VBG	B-PP	O
CD14	CD14	NN	B-NP	B-protein
and	and	CC	O	O
Toll-like	Toll-like	JJ	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
(	(	(	O	O
TLR2	TLR2	NN	B-NP	B-protein
)	)	)	O	O
or	or	CC	O	O
TLR4	TLR4	NN	B-NP	B-protein
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
signal-transducing	signal-transducing	JJ	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
for	for	IN	B-PP	O
other	other	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
cell	cell	NN	I-NP	O
wall	wall	NN	I-NP	O
components	component	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
unlike	unlike	IN	B-PP	O
LPS	LPS	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
safe	safe	JJ	I-NP	O
immunomodulator	immunomodulator	NN	I-NP	O
MB	MB	NN	I-NP	O
selectively	selectively	RB	B-ADVP	O
activates	activate	VBZ	B-VP	O
extracellular	extracellular	JJ	B-NP	B-protein
signal-regulated	signal-regulated	JJ	I-NP	I-protein
kinases	kinase	NNS	I-NP	I-protein
(	(	(	O	O
Erk	Erk	NN	B-NP	B-protein
)	)	)	O	O
1/2	1/2	CD	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
detectable	detectable	JJ	B-NP	O
Jun	Jun	NN	I-NP	B-protein
N-terminal	N-terminal	JJ	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
JNK	JNK	NN	B-NP	B-protein
)	)	)	O	O
or	or	CC	O	O
p38	p38	NN	B-NP	B-protein
mitogen-activated	mitogen-activated	JJ	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
STAT1	STAT1	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
but	but	CC	O	O
weak	weak	JJ	B-ADJP	O
or	or	CC	O	O
no	no	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
STAT3	STAT3	NN	B-NP	B-protein
or	or	CC	I-NP	O
STAT5	STAT5	NN	I-NP	B-protein
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
MB-stimulated	MB-stimulated	JJ	B-NP	B-cell_line
MDM	MDM	NN	I-NP	I-cell_line
.	.	.	O	O

Using	Use	VBG	B-VP	O
MonoMac6	MonoMac6	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
we	we	PRP	B-NP	O
observed	observe	VBD	B-VP	O
high	high	JJ	B-NP	O
C/EBPbeta	C/EBPbeta	NN	I-NP	B-protein
and	and	CC	O	O
AP-1	AP-1	NN	B-NP	B-protein
but	but	CC	O	O
weaker	weak	JJR	B-NP	O
and	and	CC	I-NP	O
transient	transient	JJ	I-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
MB	MB	NN	B-NP	B-protein
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
truncated	truncate	VBN	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
C/EBPbeta	C/EBPbeta	NN	B-NP	B-protein
,	,	,	O	O
known	know	VBN	B-VP	O
to	to	TO	I-VP	O
repress	repress	VB	I-VP	O
HIV-1	HIV-1	NN	B-NP	O
transcription	transcription	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
extracts	extract	NNS	B-NP	O
from	from	IN	B-PP	O
MB-treated	MB-treated	JJ	B-NP	B-cell_line
THP-1	THP-1	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Surprisingly	Surprisingly	RB	B-ADVP	O
,	,	,	O	O
neither	neither	CC	O	O
MB	MB	NN	B-NP	B-protein
nor	nor	CC	I-NP	O
MDP	MDP	NN	I-NP	O
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
transduce	transduce	VB	I-VP	O
signals	signal	NNS	B-NP	O
via	via	IN	B-PP	O
CD14	CD14	NN	B-NP	B-protein
and	and	CC	I-NP	O
TLR2	TLR2	NN	I-NP	B-protein
or	or	CC	O	O
4	4	CD	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
present	present	VBP	B-VP	O
major	major	JJ	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
process	process	NN	I-NP	O
between	between	IN	B-PP	O
LPS	LPS	NN	B-NP	O
and	and	CC	I-NP	O
muramyl	muramyl	NN	I-NP	O
peptides	peptide	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
strongly	strongly	RB	B-VP	O
argue	argue	VBP	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
implication	implication	NN	I-NP	O
of	of	IN	B-PP	O
co-receptors	co-receptor	NNS	B-NP	B-protein
other	other	JJ	B-ADJP	O
than	than	IN	B-PP	O
TLR2	TLR2	NN	B-NP	B-protein
and	and	CC	I-NP	O
TLR4	TLR4	NN	I-NP	B-protein
in	in	IN	B-PP	O
mediating	mediate	VBG	B-VP	O
the	the	DT	B-NP	O
signaling	signaling	NN	I-NP	O
events	event	NNS	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
defined	define	VBN	B-NP	O
subunits	subunit	NNS	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
peptidoglycans	peptidoglycan	NNS	I-NP	O
.	.	.	O	O

Nuclear	Nuclear	JJ	B-NP	B-protein
peroxisome	peroxisome	NN	I-NP	I-protein
proliferator-activated	proliferator-activated	JJ	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
and	and	CC	I-NP	O
gamma	gamma	NN	I-NP	O
have	have	VBP	B-VP	O
opposing	oppose	VBG	I-VP	O
effects	effect	NNS	B-NP	O
on	on	IN	B-PP	O
monocyte	monocyte	NN	B-NP	O
chemotaxis	chemotaxis	NN	I-NP	O
in	in	IN	B-PP	O
endometriosis	endometriosis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
peroxisome	peroxisome	NN	I-NP	B-protein
proliferator-activated	proliferator-activated	JJ	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
(	(	(	O	O
PPARs	PPAR	NNS	B-NP	B-protein
)	)	)	O	O
alpha	alpha	NN	B-NP	O
and	and	CC	O	O
gamma	gamma	NN	B-NP	O
are	be	VBP	B-VP	O
nuclear	nuclear	JJ	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
play	play	VBP	B-VP	O
important	important	JJ	B-NP	O
roles	role	NNS	I-NP	O
in	in	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
like	like	IN	B-PP	O
ulcerative	ulcerative	JJ	B-NP	O
colitis	colitis	NN	I-NP	O
and	and	CC	I-NP	O
arthritis	arthritis	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
PPARs	PPAR	NNS	B-NP	B-protein
in	in	IN	B-PP	O
macrophage	macrophage	NN	B-NP	O
attraction	attraction	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
peritoneal	peritoneal	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
endometriosis	endometriosis	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
identified	identify	VBD	B-VP	O
PPAR-alpha	PPAR-alpha	NN	B-NP	B-protein
and	and	CC	I-NP	O
-gamma	-gamma	NN	I-NP	B-RNA
messenger	messenger	NN	I-NP	I-RNA
RNA	RNA	NN	I-NP	I-RNA
by	by	IN	B-PP	O
RT-PCR	RT-PCR	NN	B-NP	O
and	and	CC	I-NP	O
protein	protein	NN	I-NP	O
by	by	IN	B-PP	O
immunoblotting	immunoblotting	NN	B-NP	O
of	of	IN	B-PP	O
lysates	lysate	NNS	B-NP	O
of	of	IN	B-PP	O
peritoneal	peritoneal	JJ	B-NP	B-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
and	and	CC	O	O
monocytic	monocytic	JJ	B-NP	B-cell_line
U937	U937	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Using	Use	VBG	B-VP	O
immunocytochemistry	immunocytochemistry	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
localized	localize	VBD	B-VP	O
PPAR-alpha	PPAR-alpha	NN	B-NP	B-protein
and	and	CC	I-NP	O
-gamma	-gamma	NN	I-NP	B-protein
within	within	IN	B-PP	O
the	the	DT	B-NP	O
nuclei	nucleus	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
.	.	.	O	O

Monocyte	Monocyte	NN	B-NP	O
chemotactic	chemotactic	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
peritoneal	peritoneal	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
endometriosis	endometriosis	NN	B-NP	O
was	be	VBD	B-VP	O
quantified	quantify	VBN	I-VP	O
in	in	IN	B-PP	O
Boyden	Boyden	NNP	B-NP	O
chambers	chamber	NNS	I-NP	O
.	.	.	O	O

Migration	Migration	NN	B-NP	O
of	of	IN	B-PP	O
U937	U937	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
by	by	IN	B-PP	O
WY	WY	NN	B-NP	O
14643	14643	CD	I-NP	O
and	and	CC	O	O
reduced	reduce	VBN	B-VP	O
by	by	IN	B-PP	O
rosiglitazone	rosiglitazone	NN	B-NP	O
.	.	.	O	O

Peritoneal	Peritoneal	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
endometriosis	endometriosis	NN	B-NP	O
activated	activated	JJ	I-NP	O
U937	U937	NN	I-NP	O
cells	cell	NNS	I-NP	O
transiently	transiently	RB	B-VP	O
transfected	transfecte	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
PPAR-alpha/GAL4	PPAR-alpha/GAL4	NN	I-NP	B-DNA
luciferase	luciferase	NN	I-NP	I-DNA
reporter	reporter	NN	I-NP	I-DNA
.	.	.	O	O

By	By	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
peritoneal	peritoneal	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
cause	cause	VB	I-VP	O
significant	significant	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
PPAR-gamma/GAL4	PPAR-gamma/GAL4	NN	B-NP	B-DNA
constructs	construct	NNS	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
U937	U937	NN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
transiently	transiently	RB	B-VP	O
transfected	transfecte	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
PPAR	PPAR	NN	I-NP	B-DNA
response	response	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
luciferase	luciferase	NN	I-NP	I-DNA
reporter	reporter	NN	I-NP	I-DNA
showed	show	VBD	B-VP	O
disease	disease	NN	B-NP	O
stage-dependent	stage-dependent	JJ	I-NP	O
up-regulation	up-regulation	NN	I-NP	O
when	when	WRB	B-ADVP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
peritoneal	peritoneal	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
endometriosis	endometriosis	NN	B-NP	O
.	.	.	O	O

Treatment	Treatment	NN	B-NP	O
with	with	IN	B-PP	O
peritoneal	peritoneal	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
from	from	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
controls	control	NNS	I-NP	O
down-regulated	down-regulate	VBD	B-VP	O
PPAR	PPAR	NN	B-NP	B-DNA
response	response	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
transactivation	transactivation	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
peritoneal	peritoneal	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
of	of	IN	B-PP	O
endometriosis	endometriosis	NN	B-NP	O
patients	patient	NNS	I-NP	O
contains	contain	VBZ	B-VP	O
activators	activator	NNS	B-NP	O
of	of	IN	B-PP	O
PPAR-alpha	PPAR-alpha	NN	B-NP	B-protein
that	that	WDT	B-NP	O
stimulate	stimulate	VBP	B-VP	O
macrophage	macrophage	NN	B-NP	O
chemotaxis	chemotaxis	NN	I-NP	O
.	.	.	O	O

Inhibitors	Inhibitor	NNS	B-NP	O
of	of	IN	B-PP	O
PPAR-alpha	PPAR-alpha	NN	B-NP	B-protein
or	or	CC	I-NP	O
activators	activator	NNS	I-NP	O
of	of	IN	B-PP	O
PPAR-gamma	PPAR-gamma	NN	B-NP	B-protein
could	could	MD	B-VP	O
be	be	VB	I-VP	O
developed	develop	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
inflammation	inflammation	NN	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
endometriosis	endometriosis	NN	B-NP	O
.	.	.	O	O

Long-term-impaired	Long-term-impaired	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor-kappa	factor-kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
and	and	CC	O	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
in	in	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
trauma	trauma	NN	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Nuclear	Nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	I-protein
NF	NF	NN	B-NP	I-protein
)	)	)	O	I-protein
-kappa	-kappa	NN	B-NP	I-protein
B	B	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
dimer	dimer	NN	B-NP	O
characteristics	characteristic	NNS	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
PBMCs	PBMC	NNS	B-NP	B-cell_type
)	)	)	O	O
of	of	IN	B-PP	O
major-trauma	major-trauma	NN	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
healthy	healthy	JJ	B-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
PBMCs	PBMC	NNS	B-NP	B-cell_type
on	on	IN	B-PP	O
days	day	NNS	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
3	3	CD	I-NP	O
,	,	,	I-NP	O
5	5	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
10	10	CD	B-NP	O
after	after	IN	B-SBAR	O
trauma	trauma	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
p65p50	p65p50	NN	I-NP	B-protein
heterodimers	heterodimer	NNS	I-NP	I-protein
and	and	CC	O	O
p50p50	p50p50	NN	B-NP	B-protein
homodimers	homodimer	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
controls	control	NNS	B-NP	O
.	.	.	O	O

In	In	FW	B-NP	O
vitro	vitro	FW	I-NP	O
lipopolysaccharide	lipopolysaccharide	NN	I-NP	O
(	(	(	O	O
LPS	LPS	NN	B-NP	O
)	)	)	O	O
stimulation	stimulation	NN	B-NP	O
of	of	IN	B-PP	O
PBMCs	PBMC	NNS	B-NP	B-cell_type
induced	induce	VBD	B-VP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
translocation	translocation	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
survey	survey	NN	I-NP	O
,	,	,	O	O
p65p50	p65p50	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
remained	remain	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
in	in	IN	B-PP	O
trauma	trauma	NN	B-NP	O
patients	patient	NNS	I-NP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
controls	control	NNS	B-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
LPS	LPS	NN	B-NP	O
stimulation	stimulation	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
p65p50/p50p50	p65p50/p50p50	NN	I-NP	B-protein
ratio	ratio	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
in	in	IN	B-PP	O
PBMCs	PBMC	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
trauma	trauma	NN	B-NP	O
patients	patient	NNS	I-NP	O
than	than	IN	B-PP	O
from	from	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ex	ex	FW	I-NP	O
vivo	vivo	FW	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
was	be	VBD	B-VP	O
higher	high	JJR	B-ADJP	O
in	in	IN	B-PP	O
PBMCs	PBMC	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
controls	control	NNS	B-NP	O
than	than	IN	B-PP	O
of	of	IN	B-PP	O
trauma	trauma	NN	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

LPS	LPS	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
induce	induce	VB	I-VP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
PBMCs	PBMC	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
trauma	trauma	NN	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
strong	strong	JJ	B-NP	O
induction	induction	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
with	with	IN	B-PP	O
staphylococci	staphylococci	NNS	B-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
defect	defect	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
universal	universal	JJ	B-ADJP	O
and	and	CC	O	O
depends	depend	VBZ	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
nature	nature	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
activating	activate	VBG	I-NP	O
signal	signal	NN	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
no	no	DT	B-NP	O
direct	direct	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
interleukin-10	interleukin-10	NN	B-NP	B-protein
or	or	CC	O	O
transforming	transform	VBG	B-NP	B-protein
growth	growth	NN	I-NP	I-protein
factor-beta	factor-beta	NN	I-NP	I-protein
and	and	CC	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
,	,	,	O	O
these	these	DT	B-NP	O
immunosuppressive	immunosuppressive	JJ	I-NP	B-protein
cytokines	cytokine	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
elevated	elevate	VBN	I-VP	O
in	in	IN	B-PP	O
trauma	trauma	NN	B-NP	O
patients	patient	NNS	I-NP	O
by	by	IN	B-PP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
long-term	long-term	JJ	I-NP	O
low-basal	low-basal	JJ	I-NP	O
and	and	CC	I-NP	O
LPS-induced	LPS-induced	JJ	I-NP	O
nuclear	nuclear	JJ	I-NP	O
translocation	translocation	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
recalled	recall	VBD	B-VP	O
long-term	long-term	JJ	B-NP	O
immunoparalysis	immunoparalysis	NN	I-NP	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
stress	stress	NN	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
trauma	trauma	NN	B-NP	O
.	.	.	O	O

Hepatic	Hepatic	JJ	B-NP	O
ischemia-reperfusion	ischemia-reperfusion	NN	I-NP	O
injury	injury	NN	I-NP	O
.	.	.	O	O

BACKGROUND	BACKGROUND	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
morbidity	morbidity	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
liver	liver	NN	B-NP	O
transplantation	transplantation	NN	I-NP	O
and	and	CC	O	O
major	major	JJ	B-NP	O
hepatic	hepatic	JJ	I-NP	O
resections	resection	NNS	I-NP	O
is	be	VBZ	B-VP	O
partly	partly	RB	B-ADVP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
ischemia-reperfusion	ischemia-reperfusion	NN	B-NP	O
injury	injury	NN	I-NP	O
.	.	.	O	O

DATA	DATA	NN	B-NP	O
SOURCES	SOURCES	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
entire	entire	JJ	I-NP	O
world	world	NN	I-NP	O
literature	literature	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
subject	subject	NN	I-NP	O
was	be	VBD	B-VP	O
searched	search	VBN	I-VP	O
via	via	IN	B-PP	O
Medline	Medline	NN	B-NP	O
.	.	.	O	O

Keywords	Keyword	NNS	B-NP	O
included	include	VBD	B-VP	O
reperfusion	reperfusion	NN	B-NP	O
injury	injury	NN	I-NP	O
,	,	,	O	O
transplantation	transplantation	NN	B-NP	O
,	,	,	O	O
liver	liver	NN	B-NP	O
resection	resection	NN	I-NP	O
,	,	,	O	O
nitric	nitric	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
,	,	,	O	O
endothelin	endothelin	NN	B-NP	B-protein
,	,	,	O	O
cytokines	cytokine	NNS	B-NP	B-protein
,	,	,	O	O
Kupffer	Kupffer	NNP	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
ischemic/ischaemic	ischemic/ischaemic	JJ	B-NP	O
preconditioning	preconditioning	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	B-protein
factor-kappa	factor-kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
.	.	.	O	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
An	An	DT	B-NP	O
imbalance	imbalance	NN	I-NP	O
between	between	IN	B-PP	O
endothelin	endothelin	NN	B-NP	B-protein
and	and	CC	O	O
nitric	nitric	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
levels	level	NNS	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
failure	failure	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hepatic	hepatic	JJ	I-NP	O
microcirculation	microcirculation	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
reperfusion	reperfusion	NN	B-NP	O
.	.	.	O	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor-kappa	factor-kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
promotes	promote	VBZ	B-VP	O
proinflammatory	proinflammatory	JJ	B-NP	B-protein
cytokine	cytokine	NN	I-NP	I-protein
and	and	CC	I-NP	O
adhesion	adhesion	NN	I-NP	B-protein
molecule	molecule	NN	I-NP	I-protein
synthesis	synthesis	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
result	result	VBP	B-VP	O
in	in	IN	B-PP	O
oxygen-derived	oxygen-derived	JJ	B-NP	O
free	free	JJ	I-NP	O
radical	radical	NN	I-NP	O
production	production	NN	I-NP	O
and	and	CC	I-NP	O
neutrophil	neutrophil	NN	I-NP	B-cell_type
recruitment	recruitment	NN	I-NP	O
,	,	,	O	O
further	further	RB	B-VP	O
contributing	contribute	VBG	I-VP	O
to	to	TO	B-PP	O
cellular	cellular	JJ	B-NP	O
injury	injury	NN	I-NP	O
.	.	.	O	O

Various	Various	JJ	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
modalities	modality	NNS	I-NP	O
acting	act	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
above	above	JJ	I-NP	O
mediators	mediator	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
successfully	successfully	RB	I-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
attenuate	attenuate	VB	I-VP	O
reperfusion	reperfusion	NN	B-NP	O
injury	injury	NN	I-NP	O
in	in	IN	B-PP	O
animal	animal	NN	B-NP	O
models	model	NNS	I-NP	O
of	of	IN	B-PP	O
hepatic	hepatic	JJ	B-NP	O
transplantation	transplantation	NN	I-NP	O
and	and	CC	I-NP	O
resection	resection	NN	I-NP	O
.	.	.	O	O

Application	Application	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
knowledge	knowledge	NN	I-NP	O
gained	gain	VBN	B-VP	O
from	from	IN	B-PP	O
animal	animal	NN	B-NP	O
models	model	NNS	I-NP	O
of	of	IN	B-PP	O
hepatic	hepatic	JJ	B-NP	O
ischemia-reperfusion	ischemia-reperfusion	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
setting	setting	NN	I-NP	O
will	will	MD	B-VP	O
improve	improve	VB	I-VP	O
the	the	DT	B-NP	O
outcome	outcome	NN	I-NP	O
of	of	IN	B-PP	O
hepatic	hepatic	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

Down-regulation	Down-regulation	NN	B-NP	O
of	of	IN	B-PP	O
IL-12	IL-12	NN	B-NP	B-DNA
p40	p40	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
in	in	IN	B-PP	O
Plasmodium	Plasmodium	NN	B-NP	O
berghei-infected	berghei-infected	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
analyzed	analyze	VBD	B-VP	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
that	that	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
suppression	suppression	NN	B-NP	O
of	of	IN	B-PP	O
IL-12	IL-12	NN	B-NP	B-protein
p40	p40	NN	I-NP	O
gene	gene	NN	I-NP	O
induction	induction	NN	I-NP	O
during	during	IN	B-PP	O
Plasmodium	Plasmodium	NNP	B-NP	O
berghei	berghei	NNP	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
IL-12	IL-12	NN	B-NP	B-protein
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
plays	play	VBZ	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
protection	protection	NN	B-NP	O
against	against	IN	B-PP	O
pathogenic	pathogenic	JJ	B-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
IL-12	IL-12	NN	I-NP	B-protein
p70	p70	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
production	production	NN	I-NP	O
of	of	IN	B-PP	O
infected	infected	JJ	B-NP	B-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
lower	low	JJR	B-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
uninfected	uninfected	JJ	I-NP	B-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
showed	show	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
IL-12	IL-12	NN	B-NP	B-protein
p40	p40	NN	I-NP	O
gene	gene	NN	I-NP	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
IL-12	IL-12	NN	B-NP	B-protein
p35	p35	NN	I-NP	O
gene	gene	NN	I-NP	O
in	in	IN	B-PP	O
macrophages	macrophage	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
berghei-infected	berghei-infected	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
was	be	VBD	B-VP	O
profoundly	profoundly	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
was	be	VBD	B-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
interaction	interaction	NN	B-NP	O
with	with	IN	B-PP	O
macrophages	macrophage	NNS	B-NP	B-cell_type
that	that	WDT	B-NP	O
had	have	VBD	B-VP	O
contacted	contact	VBN	I-VP	O
with	with	IN	B-PP	O
P.	P.	NN	B-NP	B-cell_type
berghei-infected	berghei-infected	JJ	I-NP	I-cell_type
erythrocytes	erythrocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
was	be	VBD	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
soluble	soluble	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
IL-10	IL-10	NN	B-NP	B-protein
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
comparable	comparable	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
in	in	IN	B-PP	O
uninfected	uninfected	JJ	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
infected	infected	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
IFN-regulatory	IFN-regulatory	JJ	B-NP	B-DNA
factor-1	factor-1	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
comparable	comparable	JJ	B-ADJP	O
in	in	IN	B-PP	O
transcription	transcription	NN	B-NP	O
level	level	NN	I-NP	O
in	in	IN	B-PP	O
uninfected	uninfected	JJ	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
infected	infected	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
unidentified	unidentified	JJ	I-NP	O
complex	complex	NN	I-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
IFN-regulatory	IFN-regulatory	JJ	B-NP	B-protein
factor-1	factor-1	NN	I-NP	I-protein
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
infected	infected	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-12	IL-12	NN	I-NP	B-protein
p40	p40	NN	I-NP	O
gene	gene	NN	I-NP	O
induction	induction	NN	I-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
regulated	regulate	VBN	I-VP	O
at	at	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Friend	Friend	NN	I-NP	O
of	of	IN	B-PP	O
GATA	GATA	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
U-shaped	U-shaped	JJ	B-ADJP	O
,	,	,	O	O
FOG-1	FOG-1	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
FOG-2	FOG-2	NN	B-NP	B-protein
function	function	NN	I-NP	O
as	as	IN	B-PP	O
negative	negative	JJ	B-NP	O
regulators	regulator	NNS	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
eye	eye	NN	B-NP	O
development	development	NN	I-NP	O
in	in	IN	B-PP	O
Drosophila	Drosophila	NNP	B-NP	O
.	.	.	O	O

Friend	Friend	NN	B-NP	O
of	of	IN	B-PP	O
GATA	GATA	NN	B-NP	B-protein
(	(	(	O	I-protein
FOG	FOG	NN	B-NP	I-protein
)	)	)	O	I-protein
proteins	protein	NNS	B-NP	I-protein
regulate	regulate	VBP	B-VP	O
GATA	GATA	NN	B-NP	B-DNA
factor-activated	factor-activated	JJ	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
transcription	transcription	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
vertebrate	vertebrate	NN	B-NP	O
hematopoiesis	hematopoiesis	NN	I-NP	O
,	,	,	O	O
FOG	FOG	NN	B-NP	B-protein
and	and	CC	I-NP	O
GATA	GATA	NN	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
cooperate	cooperate	VBP	B-VP	O
to	to	TO	I-VP	O
promote	promote	VB	I-VP	O
erythrocyte	erythrocyte	NN	B-NP	B-cell_type
and	and	CC	I-NP	O
megakaryocyte	megakaryocyte	NN	I-NP	O
differentiation	differentiation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Drosophila	Drosophila	NNP	I-NP	O
FOG	FOG	NN	I-NP	O
homologue	homologue	NN	I-NP	O
U-shaped	U-shaped	JJ	B-ADJP	O
(	(	(	O	O
Ush	Ush	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
similarly	similarly	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
anlage	anlage	NN	I-NP	O
during	during	IN	B-PP	O
embryogenesis	embryogenesis	NN	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
hematopoiesis	hematopoiesis	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
acute	acute	JJ	I-NP	O
myeloid	myeloid	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
1	1	CD	I-NP	O
homologue	homologue	NN	I-NP	O
Lozenge	Lozenge	NN	I-NP	O
and	and	CC	O	O
Glial	Glial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
missing	miss	VBG	B-VP	O
are	be	VBP	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
crystal	crystal	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
plasmatocytes	plasmatocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
additional	additional	JJ	B-NP	O
factors	factor	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
predicted	predict	VBN	I-VP	O
to	to	TO	I-VP	O
control	control	VB	I-VP	O
crystal	crystal	JJ	B-NP	O
cell	cell	NN	I-NP	O
proliferation	proliferation	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
Ush	Ush	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
hemocyte	hemocyte	NN	B-NP	B-cell_type
precursors	precursor	NNS	I-NP	I-cell_type
and	and	CC	I-NP	O
plasmatocytes	plasmatocyte	NNS	I-NP	B-cell_type
throughout	throughout	IN	B-PP	O
embryogenesis	embryogenesis	NN	B-NP	O
and	and	CC	O	O
larval	larval	JJ	B-NP	O
development	development	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
GATA	GATA	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
Serpent	Serpent	NN	I-NP	O
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
Ush	Ush	NNP	B-NP	O
embryonic	embryonic	JJ	I-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
ush	ush	JJ	B-NP	O
function	function	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
overproduction	overproduction	NN	I-NP	O
of	of	IN	B-PP	O
crystal	crystal	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
whereas	whereas	IN	O	O
forced	force	VBN	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
Ush	Ush	NNP	B-NP	O
reduces	reduce	VBZ	B-VP	O
this	this	DT	B-NP	O
cell	cell	NN	I-NP	O
population	population	NN	I-NP	O
.	.	.	O	O

Murine	Murine	JJ	B-NP	B-protein
FOG-1	FOG-1	NN	I-NP	I-protein
and	and	CC	I-NP	O
FOG-2	FOG-2	NN	I-NP	B-protein
also	also	RB	B-ADVP	O
can	can	MD	B-VP	O
repress	repress	VB	I-VP	O
crystal	crystal	JJ	B-NP	O
cell	cell	NN	I-NP	O
production	production	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
a	a	DT	B-NP	O
mutant	mutant	JJ	I-NP	O
version	version	NN	I-NP	O
of	of	IN	B-PP	O
FOG-2	FOG-2	NN	B-NP	B-protein
lacking	lack	VBG	B-VP	O
a	a	DT	B-NP	O
conserved	conserve	VBN	I-NP	B-DNA
motif	motif	NN	I-NP	I-DNA
that	that	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
the	the	DT	B-NP	O
corepressor	corepressor	NN	I-NP	B-protein
C-terminal	C-terminal	JJ	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
fails	fail	VBZ	B-VP	O
to	to	TO	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	B-cell_type
lineage	lineage	NN	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
GATA	GATA	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
Pannier	Pannier	NN	I-NP	O
(	(	(	O	O
Pnr	Pnr	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
eye	eye	NN	B-NP	O
and	and	CC	I-NP	O
heart	heart	NN	I-NP	O
development	development	NN	I-NP	O
in	in	IN	B-PP	O
Drosophila	Drosophila	NNP	B-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
Ush	Ush	NN	B-NP	B-protein
,	,	,	O	O
FOG-1	FOG-1	NN	B-NP	B-protein
,	,	,	O	O
FOG-2	FOG-2	NN	B-NP	B-protein
,	,	,	O	O
or	or	CC	O	O
mutant	mutant	JJ	B-NP	O
FOG-2	FOG-2	NN	I-NP	O
is	be	VBZ	B-VP	O
coexpressed	coexpresse	VBN	I-VP	O
with	with	IN	B-PP	O
Pnr	Pnr	NN	B-NP	B-protein
during	during	IN	B-PP	O
these	these	DT	B-NP	O
developmental	developmental	JJ	I-NP	O
processes	process	NNS	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
eye	eye	NN	I-NP	O
and	and	CC	I-NP	O
heart	heart	NN	I-NP	O
phenotypes	phenotype	NNS	I-NP	O
result	result	VBP	B-VP	O
,	,	,	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
negative	negative	JJ	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
Pnr	Pnr	NN	B-NP	B-protein
function	function	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
fly	fly	NN	I-NP	B-protein
and	and	CC	I-NP	I-protein
mouse	mouse	NN	I-NP	I-protein
FOG	FOG	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
function	function	VBP	B-VP	O
similarly	similarly	RB	B-ADVP	O
in	in	IN	B-PP	O
three	three	CD	B-NP	O
distinct	distinct	JJ	I-NP	O
cellular	cellular	JJ	I-NP	O
contexts	context	NNS	I-NP	O
in	in	IN	B-PP	O
Drosophila	Drosophila	NNP	B-NP	O
,	,	,	O	O
but	but	CC	O	O
may	may	MD	B-VP	O
use	use	VB	I-VP	O
different	different	JJ	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
to	to	TO	B-VP	O
regulate	regulate	VB	I-VP	O
genetic	genetic	JJ	B-NP	O
events	event	NNS	I-NP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
vs	v	NNS	I-NP	O
.	.	.	O	O
cardial	cardial	JJ	B-NP	B-cell_type
or	or	CC	I-NP	I-cell_type
eye	eye	NN	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
lineages	lineage	NNS	I-NP	I-cell_type

The	The	DT	B-NP	O
RING	RING	NN	I-NP	B-protein
finger	finger	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
Siah-1	Siah-1	NN	I-NP	O
regulates	regulate	VBZ	B-VP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
coactivator	coactivator	NN	I-NP	O
OBF-1	OBF-1	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
coactivator	coactivator	NN	I-NP	O
OBF-1	OBF-1	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
interacts	interact	VBZ	B-VP	O
with	with	IN	B-PP	O
Oct-1	Oct-1	NN	B-NP	B-protein
and	and	CC	I-NP	O
Oct-2	Oct-2	NN	I-NP	B-protein
and	and	CC	O	O
the	the	DT	B-NP	O
octamer	octamer	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
DNA	DNA	NN	I-NP	I-DNA
,	,	,	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
critical	critical	JJ	B-ADJP	O
for	for	IN	B-PP	O
development	development	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
germinal	germinal	JJ	B-NP	O
centers	center	NNS	I-NP	O
in	in	IN	B-PP	O
secondary	secondary	JJ	B-NP	O
lymphoid	lymphoid	JJ	I-NP	O
organs	organ	NNS	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
identified	identify	VBN	I-VP	O
the	the	DT	B-NP	O
RING	RING	NN	I-NP	B-protein
finger	finger	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
Siah-1	Siah-1	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
interacting	interact	VBG	B-VP	O
specifically	specifically	RB	B-ADVP	O
with	with	IN	B-PP	O
OBF-1	OBF-1	NN	B-NP	B-protein
.	.	.	O	O

This	This	DT	B-NP	O
interaction	interaction	NN	I-NP	O
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
C-terminal	C-terminal	JJ	I-NP	B-protein
part	part	NN	I-NP	I-protein
of	of	IN	B-PP	O
Siah-1	Siah-1	NN	B-NP	B-protein
and	and	CC	B-PP	O
by	by	IN	B-PP	O
residues	residue	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
N-terminus	N-terminus	NN	I-NP	B-protein
of	of	IN	B-PP	O
OBF-1	OBF-1	NN	B-NP	B-protein
,	,	,	O	O
partly	partly	RB	B-ADJP	O
distinct	distinct	JJ	I-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
residues	residue	NNS	I-NP	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
formation	formation	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
complex	complex	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Oct	Oct	NN	I-NP	B-protein
POU	POU	NN	I-NP	I-protein
domains	domain	NNS	I-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
.	.	.	O	O

Interaction	Interaction	NN	B-NP	O
between	between	IN	B-PP	O
Siah-1	Siah-1	NN	B-NP	B-protein
and	and	CC	I-NP	O
OBF-1	OBF-1	NN	I-NP	B-protein
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
downregulation	downregulation	NN	B-NP	O
of	of	IN	B-PP	O
OBF-1	OBF-1	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
level	level	NN	I-NP	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
mRNA	mRNA	NN	B-NP	B-RNA
,	,	,	O	O
and	and	CC	O	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
corresponding	corresponding	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
octamer	octamer	NN	B-NP	O
site-dependent	site-dependent	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ubiquitin-proteasome	ubiquitin-proteasome	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
elevated	elevate	VBN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
OBF-1	OBF-1	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
immunized	immunize	VBN	B-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
OBF-1	OBF-1	NN	B-NP	B-protein
protein	protein	NN	I-NP	O
amounts	amount	NNS	I-NP	O
are	be	VBP	B-VP	O
dramatically	dramatically	RB	I-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
activated	activate	VBN	I-NP	I-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
without	without	IN	B-PP	O
concomitant	concomitant	JJ	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
OBF-1	OBF-1	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
Siah-1	Siah-1	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
loop	loop	NN	I-NP	O
controlling	control	VBG	B-VP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
OBF-1	OBF-1	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
beta-catenin	beta-catenin	NN	I-NP	B-protein
--	--	:	O	O
TCF-1	TCF-1	NN	B-NP	B-protein
pathway	pathway	NN	I-NP	O
ensures	ensure	NNS	I-NP	O
CD4	CD4	NN	I-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
CD8	CD8	NN	B-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
thymocyte	thymocyte	NN	B-NP	O
survival	survival	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
trans-acting	trans-acting	JJ	B-NP	B-protein
T	T	NN	I-NP	I-protein
cell	cell	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
(	(	(	O	O
TCFs	TCF	NNS	B-NP	B-protein
)	)	)	O	O
or	or	CC	O	O
lymphoid	lymphoid	JJ	B-NP	B-protein
enhancer	enhancer	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
(	(	(	O	O
LEF-1	LEF-1	NN	B-NP	B-protein
)	)	)	O	O
with	with	IN	B-PP	O
their	their	PRP$	B-NP	O
coactivator	coactivator	NN	I-NP	B-protein
beta-catenin	beta-catenin	NN	I-NP	I-protein
mediates	mediate	VBZ	B-VP	O
transient	transient	JJ	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
extracellular	extracellular	JJ	B-NP	O
Wnt	Wnt	NN	I-NP	O
signals	signal	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
here	here	RB	B-ADVP	O
that	that	IN	B-SBAR	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
maturation	maturation	NN	I-NP	O
depends	depend	VBZ	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
beta-catenin	beta-catenin	NN	I-NP	B-protein
--	--	:	O	I-protein
binding	binding	NN	B-NP	I-protein
domain	domain	NN	I-NP	I-protein
in	in	IN	B-PP	O
TCF-1	TCF-1	NN	B-NP	B-protein
.	.	.	O	O

This	This	DT	B-NP	O
domain	domain	NN	I-NP	O
is	be	VBZ	B-VP	O
necessary	necessary	JJ	B-ADJP	O
to	to	TO	B-VP	O
mediate	mediate	VB	I-VP	O
the	the	DT	B-NP	O
survival	survival	NN	I-NP	O
of	of	IN	B-PP	O
immature	immature	JJ	B-NP	B-cell_type
CD4	CD4	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
CD8	CD8	NN	B-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
double-positive	double-positive	JJ	O	I-cell_type
(	(	(	O	I-cell_type
DP	DP	NN	B-NP	I-cell_type
)	)	)	O	I-cell_type
thymocytes	thymocyte	NNS	B-NP	I-cell_type
.	.	.	O	O

Accelerated	Accelerate	VBN	B-NP	O
spontaneous	spontaneous	JJ	I-NP	O
thymocyte	thymocyte	NN	I-NP	O
death	death	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
TCF-1	TCF-1	NN	B-NP	B-protein
correlates	correlate	VBZ	B-VP	O
with	with	IN	B-PP	O
aberrantly	aberrantly	RB	B-NP	O
low	low	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
anti-apoptotic	anti-apoptotic	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
Bcl-x	Bcl-x	NN	I-NP	B-protein
(	(	(	O	I-protein
L	L	NN	B-NP	I-protein
)	)	)	O	I-protein
.	.	.	O	O

Increasing	Increase	VBG	B-VP	O
anti-apoptotic	anti-apoptotic	JJ	B-NP	B-protein
effectors	effector	NNS	I-NP	I-protein
in	in	IN	B-PP	O
thymocytes	thymocyte	NNS	B-NP	B-cell_type
by	by	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
Bcl-2	Bcl-2	NN	I-NP	B-protein
transgene	transgene	NN	I-NP	O
rescued	rescue	VBD	B-VP	O
TCF-1-deficient	TCF-1-deficient	JJ	B-NP	B-cell_type
DP	DP	NN	I-NP	I-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
TCF-1	TCF-1	NN	B-NP	B-protein
,	,	,	O	O
upon	upon	IN	B-PP	O
association	association	NN	B-NP	O
with	with	IN	B-PP	O
beta-catenin	beta-catenin	NN	B-NP	B-protein
,	,	,	O	O
transiently	transiently	RB	B-ADVP	O
ensures	ensure	VBZ	B-VP	O
the	the	DT	B-NP	O
survival	survival	NN	I-NP	O
of	of	IN	B-PP	O
immature	immature	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
which	which	WDT	B-NP	O
enables	enable	VBZ	B-VP	O
them	them	PRP	B-NP	O
to	to	TO	B-VP	O
generate	generate	VB	I-VP	O
and	and	CC	I-VP	O
edit	edit	VB	I-VP	O
T	T	NN	B-NP	B-protein
cell	cell	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	I-protein
TCR	TCR	NN	B-NP	I-protein
)	)	)	O	I-protein
alpha	alpha	NN	B-NP	I-protein
chains	chain	NNS	I-NP	I-protein
and	and	CC	O	O
attempt	attempt	NN	B-NP	O
TCR	TCR	NN	I-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
positive	positive	JJ	I-NP	O
selection	selection	NN	I-NP	O
.	.	.	O	O

TRAIL/Apo2L	TRAIL/Apo2L	NN	B-NP	B-protein
ligand	ligand	NN	I-NP	I-protein
selectively	selectively	RB	B-ADVP	O
induces	induce	VBZ	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
and	and	CC	O	O
overcomes	overcome	VBZ	B-VP	O
drug	drug	NN	B-NP	O
resistance	resistance	NN	I-NP	O
in	in	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
myeloma	myeloma	NN	I-NP	O
:	:	:	O	O
therapeutic	therapeutic	JJ	B-NP	O
applications	application	NNS	I-NP	O
.	.	.	O	O

Multiple	Multiple	JJ	B-NP	O
myeloma	myeloma	NN	I-NP	O
(	(	(	O	O
MM	MM	NN	B-NP	O
)	)	)	O	O
remains	remain	VBZ	B-VP	O
incurable	incurable	JJ	B-NP	O
and	and	CC	I-NP	O
novel	novel	JJ	I-NP	O
treatments	treatment	NNS	I-NP	O
are	be	VBP	B-VP	O
urgently	urgently	RB	I-VP	O
needed	need	VBN	I-VP	O
.	.	.	O	O

Preclinical	Preclinical	JJ	B-ADJP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
evaluations	evaluation	NNS	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
potential	potential	JJ	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
applications	application	NNS	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-protein
recombinant	recombinant	JJ	I-NP	I-protein
tumor	tumor	NN	I-NP	I-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
TNF	TNF	NN	B-NP	B-protein
)	)	)	O	O
-related	-related	JJ	B-NP	O
apoptosis-inducing	apoptosis-inducing	JJ	I-NP	B-protein
ligand/Apo2	ligand/Apo2	NN	I-NP	I-protein
ligand	ligand	NN	I-NP	I-protein
(	(	(	O	O
TRAIL/Apo2L	TRAIL/Apo2L	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
MM	MM	NN	B-NP	O
.	.	.	O	O

TRAIL/Apo2L	TRAIL/Apo2L	NN	B-NP	O
potently	potently	RB	B-ADVP	O
induced	induce	VBD	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
of	of	IN	B-PP	O
MM	MM	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
MM	MM	NN	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
including	include	VBG	B-PP	O
cells	cell	NNS	B-NP	O
sensitive	sensitive	JJ	B-ADJP	O
or	or	CC	O	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
(	(	(	O	O
Dex	Dex	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
doxorubicin	doxorubicin	NN	B-NP	O
(	(	(	O	O
Dox	Dox	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
melphalan	melphalan	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
mitoxantrone	mitoxantrone	NN	B-NP	O
.	.	.	O	O

TRAIL/Apo2L	TRAIL/Apo2L	NN	B-NP	B-protein
also	also	RB	B-ADVP	O
overcame	overcome	VBD	B-VP	O
the	the	DT	B-NP	O
survival	survival	NN	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
interleukin	interleukin	NN	B-NP	B-protein
6	6	CD	I-NP	I-protein
on	on	IN	B-PP	O
MM	MM	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
survival	survival	NN	I-NP	O
of	of	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
and	and	CC	I-NP	I-cell_type
bone	bone	NN	I-NP	I-cell_type
marrow	marrow	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
purified	purify	VBN	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
donors	donor	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
status	status	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TRAIL	TRAIL	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
(	(	(	O	O
assessed	assess	VBN	B-VP	O
by	by	IN	B-PP	O
immunoblotting	immunoblotting	NN	B-NP	O
and	and	CC	I-NP	O
flow	flow	NN	I-NP	O
cytometry	cytometry	NN	I-NP	O
)	)	)	O	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
predict	predict	VB	I-VP	O
TRAIL	TRAIL	NN	B-NP	B-protein
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
MM	MM	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
anti-MM	anti-MM	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
TRAIL/Apo2L	TRAIL/Apo2L	NN	B-NP	B-protein
was	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
in	in	IN	B-PP	O
nu/xid/bg	nu/xid/bg	NN	B-NP	O
mice	mouse	NNS	I-NP	O
xenografted	xenografte	VBN	B-VP	O
with	with	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
MM	MM	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
;	;	:	O	O
TRAIL	TRAIL	NN	B-NP	B-protein
(	(	(	O	O
500	500	CD	B-NP	O
microg	microg	NN	I-NP	O
intraperitoneally	intraperitoneally	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
for	for	IN	B-PP	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
tolerated	tolerate	VBN	I-VP	O
and	and	CC	O	O
significantly	significantly	RB	B-VP	O
suppressed	suppress	VBD	I-VP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
plasmacytomas	plasmacytoma	NNS	B-NP	B-cell_type
.	.	.	O	O

Dox	Dox	NNP	B-NP	O
up-regulated	up-regulate	VBD	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TRAIL	TRAIL	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
death	death	NN	I-NP	O
receptor	receptor	NN	I-NP	O
5	5	CD	I-NP	O
(	(	(	O	O
DR5	DR5	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
synergistically	synergistically	RB	B-VP	O
enhanced	enhance	VBD	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
TRAIL	TRAIL	NN	B-NP	B-protein
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
against	against	IN	B-PP	O
MM	MM	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
,	,	,	O	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
against	against	IN	B-PP	O
those	those	DT	B-NP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
,	,	,	O	O
Dex-	Dex-	NN	B-NP	O
or	or	CC	O	O
Dox-induced	Dox-induced	JJ	B-NP	O
apoptosis	apoptosis	NN	I-NP	O
.	.	.	O	O

Nuclear	Nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	I-protein
NF	NF	NN	B-NP	I-protein
)	)	)	O	I-protein
-kappaB	-kappaB	NN	B-NP	I-protein
inhibitors	inhibitor	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
SN50	SN50	NN	B-NP	B-protein
(	(	(	O	O
a	a	DT	B-NP	O
cell-permeable	cell-permeable	JJ	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
translocation	translocation	NN	I-NP	O
and	and	CC	O	O
transcriptional	transcriptional	JJ	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
)	)	)	O	O
or	or	CC	O	O
the	the	DT	B-NP	O
proteasome	proteasome	NN	I-NP	B-protein
inhibitor	inhibitor	NN	I-NP	O
PS-341	PS-341	NN	I-NP	O
,	,	,	O	O
enhanced	enhance	VBD	B-VP	O
the	the	DT	B-NP	O
proapoptotic	proapoptotic	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
TRAIL/Apo2L	TRAIL/Apo2L	NN	B-NP	B-protein
against	against	IN	B-PP	O
TRAIL-sensitive	TRAIL-sensitive	JJ	B-NP	B-cell_line
MM	MM	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
whereas	whereas	IN	O	O
SN50	SN50	NN	B-NP	B-protein
reversed	reverse	VBD	B-VP	O
the	the	DT	B-NP	O
TRAIL	TRAIL	NN	I-NP	B-protein
resistance	resistance	NN	I-NP	O
of	of	IN	B-PP	O
ARH-77	ARH-77	NN	B-NP	B-protein
and	and	CC	I-NP	O
IM-9	IM-9	NN	I-NP	B-cell_line
MM	MM	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Importantly	Importantly	RB	B-ADVP	O
,	,	,	O	O
normal	normal	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
sensitized	sensitize	VBN	I-VP	O
to	to	TO	B-PP	O
TRAIL	TRAIL	NN	B-NP	B-protein
by	by	IN	B-PP	O
either	either	CC	O	O
Dox	Dox	NNP	B-NP	O
,	,	,	O	O
SN50	SN50	NN	B-NP	B-protein
,	,	,	O	O
or	or	CC	O	O
PS-341	PS-341	NN	B-NP	B-protein
.	.	.	O	O

These	These	DT	B-NP	O
preclinical	preclinical	JJ	I-NP	O
studies	study	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
TRAIL/Apo2L	TRAIL/Apo2L	NN	B-NP	B-protein
can	can	MD	B-VP	O
overcome	overcome	VB	I-VP	O
conventional	conventional	JJ	B-NP	O
drug	drug	NN	I-NP	O
resistance	resistance	NN	I-NP	O
and	and	CC	O	O
provide	provide	VBP	B-VP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
trials	trial	NNS	I-NP	O
of	of	IN	B-PP	O
TRAIL	TRAIL	NN	B-NP	B-protein
-based	-based	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
regimens	regimen	VBZ	B-VP	O
to	to	TO	I-VP	O
improve	improve	VB	I-VP	O
outcome	outcome	NN	B-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
MM	MM	NN	B-NP	O
.	.	.	O	O

(	(	(	O	O
Blood.	Blood.	NNP	B-NP	O
2001	2001	CD	I-NP	O
;	;	:	O	O
98	98	CD	B-NP	O
:	:	:	O	O
795-804	795-804	CD	B-NP	O
)	)	)	O	O

CD28	CD28	NN	B-NP	B-protein
costimulation	costimulation	NN	I-NP	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
IL-12	IL-12	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
to	to	TO	B-VP	O
render	render	VB	I-VP	O
janus	janus	NN	B-NP	O
kinases/STAT4	kinases/STAT4	NN	I-NP	O
responsive	responsive	JJ	B-ADJP	O
to	to	TO	B-PP	O
IL-12	IL-12	NN	B-NP	B-protein
stimulation	stimulation	NN	I-NP	O
in	in	IN	B-PP	O
TCR-triggered	TCR-triggered	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
resting	rest	VBG	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
for	for	IN	B-PP	O
the	the	DT	B-NP	O
acquisition	acquisition	NN	I-NP	O
of	of	IN	B-PP	O
various	various	JJ	B-NP	O
functions	function	NNS	I-NP	O
depends	depend	VBZ	B-VP	O
on	on	IN	B-PP	O
whether	whether	IN	B-SBAR	O
CD28	CD28	NN	B-NP	B-protein
costimulatory	costimulatory	JJ	I-NP	O
signals	signal	NNS	I-NP	O
are	be	VBP	B-VP	O
provided	provide	VBN	I-VP	O
upon	upon	IN	B-PP	O
T	T	NN	B-NP	B-protein
cell	cell	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
how	how	WRB	B-ADVP	O
CD28	CD28	NN	B-NP	B-protein
costimulation	costimulation	NN	I-NP	O
functions	function	VBZ	B-VP	O
to	to	TO	I-VP	O
allow	allow	VB	I-VP	O
TCR	TCR	NN	B-NP	B-protein
-triggered	-triggered	JJ	I-NP	O
resting	rest	VBG	I-NP	O
T	T	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-VP	O
acquire	acquire	VB	I-VP	O
IL-12	IL-12	NN	B-NP	B-protein
responsiveness	responsiveness	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
stimulated	stimulate	VBN	I-VP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
anti-CD3	anti-CD3	JJ	B-NP	B-protein
mAb	mAb	NN	I-NP	I-protein
,	,	,	O	O
CD28	CD28	NN	B-NP	B-protein
costimulation	costimulation	NN	I-NP	O
was	be	VBD	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
optimal	optimal	JJ	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
IL-12	IL-12	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
IL-12R	IL-12R	NN	B-NP	B-protein
)	)	)	O	O
expression	expression	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
stimulation	stimulation	NN	B-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
anti-CD3	anti-CD3	NN	B-NP	B-protein
alone	alone	RB	B-ADVP	O
induced	induce	VBD	B-VP	O
comparable	comparable	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
IL-12R	IL-12R	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
induced	induce	VBN	B-VP	O
upon	upon	IN	B-PP	O
CD28	CD28	NN	B-NP	B-protein
costimulation	costimulation	NN	I-NP	O
.	.	.	O	O

Nevertheless	Nevertheless	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
substantial	substantial	JJ	I-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
IL-12	IL-12	NN	B-NP	B-protein
responsiveness	responsiveness	NN	I-NP	O
between	between	IN	B-PP	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
groups	group	NNS	I-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
:	:	:	O	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
anti-CD28-costimulated	anti-CD28-costimulated	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
costimulated	costimulate	VBN	I-VP	O
with	with	IN	B-PP	O
anti-CD28	anti-CD28	NN	B-NP	B-protein
exhibited	exhibit	VBD	B-VP	O
decreased	decrease	VBN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
Janus	Janus	NN	B-NP	B-protein
kinases	kinase	NNS	I-NP	I-protein
(	(	(	O	O
JAK	JAK	NN	B-NP	B-protein
)	)	)	O	O
JAK2/TYK2	JAK2/TYK2	NN	B-NP	O
and	and	CC	I-NP	O
STAT4	STAT4	NN	I-NP	B-protein
phosphorylation	phosphorylation	NN	I-NP	O
and	and	CC	O	O
IFN-y	IFN-y	NN	B-NP	O
production	production	NN	I-NP	O
following	follow	VBG	B-PP	O
IL-12	IL-12	NN	B-NP	B-protein
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

Importantly	Importantly	RB	B-ADVP	O
,	,	,	O	O
STAT6	STAT6	NN	B-NP	B-protein
phosphorylation	phosphorylation	NN	I-NP	O
following	follow	VBG	B-PP	O
IL-4	IL-4	NN	B-NP	B-protein
stimulation	stimulation	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
in	in	IN	B-PP	O
anti-CD28-uncostimulated	anti-CD28-uncostimulated	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

These	These	DT	B-NP	O
resutls	resutl	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
CD28	CD28	NN	B-NP	B-protein
costimulation	costimulation	NN	I-NP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
contributes	contribute	VBZ	B-VP	O
to	to	TO	B-PP	O
up-regulating	up-regulate	VBG	B-VP	O
IL-12R	IL-12R	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
but	but	CC	O	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
required	require	VBN	I-VP	O
to	to	TO	I-VP	O
render	render	VB	I-VP	O
JAKs/STAT4	JAKs/STAT4	NN	B-NP	O
responsive	responsive	JJ	B-ADJP	O
to	to	TO	B-PP	O
IL-12	IL-12	NN	B-NP	B-protein
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

Constitutively	Constitutively	RB	B-NP	O
activated	activate	VBN	I-NP	O
Akt-1	Akt-1	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
vital	vital	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
survival	survival	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
monocyte-differentiated	monocyte-differentiated	JJ	I-NP	I-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
.	.	.	O	O

Role	Role	NN	B-NP	O
of	of	IN	B-PP	O
Mcl-1	Mcl-1	NN	B-NP	B-protein
,	,	,	O	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	I-protein
NF	NF	NN	B-NP	I-protein
)	)	)	O	I-protein
-kappaB	-kappaB	NN	B-NP	I-protein
,	,	,	O	O
Bad	Bad	NN	B-NP	B-protein
,	,	,	O	O
or	or	CC	O	O
caspase	caspase	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
data	datum	NNS	I-NP	O
from	from	IN	B-PP	O
mice	mouse	NNS	B-NP	O
deficient	deficient	JJ	B-ADJP	O
for	for	IN	B-PP	O
phosphatase	phosphatase	NN	B-NP	B-protein
and	and	CC	I-NP	O
tensin	tensin	NN	I-NP	O
homologue	homologue	NN	I-NP	O
deleted	delete	VBN	B-VP	O
from	from	IN	B-PP	O
chromosome	chromosome	NN	B-NP	B-DNA
10	10	CD	I-NP	I-DNA
or	or	CC	I-NP	O
src	src	NN	I-NP	B-protein
homology	homology	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
domain-containing	domain-containing	JJ	I-NP	I-protein
5	5	CD	I-NP	I-protein
'	'	SYM	I-NP	I-protein
inositol	inositol	NN	I-NP	I-protein
phosphatase	phosphatase	NN	I-NP	I-protein
,	,	,	O	O
phosphatases	phosphatas	NNS	B-NP	B-protein
that	that	WDT	B-NP	O
negatively	negatively	RB	B-ADVP	O
regulate	regulate	VBP	B-VP	O
the	the	DT	B-NP	O
phosphatidylinositol	phosphatidylinositol	NN	I-NP	B-protein
3-kinase	3-kinase	NN	I-NP	I-protein
(	(	(	O	O
PI3K	PI3K	NN	B-NP	B-protein
)	)	)	O	O
pathway	pathway	NN	B-NP	O
,	,	,	O	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
macrophages	macrophage	NNS	B-NP	B-cell_type
in	in	IN	B-PP	O
these	these	DT	B-NP	O
animals	animal	NNS	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
an	an	DT	B-NP	O
essential	essential	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
PI3K	PI3K	NN	I-NP	B-protein
pathway	pathway	NN	I-NP	O
for	for	IN	B-PP	O
macro-phage	macro-phage	NN	B-NP	O
survival	survival	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
focused	focus	VBD	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PI3K-regulated	PI3K-regulated	JJ	I-NP	B-protein
serine/threonine	serine/threonine	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
Akt-1	Akt-1	NN	I-NP	B-protein
in	in	IN	B-PP	O
modulating	modulate	VBG	B-VP	O
macrophage	macrophage	NN	B-NP	O
survival	survival	NN	I-NP	O
.	.	.	O	O

Akt-1	Akt-1	NN	B-NP	B-protein
was	be	VBD	B-VP	O
constitutively	constitutively	RB	I-VP	O
activated	activate	VBN	I-VP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
and	and	CC	O	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PI3K	PI3K	NN	I-NP	B-protein
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
LY294002	LY294002	NN	B-NP	O
,	,	,	O	O
suppressed	suppress	VBD	B-VP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
Akt-1	Akt-1	NN	B-NP	B-protein
and	and	CC	O	O
induced	induce	VBD	B-VP	O
cell	cell	NN	B-NP	O
death	death	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
suppression	suppression	NN	B-NP	O
of	of	IN	B-PP	O
Akt-1	Akt-1	NN	B-NP	B-protein
by	by	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
PI3K	PI3K	NN	B-NP	B-protein
or	or	CC	O	O
a	a	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
negative	negative	JJ	I-NP	O
(	(	(	O	O
DN	DN	JJ	B-ADJP	O
)	)	)	O	O
Akt-1	Akt-1	NN	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
mitochondrial	mitochondrial	JJ	B-NP	O
transmembrane	transmembrane	JJ	I-NP	O
potential	potential	NN	I-NP	O
,	,	,	O	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
caspases-9	caspases-9	NN	B-NP	B-protein
and	and	CC	O	I-protein
-3	-3	CD	B-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
DNA	DNA	NN	B-NP	O
fragmentation	fragmentation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
PI3K	PI3K	NN	B-NP	B-protein
inhibition	inhibition	NN	I-NP	O
were	be	VBD	B-VP	O
reversed	reverse	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
ectopic	ectopic	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
constitutively	constitutively	RB	B-NP	O
activated	activate	VBN	I-NP	O
Akt-1	Akt-1	NN	I-NP	B-protein
or	or	CC	I-NP	O
Bcl-x	Bcl-x	NN	I-NP	B-protein
(	(	(	O	I-protein
L	L	NN	B-NP	I-protein
)	)	)	O	I-protein
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
PI3K	PI3K	NN	B-NP	B-protein
/Akt-1	/Akt-1	NN	I-NP	B-protein
pathway	pathway	NN	I-NP	O
either	either	CC	B-PP	O
by	by	IN	B-PP	O
LY294002	LY294002	NN	B-NP	O
or	or	CC	I-NP	O
DN	DN	NN	I-NP	O
Akt-1	Akt-1	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
constitutive	constitutive	JJ	I-NP	O
or	or	CC	I-NP	O
inducible	inducible	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	I-protein
NF	NF	NN	B-NP	I-protein
)	)	)	O	I-protein
-kappaB	-kappaB	NN	B-NP	I-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
after	after	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PI3K	PI3K	NN	I-NP	B-protein
/	/	SYM	B-NP	O
Akt-1	Akt-1	NN	I-NP	B-protein
pathway	pathway	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
marked	marked	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
antiapoptotic	antiapoptotic	JJ	I-NP	B-protein
molecule	molecule	NN	I-NP	I-protein
Mcl-1	Mcl-1	NN	I-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
other	other	JJ	B-NP	O
Bcl-2	Bcl-2	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
members	member	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
Mcl-1	Mcl-1	NN	B-NP	B-protein
rescued	rescue	VBD	B-VP	O
macrophages	macrophage	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
LY294002-induced	LY294002-induced	JJ	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
death	death	NN	I-NP	O
.	.	.	O	O

Further	Further	RB	B-ADVP	O
,	,	,	O	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
Mcl-1	Mcl-1	NN	B-NP	B-protein
by	by	IN	B-PP	O
antisense	antisense	JJ	B-NP	O
oligonucleotides	oligonucleotide	NNS	I-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
macrophage	macrophage	NN	B-NP	B-cell_type
apoptosis	apoptosis	NN	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
our	our	PRP$	B-NP	O
findings	finding	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
constitutive	constitutive	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
Akt-1	Akt-1	NN	B-NP	B-protein
regulates	regulate	VBZ	B-VP	O
macrophage	macrophage	NN	B-NP	O
survival	survival	NN	I-NP	O
through	through	IN	B-PP	O
Mcl-1	Mcl-1	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
caspases	caspas	NNS	B-NP	B-protein
,	,	,	O	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
,	,	,	O	O
or	or	CC	O	O
Bad	Bad	NNP	B-NP	B-protein
.	.	.	O	O

GRbeta	GRbeta	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
nasal	nasal	JJ	B-NP	B-cell_type
polyp	polyp	NN	I-NP	I-cell_type
inflammatory	inflammatory	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
its	its	PRP$	B-NP	O
relationship	relationship	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
intranasal	intranasal	JJ	B-NP	O
fluticasone	fluticasone	NN	I-NP	O
.	.	.	O	O

BACKGROUND	BACKGROUND	NN	B-NP	O
:	:	:	O	O
Nasal	Nasal	JJ	B-NP	O
polyposis	polyposis	NN	I-NP	O
disease	disease	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
disorder	disorder	NN	I-NP	O
with	with	IN	B-PP	O
intense	intense	JJ	B-NP	O
eosinophilic	eosinophilic	JJ	I-NP	O
infiltration	infiltration	NN	I-NP	O
of	of	IN	B-PP	O
respiratory	respiratory	JJ	B-NP	O
mucosa	mucosa	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
often	often	RB	B-ADVP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
with	with	IN	B-PP	O
topical	topical	JJ	B-NP	O
steroids	steroid	NNS	I-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
splice	splice	NN	I-NP	O
variant	variant	JJ	I-NP	O
GRbeta	GRbeta	NN	I-NP	B-protein
in	in	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
might	might	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
steroid	steroid	NN	B-NP	O
insensitivity	insensitivity	NN	I-NP	O
in	in	IN	B-PP	O
diseases	disease	NNS	B-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
asthma	asthma	NN	B-NP	O
.	.	.	O	O

OBJECTIVE	OBJECTIVE	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
purposes	purpose	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
investigation	investigation	NN	I-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
nasal	nasal	JJ	B-NP	B-cell_type
polyp	polyp	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
NP	NP	NN	B-NP	I-cell_type
)	)	)	O	I-cell_type
inflammatory	inflammatory	JJ	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
overexpress	overexpres	VBP	B-VP	O
GRbeta	GRbeta	NN	B-NP	B-protein
and	and	CC	O	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
GRbeta	GRbeta	NN	B-NP	B-protein
overexpression	overexpression	NN	I-NP	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
insensitivity	insensitivity	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
potent	potent	JJ	I-NP	O
topical	topical	JJ	I-NP	O
steroid	steroid	NN	I-NP	O
fluticasone	fluticasone	NN	I-NP	O
propionate	propionate	NN	I-NP	O
(	(	(	O	O
FP	FP	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
Biopsies	Biopsy	NNS	B-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
10	10	CD	B-NP	O
subjects	subject	NNS	I-NP	O
with	with	IN	B-PP	O
NPs	NP	NNS	B-NP	B-protein
before	before	IN	B-PP	O
and	and	CC	B-NP	O
4	4	CD	I-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
intranasal	intranasal	JJ	B-NP	O
FP	FP	NN	I-NP	O
.	.	.	O	O

Middle	Middle	NNP	B-NP	O
turbinates	turbinate	VBZ	B-VP	O
biopsies	biopsy	NNS	B-NP	O
from	from	IN	B-PP	O
6	6	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
,	,	,	I-NP	O
nonallergic	nonallergic	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
served	serve	VBD	B-VP	O
as	as	IN	B-PP	O
normal	normal	JJ	B-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

Biopsies	Biopsy	NNS	B-NP	O
were	be	VBD	B-VP	O
immunostained	immunostaine	VBN	I-VP	O
for	for	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	B-protein
cell	cell	NN	I-NP	I-protein
markers	marker	NNS	I-NP	I-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
GRbeta	GRbeta	NN	B-NP	B-protein
and	and	CC	O	O
probed	probe	VBD	B-VP	O
for	for	IN	B-PP	O
various	various	JJ	B-NP	O
cytokine	cytokine	NN	I-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
.	.	.	O	O

The	The	DT	B-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
FP	FP	NN	B-NP	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
in	in	IN	B-PP	O
relation	relation	NN	B-NP	O
to	to	TO	B-PP	O
pretreatment	pretreatment	NN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
GRbeta	GRbeta	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
total	total	JJ	I-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
NPs	NP	NNS	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
percentage	percentage	NN	I-NP	O
of	of	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
expressing	express	VBG	B-VP	O
GRbeta	GRbeta	NN	B-NP	B-protein
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
increased	increase	VBN	I-VP	O
(	(	(	O	O
40.5	40.5	CD	B-NP	O
%	%	NN	I-NP	O
+/-	+/-	SYM	B-NP	O
19.2	19.2	CD	B-NP	O
%	%	NN	I-NP	O
vs	vs	IN	B-PP	O
16.1	16.1	CD	B-NP	O
%	%	NN	I-NP	O
+/-	+/-	SYM	B-NP	O
4.0	4.0	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
=.009	=.009	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

GRbeta	GRbeta	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
NPs	NP	NNS	B-NP	B-protein
was	be	VBD	B-VP	O
almost	almost	RB	B-ADJP	O
exclusive	exclusive	JJ	I-ADJP	O
to	to	TO	B-PP	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
eosinophils	eosinophil	NNS	B-NP	B-cell_type
,	,	,	O	O
and	and	CC	O	O
macrophages	macrophage	NNS	B-NP	B-cell_type
.	.	.	O	O

An	An	DT	B-NP	O
inverse	inverse	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
baseline	baseline	NN	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
cell	cell	NN	I-NP	O
GRbeta	GRbeta	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
reduction	reduction	NN	I-NP	O
after	after	IN	B-PP	O
FP	FP	NN	B-NP	O
treatment	treatment	NN	I-NP	O
in	in	IN	B-PP	O
EG2-positive	EG2-positive	JJ	B-NP	B-cell_type
eosinophils	eosinophil	NNS	I-NP	I-cell_type
,	,	,	O	O
CD4-positive	CD4-positive	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
endothelial	endothelial	JJ	B-NP	O
VCAM-1	VCAM-1	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
IL-4	IL-4	NN	B-NP	B-protein
mRNA-positive	mRNA-positive	JJ	I-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

NPs	NP	NNS	B-NP	B-protein
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
``	``	``	B-ADJP	O
FP-insensitive	FP-insensitive	JJ	I-ADJP	O
''	''	''	O	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
suppression	suppression	NN	B-NP	O
of	of	IN	B-PP	O
eosinophil	eosinophil	NN	B-NP	O
numbers	number	NNS	I-NP	O
(	(	(	O	O
major	major	JJ	B-NP	O
basic	basic	JJ	I-NP	O
protein	protein	NN	I-NP	O
-positive	-positive	JJ	B-ADJP	O
)	)	)	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
significantly	significantly	RB	I-NP	O
greater	great	JJR	I-NP	O
percentage	percentage	NN	I-NP	O
of	of	IN	B-PP	O
GRbeta-positive	GRbeta-positive	JJ	B-NP	B-cell_type
inflammatory	inflammatory	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
GRbeta-positive/GRalpha-positive	GRbeta-positive/GRalpha-positive	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
GRbeta-positive	GRbeta-positive	JJ	B-NP	B-cell_type
eosinophils	eosinophil	NNS	I-NP	I-cell_type
and	and	CC	O	O
macrophages	macrophage	NNS	B-NP	B-cell_type
in	in	IN	B-PP	O
comparison	comparison	NN	B-NP	O
with	with	IN	B-PP	O
those	those	DT	B-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
``	``	``	O	O
FP-sensitive.	FP-sensitive.	NNP	B-NP	O
''	''	''	O	O

``	``	``	B-NP	O
FP-insensitive	FP-insensitive	JJ	I-NP	O
''	''	''	I-NP	O
NPs	NP	NNS	I-NP	B-protein
also	also	RB	B-ADVP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
percentage	percentage	NN	I-NP	O
of	of	IN	B-PP	O
IL-5-positive	IL-5-positive	JJ	B-NP	B-cell_line
inflammatory	inflammatory	JJ	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
expressing	express	VBG	B-VP	O
GRbeta	GRbeta	NN	B-NP	B-protein
before	before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
FP	FP	NN	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
GRbeta	GRbeta	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
marker	marker	NN	I-NP	O
of	of	IN	B-PP	O
steroid	steroid	NN	B-NP	O
insensitivity	insensitivity	NN	I-NP	O
in	in	IN	B-PP	O
NPs	NP	NNS	B-NP	B-protein
.	.	.	O	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
GRbeta	GRbeta	NN	B-NP	B-protein
by	by	IN	B-PP	O
NP	NP	NN	B-NP	B-cell_type
inflammatory	inflammatory	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
particularly	particularly	RB	B-NP	O
T	T	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	I-NP	O
eosinophils	eosinophil	NNS	I-NP	B-cell_type
,	,	,	O	O
might	might	MD	B-VP	O
render	render	VB	I-VP	O
them	them	PRP	B-NP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
suppression	suppression	NN	B-NP	O
by	by	IN	B-PP	O
topical	topical	JJ	B-NP	O
steroids	steroid	NNS	I-NP	O
and	and	CC	O	O
thereby	thereby	RB	B-VP	O
contribute	contribute	VBP	I-VP	O
to	to	TO	B-PP	O
persistent	persistent	JJ	B-NP	O
NP	NP	NN	I-NP	O
inflammation	inflammation	NN	I-NP	O
.	.	.	O	O

Transcriptional	Transcriptional	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
galectin-10	galectin-10	NN	B-NP	B-protein
(	(	(	O	O
eosinophil	eosinophil	NN	B-NP	B-protein
Charcot-Leyden	Charcot-Leyden	NN	I-NP	I-protein
crystal	crystal	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
)	)	)	O	O
:	:	:	O	O
a	a	DT	B-NP	O
GC	GC	NN	I-NP	B-DNA
box	box	NN	I-NP	I-DNA
(	(	(	O	O
-44	-44	CD	B-NP	B-DNA
to	to	TO	O	I-DNA
-50	-50	CD	B-NP	I-DNA
)	)	)	O	O
controls	control	VBZ	B-VP	O
butyric	butyric	JJ	B-NP	O
acid	acid	NN	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O

Galectin-10	Galectin-10	NN	B-NP	B-protein
(	(	(	O	O
gal-10	gal-10	NN	B-NP	B-protein
,	,	,	O	O
also	also	RB	B-VP	O
known	know	VBN	I-VP	O
as	as	IN	B-PP	O
Charcot-Leyden	Charcot-Leyden	JJ	B-NP	B-protein
crystal	crystal	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
galectin	galectin	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
of	of	IN	B-PP	O
beta-galactoside	beta-galactoside	NN	B-NP	B-protein
binding	binding	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
uniquely	uniquely	RB	B-ADVP	O
in	in	IN	B-PP	O
eosinophilic	eosinophilic	JJ	B-NP	O
and	and	CC	I-NP	O
basophilic	basophilic	JJ	I-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

To	To	TO	B-VP	O
gain	gain	VB	I-VP	O
a	a	DT	B-NP	O
better	good	JJR	I-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
galectin	galectin	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
present	present	VBP	B-VP	O
an	an	DT	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
encoding	encode	VBG	B-VP	O
gal-10	gal-10	NN	B-NP	B-protein
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
minimal	minimal	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
revealed	reveal	VBD	B-VP	O
nine	nine	CD	B-NP	O
consensus-binding	consensus-binding	JJ	I-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
for	for	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
,	,	,	O	O
including	include	VBG	B-PP	O
several	several	JJ	B-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
also	also	RB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
minimal	minimal	JJ	I-NP	B-DNA
promoters	promoter	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
galectins	galectin	NNS	B-NP	B-protein
-1	-1	CD	I-NP	I-protein
,	,	,	I-NP	O
-2	-2	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
-3	-3	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
gal-10	gal-10	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
activity	activity	NN	I-NP	O
after	after	IN	B-PP	O
disruption	disruption	NN	B-NP	O
of	of	IN	B-PP	O
either	either	CC	O	O
the	the	DT	B-NP	O
GC	GC	NN	I-NP	B-DNA
box	box	NN	I-NP	I-DNA
(	(	(	O	O
-44	-44	CD	B-NP	B-DNA
to	to	TO	O	I-DNA
-50	-50	CD	B-NP	I-DNA
)	)	)	O	O
or	or	CC	O	O
the	the	DT	B-NP	O
Oct	Oct	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
(	(	(	O	O
-255	-255	CD	B-NP	B-DNA
to	to	TO	O	I-DNA
-261	-261	CD	B-NP	I-DNA
)	)	)	O	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
sites	site	NNS	I-NP	O
,	,	,	O	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
characterized	characterize	VBN	I-NP	O
GATA	GATA	NN	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
EoTF	EoTF	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
,	,	,	O	O
are	be	VBP	B-VP	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
full	full	JJ	B-NP	O
promoter	promoter	NN	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
supershift	supershift	NN	B-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
binding	binding	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
Sp1	Sp1	NN	B-NP	B-protein
and	and	CC	O	O
Oct1	Oct1	NN	B-NP	B-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
consensus	consensus	NN	I-NP	B-DNA
GC	GC	NN	I-NP	I-DNA
box	box	NN	I-NP	I-DNA
and	and	CC	O	O
the	the	DT	B-NP	O
Oct	Oct	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

Similar	Similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
gal-1	gal-1	NN	B-NP	B-protein
,	,	,	O	O
gal-10	gal-10	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
butyric	butyric	JJ	B-NP	O
acid	acid	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
effect	effect	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
lost	lose	VBN	I-VP	O
upon	upon	IN	B-PP	O
ablation	ablation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
GC	GC	NN	I-NP	B-DNA
box	box	NN	I-NP	I-DNA
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
AML3	AML3	NN	B-NP	B-protein
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
consensus	consensus	NN	I-NP	B-DNA
AML	AML	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
and	and	CC	O	O
YY1	YY1	NN	B-NP	B-protein
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Inr	Inr	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
,	,	,	O	O
both	both	DT	B-NP	O
elements	element	NNS	I-NP	O
functioning	function	VBG	B-VP	O
as	as	IN	B-PP	O
silencers	silencer	NNS	B-NP	B-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
gal-10	gal-10	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

Tumour-stromal	Tumour-stromal	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
.	.	.	O	O

Role	Role	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
stroma	stroma	NN	I-NP	O
in	in	IN	B-PP	O
mammary	mammary	JJ	B-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

Mammary	Mammary	JJ	B-NP	O
development	development	NN	I-NP	O
depends	depend	VBZ	B-VP	O
on	on	IN	B-PP	O
branching	branch	VBG	B-VP	O
morphogenesis	morphogenesis	NN	B-NP	O
,	,	,	O	O
namely	namely	RB	B-ADVP	O
the	the	DT	B-NP	O
bifurcation	bifurcation	NN	I-NP	O
and	and	CC	I-NP	O
extension	extension	NN	I-NP	O
of	of	IN	B-PP	O
ductal	ductal	JJ	B-NP	O
growth	growth	NN	I-NP	O
points	point	NNS	I-NP	O
(	(	(	O	O
end	end	NN	B-NP	O
buds	bud	NNS	I-NP	O
)	)	)	O	O
and	and	CC	O	O
secretory	secretory	JJ	B-NP	O
lobules	lobule	NNS	I-NP	O
into	into	IN	B-PP	O
a	a	DT	O	O
more	more	RBR	B-ADVP	O
or	or	CC	I-ADVP	O
less	less	RBR	B-NP	O
fatty	fatty	JJ	I-NP	O
stroma	stroma	NN	I-NP	O
.	.	.	O	O

Because	Because	IN	B-SBAR	O
breast	breast	NN	B-NP	O
carcinomas	carcinoma	NNS	I-NP	O
are	be	VBP	B-VP	O
overwhelmingly	overwhelmingly	RB	B-ADJP	O
ductal	ductal	JJ	I-ADJP	O
in	in	IN	B-PP	O
origin	origin	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
review	review	NN	I-NP	O
focuses	focus	VBZ	B-VP	O
on	on	IN	B-PP	O
stromal	stromal	JJ	B-NP	O
influences	influence	NNS	I-NP	O
guiding	guide	VBG	B-VP	O
postnatal	postnatal	JJ	B-NP	O
ductal	ductal	JJ	I-NP	O
development	development	NN	I-NP	O
and	and	CC	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
only	only	RB	B-NP	O
the	the	DT	I-NP	O
briefest	brief	JJS	I-NP	O
account	account	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
embryonic	embryonic	JJ	B-NP	O
stroma	stroma	NN	I-NP	O
(	(	(	O	O
mesenchyme	mesenchyme	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
stroma	stroma	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
necessary	necessary	JJ	I-NP	O
target	target	NN	I-NP	O
for	for	IN	B-PP	O
endocrine	endocrine	JJ	B-NP	B-protein
mammogens	mammogen	NNS	I-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
stimulatory	stimulatory	JJ	B-NP	B-protein
growth	growth	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
is	be	VBZ	B-VP	O
described	describe	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
mammary	mammary	JJ	B-NP	O
epithelium-induced	epithelium-induced	JJ	I-NP	O
modifications	modification	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
periductal	periductal	JJ	I-NP	O
stroma	stroma	NN	I-NP	O
is	be	VBZ	B-VP	O
emphasized	emphasize	VBN	I-VP	O
.	.	.	O	O

Evidence	Evidence	NN	B-NP	O
is	be	VBZ	B-VP	O
presented	present	VBN	I-VP	O
that	that	IN	B-SBAR	O
if	if	IN	B-SBAR	O
they	they	PRP	B-NP	O
are	be	VBP	B-VP	O
to	to	TO	I-VP	O
grow	grow	VB	I-VP	O
,	,	,	O	O
end	end	NN	B-NP	O
buds	bud	NNS	I-NP	O
must	must	MD	B-VP	O
condition	condition	VB	I-VP	O
proximal	proximal	JJ	B-NP	O
fatty	fatty	JJ	I-NP	O
stroma	stroma	NN	I-NP	O
by	by	IN	B-PP	O
recruiting	recruit	VBG	B-VP	O
white	white	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
inducing	induce	VBG	B-VP	O
stromal	stromal	JJ	B-NP	O
cell	cell	NN	I-NP	O
division	division	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
possibly	possibly	RB	B-ADVP	O
,	,	,	O	O
estrogen	estrogen	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
fibrous	fibrous	JJ	I-NP	O
stromal	stromal	JJ	I-NP	O
tunic	tunic	NN	I-NP	O
around	around	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
bud	bud	NN	I-NP	O
is	be	VBZ	B-VP	O
described	describe	VBN	I-VP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
likely	likely	JJ	I-NP	O
role	role	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
complex	complex	JJ	I-NP	O
ductal	ductal	JJ	I-NP	O
morphogen	morphogen	NN	I-NP	O
is	be	VBZ	B-VP	O
discussed	discuss	VBN	I-VP	O
;	;	:	O	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
growth	growth	NN	B-NP	O
inhibition	inhibition	NN	I-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
considered	consider	VBN	I-VP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
signals	signal	NNS	I-NP	O
governing	govern	VBG	B-VP	O
fibrotic	fibrotic	JJ	B-NP	O
induction	induction	NN	I-NP	O
,	,	,	O	O
ductal	ductal	JJ	B-NP	O
morphogenesis	morphogenesis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
growth	growth	NN	B-NP	O
inhibition	inhibition	NN	I-NP	O
are	be	VBP	B-VP	O
unknown	unknown	JJ	B-ADJP	O
,	,	,	O	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
transforming	transform	VBG	B-VP	B-protein
growth	growth	NN	B-NP	I-protein
factor-beta	factor-beta	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
highly	highly	RB	B-ADJP	O
likely	likely	JJ	I-ADJP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
discussed	discuss	VBN	I-VP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
new	new	JJ	B-NP	O
conceptual	conceptual	JJ	I-NP	O
and	and	CC	I-NP	O
experimental	experimental	JJ	I-NP	O
approaches	approach	NNS	I-NP	O
to	to	TO	B-PP	O
understanding	understand	VBG	B-VP	O
stromal-epithelial	stromal-epithelial	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
is	be	VBZ	B-VP	O
discussed	discuss	VBN	I-VP	O
.	.	.	O	O

Adipophilin	Adipophilin	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
sensitive	sensitive	JJ	I-NP	O
marker	marker	NN	I-NP	O
for	for	IN	B-PP	O
lipid	lipid	NN	B-NP	O
loading	loading	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Adipophilin	Adipophilin	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
marker	marker	NN	I-NP	O
of	of	IN	B-PP	O
lipid	lipid	NN	B-NP	O
accumulation	accumulation	NN	I-NP	O
initially	initially	RB	B-VP	O
described	describe	VBN	I-VP	O
in	in	IN	B-PP	O
adipocytes	adipocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
induced	induce	VBN	I-VP	O
in	in	IN	B-PP	O
macrophage	macrophage	NN	B-NP	B-cell_type
foam	foam	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
even	even	RB	B-NP	O
freshly	freshly	RB	I-NP	O
isolated	isolate	VBN	I-NP	O
blood	blood	NN	I-NP	B-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
express	express	VBP	B-VP	O
adipophilin	adipophilin	NN	B-NP	B-protein
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
adipophilin	adipophilin	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
variable	variable	JJ	B-ADJP	O
in	in	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
different	different	JJ	B-NP	O
healthy	healthy	JJ	I-NP	O
individuals	individual	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
physiological	physiological	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
adipophilin	adipophilin	NN	B-NP	B-protein
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
correlate	correlate	VB	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
free	free	JJ	B-NP	O
fatty	fatty	JJ	I-NP	O
acids	acid	NNS	I-NP	O
,	,	,	O	O
cholesterylesters	cholesterylester	NNS	B-NP	O
or	or	CC	O	O
free	free	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
.	.	.	O	O

Enzymatically	Enzymatically	RB	B-NP	O
modified	modify	VBN	I-NP	O
low-density	low-density	JJ	I-NP	B-protein
lipoprotein	lipoprotein	NN	I-NP	I-protein
(	(	(	O	O
E-LDL	E-LDL	NN	B-NP	B-protein
)	)	)	O	O
induces	induce	VBZ	B-VP	O
rapid	rapid	JJ	B-NP	O
foam	foam	NN	I-NP	O
cell	cell	NN	I-NP	O
formation	formation	NN	I-NP	O
in	in	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
upregulates	upregulate	VBZ	B-VP	O
adipophilin	adipophilin	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
and	and	CC	I-NP	O
protein	protein	NN	I-NP	O
within	within	IN	B-PP	O
2	2	CD	B-NP	O
h	h	NN	I-NP	O
of	of	IN	B-PP	O
incubation	incubation	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
adipophilin	adipophilin	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
free	free	JJ	B-NP	O
fatty	fatty	JJ	I-NP	O
acids	acid	NNS	I-NP	O
in	in	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
incubated	incubate	VBN	B-VP	O
with	with	IN	B-PP	O
E-LDL	E-LDL	NN	B-NP	B-protein
.	.	.	O	O

Adipophilin	Adipophilin	NN	B-NP	B-protein
facilitates	facilitate	VBZ	B-VP	O
the	the	DT	B-NP	O
uptake	uptake	NN	I-NP	O
of	of	IN	B-PP	O
free	free	JJ	B-NP	O
fatty	fatty	JJ	I-NP	O
acids	acid	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
here	here	RB	B-ADVP	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
free	free	JJ	B-NP	O
fatty	fatty	JJ	I-NP	O
acids	acid	NNS	I-NP	O
increase	increase	VBP	B-VP	O
is	be	VBZ	B-VP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
upregulation	upregulation	NN	I-NP	O
of	of	IN	B-PP	O
adipophilin	adipophilin	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	B-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Fatty	Fatty	JJ	B-NP	O
acids	acid	NNS	I-NP	O
are	be	VBP	B-VP	O
ligands	ligand	NNS	B-NP	O
for	for	IN	B-PP	O
peroxisome	peroxisome	NN	B-NP	B-protein
proliferator-activated	proliferator-activated	JJ	I-NP	I-protein
receptor-gamma	receptor-gamma	NN	I-NP	I-protein
(	(	(	O	O
PPARgamma	PPARgamma	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
upregulation	upregulation	NN	I-NP	O
of	of	IN	B-PP	O
adipophilin	adipophilin	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
by	by	IN	B-PP	O
PPARgamma	PPARgamma	NN	B-NP	B-protein
agonists	agonist	NNS	I-NP	O
like	like	IN	B-PP	O
15d-PGJ	15d-PGJ	NN	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
ciglitazone	ciglitazone	NN	B-NP	O
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
PPARgamma	PPARgamma	NN	B-NP	B-protein
may	may	MD	B-VP	O
mediate	mediate	VB	I-VP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
adipophilin	adipophilin	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Constitutive	Constitutive	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
MHC	MHC	NN	B-NP	B-DNA
class	class	NN	I-NP	I-DNA
II	II	CD	B-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
melanoma	melanoma	NN	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
results	result	VBZ	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
class	class	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
transactivator	transactivator	NN	I-NP	I-protein
abnormally	abnormally	RB	B-VP	O
initiated	initiate	VBN	I-VP	O
from	from	IN	B-PP	O
its	its	PRP$	B-NP	O
B	B	NN	I-NP	B-DNA
cell-specific	cell-specific	JJ	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

In	In	IN	B-PP	O
melanoma	melanoma	NN	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
two	two	CD	B-NP	O
different	different	JJ	I-NP	O
patterns	pattern	NNS	I-NP	O
of	of	IN	B-PP	O
MHC	MHC	NN	B-NP	B-protein
class	class	NN	I-NP	I-protein
II	II	CD	I-NP	I-protein
expression	expression	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
described	describe	VBN	I-VP	O
,	,	,	O	O
either	either	CC	O	O
an	an	DT	B-NP	O
IFN	IFN	NN	I-NP	B-protein
gamma-inducible	gamma-inducible	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
HLA-DR	HLA-DR	NN	B-NP	B-protein
and	and	CC	I-NP	O
HLA-DP	HLA-DP	NN	I-NP	B-DNA
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
faint	faint	JJ	I-NP	O
or	or	CC	I-NP	O
null	null	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
HLA-DQ	HLA-DQ	NN	B-NP	B-DNA
,	,	,	O	O
resembling	resemble	VBG	B-VP	O
that	that	IN	B-SBAR	O
described	describe	VBN	B-VP	O
for	for	IN	B-PP	O
melanocytes	melanocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
or	or	CC	O	O
a	a	DT	B-NP	O
constitutive	constitutive	JJ	I-NP	O
expression	expression	NN	I-NP	O
,	,	,	O	O
i.e.	i.e.	FW	B-NP	O
,	,	,	O	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
independent	independent	JJ	I-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
three	three	CD	I-NP	O
HLA-D	HLA-D	NN	I-NP	B-protein
isotypes	isotype	NNS	I-NP	I-protein
.	.	.	O	O

As	As	IN	B-SBAR	O
this	this	DT	B-NP	O
latter	latter	JJ	I-NP	O
phenotype	phenotype	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
rapid	rapid	JJ	I-NP	O
progression	progression	NN	I-NP	O
of	of	IN	B-PP	O
melanoma	melanoma	NN	B-NP	O
tumors	tumor	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
analyzed	analyze	VBN	I-VP	O
in	in	IN	B-PP	O
different	different	JJ	B-NP	O
melanoma	melanoma	NN	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
abnormal	abnormal	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
MHC	MHC	NN	B-NP	B-protein
class	class	NN	I-NP	I-protein
II	II	CD	I-NP	I-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
agreement	agreement	NN	I-PP	O
with	with	IN	I-PP	O
the	the	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
coordinate	coordinate	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HLA-D	HLA-D	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
these	these	DT	B-NP	O
cell	cell	NN	I-NP	B-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
the	the	DT	B-NP	O
constitutive	constitutive	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
CIITA	CIITA	NN	B-NP	B-protein
(	(	(	O	O
class	class	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
transactivator	transactivator	NN	I-NP	I-protein
)	)	)	O	O
transcripts	transcript	NNS	B-NP	O
,	,	,	O	O
CIITA	CIITA	NN	B-NP	B-protein
being	be	VBG	B-VP	O
known	know	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
master	master	NN	I-NP	O
switch	switch	NN	I-NP	O
of	of	IN	B-PP	O
MHC	MHC	NN	B-NP	B-protein
class	class	NN	I-NP	I-protein
II	II	CD	I-NP	I-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

Unexpectedly	Unexpectedly	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
transcripts	transcript	NNS	I-NP	O
initiate	initiate	VBP	B-VP	O
from	from	IN	B-PP	O
promoter	promoter	NN	B-NP	B-DNA
III	III	CD	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CIITA	CIITA	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
,	,	,	O	O
a	a	DT	B-NP	O
promoter	promoter	NN	I-NP	B-DNA
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
mainly	mainly	RB	I-VP	O
used	use	VBN	I-VP	O
constitutively	constitutively	RB	B-ADVP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

This	This	DT	B-NP	O
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
further	further	RB	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
occur	occur	VB	I-VP	O
through	through	IN	B-PP	O
factor	factor	NN	B-NP	O
(	(	(	O	O
s	s	NNS	B-NP	O
)	)	)	O	O
acting	act	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
enhancer	enhancer	NN	I-NP	B-DNA
located	located	JJ	B-ADJP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
CIITA	CIITA	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
III	III	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
previously	previously	RB	I-VP	O
described	describe	VBN	I-VP	O
in	in	IN	B-PP	O
epithelioid	epithelioid	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
as	as	IN	B-PP	O
an	an	DT	B-NP	O
IFN-gamma-response	IFN-gamma-response	JJ	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
general	general	JJ	I-NP	O
abnormality	abnormality	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IFN-gamma	IFN-gamma	NN	I-NP	B-protein
transduction	transduction	NN	I-NP	O
pathway	pathway	NN	I-NP	O
was	be	VBD	B-VP	O
dismissed	dismiss	VBN	I-VP	O
.	.	.	O	O

Constitutive	Constitutive	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
CIITA	CIITA	NN	B-NP	B-protein
from	from	IN	B-PP	O
promoter	promoter	NN	B-NP	B-DNA
III	III	CD	I-NP	I-DNA
having	have	VBG	B-VP	O
been	be	VBN	I-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
unrelated	unrelated	JJ	B-NP	B-cell_line
melanoma	melanoma	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
we	we	PRP	B-NP	O
propose	propose	VBP	B-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
phenomenon	phenomenon	NN	I-NP	O
might	might	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
random	random	JJ	I-NP	O
event	event	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
linked	link	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
neoplasic	neoplasic	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
melanoma	melanoma	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type

Caspase	Caspase	NN	B-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
calcineurin	calcineurin	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
contributes	contribute	VBZ	B-VP	O
to	to	TO	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
release	release	NN	I-NP	O
during	during	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

Calcineurin	Calcineurin	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
Ca	Ca	NN	I-NP	O
(	(	(	O	O
2+	2+	JJ	B-ADJP	O
)	)	)	O	O
/calmodulin-dependent	/calmodulin-dependent	JJ	B-NP	B-protein
Ser/Thr	Ser/Thr	NN	I-NP	I-protein
phosphatase	phosphatase	NN	I-NP	I-protein
(	(	(	O	O
protein	protein	NN	B-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
2B	2B	NN	I-NP	I-protein
)	)	)	O	O
,	,	,	O	O
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
production	production	NN	I-NP	O
during	during	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
previously	previously	RB	I-VP	O
reported	report	VBN	I-VP	O
that	that	IN	B-SBAR	O
IL-2	IL-2	NN	B-NP	B-protein
release	release	NN	I-NP	O
in	in	IN	B-PP	O
activated	activate	VBN	B-NP	O
Jurkat	Jurkat	NN	I-NP	O
T	T	NN	I-NP	O
requires	require	VBZ	B-VP	O
caspase-like	caspase-like	JJ	B-NP	O
activity	activity	NN	I-NP	O
(	(	(	O	O
Posmantur	Posmantur	NNP	B-NP	O
et	et	FW	I-NP	O
al.	al.	FW	I-NP	O
(	(	(	O	O
1998	1998	CD	B-NP	O
)	)	)	O	O
Exp.	Exp.	NNP	B-NP	O
Cell.	Cell.	NNP	I-NP	O
Res.	Res.	NNP	I-NP	O
244	244	CD	I-NP	O
,	,	,	I-NP	O
302-309	302-309	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
here	here	RB	B-ADVP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
60-kDa	60-kDa	JJ	I-NP	B-protein
catalytic	catalytic	JJ	I-NP	I-protein
subunit	subunit	NN	I-NP	I-protein
of	of	IN	B-PP	O
calcineurin	calcineurin	NN	B-NP	B-protein
A	A	NN	I-NP	O
(	(	(	O	O
Cn	Cn	NN	B-NP	B-protein
A	A	NN	I-NP	I-protein
)	)	)	O	O
was	be	VBD	B-VP	O
partially	partially	RB	I-VP	O
cleaved	cleave	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
45-kDa	45-kDa	JJ	I-NP	B-protein
form	form	NN	I-NP	I-protein
in	in	IN	B-PP	O
phytohemagglutinin	phytohemagglutinin	NN	B-NP	B-protein
A	A	NN	I-NP	O
(	(	(	O	O
PHA	PHA	NN	B-NP	B-protein
)	)	)	O	O
or	or	CC	O	O
phorbol	phorbol	NN	B-NP	O
ester	ester	NN	I-NP	O
+	+	SYM	O	O
ionomycin	ionomycin	NN	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
+	+	SYM	I-NP	O
I	I	NN	I-NP	O
)	)	)	I-NP	O
-activated	-activated	JJ	I-NP	O
Jurkat	Jurkat	NN	I-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
parallel	parallel	JJ	B-NP	O
,	,	,	I-NP	O
proteolytic	proteolytic	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
upstream	upstream	JJ	B-NP	B-protein
caspases	caspas	NNS	I-NP	I-protein
(	(	(	O	O
caspase-8	caspase-8	NN	B-NP	B-protein
and	and	CC	O	I-protein
-9	-9	CD	B-NP	I-protein
)	)	)	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
effector	effector	NN	B-NP	B-protein
caspase-3	caspase-3	NN	I-NP	I-protein
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

Cn	Cn	NN	B-NP	O
A	A	NN	I-NP	O
cleavage	cleavage	NN	I-NP	O
was	be	VBD	B-VP	O
caspase	caspase	NN	I-VP	B-protein
mediated	mediate	VBN	I-VP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
inhibitable	inhibitable	JJ	B-ADJP	O
by	by	IN	B-PP	O
pan-caspase	pan-caspase	NN	B-NP	B-protein
inhibitor	inhibitor	NN	I-NP	O
Cbz-Asp-CH	Cbz-Asp-CH	NN	I-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
OC	OC	NN	B-NP	B-protein
(	(	(	O	I-protein
O	O	NN	B-NP	I-protein
)	)	)	O	I-protein
-2	-2	CD	B-NP	I-protein
,	,	,	O	O
6-dichlorobenzene	6-dichlorobenzene	NN	B-NP	O
(	(	(	O	O
Z-D-DCB	Z-D-DCB	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Cn	Cn	NN	B-NP	O
A	A	NN	I-NP	O
cleavage	cleavage	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
observed	observe	VBN	I-VP	O
when	when	WRB	B-ADVP	O
purified	purify	VBN	B-NP	O
calcineurin	calcineurin	NN	I-NP	B-protein
was	be	VBD	B-VP	O
digested	digest	VBN	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
with	with	IN	B-PP	O
caspase-3	caspase-3	NN	B-NP	B-protein
.	.	.	O	O

Truncated	Truncate	VBN	B-NP	O
Cn	Cn	NN	I-NP	O
A	A	NN	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
enhanced	enhance	VBN	B-NP	O
phosphatase	phosphatase	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
and	and	CC	O	O
reduced	reduce	VBD	B-VP	O
calmodulin	calmodulin	NN	B-NP	B-protein
sensitivity	sensitivity	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
PHA	PHA	NN	B-NP	B-protein
or	or	CC	O	O
P	P	NN	B-NP	B-cell_line
+	+	CC	I-NP	I-cell_line
I-activated	I-activated	JJ	I-NP	I-cell_line
Jurkat	Jurkat	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
dephosphorylation	dephosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
calcineurin	calcineurin	NN	B-NP	B-protein
substrate	substrate	NN	I-NP	I-protein
NFATc	NFATc	NN	I-NP	I-protein
(	(	(	O	O
a	a	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
known	know	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
transactivation	transactivation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
)	)	)	O	O
,	,	,	O	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
suppressed	suppress	VBN	I-VP	O
by	by	IN	B-PP	O
Z-D-DCB	Z-D-DCB	NN	B-NP	B-protein
.	.	.	O	O

Taken	Take	VBN	B-VP	O
together	together	RB	B-ADVP	O
,	,	,	O	O
our	our	PRP$	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
caspase-mediated	caspase-mediated	JJ	B-NP	O
cleavage	cleavage	NN	I-NP	O
of	of	IN	B-PP	O
Cn	Cn	NN	B-NP	B-protein
A	A	NN	I-NP	I-protein
contributes	contribute	VBZ	B-VP	O
to	to	TO	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
production	production	NN	I-NP	O
during	during	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

Copyright	Copyright	NN	B-NP	O
2001	2001	CD	I-NP	O
Academic	Academic	NNP	I-NP	O
Press	Press	NNP	I-NP	O
.	.	.	O	O

Maturation	Maturation	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
dendritic	dendritic	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
as	as	IN	B-PP	O
sulfasalazine	sulfasalazine	NN	B-NP	O
target	target	NN	I-NP	O
.	.	.	O	O

AIM	AIM	NN	B-NP	O
:	:	:	O	O
Sulfasalazine	Sulfasalazine	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
nonsteroidal	nonsteroidal	JJ	I-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	O
drug	drug	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
effective	effective	JJ	B-ADJP	O
in	in	IN	B-PP	O
treating	treat	VBG	B-VP	O
some	some	DT	B-NP	O
autoimmune	autoimmune	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
its	its	PRP$	B-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
action	action	NN	B-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
.	.	.	O	O

To	To	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
dendritic	dendritic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
could	could	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
target	target	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
drug	drug	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
studied	study	VBD	B-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
sulfasalazine	sulfasalazine	NN	B-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
metabolites	metabolite	NNS	I-NP	O
,	,	,	I-NP	O
aminosalicylate	aminosalicylate	NN	I-NP	O
and	and	CC	I-NP	O
sulfapyridine	sulfapyridine	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
maturation	maturation	NN	I-NP	O
(	(	(	O	O
terminal	terminal	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
myeloid	myeloid	JJ	I-NP	I-cell_type
dendritic	dendritic	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
We	We	PRP	B-NP	O
prepared	prepare	VBD	B-VP	O
immature	immature	JJ	B-NP	B-cell_type
dendritic	dendritic	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
incubating	incubate	VBG	B-VP	O
CD14-positive	CD14-positive	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
the	the	DT	I-PP	O
presence	presence	NN	I-PP	O
of	of	IN	I-PP	O
granulocyte-	granulocyte-	NN	B-NP	B-protein
macrophage	macrophage	NN	B-NP	I-protein
colony-stimulating	colony-stimulating	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
and	and	CC	O	O
interleukin	interleukin	NN	B-NP	B-protein
(	(	(	O	I-protein
IL	IL	NN	B-NP	I-protein
)	)	)	O	I-protein
-4	-4	CD	B-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
cells	cell	NNS	I-NP	O
were	be	VBD	B-VP	O
matured	mature	VBN	I-VP	O
by	by	IN	B-PP	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
tumor	tumor	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
TNF	TNF	NN	B-NP	B-protein
)	)	)	O	O
-a	-a	NN	B-NP	O
,	,	,	O	O
IL-1	IL-1	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
prostaglandin	prostaglandin	NN	B-NP	B-protein
E2	E2	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	I-PP	O
presence	presence	NN	I-PP	O
of	of	IN	I-PP	O
sulfasalazine	sulfasalazine	NN	B-NP	O
or	or	CC	O	O
its	its	PRP$	B-NP	O
metabolites	metabolite	NNS	I-NP	O
--	--	:	O	O
aminosalicylate	aminosalicylate	NN	B-NP	O
and	and	CC	I-NP	O
sulfapyridine	sulfapyridine	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
their	their	PRP$	B-NP	O
combinations	combination	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
quantified	quantify	VBD	B-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
drugs	drug	NNS	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
dendritic	dendritic	JJ	I-NP	O
cell	cell	NN	I-NP	O
characteristics	characteristic	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
stimulation	stimulation	NN	B-NP	O
of	of	IN	B-PP	O
autologous	autologous	JJ	B-NP	O
and	and	CC	I-NP	O
allogeneic	allogeneic	JJ	I-NP	O
pan-T	pan-T	NN	I-NP	O
cell	cell	NN	I-NP	O
proliferation	proliferation	NN	I-NP	O
,	,	,	O	O
surface	surface	NN	B-NP	O
marker	marker	NN	I-NP	O
phenotype	phenotype	NN	I-NP	O
,	,	,	O	O
IL-12	IL-12	NN	B-NP	B-protein
p40	p40	NN	I-NP	O
subunit	subunit	NN	I-NP	O
secretion	secretion	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	I-protein
NF	NF	NN	B-NP	I-protein
)	)	)	O	I-protein
-kappa	-kappa	NN	B-NP	I-protein
B	B	NN	I-NP	I-protein
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Dendritic	Dendritic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
sulfasalazine	sulfasalazine	NN	B-NP	O
(	(	(	O	O
1.25	1.25	CD	B-NP	O
micromol/L	micromol/L	NN	I-NP	O
or	or	CC	O	O
2.5	2.5	CD	B-NP	O
micromol/L	micromol/L	NN	I-NP	O
)	)	)	O	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
stimulate	stimulate	VB	I-VP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
p	p	NN	B-NP	O
<	<	JJR	B-NP	O
0.028	0.028	CD	I-NP	O
,	,	,	O	O
two-sided	two-sided	JJ	B-NP	O
paired	paired	JJ	I-NP	O
t-test	t-test	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
distinction	distinction	NN	B-NP	O
to	to	TO	B-PP	O
drug-free	drug-free	JJ	B-NP	B-cell_type
maturing	mature	VBG	I-NP	I-cell_type
dendritic	dendritic	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
2.5	2.5	CD	B-NP	O
micromol/L	micromol/L	NN	I-NP	O
sulfasalazine	sulfasalazine	NN	I-NP	O
upregulated	upregulate	VBD	B-VP	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
CD14	CD14	NN	B-NP	B-protein
and	and	CC	I-NP	O
CD68	CD68	NN	I-NP	B-protein
and	and	CC	O	O
downregulated	downregulate	VBD	B-VP	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
CD40	CD40	NN	B-NP	B-protein
,	,	,	O	O
CD80	CD80	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
CD83	CD83	NN	B-NP	B-protein
(	(	(	O	O
for	for	IN	B-PP	O
all	all	DT	B-NP	O
CD	CD	NNP	I-NP	B-protein
markers	marker	NNS	I-NP	I-protein
,	,	,	O	O
p	p	NN	B-NP	O
<	<	SYM	B-VP	O
0.03	0.03	CD	B-NP	O
for	for	IN	B-PP	O
difference	difference	NN	B-NP	O
between	between	IN	B-PP	O
measurements	measurement	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
sulfasalazine	sulfasalazine	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

From	From	IN	B-PP	O
concentration-dependent	concentration-dependent	JJ	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
CD83	CD83	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
an	an	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
ID50	ID50	NN	I-NP	B-protein
>	>	SYM	O	O
>	>	SYM	O	O
1.5	1.5	CD	B-NP	O
micromol/L	micromol/L	NN	I-NP	O
sulfasalazine	sulfasalazine	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
ID50	ID50	NN	I-NP	O
value	value	NN	I-NP	O
for	for	IN	B-PP	O
aminosalicylate-inhibited	aminosalicylate-inhibited	JJ	B-NP	O
maturation	maturation	NN	I-NP	O
was	be	VBD	B-VP	O
4	4	CD	B-NP	O
micromol/L	micromol/L	NN	I-NP	O
.	.	.	O	O

Sulfapyridine	Sulfapyridine	NN	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
1.25	1.25	CD	B-NP	O
micromol/L	micromol/L	NN	I-NP	O
,	,	,	O	O
sulfasalazine	sulfasalazine	NN	B-NP	O
largely	largely	RB	B-VP	O
inhibited	inhibit	VBD	I-VP	O
NF-kB	NF-kB	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
dendritic	dendritic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
Maturing	Mature	VBG	B-VP	O
human	human	JJ	B-NP	B-cell_type
dendritic	dendritic	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
hundred-fold	hundred-fold	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
sensitive	sensitive	JJ	I-ADJP	O
to	to	TO	B-PP	O
sulfasalazine	sulfasalazine	NN	B-NP	O
than	than	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
NK	NK	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
sensitive	sensitive	JJ	I-NP	O
human	human	JJ	I-NP	O
cells	cell	NNS	I-NP	O
described	describe	VBN	B-VP	O
so	so	RB	B-ADVP	O
far	far	RB	I-ADVP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
dendritic	dendritic	JJ	B-NP	O
cell	cell	NN	I-NP	O
maturation	maturation	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
target	target	NN	I-NP	O
of	of	IN	B-PP	O
sulfasalazine	sulfasalazine	NN	B-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
dendritic	dendritic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
(	(	(	O	O
auto	auto	NN	B-NP	O
)	)	)	O	O
immunity	immunity	NN	B-NP	O
,	,	,	O	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
maturation	maturation	NN	I-NP	O
might	might	MD	B-VP	O
provide	provide	VB	I-VP	O
a	a	DT	B-NP	O
target	target	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
optimization	optimization	NN	I-NP	O
of	of	IN	B-PP	O
sulfasalazine	sulfasalazine	NN	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

Defective	Defective	JJ	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proteasome	proteasome	NN	I-NP	B-protein
in	in	IN	B-PP	O
autoimmunity	autoimmunity	NN	B-NP	O
:	:	:	O	O
involvement	involvement	NN	B-NP	O
of	of	IN	B-PP	O
impaired	impaired	JJ	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

Type	Type	NN	B-NP	O
1	1	CD	I-NP	O
diabetes	diabetes	NN	I-NP	O
(	(	(	O	O
also	also	RB	B-VP	O
known	know	VBN	I-VP	O
as	as	IN	B-PP	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
or	or	CC	O	O
juvenile-onset	juvenile-onset	NN	B-NP	O
diabetes	diabetes	NN	I-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
usually	usually	RB	I-VP	O
caused	cause	VBN	I-VP	O
by	by	IN	B-PP	O
T	T	NN	B-NP	O
cell-mediated	cell-mediated	JJ	I-NP	O
autoimmunity	autoimmunity	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
prediabetic	prediabetic	JJ	I-NP	O
state	state	NN	I-NP	O
characterized	characterize	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
autoantibodies	autoantibody	NNS	B-NP	B-protein
specific	specific	JJ	B-ADJP	O
for	for	IN	B-PP	O
proteins	protein	NNS	B-NP	O
expressed	express	VBN	B-VP	O
by	by	IN	B-PP	O
pancreatic	pancreatic	JJ	B-NP	B-cell_type
beta	beta	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
nonobese	nonobese	JJ	I-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
(	(	(	O	O
NOD	NOD	NN	B-NP	O
)	)	)	O	O
mouse	mouse	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
spontaneous	spontaneous	JJ	I-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
type	type	NN	B-NP	O
1	1	CD	I-NP	O
diabetes	diabetes	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
strong	strong	JJ	I-NP	O
genetic	genetic	JJ	I-NP	O
component	component	NN	I-NP	O
that	that	WDT	B-NP	O
maps	map	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	B-DNA
histocompatibility	histocompatibility	NN	I-NP	I-DNA
complex	complex	NN	I-NP	I-DNA
(	(	(	O	I-DNA
MHC	MHC	NN	B-NP	I-DNA
)	)	)	O	I-DNA
region	region	NN	B-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genome	genome	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
specific	specific	JJ	I-NP	O
proteasome	proteasome	NN	I-NP	B-protein
defect	defect	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
NOD	NOD	NN	B-NP	O
mouse	mouse	NN	I-NP	O
in	in	IN	B-PP	O
select	select	JJ	B-NP	O
lymphocytic	lymphocytic	JJ	I-NP	O
and	and	CC	I-NP	O
monocytic	monocytic	JJ	I-NP	B-cell_type
lineages	lineage	NNS	I-NP	I-cell_type
that	that	WDT	B-NP	O
results	result	VBZ	B-VP	O
from	from	IN	B-PP	O
down-regulation	down-regulation	NN	B-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proteasome	proteasome	NN	I-NP	B-protein
subunit	subunit	NN	I-NP	I-protein
LMP2	LMP2	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
encoded	encode	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
gene	gene	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MHC	MHC	NN	I-NP	B-DNA
genomic	genomic	JJ	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
.	.	.	O	O

This	This	DT	B-NP	O
defect	defect	NN	I-NP	O
prevents	prevent	VBZ	B-VP	O
the	the	DT	B-NP	O
proteolytic	proteolytic	JJ	I-NP	O
processing	processing	NN	I-NP	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
and	and	CC	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
nuclear	nuclear	JJ	I-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
(	(	(	O	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
plays	play	VBZ	B-VP	O
important	important	JJ	B-NP	O
roles	role	NNS	I-NP	O
in	in	IN	B-PP	O
immune	immune	JJ	B-NP	O
and	and	CC	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
responses	response	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
increases	increase	VBZ	B-VP	O
the	the	DT	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
affected	affect	VBN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
tumor	tumor	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor-alpha	factor-alpha	NN	I-NP	I-protein
(	(	(	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
novel	novel	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proteasome	proteasome	NN	I-NP	B-protein
in	in	IN	B-PP	O
dysfunction	dysfunction	NN	B-NP	O
in	in	IN	B-PP	O
autoimmunity	autoimmunity	NN	B-NP	O
is	be	VBZ	B-VP	O
presented	present	VBN	I-VP	O
and	and	CC	O	O
documented	document	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
both	both	CC	O	O
tissue	tissue	NN	B-NP	O
and	and	CC	O	O
developmental	developmental	JJ	B-NP	O
stage	stage	NN	I-NP	O
specific	specific	JJ	B-ADJP	O
.	.	.	O	O

We	We	PRP	B-NP	O
propose	propose	VBP	B-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proteasome	proteasome	NN	I-NP	B-protein
as	as	IN	B-PP	O
a	a	DT	B-NP	O
step	step	NN	I-NP	O
in	in	IN	B-PP	O
disease	disease	NN	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
and	and	CC	O	O
tissue	tissue	NN	B-NP	O
targeting	targeting	NN	I-NP	O
.	.	.	O	O

Down-regulation	Down-regulation	NN	B-NP	O
of	of	IN	B-PP	O
TDT	TDT	NN	B-NP	O
transcription	transcription	NN	I-NP	O
in	in	IN	B-PP	O
CD4	CD4	NN	B-NP	B-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
CD8	CD8	NN	B-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
thymocytes	thymocyte	NNS	B-NP	I-cell_type
by	by	IN	B-PP	O
Ikaros	Ikaros	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
in	in	IN	B-PP	O
direct	direct	JJ	B-NP	O
competition	competition	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
Ets	Ets	NN	I-NP	B-DNA
activator	activator	NN	I-NP	I-DNA
.	.	.	O	O

Ikaros	Ikaros	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
unique	unique	JJ	I-NP	O
regulator	regulator	NN	I-NP	O
of	of	IN	B-PP	O
lymphopoiesis	lymphopoiesis	NN	B-NP	O
that	that	WDT	B-NP	O
associates	associate	VBZ	B-VP	O
with	with	IN	B-PP	O
pericentromeric	pericentromeric	JJ	B-NP	B-protein
heterochromatin	heterochromatin	NN	I-NP	I-protein
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
heritable	heritable	JJ	B-NP	O
gene	gene	NN	I-NP	O
inactivation	inactivation	NN	I-NP	O
.	.	.	O	O

Binding	Binding	NN	B-NP	O
and	and	CC	I-NP	O
competition	competition	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
Ikaros	Ikaros	NN	B-NP	B-protein
dimers	dimer	NNS	I-NP	I-protein
compete	compete	VBP	B-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
Ets	Ets	NN	I-NP	O
activator	activator	NN	I-NP	O
for	for	IN	B-PP	O
occupancy	occupancy	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lymphocyte-specific	lymphocyte-specific	JJ	I-NP	B-DNA
TdT	TdT	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

Mutations	Mutation	NNS	B-NP	O
that	that	WDT	B-NP	O
selectively	selectively	RB	B-ADVP	O
disrupt	disrupt	VBP	B-VP	O
Ikaros	Ikaros	NN	B-NP	B-protein
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
integrated	integrate	VBN	I-NP	O
TdT	TdT	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
promoter	promoter	NN	B-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
CD4	CD4	NN	I-NP	B-cell_line
(	(	(	O	I-cell_line
+	+	SYM	O	I-cell_line
)	)	)	O	I-cell_line
CD8	CD8	NN	B-NP	I-cell_line
(	(	(	O	I-cell_line
+	+	SYM	O	I-cell_line
)	)	)	O	I-cell_line
thymocyte	thymocyte	NN	B-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
mutations	mutation	NNS	I-NP	O
abolished	abolish	VBD	B-VP	O
down-regulation	down-regulation	NN	B-NP	O
on	on	IN	B-PP	O
differentiation	differentiation	NN	B-NP	O
,	,	,	O	O
providing	provide	VBG	B-VP	O
evidence	evidence	NN	B-NP	O
that	that	IN	B-SBAR	O
Ikaros	Ikaros	NN	B-NP	B-protein
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
direct	direct	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
repression	repression	NN	B-NP	O
.	.	.	O	O

Reduced	Reduce	VBN	B-NP	O
access	access	NN	I-NP	O
to	to	TO	B-PP	O
restriction	restriction	NN	B-NP	B-protein
enzyme	enzyme	NN	I-NP	I-protein
cleavage	cleavage	NN	I-NP	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
chromatin	chromatin	NN	B-NP	B-DNA
alterations	alteration	NNS	I-NP	O
accompany	accompany	NN	I-NP	O
down-regulation	down-regulation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Ikaros-dependent	Ikaros-dependent	JJ	I-NP	O
down-regulation	down-regulation	NN	I-NP	O
event	event	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
observed	observe	VBN	I-NP	O
chromatin	chromatin	NN	I-NP	B-DNA
alterations	alteration	NNS	I-NP	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
precede	precede	VB	I-VP	O
pericentromeric	pericentromeric	JJ	B-NP	O
repositioning	repositioning	NN	I-NP	O
.	.	.	O	O

Current	Current	JJ	B-NP	O
models	model	NNS	I-NP	O
propose	propose	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
functions	function	NNS	I-NP	O
of	of	IN	B-PP	O
Ikaros	Ikaros	NN	B-NP	B-protein
should	should	MD	B-VP	O
be	be	VB	I-VP	O
disrupted	disrupt	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
isoform	isoform	NN	I-NP	O
that	that	WDT	B-NP	O
retains	retain	VBZ	B-VP	O
the	the	DT	B-NP	O
dimerization	dimerization	NN	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
and	and	CC	O	O
lacks	lack	VBZ	B-VP	O
the	the	DT	B-NP	O
DNA-binding	DNA-binding	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
.	.	.	O	O

Surprisingly	Surprisingly	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CD4	CD4	NN	I-NP	B-cell_line
(	(	(	O	I-cell_line
+	+	SYM	O	I-cell_line
)	)	)	O	I-cell_line
CD8	CD8	NN	B-NP	I-cell_line
(	(	(	O	I-cell_line
+	+	SYM	O	I-cell_line
)	)	)	O	I-cell_line
thymocyte	thymocyte	NN	B-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
,	,	,	O	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
Ikaros	Ikaros	NN	I-NP	B-protein
isoform	isoform	NN	I-NP	I-protein
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
differentiation	differentiation	NN	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
pericentromeric	pericentromeric	JJ	I-NP	O
targeting	targeting	NN	I-NP	O
and	and	CC	O	O
DNA-binding	DNA-binding	JJ	B-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
Ikaros	Ikaros	NN	B-NP	B-protein
.	.	.	O	O

Rather	Rather	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
small	small	JJ	I-NP	O
isoform	isoform	NN	I-NP	O
assembled	assemble	VBN	B-VP	O
into	into	IN	B-PP	O
multimeric	multimeric	JJ	B-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
with	with	IN	B-PP	O
DNA-bound	DNA-bound	JJ	B-NP	B-protein
Ikaros	Ikaros	NN	I-NP	I-protein
at	at	IN	B-PP	O
the	the	DT	B-NP	O
pericentromeric	pericentromeric	JJ	I-NP	B-cell_type
foci	focus	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
capacity	capacity	NN	I-NP	O
for	for	IN	B-PP	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
multimer	multimer	NN	I-NP	O
formation	formation	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
interactions	interaction	NNS	B-NP	O
between	between	IN	B-PP	O
Ikaros	Ikaros	NN	B-NP	B-protein
dimers	dimer	NNS	I-NP	I-protein
bound	bind	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
TdT	TdT	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
and	and	CC	O	O
those	those	DT	B-NP	O
bound	bind	VBN	B-VP	O
to	to	TO	B-PP	O
pericentromeric	pericentromeric	JJ	B-NP	B-DNA
repeat	repeat	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
may	may	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
pericentromeric	pericentromeric	JJ	I-NP	O
repositioning	repositioning	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inactive	inactive	JJ	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

Type	Type	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
interferons	interferon	NNS	I-NP	I-protein
and	and	CC	O	O
IL-12	IL-12	NN	B-NP	B-protein
:	:	:	O	O
convergence	convergence	NN	B-NP	O
and	and	CC	I-NP	O
cross-regulation	cross-regulation	NN	I-NP	O
among	among	IN	B-PP	O
mediators	mediator	NNS	B-NP	O
of	of	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
immunity	immunity	NN	I-NP	O
.	.	.	O	O

Therapeutic	Therapeutic	JJ	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
type	type	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
IFN	IFN	NN	I-NP	I-protein
(	(	(	O	O
IFN-alpha/beta	IFN-alpha/beta	NN	B-NP	B-protein
)	)	)	O	O
has	have	VBZ	B-VP	O
become	become	VBN	I-VP	O
common	common	JJ	B-ADJP	O
.	.	.	O	O

Many	Many	JJ	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
diverse	diverse	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
targeted	target	VBN	B-VP	O
are	be	VBP	B-VP	O
marked	mark	VBN	I-VP	O
by	by	IN	B-PP	O
pathogenetic	pathogenetic	JJ	B-NP	O
abnormalities	abnormality	NNS	I-NP	O
in	in	IN	B-PP	O
cell-mediated	cell-mediated	JJ	B-NP	O
immunity	immunity	NN	I-NP	O
(	(	(	O	O
CMI	CMI	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
these	these	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
either	either	CC	O	O
causing	cause	VBG	B-VP	O
injury	injury	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
host	host	NN	I-NP	O
,	,	,	O	O
lacking	lack	VBG	B-VP	O
sufficient	sufficient	JJ	B-NP	O
vigor	vigor	NN	I-NP	O
for	for	IN	B-PP	O
virus	virus	NN	B-NP	O
or	or	CC	O	O
tumor	tumor	NN	B-NP	O
clearance	clearance	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
both	both	DT	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-NP	O
,	,	,	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
efficacy	efficacy	NN	I-NP	O
is	be	VBZ	B-VP	O
limited	limit	VBN	B-ADJP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
thus	thus	RB	B-ADJP	O
notable	notable	JJ	I-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
pleiotropic	pleiotropic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
type	type	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
IFN	IFN	NN	I-NP	I-protein
on	on	IN	B-PP	O
CMI	CMI	NN	B-NP	B-protein
remain	remain	VBP	B-VP	O
poorly	poorly	RB	B-ADJP	O
understood	understand	VBN	I-ADJP	O
.	.	.	O	O

We	We	PRP	B-NP	O
characterized	characterize	VBD	B-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
type	type	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
IFN	IFN	NN	I-NP	I-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
IL-12	IL-12	NN	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
central	central	JJ	I-NP	B-protein
immunoregulatory	immunoregulatory	JJ	I-NP	I-protein
cytokine	cytokine	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CD4	CD4	NN	I-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
arm	arm	NN	I-NP	O
of	of	IN	B-PP	O
CMI	CMI	NN	B-NP	B-protein
.	.	.	O	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
type	type	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
IFN	IFN	NN	I-NP	I-protein
are	be	VBP	B-VP	O
potent	potent	JJ	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
of	of	IN	B-PP	O
IL-12	IL-12	NN	B-NP	B-protein
production	production	NN	I-NP	O
by	by	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
monocytes/macrophages	monocytes/macrophage	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
underlying	underlying	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
involves	involve	VBZ	B-VP	O
transcriptional	transcriptional	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-12p40	IL-12p40	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
,	,	,	O	O
marked	mark	VBN	B-VP	O
by	by	IN	B-PP	O
down-regulation	down-regulation	NN	B-NP	O
of	of	IN	B-PP	O
PU.1	PU.1	NN	B-NP	B-protein
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
upstream	upstream	JJ	I-NP	B-DNA
Ets	Ets	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-12p40	IL-12p40	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

Type	Type	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
IFN	IFN	NN	I-NP	I-protein
have	have	VBP	B-VP	O
previously	previously	RB	I-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
substitute	substitute	VB	I-VP	O
for	for	IN	B-PP	O
IL-12	IL-12	NN	B-NP	B-protein
in	in	IN	B-PP	O
driving	drive	VBG	B-VP	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
production	production	NN	I-NP	O
from	from	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
NK	NK	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
IFN-alpha/beta	IFN-alpha/beta	NN	B-NP	B-protein
to	to	TO	B-VP	O
suppress	suppress	VB	I-VP	O
IL-12	IL-12	NN	B-NP	B-protein
production	production	NN	I-NP	O
while	while	IN	B-SBAR	O
up-regulating	up-regulate	VBG	B-VP	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
production	production	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
mechanistic	mechanistic	JJ	I-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
difficulties	difficulty	NNS	I-NP	O
of	of	IN	B-PP	O
employing	employ	VBG	B-VP	O
these	these	DT	B-NP	O
cytokines	cytokine	NNS	I-NP	B-protein
in	in	IN	B-PP	O
diseases	disease	NNS	B-NP	O
involving	involve	VBG	B-VP	O
abnormalities	abnormality	NNS	B-NP	O
of	of	IN	B-PP	O
CMI	CMI	NN	B-NP	B-protein
.	.	.	O	O

Nuclear	Nuclear	JJ	B-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
suppressive	suppressive	JJ	I-NP	O
and	and	CC	I-NP	O
inhibitor-kappaB	inhibitor-kappaB	NN	I-NP	O
stimulatory	stimulatory	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
troglitazone	troglitazone	NN	B-NP	O
in	in	IN	B-PP	O
obese	obese	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
type	type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
:	:	:	O	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
antiinflammatory	antiinflammatory	JJ	I-NP	O
action	action	NN	I-NP	O
?	?	.	O	O

It	It	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
recently	recently	RB	B-ADVP	O
that	that	IN	B-SBAR	O
troglitazone	troglitazone	NN	B-NP	O
exerts	exert	VBZ	B-VP	O
an	an	DT	B-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	O
effect	effect	NN	I-NP	O
,	,	,	O	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
experimental	experimental	JJ	B-NP	O
animals	animal	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
test	test	VB	I-VP	O
these	these	DT	B-NP	O
properties	property	NNS	I-NP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
troglitazone	troglitazone	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
proinflammatory	proinflammatory	JJ	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
nuclear	nuclear	JJ	I-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
and	and	CC	O	O
its	its	PRP$	B-NP	O
inhibitory	inhibitory	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
IkappaB	IkappaB	NN	I-NP	B-protein
in	in	IN	B-PP	O
mononuclear	mononuclear	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
MNC	MNC	NN	B-NP	B-cell_type
)	)	)	O	O
and	and	CC	O	O
plasma	plasma	NN	B-NP	B-protein
soluble	soluble	JJ	I-NP	I-protein
intracellular	intracellular	JJ	I-NP	I-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
,	,	,	O	O
monocyte	monocyte	NN	B-NP	B-protein
chemoattractant	chemoattractant	NN	I-NP	I-protein
protein-1	protein-1	NN	I-NP	I-protein
,	,	,	O	O
plasminogen	plasminogen	NN	B-NP	B-protein
activator	activator	NN	I-NP	I-protein
inhibitor-1	inhibitor-1	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
C-reactive	C-reactive	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
troglitazone	troglitazone	NN	B-NP	O
on	on	IN	B-PP	O
reactive	reactive	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
species	specie	NNS	I-NP	O
generation	generation	NN	I-NP	O
,	,	,	O	O
p47	p47	NN	B-NP	B-protein
(	(	(	O	I-protein
phox	phox	NN	B-NP	I-protein
)	)	)	O	I-protein
subunit	subunit	NN	B-NP	I-protein
expression	expression	NN	I-NP	O
,	,	,	O	O
9-hydroxyoctadecadienoic	9-hydroxyoctadecadienoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
9-HODE	9-HODE	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
13-HODE	13-HODE	NN	B-NP	O
,	,	,	O	O
o-tyrosine	o-tyrosine	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
m-tyrosine	m-tyrosine	NN	B-NP	O
in	in	IN	B-PP	O
obese	obese	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
type	type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
.	.	.	O	O

Seven	Seven	CD	B-NP	O
obese	obese	JJ	I-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
type	type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
troglitazone	troglitazone	NN	B-NP	O
(	(	(	O	O
400	400	CD	B-NP	O
mg/day	mg/day	NN	I-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
4	4	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
at	at	IN	B-PP	O
weekly	weekly	JJ	B-NP	O
intervals	interval	NNS	I-NP	O
.	.	.	O	O

Nuclear	Nuclear	JJ	B-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
MNC	MNC	NN	B-NP	B-cell_type
nuclear	nuclear	JJ	I-NP	O
extracts	extract	NNS	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
after	after	IN	B-PP	O
troglitazone	troglitazone	NN	B-NP	O
treatment	treatment	NN	I-NP	O
at	at	IN	B-PP	O
week	week	NN	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
week	week	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
hand	hand	NN	I-NP	O
,	,	,	O	O
IkappaB	IkappaB	NN	B-NP	B-protein
protein	protein	NN	I-NP	O
levels	level	NNS	I-NP	O
increased	increase	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
after	after	IN	B-PP	O
troglitazone	troglitazone	NN	B-NP	O
treatment	treatment	NN	I-NP	O
at	at	IN	B-PP	O
week	week	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
increase	increase	NN	I-NP	O
persisted	persist	VBD	B-VP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

Plasma	Plasma	NN	B-NP	B-protein
monocyte	monocyte	NN	I-NP	I-protein
chemoattractant	chemoattractant	NN	I-NP	I-protein
protein-1	protein-1	NN	I-NP	I-protein
and	and	CC	O	O
soluble	soluble	JJ	B-NP	O
intracellular	intracellular	JJ	I-NP	O
adhesion	adhesion	NN	I-NP	O
molecule-1	molecule-1	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
decrease	decrease	VB	I-VP	O
significantly	significantly	RB	B-ADVP	O
after	after	IN	B-PP	O
troglitazone	troglitazone	NN	B-NP	O
treatment	treatment	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
trend	trend	NN	I-NP	O
toward	toward	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
.	.	.	O	O

Reactive	Reactive	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
species	species	NN	I-NP	O
generation	generation	NN	I-NP	O
by	by	IN	B-PP	O
polymorphonuclear	polymorphonuclear	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
MNC	MNC	NN	B-NP	B-cell_type
,	,	,	O	O
p47	p47	NN	B-NP	B-protein
(	(	(	O	I-protein
phox	phox	NN	B-NP	I-protein
)	)	)	O	I-protein
subunit	subunit	NN	B-NP	I-protein
protein	protein	NN	I-NP	O
quantities	quantity	NNS	I-NP	O
,	,	,	O	O
plasminogen	plasminogen	NN	B-NP	B-protein
activator	activator	NN	I-NP	I-protein
inhibitor-1	inhibitor-1	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
C-reactive	C-reactive	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
levels	level	NNS	I-NP	O
decreased	decrease	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
after	after	IN	B-PP	O
troglitazone	troglitazone	NN	B-NP	O
intake	intake	NN	I-NP	O
.	.	.	O	O

13-HODE/linoleic	13-HODE/linoleic	JJ	B-NP	O
acid	acid	NN	I-NP	O
and	and	CC	O	O
9-HODE/linoleic	9-HODE/linoleic	JJ	B-NP	O
acid	acid	NN	I-NP	O
ratios	ratio	NNS	I-NP	O
also	also	RB	B-ADVP	O
decreased	decrease	VBD	B-VP	O
after	after	IN	B-PP	O
troglitazone	troglitazone	NN	B-NP	O
intake	intake	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
o-tyrosine/phenylalanine	o-tyrosine/phenylalanine	JJ	B-NP	O
and	and	CC	I-NP	O
m-tyrosine/phenylalanine	m-tyrosine/phenylalanine	JJ	I-NP	O
ratios	ratio	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
change	change	VB	I-VP	O
significantly	significantly	RB	B-ADVP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
troglitazone	troglitazone	NN	B-NP	O
has	have	VBZ	B-VP	O
profound	profound	VBN	I-VP	O
antiinflammatory	antiinflammatory	JJ	B-NP	O
effects	effect	NNS	I-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
antioxidant	antioxidant	JJ	B-NP	O
effects	effect	NNS	I-NP	O
in	in	IN	B-PP	O
obese	obese	JJ	B-NP	O
type	type	NN	I-NP	O
2	2	CD	B-NP	O
diabetics	diabetic	NNS	I-NP	O
;	;	:	O	O
these	these	DT	B-NP	O
effects	effect	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
relevant	relevant	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
recently	recently	RB	I-NP	O
described	describe	VBN	I-NP	O
beneficial	beneficial	JJ	I-NP	O
antiatherosclerotic	antiatherosclerotic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
troglitazone	troglitazone	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
vascular	vascular	JJ	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

OX40	OX40	NN	B-NP	B-protein
stimulation	stimulation	NN	I-NP	O
by	by	IN	B-PP	O
gp34/OX40	gp34/OX40	NN	B-NP	B-protein
ligand	ligand	NN	I-NP	I-protein
enhances	enhance	VBZ	B-VP	O
productive	productive	JJ	B-NP	O
human	human	JJ	I-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

OX40	OX40	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tumor	tumor	NN	I-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	I-protein
TNF	TNF	NN	B-NP	I-protein
)	)	)	O	I-protein
receptor	receptor	NN	B-NP	I-protein
superfamily	superfamily	NN	I-NP	I-protein
and	and	CC	O	O
known	know	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
costimulatory	costimulatory	JJ	I-NP	B-protein
molecule	molecule	NN	I-NP	I-protein
expressed	express	VBN	B-VP	O
on	on	IN	B-PP	O
activated	activate	VBN	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
costimulation	costimulation	NN	B-NP	O
of	of	IN	B-PP	O
OX40	OX40	NN	B-NP	B-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
HIV-1	HIV-1	NN	B-NP	O
)	)	)	O	O
infection	infection	NN	B-NP	O
by	by	IN	B-PP	O
its	its	PRP$	B-NP	O
natural	natural	JJ	I-NP	O
ligand	ligand	NN	I-NP	O
,	,	,	O	O
gp34	gp34	NN	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
OX40-transfected	OX40-transfected	JJ	I-NP	B-cell_line
ACH-2	ACH-2	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
,	,	,	O	O
ACH-2/OX40	ACH-2/OX40	NN	B-NP	B-cell_line
,	,	,	O	O
chronically	chronically	RB	B-VP	O
infected	infect	VBN	I-VP	O
with	with	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
cocultured	coculture	VBN	I-VP	O
with	with	IN	B-PP	O
paraformaldehyde	paraformaldehyde	NN	B-NP	B-cell_line
(	(	(	O	I-cell_line
PFA	PFA	NN	B-NP	I-cell_line
)	)	)	O	I-cell_line
-fixed	-fixed	JJ	B-NP	I-cell_line
gp34-transfected	gp34-transfected	JJ	I-NP	I-cell_line
mouse	mouse	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
,	,	,	O	O
SV-T2/gp34	SV-T2/gp34	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
HIV-1	HIV-1	NN	B-NP	O
production	production	NN	I-NP	O
was	be	VBD	B-VP	O
strongly	strongly	RB	I-VP	O
induced	induce	VBN	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
apparent	apparent	JJ	B-NP	O
apoptosis	apoptosis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
both	both	DT	B-NP	O
processes	process	NNS	I-NP	O
were	be	VBD	B-VP	O
specifically	specifically	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
gp34	gp34	NN	I-NP	B-protein
-specific	-specific	JJ	I-NP	O
neutralizing	neutralize	VBG	B-VP	O
monoclonal	monoclonal	JJ	B-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
5A8	5A8	NN	I-NP	I-protein
.	.	.	O	O

Endogenous	Endogenous	JJ	B-NP	O
TNF	TNF	NN	I-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
(	(	(	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
TNF-beta	TNF-beta	NN	B-NP	B-protein
production	production	NN	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
enhanced	enhance	VBN	I-NP	O
HIV-1	HIV-1	NN	I-NP	O
production	production	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
enhanced	enhance	VBN	B-NP	O
HIV-1	HIV-1	NN	I-NP	O
transcription	transcription	NN	I-NP	O
in	in	IN	B-PP	O
gp34	gp34	NN	B-NP	B-cell_line
-stimulated	-stimulated	JJ	I-NP	I-cell_line
ACH-2/OX40	ACH-2/OX40	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
was	be	VBD	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
kappa	kappa	NN	I-NP	B-DNA
B	B	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HIV-1	HIV-1	NN	I-NP	B-DNA
long	long	JJ	I-NP	I-DNA
terminal	terminal	JJ	I-NP	I-DNA
repeat	repeat	NN	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
OX40-gp34	OX40-gp34	NN	I-NP	O
interaction	interaction	NN	I-NP	O
activated	activate	VBD	B-VP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
p50	p50	NN	B-NP	B-protein
and	and	CC	I-NP	O
p65	p65	NN	I-NP	B-protein
subunits	subunit	NNS	I-NP	I-protein
.	.	.	O	O

When	When	WRB	B-ADVP	O
primary	primary	JJ	B-NP	B-cell_type
activated	activate	VBN	I-NP	I-cell_type
CD4	CD4	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
T	T	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
acutely	acutely	RB	B-VP	O
infected	infect	VBN	I-VP	O
with	with	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	O
(	(	(	O	O
NL4-3	NL4-3	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
CXCR4-using	CXCR4-using	JJ	B-NP	O
T-cell-line-tropic	T-cell-line-tropic	JJ	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
cocultured	coculture	VBN	I-VP	O
with	with	IN	B-PP	O
PFA-fixed	PFA-fixed	JJ	B-NP	B-cell_line
gp34	gp34	NN	I-NP	I-cell_line
(	(	(	O	I-cell_line
+	+	SYM	O	I-cell_line
)	)	)	O	I-cell_line
human	human	JJ	B-NP	I-cell_line
T-cell	T-cell	NN	I-NP	I-cell_line
leukemia	leukemia	NN	I-NP	I-cell_line
virus	virus	NN	I-NP	I-cell_line
type	type	NN	I-NP	I-cell_line
1-bearing	1-bearing	JJ	I-NP	I-cell_line
MT-2	MT-2	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
or	or	CC	O	O
SV-T2/gp34	SV-T2/gp34	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
HIV-1	HIV-1	NN	B-NP	O
production	production	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
markedly	markedly	RB	I-VP	O
enhanced	enhance	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
enhancement	enhancement	NN	I-NP	O
was	be	VBD	B-VP	O
again	again	RB	I-VP	O
significantly	significantly	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
5A8	5A8	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
first	first	RB	B-ADVP	O
shows	show	VBZ	B-VP	O
that	that	IN	B-SBAR	O
OX40-gp34	OX40-gp34	NN	B-NP	O
interaction	interaction	NN	I-NP	O
stimulates	stimulate	VBZ	B-VP	O
HIV-1	HIV-1	NN	B-NP	O
expression	expression	NN	I-NP	O
and	and	CC	O	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
OX40	OX40	NN	B-NP	B-protein
triggering	triggering	NN	I-NP	O
by	by	IN	B-PP	O
gp34	gp34	NN	B-NP	B-protein
may	may	MD	B-VP	O
play	play	VB	I-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
enhancing	enhance	VBG	B-VP	O
HIV-1	HIV-1	NN	B-NP	O
production	production	NN	I-NP	O
in	in	IN	B-PP	O
both	both	CC	I-PP	O
acutely	acutely	RB	I-PP	O
and	and	CC	O	O
latently	latently	RB	B-NP	O
infected	infected	JJ	I-NP	O
CD4	CD4	NN	I-NP	B-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
T	T	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

Troglitazone	Troglitazone	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
PPARgamma	PPARgamma	NN	I-NP	B-protein
ligand	ligand	NN	I-NP	O
,	,	,	O	O
inhibits	inhibit	VBZ	B-VP	O
osteopontin	osteopontin	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
monocytes/macrophage	monocytes/macrophage	NN	I-NP	I-cell_line
THP-1	THP-1	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Peroxizome	Peroxizome	NN	B-NP	B-protein
proliferator-activated	proliferator-activated	JJ	I-NP	I-protein
receptor-gamma	receptor-gamma	NN	I-NP	I-protein
(	(	(	O	O
PPARgamma	PPARgamma	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
family	family	NN	I-NP	I-protein
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
regulate	regulate	VBP	B-VP	O
adipocyte	adipocyte	NN	B-NP	B-cell_type
differentiation	differentiation	NN	I-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
studies	study	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
liganded	liganded	JJ	B-NP	O
PPARgamma	PPARgamma	NN	I-NP	B-protein
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
promotes	promote	VBZ	B-VP	O
differentiation	differentiation	NN	B-NP	O
but	but	CC	O	O
also	also	RB	B-VP	O
inhibits	inhibit	VBZ	I-VP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
macrophages	macrophage	NNS	B-NP	B-cell_type
.	.	.	O	O

Osteopontin	Osteopontin	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
extracellular	extracellular	JJ	B-NP	O
matrix	matrix	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
synthesized	synthesize	VBN	I-VP	O
by	by	IN	B-PP	O
macrophages	macrophage	NNS	B-NP	B-cell_type
in	in	IN	B-PP	O
atherosclerotic	atherosclerotic	JJ	B-NP	O
plaques	plaque	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
examined	examine	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
PPARgamma	PPARgamma	NN	B-NP	B-protein
ligand	ligand	NN	I-NP	O
regulates	regulate	VBZ	B-VP	O
osteopontin	osteopontin	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
THP-1	THP-1	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
a	a	DT	B-NP	O
cell	cell	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
monocytic	monocytic	JJ	I-NP	I-cell_type
leukemia	leukemia	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
which	which	WDT	B-NP	O
can	can	MD	B-VP	O
differentiate	differentiate	VB	I-VP	O
to	to	TO	B-PP	O
macrophage	macrophage	NN	B-NP	B-cell_type
upon	upon	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
with	with	IN	B-PP	O
phorbol	phorbol	NN	B-NP	O
ester	ester	NN	I-NP	O
PMA	PMA	NN	I-NP	O
.	.	.	O	O

Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
osteopontin	osteopontin	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
markedly	markedly	RB	I-VP	O
induced	induce	VBN	I-VP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
PMA	PMA	NN	B-NP	O
.	.	.	O	O

Troglitazone	Troglitazone	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
PPARgamma	PPARgamma	NN	I-NP	B-protein
ligand	ligand	NN	I-NP	O
,	,	,	O	O
dramatically	dramatically	RB	B-ADVP	O
attenuated	attenuate	VBD	B-VP	O
the	the	DT	B-NP	O
PMA-induced	PMA-induced	JJ	I-NP	O
osteopontin	osteopontin	NN	I-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O

Transient	Transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
assays	assay	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
osteopontin	osteopontin	NN	I-NP	I-DNA
promoter/luciferase	promoter/luciferase	NN	I-NP	I-DNA
construct	construct	NN	I-NP	I-DNA
which	which	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
5'-flanking	5'-flanking	JJ	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
between	between	IN	B-PP	O
-1500	-1500	CD	B-NP	O
and	and	CC	I-NP	O
+87	+87	CD	I-NP	O
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-DNA
start	start	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
either	either	CC	O	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
troglitazone	troglitazone	NN	B-NP	O
or	or	CC	I-NP	O
cotransfection	cotransfection	NN	I-NP	O
of	of	IN	B-PP	O
PPARgamma	PPARgamma	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
vector	vector	NN	I-NP	O
inhibits	inhibit	VBZ	B-VP	O
osteopontin	osteopontin	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
activity	activity	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
troglitazone	troglitazone	NN	B-NP	O
reduces	reduce	VBZ	B-VP	O
osteopontin	osteopontin	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
at	at	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
level	level	NN	I-NP	O
through	through	IN	B-PP	O
PPARgamma	PPARgamma	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
suggest	suggest	VBP	B-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
troglitazone	troglitazone	NN	B-NP	O
in	in	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
macrophages	macrophage	NNS	B-NP	B-cell_type
to	to	TO	B-VP	O
produce	produce	VB	I-VP	O
extracellular	extracellular	JJ	B-NP	O
matrix	matrix	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
particularly	particularly	RB	B-ADJP	O
relevant	relevant	JJ	I-ADJP	O
to	to	TO	B-PP	O
atherosclerotic	atherosclerotic	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
formation	formation	NN	I-NP	O
.	.	.	O	O

Transcription	Transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
regulates	regulate	VBZ	B-VP	O
Ig	Ig	NN	B-NP	B-DNA
lambda	lambda	NN	I-NP	I-DNA
light	light	JJ	I-NP	I-DNA
chain	chain	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
rearrangement	rearrangement	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
tissue-	tissue-	NN	I-NP	O
and	and	CC	I-NP	O
stage-specific	stage-specific	JJ	I-NP	O
assembly	assembly	NN	I-NP	O
of	of	IN	B-PP	O
Ig	Ig	NN	B-NP	B-DNA
and	and	CC	I-NP	I-DNA
TCR	TCR	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	B-protein
V	V	NN	I-NP	I-protein
(	(	(	O	I-protein
D	D	NN	B-NP	I-protein
)	)	)	O	I-protein
J	J	NN	B-NP	I-protein
recombinase	recombinase	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
in	in	IN	B-PP	O
precursor	precursor	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Directed	Direct	VBN	B-NP	O
alterations	alteration	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
accessibility	accessibility	NN	I-NP	O
of	of	IN	B-PP	O
V	V	NNP	B-NP	O
,	,	,	O	O
D	D	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
J	J	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
segments	segment	NNS	I-NP	I-DNA
target	target	VBP	B-VP	O
the	the	DT	B-NP	O
recombinase	recombinase	NN	I-NP	O
to	to	TO	B-PP	O
specific	specific	JJ	B-NP	O
Ag	Ag	NN	I-NP	O
receptor	receptor	NN	I-NP	O
loci	locus	NNS	I-NP	O
.	.	.	O	O

Accessibility	Accessibility	NN	B-NP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
given	give	VBN	I-NP	O
locus	locus	NN	I-NP	O
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
with	with	IN	B-PP	O
cognate	cognate	JJ	B-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
and	and	CC	O	O
correlates	correlate	VBZ	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
unrearranged	unrearranged	JJ	B-NP	O
gene	gene	NN	I-NP	O
segments	segment	NNS	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
demonstrated	demonstrate	VBN	B-VP	O
in	in	IN	B-PP	O
our	our	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
rearrangement	rearrangement	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Igkappa	Igkappa	NN	I-NP	B-DNA
locus	locus	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
inducible	inducible	JJ	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Igkappa	Igkappa	NN	I-NP	B-DNA
locus	locus	NN	I-NP	I-DNA
,	,	,	O	O
known	know	VBN	B-VP	O
transcriptional	transcriptional	JJ	B-NP	B-DNA
control	control	NN	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Iglambda	Iglambda	NNP	I-NP	B-DNA
locus	locus	NN	I-NP	I-DNA
lack	lack	VBP	B-VP	O
functional	functional	JJ	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
.	.	.	O	O

Consistent	Consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
observation	observation	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
assembled	assemble	VBN	B-NP	O
Iglambda	Iglambda	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
mature	mature	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
independent	independent	JJ	B-ADJP	O
.	.	.	O	O

Nonetheless	Nonetheless	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
now	now	RB	B-ADVP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
specific	specific	JJ	B-NP	O
repression	repression	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
inhibits	inhibit	VBZ	B-VP	O
germline	germline	NN	B-NP	B-DNA
transcription	transcription	NN	I-NP	O
and	and	CC	O	O
recombination	recombination	NN	B-NP	O
of	of	IN	B-PP	O
Iglambda	Iglambda	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
segments	segment	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
precursor	precursor	NN	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Molecular	Molecular	JJ	B-NP	O
analyses	analysis	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
block	block	NN	I-NP	O
in	in	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
impairs	impair	VBZ	B-VP	O
Iglambda	Iglambda	NNP	B-NP	O
rearrangement	rearrangement	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
recombinase	recombinase	NN	B-NP	O
accessibility	accessibility	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
known	know	VBN	B-NP	O
Iglambda	Iglambda	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
and	and	CC	I-NP	O
enhancer	enhancer	NN	I-NP	B-DNA
elements	element	NNS	I-NP	I-DNA
are	be	VBP	B-VP	O
unaffected	unaffected	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
cellular	cellular	JJ	I-NP	O
background	background	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
expand	expand	VBP	B-VP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
action	action	NN	I-NP	O
in	in	IN	B-PP	O
precursor	precursor	NN	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
beyond	beyond	IN	B-PP	O
Igkappa	Igkappa	NN	B-NP	B-protein
to	to	TO	B-VP	O
include	include	VB	I-VP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
recombinational	recombinational	JJ	B-NP	O
accessibility	accessibility	NN	I-NP	O
at	at	IN	B-PP	O
both	both	CC	O	O
L	L	NN	B-NP	B-DNA
chain	chain	NN	I-NP	I-DNA
loci	locus	NNS	I-NP	I-DNA
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
our	our	PRP$	B-NP	O
results	result	NNS	I-NP	O
strongly	strongly	RB	B-ADVP	O
suggest	suggest	VBP	B-VP	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
Iglambda	Iglambda	NN	I-NP	B-DNA
regulatory	regulatory	JJ	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
either	either	CC	O	O
directly	directly	RB	B-VP	O
or	or	CC	I-VP	O
indirectly	indirectly	RB	I-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
during	during	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
stages	stage	NNS	I-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

Transcription	Transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
STAT5A	STAT5A	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
substrate	substrate	NN	I-NP	O
of	of	IN	B-PP	O
Bruton	Bruton	NNP	B-NP	B-protein
's	's	POS	B-NP	I-protein
tyrosine	tyrosine	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

STAT5A	STAT5A	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
regulator	regulator	NN	I-NP	O
of	of	IN	B-PP	O
proliferation	proliferation	NN	B-NP	O
,	,	,	O	O
differentiation	differentiation	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
apoptosis	apoptosis	NN	B-NP	O
in	in	IN	B-PP	O
lymphohematopoietic	lymphohematopoietic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
STAT5A	STAT5A	NN	B-NP	B-protein
can	can	MD	B-VP	O
serve	serve	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
substrate	substrate	NN	I-NP	O
of	of	IN	B-PP	O
Bruton	Bruton	NNP	B-NP	B-protein
's	's	POS	B-NP	I-protein
tyrosine	tyrosine	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
BTK	BTK	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Purified	Purify	VBN	B-NP	B-protein
recombinant	recombinant	JJ	I-NP	I-protein
BTK	BTK	NN	I-NP	I-protein
was	be	VBD	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
directly	directly	RB	B-VP	O
binding	bind	VBG	I-VP	O
purified	purify	VBN	I-VP	O
recombinant	recombinant	JJ	B-NP	O
STAT5A	STAT5A	NN	I-NP	B-protein
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
(	(	(	O	O
K	K	NN	B-NP	O
(	(	(	O	O
d	d	NN	B-NP	O
)	)	)	O	O
=	=	SYM	B-VP	O
44	44	CD	B-NP	O
nm	nm	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
as	as	IN	B-SBAR	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
surface	surface	NN	B-NP	O
plasmon	plasmon	NN	I-NP	O
resonance	resonance	NN	I-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
BIAcore	BIAcore	NN	I-NP	O
biosensor	biosensor	NN	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

BTK	BTK	NN	B-NP	B-protein
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
tyrosine-phosphorylating	tyrosine-phosphorylate	VBG	B-VP	O
ectopically	ectopically	RB	B-NP	O
expressed	express	VBN	I-NP	O
recombinant	recombinant	JJ	I-NP	O
STAT5A	STAT5A	NN	I-NP	B-protein
on	on	IN	B-PP	O
Tyr	Tyr	NN	B-NP	B-protein
(	(	(	O	O
694	694	CD	B-NP	O
)	)	)	O	O
both	both	CC	O	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
Janus	Janus	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
-independent	-independent	JJ	I-NP	O
fashion	fashion	NN	I-NP	O
.	.	.	O	O

BTK	BTK	NN	B-NP	B-protein
phosphorylated	phosphorylate	VBD	B-VP	O
the	the	DT	B-NP	O
Y665F	Y665F	NN	I-NP	B-protein
,	,	,	O	O
Y668F	Y668F	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
Y682F	Y682F	NN	B-NP	B-protein
,	,	,	O	O
Y683F	Y683F	NN	B-NP	B-protein
mutants	mutant	NNS	I-NP	I-protein
but	but	CC	B-NP	O
not	not	RB	I-NP	O
the	the	DT	B-NP	O
Y694F	Y694F	NN	I-NP	B-protein
mutant	mutant	NN	I-NP	I-protein
of	of	IN	B-PP	O
STAT5A	STAT5A	NN	B-NP	B-protein
.	.	.	O	O

STAT5A	STAT5A	NN	B-NP	B-protein
mutations	mutation	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Src	Src	NN	I-NP	B-protein
homology	homology	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
(	(	(	O	I-protein
SH2	SH2	NN	B-NP	I-protein
)	)	)	O	I-protein
and	and	CC	O	I-protein
SH3	SH3	NN	B-NP	I-protein
domains	domain	NNS	I-NP	I-protein
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
alter	alter	VB	I-VP	O
the	the	DT	B-NP	O
BTK	BTK	NN	I-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
tyrosine	tyrosine	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
.	.	.	O	O

Recombinant	Recombinant	JJ	B-NP	B-protein
BTK	BTK	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
with	with	IN	B-PP	O
mutant	mutant	JJ	B-NP	O
pleckstrin	pleckstrin	NN	I-NP	O
homology	homology	NN	I-NP	O
,	,	,	O	O
SH2	SH2	NN	B-NP	B-protein
,	,	,	O	O
or	or	CC	O	O
SH3	SH3	NN	B-NP	B-protein
domains	domain	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
phosphorylating	phosphorylate	VBG	B-VP	O
STAT5A	STAT5A	NN	B-NP	B-protein
,	,	,	O	O
whereas	whereas	IN	O	O
recombinant	recombinant	JJ	B-NP	B-protein
BTK	BTK	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
with	with	IN	B-PP	O
SH1/kinase	SH1/kinase	NN	B-NP	B-protein
domain	domain	NN	I-NP	I-protein
mutations	mutation	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O
.	.	.	O	O

In	In	IN	B-PP	O
pull-down	pull-down	JJ	B-NP	O
experiments	experiment	NNS	I-NP	O
,	,	,	O	O
only	only	RB	B-NP	O
full-length	full-length	JJ	I-NP	O
BTK	BTK	NN	I-NP	B-protein
and	and	CC	O	O
its	its	PRP$	B-NP	O
SH1/kinase	SH1/kinase	NN	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
(	(	(	O	O
but	but	CC	B-CONJP	O
not	not	RB	I-CONJP	O
the	the	DT	B-NP	O
pleckstrin	pleckstrin	NN	I-NP	O
homology	homology	NN	I-NP	O
,	,	,	O	O
SH2	SH2	NN	B-NP	B-protein
,	,	,	O	O
or	or	CC	O	O
SH3	SH3	NN	B-NP	B-protein
domains	domain	NNS	I-NP	I-protein
)	)	)	O	O
were	be	VBD	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
binding	bind	VBG	B-VP	O
STAT5A	STAT5A	NN	B-NP	B-protein
.	.	.	O	O

Ectopically	Ectopically	RB	B-NP	O
expressed	express	VBN	I-NP	O
BTK	BTK	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
was	be	VBD	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
tyrosine-phosphorylating	tyrosine-phosphorylating	JJ	B-NP	O
STAT5A	STAT5A	NN	I-NP	B-protein
both	both	CC	O	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

BTK	BTK	NN	B-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
tyrosine	tyrosine	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
ectopically	ectopically	RB	B-NP	O
expressed	express	VBN	I-NP	O
wild	wild	JJ	I-NP	O
type	type	NN	I-NP	O
(	(	(	O	O
but	but	CC	O	O
not	not	RB	O	O
Tyr	Tyr	NN	B-NP	B-protein
(	(	(	O	O
694	694	CD	B-NP	O
)	)	)	O	O
mutant	mutant	NN	B-NP	O
)	)	)	O	O
STAT5A	STAT5A	NN	B-NP	B-protein
enhanced	enhance	VBD	B-VP	O
its	its	PRP$	B-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
BTK	BTK	NN	B-NP	B-cell_line
-competent	-competent	JJ	I-NP	I-cell_line
chicken	chicken	NN	I-NP	I-cell_line
B	B	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
anti-IgM-stimulated	anti-IgM-stimulated	JJ	B-NP	O
tyrosine	tyrosine	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
STAT5	STAT5	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
was	be	VBD	B-VP	O
prevented	prevent	VBN	I-VP	O
by	by	IN	B-PP	O
pretreatment	pretreatment	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
BTK	BTK	NN	I-NP	B-protein
inhibitor	inhibitor	NN	I-NP	O
LFM-A13	LFM-A13	NN	I-NP	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
by	by	IN	I-PP	O
pretreatment	pretreatment	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
JAK3	JAK3	NN	I-NP	B-protein
inhibitor	inhibitor	NN	I-NP	O
HI-P131	HI-P131	NN	I-NP	O
.	.	.	O	O

B	B	NN	B-NP	B-protein
cell	cell	NN	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
ligation	ligation	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
enhanced	enhance	VBN	B-NP	O
tyrosine	tyrosine	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
STAT5	STAT5	NN	B-NP	B-protein
in	in	IN	B-PP	O
BTK	BTK	NN	B-NP	B-protein
-deficient	-deficient	JJ	I-NP	O
chicken	chicken	NN	I-NP	O
B	B	NN	I-NP	O
cells	cell	NNS	I-NP	O
reconstituted	reconstitute	VBN	B-VP	O
with	with	IN	B-PP	O
wild	wild	JJ	B-NP	B-protein
type	type	NN	I-NP	I-protein
human	human	JJ	I-NP	I-protein
BTK	BTK	NN	I-NP	I-protein
but	but	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
BTK	BTK	NN	B-NP	B-cell_line
-deficient	-deficient	JJ	I-NP	I-cell_line
chicken	chicken	NN	I-NP	I-cell_line
B	B	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
reconstituted	reconstitute	VBN	B-VP	O
with	with	IN	B-PP	O
kinase-inactive	kinase-inactive	JJ	B-NP	B-protein
mutant	mutant	JJ	I-NP	I-protein
BTK	BTK	NN	I-NP	I-protein
.	.	.	O	O

Similarly	Similarly	RB	B-ADVP	O
,	,	,	O	O
anti-IgM	anti-IgM	JJ	B-NP	B-protein
stimulation	stimulation	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
enhanced	enhance	VBN	B-NP	O
tyrosine	tyrosine	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
STAT5A	STAT5A	NN	B-NP	B-protein
in	in	IN	B-PP	O
BTK	BTK	NN	B-NP	B-cell_type
-competent	-competent	JJ	I-NP	I-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
wild	wild	JJ	B-NP	O
type	type	NN	I-NP	O
mice	mouse	NNS	I-NP	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
BTK	BTK	NN	B-NP	B-cell_line
-deficient	-deficient	JJ	I-NP	I-cell_line
B	B	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
from	from	IN	B-PP	O
XID	XID	NN	B-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
XID	XID	NN	B-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
JAK3	JAK3	NN	B-NP	B-protein
knockout	knockout	NN	I-NP	O
mice	mouse	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
STAT5A	STAT5A	NN	I-NP	B-protein
phosphorylation	phosphorylation	NN	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
anti-IgM	anti-IgM	JJ	B-NP	B-protein
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
provide	provide	VBP	B-VP	O
unprecedented	unprecedented	JJ	B-NP	O
experimental	experimental	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
that	that	IN	B-SBAR	O
BTK	BTK	NN	B-NP	B-protein
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
nonredundant	nonredundant	JJ	I-NP	O
and	and	CC	I-NP	O
pivotal	pivotal	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
antigen	antigen	NN	I-NP	O
receptor-mediated	receptor-mediated	JJ	I-NP	O
STAT5A	STAT5A	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type

Role	Role	NN	B-NP	O
of	of	IN	B-PP	O
T-bet	T-bet	NN	B-NP	B-protein
in	in	IN	B-PP	O
commitment	commitment	NN	B-NP	O
of	of	IN	B-PP	O
TH1	TH1	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
before	before	IN	B-PP	O
IL-12	IL-12	NN	B-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
selection	selection	NN	I-NP	O
.	.	.	O	O

How	How	WRB	B-ADVP	O
cytokines	cytokine	NNS	B-NP	B-protein
control	control	VBP	B-VP	O
differentiation	differentiation	NN	B-NP	O
of	of	IN	B-PP	O
helper	helper	NN	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
(	(	(	I-NP	I-cell_type
TH	TH	NN	I-NP	I-cell_type
)	)	)	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
controversial	controversial	JJ	B-ADJP	O
.	.	.	O	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
T-bet	T-bet	NN	B-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
apparent	apparent	JJ	B-NP	O
assistance	assistance	NN	I-NP	O
from	from	IN	B-PP	O
interleukin	interleukin	NN	B-NP	B-protein
12	12	CD	I-NP	I-protein
(	(	(	O	O
IL-12	IL-12	NN	B-NP	B-protein
)	)	)	O	O
/	/	SYM	B-NP	O
STAT4	STAT4	NN	I-NP	B-protein
,	,	,	O	O
specifies	specify	VBZ	B-VP	O
TH1	TH1	NN	B-NP	O
effector	effector	NN	I-NP	O
fate	fate	NN	I-NP	O
by	by	IN	B-PP	O
targeting	target	VBG	B-VP	O
chromatin	chromatin	NN	B-NP	B-DNA
remodeling	remodeling	NN	I-NP	O
to	to	TO	B-PP	O
individual	individual	JJ	B-NP	O
interferon-gamma	interferon-gamma	NN	I-NP	B-protein
(	(	(	O	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
)	)	)	O	O
alleles	allele	NNS	B-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
inducing	induce	VBG	B-VP	O
IL-12	IL-12	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
beta2	beta2	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

Subsequently	Subsequently	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
appears	appear	VBZ	B-VP	O
that	that	IN	B-SBAR	O
IL-12	IL-12	NN	B-NP	B-protein
/	/	SYM	B-NP	O
STAT4	STAT4	NN	I-NP	B-protein
serves	serve	VBZ	B-VP	O
two	two	CD	B-NP	O
essential	essential	JJ	I-NP	O
functions	function	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
TH1	TH1	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
:	:	:	O	O
as	as	IN	B-SBAR	O
growth	growth	NN	B-NP	O
signal	signal	NN	I-NP	O
,	,	,	O	O
inducing	induce	VBG	B-VP	O
survival	survival	NN	B-NP	O
and	and	CC	I-NP	O
cell	cell	NN	I-NP	O
division	division	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
as	as	IN	B-PP	O
trans-activator	trans-activator	NN	B-NP	B-protein
,	,	,	O	O
prolonging	prolong	VBG	B-VP	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
synthesis	synthesis	NN	I-NP	O
through	through	IN	B-PP	O
a	a	DT	B-NP	O
genetic	genetic	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
coactivator	coactivator	NN	I-NP	B-protein
,	,	,	O	O
CREB-binding	CREB-binding	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
cytokine	cytokine	NN	I-NP	B-protein
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
simply	simply	RB	I-VP	O
induce	induce	VB	I-VP	O
TH	TH	NN	B-NP	O
fate	fate	NN	I-NP	O
choice	choice	NN	I-NP	O
but	but	CC	O	O
instead	instead	RB	B-VP	O
may	may	MD	I-VP	O
act	act	VB	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
essential	essential	JJ	I-NP	O
secondary	secondary	JJ	I-NP	O
stimulus	stimulus	NN	I-NP	O
that	that	WDT	B-NP	O
mediates	mediate	VBZ	B-VP	O
selective	selective	JJ	B-NP	O
survival	survival	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
lineage	lineage	NN	I-NP	O
.	.	.	O	O

Stat6	Stat6	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
necessary	necessary	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
sufficient	sufficient	JJ	I-ADJP	O
for	for	IN	B-PP	O
IL-4	IL-4	NN	B-NP	B-protein
's	's	POS	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
Th2	Th2	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
and	and	CC	O	O
cell	cell	NN	B-NP	O
expansion	expansion	NN	I-NP	O
.	.	.	O	O

IL-4	IL-4	NN	B-NP	B-protein
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
differentiation	differentiation	NN	I-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
CR-stimulated	CR-stimulated	JJ	I-NP	I-cell_type
naive	naive	JJ	I-NP	I-cell_type
CD4	CD4	NN	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Th2	Th2	NN	I-NP	B-cell_type
phenotype	phenotype	NN	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
IL-4	IL-4	NN	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
IL-4R	IL-4R	NN	I-NP	B-protein
activates	activate	VBZ	B-VP	O
a	a	DT	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
phosphotyrosine	phosphotyrosine	NN	B-NP	B-protein
binding	binding	NN	I-NP	I-protein
domain-containing	domain-containing	JJ	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
,	,	,	O	O
including	include	VBG	B-PP	O
insulin	insulin	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
substrate	substrate	NN	I-NP	I-protein
1/2	1/2	CD	I-NP	I-protein
,	,	,	O	O
Shc	Shc	NNP	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
IL-4R	IL-4R	NN	B-NP	B-protein
interacting	interact	VBG	B-VP	I-protein
protein	protein	NN	B-NP	I-protein
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Stat6	Stat6	NN	B-NP	B-protein
.	.	.	O	O

Stat6	Stat6	NN	B-NP	B-protein
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
Th2	Th2	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
roles	role	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
phosphotyrosine	phosphotyrosine	NN	I-NP	B-protein
binding	binding	NN	I-NP	I-protein
adaptors	adaptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
Th2	Th2	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
prepared	prepare	VBD	B-VP	O
a	a	DT	B-NP	O
retrovirus	retrovirus	NN	I-NP	O
containing	contain	VBG	B-VP	O
a	a	DT	B-NP	O
mutant	mutant	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-protein
(	(	(	O	I-protein
h	h	NN	B-NP	I-protein
)	)	)	O	I-protein
IL-4R	IL-4R	NN	B-NP	I-protein
alpha-chain	alpha-chain	NN	I-NP	I-protein
,	,	,	O	O
Y497F	Y497F	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
recruit	recruit	VB	I-VP	O
these	these	DT	B-NP	O
adaptors	adaptor	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mutant	mutant	JJ	I-NP	B-protein
hIL-4Ralpha	hIL-4Ralpha	NN	I-NP	I-protein
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
wild-type	wild-type	JJ	I-NP	B-protein
(	(	(	O	I-protein
WT	WT	JJ	O	I-protein
)	)	)	O	I-protein
hIL-4Ralpha	hIL-4Ralpha	NN	B-NP	I-protein
,	,	,	O	O
was	be	VBD	B-VP	O
introduced	introduce	VBN	I-VP	O
into	into	IN	B-PP	O
naive	naive	JJ	B-NP	B-cell_type
CD4	CD4	NN	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Upon	Upon	IN	B-PP	O
hIL-4	hIL-4	NN	B-NP	B-protein
stimulation	stimulation	NN	I-NP	O
,	,	,	O	O
Y497F	Y497F	NN	B-NP	B-protein
worked	work	VBD	B-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
WT	WT	JJ	I-NP	B-protein
hIL-4Ralpha	hIL-4Ralpha	NN	I-NP	I-protein
in	in	IN	B-PP	O
driving	drive	VBG	B-VP	O
Th2	Th2	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
measured	measure	VBN	B-VP	O
by	by	IN	B-PP	O
Gata3	Gata3	NN	B-NP	B-protein
up-regulation	up-regulation	NN	I-NP	O
and	and	CC	O	O
IL-4	IL-4	NN	B-NP	B-protein
production	production	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
IL-4-driven	IL-4-driven	JJ	B-NP	O
cell	cell	NN	I-NP	O
expansion	expansion	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
normal	normal	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
infected	infect	VBN	B-VP	O
with	with	IN	B-PP	O
Y497F	Y497F	NN	B-NP	B-protein
,	,	,	O	O
although	although	IN	B-SBAR	O
cells	cell	NNS	B-NP	O
infected	infect	VBN	B-VP	O
with	with	IN	B-PP	O
Y497F	Y497F	NN	B-NP	B-protein
were	be	VBD	B-VP	O
not	not	RB	B-ADJP	O
capable	capable	JJ	I-ADJP	O
of	of	IN	B-PP	O
phosphorylating	phosphorylate	VBG	B-VP	O
insulin	insulin	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
substrate	substrate	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
signal	signal	NN	I-NP	O
pathway	pathway	NN	I-NP	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
Y497	Y497	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
dispensable	dispensable	JJ	B-ADJP	O
for	for	IN	B-PP	O
both	both	CC	O	O
IL-4	IL-4	NN	B-NP	B-protein
-driven	-driven	JJ	I-NP	O
Th2	Th2	NN	I-NP	O
differentiation	differentiation	NN	I-NP	O
and	and	CC	O	O
cell	cell	NN	B-NP	O
expansion	expansion	NN	I-NP	O
.	.	.	O	O

Both	Both	CC	O	O
WT	WT	NN	B-NP	O
and	and	CC	I-NP	O
Y497F	Y497F	NN	I-NP	B-protein
hIL-4Ralpha	hIL-4Ralpha	NN	I-NP	I-protein
lose	lose	VBP	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
drive	drive	VB	I-VP	O
Th2	Th2	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
and	and	CC	O	O
cell	cell	NN	B-NP	O
expansion	expansion	NN	I-NP	O
in	in	IN	B-PP	O
Stat6-knockout	Stat6-knockout	JJ	B-NP	B-cell_type
CD4	CD4	NN	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

A	A	DT	B-NP	O
constitutively	constitutively	RB	I-NP	O
activated	activated	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
Stat6	Stat6	NN	B-NP	B-protein
introduced	introduce	VBN	B-VP	O
into	into	IN	B-PP	O
CD4	CD4	NN	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
both	both	CC	O	O
Th2	Th2	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
and	and	CC	O	O
enhanced	enhance	VBN	B-NP	O
cell	cell	NN	I-NP	O
expansion	expansion	NN	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
activated	activate	VBN	B-NP	O
Stat6	Stat6	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
necessary	necessary	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
sufficient	sufficient	JJ	I-ADJP	O
to	to	TO	B-VP	O
mediate	mediate	VB	I-VP	O
both	both	CC	O	O
IL-4	IL-4	NN	B-NP	B-protein
-driven	-driven	JJ	I-NP	O
Th2	Th2	NN	I-NP	O
differentiation	differentiation	NN	I-NP	O
and	and	CC	O	O
cell	cell	NN	B-NP	O
expansion	expansion	NN	I-NP	O
in	in	IN	B-PP	O
CD4	CD4	NN	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	B-protein
regulatory	regulatory	JJ	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
on	on	IN	B-PP	O
cellular	cellular	JJ	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
:	:	:	O	O
derepression	derepression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
by	by	IN	B-PP	O
Tat	Tat	NN	B-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
HIV-infected	HIV-infected	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
dysregulation	dysregulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
immune	immune	JJ	I-NP	O
system	system	NN	I-NP	O
is	be	VBZ	B-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
severe	severe	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cytokine	cytokine	NN	I-NP	B-protein
network	network	NN	I-NP	I-protein
.	.	.	O	O

Increase	Increase	NN	B-NP	O
secretion	secretion	NN	I-NP	O
of	of	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
growth	growth	NN	I-NP	O
and	and	CC	O	O
differentiation	differentiation	NN	B-NP	O
cytokine	cytokine	NN	I-NP	B-protein
,	,	,	O	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
decisive	decisive	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
sensitization	sensitization	NN	B-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
for	for	IN	B-PP	O
activation	activation	NN	B-NP	O
induced	induce	VBD	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
and	and	CC	O	O
indirect	indirect	JJ	B-NP	O
death	death	NN	I-NP	O
of	of	IN	B-PP	O
activated	activate	VBN	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
through	through	IN	B-PP	O
augmented	augmented	JJ	B-NP	O
virus	virus	NN	I-NP	O
replication	replication	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
enhanced	enhance	VBN	B-NP	O
IL-2	IL-2	NN	I-NP	B-protein
secretion	secretion	NN	I-NP	O
and	and	CC	O	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
HIV	HIV	NN	I-NP	B-protein
Tat	Tat	NN	I-NP	I-protein
induces	induce	VBZ	B-VP	O
this	this	DT	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
increased	increase	VBN	B-NP	O
IL-2	IL-2	NN	I-NP	B-protein
secretion	secretion	NN	I-NP	O
is	be	VBZ	B-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
Tat	Tat	NN	B-NP	B-protein
-enhanced	-enhanced	JJ	I-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
activation	activation	NN	I-NP	O
.	.	.	O	O

Tat	Tat	NN	B-NP	B-protein
derepresses	derepresse	VBZ	B-VP	O
and	and	CC	I-VP	O
activates	activate	VBZ	I-VP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	B-DNA
AP-1	AP-1	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
(	(	(	O	O
position	position	NN	B-NP	B-DNA
-185	-185	CD	I-NP	I-DNA
to	to	TO	I-NP	I-DNA
-177	-177	CD	I-NP	I-DNA
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

In	In	IN	B-PP	O
nonstimulated	nonstimulated	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
a	a	DT	B-NP	O
repressor	repressor	NN	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
containing	contain	VBG	B-VP	O
NF-IL6	NF-IL6	NN	B-NP	B-protein
,	,	,	O	O
JunB	JunB	NN	B-NP	B-protein
,	,	,	O	O
c-Fos	c-Fos	NN	B-NP	B-protein
and	and	CC	I-NP	O
Fra-1	Fra-1	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
formed	form	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
AP-1	AP-1	NN	I-NP	B-DNA
(	(	(	O	I-DNA
IL-2/d	IL-2/d	NN	B-NP	I-DNA
)	)	)	O	I-DNA
site	site	NN	B-NP	I-DNA
and	and	CC	O	O
represses	repress	VBZ	B-VP	O
IL-2	IL-2	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
activity	activity	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
heterodimeric	heterodimeric	JJ	I-NP	B-protein
activator	activator	NN	I-NP	I-protein
containing	contain	VBG	B-VP	O
p65	p65	NN	B-NP	B-protein
and	and	CC	I-NP	O
c-Jun	c-Jun	NN	I-NP	B-protein
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
AP-1	AP-1	NN	B-NP	B-DNA
(	(	(	O	I-DNA
IL-2/d	IL-2/d	NN	B-NP	I-DNA
)	)	)	O	I-DNA
site	site	NN	B-NP	I-DNA
.	.	.	O	O

HIV	HIV	NN	B-NP	B-protein
Tat	Tat	NN	I-NP	I-protein
enhances	enhance	VBZ	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
and	and	CC	O	O
consequently	consequently	RB	B-ADVP	O
,	,	,	O	O
activates	activate	VBZ	B-VP	O
the	the	DT	B-NP	O
AP-1	AP-1	NN	B-NP	B-DNA
(	(	(	O	I-DNA
IL-2/d	IL-2/d	NN	B-NP	I-DNA
)	)	)	O	I-DNA
site	site	NN	B-NP	I-DNA
.	.	.	O	O

Our	Our	PRP$	B-NP	O
data	datum	NNS	I-NP	O
provide	provide	VBP	B-VP	O
evidence	evidence	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
HIV	HIV	NN	B-NP	B-protein
Tat	Tat	NN	I-NP	I-protein
dysregulates	dysregulate	VBZ	B-VP	O
IL-2	IL-2	NN	B-NP	B-protein
production	production	NN	I-NP	O
and	and	CC	O	O
therefore	therefore	RB	B-VP	O
may	may	MD	I-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
HIV-1	HIV-1	NN	I-NP	O
infection	infection	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
way	way	NN	I-NP	O
yet	yet	RB	B-ADVP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
clarified	clarify	VBN	I-VP	O
.	.	.	O	O

Transforming	Transform	VBG	B-NP	B-protein
growth	growth	NN	I-NP	I-protein
factor-beta1	factor-beta1	NN	I-NP	I-protein
interferes	interfere	VBZ	B-VP	O
with	with	IN	B-PP	O
thrombopoietin-induced	thrombopoietin-induced	JJ	B-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
in	in	IN	B-PP	O
megakaryoblastic	megakaryoblastic	JJ	B-NP	O
and	and	CC	I-NP	O
erythroleukemic	erythroleukemic	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

OBJECTIVE	OBJECTIVE	NN	B-NP	O
:	:	:	O	O
Thrombopoietin	Thrombopoietin	NN	B-NP	B-protein
(	(	(	O	O
TPO	TPO	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
transforming	transform	VBG	B-VP	B-protein
growth	growth	NN	B-NP	I-protein
factor-beta	factor-beta	NN	I-NP	I-protein
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
(	(	(	O	O
TGF-beta	TGF-beta	NN	B-NP	B-protein
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
)	)	)	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
exert	exert	VB	I-VP	O
opposite	opposite	JJ	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
proliferation	proliferation	NN	B-NP	O
and	and	CC	O	O
megakaryocytic	megakaryocytic	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
of	of	IN	B-PP	O
hematopoietic	hematopoietic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

To	To	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
TGF-beta	TGF-beta	NN	B-NP	B-protein
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
interferes	interfere	VBZ	B-VP	O
directly	directly	RB	B-ADVP	O
with	with	IN	B-PP	O
TPO	TPO	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
in	in	IN	B-PP	O
hematopoietic	hematopoietic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
we	we	PRP	B-NP	O
compared	compare	VBD	B-VP	O
the	the	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	O
effects	effect	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
TPO	TPO	NN	I-NP	B-cell_line
-responsive	-responsive	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
Mo-7e	Mo-7e	NN	I-NP	O
and	and	CC	I-NP	O
HEL	HEL	NN	I-NP	B-protein
.	.	.	O	O

MATERIALS	MATERIALS	NNS	B-NP	O
AND	AND	CC	I-NP	O
METHODS	METHODS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
cells	cell	NNS	I-NP	O
were	be	VBD	B-VP	O
stimulated	stimulate	VBN	I-VP	O
by	by	IN	B-PP	O
100	100	CD	B-NP	O
ng/mL	ng/mL	NN	I-NP	O
TPO	TPO	NN	I-NP	B-protein
and/or	and/or	CC	O	O
100	100	CD	B-NP	O
ng/mL	ng/mL	NN	I-NP	O
TGF-beta1	TGF-beta1	NN	I-NP	B-protein
and	and	CC	O	O
analyzed	analyze	VBN	B-VP	O
for	for	IN	B-PP	O
proliferation	proliferation	NN	B-NP	O
(	(	(	O	O
3H	3H	NN	B-NP	O
thymidine	thymidine	NN	I-NP	O
incorporation	incorporation	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
viability	viability	NN	B-NP	O
(	(	(	O	O
trypan	trypan	NN	B-NP	O
blue	blue	JJ	I-NP	O
exclusion	exclusion	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
protein	protein	NN	B-NP	O
expression	expression	NN	B-NP	O
and	and	CC	O	O
phosphorylation	phosphorylation	NN	B-NP	O
(	(	(	O	O
Western	Western	NN	B-NP	O
blot	blot	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
TPO	TPO	NN	B-NP	B-protein
enhanced	enhance	VBD	B-VP	O
the	the	DT	B-NP	O
proliferation	proliferation	NN	I-NP	O
of	of	IN	B-PP	O
Mo-7e	Mo-7e	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
as	as	IN	B-SBAR	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
3H-thymidine	3H-thymidine	NN	B-NP	O
incorporation	incorporation	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
TGF-beta1	TGF-beta1	NN	B-NP	B-protein
suppressed	suppress	VBD	B-VP	O
baseline	baseline	NN	B-NP	O
cell	cell	NN	I-NP	O
growth	growth	NN	I-NP	O
and	and	CC	O	O
antagonized	antagonize	VBD	B-VP	O
the	the	DT	B-NP	O
proliferative	proliferative	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
TPO	TPO	NN	B-NP	B-protein
.	.	.	O	O

TPO	TPO	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
proliferation	proliferation	NN	I-NP	O
also	also	RB	B-ADVP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mitogen-activated	mitogen-activated	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
MAPK	MAPK	NN	B-NP	B-protein
)	)	)	O	O
pathway	pathway	NN	B-NP	O
(	(	(	O	O
PD098059	PD098059	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
inhibits	inhibit	VBZ	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MAPK	MAPK	NN	I-NP	B-protein
extracellular	extracellular	JJ	I-NP	O
signal-regulated	signal-regulated	JJ	I-NP	O
kinases	kinase	NNS	I-NP	O
(	(	(	O	O
ERK	ERK	NN	B-NP	B-protein
)	)	)	O	O
ERK1	ERK1	NN	B-NP	B-protein
and	and	CC	I-NP	O
ERK2	ERK2	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
AG490	AG490	NN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
of	of	IN	B-PP	O
Janus	Janus	NN	B-NP	B-protein
kinase-2	kinase-2	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
completely	completely	RB	B-ADVP	O
blocked	block	VBD	B-VP	O
TPO	TPO	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
proliferation	proliferation	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
demonstrated	demonstrate	VBN	B-VP	O
by	by	IN	B-PP	O
Western	Western	JJ	B-NP	O
blotting	blotting	NN	I-NP	O
,	,	,	O	O
TGF-beta1	TGF-beta1	NN	B-NP	B-protein
reduced	reduce	VBD	B-VP	O
the	the	DT	B-NP	O
TPO	TPO	NN	I-NP	B-protein
-stimulated	-stimulated	JJ	I-NP	O
ERK1	ERK1	NN	I-NP	B-protein
/	/	SYM	B-NP	O
ERK2	ERK2	NN	B-NP	B-protein
and	and	CC	I-NP	O
STAT5	STAT5	NN	I-NP	B-protein
phosphorylation	phosphorylation	NN	I-NP	O
in	in	IN	B-PP	O
Mo-7e	Mo-7e	NN	B-NP	O
and	and	CC	I-NP	O
HEL	HEL	NN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

This	This	DT	B-NP	O
effect	effect	NN	I-NP	O
was	be	VBD	B-VP	O
completely	completely	RB	I-VP	O
reversed	reverse	VBN	I-VP	O
by	by	IN	B-PP	O
preincubation	preincubation	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
tyrosine	tyrosine	NN	I-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	O
(	(	(	O	O
Na3VO4	Na3VO4	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
TGF-beta1	TGF-beta1	NN	B-NP	B-protein
activated	activate	VBD	B-VP	O
a	a	DT	B-NP	O
phosphatase	phosphatase	NN	I-NP	B-protein
.	.	.	O	O

Although	Although	IN	B-SBAR	O
STAT3	STAT3	NN	B-NP	B-protein
also	also	RB	B-ADVP	O
was	be	VBD	B-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
TPO	TPO	NN	B-NP	B-protein
,	,	,	O	O
STAT3	STAT3	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
remained	remain	VBD	B-VP	O
unaltered	unaltered	JJ	B-ADJP	O
by	by	IN	B-PP	O
TGF-beta1	TGF-beta1	NN	B-NP	B-protein
.	.	.	O	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
Taken	Take	VBN	B-VP	O
together	together	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
TGF-beta1	TGF-beta1	NN	B-NP	B-protein
modulates	modulate	VBZ	B-VP	O
TPO	TPO	NN	B-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
megakaryocytic	megakaryocytic	JJ	B-NP	O
proliferation	proliferation	NN	I-NP	O
by	by	IN	B-PP	O
interfering	interfere	VBG	B-VP	O
with	with	IN	B-PP	O
TPO	TPO	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
by	by	IN	B-PP	O
reducing	reduce	VBG	B-VP	O
the	the	DT	B-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
MAPK	MAPK	NN	B-NP	B-protein
ERK1/ERK2	ERK1/ERK2	NN	I-NP	O
and	and	CC	I-NP	O
STAT5	STAT5	NN	I-NP	B-protein
.	.	.	O	O

Invariant	Invariant	JJ	B-NP	B-protein
chain	chain	NN	I-NP	I-protein
induces	induce	VBZ	B-VP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
maturation	maturation	NN	I-NP	O
by	by	IN	B-PP	O
activating	activate	VBG	B-VP	O
a	a	DT	B-NP	O
TAF	TAF	NN	I-NP	B-protein
(	(	(	O	O
II	II	CD	B-NP	O
)	)	)	O	O
105-NF-kappaB	105-NF-kappaB	NN	B-NP	O
-dependent	-dependent	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
program	program	NN	I-NP	O
.	.	.	O	O

Early	Early	JJ	B-NP	O
stages	stage	NNS	I-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
development	development	NN	I-NP	O
occur	occur	VBP	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
bone	bone	NN	I-NP	O
marrow	marrow	NN	I-NP	O
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
formation	formation	NN	B-NP	O
of	of	IN	B-PP	O
immature	immature	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

From	From	IN	B-PP	O
there	there	EX	B-NP	O
these	these	DT	B-NP	O
immature	immature	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
migrate	migrate	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
spleen	spleen	NN	I-NP	O
where	where	WRB	B-ADVP	O
they	they	PRP	B-NP	O
differentiate	differentiate	VBP	B-VP	O
to	to	TO	B-PP	O
mature	mature	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

This	This	DT	B-NP	O
final	final	JJ	I-NP	O
maturation	maturation	NN	I-NP	O
step	step	NN	I-NP	O
is	be	VBZ	B-VP	O
crucial	crucial	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
B	B	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-VP	O
become	become	VB	I-VP	O
responsive	responsive	JJ	B-ADJP	O
to	to	TO	B-PP	O
antigens	antigen	NNS	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
participate	participate	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Recently	Recently	RB	B-ADVP	O
,	,	,	O	O
invariant	invariant	JJ	B-NP	B-protein
chain	chain	NN	I-NP	I-protein
(	(	(	O	O
Ii	Ii	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
histocompatibility	histocompatibility	NN	I-NP	O
complex	complex	NN	I-NP	O
class	class	NN	I-NP	O
II	II	CD	I-NP	O
chaperone	chaperone	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
c-Rel	c-Rel	NN	B-NP	B-protein
and	and	CC	I-NP	O
p65/RelA	p65/RelA	NN	I-NP	B-protein
,	,	,	O	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
final	final	JJ	I-NP	O
antigen-independent	antigen-independent	JJ	I-NP	O
differentiation	differentiation	NN	I-NP	O
stage	stage	NN	I-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
the	the	DT	B-NP	O
spleen	spleen	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
link	link	NN	I-NP	O
between	between	IN	B-PP	O
Ii	Ii	NN	B-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
B	B	NN	I-NP	O
cell	cell	NN	I-NP	O
maturation	maturation	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
pathway	pathway	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
studies	study	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
Ii	Ii	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
B	B	NN	I-NP	O
cell	cell	NN	I-NP	O
maturation	maturation	NN	I-NP	O
involves	involve	VBZ	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
p65/RelA	p65/RelA	NN	I-NP	B-protein
homodimer	homodimer	NN	I-NP	I-protein
and	and	CC	O	O
requires	require	VBZ	B-VP	O
the	the	DT	B-NP	O
B	B	NN	I-NP	B-protein
cell-enriched	cell-enriched	JJ	I-NP	I-protein
coactivator	coactivator	NN	I-NP	I-protein
TBP-associated	TBP-associated	JJ	I-NP	O
factor	factor	NN	I-NP	O
(	(	(	O	O
II	II	CD	B-NP	O
)	)	)	O	O
105	105	CD	B-NP	O
.	.	.	O	O

Androgens	Androgen	NNS	B-NP	O
indirectly	indirectly	RB	B-ADVP	O
accelerate	accelerate	VBP	B-VP	O
thymocyte	thymocyte	NN	B-NP	B-cell_type
apoptosis	apoptosis	NN	I-NP	O
.	.	.	O	O

Apoptotic	Apoptotic	JJ	B-NP	O
processes	process	NNS	I-NP	O
,	,	,	O	O
or	or	CC	O	O
the	the	DT	B-NP	O
disturbance	disturbance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
natural	natural	JJ	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
processes	process	NNS	I-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
autoimmune	autoimmune	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
(	(	(	O	O
AID	AID	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Women	Woman	NNS	B-NP	O
are	be	VBP	B-VP	O
,	,	,	O	O
in	in	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
more	more	RBR	B-ADJP	O
susceptible	susceptible	JJ	I-ADJP	O
than	than	IN	B-SBAR	O
men	man	NNS	B-NP	O
to	to	TO	B-VP	O
develop	develop	VB	I-VP	O
AID	AID	NN	B-NP	O
like	like	IN	B-PP	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
.	.	.	O	O

Androgens	Androgen	NNS	B-NP	O
and	and	CC	I-NP	O
glucocorticoids	glucocorticoid	NNS	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
oestrogens	oestrogen	NNS	B-NP	O
,	,	,	O	O
have	have	VBP	B-VP	O
favourable	favourable	JJ	B-NP	O
effects	effect	NNS	I-NP	O
in	in	IN	B-PP	O
AID	AID	NN	B-NP	B-cell_line
models	model	NNS	I-NP	I-cell_line
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
AID	AID	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
that	that	IN	B-SBAR	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
(	(	(	O	O
GC	GC	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
used	use	VBN	B-VP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
AID	AID	NN	B-NP	O
,	,	,	O	O
increase	increase	VBP	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
thymus	thymus	NN	I-NP	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
CD4+	CD4+	JJ	B-NP	B-cell_type
CD8+	CD8+	JJ	I-NP	I-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
asked	ask	VBN	I-VP	O
whether	whether	IN	B-SBAR	O
androgens	androgen	NNS	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
oestrogens	oestrogen	NNS	B-NP	O
,	,	,	O	O
exert	exert	VBP	B-VP	O
their	their	PRP$	B-NP	O
favourable	favourable	JJ	I-NP	O
effects	effect	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
AID	AID	NN	B-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
comparable	comparable	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
described	describe	VBN	B-VP	O
for	for	IN	B-PP	O
GC	GC	NN	B-NP	O
by	by	IN	B-PP	O
eliminating	eliminate	VBG	B-VP	O
the	the	DT	B-NP	O
apoptosis	apoptosis	NN	I-NP	O
prone	prone	JJ	I-NP	O
CD4+	CD4+	JJ	I-NP	O
CD8+	CD8+	JJ	I-NP	O
population	population	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
thymus	thymus	NN	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
both	both	DT	B-NP	O
androgens	androgen	NNS	I-NP	O
and	and	CC	I-NP	O
oestrogens	oestrogen	NNS	I-NP	O
proved	prove	VBD	B-VP	O
thymolytic	thymolytic	JJ	B-ADJP	O
,	,	,	O	O
a	a	DT	B-NP	O
significantly	significantly	RB	I-NP	O
decreased	decrease	VBN	I-NP	O
percentage	percentage	NN	I-NP	O
of	of	IN	B-PP	O
CD4+	CD4+	JJ	B-NP	B-cell_type
CD8+	CD8+	JJ	I-NP	I-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
by	by	IN	B-PP	O
flow	flow	NN	B-NP	O
cytometry	cytometry	NN	I-NP	O
after	after	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
mice	mouse	NNS	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
androgen	androgen	NN	I-NP	O
methyltestosterone	methyltestosterone	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
oestrogen	oestrogen	NN	I-NP	O
ethinylestradiol	ethinylestradiol	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
whether	whether	IN	B-SBAR	O
the	the	DT	B-NP	O
observed	observe	VBN	I-NP	O
thymolytic	thymolytic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
were	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
hormone	hormone	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
on	on	IN	B-PP	O
thymocytes	thymocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
cells	cell	NNS	B-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
thymus	thymus	NN	I-NP	O
and	and	CC	O	O
incubated	incubate	VBN	B-VP	O
with	with	IN	B-PP	O
androgens	androgen	NNS	B-NP	O
or	or	CC	I-NP	O
oestrogens	oestrogen	NNS	I-NP	O
to	to	TO	B-VP	O
measure	measure	VB	I-VP	O
apoptosis	apoptosis	NN	B-NP	O
.	.	.	O	O

Several	Several	JJ	B-NP	O
techniques	technique	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
thymocyte	thymocyte	NN	B-NP	B-cell_type
apoptosis	apoptosis	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
enhanced	enhance	VBN	I-NP	O
apoptotic	apoptotic	JJ	I-NP	O
signal	signal	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
the	the	DT	B-NP	O
very	very	RB	I-NP	O
sensitive	sensitive	JJ	I-NP	O
TUNEL	TUNEL	NN	I-NP	O
assay	assay	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
direct	direct	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
androgens	androgen	NNS	B-NP	O
on	on	IN	B-PP	O
thymocytes	thymocyte	NNS	B-NP	B-cell_type
in	in	FW	B-PP	O
vitro	vitro	FW	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
sharp	sharp	JJ	B-NP	O
contrast	contrast	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
signal	signal	NN	I-NP	O
observed	observe	VBN	B-VP	O
with	with	IN	B-PP	O
GC	GC	NN	B-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
upon	upon	IN	B-PP	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
androgen	androgen	NN	I-NP	O
treatment	treatment	NN	I-NP	O
,	,	,	O	O
other	other	JJ	B-NP	O
cells	cell	NNS	I-NP	O
containing	contain	VBG	B-VP	O
androgen	androgen	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
than	than	IN	B-SBAR	O
thymocytes	thymocyte	NNS	B-NP	B-cell_type
are	be	VBP	B-VP	O
probably	probably	RB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
inducing	induce	VBG	B-VP	O
the	the	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
thymic	thymic	JJ	B-NP	O
apoptosis	apoptosis	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
study	study	VB	I-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
androgen	androgen	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
on	on	IN	B-PP	O
thymocyte	thymocyte	NN	B-NP	B-cell_type
apoptosis	apoptosis	NN	I-NP	O
,	,	,	O	O
androgen	androgen	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
mutant	mutant	NN	I-NP	I-protein
(	(	(	O	O
Tfm/Y	Tfm/Y	NN	B-NP	B-protein
)	)	)	O	O
mice	mouse	NNS	B-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
androgens	androgen	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
alterations	alteration	NNS	I-NP	O
of	of	IN	B-PP	O
thymocyte	thymocyte	NN	B-NP	B-cell_type
subpopulations	subpopulation	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
percentage	percentage	NN	I-NP	O
of	of	IN	B-PP	O
CD4+	CD4+	JJ	B-NP	B-cell_type
CD8+	CD8+	JJ	I-NP	I-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
after	after	IN	B-PP	O
administration	administration	NN	B-NP	O
of	of	IN	B-PP	O
androgens	androgen	NNS	B-NP	O
depend	depend	VBP	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
functional	functional	JJ	B-NP	O
androgen	androgen	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
androgens	androgen	NNS	B-NP	O
indirectly	indirectly	RB	B-ADVP	O
accelerate	accelerate	VBP	B-VP	O
thymocyte	thymocyte	NN	B-NP	B-cell_type
apoptosis	apoptosis	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
AP-1	AP-1	NN	B-NP	B-protein
and	and	CC	O	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
in	in	IN	B-PP	O
CD4	CD4	NN	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
peroxisome	peroxisome	NN	B-NP	B-protein
proliferator-activated	proliferator-activated	JJ	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
gamma	gamma	NN	I-NP	I-protein
ligands	ligand	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
peroxisome	peroxisome	NN	I-NP	B-protein
proliferator-activated	proliferator-activated	JJ	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
gamma	gamma	NN	I-NP	I-protein
(	(	(	O	O
PPARgamma	PPARgamma	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
hormone	hormone	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
superfamily	superfamily	NN	I-NP	I-protein
,	,	,	O	O
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
adipocyte	adipocyte	NN	B-NP	B-cell_type
differentiation	differentiation	NN	I-NP	O
and	and	CC	O	O
glucose	glucose	NN	B-NP	O
homeostasis	homeostasis	NN	I-NP	O
.	.	.	O	O

PPARgamma	PPARgamma	NN	B-NP	B-protein
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
recently	recently	RB	B-ADVP	O
to	to	TO	B-VP	O
regulate	regulate	VB	I-VP	O
macrophage	macrophage	NN	B-NP	O
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
mitogens	mitogen	NNS	B-NP	B-protein
and	and	CC	I-NP	O
inflammation	inflammation	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
study	study	NN	I-NP	O
shows	show	VBZ	B-VP	O
PPARgamma	PPARgamma	NN	B-NP	B-protein
to	to	TO	B-VP	O
be	be	VB	I-VP	O
preferentially	preferentially	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
nuclei	nucleus	NNS	I-NP	O
of	of	IN	B-PP	O
resting	rest	VBG	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
to	to	TO	B-VP	O
increase	increase	VB	I-VP	O
upon	upon	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
either	either	CC	B-NP	O
anti-CD3	anti-CD3	JJ	I-NP	B-protein
and	and	CC	I-NP	O
anti-CD28	anti-CD28	JJ	I-NP	B-protein
or	or	CC	I-NP	O
phorbol	phorbol	NN	I-NP	O
myristyl	myristyl	NN	I-NP	O
acetate	acetate	NN	I-NP	O
(	(	(	O	O
PMA	PMA	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
found	find	VBD	B-VP	O
the	the	DT	B-NP	O
PPARgamma	PPARgamma	NN	I-NP	B-protein
ligand	ligand	NN	I-NP	O
ciglitizone	ciglitizone	NN	I-NP	O
to	to	TO	B-VP	O
attenuate	attenuate	VB	I-VP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
cytokine	cytokine	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
and	and	CC	O	O
anti-CD3	anti-CD3	JJ	B-NP	B-protein
and	and	CC	I-NP	O
anti-CD28	anti-CD28	JJ	I-NP	B-protein
or	or	CC	I-NP	O
PMA-induced	PMA-induced	JJ	I-NP	O
proliferative	proliferative	JJ	I-NP	O
responses	response	NNS	I-NP	O
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
proliferative	proliferative	JJ	I-NP	O
response	response	NN	I-NP	O
and	and	CC	O	O
inflammatory	inflammatory	JJ	B-NP	B-protein
cytokine	cytokine	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
CD4	CD4	NN	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
suppression	suppression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
activated	activate	VBN	I-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
AP1	AP1	NN	B-NP	B-protein
and	and	CC	I-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
.	.	.	O	O

PPARgamma	PPARgamma	NN	B-NP	B-protein
ligands	ligand	NNS	I-NP	I-protein
also	also	RB	B-ADVP	O
strongly	strongly	RB	B-VP	O
inhibited	inhibit	VBD	I-VP	O
SEA-induced	SEA-induced	JJ	B-NP	O
Vbeta3	Vbeta3	NN	I-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
,	,	,	O	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
previous	previous	JJ	B-NP	O
findings	finding	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
PPARgamma	PPARgamma	NN	B-NP	B-protein
ligands	ligand	NNS	I-NP	I-protein
on	on	IN	B-PP	O
activated	activate	VBN	B-NP	B-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
,	,	,	O	O
provide	provide	VBP	B-VP	O
clear	clear	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
PPARgamma	PPARgamma	NN	B-NP	B-protein
as	as	IN	B-PP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
regulator	regulator	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
macrophage	macrophage	NN	B-NP	B-cell_type
and	and	CC	O	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	B-NP	I-cell_type
.	.	.	O	O

PPARgamma	PPARgamma	NN	B-NP	B-protein
may	may	MD	B-VP	O
thus	thus	RB	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
target	target	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
autoimmunity	autoimmunity	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
prominent	prominent	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
activator	activator	NN	B-NP	B-protein
protein-1	protein-1	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
2B4	2B4	NN	I-NP	I-DNA
(	(	(	O	I-DNA
CD244	CD244	NN	B-NP	I-DNA
)	)	)	O	I-DNA
gene	gene	NN	B-NP	I-DNA
in	in	IN	B-PP	O
NK	NK	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
cell	cell	NN	I-NP	B-protein
surface	surface	NN	I-NP	I-protein
glycoprotein	glycoprotein	NN	I-NP	I-protein
2B4	2B4	NN	I-NP	I-protein
(	(	(	O	O
CD244	CD244	NN	B-NP	B-protein
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ig	Ig	NN	I-NP	B-protein
superfamily	superfamily	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
NK	NK	NN	B-NP	O
and	and	CC	I-NP	O
T	T	NN	I-NP	O
lymphocyte	lymphocyte	NN	I-NP	O
functions	function	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
recently	recently	RB	I-VP	O
identified	identify	VBN	I-VP	O
CD48	CD48	NN	B-NP	B-protein
as	as	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	B-protein
affinity	affinity	NN	I-NP	I-protein
counterreceptor	counterreceptor	NN	I-NP	I-protein
for	for	IN	B-PP	O
2B4	2B4	NN	B-NP	B-protein
in	in	IN	B-PP	O
both	both	CC	B-NP	O
mice	mouse	NNS	I-NP	O
and	and	CC	I-NP	O
humans	human	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
2B4	2B4	NN	B-NP	B-protein
associates	associate	VBZ	B-VP	O
with	with	IN	B-PP	O
src	src	NN	B-NP	B-protein
homology	homology	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
domain-containing	domain-containing	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
or	or	CC	I-NP	O
signaling	signaling	NN	I-NP	B-protein
lymphocyte	lymphocyte	NN	I-NP	I-protein
activation	activation	NN	I-NP	I-protein
molecule-associated	molecule-associated	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
,	,	,	O	O
whose	whose	WP$	B-NP	O
mutation	mutation	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
underlying	underlie	VBG	I-NP	O
genetic	genetic	JJ	I-NP	O
defect	defect	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
X-linked	X-linked	JJ	I-NP	O
lymphoproliferative	lymphoproliferative	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
cloning	cloning	NN	I-NP	O
and	and	CC	I-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
2B4	2B4	NN	I-NP	I-DNA
(	(	(	O	I-DNA
h2B4	h2B4	NN	B-NP	I-DNA
)	)	)	O	I-DNA
promoter	promoter	NN	B-NP	I-DNA
.	.	.	O	O

Through	Through	IN	B-PP	O
primer	primer	NN	B-NP	O
extension	extension	NN	I-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
h2B4	h2B4	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
initiates	initiate	VBZ	B-VP	O
at	at	IN	B-PP	O
multiple	multiple	JJ	B-NP	B-DNA
start	start	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
isolated	isolate	VBD	B-VP	O
h2B4	h2B4	NN	B-NP	B-cell_line
genomic	genomic	JJ	I-NP	I-cell_line
clones	clone	NNS	I-NP	I-cell_line
and	and	CC	I-NP	O
PCR	PCR	NN	I-NP	O
amplified	amplify	VBD	B-VP	O
the	the	DT	B-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
untranslated	untranslated	JJ	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	B-DNA
elements	element	NNS	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
identified	identify	VBN	I-VP	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
AP-1	AP-1	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
that	that	WDT	B-NP	O
lies	lie	VBZ	B-VP	O
between	between	IN	B-PP	O
(	(	(	O	O
-106	-106	CD	O	B-DNA
to	to	TO	O	I-DNA
-100	-100	CD	B-NP	I-DNA
)	)	)	O	O
through	through	IN	B-PP	O
transient	transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
analysis	analysis	NN	I-NP	O
in	in	IN	B-PP	O
YT	YT	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	B-cell_line
NK	NK	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

EMSAs	EMSA	NNS	B-NP	O
with	with	IN	B-PP	O
Abs	Ab	NNS	B-NP	B-protein
specific	specific	JJ	B-ADJP	O
for	for	IN	B-PP	O
various	various	JJ	B-NP	O
protein	protein	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
AP-1	AP-1	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
multiple	multiple	JJ	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Jun	Jun	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
are	be	VBP	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
h2B4	h2B4	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

Mutation	Mutation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
AP-1	AP-1	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
abolishes	abolish	VBZ	B-VP	O
protein/DNA	protein/DNA	NN	B-NP	O
interactions	interaction	NNS	I-NP	O
but	but	CC	B-NP	O
also	also	RB	I-NP	O
promoter	promoter	NN	B-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
h2B4	h2B4	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

Functional	Functional	JJ	B-NP	O
correction	correction	NN	I-NP	O
of	of	IN	B-PP	O
FA-C	FA-C	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
with	with	IN	B-PP	O
FANCC	FANCC	NN	B-NP	B-protein
suppresses	suppress	VBZ	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
interferon	interferon	NN	B-NP	B-DNA
gamma-inducible	gamma-inducible	JJ	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

Because	Because	IN	B-SBAR	O
hematopoietic	hematopoietic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
Fanconi	Fanconi	NNP	B-NP	O
anemia	anemia	NN	I-NP	O
(	(	(	O	O
FA	FA	NN	B-NP	O
)	)	)	O	O
patients	patient	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
C-complementation	C-complementation	NN	I-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
FA-C	FA-C	NN	B-NP	B-protein
)	)	)	O	O
are	be	VBP	B-VP	O
hypersensitive	hypersensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
interferon	interferon	NN	B-NP	B-protein
gamma	gamma	NN	I-NP	I-protein
(	(	(	O	O
IFNgamma	IFNgamma	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
products	product	NNS	I-NP	O
of	of	IN	B-PP	O
certain	certain	JJ	B-NP	O
IFNgamma-inducible	IFNgamma-inducible	JJ	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
known	know	VBN	B-VP	O
to	to	TO	I-VP	O
influence	influence	VB	I-VP	O
hematopoietic	hematopoietic	JJ	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
survival	survival	NN	I-NP	O
were	be	VBD	B-VP	O
quantified	quantify	VBN	I-VP	O
.	.	.	O	O

High	High	JJ	B-NP	O
constitutive	constitutive	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IFNgamma-inducible	IFNgamma-inducible	JJ	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
,	,	,	O	O
IFN-stimulated	IFN-stimulated	JJ	B-NP	B-protein
gene	gene	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
3	3	CD	B-NP	I-protein
gamma	gamma	NN	I-NP	I-protein
subunit	subunit	NN	I-NP	I-protein
(	(	(	O	O
ISGF3gamma	ISGF3gamma	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
IFN	IFN	NN	B-NP	B-protein
regulatory	regulatory	JJ	I-NP	I-protein
factor-1	factor-1	NN	I-NP	I-protein
(	(	(	O	O
IRF-1	IRF-1	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
cyclin-dependent	cyclin-dependent	JJ	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	O
p21	p21	NN	I-NP	O
(	(	(	O	O
WAF1	WAF1	NN	B-NP	B-protein
)	)	)	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
FANCC	FANCC	NN	B-NP	B-cell_line
mutant	mutant	JJ	I-NP	I-cell_line
B	B	NN	I-NP	I-cell_line
lymphoblasts	lymphoblast	NNS	I-NP	I-cell_line
,	,	,	O	O
low-density	low-density	JJ	B-NP	B-cell_type
bone	bone	NN	I-NP	I-cell_type
marrow	marrow	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
murine	murine	JJ	B-NP	B-cell_type
embryonic	embryonic	JJ	I-NP	I-cell_type
fibroblasts	fibroblast	NNS	I-NP	I-cell_type
.	.	.	O	O

Paradoxically	Paradoxically	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
activate	activate	VB	I-VP	O
signal	signal	NN	B-NP	B-protein
transducer	transducer	NN	I-NP	I-protein
and	and	CC	I-NP	I-protein
activator	activator	NN	I-NP	I-protein
of	of	IN	B-PP	I-protein
transcription	transcription	NN	B-NP	I-protein
(	(	(	O	I-protein
STAT	STAT	NN	B-NP	I-protein
)	)	)	O	I-protein
1	1	CD	B-NP	I-protein
properly	properly	RB	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
an	an	DT	B-NP	O
attempt	attempt	NN	I-NP	O
to	to	TO	B-VP	O
clarify	clarify	VB	I-VP	O
mechanisms	mechanism	NNS	B-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
FA-C	FA-C	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
overexpress	overexpres	VBP	B-VP	O
IFNgamma-inducible	IFNgamma-inducible	JJ	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
face	face	NN	I-NP	O
of	of	IN	B-PP	O
defective	defective	JJ	B-NP	O
STAT1	STAT1	NN	I-NP	B-protein
phosphorylation	phosphorylation	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
reasoned	reason	VBN	I-VP	O
that	that	IN	B-SBAR	O
decreased	decrease	VBN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
activated	activate	VBN	B-NP	O
STAT1	STAT1	NN	I-NP	B-protein
might	might	MD	B-VP	O
result	result	VB	I-VP	O
in	in	IN	B-PP	O
reduced	reduce	VBN	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
hematopoietic	hematopoietic	JJ	I-NP	B-protein
IFNgamma-responsive	IFNgamma-responsive	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
that	that	WDT	B-NP	O
normally	normally	RB	B-ADVP	O
modulates	modulate	VBZ	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
IFNgamma-responsive	IFNgamma-responsive	JJ	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

Levels	Level	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IFNgamma	IFNgamma	NN	I-NP	B-protein
-inducible	-inducible	JJ	I-NP	O
factor	factor	NN	I-NP	O
IFN	IFN	NN	I-NP	O
consensus	consensus	NN	I-NP	O
sequence	sequence	NN	I-NP	O
binding	binding	NN	I-NP	O
protein	protein	NN	I-NP	O
(	(	(	O	O
ICSBP	ICSBP	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
trans-acting	trans-acting	JJ	I-NP	O
regulator	regulator	NN	I-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
IFNgamma-inducible	IFNgamma-inducible	JJ	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
,	,	,	O	O
were	be	VBD	B-VP	O
quantified	quantify	VBN	I-VP	O
.	.	.	O	O

ICSBP	ICSBP	NN	B-NP	B-protein
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
in	in	IN	B-PP	O
FA-C	FA-C	NN	B-NP	B-cell_line
B	B	NN	I-NP	I-cell_line
lymphoblasts	lymphoblast	NNS	I-NP	I-cell_line
and	and	CC	I-NP	O
MEFs	MEF	NNS	I-NP	B-protein
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
enforced	enforce	VBN	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
ICSBP	ICSBP	NN	B-NP	B-protein
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
down-regulate	down-regulate	VB	I-VP	O
IRF-1	IRF-1	NN	B-NP	B-protein
,	,	,	O	O
ISGF3gamma	ISGF3gamma	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
p21	p21	NN	B-NP	B-protein
(	(	(	O	I-protein
WAF1	WAF1	NN	B-NP	I-protein
)	)	)	O	I-protein
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
FANCC	FANCC	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
functions	function	VBZ	B-VP	O
to	to	TO	I-VP	O
modulate	modulate	VB	I-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
genes	gene	NNS	B-NP	O
that	that	IN	B-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
inducible	inducible	JJ	B-ADJP	O
only	only	RB	B-ADVP	O
by	by	IN	B-PP	O
specific	specific	JJ	B-NP	O
environmental	environmental	JJ	I-NP	O
cues	cue	NNS	I-NP	O
for	for	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
or	or	CC	O	O
mitogenic	mitogenic	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
it	it	PRP	B-NP	O
does	do	VBZ	B-VP	O
so	so	RB	B-ADVP	O
independently	independently	RB	I-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
classic	classic	JJ	I-NP	O
IFN-STAT1	IFN-STAT1	NN	I-NP	B-protein
pathway	pathway	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
the	the	DT	B-NP	O
direct	direct	JJ	I-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
reduced	reduce	VBN	B-NP	O
ICSBP	ICSBP	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
genetic	genetic	JJ	I-NP	O
investigation	investigation	NN	I-NP	O
of	of	IN	B-PP	O
E2A	E2A	NN	B-NP	B-protein
function	function	NN	I-NP	O
in	in	IN	B-PP	O
lymphocyte	lymphocyte	NN	B-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

Lymphocytes	Lymphocyte	NNS	B-NP	B-cell_type
are	be	VBP	B-VP	O
derived	derive	VBN	I-VP	O
from	from	IN	B-PP	O
hematopoietic	hematopoietic	JJ	B-NP	B-cell_type
stem	stem	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
HSC	HSC	NN	B-NP	B-cell_type
)	)	)	O	O
following	follow	VBG	B-PP	O
a	a	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
regulated	regulate	VBN	B-NP	O
differentiation	differentiation	NN	I-NP	O
events	event	NNS	I-NP	O
.	.	.	O	O

Multipotent	Multipotent	JJ	B-NP	O
HSCs	HSC	NNS	I-NP	B-cell_type
become	become	VBP	B-VP	O
committed	commit	VBN	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
B	B	NN	I-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
lineage	lineage	NN	I-NP	I-cell_type
in	in	IN	B-PP	O
bone	bone	NN	B-NP	O
marrow	marrow	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
lineage	lineage	NN	I-NP	I-cell_type
in	in	IN	B-PP	O
the	the	DT	B-NP	O
thymus	thymus	NN	I-NP	O
after	after	IN	B-PP	O
receiving	receive	VBG	B-VP	O
appropriate	appropriate	JJ	B-NP	O
signals	signal	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
corresponding	corresponding	JJ	I-NP	O
microenvironment	microenvironment	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
committed	commit	VBN	I-NP	B-cell_type
lymphoid	lymphoid	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
must	must	MD	B-VP	O
then	then	RB	I-VP	O
undergo	undergo	VB	I-VP	O
V	V	NN	B-NP	O
(	(	(	O	O
D	D	NN	B-NP	O
)	)	)	O	O
J	J	NN	B-NP	O
recombination	recombination	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
or	or	CC	O	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
receptor	receptor	NN	I-NP	O
gene	gene	NN	I-NP	O
locus	locus	NN	I-NP	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
clonal	clonal	JJ	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
functional	functional	JJ	B-NP	O
B	B	NN	I-NP	O
or	or	CC	I-NP	O
T	T	NN	I-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

Lymphocyte	Lymphocyte	NN	B-NP	O
commitment	commitment	NN	I-NP	O
and	and	CC	O	O
differentiation	differentiation	NN	B-NP	O
are	be	VBP	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
programmed	program	VBN	B-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
or	or	CC	O	O
repression	repression	NN	B-NP	O
events	event	NNS	I-NP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
driven	drive	VBN	I-VP	O
by	by	IN	B-PP	O
lineage	lineage	NN	B-NP	O
and	and	CC	O	O
stage	stage	NN	B-NP	O
specific	specific	JJ	I-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
basic-helix-loop-helix	basic-helix-loop-helix	JJ	I-NP	B-protein
(	(	(	O	I-protein
bHLH	bHLH	JJ	B-ADJP	I-protein
)	)	)	O	I-protein
transcription	transcription	NN	B-NP	I-protein
factors	factor	NNS	I-NP	I-protein
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
E2A	E2A	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
are	be	VBP	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
several	several	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
events	event	NNS	I-NP	O
during	during	IN	B-PP	O
B	B	NN	B-NP	O
and	and	CC	I-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
development	development	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
lineage	lineage	NN	B-NP	O
commitment	commitment	NN	I-NP	O
,	,	,	O	O
initiation	initiation	NN	B-NP	O
of	of	IN	B-PP	O
V	V	NN	B-NP	O
(	(	(	O	O
D	D	NN	B-NP	O
)	)	)	O	O
J	J	NN	B-NP	O
recombination	recombination	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
antigen	antigen	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
mediated	mediate	VBD	B-VP	O
proliferation	proliferation	NN	B-NP	O
and	and	CC	O	O
differentiation	differentiation	NN	B-NP	O
.	.	.	O	O

Several	Several	JJ	B-NP	O
recent	recent	JJ	I-NP	O
reviews	review	NNS	I-NP	O
have	have	VBP	B-VP	O
provided	provide	VBN	I-VP	O
a	a	DT	B-NP	O
comprehensive	comprehensive	JJ	I-NP	O
discussion	discussion	NN	I-NP	O
of	of	IN	B-PP	O
biochemical	biochemical	JJ	B-NP	O
,	,	,	I-NP	O
cellular	cellular	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
genetic	genetic	JJ	B-NP	O
research	research	NN	I-NP	O
on	on	IN	B-PP	O
E2A	E2A	NN	B-NP	B-protein
function	function	NN	I-NP	O
in	in	IN	B-PP	O
lymphocyte	lymphocyte	NN	B-NP	O
development	development	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
2	2	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
only	only	RB	B-ADVP	O
discuss	discuss	VBZ	B-VP	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genetic	genetic	JJ	I-NP	O
approaches	approach	VBZ	B-VP	O
our	our	PRP$	B-NP	O
laboratory	laboratory	NN	I-NP	O
(	(	(	O	O
except	except	IN	B-PP	O
where	where	WRB	B-ADVP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
noted	note	VBN	I-VP	O
)	)	)	O	O
has	have	VBZ	B-VP	O
undertaken	undertake	VBN	I-VP	O
to	to	TO	I-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
pathways	pathway	NNS	I-NP	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
E2A	E2A	NN	B-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
lymphocyte	lymphocyte	NN	B-NP	O
development	development	NN	I-NP	O

D609	D609	NN	B-NP	O
inhibits	inhibit	VBZ	B-VP	O
ionizing	ionize	VBG	I-VP	O
radiation-induced	radiation-induced	JJ	B-NP	O
oxidative	oxidative	JJ	I-NP	O
damage	damage	NN	I-NP	O
by	by	IN	B-PP	O
acting	act	VBG	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
antioxidant	antioxidant	NN	I-NP	O
.	.	.	O	O

Tricyclodecan-9-yl-xanthogenate	Tricyclodecan-9-yl-xanthogenate	NN	B-NP	O
(	(	(	O	O
D609	D609	NN	B-NP	O
)	)	)	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
extensively	extensively	RB	I-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
biological	biological	JJ	B-NP	O
systems	system	NNS	I-NP	O
and	and	CC	O	O
exhibits	exhibit	VBZ	B-VP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
biological	biological	JJ	B-NP	O
functions	function	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
antiviral	antiviral	JJ	B-NP	O
,	,	,	I-NP	O
antitumor	antitumor	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
anti-inflammatory	anti-inflammatory	JJ	B-NP	O
activities	activity	NNS	I-NP	O
.	.	.	O	O

Most	Most	JJS	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
activities	activity	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
largely	largely	RB	I-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
D609	D609	NN	B-NP	O
on	on	IN	B-PP	O
phosphatidylcholine-specific	phosphatidylcholine-specific	JJ	B-NP	B-protein
phospholipase	phospholipase	NN	I-NP	I-protein
C	C	NN	I-NP	I-protein
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
xanthate	xanthate	NN	I-NP	O
derivative	derivative	NN	I-NP	O
,	,	,	O	O
D609	D609	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
strong	strong	JJ	I-NP	O
electrolyte	electrolyte	NN	I-NP	O
and	and	CC	O	O
readily	readily	RB	B-VP	O
dissociates	dissociate	VBZ	I-VP	O
to	to	TO	I-VP	O
xanthate	xanthate	VB	I-VP	O
anions	anion	NNS	B-NP	O
and	and	CC	I-NP	O
cations	cation	NNS	I-NP	O
of	of	IN	B-PP	O
alkali	alkali	JJ	B-NP	O
metals	metal	NNS	I-NP	O
in	in	IN	B-PP	O
solution	solution	NN	B-NP	O
.	.	.	O	O

Xanthate	Xanthate	NN	B-NP	O
anions	anion	NNS	I-NP	O
and	and	CC	O	O
protonated	protonate	VBN	B-VP	O
xanthic	xanthic	JJ	B-NP	O
acid	acid	NN	I-NP	O
contain	contain	VBP	B-VP	O
a	a	DT	B-NP	O
free	free	JJ	I-NP	O
thiol	thiol	NN	I-NP	O
moiety	moiety	NN	I-NP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
highly	highly	RB	B-ADJP	O
reductive	reductive	JJ	I-ADJP	O
.	.	.	O	O

This	This	DT	B-NP	O
implies	imply	VBZ	B-VP	O
that	that	IN	B-SBAR	O
D609	D609	NN	B-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
xanthate	xanthate	NN	I-NP	O
derivatives	derivative	NNS	I-NP	O
may	may	MD	B-VP	O
function	function	VB	I-VP	O
as	as	IN	B-PP	O
potent	potent	JJ	B-NP	O
antioxidants	antioxidant	NNS	I-NP	O
.	.	.	O	O

Indeed	Indeed	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
D609	D609	NN	B-NP	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
Fenton	Fenton	NNP	I-NP	O
reaction-induced	reaction-induced	JJ	I-NP	O
oxidation	oxidation	NN	I-NP	O
of	of	IN	B-PP	O
dihydrorhodamine	dihydrorhodamine	NN	B-NP	O
123	123	CD	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
dose-dependent	dose-dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
pyrrolidinedithiocarbamate	pyrrolidinedithiocarbamate	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
well	well	RB	I-NP	O
known	know	VBN	I-NP	O
antioxidant	antioxidant	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
D609	D609	NN	B-NP	B-protein
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
alpha-phenyl-tert-butylnitrone-free	alpha-phenyl-tert-butylnitrone-free	JJ	I-NP	O
radical	radical	NN	I-NP	O
spin	spin	NN	I-NP	O
adducts	adduct	NNS	I-NP	O
and	and	CC	O	O
lipid	lipid	NN	B-NP	O
peroxidation	peroxidation	NN	I-NP	O
of	of	IN	B-PP	O
synaptosomal	synaptosomal	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Fenton	Fenton	NNP	I-NP	O
reagents	reagent	NNS	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
preincubation	preincubation	NN	B-NP	O
of	of	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
with	with	IN	B-PP	O
D609	D609	NN	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
diminution	diminution	NN	I-NP	O
of	of	IN	B-PP	O
ionizing	ionize	VBG	B-VP	O
radiation	radiation	NN	B-NP	O
(	(	(	O	O
IR	IR	NN	B-NP	O
)	)	)	O	O
-induced	-induced	JJ	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
production	production	NN	B-NP	O
of	of	IN	B-PP	O
reactive	reactive	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
species	specie	NNS	I-NP	O
;	;	:	O	O
2	2	LS	B-LST	O
)	)	)	O	O
decrease	decrease	VB	B-VP	O
in	in	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
reduced	reduce	VBN	I-NP	O
glutathione	glutathione	NN	I-NP	O
;	;	:	O	O
3	3	LS	B-LST	O
)	)	)	O	O
oxidative	oxidative	JJ	B-NP	O
damage	damage	NN	I-NP	O
to	to	TO	B-PP	O
proteins	protein	NNS	B-NP	O
and	and	CC	I-NP	O
lipids	lipid	NNS	I-NP	O
;	;	:	O	O
and	and	CC	O	O
4	4	LS	B-LST	O
)	)	)	O	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
D609	D609	NN	B-NP	O
(	(	(	O	O
50	50	CD	B-NP	O
mg/kg	mg/kg	NN	I-NP	O
i.v.	i.v.	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
to	to	TO	B-PP	O
mice	mouse	NNS	B-NP	O
10	10	CD	B-NP	O
min	min	NN	I-NP	O
prior	prior	JJ	B-ADVP	O
to	to	TO	B-PP	O
total	total	JJ	B-NP	O
body	body	NN	I-NP	O
IR	IR	NN	I-NP	O
(	(	(	O	O
6.5	6.5	CD	B-NP	O
and	and	CC	I-NP	O
8.5	8.5	CD	I-NP	O
Gy	Gy	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
it	it	PRP	B-NP	O
protected	protect	VBD	B-VP	O
the	the	DT	B-NP	O
mice	mouse	NNS	I-NP	O
from	from	IN	B-PP	O
IR-induced	IR-induced	JJ	B-NP	O
lethality	lethality	NN	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
D609	D609	NN	B-NP	B-DNA
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
antioxidant	antioxidant	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
inhibit	inhibit	VB	I-VP	O
IR-induced	IR-induced	JJ	B-NP	O
cellular	cellular	JJ	I-NP	O
oxidative	oxidative	JJ	I-NP	O
stress	stress	NN	I-NP	O
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-protein
by	by	IN	B-PP	O
the	the	DT	B-NP	O
glucocorticoid-inducible	glucocorticoid-inducible	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
GILZ	GILZ	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
immunosuppressive	immunosuppressive	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
arise	arise	VBP	B-VP	O
largely	largely	RB	B-ADVP	O
by	by	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
ascribed	ascribe	VBN	I-VP	O
to	to	TO	B-PP	O
interference	interference	NN	B-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
and	and	CC	O	O
transcription	transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
AP-1	AP-1	NN	B-NP	B-protein
and	and	CC	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
by	by	IN	B-PP	O
competition	competition	NN	B-NP	O
for	for	IN	B-PP	O
common	common	JJ	B-NP	B-protein
coactivators	coactivator	NNS	I-NP	I-protein
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
glucocorticoid-induced	glucocorticoid-induced	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
interleukin-2	interleukin-2	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
activated	activate	VBN	B-NP	O
normal	normal	JJ	I-NP	O
T	T	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
required	require	VBD	B-VP	O
new	new	JJ	B-NP	O
protein	protein	NN	I-NP	O
synthesis	synthesis	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
phenomenon	phenomenon	NN	I-NP	O
is	be	VBZ	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
glucocorticoid-regulated	glucocorticoid-regulated	JJ	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

One	One	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	B-DNA
prominent	prominent	JJ	I-NP	I-DNA
glucocorticoid-induced	glucocorticoid-induced	JJ	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
is	be	VBZ	B-VP	O
glucocorticoid-induced	glucocorticoid-induced	JJ	B-NP	O
leucine	leucine	NN	I-NP	O
zipper	zipper	NN	I-NP	O
(	(	(	O	O
GILZ	GILZ	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
to	to	TO	I-VP	O
inhibit	inhibit	VB	I-VP	O
activation-induced	activation-induced	JJ	B-NP	O
up-regulation	up-regulation	NN	I-NP	O
of	of	IN	B-PP	O
Fas	Fas	NN	B-NP	B-RNA
ligand	ligand	NN	I-NP	I-RNA
(	(	(	O	I-RNA
FasL	FasL	NN	B-NP	I-RNA
)	)	)	O	I-RNA
mRNA	mRNA	NN	B-NP	I-RNA
.	.	.	O	O

Indeed	Indeed	RB	B-ADVP	O
,	,	,	O	O
transient	transient	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
GILZ	GILZ	NN	B-NP	B-protein
in	in	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
blocked	block	VBD	B-VP	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
reporter	reporter	NN	I-NP	B-DNA
construct	construct	NN	I-NP	I-DNA
driven	drive	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
FasL	FasL	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

This	This	DT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
accounted	account	VBN	I-VP	O
for	for	IN	B-PP	O
by	by	IN	B-PP	O
GILZ	GILZ	NN	B-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
Egr-2	Egr-2	NN	B-NP	B-protein
and	and	CC	I-NP	O
Egr-3	Egr-3	NN	I-NP	B-protein
,	,	,	O	O
NFAT/AP-1	NFAT/AP-1	NN	B-NP	B-protein
-inducible	-inducible	JJ	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
bind	bind	VBP	B-VP	O
a	a	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
FasL	FasL	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
and	and	CC	O	O
up-regulate	up-regulate	VBP	B-VP	O
FasL	FasL	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

GILZ	GILZ	NN	B-NP	B-protein
also	also	RB	B-ADVP	O
potently	potently	RB	B-ADVP	O
inhibited	inhibit	VBD	B-VP	O
AP-1-driven	AP-1-driven	JJ	B-ADJP	O
and	and	CC	O	O
IL-2	IL-2	NN	B-NP	B-DNA
promoter-driven	promoter-driven	JJ	I-NP	I-DNA
reporter	reporter	NN	I-NP	I-DNA
constructs	construct	NNS	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
recombinant	recombinant	JJ	B-NP	B-protein
GILZ	GILZ	NN	I-NP	I-protein
specifically	specifically	RB	B-ADVP	O
interacted	interact	VBD	B-VP	O
with	with	IN	B-PP	O
c-Fos	c-Fos	NN	B-NP	B-protein
and	and	CC	I-NP	O
c-Jun	c-Jun	NN	I-NP	B-protein
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
active	active	JJ	B-NP	O
AP-1	AP-1	NN	I-NP	B-protein
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
target	target	NN	I-NP	O
DNA	DNA	NN	I-NP	O
.	.	.	O	O

Whereas	Whereas	IN	B-PP	O
homodimerization	homodimerization	NN	B-NP	O
of	of	IN	B-PP	O
GILZ	GILZ	NN	B-NP	B-protein
required	require	VBD	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
leucine	leucine	NN	I-NP	B-protein
zipper	zipper	NN	I-NP	I-protein
,	,	,	O	O
the	the	DT	B-NP	O
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
c-Fos	c-Fos	NN	B-NP	B-protein
and	and	CC	I-NP	O
c-Jun	c-Jun	NN	I-NP	B-protein
occurred	occur	VBD	B-VP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
N-terminal	N-terminal	JJ	I-NP	B-protein
60-amino	60-amino	JJ	I-NP	I-protein
acid	acid	NN	I-NP	I-protein
region	region	NN	I-NP	I-protein
of	of	IN	B-PP	O
GILZ	GILZ	NN	B-NP	B-protein
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
GILZ	GILZ	NN	B-NP	B-protein
represents	represent	VBZ	B-VP	O
a	a	DT	B-NP	O
glucocorticoid-induced	glucocorticoid-induced	JJ	I-NP	B-protein
gene	gene	NN	I-NP	I-protein
product	product	NN	I-NP	I-protein
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
inhibit	inhibit	VB	I-VP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
activation-induced	activation-induced	JJ	B-NP	O
events	event	NNS	I-NP	O
,	,	,	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
by	by	IN	B-PP	O
direct	direct	JJ	B-NP	O
interference	interference	NN	I-NP	O
with	with	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
therefore	therefore	RB	B-ADVP	O
a	a	DT	B-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
mediator	mediator	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid-induced	glucocorticoid-induced	JJ	B-NP	O
immunosuppression	immunosuppression	NN	I-NP	O
.	.	.	O	O

Pharmacokinetic	Pharmacokinetic	JJ	B-NP	O
differences	difference	NNS	I-NP	O
between	between	IN	B-PP	O
a	a	DT	B-NP	O
T	T	NN	I-NP	O
cell-tolerizing	cell-tolerizing	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
T	T	NN	I-NP	O
cell-activating	cell-activating	JJ	I-NP	O
peptide	peptide	NN	I-NP	O
.	.	.	O	O

Vaccination	Vaccination	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peptide	peptide	NN	I-NP	O
representing	represent	VBG	B-VP	O
a	a	DT	B-NP	O
CTL	CTL	NN	I-NP	B-protein
epitope	epitope	NN	I-NP	I-protein
from	from	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-protein
papillomavirus	papillomavirus	NN	I-NP	I-protein
(	(	(	O	I-protein
HPV	HPV	NN	B-NP	I-protein
)	)	)	O	I-protein
16	16	CD	B-NP	I-protein
E7	E7	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
induces	induce	VBZ	B-VP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
CTL	CTL	NN	I-NP	O
response	response	NN	I-NP	O
that	that	WDT	B-NP	O
prevents	prevent	VBZ	B-VP	O
the	the	DT	B-NP	O
outgrowth	outgrowth	NN	I-NP	O
of	of	IN	B-PP	O
HPV16	HPV16	NN	B-NP	O
E7-expressing	E7-expressing	JJ	I-NP	O
tumors	tumor	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
vaccination	vaccination	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peptide	peptide	NN	I-NP	O
encoding	encode	VBG	B-VP	O
an	an	DT	B-NP	O
adenovirus	adenovirus	NN	I-NP	B-protein
type	type	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
(	(	(	O	I-protein
Ad5	Ad5	NN	B-NP	I-protein
)	)	)	O	I-protein
E1A	E1A	NN	B-NP	I-protein
CTL	CTL	NN	I-NP	I-protein
epitope	epitope	NN	I-NP	I-protein
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
CTL	CTL	NN	B-NP	O
tolerance	tolerance	NN	I-NP	O
and	and	CC	O	O
enhanced	enhance	VBN	B-VP	O
growth	growth	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
Ad5	Ad5	NN	I-NP	O
E1A-expressing	E1A-expressing	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
why	why	WRB	B-ADVP	O
these	these	DT	B-NP	O
peptides	peptide	NNS	I-NP	O
induce	induce	VBP	B-VP	O
such	such	JJ	B-NP	O
opposite	opposite	JJ	I-NP	O
effects	effect	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
a	a	DT	B-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
pharmacokinetics	pharmacokinetic	NNS	B-NP	O
can	can	MD	B-VP	O
explain	explain	VB	I-VP	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	O
contrasts	contrast	NNS	I-NP	O
,	,	,	O	O
tritiated	tritiate	VBD	B-VP	O
Ad5	Ad5	NN	B-NP	B-protein
E1A	E1A	NN	I-NP	I-protein
and	and	CC	O	O
HPV16	HPV16	NN	B-NP	O
E7	E7	NN	I-NP	O
peptides	peptide	NNS	I-NP	O
were	be	VBD	B-VP	O
injected	inject	VBN	I-VP	O
into	into	IN	B-PP	O
mice	mouse	NNS	B-NP	O
.	.	.	O	O

Results	Result	NNS	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
tolerizing	tolerize	VBG	I-NP	O
peptide	peptide	NN	I-NP	O
spread	spread	NN	I-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
body	body	NN	I-NP	O
16	16	CD	B-NP	O
times	time	NNS	I-NP	O
faster	faster	RBR	B-ADVP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
activating	activate	VBG	I-NP	O
peptide	peptide	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
cleared	clear	VBN	I-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
2	2	CD	I-NP	O
times	time	NNS	I-NP	O
faster	faster	RBR	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
HPV16	HPV16	NN	I-NP	O
E7	E7	NN	I-NP	O
peptide	peptide	NN	I-NP	O
kinetics	kinetic	NNS	I-NP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
kinetics	kinetic	NNS	I-NP	O
of	of	IN	B-PP	O
HPV16	HPV16	NN	B-NP	O
E7	E7	NN	I-NP	O
-specific	-specific	JJ	I-NP	O
CTL	CTL	NN	I-NP	O
induction	induction	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
Ad5	Ad5	NN	B-NP	O
E1A	E1A	NN	I-NP	O
peptide	peptide	NN	I-NP	O
injection	injection	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
physical	physical	JJ	B-NP	O
deletion	deletion	NN	I-NP	O
of	of	IN	B-PP	O
preexisting	preexist	VBG	B-VP	O
Ad5	Ad5	NN	B-NP	B-protein
E1A	E1A	NN	I-NP	I-protein
-specific	-specific	JJ	I-NP	O
CTLs	CTL	NNS	I-NP	B-cell_type
within	within	IN	B-PP	O
24	24	CD	B-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
injection	injection	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
tolerization	tolerization	NN	I-NP	O
occurred	occur	VBD	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
peptide	peptide	NN	I-NP	O
reached	reach	VBD	B-VP	O
its	its	PRP$	B-NP	O
maximum	maximum	JJ	I-NP	O
peptide	peptide	NN	I-NP	O
concentration	concentration	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
organs	organ	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
ubiquitous	ubiquitous	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tolerizing	tolerize	VBG	I-NP	O
Ad5	Ad5	NN	I-NP	O
E1A	E1A	NN	I-NP	O
peptide	peptide	NN	I-NP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
short	short	JJ	I-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
time	time	NN	B-NP	O
causes	cause	VBZ	B-VP	O
activation-induced	activation-induced	JJ	B-NP	O
cell	cell	NN	I-NP	O
death	death	NN	I-NP	O
of	of	IN	B-PP	O
Ad5	Ad5	NN	B-NP	B-protein
E1A	E1A	NN	I-NP	I-protein
-specific	-specific	JJ	I-NP	O
CTLs	CTL	NNS	I-NP	B-cell_type
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
information	information	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
pharmacokinetics	pharmacokinetic	NNS	I-NP	O
of	of	IN	B-PP	O
peptides	peptide	NNS	B-NP	O
is	be	VBZ	B-VP	O
vital	vital	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
safety	safety	NN	I-NP	O
and	and	CC	I-NP	O
efficacy	efficacy	NN	I-NP	O
of	of	IN	B-PP	O
peptide-based	peptide-based	JJ	B-NP	O
vaccines	vaccine	NNS	I-NP	O
.	.	.	O	O

Smad3	Smad3	NN	B-NP	B-protein
and	and	CC	I-NP	O
Smad4	Smad4	NN	I-NP	B-protein
mediate	mediate	VBP	B-VP	O
transforming	transform	VBG	I-VP	B-protein
growth	growth	NN	B-NP	I-protein
factor-beta1	factor-beta1	NN	I-NP	I-protein
-induced	-induced	JJ	I-NP	O
IgA	IgA	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
murine	murine	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Transforming	Transform	VBG	B-NP	B-protein
growth	growth	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	I-protein
TGF	TGF	NN	B-NP	I-protein
)	)	)	O	I-protein
-beta1	-beta1	NN	B-NP	I-protein
is	be	VBZ	B-VP	O
well	well	RB	I-VP	O
established	establish	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
IgA	IgA	NN	I-NP	B-protein
isotype	isotype	NN	I-NP	I-protein
switching	switching	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
and	and	CC	O	O
Smad	Smad	NN	B-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
to	to	TO	I-VP	O
act	act	VB	I-VP	O
as	as	IN	B-PP	O
transducers	transducer	NNS	B-NP	O
and	and	CC	O	O
transcriptional	transcriptional	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
TGF-beta1	TGF-beta1	NN	B-NP	B-DNA
-targeted	-targeted	JJ	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
Smad	Smad	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
in	in	IN	B-PP	O
TGF-beta1	TGF-beta1	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
IgA	IgA	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

First	First	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
TGF-beta1	TGF-beta1	NN	B-NP	B-protein
significantly	significantly	RB	B-VP	O
increases	increase	VBZ	I-VP	O
endogenous	endogenous	JJ	B-NP	O
germ-line	germ-line	NN	I-NP	B-DNA
(	(	(	O	O
GL	GL	NN	B-NP	O
)	)	)	O	O
alpha	alpha	NN	B-NP	O
transcripts	transcript	NNS	I-NP	O
by	by	IN	B-PP	O
LPS-stimulated	LPS-stimulated	JJ	B-NP	O
CH12.LX.4933	CH12.LX.4933	NN	I-NP	O
(	(	(	O	O
mu	mu	SYM	O	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
)	)	)	O	O
B	B	NN	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
its	its	PRP$	B-NP	O
signaling	signaling	NN	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
lymphoma	lymphoma	NN	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
transfected	transfecte	VBN	I-VP	O
with	with	IN	B-PP	O
pFL3	pFL3	NN	B-NP	B-protein
that	that	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
the	the	DT	B-NP	O
TGF-beta-responsive	TGF-beta-responsive	JJ	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
GLalpha	GLalpha	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
stimulated	stimulate	VBN	B-VP	O
with	with	IN	B-PP	O
TGF-beta1	TGF-beta1	NN	B-NP	B-protein
.	.	.	O	O

Similar	Similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
endogenous	endogenous	JJ	B-NP	O
GLalpha	GLalpha	NN	I-NP	B-RNA
transcripts	transcript	NNS	I-NP	I-RNA
,	,	,	O	O
TGF-beta1	TGF-beta1	NN	B-NP	B-protein
induces	induce	VBZ	B-VP	O
GLalpha	GLalpha	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
activity	activity	NN	I-NP	O
and	and	CC	O	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
Smad3	Smad3	NN	B-NP	B-protein
markedly	markedly	RB	B-ADVP	O
enhances	enhance	VBZ	B-VP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
activity	activity	NN	I-NP	O
is	be	VBZ	B-VP	O
further	further	RBR	I-VP	O
augmented	augment	VBN	I-VP	O
by	by	IN	B-PP	O
cotransfected	cotransfecte	VBN	B-NP	O
Smad4	Smad4	NN	I-NP	B-protein
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
hand	hand	NN	I-NP	O
,	,	,	O	O
Smad7	Smad7	NN	B-NP	B-protein
substantially	substantially	RB	B-VP	O
abrogates	abrogate	VBZ	I-VP	O
the	the	DT	B-NP	O
synergistic	synergistic	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
Smad3/4	Smad3/4	NN	B-NP	B-protein
on	on	IN	B-PP	O
GLalpha	GLalpha	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
activity	activity	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
Smad3/4	Smad3/4	NN	B-NP	B-protein
enhances	enhance	VBZ	B-VP	O
TGF-beta1	TGF-beta1	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
endogenous	endogenous	JJ	I-NP	O
GLalpha	GLalpha	NN	I-NP	B-RNA
transcripts	transcript	NNS	I-NP	I-RNA
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
spleen	spleen	NN	I-NP	O
B	B	NN	I-NP	O
cell	cell	NN	I-NP	O
s	s	NNS	I-NP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
TGF-beta1	TGF-beta1	NN	B-NP	B-protein
,	,	,	O	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
Smad3/4	Smad3/4	NN	B-NP	B-protein
selectively	selectively	RB	B-ADVP	O
increases	increase	VBZ	B-VP	O
both	both	CC	O	O
surface	surface	NN	B-NP	O
IgA	IgA	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
IgA	IgA	NN	B-NP	B-protein
production	production	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
Smad3	Smad3	NN	B-NP	B-protein
,	,	,	O	O
Smad4	Smad4	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
Smad7	Smad7	NN	B-NP	B-protein
,	,	,	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
,	,	,	O	O
serve	serve	VBP	B-VP	O
as	as	IN	B-PP	O
mediators	mediator	NNS	B-NP	O
linking	link	VBG	B-VP	O
TGF-beta1	TGF-beta1	NN	B-NP	B-protein
to	to	TO	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
IgA	IgA	NN	B-NP	B-DNA
switching	switching	NN	I-NP	I-DNA
related	related	JJ	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
and	and	CC	O	O
regulation	regulation	NN	B-NP	O
of	of	IN	B-PP	O
IgA	IgA	NN	B-NP	B-protein
class	class	NN	I-NP	O
switching	switching	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
translesion	translesion	NN	I-NP	B-protein
DNA	DNA	NN	I-NP	I-protein
polymerase	polymerase	NN	I-NP	I-protein
zeta	zeta	NN	I-NP	I-protein
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
Ig	Ig	NN	B-NP	B-protein
and	and	CC	O	O
bcl-6	bcl-6	NN	B-NP	B-protein
somatic	somatic	JJ	I-NP	O
hypermutation	hypermutation	NN	I-NP	O
.	.	.	O	O

Ig	Ig	NN	B-NP	O
somatic	somatic	JJ	I-NP	O
mutations	mutation	NNS	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
introduced	introduce	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
polymerase	polymerase	NN	I-NP	O
(	(	(	O	O
pol	pol	NN	B-NP	O
)	)	)	O	O
while	while	IN	B-SBAR	O
repairing	repair	VBG	B-VP	O
DNA	DNA	NN	B-NP	O
outside	outside	IN	B-PP	O
main	main	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
replication	replication	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
human	human	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
constitutively	constitutively	RB	B-ADVP	O
express	express	VBP	B-VP	O
the	the	DT	B-NP	O
translesion	translesion	NN	I-NP	B-protein
pol	pol	NN	I-NP	I-protein
zeta	zeta	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
effectively	effectively	RB	B-ADVP	O
extends	extend	VBZ	B-VP	O
DNA	DNA	NN	B-NP	O
past	past	IN	B-PP	O
mismatched	mismatch	VBN	B-NP	O
bases	base	NNS	I-NP	O
(	(	(	O	O
mispair	mispair	NN	B-NP	O
extender	extender	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
pol	pol	NN	B-NP	O
eta	eta	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
bypasses	bypass	VBZ	B-VP	O
DNA	DNA	NN	B-NP	O
lesions	lesion	NNS	I-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
error-free	error-free	JJ	I-NP	O
fashion	fashion	NN	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
B	B	NN	B-NP	B-protein
cell	cell	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
BCR	BCR	NN	B-NP	B-protein
)	)	)	O	O
engagement	engagement	NN	B-NP	O
and	and	CC	I-NP	O
coculture	coculture	NN	I-NP	O
with	with	IN	B-PP	O
activated	activate	VBN	B-NP	B-cell_type
CD4+	CD4+	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
these	these	DT	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	B-cell_type
upregulated	upregulate	VBD	B-VP	O
pol	pol	NN	B-NP	O
zeta	zeta	NN	I-NP	O
,	,	,	O	O
downregulated	downregulate	VBD	B-VP	O
pol	pol	NN	B-NP	O
eta	eta	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
mutated	mutate	VBD	B-VP	O
the	the	DT	B-NP	O
Ig	Ig	NN	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
bcl-6	bcl-6	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pol	pol	NN	I-NP	B-protein
zeta	zeta	NN	I-NP	I-protein
REV3	REV3	NN	I-NP	I-protein
catalytic	catalytic	JJ	I-NP	I-protein
subunit	subunit	NN	I-NP	I-protein
by	by	IN	B-PP	O
specific	specific	JJ	B-NP	O
phosphorothioate-modified	phosphorothioate-modified	JJ	I-NP	O
oligonucleotides	oligonucleotide	NNS	I-NP	O
impaired	impair	VBD	B-VP	O
Ig	Ig	NN	B-NP	B-protein
and	and	CC	I-NP	O
bcl-6	bcl-6	NN	I-NP	B-protein
hypermutation	hypermutation	NN	I-NP	O
and	and	CC	O	O
UV	UV	NN	B-NP	O
damage-induced	damage-induced	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
mutagenesis	mutagenesis	NN	I-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
affecting	affect	VBG	B-VP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
or	or	CC	O	O
viability	viability	NN	B-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
pol	pol	NN	B-NP	B-protein
zeta	zeta	NN	I-NP	I-protein
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
Ig	Ig	NN	B-NP	B-protein
and	and	CC	I-NP	O
bcl-6	bcl-6	NN	I-NP	B-protein
hypermutation	hypermutation	NN	I-NP	O
,	,	,	O	O
perhaps	perhaps	RB	B-VP	O
facilitated	facilitate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
downregulation	downregulation	NN	I-NP	O
of	of	IN	B-PP	O
pol	pol	NN	B-NP	O
eta	eta	NN	I-NP	O
.	.	.	O	O

Molecular	Molecular	JJ	B-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
progression	progression	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
oncogene	oncogene	NN	I-NP	B-protein
product	product	NN	I-NP	I-protein
Tax	Tax	NN	I-NP	B-protein
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
T-cell	T-cell	NN	I-NP	O
leukemia	leukemia	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
I	I	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
trans-activator	trans-activator	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
Tax	Tax	NN	I-NP	B-protein
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
T-cell	T-cell	NN	I-NP	O
leukemia	leukemia	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
I	I	CD	I-NP	O
(	(	(	O	O
HTLV-I	HTLV-I	NN	B-NP	O
)	)	)	O	O
plays	play	VBZ	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
adult	adult	JJ	B-NP	O
T-cell	T-cell	NN	I-NP	O
leukemia	leukemia	NN	I-NP	O
through	through	IN	B-PP	O
,	,	,	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
,	,	,	O	O
its	its	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
stimulate	stimulate	VB	I-VP	O
cell	cell	NN	B-NP	O
growth	growth	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
previously	previously	RB	B-ADVP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
Tax	Tax	NN	B-NP	B-protein
induced	induce	VBD	B-VP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
progression	progression	NN	I-NP	O
from	from	IN	B-PP	O
G0/G1	G0/G1	NN	B-NP	O
phase	phase	NN	I-NP	O
to	to	TO	B-PP	O
S	S	NN	B-NP	O
and	and	CC	I-NP	O
G2/M	G2/M	NN	I-NP	O
phases	phase	NNS	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
T-cell	T-cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
Kit	Kit	NN	I-NP	I-cell_line
225	225	CD	B-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

To	To	TO	B-VP	O
elucidate	elucidate	VB	I-VP	O
molecular	molecular	JJ	B-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
Tax	Tax	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
progression	progression	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
systematically	systematically	RB	B-ADVP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
Tax	Tax	NN	B-NP	B-protein
on	on	IN	B-PP	O
biochemical	biochemical	JJ	B-NP	O
events	event	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
progression	progression	NN	I-NP	O
.	.	.	O	O

Introduction	Introduction	NN	B-NP	O
of	of	IN	B-PP	O
Tax	Tax	NN	B-NP	B-protein
into	into	IN	B-PP	O
resting	rest	VBG	B-NP	B-cell_line
Kit	Kit	NN	I-NP	I-cell_line
225	225	CD	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
induced	induce	VBD	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
G1/S	G1/S	NN	I-NP	O
transition	transition	NN	I-NP	O
regulation	regulation	NN	I-NP	O
cascade	cascade	NN	I-NP	O
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
cyclin	cyclin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
(	(	(	O	O
CDK2	CDK2	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
CDK4	CDK4	NN	B-NP	B-protein
,	,	,	O	O
phosphorylation	phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Rb	Rb	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
and	and	CC	O	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
free	free	JJ	B-NP	O
E2F	E2F	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
kinase	kinase	NN	I-NP	O
activation	activation	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
result	result	VB	I-VP	O
from	from	IN	B-PP	O
Tax	Tax	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
genes	gene	NNS	B-NP	O
for	for	IN	B-PP	O
cell	cell	NN	B-NP	B-protein
cycle	cycle	NN	I-NP	I-protein
regulatory	regulatory	JJ	I-NP	I-protein
molecules	molecule	NNS	I-NP	I-protein
including	include	VBG	B-PP	O
cyclin	cyclin	NN	B-NP	B-protein
D2	D2	NN	I-NP	I-protein
,	,	,	O	O
cyclin	cyclin	NN	B-NP	B-DNA
E	E	NN	I-NP	I-DNA
,	,	,	O	O
E2F1	E2F1	NN	B-NP	B-protein
,	,	,	O	O
CDK2	CDK2	NN	B-NP	B-protein
,	,	,	O	O
CDK4	CDK4	NN	B-NP	B-protein
and	and	CC	I-NP	O
CDK6	CDK6	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
Tax	Tax	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
of	of	IN	B-PP	O
CDK	CDK	NN	B-NP	B-protein
inhibitors	inhibitor	NNS	I-NP	O
p19	p19	NN	I-NP	B-protein
(	(	(	O	I-protein
INK4d	INK4d	NN	B-NP	I-protein
)	)	)	O	I-protein
and	and	CC	O	O
p27	p27	NN	B-NP	B-protein
(	(	(	O	I-protein
Kip1	Kip1	NN	B-NP	I-protein
)	)	)	O	I-protein
.	.	.	O	O

These	These	DT	B-NP	O
modulations	modulation	NNS	I-NP	O
by	by	IN	B-PP	O
Tax	Tax	NN	B-NP	B-protein
always	always	RB	B-ADVP	O
paralleled	parallel	VBD	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
Tax	Tax	NN	B-NP	B-protein
to	to	TO	B-VP	O
activate	activate	VB	I-VP	O
the	the	DT	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
transcription	transcription	NN	I-NP	O
pathway	pathway	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
the	the	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
Tax	Tax	NN	B-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
trans-activation	trans-activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genes	gene	NNS	I-NP	O
for	for	IN	B-PP	O
cell	cell	NN	B-NP	B-protein
cycle	cycle	NN	I-NP	I-protein
regulatory	regulatory	JJ	I-NP	I-protein
molecules	molecule	NNS	I-NP	I-protein
in	in	IN	B-PP	O
Tax	Tax	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
progression	progression	NN	I-NP	O
.	.	.	O	O

Cot	Cot	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
induces	induce	VBZ	B-VP	O
cyclooxygenase-2	cyclooxygenase-2	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
through	through	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
of	of	IN	B-PP	I-protein
activated	activate	VBN	B-NP	I-protein
T	T	NN	I-NP	I-protein
cells	cell	NNS	I-NP	I-protein
.	.	.	O	O

Cyclooxygenase-2	Cyclooxygenase-2	NN	B-NP	B-protein
(	(	(	O	O
COX-2	COX-2	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
induced	induce	VBN	I-VP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
upon	upon	IN	B-PP	O
T	T	NN	B-NP	B-protein
cell	cell	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
triggering	triggering	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
that	that	IN	B-SBAR	O
Cot	Cot	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
,	,	,	O	O
a	a	DT	B-NP	O
mitogen-activated	mitogen-activated	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
,	,	,	O	O
up-regulates	up-regulate	VBZ	B-VP	O
COX-2	COX-2	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Induction	Induction	NN	B-NP	O
of	of	IN	B-PP	O
COX-2	COX-2	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
activity	activity	NN	I-NP	O
by	by	IN	B-PP	O
Cot	Cot	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
occurred	occur	VBD	B-VP	O
mainly	mainly	RB	B-ADVP	O
through	through	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
of	of	IN	B-PP	I-protein
activated	activate	VBN	B-NP	I-protein
T	T	NN	I-NP	I-protein
cells	cell	NNS	I-NP	I-protein
(	(	(	O	O
NFAT	NFAT	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Mutation	Mutation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	B-DNA
(	(	(	O	I-DNA
-105/-97	-105/-97	CD	B-NP	I-DNA
)	)	)	O	I-DNA
and	and	CC	O	I-DNA
proximal	proximal	JJ	B-ADJP	I-DNA
(	(	(	O	I-DNA
-76/-61	-76/-61	CD	O	I-DNA
)	)	)	O	I-DNA
NFAT	NFAT	NN	B-NP	I-DNA
response	response	NN	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
COX-2	COX-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
abolished	abolish	VBD	B-VP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
Cot	Cot	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
.	.	.	O	O

Even	Even	RB	B-ADVP	O
more	more	RBR	I-ADVP	O
,	,	,	O	O
coexpression	coexpression	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
negative	negative	JJ	I-NP	O
version	version	NN	I-NP	O
of	of	IN	B-PP	O
NFAT	NFAT	NN	B-NP	B-protein
inhibited	inhibit	VBD	B-VP	O
Cot	Cot	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
-mediated	-mediated	JJ	I-NP	O
COX-2	COX-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
activation	activation	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
cotransfection	cotransfection	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
constitutively	constitutively	RB	I-NP	O
active	active	JJ	I-NP	O
version	version	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
calcium-dependent	calcium-dependent	JJ	I-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
calcineurin	calcineurin	NN	I-NP	B-protein
synergizes	synergize	VBZ	B-VP	O
with	with	IN	B-PP	O
Cot	Cot	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
up-regulation	up-regulation	NN	I-NP	O
of	of	IN	B-PP	O
COX-2	COX-2	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
-driven	-driven	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
.	.	.	O	O

Strikingly	Strikingly	RB	B-ADVP	O
,	,	,	O	O
Cot	Cot	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
increased	increase	VBD	B-VP	O
transactivation	transactivation	NN	B-NP	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
GAL4-NFAT	GAL4-NFAT	NN	I-NP	B-protein
fusion	fusion	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
N-terminal	N-terminal	JJ	I-NP	B-protein
transactivation	transactivation	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
NFATp	NFATp	NN	B-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
phorbol	phorbol	NN	B-NP	O
ester	ester	NN	I-NP	O
plus	plus	CC	O	O
calcium	calcium	NN	B-NP	O
ionophore	ionophore	NN	I-NP	O
A23187	A23187	NN	I-NP	O
,	,	,	O	O
Cot	Cot	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
increases	increase	VBZ	B-VP	O
both	both	CC	O	O
COX-2	COX-2	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
activity	activity	NN	I-NP	O
and	and	CC	O	O
NFAT	NFAT	NN	B-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
transactivation	transactivation	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
cyclosporin	cyclosporin	NN	I-NP	O
A-independent	A-independent	JJ	I-NP	O
manner	manner	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
Cot	Cot	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
up-regulates	up-regulate	VBZ	B-VP	O
COX-2	COX-2	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
-driven	-driven	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
NFAT	NFAT	NN	I-NP	B-DNA
response	response	NN	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
,	,	,	O	O
being	be	VBG	B-VP	O
the	the	DT	B-NP	O
Cot	Cot	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
-induced	-induced	JJ	I-NP	O
NFAT	NFAT	NN	I-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
transactivation	transactivation	NN	I-NP	O
presumably	presumably	RB	B-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
up-regulation	up-regulation	NN	I-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
and	and	CC	I-NP	O
negative	negative	JJ	I-NP	O
roles	role	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
trans-acting	trans-acting	JJ	I-NP	B-protein
T	T	NN	I-NP	I-protein
cell	cell	NN	I-NP	I-protein
factor-1	factor-1	NN	I-NP	I-protein
for	for	IN	B-PP	O
the	the	DT	B-NP	O
acquisition	acquisition	NN	I-NP	O
of	of	IN	B-PP	O
distinct	distinct	JJ	B-NP	O
Ly-49	Ly-49	NN	I-NP	B-protein
MHC	MHC	NN	I-NP	I-protein
class	class	NN	I-NP	I-protein
I	I	CD	B-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
by	by	IN	B-PP	O
NK	NK	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Members	Member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ly-49	Ly-49	NN	I-NP	B-protein
gene	gene	NN	I-NP	I-protein
family	family	NN	I-NP	I-protein
code	code	NN	I-NP	O
for	for	IN	B-PP	O
class	class	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
MHC-specific	MHC-specific	JJ	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
regulate	regulate	VBP	B-VP	O
NK	NK	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
function	function	NN	I-NP	O
.	.	.	O	O

Due	Due	JJ	B-PP	O
to	to	TO	I-PP	O
a	a	DT	B-NP	O
combinatorial	combinatorial	JJ	I-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
Ly-49	Ly-49	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
,	,	,	O	O
NK	NK	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
display	display	VBP	B-VP	O
considerable	considerable	JJ	B-NP	O
clonal	clonal	JJ	I-NP	O
heterogeneity	heterogeneity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
acquisition	acquisition	NN	I-NP	O
of	of	IN	B-PP	O
one	one	CD	B-NP	O
Ly-49	Ly-49	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
,	,	,	O	O
Ly-49A	Ly-49A	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
strictly	strictly	RB	B-ADJP	O
dependent	dependent	JJ	I-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	B-protein
trans-acting	trans-acting	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
T	T	NN	I-NP	I-protein
cell-specific	cell-specific	JJ	I-NP	I-protein
factor-1	factor-1	NN	I-NP	I-protein
(	(	(	O	O
TCF-1	TCF-1	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Indeed	Indeed	RB	B-ADVP	O
,	,	,	O	O
TCF-1	TCF-1	NN	B-NP	B-protein
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
sites	site	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Ly-49a	Ly-49a	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
and	and	CC	O	O
regulates	regulate	VBZ	B-VP	O
its	its	PRP$	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
Ly-49a	Ly-49a	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
direct	direct	JJ	I-NP	O
TCF-1	TCF-1	NN	I-NP	B-protein
target	target	NN	I-NP	O
.	.	.	O	O

TCF-1	TCF-1	NN	B-NP	B-protein
deficiency	deficiency	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
altered	altered	JJ	I-NP	O
usage	usage	NN	I-NP	O
of	of	IN	B-PP	O
additional	additional	JJ	B-NP	O
Ly-49	Ly-49	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
.	.	.	O	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
TCF-1	TCF-1	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
-microglobulin	-microglobulin	JJ	B-NP	O
double-deficient	double-deficient	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
repertoire	repertoire	NN	I-NP	O
alterations	alteration	NNS	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	O	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
Ly-49/MHC	Ly-49/MHC	NN	B-NP	O
class	class	NN	I-NP	O
I	I	CD	B-NP	O
interactions	interaction	NNS	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
findings	finding	NNS	I-NP	O
rather	rather	RB	B-ADVP	O
suggest	suggest	VBP	B-VP	O
a	a	DT	B-NP	O
TCF-1	TCF-1	NN	I-NP	B-protein
-dependent	-dependent	JJ	B-ADJP	O
,	,	,	O	O
cell	cell	NN	B-NP	O
autonomous	autonomous	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
acquisition	acquisition	NN	I-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
Ly-49	Ly-49	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
.	.	.	O	O

Besides	Besides	IN	B-PP	O
reduced	reduce	VBN	B-NP	O
receptor	receptor	NN	I-NP	O
usage	usage	NN	I-NP	O
(	(	(	O	O
Ly-49A	Ly-49A	NN	B-NP	O
and	and	CC	O	O
D	D	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
we	we	PRP	B-NP	O
also	also	RB	B-ADVP	O
observed	observe	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
(	(	(	O	O
Ly-49C	Ly-49C	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
significantly	significantly	RB	B-VP	O
expanded	expand	VBN	I-VP	O
(	(	(	O	O
Ly-49G	Ly-49G	NN	B-NP	O
and	and	CC	O	O
I	I	NN	B-NP	O
)	)	)	O	O
receptor	receptor	NN	B-NP	O
usage	usage	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
TCF-1	TCF-1	NN	B-NP	B-protein
.	.	.	O	O

These	These	DT	B-NP	O
effects	effect	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	O	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
cases	case	NNS	I-NP	O
correlate	correlate	VBP	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
TCF	TCF	NN	B-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
respective	respective	JJ	I-NP	O
proximal	proximal	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
besides	besides	IN	B-PP	O
TCF-1	TCF-1	NN	B-NP	B-protein
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
,	,	,	O	O
Ly-49	Ly-49	NN	B-NP	O
acquisition	acquisition	NN	I-NP	O
may	may	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
TCF-1	TCF-1	NN	B-NP	B-protein
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
more	more	RBR	B-NP	O
distant	distant	JJ	I-NP	B-DNA
cis-acting	cis-acting	JJ	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
and/or	and/or	CC	B-PP	O
by	by	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
additional	additional	JJ	B-NP	O
trans-acting	trans-acting	JJ	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

Consistent	Consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
observed	observe	VBN	I-NP	O
differential	differential	JJ	I-NP	O
,	,	,	I-NP	O
positive	positive	JJ	I-NP	O
or	or	CC	I-NP	O
negative	negative	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
TCF-1	TCF-1	NN	B-NP	B-protein
for	for	IN	B-PP	O
Ly-49	Ly-49	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
acquisition	acquisition	NN	I-NP	O
,	,	,	O	O
reporter	reporter	NN	B-NP	O
gene	gene	NN	I-NP	O
assays	assay	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
inducing	induce	VBG	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
repressing	repress	VBG	I-NP	O
TCF	TCF	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
in	in	IN	B-PP	O
certain	certain	JJ	B-NP	O
proximal	proximal	JJ	I-NP	B-DNA
Ly-49	Ly-49	NN	I-NP	I-DNA
promoters	promoter	NNS	I-NP	I-DNA
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
reveal	reveal	VBP	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
TCF-1	TCF-1	NN	B-NP	B-protein
for	for	IN	B-PP	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NK	NK	NN	I-NP	O
cell	cell	NN	I-NP	O
receptor	receptor	NN	I-NP	O
repertoire	repertoire	NN	I-NP	O
.	.	.	O	O

Ligation	Ligation	NN	B-NP	O
of	of	IN	B-PP	O
CD11b	CD11b	NN	B-NP	B-protein
and	and	CC	O	O
CD11c	CD11c	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
(	(	(	O	I-protein
2	2	CD	B-NP	I-protein
)	)	)	O	I-protein
integrins	integrin	NNS	B-NP	I-protein
by	by	IN	B-PP	O
antibodies	antibody	NNS	B-NP	B-protein
or	or	CC	O	O
soluble	soluble	JJ	B-NP	O
CD23	CD23	NN	I-NP	B-protein
induces	induce	VBZ	B-VP	O
macrophage	macrophage	NN	B-NP	B-protein
inflammatory	inflammatory	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
1alpha	1alpha	NN	I-NP	I-protein
(	(	(	O	O
MIP-1alpha	MIP-1alpha	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
MIP-1beta	MIP-1beta	NN	B-NP	B-protein
production	production	NN	I-NP	O
in	in	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
through	through	IN	B-PP	O
a	a	DT	B-NP	O
pathway	pathway	NN	I-NP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
.	.	.	O	O

Chemokines	Chemokine	NNS	B-NP	B-protein
and	and	CC	O	O
adhesion	adhesion	NN	B-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
integrins	integrin	NNS	B-NP	B-protein
play	play	VBP	B-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
part	part	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
trafficking	trafficking	NN	I-NP	O
,	,	,	O	O
extravasation	extravasation	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
recruitment	recruitment	NN	B-NP	O
of	of	IN	B-PP	O
leukocytes	leukocyte	NNS	B-NP	B-cell_type
to	to	TO	B-PP	O
inflammatory	inflammatory	JJ	B-NP	O
sites	site	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
beta	beta	NN	B-NP	B-protein
(	(	(	O	I-protein
2	2	CD	B-NP	I-protein
)	)	)	O	I-protein
integrin	integrin	NN	B-NP	I-protein
engagement	engagement	NN	I-NP	O
on	on	IN	B-PP	O
chemokine	chemokine	NN	B-NP	B-protein
production	production	NN	I-NP	O
by	by	IN	B-PP	O
freshly	freshly	RB	B-NP	B-cell_type
isolated	isolate	VBN	I-NP	I-cell_type
human	human	JJ	I-NP	I-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
ligation	ligation	NN	B-NP	O
of	of	IN	B-PP	O
CD11b	CD11b	NN	B-NP	B-protein
or	or	CC	I-NP	O
CD11c	CD11c	NN	I-NP	B-protein
but	but	CC	B-NP	O
not	not	RB	I-NP	O
CD11a	CD11a	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
chains	chain	NNS	I-NP	I-protein
of	of	IN	B-PP	O
beta	beta	NN	B-NP	B-protein
(	(	(	O	I-protein
2	2	CD	B-NP	I-protein
)	)	)	O	I-protein
integrins	integrin	NNS	B-NP	I-protein
by	by	IN	B-PP	O
antibodies	antibody	NNS	B-NP	B-protein
or	or	CC	O	O
soluble	soluble	JJ	B-NP	O
CD23	CD23	NN	I-NP	B-protein
(	(	(	O	O
sCD23	sCD23	NN	B-NP	B-protein
)	)	)	O	O
fusion	fusion	NN	B-NP	O
proteins	protein	NNS	I-NP	O
rapidly	rapidly	RB	B-ADVP	O
induced	induce	VBD	B-VP	O
transcription	transcription	NN	B-NP	O
and	and	CC	O	O
secretion	secretion	NN	B-NP	O
of	of	IN	B-PP	O
interleukin	interleukin	NN	B-NP	B-protein
8	8	CD	I-NP	I-protein
,	,	,	O	O
macrophage	macrophage	NN	B-NP	B-protein
inflammatory	inflammatory	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	I-protein
MIP	MIP	NN	B-NP	I-protein
)	)	)	O	I-protein
1alpha	1alpha	NN	B-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
MIP-1beta	MIP-1beta	NN	B-NP	B-protein
.	.	.	O	O

Because	Because	IN	B-SBAR	O
the	the	DT	B-NP	O
promoters	promoter	NNS	I-NP	B-DNA
of	of	IN	B-PP	O
these	these	DT	B-NP	O
chemokine	chemokine	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
contain	contain	VBP	B-VP	O
kappaB	kappaB	NN	B-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
,	,	,	O	O
we	we	PRP	B-NP	O
assessed	assess	VBD	B-VP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
(	(	(	O	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
controlling	control	VBG	B-VP	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genes	gene	NNS	I-NP	O
through	through	IN	B-PP	O
beta	beta	NN	B-NP	B-protein
(	(	(	O	I-protein
2	2	CD	B-NP	I-protein
)	)	)	O	I-protein
integrin	integrin	NN	B-NP	I-protein
engagement	engagement	NN	I-NP	O
.	.	.	O	O

Electrophoretic	Electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
sCD23	sCD23	NN	B-NP	B-protein
or	or	CC	I-NP	O
antibodies	antibody	NNS	I-NP	B-protein
to	to	TO	B-PP	O
CD11b	CD11b	NN	B-NP	B-protein
or	or	CC	B-PP	O
to	to	TO	B-PP	O
CD11c	CD11c	NN	B-NP	B-protein
up-regulated	up-regulated	JJ	I-NP	O
DNA-binding	DNA-binding	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
.	.	.	O	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
was	be	VBD	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
degradation	degradation	NN	B-NP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
cytosolic	cytosolic	JJ	I-NP	B-protein
inhibitor	inhibitor	NN	I-NP	I-protein
IkappaB-alpha	IkappaB-alpha	NN	I-NP	B-protein
.	.	.	O	O

Blockade	Blockade	NN	B-NP	O
of	of	IN	B-PP	O
depletion	depletion	NN	B-NP	O
of	of	IN	B-PP	O
IkappaB-alpha	IkappaB-alpha	NN	B-NP	B-protein
by	by	IN	B-PP	O
proteasome	proteasome	NN	B-NP	B-protein
inhibitors	inhibitor	NNS	I-NP	O
(	(	(	O	O
proteasome	proteasome	NN	B-NP	B-protein
inhibitor	inhibitor	NN	I-NP	O
I	I	CD	I-NP	O
or	or	CC	O	O
acetyl-leucinyl-leucinyl-norleucinal	acetyl-leucinyl-leucinyl-norleucinal	JJ	B-ADJP	O
)	)	)	O	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
concomitant	concomitant	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
DNA-binding	DNA-binding	JJ	I-NP	O
activity	activity	NN	I-NP	O
and	and	CC	O	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
MIP-1alpha	MIP-1alpha	NN	B-NP	B-protein
and	and	CC	I-NP	O
MIP-1beta	MIP-1beta	NN	I-NP	B-RNA
messenger	messenger	NN	I-NP	I-RNA
RNA	RNA	NN	I-NP	I-RNA
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
beta	beta	NN	B-NP	B-protein
(	(	(	O	I-protein
2	2	CD	B-NP	I-protein
)	)	)	O	I-protein
integrin	integrin	NN	B-NP	I-protein
ligation	ligation	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
triggering	triggering	NN	B-NP	O
of	of	IN	B-PP	O
CD11b	CD11b	NN	B-NP	B-protein
or	or	CC	I-NP	O
CD11c	CD11c	NN	I-NP	B-protein
beta	beta	SYM	B-NP	I-protein
(	(	(	B-LST	I-protein
2	2	LS	I-LST	I-protein
)	)	)	O	I-protein
integrin	integrin	NN	B-NP	I-protein
on	on	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
provides	provide	VBZ	B-VP	O
activation	activation	NN	B-NP	O
signals	signal	NNS	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
nuclear	nuclear	JJ	B-NP	O
translocation	translocation	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
and	and	CC	O	O
subsequent	subsequent	JJ	B-NP	O
secretion	secretion	NN	I-NP	O
of	of	IN	B-PP	O
MIP-1alpha	MIP-1alpha	NN	B-NP	B-protein
and	and	CC	I-NP	O
MIP-1beta	MIP-1beta	NN	I-NP	B-protein
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
recruitment	recruitment	NN	B-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
inflammatory	inflammatory	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
during	during	IN	B-PP	O
initiation	initiation	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
response	response	NN	I-NP	O

Synergistic	Synergistic	JJ	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-protein
Acyl-coenzyme	Acyl-coenzyme	NN	I-NP	I-protein
A	A	NN	I-NP	I-protein
:	:	:	O	O
cholesterol	cholesterol	NN	B-NP	B-DNA
acyltransterase-1	acyltransterase-1	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
by	by	IN	B-PP	O
interferon-gamma	interferon-gamma	NN	B-NP	B-protein
and	and	CC	O	O
all-trans-retinoic	all-trans-retinoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
THP-1	THP-1	NN	I-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

Acyl-coenzyme	Acyl-coenzyme	NN	B-NP	O
A	A	NN	I-NP	O
:	:	:	O	O
cholesterol	cholesterol	NN	B-NP	O
acyltransferase	acyltransferase	NN	I-NP	O
(	(	(	O	O
ACAT	ACAT	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	B-protein
enzyme	enzyme	NN	I-NP	I-protein
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
homeostasis	homeostasis	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
atherosclerotic	atherosclerotic	JJ	B-NP	O
foam	foam	NN	I-NP	O
cell	cell	NN	I-NP	O
formation	formation	NN	I-NP	O
.	.	.	O	O

Human	Human	JJ	B-NP	B-DNA
ACAT-1	ACAT-1	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
contains	contain	VBZ	B-VP	O
two	two	CD	B-NP	O
promoters	promoter	NNS	I-NP	B-DNA
(	(	(	O	O
P1	P1	NN	B-NP	B-DNA
and	and	CC	O	O
P7	P7	NN	B-NP	B-DNA
)	)	)	O	O
,	,	,	O	O
each	each	DT	B-NP	O
located	located	JJ	B-ADJP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
different	different	JJ	I-NP	O
chromosome	chromosome	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
7	7	CD	I-NP	O
)	)	)	O	O
(	(	(	O	O
Li	Li	NNP	B-NP	O
,	,	,	O	O
B.	B.	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
Li	Li	NNP	B-NP	O
,	,	,	O	O
X.	X.	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
Duan	Duan	NNP	B-NP	O
,	,	,	O	O
Z.	Z.	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
Lee	Lee	NNP	B-NP	O
,	,	,	O	O
O.	O.	NNP	B-NP	O
,	,	,	O	O
Lin	Lin	NNP	B-NP	B-protein
,	,	,	O	O
S.	S.	NNP	B-NP	O
,	,	,	O	O
Ma	Ma	NNP	B-NP	O
,	,	,	O	O
Z.	Z.	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
Chang	Chang	NNP	B-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
Yang	Yang	NNP	B-NP	O
,	,	,	O	O
X.	X.	NNP	B-NP	O
Y.	Y.	NNP	I-NP	O
,	,	,	O	O
Park	Park	NNP	B-NP	O
,	,	,	O	O
J.	J.	NNP	B-NP	O
P.	P.	NNP	I-NP	O
,	,	,	O	O
Mohandas	Mohandas	NNP	B-NP	O
,	,	,	O	O
T.	T.	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
Noll	Noll	NNP	B-NP	O
,	,	,	O	O
W.	W.	NNP	B-NP	O
,	,	,	O	O
Chan	Chan	NNP	B-NP	O
,	,	,	O	O
L.	L.	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Chang	Chang	NNP	B-NP	O
,	,	,	O	O
T.	T.	NNP	B-NP	O
Y.	Y.	NNP	I-NP	O
(	(	(	O	O
1999	1999	CD	B-NP	O
)	)	)	O	O
J.	J.	NNP	B-NP	O
Biol	Biol	NNP	I-NP	O
Chem.	Chem.	NNP	I-NP	O
274	274	CD	I-NP	O
,	,	,	I-NP	O
11060-11071	11060-11071	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

Interferon-gamma	Interferon-gamma	NN	B-NP	B-protein
(	(	(	O	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
cytokine	cytokine	NN	I-NP	B-protein
that	that	WDT	B-NP	O
exerts	exert	VBZ	B-VP	O
many	many	JJ	B-NP	O
pro-atherosclerotic	pro-atherosclerotic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
,	,	,	O	O
causes	cause	VBZ	B-VP	O
up-regulation	up-regulation	NN	B-NP	O
of	of	IN	B-PP	O
ACAT-1	ACAT-1	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
monocyte-derived	monocyte-derived	JJ	I-NP	I-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
and	and	CC	O	O
macrophage-like	macrophage-like	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
but	but	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
other	other	JJ	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
nature	nature	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
observation	observation	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
identified	identify	VBD	B-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
ACAT-1	ACAT-1	NN	I-NP	B-DNA
P1	P1	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
a	a	DT	B-NP	O
159-base	159-base	JJ	I-NP	B-DNA
pair	pair	NN	I-NP	I-DNA
core	core	NN	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
.	.	.	O	O

This	This	DT	B-NP	O
region	region	NN	I-NP	O
contains	contain	VBZ	B-VP	O
4	4	CD	B-NP	B-DNA
Sp1	Sp1	NN	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
and	and	CC	O	O
an	an	DT	B-NP	O
IFN-gamma	IFN-gamma	NN	I-NP	B-protein
activated	activate	VBN	B-VP	O
sequence	sequence	NN	B-NP	O
(	(	(	O	O
GAS	GAS	NN	B-NP	B-DNA
)	)	)	O	O
that	that	WDT	B-NP	O
overlaps	overlap	VBZ	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	B-DNA
Sp1	Sp1	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
monocytic	monocytic	JJ	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
THP-1	THP-1	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
,	,	,	O	O
the	the	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
and	and	CC	O	O
all-trans-retinoic	all-trans-retinoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
a	a	DT	B-NP	O
known	know	VBN	I-NP	O
differentiation	differentiation	NN	I-NP	O
agent	agent	NN	I-NP	O
)	)	)	O	O
enhances	enhance	VBZ	B-VP	O
the	the	DT	B-NP	O
ACAT-1	ACAT-1	NN	I-NP	B-DNA
P1	P1	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
but	but	CC	B-NP	O
not	not	RB	I-NP	O
the	the	DT	B-NP	O
P7	P7	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

Additional	Additional	JJ	B-NP	O
experiments	experiment	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
all-trans-retinoic	all-trans-retinoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
causes	cause	VBZ	B-VP	O
large	large	JJ	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
STAT1	STAT1	NN	I-NP	B-protein
,	,	,	O	O
while	while	IN	B-SBAR	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
causes	cause	VBZ	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
STAT1	STAT1	NN	B-NP	B-protein
such	such	JJ	B-NP	O
that	that	IN	B-NP	O
it	it	PRP	B-NP	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
GAS/Sp1	GAS/Sp1	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ACAT-1	ACAT-1	NN	I-NP	B-DNA
P1	P1	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

Our	Our	PRP$	B-NP	O
work	work	NN	I-NP	O
provides	provide	VBZ	B-VP	O
a	a	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
to	to	TO	B-VP	O
account	account	VB	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
in	in	IN	B-PP	O
causing	cause	VBG	B-VP	O
transcriptional	transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
ACAT-1	ACAT-1	NN	B-NP	B-protein
in	in	IN	B-PP	O
macrophage-like	macrophage-like	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Inhaled	Inhale	VBN	B-NP	O
nitric	nitric	JJ	I-NP	O
oxide	oxide	NN	I-NP	O
down-regulates	down-regulate	VBZ	B-VP	O
intrapulmonary	intrapulmonary	JJ	B-NP	O
nitric	nitric	JJ	I-NP	O
oxide	oxide	NN	I-NP	O
production	production	NN	I-NP	O
in	in	IN	B-PP	O
lipopolysaccharide-induced	lipopolysaccharide-induced	JJ	B-NP	O
acute	acute	JJ	I-NP	O
lung	lung	NN	I-NP	O
injury	injury	NN	I-NP	O
.	.	.	O	O

OBJECTIVE	OBJECTIVE	NN	B-NP	O
:	:	:	O	O
To	To	TO	B-VP	O
examine	examine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
inhaled	inhale	VBN	B-NP	O
nitric	nitric	JJ	I-NP	O
oxide	oxide	NN	I-NP	O
(	(	(	O	O
NO	NO	NN	B-NP	O
)	)	)	O	O
affected	affect	VBD	B-VP	O
the	the	DT	B-NP	O
intrapulmonary	intrapulmonary	JJ	I-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
NO	NO	NN	B-NP	O
,	,	,	O	O
reactive	reactive	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
in	in	IN	B-PP	O
a	a	DT	B-NP	O
lipopolysaccharide	lipopolysaccharide	NN	I-NP	O
(	(	(	O	O
LPS	LPS	NN	B-NP	O
)	)	)	O	O
-induced	-induced	JJ	B-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
lung	lung	NN	I-NP	O
injury	injury	NN	I-NP	O
.	.	.	O	O

DESIGN	DESIGN	NN	B-NP	O
:	:	:	O	O
Prospective	Prospective	JJ	B-ADJP	O
,	,	,	O	O
randomized	randomize	VBN	B-VP	O
,	,	,	O	O
laboratory	laboratory	NN	B-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

SETTING	SETTING	NN	B-NP	O
:	:	:	O	O
Experimental	Experimental	JJ	B-NP	O
laboratory	laboratory	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
biomedical	biomedical	JJ	I-NP	O
institute	institute	NN	I-NP	O
.	.	.	O	O

SUBJECTS	SUBJECTS	NNS	B-NP	O
:	:	:	O	O
Twenty	Twenty	CD	B-NP	O
male	male	JJ	I-NP	O
rabbits	rabbit	NNS	I-NP	O
weighing	weigh	VBG	B-VP	O
2.5-3.5	2.5-3.5	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

INTERVENTIONS	INTERVENTIONS	NNS	B-NP	O
:	:	:	O	O
Saline	Saline	NN	B-NP	O
or	or	CC	O	O
LPS	LPS	NN	B-NP	O
(	(	(	O	O
5	5	CD	B-NP	O
mg/kg	mg/kg	NN	I-NP	O
of	of	IN	B-PP	O
body	body	NN	B-NP	O
weight	weight	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
intravenously	intravenously	RB	B-ADVP	O
with	with	IN	B-PP	O
or	or	CC	B-PP	O
without	without	IN	B-PP	O
NO	NO	NN	B-NP	O
inhalation	inhalation	NN	I-NP	O
(	(	(	O	O
10	10	CD	B-NP	O
ppm	ppm	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
five	five	CD	B-NP	O
rabbits	rabbit	NNS	I-NP	O
.	.	.	O	O

MEASUREMENTS	MEASUREMENTS	NNS	B-NP	O
AND	AND	CC	I-NP	O
MAIN	MAIN	NN	I-NP	O
RESULTS	RESULTS	NNS	I-NP	O
:	:	:	O	O
LPS	LPS	NN	B-NP	O
increased	increase	VBD	B-VP	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
leak	leak	NN	I-NP	O
index	index	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
neutrophils	neutrophil	NNS	I-NP	B-cell_type
and	and	CC	I-NP	O
NO	NO	NN	I-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
bronchoalveolar	bronchoalveolar	JJ	B-NP	O
lavage	lavage	NN	I-NP	O
fluid	fluid	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
NO	NO	NN	B-NP	O
levels	level	NNS	I-NP	O
produced	produce	VBN	B-VP	O
by	by	IN	B-PP	O
resting	rest	VBG	B-NP	O
and	and	CC	I-NP	O
stimulated	stimulate	VBN	I-NP	O
alveolar	alveolar	JJ	I-NP	B-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
.	.	.	O	O

Inhaled	Inhaled	JJ	B-NP	O
NO	NO	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
leak	leak	NN	I-NP	O
index	index	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
neutrophils	neutrophil	NNS	I-NP	B-cell_type
and	and	CC	I-NP	O
NO	NO	NN	I-NP	O
levels	level	NNS	I-NP	O
as	as	IN	B-SBAR	O
measured	measure	VBN	B-VP	O
by	by	IN	B-PP	O
nitrite	nitrite	NN	B-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lavage	lavage	NN	I-NP	O
fluid	fluid	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
NO	NO	NN	B-NP	O
produced	produce	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
resting	resting	NN	I-NP	B-cell_type
and	and	CC	O	I-cell_type
stimulated	stimulate	VBN	B-VP	I-cell_type
alveolar	alveolar	JJ	B-NP	I-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
.	.	.	O	O

Inhaled	Inhaled	JJ	B-NP	O
NO	NO	NN	I-NP	O
also	also	RB	B-ADVP	O
blocked	block	VBD	B-VP	O
the	the	DT	B-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
reactive	reactive	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
species	specie	NNS	I-NP	O
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
DNA	DNA	NN	B-NP	O
in	in	IN	B-PP	O
lavage	lavage	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	B-PP	O
in	in	IN	B-PP	O
alveolar	alveolar	JJ	B-NP	B-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
.	.	.	O	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
Inhaled	Inhaled	JJ	B-NP	O
NO	NO	NN	I-NP	O
attenuates	attenuate	VBZ	B-VP	O
LPS-induced	LPS-induced	JJ	B-NP	O
acute	acute	JJ	I-NP	O
lung	lung	NN	I-NP	O
injury	injury	NN	I-NP	O
,	,	,	O	O
possibly	possibly	RB	B-ADVP	O
by	by	IN	B-PP	O
decreasing	decrease	VBG	B-VP	O
NO	NO	NN	B-NP	O
production	production	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lungs	lung	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
reducing	reduce	VBG	B-VP	O
NO	NO	NN	B-NP	O
production	production	NN	I-NP	O
resulting	result	VBG	B-VP	O
from	from	IN	B-PP	O
inhaled	inhale	VBN	B-NP	O
NO	NO	NN	I-NP	O
may	may	MD	B-VP	O
involve	involve	VB	I-VP	O
,	,	,	O	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
reactive	reactive	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
species	specie	NNS	I-NP	O
and/or	and/or	CC	O	O
nuclear	nuclear	JJ	B-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
.	.	.	O	O

Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
allergic	allergic	JJ	B-NP	O
airway	airway	NN	I-NP	O
inflammation	inflammation	NN	I-NP	O
and	and	CC	I-NP	O
hyperresponsiveness	hyperresponsiveness	NN	I-NP	O
by	by	IN	B-PP	O
antisense-induced	antisense-induced	JJ	B-NP	O
local	local	JJ	I-NP	O
blockade	blockade	NN	I-NP	O
of	of	IN	B-PP	O
GATA-3	GATA-3	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
studies	study	NNS	I-NP	O
in	in	IN	B-PP	O
transgenic	transgenic	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
have	have	VBP	B-VP	O
revealed	reveal	VBN	I-VP	O
that	that	IN	B-SBAR	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
negative	negative	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
GATA-3	GATA-3	NN	I-NP	B-protein
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
can	can	MD	B-VP	O
prevent	prevent	VB	I-VP	O
T	T	NN	B-NP	O
helper	helper	NN	I-NP	O
cell	cell	NN	I-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
(	(	(	O	O
Th2	Th2	NN	B-NP	O
)	)	)	O	O
-mediated	-mediated	JJ	B-NP	O
allergic	allergic	JJ	I-NP	O
airway	airway	NN	I-NP	O
inflammation	inflammation	NN	I-NP	O
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
remains	remain	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
whether	whether	IN	B-SBAR	O
GATA-3	GATA-3	NN	B-NP	B-protein
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
effector	effector	NN	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
allergic	allergic	JJ	B-NP	O
airway	airway	NN	I-NP	O
inflammation	inflammation	NN	I-NP	O
and	and	CC	B-PP	O
whether	whether	IN	B-SBAR	O
antagonizing	antagonize	VBG	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
and/or	and/or	CC	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
GATA-3	GATA-3	NN	B-NP	B-protein
can	can	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
therapy	therapy	NN	I-NP	O
of	of	IN	B-PP	O
allergic	allergic	JJ	B-NP	O
airway	airway	NN	I-NP	O
inflammation	inflammation	NN	I-NP	O
and	and	CC	I-NP	O
hyperresponsiveness	hyperresponsiveness	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
analyzed	analyze	VBD	B-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
locally	locally	RB	B-VP	O
antagonizing	antagonize	VBG	I-VP	O
GATA-3	GATA-3	NN	B-NP	B-protein
function	function	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
murine	murine	JJ	I-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
asthma	asthma	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
could	could	MD	B-VP	O
suppress	suppress	VB	I-VP	O
GATA-3	GATA-3	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
interleukin	interleukin	NN	B-NP	B-cell_type
(	(	(	O	I-cell_type
IL	IL	NN	B-NP	I-cell_type
)	)	)	O	I-cell_type
-4	-4	CD	B-NP	I-cell_type
-producing	-producing	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
antisense	antisense	JJ	I-NP	O
phosphorothioate	phosphorothioate	NN	I-NP	O
oligonucleotide	oligonucleotide	NN	I-NP	O
overlapping	overlap	VBG	B-VP	O
the	the	DT	B-NP	O
translation	translation	NN	I-NP	B-DNA
start	start	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
of	of	IN	B-PP	O
GATA-3	GATA-3	NN	B-NP	B-protein
,	,	,	O	O
whereas	whereas	IN	O	O
nonsense	nonsense	NN	B-NP	O
control	control	NN	I-NP	O
oligonucleotides	oligonucleotide	NNS	I-NP	O
were	be	VBD	B-VP	O
virtually	virtually	RB	B-ADJP	O
inactive	inactive	JJ	I-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
a	a	DT	B-NP	O
murine	murine	JJ	I-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
asthma	asthma	NN	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
allergic	allergic	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
inflammation	inflammation	NN	I-NP	O
and	and	CC	I-NP	O
hyperresponsiveness	hyperresponsiveness	NN	I-NP	O
in	in	IN	B-PP	O
ovalbumin	ovalbumin	NN	B-NP	O
(	(	(	O	O
OVA	OVA	NN	B-NP	O
)	)	)	O	O
-sensitized	-sensitized	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
local	local	JJ	B-NP	O
intranasal	intranasal	JJ	I-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
fluorescein	fluorescein	NN	B-NP	O
isothiocyanate-labeled	isothiocyanate-labeled	JJ	I-NP	O
GATA-3	GATA-3	NN	I-NP	B-protein
antisense	antisense	JJ	I-NP	O
oligonucleotides	oligonucleotide	NNS	I-NP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
DNA	DNA	NN	B-NP	O
uptake	uptake	NN	I-NP	O
in	in	IN	B-PP	O
lung	lung	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
reduction	reduction	NN	I-NP	O
of	of	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
GATA-3	GATA-3	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

Such	Such	JJ	B-NP	O
intrapulmonary	intrapulmonary	JJ	I-NP	O
blockade	blockade	NN	I-NP	O
of	of	IN	B-PP	O
GATA-3	GATA-3	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
caused	cause	VBD	B-VP	O
an	an	DT	B-NP	O
abrogation	abrogation	NN	I-NP	O
of	of	IN	B-PP	O
signs	sign	NNS	B-NP	O
of	of	IN	B-PP	O
lung	lung	NN	B-NP	O
inflammation	inflammation	NN	I-NP	O
including	include	VBG	B-PP	O
infiltration	infiltration	NN	B-NP	O
of	of	IN	B-PP	O
eosinophils	eosinophil	NNS	B-NP	B-cell_type
and	and	CC	O	O
Th2	Th2	NN	B-NP	B-protein
cytokine	cytokine	NN	I-NP	I-protein
production	production	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
antisense	antisense	JJ	B-NP	O
but	but	CC	I-NP	O
not	not	RB	I-ADJP	O
nonsense	nonsense	JJ	B-NP	O
oligonucleotides	oligonucleotide	NNS	I-NP	O
induced	induce	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
of	of	IN	B-PP	O
airway	airway	NN	B-NP	O
hyperresponsiveness	hyperresponsiveness	NN	I-NP	O
in	in	IN	B-PP	O
OVA-sensitized	OVA-sensitized	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
to	to	TO	B-PP	O
levels	level	NNS	B-NP	O
comparable	comparable	JJ	B-ADJP	O
to	to	TO	B-PP	O
saline-treated	saline-treated	JJ	B-NP	O
control	control	NN	I-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
assessed	assess	VBN	B-VP	O
by	by	IN	B-PP	O
both	both	CC	O	O
enhanced	enhance	VBN	B-VP	O
pause	pause	NN	B-NP	O
(	(	(	O	O
PenH	PenH	NN	B-NP	O
)	)	)	O	O
responses	response	NNS	B-NP	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
body	body	NN	B-NP	O
plethysmography	plethysmography	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
GATA-3	GATA-3	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
effector	effector	NN	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
murine	murine	JJ	I-NP	B-cell_line
asthma	asthma	NN	I-NP	I-cell_line
model	model	NN	I-NP	I-cell_line
and	and	CC	O	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
local	local	JJ	B-NP	O
delivery	delivery	NN	I-NP	O
of	of	IN	B-PP	O
GATA-3	GATA-3	NN	B-NP	B-protein
antisense	antisense	JJ	I-NP	O
oligonucleotides	oligonucleotide	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
approach	approach	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
airway	airway	NN	B-NP	O
hyperresponsiveness	hyperresponsiveness	NN	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
in	in	IN	B-PP	O
asthma	asthma	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
approach	approach	NN	I-NP	O
has	have	VBZ	B-VP	O
the	the	DT	B-NP	O
potential	potential	JJ	I-NP	O
advantage	advantage	NN	I-NP	O
of	of	IN	B-PP	O
suppressing	suppress	VBG	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
various	various	JJ	B-NP	O
proinflammatory	proinflammatory	JJ	I-NP	B-protein
Th2	Th2	NN	I-NP	I-protein
cytokines	cytokine	NNS	I-NP	I-protein
simultaneously	simultaneously	RB	B-ADVP	O
rather	rather	RB	B-CONJP	O
than	than	IN	I-CONJP	O
suppressing	suppress	VBG	B-VP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
cytokine	cytokine	NN	I-NP	B-protein
.	.	.	O	O

T	T	NN	B-NP	O
helper-cell	helper-cell	JJ	I-NP	O
phenotype	phenotype	NN	I-NP	O
regulates	regulate	VBZ	B-VP	O
atherosclerosis	atherosclerosis	NN	B-NP	O
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
under	under	IN	B-PP	O
conditions	condition	NNS	B-NP	O
of	of	IN	B-PP	O
mild	mild	JJ	B-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
.	.	.	O	O

BACKGROUND	BACKGROUND	NN	B-NP	O
:	:	:	O	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
atherosclerosis	atherosclerosis	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
little	little	JJ	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
genetic	genetic	JJ	I-NP	O
control	control	NN	I-NP	O
or	or	CC	O	O
molecular	molecular	JJ	B-NP	O
pathways	pathway	NNS	I-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
under	under	IN	B-PP	O
conditions	condition	NNS	B-NP	O
of	of	IN	B-PP	O
mild	mild	JJ	B-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
.	.	.	O	O

METHODS	METHODS	NNS	B-NP	O
AND	AND	CC	I-NP	O
RESULTS	RESULTS	NNS	I-NP	O
:	:	:	O	O
BALB/c	BALB/c	NN	B-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
making	make	VBG	B-VP	O
a	a	DT	B-NP	O
CD4+	CD4+	JJ	I-NP	B-cell_type
Th2	Th2	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
IL-4+	IL-4+	JJ	O	I-cell_type
)	)	)	O	I-cell_type
cell	cell	NN	B-NP	I-cell_type
response	response	NN	I-NP	O
,	,	,	O	O
express	express	VBP	B-VP	O
both	both	CC	O	O
MHC	MHC	NN	B-NP	B-protein
class	class	NN	I-NP	I-protein
II	II	CD	B-NP	I-protein
antigens	antigen	NNS	I-NP	I-protein
(	(	(	O	O
IA	IA	NN	B-NP	O
(	(	(	O	O
d	d	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
IE	IE	NN	B-NP	B-protein
(	(	(	O	I-protein
d	d	NN	B-NP	I-protein
)	)	)	O	I-protein
)	)	)	O	O
and	and	CC	O	O
are	be	VBP	B-VP	O
atherosclerosis-resistant	atherosclerosis-resistant	JJ	B-ADJP	O
.	.	.	O	O

C57Bl/6	C57Bl/6	NN	B-NP	O
mice	mouse	NNS	I-NP	O
produce	produce	VBP	B-VP	O
a	a	DT	B-NP	O
CD4+	CD4+	JJ	I-NP	O
Th1	Th1	NN	I-NP	O
(	(	(	O	O
interferon	interferon	NN	B-NP	B-protein
[	[	(	O	O
IFN	IFN	NN	B-NP	B-protein
]	]	)	O	O
gamma+	gamma+	NN	B-NP	O
)	)	)	O	O
response	response	NN	B-NP	O
,	,	,	O	O
express	express	VBP	B-VP	O
IA	IA	NN	B-NP	O
(	(	(	O	O
b	b	NN	B-NP	O
)	)	)	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
IE	IE	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
are	be	VBP	B-VP	O
atherosclerosis-prone	atherosclerosis-prone	JJ	B-ADJP	O
.	.	.	O	O

To	To	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
T	T	NN	B-NP	O
helper-cell	helper-cell	JJ	I-NP	O
phenotype	phenotype	NN	I-NP	O
in	in	IN	B-PP	O
fatty	fatty	JJ	B-NP	O
streak	streak	NN	I-NP	O
formation	formation	NN	I-NP	O
,	,	,	O	O
wild-type	wild-type	JJ	B-NP	O
C57Bl/6	C57Bl/6	NN	I-NP	O
mice	mouse	NNS	I-NP	O
(	(	(	O	O
IA	IA	NN	B-NP	O
(	(	(	O	O
b	b	NN	B-NP	O
)	)	)	O	O
+IE-	+IE-	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
transgenic	transgenic	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
either	either	CC	O	O
AB	AB	NN	B-NP	O
(	(	(	O	O
o	o	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
IA	IA	NN	B-NP	O
(	(	(	O	O
b	b	NN	B-NP	O
)	)	)	O	O
-IE-	-IE-	NN	B-NP	O
;	;	:	O	O
ABEalpha	ABEalpha	NN	B-NP	B-protein
,	,	,	O	O
IA-IE	IA-IE	NN	B-NP	B-protein
(	(	(	O	O
k	k	NN	B-NP	O
)	)	)	O	O
+	+	SYM	B-NP	O
;	;	:	O	O
or	or	CC	O	O
BL	BL	NN	B-NP	O
:	:	:	O	O
TG	TG	NN	B-NP	B-protein
:	:	:	O	I-protein
Ealpha	Ealpha	NN	B-NP	I-protein
,	,	,	O	O
IA	IA	NN	B-NP	O
(	(	(	O	O
b	b	NN	B-NP	O
)	)	)	O	O
+IE	+IE	NN	B-NP	O
(	(	(	O	O
k	k	NN	B-NP	O
)	)	)	O	O
+	+	SYM	B-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
fed	feed	VBN	I-VP	O
a	a	DT	B-NP	O
high-cholesterol	high-cholesterol	JJ	I-NP	O
diet	diet	NN	I-NP	O
for	for	IN	B-PP	O
16	16	CD	B-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
evaluated	evaluate	VBN	B-VP	O
histomorphometrically	histomorphometrically	RB	B-ADVP	O
for	for	IN	B-PP	O
aortic	aortic	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

Lesion	Lesion	NN	B-NP	O
size	size	NN	I-NP	O
in	in	IN	B-PP	O
AB	AB	NN	B-NP	O
(	(	(	O	O
o	o	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
ABEalpha	ABEalpha	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
BL	BL	NN	B-NP	O
:	:	:	O	O
TG	TG	NN	B-NP	O
:	:	:	O	O
Ealpha	Ealpha	NN	B-NP	O
strains	strain	NNS	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
by	by	IN	B-PP	O
54	54	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
79	79	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
82	82	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
wild-type	wild-type	JJ	B-ADJP	O
,	,	,	O	O
correlating	correlate	VBG	B-VP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
Th1	Th1	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBD	B-VP	O
Th2	Th2	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
T	T	NN	B-NP	O
helper-cell	helper-cell	NN	I-NP	O
phenotype	phenotype	NN	I-NP	O
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
in	in	IN	B-PP	O
fatty	fatty	JJ	B-NP	O
lesion	lesion	NN	I-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

Decreasing	Decrease	VBG	B-VP	O
Th1	Th1	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
antibodies	antibody	NNS	B-NP	B-protein
(	(	(	O	O
alpha-CD4	alpha-CD4	NN	B-NP	B-protein
)	)	)	O	O
or	or	CC	O	O
cytokines	cytokine	NNS	B-NP	B-protein
(	(	(	O	O
IL-4	IL-4	NN	B-NP	B-protein
)	)	)	O	O
also	also	RB	B-ADVP	O
caused	cause	VBD	B-VP	O
>	>	SYM	B-NP	O
/=80	/=80	CD	B-NP	O
%	%	NN	I-NP	O
reductions	reduction	NNS	I-NP	O
in	in	IN	B-PP	O
lesion	lesion	NN	B-NP	O
size	size	NN	I-NP	O
.	.	.	O	O

Immunohistology	Immunohistology	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
IL-4	IL-4	NN	B-NP	B-protein
,	,	,	O	O
colocalized	colocalize	VBD	B-VP	O
with	with	IN	B-PP	O
activated	activate	VBN	B-NP	B-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
.	.	.	O	O

Confirming	Confirm	VBG	B-VP	O
these	these	DT	B-NP	O
findings	finding	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
different	different	JJ	I-NP	O
mouse	mouse	NN	I-NP	O
strain	strain	NN	I-NP	O
,	,	,	O	O
BALB/c	BALB/c	NN	B-NP	O
Stat	Stat	NN	I-NP	O
6	6	CD	I-NP	O
knockout	knockout	NN	I-NP	O
mice	mouse	NNS	I-NP	O
(	(	(	O	O
Th2	Th2	NN	B-NP	O
cell-deficient	cell-deficient	JJ	I-NP	O
)	)	)	O	O
developed	develop	VBD	B-VP	O
aortic	aortic	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
comparable	comparable	JJ	B-ADJP	O
to	to	TO	B-PP	O
C57Bl/6	C57Bl/6	NN	B-NP	O
mice	mouse	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
mildly	mildly	RB	B-NP	O
hypercholesterolemic	hypercholesterolemic	JJ	I-NP	O
C57Bl/6	C57Bl/6	NN	I-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
presence	presence	NN	B-NP	O
of	of	IN	B-PP	O
IA	IA	NN	B-NP	O
(	(	(	O	O
b	b	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
absence	absence	NN	B-NP	O
of	of	IN	B-PP	O
IE	IE	JJ	B-NP	O
regulated	regulate	VBN	I-NP	O
CD4+	CD4+	JJ	I-NP	O
T	T	NN	I-NP	O
helper-cell	helper-cell	NN	I-NP	O
phenotype	phenotype	NN	I-NP	O
;	;	:	O	O
fatty	fatty	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
were	be	VBD	B-VP	O
proportional	proportional	JJ	B-ADJP	O
to	to	TO	B-PP	O
IFNgamma+	IFNgamma+	JJ	B-NP	B-cell_line
Th1	Th1	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
in	in	IN	B-PP	O
both	both	CC	O	O
C57Bl/6	C57Bl/6	NN	B-NP	O
and	and	CC	I-NP	O
BALB/c	BALB/c	NN	I-NP	O
strains	strain	NNS	I-NP	O
.	.	.	O	O

IFN-gamma	IFN-gamma	NN	B-NP	B-protein
may	may	MD	B-VP	O
participate	participate	VB	I-VP	O
through	through	IN	B-PP	O
macrophage	macrophage	NN	B-NP	O
activation	activation	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
IL-4	IL-4	NN	B-NP	B-protein
may	may	MD	B-VP	O
act	act	VB	I-VP	O
to	to	TO	I-VP	O
limit	limit	VB	I-VP	O
Th1-cell	Th1-cell	NN	B-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Requirement	Requirement	NN	B-NP	O
for	for	IN	B-PP	O
p38	p38	NN	B-NP	B-protein
and	and	CC	I-NP	O
p44/p42	p44/p42	NN	I-NP	B-protein
mitogen-activated	mitogen-activated	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
kinases	kinase	NNS	I-NP	I-protein
in	in	IN	B-PP	O
RAGE	RAGE	NN	B-NP	O
-mediated	-mediated	JJ	I-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
transcriptional	transcriptional	JJ	I-NP	O
activation	activation	NN	I-NP	O
and	and	CC	O	O
cytokine	cytokine	NN	B-NP	B-protein
secretion	secretion	NN	I-NP	O
.	.	.	O	O

Advanced	Advance	VBN	B-NP	O
glycation	glycation	NN	I-NP	B-protein
end	end	NN	I-NP	I-protein
product	product	NN	I-NP	I-protein
(	(	(	O	O
AGE	AGE	NN	B-NP	O
)	)	)	O	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
signal-transducing	signal-transducing	JJ	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
for	for	IN	B-PP	O
AGE	AGE	NN	B-NP	O
(	(	(	O	O
RAGE	RAGE	NN	B-NP	O
)	)	)	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
linked	link	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
proinflammatory	proinflammatory	JJ	I-NP	O
phenotypic	phenotypic	JJ	I-NP	O
change	change	NN	I-NP	O
within	within	IN	B-PP	O
cells	cell	NNS	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
precise	precise	JJ	I-NP	O
intracellular	intracellular	JJ	I-NP	O
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
involved	involve	VBN	B-VP	O
have	have	VBP	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
elucidated	elucidate	VBN	I-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
here	here	RB	B-ADVP	O
that	that	IN	B-SBAR	O
human	human	JJ	B-NP	B-protein
serum	serum	NN	I-NP	I-protein
albumin	albumin	NN	I-NP	I-protein
modified	modify	VBN	B-VP	O
with	with	IN	B-PP	O
N	N	NN	B-NP	O
(	(	(	O	O
varepsilon	varepsilon	NN	B-NP	O
)	)	)	O	O
-	-	HYPH	O	O
(	(	(	O	O
carboxymethyl	carboxymethyl	NN	B-NP	O
)	)	)	O	O
lysine	lysine	NN	B-NP	O
(	(	(	O	O
CML	CML	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
AGE	AGE	NN	I-NP	O
adduct	adduct	NN	I-NP	O
that	that	WDT	B-NP	O
progressively	progressively	RB	B-ADVP	O
accumulates	accumulate	VBZ	B-VP	O
with	with	IN	B-PP	O
aging	aging	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
induced	induce	VBD	B-VP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	I-protein
NF	NF	NN	B-NP	I-protein
)	)	)	O	I-protein
-kappaB	-kappaB	NN	B-NP	I-protein
-driven	-driven	JJ	I-NP	O
reporter	reporter	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
monocytic	monocytic	JJ	I-NP	I-cell_line
THP-1	THP-1	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
response	response	NN	I-NP	O
was	be	VBD	B-VP	O
blocked	block	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
synthetic	synthetic	JJ	I-NP	O
peptide	peptide	NN	I-NP	O
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
putative	putative	JJ	I-NP	B-protein
ligand-binding	ligand-binding	JJ	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
RAGE	RAGE	NN	B-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
anti-	anti-	JJ	B-NP	O
RAGE	RAGE	NN	I-NP	O
antiserum	antiserum	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
by	by	IN	B-PP	O
coexpression	coexpression	NN	B-NP	O
of	of	IN	B-PP	O
truncated	truncate	VBN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
lacking	lack	VBG	B-VP	O
the	the	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
.	.	.	O	O

Signal	Signal	NN	B-NP	O
transduction	transduction	NN	I-NP	O
from	from	IN	B-PP	O
RAGE	RAGE	NN	B-NP	O
to	to	TO	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
involved	involve	VBD	B-VP	O
the	the	DT	B-NP	O
generation	generation	NN	I-NP	O
of	of	IN	B-PP	O
reactive	reactive	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
reporter	reporter	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
blocked	block	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
antioxidant	antioxidant	JJ	I-NP	O
N-acetyl-L-cysteine	N-acetyl-L-cysteine	NN	I-NP	O
.	.	.	O	O

CML-modified	CML-modified	JJ	B-NP	O
albumin	albumin	NN	I-NP	O
produced	produce	VBD	B-VP	O
rapid	rapid	JJ	B-NP	O
transient	transient	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
tyrosine	tyrosine	NN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
,	,	,	O	O
extracellular	extracellular	JJ	B-NP	B-protein
signal-regulated	signal-regulated	JJ	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
and	and	CC	I-NP	I-protein
2	2	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
p38	p38	NN	B-NP	B-protein
mitogen-activated	mitogen-activated	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
MAPK	MAPK	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
c-Jun	c-Jun	NN	B-NP	B-protein
NH	NH	NN	I-NP	I-protein
(	(	(	O	I-protein
2	2	CD	B-NP	I-protein
)	)	)	O	I-protein
-terminal	-terminal	JJ	B-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
.	.	.	O	O

RAGE	RAGE	NN	B-NP	O
-mediated	-mediated	JJ	I-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
was	be	VBD	B-VP	O
suppressed	suppress	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
selective	selective	JJ	I-NP	O
p38	p38	NN	I-NP	B-protein
MAPK	MAPK	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	O
SB203580	SB203580	NN	I-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
coexpression	coexpression	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
kinase-dead	kinase-dead	JJ	I-NP	B-protein
p38	p38	NN	I-NP	I-protein
dominant-negative	dominant-negative	JJ	I-NP	I-protein
mutant	mutant	NN	I-NP	I-protein
.	.	.	O	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
by	by	IN	B-PP	O
CML-modified	CML-modified	JJ	B-NP	B-protein
albumin	albumin	NN	I-NP	I-protein
increased	increase	VBD	B-VP	O
secretion	secretion	NN	B-NP	O
of	of	IN	B-PP	O
proinflammatory	proinflammatory	JJ	B-NP	B-protein
cytokines	cytokine	NNS	I-NP	I-protein
(	(	(	O	O
tumor	tumor	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor-alpha	factor-alpha	NN	I-NP	I-protein
,	,	,	O	O
interleukin-1beta	interleukin-1beta	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
monocyte	monocyte	NN	B-NP	B-protein
chemoattractant	chemoattractant	NN	I-NP	I-protein
protein-1	protein-1	NN	I-NP	I-protein
)	)	)	O	O
severalfold	severalfold	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
p38	p38	NN	B-NP	B-protein
MAPK	MAPK	NN	I-NP	I-protein
blocked	block	VBD	B-VP	O
these	these	DT	B-NP	O
increases	increase	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
p38	p38	NN	B-NP	B-protein
MAPK	MAPK	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
mediates	mediate	VBZ	B-VP	O
RAGE	RAGE	NN	B-NP	O
-induced	-induced	JJ	I-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
secretion	secretion	NN	I-NP	O
of	of	IN	B-PP	O
proinflammatory	proinflammatory	JJ	B-NP	B-protein
cytokines	cytokine	NNS	I-NP	I-protein
and	and	CC	O	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
accelerated	accelerate	VBN	B-NP	O
inflammation	inflammation	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
consequence	consequence	NN	I-NP	O
of	of	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
activation	activation	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
this	this	DT	B-NP	O
receptor	receptor	NN	I-NP	O
.	.	.	O	O

Antigen-receptor	Antigen-receptor	JJ	B-NP	O
cross-linking	cross-linking	NN	I-NP	O
and	and	CC	I-NP	O
lipopolysaccharide	lipopolysaccharide	NN	I-NP	O
trigger	trigger	NN	I-NP	O
distinct	distinct	JJ	I-NP	O
phosphoinositide	phosphoinositide	NN	I-NP	B-protein
3-kinase	3-kinase	NN	I-NP	I-protein
-dependent	-dependent	JJ	I-NP	O
pathways	pathway	NNS	I-NP	O
to	to	TO	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
NF-kappaB/Rel	NF-kappaB/Rel	NN	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
play	play	VBP	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
genes	gene	NNS	B-NP	B-DNA
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
development	development	NN	I-NP	O
,	,	,	O	O
differentiation	differentiation	NN	B-NP	O
and	and	CC	O	O
function	function	NN	B-NP	O
.	.	.	O	O

Nuclear	Nuclear	JJ	B-NP	B-protein
NF-kappaB	NF-kappaB	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
induced	induce	VBN	I-VP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
engagement	engagement	NN	B-NP	O
of	of	IN	B-PP	O
either	either	CC	O	O
the	the	DT	B-NP	O
BCR	BCR	NN	I-NP	B-protein
or	or	CC	I-NP	O
CD40	CD40	NN	I-NP	B-protein
or	or	CC	B-PP	O
by	by	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
with	with	IN	B-PP	O
lipopolysaccharide	lipopolysaccharide	NN	B-NP	O
(	(	(	O	O
LPS	LPS	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
to	to	TO	B-PP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
little	little	JJ	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
we	we	PRP	B-NP	O
address	address	VBP	B-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
phosphoinositide	phosphoinositide	NN	B-NP	B-protein
3'-kinase	3'-kinase	NN	I-NP	I-protein
(	(	(	O	O
PI	PI	NN	B-NP	B-protein
3-kinase	3-kinase	NN	I-NP	I-protein
)	)	)	O	O
in	in	IN	B-PP	O
BCR	BCR	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
LPS-induced	LPS-induced	JJ	I-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
using	use	VBG	B-VP	O
populations	population	NNS	B-NP	O
of	of	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
murine	murine	JJ	I-NP	I-cell_type
resting	rest	VBG	I-NP	I-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Using	Use	VBG	B-VP	O
the	the	DT	B-NP	O
specific	specific	JJ	I-NP	O
pharmacological	pharmacological	JJ	I-NP	O
inhibitors	inhibitor	NNS	I-NP	O
of	of	IN	B-PP	O
PI	PI	NN	B-NP	B-protein
3-kinase	3-kinase	NN	I-NP	I-protein
,	,	,	O	O
Wortmannin	Wortmannin	NN	B-NP	O
and	and	CC	I-NP	O
LY294002	LY294002	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
PI	PI	NN	B-NP	B-protein
3-kinase	3-kinase	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
is	be	VBZ	B-VP	O
vital	vital	JJ	B-ADJP	O
for	for	IN	B-PP	O
BCR	BCR	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
DNA-binding	DNA-binding	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
achieved	achieve	VBN	I-VP	O
via	via	IN	B-PP	O
protein	protein	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
C	C	NN	I-NP	I-protein
-dependent	-dependent	JJ	I-NP	O
degradation	degradation	NN	I-NP	O
of	of	IN	B-PP	O
IkappaBalpha	IkappaBalpha	NN	B-NP	B-protein
.	.	.	O	O

Similar	Similar	JJ	B-NP	O
analyses	analysis	NNS	I-NP	O
reveal	reveal	VBP	B-VP	O
that	that	IN	B-SBAR	O
PI	PI	NN	B-NP	B-protein
3-kinase	3-kinase	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
critical	critical	JJ	B-ADJP	O
in	in	IN	B-PP	O
triggering	trigger	VBG	B-VP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
DNA-binding	DNA-binding	JJ	I-NP	O
activity	activity	NN	I-NP	O
and	and	CC	I-NP	O
IkappaBalpha	IkappaBalpha	NN	I-NP	B-protein
degradation	degradation	NN	I-NP	O
following	follow	VBG	B-PP	O
LPS	LPS	NN	B-NP	O
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
PKC	PKC	NN	I-NP	B-protein
inhibitor	inhibitor	NN	I-NP	O
which	which	WDT	B-NP	O
blocked	block	VBD	B-VP	O
the	the	DT	B-NP	O
BCR	BCR	NN	I-NP	B-protein
-induced	-induced	JJ	I-NP	O
IkappaBalpha	IkappaBalpha	NN	I-NP	B-protein
degradation	degradation	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
degradation	degradation	NN	I-NP	O
of	of	IN	B-PP	O
IkappaBalpha	IkappaBalpha	NN	B-NP	B-protein
after	after	IN	B-PP	O
LPS	LPS	NN	B-NP	O
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

Taken	Take	VBN	B-VP	O
together	together	RB	B-ADVP	O
,	,	,	O	O
our	our	PRP$	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
the	the	DT	B-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
PI	PI	NN	B-NP	B-protein
3-kinase	3-kinase	NN	I-NP	I-protein
in	in	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
two	two	CD	I-NP	O
distinct	distinct	JJ	I-NP	O
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Tetramer-guided	Tetramer-guided	JJ	B-NP	O
epitope	epitope	NN	I-NP	O
mapping	mapping	NN	I-NP	O
:	:	:	O	O
rapid	rapid	JJ	B-NP	O
identification	identification	NN	I-NP	O
and	and	CC	I-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
immunodominant	immunodominant	JJ	B-NP	B-protein
CD4+	CD4+	JJ	I-NP	I-protein
T	T	NN	I-NP	I-protein
cell	cell	NN	I-NP	I-protein
epitopes	epitope	NNS	I-NP	I-protein
from	from	IN	B-PP	O
complex	complex	NN	B-NP	B-protein
antigens	antigen	NNS	I-NP	I-protein
.	.	.	O	O

T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
Ags	Ag	NNS	B-NP	B-protein
involve	involve	VB	B-VP	O
recognition	recognition	NN	B-NP	O
of	of	IN	B-PP	O
selected	select	VBN	B-NP	O
peptide	peptide	NN	I-NP	B-protein
epitopes	epitope	NNS	I-NP	I-protein
contained	contain	VBD	B-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
antigenic	antigenic	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
describe	describe	VBP	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
approach	approach	NN	I-NP	O
for	for	IN	B-PP	O
direct	direct	JJ	B-NP	O
identification	identification	NN	I-NP	O
of	of	IN	B-PP	O
CD4+	CD4+	JJ	B-NP	B-protein
T	T	NN	I-NP	I-protein
cell	cell	NN	I-NP	I-protein
epitopes	epitope	NNS	I-NP	I-protein
of	of	IN	B-PP	O
complex	complex	JJ	B-NP	O
Ags	Ag	NNS	I-NP	B-protein
that	that	WDT	B-NP	O
uses	use	VBZ	B-VP	O
human	human	JJ	B-NP	B-protein
class	class	NN	I-NP	I-protein
II	II	CD	B-NP	I-protein
tetramers	tetramer	NNS	I-NP	I-protein
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
reactive	reactive	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

With	With	IN	B-PP	O
a	a	DT	B-NP	O
panel	panel	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
overlapping	overlap	VBG	I-NP	O
peptides	peptide	NNS	I-NP	O
covering	cover	VBG	B-VP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
VP16	VP16	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
,	,	,	O	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
Ag	Ag	NN	I-NP	B-protein
for	for	IN	B-PP	O
HSV-2	HSV-2	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
generated	generate	VBD	B-VP	O
a	a	DT	B-NP	O
panel	panel	NN	I-NP	O
of	of	IN	B-PP	O
class	class	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
MHC	MHC	NN	I-NP	I-protein
tetramers	tetramer	NNS	I-NP	I-protein
loaded	load	VBN	B-VP	O
with	with	IN	B-PP	O
peptide	peptide	NN	B-NP	O
pools	pool	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
stain	stain	VB	I-VP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
an	an	DT	B-NP	O
HSV-2	HSV-2	NN	I-NP	O
infected	infected	JJ	I-NP	O
individual	individual	NN	I-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
this	this	DT	B-NP	O
approach	approach	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
identified	identify	VBD	B-VP	O
four	four	CD	B-NP	O
new	new	JJ	I-NP	O
DRA1*0101/DRB1*0401-	DRA1*0101/DRB1*0401-	NN	I-NP	O
and	and	CC	O	O
two	two	CD	B-NP	O
DRA1*0101/DRB1*0404-restricted	DRA1*0101/DRB1*0404-restricted	JJ	I-NP	O
,	,	,	I-NP	O
VP16-specific	VP16-specific	JJ	I-NP	B-protein
epitopes	epitope	NNS	I-NP	I-protein
.	.	.	O	O

By	By	IN	B-PP	O
using	use	VBG	B-VP	O
tetramers	tetramer	NNS	B-NP	O
to	to	TO	B-VP	O
sort	sort	VB	I-VP	O
individual	individual	JJ	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
easily	easily	RB	B-ADVP	O
obtained	obtain	VBD	B-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
clones	clone	NNS	B-NP	O
specific	specific	JJ	B-ADJP	O
to	to	TO	B-PP	O
these	these	DT	B-NP	O
epitopes	epitope	NNS	I-NP	B-protein
.	.	.	O	O

Although	Although	IN	B-SBAR	O
DRA1*0101/DRB1*0401	DRA1*0101/DRB1*0401	NN	B-NP	O
and	and	CC	I-NP	O
DRA1*0101/DRB1*0404	DRA1*0101/DRB1*0404	NN	I-NP	O
are	be	VBP	B-VP	O
structurally	structurally	RB	B-NP	O
very	very	RB	I-NP	O
similar	similar	JJ	I-NP	O
,	,	,	I-NP	O
nonoverlapping	nonoverlapping	JJ	I-NP	B-protein
VP16	VP16	NN	I-NP	I-protein
epitopes	epitope	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
,	,	,	O	O
illustrating	illustrate	VBG	B-VP	O
high	high	JJ	B-NP	O
selectivity	selectivity	NN	I-NP	O
of	of	IN	B-PP	O
individual	individual	JJ	B-NP	O
allele	allele	NN	I-NP	B-DNA
polymorphisms	polymorphism	NNS	I-NP	I-DNA
within	within	IN	B-PP	O
common	common	JJ	B-NP	O
MHC	MHC	NN	I-NP	O
variants	variant	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
approach	approach	NN	I-NP	O
to	to	TO	B-PP	O
detecting	detect	VBG	B-VP	O
CD4+	CD4+	JJ	B-NP	B-protein
T	T	NN	I-NP	I-protein
cell	cell	NN	I-NP	I-protein
epitopes	epitope	NNS	I-NP	I-protein
from	from	IN	B-PP	O
complex	complex	JJ	B-NP	O
Ags	Ag	NNS	I-NP	B-protein
can	can	MD	B-VP	O
be	be	VB	I-VP	O
applied	apply	VBN	I-VP	O
to	to	TO	B-PP	O
any	any	DT	B-NP	O
known	know	VBN	I-NP	O
Ag	Ag	NN	I-NP	B-protein
that	that	WDT	B-NP	O
gives	give	VBZ	B-VP	O
a	a	DT	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Localized	Localize	VBN	B-NP	O
pancreatic	pancreatic	JJ	I-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
and	and	CC	O	O
inflammatory	inflammatory	JJ	B-NP	O
response	response	NN	I-NP	O
in	in	IN	B-PP	O
taurocholate-induced	taurocholate-induced	JJ	B-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
.	.	.	O	O

Transcription	Transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
nuclear	nuclear	JJ	I-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
(	(	(	O	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
activated	activate	VBN	I-VP	O
in	in	IN	B-PP	O
cerulein	cerulein	NN	B-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
and	and	CC	O	O
mediates	mediate	VBZ	B-VP	O
cytokine	cytokine	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
other	other	JJ	B-NP	O
models	model	NNS	I-NP	O
of	of	IN	B-PP	O
pancreatitis	pancreatitis	NN	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
established	establish	VBN	I-VP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
upregulation	upregulation	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
and	and	CC	O	O
inflammatory	inflammatory	JJ	B-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
correlation	correlation	NN	I-NP	O
with	with	IN	B-PP	O
local	local	JJ	B-NP	O
pancreatic	pancreatic	JJ	I-NP	O
injury	injury	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
.	.	.	O	O

Rats	Rat	NNS	B-NP	O
received	receive	VBD	B-VP	O
intraductal	intraductal	JJ	B-NP	O
infusion	infusion	NN	I-NP	O
of	of	IN	B-PP	O
taurocholate	taurocholate	NN	B-NP	O
or	or	CC	I-NP	O
saline	saline	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
pancreatic	pancreatic	JJ	I-NP	O
head	head	NN	I-NP	O
and	and	CC	I-NP	O
tail	tail	NN	I-NP	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
separately	separately	RB	B-ADVP	O
.	.	.	O	O

NF-kappaB	NF-kappaB	NN	B-NP	B-protein
and	and	CC	I-NP	O
activator	activator	NN	I-NP	B-protein
protein-1	protein-1	NN	I-NP	I-protein
(	(	(	O	O
AP-1	AP-1	NN	B-NP	B-protein
)	)	)	O	O
activation	activation	NN	B-NP	O
were	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
by	by	IN	B-PP	O
gel	gel	NN	B-NP	O
shift	shift	NN	I-NP	O
assay	assay	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
mRNA	mRNA	NN	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
interleukin-6	interleukin-6	NN	B-NP	B-protein
,	,	,	O	O
tumor	tumor	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor-alpha	factor-alpha	NN	I-NP	I-protein
,	,	,	O	O
KC	KC	NN	B-NP	O
,	,	,	O	O
monocyte	monocyte	NN	B-NP	B-protein
chemoattractant	chemoattractant	NN	I-NP	I-protein
protein-1	protein-1	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
inducible	inducible	JJ	B-NP	O
nitric	nitric	JJ	I-NP	B-protein
oxide	oxide	NN	I-NP	I-protein
synthase	synthase	NN	I-NP	I-protein
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
by	by	IN	B-PP	O
semiquantitative	semiquantitative	JJ	B-NP	O
RT-PCR	RT-PCR	NN	I-NP	O
.	.	.	O	O

Morphological	Morphological	JJ	B-NP	O
damage	damage	NN	I-NP	O
and	and	CC	I-NP	O
trypsin	trypsin	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
were	be	VBD	B-VP	O
much	much	RB	B-ADJP	O
greater	great	JJR	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pancreatic	pancreatic	JJ	I-NP	O
head	head	NN	I-NP	O
than	than	IN	B-PP	O
tail	tail	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
parallel	parallel	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
stronger	strong	JJR	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
and	and	CC	O	O
cytokine	cytokine	NN	B-NP	B-RNA
mRNA	mRNA	NN	B-NP	I-RNA
.	.	.	O	O

Saline	Saline	NN	B-NP	O
infusion	infusion	NN	I-NP	O
mildly	mildly	RB	B-VP	O
affected	affect	VBD	I-VP	O
these	these	DT	B-NP	O
parameters	parameter	NNS	I-NP	O
.	.	.	O	O

AP-1	AP-1	NN	B-NP	B-protein
was	be	VBD	B-VP	O
strongly	strongly	RB	I-VP	O
activated	activate	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
pancreatic	pancreatic	JJ	I-NP	O
segments	segment	NNS	I-NP	O
after	after	IN	B-PP	O
either	either	CC	O	O
taurocholate	taurocholate	NN	B-NP	O
or	or	CC	O	O
saline	saline	NN	B-NP	O
infusion	infusion	NN	I-NP	O
.	.	.	O	O

NF-kappaB	NF-kappaB	NN	B-NP	B-protein
inhibition	inhibition	NN	I-NP	O
with	with	IN	B-PP	O
N-acetylcysteine	N-acetylcysteine	NN	B-NP	O
ameliorated	ameliorate	VBD	B-VP	O
the	the	DT	B-NP	O
local	local	JJ	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Correlation	Correlation	NN	B-NP	O
between	between	IN	B-PP	O
localized	localized	JJ	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
,	,	,	O	O
cytokine	cytokine	NN	B-NP	B-protein
upregulation	upregulation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
tissue	tissue	NN	B-NP	O
damage	damage	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
a	a	DT	B-NP	O
key	key	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
response	response	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
.	.	.	O	O

CD45	CD45	NN	B-NP	B-protein
tyrosine	tyrosine	NN	I-NP	I-protein
phosphatase	phosphatase	NN	I-NP	I-protein
controls	control	VBZ	B-VP	O
common	common	JJ	B-NP	B-protein
gamma-chain	gamma-chain	NN	I-NP	I-protein
cytokine	cytokine	NN	I-NP	I-protein
-mediated	-mediated	JJ	I-NP	O
STAT	STAT	NN	I-NP	B-protein
and	and	CC	O	O
extracellular	extracellular	JJ	B-NP	O
signal-related	signal-related	JJ	I-NP	O
kinase	kinase	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
in	in	IN	B-PP	O
activated	activate	VBN	B-NP	O
human	human	JJ	I-NP	B-cell_type
lymphoblasts	lymphoblast	NNS	I-NP	I-cell_type
:	:	:	O	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
proliferation	proliferation	NN	B-NP	O
without	without	IN	B-PP	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
objective	objective	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
test	test	VB	I-VP	O
whether	whether	IN	B-SBAR	O
CD45	CD45	NN	B-NP	B-protein
signals	signal	NNS	I-NP	O
can	can	MD	B-VP	O
influence	influence	VB	I-VP	O
signaling	signaling	NN	B-NP	O
processes	process	NNS	I-NP	O
in	in	IN	B-PP	O
activated	activate	VBN	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
lymphoblasts	lymphoblast	NNS	I-NP	I-cell_type
.	.	.	O	O

To	To	TO	B-PP	O
this	this	DT	B-NP	O
end	end	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
generated	generate	VBD	B-VP	O
lymphoblasts	lymphoblast	NNS	B-NP	B-cell_type
which	which	WDT	B-NP	O
proliferate	proliferate	VBP	B-VP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
common	common	JJ	B-NP	B-protein
gamma-chain	gamma-chain	NN	I-NP	I-protein
cytokines	cytokine	NNS	I-NP	I-protein
,	,	,	O	O
but	but	CC	O	O
readily	readily	RB	B-VP	O
undergo	undergo	VBP	I-VP	O
apoptosis	apoptosis	NN	B-NP	O
after	after	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-protein
withdrawal	withdrawal	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
experiments	experiment	NNS	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
CD45R0	CD45R0	NN	I-NP	B-protein
mAb	mAb	NN	I-NP	I-protein
UCHL-1	UCHL-1	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
control	control	VB	B-VP	O
CD45	CD45	NN	B-NP	B-protein
mAbs	mAb	NNS	I-NP	I-protein
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
significant	significant	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
proliferation	proliferation	NN	B-NP	O
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
pan-CD45	pan-CD45	NN	I-NP	O
mAb	mAb	NN	I-NP	O
GAP8.3	GAP8.3	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
most	most	RBS	B-ADJP	O
effective	effective	JJ	I-ADJP	O
in	in	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
OKT-3-mediated	OKT-3-mediated	JJ	B-NP	O
proliferation	proliferation	NN	I-NP	O
in	in	IN	B-PP	O
quiescent	quiescent	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
was	be	VBD	B-VP	O
ineffective	ineffective	JJ	B-ADJP	O
in	in	IN	B-PP	O
lymphoblasts	lymphoblast	NNS	B-NP	B-cell_type
.	.	.	O	O

Addition	Addition	NN	B-NP	O
of	of	IN	B-PP	O
CD3	CD3	NN	B-NP	B-protein
mAb	mAb	NN	I-NP	O
OKT-3	OKT-3	NN	I-NP	B-protein
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
influence	influence	NN	I-NP	O
on	on	IN	B-PP	O
IL-2-mediated	IL-2-mediated	JJ	B-NP	O
proliferation	proliferation	NN	I-NP	O
(	(	(	O	O
with	with	IN	B-PP	O
or	or	CC	I-PP	O
without	without	IN	I-PP	O
UCHL-1	UCHL-1	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
after	after	IN	B-PP	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
OKT-3	OKT-3	NN	B-NP	B-protein
to	to	TO	B-PP	O
IL-4	IL-4	NN	B-NP	B-protein
-	-	HYPH	O	O
and	and	CC	O	O
IL-7	IL-7	NN	B-NP	B-protein
-stimulated	-stimulated	JJ	I-NP	O
proliferation	proliferation	NN	I-NP	O
assays	assay	NNS	I-NP	O
,	,	,	O	O
UCHL-1	UCHL-1	NN	B-NP	B-protein
signals	signal	NNS	I-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
significantly	significantly	RB	I-VP	O
alter	alter	VB	I-VP	O
cellular	cellular	JJ	B-NP	O
proliferation	proliferation	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
find	find	VB	I-VP	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
following	follow	VBG	B-PP	O
CD45R0	CD45R0	NN	B-NP	B-protein
signaling	signaling	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
Western	Western	JJ	B-NP	O
blots	blot	NNS	I-NP	O
using	use	VBG	B-VP	O
mAbs	mAb	NNS	B-NP	B-protein
detecting	detect	VBG	B-VP	O
phosphorylated	phosphorylate	VBN	B-NP	O
STAT-3	STAT-3	NN	I-NP	B-protein
,	,	,	O	O
STAT-5	STAT-5	NN	B-NP	B-protein
,	,	,	O	O
STAT-6	STAT-6	NN	B-NP	B-protein
,	,	,	O	O
or	or	CC	O	O
extracellular	extracellular	JJ	B-NP	B-protein
signal-related	signal-related	JJ	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
1/2	1/2	CD	I-NP	I-protein
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
CD45R0	CD45R0	NN	B-NP	B-protein
signaling	signaling	NN	I-NP	O
could	could	MD	B-VP	O
effectively	effectively	RB	I-VP	O
diminish	diminish	VB	I-VP	O
phosphorylation	phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	O
signaling	signaling	NN	I-NP	O
components	component	NNS	I-NP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
RT-PCR	RT-PCR	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
CD45R0	CD45R0	NN	B-NP	B-protein
signaling	signaling	NN	I-NP	O
inhibited	inhibit	VBD	B-VP	O
IL-2	IL-2	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
production	production	NN	I-NP	O
without	without	IN	B-PP	O
major	major	JJ	B-NP	O
influence	influence	NN	I-NP	O
on	on	IN	B-PP	O
IL-13	IL-13	NN	B-NP	B-protein
,	,	,	O	O
IL-5	IL-5	NN	B-NP	B-protein
,	,	,	O	O
or	or	CC	O	O
IFN-gamma	IFN-gamma	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
levels	level	NNS	I-NP	O
.	.	.	O	O

Costimulation	Costimulation	NN	B-NP	O
with	with	IN	B-PP	O
OKT-3	OKT-3	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-2	IL-2	NN	I-NP	B-protein
optimally	optimally	RB	B-ADVP	O
induced	induce	VBD	B-VP	O
secretion	secretion	NN	B-NP	O
of	of	IN	B-PP	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
,	,	,	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
IL-5	IL-5	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
by	by	IN	B-PP	O
CD45	CD45	NN	B-NP	B-protein
signals	signal	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
conclusion	conclusion	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
illustrate	illustrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
CD45R0	CD45R0	NN	B-NP	B-protein
signals	signal	NNS	I-NP	O
control	control	VBP	B-VP	O
early	early	JJ	B-NP	O
cytokine	cytokine	NN	I-NP	O
receptor-associated	receptor-associated	JJ	I-NP	O
signaling	signaling	NN	I-NP	O
processes	process	NNS	I-NP	O
and	and	CC	O	O
mRNA	mRNA	NN	B-NP	O
and	and	CC	I-NP	O
DNA	DNA	NN	I-NP	O
synthesis	synthesis	NN	I-NP	O
in	in	IN	B-PP	O
activated	activate	VBN	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
lymphoblasts	lymphoblast	NNS	I-NP	I-cell_type
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
CD45	CD45	NN	B-NP	B-protein
epitopes	epitope	NNS	I-NP	I-protein
(	(	(	O	O
GAP8.3	GAP8.3	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
active	active	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
critical	critical	JJ	I-ADJP	O
for	for	IN	B-PP	O
signaling	signaling	NN	B-NP	O
in	in	IN	B-PP	O
quiescent	quiescent	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
but	but	CC	O	O
are	be	VBP	B-VP	O
nonfunctional	nonfunctional	JJ	B-ADJP	O
in	in	IN	B-PP	O
activated	activate	VBN	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
lymphoblasts	lymphoblast	NNS	I-NP	I-cell_type
.	.	.	O	O

Pax5	Pax5	NN	B-NP	B-protein
determines	determine	VBZ	B-VP	O
the	the	DT	B-NP	O
identity	identity	NN	I-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
the	the	DT	B-NP	O
beginning	beginning	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
B-lymphopoiesis	B-lymphopoiesis	NN	B-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
being	be	VBG	B-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
intensively	intensively	RB	I-NP	O
studied	study	VBN	I-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
specification	specification	NN	I-NP	O
is	be	VBZ	B-VP	O
largely	largely	RB	B-ADJP	O
unknown	unknown	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
Pax5	Pax5	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
BSAP	BSAP	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
progression	progression	NN	B-NP	O
of	of	IN	B-PP	O
B-lymphopoiesis	B-lymphopoiesis	NN	B-NP	O
beyond	beyond	IN	B-PP	O
the	the	DT	B-NP	O
pro-B	pro-B	JJ	I-NP	O
cell	cell	NN	I-NP	O
stage	stage	NN	I-NP	O
.	.	.	O	O

Pax5-deficient	Pax5-deficient	JJ	B-NP	B-cell_type
pro-B	pro-B	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
not	not	RB	B-VP	O
yet	yet	RB	I-VP	O
committed	commit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
B-lymphoid	B-lymphoid	JJ	I-NP	B-cell_type
lineage	lineage	NN	I-NP	I-cell_type
,	,	,	O	O
but	but	CC	O	O
instead	instead	RB	B-ADVP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
broad	broad	JJ	I-NP	O
lymphomyeloid	lymphomyeloid	JJ	I-NP	O
developmental	developmental	JJ	I-NP	O
potential	potential	NN	I-NP	O
.	.	.	O	O

Pax5	Pax5	NN	B-NP	B-protein
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
mediate	mediate	VB	I-VP	O
B-lineage	B-lineage	NN	B-NP	O
commitment	commitment	NN	I-NP	O
by	by	IN	B-PP	O
repressing	repress	VBG	B-VP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
non-B-lymphoid	non-B-lymphoid	JJ	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
and	and	CC	B-PP	O
by	by	IN	B-PP	O
simultaneously	simultaneously	RB	B-VP	O
activating	activate	VBG	I-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
B-lineage-specific	B-lineage-specific	JJ	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

Pax5	Pax5	NN	B-NP	B-protein
thus	thus	RB	B-ADVP	O
functions	function	VBZ	B-VP	O
both	both	DT	B-PP	O
as	as	IN	I-PP	O
a	a	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	B-protein
repressor	repressor	NN	I-NP	I-protein
and	and	CC	I-NP	O
activator	activator	NN	I-NP	O
,	,	,	O	O
depending	depend	VBG	B-PP	O
on	on	IN	B-PP	O
its	its	PRP$	B-NP	O
interactions	interaction	NNS	I-NP	O
with	with	IN	B-PP	O
corepressors	corepressor	NNS	B-NP	B-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Groucho	Groucho	NNP	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
family	family	NN	I-NP	I-protein
or	or	CC	B-PP	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	B-protein
regulators	regulator	NNS	I-NP	I-protein
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
the	the	DT	B-NP	O
TATA-binding	TATA-binding	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

Once	Once	RB	O	O
committed	commit	VBN	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
B-lineage	B-lineage	NN	I-NP	O
,	,	,	O	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
require	require	VBP	B-VP	O
Pax5	Pax5	NN	B-NP	B-protein
function	function	NN	I-NP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
their	their	PRP$	B-NP	O
B-lymphoid	B-lymphoid	JJ	I-NP	O
identity	identity	NN	I-NP	O
throughout	throughout	IN	B-PP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
development	development	NN	I-NP	O

Partners	Partner	NNS	B-NP	O
in	in	IN	B-PP	O
transcription	transcription	NN	B-NP	O
:	:	:	O	O
NFAT	NFAT	NN	B-NP	B-protein
and	and	CC	O	O
AP-1	AP-1	NN	B-NP	B-protein
.	.	.	O	O

Combinatorial	Combinatorial	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
powerful	powerful	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
that	that	WDT	B-NP	O
enables	enable	VBZ	B-VP	O
tight	tight	JJ	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
,	,	,	O	O
via	via	IN	B-PP	O
integration	integration	NN	B-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
that	that	WDT	B-NP	O
induce	induce	VBP	B-VP	O
different	different	JJ	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
enhanceosome	enhanceosome	NN	B-NP	O
assembly	assembly	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
four	four	CD	I-NP	O
calcium-regulated	calcium-regulated	JJ	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NFAT	NFAT	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
act	act	VBP	B-VP	O
synergistically	synergistically	RB	B-ADVP	O
with	with	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-protein
(	(	(	O	I-protein
Fos/Jun	Fos/Jun	NN	B-NP	I-protein
)	)	)	O	I-protein
proteins	protein	NNS	B-NP	I-protein
on	on	IN	B-PP	O
composite	composite	JJ	B-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
which	which	WDT	B-NP	O
contain	contain	VBP	B-VP	O
adjacent	adjacent	JJ	B-NP	O
NFAT	NFAT	NN	I-NP	B-protein
and	and	CC	O	O
AP-1	AP-1	NN	B-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
,	,	,	O	O
where	where	WRB	B-ADVP	O
they	they	PRP	B-NP	O
form	form	VBP	B-VP	O
highly	highly	RB	B-NP	O
stable	stable	JJ	I-NP	O
ternary	ternary	JJ	I-NP	O
complexes	complex	NNS	I-NP	O
to	to	TO	B-VP	O
regulate	regulate	VB	I-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
diverse	diverse	JJ	B-NP	B-DNA
inducible	inducible	JJ	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

Concomitant	Concomitant	JJ	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
NFAT	NFAT	NN	B-NP	B-protein
and	and	CC	O	O
AP-1	AP-1	NN	B-NP	B-protein
requires	require	VBZ	B-VP	O
concerted	concerted	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
different	different	JJ	I-NP	O
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
:	:	:	O	O
calcium/calcineurin	calcium/calcineurin	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
promotes	promote	VBZ	B-VP	O
NFAT	NFAT	NN	B-NP	B-protein
dephosphorylation	dephosphorylation	NN	I-NP	O
,	,	,	O	O
nuclear	nuclear	JJ	B-NP	O
translocation	translocation	NN	I-NP	O
and	and	CC	I-NP	O
activation	activation	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
protein	protein	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
C	C	NN	I-NP	I-protein
(	(	(	O	O
PKC	PKC	NN	B-NP	B-protein
)	)	)	O	O
/Ras	/Ras	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
promotes	promote	VBZ	B-VP	O
the	the	DT	B-NP	O
synthesis	synthesis	NN	I-NP	O
,	,	,	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
and	and	CC	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Fos	Fos	NN	I-NP	B-protein
and	and	CC	I-NP	O
Jun	Jun	NN	I-NP	B-protein
families	family	NNS	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

A	A	DT	B-NP	O
fifth	fifth	JJ	I-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NFAT	NFAT	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
,	,	,	O	O
NFAT5	NFAT5	NN	B-NP	B-protein
,	,	,	O	O
controls	control	VBZ	B-VP	O
the	the	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
osmotic	osmotic	JJ	B-NP	O
stress	stress	NN	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
that	that	WDT	B-NP	O
requires	require	VBZ	B-VP	O
dimer	dimer	NN	B-NP	O
formation	formation	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
calcineurin	calcineurin	NN	B-NP	B-protein
or	or	CC	B-PP	O
of	of	IN	B-PP	O
interaction	interaction	NN	B-NP	O
with	with	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-protein
.	.	.	O	O

Pharmacological	Pharmacological	JJ	B-NP	O
interference	interference	NN	I-NP	O
with	with	IN	B-PP	O
theNFAT	theNFAT	NN	B-NP	O
:	:	:	O	O
AP-1	AP-1	NN	B-NP	B-protein
interaction	interaction	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
useful	useful	JJ	B-ADJP	O
in	in	IN	B-PP	O
selective	selective	JJ	B-NP	O
manipulation	manipulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Balanced	Balanced	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
NFAT	NFAT	NN	B-NP	B-protein
and	and	CC	O	O
AP-1	AP-1	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
productive	productive	JJ	B-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
NFAT	NFAT	NN	B-NP	B-protein
:	:	:	O	O
AP-1	AP-1	NN	B-NP	B-protein
interactions	interaction	NNS	I-NP	O
in	in	IN	B-PP	O
other	other	JJ	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
and	and	CC	O	O
biological	biological	JJ	B-NP	O
processes	process	NNS	I-NP	O
remains	remain	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
understood	understand	VBN	I-VP	O
.	.	.	O	O

Cytokine	Cytokine	NN	B-NP	B-protein
production	production	NN	I-NP	O
by	by	IN	B-PP	O
Vgamma	Vgamma	NN	B-NP	B-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
-T-cell	-T-cell	NN	B-NP	I-cell_type
subsets	subset	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
factor	factor	NN	I-NP	O
determining	determine	VBG	B-VP	O
CD4	CD4	NN	B-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
-Th-cell	-Th-cell	NN	B-NP	O
phenotype	phenotype	NN	I-NP	O
and	and	CC	O	O
susceptibility	susceptibility	NN	B-NP	O
of	of	IN	B-PP	O
BALB/c	BALB/c	NN	B-NP	O
mice	mouse	NNS	I-NP	O
to	to	TO	B-PP	O
coxsackievirus	coxsackievirus	NN	B-NP	O
B3-induced	B3-induced	JJ	I-NP	O
myocarditis	myocarditis	NN	I-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
coxsackievirus	coxsackievirus	NN	I-NP	O
B3	B3	NN	I-NP	O
(	(	(	O	O
CVB3	CVB3	NN	B-NP	B-protein
)	)	)	O	O
variants	variant	NNS	B-NP	O
(	(	(	O	O
H3	H3	NN	B-NP	B-cell_line
and	and	CC	O	O
H310A1	H310A1	NN	B-NP	O
)	)	)	O	O
differ	differ	VBP	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
mutation	mutation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
VP2	VP2	NN	I-NP	B-protein
capsid	capsid	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

H3	H3	NN	B-NP	O
induces	induce	VBZ	B-VP	O
severe	severe	JJ	B-NP	O
myocarditis	myocarditis	NN	I-NP	O
in	in	IN	B-PP	O
BALB/c	BALB/c	NN	B-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
H310A1	H310A1	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
amyocarditic	amyocarditic	JJ	B-ADJP	O
.	.	.	O	O

Infection	Infection	NN	B-NP	O
with	with	IN	B-PP	O
H3	H3	NN	B-NP	B-protein
,	,	,	B-NP	O
but	but	CC	I-NP	O
not	not	RB	I-NP	O
H310A1	H310A1	NN	B-NP	B-protein
,	,	,	O	O
preferentially	preferentially	RB	B-VP	O
activates	activate	VBZ	I-VP	O
Vgamma4	Vgamma4	NN	B-NP	B-cell_line
Vdelta4	Vdelta4	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
strongly	strongly	RB	B-ADJP	O
positive	positive	JJ	I-ADJP	O
for	for	IN	B-PP	O
gamma	gamma	NN	B-NP	B-protein
interferon	interferon	NN	I-NP	I-protein
(	(	(	O	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
whereas	whereas	IN	O	O
Vgamma1	Vgamma1	NN	B-NP	B-cell_line
Vdelta4	Vdelta4	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
are	be	VBP	B-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	CC	O	O
H3	H3	NN	B-NP	B-cell_line
and	and	CC	O	O
H310A1	H310A1	NN	B-NP	O
virus-infected	virus-infected	JJ	I-NP	O
animals	animal	NNS	I-NP	O
.	.	.	O	O

Depletion	Depletion	NN	B-NP	O
of	of	IN	B-PP	O
Vgamma1	Vgamma1	NN	B-NP	B-cell_line
(	(	(	O	I-cell_line
+	+	SYM	O	I-cell_line
)	)	)	O	I-cell_line
cells	cell	NNS	B-NP	I-cell_line
using	use	VBG	B-VP	O
monoclonal	monoclonal	JJ	B-NP	B-protein
anti-Vgamma1	anti-Vgamma1	NN	I-NP	I-protein
antibody	antibody	NN	I-NP	I-protein
enhanced	enhance	VBD	B-VP	O
myocarditis	myocarditis	NN	B-NP	O
and	and	CC	O	O
CD4	CD4	NN	B-NP	O
(	(	(	O	O
+	+	SYM	B-NP	O
)	)	)	O	O
-	-	HYPH	O	O
,	,	,	O	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
-cell	-cell	JJ	B-NP	O
responses	response	NNS	I-NP	O
in	in	IN	B-PP	O
both	both	CC	O	O
H3-	H3-	NN	B-NP	O
and	and	CC	O	O
H310A1-infected	H310A1-infected	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
yet	yet	RB	B-ADVP	O
decreased	decrease	VBD	B-VP	O
the	the	DT	B-NP	O
CD4	CD4	NN	I-NP	O
(	(	(	O	O
+	+	SYM	B-NP	O
)	)	)	O	O
-	-	HYPH	O	O
,	,	,	O	O
IL-4	IL-4	NN	B-NP	B-protein
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
-cell	-cell	JJ	B-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Depleting	Deplete	VBG	B-VP	O
Vgamma4	Vgamma4	NN	B-NP	B-protein
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
cells	cell	NNS	B-NP	O
suppressed	suppress	VBD	B-VP	O
myocarditis	myocarditis	NN	B-NP	O
and	and	CC	O	O
reduced	reduce	VBN	B-NP	O
CD4	CD4	NN	I-NP	B-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
IFN-gamma	IFN-gamma	NN	B-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
cells	cell	NNS	B-NP	I-cell_type
but	but	CC	O	O
increased	increase	VBD	B-VP	O
CD4	CD4	NN	B-NP	B-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
IL-4	IL-4	NN	B-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
T	T	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-protein
production	production	NN	I-NP	O
by	by	IN	B-PP	O
Vgamma1	Vgamma1	NN	B-NP	B-protein
(	(	(	O	O
+	+	SYM	B-NP	O
)	)	)	O	O
and	and	CC	O	O
Vgamma4	Vgamma4	NN	B-NP	B-protein
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
T	T	NN	B-NP	O
cells	cell	NNS	I-NP	O
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
by	by	IN	B-PP	O
adoptively	adoptively	RB	B-VP	O
transferring	transfer	VBG	I-VP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
H3-infected	H3-infected	JJ	B-NP	O
BALB/c	BALB/c	NN	I-NP	O
Stat4	Stat4	NN	I-NP	O
knockout	knockout	NN	I-NP	O
(	(	(	O	O
Stat4ko	Stat4ko	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
defective	defective	JJ	B-ADJP	O
in	in	IN	B-PP	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
)	)	)	O	O
or	or	CC	O	O
BALB/c	BALB/c	NN	B-NP	O
Stat6ko	Stat6ko	NN	I-NP	O
(	(	(	O	O
defective	defective	JJ	B-ADJP	O
in	in	IN	B-PP	O
IL-4	IL-4	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
)	)	)	O	O
mice	mouse	NNS	B-NP	O
into	into	IN	B-PP	O
H3	H3	NN	B-NP	O
virus-infected	virus-infected	JJ	I-NP	O
wild-type	wild-type	JJ	I-NP	O
BALB/c	BALB/c	NN	I-NP	O
recipients	recipient	NNS	I-NP	O
.	.	.	O	O

Vgamma4	Vgamma4	NN	B-NP	B-protein
and	and	CC	I-NP	O
Vgamma1	Vgamma1	NN	I-NP	B-protein
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
T	T	NN	B-NP	O
cells	cell	NNS	I-NP	O
from	from	IN	B-PP	O
Stat4ko	Stat4ko	NN	B-NP	O
mice	mouse	NNS	I-NP	O
expressed	express	VBD	B-VP	O
IL-4	IL-4	NN	B-NP	B-protein
but	but	CC	O	O
no	no	DT	B-NP	O
or	or	CC	I-NP	O
minimal	minimal	JJ	I-NP	O
IFN-gamma	IFN-gamma	NN	I-NP	B-protein
,	,	,	O	O
whereas	whereas	IN	O	O
these	these	DT	B-NP	O
cell	cell	NN	I-NP	B-cell_line
populations	population	NNS	I-NP	I-cell_line
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
Stat6ko	Stat6ko	NN	B-NP	O
mice	mouse	NNS	I-NP	O
expressed	express	VBD	B-VP	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
but	but	CC	O	O
no	no	DT	B-NP	O
IL-4	IL-4	NN	I-NP	B-protein
.	.	.	O	O

Stat4ko	Stat4ko	NN	B-NP	B-cell_type
Vgamma1	Vgamma1	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
cells	cell	NNS	B-NP	I-cell_type
(	(	(	O	O
IL-4	IL-4	NN	B-NP	B-protein
(	(	(	O	O
+	+	SYM	B-NP	O
)	)	)	O	O
)	)	)	O	O
suppress	suppress	VBP	B-VP	O
myocarditis	myocarditis	NN	B-NP	O
.	.	.	O	O

Stat6ko	Stat6ko	NN	B-NP	B-cell_type
Vgamma1	Vgamma1	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
cells	cell	NNS	B-NP	I-cell_type
(	(	(	O	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
(	(	(	O	O
+	+	SYM	B-NP	O
)	)	)	O	O
)	)	)	O	O
were	be	VBD	B-VP	O
not	not	RB	O	O
inhibitory	inhibitory	JJ	B-ADJP	O
.	.	.	O	O

Stat6ko	Stat6ko	NN	B-NP	B-cell_type
Vgamma4	Vgamma4	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
cells	cell	NNS	B-NP	I-cell_type
(	(	(	O	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
(	(	(	O	O
+	+	SYM	B-NP	O
)	)	)	O	O
)	)	)	O	O
significantly	significantly	RB	B-ADVP	O
enhanced	enhance	VBD	B-VP	O
myocarditis	myocarditis	NN	B-NP	O
.	.	.	O	O

Stat4ko	Stat4ko	NN	B-NP	B-cell_type
Vgamma4	Vgamma4	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
cells	cell	NNS	B-NP	I-cell_type
(	(	(	O	O
IL-4	IL-4	NN	B-NP	B-protein
(	(	(	O	O
+	+	SYM	B-NP	O
)	)	)	O	O
)	)	)	O	O
neither	neither	CC	B-VP	O
inhibited	inhibit	VBN	I-VP	O
nor	nor	CC	I-VP	O
enhanced	enhance	VBN	I-VP	O
disease	disease	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
distinct	distinct	JJ	B-NP	O
gammadelta-T-cell	gammadelta-T-cell	NN	I-NP	B-cell_type
subsets	subset	NNS	I-NP	I-cell_type
control	control	VBP	B-VP	O
myocarditis	myocarditis	PRP$	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
and	and	CC	I-NP	O
bias	bias	NN	I-NP	O
the	the	DT	B-NP	O
CD4	CD4	NN	I-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
-Th-cell	-Th-cell	NN	B-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cytokines	cytokine	NNS	I-NP	B-protein
produced	produce	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Vgamma	Vgamma	NN	I-NP	O
subpopulation	subpopulation	NN	I-NP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
influence	influence	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
CD4	CD4	NN	I-NP	B-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
-Th-cell	-Th-cell	NN	B-NP	I-cell_type
phenotype	phenotype	NN	I-NP	I-cell_type
.	.	.	O	O

Plasmin	Plasmin	NN	B-NP	O
-induced	-induced	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
cytokines	cytokine	NNS	B-NP	B-protein
and	and	CC	O	O
tissue	tissue	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
involves	involve	VBZ	B-VP	O
AP-1	AP-1	NN	B-NP	B-protein
and	and	CC	O	O
IKKbeta	IKKbeta	NN	B-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
previously	previously	RB	I-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
plasmin	plasmin	NN	B-NP	O
activates	activate	VBZ	B-VP	O
human	human	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
lipid	lipid	NN	B-NP	O
mediator	mediator	NN	I-NP	O
release	release	NN	I-NP	O
and	and	CC	O	O
chemotactic	chemotactic	JJ	B-NP	O
migration	migration	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
that	that	IN	B-SBAR	O
plasmin	plasmin	NN	B-NP	O
induces	induce	VBZ	B-VP	O
proinflammatory	proinflammatory	JJ	B-NP	B-protein
cytokine	cytokine	NN	I-NP	I-protein
release	release	NN	I-NP	O
and	and	CC	O	O
tissue	tissue	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
TF	TF	NN	B-NP	B-protein
)	)	)	O	O
expression	expression	NN	B-NP	O
by	by	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
.	.	.	O	O

Plasmin	Plasmin	NN	B-NP	O
0.043	0.043	CD	I-NP	O
to	to	TO	I-NP	O
1.43	1.43	CD	I-NP	O
CTA	CTA	NN	I-NP	O
U/mL	U/mL	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
active	active	JJ	B-NP	O
site-blocked	site-blocked	JJ	I-NP	O
plasmin	plasmin	NN	I-NP	O
,	,	,	O	O
triggered	trigger	VBD	B-VP	O
concentration-dependent	concentration-dependent	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
mRNA	mRNA	NN	B-NP	B-RNA
for	for	IN	B-PP	O
interleukin-1alpha	interleukin-1alpha	NN	B-NP	B-protein
(	(	(	O	O
IL-1alpha	IL-1alpha	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
IL-1beta	IL-1beta	NN	B-NP	B-protein
,	,	,	O	O
tumor	tumor	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor-alpha	factor-alpha	NN	I-NP	I-protein
(	(	(	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
TF	TF	NN	B-NP	B-protein
with	with	IN	B-PP	O
maximum	maximum	JJ	B-NP	O
responses	response	NNS	I-NP	O
after	after	IN	B-PP	O
4	4	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

Plasmin	Plasmin	NN	B-NP	O
-mediated	-mediated	JJ	I-NP	O
mRNA	mRNA	NN	I-NP	O
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
concentration-dependent	concentration-dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
lysine	lysine	NN	I-NP	O
analogue	analogue	NN	I-NP	O
trans-4-	trans-4-	NN	I-NP	O
(	(	(	O	O
aminomethyl	aminomethyl	NN	B-NP	O
)	)	)	O	O
cyclohexane-1-carboxylic	cyclohexane-1-carboxylic	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
t-AMCA	t-AMCA	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Increases	Increase	NNS	B-NP	O
in	in	IN	B-PP	O
mRNA	mRNA	NN	B-NP	B-RNA
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
concentration-	concentration-	NN	B-NP	O
and	and	CC	O	O
time-dependent	time-dependent	JJ	B-NP	O
release	release	NN	I-NP	O
of	of	IN	B-PP	O
IL-1alpha	IL-1alpha	NN	B-NP	B-protein
,	,	,	I-NP	O
IL-1beta	IL-1beta	NN	I-NP	B-protein
and	and	CC	I-NP	O
TNF-alpha	TNF-alpha	NN	I-NP	B-protein
and	and	CC	B-PP	O
by	by	IN	B-PP	O
TF	TF	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
on	on	IN	B-PP	O
monocyte	monocyte	NN	B-NP	O
surfaces	surface	NNS	I-NP	O
.	.	.	O	O

Neither	Neither	CC	O	O
cytokines	cytokine	NNS	B-NP	B-protein
nor	nor	CC	O	O
TF	TF	NN	B-NP	B-protein
could	could	MD	B-VP	O
be	be	VB	I-VP	O
detected	detect	VBN	I-VP	O
when	when	WRB	B-ADVP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
were	be	VBD	B-VP	O
preincubated	preincubate	VBN	I-VP	O
with	with	IN	B-PP	O
actinomycin	actinomycin	NN	B-NP	O
D	D	NN	I-NP	O
or	or	CC	I-NP	O
cycloheximide	cycloheximide	NN	I-NP	O
.	.	.	O	O

Electrophoretic	Electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
plasmin	plasmin	NN	B-NP	O
-induced	-induced	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
;	;	:	O	O
DNA-binding	DNA-binding	JJ	B-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
composed	compose	VBN	I-VP	O
of	of	IN	B-PP	O
p50	p50	NN	B-NP	B-protein
,	,	,	O	O
p65	p65	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
c-Rel	c-Rel	NN	B-NP	B-protein
,	,	,	O	O
as	as	IN	B-SBAR	O
shown	show	VBN	B-VP	O
by	by	IN	B-PP	O
supershift	supershift	NN	B-NP	O
experiments	experiment	NNS	I-NP	O
.	.	.	O	O

Nuclear	Nuclear	JJ	B-NP	O
translocation	translocation	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappaB/Rel	NF-kappaB/Rel	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
coincided	coincide	VBD	B-VP	O
with	with	IN	B-PP	O
IkappaBalpha	IkappaBalpha	NN	B-NP	B-protein
degradation	degradation	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
variance	variance	NN	B-NP	O
with	with	IN	B-PP	O
endotoxic	endotoxic	JJ	B-NP	O
lipopolysaccharide	lipopolysaccharide	NN	I-NP	O
,	,	,	O	O
plasmin	plasmin	NN	B-NP	O
elicited	elicit	VBD	B-VP	O
the	the	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
degradation	degradation	NN	I-NP	O
of	of	IN	B-PP	O
another	another	DT	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
p105	p105	NN	B-NP	B-protein
.	.	.	O	O

Proteolysis	Proteolysis	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
inhibitors	inhibitor	NNS	I-NP	O
was	be	VBD	B-VP	O
apparently	apparently	RB	B-ADVP	O
due	due	JJ	B-PP	O
to	to	TO	I-PP	O
transient	transient	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
IkappaB	IkappaB	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
IKK	IKK	NN	B-NP	B-protein
)	)	)	O	O
beta	beta	NN	B-NP	O
that	that	WDT	B-NP	O
reached	reach	VBD	B-VP	O
maximum	maximum	JJ	B-NP	O
activity	activity	NN	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
hour	hour	NN	I-NP	O
after	after	IN	B-PP	O
plasmin	plasmin	NN	B-NP	O
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
AP-1	AP-1	NN	B-NP	B-protein
binding	binding	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
plasmin	plasmin	NN	B-NP	O
-treated	-treated	JJ	I-NP	O
monocytes	monocyte	NNS	I-NP	B-cell_type
,	,	,	O	O
with	with	IN	B-PP	O
most	most	JJS	B-NP	O
complexes	complex	NNS	I-NP	O
composed	compose	VBN	B-VP	O
of	of	IN	B-PP	O
JunD	JunD	NN	B-NP	B-protein
,	,	,	O	O
c-Fos	c-Fos	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
FosB	FosB	NN	B-NP	B-protein
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
further	further	RBR	B-VP	O
substantiate	substantiate	VB	I-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
plasmin	plasmin	NN	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
proinflammatory	proinflammatory	JJ	I-NP	B-protein
activator	activator	NN	I-NP	I-protein
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
reveal	reveal	VB	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
new	new	JJ	I-NP	O
link	link	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
plasminogen-plasmin	plasminogen-plasmin	NN	I-NP	O
system	system	NN	I-NP	O
and	and	CC	I-NP	O
inflammation	inflammation	NN	I-NP	O
.	.	.	O	O

(	(	(	O	O
Blood.	Blood.	NNP	B-NP	O
2001	2001	CD	I-NP	O
;	;	:	O	O
97	97	CD	B-NP	O
:	:	:	O	O
3941-3950	3941-3950	CD	B-NP	O
)	)	)	O	O

STAT3	STAT3	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
constitutively	constitutively	RB	B-ADJP	O
active	active	JJ	I-ADJP	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
Polycythemia	Polycythemia	NN	B-NP	O
rubra	rubra	NN	I-NP	O
vera	vera	NN	I-NP	O
.	.	.	O	O

OBJECTIVE	OBJECTIVE	NN	B-NP	O
:	:	:	O	O
Polycythemia	Polycythemia	NN	B-NP	O
vera	vera	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
clonal	clonal	JJ	I-NP	O
stem	stem	NN	I-NP	O
cell	cell	NN	I-NP	O
disorder	disorder	NN	I-NP	O
characterized	characterize	VBN	B-VP	O
by	by	IN	B-PP	O
hyperproliferation	hyperproliferation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
erythroid	erythroid	JJ	I-NP	B-cell_type
,	,	,	I-NP	I-cell_type
myeloid	myeloid	JJ	I-NP	I-cell_type
,	,	,	O	I-cell_type
and	and	CC	O	I-cell_type
megakaryocytic	megakaryocytic	JJ	B-NP	I-cell_type
lineages	lineage	NNS	I-NP	I-cell_type
.	.	.	O	O

While	While	IN	B-SBAR	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
progenitor	progenitor	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
vera	vera	NN	I-NP	O
patients	patient	NNS	I-NP	O
are	be	VBP	B-VP	O
hypersensitive	hypersensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
several	several	JJ	B-NP	O
growth	growth	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
including	include	VBG	B-PP	O
erythropoietin	erythropoietin	NN	B-NP	B-protein
,	,	,	O	O
insulin-like	insulin-like	JJ	B-NP	B-protein
growth	growth	NN	I-NP	I-protein
factor-1	factor-1	NN	I-NP	I-protein
,	,	,	O	O
thrombopoietin	thrombopoietin	NN	B-NP	B-protein
,	,	,	O	O
interleukin-3	interleukin-3	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
granulocyte/monocyte	granulocyte/monocyte	NN	B-NP	B-protein
colony-stimulating	colony-stimulating	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
disease	disease	NN	I-NP	O
remains	remain	VBZ	B-VP	O
unknown	unknown	JJ	B-ADJP	O
.	.	.	O	O

Growth	Growth	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
hypersensitivity	hypersensitivity	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
signal	signal	NN	B-NP	O
transduction	transduction	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
therefore	therefore	RB	B-ADVP	O
investigated	investigate	VBD	B-VP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
downstream	downstream	JJ	I-NP	O
effector	effector	NN	I-NP	O
of	of	IN	B-PP	O
cytokines	cytokine	NNS	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
signal	signal	NN	I-NP	O
transducers	transducer	NNS	I-NP	O
and	and	CC	I-NP	O
activators	activator	NNS	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
(	(	(	O	O
STATs	STAT	NNS	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

A	A	DT	B-NP	O
constitutive	constitutive	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
STAT	STAT	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
could	could	MD	B-VP	O
explain	explain	VB	I-VP	O
the	the	DT	B-NP	O
increased	increase	VBN	I-NP	O
proliferation	proliferation	NN	I-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	B-cell_line
vera	vera	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
even	even	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
growth	growth	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
Peripheral	Peripheral	JJ	B-NP	B-cell_type
granulocytes	granulocyte	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
P.	P.	NNP	B-NP	O
vera	vera	NN	I-NP	O
and	and	CC	B-PP	O
from	from	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
volunteers	volunteer	NNS	I-NP	O
were	be	VBD	B-VP	O
assayed	assay	VBN	I-VP	O
for	for	IN	B-PP	O
STAT1	STAT1	NN	B-NP	B-protein
,	,	,	O	O
3	3	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
5	5	CD	B-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
by	by	IN	B-PP	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Four	Four	CD	B-NP	O
of	of	IN	B-PP	O
14	14	CD	B-NP	O
P.	P.	NNP	I-NP	O
vera	vera	NN	I-NP	O
patients	patient	NNS	I-NP	O
analyzed	analyze	VBN	B-VP	O
showed	show	VBD	B-VP	O
constitutive	constitutive	JJ	B-NP	O
STAT3	STAT3	NN	I-NP	B-protein
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
in	in	IN	B-PP	O
unstimulated	unstimulated	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
granulocytes	granulocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
while	while	IN	B-SBAR	O
none	none	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
17	17	CD	I-NP	O
healthy	healthy	JJ	I-NP	O
volunteers	volunteer	NNS	I-NP	O
tested	test	VBN	B-VP	O
did	do	VBD	B-VP	O
.	.	.	O	O

None	None	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
subjects	subject	NNS	I-NP	O
showed	show	VBD	B-VP	O
constitutive	constitutive	JJ	B-NP	O
STAT1	STAT1	NN	I-NP	B-protein
or	or	CC	I-NP	O
STAT5	STAT5	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
.	.	.	O	O

Western	Western	NN	B-NP	O
blotting	blotting	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
STAT3	STAT3	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
constitutively	constitutively	RB	I-VP	O
phosphorylated	phosphorylate	VBN	I-VP	O
on	on	IN	B-PP	O
Tyr	Tyr	NN	B-NP	O
705	705	CD	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
unphosphorylated	unphosphorylate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
controls	control	NNS	B-NP	O
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
constitutive	constitutive	JJ	B-NP	O
STAT3	STAT3	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
correlate	correlate	VB	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
duration	duration	NN	I-NP	O
of	of	IN	B-PP	O
disease	disease	NN	B-NP	O
or	or	CC	O	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
recently	recently	RB	I-NP	O
diagnosed	diagnose	VBN	I-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
patients	patient	NNS	I-NP	O
treated	treat	VBN	B-VP	O
only	only	RB	B-ADVP	O
with	with	IN	B-PP	O
phlebotomy	phlebotomy	NN	B-NP	O
.	.	.	O	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
Our	Our	PRP$	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
constitutive	constitutive	JJ	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
and	and	CC	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
STAT3	STAT3	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
not	not	RB	O	O
a	a	DT	B-NP	O
secondary	secondary	JJ	I-NP	O
event	event	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
mutagenizing	mutagenize	VBG	B-NP	O
agents	agent	NNS	I-NP	O
or	or	CC	B-PP	O
by	by	IN	B-PP	O
prolonged	prolong	VBN	B-NP	O
hyperproliferation	hyperproliferation	NN	I-NP	O
of	of	IN	B-PP	O
hematopoietic	hematopoietic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
but	but	CC	O	O
rather	rather	RB	B-VP	O
represents	represent	VBZ	I-VP	O
a	a	DT	B-NP	O
primary	primary	JJ	I-NP	O
molecular	molecular	JJ	I-NP	O
aberration	aberration	NN	I-NP	O
.	.	.	O	O

Constitutively	Constitutively	RB	B-NP	O
active	active	JJ	I-NP	O
STAT3	STAT3	NN	I-NP	B-protein
may	may	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
hypersensitivity	hypersensitivity	NN	I-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	B-cell_line
vera	vera	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Identification	Identification	NN	B-NP	O
of	of	IN	B-PP	O
phosphorylation	phosphorylation	NN	B-NP	B-protein
sites	site	NNS	I-NP	I-protein
for	for	IN	B-PP	O
Bruton	Bruton	NNP	B-NP	B-protein
's	's	POS	B-NP	I-protein
tyrosine	tyrosine	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
within	within	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	B-DNA
regulator	regulator	NN	I-NP	I-DNA
BAP/TFII-I	BAP/TFII-I	NN	I-NP	I-DNA
.	.	.	O	O

Bruton	Bruton	NNP	B-NP	B-protein
's	's	POS	B-NP	I-protein
tyrosine	tyrosine	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
Btk	Btk	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Tec	Tec	NNP	I-NP	B-protein
family	family	NN	I-NP	I-protein
of	of	IN	B-PP	O
cytosolic	cytosolic	JJ	B-NP	B-protein
kinases	kinase	NNS	I-NP	I-protein
,	,	,	O	O
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
development	development	NN	I-NP	O
and	and	CC	O	O
function	function	NN	B-NP	O
.	.	.	O	O

BAP/TFII-I	BAP/TFII-I	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
implicated	implicate	VBN	B-VP	O
in	in	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
Btk	Btk	NN	B-NP	B-protein
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
is	be	VBZ	B-VP	O
transiently	transiently	RB	I-VP	O
phosphorylated	phosphorylate	VBN	I-VP	O
on	on	IN	B-PP	O
tyrosine	tyrosine	NN	B-NP	O
following	follow	VBG	B-PP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
receptor	receptor	NN	I-NP	O
engagement	engagement	NN	I-NP	O
.	.	.	O	O

BAP/TFII-I	BAP/TFII-I	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
substrate	substrate	NN	I-NP	O
for	for	IN	B-PP	O
Btk	Btk	NN	B-NP	B-protein
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
hyperphosphorylated	hyperphosphorylate	VBN	I-VP	O
on	on	IN	B-PP	O
tyrosine	tyrosine	NN	B-NP	O
upon	upon	IN	B-PP	O
coexpression	coexpression	NN	B-NP	O
with	with	IN	B-PP	O
Btk	Btk	NN	B-NP	B-protein
in	in	IN	B-PP	O
mammalian	mammalian	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
an	an	DT	B-NP	O
effort	effort	NN	I-NP	O
to	to	TO	B-VP	O
understand	understand	VB	I-VP	O
the	the	DT	B-NP	O
physiologic	physiologic	JJ	I-NP	O
consequences	consequence	NNS	I-NP	O
of	of	IN	B-PP	O
BAP/TFII-I	BAP/TFII-I	NN	B-NP	O
tyrosine	tyrosine	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
following	follow	VBG	B-PP	O
B	B	NN	B-NP	B-protein
cell	cell	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
stimulation	stimulation	NN	I-NP	O
,	,	,	O	O
site-directed	site-directed	JJ	B-NP	O
mutagenesis	mutagenesis	NN	I-NP	O
and	and	CC	I-NP	O
phosphopeptide	phosphopeptide	NN	I-NP	O
mapping	mapping	NN	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
locate	locate	VB	I-VP	O
the	the	DT	B-NP	O
predominant	predominant	JJ	I-NP	O
sites	site	NNS	I-NP	O
of	of	IN	B-PP	O
BAP/TFII-I	BAP/TFII-I	NN	B-NP	B-protein
phosphorylation	phosphorylation	NN	I-NP	O
by	by	IN	B-PP	O
Btk	Btk	NN	B-NP	B-protein
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

These	These	DT	B-NP	O
residues	residue	NNS	I-NP	O
,	,	,	O	O
Tyr248	Tyr248	NN	B-NP	O
,	,	,	O	O
Tyr357	Tyr357	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Tyr462	Tyr462	NN	B-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
sites	site	NNS	I-NP	O
for	for	IN	B-PP	O
Btk	Btk	NN	B-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
BAP/TFII-I	BAP/TFII-I	NN	B-NP	B-protein
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

Residues	Residue	NNS	B-NP	O
Tyr357	Tyr357	NN	I-NP	O
and	and	CC	I-NP	O
Tyr462	Tyr462	NN	I-NP	O
are	be	VBP	B-VP	O
contained	contain	VBN	I-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
loop	loop	NN	I-NP	B-protein
regions	region	NNS	I-NP	I-protein
of	of	IN	B-PP	O
adjacent	adjacent	JJ	B-NP	B-DNA
helix-loop-helix-like	helix-loop-helix-like	JJ	I-NP	I-DNA
repeats	repeat	NNS	I-NP	I-DNA
within	within	IN	B-PP	O
BAP/TFII-I	BAP/TFII-I	NN	B-NP	B-protein
.	.	.	O	O

Mutation	Mutation	NN	B-NP	O
of	of	IN	B-PP	O
either	either	DT	B-NP	O
Tyr248	Tyr248	NN	I-NP	O
,	,	,	O	O
Tyr357	Tyr357	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
Tyr462	Tyr462	NN	B-NP	O
to	to	TO	B-PP	O
phenylalanine	phenylalanine	NN	B-NP	O
reduced	reduce	VBD	B-VP	O
transcription	transcription	NN	B-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
c-fos	c-fos	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
wild-type	wild-type	JJ	B-NP	B-protein
BAP/TFII-I	BAP/TFII-I	NN	I-NP	I-protein
in	in	IN	B-PP	O
transfected	transfecte	VBN	B-NP	B-cell_line
COS-7	COS-7	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
interpretation	interpretation	NN	I-NP	O
that	that	IN	B-SBAR	O
phosphorylation	phosphorylation	NN	B-NP	O
at	at	IN	B-PP	O
these	these	DT	B-NP	O
sites	site	NNS	I-NP	O
contributes	contribute	VBZ	B-VP	O
to	to	TO	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

Phosphorylation	Phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
BAP/TFII-I	BAP/TFII-I	NN	B-NP	B-protein
by	by	IN	B-PP	O
Btk	Btk	NN	B-NP	B-protein
may	may	MD	B-VP	O
link	link	VB	I-VP	O
engagement	engagement	NN	B-NP	O
of	of	IN	B-PP	O
receptors	receptor	NNS	B-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
surface	surface	NN	B-NP	B-protein
immunoglobulin	immunoglobulin	NN	I-NP	I-protein
to	to	TO	B-PP	O
modulation	modulation	NN	B-NP	O
of	of	IN	B-PP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
interferon	interferon	NN	B-NP	B-protein
consensus	consensus	NN	I-NP	I-protein
sequence	sequence	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
induces	induce	VBZ	B-VP	O
potent	potent	JJ	B-NP	O
immunity	immunity	NN	I-NP	O
against	against	IN	B-PP	O
BCR/ABL-induced	BCR/ABL-induced	JJ	B-NP	O
leukemia	leukemia	NN	I-NP	O
.	.	.	O	O

Mice	Mouse	NNS	B-NP	O
deficient	deficient	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
interferon	interferon	NN	I-NP	B-protein
consensus	consensus	NN	I-NP	I-protein
sequence	sequence	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	O
ICSBP	ICSBP	NN	B-NP	B-protein
)	)	)	O	O
develop	develop	VBP	B-VP	O
a	a	DT	B-NP	O
disease	disease	NN	I-NP	O
resembling	resemble	VBG	B-VP	O
chronic	chronic	JJ	B-NP	O
myeloid	myeloid	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
CML	CML	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
is	be	VBZ	B-VP	O
caused	cause	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
BCR/ABL	BCR/ABL	NN	I-NP	B-protein
oncoprotein	oncoprotein	NN	I-NP	I-protein
.	.	.	O	O

Interferon-alpha	Interferon-alpha	NN	B-NP	B-protein
(	(	(	O	O
IFN-alpha	IFN-alpha	NN	B-NP	B-protein
)	)	)	O	O
induces	induce	VBZ	B-VP	O
ICSBP	ICSBP	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
effective	effective	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
CML	CML	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
examined	examine	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
enforced	enforce	VBN	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
ICSBP	ICSBP	NN	B-NP	B-protein
might	might	MD	B-VP	O
antagonize	antagonize	VB	I-VP	O
BCR/ABL-induced	BCR/ABL-induced	JJ	B-NP	O
leukemia	leukemia	NN	I-NP	O
;	;	:	O	O
results	result	NNS	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
ICSBP-modified	ICSBP-modified	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
generated	generate	VBD	B-VP	O
a	a	DT	B-NP	O
protective	protective	JJ	I-NP	O
CD8	CD8	NN	I-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
cytotoxic	cytotoxic	JJ	B-NP	O
T-cell	T-cell	NN	I-NP	O
response	response	NN	I-NP	O
against	against	IN	B-PP	O
BCR/ABL-transformed	BCR/ABL-transformed	JJ	B-NP	B-cell_line
BaF3	BaF3	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
in	in	IN	B-PP	O
a	a	DT	B-NP	O
murine	murine	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
model	model	NN	I-NP	O
.	.	.	O	O

ICSBP	ICSBP	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
represents	represent	VBZ	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
means	mean	NNS	I-NP	O
of	of	IN	B-PP	O
stimulating	stimulate	VBG	B-VP	O
a	a	DT	B-NP	O
host	host	NN	I-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
BCR/ABL	BCR/ABL	NN	B-NP	B-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
leukemia	leukemia	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
strategy	strategy	NN	I-NP	O
for	for	IN	B-PP	O
immunotherapy	immunotherapy	NN	B-NP	O
of	of	IN	B-PP	O
CML	CML	NN	B-NP	O
.	.	.	O	O

(	(	(	O	O
Blood.	Blood.	NNP	B-NP	O
2001	2001	CD	I-NP	O
;	;	:	O	O
97	97	CD	B-NP	O
:	:	:	O	O
3491-3497	3491-3497	CD	B-NP	O
)	)	)	O	O

A	A	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
block	block	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
at	at	IN	B-PP	O
the	the	DT	B-NP	O
-150	-150	CD	I-NP	B-DNA
AP-1	AP-1	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
in	in	IN	B-PP	O
effector	effector	NN	B-NP	B-cell_type
CD8+	CD8+	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Both	Both	CC	O	O
CD4+	CD4+	JJ	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
CD8+	CD8+	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
that	that	WDT	B-NP	O
produce	produce	VBP	B-VP	O
IL-2	IL-2	NN	B-NP	B-protein
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
Ag	Ag	NN	B-NP	O
recognition	recognition	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
isolated	isolate	VBN	I-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
most	most	JJS	B-NP	O
effector	effector	NN	I-NP	O
CD8+	CD8+	JJ	I-NP	O
T	T	NN	I-NP	O
cells	cell	NNS	I-NP	O
recovered	recover	VBN	B-VP	O
after	after	IN	B-PP	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-PP	O
Ag	Ag	NN	B-NP	B-protein
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
produce	produce	VB	I-VP	O
sufficient	sufficient	JJ	B-NP	O
IL-2	IL-2	NN	I-NP	B-protein
to	to	TO	B-VP	O
sustain	sustain	VB	I-VP	O
growth	growth	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
depend	depend	VB	B-VP	O
on	on	IN	B-PP	O
CD4+	CD4+	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
helper	helper	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
for	for	IN	B-PP	O
this	this	DT	B-NP	O
obligate	obligate	JJ	I-NP	B-protein
growth	growth	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
.	.	.	O	O

IL-2	IL-2	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
CD4+	CD4+	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
primarily	primarily	RB	I-VP	O
controlled	control	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
mechanisms	mechanism	NNS	B-NP	O
restricting	restrict	VBG	B-VP	O
IL-2	IL-2	NN	B-NP	B-protein
production	production	NN	I-NP	O
in	in	IN	B-PP	O
CD8+	CD8+	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
have	have	VBP	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
elucidated	elucidate	VBN	I-VP	O
.	.	.	O	O

To	To	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
transcriptional	transcriptional	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
in	in	IN	B-PP	O
CD8+	CD8+	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
we	we	PRP	B-NP	O
stably	stably	RB	B-VP	O
transfected	transfecte	VBN	I-VP	O
reporter	reporter	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
into	into	IN	B-PP	O
Ag	Ag	NN	B-NP	B-cell_line
-specific	-specific	JJ	B-NP	I-cell_line
CD8+	CD8+	JJ	I-NP	I-cell_line
T	T	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
clones	clone	NNS	I-NP	I-cell_line
.	.	.	O	O

CD28+	CD28+	JJ	B-NP	B-cell_type
CD8	CD8	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
T	T	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
transcribe	transcribe	VB	I-VP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
antigenic	antigenic	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
block	block	NN	I-NP	O
in	in	IN	B-PP	O
transactivation	transactivation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
-150	-150	CD	I-NP	B-DNA
CD28	CD28	NN	I-NP	I-DNA
response	response	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
(	(	(	O	O
CD28RE	CD28RE	NN	B-NP	B-DNA
)	)	)	O	O
/AP-1	/AP-1	NN	B-NP	B-protein
site	site	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
,	,	,	O	O
but	but	CC	O	O
did	do	VBD	B-VP	O
transactivate	transactivate	VB	I-VP	O
the	the	DT	B-NP	O
composite	composite	JJ	I-NP	B-DNA
NFAT/AP-1	NFAT/AP-1	NN	I-NP	I-DNA
and	and	CC	I-NP	I-DNA
OCT/AP-1	OCT/AP-1	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
consensus	consensus	NN	I-NP	B-DNA
AP-1	AP-1	NN	I-NP	I-DNA
motif	motif	NN	I-NP	I-DNA
.	.	.	O	O

Mutation	Mutation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nonconsensus	nonconsensus	JJ	I-NP	B-DNA
-150	-150	CD	I-NP	I-DNA
AP-1	AP-1	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
to	to	TO	B-PP	O
a	a	DT	B-NP	O
consensus	consensus	NN	I-NP	B-DNA
AP-1	AP-1	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
,	,	,	O	O
or	or	CC	O	O
insertion	insertion	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
CD28RE/AP-1	CD28RE/AP-1	NN	I-NP	B-DNA
consensus	consensus	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
upstream	upstream	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
native	native	JJ	I-NP	B-DNA
-150	-150	CD	I-NP	I-DNA
CD28RE/AP-1	CD28RE/AP-1	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
restored	restore	VBD	B-VP	O
transactivation	transactivation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
altered	altered	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
defect	defect	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
-150	-150	CD	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
may	may	MD	B-VP	O
reflect	reflect	VB	I-VP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
or	or	CC	I-NP	O
inactivity	inactivity	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
required	required	JJ	I-NP	O
factor	factor	NN	I-NP	O
rather	rather	RB	B-CONJP	O
than	than	IN	I-CONJP	O
repression	repression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

Stem	Stem	NN	B-NP	B-protein
cell	cell	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
and	and	CC	O	O
interleukin-3	interleukin-3	NN	B-NP	B-protein
induce	induce	VBP	B-VP	O
stepwise	stepwise	JJ	B-NP	O
generation	generation	NN	I-NP	O
of	of	IN	B-PP	O
erythroid	erythroid	JJ	B-NP	B-cell_type
precursor	precursor	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
a	a	DT	B-NP	O
basic	basic	JJ	I-NP	B-protein
fibroblast	fibroblast	NN	I-NP	I-protein
growth	growth	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
-dependent	-dependent	JJ	I-NP	O
hematopoietic	hematopoietic	JJ	I-NP	O
stem	stem	NN	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
,	,	,	O	O
A-6	A-6	NN	B-NP	B-protein
.	.	.	O	O

A	A	DT	B-NP	O
m	m	NN	I-NP	O
ultipotent	ultipotent	JJ	I-NP	O
immature	immature	JJ	I-NP	O
myeloid	myeloid	JJ	I-NP	O
cell	cell	NN	I-NP	O
population	population	NN	I-NP	O
was	be	VBD	B-VP	O
produced	produce	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
basic	basic	JJ	I-NP	B-protein
fibroblast	fibroblast	NN	I-NP	I-protein
growth	growth	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
bFGF	bFGF	NN	B-NP	B-protein
)	)	)	O	O
-dependent	-dependent	JJ	B-NP	O
hematopoietic	hematopoietic	JJ	I-NP	O
stem	stem	NN	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
,	,	,	O	O
A-6	A-6	NN	B-NP	B-protein
,	,	,	O	O
when	when	WRB	B-ADVP	O
cultured	culture	VBN	B-VP	O
with	with	IN	B-PP	O
stem	stem	NN	B-NP	B-protein
cell	cell	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
SCF	SCF	NN	B-NP	B-protein
)	)	)	O	O
replacing	replace	VBG	B-VP	O
bFGF	bFGF	NN	B-NP	B-protein
.	.	.	O	O

Those	Those	DT	B-NP	O
cells	cell	NNS	I-NP	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
stem	stem	NN	B-NP	B-protein
cell	cell	NN	I-NP	I-protein
markers	marker	NNS	I-NP	I-protein
,	,	,	O	O
c-kit	c-kit	NN	B-NP	B-protein
and	and	CC	I-NP	O
CD34	CD34	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
myeloid	myeloid	JJ	I-NP	B-protein
cell	cell	NN	I-NP	I-protein
marker	marker	NN	I-NP	I-protein
,	,	,	O	O
F4/80	F4/80	NN	B-NP	O
.	.	.	O	O

Some	Some	DT	B-NP	O
cell	cell	NN	I-NP	O
fractions	fraction	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
Mac-1	Mac-1	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
macrophage	macrophage	NN	I-NP	B-protein
marker	marker	NN	I-NP	I-protein
or	or	CC	I-NP	O
Gr-1	Gr-1	NN	I-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
granulocytic	granulocytic	JJ	I-NP	O
maker	maker	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
erythroid	erythroid	JJ	I-NP	O
marker	marker	NN	I-NP	O
TER119	TER119	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
mRNA	mRNA	NN	B-NP	B-RNA
for	for	IN	B-PP	O
the	the	DT	B-NP	O
myeloid-specific	myeloid-specific	JJ	I-NP	O
PU.1	PU.1	NN	I-NP	B-protein
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	O	O
that	that	DT	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
erythroid-specific	erythroid-specific	JJ	I-NP	B-protein
GATA-1	GATA-1	NN	I-NP	I-protein
.	.	.	O	O

Among	Among	IN	B-PP	O
various	various	JJ	B-NP	O
cytokines	cytokine	NNS	I-NP	B-protein
,	,	,	O	O
interleukin-3	interleukin-3	NN	B-NP	B-protein
(	(	(	O	O
IL-3	IL-3	NN	B-NP	B-protein
)	)	)	O	O
induced	induce	VBD	B-VP	O
erythroid	erythroid	JJ	B-NP	B-cell_type
precursor	precursor	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
that	that	WDT	B-NP	O
expressed	express	VBD	B-VP	O
the	the	DT	B-NP	O
erythroid-specific	erythroid-specific	JJ	I-NP	O
GATA-1	GATA-1	NN	I-NP	B-protein
and	and	CC	O	O
beta-major	beta-major	JJ	B-NP	B-protein
globin	globin	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
quantitative	quantitative	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
erythroid	erythroid	JJ	B-NP	B-cell_type
precursor	precursor	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
newly	newly	RB	I-VP	O
produced	produce	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
immature	immature	JJ	I-NP	B-cell_type
myeloid	myeloid	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
cultivation	cultivation	NN	B-NP	O
with	with	IN	B-PP	O
IL-3	IL-3	NN	B-NP	B-protein
.	.	.	O	O

SCF	SCF	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-3	IL-3	NN	I-NP	B-protein
induced	induce	VBD	B-VP	O
stepwise	stepwise	JJ	B-NP	O
generation	generation	NN	I-NP	O
of	of	IN	B-PP	O
erythroid	erythroid	JJ	B-NP	B-cell_type
precursor	precursor	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
an	an	DT	B-NP	O
A-6	A-6	NN	I-NP	B-cell_line
hematopoietic	hematopoietic	JJ	I-NP	I-cell_line
stem	stem	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

Copyright	Copyright	NN	B-NP	O
2001	2001	CD	I-NP	O
Academic	Academic	NNP	I-NP	O
Press	Press	NNP	I-NP	O
.	.	.	O	O

Distinct	Distinct	JJ	B-NP	O
BMI-1	BMI-1	NN	I-NP	B-protein
and	and	CC	I-NP	O
EZH2	EZH2	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
patterns	pattern	NNS	I-NP	O
in	in	IN	B-PP	O
thymocytes	thymocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
mature	mature	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
suggest	suggest	VBP	B-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
Polycomb	Polycomb	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
differentiation	differentiation	NN	I-NP	O
.	.	.	O	O

BMI-1	BMI-1	NN	B-NP	B-protein
and	and	CC	I-NP	O
EZH2	EZH2	NN	I-NP	B-protein
Polycomb-group	Polycomb-group	NN	I-NP	I-protein
(	(	(	O	I-protein
PcG	PcG	NN	B-NP	I-protein
)	)	)	O	I-protein
proteins	protein	NNS	B-NP	I-protein
belong	belong	VBP	B-VP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
distinct	distinct	JJ	I-NP	O
protein	protein	NN	I-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
hematopoiesis	hematopoiesis	NN	B-NP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
unique	unique	JJ	B-NP	O
PcG-specific	PcG-specific	JJ	I-NP	O
antisera	antiserum	NNS	I-NP	O
and	and	CC	O	O
triple	triple	JJ	B-NP	O
immunofluorescence	immunofluorescence	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
mature	mature	JJ	B-NP	B-cell_type
resting	rest	VBG	I-NP	I-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
expressed	express	VBD	B-VP	O
BMI-1	BMI-1	NN	B-NP	B-protein
,	,	,	O	O
whereas	whereas	IN	B-PP	O
dividing	divide	VBG	B-NP	B-cell_type
blasts	blast	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
EZH2	EZH2	NN	B-NP	B-protein
(	(	(	O	O
+	+	SYM	B-NP	O
)	)	)	O	O
.	.	.	O	O

By	By	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
subcapsular	subcapsular	JJ	B-NP	O
immature	immature	JJ	I-NP	O
double-negative	double-negative	JJ	I-NP	O
(	(	(	O	O
DN	DN	JJ	B-ADJP	O
)	)	)	O	O
(	(	(	O	O
CD4	CD4	NN	B-NP	O
(	(	(	O	O
-	-	SYM	O	O
)	)	)	O	O
/CD8	/CD8	NN	B-NP	B-protein
(	(	(	O	O
-	-	SYM	B-NP	O
)	)	)	O	O
)	)	)	O	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
the	the	DT	B-NP	O
thymus	thymus	NN	I-NP	O
coexpressed	coexpresse	VBD	B-VP	O
BMI-1	BMI-1	NN	B-NP	B-protein
and	and	CC	I-NP	O
EZH2	EZH2	NN	I-NP	B-protein
or	or	CC	O	O
were	be	VBD	B-VP	O
BMI-1	BMI-1	NN	B-NP	B-protein
single	single	JJ	B-ADJP	O
positive	positive	JJ	I-ADJP	O
.	.	.	O	O

Their	Their	PRP$	B-NP	O
descendants	descendant	NNS	I-NP	O
,	,	,	O	O
double-positive	double-positive	JJ	B-ADJP	O
(	(	(	O	O
DP	DP	NN	B-NP	O
;	;	:	O	O
CD4	CD4	NN	B-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
/CD8	/CD8	NN	B-NP	O
(	(	(	O	O
+	+	SYM	B-NP	O
)	)	)	O	O
)	)	)	O	O
cortical	cortical	JJ	B-NP	O
thymocytes	thymocyte	NNS	I-NP	O
,	,	,	O	O
expressed	express	VBD	B-VP	O
EZH2	EZH2	NN	B-NP	B-protein
without	without	IN	B-PP	O
BMI-1	BMI-1	NN	B-NP	B-protein
.	.	.	O	O

Most	Most	JJS	B-NP	O
EZH2	EZH2	NN	I-NP	B-protein
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
DN	DN	NN	B-NP	O
and	and	CC	I-NP	O
DP	DP	NN	I-NP	B-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
dividing	divide	VBG	I-VP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
DN	DN	NN	B-NP	O
BMI-1	BMI-1	NN	I-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
/EZH2	/EZH2	NN	B-NP	B-protein
(	(	(	O	O
-	-	SYM	O	O
)	)	)	O	O
thymocytes	thymocyte	NNS	B-NP	B-cell_type
were	be	VBD	B-VP	O
resting	rest	VBG	I-VP	O
and	and	CC	O	O
proliferation	proliferation	NN	B-NP	O
was	be	VBD	B-VP	O
occasionally	occasionally	RB	I-VP	O
noted	note	VBN	I-VP	O
in	in	IN	B-PP	O
DN	DN	NN	B-NP	B-cell_line
BMI-1	BMI-1	NN	I-NP	I-cell_line
(	(	(	O	I-cell_line
+	+	SYM	O	I-cell_line
)	)	)	O	I-cell_line
/EZH2	/EZH2	NN	B-NP	I-cell_line
(	(	(	O	I-cell_line
+	+	SYM	O	I-cell_line
)	)	)	O	I-cell_line
cells	cell	NNS	B-NP	I-cell_line
.	.	.	O	O

Maturation	Maturation	NN	B-NP	O
of	of	IN	B-PP	O
DP	DP	NN	B-NP	B-cell_type
cortical	cortical	JJ	I-NP	I-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
single-positive	single-positive	JJ	B-NP	O
(	(	(	O	O
CD4	CD4	NN	B-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
/CD8	/CD8	NN	B-NP	B-protein
(	(	(	O	O
-	-	SYM	B-NP	O
)	)	)	O	O
or	or	CC	O	O
CD8	CD8	NN	B-NP	B-protein
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
/CD4	/CD4	NN	B-NP	B-protein
(	(	(	O	O
-	-	SYM	B-NP	O
)	)	)	O	O
)	)	)	O	O
medullar	medullar	JJ	B-NP	O
thymocytes	thymocyte	NNS	I-NP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
detectability	detectability	NN	I-NP	O
of	of	IN	B-PP	O
EZH2	EZH2	NN	B-NP	B-protein
and	and	CC	O	O
continued	continue	VBD	B-NP	O
relative	relative	JJ	I-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
BMI-1	BMI-1	NN	B-NP	B-protein
.	.	.	O	O

Our	Our	PRP$	B-NP	O
data	datum	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
BMI-1	BMI-1	NN	B-NP	B-protein
and	and	CC	O	O
EZH2	EZH2	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
mature	mature	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
mutually	mutually	RB	B-ADJP	O
exclusive	exclusive	JJ	I-ADJP	O
and	and	CC	O	O
linked	link	VBN	B-VP	O
to	to	TO	B-PP	O
proliferation	proliferation	NN	B-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
pattern	pattern	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
yet	yet	RB	I-VP	O
established	establish	VBN	I-VP	O
in	in	IN	B-PP	O
thymocytes	thymocyte	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cortex	cortex	NN	I-NP	O
and	and	CC	I-NP	O
medulla	medulla	NN	I-NP	O
.	.	.	O	O

T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
stage-specific	stage-specific	JJ	I-NP	O
PcG	PcG	NN	I-NP	O
expression	expression	NN	I-NP	O
profiles	profile	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
PcG	PcG	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
contribute	contribute	VBP	B-VP	O
to	to	TO	B-PP	O
regulation	regulation	NN	B-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
differentiation	differentiation	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
probably	probably	RB	B-ADVP	O
reflect	reflect	VBP	B-VP	O
stabilization	stabilization	NN	B-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	B-DNA
type-specific	type-specific	JJ	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
and	and	CC	O	O
irreversibility	irreversibility	NN	B-NP	O
of	of	IN	B-PP	O
lineage	lineage	NN	B-NP	O
choice	choice	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
PcG	PcG	NN	B-NP	O
expression	expression	NN	I-NP	O
between	between	IN	B-PP	O
medullar	medullar	JJ	B-NP	B-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
mature	mature	JJ	B-NP	B-cell_type
interfollicular	interfollicular	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
additional	additional	JJ	B-NP	O
maturation	maturation	NN	I-NP	O
processes	process	NNS	I-NP	O
occur	occur	VBP	B-VP	O
after	after	IN	B-SBAR	O
thymocyte	thymocyte	NN	B-NP	O
transportation	transportation	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
thymus	thymus	NN	I-NP	O
.	.	.	O	O

Stepwise	Stepwise	JJ	B-NP	O
lineage	lineage	NN	I-NP	O
restriction	restriction	NN	I-NP	O
of	of	IN	B-PP	O
progenitors	progenitor	NNS	B-NP	B-cell_type
in	in	IN	B-PP	O
lympho-myelopoiesis	lympho-myelopoiesis	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
has	have	VBZ	B-VP	O
long	long	RB	I-VP	O
been	be	VBN	I-VP	O
controversial	controversial	JJ	B-ADJP	O
whether	whether	IN	B-SBAR	O
hematopoiesis	hematopoiesis	NN	B-NP	O
progresses	progress	VBZ	B-VP	O
through	through	IN	B-PP	O
ordered	order	VBN	B-NP	O
stages	stage	NNS	I-NP	O
of	of	IN	B-PP	O
determination	determination	NN	B-NP	O
as	as	IN	B-PP	O
in	in	IN	B-PP	O
embryonic	embryonic	JJ	B-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
methodology	methodology	NN	I-NP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
exactly	exactly	RB	B-VP	O
determining	determine	VBG	I-VP	O
the	the	DT	B-NP	O
developmental	developmental	JJ	I-NP	O
potential	potential	NN	I-NP	O
of	of	IN	B-PP	O
hematopoietic	hematopoietic	JJ	B-NP	B-cell_type
stem/progenitor	stem/progenitor	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
multilineage	multilineage	JJ	I-NP	O
progenitor	progenitor	NN	I-NP	O
(	(	(	O	O
MLP	MLP	NN	B-NP	O
)	)	)	O	O
assay	assay	NN	B-NP	O
enabled	enable	VBD	B-VP	O
us	us	PRP	B-NP	O
to	to	TO	B-VP	O
discriminate	discriminate	VB	I-VP	O
among	among	IN	B-PP	O
seven	seven	CD	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
hematopoietic	hematopoietic	JJ	B-NP	B-cell_type
progenitors	progenitor	NNS	I-NP	I-cell_type
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
multipotent	multipotent	JJ	B-NP	O
progenitor	progenitor	NN	I-NP	O
p-MTB	p-MTB	NN	I-NP	O
(	(	(	O	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
generating	generate	VBG	B-VP	O
myeloid	myeloid	JJ	B-NP	O
,	,	,	I-NP	O
T	T	NN	I-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
)	)	)	O	O
,	,	,	O	O
bipotent	bipotent	JJ	B-NP	B-cell_type
progenitors	progenitor	NNS	I-NP	I-cell_type
p-MT	p-MT	NN	I-NP	O
,	,	,	I-NP	O
p-MB	p-MB	NN	I-NP	B-protein
and	and	CC	I-NP	O
p-TB	p-TB	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
unipotent	unipotent	JJ	B-NP	O
progenitors	progenitor	NNS	I-NP	O
p-M	p-M	NN	I-NP	O
,	,	,	I-NP	O
p-T	p-T	NN	I-NP	O
and	and	CC	I-NP	O
p-B	p-B	NN	I-NP	O
.	.	.	O	O

Among	Among	IN	B-PP	O
these	these	DT	B-NP	O
seven	seven	CD	I-NP	O
types	type	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
p-TB	p-TB	NN	I-NP	B-protein
type	type	NN	I-NP	I-protein
progenitor	progenitor	NN	I-NP	I-protein
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
absent	absent	JJ	B-ADJP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
process	process	NN	I-NP	O
of	of	IN	B-PP	O
lineage	lineage	NN	B-NP	O
commitment	commitment	NN	I-NP	O
proceeds	proceed	VBZ	B-VP	O
through	through	IN	B-PP	O
an	an	DT	B-NP	O
ordered	order	VBN	I-NP	O
but	but	CC	O	O
not	not	RB	O	O
random	random	VB	B-VP	O
process	process	NN	B-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
extending	extend	VBG	B-VP	O
the	the	DT	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
investigation	investigation	NN	B-NP	O
to	to	TO	B-VP	O
include	include	VB	I-VP	O
the	the	DT	B-NP	O
erythroid	erythroid	JJ	I-NP	B-cell_type
lineage	lineage	NN	I-NP	I-cell_type
,	,	,	O	O
more	more	RBR	B-NP	O
convincing	convincing	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
ordered	order	VBN	I-NP	O
process	process	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
.	.	.	O	O

Detailed	Detailed	JJ	B-NP	O
and	and	CC	I-NP	O
exact	exact	JJ	I-NP	O
illustration	illustration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
process	process	NN	I-NP	O
of	of	IN	B-PP	O
hematopoiesis	hematopoiesis	NN	B-NP	O
will	will	MD	B-VP	O
provide	provide	VB	I-VP	O
an	an	DT	B-NP	O
opportunity	opportunity	NN	I-NP	O
to	to	TO	B-VP	O
revive	revive	VB	I-VP	O
hematopoiesis	hematopoiesis	NN	B-NP	O
as	as	IN	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
fascinating	fascinating	JJ	I-NP	O
targets	target	NNS	I-NP	O
of	of	IN	B-PP	O
research	research	NN	B-NP	O
in	in	IN	B-PP	O
developmental	developmental	JJ	B-NP	O
biology	biology	NN	I-NP	O

Epstein-Barr	Epstein-Barr	JJ	B-NP	O
Virus	Virus	NN	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
glycoprotein-350	glycoprotein-350	NN	I-NP	B-protein
upregulate	upregulate	VBP	B-VP	O
IL-6	IL-6	NN	B-NP	B-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
B-lymphocytes	B-lymphocyte	NNS	I-NP	I-cell_type
via	via	IN	B-PP	O
CD21	CD21	NN	B-NP	B-protein
,	,	,	O	O
involving	involve	VBG	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
and	and	CC	O	O
different	different	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
.	.	.	O	O

Epstein-Barr	Epstein-Barr	JJ	B-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
EBV	EBV	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
ubiquitous	ubiquitous	JJ	I-NP	O
and	and	CC	I-NP	O
highly	highly	RB	I-NP	O
immunotropic	immunotropic	JJ	I-NP	O
gamma	gamma	NN	I-NP	O
herpesvirus	herpesvirus	NN	I-NP	O
that	that	WDT	B-NP	O
infects	infect	VBZ	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
humans	human	NNS	B-NP	O
worldwide	worldwide	RB	B-ADVP	O
.	.	.	O	O

Its	Its	PRP$	B-NP	O
pathogenicity	pathogenicity	NN	I-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
diseases	disease	NNS	B-NP	O
including	include	VBG	B-PP	O
tumors	tumor	NNS	B-NP	O
that	that	WDT	B-NP	O
result	result	VBP	B-VP	O
from	from	IN	B-PP	O
EBV	EBV	NN	B-NP	O
's	's	POS	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
readily	readily	RB	I-VP	O
transform	transform	VB	I-VP	O
B-lymphocytes	B-lymphocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
,	,	,	O	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
lesser	less	JJR	I-NP	O
extent	extent	NN	I-NP	O
,	,	,	O	O
epithelial	epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

EBV	EBV	NN	B-NP	O
utilizes	utilize	VBZ	B-VP	O
CD21/CR2	CD21/CR2	NN	B-NP	B-protein
as	as	IN	B-PP	O
its	its	PRP$	B-NP	O
receptor	receptor	NN	I-NP	O
on	on	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-VP	O
initiate	initiate	VB	I-VP	O
the	the	DT	B-NP	O
infection	infection	NN	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

EBV	EBV	NN	B-NP	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
CR2	CR2	NN	B-NP	B-protein
through	through	IN	B-PP	O
its	its	PRP$	B-NP	O
major	major	JJ	I-NP	B-protein
envelope	envelope	NN	I-NP	I-protein
glycoprotein-350	glycoprotein-350	NN	I-NP	I-protein
(	(	(	O	O
gp350	gp350	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
a	a	DT	B-NP	O
remarkable	remarkable	JJ	I-NP	O
immunomodulating	immunomodulating	JJ	I-NP	O
agent	agent	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
had	have	VBD	B-VP	O
previously	previously	RB	I-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
EBV	EBV	NN	B-NP	O
is	be	VBZ	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
modulating	modulate	VBG	B-VP	O
the	the	DT	B-NP	O
synthesis	synthesis	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
cytokines	cytokine	NNS	B-NP	B-protein
.	.	.	O	O

We	We	PRP	B-NP	O
now	now	RB	B-ADVP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
while	while	IN	B-SBAR	O
both	both	CC	O	O
purified	purify	VBN	B-VP	O
recombinant	recombinant	JJ	B-NP	O
gp350	gp350	NN	I-NP	O
(	(	(	O	O
rgp350	rgp350	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
EBV	EBV	NN	B-NP	O
upregulate	upregulate	VBP	B-VP	O
IL-6	IL-6	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
synthesis	synthesis	NN	I-NP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
EBV-induced	EBV-induced	JJ	B-NP	O
IL-6	IL-6	NN	I-NP	O
gene	gene	NN	I-NP	O
activation	activation	NN	I-NP	O
occurs	occur	VBZ	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
significantly	significantly	RB	I-NP	O
longer	long	JJR	I-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
time	time	NN	B-NP	O
(	(	(	O	O
i.e.	i.e.	FW	B-NP	O
12	12	CD	I-NP	O
hours	hour	NNS	I-NP	O
for	for	IN	B-PP	O
EBV	EBV	NN	B-NP	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
6	6	CD	B-NP	O
hours	hour	NNS	I-NP	O
for	for	IN	B-PP	O
rgp350	rgp350	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
half-life	half-life	NN	I-NP	O
of	of	IN	B-PP	O
EBV-induced	EBV-induced	JJ	B-NP	B-RNA
IL-6	IL-6	NN	I-NP	I-RNA
mRNA	mRNA	NN	I-NP	I-RNA
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
significantly	significantly	RB	B-ADJP	O
longer	long	JJR	I-ADJP	O
(	(	(	O	O
10	10	CD	B-NP	O
hours	hour	NNS	I-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
mRNA	mRNA	NN	B-NP	B-RNA
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
rgp350	rgp350	NN	B-NP	B-protein
(	(	(	O	O
about	about	RB	B-NP	O
6	6	CD	I-NP	O
hours	hour	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

Both	Both	CC	O	O
EBV	EBV	NN	B-NP	O
and	and	CC	I-NP	O
gp350	gp350	NN	I-NP	B-protein
enhance	enhance	VBP	B-VP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
as	as	IN	B-SBAR	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
band-shift	band-shift	NN	B-NP	O
and	and	CC	I-NP	O
augment	augment	NN	I-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
CAT	CAT	NN	I-NP	B-DNA
reporter	reporter	NN	I-NP	I-DNA
plasmid	plasmid	NN	I-NP	I-DNA
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
IL-6	IL-6	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
by	by	IN	B-PP	O
gp350	gp350	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
primarily	primarily	RB	B-ADVP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
C	C	NN	I-NP	I-protein
pathway	pathway	NN	I-NP	O
,	,	,	O	O
EBV	EBV	NN	B-NP	O
can	can	MD	B-VP	O
mediate	mediate	VB	I-VP	O
its	its	PRP$	B-NP	O
effects	effect	NNS	I-NP	O
through	through	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-PP	O
our	our	PRP$	B-NP	O
knowledge	knowledge	NN	I-NP	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
report	report	NN	I-NP	O
showing	show	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
herpesvirus	herpesvirus	NN	I-NP	B-protein
envelope	envelope	NN	I-NP	I-protein
glycoprotein	glycoprotein	NN	I-NP	I-protein
to	to	TO	B-PP	O
CR2	CR2	NN	B-NP	B-protein
on	on	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
upregulation	upregulation	NN	I-NP	O
of	of	IN	B-PP	O
IL-6	IL-6	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	B-cell_type
.	.	.	O	O

Copyright	Copyright	NN	B-NP	O
2001	2001	CD	I-NP	O
Academic	Academic	NNP	I-NP	O
Press	Press	NNP	I-NP	O
.	.	.	O	O

Gene-	Gene-	NN	B-NP	O
and	and	CC	I-NP	O
tissue-specificity	tissue-specificity	NN	I-NP	O
of	of	IN	B-PP	O
mutation	mutation	NN	B-NP	O
in	in	IN	B-PP	O
Big	Big	JJ	B-NP	O
Blue	Blue	JJ	I-NP	O
rats	rat	NNS	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
hepatocarcinogen	hepatocarcinogen	NN	I-NP	B-DNA
N-hydroxy-2-acetylaminofluorene	N-hydroxy-2-acetylaminofluorene	NN	I-NP	I-DNA
.	.	.	O	O

In	In	IN	B-PP	O
a	a	DT	B-NP	O
previous	previous	JJ	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
treating	treat	VBG	B-VP	O
transgenic	transgenic	JJ	B-NP	O
Big	Big	JJ	I-NP	O
Blue	Blue	JJ	I-NP	O
rats	rat	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
hepatocarcinogen	hepatocarcinogen	NN	I-NP	B-DNA
N-hydroxy-2-acetylaminofluorene	N-hydroxy-2-acetylaminofluorene	NN	I-NP	I-DNA
(	(	(	O	O
N-OH-AAF	N-OH-AAF	NN	B-NP	O
)	)	)	O	O
produced	produce	VBD	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
major	major	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
adduct	adduct	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
target	target	NN	I-NP	O
liver	liver	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
nontarget	nontarget	JJ	I-NP	B-cell_type
spleen	spleen	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
bone	bone	NN	B-NP	B-cell_type
marrow	marrow	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
induced	induce	VBD	B-VP	O
lacI	lacI	NN	B-NP	B-protein
mutants	mutant	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
induced	induce	VBD	B-VP	O
much	much	RB	B-NP	O
lower	low	JJR	I-NP	O
frequencies	frequency	NNS	I-NP	O
of	of	IN	B-PP	O
l	l	NN	B-NP	B-DNA
acI	acI	NN	I-NP	I-DNA
and	and	CC	I-NP	O
hprt	hprt	NN	I-NP	B-protein
mutants	mutant	NNS	I-NP	I-protein
in	in	IN	B-PP	O
spleen	spleen	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
sequence	sequence	NN	B-NP	O
analysis	analysis	NN	I-NP	O
was	be	VBD	B-VP	O
conducted	conduct	VBN	I-VP	O
on	on	IN	B-PP	O
lacI	lacI	NN	B-NP	O
DNA	DNA	NN	I-NP	O
and	and	CC	O	O
hprt	hprt	NN	B-NP	B-DNA
cDNA	cDNA	NN	I-NP	I-DNA
from	from	IN	B-PP	O
the	the	DT	B-NP	O
mutants	mutant	NNS	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
mutational	mutational	JJ	I-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
N-OH-AAF	N-OH-AAF	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O
.	.	.	O	O

All	All	PDT	B-NP	O
the	the	DT	I-NP	O
mutation	mutation	NN	I-NP	O
spectra	spectrum	NNS	I-NP	O
from	from	IN	B-PP	O
N-OH-AAF-treated	N-OH-AAF-treated	JJ	B-NP	O
rats	rat	NNS	I-NP	O
differed	differ	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
from	from	IN	B-PP	O
corresponding	correspond	VBG	B-VP	O
mutation	mutation	NN	B-NP	O
profiles	profile	NNS	I-NP	O
from	from	IN	B-PP	O
untreated	untreated	JJ	B-NP	O
animals	animal	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
0.02	0.02	CD	B-NP	O
to	to	TO	B-PP	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
0.0001	0.0001	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
similarities	similarity	NNS	B-NP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
mutational	mutational	JJ	I-NP	O
patterns	pattern	NNS	I-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
N-OH-AAF-treated	N-OH-AAF-treated	JJ	B-NP	O
rats	rat	NNS	I-NP	O
(	(	(	O	O
e.g.	e.g.	FW	B-NP	O
,	,	,	O	O
G	G	NN	B-NP	O
:	:	SYM	I-NP	O
C	C	NN	I-NP	O
--	--	:	O	O
>	>	JJ	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
transversion	transversion	NN	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
mutation	mutation	NN	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
mutation	mutation	NN	I-NP	O
sets	set	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
significant	significant	JJ	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patterns	pattern	NNS	I-NP	O
of	of	IN	B-PP	O
basepair	basepair	NN	B-NP	O
substitution	substitution	NN	I-NP	O
and	and	CC	O	O
frameshift	frameshift	NN	B-NP	O
mutation	mutation	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
and	and	CC	I-NP	O
spleen	spleen	NN	I-NP	B-protein
lymphocyte	lymphocyte	NN	I-NP	I-protein
lacI	lacI	NN	I-NP	I-protein
mutants	mutant	NNS	I-NP	I-protein
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
0.02	0.02	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
spleen	spleen	NN	I-NP	O
lymphocyte	lymphocyte	NN	I-NP	O
lacI	lacI	NN	I-NP	O
and	and	CC	I-NP	O
hprt	hprt	NN	I-NP	B-protein
mutants	mutant	NNS	I-NP	I-protein
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
0.04	0.04	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
multiplex	multiplex	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
genomic	genomic	JJ	B-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
from	from	IN	B-PP	O
the	the	DT	B-NP	O
hprt	hprt	NN	I-NP	B-protein
mutants	mutant	NNS	I-NP	I-protein
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
12	12	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
mutants	mutant	NNS	B-NP	O
from	from	IN	B-PP	O
treated	treat	VBN	B-NP	O
rats	rat	NNS	I-NP	O
had	have	VBD	B-VP	O
major	major	JJ	B-NP	O
deletions	deletion	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hprt	hprt	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
;	;	:	O	O
no	no	DT	B-NP	O
corresponding	corresponding	JJ	I-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
large	large	JJ	B-NP	O
deletions	deletion	NNS	I-NP	O
was	be	VBD	B-VP	O
evident	evident	JJ	B-ADJP	O
among	among	IN	B-PP	O
lacI	lacI	NN	B-NP	O
mutations	mutation	NNS	I-NP	O
.	.	.	O	O

All	All	PDT	B-NP	O
the	the	DT	I-NP	O
mutation	mutation	NN	I-NP	O
profiles	profile	NNS	I-NP	O
reflect	reflect	VBP	B-VP	O
the	the	DT	B-NP	O
general	general	JJ	I-NP	O
mutational	mutational	JJ	I-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
adduct	adduct	NN	I-NP	O
formed	form	VBN	B-VP	O
by	by	IN	B-PP	O
N-OH-AAF	N-OH-AAF	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
differences	difference	NNS	I-NP	O
between	between	IN	B-PP	O
N-OH-AAF	N-OH-AAF	NN	B-NP	O
mutation	mutation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
endogenous	endogenous	JJ	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
and	and	CC	I-NP	O
transgene	transgene	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
partially	partially	RB	I-VP	O
explained	explain	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
structures	structure	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
genes	gene	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
tissue-specificity	tissue-specificity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mutation	mutation	NN	I-NP	O
spectra	spectrum	NNS	I-NP	O
may	may	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
targeting	target	VBG	B-VP	O
tumor	tumor	NN	B-NP	O
formation	formation	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
.	.	.	O	O

Environ.	Environ.	NNP	B-NP	O
Mol.	Mol.	NNP	I-NP	O
Mutagen.	Mutagen.	NNP	I-NP	O
37	37	CD	I-NP	O
:	:	:	O	O
203-214	203-214	CD	B-NP	O
,	,	,	I-NP	O
2001	2001	CD	I-NP	O
.	.	.	O	O

Published	Published	NNP	B-NP	O
2001	2001	CD	I-NP	O
Wiley-Liss	Wiley-Liss	NNP	I-NP	O
,	,	,	O	O
Inc	Inc	NNP	B-NP	O
.	.	.	O	O

Caspase	Caspase	NN	B-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
cleavage	cleavage	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hematopoietic	hematopoietic	JJ	I-NP	O
specific	specific	JJ	I-NP	O
adaptor	adaptor	NN	I-NP	O
protein	protein	NN	I-NP	O
Gads	Gad	NNS	I-NP	O
alters	alter	VBZ	B-VP	O
signalling	signalling	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-protein
cell	cell	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

Gads	Gad	NNS	B-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
SH2	SH2	NN	I-NP	B-protein
and	and	CC	I-NP	O
SH3	SH3	NN	I-NP	O
domain	domain	NN	I-NP	O
-containing	-containing	JJ	B-NP	O
,	,	,	I-NP	O
hematopoietic-specific	hematopoietic-specific	JJ	I-NP	B-protein
adaptor	adaptor	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
that	that	WDT	B-NP	O
functions	function	VBZ	B-VP	O
in	in	IN	B-PP	O
signalling	signalling	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-protein
cell	cell	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

Gads	Gad	NNS	B-NP	B-protein
acts	act	VBZ	B-VP	O
by	by	IN	B-PP	O
linking	link	VBG	B-VP	O
SLP-76	SLP-76	NN	B-NP	B-protein
,	,	,	O	O
bound	bind	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
carboxy-terminal	carboxy-terminal	JJ	I-NP	B-protein
Gads	Gads	NNP	I-NP	I-protein
SH3	SH3	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
,	,	,	O	O
to	to	TO	B-PP	O
tyrosine	tyrosine	NN	B-NP	B-protein
phosphorylated	phosphorylated	JJ	I-NP	I-protein
LAT	LAT	NN	I-NP	I-protein
which	which	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
binding	bind	VBG	B-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
for	for	IN	B-PP	O
the	the	DT	B-NP	O
Gads	Gad	NNS	I-NP	B-protein
SH2	SH2	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
.	.	.	O	O

Gads	Gad	NNS	B-NP	B-protein
is	be	VBZ	B-VP	O
distinguished	distinguish	VBN	I-VP	O
from	from	IN	B-PP	O
Grb2	Grb2	NN	B-NP	B-protein
and	and	CC	O	O
the	the	DT	B-NP	O
closely	closely	RB	I-NP	O
related	related	JJ	I-NP	O
Grap	Grap	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
by	by	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
120	120	CD	I-NP	B-DNA
amino	amino	NN	I-NP	I-DNA
acid	acid	NN	I-NP	I-DNA
unique	unique	JJ	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
between	between	IN	B-PP	O
the	the	DT	B-NP	O
SH2	SH2	NN	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
carboxy	carboxy	NN	I-NP	B-protein
terminal	terminal	JJ	I-NP	I-protein
SH3	SH3	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
unique	unique	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
Gads	Gad	NNS	B-NP	B-protein
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
capase	capase	NN	I-NP	B-DNA
cleavage	cleavage	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

Induction	Induction	NN	B-NP	O
of	of	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
in	in	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
detectable	detectable	JJ	B-NP	O
Gads	Gad	NNS	I-NP	O
cleavage	cleavage	NN	I-NP	O
by	by	IN	B-PP	O
60	60	CD	B-NP	O
min	min	NN	I-NP	O
.	.	.	O	O

Gads	Gad	NNS	B-NP	O
cleavage	cleavage	NN	I-NP	O
is	be	VBZ	B-VP	O
blocked	block	VBN	I-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
by	by	IN	B-PP	O
treating	treat	VBG	B-VP	O
cells	cell	NNS	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
caspase	caspase	NN	I-NP	B-protein
3	3	CD	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	I-protein
.	.	.	O	O

A	A	DT	B-NP	O
putative	putative	JJ	I-NP	B-DNA
caspase	caspase	NN	I-NP	I-DNA
3	3	CD	I-NP	I-DNA
cleavage	cleavage	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
unique	unique	JJ	I-NP	O
region	region	NN	I-NP	O
and	and	CC	I-NP	O
mutation	mutation	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
site	site	NN	I-NP	O
prevented	prevent	VBD	B-VP	O
Gads	Gad	NNS	B-NP	O
cleavage	cleavage	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
Gads	Gads	NNP	I-NP	B-protein
cleavage	cleavage	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
retained	retain	VBD	B-VP	O
the	the	DT	B-NP	O
predicted	predict	VBN	I-NP	O
binding	binding	NN	I-NP	O
specificity	specificity	NN	I-NP	O
for	for	IN	B-PP	O
SLP-76	SLP-76	NN	B-NP	B-protein
and	and	CC	I-NP	O
LAT	LAT	NN	I-NP	B-protein
.	.	.	O	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Gads	Gads	NNP	I-NP	B-protein
cleavage	cleavage	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
in	in	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
inhibited	inhibit	VBD	B-VP	O
NFAT	NFAT	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
following	follow	VBG	B-PP	O
TCR	TCR	NN	B-NP	B-protein
cross	cross	NN	I-NP	O
linking	linking	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
cleavage	cleavage	NN	B-NP	O
of	of	IN	B-PP	O
Gads	Gad	NNPS	B-NP	B-protein
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
could	could	MD	B-VP	O
function	function	VB	I-VP	O
to	to	TO	I-VP	O
alter	alter	VB	I-VP	O
signalling	signalling	NN	B-NP	O
downstream	downstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-protein
cell	cell	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
by	by	IN	B-PP	O
disrupting	disrupt	VBG	B-VP	O
cross	cross	JJ	B-NP	O
talk	talk	NN	I-NP	O
between	between	IN	B-PP	O
SLP-76	SLP-76	NN	B-NP	B-protein
and	and	CC	I-NP	O
LAT	LAT	NN	I-NP	B-protein
.	.	.	O	O

Targeting	Targeting	NN	B-NP	O
of	of	IN	B-PP	O
p300	p300	NN	B-NP	B-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
interleukin-2	interleukin-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
via	via	IN	B-PP	O
CREB-Rel	CREB-Rel	NN	B-NP	B-protein
cross-talk	cross-talk	NN	I-NP	I-protein
during	during	IN	B-PP	I-protein
mitogen	mitogen	NN	B-NP	I-protein
and	and	CC	O	O
oncogenic	oncogenic	JJ	B-NP	O
molecular	molecular	JJ	I-NP	O
signaling	signaling	NN	I-NP	O
in	in	IN	B-PP	O
activated	activate	VBN	B-NP	B-cell_type
T-cells	T-cell	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
explore	explore	VBP	B-VP	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
of	of	IN	B-PP	O
targeting	targeting	NN	B-NP	O
of	of	IN	B-PP	O
p300	p300	NN	B-NP	B-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
interleukin-2	interleukin-2	NN	I-NP	B-DNA
(	(	(	O	I-DNA
IL-2	IL-2	NN	B-NP	I-DNA
)	)	)	O	I-DNA
promoter	promoter	NN	B-NP	I-DNA
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
mitogenic	mitogenic	JJ	B-NP	O
and	and	CC	I-NP	O
oncogenic	oncogenic	JJ	I-NP	O
molecular	molecular	JJ	I-NP	O
signals	signal	NNS	I-NP	O
.	.	.	O	O

Recruitment	Recruitment	NN	B-NP	O
of	of	IN	B-PP	O
p300	p300	NN	B-NP	B-protein
by	by	IN	B-PP	O
cAMP-responsive	cAMP-responsive	JJ	B-NP	B-protein
element-binding	element-binding	JJ	I-NP	I-protein
protein-Rel	protein-Rel	NN	I-NP	I-protein
cross-talk	cross-talk	NN	I-NP	I-protein
at	at	IN	B-PP	O
the	the	DT	B-NP	O
composite	composite	JJ	I-NP	B-DNA
CD28	CD28	NN	I-NP	I-DNA
response	response	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
(	(	(	O	O
CD28RE	CD28RE	NN	B-NP	B-DNA
)	)	)	O	O
-	-	HYPH	B-NP	O
TRE	TRE	NN	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
promoter	promoter	NN	B-NP	O
inducibility	inducibility	NN	I-NP	O
during	during	IN	B-PP	O
T-cell	T-cell	NN	B-NP	O
activation	activation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
CD28RE-TRE	CD28RE-TRE	NN	B-NP	B-DNA
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
exclusive	exclusive	JJ	I-NP	O
target	target	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-protein
T-cell	T-cell	NN	I-NP	I-protein
lymphotropic	lymphotropic	JJ	I-NP	I-protein
virus	virus	NN	I-NP	I-protein
type	type	NN	I-NP	I-protein
I	I	CD	I-NP	I-protein
oncoprotein	oncoprotein	NN	I-NP	I-protein
Tax	Tax	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
intrinsic	intrinsic	JJ	I-NP	O
histone	histone	NN	I-NP	B-protein
acetyltransferase	acetyltransferase	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
p300	p300	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
dispensable	dispensable	JJ	B-ADJP	O
for	for	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
N-terminal	N-terminal	JJ	I-NP	B-protein
743	743	CD	I-NP	I-protein
residues	residue	NNS	I-NP	I-protein
contain	contain	VBP	B-VP	O
the	the	DT	B-NP	O
minimal	minimal	JJ	I-NP	O
structural	structural	JJ	I-NP	O
requirements	requirement	NNS	I-NP	O
for	for	IN	B-PP	O
synergistic	synergistic	JJ	B-NP	O
transactivation	transactivation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CD28RE-TRE	CD28RE-TRE	NN	I-NP	B-DNA
,	,	,	O	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
endogenous	endogenous	JJ	B-NP	O
IL-2	IL-2	NN	I-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O

Mutational	Mutational	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
p300	p300	NN	B-NP	B-protein
reveals	reveal	VBZ	B-VP	O
differential	differential	JJ	B-NP	O
structural	structural	JJ	I-NP	O
requirements	requirement	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
N-terminal	N-terminal	JJ	I-NP	B-protein
p300	p300	NN	I-NP	I-protein
module	module	NN	I-NP	I-protein
by	by	IN	B-PP	O
individual	individual	JJ	B-NP	O
cis-elements	cis-element	NNS	I-NP	B-DNA
within	within	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
provide	provide	VBP	B-VP	O
evidence	evidence	NN	B-NP	O
that	that	IN	B-SBAR	O
p300	p300	NN	B-NP	B-protein
assembles	assemble	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
to	to	TO	B-VP	O
form	form	VB	I-VP	O
an	an	DT	B-NP	O
enhanceosome-like	enhanceosome-like	JJ	I-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
target	target	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
centrally	centrally	RB	I-VP	O
integrated	integrate	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
CD28RE-TRE	CD28RE-TRE	NN	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
through	through	IN	B-PP	O
specific	specific	JJ	B-NP	O
protein	protein	NN	I-NP	O
module-targeted	module-targeted	JJ	I-NP	O
associations	association	NNS	I-NP	O
in	in	IN	B-PP	O
activated	activate	VBN	B-NP	B-cell_type
T-cells	T-cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Regulation	Regulation	NN	B-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-protein
production	production	NN	I-NP	O
in	in	IN	B-PP	O
T-cell	T-cell	NN	B-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-VP	O
inhalant	inhalant	VB	I-VP	O
allergen	allergen	NN	B-NP	O
:	:	:	O	O
GATA-3	GATA-3	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
distinguishes	distinguish	VBZ	B-VP	O
between	between	IN	B-PP	O
Th1-	Th1-	NN	B-NP	O
and	and	CC	O	O
Th2-polarized	Th2-polarized	JJ	B-NP	O
immunity	immunity	NN	I-NP	O
.	.	.	O	O

BACKGROUND	BACKGROUND	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
precise	precise	JJ	I-NP	O
nature	nature	NN	I-NP	O
of	of	IN	B-PP	O
allergen-specific	allergen-specific	JJ	B-NP	B-protein
cytokine	cytokine	NN	I-NP	I-protein
responses	response	NNS	I-NP	O
in	in	IN	B-PP	O
atopics	atopic	NNS	B-NP	O
versus	versus	IN	B-PP	O
non-atopics	non-atopic	NNS	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
particular	particular	JJ	B-ADJP	O
the	the	DT	B-NP	O
'Th1	'Th1	NN	I-NP	O
polarity	polarity	NN	I-NP	O
'	'	''	O	O
of	of	IN	B-PP	O
responses	response	NNS	B-NP	O
in	in	IN	B-PP	O
non-atopics	non-atopic	NNS	B-NP	O
,	,	,	O	O
remains	remain	VBZ	B-VP	O
controversial	controversial	JJ	B-ADJP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
due	due	JJ	B-ADJP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
relative	relative	JJ	I-NP	O
insensitivity	insensitivity	NN	I-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-protein
detection	detection	NN	I-NP	O
systems	system	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
associated	associate	VBN	B-VP	O
variations	variation	NNS	B-NP	O
in	in	IN	B-PP	O
kinetics	kinetic	NNS	B-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-protein
production	production	NN	I-NP	O
and	and	CC	I-NP	O
catabolism	catabolism	NN	I-NP	O
in	in	IN	B-PP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
culture	culture	NN	I-NP	O
systems	system	NNS	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
an	an	DT	B-NP	O
alternative	alternative	NN	I-NP	O
to	to	TO	B-PP	O
cytokine	cytokine	NN	B-NP	B-protein
measurement	measurement	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
focuses	focus	VBZ	B-VP	O
on	on	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
GATA-3	GATA-3	NN	I-NP	B-protein
for	for	IN	B-PP	O
analysis	analysis	NN	B-NP	O
of	of	IN	B-PP	O
allergen-specific	allergen-specific	JJ	B-NP	O
Th	Th	NN	I-NP	O
cell	cell	NN	I-NP	O
responses	response	NNS	I-NP	O
.	.	.	O	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
Cord	Cord	NN	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
Th1-	Th1-	NN	B-NP	O
or	or	CC	O	O
Th2-polarized	Th2-polarize	VBN	B-VP	O
by	by	IN	B-PP	O
culture	culture	NN	B-NP	O
in	in	IN	B-PP	O
IL-12-	IL-12-	NN	B-NP	B-protein
or	or	CC	O	O
IL-4-employing	IL-4-employing	JJ	B-NP	O
established	established	JJ	I-NP	O
methods	method	NNS	I-NP	O
;	;	:	O	O
PBMC	PBMC	NN	B-NP	B-cell_type
from	from	IN	B-PP	O
house	house	NN	B-NP	O
dust	dust	NN	I-NP	O
mite	mite	NN	I-NP	O
(	(	(	O	O
HDM	HDM	NN	B-NP	O
)	)	)	O	O
-sensitive	-sensitive	JJ	B-NP	O
atopics	atopic	NNS	I-NP	O
and	and	CC	I-NP	O
controls	control	NNS	I-NP	O
were	be	VBD	B-VP	O
stimulated	stimulate	VBN	I-VP	O
overnight	overnight	RB	B-ADVP	O
with	with	IN	B-PP	O
HDM	HDM	NN	B-NP	B-protein
;	;	:	O	O
cytokine	cytokine	NN	B-NP	B-protein
production	production	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
by	by	IN	B-PP	O
ELISA	ELISA	NN	B-NP	O
and	and	CC	I-NP	O
GATA-3	GATA-3	NN	I-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
expression	expression	NN	I-NP	O
by	by	IN	B-PP	O
PCR	PCR	NN	B-NP	O
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Cytokine	Cytokine	NN	B-NP	B-protein
-driven	-driven	JJ	I-NP	O
Th2	Th2	NN	I-NP	O
polarization	polarization	NN	I-NP	O
of	of	IN	B-PP	O
naive	naive	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
marked	marked	JJ	B-NP	O
upregulation	upregulation	NN	I-NP	O
of	of	IN	B-PP	O
GATA-3	GATA-3	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
a	a	DT	B-NP	O
reciprocal	reciprocal	JJ	I-NP	O
expression	expression	NN	I-NP	O
pattern	pattern	NN	I-NP	O
accompanies	accompany	VBZ	B-VP	O
differentiation	differentiation	NN	B-NP	O
towards	towards	IN	B-PP	O
the	the	DT	B-NP	O
Th1	Th1	NN	I-NP	B-protein
cytokine	cytokine	NN	I-NP	I-protein
phenotype	phenotype	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
HDM	HDM	NN	B-NP	O
skin	skin	NN	I-NP	O
prick	prick	NN	I-NP	O
test-positive	test-positive	JJ	B-ADJP	O
(	(	(	O	O
HDM-SPT+/HDM-IgE+	HDM-SPT+/HDM-IgE+	JJ	B-ADJP	O
)	)	)	O	O
volunteers	volunteer	NNS	B-NP	O
,	,	,	O	O
overnight	overnight	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
marked	marked	JJ	B-NP	O
upregulation	upregulation	NN	I-NP	O
of	of	IN	B-PP	O
GATA-3	GATA-3	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
,	,	,	O	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
equally	equally	RB	I-NP	O
marked	marked	JJ	I-NP	O
downregulation	downregulation	NN	I-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
SPT-/IgE-	SPT-/IgE-	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
subjects	subject	NNS	B-NP	O
who	who	WP	B-NP	O
are	be	VBP	B-VP	O
HDM-SPT+	HDM-SPT+	JJ	B-ADJP	O
but	but	CC	I-ADJP	O
IgE-	IgE-	JJ	I-ADJP	B-protein
,	,	,	O	O
GATA-3	GATA-3	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
levels	level	NNS	I-NP	O
remained	remain	VBD	B-VP	O
relatively	relatively	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
during	during	IN	B-PP	O
culture	culture	NN	B-NP	O
with	with	IN	B-PP	O
HDM	HDM	NN	B-NP	B-protein
.	.	.	O	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
Upregulation	Upregulation	NN	B-NP	O
of	of	IN	B-PP	O
GATA-3	GATA-3	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
PBMC	PBMC	NN	B-NP	B-cell_type
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
hallmark	hallmark	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
Th2	Th2	NN	B-NP	O
recall	recall	NN	I-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
specific	specific	JJ	B-NP	O
allergen	allergen	NN	I-NP	O
in	in	IN	B-PP	O
atopics	atopic	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
reciprocal	reciprocal	JJ	I-NP	O
expression	expression	NN	I-NP	O
pattern	pattern	NN	I-NP	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
HDM-specific	HDM-specific	JJ	B-NP	O
recall	recall	NN	I-NP	O
responses	response	NNS	I-NP	O
of	of	IN	B-PP	O
non-atopics	non-atopic	NNS	B-NP	O
provides	provide	VBZ	B-VP	O
independent	independent	JJ	B-NP	O
confirmation	confirmation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
underlying	underlie	VBG	B-VP	O
Th1-like	Th1-like	JJ	B-NP	O
immunity	immunity	NN	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
parallel	parallel	JJ	I-NP	O
findings	finding	NNS	I-NP	O
in	in	IN	B-PP	O
neonatal	neonatal	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
approach	approach	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
utilized	utilize	VBN	I-VP	O
for	for	IN	B-PP	O
monitoring	monitor	VBG	B-VP	O
the	the	DT	B-NP	O
progress	progress	NN	I-NP	O
of	of	IN	B-PP	O
allergen-specific	allergen-specific	JJ	B-NP	O
Th1/Th2	Th1/Th2	NN	I-NP	O
memory	memory	NN	I-NP	O
development	development	NN	I-NP	O
during	during	IN	B-PP	O
early	early	JJ	B-NP	O
childhood	childhood	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hence	hence	RB	B-ADVP	O
in	in	IN	B-PP	O
assessment	assessment	NN	B-NP	O
of	of	IN	B-PP	O
risk	risk	NN	B-NP	O
for	for	IN	B-PP	O
future	future	JJ	B-NP	O
allergic	allergic	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Copyright	Copyright	NN	B-NP	O
2001	2001	CD	I-NP	O
S.	S.	NNP	I-NP	O
Karger	Karger	NNP	I-NP	O
AG	AG	NNP	I-NP	O
,	,	,	O	O
Basel	Basel	NNP	B-NP	O

The	The	DT	B-NP	O
heat	heat	NN	I-NP	O
shock	shock	NN	I-NP	O
response	response	NN	I-NP	O
reduces	reduce	VBZ	B-VP	O
myelin	myelin	NN	B-NP	B-protein
oligodendrocyte	oligodendrocyte	NN	I-NP	I-protein
glycoprotein	glycoprotein	NN	I-NP	I-protein
-induced	-induced	JJ	I-NP	O
experimental	experimental	JJ	I-NP	O
autoimmune	autoimmune	JJ	I-NP	O
encephalomyelitis	encephalomyelitis	NN	I-NP	O
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
stress	stress	NN	I-NP	O
response	response	NN	I-NP	O
(	(	(	O	O
SR	SR	NN	B-NP	B-protein
)	)	)	O	O
can	can	MD	B-VP	O
block	block	VB	I-VP	O
inflammatory	inflammatory	JJ	B-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
by	by	IN	B-PP	O
preventing	prevent	VBG	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
nuclear	nuclear	JJ	I-NP	B-protein
factor-kappa	factor-kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
(	(	(	O	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

As	As	IN	B-SBAR	O
inflammatory	inflammatory	JJ	B-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
contributes	contribute	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
demyelinating	demyelinate	VBG	B-VP	O
diseases	disease	NNS	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
tested	test	VBD	B-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
SR	SR	NN	I-NP	B-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
progression	progression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
demyelinating	demyelinate	VBG	I-NP	O
disease	disease	NN	I-NP	O
experimental	experimental	JJ	I-NP	O
autoimmune	autoimmune	JJ	I-NP	O
encephalomyelitis	encephalomyelitis	NN	I-NP	O
(	(	(	O	O
EAE	EAE	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

EAE	EAE	NN	B-NP	B-protein
was	be	VBD	B-VP	O
actively	actively	RB	I-VP	O
induced	induce	VBN	I-VP	O
in	in	IN	B-PP	O
C57BL/6	C57BL/6	NN	B-NP	O
mice	mouse	NNS	I-NP	O
using	use	VBG	B-VP	O
an	an	DT	B-NP	O
encephalitogenic	encephalitogenic	JJ	I-NP	O
myelin	myelin	NN	I-NP	O
oligodendrocyte	oligodendrocyte	NN	I-NP	O
glycoprotein	glycoprotein	NN	I-NP	O
(	(	(	O	O
MOG	MOG	NN	B-NP	O
(	(	(	O	O
35-55	35-55	CD	B-NP	O
)	)	)	O	O
)	)	)	O	O
peptide	peptide	NN	B-NP	O
.	.	.	O	O

Whole	Whole	JJ	B-NP	O
body	body	NN	I-NP	O
hyperthermia	hyperthermia	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
a	a	DT	B-NP	O
heat	heat	NN	I-NP	O
shock	shock	NN	I-NP	O
response	response	NN	I-NP	O
(	(	(	O	O
HSR	HSR	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
immunized	immunize	VBN	B-NP	O
mice	mouse	NNS	I-NP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
booster	booster	NN	I-NP	O
MOG	MOG	NN	I-NP	O
(	(	(	O	O
35-55	35-55	CD	B-NP	O
)	)	)	O	O
peptide	peptide	NN	B-NP	O
injection	injection	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
HSR	HSR	NN	I-NP	B-protein
reduced	reduce	VBD	B-VP	O
the	the	DT	B-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
EAE	EAE	NN	B-NP	B-protein
by	by	IN	B-PP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
delayed	delay	VBD	B-VP	O
disease	disease	NN	B-NP	O
onset	onset	NN	I-NP	O
by	by	IN	B-PP	O
6	6	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
attenuated	attenuate	VBD	B-VP	O
disease	disease	NN	B-NP	O
severity	severity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
HSR	HSR	NN	I-NP	B-protein
attenuated	attenuate	VBD	B-VP	O
leukocyte	leukocyte	NN	B-NP	O
infiltration	infiltration	NN	I-NP	O
into	into	IN	B-PP	O
CNS	CNS	NN	B-NP	B-protein
assessed	assess	VBN	B-VP	O
by	by	IN	B-PP	O
quantitation	quantitation	NN	B-NP	O
of	of	IN	B-PP	O
perivascular	perivascular	JJ	B-NP	B-cell_type
infiltrates	infiltrate	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
by	by	IN	B-PP	O
reduced	reduce	VBN	B-NP	O
staining	staining	NN	I-NP	O
for	for	IN	B-PP	O
CD4	CD4	NN	B-NP	B-protein
and	and	CC	I-NP	O
CD25	CD25	NN	I-NP	B-protein
immunopositive	immunopositive	JJ	I-NP	O
T-cells	T-cell	NNS	I-NP	O
.	.	.	O	O

T-cell	T-cell	NN	B-NP	O
activation	activation	NN	I-NP	O
,	,	,	O	O
assessed	assess	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
interferon	interferon	NN	B-NP	B-protein
gamma	gamma	NN	I-NP	I-protein
(	(	(	O	O
IFNgamma	IFNgamma	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
MOG	MOG	NN	B-NP	O
(	(	(	O	O
35-55	35-55	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
HSR	HSR	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
HSR	HSR	NN	I-NP	B-DNA
reduced	reduce	VBD	B-VP	I-DNA
inflammatory	inflammatory	JJ	B-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
that	that	WDT	B-NP	O
normally	normally	RB	B-ADVP	O
occurs	occur	VBZ	B-VP	O
during	during	IN	B-PP	O
EAE	EAE	NN	B-NP	B-protein
,	,	,	O	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
RANTES	RANTES	NN	B-NP	B-protein
(	(	(	O	O
regulated	regulate	VBN	B-VP	O
on	on	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
T-cell	T-cell	NN	I-NP	O
expressed	express	VBN	B-VP	O
and	and	CC	I-VP	O
secreted	secrete	VBN	I-VP	O
)	)	)	O	O
expression	expression	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
later	later	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inducible	inducible	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
nitric	nitric	JJ	B-NP	B-protein
oxide	oxide	NN	I-NP	I-protein
synthase	synthase	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
early	early	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
blocked	block	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
HSR	HSR	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
finding	finding	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
SR	SR	NN	I-NP	B-protein
reduces	reduce	VBZ	B-VP	O
inflammation	inflammation	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
severity	severity	NN	I-NP	O
of	of	IN	B-PP	O
EAE	EAE	NN	B-NP	B-protein
opens	open	VBZ	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
approach	approach	NN	I-NP	O
for	for	IN	B-PP	O
prevention	prevention	NN	B-NP	O
of	of	IN	B-PP	O
autoimmune	autoimmune	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

In	In	FW	B-NP	O
vivo	vivo	FW	I-NP	O
detection	detection	NN	I-NP	O
of	of	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
in	in	IN	B-PP	O
developing	develop	VBG	B-NP	B-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Information	Information	NN	B-NP	O
regarding	regard	VBG	B-VP	O
the	the	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	O
signaling	signaling	NN	I-NP	O
processes	process	NNS	I-NP	O
that	that	WDT	B-NP	O
occur	occur	VBP	B-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
has	have	VBZ	B-VP	O
largely	largely	RB	I-VP	O
been	be	VBN	I-VP	O
obtained	obtain	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
transgenic	transgenic	JJ	B-NP	O
mouse	mouse	NN	I-NP	O
models	model	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
although	although	IN	B-SBAR	O
providing	provide	VBG	B-VP	O
invaluable	invaluable	JJ	B-NP	O
information	information	NN	I-NP	O
are	be	VBP	B-VP	O
time	time	NN	B-NP	O
consuming	consuming	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
costly	costly	JJ	I-ADJP	O
.	.	.	O	O

To	To	TO	B-PP	O
this	this	DT	B-NP	O
end	end	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
developed	develop	VBN	I-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
system	system	NN	I-NP	O
that	that	WDT	B-NP	O
facilitates	facilitate	VBZ	B-VP	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
signal	signal	NN	B-NP	O
transduction	transduction	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
during	during	IN	B-PP	O
T-lymphocyte	T-lymphocyte	NN	B-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
approach	approach	NN	I-NP	O
uses	use	VBZ	B-VP	O
reporter-plasmids	reporter-plasmid	NNS	B-NP	B-DNA
for	for	IN	B-PP	O
the	the	DT	B-NP	O
detection	detection	NN	I-NP	O
of	of	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
signals	signal	NNS	I-NP	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
mitogen-activated	mitogen-activated	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
or	or	CC	O	O
cyclic	cyclic	JJ	B-NP	B-protein
AMP-dependent	AMP-dependent	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
.	.	.	O	O

Reporter-plasmids	Reporter-plasmid	NNS	B-NP	B-DNA
are	be	VBP	B-VP	O
transfected	transfecte	VBN	I-VP	O
into	into	IN	B-PP	O
thymocytes	thymocyte	NNS	B-NP	B-cell_type
in	in	IN	B-PP	O
fetal	fetal	JJ	B-NP	B-cell_line
thymic	thymic	JJ	I-NP	I-cell_line
organ	organ	NN	I-NP	I-cell_line
culture	culture	NN	I-NP	I-cell_line
by	by	IN	B-PP	O
accelerated	accelerate	VBN	B-NP	O
DNA/particle	DNA/particle	NN	I-NP	O
bombardment	bombardment	NN	I-NP	O
(	(	(	O	O
gene	gene	NN	B-NP	O
gun	gun	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
signaling	signaling	NN	I-NP	O
pathway	pathway	NN	I-NP	O
is	be	VBZ	B-VP	O
determined	determine	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
standard	standard	JJ	I-NP	O
luciferase	luciferase	NN	I-NP	B-protein
assay	assay	NN	I-NP	O
.	.	.	O	O

Importantly	Importantly	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
powerful	powerful	JJ	I-NP	O
technique	technique	NN	I-NP	O
preserves	preserve	VBZ	B-VP	O
the	the	DT	B-NP	O
structural	structural	JJ	I-NP	O
integrity	integrity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
thymus	thymus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
will	will	MD	B-VP	O
provide	provide	VB	I-VP	O
an	an	DT	B-NP	O
invaluable	invaluable	JJ	I-NP	O
tool	tool	NN	I-NP	O
to	to	TO	B-VP	O
study	study	VB	I-VP	O
how	how	WRB	B-ADVP	O
thymocytes	thymocyte	NNS	B-NP	B-cell_type
respond	respond	VBP	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
environmental	environmental	JJ	I-NP	O
stimuli	stimulus	NNS	I-NP	O
encountered	encounter	VBN	B-VP	O
during	during	IN	B-PP	O
differentiation	differentiation	NN	B-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
thymic	thymic	JJ	I-NP	O
milieu	milieu	NN	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
method	method	NN	I-NP	O
allows	allow	VBZ	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
monitoring	monitoring	NN	I-NP	O
of	of	IN	B-PP	O
signals	signal	NNS	B-NP	O
that	that	WDT	B-NP	O
occur	occur	VBP	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
biological	biological	JJ	I-NP	O
time	time	NN	I-NP	O
frame	frame	NN	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
during	during	IN	B-PP	O
differentiation	differentiation	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
natural	natural	JJ	I-NP	O
environment	environment	NN	I-NP	O
of	of	IN	B-PP	O
differentiating	differentiate	VBG	B-VP	B-cell_type
cells	cell	NNS	B-NP	I-cell_type
.	.	.	O	O

Core-binding	Core-binding	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
beta	beta	NN	I-NP	I-protein
(	(	(	O	O
CBFbeta	CBFbeta	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
CBFbeta-smooth	CBFbeta-smooth	JJ	B-NP	B-protein
muscle	muscle	NN	I-NP	I-protein
myosin	myosin	NN	I-NP	I-protein
heavy	heavy	JJ	I-NP	I-protein
chain	chain	NN	I-NP	I-protein
,	,	,	O	O
rescues	rescue	VBZ	B-VP	O
definitive	definitive	JJ	B-NP	O
hematopoiesis	hematopoiesis	NN	I-NP	O
in	in	IN	B-PP	O
CBFbeta	CBFbeta	NN	B-NP	B-cell_line
-deficient	-deficient	JJ	I-NP	I-cell_line
embryonic	embryonic	JJ	I-NP	I-cell_line
stem	stem	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Core-binding	Core-binding	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
beta	beta	NN	I-NP	I-protein
(	(	(	O	O
CBFbeta	CBFbeta	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
non-DNA-binding	non-DNA-binding	JJ	I-NP	B-protein
subunit	subunit	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
heterodimeric	heterodimeric	JJ	I-NP	B-protein
CBFs	CBF	NNS	I-NP	I-protein
.	.	.	O	O

Genes	Gene	NNS	B-NP	O
encoding	encode	VBG	B-VP	O
CBFbeta	CBFbeta	NN	B-NP	B-protein
(	(	(	O	O
CBFB	CBFB	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
DNA-binding	DNA-binding	JJ	I-NP	B-protein
CBFalpha	CBFalpha	NN	I-NP	I-protein
subunits	subunit	NNS	I-NP	I-protein
,	,	,	O	O
Runx1	Runx1	NN	B-NP	B-protein
(	(	(	O	O
also	also	RB	B-VP	O
known	know	VBN	I-VP	O
as	as	IN	B-PP	O
CBFalpha2	CBFalpha2	NN	B-NP	B-protein
,	,	,	O	O
AML1	AML1	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
PEBP2alphaB	PEBP2alphaB	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
are	be	VBP	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
normal	normal	JJ	B-NP	O
hematopoiesis	hematopoiesis	NN	I-NP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
also	also	RB	B-ADVP	O
frequent	frequent	JJ	B-NP	O
targets	target	NNS	I-NP	O
of	of	IN	B-PP	O
chromosomal	chromosomal	JJ	B-NP	O
translocations	translocation	NNS	I-NP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
leukemias	leukemia	NNS	I-NP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
.	.	.	O	O

Homozygous	Homozygous	JJ	B-NP	O
disruption	disruption	NN	I-NP	O
of	of	IN	B-PP	O
either	either	CC	O	O
the	the	DT	B-NP	O
Runx1	Runx1	NN	I-NP	B-protein
or	or	CC	I-NP	O
Cbfb	Cbfb	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
embryonic	embryonic	JJ	B-NP	O
lethality	lethality	NN	I-NP	O
at	at	IN	B-PP	O
midgestation	midgestation	NN	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
hemorrhaging	hemorrhaging	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
central	central	JJ	I-NP	O
nervous	nervous	JJ	I-NP	O
system	system	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
severely	severely	RB	B-VP	O
impairs	impair	VBZ	I-VP	O
fetal	fetal	JJ	B-NP	O
liver	liver	NN	I-NP	O
hematopoiesis	hematopoiesis	NN	I-NP	O
.	.	.	O	O

Results	Result	NNS	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
Cbfb-deficient	Cbfb-deficient	JJ	B-NP	B-cell_type
mouse	mouse	NN	I-NP	I-cell_type
embryonic	embryonic	JJ	I-NP	I-cell_type
stem	stem	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
ES	ES	NN	B-NP	I-cell_type
)	)	)	O	I-cell_type
cells	cell	NNS	B-NP	I-cell_type
can	can	MD	B-VP	O
differentiate	differentiate	VB	I-VP	O
into	into	IN	B-PP	O
primitive	primitive	JJ	B-NP	B-cell_line
erythroid	erythroid	JJ	I-NP	I-cell_line
colonies	colony	NNS	I-NP	I-cell_line
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
but	but	CC	O	O
are	be	VBP	B-VP	O
impaired	impair	VBN	I-VP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
produce	produce	VB	I-VP	O
definitive	definitive	JJ	B-NP	O
erythroid	erythroid	JJ	I-NP	O
and	and	CC	I-NP	O
myeloid	myeloid	JJ	I-NP	B-cell_line
colonies	colony	NNS	I-NP	I-cell_line
,	,	,	O	O
mimicking	mimic	VBG	B-VP	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
defect	defect	NN	I-NP	O
.	.	.	O	O

Definitive	Definitive	JJ	B-NP	O
hematopoiesis	hematopoiesis	NN	I-NP	O
is	be	VBZ	B-VP	O
restored	restore	VBN	I-VP	O
by	by	IN	B-PP	O
ectopic	ectopic	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
full-length	full-length	JJ	B-NP	B-DNA
Cbfb	Cbfb	NN	I-NP	I-DNA
transgenes	transgene	NNS	I-NP	I-DNA
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
transgene	transgene	NN	I-NP	B-DNA
encoding	encode	VBG	B-VP	O
only	only	RB	B-NP	O
the	the	DT	I-NP	O
heterodimerization	heterodimerization	NN	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
CBFbeta	CBFbeta	NN	B-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
CBFbeta	CBFbeta	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
smooth	smooth	JJ	I-NP	I-protein
muscle	muscle	NN	I-NP	I-protein
myosin	myosin	NN	I-NP	I-protein
heavy	heavy	JJ	I-NP	I-protein
chain	chain	NN	I-NP	I-protein
(	(	(	O	I-protein
SMMHC	SMMHC	NN	B-NP	I-protein
)	)	)	O	I-protein
fusion	fusion	NN	B-NP	I-protein
protein	protein	NN	I-NP	I-protein
generated	generate	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
inv	inv	NN	I-NP	O
(	(	(	O	O
16	16	CD	B-NP	O
)	)	)	O	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
myeloid	myeloid	JJ	I-NP	O
leukemias	leukemia	NNS	I-NP	O
(	(	(	O	O
M4Eo	M4Eo	NN	B-NP	O
)	)	)	O	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
rescue	rescue	VB	I-VP	O
definitive	definitive	JJ	B-NP	O
hematopoiesis	hematopoiesis	NN	I-NP	O
by	by	IN	B-PP	O
Cbfb-deficient	Cbfb-deficient	JJ	B-NP	B-cell_type
ES	ES	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Sequences	Sequence	NNS	B-NP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
inability	inability	NN	I-NP	O
of	of	IN	B-PP	O
CBFbeta	CBFbeta	NN	B-NP	B-protein
-SMMHC	-SMMHC	NN	I-NP	O
to	to	TO	B-VP	O
rescue	rescue	VB	I-VP	O
definitive	definitive	JJ	B-NP	O
hematopoiesis	hematopoiesis	NN	I-NP	O
reside	reside	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
SMMHC	SMMHC	NN	I-NP	B-protein
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
fusion	fusion	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

Results	Result	NNS	B-NP	O
also	also	RB	B-ADVP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
CBFbeta-SMMHC	CBFbeta-SMMHC	NN	I-NP	B-protein
fusion	fusion	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
transdominantly	transdominantly	RB	B-ADVP	O
inhibits	inhibit	VBZ	B-VP	O
definitive	definitive	JJ	B-NP	O
hematopoiesis	hematopoiesis	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
extent	extent	NN	I-NP	O
as	as	IN	B-PP	O
homozygous	homozygous	JJ	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
Runx1	Runx1	NN	B-NP	B-protein
or	or	CC	I-NP	O
Cbfb	Cbfb	NN	I-NP	B-protein
.	.	.	O	O

CBFbeta-SMMHC	CBFbeta-SMMHC	NN	B-NP	B-protein
preferentially	preferentially	RB	B-ADVP	O
inhibits	inhibit	VBZ	B-VP	O
the	the	DT	B-NP	O
differentiation	differentiation	NN	I-NP	O
of	of	IN	B-PP	O
myeloid	myeloid	JJ	B-NP	B-cell_type
lineage	lineage	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
while	while	IN	B-SBAR	O
increasing	increase	VBG	B-VP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
blastlike	blastlike	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
culture	culture	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
latency	latency	NN	I-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
Epstein-Barr	Epstein-Barr	JJ	B-NP	O
virus	virus	NN	I-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
viral	viral	JJ	B-NP	O
IL-10	IL-10	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
cutaneous	cutaneous	JJ	B-NP	B-cell_type
natural	natural	JJ	I-NP	I-cell_type
killer/T-cell	killer/T-cell	NN	I-NP	I-cell_type
lymphomas	lymphoma	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
nasal	nasal	JJ	I-NP	O
type	type	NN	I-NP	O
,	,	,	O	O
extranodal	extranodal	JJ	B-NP	O
natural	natural	JJ	I-NP	O
killer	killer	NN	I-NP	O
or	or	CC	O	O
T	T	NN	B-NP	O
(	(	(	O	O
NK/T	NK/T	NN	B-NP	O
)	)	)	O	O
-cell	-cell	JJ	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
is	be	VBZ	B-VP	O
usually	usually	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
latent	latent	JJ	O	O
Epstein-Barr	Epstein-Barr	JJ	B-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
EBV	EBV	NN	B-NP	O
)	)	)	O	O
infection	infection	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
elucidate	elucidate	VB	I-VP	O
the	the	DT	B-NP	O
EBV	EBV	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
patterns	pattern	NNS	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
examined	examine	VBD	B-VP	O
eight	eight	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
cutaneous	cutaneous	JJ	B-NP	O
EBV-related	EBV-related	JJ	I-NP	O
NK/T-cell	NK/T-cell	NN	I-NP	O
lymphomas	lymphoma	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
six	six	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
NK-cell	NK-cell	NN	I-NP	O
phenotype	phenotype	NN	I-NP	O
and	and	CC	O	O
two	two	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
T-cell	T-cell	NN	I-NP	O
phenotype	phenotype	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
implication	implication	NN	I-NP	O
of	of	IN	B-PP	O
EBV	EBV	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
skin	skin	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
EBV-DNA	EBV-DNA	NN	B-NP	B-DNA
,	,	,	O	O
EBV-encoded	EBV-encoded	JJ	B-NP	B-RNA
nuclear	nuclear	JJ	I-NP	I-RNA
RNA	RNA	NN	I-NP	I-RNA
(	(	(	O	O
EBER	EBER	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
clonality	clonality	NN	I-NP	O
of	of	IN	B-PP	O
EBV-DNA	EBV-DNA	NN	B-NP	B-DNA
fragments	fragment	NNS	I-NP	I-DNA
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
terminal	terminal	JJ	I-NP	B-DNA
repeats	repeat	NNS	I-NP	I-DNA
.	.	.	O	O

Transcripts	Transcript	NNS	B-NP	O
of	of	IN	B-PP	O
EBV-encoded	EBV-encoded	JJ	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
screened	screen	VBN	I-VP	O
by	by	IN	B-PP	O
reverse	reverse	JJ	B-NP	O
transcription-	transcription-	NN	I-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
(	(	(	O	O
RT-PCR	RT-PCR	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
confirmed	confirm	VBN	B-VP	O
by	by	IN	B-PP	O
Southern	Southern	JJ	B-NP	O
blot	blot	NN	I-NP	O
hybridization	hybridization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
EBV-related	EBV-related	JJ	B-NP	B-protein
antigens	antigen	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
by	by	IN	B-PP	O
immunostaining	immunostaining	NN	B-NP	O
using	use	VBG	B-VP	O
paraffin-embedded	paraffin-embedded	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
sections	section	NNS	I-NP	O
and	and	CC	O	O
cell	cell	NN	B-NP	O
pellets	pellet	NNS	I-NP	O
of	of	IN	B-PP	O
EBV-positive	EBV-positive	JJ	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
.	.	.	O	O

Our	Our	PRP$	B-NP	O
study	study	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
all	all	DT	B-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
contained	contain	VBD	B-VP	O
EBV	EBV	NN	B-NP	B-RNA
nuclear	nuclear	JJ	I-NP	I-RNA
antigen	antigen	NN	I-NP	I-RNA
(	(	(	O	I-RNA
EBNA	EBNA	NN	B-NP	I-RNA
)	)	)	O	I-RNA
-1	-1	CD	B-NP	I-RNA
mRNA	mRNA	NN	I-NP	I-RNA
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
transcribed	transcribe	VBN	I-VP	O
using	use	VBG	I-VP	O
the	the	DT	B-NP	O
Q	Q	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
,	,	,	O	O
whereas	whereas	IN	O	O
both	both	CC	O	O
the	the	DT	B-NP	O
Q	Q	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
and	and	CC	O	O
another	another	DT	B-NP	O
upstream	upstream	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
(	(	(	O	O
Cp/Wp	Cp/Wp	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
EBV-positive	EBV-positive	JJ	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
B95.8	B95.8	NN	B-NP	B-cell_line
,	,	,	O	O
Raji	Raji	NN	B-NP	B-cell_line
and	and	CC	I-NP	O
Jiyoye	Jiyoye	NN	I-NP	O
.	.	.	O	O

Latent	Latent	JJ	B-NP	B-protein
membrane	membrane	NN	I-NP	I-protein
protein-1	protein-1	NN	I-NP	I-protein
(	(	(	O	O
LMP-1	LMP-1	NN	B-NP	B-protein
)	)	)	O	O
mRNA	mRNA	NN	B-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
seven	seven	CD	B-NP	O
of	of	IN	B-PP	O
eight	eight	CD	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
all	all	DT	B-NP	O
cell	cell	NN	I-NP	B-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
whereas	whereas	IN	O	O
EBNA-2	EBNA-2	NN	B-NP	B-RNA
transcripts	transcript	NNS	I-NP	I-RNA
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
only	only	RB	B-PP	O
in	in	IN	I-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	B-cell_line
lines	line	NNS	I-NP	I-cell_line
.	.	.	O	O

Immunostaining	Immunostaining	NN	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
LMP-1	LMP-1	NN	I-NP	B-protein
,	,	,	O	O
EBNA-2	EBNA-2	NN	B-NP	B-protein
or	or	CC	O	O
ZEBRA	ZEBRA	NN	B-NP	B-protein
antigens	antigen	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
paraffin-embedded	paraffin-embedded	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
sections	section	NNS	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

Latent	Latent	JJ	B-NP	B-RNA
BHRF1	BHRF1	NN	I-NP	I-RNA
transcripts	transcript	NNS	I-NP	I-RNA
encoding	encode	VBG	B-VP	O
bcl-2	bcl-2	NN	B-NP	B-RNA
homologue	homologue	NN	I-NP	I-RNA
and	and	CC	O	I-RNA
BCRF1	BCRF1	NN	B-NP	I-RNA
transcripts	transcript	NNS	I-NP	I-RNA
encoding	encode	VBG	B-VP	O
viral	viral	JJ	B-NP	B-protein
interleukin	interleukin	NN	I-NP	I-protein
(	(	(	O	I-protein
vIL	vIL	NN	B-NP	I-protein
)	)	)	O	I-protein
-10	-10	CD	B-NP	I-protein
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
and	and	CC	I-NP	O
two	two	CD	I-NP	O
of	of	IN	B-PP	O
eight	eight	CD	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

A	A	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
NK-cell	NK-cell	NN	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
expressing	express	VBG	B-VP	O
both	both	DT	B-NP	O
transcripts	transcript	NNS	I-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
progression	progression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
illness	illness	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
restricted	restricted	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
latency-associated	latency-associated	JJ	I-NP	O
EBV	EBV	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
and	and	CC	O	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
vIL-10	vIL-10	NN	B-NP	B-protein
and	and	CC	I-NP	O
bcl-2	bcl-2	NN	I-NP	B-protein
homologue	homologue	NN	I-NP	I-protein
may	may	MD	B-VP	O
favour	favour	VB	I-VP	O
tumour	tumour	NN	B-NP	O
growth	growth	NN	I-NP	O
,	,	,	O	O
evading	evade	VBG	B-VP	O
the	the	DT	B-NP	O
host	host	NN	I-NP	O
immune	immune	JJ	I-NP	O
surveillance	surveillance	NN	I-NP	O
.	.	.	O	O

Copyright	Copyright	NN	B-NP	O
2001	2001	CD	I-NP	O
Cancer	Cancer	NNP	I-NP	O
Research	Research	NNP	I-NP	O
Campaign	Campaign	NNP	I-NP	O
.	.	.	O	O

Oxidized	Oxidize	VBN	B-NP	O
alkyl	alkyl	NN	I-NP	O
phospholipids	phospholipid	NNS	I-NP	O
are	be	VBP	B-VP	O
specific	specific	JJ	B-NP	O
,	,	,	I-NP	O
high	high	JJ	I-NP	B-protein
affinity	affinity	NN	I-NP	I-protein
peroxisome	peroxisome	NN	I-NP	I-protein
proliferator-activated	proliferator-activated	JJ	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
gamma	gamma	NN	I-NP	I-protein
ligands	ligand	NNS	I-NP	I-protein
and	and	CC	I-NP	O
agonists	agonist	NNS	I-NP	O
.	.	.	O	O

Synthetic	Synthetic	JJ	B-NP	B-protein
high	high	JJ	I-NP	I-protein
affinity	affinity	NN	I-NP	I-protein
peroxisome	peroxisome	NN	I-NP	I-protein
proliferator-activated	proliferator-activated	JJ	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
PPAR	PPAR	NN	B-NP	B-protein
)	)	)	O	O
agonists	agonist	NNS	B-NP	O
are	be	VBP	B-VP	O
known	know	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
biologic	biologic	JJ	B-NP	O
ligands	ligand	NNS	I-NP	O
are	be	VBP	B-VP	O
of	of	IN	B-PP	O
low	low	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
.	.	.	O	O

Oxidized	Oxidize	VBN	B-NP	O
low	low	JJ	I-NP	O
density	density	NN	I-NP	O
lipoprotein	lipoprotein	NN	I-NP	O
(	(	(	O	O
oxLDL	oxLDL	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
inflammatory	inflammatory	JJ	B-ADJP	O
and	and	CC	O	O
signals	signal	NNS	B-NP	O
through	through	IN	B-PP	O
PPARs	PPAR	NNS	B-NP	B-protein
.	.	.	O	O

We	We	PRP	B-NP	O
showed	show	VBD	B-VP	O
,	,	,	O	O
by	by	IN	B-PP	O
phospholipase	phospholipase	NN	B-NP	B-protein
A	A	NN	I-NP	I-protein
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
digestion	digestion	NN	B-NP	O
,	,	,	O	O
that	that	IN	B-SBAR	O
PPARgamma	PPARgamma	NN	B-NP	B-protein
agonists	agonist	NNS	I-NP	O
in	in	IN	B-PP	O
oxLDL	oxLDL	NN	B-NP	B-protein
arise	arise	VBP	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
small	small	JJ	I-NP	O
pool	pool	NN	I-NP	O
of	of	IN	B-PP	O
alkyl	alkyl	NN	B-NP	O
phosphatidylcholines	phosphatidylcholine	NNS	I-NP	O
in	in	IN	B-PP	O
LDL	LDL	NN	B-NP	B-protein
.	.	.	O	O

We	We	PRP	B-NP	O
identified	identify	VBD	B-VP	O
an	an	DT	B-NP	O
abundant	abundant	JJ	I-NP	O
oxidatively	oxidatively	RB	I-NP	O
fragmented	fragmented	JJ	I-NP	O
alkyl	alkyl	NN	I-NP	O
phospholipid	phospholipid	NN	I-NP	O
in	in	IN	B-PP	O
oxLDL	oxLDL	NN	B-NP	B-protein
,	,	,	O	O
hexadecyl	hexadecyl	NN	B-NP	O
azelaoyl	azelaoyl	NN	I-NP	O
phosphatidylcholine	phosphatidylcholine	NN	I-NP	O
(	(	(	O	O
azPC	azPC	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
affinity	affinity	NN	I-NP	O
ligand	ligand	NN	I-NP	O
and	and	CC	I-NP	O
agonist	agonist	NN	I-NP	O
for	for	IN	B-PP	O
PPARgamma	PPARgamma	NN	B-NP	B-protein
.	.	.	O	O

[	[	(	O	O
(	(	(	O	O
3	3	CD	O	O
)	)	)	O	O
H	H	NN	B-NP	O
]	]	)	O	O
azPC	azPC	NN	B-NP	O
bound	bind	VBD	B-VP	O
recombinant	recombinant	JJ	B-NP	B-protein
PPARgamma	PPARgamma	NN	I-NP	I-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
affinity	affinity	NN	I-NP	O
(	(	(	O	O
K	K	NN	B-NP	O
(	(	(	O	O
d	d	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
(	(	(	O	O
app	app	NN	B-NP	O
)	)	)	O	O
)	)	)	O	O
approximately	approximately	RB	B-NP	O
40	40	CD	I-NP	O
nm	nm	NN	I-NP	O
)	)	)	O	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
equivalent	equivalent	JJ	B-ADJP	O
to	to	TO	B-PP	O
rosiglitazone	rosiglitazone	NN	B-NP	O
(	(	(	O	O
BRL49653	BRL49653	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
competition	competition	NN	B-NP	O
with	with	IN	B-PP	O
rosiglitazone	rosiglitazone	NN	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
binding	binding	NN	B-NP	O
occurred	occur	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ligand-binding	ligand-binding	JJ	I-NP	O
pocket	pocket	NN	I-NP	O
.	.	.	O	O

azPC	azPC	NN	B-NP	O
induced	induce	VBD	B-VP	O
PPRE	PPRE	NN	B-NP	B-DNA
reporter	reporter	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
did	do	VBD	O	O
rosiglitazone	rosiglitazone	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
half-maximal	half-maximal	JJ	I-NP	O
effect	effect	NN	I-NP	O
at	at	IN	B-PP	O
100	100	CD	B-NP	O
nm	nm	NN	I-NP	O
.	.	.	O	O

Overexpression	Overexpression	NN	B-NP	O
of	of	IN	B-PP	O
PPARalpha	PPARalpha	NN	B-NP	B-protein
or	or	CC	I-NP	O
PPARgamma	PPARgamma	NN	I-NP	B-protein
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
azPC	azPC	NN	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
PPARgamma	PPARgamma	NN	I-NP	B-protein
agonist	agonist	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
scavenger	scavenger	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
CD36	CD36	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
encoded	encode	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
PPRE-responsive	PPRE-responsive	JJ	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
azPC	azPC	NN	B-NP	O
enhanced	enhance	VBD	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
CD36	CD36	NN	B-NP	B-protein
in	in	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
anti-CD36	anti-CD36	NN	B-NP	B-protein
inhibited	inhibit	VBD	B-VP	O
azPC	azPC	NN	B-NP	O
uptake	uptake	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
inhibited	inhibit	VBD	B-VP	O
PPRE	PPRE	NN	B-NP	O
reporter	reporter	NN	I-NP	O
induction	induction	NN	I-NP	O
.	.	.	O	O

Results	Result	NNS	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
molecule	molecule	NN	I-NP	O
phospholipid	phospholipid	NN	I-NP	O
flippase	flippase	NN	I-NP	O
mimetic	mimetic	NN	I-NP	O
suggest	suggest	VBP	B-VP	O
azPC	azPC	NN	B-NP	O
acts	act	VBZ	B-VP	O
intracellularly	intracellularly	RB	B-ADVP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
cellular	cellular	JJ	B-NP	O
azPC	azPC	NN	I-NP	O
accumulation	accumulation	NN	I-NP	O
was	be	VBD	B-VP	O
efficient	efficient	JJ	B-ADJP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
certain	certain	JJ	B-NP	O
alkyl	alkyl	NN	I-NP	O
phospholipid	phospholipid	NN	I-NP	O
oxidation	oxidation	NN	I-NP	O
products	product	NNS	I-NP	O
in	in	IN	B-PP	O
oxLDL	oxLDL	NN	B-NP	B-protein
are	be	VBP	B-VP	O
specific	specific	JJ	B-NP	O
,	,	,	I-NP	O
high	high	JJ	I-NP	O
affinity	affinity	NN	I-NP	O
extracellular	extracellular	JJ	I-NP	O
ligands	ligand	NNS	I-NP	O
and	and	CC	I-NP	O
agonists	agonist	NNS	I-NP	O
for	for	IN	B-PP	O
PPARgamma	PPARgamma	NN	B-NP	B-protein
that	that	WDT	B-NP	O
induce	induce	VBP	B-VP	O
PPAR-responsive	PPAR-responsive	JJ	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA

Regulation	Regulation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
MAT2B	MAT2B	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	B-protein
beta	beta	NN	I-NP	I-protein
subunit	subunit	NN	I-NP	I-protein
of	of	IN	B-PP	O
methionine	methionine	NN	B-NP	B-protein
adenosyltransferase	adenosyltransferase	NN	I-NP	I-protein
,	,	,	O	O
MAT	MAT	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
.	.	.	O	O

Methionine	Methionine	NN	B-NP	B-protein
adenosyltransferase	adenosyltransferase	NN	I-NP	I-protein
(	(	(	O	O
MAT	MAT	NN	B-NP	O
)	)	)	O	O
catalyzes	catalyze	VBZ	B-VP	O
the	the	DT	B-NP	O
biosynthesis	biosynthesis	NN	I-NP	O
of	of	IN	B-PP	O
S-adenosylmethionine	S-adenosylmethionine	NN	B-NP	O
(	(	(	O	O
AdoMet	AdoMet	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
key	key	JJ	I-NP	O
molecule	molecule	NN	I-NP	O
in	in	IN	B-PP	O
transmethylation	transmethylation	NN	B-NP	O
reactions	reaction	NNS	I-NP	O
and	and	CC	O	O
polyamine	polyamine	NN	B-NP	O
biosynthesis	biosynthesis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
MAT	MAT	NN	I-NP	B-protein
II	II	CD	I-NP	I-protein
isozyme	isozyme	NN	I-NP	I-protein
consists	consist	VBZ	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
catalytic	catalytic	JJ	I-NP	B-protein
alpha2	alpha2	NN	I-NP	I-protein
and	and	CC	O	O
a	a	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	B-protein
beta	beta	NN	I-NP	I-protein
subunit	subunit	NN	I-NP	I-protein
.	.	.	O	O

Down-regulation	Down-regulation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MAT	MAT	NN	I-NP	B-protein
II	II	CD	I-NP	I-protein
beta	beta	SYM	I-NP	I-protein
subunit	subunit	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
causes	cause	VBZ	B-VP	O
a	a	DT	B-NP	O
6-10-fold	6-10-fold	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
AdoMet	AdoMet	NN	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
understand	understand	VB	I-VP	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
beta	beta	NN	I-NP	B-protein
subunit	subunit	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
,	,	,	O	O
we	we	PRP	B-NP	O
cloned	clone	VBD	B-VP	O
the	the	DT	B-NP	O
MAT2B	MAT2B	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
,	,	,	O	O
determined	determine	VBD	B-VP	O
its	its	PRP$	B-NP	O
organization	organization	NN	I-NP	O
,	,	,	O	O
characterized	characterize	VBD	B-VP	O
its	its	PRP$	B-NP	O
5'-flanking	5'-flanking	JJ	I-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
elucidated	elucidate	VBD	B-VP	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
and	and	CC	O	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
promoter	promoter	NN	I-NP	B-DNA
.	.	.	O	O

Transcription	Transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MAT2B	MAT2B	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
initiates	initiate	VBZ	B-VP	O
at	at	IN	B-PP	O
position	position	NN	B-NP	B-DNA
-203	-203	CD	I-NP	I-DNA
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
translation	translation	NN	I-NP	B-DNA
start	start	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

Promoter	Promoter	NN	B-NP	O
deletion	deletion	NN	I-NP	O
analysis	analysis	NN	I-NP	O
defined	define	VBD	B-VP	O
a	a	DT	B-NP	O
minimal	minimal	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
between	between	IN	B-PP	O
positions	position	NNS	B-NP	O
+52	+52	CD	B-NP	O
and	and	CC	I-NP	O
+93	+93	CD	I-NP	O
base	base	NN	I-NP	O
pairs	pair	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
GC-rich	GC-rich	JJ	I-NP	B-protein
region	region	NN	I-NP	I-protein
.	.	.	O	O

Inclusion	Inclusion	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
between	between	IN	B-PP	O
-4	-4	CD	B-NP	O
and	and	CC	I-NP	O
+52	+52	CD	I-NP	O
enhanced	enhance	VBD	B-VP	O
promoter	promoter	NN	B-NP	O
activity	activity	NN	I-NP	O
;	;	:	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
primarily	primarily	RB	B-ADVP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
an	an	DT	B-NP	O
Sp1	Sp1	NN	I-NP	B-DNA
recognition	recognition	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
at	at	IN	B-PP	O
+9/+15	+9/+15	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
inclusion	inclusion	NN	I-NP	O
of	of	IN	B-PP	O
sequences	sequence	NNS	B-NP	O
up	up	RB	B-PP	O
to	to	TO	B-PP	O
position	position	NN	B-NP	O
-115	-115	CD	I-NP	O
provided	provide	VBD	B-VP	O
full	full	JJ	B-NP	O
activity	activity	NN	I-NP	O
;	;	:	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
TATA	TATA	NN	I-NP	B-DNA
at	at	IN	B-PP	O
-32	-32	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Sp1	Sp1	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
at	at	IN	B-PP	O
position	position	NN	B-NP	B-DNA
+9	+9	CD	I-NP	I-DNA
was	be	VBD	B-VP	O
key	key	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
protein.DNA	protein.DNA	NN	B-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
.	.	.	O	O

Mutation	Mutation	NN	B-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
Sp1	Sp1	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
at	at	IN	B-PP	O
+9	+9	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
TATA	TATA	NN	I-NP	B-DNA
at	at	IN	B-PP	O
-32	-32	CD	B-NP	B-DNA
reduced	reduce	VBD	B-VP	I-DNA
promoter	promoter	NN	B-NP	I-DNA
activity	activity	NN	I-NP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
minimal	minimal	JJ	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

Supershift	Supershift	NN	B-NP	O
assays	assay	NNS	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
anti-Sp1	anti-Sp1	JJ	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
on	on	IN	B-PP	O
complex	complex	NN	B-NP	O
formation	formation	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
anti-Sp3	anti-Sp3	JJ	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
strong	strong	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
protein.DNA	protein.DNA	NN	B-NP	O
complex	complex	NN	I-NP	O
formation	formation	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
Sp3	Sp3	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
main	main	JJ	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
Sp1	Sp1	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

Chromatin	Chromatin	NN	B-NP	B-DNA
immunoprecipitation	immunoprecipitation	NN	I-NP	O
assays	assay	NNS	I-NP	O
supported	support	VBD	B-VP	O
the	the	DT	B-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
Sp1	Sp1	NN	B-NP	B-protein
and	and	CC	O	O
Sp3	Sp3	NN	B-NP	B-protein
in	in	IN	B-PP	O
complexes	complex	NNS	B-NP	O
formed	form	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
MAT2B	MAT2B	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
data	datum	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
5'-untranslated	5'-untranslated	JJ	I-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
play	play	VBP	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
the	the	DT	B-NP	O
MAT2B	MAT2B	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
and	and	CC	O	O
identifies	identify	VBZ	B-VP	O
the	the	DT	B-NP	O
Sp1	Sp1	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
at	at	IN	B-PP	O
+9	+9	CD	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
target	target	NN	I-NP	O
for	for	IN	B-PP	O
modulating	modulate	VBG	B-VP	O
MAT2B	MAT2B	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
process	process	NN	I-NP	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
AdoMet	AdoMet	NN	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

Molecular	Molecular	JJ	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
influenza	influenza	NN	B-NP	O
A	A	NN	I-NP	O
virus	virus	NN	I-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
virus-induced	virus-induced	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
vaccines	vaccine	NNS	B-NP	O
and	and	CC	O	O
antiviral	antiviral	JJ	B-NP	O
substances	substance	NNS	I-NP	O
influenza	influenza	NN	I-NP	O
still	still	RB	B-ADVP	O
causes	cause	VBZ	B-VP	O
significant	significant	JJ	B-NP	O
morbidity	morbidity	NN	I-NP	O
and	and	CC	I-NP	O
mortality	mortality	NN	I-NP	O
world	world	NN	I-NP	O
wide	wide	RB	B-ADVP	O
.	.	.	O	O

Better	Good	JJR	B-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
of	of	IN	B-PP	O
influenza	influenza	NN	B-NP	O
virus	virus	NN	I-NP	O
replication	replication	NN	I-NP	O
,	,	,	O	O
pathogenesis	pathogenesis	NN	B-NP	O
and	and	CC	O	O
host	host	NN	B-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
more	more	JJR	B-NP	O
efficient	efficient	JJ	I-NP	O
means	mean	NNS	I-NP	O
of	of	IN	B-PP	O
prevention	prevention	NN	B-NP	O
and	and	CC	I-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
influenza	influenza	NN	B-NP	O
.	.	.	O	O

Influenza	Influenza	NN	B-NP	O
A	A	NN	I-NP	O
virus	virus	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
replicates	replicate	VBZ	B-VP	O
in	in	IN	B-PP	O
epithelial	epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
leukocytes	leukocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
regulates	regulate	VBZ	B-VP	O
host	host	NN	B-NP	O
cell	cell	NN	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
and	and	CC	I-NP	O
translational	translational	JJ	I-NP	O
systems	system	NNS	I-NP	O
and	and	CC	O	O
activates	activate	VBZ	B-VP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
downregulates	downregulate	VBZ	B-VP	O
apoptotic	apoptotic	JJ	B-NP	O
pathways	pathway	NNS	I-NP	O
.	.	.	O	O

Influenza	Influenza	NN	B-NP	O
A	A	NN	I-NP	O
virus	virus	NN	I-NP	O
infection	infection	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
chemotactic	chemotactic	JJ	B-NP	O
(	(	(	O	O
RANTES	RANTES	NN	B-NP	B-protein
,	,	,	O	O
MIP-1	MIP-1	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
,	,	,	O	O
MCP-1	MCP-1	NN	B-NP	B-protein
,	,	,	O	O
MCP-3	MCP-3	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
IP-10	IP-10	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
pro-inflammatory	pro-inflammatory	JJ	B-ADJP	O
(	(	(	O	O
IL-1	IL-1	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
,	,	,	O	O
IL-6	IL-6	NN	B-NP	B-protein
,	,	,	O	O
IL-18	IL-18	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
antiviral	antiviral	JJ	B-ADJP	B-protein
(	(	(	O	I-protein
IFN-alpha/beta	IFN-alpha/beta	NN	B-NP	I-protein
)	)	)	O	I-protein
cytokines	cytokine	NNS	B-NP	I-protein
.	.	.	O	O

Cytokine	Cytokine	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
,	,	,	O	O
AP-1	AP-1	NN	B-NP	B-protein
,	,	,	O	O
STAT	STAT	NN	B-NP	B-protein
and	and	CC	O	O
IRF	IRF	NN	B-NP	B-protein
signal	signal	NN	I-NP	I-protein
transducing	transducing	NN	I-NP	I-protein
molecules	molecule	NNS	I-NP	I-protein
in	in	IN	B-PP	O
influenza	influenza	NN	B-NP	B-cell_type
A	A	NN	I-NP	I-cell_type
virus-infected	virus-infected	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
upregulating	upregulate	VBG	B-VP	O
cytokine	cytokine	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
,	,	,	O	O
influenza	influenza	NN	B-NP	O
A	A	NN	I-NP	O
virus	virus	NN	I-NP	O
infection	infection	NN	I-NP	O
activates	activate	VBZ	B-VP	O
caspase-1	caspase-1	NN	B-NP	B-protein
enzyme	enzyme	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
proteolytic	proteolytic	JJ	I-NP	O
processing	processing	NN	I-NP	O
of	of	IN	B-PP	O
proIL-1	proIL-1	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
and	and	CC	I-NP	O
proIL-18	proIL-18	NN	I-NP	B-protein
into	into	IN	B-PP	O
their	their	PRP$	B-NP	O
biologically	biologically	RB	I-NP	O
active	active	JJ	I-NP	O
forms	form	NNS	I-NP	O
.	.	.	O	O

Influenza	Influenza	NN	B-NP	O
A	A	DT	B-NP	O
virus-induced	virus-induced	JJ	I-NP	O
IFN-alpha/beta	IFN-alpha/beta	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
in	in	IN	B-PP	O
host	host	NN	B-NP	O
's	's	POS	B-NP	O
antiviral	antiviral	JJ	I-NP	O
defence	defence	NN	I-NP	O
by	by	IN	B-PP	O
activating	activate	VBG	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
antiviral	antiviral	JJ	B-NP	B-protein
Mx	Mx	NN	I-NP	I-protein
,	,	,	O	O
PKR	PKR	NN	B-NP	B-protein
and	and	CC	O	O
oligoadenylate	oligoadenylate	NN	B-NP	O
synthetase	synthetase	NN	I-NP	O
genes	gene	NNS	I-NP	O
.	.	.	O	O

IFN-alpha/beta	IFN-alpha/beta	NN	B-NP	B-protein
also	also	RB	B-ADVP	O
prolongs	prolong	VBZ	B-VP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
survival	survival	NN	I-NP	O
,	,	,	O	O
upregulates	upregulate	VBZ	B-VP	O
IL-12	IL-12	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-18	IL-18	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
and	and	CC	O	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
IL-18	IL-18	NN	B-NP	B-protein
stimulates	stimulate	VBZ	B-VP	O
NK	NK	NN	B-NP	O
and	and	CC	I-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
IFN-gamma	IFN-gamma	NN	I-NP	B-protein
production	production	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
Th1-type	Th1-type	JJ	B-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Comparison	Comparison	NN	B-NP	O
of	of	IN	B-PP	O
hprt	hprt	NN	B-NP	O
and	and	CC	I-NP	O
lacI	lacI	NN	I-NP	O
mutant	mutant	JJ	I-NP	O
frequency	frequency	NN	I-NP	O
with	with	IN	B-PP	O
DNA	DNA	NN	B-NP	O
adduct	adduct	NN	I-NP	O
formation	formation	NN	I-NP	O
in	in	IN	B-PP	O
N-hydroxy-2-acetylaminofluorene-treated	N-hydroxy-2-acetylaminofluorene-treated	JJ	B-NP	O
Big	Big	JJ	I-NP	O
Blue	Blue	NN	I-NP	O
rats	rat	NNS	I-NP	O
.	.	.	O	O

N-Hydroxy-2-acetylaminofluorene	N-Hydroxy-2-acetylaminofluorene	NN	B-NP	O
(	(	(	O	O
N-OH-AAF	N-OH-AAF	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
proximate	proximate	JJ	I-NP	O
carcinogenic	carcinogenic	JJ	I-NP	O
metabolite	metabolite	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
powerful	powerful	JJ	I-NP	O
rat	rat	NN	I-NP	O
liver	liver	NN	I-NP	O
carcinogen	carcinogen	NN	I-NP	O
2-acetylaminofluorene	2-acetylaminofluorene	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
transgenic	transgenic	JJ	B-NP	O
Big	Big	JJ	I-NP	O
Blue	Blue	NN	I-NP	O
(	(	(	O	O
R	R	NN	B-NP	O
)	)	)	O	O
rats	rat	NNS	B-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
mutagenicity	mutagenicity	NN	I-NP	O
and	and	CC	I-NP	O
DNA	DNA	NN	I-NP	O
adduct	adduct	NN	I-NP	O
formation	formation	NN	I-NP	O
by	by	IN	B-PP	O
N-OH-AAF	N-OH-AAF	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
target	target	NN	I-NP	O
liver	liver	NN	I-NP	O
compared	compare	VBN	B-VP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
nontarget	nontarget	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
.	.	.	O	O

Male	Male	JJ	B-NP	O
rats	rat	NNS	I-NP	O
were	be	VBD	B-VP	O
given	give	VBN	I-VP	O
one	one	CD	B-NP	O
,	,	,	I-NP	O
two	two	CD	I-NP	O
,	,	,	O	O
or	or	CC	O	O
four	four	CD	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
N-OH-AAF/kg	N-OH-AAF/kg	NN	I-NP	O
body	body	NN	I-NP	O
weight	weight	NN	I-NP	O
by	by	IN	B-PP	O
i.p.	i.p.	JJ	B-NP	O
injection	injection	NN	I-NP	O
at	at	IN	B-PP	O
4-day	4-day	JJ	B-NP	O
intervals	interval	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
groups	group	NNS	B-NP	O
of	of	IN	B-PP	O
treated	treat	VBN	B-NP	O
and	and	CC	I-NP	O
control	control	NN	I-NP	O
rats	rat	NNS	I-NP	O
were	be	VBD	B-VP	O
euthanized	euthanize	VBN	I-VP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
10	10	CD	I-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
beginning	begin	VBG	B-VP	O
the	the	DT	B-NP	O
dosing	dosing	NN	I-NP	O
.	.	.	O	O

Mutant	Mutant	JJ	B-NP	O
frequencies	frequency	NNS	I-NP	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
spleen	spleen	NN	I-NP	B-DNA
lymphocyte	lymphocyte	NN	I-NP	I-DNA
hprt	hprt	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
lacI	lacI	NN	B-NP	O
mutant	mutant	JJ	I-NP	O
frequencies	frequency	NNS	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
and	and	CC	I-NP	O
spleen	spleen	NN	I-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

At	At	IN	B-PP	O
6	6	CD	B-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
beginning	begin	VBG	B-VP	O
the	the	DT	B-NP	O
dosing	dosing	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
hprt	hprt	NN	I-NP	O
mutant	mutant	JJ	I-NP	O
frequency	frequency	NN	I-NP	O
in	in	IN	B-PP	O
spleen	spleen	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
the	the	DT	B-NP	O
four-dose	four-dose	JJ	I-NP	O
group	group	NN	I-NP	O
was	be	VBD	B-VP	O
16.5	16.5	CD	B-NP	O
x	x	SYM	O	O
10	10	CD	B-NP	O
(	(	(	O	O
-6	-6	CD	B-NP	O
)	)	)	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
3.2	3.2	CD	B-NP	O
x	x	SYM	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
-6	-6	CD	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
control	control	NN	B-NP	O
animals	animal	NNS	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
at	at	IN	B-PP	O
6	6	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
rats	rat	NNS	B-NP	O
given	give	VBN	B-PP	O
one	one	CD	B-NP	O
,	,	,	I-NP	O
two	two	CD	I-NP	O
,	,	,	O	O
or	or	CC	O	O
four	four	CD	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
N-OH-AAF	N-OH-AAF	NN	B-NP	O
had	have	VBD	B-VP	O
lacI	lacI	NN	B-NP	O
mutant	mutant	JJ	I-NP	O
frequencies	frequency	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
of	of	IN	B-PP	O
97.6	97.6	CD	B-NP	O
,	,	,	I-NP	O
155.6	155.6	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
406.8	406.8	CD	B-NP	O
x	x	CC	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
-6	-6	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
control	control	NN	I-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
25.7	25.7	CD	B-NP	O
x	x	SYM	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
-6	-6	CD	B-NP	O
)	)	)	O	O
;	;	:	O	O
rats	rat	NNS	B-NP	O
given	give	VBN	B-VP	O
four	four	CD	B-NP	O
doses	dose	NNS	I-NP	O
had	have	VBD	B-VP	O
lacI	lacI	NN	B-NP	O
mutant	mutant	JJ	I-NP	O
frequencies	frequency	NNS	I-NP	O
in	in	IN	B-PP	O
spleen	spleen	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
55.8	55.8	CD	B-NP	O
x	x	SYM	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
-6	-6	CD	B-NP	O
)	)	)	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
control	control	NN	I-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
20.4	20.4	CD	B-NP	O
x	x	SYM	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
-6	-6	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Additional	Additional	JJ	B-NP	O
rats	rat	NNS	I-NP	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
for	for	IN	B-PP	O
DNA	DNA	NN	B-NP	O
adduct	adduct	NN	I-NP	O
formation	formation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
,	,	,	O	O
spleen	spleen	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
bone	bone	NN	B-NP	O
marrow	marrow	NN	I-NP	O
by	by	IN	B-PP	O
(	(	(	O	O
32	32	CD	B-NP	O
)	)	)	O	O
P-postlabeling	P-postlabeling	NN	B-NP	O
.	.	.	O	O

Adduct	Adduct	NN	B-NP	O
analysis	analysis	NN	I-NP	O
was	be	VBD	B-VP	O
conducted	conduct	VBN	I-VP	O
1	1	CD	B-NP	O
day	day	NN	I-NP	O
after	after	IN	B-PP	O
one	one	CD	B-NP	O
,	,	,	I-NP	O
two	two	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
four	four	CD	B-NP	O
treatments	treatment	NNS	I-NP	O
with	with	IN	B-PP	O
N-OH-AAF	N-OH-AAF	NN	B-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
one	one	CD	B-NP	O
treatment	treatment	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
9	9	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
two	two	CD	B-NP	O
treatments	treatment	NNS	I-NP	O
.	.	.	O	O

N-	N-	NN	B-NP	O
(	(	(	O	O
Deoxyguanosin-8-yl	Deoxyguanosin-8-yl	NN	B-NP	O
)	)	)	O	O
-2-aminofluorene	-2-aminofluorene	NN	B-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
adduct	adduct	NN	I-NP	O
identified	identify	VBN	B-VP	O
in	in	IN	B-PP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
tissues	tissue	NNS	I-NP	O
examined	examine	VBN	B-VP	O
.	.	.	O	O

Adduct	Adduct	NN	B-NP	O
concentrations	concentration	NNS	I-NP	O
increased	increase	VBD	B-VP	O
with	with	IN	B-PP	O
total	total	JJ	B-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-PP	O
maximum	maximum	JJ	B-NP	O
values	value	NNS	I-NP	O
in	in	IN	B-PP	O
samples	sample	NNS	B-NP	O
taken	take	VBN	B-VP	O
1	1	CD	B-NP	O
day	day	NN	I-NP	O
after	after	IN	B-PP	O
two	two	CD	B-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
essentially	essentially	RB	B-NP	O
the	the	DT	I-NP	O
same	same	JJ	I-NP	O
after	after	IN	B-PP	O
four	four	CD	B-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
samples	sample	NNS	B-NP	O
taken	take	VBN	B-VP	O
after	after	IN	B-PP	O
four	four	CD	B-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
adduct	adduct	NN	B-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
103	103	CD	B-NP	O
,	,	,	I-NP	O
28	28	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
7	7	CD	B-NP	O
fmol/microg	fmol/microg	NN	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
in	in	IN	B-PP	O
liver	liver	NN	B-NP	O
,	,	,	O	O
spleen	spleen	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
bone	bone	NN	B-NP	O
marrow	marrow	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
extent	extent	NN	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
DNA	DNA	NN	B-NP	O
adduct	adduct	NN	I-NP	O
formation	formation	NN	I-NP	O
and	and	CC	O	O
mutant	mutant	JJ	B-NP	O
induction	induction	NN	I-NP	O
correlates	correlate	VBZ	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
organ	organ	NN	I-NP	O
specificity	specificity	NN	I-NP	O
for	for	IN	B-PP	O
N-OH-AAF	N-OH-AAF	NN	B-NP	O
carcinogenesis	carcinogenesis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O
.	.	.	O	O

Environ.	Environ.	NNP	B-NP	O
Mol.	Mol.	NNP	I-NP	O
Mutagen.	Mutagen.	NNP	I-NP	O
37	37	CD	I-NP	O
:	:	:	O	O
195-202	195-202	CD	B-NP	O
,	,	,	I-NP	O
2001	2001	CD	I-NP	O
.	.	.	O	O

Published	Published	NNP	B-NP	O
2001	2001	CD	I-NP	O
Wiley-Liss	Wiley-Liss	NNP	I-NP	O
,	,	,	O	O
Inc	Inc	NNP	B-NP	O
.	.	.	O	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
Mad1	Mad1	NN	B-NP	B-protein
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
reduced	reduce	VBN	B-NP	O
thymic	thymic	JJ	I-NP	O
cellularity	cellularity	NN	I-NP	O
and	and	CC	O	O
impaired	impaired	JJ	B-NP	O
mitogen-induced	mitogen-induced	JJ	I-NP	O
proliferation	proliferation	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
Mad1	Mad1	NN	B-NP	B-protein
function	function	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
,	,	,	O	O
transgenic	transgenic	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
were	be	VBD	B-VP	O
generated	generate	VBN	I-VP	O
that	that	WDT	B-NP	O
express	express	VBP	B-VP	O
a	a	DT	B-NP	O
Mad1	Mad1	NN	I-NP	B-DNA
transgene	transgene	NN	I-NP	I-DNA
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
lineage	lineage	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
under	under	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	B-DNA
lck	lck	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

Thymus	Thymus	NN	B-NP	O
size	size	NN	I-NP	O
in	in	IN	B-PP	O
lck-Mad1	lck-Mad1	NN	B-NP	O
transgenic	transgenic	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
is	be	VBZ	B-VP	O
drastically	drastically	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
although	although	IN	B-SBAR	O
representation	representation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
various	various	JJ	I-NP	O
thymocyte	thymocyte	NN	I-NP	B-cell_type
sub	sub	NN	I-NP	I-cell_type
populations	population	NNS	I-NP	I-cell_type
appears	appear	VBZ	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
more	more	RBR	B-ADVP	O
closely	closely	RB	I-ADVP	O
any	any	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
Mad1	Mad1	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
on	on	IN	B-PP	O
thymocytes	thymocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
we	we	PRP	B-NP	O
examined	examine	VBD	B-VP	O
thymic	thymic	JJ	B-NP	O
selection	selection	NN	I-NP	O
using	use	VBG	B-VP	O
MHC	MHC	NN	B-NP	O
class	class	NN	I-NP	O
I-restricted	I-restricted	JJ	I-NP	O
H-Y-TCR	H-Y-TCR	NN	I-NP	O
transgenic	transgenic	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

Mad1	Mad1	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
reduces	reduce	VBZ	B-VP	O
the	the	DT	B-NP	O
efficiency	efficiency	NN	I-NP	O
of	of	IN	B-PP	O
positive	positive	JJ	B-NP	O
selection	selection	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
thymocytes	thymocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
splenic	splenic	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
lck-Mad1	lck-Mad1	NN	B-NP	O
transgenic	transgenic	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
display	display	VBP	B-VP	O
a	a	DT	B-NP	O
profound	profound	JJ	I-NP	O
proliferative	proliferative	JJ	I-NP	O
defect	defect	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
activation	activation	NN	B-NP	O
with	with	IN	B-PP	O
either	either	CC	O	O
PMA/Ionomycin	PMA/Ionomycin	NN	B-NP	O
or	or	CC	O	O
immobilized	immobilize	VBN	B-NP	O
anti-CD3/CD28	anti-CD3/CD28	JJ	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
.	.	.	O	O

This	This	DT	B-NP	O
proliferative	proliferative	JJ	I-NP	O
defect	defect	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
reversed	reverse	VBN	I-VP	O
by	by	IN	B-PP	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
exogenous	exogenous	JJ	B-NP	O
IL-2	IL-2	NN	I-NP	B-protein
and	and	CC	O	O
is	be	VBZ	B-VP	O
p53-independent	p53-independent	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
growth	growth	NN	I-NP	O
inhibition	inhibition	NN	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
Mad1	Mad1	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
overcome	overcome	VBN	I-VP	O
by	by	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
active	active	JJ	B-NP	O
c-Myc	c-Myc	NN	I-NP	B-protein
.	.	.	O	O

Differential	Differential	JJ	B-NP	O
requirement	requirement	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
PU.1	PU.1	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
generation	generation	NN	I-NP	O
of	of	IN	B-PP	O
natural	natural	JJ	B-NP	B-cell_type
killer	killer	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
versus	versus	CC	O	O
B	B	NN	B-NP	O
and	and	CC	O	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	B-NP	I-cell_type
.	.	.	O	O

PU.1	PU.1	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ets	Ets	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
various	various	JJ	B-NP	O
lymphoid	lymphoid	JJ	I-NP	O
and	and	CC	I-NP	O
myeloid	myeloid	JJ	I-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
lineages	lineage	NNS	I-NP	I-cell_type
,	,	,	O	O
but	but	CC	O	O
its	its	PRP$	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
natural	natural	JJ	B-NP	O
killer	killer	NN	I-NP	O
(	(	(	O	O
NK	NK	NN	B-NP	O
)	)	)	O	O
cell	cell	NN	B-NP	O
development	development	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
known	know	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
study	study	NN	I-NP	O
shows	show	VBZ	B-VP	O
that	that	IN	B-SBAR	O
PU.1	PU.1	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
NK	NK	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
that	that	IN	B-SBAR	O
,	,	,	O	O
on	on	IN	B-PP	O
cell	cell	NN	B-NP	O
transfer	transfer	NN	I-NP	O
into	into	IN	B-PP	O
alymphoid	alymphoid	JJ	B-NP	B-protein
Rag2/gammac	Rag2/gammac	NN	I-NP	I-protein
(	(	(	O	O
-/-	-/-	JJ	O	O
)	)	)	O	O
mice	mouse	NNS	B-NP	O
,	,	,	O	O
hematopoietic	hematopoietic	JJ	B-NP	B-cell_type
progenitors	progenitor	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
PU.1	PU.1	NN	B-NP	B-protein
(	(	(	O	O
-/-	-/-	JJ	B-ADJP	O
)	)	)	O	O
fetal	fetal	JJ	B-NP	O
liver	liver	NN	I-NP	O
cells	cell	NNS	I-NP	O
could	could	MD	B-VP	O
generate	generate	VB	I-VP	O
functional	functional	JJ	B-NP	O
NK	NK	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
but	but	CC	B-NP	O
not	not	RB	I-NP	O
B	B	NN	B-NP	O
or	or	CC	O	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Nevertheless	Nevertheless	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
bone	bone	NN	B-NP	B-cell_type
marrow	marrow	NN	I-NP	I-cell_type
NK	NK	NN	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
precursors	precursor	NNS	I-NP	I-cell_type
and	and	CC	O	O
splenic	splenic	JJ	B-NP	B-cell_type
mature	mature	JJ	I-NP	I-cell_type
NK	NK	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
controls	control	NNS	B-NP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
PU.1	PU.1	NN	B-NP	B-protein
(	(	(	O	O
-/-	-/-	JJ	O	O
)	)	)	O	O
NK	NK	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
displayed	display	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
receptors	receptor	NNS	I-NP	O
for	for	IN	B-PP	O
stem	stem	NN	B-NP	B-protein
cell	cell	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
and	and	CC	O	O
interleukin	interleukin	NN	B-NP	B-protein
(	(	(	O	I-protein
IL	IL	NN	B-NP	I-protein
)	)	)	O	I-protein
-7	-7	CD	B-NP	I-protein
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
a	a	DT	B-NP	O
nonredundant	nonredundant	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
PU.1	PU.1	NN	B-NP	B-protein
in	in	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
cytokine	cytokine	NN	I-NP	B-DNA
receptor	receptor	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
during	during	IN	B-PP	O
NK	NK	NN	B-NP	O
cell	cell	NN	I-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

PU.1	PU.1	NN	B-NP	B-protein
(	(	(	O	O
-/-	-/-	JJ	O	O
)	)	)	O	O
NK	NK	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
defective	defective	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
inhibitory	inhibitory	JJ	O	O
and	and	CC	O	O
activating	activate	VBG	B-VP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ly49	Ly49	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
and	and	CC	O	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
proliferate	proliferate	VB	I-VP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-12	IL-12	NN	I-NP	B-protein
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
despite	despite	IN	B-PP	O
the	the	DT	B-NP	O
less	less	RBR	I-NP	O
stringent	stringent	JJ	I-NP	O
requirement	requirement	NN	I-NP	O
for	for	IN	B-PP	O
PU.1	PU.1	NN	B-NP	B-protein
in	in	IN	B-PP	O
NK	NK	NN	B-NP	O
cell	cell	NN	I-NP	O
development	development	NN	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
B	B	NN	B-NP	B-cell_type
and	and	CC	O	I-cell_type
T	T	NN	B-NP	I-cell_type
cells	cell	NNS	B-NP	I-cell_type
,	,	,	O	O
PU.1	PU.1	NN	B-NP	B-protein
regulates	regulate	VBZ	B-VP	O
NK	NK	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
differentiation	differentiation	NN	I-NP	O
and	and	CC	O	O
homeostasis	homeostasis	NN	B-NP	O
.	.	.	O	O

Benzene-extracted	Benzene-extracted	JJ	B-NP	O
components	component	NNS	I-NP	O
are	be	VBP	B-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
diesel	diesel	NN	B-NP	O
exhaust	exhaust	NN	I-NP	O
particles	particle	NNS	I-NP	O
:	:	:	O	O
effect	effect	NN	B-NP	O
on	on	IN	B-PP	O
interleukin-8	interleukin-8	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
bronchial	bronchial	JJ	I-NP	I-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Epidemiologic	Epidemiologic	JJ	B-NP	O
and	and	CC	I-NP	O
experimental	experimental	JJ	I-NP	O
studies	study	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
diesel	diesel	NN	B-NP	O
exhaust	exhaust	NN	I-NP	O
particles	particle	NNS	I-NP	O
(	(	(	O	O
DEPs	DEP	NNS	B-NP	O
)	)	)	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
increasing	increase	VBG	B-VP	O
respiratory	respiratory	JJ	B-NP	O
mortality	mortality	NN	I-NP	O
and	and	CC	I-NP	O
morbidity	morbidity	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
DEPs	DEP	NNS	B-NP	O
augmented	augment	VBD	B-VP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	B-protein
cytokines	cytokine	NNS	I-NP	I-protein
by	by	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
airway	airway	NN	I-NP	I-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

To	To	TO	B-VP	O
better	well	RBR	I-VP	O
understand	understand	VB	I-VP	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
proinflammatory	proinflammatory	JJ	I-NP	O
activities	activity	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
studied	study	VBD	B-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
components	component	NNS	I-NP	O
extracted	extract	VBN	B-VP	O
from	from	IN	B-PP	O
DEPs	DEP	NNS	B-NP	O
on	on	IN	B-PP	O
interleukin	interleukin	NN	B-NP	B-protein
(	(	(	O	I-protein
IL	IL	NN	B-NP	I-protein
)	)	)	O	I-protein
-8	-8	CD	B-NP	I-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
bronchial	bronchial	JJ	I-NP	I-cell_line
epithelial	epithelial	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
BEAS-2B	BEAS-2B	NN	I-NP	O
and	and	CC	O	O
normal	normal	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
airway	airway	NN	I-NP	I-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
very	very	RB	B-NP	O
peripheral	peripheral	JJ	I-NP	O
airways	airway	NNS	I-NP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
ultrathin	ultrathin	JJ	I-NP	O
bronchoscope	bronchoscope	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
used	use	VBD	B-VP	O
several	several	JJ	B-NP	O
agents	agent	NNS	I-NP	O
active	active	JJ	B-ADJP	O
on	on	IN	B-PP	O
signal	signal	NN	B-NP	O
transduction	transduction	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
in	in	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
C	C	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	O
staurosporin	staurosporin	NN	I-NP	O
,	,	,	O	O
antioxidant	antioxidant	JJ	B-NP	O
agents	agent	NNS	I-NP	O
including	include	VBG	B-PP	O
N-acetyl	N-acetyl	NN	B-NP	O
cysteine	cysteine	NN	I-NP	O
(	(	(	O	O
NAC	NAC	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
pyrrolidine	pyrrolidine	NN	B-NP	O
dithiocarbamate	dithiocarbamate	NN	I-NP	O
(	(	(	O	O
PDTC	PDTC	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
p38	p38	NN	B-NP	B-protein
mitogen-activated	mitogen-activated	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
MAPK	MAPK	NN	B-NP	B-protein
)	)	)	O	O
inhibitor	inhibitor	NN	B-NP	O
SB203580	SB203580	NN	I-NP	O
.	.	.	O	O

Benzene-extracted	Benzene-extracted	JJ	B-NP	O
components	component	NNS	I-NP	O
showed	show	VBD	B-VP	O
effects	effect	NNS	B-NP	O
mimicking	mimic	VBG	B-VP	O
DEPs	DEP	NNS	B-NP	O
on	on	IN	B-PP	O
IL-8	IL-8	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
,	,	,	O	O
release	release	NN	B-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
cytokines	cytokine	NNS	I-NP	B-protein
(	(	(	O	O
IL-8	IL-8	NN	B-NP	B-protein
;	;	:	O	O
granulocyte	granulocyte	NN	B-NP	B-protein
macrophage	macrophage	NN	B-NP	I-protein
colony-stimulating	colony-stimulating	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
;	;	:	O	O
and	and	CC	O	O
regulated	regulate	VBN	B-VP	O
on	on	IN	B-PP	O
activation	activation	NN	B-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
T	T	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
expressed	express	VBN	B-VP	O
and	and	CC	I-VP	O
secreted	secrete	VBN	I-VP	O
)	)	)	O	O
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	I-protein
NF	NF	NN	B-NP	I-protein
)	)	)	O	I-protein
-kappa	-kappa	NN	B-NP	I-protein
B	B	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
NAC	NAC	NN	B-NP	O
,	,	,	O	O
PDTC	PDTC	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
SB203580	SB203580	NN	B-NP	O
suppressed	suppress	VBD	B-VP	O
the	the	DT	B-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
DEPs	DEP	NNS	B-NP	B-protein
and	and	CC	O	O
their	their	PRP$	B-NP	O
benzene	benzene	NN	I-NP	O
extracts	extract	NNS	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
the	the	DT	B-NP	O
roles	role	NNS	I-NP	O
of	of	IN	B-PP	O
oxidants-mediated	oxidants-mediated	JJ	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
and	and	CC	O	O
p38MAPK	p38MAPK	NN	B-NP	B-protein
pathways	pathway	NNS	I-NP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
benzo	benzo	NN	B-NP	O
[	[	(	O	O
a	a	DT	O	O
]	]	)	O	O
pyrene	pyrene	NN	B-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
important	important	JJ	I-NP	O
compounds	compound	NNS	I-NP	O
included	include	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
benzene	benzene	NN	I-NP	O
component	component	NN	I-NP	O
,	,	,	O	O
replicated	replicate	VBD	B-VP	O
the	the	DT	B-NP	O
activities	activity	NNS	I-NP	O
shown	show	VBN	B-VP	O
by	by	IN	B-PP	O
DEPs	DEP	NNS	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
PPAR	PPAR	NN	I-NP	I-protein
gamma	gamma	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
by	by	IN	B-PP	O
mouse	mouse	NN	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
PPAR	PPAR	NN	B-NP	B-protein
gamma	gamma	NN	I-NP	I-protein
agonists	agonist	NNS	I-NP	O
induce	induce	VBP	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
.	.	.	O	O

Peroxisome	Peroxisome	NN	B-NP	B-protein
proliferator-activated	proliferator-activated	JJ	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
PPAR	PPAR	NN	B-NP	B-protein
)	)	)	O	O
-gamma	-gamma	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
hormone	hormone	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
that	that	WDT	B-NP	O
serves	serve	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
trans	trans	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
to	to	TO	B-VP	O
regulate	regulate	VB	I-VP	O
lipid	lipid	NN	B-NP	O
metabolism	metabolism	NN	I-NP	O
.	.	.	O	O

Intense	Intense	JJ	B-NP	O
interest	interest	NN	I-NP	O
is	be	VBZ	B-VP	O
focused	focus	VBN	I-VP	O
on	on	IN	B-PP	O
PPAR-gamma	PPAR-gamma	NN	B-NP	B-protein
and	and	CC	O	O
its	its	PRP$	B-NP	O
ligands	ligand	NNS	I-NP	O
owing	owe	VBG	B-VP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
putative	putative	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
adipocyte	adipocyte	NN	B-NP	B-cell_type
differentiation	differentiation	NN	I-NP	O
.	.	.	O	O

Little	Little	JJ	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
functions	function	NNS	I-NP	O
of	of	IN	B-PP	O
PPAR-gamma	PPAR-gamma	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
immune	immune	JJ	I-NP	O
system	system	NN	I-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
both	both	CC	O	O
naive	naive	JJ	B-ADJP	O
and	and	CC	O	O
activated	activate	VBN	B-VP	B-cell_type
ovalbumin-specific	ovalbumin-specific	JJ	B-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
DO11.10-transgenic	DO11.10-transgenic	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
express	express	VBP	B-VP	O
PPAR-gamma	PPAR-gamma	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
and	and	CC	I-NP	O
protein	protein	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
PPAR-gamma	PPAR-gamma	NN	B-NP	B-protein
,	,	,	O	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
stimulated	stimulate	VBN	I-VP	O
with	with	IN	B-PP	O
phorbol	phorbol	NN	B-NP	O
12-myristate	12-myristate	NN	I-NP	O
13-acetate	13-acetate	NN	I-NP	O
and	and	CC	O	O
ionomycin	ionomycin	NN	B-NP	O
or	or	CC	O	O
antigen	antigen	NN	B-NP	O
and	and	CC	O	O
antigen-presenting	antigen-presenting	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Simultaneous	Simultaneous	JJ	B-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-PP	O
PPAR-gamma	PPAR-gamma	NN	B-NP	B-protein
ligands	ligand	NNS	I-NP	I-protein
(	(	(	O	O
e.g.	e.g.	FW	B-NP	O
15-deoxy-Delta	15-deoxy-Delta	FW	I-NP	O
(	(	(	O	O
12	12	CD	B-NP	O
,	,	,	O	O
14	14	CD	B-NP	O
)	)	)	O	O
-prostaglandin	-prostaglandin	NN	B-NP	O
J	J	NN	I-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
troglitazone	troglitazone	NN	B-NP	O
)	)	)	O	O
showed	show	VBD	B-VP	O
drastic	drastic	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
proliferation	proliferation	NN	B-NP	O
and	and	CC	O	O
significant	significant	JJ	B-NP	O
decreases	decrease	NNS	I-NP	O
in	in	IN	B-PP	O
cell	cell	NN	B-NP	O
viability	viability	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
cell	cell	NN	B-NP	O
viability	viability	NN	I-NP	O
was	be	VBD	B-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
occurred	occur	VBD	B-VP	O
only	only	RB	B-ADVP	O
when	when	WRB	I-ADVP	O
cells	cell	NNS	B-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
PPAR-gamma	PPAR-gamma	NN	B-NP	B-protein
,	,	,	B-NP	O
and	and	CC	I-NP	O
not	not	RB	I-NP	O
PPAR-alpha	PPAR-alpha	NN	B-NP	B-protein
agonists	agonist	NNS	I-NP	O
,	,	,	O	O
revealing	reveal	VBG	B-VP	O
specificity	specificity	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
response	response	NN	I-NP	O
for	for	IN	B-PP	O
PPAR-gamma	PPAR-gamma	NN	B-NP	B-protein
.	.	.	O	O

These	These	DT	B-NP	O
observations	observation	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
PPAR-gamma	PPAR-gamma	NN	B-NP	B-protein
agonists	agonist	NNS	I-NP	O
play	play	VBP	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
T	T	NN	B-NP	O
cell-mediated	cell-mediated	JJ	I-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
by	by	IN	B-PP	O
inducing	induce	VBG	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
.	.	.	O	O

T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
death	death	NN	I-NP	O
via	via	IN	B-PP	O
PPAR-gamma	PPAR-gamma	NN	B-NP	B-protein
ligation	ligation	NN	I-NP	O
may	may	MD	B-VP	O
act	act	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	O
signal	signal	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
immune	immune	JJ	I-NP	O
system	system	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
ligands	ligand	NNS	B-NP	O
could	could	MD	B-VP	O
possibly	possibly	RB	I-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
disorders	disorder	NNS	B-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
excessive	excessive	JJ	B-NP	O
inflammation	inflammation	NN	I-NP	O
occurs	occur	VBZ	B-VP	O
.	.	.	O	O

Suppression	Suppression	NN	B-NP	O
of	of	IN	B-PP	O
lung	lung	NN	B-NP	O
inflammation	inflammation	NN	I-NP	O
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O
by	by	IN	B-PP	O
prevention	prevention	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
.	.	.	O	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
and	and	CC	I-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
chemokines	chemokine	NNS	I-NP	B-protein
are	be	VBP	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
neutrophilic	neutrophilic	JJ	B-NP	O
lung	lung	NN	I-NP	O
inflammation	inflammation	NN	I-NP	O
.	.	.	O	O

Calpain-1	Calpain-1	NN	B-NP	B-protein
inhibitor	inhibitor	NN	I-NP	O
(	(	(	O	O
CI-1	CI-1	NN	B-NP	B-protein
)	)	)	O	O
blocks	block	VBZ	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
by	by	IN	B-PP	O
preventing	prevent	VBG	B-VP	O
proteolysis	proteolysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
IkappaB-alpha	IkappaB-alpha	NN	I-NP	B-protein
by	by	IN	B-PP	O
the	the	DT	B-NP	O
ubiquitin/proteasome	ubiquitin/proteasome	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
hypothesized	hypothesize	VBD	B-VP	O
that	that	IN	B-SBAR	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
proteasome	proteasome	NN	B-NP	B-protein
function	function	NN	I-NP	O
with	with	IN	B-PP	O
CI-1	CI-1	NN	B-NP	B-protein
would	would	MD	B-VP	O
block	block	VB	I-VP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
after	after	IN	B-PP	O
intraperitoneal	intraperitoneal	JJ	O	O
(	(	(	O	O
i.p.	i.p.	JJ	B-ADJP	O
)	)	)	O	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
lipopolysaccharide	lipopolysaccharide	NN	I-NP	O
(	(	(	O	O
LPS	LPS	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
inhibition	inhibition	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
suppression	suppression	NN	B-NP	O
of	of	IN	B-PP	O
chemokine	chemokine	NN	B-NP	B-protein
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
and	and	CC	O	O
attenuation	attenuation	NN	B-NP	O
of	of	IN	B-PP	O
neutrophilic	neutrophilic	JJ	B-NP	O
alveolitis	alveolitis	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
treated	treat	VBD	B-VP	O
rats	rat	NNS	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
i.p.	i.p.	JJ	I-NP	O
injection	injection	NN	I-NP	O
of	of	IN	B-PP	O
CI-1	CI-1	NN	B-NP	B-protein
(	(	(	O	O
10	10	CD	B-NP	O
mg/kg	mg/kg	NN	I-NP	O
)	)	)	O	O
two	two	CD	B-NP	O
hours	hour	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
i.p.	i.p.	JJ	B-NP	O
LPS	LPS	NN	I-NP	O
(	(	(	O	O
7	7	CD	B-NP	O
mg/kg	mg/kg	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Treatment	Treatment	NN	B-NP	O
with	with	IN	B-PP	O
Cl-1	Cl-1	NN	B-NP	B-protein
prevented	prevent	VBD	B-VP	O
degradation	degradation	NN	B-NP	O
of	of	IN	B-PP	O
IkappaB-alpha	IkappaB-alpha	NN	B-NP	B-protein
and	and	CC	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
LPS	LPS	NN	B-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
Cl-1	Cl-1	NN	B-NP	B-protein
treatment	treatment	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
detected	detect	VBN	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
lung	lung	NN	B-NP	O
tissue	tissue	NN	I-NP	O
.	.	.	O	O

CI-1	CI-1	NN	B-NP	B-protein
treatment	treatment	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
LPS	LPS	NN	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
lower	low	JJR	B-NP	O
MIP-2	MIP-2	NN	I-NP	B-protein
concentration	concentration	NN	I-NP	O
in	in	IN	B-PP	O
lung	lung	NN	B-NP	O
lavage	lavage	NN	I-NP	O
fluid	fluid	NN	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
rats	rat	NNS	B-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
vehicle	vehicle	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
LPS	LPS	NN	B-NP	O
(	(	(	O	O
502	502	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
112	112	CD	I-NP	O
pg/ml	pg/ml	NN	I-NP	O
vs.	vs.	IN	B-PP	O
859	859	CD	B-NP	O
+/-144	+/-144	CD	I-NP	O
pg/ml	pg/ml	NN	I-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
0.05	0.05	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
CI-1	CI-1	NN	B-NP	B-protein
treatment	treatment	NN	I-NP	O
substantially	substantially	RB	B-VP	O
inhibited	inhibit	VBD	I-VP	O
LPS-induced	LPS-induced	JJ	B-NP	O
neutrophilic	neutrophilic	JJ	I-NP	O
alveolitis	alveolitis	NN	I-NP	O
(	(	(	O	O
2.7+	2.7+	CD	B-NP	O
/-	/-	SYM	O	O
1.2	1.2	CD	B-NP	O
x	x	SYM	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
5	5	CD	B-NP	O
)	)	)	O	O
vs.	vs.	IN	B-PP	O
43.7	43.7	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
12.2	12.2	CD	I-NP	O
x	x	SYM	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
5	5	CD	B-NP	O
)	)	)	O	O
lung	lung	NN	B-NP	B-cell_type
lavage	lavage	NN	I-NP	I-cell_type
neutrophils	neutrophil	NNS	I-NP	I-cell_type
,	,	,	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
0.01	0.01	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
inhibition	inhibition	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
can	can	MD	B-VP	O
alter	alter	VB	I-VP	O
lung	lung	NN	B-NP	O
inflammation	inflammation	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
LPS	LPS	NN	I-NP	O
treatment	treatment	NN	I-NP	O
and	and	CC	O	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
liver-lung	liver-lung	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
contributes	contribute	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
response	response	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
.	.	.	O	O

Notch1	Notch1	NN	B-NP	B-protein
regulates	regulate	VBZ	B-VP	O
maturation	maturation	NN	B-NP	O
of	of	IN	B-PP	O
CD4+	CD4+	JJ	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
CD8+	CD8+	JJ	I-NP	I-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
modulating	modulate	VBG	B-VP	O
TCR	TCR	NN	B-NP	B-protein
signal	signal	NN	I-NP	O
strength	strength	NN	I-NP	O
.	.	.	O	O

Notch	Notch	NN	B-NP	O
signaling	signaling	NN	I-NP	O
regulates	regulate	VBZ	B-VP	O
cell	cell	NN	B-NP	O
fate	fate	NN	I-NP	O
decisions	decision	NNS	I-NP	O
in	in	IN	B-PP	O
multiple	multiple	JJ	B-NP	B-cell_type
lineages	lineage	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
that	that	IN	B-SBAR	O
retroviral	retroviral	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
activated	activate	VBN	B-NP	O
Notch1	Notch1	NN	I-NP	B-protein
in	in	IN	B-PP	O
mouse	mouse	NN	B-NP	B-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
abrogates	abrogate	VBZ	B-VP	O
differentiation	differentiation	NN	B-NP	O
of	of	IN	B-PP	O
immature	immature	JJ	B-NP	B-cell_type
CD4+CD8+	CD4+CD8+	JJ	I-NP	I-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
into	into	IN	B-PP	O
both	both	CC	O	O
CD4	CD4	NN	B-NP	B-protein
and	and	CC	O	O
CD8	CD8	NN	B-NP	B-cell_type
mature	mature	JJ	I-NP	I-cell_type
single-positive	single-positive	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
Notch1	Notch1	NN	B-NP	B-protein
to	to	TO	B-VP	O
inhibit	inhibit	VB	I-VP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
development	development	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
with	with	IN	B-PP	O
both	both	CC	B-NP	O
normal	normal	JJ	I-NP	O
and	and	CC	O	O
TCR	TCR	NN	B-NP	B-protein
transgenic	transgenic	JJ	I-NP	O
thymocytes	thymocyte	NNS	I-NP	O
.	.	.	O	O

Notch1	Notch1	NN	B-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
developmental	developmental	JJ	I-NP	O
arrest	arrest	NN	I-NP	O
was	be	VBD	B-VP	O
dose	dose	NN	B-NP	O
dependent	dependent	JJ	B-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
impaired	impair	VBN	B-NP	O
thymocyte	thymocyte	NN	I-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
TCR	TCR	NN	B-NP	B-protein
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

Notch1	Notch1	NN	B-NP	B-protein
also	also	RB	B-ADVP	O
inhibited	inhibit	VBD	B-VP	O
TCR-mediated	TCR-mediated	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
in	in	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
constitutively	constitutively	RB	B-NP	O
active	active	JJ	I-NP	O
Notch1	Notch1	NN	I-NP	B-protein
abrogates	abrogate	VBZ	B-VP	O
CD4+	CD4+	JJ	B-NP	O
and	and	CC	I-NP	O
CD8+	CD8+	JJ	I-NP	O
maturation	maturation	NN	I-NP	O
by	by	IN	B-PP	O
interfering	interfere	VBG	B-VP	O
with	with	IN	B-PP	O
TCR	TCR	NN	B-NP	B-protein
signal	signal	NN	I-NP	O
strength	strength	NN	I-NP	O
and	and	CC	O	O
provide	provide	VBP	B-VP	O
an	an	DT	B-NP	O
explanation	explanation	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
physiological	physiological	JJ	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
Notch	Notch	NN	B-NP	O
expression	expression	NN	I-NP	O
during	during	IN	B-PP	O
thymocyte	thymocyte	NN	B-NP	B-cell_type
development	development	NN	I-NP	O
.	.	.	O	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
SART3	SART3	NN	B-NP	B-protein
antigen	antigen	NN	I-NP	I-protein
and	and	CC	O	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
CTLs	CTL	NNS	B-NP	B-cell_type
by	by	IN	B-PP	O
SART3-derived	SART3-derived	JJ	B-NP	O
peptides	peptide	NNS	I-NP	O
in	in	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
recently	recently	RB	B-ADVP	O
reported	report	VBD	B-VP	O
the	the	DT	B-NP	O
SART3	SART3	NN	I-NP	B-protein
tumour-rejection	tumour-rejection	NN	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
as	as	IN	B-PP	O
possessing	possess	VBG	B-VP	O
tumour	tumour	NN	B-NP	B-protein
epitopes	epitope	NNS	I-NP	I-protein
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
inducing	induce	VBG	B-VP	O
HLA-class	HLA-class	JJ	B-NP	B-cell_type
I-restricted	I-restricted	JJ	I-NP	I-cell_type
cytotoxic	cytotoxic	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
(	(	(	O	O
CTLs	CTL	NNS	B-NP	B-cell_type
)	)	)	O	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
investigated	investigate	VBD	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
SART3	SART3	NN	I-NP	B-protein
antigen	antigen	NN	I-NP	I-protein
in	in	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
to	to	TO	B-VP	O
explore	explore	VB	I-VP	O
an	an	DT	B-NP	O
appropriate	appropriate	JJ	I-NP	O
molecule	molecule	NN	I-NP	O
for	for	IN	B-PP	O
use	use	NN	B-NP	O
in	in	IN	B-PP	O
specific	specific	JJ	B-NP	O
immunotherapy	immunotherapy	NN	I-NP	O
of	of	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
SART3	SART3	NN	I-NP	B-protein
antigen	antigen	NN	I-NP	I-protein
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
breast	breast	NN	I-NP	B-cell_line
cancer	cancer	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
tested	test	VBN	B-VP	O
,	,	,	O	O
30	30	CD	B-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
(	(	(	O	O
75	75	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
tissue	tissue	NN	I-NP	O
samples	sample	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
0	0	CD	B-NP	O
of	of	IN	B-PP	O
3	3	CD	B-NP	O
non-tumourous	non-tumourous	JJ	I-NP	O
breast	breast	NN	I-NP	O
tissue	tissue	NN	I-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

SART3	SART3	NN	B-NP	B-protein
derived	derive	VBN	I-NP	O
peptides	peptide	NNS	I-NP	O
at	at	IN	B-PP	O
positions	position	NNS	B-NP	O
109-118	109-118	CD	B-NP	O
and	and	CC	I-NP	O
315-323	315-323	CD	I-NP	O
induced	induce	VBD	B-VP	O
HLA-A24	HLA-A24	NN	B-NP	B-protein
restricted	restricted	JJ	I-NP	O
CTLs	CTL	NNS	I-NP	O
that	that	WDT	B-NP	O
reacted	react	VBD	B-VP	O
to	to	TO	B-PP	O
breast	breast	NN	B-NP	B-cell_type
cancer	cancer	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
the	the	DT	B-NP	O
peripheral	peripheral	JJ	I-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
PBMCs	PBMC	NNS	B-NP	B-cell_type
)	)	)	O	O
of	of	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
SART3	SART3	NN	I-NP	B-protein
antigen	antigen	NN	I-NP	I-protein
and	and	CC	O	O
its	its	PRP$	B-NP	O
peptides	peptide	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
appropriate	appropriate	JJ	I-NP	O
molecule	molecule	NN	I-NP	O
for	for	IN	B-PP	O
use	use	NN	B-NP	O
in	in	IN	B-PP	O
specific	specific	JJ	B-NP	O
immunotherapy	immunotherapy	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
HLA-A24-positive	HLA-A24-positive	JJ	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
patients	patient	NNS	I-NP	O

Autostimulation	Autostimulation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Epstein-Barr	Epstein-Barr	JJ	I-NP	B-DNA
virus	virus	NN	I-NP	I-DNA
BRLF1	BRLF1	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
through	through	IN	B-PP	O
consensus	consensus	NN	B-NP	B-DNA
Sp1	Sp1	NN	I-NP	I-DNA
and	and	CC	O	I-DNA
Sp3	Sp3	NN	B-NP	I-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
.	.	.	O	O

As	As	IN	B-PP	O
an	an	DT	B-NP	O
essential	essential	JJ	I-NP	O
step	step	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lytic	lytic	JJ	I-NP	O
cascade	cascade	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Rta	Rta	NN	I-NP	B-protein
homologues	homologue	NNS	I-NP	I-protein
of	of	IN	B-PP	O
gammaherpesviruses	gammaherpesvirus	NNS	B-NP	O
all	all	DT	B-ADVP	O
activate	activate	VBP	B-VP	O
their	their	PRP$	B-NP	O
own	own	JJ	I-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O

Consistent	Consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
biologic	biologic	JJ	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Epstein-Barr	Epstein-Barr	JJ	I-NP	B-protein
virus	virus	NN	I-NP	I-protein
(	(	(	O	I-protein
EBV	EBV	NN	B-NP	I-protein
)	)	)	O	I-protein
Rta	Rta	NN	B-NP	I-protein
protein	protein	NN	I-NP	I-protein
powerfully	powerfully	RB	B-ADVP	O
stimulates	stimulate	VBZ	B-VP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	B-DNA
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
own	own	JJ	I-NP	O
gene	gene	NN	I-NP	O
,	,	,	O	O
Rp	Rp	NN	B-NP	B-DNA
,	,	,	O	O
in	in	IN	B-PP	O
EBV-positive	EBV-positive	JJ	B-NP	B-cell_line
B	B	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
in	in	IN	B-PP	O
transient-transfection	transient-transfection	JJ	B-NP	O
reporter-based	reporter-based	JJ	I-NP	O
assays	assay	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
analyzed	analyze	VBD	B-VP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
RpCAT	RpCAT	NN	B-NP	B-protein
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
Rta	Rta	NN	B-NP	B-protein
by	by	IN	B-PP	O
deletional	deletional	JJ	B-NP	O
and	and	CC	I-NP	O
site-directed	site-directed	JJ	I-NP	O
mutagenesis	mutagenesis	NN	I-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
cognate	cognate	JJ	I-NP	B-DNA
Sp1	Sp1	NN	I-NP	I-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
located	located	JJ	B-ADJP	O
at	at	IN	B-PP	O
-279	-279	CD	B-NP	B-DNA
and	and	CC	I-NP	I-DNA
-45	-45	CD	I-NP	I-DNA
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	B-DNA
start	start	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
proved	prove	VBD	B-VP	O
crucial	crucial	JJ	B-ADJP	O
for	for	IN	B-PP	O
Rta-mediated	Rta-mediated	JJ	B-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

Previously	Previously	RB	B-ADVP	O
described	describe	VBN	B-VP	O
binding	bind	VBG	B-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
for	for	IN	B-PP	O
the	the	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
factor	factor	NN	I-NP	O
Zif268	Zif268	NN	I-NP	B-protein
and	and	CC	O	O
the	the	DT	B-NP	O
viral	viral	JJ	I-NP	B-protein
transactivator	transactivator	NN	I-NP	I-protein
ZEBRA	ZEBRA	NN	I-NP	B-protein
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
dispensable	dispensable	JJ	B-ADJP	O
for	for	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
RpCAT	RpCAT	NN	B-NP	B-protein
by	by	IN	B-PP	O
Rta	Rta	NN	B-NP	B-protein
.	.	.	O	O

Gel	Gel	NN	B-NP	O
shift	shift	NN	I-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
extracts	extract	NNS	B-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
latency	latency	NN	B-NP	O
or	or	CC	O	O
induced	induce	VBN	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
lytic	lytic	JJ	I-NP	O
cycle	cycle	NN	I-NP	O
,	,	,	O	O
identified	identify	VBD	B-VP	O
Sp1	Sp1	NN	B-NP	B-protein
and	and	CC	I-NP	O
Sp3	Sp3	NN	I-NP	B-protein
as	as	IN	B-PP	O
the	the	DT	B-NP	O
predominant	predominant	JJ	I-NP	O
cellular	cellular	JJ	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
bound	bind	VBN	B-VP	O
to	to	TO	B-PP	O
Rp	Rp	NN	B-NP	B-protein
near	near	IN	B-PP	O
-45	-45	CD	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
lytic	lytic	JJ	I-NP	O
cycle	cycle	NN	I-NP	O
,	,	,	O	O
ZEBRA	ZEBRA	NN	B-NP	B-protein
bound	bind	VBD	B-VP	O
Rp	Rp	NN	B-NP	B-protein
near	near	IN	B-PP	O
the	the	DT	B-NP	O
Sp1/Sp3	Sp1/Sp3	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
Sp1	Sp1	NN	B-NP	B-protein
and	and	CC	O	O
Sp3	Sp3	NN	B-NP	B-protein
to	to	TO	B-PP	O
Rp	Rp	NN	B-NP	B-protein
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
reporter	reporter	NN	I-NP	O
activities	activity	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mutagenesis	mutagenesis	NN	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
establishing	establish	VBG	B-VP	O
a	a	DT	B-NP	O
direct	direct	JJ	I-NP	O
link	link	NN	I-NP	O
between	between	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
Rp	Rp	NN	B-NP	B-protein
by	by	IN	B-PP	O
Rta	Rta	NN	B-NP	B-protein
and	and	CC	I-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
by	by	IN	B-PP	O
Sp1	Sp1	NN	B-NP	B-protein
and/or	and/or	CC	O	O
Sp3	Sp3	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
relative	relative	JJ	I-NP	O
abundance	abundance	NN	I-NP	O
or	or	CC	O	O
functional	functional	JJ	B-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
Sp1	Sp1	NN	I-NP	B-protein
and	and	CC	O	O
Sp3	Sp3	NN	B-NP	B-protein
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
may	may	MD	B-VP	O
be	be	VB	I-VP	O
altered	alter	VBN	I-VP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
stimuli	stimulus	NNS	B-NP	O
that	that	WDT	B-NP	O
induce	induce	VBP	B-VP	O
the	the	DT	B-NP	O
BRLF1	BRLF1	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
and	and	CC	O	O
thereby	thereby	RB	B-VP	O
contribute	contribute	VBP	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
viral	viral	JJ	I-NP	O
lytic	lytic	JJ	I-NP	O
cycle	cycle	NN	I-NP	O
.	.	.	O	O

Gene	Gene	NN	B-NP	O
transfer	transfer	NN	I-NP	O
of	of	IN	B-PP	O
antisense	antisense	JJ	B-NP	B-protein
hypoxia	hypoxia	NN	I-NP	I-protein
inducible	inducible	JJ	I-NP	I-protein
factor-1	factor-1	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
enhances	enhance	VBZ	B-VP	O
the	the	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
efficacy	efficacy	NN	I-NP	O
of	of	IN	B-PP	O
cancer	cancer	NN	B-NP	O
immunotherapy	immunotherapy	NN	I-NP	O
.	.	.	O	O

Solid	Solid	JJ	B-NP	O
tumors	tumor	NNS	I-NP	O
meet	meet	VBP	B-VP	O
their	their	PRP$	B-NP	O
demands	demand	NNS	I-NP	O
for	for	IN	B-PP	O
nascent	nascent	JJ	B-NP	O
blood	blood	NN	I-NP	O
vessels	vessel	NNS	I-NP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
glycolysis	glycolysis	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
combat	combat	VB	I-VP	O
hypoxia	hypoxia	NN	B-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
activating	activate	VBG	B-VP	O
multiple	multiple	JJ	B-NP	O
genes	gene	NNS	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
angiogenesis	angiogenesis	NN	B-NP	O
and	and	CC	I-NP	O
glucose	glucose	NN	I-NP	O
metabolism	metabolism	NN	I-NP	O
.	.	.	O	O

Hypoxia	Hypoxia	NN	B-NP	B-protein
inducible	inducible	JJ	I-NP	I-protein
factor-1	factor-1	NN	I-NP	I-protein
(	(	(	O	O
HIF-1	HIF-1	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
constitutively	constitutively	RB	I-NP	O
expressed	express	VBN	I-NP	O
basic	basic	JJ	I-NP	B-protein
helix-loop-helix	helix-loop-helix	JJ	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
formed	form	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
assembly	assembly	NN	I-NP	O
of	of	IN	B-PP	O
HIF-1alpha	HIF-1alpha	NN	B-NP	B-protein
and	and	CC	O	O
HIF-1beta	HIF-1beta	NN	B-NP	B-protein
(	(	(	O	O
Arnt	Arnt	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
stablized	stablize	VBN	I-VP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
hypoxia	hypoxia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
rapidly	rapidly	RB	B-VP	O
degraded	degrade	VBN	I-VP	O
under	under	IN	B-PP	O
normoxic	normoxic	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
activates	activate	VBZ	B-VP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
genes	gene	NNS	B-NP	B-DNA
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
maintaining	maintain	VBG	B-VP	O
oxygen	oxygen	NN	B-NP	O
homeostasis	homeostasis	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
engineered	engineer	VBN	B-NP	O
down-regulation	down-regulation	NN	I-NP	O
of	of	IN	B-PP	O
HIF-1alpha	HIF-1alpha	NN	B-NP	B-protein
by	by	IN	B-PP	O
intratumoral	intratumoral	JJ	B-NP	O
gene	gene	NN	I-NP	O
transfer	transfer	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
antisense	antisense	JJ	I-NP	B-DNA
HIF-1alpha	HIF-1alpha	NN	I-NP	I-DNA
plasmid	plasmid	NN	I-NP	I-DNA
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
down-regulation	down-regulation	NN	I-NP	O
of	of	IN	B-PP	O
VEGF	VEGF	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
tumor	tumor	NN	B-NP	O
microvessel	microvessel	NN	I-NP	O
density	density	NN	I-NP	O
.	.	.	O	O

Antisense	Antisense	JJ	B-NP	O
HIF-1alpha	HIF-1alpha	NN	I-NP	O
monotherapy	monotherapy	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
complete	complete	JJ	I-NP	O
and	and	CC	I-NP	O
permanent	permanent	JJ	I-NP	O
rejection	rejection	NN	I-NP	O
of	of	IN	B-PP	O
small	small	JJ	B-NP	O
(	(	(	O	O
0.1	0.1	CD	B-NP	O
cm	cm	NN	I-NP	O
in	in	IN	B-PP	O
diameter	diameter	NN	B-NP	O
)	)	)	O	O
EL-4	EL-4	NN	B-NP	O
tumors	tumor	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
unusual	unusual	JJ	B-ADJP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
anti-angiogenic	anti-angiogenic	JJ	I-NP	O
agent	agent	NN	I-NP	O
where	where	WRB	B-ADVP	O
transient	transient	JJ	B-NP	O
suppression	suppression	NN	I-NP	O
of	of	IN	B-PP	O
tumor	tumor	NN	B-NP	O
growth	growth	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
norm	norm	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
induced	induce	VBD	B-VP	O
NK	NK	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
-dependent	-dependent	JJ	I-NP	O
rejection	rejection	NN	I-NP	O
of	of	IN	B-PP	O
tumors	tumor	NNS	B-NP	O
,	,	,	O	O
but	but	CC	O	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
stimulate	stimulate	VB	I-VP	O
systemic	systemic	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
-mediated	-mediated	JJ	I-NP	O
anti-tumor	anti-tumor	JJ	I-NP	O
immunity	immunity	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
synergized	synergize	VBD	B-VP	O
with	with	IN	B-PP	O
B7-1-mediated	B7-1-mediated	JJ	B-NP	O
immunotherapy	immunotherapy	NN	I-NP	O
to	to	TO	B-VP	O
cause	cause	VB	I-VP	O
the	the	DT	B-NP	O
NK	NK	NN	I-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
and	and	CC	I-NP	O
CD8	CD8	NN	I-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
-dependent	-dependent	JJ	I-NP	O
rejection	rejection	NN	I-NP	O
of	of	IN	B-PP	O
larger	large	JJR	B-NP	O
EL-4	EL-4	NN	I-NP	O
tumors	tumor	NNS	I-NP	O
(	(	(	O	O
0.4	0.4	CD	B-NP	O
cm	cm	NN	I-NP	O
in	in	IN	B-PP	O
diameter	diameter	NN	B-NP	O
)	)	)	O	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
refractory	refractory	JJ	B-ADJP	O
to	to	TO	B-PP	O
monotherapies	monotherapy	NNS	B-NP	O
.	.	.	O	O

Mice	Mouse	NNS	B-NP	O
cured	cure	VBN	B-VP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
tumors	tumor	NNS	I-NP	O
by	by	IN	B-PP	O
combination	combination	NN	B-NP	O
therapy	therapy	NN	I-NP	O
resisted	resist	VBD	B-VP	O
a	a	DT	B-NP	O
rechallenge	rechallenge	NN	I-NP	O
with	with	IN	B-PP	O
parental	parental	JJ	B-NP	B-cell_type
tumor	tumor	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
systemic	systemic	JJ	B-NP	O
antitumor	antitumor	NN	I-NP	O
immunity	immunity	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
achieved	achieve	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
summary	summary	NN	B-NP	O
,	,	,	O	O
whilst	whilst	IN	B-PP	O
intensive	intensive	JJ	B-NP	O
investigations	investigation	NNS	I-NP	O
are	be	VBP	B-VP	O
in	in	IN	B-PP	O
progress	progress	NN	B-NP	O
to	to	TO	B-VP	O
target	target	VB	I-VP	O
the	the	DT	B-NP	O
many	many	JJ	I-NP	O
HIF-1	HIF-1	NN	I-NP	B-protein
effectors	effector	NNS	I-NP	I-protein
,	,	,	O	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
herein	herein	RB	B-VP	O
indicate	indicate	VBP	I-VP	O
that	that	IN	B-SBAR	O
blocking	block	VBG	B-VP	O
hypoxia-inducible	hypoxia-inducible	JJ	B-NP	O
pathways	pathway	NNS	I-NP	O
and	and	CC	O	O
enhancing	enhance	VBG	B-VP	O
NK-mediated	NK-mediated	JJ	B-NP	O
antitumor	antitumor	NN	I-NP	O
immunity	immunity	NN	I-NP	O
by	by	IN	B-PP	O
targeting	target	VBG	B-VP	O
HIF-1	HIF-1	NN	B-NP	B-protein
itself	itself	PRP	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
advantageous	advantageous	JJ	B-ADJP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
combined	combine	VBN	B-VP	O
with	with	IN	B-PP	O
cancer	cancer	NN	B-NP	O
immunotherapy	immunotherapy	NN	I-NP	O
.	.	.	O	O

Runx2	Runx2	NN	B-NP	B-protein
:	:	:	O	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
oncogenic	oncogenic	JJ	I-NP	O
effector	effector	NN	I-NP	O
revealed	reveal	VBN	B-VP	O
by	by	IN	B-PP	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
complementation	complementation	NN	I-NP	O
and	and	CC	O	O
retroviral	retroviral	JJ	B-NP	O
tagging	tagging	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Runx2	Runx2	NN	I-NP	B-protein
(	(	(	O	O
Cbfa1	Cbfa1	NN	B-NP	B-protein
,	,	,	O	O
Pebp2alphaA	Pebp2alphaA	NN	B-NP	B-protein
,	,	,	O	O
Aml3	Aml3	NN	B-NP	O
)	)	)	O	O
gene	gene	NN	B-NP	O
was	be	VBD	B-VP	O
previously	previously	RB	I-VP	O
identified	identify	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
frequent	frequent	JJ	I-NP	O
target	target	NN	I-NP	O
for	for	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
proviral	proviral	JJ	B-NP	O
insertion	insertion	NN	I-NP	O
in	in	IN	B-PP	O
T-cell	T-cell	NN	B-NP	B-cell_type
lymphomas	lymphoma	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
CD2-MYC	CD2-MYC	NN	B-NP	O
transgenic	transgenic	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
recently	recently	RB	I-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
over-expression	over-expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
full-length	full-length	NN	I-NP	B-DNA
,	,	,	O	O
most	most	RBS	B-NP	O
highly	highly	RB	I-NP	O
expressed	express	VBN	I-NP	O
Runx2	Runx2	NN	I-NP	B-protein
isoform	isoform	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
thymus	thymus	NN	I-NP	O
perturbs	perturb	VBZ	B-VP	O
T-cell	T-cell	NN	B-NP	O
development	development	NN	I-NP	O
,	,	,	O	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
development	development	NN	B-NP	O
of	of	IN	B-PP	O
spontaneous	spontaneous	JJ	B-NP	O
lymphomas	lymphoma	NNS	I-NP	O
at	at	IN	B-PP	O
low	low	JJ	B-NP	O
frequency	frequency	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
strongly	strongly	RB	B-ADJP	O
synergistic	synergistic	JJ	I-ADJP	O
with	with	IN	B-PP	O
Myc	Myc	NN	B-NP	B-protein
.	.	.	O	O

To	To	TO	B-VP	O
gain	gain	VB	I-VP	O
further	further	JJ	B-NP	O
insight	insight	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
of	of	IN	B-PP	O
Runx2	Runx2	NN	B-NP	B-protein
to	to	TO	B-PP	O
other	other	JJ	B-NP	O
lymphomagenic	lymphomagenic	JJ	I-NP	O
pathways	pathway	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
tested	test	VBD	B-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
combining	combine	VBG	B-VP	O
the	the	DT	B-NP	O
CD2-Runx2	CD2-Runx2	NN	I-NP	B-DNA
transgene	transgene	NN	I-NP	I-DNA
either	either	CC	B-PP	O
with	with	IN	I-PP	O
a	a	DT	B-NP	O
Pim1	Pim1	NN	I-NP	B-DNA
transgene	transgene	NN	I-NP	I-DNA
(	(	(	O	O
E	E	NN	B-NP	O
(	(	(	O	O
mu	mu	NN	B-NP	O
)	)	)	O	O
-Pim1	-Pim1	NN	B-NP	O
)	)	)	O	O
or	or	CC	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
p53	p53	NN	I-NP	B-protein
null	null	JJ	I-NP	O
genotype	genotype	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
displays	display	NNS	I-NP	O
independent	independent	JJ	B-NP	O
synergy	synergy	NN	I-NP	O
with	with	IN	B-PP	O
Myc	Myc	NN	B-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
both	both	DT	B-NP	O
cases	case	NNS	I-NP	O
we	we	PRP	B-NP	O
observed	observe	VBD	B-VP	O
synergistic	synergistic	JJ	B-NP	O
tumour	tumour	NN	I-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
Runx2	Runx2	NN	B-NP	B-protein
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
tumour	tumour	NN	I-NP	O
phenotype	phenotype	NN	I-NP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
case	case	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
most	most	JJS	B-NP	O
tumours	tumour	NNS	I-NP	O
conforming	conform	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CD3	CD3	NN	I-NP	O
(	(	(	O	O
+	+	SYM	B-NP	O
)	)	)	O	O
,	,	,	O	O
CD8	CD8	NN	B-NP	B-protein
(	(	(	O	O
+	+	SYM	B-NP	O
)	)	)	O	O
,	,	,	O	O
CD4	CD4	NN	B-NP	B-protein
(	(	(	O	O
+/-	+/-	CC	O	O
)	)	)	O	O
phenotype	phenotype	NN	B-NP	O
seen	see	VBN	B-VP	O
in	in	IN	B-PP	O
CD2-Runx2	CD2-Runx2	NN	B-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

Neonatal	Neonatal	JJ	B-NP	O
infection	infection	NN	I-NP	O
of	of	IN	B-PP	O
CD2-Runx2	CD2-Runx2	NN	B-NP	O
mice	mouse	NNS	I-NP	O
with	with	IN	B-PP	O
Moloney	Moloney	NN	B-NP	O
murine	murine	JJ	I-NP	O
leukaemia	leukaemia	NN	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
Moloney	Moloney	NN	B-NP	O
MLV	MLV	NN	I-NP	O
)	)	)	O	O
also	also	RB	B-ADVP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
dramatic	dramatic	JJ	I-NP	O
acceleration	acceleration	NN	I-NP	O
of	of	IN	B-PP	O
tumour	tumour	NN	B-NP	O
onset	onset	NN	I-NP	O
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
known	known	JJ	B-NP	O
Moloney	Moloney	NNP	I-NP	O
MLV	MLV	NNP	I-NP	O
target	target	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
these	these	DT	B-NP	O
lymphomas	lymphoma	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
rearrangement	rearrangement	NN	B-NP	O
at	at	IN	B-PP	O
c-Myc	c-Myc	NN	B-NP	B-protein
or	or	CC	O	O
N-Myc	N-Myc	NN	B-NP	B-protein
(	(	(	O	O
82	82	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
number	number	NN	I-NP	O
at	at	IN	B-PP	O
Pim1	Pim1	NN	B-NP	B-protein
or	or	CC	I-NP	O
Pim2	Pim2	NN	I-NP	B-protein
(	(	(	O	O
23	23	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
at	at	IN	B-PP	O
Pal1/Gfi1	Pal1/Gfi1	NN	B-NP	O
(	(	(	O	O
18	18	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
Runx2	Runx2	NN	B-NP	B-protein
makes	make	VBZ	B-VP	O
a	a	DT	B-NP	O
distinct	distinct	JJ	I-NP	O
contribution	contribution	NN	I-NP	O
to	to	TO	B-PP	O
T-cell	T-cell	NN	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
development	development	NN	I-NP	O
which	which	WDT	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
coincide	coincide	VB	I-VP	O
with	with	IN	B-PP	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oncogene	oncogene	NN	I-NP	O
complementation	complementation	NN	I-NP	O
groups	group	NNS	I-NP	O
previously	previously	RB	B-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
retroviral	retroviral	JJ	B-NP	O
tagging	tagging	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
-related	-related	JJ	I-NP	O
apoptosis-inducing	apoptosis-inducing	JJ	I-NP	B-protein
ligand	ligand	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
enhanced	enhance	VBN	I-NP	O
cytotoxicity	cytotoxicity	NN	I-NP	O
of	of	IN	B-PP	O
IFN-beta	IFN-beta	NN	B-NP	B-protein
-stimulated	-stimulated	JJ	I-NP	O
human	human	JJ	I-NP	O
dendritic	dendritic	JJ	I-NP	O
cells	cell	NNS	I-NP	O
to	to	TO	B-PP	O
tumor	tumor	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

TNF-alpha	TNF-alpha	NN	B-NP	B-protein
-related	-related	JJ	I-NP	O
apoptosis-inducing	apoptosis-inducing	JJ	I-NP	B-protein
ligand	ligand	NN	I-NP	I-protein
(	(	(	O	O
TRAIL	TRAIL	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
its	its	PRP$	B-NP	O
preferential	preferential	JJ	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
of	of	IN	B-PP	O
tumor	tumor	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
but	but	CC	O	O
not	not	RB	O	O
normal	normal	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Dendritic	Dendritic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
DCs	DC	NNS	B-NP	B-cell_type
)	)	)	O	O
,	,	,	O	O
besides	besides	IN	B-PP	O
their	their	PRP$	B-NP	O
role	role	NN	I-NP	O
as	as	IN	B-PP	O
APCs	APC	NNS	B-NP	B-cell_type
,	,	,	O	O
now	now	RB	B-ADVP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
demonstrated	demonstrate	VBN	I-VP	O
to	to	TO	I-VP	O
exert	exert	VB	I-VP	O
cytotoxicity	cytotoxicity	NN	B-NP	O
or	or	CC	I-NP	O
cytostasis	cytostasis	NN	I-NP	O
on	on	IN	B-PP	O
some	some	DT	B-NP	O
tumor	tumor	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
that	that	IN	B-SBAR	O
both	both	CC	O	O
human	human	JJ	B-NP	B-cell_line
CD34	CD34	NN	I-NP	I-cell_line
(	(	(	O	I-cell_line
+	+	SYM	O	I-cell_line
)	)	)	O	I-cell_line
stem	stem	NN	B-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
-derived	-derived	JJ	I-NP	I-cell_line
DCs	DC	NNS	I-NP	I-cell_line
(	(	(	O	O
CD34DCs	CD34DC	NNS	B-NP	B-cell_type
)	)	)	O	O
and	and	CC	O	O
human	human	JJ	B-NP	O
CD14	CD14	NN	I-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
monocyte	monocyte	NN	B-NP	O
-derived	-derived	JJ	I-NP	O
DCs	DC	NNS	I-NP	B-cell_type
(	(	(	O	O
MoDCs	MoDC	NNS	B-NP	O
)	)	)	O	O
express	express	VBP	B-VP	O
TRAIL	TRAIL	NN	B-NP	B-protein
and	and	CC	O	O
exhibit	exhibit	VBP	B-VP	O
cytotoxicity	cytotoxicity	NN	B-NP	O
to	to	TO	B-PP	O
some	some	DT	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
tumor	tumor	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
partially	partially	RB	B-ADVP	O
through	through	IN	B-PP	O
TRAIL	TRAIL	NN	B-NP	B-protein
.	.	.	O	O

Moderate	Moderate	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
TRAIL	TRAIL	NN	B-NP	B-protein
appeared	appear	VBD	B-VP	O
on	on	IN	B-PP	O
CD34DCs	CD34DC	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
the	the	DT	B-NP	O
8th	8th	JJ	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
culture	culture	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
seen	see	VBN	I-VP	O
on	on	IN	B-PP	O
freshly	freshly	RB	B-NP	B-cell_type
isolated	isolate	VBN	I-NP	I-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
TRAIL	TRAIL	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
remained	remain	VBD	B-VP	O
constant	constant	JJ	B-ADJP	O
until	until	IN	B-SBAR	O
DC	DC	NN	B-NP	B-cell_type
maturation	maturation	NN	I-NP	O
.	.	.	O	O

TRAIL	TRAIL	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
on	on	IN	B-PP	O
immature	immature	JJ	B-NP	B-cell_type
CD34DCs	CD34DC	NNS	I-NP	I-cell_type
or	or	CC	I-NP	O
MoDCs	MoDC	NNS	I-NP	O
was	be	VBD	B-VP	O
greatly	greatly	RB	I-VP	O
up-regulated	up-regulate	VBN	I-VP	O
after	after	IN	B-PP	O
IFN-beta	IFN-beta	NN	B-NP	B-protein
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
IFN-beta	IFN-beta	NN	B-NP	B-protein
could	could	MD	B-VP	O
strikingly	strikingly	RB	I-VP	O
enhance	enhance	VB	I-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
CD34DCs	CD34DC	NNS	B-NP	B-cell_type
or	or	CC	I-NP	O
MoDCs	MoDC	NNS	I-NP	O
to	to	TO	B-VP	O
kill	kill	VB	I-VP	O
TRAIL-sensitive	TRAIL-sensitive	JJ	B-NP	B-cell_type
tumor	tumor	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
but	but	CC	O	O
LPS	LPS	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
such	such	JJ	B-NP	O
an	an	DT	I-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
up-regulation	up-regulation	NN	I-NP	O
of	of	IN	B-PP	O
TRAIL	TRAIL	NN	B-NP	B-protein
on	on	IN	B-PP	O
IFN-beta	IFN-beta	NN	B-NP	B-protein
-stimulated	-stimulated	JJ	I-NP	O
DCs	DC	NNS	I-NP	B-cell_type
partially	partially	RB	B-ADVP	O
contributed	contribute	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
increased	increase	VBN	I-NP	O
cytotoxicity	cytotoxicity	NN	I-NP	O
of	of	IN	B-PP	O
DCS	DCS	NN	B-NP	B-cell_type
:	:	:	O	O
Pretreatment	Pretreatment	NN	B-NP	O
of	of	IN	B-PP	O
TRAIL-sensitive	TRAIL-sensitive	JJ	B-NP	B-cell_type
tumor	tumor	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
caspase-3	caspase-3	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
could	could	MD	B-VP	O
significantly	significantly	RB	I-VP	O
increase	increase	VB	I-VP	O
their	their	PRP$	B-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cytotoxicity	cytotoxicity	NN	I-NP	O
of	of	IN	B-PP	O
IFN-beta	IFN-beta	NN	B-NP	B-protein
-stimulated	-stimulated	JJ	I-NP	O
DCS	DCS	NN	I-NP	B-cell_type
:	:	:	O	O
In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
inhibitor	inhibitor	NN	I-NP	O
could	could	MD	B-VP	O
significantly	significantly	RB	I-VP	O
increase	increase	VB	I-VP	O
the	the	DT	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
tumor	tumor	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
the	the	DT	B-NP	O
killing	killing	NN	I-NP	O
by	by	IN	B-PP	O
nonstimulated	nonstimulated	JJ	B-NP	O
or	or	CC	I-NP	O
LPS-stimulated	LPS-stimulated	JJ	I-NP	O
DCS	DCS	NN	I-NP	B-cell_type
:	:	:	O	O
Our	Our	PRP$	B-NP	O
studies	study	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
IFN-beta	IFN-beta	NN	B-NP	B-protein
-stimulated	-stimulated	JJ	I-NP	O
DCs	DC	NNS	I-NP	B-cell_type
are	be	VBP	B-VP	O
functionally	functionally	RB	B-ADJP	O
cytotoxic	cytotoxic	JJ	I-ADJP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
an	an	DT	B-NP	O
innate	innate	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
DC-mediated	DC-mediated	JJ	B-NP	O
antitumor	antitumor	NN	I-NP	O
immunity	immunity	NN	I-NP	O
might	might	MD	B-VP	O
exist	exist	VB	I-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
DCs	DC	NNS	B-NP	B-cell_type
act	act	VBP	B-VP	O
as	as	IN	B-SBAR	O
effectors	effector	NNS	B-NP	O
to	to	TO	B-VP	O
directly	directly	RB	I-VP	O
kill	kill	VB	I-VP	O
tumor	tumor	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
partially	partially	RB	B-ADVP	O
via	via	IN	B-PP	O
TRAIL	TRAIL	NN	B-NP	B-protein
.	.	.	O	O

Subsequently	Subsequently	RB	B-ADVP	O
,	,	,	O	O
DCs	DC	NNS	B-NP	B-cell_type
act	act	VBP	B-VP	O
as	as	IN	B-SBAR	O
APCs	APC	NNS	B-NP	B-cell_type
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
uptake	uptake	NN	I-NP	O
,	,	,	O	O
processing	processing	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
presentation	presentation	NN	B-NP	O
of	of	IN	B-PP	O
apoptotic	apoptotic	JJ	B-NP	B-protein
tumor	tumor	NN	I-NP	I-protein
Ags	Ag	NNS	I-NP	I-protein
to	to	TO	B-PP	O
cross-prime	cross-prime	JJ	B-NP	B-cell_type
CD8	CD8	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
CTL	CTL	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Tumor	Tumor	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
regulate	regulate	VBP	B-VP	O
the	the	DT	B-NP	O
lytic	lytic	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
tumor-specific	tumor-specific	JJ	B-NP	B-cell_type
cytotoxic	cytotoxic	JJ	I-NP	I-cell_type
t	t	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
modulating	modulate	VBG	B-VP	O
the	the	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	B-protein
natural	natural	JJ	I-NP	I-protein
killer	killer	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
function	function	NN	I-NP	O
.	.	.	O	O

Tumor-infiltrating	Tumor-infiltrating	JJ	B-NP	B-cell_type
p58+	p58+	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
were	be	VBD	B-VP	O
specifically	specifically	RB	I-VP	O
expanded	expand	VBN	I-VP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
tumor	tumor	NN	B-NP	O
cell	cell	NN	I-NP	O
stimulation	stimulation	NN	I-NP	O
and	and	CC	O	O
cloned	clone	VBN	B-VP	O
.	.	.	O	O

These	These	DT	B-NP	O
p58+	p58+	JJ	I-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
express	express	VB	I-VP	O
a	a	DT	B-NP	O
memory	memory	NN	I-NP	O
phenotype	phenotype	NN	I-NP	O
and	and	CC	O	O
corresponded	correspond	VBD	B-VP	O
to	to	TO	B-PP	O
clonal	clonal	JJ	B-NP	O
TCRBV3	TCRBV3	NN	I-NP	O
T-cell	T-cell	NN	I-NP	O
expansion	expansion	NN	I-NP	O
.	.	.	O	O

Functionally	Functionally	RB	B-ADVP	O
,	,	,	O	O
p58	p58	NN	B-NP	B-protein
(	(	(	O	I-protein
+	+	SYM	O	I-protein
)	)	)	O	I-protein
CTLs	CTL	NNS	B-NP	I-protein
displayed	display	VBD	B-VP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
lytic	lytic	JJ	I-NP	O
activity	activity	NN	I-NP	O
for	for	IN	B-PP	O
HLA-A2	HLA-A2	NN	B-NP	B-protein
tumor	tumor	NN	I-NP	O
and	and	CC	O	O
normal	normal	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
lytic	lytic	JJ	I-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
increased	increase	VBN	I-VP	O
after	after	IN	B-PP	O
blockade	blockade	NN	B-NP	O
of	of	IN	B-PP	O
p58	p58	NN	B-NP	B-protein
with	with	IN	B-PP	O
specific	specific	JJ	B-NP	O
monoclonal	monoclonal	JJ	I-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
stimulation	stimulation	NN	B-NP	O
by	by	IN	B-PP	O
tumor	tumor	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
required	require	VBN	I-VP	O
to	to	TO	I-VP	O
trigger	trigger	VB	I-VP	O
the	the	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
p58	p58	NN	B-NP	B-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
lytic	lytic	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
antigen-specific	antigen-specific	JJ	B-NP	B-cell_type
CTLs	CTL	NNS	I-NP	I-cell_type
and	and	CC	O	O
that	that	IN	B-SBAR	O
stimulation	stimulation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
p58	p58	NN	B-NP	B-protein
by	by	IN	B-PP	O
tumor	tumor	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
p58+	p58+	JJ	B-NP	B-cell_type
tumor-specific	tumor-specific	JJ	I-NP	I-cell_type
CTLS	CTLS	NN	I-NP	I-cell_type
.	.	.	O	O

T-cell	T-cell	NN	B-NP	B-protein
factor-1	factor-1	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
during	during	IN	B-PP	O
human	human	JJ	B-NP	O
natural	natural	JJ	I-NP	O
killer	killer	NN	I-NP	O
cell	cell	NN	I-NP	O
development	development	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
circulating	circulate	VBG	B-VP	B-cell_type
CD56	CD56	NN	B-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
bright	bright	JJ	B-NP	I-cell_type
natural	natural	JJ	I-NP	I-cell_type
killer	killer	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Transcription	Transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
essential	essential	JJ	B-ADJP	O
to	to	TO	B-VP	O
govern	govern	VB	I-VP	O
differentiation	differentiation	NN	B-NP	O
along	along	IN	B-PP	O
the	the	DT	B-NP	O
lymphoid	lymphoid	JJ	I-NP	B-cell_type
lineage	lineage	NN	I-NP	I-cell_type
from	from	IN	B-PP	O
uncommitted	uncommitted	JJ	B-NP	B-cell_type
hematopoietic	hematopoietic	JJ	I-NP	I-cell_type
stem	stem	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Although	Although	IN	B-SBAR	O
many	many	JJ	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
have	have	VBP	B-VP	O
putative	putative	JJ	B-NP	O
roles	role	NNS	I-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
murine	murine	JJ	B-NP	O
knockout	knockout	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
,	,	,	O	O
their	their	PRP$	B-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
lymphoid	lymphoid	JJ	I-NP	O
development	development	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	RBR	B-ADJP	O
known	known	JJ	I-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
further	further	RB	B-ADVP	O
.	.	.	O	O

Transcription	Transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
fresh	fresh	JJ	B-ADJP	O
and	and	CC	O	O
cultured	culture	VBN	B-VP	O
adult	adult	JJ	B-NP	O
human	human	JJ	I-NP	O
bone	bone	NN	I-NP	O
marrow	marrow	NN	I-NP	O
and	and	CC	O	O
umbilical	umbilical	JJ	B-NP	B-cell_type
cord	cord	NN	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
progenitors	progenitor	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
fresh	fresh	JJ	B-NP	O
CD34	CD34	NN	I-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
Lin	Lin	NN	B-NP	O
(	(	(	O	O
-	-	SYM	O	O
)	)	)	O	O
cells	cell	NNS	B-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
human	human	JJ	B-NP	B-protein
leukocyte	leukocyte	NN	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
(	(	(	O	O
HLA	HLA	NN	B-NP	O
)	)	)	O	O
-DR	-DR	NN	B-NP	O
(	(	(	O	O
-	-	SYM	B-NP	O
)	)	)	O	O
or	or	CC	O	O
CD38	CD38	NN	B-NP	B-protein
(	(	(	O	O
-	-	SYM	B-NP	O
)	)	)	O	O
constitutively	constitutively	RB	B-ADVP	O
express	express	VBP	B-VP	O
GATA-3	GATA-3	NN	B-NP	B-protein
but	but	CC	B-NP	O
not	not	RB	I-NP	O
T-cell	T-cell	NN	B-NP	B-protein
factor-1	factor-1	NN	I-NP	I-protein
(	(	(	O	O
TCF-1	TCF-1	NN	B-NP	B-protein
)	)	)	O	O
or	or	CC	O	O
Id-3	Id-3	NN	B-NP	B-protein
.	.	.	O	O

Culture	Culture	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	O
fetal	fetal	JJ	I-NP	O
liver	liver	NN	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
AFT024	AFT024	NN	I-NP	O
and	and	CC	O	O
defined	define	VBN	B-NP	O
cytokines	cytokine	NNS	I-NP	B-protein
was	be	VBD	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
inducing	induce	VBG	B-VP	O
TCF-1	TCF-1	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
T-cell	T-cell	NN	I-NP	B-DNA
receptor	receptor	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
rearrangement	rearrangement	NN	I-NP	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
cultured	culture	VBN	B-NP	B-cell_line
progeny	progeny	NN	I-NP	I-cell_line
.	.	.	O	O

Id-3	Id-3	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
basic	basic	JJ	I-NP	B-protein
helix	helix	NN	I-NP	I-protein
loop	loop	NN	I-NP	I-protein
helix	helix	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
with	with	IN	B-PP	O
dominant	dominant	JJ	B-NP	O
negative	negative	JJ	I-NP	O
function	function	NN	I-NP	O
for	for	IN	B-PP	O
T-cell	T-cell	NN	B-NP	B-protein
differentiation	differentiation	NN	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
,	,	,	O	O
also	also	RB	B-ADVP	O
was	be	VBD	B-VP	O
upregulated	upregulate	VBN	I-VP	O
and	and	CC	O	O
may	may	MD	B-VP	O
explain	explain	VB	I-VP	O
unsuccessful	unsuccessful	JJ	B-NP	O
T-cell	T-cell	NN	I-NP	O
maturation	maturation	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
better	well	RBR	I-VP	O
understand	understand	VB	I-VP	O
the	the	DT	B-NP	O
developmental	developmental	JJ	I-NP	O
link	link	NN	I-NP	O
between	between	IN	B-PP	O
natural	natural	JJ	B-NP	B-cell_type
killer	killer	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
NK	NK	NN	B-NP	I-cell_type
)	)	)	O	I-cell_type
cells	cell	NNS	B-NP	I-cell_type
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
progenitors	progenitor	NNS	B-NP	B-cell_type
,	,	,	O	O
we	we	PRP	B-NP	O
studied	study	VBD	B-VP	O
NK	NK	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
subsets	subset	NNS	I-NP	I-cell_type
circulating	circulate	VBG	B-VP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
.	.	.	O	O

CD56	CD56	NN	B-NP	B-protein
(	(	(	O	O
+bright	+bright	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
CD56	CD56	NN	B-NP	B-protein
(	(	(	O	O
+dim	+dim	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
NK	NK	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
constitutively	constitutively	RB	B-ADVP	O
express	express	VBP	B-VP	O
TCF-1	TCF-1	NN	B-NP	B-protein
by	by	IN	B-PP	O
reverse	reverse	JJ	B-NP	B-protein
transcriptase	transcriptase	NN	I-NP	I-protein
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
and	and	CC	O	O
Western	Western	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
TCF-1	TCF-1	NN	I-NP	B-protein
isoform	isoform	NN	I-NP	I-protein
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
CD56	CD56	NN	B-NP	B-protein
(	(	(	O	O
+bright	+bright	NN	B-NP	O
)	)	)	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
express	express	VBP	B-VP	O
lectin	lectin	NN	B-NP	B-protein
but	but	CC	B-NP	O
not	not	RB	I-NP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-protein
class	class	NN	I-NP	I-protein
I	I	CD	I-NP	I-protein
recognizing	recognize	VBG	B-VP	I-protein
inhibitory	inhibitory	JJ	B-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
,	,	,	O	O
was	be	VBD	B-VP	O
identical	identical	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
induced	induce	VBN	B-VP	O
in	in	IN	B-PP	O
NK	NK	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
differentiation	differentiation	NN	I-NP	O
culture	culture	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
distinctly	distinctly	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
from	from	IN	B-PP	O
isoforms	isoform	NNS	B-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
TCF-1	TCF-1	NN	B-NP	B-protein
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
target	target	VB	I-VP	O
human	human	JJ	B-NP	B-DNA
killer	killer	NN	I-NP	I-DNA
immunoglobulin	immunoglobulin	NN	I-NP	I-DNA
receptor	receptor	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
,	,	,	O	O
TCF-1	TCF-1	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
uniquely	uniquely	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
circulating	circulate	VBG	B-VP	B-cell_type
CD56	CD56	NN	B-NP	I-cell_type
(	(	(	O	I-cell_type
+bright	+bright	NN	B-NP	I-cell_type
)	)	)	O	I-cell_type
NK	NK	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
specific	specific	JJ	B-NP	O
TCF-1	TCF-1	NN	I-NP	B-protein
isoforms	isoform	NNS	I-NP	I-protein
may	may	MD	B-VP	O
play	play	VB	I-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
NK	NK	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
NK/T-cell	NK/T-cell	NN	I-NP	O
progenitor	progenitor	NN	I-NP	O
.	.	.	O	O

Transcriptional	Transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
matrix	matrix	NN	I-NP	B-protein
associating	associate	VBG	B-VP	I-protein
region-binding	region-binding	JJ	B-NP	I-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

contextual	contextual	JJ	B-NP	O
requirements	requirement	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
bright	bright	NN	B-NP	O
.	.	.	O	O

Bright	Bright	JJ	B-NP	O
(	(	(	O	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
regulator	regulator	NN	I-NP	O
of	of	IN	B-PP	O
IgH	IgH	NN	B-NP	O
transcription	transcription	NN	I-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
B	B	NN	I-NP	O
cell	cell	NN	I-NP	O
-specific	-specific	JJ	B-ADJP	O
,	,	,	O	O
matrix	matrix	NN	B-NP	B-protein
associating	associate	VBG	B-VP	I-protein
region-binding	region-binding	JJ	B-NP	I-protein
protein	protein	NN	I-NP	I-protein
that	that	WDT	B-NP	O
transactivates	transactivate	VBZ	B-VP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
IgH	IgH	NN	I-NP	B-DNA
intronic	intronic	JJ	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
(	(	(	O	O
E	E	NN	B-NP	B-protein
mu	mu	NN	I-NP	I-protein
)	)	)	O	O
.	.	.	O	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
here	here	RB	B-ADVP	O
that	that	IN	B-SBAR	O
Bright	Bright	NNP	B-NP	O
has	have	VBZ	B-VP	O
multiple	multiple	JJ	B-NP	O
contextual	contextual	JJ	I-NP	O
requirements	requirement	NNS	I-NP	O
to	to	TO	B-VP	O
function	function	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	B-protein
activator	activator	NN	I-NP	I-protein
.	.	.	O	O

Bright	Bright	NNP	B-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
transactivate	transactivate	VB	I-VP	O
via	via	IN	B-PP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
context	context	NN	B-NP	O
,	,	,	O	O
concatenated	concatenate	VBN	B-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
.	.	.	O	O

Transactivation	Transactivation	NN	B-NP	O
is	be	VBZ	B-VP	O
maximal	maximal	JJ	B-ADJP	O
on	on	IN	B-PP	O
integrated	integrate	VBN	B-NP	O
substrates	substrate	NNS	I-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
previously	previously	RB	I-NP	O
identified	identify	VBN	I-NP	O
binding	bind	VBG	I-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
E	E	NN	B-NP	B-protein
mu	mu	NN	I-NP	I-protein
are	be	VBP	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
full	full	JJ	B-NP	O
Bright	Bright	JJ	I-NP	O
transactivation	transactivation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Bright	Bright	NNP	I-NP	O
DNA	DNA	NN	I-NP	B-protein
binding	binding	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
defined	define	VBD	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
family	family	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
includes	include	VBZ	B-VP	O
SWI1	SWI1	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
SWI.SNF	SWI.SNF	NN	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
shown	show	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
high	high	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
group-like	group-like	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
characteristics	characteristic	NNS	I-NP	O
.	.	.	O	O

Similar	Similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
one	one	CD	B-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
high	high	JJ	B-NP	B-protein
mobility	mobility	NN	I-NP	I-protein
group	group	NN	I-NP	I-protein
box	box	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
,	,	,	O	O
Bright	Bright	NNP	B-NP	O
distorts	distort	VBZ	B-VP	O
E	E	NNP	B-NP	O
mu	mu	NN	I-NP	O
binding	binding	NN	I-NP	O
site	site	NN	I-NP	O
-containing	-containing	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
on	on	IN	B-PP	O
binding	binding	NN	B-NP	O
,	,	,	O	O
supporting	support	VBG	B-VP	O
the	the	DT	B-NP	O
concept	concept	NN	I-NP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
mediates	mediate	VBZ	B-VP	O
E	E	NN	B-NP	O
mu	mu	NN	I-NP	O
remodeling	remodeling	NN	I-NP	O
.	.	.	O	O

Transfection	Transfection	NN	B-NP	O
studies	study	NNS	I-NP	O
further	further	RB	B-ADVP	O
implicate	implicate	VBP	B-VP	O
Bright	Bright	NNP	B-NP	O
in	in	IN	B-PP	O
facilitating	facilitate	VBG	B-VP	O
spatially	spatially	RB	B-NP	O
separated	separate	VBN	I-NP	O
promoter-enhancer	promoter-enhancer	JJ	I-NP	O
interactions	interaction	NNS	I-NP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
transient	transient	JJ	I-NP	O
and	and	CC	I-NP	O
stable	stable	JJ	I-NP	O
assays	assay	NNS	I-NP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
Bright	Bright	NNP	B-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
enhanced	enhance	VBN	B-NP	O
DNase	DNase	NN	I-NP	B-protein
I	I	CD	I-NP	I-protein
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
endogenous	endogenous	JJ	I-NP	B-DNA
E	E	NN	I-NP	I-DNA
mu	mu	NN	I-NP	I-DNA
matrix	matrix	NN	I-NP	I-DNA
associating	associate	VBG	B-VP	I-DNA
regions	region	NNS	B-NP	I-DNA
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
further	further	RB	B-VP	O
suggest	suggest	VBP	I-VP	O
that	that	IN	B-SBAR	O
Bright	Bright	NNP	B-NP	O
may	may	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
increased	increase	VBN	B-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
by	by	IN	B-PP	O
remodeling	remodel	VBG	B-VP	O
the	the	DT	B-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	B-DNA
locus	locus	NN	I-NP	I-DNA
during	during	IN	B-PP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
BCL-6	BCL-6	NN	B-NP	B-protein
mutations	mutation	NNS	I-NP	O
in	in	IN	B-PP	O
classic	classic	JJ	B-NP	O
Hodgkin	Hodgkin	NN	I-NP	O
disease	disease	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
B-	B-	NN	I-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
T-cell	T-cell	NN	I-NP	I-cell_type
type	type	NN	I-NP	I-cell_type
.	.	.	O	O

BCL-6	BCL-6	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
germinal	germinal	JJ	B-NP	O
center	center	NN	I-NP	O
formation	formation	NN	I-NP	O
and	and	CC	O	O
thus	thus	RB	B-ADVP	O
for	for	IN	B-PP	O
affinity	affinity	NN	B-NP	O
maturation	maturation	NN	I-NP	O
of	of	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-DNA
(	(	(	O	I-DNA
Ig	Ig	NN	B-NP	I-DNA
)	)	)	O	I-DNA
genes	gene	NNS	B-NP	I-DNA
by	by	IN	B-PP	O
somatic	somatic	JJ	B-NP	O
mutations	mutation	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
5'-noncoding	5'-noncoding	JJ	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
BCL-6	BCL-6	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
even	even	RB	B-NP	O
a	a	DT	I-NP	O
target	target	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
mutation	mutation	NN	I-NP	O
machinery	machinery	NN	I-NP	O
.	.	.	O	O

Translocations	Translocation	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
BCL-6	BCL-6	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
to	to	TO	B-PP	O
heterologous	heterologous	JJ	B-NP	B-DNA
promoters	promoter	NNS	I-NP	I-DNA
and	and	CC	I-NP	O
mutations	mutation	NNS	I-NP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
5'-noncoding	5'-noncoding	JJ	I-NP	B-DNA
regulatory	regulatory	JJ	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
were	be	VBD	B-VP	O
reported	report	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
potential	potential	JJ	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
for	for	IN	B-PP	O
deregulating	deregulate	VBG	B-VP	O
BCL-6	BCL-6	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
playing	play	VBG	B-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
genesis	genesis	NN	I-NP	O
of	of	IN	B-PP	O
non-Hodgkin	non-Hodgkin	JJ	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
line	line	NN	B-NP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
observation	observation	NN	I-NP	O
that	that	IN	B-SBAR	O
B-cell	B-cell	NN	B-NP	B-cell_type
lymphoma	lymphoma	NN	I-NP	I-cell_type
with	with	IN	B-PP	O
somatic	somatic	JJ	B-NP	O
mutations	mutation	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
diffuse	diffuse	JJ	B-NP	O
large	large	JJ	I-NP	O
B-cell	B-cell	NN	I-NP	O
lymphoma	lymphoma	NN	I-NP	O
and	and	CC	O	O
follicular	follicular	JJ	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
carry	carry	VBP	B-VP	O
BCL-6	BCL-6	NN	B-NP	B-protein
mutations	mutation	NNS	I-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
recurrently	recurrently	RB	B-ADJP	O
detectable	detectable	JJ	I-ADJP	O
.	.	.	O	O

Classic	Classic	JJ	B-NP	O
Hodgkin	Hodgkin	NN	I-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
cHD	cHD	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
derived	derive	VBN	I-VP	O
from	from	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
loads	load	NNS	I-NP	O
of	of	IN	B-PP	O
somatic	somatic	JJ	B-NP	O
mutations	mutation	NNS	I-NP	O
and	and	CC	O	O
thus	thus	RB	O	O
a	a	DT	B-NP	O
further	further	JJ	I-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
BCL-6	BCL-6	NN	B-NP	B-protein
mutations	mutation	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
and	and	CC	I-NP	O
potential	potential	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
BCL-6	BCL-6	NN	B-NP	B-protein
mutations	mutation	NNS	I-NP	O
in	in	IN	B-PP	O
cHD	cHD	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
5'-noncoding	5'-noncoding	JJ	I-NP	O
BCL-6	BCL-6	NN	I-NP	B-protein
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
single	single	JJ	B-NP	O
Hodgkin	Hodgkin	NN	I-NP	O
and	and	CC	I-NP	O
Reed-Sternberg	Reed-Sternberg	NN	I-NP	B-cell_line
(	(	(	I-NP	I-cell_line
HRS	HRS	NN	I-NP	I-cell_line
)	)	)	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
from	from	IN	B-PP	O
6	6	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
cHD	cHD	NN	B-NP	O
and	and	CC	O	O
6	6	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
HD-derived	HD-derived	JJ	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
was	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
.	.	.	O	O

All	All	DT	B-NP	O
B-cell-derived	B-cell-derived	JJ	I-NP	B-cell_line
HD	HD	NN	I-NP	I-cell_line
cases	case	NNS	I-NP	I-cell_line
and	and	CC	O	I-cell_line
cell	cell	NN	B-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
harbored	harbor	VBD	B-VP	O
BCL-6	BCL-6	NN	B-NP	B-protein
mutations	mutation	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
T-cell-derived	T-cell-derived	JJ	I-NP	B-cell_line
HD	HD	NN	I-NP	I-cell_line
cases	case	NNS	I-NP	I-cell_line
and	and	CC	O	I-cell_line
cell	cell	NN	B-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
devoid	devoid	JJ	B-ADJP	O
of	of	IN	B-PP	O
BCL-6	BCL-6	NN	B-NP	B-protein
mutations	mutation	NNS	I-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
only	only	RB	B-NP	O
one	one	CD	I-NP	O
exception	exception	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
lymphoma-specific	lymphoma-specific	JJ	I-NP	O
recurrent	recurrent	JJ	I-NP	O
BCL-6	BCL-6	NN	I-NP	B-protein
mutations	mutation	NNS	I-NP	O
detected	detect	VBN	B-VP	O
,	,	,	O	O
and	and	CC	O	O
BCL-6	BCL-6	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
was	be	VBD	B-VP	O
absent	absent	JJ	B-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
HRS	HRS	NN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
of	of	IN	B-PP	O
most	most	JJS	B-NP	O
cases	case	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
conclusion	conclusion	NN	B-NP	O
,	,	,	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
somatic	somatic	JJ	B-NP	O
BCL-6	BCL-6	NN	I-NP	B-protein
mutations	mutation	NNS	I-NP	O
are	be	VBP	B-VP	O
restricted	restricted	JJ	B-ADJP	O
to	to	TO	B-PP	O
cHD	cHD	NN	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
B-cell	B-cell	NN	B-NP	B-cell_type
origin	origin	NN	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
(	(	(	B-LST	O
2	2	LS	I-LST	O
)	)	)	O	O
the	the	DT	B-NP	O
BCL-6	BCL-6	NN	I-NP	B-protein
mutations	mutation	NNS	I-NP	O
represent	represent	VBP	B-VP	O
mostly	mostly	RB	B-NP	O
irrelevant	irrelevant	JJ	I-NP	O
somatic	somatic	JJ	I-NP	O
base	base	NN	I-NP	O
substitutions	substitution	NNS	I-NP	O
without	without	IN	B-PP	O
consequences	consequence	NNS	B-NP	O
for	for	IN	B-PP	O
BCL-6	BCL-6	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
cHD	cHD	NN	B-NP	O
.	.	.	O	O

Gadd45gamma	Gadd45gamma	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
dispensable	dispensable	JJ	B-ADJP	O
for	for	IN	B-PP	O
normal	normal	JJ	B-NP	O
mouse	mouse	NN	I-NP	O
development	development	NN	I-NP	O
and	and	CC	O	O
T-cell	T-cell	NN	B-NP	O
proliferation	proliferation	NN	I-NP	O
.	.	.	O	O

Gadd45gamma	Gadd45gamma	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
family	family	NN	I-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
arrest	arrest	NN	I-NP	O
and	and	CC	O	O
DNA	DNA	NN	B-NP	O
damage-inducible	damage-inducible	JJ	I-NP	O
gene	gene	NN	I-NP	O
family	family	NN	I-NP	O
45	45	CD	I-NP	O
(	(	(	O	O
Gadd45	Gadd45	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
is	be	VBZ	B-VP	O
strongly	strongly	RB	I-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
interleukin-2	interleukin-2	NN	B-NP	B-protein
(	(	(	O	O
IL-2	IL-2	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

While	While	IN	B-SBAR	O
in	in	IN	B-PP	O
most	most	JJS	B-NP	O
tissues	tissue	NNS	I-NP	O
all	all	DT	B-NP	O
Gadd45	Gadd45	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
members	member	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
expressed	express	VBN	I-VP	O
,	,	,	O	O
Gadd45gamma	Gadd45gamma	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
only	only	JJ	I-NP	O
member	member	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-protein
-induced	-induced	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
Gadd45gamma	Gadd45gamma	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
signaling	signaling	NN	I-NP	O
pathway	pathway	NN	I-NP	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
tyrosine	tyrosine	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
Jak3	Jak3	NN	I-NP	B-protein
and	and	CC	O	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
Stat5a	Stat5a	NN	B-NP	B-protein
and	and	CC	O	O
Stat5b	Stat5b	NN	B-NP	B-protein
(	(	(	O	O
signal	signal	NN	B-NP	B-protein
transducer	transducer	NN	I-NP	I-protein
and	and	CC	O	I-protein
activator	activator	NN	B-NP	I-protein
of	of	IN	B-PP	I-protein
transcription	transcription	NN	B-NP	I-protein
)	)	)	O	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
studies	study	NNS	I-NP	O
with	with	IN	B-PP	O
ectopically	ectopically	RB	B-NP	O
overexpressed	overexpresse	VBN	I-NP	O
Gadd45gamma	Gadd45gamma	NN	I-NP	B-protein
in	in	IN	B-PP	O
various	various	JJ	B-NP	O
cell	cell	NN	I-NP	B-cell_line
lines	line	NNS	I-NP	I-cell_line
implicated	implicate	VBD	B-VP	O
its	its	PRP$	B-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
negative	negative	JJ	B-NP	O
growth	growth	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
analyze	analyze	VB	I-VP	O
the	the	DT	B-NP	O
physiological	physiological	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
Gadd45gamma	Gadd45gamma	NN	B-NP	B-protein
we	we	PRP	B-NP	O
used	use	VBD	B-VP	O
homologous	homologous	JJ	B-NP	O
recombination	recombination	NN	I-NP	O
to	to	TO	B-VP	O
generate	generate	VB	I-VP	O
mice	mouse	NNS	B-NP	O
lacking	lack	VBG	B-VP	O
Gadd45gamma	Gadd45gamma	NN	B-NP	B-protein
.	.	.	O	O

Gadd45gamma	Gadd45gamma	NN	B-NP	B-protein
-deficient	-deficient	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
develop	develop	VBP	B-VP	O
normally	normally	RB	B-ADVP	O
,	,	,	O	O
are	be	VBP	B-VP	O
indistinguishable	indistinguishable	JJ	B-ADJP	O
from	from	IN	B-PP	O
their	their	PRP$	B-NP	O
littermates	littermate	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
are	be	VBP	B-VP	O
fertile	fertile	JJ	B-ADJP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
hematopoiesis	hematopoiesis	NN	B-NP	O
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
lacking	lack	VBG	B-VP	O
Gadd45gamma	Gadd45gamma	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
not	not	RB	O	O
impaired	impaired	JJ	B-ADJP	O
and	and	CC	O	O
Gadd45gamma	Gadd45gamma	NN	B-NP	O
-deficient	-deficient	JJ	I-NP	O
T	T	NN	I-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
show	show	VBP	B-VP	O
normal	normal	JJ	B-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
Gadd45gamma	Gadd45gamma	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
not	not	RB	O	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
normal	normal	JJ	B-NP	O
mouse	mouse	NN	I-NP	O
development	development	NN	I-NP	O
and	and	CC	I-NP	O
hematopoiesis	hematopoiesis	NN	I-NP	O
,	,	,	O	O
possibly	possibly	RB	B-ADVP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
functional	functional	JJ	B-NP	O
redundancy	redundancy	NN	I-NP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
Gadd45	Gadd45	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
members	member	NNS	I-NP	I-protein
.	.	.	O	O

Gadd45gamma	Gadd45gamma	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
dispensable	dispensable	JJ	B-ADJP	O
for	for	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
T-cell	T-cell	NN	I-NP	O
proliferation	proliferation	NN	I-NP	O
.	.	.	O	O

Decreased	Decrease	VBN	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
c-myc	c-myc	NN	B-NP	B-DNA
family	family	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
thymuses	thymus	NNS	B-NP	O
from	from	IN	B-PP	O
myasthenia	myasthenia	NN	B-NP	O
gravis	gravis	NN	I-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
thymus	thymus	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
organ	organ	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
elimination	elimination	NN	I-NP	O
of	of	IN	B-PP	O
autoreactive	autoreactive	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
studied	study	VBD	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
apoptosis-associated	apoptosis-associated	JJ	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
,	,	,	O	O
bcl-xL	bcl-xL	NN	B-NP	B-protein
,	,	,	O	O
bad	bad	NN	B-NP	B-protein
,	,	,	O	O
caspase-3	caspase-3	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
c-myc	c-myc	NN	B-NP	B-DNA
family	family	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
myasthenia	myasthenia	NN	B-NP	O
gravis	gravis	NN	I-NP	O
(	(	(	O	O
MG	MG	NN	B-NP	O
)	)	)	O	O
thymuses	thymus	NNS	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
observed	observe	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
mRNA	mRNA	NN	I-NP	B-RNA
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
myc	myc	NN	B-NP	B-DNA
family	family	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
,	,	,	O	O
c-myc	c-myc	NN	B-NP	B-DNA
and	and	CC	O	O
max	max	NN	B-NP	B-protein
,	,	,	O	O
were	be	VBD	B-VP	O
markedly	markedly	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
in	in	IN	B-PP	O
MG	MG	NN	B-NP	O
thymuses	thymus	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
c-myc	c-myc	NN	B-NP	B-DNA
-mediated	-mediated	JJ	I-NP	O
signaling	signaling	NN	I-NP	O
is	be	VBZ	B-VP	O
abnormal	abnormal	JJ	B-ADJP	O
in	in	IN	B-PP	O
MG	MG	NN	B-NP	O
thymuses	thymus	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
molecules	molecule	NNS	B-NP	O
whose	whose	WP$	B-NP	O
expressions	expression	NNS	I-NP	O
are	be	VBP	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
myc	myc	NN	B-NP	B-protein
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
STAM	STAM	NN	B-NP	B-protein
,	,	,	O	O
prothymosin-alpha	prothymosin-alpha	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
NFkappaB	NFkappaB	NN	B-NP	B-protein

Immunohistochemical	Immunohistochemical	JJ	B-NP	O
detection	detection	NN	I-NP	O
of	of	IN	B-PP	O
interferon-gamma-producing	interferon-gamma-producing	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
dermatophytosis	dermatophytosis	NN	B-NP	O
.	.	.	O	O

Skin	Skin	NN	B-NP	O
lesions	lesion	NNS	I-NP	O
of	of	IN	B-PP	O
dermatophytosis	dermatophytosis	NN	B-NP	O
are	be	VBP	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
-dependent	-dependent	JJ	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
response	response	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
various	various	JJ	B-NP	O
cytokines	cytokine	NNS	I-NP	B-protein
.	.	.	O	O

We	We	PRP	B-NP	O
examined	examine	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
IFN-gamma-positive	IFN-gamma-positive	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
(	(	(	O	O
as	as	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
Th1	Th1	NN	B-NP	O
response	response	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
skin	skin	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
of	of	IN	B-PP	O
dermatophytosis	dermatophytosis	NN	B-NP	O
in	in	FW	B-ADVP	O
situ	situ	FW	I-ADVP	O
by	by	IN	B-PP	O
immunohistochemical	immunohistochemical	JJ	B-NP	O
techniques	technique	NNS	I-NP	O
.	.	.	O	O

Mixtures	Mixture	NNS	B-NP	O
of	of	IN	B-PP	O
CD4-positive	CD4-positive	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
CD8-positive	CD8-positive	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
dermal	dermal	JJ	I-NP	O
infiltrates	infiltrate	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

Considerable	Considerable	JJ	B-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
CD1a-positive	CD1a-positive	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
dermis	dermis	NN	I-NP	O
and	and	CC	I-NP	O
epidermis	epidermis	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
marked	marked	JJ	I-NP	O
accumulation	accumulation	NN	I-NP	O
of	of	IN	B-PP	O
CD68-positive	CD68-positive	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
dermis	dermis	NN	I-NP	O
.	.	.	O	O

IFN-gamma-positive	IFN-gamma-positive	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
dermis	dermis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
staining	staining	NN	I-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
intracellular	intracellular	JJ	B-ADJP	O
in	in	IN	B-PP	O
mononuclear	mononuclear	JJ	B-NP	B-cell_type
lymphoid	lymphoid	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
staining	staining	NN	I-NP	O
was	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
highly	highly	RB	B-ADJP	O
specific	specific	JJ	I-ADJP	O
because	because	IN	B-SBAR	O
it	it	PRP	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
completely	completely	RB	I-VP	O
blocked	block	VBN	I-VP	O
by	by	IN	B-PP	O
preabsorption	preabsorption	NN	B-NP	O
with	with	IN	B-PP	O
recombinant	recombinant	JJ	B-NP	O
IFN-gamma	IFN-gamma	NN	I-NP	B-protein
.	.	.	O	O

Our	Our	PRP$	B-NP	O
data	datum	NNS	I-NP	O
support	support	VBP	B-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
skin	skin	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
of	of	IN	B-PP	O
dermatophytosis	dermatophytosis	NN	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Th1	Th1	NN	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Th1	Th1	NN	B-NP	O
response	response	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
release	release	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
host	host	NN	I-NP	O
defense	defense	NN	I-NP	O
against	against	IN	B-PP	O
dermatophytes	dermatophyte	NNS	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
reflect	reflect	VB	I-VP	O
cutaneous	cutaneous	JJ	B-NP	O
reaction	reaction	NN	I-NP	O
in	in	IN	B-PP	O
dermatophytosis	dermatophytosis	NN	B-NP	O
.	.	.	O	O

Regulation	Regulation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
helix-loop-helix	helix-loop-helix	JJ	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
,	,	,	O	O
E2A	E2A	NN	B-NP	B-protein
and	and	CC	I-NP	O
Id3	Id3	NN	I-NP	B-protein
,	,	,	O	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Ras	Ras	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
ERK	ERK	NN	I-NP	B-protein
MAPK	MAPK	NN	I-NP	I-protein
cascade	cascade	NN	I-NP	O
.	.	.	O	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
mitogen-activated	mitogen-activated	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
MAPK	MAPK	NN	B-NP	B-protein
)	)	)	O	O
pathways	pathway	NNS	B-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
cellular	cellular	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
and/or	and/or	CC	O	O
proliferation	proliferation	NN	B-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
wide	wide	JJ	I-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
types	type	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
developing	develop	VBG	B-NP	O
thymocytes	thymocyte	NNS	I-NP	B-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
basic	basic	JJ	I-NP	B-protein
helix-loop-helix	helix-loop-helix	JJ	I-NP	I-protein
(	(	(	O	I-protein
bHLH	bHLH	JJ	B-ADJP	I-protein
)	)	)	O	I-protein
proteins	protein	NNS	B-NP	I-protein
E12	E12	NN	I-NP	B-protein
and	and	CC	I-NP	O
E47	E47	NN	I-NP	B-protein
and	and	CC	O	O
an	an	DT	B-NP	O
inhibitor	inhibitor	NN	I-NP	B-protein
HLH	HLH	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
,	,	,	O	O
Id3	Id3	NN	B-NP	B-protein
,	,	,	O	O
play	play	VBP	B-VP	O
key	key	JJ	B-NP	O
roles	role	NNS	I-NP	O
in	in	IN	B-PP	O
thymocyte	thymocyte	NN	B-NP	B-cell_type
differentiation	differentiation	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
here	here	RB	B-ADVP	O
that	that	IN	B-SBAR	O
E2A	E2A	NN	B-NP	B-protein
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
is	be	VBZ	B-VP	O
lowered	lower	VBN	I-VP	O
in	in	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
immature	immature	JJ	I-NP	I-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
consequent	consequent	JJ	B-ADJP	O
to	to	TO	B-PP	O
T	T	NN	B-NP	B-protein
cell	cell	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	I-NP	O
TCR	TCR	NN	I-NP	B-protein
)	)	)	I-NP	O
-mediated	-mediated	JJ	I-NP	O
ligation	ligation	NN	I-NP	O
.	.	.	O	O

Whereas	Whereas	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
E2A	E2A	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
and	and	CC	I-NP	O
protein	protein	NN	I-NP	O
are	be	VBP	B-VP	O
unaltered	unaltered	JJ	B-ADJP	O
,	,	,	O	O
Id3	Id3	NN	B-NP	B-RNA
transcripts	transcript	NNS	I-NP	I-RNA
are	be	VBP	B-VP	O
rapidly	rapidly	RB	I-VP	O
induced	induce	VBN	I-VP	O
upon	upon	IN	B-PP	O
signaling	signaling	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
TCR	TCR	NN	I-NP	B-protein
.	.	.	O	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
Id3	Id3	NN	B-NP	B-protein
transcription	transcription	NN	I-NP	O
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
dose-dependent	dose-dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
extracellular	extracellular	JJ	I-NP	B-protein
signal-regulated	signal-regulated	JJ	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
ERK	ERK	NN	B-NP	B-protein
)	)	)	O	O
MAPK	MAPK	NN	B-NP	O
module	module	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
observations	observation	NNS	I-NP	O
directly	directly	RB	B-VP	O
connect	connect	VBP	I-VP	O
the	the	DT	B-NP	O
ERK	ERK	NN	I-NP	B-protein
MAPK	MAPK	NN	I-NP	I-protein
cascade	cascade	NN	I-NP	I-protein
and	and	CC	I-NP	I-protein
HLH	HLH	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
in	in	IN	B-PP	O
a	a	DT	B-NP	O
linear	linear	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
.	.	.	O	O

Retinoic	Retinoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
up-regulates	up-regulate	VBZ	B-VP	O
myeloid	myeloid	JJ	B-NP	O
ICAM-3	ICAM-3	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
function	function	NN	B-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
cell-specific	cell-specific	JJ	I-NP	O
fashion	fashion	NN	I-NP	O
--	--	:	O	O
evidence	evidence	NN	B-NP	O
for	for	IN	B-PP	O
retinoid	retinoid	NN	B-NP	O
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mast	mast	NN	I-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
lineage	lineage	NN	I-NP	I-cell_type
.	.	.	O	O

Investigation	Investigation	NN	B-NP	O
of	of	IN	B-PP	O
mast	mast	NN	B-NP	O
cell	cell	NN	I-NP	O
responsiveness	responsiveness	NN	I-NP	O
toward	toward	IN	B-PP	O
retinoic	retinoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
RA	RA	NN	B-NP	O
)	)	)	O	O
revealed	reveal	VBD	B-VP	O
selective	selective	JJ	B-NP	O
promotion	promotion	NN	I-NP	O
of	of	IN	B-PP	O
ICAM-3	ICAM-3	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-cell_line
mast	mast	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
HMC-1	HMC-1	NN	I-NP	I-cell_line
.	.	.	O	O

This	This	DT	B-NP	O
process	process	NN	I-NP	O
was	be	VBD	B-VP	O
dose-	dose-	NN	B-NP	O
and	and	CC	O	O
time-dependent	time-dependent	JJ	B-NP	O
and	and	CC	I-NP	O
detectable	detectable	JJ	I-NP	O
by	by	IN	B-PP	O
flow	flow	NN	B-NP	O
cytometry	cytometry	NN	I-NP	O
,	,	,	O	O
Western	Western	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
ELISA	ELISA	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O

ICAM-3	ICAM-3	NN	B-NP	B-protein
modulation	modulation	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
cell-type	cell-type	JJ	B-NP	O
dependent	dependent	JJ	I-NP	O
,	,	,	I-NP	O
detectable	detectable	JJ	I-NP	O
also	also	RB	B-ADVP	O
for	for	IN	B-PP	O
HL-60	HL-60	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
and	and	CC	O	O
monocytes	monocyte	NNS	B-NP	B-cell_type
but	but	CC	B-NP	O
not	not	RB	I-NP	O
U-937	U-937	NN	B-NP	B-cell_line
and	and	CC	O	O
only	only	RB	B-ADVP	O
weakly	weakly	RB	I-ADVP	O
for	for	IN	B-PP	O
KU812	KU812	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Terminally	Terminally	RB	B-NP	B-cell_type
differentiated	differentiate	VBN	I-NP	I-cell_type
skin	skin	NN	I-NP	I-cell_type
mast	mast	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
also	also	RB	B-ADVP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
up-modulate	up-modulate	VB	I-VP	O
their	their	PRP$	B-NP	O
ICAM-3	ICAM-3	NN	I-NP	B-protein
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
the	the	DT	B-NP	O
requirement	requirement	NN	I-NP	O
for	for	IN	B-PP	O
some	some	DT	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
immaturity	immaturity	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

RA-mediated	RA-mediated	JJ	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
ICAM-1	ICAM-1	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
,	,	,	O	O
studied	study	VBN	B-VP	O
in	in	IN	B-PP	O
parallel	parallel	NN	B-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
clearly	clearly	RB	B-ADJP	O
distinct	distinct	JJ	I-ADJP	O
from	from	IN	B-PP	O
those	those	DT	B-NP	O
on	on	IN	B-PP	O
ICAM-3	ICAM-3	NN	B-NP	B-protein
.	.	.	O	O

Investigation	Investigation	NN	B-NP	O
of	of	IN	B-PP	O
retinoid	retinoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
,	,	,	O	O
known	know	VBN	B-VP	O
to	to	TO	I-VP	O
mediate	mediate	VB	I-VP	O
intracellular	intracellular	JJ	B-NP	O
RA	RA	NN	I-NP	O
signaling	signaling	NN	I-NP	O
,	,	,	O	O
revealed	reveal	VBD	B-VP	O
presence	presence	NN	B-NP	O
of	of	IN	B-PP	O
RAR	RAR	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
,	,	,	O	O
RAR	RAR	NN	B-NP	B-protein
gamma	gamma	NN	I-NP	I-protein
,	,	,	O	O
RXR	RXR	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
RXR	RXR	NN	B-NP	B-protein
gamma	gamma	NN	I-NP	O
transcripts	transcript	NNS	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
cell	cell	NN	I-NP	B-cell_line
lines	line	NNS	I-NP	I-cell_line
studied	study	VBN	B-VP	O
,	,	,	O	O
and	and	CC	O	O
HMC-1	HMC-1	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
only	only	JJ	I-NP	O
line	line	NN	I-NP	O
lacking	lack	VBG	B-VP	O
RXR	RXR	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
.	.	.	O	O

RAR	RAR	NN	B-NP	B-protein
beta	beta	SYM	B-NP	I-protein
,	,	,	O	O
not	not	RB	B-VP	O
expressed	express	VBN	I-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
RA	RA	NN	B-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
fashion	fashion	NN	I-NP	O
obviously	obviously	RB	B-VP	O
correlating	correlate	VBG	I-VP	O
with	with	IN	B-PP	O
ICAM-3	ICAM-3	NN	B-NP	B-protein
up-regulation	up-regulation	NN	I-NP	O
.	.	.	O	O

Increased	Increase	VBN	B-NP	O
ICAM-3	ICAM-3	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
of	of	IN	B-PP	O
functional	functional	JJ	B-NP	O
significance	significance	NN	I-NP	O
,	,	,	O	O
such	such	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
processes	process	NNS	B-NP	O
stimulated	stimulate	VBN	B-VP	O
or	or	CC	I-VP	O
co-stimulated	co-stimulate	VBN	I-VP	O
via	via	IN	B-PP	O
ICAM-3	ICAM-3	NN	B-NP	B-protein
(	(	(	O	O
homotypic	homotypic	JJ	B-NP	O
aggregation	aggregation	NN	I-NP	O
,	,	,	O	O
IL-8	IL-8	NN	B-NP	B-protein
secretion	secretion	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
clearly	clearly	RB	I-VP	O
enhanced	enhance	VBN	I-VP	O
upon	upon	IN	B-PP	O
RA	RA	NN	B-NP	O
pretreatment	pretreatment	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
RA	RA	NN	B-NP	B-protein
may	may	MD	B-VP	O
contribute	contribute	VB	I-VP	O
via	via	IN	B-PP	O
hitherto	hitherto	RB	B-NP	O
unrecognized	unrecognized	JJ	I-NP	O
pathways	pathway	NNS	I-NP	O
to	to	TO	B-PP	O
immune	immune	JJ	B-NP	O
function	function	NN	I-NP	O
and	and	CC	I-NP	O
host	host	NN	I-NP	O
defense	defense	NN	I-NP	O
.	.	.	O	O

CD28	CD28	NN	B-NP	B-protein
and	and	CC	I-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
co-stimulation	co-stimulation	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
decade	decade	NN	I-NP	O
the	the	DT	B-NP	O
concept	concept	NN	I-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
co-stimulation	co-stimulation	NN	I-NP	O
has	have	VBZ	B-VP	O
emerged	emerge	VBN	I-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
a	a	DT	B-NP	O
central	central	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
process	process	NN	I-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
exact	exact	JJ	I-NP	O
definition	definition	NN	I-NP	O
of	of	IN	B-PP	O
co-stimulation	co-stimulation	NN	B-NP	O
is	be	VBZ	B-VP	O
still	still	RB	B-ADVP	O
unclear	unclear	JJ	B-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
review	review	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
re-examine	re-examine	VBP	B-VP	O
the	the	DT	B-NP	O
concept	concept	NN	I-NP	O
of	of	IN	B-PP	O
co-stimulation	co-stimulation	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
while	while	IN	B-SBAR	O
co-stimulation	co-stimulation	NN	B-NP	O
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
,	,	,	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
little	little	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
to	to	TO	B-VP	O
link	link	VB	I-VP	O
co-stimulation	co-stimulation	NN	B-NP	O
with	with	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
anergy	anergy	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
then	then	RB	B-ADVP	O
suggest	suggest	VBP	B-VP	O
a	a	DT	B-NP	O
framework	framework	NN	I-NP	O
for	for	IN	B-PP	O
studying	study	VBG	B-VP	O
co-stimulation	co-stimulation	NN	B-NP	O
.	.	.	O	O

Focusing	Focus	VBG	B-VP	O
on	on	IN	B-PP	O
recent	recent	JJ	B-NP	O
advances	advance	NNS	I-NP	O
in	in	IN	B-PP	O
our	our	PRP$	B-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
CD28	CD28	NN	B-NP	B-protein
,	,	,	O	O
we	we	PRP	B-NP	O
discuss	discuss	VBP	B-VP	O
four	four	CD	B-NP	O
areas	area	NNS	I-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
where	where	WRB	B-ADVP	O
co-stimulation	co-stimulation	NN	B-NP	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
.	.	.	O	O

Regulation	Regulation	NN	B-NP	O
of	of	IN	B-PP	O
activator	activator	NN	B-NP	B-protein
protein-1	protein-1	NN	I-NP	I-protein
and	and	CC	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
in	in	IN	B-PP	O
CD8+	CD8+	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
peripheral	peripheral	JJ	B-NP	B-protein
self-antigens	self-antigen	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
events	event	NNS	I-NP	O
that	that	WDT	B-NP	O
control	control	VBP	B-VP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
to	to	TO	B-PP	O
peripheral	peripheral	JJ	B-NP	B-protein
self	self	NN	I-NP	I-protein
Ags	Ag	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
still	still	RB	B-ADVP	O
unknown	unknown	JJ	B-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
analyzed	analyze	VBD	B-VP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
and	and	CC	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
-mediated	-mediated	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
during	during	IN	B-PP	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
tolerance	tolerance	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
self	self	NN	I-NP	B-protein
Ag	Ag	NN	I-NP	I-protein
expressed	express	VBN	B-VP	O
exclusively	exclusively	RB	B-ADVP	O
on	on	IN	B-PP	O
hepatocytes	hepatocyte	NNS	B-NP	B-cell_type
.	.	.	O	O

Naive	Naive	JJ	B-NP	B-cell_type
CD8	CD8	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
Desire	Desire	NN	B-NP	I-cell_type
(	(	(	O	I-cell_type
Des	De	NNS	B-NP	I-cell_type
)	)	)	O	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
T	T	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Des	De	NNPS	I-NP	O
TCR-transgenic	TCR-transgenic	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
specific	specific	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
H-2K	H-2K	NN	I-NP	B-protein
(	(	(	O	I-protein
b	b	NN	B-NP	I-protein
)	)	)	O	I-protein
class	class	NN	B-NP	I-protein
I	I	CD	I-NP	I-protein
Ag	Ag	NN	I-NP	I-protein
were	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
into	into	IN	B-PP	O
Alb-K	Alb-K	NN	B-NP	B-protein
(	(	(	B-LST	O
b	b	LS	I-LST	O
)	)	)	O	O
-transgenic	-transgenic	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
that	that	WDT	B-NP	O
express	express	VBP	B-VP	O
the	the	DT	B-NP	O
H-2K	H-2K	NN	I-NP	B-protein
(	(	(	O	I-protein
b	b	NN	B-NP	I-protein
)	)	)	O	I-protein
Ag	Ag	NN	B-NP	I-protein
on	on	IN	B-PP	O
hepatocytes	hepatocyte	NNS	B-NP	B-cell_type
only	only	RB	B-ADVP	O
.	.	.	O	O

Tolerance	Tolerance	NNP	B-NP	O
develops	develop	VBZ	B-VP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
self-reactive	self-reactive	JJ	I-NP	B-cell_type
CD8	CD8	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
Des	De	NNPS	B-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
T	T	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
transiently	transiently	RB	I-VP	O
activated	activate	VBN	I-VP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
became	become	VBD	B-VP	O
unresponsive	unresponsive	JJ	B-ADJP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
further	further	RB	I-VP	O
deleted	delete	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
CD8	CD8	NN	B-NP	B-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
Des	De	NNPS	B-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
T	T	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
activated	activate	VBN	B-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
with	with	IN	B-PP	O
APCs	APC	NNS	B-NP	B-cell_type
,	,	,	O	O
which	which	WDT	B-NP	O
express	express	VBP	B-VP	O
high	high	JJ	B-NP	O
AP-1	AP-1	NN	I-NP	B-protein
and	and	CC	O	O
high	high	JJ	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
unresponsive	unresponsive	JJ	I-NP	B-cell_type
CD8	CD8	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
Des	De	NNPS	B-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
T	T	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
expressed	express	VBD	B-VP	O
no	no	DT	B-NP	O
AP-1	AP-1	NN	I-NP	B-protein
and	and	CC	O	O
only	only	RB	B-NP	O
weak	weak	JJ	I-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
generation	generation	NN	I-NP	O
of	of	IN	B-PP	O
distinct	distinct	JJ	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
.	.	.	O	O

Indeed	Indeed	RB	B-ADVP	O
,	,	,	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
primed	prim	VBN	B-NP	O
T	T	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
predominantly	predominantly	RB	B-ADVP	O
express	express	VBP	B-VP	O
p50/p50	p50/p50	NN	B-NP	B-protein
and	and	CC	I-NP	O
p65/p50	p65/p50	NN	I-NP	B-protein
dimers	dimer	NNS	I-NP	I-protein
,	,	,	O	O
whereas	whereas	IN	O	O
these	these	DT	B-NP	O
p50-containing	p50-containing	JJ	I-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
barely	barely	RB	B-ADJP	O
detectable	detectable	JJ	I-ADJP	O
in	in	IN	B-PP	O
tolerant	tolerant	JJ	B-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
that	that	WDT	B-NP	O
express	express	VBP	B-VP	O
p65-	p65-	NN	B-NP	B-protein
and	and	CC	I-NP	I-protein
c-Rel-containing	c-Rel-containing	NN	I-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
.	.	.	O	O

These	These	DT	B-NP	O
observations	observation	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
fine	fine	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
formation	formation	NN	I-NP	O
may	may	MD	B-VP	O
determine	determine	VB	I-VP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
fate	fate	NN	I-NP	O
.	.	.	O	O

Transcriptional	Transcriptional	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
in	in	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
.	.	.	O	O

Lymphocytes	Lymphocyte	NNS	B-NP	B-cell_type
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
many	many	JJ	B-NP	O
cellular	cellular	JJ	I-NP	O
processes	process	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
lineage	lineage	NN	B-NP	O
commitment	commitment	NN	I-NP	O
,	,	,	O	O
differentiation	differentiation	NN	B-NP	O
,	,	,	O	O
proliferation	proliferation	NN	B-NP	O
and	and	CC	I-NP	O
apoptosis	apoptosis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
mediate	mediate	VBP	B-VP	O
these	these	DT	B-NP	O
processes	process	NNS	I-NP	O
are	be	VBP	B-VP	O
often	often	RB	I-VP	O
expressed	express	VBN	I-VP	O
broadly	broadly	RB	B-ADVP	O
in	in	IN	B-PP	O
many	many	JJ	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
emerging	emerge	VBG	I-NP	O
theme	theme	NN	I-NP	O
is	be	VBZ	B-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
cell-type-specific	cell-type-specific	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
their	their	PRP$	B-NP	O
access	access	NN	I-NP	O
to	to	TO	B-PP	O
appropriate	appropriate	JJ	B-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
.	.	.	O	O

Existence	Existence	NN	B-NP	O
of	of	IN	B-PP	O
retinoic	retinoic	JJ	B-NP	B-protein
acid-receptor	acid-receptor	NN	I-NP	I-protein
-independent	-independent	JJ	I-NP	O
retinoid	retinoid	NN	I-NP	B-protein
X-receptor	X-receptor	NN	I-NP	I-protein
-dependent	-dependent	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
in	in	IN	B-PP	O
myeloid	myeloid	JJ	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
function	function	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
previously	previously	RB	B-ADVP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
ER-27191	ER-27191	NN	B-NP	O
(	(	(	O	O
4-	4-	CD	B-NP	O
[	[	(	O	O
4	4	CD	B-NP	O
,	,	,	I-NP	O
5	5	CD	I-NP	O
,	,	,	I-NP	O
7	7	CD	I-NP	O
,	,	,	I-NP	O
8	8	CD	I-NP	O
,	,	,	I-NP	O
9	9	CD	I-NP	O
,	,	,	I-NP	O
10-hexahydro-7	10-hexahydro-7	CD	I-NP	O
,	,	,	I-NP	O
7	7	CD	I-NP	O
,	,	,	I-NP	O
10	10	CD	I-NP	O
,	,	,	I-NP	O
10-tetramethyl-1-	10-tetramethyl-1-	CD	I-NP	O
(	(	(	O	O
3-pyridylmethyl	3-pyridylmethyl	NN	B-NP	O
)	)	)	O	O
anthra	anthra	NN	B-NP	O
[	[	(	O	O
1	1	CD	B-NP	O
,	,	,	O	O
2-b	2-b	JJ	B-NP	O
]	]	)	I-NP	O
pyrrol-3-yl	pyrrol-3-yl	NN	I-NP	O
]	]	)	I-NP	O
benzoic	benzoic	JJ	I-NP	O
acid	acid	NN	I-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
antagonist	antagonist	NN	I-NP	O
of	of	IN	B-PP	O
retinoic	retinoic	JJ	B-NP	B-protein
acid	acid	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
RAR	RAR	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
ER-35795	ER-35795	NN	B-NP	B-protein
(	(	(	O	O
(	(	(	O	O
2E	2E	NN	B-NP	O
,	,	,	O	O
4E	4E	NN	B-NP	O
,	,	,	O	O
6E	6E	NN	B-NP	O
)	)	)	O	O
-7-	-7-	CD	B-NP	O
[	[	(	O	O
1-	1-	NN	B-NP	O
(	(	(	O	O
1-methylethyl	1-methylethyl	NN	B-NP	O
)	)	)	O	O
-8-chloro-1	-8-chloro-1	CD	B-NP	O
,	,	,	I-NP	O
2	2	CD	I-NP	O
,	,	,	I-NP	O
3	3	CD	I-NP	O
,	,	,	I-NP	O
4-tetrahydroquinolin-6-yl	4-tetrahydroquinolin-6-yl	NN	I-NP	O
]	]	)	O	O
-6-fluoro-3-methyl-2	-6-fluoro-3-methyl-2	CD	B-NP	O
,	,	,	I-NP	O
4	4	CD	I-NP	O
,	,	,	O	O
6-nonatrienoic	6-nonatrienoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
retinoid	retinoid	NN	I-NP	B-protein
X	X	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	I-NP	O
RXR	RXR	NN	I-NP	B-protein
)	)	)	I-NP	O
-specific	-specific	JJ	I-NP	O
agonist	agonist	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
using	use	VBG	B-VP	O
these	these	DT	B-NP	O
compounds	compound	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
distinct	distinct	JJ	B-NP	O
RAR	RAR	NN	I-NP	B-protein
-dependent	-dependent	JJ	B-ADJP	O
and	and	CC	O	O
RXR	RXR	NN	B-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
pathways	pathway	NNS	I-NP	O
operate	operate	VBP	B-VP	O
to	to	TO	I-VP	O
mediate	mediate	VB	I-VP	O
the	the	DT	B-NP	O
diverse	diverse	JJ	I-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
retinoids	retinoid	NNS	B-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
RXR	RXR	NN	I-NP	B-protein
pathway	pathway	NN	I-NP	O
on	on	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

ER-27191	ER-27191	NN	B-NP	O
completely	completely	RB	B-ADVP	O
antagonized	antagonize	VBD	B-VP	O
HL60	HL60	NN	B-NP	O
cell	cell	NN	I-NP	O
differentiation	differentiation	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
all-trans-retinoic	all-trans-retinoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
atRA	atRA	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
differentiation	differentiation	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
ER-35795	ER-35795	NN	I-NP	B-protein
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
antagonized	antagonize	VBN	I-VP	O
at	at	IN	B-ADVP	O
all	all	DT	I-ADVP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
RAR	RAR	NN	I-NP	B-protein
antagonist	antagonist	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
RXR	RXR	NN	I-NP	B-protein
homodimer	homodimer	NN	I-NP	O
antagonist	antagonist	NN	I-NP	O
(	(	(	O	O
LGD100754	LGD100754	NN	B-NP	O
,	,	,	O	O
(	(	(	O	O
2E	2E	NN	B-NP	O
,	,	,	O	O
4E	4E	NN	B-NP	O
,	,	,	O	O
6Z	6Z	NN	B-NP	O
)	)	)	O	O
-7-	-7-	CD	B-NP	O
(	(	(	O	O
3-n-propoxy-5	3-n-propoxy-5	CD	B-NP	O
,	,	,	I-NP	O
6	6	CD	I-NP	O
,	,	,	I-NP	O
7	7	CD	I-NP	O
,	,	,	I-NP	O
8-tetrahydro-5	8-tetrahydro-5	CD	I-NP	O
,	,	,	I-NP	O
5	5	CD	I-NP	O
,	,	,	I-NP	O
8	8	CD	I-NP	O
,	,	,	I-NP	O
8-tetramethylnaphthalen-2-yl	8-tetramethylnaphthalen-2-yl	NN	I-NP	O
)	)	)	O	O
-3-methylocta-2	-3-methylocta-2	CD	B-NP	O
,	,	,	I-NP	O
4	4	CD	I-NP	O
,	,	,	O	O
6-trienoic	6-trienoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Its	Its	PRP$	B-NP	O
agonistic	agonistic	JJ	I-NP	O
action	action	NN	I-NP	O
on	on	IN	B-PP	O
RXR/RAR	RXR/RAR	NN	B-NP	B-protein
heterodimer	heterodimer	NN	I-NP	I-protein
,	,	,	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
hand	hand	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
neutralized	neutralize	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
RAR	RAR	NN	I-NP	B-protein
antagonist	antagonist	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
HL60	HL60	NN	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
differentiation	differentiation	NN	I-NP	O
,	,	,	O	O
atRA	atRA	NN	B-NP	O
induced	induce	VBD	B-VP	O
RARbeta	RARbeta	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
RXR	RXR	NN	I-NP	B-protein
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
RXR	RXR	NN	I-NP	B-protein
-pathway	-pathway	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
lipopolysaccharide-induced	lipopolysaccharide-induced	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
mouse	mouse	NN	B-NP	B-cell_type
splenocyte	splenocyte	NN	I-NP	I-cell_type
proliferation	proliferation	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
strongly	strongly	RB	B-VP	O
suggest	suggest	VBP	I-VP	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
pharmacological	pharmacological	JJ	I-NP	O
RXR	RXR	NN	I-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
ligand	ligand	NN	I-NP	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
RXR	RXR	NN	B-NP	B-protein
.	.	.	O	O

Targeting	Target	VBG	B-VP	O
Src	Src	NN	B-NP	B-protein
homology	homology	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
domain-containing	domain-containing	JJ	I-NP	I-protein
tyrosine	tyrosine	NN	I-NP	I-protein
phosphatase	phosphatase	NN	I-NP	I-protein
(	(	(	O	O
SHP-1	SHP-1	NN	B-NP	B-protein
)	)	)	O	O
into	into	IN	B-PP	O
lipid	lipid	NN	B-NP	O
rafts	raft	NNS	I-NP	O
inhibits	inhibit	VBZ	B-VP	O
CD3	CD3	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
study	study	VB	I-VP	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
protein	protein	NN	B-NP	B-protein
tyrosine	tyrosine	NN	I-NP	I-protein
phosphatases	phosphatas	NNS	I-NP	I-protein
(	(	(	O	O
PTPs	PTP	NNS	B-NP	B-protein
)	)	)	O	O
regulate	regulate	VBP	B-VP	O
CD3	CD3	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
tyrosine	tyrosine	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
PTPs	PTP	NNS	B-NP	B-protein
in	in	IN	B-PP	O
subdomains	subdomain	NNS	B-NP	O
of	of	IN	B-PP	O
plasma	plasma	NN	B-NP	O
membrane	membrane	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
here	here	RB	B-ADVP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
bulk	bulk	NN	I-NP	O
PTP	PTP	NN	I-NP	O
activity	activity	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
membrane	membrane	NN	I-NP	O
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
outside	outside	IN	B-PP	O
the	the	DT	B-NP	O
lipid	lipid	NN	I-NP	O
rafts	raft	NNS	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
sucrose	sucrose	NN	B-NP	O
density	density	NN	I-NP	O
gradient	gradient	NN	I-NP	O
sedimentation	sedimentation	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
approximately	approximately	RB	B-NP	O
5	5	CD	I-NP	O
--	--	HYPH	I-NP	O
10	10	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
Src	Src	NN	B-NP	B-protein
homology	homology	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
domain-containing	domain-containing	JJ	I-NP	I-protein
tyrosine	tyrosine	NN	I-NP	I-protein
phosphatase	phosphatase	NN	I-NP	I-protein
(	(	(	O	O
SHP-1	SHP-1	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
constitutively	constitutively	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
plasma	plasma	NN	B-NP	O
membrane	membrane	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
nearly	nearly	RB	B-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
SHP-2	SHP-2	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
translocated	translocate	VBN	I-VP	O
to	to	TO	B-PP	O
plasma	plasma	NN	B-NP	O
membrane	membrane	NN	I-NP	O
after	after	IN	B-PP	O
vanadate	vanadate	NN	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

Similar	Similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
transmembrane	transmembrane	JJ	B-NP	B-protein
PTP	PTP	NN	I-NP	I-protein
,	,	,	O	O
CD45	CD45	NN	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
membrane-associated	membrane-associated	JJ	I-NP	B-cell_type
populations	population	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
SHP-1	SHP-1	NN	B-NP	B-protein
and	and	CC	I-NP	O
SHP-2	SHP-2	NN	I-NP	B-protein
are	be	VBP	B-VP	O
essentially	essentially	RB	I-VP	O
excluded	exclude	VBN	I-VP	O
from	from	IN	B-PP	O
lipid	lipid	NN	B-NP	O
rafts	raft	NNS	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
other	other	JJ	B-NP	O
signaling	signal	VBG	I-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
Lck	Lck	NN	B-NP	B-protein
,	,	,	O	O
linker	linker	NN	B-NP	O
for	for	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
CD3	CD3	NN	B-NP	B-protein
zeta	zeta	NN	I-NP	I-protein
are	be	VBP	B-VP	O
enriched	enrich	VBN	I-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
further	further	RB	B-ADVP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
CD3	CD3	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
tyrosine	tyrosine	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
substrates	substrate	NNS	I-NP	O
is	be	VBZ	B-VP	O
largely	largely	RB	B-ADJP	O
restricted	restricted	JJ	I-ADJP	O
to	to	TO	B-PP	O
lipid	lipid	NN	B-NP	O
rafts	raft	NNS	I-NP	O
,	,	,	O	O
unless	unless	IN	B-SBAR	O
PTPs	PTP	NNS	B-NP	B-protein
are	be	VBP	B-VP	O
inhibited	inhibit	VBN	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
restricted	restricted	JJ	I-NP	O
partition	partition	NN	I-NP	O
of	of	IN	B-PP	O
PTPs	PTP	NNS	B-NP	B-protein
among	among	IN	B-PP	O
membrane	membrane	NN	B-NP	B-protein
subdomains	subdomain	NNS	I-NP	I-protein
may	may	MD	B-VP	O
regulate	regulate	VB	I-VP	O
protein	protein	NN	B-NP	O
tyrosine	tyrosine	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
membrane	membrane	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
test	test	VB	I-VP	O
this	this	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
targeted	target	VBD	B-VP	O
SHP-1	SHP-1	NN	B-NP	B-protein
into	into	IN	B-PP	O
lipid	lipid	NN	B-NP	O
rafts	raft	NNS	I-NP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
N-terminal	N-terminal	JJ	I-NP	B-protein
region	region	NN	I-NP	I-protein
of	of	IN	B-PP	O
Lck	Lck	NN	B-NP	B-protein
(	(	(	O	O
residues	residue	NNS	B-NP	O
1	1	CD	I-NP	O
--	--	HYPH	I-NP	O
14	14	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
Lck/SHP-1	Lck/SHP-1	NN	B-NP	B-protein
chimera	chimera	NN	I-NP	I-protein
inside	inside	IN	B-PP	O
lipid	lipid	NN	B-NP	O
rafts	raft	NNS	I-NP	O
profoundly	profoundly	RB	B-ADVP	O
inhibits	inhibit	VBZ	B-VP	O
CD3	CD3	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
tyrosine	tyrosine	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
CD3	CD3	NN	B-NP	B-protein
zeta/epsilon	zeta/epsilon	NN	I-NP	O
,	,	,	O	O
IL-2	IL-2	NN	B-NP	B-protein
generation	generation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	O
mobilization	mobilization	NN	I-NP	O
of	of	IN	B-PP	O
NF-AT	NF-AT	NN	B-NP	B-protein
.	.	.	O	O

Collectively	Collectively	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
exclusion	exclusion	NN	I-NP	O
of	of	IN	B-PP	O
PTPs	PTP	NNS	B-NP	B-protein
from	from	IN	B-PP	O
lipid	lipid	NN	B-NP	O
rafts	raft	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
that	that	WDT	B-NP	O
potentiates	potentiate	VBZ	B-VP	O
TCR	TCR	NN	B-NP	B-protein
/	/	SYM	O	O
CD3	CD3	NN	B-NP	B-protein
activation	activation	NN	I-NP	O

An	An	DT	B-NP	O
instructive	instructive	JJ	I-NP	O
component	component	NN	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	O
helper	helper	NN	I-NP	O
cell	cell	NN	I-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
(	(	(	O	O
Th2	Th2	NN	B-NP	O
)	)	)	O	O
development	development	NN	B-NP	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
GATA-3	GATA-3	NN	B-NP	B-protein
.	.	.	O	O

Although	Although	IN	B-SBAR	O
interleukin	interleukin	NN	B-NP	B-protein
(	(	(	O	I-protein
IL	IL	NN	B-NP	I-protein
)	)	)	O	I-protein
-12	-12	CD	B-NP	I-protein
and	and	CC	O	O
IL-4	IL-4	NN	B-NP	B-protein
polarize	polarize	VBP	B-VP	O
naive	naive	JJ	B-NP	B-cell_type
CD4	CD4	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
T	T	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
toward	toward	IN	B-PP	O
T	T	NN	B-NP	O
helper	helper	NN	I-NP	O
cell	cell	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
Th1	Th1	NN	B-NP	O
)	)	)	O	O
or	or	CC	O	O
Th2	Th2	NN	B-NP	B-cell_type
phenotypes	phenotype	NNS	I-NP	I-cell_type
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
known	know	VBN	I-VP	O
whether	whether	IN	B-SBAR	O
cytokines	cytokine	NNS	B-NP	B-protein
instruct	instruct	VBP	B-VP	O
the	the	DT	B-NP	O
developmental	developmental	JJ	I-NP	O
fate	fate	NN	I-NP	O
in	in	IN	B-PP	O
uncommitted	uncommitted	JJ	B-NP	B-cell_type
progenitors	progenitor	NNS	I-NP	I-cell_type
or	or	CC	O	O
select	select	VB	B-VP	O
for	for	IN	B-PP	O
outgrowth	outgrowth	NN	B-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
that	that	WDT	B-NP	O
have	have	VBP	B-VP	O
stochastically	stochastically	RB	I-VP	O
committed	commit	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
particular	particular	JJ	I-NP	O
fate	fate	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
distinguish	distinguish	VB	I-VP	O
these	these	DT	B-NP	O
instructive	instructive	JJ	I-NP	O
and	and	CC	I-NP	O
selective	selective	JJ	I-NP	O
models	model	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
used	use	VBD	B-VP	O
surface	surface	NN	B-NP	O
affinity	affinity	NN	I-NP	O
matrix	matrix	NN	I-NP	O
technology	technology	NN	I-NP	O
to	to	TO	B-VP	O
isolate	isolate	VB	I-VP	O
committed	committed	JJ	B-NP	B-cell_type
progenitors	progenitor	NNS	I-NP	I-cell_type
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-protein
secretion	secretion	NN	I-NP	O
phenotype	phenotype	NN	I-NP	O
and	and	CC	O	O
developed	develop	VBD	B-VP	O
retroviral-based	retroviral-based	JJ	B-NP	O
tagging	tag	VBG	I-NP	O
approaches	approach	NNS	I-NP	O
to	to	TO	B-VP	O
directly	directly	RB	I-VP	O
monitor	monitor	VB	I-VP	O
individual	individual	JJ	B-NP	O
progenitor	progenitor	NN	I-NP	O
fate	fate	NN	I-NP	O
decisions	decision	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
clonal	clonal	JJ	I-NP	O
and	and	CC	I-NP	O
population	population	NN	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
observe	observe	VBP	B-VP	O
IL-4	IL-4	NN	B-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
redirection	redirection	NN	I-NP	O
of	of	IN	B-PP	O
phenotype	phenotype	NN	B-NP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
that	that	WDT	B-NP	O
have	have	VBP	B-VP	O
already	already	RB	I-VP	O
committed	commit	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
non-IL-4-producing	non-IL-4-producing	JJ	I-NP	O
fate	fate	NN	I-NP	O
,	,	,	O	O
inconsistent	inconsistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
predictions	prediction	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
selective	selective	JJ	I-NP	O
model	model	NN	I-NP	O
.	.	.	O	O

Further	Further	RB	B-ADVP	O
,	,	,	O	O
retroviral	retroviral	JJ	B-NP	O
tagging	tagging	NN	I-NP	O
of	of	IN	B-PP	O
naive	naive	JJ	B-NP	B-cell_type
progenitors	progenitor	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Th2-specific	Th2-specific	JJ	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
GATA-3	GATA-3	NN	I-NP	B-protein
provided	provide	VBD	B-VP	O
direct	direct	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
instructive	instructive	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
selective	selective	JJ	I-NP	O
outgrowth	outgrowth	NN	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
committed	commit	VBN	B-VP	O
to	to	TO	B-PP	O
either	either	CC	O	O
the	the	DT	B-NP	O
Th1	Th1	NN	I-NP	B-cell_type
or	or	CC	I-NP	O
Th2	Th2	NN	I-NP	O
fate	fate	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
would	would	MD	B-VP	O
seem	seem	VB	I-VP	O
to	to	TO	I-VP	O
exclude	exclude	VB	I-VP	O
selection	selection	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
exclusive	exclusive	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
in	in	IN	B-PP	O
Th1	Th1	NN	B-NP	B-cell_type
/	/	SYM	B-NP	O
Th2	Th2	NN	I-NP	O
differentiation	differentiation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
support	support	VBP	B-VP	O
an	an	DT	B-NP	O
instructive	instructive	JJ	I-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
cytokine-driven	cytokine-driven	JJ	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
programming	programming	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
fate	fate	NN	I-NP	O
decisions	decision	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
vitro-activated	vitro-activated	JJ	B-NP	B-cell_line
human	human	JJ	I-NP	I-cell_line
lupus	lupus	NN	I-NP	I-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
express	express	VBP	B-VP	O
normal	normal	JJ	B-NP	O
estrogen	estrogen	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
which	which	WDT	B-NP	O
bind	bind	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
estrogen	estrogen	NN	I-NP	B-DNA
response	response	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
estrogen	estrogen	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
ERalpha	ERalpha	NN	B-NP	B-protein
,	,	,	O	O
ERbeta	ERbeta	NN	B-NP	B-protein
)	)	)	O	O
transcripts	transcript	NNS	B-NP	O
are	be	VBP	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
SLE	SLE	NN	B-NP	O
and	and	CC	I-NP	O
normal	normal	JJ	I-NP	O
T	T	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
nuclear	nuclear	JJ	I-NP	O
extracts	extract	NNS	I-NP	O
from	from	IN	B-PP	O
female	female	JJ	B-NP	O
lupus	lupus	NN	I-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
donors	donor	NNS	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
biologically	biologically	RB	B-NP	O
active	active	JJ	I-NP	O
ER	ER	NN	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
estrogen	estrogen	NN	I-NP	I-DNA
response	response	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
(	(	(	O	O
hERE	hERE	NN	B-NP	O
)	)	)	O	O
by	by	IN	B-PP	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
stimulated	stimulate	VBN	I-VP	O
with	with	IN	B-PP	O
17beta-estradiol	17beta-estradiol	NN	B-NP	O
(	(	(	O	O
E2	E2	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
PMA	PMA	NN	B-NP	O
and	and	CC	O	O
ionomycin	ionomycin	NN	B-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
major	major	JJ	I-NP	O
retarded	retard	VBN	I-NP	O
bands	band	NNS	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
nuclear	nuclear	JJ	I-NP	O
extracts	extract	NNS	I-NP	O
exhibited	exhibit	VBD	B-VP	O
a	a	DT	B-NP	O
migration	migration	NN	I-NP	O
pattern	pattern	NN	I-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-VP	O
slow	slow	VB	I-VP	O
migrating	migrate	VBG	I-VP	O
protein-ERE	protein-ERE	JJ	B-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
breast	breast	NN	I-NP	I-cell_type
cancer	cancer	NN	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
extracts	extract	NNS	I-NP	O
.	.	.	O	O

T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
cultured	culture	VBN	B-VP	O
only	only	RB	B-ADVP	O
with	with	IN	B-PP	O
E2	E2	NN	B-NP	B-protein
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
these	these	DT	B-NP	O
complexes	complex	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
complexes	complex	NNS	I-NP	O
was	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
competition	competition	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
hERE	hERE	NN	I-NP	O
cold	cold	JJ	I-NP	O
oligonucleotide	oligonucleotide	NN	I-NP	O
and	and	CC	O	O
partially	partially	RB	B-ADVP	O
with	with	IN	B-PP	O
anti-ERalpha	anti-ERalpha	JJ	B-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
notable	notable	JJ	I-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
migration	migration	NN	I-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
ERE-binding	ERE-binding	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
between	between	IN	B-PP	O
the	the	DT	B-NP	O
SLE	SLE	NN	I-NP	O
and	and	CC	I-NP	O
normal	normal	JJ	I-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
extracts	extract	NNS	I-NP	O
.	.	.	O	O

Together	Together	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
activated	activate	VBN	B-NP	O
human	human	JJ	I-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
whether	whether	IN	B-SBAR	O
lupus-derived	lupus-derived	JJ	B-ADJP	O
or	or	CC	I-ADJP	O
normal-derived	normal-derived	JJ	I-ADJP	O
,	,	,	O	O
contain	contain	VBP	B-VP	O
biologically	biologically	RB	B-NP	O
active	active	JJ	I-NP	O
ERalpha	ERalpha	NN	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
.	.	.	O	O

Other	Other	JJ	B-NP	O
factors	factor	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
differential	differential	JJ	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
lupus	lupus	NN	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
estrogen	estrogen	NN	B-NP	O
.	.	.	O	O

Mechanism	Mechanism	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
protease	protease	NN	B-NP	B-protein
inhibitor	inhibitor	NN	I-NP	O
on	on	IN	B-PP	O
tumor	tumor	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
production	production	NN	I-NP	O
of	of	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
.	.	.	O	O

If	If	IN	B-SBAR	O
the	the	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
response	response	NN	I-NP	O
becomes	become	VBZ	B-VP	O
excessive	excessive	JJ	B-NP	O
or	or	CC	I-NP	O
uncontrolled	uncontrolled	JJ	I-NP	O
by	by	IN	B-PP	O
some	some	DT	B-NP	O
stimuli	stimulus	NNS	I-NP	O
,	,	,	O	O
inappropriate	inappropriate	JJ	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
responses	response	NNS	I-NP	O
occur	occur	VBP	B-VP	O
.	.	.	O	O

Monocytes	Monocyte	NNS	B-NP	B-cell_type
are	be	VBP	B-VP	O
extremely	extremely	RB	B-NP	O
important	important	JJ	I-NP	O
cells	cell	NNS	I-NP	O
for	for	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
the	the	DT	B-NP	O
cytokine	cytokine	NN	I-NP	B-protein
network	network	NN	I-NP	O
and	and	CC	O	O
tumor	tumor	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
(	(	(	O	O
TNFalpha	TNFalpha	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
interleukin-	interleukin-	NN	B-NP	B-protein
(	(	(	O	I-protein
IL	IL	NN	B-NP	I-protein
)	)	)	O	I-protein
10	10	CD	B-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
mainly	mainly	RB	I-VP	O
synthesized	synthesize	VBN	I-VP	O
by	by	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
are	be	VBP	B-VP	O
representative	representative	JJ	B-NP	O
cytokines	cytokine	NNS	I-NP	B-protein
that	that	WDT	B-NP	O
play	play	VBP	B-VP	O
a	a	DT	B-NP	O
central	central	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cytokine	cytokine	NN	I-NP	B-protein
network	network	NN	I-NP	I-protein
.	.	.	O	O

Protease	Protease	NN	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
gabexate	gabexate	NN	B-NP	O
mesilate	mesilate	NN	I-NP	O
(	(	(	O	O
GM	GM	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
ulinastatin	ulinastatin	NN	B-NP	O
(	(	(	O	O
UTI	UTI	NN	B-NP	O
)	)	)	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
various	various	JJ	B-NP	O
beneficial	beneficial	JJ	I-NP	O
effects	effect	NNS	I-NP	O
by	by	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
leukocytes	leukocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
has	have	VBZ	B-VP	O
yet	yet	RB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
fully	fully	RB	I-VP	O
elucidated	elucidate	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
we	we	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
protease	protease	NN	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
proinflammatory	proinflammatory	JJ	I-NP	B-protein
cytokine	cytokine	NN	I-NP	I-protein
production	production	NN	I-NP	O
of	of	IN	B-PP	O
lipopolysaccharide-	lipopolysaccharide-	NN	B-NP	B-cell_line
(	(	(	O	I-cell_line
LPS	LPS	NN	B-NP	I-cell_line
)	)	)	O	I-cell_line
stimulated	stimulate	VBN	B-NP	I-cell_line
monocytes	monocyte	NNS	I-NP	I-cell_line
.	.	.	O	O

LPS-stimulated	LPS-stimulated	JJ	B-NP	B-cell_line
monocytes	monocyte	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
GM	GM	NNP	B-NP	O
or	or	CC	I-NP	O
UTI	UTI	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
TNFalpha	TNFalpha	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-10	IL-10	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
culture	culture	NN	I-NP	O
medium	medium	NN	I-NP	O
of	of	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
and	and	CC	O	O
each	each	DT	B-NP	O
mRNA	mRNA	NN	I-NP	B-RNA
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
assayed	assay	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
protease	protease	NN	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
protein	protein	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
C	C	NN	I-NP	I-protein
(	(	(	O	O
PKC	PKC	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
(	(	(	O	O
NFkappaB	NFkappaB	NN	B-NP	B-protein
)	)	)	O	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
evaluated	evaluate	VBN	I-VP	O
.	.	.	O	O

GM	GM	NNP	B-NP	O
decreased	decrease	VBD	B-VP	O
the	the	DT	B-NP	O
TNFalpha	TNFalpha	NN	I-NP	B-protein
production	production	NN	I-NP	O
of	of	IN	B-PP	O
LPS-stimulated	LPS-stimulated	JJ	B-NP	B-cell_line
monocytes	monocyte	NNS	I-NP	I-cell_line
as	as	IN	B-SBAR	O
shown	show	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
mRNA	mRNA	NN	B-NP	B-RNA
expression	expression	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBD	B-VP	O
the	the	DT	B-NP	O
IL-10	IL-10	NN	I-NP	B-protein
production	production	NN	I-NP	O
of	of	IN	B-PP	O
LPS-stimulated	LPS-stimulated	JJ	B-NP	B-cell_line
monocytes	monocyte	NNS	I-NP	I-cell_line
.	.	.	O	O

GM	GM	NNP	B-NP	O
also	also	RB	B-ADVP	O
suppressed	suppress	VBD	B-VP	O
the	the	DT	B-NP	O
NFkappaB	NFkappaB	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
LPS-stimulated	LPS-stimulated	JJ	B-NP	B-cell_line
monocytes	monocyte	NNS	I-NP	I-cell_line
.	.	.	O	O

UTI	UTI	NN	B-NP	O
decreased	decrease	VBD	B-VP	O
the	the	DT	B-NP	O
TNFalpha	TNFalpha	NN	I-NP	B-protein
production	production	NN	I-NP	O
of	of	IN	B-PP	O
LPS-stimulated	LPS-stimulated	JJ	B-NP	B-cell_line
monocytes	monocyte	NNS	I-NP	I-cell_line
,	,	,	O	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
inhibit	inhibit	VB	I-VP	O
the	the	DT	B-NP	O
TNFalpha	TNFalpha	NN	I-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
expression	expression	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
shows	show	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
GM	GM	NNP	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
TNFalpha	TNFalpha	NN	I-NP	B-protein
production	production	NN	I-NP	O
of	of	IN	B-PP	O
activated	activate	VBN	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
suppression	suppression	NN	I-NP	O
of	of	IN	B-PP	O
NFkappaB	NFkappaB	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
UTI	UTI	NN	B-NP	B-DNA
inhibiting	inhibit	VBG	B-VP	O
TNFalpha	TNFalpha	NN	B-NP	B-protein
production	production	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
may	may	MD	B-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
either	either	CC	O	O
the	the	DT	B-NP	O
translation	translation	NN	I-NP	O
or	or	CC	I-NP	O
secretion	secretion	NN	I-NP	O
of	of	IN	B-PP	O
TNFalpha	TNFalpha	NN	B-NP	B-protein
.	.	.	O	O

Homocysteine	Homocysteine	NN	B-NP	O
stimulates	stimulate	VBZ	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
monocyte	monocyte	NN	B-NP	B-protein
chemoattractant	chemoattractant	NN	I-NP	I-protein
protein-1	protein-1	NN	I-NP	I-protein
in	in	IN	B-PP	O
endothelial	endothelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
enhanced	enhance	VBN	B-NP	O
monocyte	monocyte	NN	I-NP	O
chemotaxis	chemotaxis	NN	I-NP	O
.	.	.	O	O

Hyperhomocysteinemia	Hyperhomocysteinemia	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
independent	independent	JJ	I-NP	O
risk	risk	NN	I-NP	O
factor	factor	NN	I-NP	O
for	for	IN	B-PP	O
atherosclerosis	atherosclerosis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
infiltration	infiltration	NN	I-NP	O
of	of	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
into	into	IN	B-PP	O
the	the	DT	B-NP	O
arterial	arterial	JJ	I-NP	O
wall	wall	NN	I-NP	O
is	be	VBZ	B-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
key	key	JJ	I-NP	O
events	event	NNS	I-NP	O
during	during	IN	B-PP	O
atherogenesis	atherogenesis	NN	B-NP	O
.	.	.	O	O

Monocyte	Monocyte	NN	B-NP	B-protein
chemoattractant	chemoattractant	NN	I-NP	I-protein
protein-1	protein-1	NN	I-NP	I-protein
(	(	(	O	O
MCP-1	MCP-1	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
chemokine	chemokine	NN	I-NP	B-protein
that	that	WDT	B-NP	O
stimulates	stimulate	VBZ	B-VP	O
the	the	DT	B-NP	O
migration	migration	NN	I-NP	O
of	of	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
into	into	IN	B-PP	O
the	the	DT	B-NP	O
intima	intima	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
arterial	arterial	JJ	I-NP	O
wall	wall	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
increased	increase	VBD	B-VP	O
monocyte	monocyte	NN	B-NP	O
infiltration	infiltration	NN	I-NP	O
occurs	occur	VBZ	B-VP	O
in	in	IN	B-PP	O
atherosclerotic	atherosclerotic	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
hyperhomocysteinemia	hyperhomocysteinemia	NN	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
delineated	delineate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
objective	objective	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
homocysteine	homocysteine	NN	B-NP	O
on	on	IN	B-PP	O
MCP-1	MCP-1	NN	B-NP	B-protein
production	production	NN	I-NP	O
in	in	IN	B-PP	O
endothelial	endothelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Cells	Cell	NNS	B-NP	O
were	be	VBD	B-VP	O
incubated	incubate	VBN	I-VP	O
with	with	IN	B-PP	O
homocysteine	homocysteine	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
secretion	secretion	NN	I-NP	O
of	of	IN	B-PP	O
MCP-1	MCP-1	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
increased	increase	VBN	I-VP	O
(	(	(	O	O
195	195	CD	B-NP	O
%	%	NN	I-NP	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
pathological	pathological	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
homocysteine	homocysteine	NN	B-NP	O
.	.	.	O	O

Such	Such	JJ	B-NP	O
effect	effect	NN	I-NP	O
was	be	VBD	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
MCP-1	MCP-1	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
(	(	(	O	O
176	176	CD	B-NP	O
%	%	NN	I-NP	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
endothelial	endothelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
which	which	WDT	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
enhanced	enhance	VBN	B-NP	O
monocyte	monocyte	NN	I-NP	O
chemotaxis	chemotaxis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
p38	p38	NN	I-NP	B-protein
MAP	MAP	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
other	other	JJ	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
p38	p38	NN	I-NP	B-protein
MAP	MAP	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
pathway	pathway	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
MKK3	MKK3	NN	B-NP	B-protein
,	,	,	I-NP	O
MKK6	MKK6	NN	I-NP	B-protein
,	,	,	I-NP	O
ATF-2	ATF-2	NN	I-NP	B-protein
and	and	CC	I-NP	O
Elk-1	Elk-1	NN	I-NP	B-protein
,	,	,	O	O
were	be	VBD	B-VP	O
activated	activate	VBN	I-VP	O
in	in	IN	B-PP	O
homocysteine-treated	homocysteine-treated	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Homocysteine-induced	Homocysteine-induced	JJ	B-NP	O
MCP-1	MCP-1	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
subsequent	subsequent	JJ	B-NP	O
monocyte	monocyte	NN	I-NP	O
chemotaxis	chemotaxis	NN	I-NP	O
were	be	VBD	B-VP	O
blocked	block	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
p38	p38	NN	I-NP	O
MAP	MAP	NN	I-NP	O
kinase	kinase	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
(	(	(	O	O
SB203580	SB203580	NN	B-NP	O
)	)	)	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
p38	p38	NN	I-NP	B-protein
MAP	MAP	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
pathway	pathway	NN	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
homocysteine-induced	homocysteine-induced	JJ	B-NP	O
MCP-1	MCP-1	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
endothelial	endothelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
staurosporine	staurosporine	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
C	C	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
homocysteine-induced	homocysteine-induced	JJ	B-NP	O
MCP-1	MCP-1	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
conclusion	conclusion	NN	B-NP	O
,	,	,	O	O
our	our	PRP$	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
homocysteine	homocysteine	NN	B-NP	O
stimulates	stimulate	VBZ	B-VP	O
MCP-1	MCP-1	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
endothelial	endothelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
enhanced	enhance	VBN	B-NP	O
monocyte	monocyte	NN	I-NP	O
chemotaxis	chemotaxis	NN	I-NP	O
.	.	.	O	O

Inducible	Inducible	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
Fas-mediated	Fas-mediated	JJ	B-NP	O
apoptosis	apoptosis	NN	I-NP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Apoptosis	Apoptosis	NN	B-NP	O
produced	produce	VBN	B-VP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
through	through	IN	B-PP	O
Fas	Fas	NN	B-NP	B-protein
(	(	(	O	O
APO-1	APO-1	NN	B-NP	B-protein
,	,	,	O	O
CD95	CD95	NN	B-NP	B-protein
)	)	)	O	O
triggering	triggering	NN	B-NP	O
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
signals	signal	NNS	B-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
other	other	JJ	B-NP	O
surface	surface	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
:	:	:	O	O
CD40	CD40	NN	B-NP	B-protein
engagement	engagement	NN	I-NP	O
produces	produce	VBZ	B-VP	O
upregulation	upregulation	NN	B-NP	O
of	of	IN	B-PP	O
Fas	Fas	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
marked	marked	JJ	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
to	to	TO	B-PP	O
Fas	Fas	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
cell	cell	NN	I-NP	O
death	death	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
antigen	antigen	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
engagement	engagement	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
IL-4R	IL-4R	NN	B-NP	B-protein
engagement	engagement	NN	I-NP	O
,	,	,	O	O
inhibits	inhibit	VBZ	B-VP	O
Fas	Fas	NN	B-NP	B-protein
killing	killing	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
so	so	RB	B-VP	O
doing	do	VBG	I-VP	O
induces	induce	VBZ	B-VP	O
a	a	DT	B-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
Fas	Fas	NN	B-NP	B-protein
-resistance	-resistance	NN	I-NP	O
,	,	,	O	O
even	even	RB	B-ADVP	O
in	in	IN	B-PP	O
otherwise	otherwise	RB	B-NP	O
sensitive	sensitive	JJ	I-NP	O
,	,	,	I-NP	O
CD40	CD40	NN	I-NP	B-protein
-stimulated	-stimulated	JJ	I-NP	O
targets	target	NNS	I-NP	O
.	.	.	O	O

Surface	Surface	NN	B-NP	B-protein
immunoglobulin	immunoglobulin	NN	I-NP	I-protein
and	and	CC	I-NP	O
IL-4R	IL-4R	NN	I-NP	B-protein
utilize	utilize	VBP	B-VP	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
partially	partially	RB	B-NP	O
distinct	distinct	JJ	I-NP	O
pathways	pathway	NNS	I-NP	O
to	to	TO	B-VP	O
produce	produce	VB	I-VP	O
Fas	Fas	NN	B-NP	B-protein
-resistance	-resistance	NN	I-NP	O
that	that	WDT	B-NP	O
differentially	differentially	RB	B-ADVP	O
depend	depend	VBP	B-VP	O
on	on	IN	B-PP	O
PKC	PKC	NN	B-NP	B-protein
and	and	CC	I-NP	O
STAT6	STAT6	NN	I-NP	B-protein
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

Further	Further	RB	B-ADVP	O
,	,	,	O	O
surface	surface	NN	B-NP	B-protein
immunoglobulin	immunoglobulin	NN	I-NP	I-protein
signaling	signaling	NN	I-NP	O
for	for	IN	B-PP	O
inducible	inducible	JJ	B-NP	O
Fas	Fas	NN	I-NP	B-protein
-resistance	-resistance	NN	I-NP	O
bypasses	bypass	VBZ	B-VP	O
Btk	Btk	NN	B-NP	B-protein
,	,	,	O	O
requires	require	VBZ	B-VP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
entails	entail	VBZ	B-VP	O
new	new	JJ	B-NP	O
macromolecular	macromolecular	JJ	I-NP	O
synthesis	synthesis	NN	I-NP	O
.	.	.	O	O

Terminal	Terminal	JJ	B-NP	O
effectors	effector	NNS	I-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
Fas	Fas	NN	I-NP	O
-resistance	-resistance	NN	I-NP	O
include	include	VBP	B-VP	O
the	the	DT	B-NP	O
known	known	JJ	I-NP	O
anti-apoptotic	anti-apoptotic	JJ	I-NP	B-protein
gene	gene	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
,	,	,	O	O
Bcl-xL	Bcl-xL	NN	B-NP	B-protein
and	and	CC	I-NP	O
FLIP	FLIP	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	B-DNA
anti-apoptotic	anti-apoptotic	JJ	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
that	that	WDT	B-NP	O
encodes	encode	VBZ	B-VP	O
FAIM	FAIM	NN	B-NP	O
(	(	(	O	O
Fas	Fas	NN	B-NP	B-protein
Apoptosis	Apoptosis	NN	I-NP	I-protein
Inhibitory	Inhibitory	JJ	I-NP	I-protein
Molecule	Molecule	NN	I-NP	I-protein
)	)	)	O	O
.	.	.	O	O

faim	faim	NN	B-NP	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
differential	differential	JJ	B-NP	O
display	display	NN	I-NP	O
and	and	CC	O	O
exists	exist	VBZ	B-VP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
alternatively	alternatively	RB	I-NP	O
spliced	splice	VBN	I-NP	O
forms	form	NNS	I-NP	O
;	;	:	O	O
faim-S	faim-S	NN	B-NP	O
is	be	VBZ	B-VP	O
broadly	broadly	RB	I-VP	O
expressed	express	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
faim-L	faim-L	NN	B-NP	O
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
tissue-specific	tissue-specific	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
FAIM	FAIM	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
highly	highly	RB	B-ADJP	O
evolu-	evolu-	JJ	I-ADJP	O
tionarily	tionarily	RB	B-VP	O
conserved	conserve	VBN	I-VP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
molecule	molecule	NN	I-NP	O
throughout	throughout	IN	B-PP	O
phylogeny	phylogeny	NN	B-NP	O
.	.	.	O	O

Inducible	Inducible	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
Fas	Fas	NN	B-NP	B-protein
killing	killing	NN	I-NP	O
is	be	VBZ	B-VP	O
hypothesized	hypothesize	VBN	I-VP	O
to	to	TO	I-VP	O
protect	protect	VB	I-VP	O
foreign	foreign	JJ	B-NP	B-cell_type
antigen-specific	antigen-specific	JJ	I-NP	I-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
during	during	IN	B-PP	O
potentially	potentially	RB	B-NP	O
hazardous	hazardous	JJ	I-NP	O
interactions	interaction	NNS	I-NP	O
with	with	IN	B-PP	O
FasL-bearing	FasL-bearing	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
whereas	whereas	IN	O	O
autoreactive	autoreactive	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
fail	fail	VBP	B-VP	O
to	to	TO	I-VP	O
become	become	VB	I-VP	O
Fas	Fas	NN	B-NP	B-protein
-resistant	-resistant	JJ	I-NP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
deleted	delete	VBN	I-VP	O
via	via	IN	B-PP	O
Fas	Fas	NN	B-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
cytotoxicity	cytotoxicity	NN	I-NP	O
.	.	.	O	O

Inadvertent	Inadvertent	JJ	B-NP	O
or	or	CC	I-NP	O
aberrant	aberrant	JJ	I-NP	O
acquisition	acquisition	NN	I-NP	O
of	of	IN	B-PP	O
Fas	Fas	NN	B-NP	B-protein
-resistance	-resistance	NN	I-NP	O
may	may	MD	B-VP	O
permit	permit	VB	I-VP	O
autoreactive	autoreactive	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-VP	O
escape	escape	VB	I-VP	O
Fas	Fas	NN	B-NP	B-protein
deletion	deletion	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
malignant	malignant	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
to	to	TO	B-VP	O
impede	impede	VB	I-VP	O
anti-tumor	anti-tumor	JJ	B-NP	O
immunity	immunity	NN	I-NP	O
.	.	.	O	O

Stromal	Stromal	JJ	B-NP	B-protein
cell-derived	cell-derived	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
-induced	-induced	JJ	I-NP	O
chemotaxis	chemotaxis	NN	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
nitric	nitric	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
.	.	.	O	O

Stromal	Stromal	JJ	B-NP	B-protein
cell-derived	cell-derived	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
(	(	(	O	O
SDF1	SDF1	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
)	)	)	O	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
cognate	cognate	JJ	I-NP	O
chemokine	chemokine	NN	I-NP	O
receptor	receptor	NN	I-NP	O
CXCR4	CXCR4	NN	I-NP	B-protein
act	act	VBP	B-VP	O
as	as	IN	B-PP	O
potent	potent	JJ	B-NP	O
chemoattractants	chemoattractant	NNS	I-NP	B-protein
and	and	CC	O	O
regulate	regulate	VB	B-VP	O
trafficking	trafficking	NN	B-NP	O
and	and	CC	I-NP	O
homing	homing	NN	I-NP	O
of	of	IN	B-PP	O
hematopoietic	hematopoietic	JJ	B-NP	B-cell_type
progenitor	progenitor	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
regulating	regulate	VBG	B-VP	O
SDF1	SDF1	NN	B-NP	O
alpha	alpha	NN	I-NP	O
-driven	-driven	JJ	I-NP	O
cell	cell	NN	I-NP	O
migration	migration	NN	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
well	well	RB	I-VP	O
defined	define	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
explored	explore	VBN	I-VP	O
the	the	DT	B-NP	O
roles	role	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
messenger	messenger	NN	I-NP	O
NO	NO	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
in	in	IN	B-PP	O
SDF1	SDF1	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
-induced	-induced	JJ	I-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
migration	migration	NN	I-NP	O
.	.	.	O	O

SDF1	SDF1	NN	B-NP	O
alpha	alpha	NN	I-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
increased	increase	VBD	B-VP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
NO	NO	NN	B-NP	B-protein
synthase	synthase	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
catalyzes	catalyze	VBZ	B-VP	O
the	the	DT	B-NP	O
generation	generation	NN	I-NP	O
of	of	IN	B-PP	O
NO	NO	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
observed	observe	VBD	B-VP	O
that	that	IN	B-SBAR	O
pretreatment	pretreatment	NN	B-NP	O
of	of	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
or	or	CC	O	O
activated	activate	VBN	B-VP	B-cell_type
PBLs	PBL	NNS	B-NP	I-cell_type
with	with	IN	B-PP	O
several	several	JJ	B-NP	O
NO	NO	NN	I-NP	O
donors	donor	NNS	I-NP	O
significantly	significantly	RB	B-ADVP	O
enhanced	enhance	VBD	B-VP	O
the	the	DT	B-NP	O
SDF1	SDF1	NN	I-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
-induced	-induced	JJ	I-NP	O
migration	migration	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
various	various	JJ	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
of	of	IN	B-PP	O
NO	NO	NN	B-NP	B-protein
synthase	synthase	NN	I-NP	I-protein
markedly	markedly	RB	B-ADVP	O
abrogated	abrogate	VBD	B-VP	O
the	the	DT	B-NP	O
chemotactic	chemotactic	JJ	I-NP	O
response	response	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
concentration-dependent	concentration-dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
observed	observe	VBD	B-VP	O
that	that	IN	B-SBAR	O
inhibitors	inhibitor	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
linked	link	VBN	I-VP	O
to	to	TO	B-PP	O
NO	NO	NN	B-NP	O
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
significantly	significantly	RB	B-VP	O
blocked	block	VBD	I-VP	O
the	the	DT	B-NP	O
SDF1	SDF1	NN	I-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
-induced	-induced	JJ	I-NP	O
chemotactic	chemotactic	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
compounds	compound	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
SDF1	SDF1	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
-induced	-induced	JJ	I-NP	O
mitogen-activated	mitogen-activated	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
MAP/Erk	MAP/Erk	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	O
PD98059	PD98059	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
abrogate	abrogate	VB	I-VP	O
SDF1	SDF1	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
-induced	-induced	JJ	I-NP	O
chemotaxis	chemotaxis	NN	I-NP	O
.	.	.	O	O

AKT	AKT	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
mediate	mediate	VB	I-VP	O
NO	NO	NN	B-NP	O
production	production	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
phosphorylated	phosphorylate	VBN	I-VP	O
upon	upon	IN	B-PP	O
SDF1	SDF1	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
studies	study	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
NO-related	NO-related	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
may	may	MD	B-VP	O
mediate	mediate	VB	I-VP	O
SDF1	SDF1	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
-induced	-induced	JJ	I-NP	O
chemotaxis	chemotaxis	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
mitogen-activated	mitogen-activated	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
transactivation	transactivation	NN	I-NP	O
and	and	CC	O	O
PKC	PKC	NN	B-NP	B-protein
epsilon	epsilon	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
CD4	CD4	NN	B-NP	B-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
CD8	CD8	NN	B-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
thymocytes	thymocyte	NNS	B-NP	I-cell_type
correlates	correlate	VBZ	B-VP	O
with	with	IN	B-PP	O
negative	negative	JJ	B-NP	O
selection	selection	NN	I-NP	O
.	.	.	O	O

Deletion	Deletion	NN	B-NP	O
of	of	IN	B-PP	O
autoreactive	autoreactive	JJ	B-NP	B-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
at	at	IN	B-PP	O
the	the	DT	B-NP	O
DP	DP	NN	I-NP	O
stage	stage	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
tolerance	tolerance	NN	B-NP	O
to	to	TO	B-PP	O
thymus-expressed	thymus-expressed	JJ	B-NP	B-protein
self	self	NN	I-NP	I-protein
antigens	antigen	NNS	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
we	we	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
distinct	distinct	JJ	B-NP	O
signalling	signalling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
are	be	VBP	B-VP	O
induced	induce	VBN	I-VP	O
in	in	IN	B-PP	O
DP	DP	NN	B-NP	B-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
as	as	IN	B-SBAR	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
mature	mature	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
upon	upon	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
with	with	IN	B-PP	O
antigen	antigen	NN	B-NP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
triple	triple	JJ	B-NP	O
transgenic	transgenic	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
expressing	express	VBG	B-VP	O
a	a	DT	B-NP	O
TCR	TCR	NN	I-NP	B-DNA
transgene	transgene	NN	I-NP	I-DNA
,	,	,	O	O
dominant	dominant	JJ	B-NP	B-protein
negative	negative	JJ	I-NP	I-protein
ras/Mek	ras/Mek	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
and	and	CC	O	O
a	a	DT	B-NP	O
reporter	reporter	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
construct	construct	NN	I-NP	I-DNA
with	with	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-protein
or	or	CC	O	O
NF-kappa	NF-kappa	NN	B-NP	B-DNA
B	B	NN	I-NP	I-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
,	,	,	O	O
we	we	PRP	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
complete	complete	JJ	I-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
but	but	CC	B-NP	O
not	not	RB	I-NP	O
AP-1	AP-1	NN	B-NP	B-protein
in	in	IN	B-PP	O
DP	DP	NN	B-NP	B-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
whereas	whereas	IN	O	O
both	both	DT	B-NP	O
were	be	VBD	B-VP	O
transcriptionally	transcriptionally	RB	B-ADJP	O
active	active	JJ	I-ADJP	O
in	in	IN	B-PP	O
mature	mature	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
after	after	IN	B-PP	O
antigenic	antigenic	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

Lack	Lack	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
induction	induction	NN	I-NP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
death	death	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
antigen	antigen	NN	B-NP	O
.	.	.	O	O

AP-1	AP-1	NN	B-NP	B-protein
induction	induction	NN	I-NP	O
was	be	VBD	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
integrity	integrity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ras/Mek	ras/Mek	NN	I-NP	B-protein
pathway	pathway	NN	I-NP	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
pathway	pathway	NN	I-NP	O
was	be	VBD	B-VP	O
activated	activate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
DP	DP	NN	I-NP	B-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
a	a	DT	B-NP	O
complete	complete	JJ	I-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
constitutive	constitutive	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
epsilon	epsilon	NN	I-NP	B-protein
isoform	isoform	NN	I-NP	I-protein
of	of	IN	B-PP	O
Protein	Protein	NN	B-NP	B-protein
Kinase	Kinase	NN	I-NP	I-protein
C	C	NN	I-NP	I-protein
(	(	(	O	O
PKC	PKC	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
DP	DP	NN	B-NP	B-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
although	although	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
mature	mature	JJ	B-NP	B-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
peripheral	peripheral	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Taken	Take	VBN	B-VP	O
together	together	RB	B-ADVP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
PKC	PKC	NN	B-NP	B-protein
epsilon	epsilon	NN	I-NP	I-protein
in	in	IN	B-PP	O
DP	DP	NN	B-NP	B-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
could	could	MD	B-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
after	after	IN	B-PP	O
antigenic	antigenic	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
contributing	contribute	VBG	B-VP	O
to	to	TO	B-PP	O
negative	negative	JJ	B-NP	O
selection	selection	NN	I-NP	O
.	.	.	O	O

Cell	Cell	NN	B-NP	O
Death	Death	NN	I-NP	O
and	and	CC	O	O
Differentiation	Differentiation	NN	B-NP	B-protein
(	(	(	O	I-protein
2000	2000	CD	B-NP	I-protein
)	)	)	O	I-protein
7	7	CD	B-NP	I-protein
,	,	,	O	O
1253	1253	CD	B-NP	O
-	-	HYPH	I-NP	O
1262	1262	CD	I-NP	O
.	.	.	O	O

CD2	CD2	NN	B-NP	B-protein
stimulation	stimulation	NN	I-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
delayed	delay	VBN	I-NP	O
and	and	CC	I-NP	O
prolonged	prolong	VBN	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
STAT1	STAT1	NN	B-NP	B-protein
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
but	but	CC	B-NP	O
not	not	RB	I-NP	O
NK	NK	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

OBJECTIVE	OBJECTIVE	NN	B-NP	O
:	:	:	O	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
can	can	MD	B-VP	O
be	be	VB	I-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
soluble	soluble	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
cytokines	cytokine	NNS	B-NP	B-protein
or	or	CC	B-PP	O
through	through	IN	B-PP	O
direct	direct	JJ	B-NP	O
cell-cell	cell-cell	JJ	I-NP	O
interactions	interaction	NNS	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
cytokine	cytokine	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
signal	signal	VB	I-VP	O
through	through	IN	B-PP	O
STAT	STAT	NN	B-NP	B-protein
family	family	NN	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
,	,	,	O	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
other	other	JJ	B-NP	O
cell-surface	cell-surface	JJ	I-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
CD2	CD2	NN	B-NP	B-protein
,	,	,	O	O
transduce	transduce	VB	B-VP	O
signals	signal	NNS	B-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
stimulation	stimulation	NN	B-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
through	through	IN	B-PP	O
CD2	CD2	NN	B-NP	B-protein
recapitulates	recapitulate	VBZ	B-VP	O
aspects	aspect	NNS	B-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
T-cell	T-cell	NN	I-NP	O
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
use	use	NN	B-NP	O
of	of	IN	B-PP	O
STAT	STAT	NN	B-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

MATERIALS	MATERIALS	NNS	B-NP	O
AND	AND	CC	I-NP	O
METHODS	METHODS	NNS	I-NP	O
:	:	:	O	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
anti-CD2	anti-CD2	JJ	B-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
or	or	CC	I-NP	O
cells	cell	NNS	I-NP	O
bearing	bear	VBG	B-VP	O
the	the	DT	B-NP	O
natural	natural	JJ	I-NP	O
CD2	CD2	NN	I-NP	O
ligand	ligand	NN	I-NP	O
CD58	CD58	NN	I-NP	B-protein
,	,	,	O	O
after	after	IN	B-PP	O
which	which	WDT	B-NP	O
signaling	signaling	NN	B-NP	O
through	through	IN	B-PP	O
STAT	STAT	NN	B-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Stimulation	Stimulation	NN	B-NP	O
of	of	IN	B-PP	O
CD2	CD2	NN	B-NP	B-protein
on	on	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
tyrosine	tyrosine	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
,	,	,	O	O
nuclear	nuclear	JJ	B-NP	O
translocation	translocation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
DNA	DNA	NN	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
STAT1	STAT1	NN	B-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
stimulation	stimulation	NN	B-NP	O
by	by	IN	B-PP	O
cytokines	cytokine	NNS	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
STAT1	STAT1	NN	B-NP	B-protein
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
CD2	CD2	NN	B-NP	B-protein
ligation	ligation	NN	I-NP	O
is	be	VBZ	B-VP	O
delayed	delay	VBN	I-VP	O
and	and	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
involve	involve	VB	I-VP	O
Jak	Jak	NN	B-NP	B-protein
kinases	kinase	NNS	I-NP	I-protein
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
STAT	STAT	NN	B-NP	B-protein
phosphorylation	phosphorylation	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
cytokines	cytokine	NNS	B-NP	B-protein
is	be	VBZ	B-VP	O
generally	generally	RB	B-ADJP	O
transient	transient	JJ	I-ADJP	O
,	,	,	O	O
STAT1	STAT1	NN	B-NP	B-protein
phosphorylation	phosphorylation	NN	I-NP	O
following	follow	VBG	B-PP	O
CD2	CD2	NN	B-NP	B-protein
stimulation	stimulation	NN	I-NP	O
persists	persist	VBZ	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
days	day	NNS	B-NP	O
.	.	.	O	O

Transcription	Transcription	NN	B-NP	O
of	of	IN	B-PP	O
key	key	JJ	B-NP	B-DNA
target	target	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
IRF1	IRF1	NN	B-NP	B-protein
and	and	CC	I-NP	O
c-fos	c-fos	NN	I-NP	B-DNA
proceeds	proceed	VBZ	B-VP	O
with	with	IN	B-PP	O
delayed	delay	VBN	B-NP	O
kinetics	kinetic	NNS	I-NP	O
following	follow	VBG	B-PP	O
CD2	CD2	NN	B-NP	B-protein
stimulation	stimulation	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
unique	unique	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
STAT	STAT	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
may	may	MD	B-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
distinct	distinct	JJ	I-NP	O
cellular	cellular	JJ	I-NP	O
response	response	NN	I-NP	O
following	follow	VBG	B-PP	O
CD2	CD2	NN	B-NP	B-protein
ligation	ligation	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
pathway	pathway	NN	I-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
restricted	restrict	VBN	I-VP	O
to	to	TO	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
as	as	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
of	of	IN	B-PP	O
CD2	CD2	NN	B-NP	B-protein
on	on	IN	B-PP	O
NK	NK	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
STAT1	STAT1	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
Stimulation	Stimulation	NN	B-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
through	through	IN	B-PP	O
cell-surface	cell-surface	JJ	B-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
CD2	CD2	NN	B-NP	B-protein
involves	involve	VBZ	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
STAT	STAT	NN	B-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
,	,	,	O	O
thus	thus	RB	B-ADVP	O
recapitulating	recapitulate	VBG	B-VP	O
elements	element	NNS	B-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-protein
signaling	signaling	NN	I-NP	O
.	.	.	O	O

NFATc1	NFATc1	NN	B-NP	B-protein
and	and	CC	I-NP	O
NFATc2	NFATc2	NN	I-NP	B-protein
together	together	RB	B-ADVP	O
control	control	VBP	B-VP	O
both	both	CC	O	O
T	T	NN	B-NP	O
and	and	CC	I-NP	O
B	B	NN	I-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	B-NP	O
and	and	CC	O	O
differentiation	differentiation	NN	B-NP	O
.	.	.	O	O

NFAT	NFAT	NN	B-NP	B-protein
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
play	play	VBP	B-VP	O
critical	critical	JJ	B-NP	O
roles	role	NNS	I-NP	O
in	in	IN	B-PP	O
gene	gene	NN	B-NP	O
transcription	transcription	NN	I-NP	O
during	during	IN	B-PP	O
immune	immune	JJ	B-NP	O
responses	response	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
further	further	RBR	B-ADVP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
most	most	RBS	I-NP	O
prominent	prominent	JJ	I-NP	O
NFAT	NFAT	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
members	member	NNS	I-NP	I-protein
,	,	,	O	O
NFATc1	NFATc1	NN	B-NP	B-protein
and	and	CC	I-NP	O
NFATc2	NFATc2	NN	I-NP	B-protein
,	,	,	O	O
we	we	PRP	B-NP	O
generated	generate	VBD	B-VP	O
mice	mouse	NNS	B-NP	O
bearing	bear	VBG	B-VP	O
lymphoid	lymphoid	JJ	B-NP	O
systems	system	NNS	I-NP	O
devoid	devoid	JJ	B-ADJP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
.	.	.	O	O

Doubly	Doubly	RB	B-NP	O
deficient	deficient	JJ	I-NP	O
T	T	NN	I-NP	O
cells	cell	NNS	I-NP	O
displayed	display	VBD	B-VP	O
cell	cell	NN	B-NP	B-protein
surface	surface	NN	I-NP	I-protein
markers	marker	NNS	I-NP	I-protein
of	of	IN	B-PP	O
activation	activation	NN	B-NP	O
yet	yet	RB	B-ADVP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
deficient	deficient	JJ	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
effector	effector	NN	I-NP	O
functions	function	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
Th	Th	NN	B-NP	B-protein
cytokine	cytokine	NN	I-NP	I-protein
production	production	NN	I-NP	O
,	,	,	O	O
surface	surface	NN	B-NP	B-protein
effector	effector	NN	I-NP	I-protein
molecule	molecule	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
cytolytic	cytolytic	JJ	B-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

Nevertheless	Nevertheless	RB	B-ADVP	O
,	,	,	O	O
doubly	doubly	RB	B-NP	O
deficient	deficient	JJ	I-NP	O
B	B	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
hyperactivated	hyperactivate	VBN	I-VP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
evidenced	evidence	VBN	B-VP	O
by	by	IN	B-PP	O
extremely	extremely	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
serum	serum	NN	I-NP	O
IgG1	IgG1	NN	I-NP	O
and	and	CC	I-NP	O
IgE	IgE	NN	I-NP	B-protein
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
plasma	plasma	NN	B-NP	O
cell	cell	NN	I-NP	O
expansion	expansion	NN	I-NP	O
and	and	CC	O	O
infiltration	infiltration	NN	B-NP	O
of	of	IN	B-PP	O
end	end	NN	B-NP	O
organs	organ	NNS	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
NFATc1	NFATc1	NN	B-NP	B-protein
and	and	CC	I-NP	O
NFATc2	NFATc2	NN	I-NP	B-protein
are	be	VBP	B-VP	O
dispensable	dispensable	JJ	B-ADJP	O
for	for	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	O
reactivity	reactivity	NN	I-NP	O
but	but	CC	O	O
are	be	VBP	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
effector	effector	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
NFATs	NFAT	NNS	B-NP	B-protein
regulate	regulate	VBP	B-VP	O
both	both	CC	O	O
normal	normal	JJ	B-ADJP	O
homeostasis	homeostasis	NN	B-NP	O
and	and	CC	O	O
differentiation	differentiation	NN	B-NP	O
.	.	.	O	O

Epstein-barr	Epstein-barr	JJ	B-NP	B-protein
virus	virus	NN	I-NP	I-protein
immediate-early	immediate-early	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
BZLF1	BZLF1	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
SUMO-1	SUMO-1	NN	B-NP	B-protein
modified	modify	VBN	B-VP	O
and	and	CC	O	O
disrupts	disrupt	VBZ	B-VP	O
promyelocytic	promyelocytic	JJ	B-NP	B-cell_type
leukemia	leukemia	NN	I-NP	I-cell_type
bodies	body	NNS	I-NP	I-cell_type
.	.	.	O	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
immediate-early	immediate-early	JJ	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
of	of	IN	B-PP	O
both	both	CC	O	O
herpes	herpes	NN	B-NP	O
simplex	simplex	NN	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
HSV	HSV	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
cytomegalovirus	cytomegalovirus	NN	B-NP	O
(	(	(	O	O
CMV	CMV	NN	B-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
modify	modify	VB	I-VP	O
promyelocytic	promyelocytic	JJ	B-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
PML	PML	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
ND10	ND10	NN	B-NP	B-protein
)	)	)	O	O
bodies	body	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
nucleus	nucleus	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
host	host	NN	I-NP	O
cell	cell	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
unclear	unclear	JJ	B-ADJP	O
whether	whether	IN	B-SBAR	O
lytic	lytic	JJ	B-NP	O
infection	infection	NN	I-NP	O
with	with	IN	B-PP	O
gamma	gamma	NN	B-NP	O
herpesviruses	herpesvirus	NNS	I-NP	O
induces	induce	VBZ	B-VP	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
PML	PML	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
interferon	interferon	NN	B-NP	B-protein
,	,	,	O	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
major	major	JJ	B-NP	O
histocompatibility	histocompatibility	NN	I-NP	O
complex	complex	NN	I-NP	O
class	class	NN	I-NP	O
I	I	CD	I-NP	O
presentation	presentation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
certain	certain	JJ	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
PML	PML	NN	B-NP	B-protein
bodies	body	NNS	I-NP	I-protein
function	function	VBP	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
antiviral	antiviral	JJ	I-NP	O
capacity	capacity	NN	I-NP	O
.	.	.	O	O

SUMO-1	SUMO-1	NN	B-NP	O
modification	modification	NN	I-NP	O
of	of	IN	B-PP	O
PML	PML	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
PML	PML	NN	B-NP	B-protein
bodies	body	NNS	I-NP	I-protein
.	.	.	O	O

To	To	TO	B-VP	O
examine	examine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
Epstein-Barr	Epstein-Barr	JJ	B-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
EBV	EBV	NN	B-NP	O
)	)	)	O	O
lytic	lytic	JJ	B-NP	O
replication	replication	NN	I-NP	O
interferes	interfere	VBZ	B-VP	O
with	with	IN	B-PP	O
PML	PML	NN	B-NP	B-protein
bodies	body	NNS	I-NP	I-protein
,	,	,	O	O
we	we	PRP	B-NP	O
expressed	express	VBD	B-VP	O
the	the	DT	B-NP	O
EBV	EBV	NN	I-NP	B-DNA
immediate-early	immediate-early	JJ	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
BZLF1	BZLF1	NN	I-NP	B-protein
(	(	(	O	O
Z	Z	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
BRLF1	BRLF1	NN	B-NP	B-protein
(	(	(	O	O
R	R	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
EBV-positive	EBV-positive	JJ	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
and	and	CC	O	O
examined	examine	VBN	B-NP	O
PML	PML	NN	I-NP	O
localization	localization	NN	I-NP	O
.	.	.	O	O

Both	Both	CC	O	O
Z	Z	NN	B-NP	B-protein
and	and	CC	I-NP	O
R	R	NN	I-NP	O
expression	expression	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
PML	PML	NN	B-NP	O
dispersion	dispersion	NN	I-NP	O
in	in	IN	B-PP	O
EBV-positive	EBV-positive	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Z	Z	NN	B-NP	B-protein
but	but	CC	B-NP	O
not	not	RB	I-NP	O
R	R	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
disrupt	disrupt	VB	I-VP	O
PML	PML	NN	B-NP	B-protein
bodies	body	NNS	I-NP	I-protein
in	in	IN	B-PP	O
EBV-negative	EBV-negative	JJ	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
.	.	.	O	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
dispersion	dispersion	NN	B-NP	O
of	of	IN	B-PP	O
PML	PML	NN	B-NP	B-protein
bodies	body	NNS	I-NP	I-protein
by	by	IN	B-PP	O
Z	Z	NN	B-NP	B-protein
requires	require	VBZ	B-VP	O
a	a	DT	B-NP	O
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	B-protein
activation	activation	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
Z	Z	NN	B-NP	B-protein
but	but	CC	B-NP	O
not	not	RB	I-NP	O
the	the	DT	B-NP	O
DNA-binding	DNA-binding	JJ	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
was	be	VBD	B-VP	O
previously	previously	RB	I-VP	O
reported	report	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
HSV-1	HSV-1	NN	I-NP	O
ICP0	ICP0	NN	I-NP	B-protein
and	and	CC	O	O
CMV	CMV	NN	B-NP	B-protein
IE1	IE1	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
,	,	,	O	O
Z	Z	NN	B-NP	B-protein
reduces	reduce	VBZ	B-VP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
SUMO-1-modified	SUMO-1-modified	JJ	B-NP	O
PML	PML	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
Z	Z	NN	B-NP	B-protein
itself	itself	PRP	B-NP	O
is	be	VBZ	B-VP	O
SUMO-1	SUMO-1	NN	B-NP	B-protein
modified	modify	VBN	B-VP	O
(	(	(	O	O
through	through	IN	B-PP	O
amino	amino	NN	B-NP	B-protein
acid	acid	NN	I-NP	I-protein
12	12	CD	I-NP	I-protein
)	)	)	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
Z	Z	NN	B-NP	B-protein
competes	compete	VBZ	B-VP	O
with	with	IN	B-PP	O
PML	PML	NN	B-NP	B-protein
for	for	IN	B-PP	O
limiting	limit	VBG	B-VP	O
amounts	amount	NNS	B-NP	O
of	of	IN	B-PP	O
SUMO-1	SUMO-1	NN	B-NP	B-protein
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
disruption	disruption	NN	B-NP	O
of	of	IN	B-PP	O
PML	PML	NN	B-NP	B-protein
bodies	body	NNS	I-NP	I-protein
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
efficient	efficient	JJ	B-NP	O
lytic	lytic	JJ	I-NP	O
replication	replication	NN	I-NP	O
of	of	IN	B-PP	O
EBV	EBV	NN	B-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
Z	Z	NN	B-NP	B-protein
may	may	MD	B-VP	O
potentially	potentially	RB	I-VP	O
alter	alter	VB	I-VP	O
the	the	DT	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
cellular	cellular	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
by	by	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
SUMO-1	SUMO-1	NN	B-NP	O
modification	modification	NN	I-NP	O

Suppression	Suppression	NN	B-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
and	and	CC	I-NP	O
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
inhibitor	inhibitor	NN	B-NP	B-protein
kappaB	kappaB	NN	I-NP	I-protein
by	by	IN	B-PP	O
troglitazone	troglitazone	NN	B-NP	O
:	:	:	O	O
evidence	evidence	NN	B-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	O
effect	effect	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
antiatherosclerotic	antiatherosclerotic	JJ	I-NP	O
effect	effect	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
obese	obese	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
elucidate	elucidate	VB	I-VP	O
whether	whether	IN	B-SBAR	O
troglitazone	troglitazone	NN	B-NP	O
exerts	exert	VBZ	B-VP	O
an	an	DT	B-NP	O
antiinflammatory	antiinflammatory	JJ	I-NP	O
effect	effect	NN	I-NP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
,	,	,	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
suppression	suppression	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
kappaB	kappaB	NN	I-NP	I-protein
(	(	(	O	O
NFkappaB	NFkappaB	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
mononuclear	mononuclear	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
MNC	MNC	NN	B-NP	B-cell_type
)	)	)	O	O
by	by	IN	B-PP	O
this	this	DT	B-NP	O
drug	drug	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
measured	measure	VBD	B-VP	O
intranuclear	intranuclear	JJ	B-NP	O
NFkappaB	NFkappaB	NN	I-NP	B-protein
,	,	,	O	O
total	total	JJ	B-NP	O
cellular	cellular	JJ	I-NP	O
NFkappaB	NFkappaB	NN	I-NP	B-protein
,	,	,	O	O
inhibitor	inhibitor	NN	B-NP	O
kappaB	kappaB	NN	I-NP	O
(	(	(	O	O
IkappaB	IkappaB	NN	B-NP	B-protein
)	)	)	O	O
alpha	alpha	NN	B-NP	O
,	,	,	O	O
reactive	reactive	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
species	specie	NNS	I-NP	O
(	(	(	O	O
ROS	ROS	NN	B-NP	O
)	)	)	O	O
generation	generation	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
p47	p47	NN	B-NP	B-protein
(	(	(	O	I-protein
phox	phox	NN	B-NP	I-protein
)	)	)	O	I-protein
subunit	subunit	NN	B-NP	I-protein
(	(	(	O	O
a	a	DT	B-NP	O
key	key	JJ	I-NP	B-protein
component	component	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
of	of	IN	B-PP	O
nicotinamide	nicotinamide	NN	B-NP	B-protein
adenine	adenine	NN	I-NP	I-protein
dinucleotide	dinucleotide	NN	I-NP	I-protein
phosphate	phosphate	NN	I-NP	I-protein
oxidase	oxidase	NN	I-NP	I-protein
)	)	)	O	O
in	in	IN	B-PP	O
MNC	MNC	NN	B-NP	B-cell_type
.	.	.	O	O

Plasma	Plasma	NN	B-NP	B-protein
tumor	tumor	NN	I-NP	I-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
TNF	TNF	NN	B-NP	B-protein
)	)	)	O	O
-alpha	-alpha	NN	B-NP	O
,	,	,	O	O
soluble	soluble	JJ	B-NP	O
intercellular	intercellular	JJ	I-NP	B-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
(	(	(	O	O
sICAM-1	sICAM-1	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
monocyte	monocyte	NN	B-NP	B-protein
chemoattractant	chemoattractant	NN	I-NP	I-protein
protein-1	protein-1	NN	I-NP	I-protein
(	(	(	O	O
MCP-1	MCP-1	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
plasminogen	plasminogen	NN	B-NP	B-protein
activator	activator	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	I-protein
type	type	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
(	(	(	O	O
PAI-1	PAI-1	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
C-reactive	C-reactive	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	O
CRP	CRP	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
interleukin	interleukin	NN	B-NP	B-protein
(	(	(	O	I-protein
IL	IL	NN	B-NP	I-protein
)	)	)	O	I-protein
-10	-10	CD	B-NP	I-protein
(	(	(	O	O
antiinflammatory	antiinflammatory	JJ	O	B-protein
cytokine	cytokine	NN	O	I-protein
)	)	)	O	O
concentrations	concentration	NNS	B-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
measured	measure	VBN	I-VP	O
as	as	IN	B-PP	O
mediators	mediator	NNS	B-NP	O
of	of	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	O
activity	activity	NN	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
proinflammatory	proinflammatory	JJ	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
NFkappaB	NFkappaB	NN	I-NP	B-protein
.	.	.	O	O

Seven	Seven	CD	B-NP	O
nondiabetic	nondiabetic	JJ	I-NP	O
obese	obese	JJ	I-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
given	give	VBN	I-VP	O
400	400	CD	B-NP	O
mg	mg	NN	I-NP	O
troglitazone	troglitazone	NN	I-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
4	4	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
at	at	IN	I-PP	O
weekly	weekly	JJ	B-NP	O
intervals	interval	NNS	I-NP	O
thereafter	thereafter	RB	B-ADVP	O
.	.	.	O	O

MNC	MNC	NN	B-NP	B-cell_type
were	be	VBD	B-VP	O
separated	separate	VBN	I-VP	O
;	;	:	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
intranuclear	intranuclear	JJ	B-NP	O
NFkappaB	NFkappaB	NN	I-NP	B-protein
,	,	,	O	O
total	total	JJ	B-NP	O
cellular	cellular	JJ	I-NP	O
NFkappaB	NFkappaB	NN	I-NP	B-protein
,	,	,	O	O
IkappaBalpha	IkappaBalpha	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
p47	p47	NN	B-NP	B-protein
(	(	(	O	I-protein
phox	phox	NN	B-NP	I-protein
)	)	)	O	I-protein
subunit	subunit	NN	B-NP	I-protein
and	and	CC	I-NP	O
ROS	ROS	NN	I-NP	O
generation	generation	NN	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
.	.	.	O	O

Plasma	Plasma	NN	B-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
measure	measure	VB	I-VP	O
insulin	insulin	NN	B-NP	O
glucose	glucose	NN	I-NP	O
,	,	,	O	O
TNFalpha	TNFalpha	NN	B-NP	B-protein
,	,	,	O	O
sICAM	sICAM	NN	B-NP	O
,	,	,	O	O
MCP-1	MCP-1	NN	B-NP	B-protein
,	,	,	O	O
PAI-1	PAI-1	NN	B-NP	B-protein
,	,	,	O	O
CRP	CRP	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
IL-10	IL-10	NN	B-NP	B-protein
.	.	.	O	O

Plasma	Plasma	NN	B-NP	O
insulin	insulin	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
fell	fall	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
at	at	IN	B-PP	O
week	week	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
from	from	IN	B-PP	O
31.2	31.2	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
29.1	29.1	CD	I-NP	O
to	to	TO	I-NP	O
14.2	14.2	CD	I-NP	O
+/-	+/-	SYM	I-NP	O
11.4	11.4	CD	I-NP	O
mU/L	mU/L	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.01	0.01	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
low	low	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
4	4	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Plasma	Plasma	NN	B-NP	O
glucose	glucose	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
alter	alter	VB	I-VP	O
significantly	significantly	RB	B-ADVP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
fall	fall	NN	I-NP	O
in	in	IN	B-PP	O
intranuclear	intranuclear	JJ	B-NP	O
NFkappaB	NFkappaB	NN	I-NP	B-protein
,	,	,	O	O
total	total	JJ	B-NP	O
cellular	cellular	JJ	I-NP	O
NFkappaB	NFkappaB	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
p47	p47	NN	B-NP	B-protein
(	(	(	O	I-protein
phox	phox	NN	B-NP	I-protein
)	)	)	O	I-protein
subunit	subunit	NN	B-NP	I-protein
,	,	,	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
IkappaBalpha	IkappaBalpha	NN	I-NP	B-protein
at	at	IN	B-PP	O
week	week	NN	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
persisted	persist	VBD	B-VP	O
until	until	IN	B-SBAR	O
week	week	NN	B-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
parallel	parallel	JJ	I-NP	O
fall	fall	NN	I-NP	O
in	in	IN	B-PP	O
ROS	ROS	NN	B-NP	O
generation	generation	NN	I-NP	O
by	by	IN	B-PP	O
MNC	MNC	NN	B-NP	B-cell_type
at	at	IN	B-PP	O
week	week	NN	B-NP	O
1	1	CD	I-NP	O
;	;	:	O	O
this	this	DT	B-NP	O
progressed	progress	VBD	B-VP	O
and	and	CC	I-VP	O
persisted	persist	VBD	I-VP	O
until	until	IN	B-SBAR	O
week	week	NN	B-NP	O
4	4	CD	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Plasma	Plasma	NN	B-NP	O
TNF-alpha	TNF-alpha	NN	I-NP	B-protein
,	,	,	O	O
sICAM-1	sICAM-1	NN	B-NP	O
,	,	,	O	O
MCP-1	MCP-1	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
PAI-1	PAI-1	NN	B-NP	B-protein
concentrations	concentration	NNS	I-NP	O
fell	fall	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
at	at	IN	B-PP	O
week	week	NN	B-NP	B-DNA
4	4	CD	I-NP	I-DNA
.	.	.	O	O

Plasma	Plasma	NN	B-NP	O
IL-10	IL-10	NN	I-NP	B-protein
concentration	concentration	NN	I-NP	O
increased	increase	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
,	,	,	O	O
whereas	whereas	IN	O	O
plasma	plasma	NN	B-NP	O
CRP	CRP	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
decreased	decrease	VBD	B-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
troglitazone	troglitazone	NN	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
antiinflammatory	antiinflammatory	JJ	I-NP	O
action	action	NN	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
putative	putative	JJ	I-NP	O
antiatherosclerotic	antiatherosclerotic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
.	.	.	O	O

Tyrosine	Tyrosine	NN	B-NP	O
phosphorylation-dependent	phosphorylation-dependent	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
.	.	.	O	O

Requirement	Requirement	NN	B-NP	O
for	for	IN	B-PP	O
p56	p56	NN	B-NP	B-protein
LCK	LCK	NN	I-NP	I-protein
and	and	CC	O	O
ZAP-70	ZAP-70	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
tyrosine	tyrosine	NN	I-NP	I-protein
kinases	kinase	NNS	I-NP	I-protein
.	.	.	O	O

Phosphorylation	Phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
N-terminal	N-terminal	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
inhibitory	inhibitory	JJ	I-NP	I-protein
subunits	subunit	NNS	I-NP	I-protein
induces	induce	VBZ	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
.	.	.	O	O

Although	Although	IN	B-SBAR	O
serine	serine	NN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
induce	induce	VB	I-VP	O
ubiquitination	ubiquitination	NN	B-NP	O
and	and	CC	O	O
subsequent	subsequent	JJ	B-NP	O
proteasome-mediated	proteasome-mediated	JJ	I-NP	O
degradation	degradation	NN	I-NP	O
of	of	IN	B-PP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B-alpha	B-alpha	NN	I-NP	I-protein
,	,	,	O	O
little	little	JJ	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
that	that	WDT	B-NP	O
lead	lead	VBP	B-VP	O
to	to	TO	I-VP	O
release	release	VB	I-VP	O
of	of	IN	B-PP	O
active	active	JJ	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
as	as	IN	B-PP	O
a	a	DT	B-NP	O
consequence	consequence	NN	I-NP	O
of	of	IN	B-PP	O
tyrosine	tyrosine	NN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B-alpha	B-alpha	NN	I-NP	I-protein
[	[	(	O	O
Imbert	Imbert	NNP	B-NP	O
,	,	,	O	O
V.	V.	NNP	B-NP	O
,	,	,	O	O
Rupec	Rupec	NNP	B-NP	O
,	,	,	O	O
R.A.	R.A.	NNP	B-NP	O
,	,	,	O	O
Livolsi	Livolsi	NNP	B-NP	O
,	,	,	O	O
A.	A.	NNP	B-NP	O
,	,	,	O	O
Pahl	Pahl	NNP	B-NP	O
,	,	,	O	O
H.L.	H.L.	NNP	B-NP	O
,	,	,	O	O
Traenckner	Traenckner	NNP	B-NP	O
,	,	,	O	O
B.M.	B.M.	NNP	B-NP	O
,	,	,	O	O
Mueller-Dieckmann	Mueller-Dieckmann	NNP	B-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
,	,	,	O	O
Farahifar	Farahifar	NNP	B-NP	O
,	,	,	O	O
D.	D.	NNP	B-NP	O
,	,	,	O	O
Rossi	Rossi	NNP	B-NP	O
,	,	,	O	O
B.	B.	NNP	B-NP	O
,	,	,	O	O
Auberger	Auberger	NNP	B-NP	O
,	,	,	O	O
P.	P.	NNP	B-NP	O
,	,	,	O	O
Baeuerle	Baeuerle	NNP	B-NP	O
,	,	,	O	O
P.	P.	NNP	B-NP	O
&	&	CC	I-NP	O
Peyron	Peyron	NNP	I-NP	O
,	,	,	O	O
J.F.	J.F.	NNP	B-NP	O
(	(	(	O	O
1996	1996	CD	B-NP	O
)	)	)	O	O
Cell	Cell	NNP	B-NP	O
86	86	CD	I-NP	O
,	,	,	I-NP	O
787	787	CD	I-NP	O
--	--	:	O	O
798	798	CD	B-NP	O
]	]	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tyrosine	tyrosine	NN	I-NP	B-protein
kinases	kinase	NNS	I-NP	I-protein
p56	p56	NN	I-NP	B-protein
(	(	(	O	I-protein
lck	lck	NN	B-NP	I-protein
)	)	)	O	I-protein
and	and	CC	O	O
ZAP-70	ZAP-70	NN	B-NP	B-protein
in	in	IN	B-PP	O
this	this	DT	B-NP	O
reaction	reaction	NN	I-NP	O
is	be	VBZ	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
here	here	RB	B-ADVP	O
using	use	VBG	B-VP	O
specific	specific	JJ	B-NP	O
pharmacological	pharmacological	JJ	I-NP	O
inhibitors	inhibitor	NNS	I-NP	O
and	and	CC	O	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
mutants	mutant	NNS	I-NP	I-cell_line
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
express	express	VB	I-VP	O
these	these	DT	B-NP	O
kinases	kinase	NNS	I-NP	B-protein
.	.	.	O	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
prevented	prevent	VBD	B-VP	O
both	both	CC	O	O
pervanadate-induced	pervanadate-induced	JJ	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B-alpha	B-alpha	NN	I-NP	I-protein
on	on	IN	B-PP	O
Tyr42	Tyr42	NN	B-NP	B-protein
and	and	CC	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
observed	observe	VBD	B-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
in	in	IN	B-PP	O
p56	p56	NN	B-NP	B-protein
(	(	(	O	I-protein
lck	lck	NN	B-NP	I-protein
)	)	)	O	I-protein
-deficient	-deficient	JJ	B-NP	O
Jurkat	Jurkat	NN	I-NP	B-cell_line
mutants	mutant	NNS	I-NP	I-cell_line
,	,	,	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
could	could	MD	B-VP	O
still	still	RB	I-VP	O
associate	associate	VB	I-VP	O
with	with	IN	B-PP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B-alpha	B-alpha	NN	I-NP	I-protein
despite	despite	IN	B-PP	O
phosphorylation	phosphorylation	NN	B-NP	O
on	on	IN	B-PP	O
Tyr42	Tyr42	NN	B-NP	B-protein
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
SH2	SH2	NN	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
p56	p56	NN	B-NP	B-protein
(	(	(	O	I-protein
lck	lck	NN	B-NP	I-protein
)	)	)	O	I-protein
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
pervanadate-induced	pervanadate-induced	JJ	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
for	for	IN	I-PP	O
Tyr42	Tyr42	NN	B-NP	B-protein
phosphorylation	phosphorylation	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
p56	p56	NN	B-NP	B-protein
(	(	(	O	I-protein
lck	lck	NN	B-NP	I-protein
)	)	)	O	I-protein
and	and	CC	O	O
ZAP-70	ZAP-70	NN	B-NP	B-protein
are	be	VBP	B-VP	O
key	key	JJ	B-NP	O
components	component	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
signaling	signaling	NN	I-NP	O
pathway	pathway	NN	I-NP	O
that	that	WDT	B-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
phosphotyrosine-dependent	phosphotyrosine-dependent	JJ	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
confirm	confirm	VBP	B-VP	O
that	that	IN	B-SBAR	O
tyrosine	tyrosine	NN	B-NP	B-protein
kinases	kinase	NNS	I-NP	I-protein
must	must	MD	B-VP	O
control	control	VB	I-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
two	two	CD	I-NP	O
different	different	JJ	I-NP	O
steps	step	NNS	I-NP	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
H	H	NN	B-NP	B-protein
(	(	(	O	I-protein
2	2	CD	B-NP	I-protein
)	)	)	O	I-protein
O	O	NN	B-NP	I-protein
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
stimulates	stimulate	VBZ	B-VP	O
p56	p56	NN	B-NP	B-protein
(	(	(	O	I-protein
lck	lck	NN	B-NP	I-protein
)	)	)	O	I-protein
and	and	CC	O	O
ZAP-70	ZAP-70	NN	B-NP	B-protein
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
activator	activator	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
through	through	IN	B-PP	O
tyrosine	tyrosine	NN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B-alpha	B-alpha	NN	I-NP	I-protein
.	.	.	O	O

Specific	Specific	JJ	B-NP	O
missense	missense	JJ	I-NP	O
mutations	mutation	NNS	I-NP	O
in	in	IN	B-PP	O
NEMO	NEMO	NN	B-NP	B-protein
result	result	VBP	B-VP	O
in	in	IN	B-PP	O
hyper-IgM	hyper-IgM	NN	B-NP	O
syndrome	syndrome	NN	I-NP	O
with	with	IN	B-PP	O
hypohydrotic	hypohydrotic	JJ	B-NP	O
ectodermal	ectodermal	JJ	I-NP	O
dysplasia	dysplasia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
gene	gene	NN	I-NP	O
that	that	WDT	B-NP	O
encodes	encode	VBZ	B-VP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
kappaB	kappaB	NN	I-NP	I-protein
(	(	(	O	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
)	)	)	O	O
essential	essential	JJ	B-NP	O
modulator	modulator	NN	I-NP	O
(	(	(	O	O
or	or	CC	O	O
NEMO	NEMO	NN	B-NP	B-protein
,	,	,	O	O
also	also	RB	B-VP	O
known	know	VBN	I-VP	O
as	as	IN	B-PP	O
IKKgamma	IKKgamma	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
.	.	.	O	O

We	We	PRP	B-NP	O
describe	describe	VBP	B-VP	O
mutations	mutation	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
putative	putative	JJ	I-NP	B-protein
zinc-finger	zinc-finger	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
NEMO	NEMO	NN	B-NP	B-protein
that	that	WDT	B-NP	O
result	result	VBP	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
X-linked	X-linked	JJ	I-NP	O
primary	primary	JJ	I-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
characterized	characterize	VBN	B-VP	O
by	by	IN	B-PP	O
hyper-IgM	hyper-IgM	NN	B-NP	O
syndrome	syndrome	NN	I-NP	O
and	and	CC	O	O
hypohydrotic	hypohydrotic	JJ	B-NP	O
ectodermal	ectodermal	JJ	I-NP	O
dysplasia	dysplasia	NN	I-NP	O
(	(	(	O	O
XHM-ED	XHM-ED	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

These	These	DT	B-NP	O
mutations	mutation	NNS	I-NP	O
prevent	prevent	VBP	B-VP	O
CD40	CD40	NN	B-NP	B-protein
ligand	ligand	NN	I-NP	I-protein
(	(	(	O	O
CD40L	CD40L	NN	B-NP	B-protein
)	)	)	O	O
-mediated	-mediated	JJ	B-NP	O
degradation	degradation	NN	I-NP	O
of	of	IN	B-PP	O
inhibitor	inhibitor	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
(	(	(	O	O
IkappaB-alpha	IkappaB-alpha	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
account	account	VBP	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
observations	observation	NNS	I-NP	O
:	:	:	O	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
XHM-ED	XHM-ED	JJ	B-NP	O
patients	patient	NNS	I-NP	O
are	be	VBP	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
undergo	undergo	VB	I-VP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-protein
class-switch	class-switch	JJ	I-NP	O
recombination	recombination	NN	I-NP	O
and	and	CC	O	O
antigen-presenting	antigen-presenting	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
APCs	APC	NNS	B-NP	B-cell_type
)	)	)	O	O
are	be	VBP	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
synthesize	synthesize	VB	I-VP	O
the	the	DT	B-NP	O
NF-kappaB-regulated	NF-kappaB-regulated	JJ	I-NP	B-protein
cytokines	cytokine	NNS	I-NP	I-protein
interleukin	interleukin	NN	I-NP	B-protein
12	12	CD	I-NP	I-protein
(	(	(	O	O
IL-12	IL-12	NN	B-NP	B-protein
)	)	)	O	O
or	or	CC	O	O
tumor	tumor	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
(	(	(	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
)	)	)	O	O
when	when	WRB	B-ADVP	O
stimulated	stimulate	VBN	B-VP	O
with	with	IN	B-PP	O
CD40L	CD40L	NN	B-NP	B-protein
.	.	.	O	O

Nevertheless	Nevertheless	RB	B-ADVP	O
,	,	,	O	O
innate	innate	JJ	B-NP	O
immunity	immunity	NN	I-NP	O
is	be	VBZ	B-VP	O
preserved	preserve	VBN	I-VP	O
in	in	IN	B-PP	O
XHM-ED	XHM-ED	JJ	B-NP	O
patients	patient	NNS	I-NP	O
because	because	IN	B-SBAR	O
APCs	APC	NNS	B-NP	B-cell_type
retain	retain	VBP	B-VP	O
the	the	DT	B-NP	O
capacity	capacity	NN	I-NP	O
to	to	TO	B-VP	O
respond	respond	VB	I-VP	O
to	to	TO	B-PP	O
stimulation	stimulation	NN	B-NP	O
by	by	IN	B-PP	O
lipopolysaccharide	lipopolysaccharide	NN	B-NP	O
or	or	CC	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	B-protein
aureus	aureus	NNP	I-NP	I-protein
Cowan	Cowan	NNP	I-NP	I-protein
's	's	POS	B-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
(	(	(	O	O
SAC	SAC	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Overall	Overall	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
phenotype	phenotype	NN	I-NP	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
XHM-ED	XHM-ED	JJ	B-NP	O
patients	patient	NNS	I-NP	O
shows	show	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
putative	putative	JJ	I-NP	B-protein
zinc-finger	zinc-finger	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
NEMO	NEMO	NN	B-NP	B-protein
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	O
function	function	NN	I-NP	O
and	and	CC	O	O
demonstrates	demonstrate	VBZ	B-VP	O
the	the	DT	B-NP	O
definite	definite	JJ	I-NP	O
requirement	requirement	NN	I-NP	O
of	of	IN	B-PP	O
CD40	CD40	NN	B-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
for	for	IN	B-PP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	O
class-switching	class-switching	NN	I-NP	O
.	.	.	O	O

Granulocytic	Granulocytic	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
NB4	NB4	NN	I-NP	I-cell_line
promyelocytic	promyelocytic	JJ	I-NP	I-cell_line
leukemia	leukemia	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
all-trans	all-trans	JJ	B-NP	O
retinoic	retinoic	JJ	I-NP	O
acid	acid	NN	I-NP	O
metabolites	metabolite	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
metabolism	metabolism	NN	I-NP	O
of	of	IN	B-PP	O
all-trans	all-trans	JJ	B-NP	O
retinoic	retinoic	JJ	I-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
ATRA	ATRA	NN	B-NP	O
)	)	)	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
partly	partly	RB	B-ADJP	O
responsible	responsible	JJ	I-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
ATRA	ATRA	NN	B-NP	O
seen	see	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
acute	acute	JJ	I-NP	O
promyelocytic	promyelocytic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
APL	APL	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
ATRA	ATRA	NN	B-NP	O
metabolism	metabolism	NN	I-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
principal	principal	JJ	I-NP	O
metabolites	metabolite	NNS	I-NP	O
of	of	IN	B-PP	O
ATRA	ATRA	NN	B-NP	O
[	[	(	O	O
4-hydroxy-retinoic	4-hydroxy-retinoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
4-OH-RA	4-OH-RA	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
18-hydroxy-retinoic	18-hydroxy-retinoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
18-OH-RA	18-OH-RA	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
4-oxo-retinoic	4-oxo-retinoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
4-oxo-RA	4-oxo-RA	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
5	5	CD	B-NP	O
,	,	,	O	O
6-epoxy-retinoic	6-epoxy-retinoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
5	5	CD	B-NP	O
,	,	,	O	O
6-epoxy-RA	6-epoxy-RA	NN	B-NP	O
)	)	)	O	O
]	]	)	O	O
in	in	IN	B-PP	O
NB4	NB4	NN	B-NP	B-cell_line
,	,	,	O	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	B-cell_line
promyelocytic	promyelocytic	JJ	I-NP	I-cell_line
leukemia	leukemia	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
that	that	WDT	B-NP	O
exhibits	exhibit	VBZ	B-VP	O
the	the	DT	B-NP	O
APL	APL	NN	I-NP	O
diagnostic	diagnostic	JJ	I-NP	O
t	t	NN	I-NP	O
(	(	(	O	O
15	15	CD	B-NP	O
;	;	:	O	O
17	17	CD	B-NP	O
)	)	)	I-NP	O
chromosomal	chromosomal	JJ	I-NP	O
translocation	translocation	NN	I-NP	O
and	and	CC	O	O
expresses	express	VBZ	B-VP	O
the	the	DT	B-NP	O
PML-RAR	PML-RAR	NN	I-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
fusion	fusion	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

We	We	PRP	B-NP	O
established	establish	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
four	four	CD	I-NP	O
ATRA	ATRA	NN	I-NP	O
metabolites	metabolite	NNS	I-NP	O
were	be	VBD	B-VP	O
indeed	indeed	RB	I-VP	O
formed	form	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
NB4	NB4	NN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

NB4	NB4	NN	B-NP	O
cell	cell	NN	I-NP	O
growth	growth	NN	I-NP	O
was	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
(	(	(	O	O
69-78	69-78	CD	B-NP	O
%	%	NN	I-NP	O
at	at	IN	B-PP	O
120	120	CD	B-NP	O
h	h	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
progression	progression	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
G1	G1	NN	I-NP	O
phase	phase	NN	I-NP	O
(	(	(	O	O
82-85	82-85	CD	B-NP	O
%	%	NN	I-NP	O
at	at	IN	B-PP	O
120	120	CD	B-NP	O
h	h	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
blocked	block	VBN	I-VP	O
by	by	IN	B-PP	O
ATRA	ATRA	NN	B-NP	O
and	and	CC	O	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
metabolites	metabolite	NNS	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
microM	microM	NN	I-NP	O
concentration	concentration	NN	I-NP	O
.	.	.	O	O

ATRA	ATRA	NN	B-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
metabolites	metabolite	NNS	I-NP	O
could	could	MD	B-VP	O
induce	induce	VB	I-VP	O
NB4	NB4	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
differentiation	differentiation	NN	B-VP	O
with	with	IN	B-PP	O
similar	similar	JJ	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
evaluated	evaluate	VBN	B-VP	O
by	by	IN	B-PP	O
cell	cell	NN	B-NP	O
morphology	morphology	NN	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
nitroblue	nitroblue	JJ	I-NP	O
tetrazolium	tetrazolium	NN	I-NP	O
reduction	reduction	NN	I-NP	O
test	test	NN	I-NP	O
(	(	(	O	O
82-88	82-88	CD	B-NP	O
%	%	NN	I-NP	O
at	at	IN	B-PP	O
120	120	CD	B-NP	O
h	h	NN	I-NP	O
)	)	)	O	O
or	or	CC	O	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
maturation	maturation	NN	I-NP	O
specific	specific	JJ	I-NP	O
cell	cell	NN	I-NP	O
surface	surface	NN	I-NP	O
marker	marker	NN	I-NP	O
CD11c	CD11c	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
nuclear	nuclear	JJ	B-NP	O
body	body	NN	I-NP	O
reorganization	reorganization	NN	I-NP	O
to	to	TO	B-PP	O
macropunctated	macropunctate	VBN	B-NP	O
structures	structure	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
degradation	degradation	NN	I-NP	O
of	of	IN	B-PP	O
PML-RAR	PML-RAR	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
,	,	,	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
similar	similar	JJ	B-ADJP	O
for	for	IN	B-PP	O
ATRA	ATRA	NN	B-NP	O
and	and	CC	O	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
metabolites	metabolite	NNS	I-NP	O
.	.	.	O	O

Comparison	Comparison	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
relative	relative	JJ	I-NP	O
potency	potency	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
retinoids	retinoid	NNS	I-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
nitroblue	nitroblue	JJ	I-NP	O
tetrazolium	tetrazolium	NN	I-NP	O
reduction	reduction	NN	I-NP	O
test	test	NN	I-NP	O
showed	show	VBD	B-VP	O
effective	effective	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
required	require	VBN	B-VP	O
to	to	TO	I-VP	O
differentiate	differentiate	VB	I-VP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
in	in	IN	B-PP	O
72	72	CD	B-NP	O
h	h	NN	I-NP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
ATRA	ATRA	NN	B-NP	O
,	,	,	O	O
15.8	15.8	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
1.7	1.7	CD	I-NP	O
nM	nM	NN	I-NP	O
;	;	:	O	O
4-oxo-RA	4-oxo-RA	NN	B-NP	O
,	,	,	O	O
38.3	38.3	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
1.3	1.3	CD	I-NP	O
nM	nM	NN	I-NP	O
;	;	:	O	O
18-OH-RA	18-OH-RA	NN	B-NP	O
,	,	,	O	O
55.5	55.5	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
1.8	1.8	CD	I-NP	O
nM	nM	NN	I-NP	O
;	;	:	O	O
4-OH-RA	4-OH-RA	NN	B-NP	O
,	,	,	O	O
79.8	79.8	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
1.8	1.8	CD	I-NP	O
nM	nM	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
5	5	CD	B-NP	O
,	,	,	O	O
6-epoxy-RA	6-epoxy-RA	NN	B-NP	O
,	,	,	O	O
99.5	99.5	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
1.5	1.5	CD	I-NP	O
nM	nM	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ATRA	ATRA	NN	I-NP	O
metabolites	metabolite	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
exert	exert	VB	I-VP	O
their	their	PRP$	B-NP	O
differentiation	differentiation	NN	I-NP	O
effects	effect	NNS	I-NP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
RAR	RAR	NN	I-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
nuclear	nuclear	JJ	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
,	,	,	O	O
because	because	IN	B-SBAR	O
the	the	DT	B-NP	O
RAR	RAR	NN	I-NP	B-protein
alpha-specific	alpha-specific	JJ	I-NP	O
antagonist	antagonist	NN	I-NP	O
BMS614	BMS614	NN	I-NP	O
blocked	block	VBD	B-VP	O
metabolite-induced	metabolite-induced	JJ	B-NP	O
CD11c	CD11c	NN	I-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
NB4	NB4	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
principal	principal	JJ	I-NP	O
ATRA	ATRA	NN	I-NP	O
Phase	Phase	NN	I-NP	O
1	1	CD	B-NP	O
metabolites	metabolite	NNS	I-NP	O
can	can	MD	B-VP	O
elicit	elicit	VB	I-VP	O
leukemia	leukemia	NN	B-NP	O
cell	cell	NN	I-NP	O
growth	growth	NN	I-NP	O
inhibition	inhibition	NN	I-NP	O
and	and	CC	O	O
differentiation	differentiation	NN	B-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
RAR	RAR	NN	I-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
signaling	signaling	NN	I-NP	O
pathway	pathway	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
they	they	PRP	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
metabolites	metabolite	NNS	I-NP	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
ATRA	ATRA	NN	B-NP	O
antileukemic	antileukemic	JJ	I-NP	O
activity	activity	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
oestrogen	oestrogen	NN	B-NP	O
and	and	CC	O	O
progesterone	progesterone	NN	B-NP	B-protein
receptors	receptor	NNS	B-NP	I-protein
by	by	IN	B-PP	O
mast	mast	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
alone	alone	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
macrophages	macrophage	NNS	B-NP	B-cell_type
or	or	CC	O	O
other	other	JJ	B-NP	O
immune	immune	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
upper	upper	JJ	I-NP	O
airways	airway	NNS	I-NP	O
.	.	.	O	O

BACKGROUND	BACKGROUND	NN	B-NP	O
:	:	:	O	O
Nasal	Nasal	JJ	B-NP	O
polyposis	polyposis	NN	I-NP	O
often	often	RB	B-ADVP	O
coexists	coexist	VBZ	B-VP	O
with	with	IN	B-PP	O
asthma	asthma	NN	B-NP	O
in	in	IN	B-PP	O
airway	airway	NN	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
characterised	characterise	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
infiltration	infiltration	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
immune	immune	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

A	A	DT	B-NP	O
potentially	potentially	RB	I-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
ovarian	ovarian	JJ	B-NP	O
hormones	hormone	NNS	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
airway	airway	NN	B-NP	O
inflammation	inflammation	NN	I-NP	O
but	but	CC	O	O
the	the	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
target	target	NN	I-NP	O
for	for	IN	B-PP	O
such	such	JJ	B-NP	O
action	action	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
known	know	VBN	B-ADJP	O
.	.	.	O	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
oestrogen	oestrogen	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
(	(	(	O	O
ER	ER	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
progesterone	progesterone	NN	B-NP	B-protein
receptors	receptor	NNS	B-NP	I-protein
(	(	(	O	O
PR	PR	NN	B-NP	B-protein
)	)	)	O	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
using	use	VBG	B-VP	O
immunohistochemistry	immunohistochemistry	NN	B-NP	O
in	in	IN	B-PP	O
formalin	formalin	NN	B-NP	O
fixed	fixed	JJ	I-NP	O
nasal	nasal	JJ	I-NP	O
polyp	polyp	NN	I-NP	O
tissues	tissue	NNS	I-NP	O
from	from	IN	B-PP	O
47	47	CD	B-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cells	cell	NNS	I-NP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
ER	ER	NN	B-NP	B-protein
or	or	CC	I-NP	O
PR	PR	NN	I-NP	B-protein
were	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
by	by	IN	B-PP	O
spatial	spatial	JJ	B-NP	O
location	location	NN	I-NP	O
,	,	,	O	O
dual	dual	JJ	B-NP	O
immunolabelling	immunolabelling	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
histochemical	histochemical	JJ	B-NP	O
staining	staining	NN	I-NP	O
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Consistent	Consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
known	known	JJ	I-NP	O
features	feature	NNS	I-NP	O
of	of	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
polyps	polyp	NNS	I-NP	O
,	,	,	O	O
CD4+	CD4+	JJ	B-NP	O
(	(	(	I-NP	O
T	T	NN	I-NP	O
helper/inducer	helper/inducer	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
CD8+	CD8+	JJ	B-ADJP	B-protein
(	(	(	O	O
cytotoxic/suppressor	cytotoxic/suppressor	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
CD68+	CD68+	JJ	B-ADJP	O
(	(	(	O	O
macrophages	macrophage	NNS	B-NP	B-cell_type
)	)	)	O	O
,	,	,	O	O
mast	mast	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
eosinophils	eosinophil	NNS	B-NP	B-cell_type
and	and	CC	I-NP	O
neutrophils	neutrophil	NNS	I-NP	B-cell_type
were	be	VBD	B-VP	O
all	all	DT	O	O
clearly	clearly	RB	B-VP	O
detected	detect	VBN	I-VP	O
by	by	IN	B-PP	O
their	their	PRP$	B-NP	O
relevant	relevant	JJ	I-NP	B-protein
monoclonal	monoclonal	JJ	I-NP	I-protein
antibodies	antibody	NNS	I-NP	I-protein
or	or	CC	O	O
appropriate	appropriate	JJ	B-NP	O
histochemical	histochemical	JJ	I-NP	O
staining	staining	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
only	only	RB	B-NP	O
mast	mast	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
tested	test	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
ER	ER	NN	B-NP	B-protein
/PR	/PR	NN	I-NP	I-protein
labelling	label	VBG	B-VP	O
with	with	IN	B-PP	O
their	their	PRP$	B-NP	O
polyclonal	polyclonal	JJ	I-NP	O
and	and	CC	I-NP	O
monoclonal	monoclonal	JJ	I-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
frequencies	frequency	NNS	I-NP	O
for	for	IN	B-PP	O
expression	expression	NN	B-NP	O
were	be	VBD	B-VP	O
61.7	61.7	CD	B-NP	O
%	%	NN	I-NP	O
for	for	IN	B-PP	O
ER	ER	NN	B-NP	B-protein
positive	positive	JJ	I-NP	O
and	and	CC	O	O
59.6	59.6	CD	B-NP	O
%	%	NN	I-NP	O
for	for	IN	B-PP	O
PR	PR	NN	B-NP	B-protein
positive	positive	JJ	I-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
ER	ER	NN	B-NP	B-protein
/	/	SYM	B-NP	O
PR	PR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
patient	patient	NN	B-NP	O
sex	sex	NN	I-NP	O
and	and	CC	I-NP	O
age	age	NN	I-NP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
highly	highly	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
mast	mast	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
0.973	0.973	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
<	<	SYM	B-VP	O
0.001	0.001	CD	B-NP	O
for	for	IN	B-PP	O
ER	ER	NN	B-NP	B-protein
;	;	:	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
0.955	0.955	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
<	<	SYM	B-VP	O
0.001	0.001	CD	B-NP	O
for	for	IN	B-PP	O
PR	PR	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Fewer	Few	JJR	B-NP	O
than	than	IN	I-NP	O
5	5	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
mast	mast	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
ER	ER	NN	B-NP	B-protein
/	/	SYM	O	O
PR	PR	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
Mast	Mast	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
alone	alone	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
macrophages	macrophage	NNS	B-NP	B-cell_type
,	,	,	O	O
or	or	CC	O	O
other	other	JJ	B-NP	O
immune	immune	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
express	express	VBP	B-VP	O
ER	ER	NN	B-NP	B-protein
/	/	SYM	B-NP	O
PR	PR	NN	I-NP	B-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
upper	upper	JJ	I-NP	O
airways	airway	NNS	I-NP	O
.	.	.	O	O

Numerous	Numerous	JJ	B-NP	O
ER/PR	ER/PR	NN	I-NP	O
positive	positive	JJ	I-NP	O
mast	mast	NN	I-NP	O
cells	cell	NNS	I-NP	O
exist	exist	VBP	B-VP	O
in	in	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
polyps	polyp	NNS	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
route	route	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
sex	sex	NN	B-NP	O
hormones	hormone	NNS	I-NP	O
in	in	IN	B-PP	O
airway	airway	NN	B-NP	O
inflammation	inflammation	NN	I-NP	O
when	when	WRB	B-ADVP	O
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
higher	high	JJR	I-NP	O
and	and	CC	I-NP	O
varying	vary	VBG	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
oestrogen	oestrogen	NN	B-NP	O
and	and	CC	O	O
progesterone	progesterone	NN	B-NP	O
characteristic	characteristic	JJ	B-ADJP	O
of	of	IN	B-PP	O
females	female	NNS	B-NP	O
.	.	.	O	O

NF	NF	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
b	b	NN	I-NP	I-protein
signaling	signaling	NN	I-NP	O
in	in	IN	B-PP	O
posthypoxic	posthypoxic	JJ	B-NP	B-cell_type
endothelial	endothelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
:	:	:	O	O
relevance	relevance	NN	B-NP	O
to	to	TO	B-PP	O
E-selectin	E-selectin	NN	B-NP	B-protein
expression	expression	NN	B-NP	O
and	and	CC	O	O
neutrophil	neutrophil	NN	B-NP	B-cell_type
adhesion	adhesion	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
implicated	implicate	VBN	I-VP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
factor	factor	NN	I-NP	O
kappa	kappa	NN	I-NP	O
B	B	NN	I-NP	O
(	(	(	O	O
NF	NF	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
adhesion	adhesion	NN	B-NP	B-protein
molecule	molecule	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
endothelial	endothelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
anoxia-reoxygenation	anoxia-reoxygenation	NN	B-NP	O
(	(	(	O	O
A/R	A/R	NN	B-NP	O
)	)	)	O	O
or	or	CC	O	O
a	a	DT	B-NP	O
redox	redox	NN	I-NP	O
imbalance	imbalance	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
objectives	objective	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
were	be	VBD	B-VP	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
to	to	TO	B-VP	O
define	define	VB	I-VP	O
the	the	DT	B-NP	O
kinetics	kinetic	NNS	I-NP	O
of	of	IN	B-PP	O
NF	NF	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
examining	examine	VBG	B-VP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
degradation	degradation	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
translocation	translocation	NN	I-NP	O
of	of	IN	B-PP	O
p65	p65	NN	B-NP	B-protein
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
A/R	A/R	NN	B-NP	O
or	or	CC	I-NP	O
redox	redox	NN	I-NP	O
imbalance	imbalance	NN	I-NP	O
(	(	(	O	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
with	with	IN	B-PP	O
diamide	diamide	NN	B-NP	O
and	and	CC	I-NP	O
buthionine	buthionine	NN	I-NP	O
sulfoximine	sulfoximine	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
(	(	(	B-LST	O
2	2	LS	I-LST	O
)	)	)	O	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
the	the	DT	B-NP	O
signal	signal	NN	I-NP	O
for	for	IN	B-PP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
degradation	degradation	NN	I-NP	O
,	,	,	O	O
nuclear	nuclear	JJ	B-NP	O
translocation	translocation	NN	I-NP	O
of	of	IN	B-PP	O
p65	p65	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
E-selectin	E-selectin	NN	B-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
neutrophil	neutrophil	NN	I-NP	O
adhesion	adhesion	NN	I-NP	O
is	be	VBZ	B-VP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	B-protein
tyrosine	tyrosine	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
PTK	PTK	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
protein	protein	NN	B-NP	B-protein
tyrosine	tyrosine	NN	I-NP	I-protein
phosphatase	phosphatase	NN	I-NP	I-protein
(	(	(	O	O
PTPase	PTPase	NN	B-NP	B-protein
)	)	)	O	O
and/or	and/or	CC	O	O
protein	protein	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
C	C	NN	I-NP	I-protein
(	(	(	O	O
PKC	PKC	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
both	both	CC	O	O
A/R	A/R	NN	B-NP	O
and	and	CC	O	O
redox	redox	NN	B-NP	O
imbalance	imbalance	NN	I-NP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
degradation	degradation	NN	I-NP	O
within	within	IN	B-PP	O
30	30	CD	B-NP	O
min	min	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
concomitant	concomitant	JJ	I-NP	O
appearance	appearance	NN	I-NP	O
of	of	IN	B-PP	O
p65	p65	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
nucleus	nucleus	NN	I-NP	O
,	,	,	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
cytosolic	cytosolic	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
NF	NF	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
and	and	CC	O	O
subsequent	subsequent	JJ	B-NP	O
nuclear	nuclear	JJ	I-NP	O
translocation	translocation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
activated	activate	VBN	I-NP	O
p65	p65	NN	I-NP	B-protein
subunit	subunit	NN	I-NP	I-protein
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
PKC	PKC	NN	B-NP	B-protein
blocked	block	VBD	B-VP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
degradation	degradation	NN	I-NP	O
and	and	CC	O	O
p65	p65	NN	B-NP	B-protein
translocation	translocation	NN	I-NP	O
in	in	IN	B-PP	O
A/R-challenged	A/R-challenged	JJ	B-NP	O
,	,	,	I-NP	O
but	but	CC	I-NP	O
not	not	RB	I-NP	O
redox-altered	redox-altered	JJ	I-NP	O
,	,	,	I-NP	O
endothelial	endothelial	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
both	both	CC	O	O
A/R-	A/R-	NN	B-NP	O
and	and	CC	O	O
redox-induced	redox-induced	JJ	B-NP	O
NF	NF	NN	I-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
was	be	VBD	B-VP	O
blocked	block	VBN	I-VP	O
by	by	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
PTK	PTK	NN	B-NP	B-protein
.	.	.	O	O

Similarly	Similarly	RB	B-ADVP	O
,	,	,	O	O
A/R-induced	A/R-induced	JJ	B-NP	O
E-selectin	E-selectin	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
neutrophil-endothelial	neutrophil-endothelial	JJ	B-NP	O
cell	cell	NN	I-NP	O
adhesion	adhesion	NN	I-NP	O
were	be	VBD	B-VP	O
blocked	block	VBN	I-VP	O
by	by	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
PKC	PKC	NN	B-NP	B-protein
or	or	CC	I-NP	O
PTK	PTK	NN	I-NP	B-protein
,	,	,	O	O
while	while	IN	B-SBAR	O
only	only	RB	B-NP	O
PTK	PTK	NN	I-NP	B-protein
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
redox-induced	redox-induced	JJ	I-NP	O
adhesion	adhesion	NN	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Pretreatment	Pretreatment	NN	B-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
with	with	IN	B-PP	O
N-acetyl	N-acetyl	NN	B-NP	O
cysteine	cysteine	NN	I-NP	O
effectively	effectively	RB	B-ADVP	O
blocked	block	VBD	B-VP	O
A/R-	A/R-	NN	B-NP	O
or	or	CC	O	O
redox-induced	redox-induced	JJ	B-NP	O
I	I	NN	I-NP	O
kappa	kappa	NN	I-NP	O
B	B	NN	I-NP	O
degradation	degradation	NN	I-NP	O
and	and	CC	O	O
significantly	significantly	RB	B-VP	O
attenuated	attenuate	VBD	I-VP	O
the	the	DT	B-NP	O
respective	respective	JJ	I-NP	O
neutrophil	neutrophil	NN	I-NP	O
adhesion	adhesion	NN	I-NP	O
responses	response	NNS	I-NP	O
.	.	.	O	O

Collectively	Collectively	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
findings	finding	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
A/R-induced	A/R-induced	JJ	B-NP	O
E-selectin	E-selectin	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
neutrophil-endothelial	neutrophil-endothelial	JJ	B-NP	O
cell	cell	NN	I-NP	O
adhesion	adhesion	NN	I-NP	O
are	be	VBP	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
both	both	CC	O	O
PKC	PKC	NN	B-NP	B-protein
and	and	CC	I-NP	O
PTK	PTK	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
signal	signal	VBP	B-VP	O
rapid	rapid	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
NF	NF	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
.	.	.	O	O

This	This	DT	B-NP	O
A/R-induced	A/R-induced	JJ	I-NP	O
NF	NF	NN	I-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
signaling	signaling	NN	I-NP	O
response	response	NN	I-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
mediated	mediate	VBN	I-VP	O
,	,	,	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
redox	redox	NN	I-NP	O
imbalance	imbalance	NN	I-NP	O
.	.	.	O	O

Copyright	Copyright	NN	B-NP	O
2001	2001	CD	I-NP	O
S.	S.	NNP	I-NP	O
Karger	Karger	NNP	I-NP	O
AG	AG	NNP	I-NP	O
,	,	,	O	O
Basel	Basel	NNP	B-NP	O

Induction	Induction	NN	B-NP	O
of	of	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
the	the	DT	B-NP	O
herbicide	herbicide	NN	I-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
4-dichlorophenoxyacetic	4-dichlorophenoxyacetic	JJ	B-NP	O
acid	acid	NN	I-NP	O
.	.	.	O	O

Dimethylammonium	Dimethylammonium	NN	B-NP	O
salt	salt	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
,	,	,	O	O
4-dichlorophenoxyacetic	4-dichlorophenoxyacetic	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
DMA-2	DMA-2	NN	B-NP	B-protein
,	,	,	O	O
4-D	4-D	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
widely	widely	RB	I-NP	O
used	use	VBN	I-NP	O
herbicide	herbicide	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
considered	consider	VBN	I-VP	O
moderately	moderately	RB	B-ADJP	O
toxic	toxic	JJ	I-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
DMA-2	DMA-2	NN	B-NP	B-protein
,	,	,	O	O
4-D	4-D	NN	B-NP	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
cause	cause	VB	I-VP	O
apoptosis	apoptosis	NN	B-NP	O
in	in	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
and	and	CC	O	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Apoptosis	Apoptosis	NN	B-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
DMA-2	DMA-2	NN	B-NP	B-protein
,	,	,	O	O
4-D	4-D	NN	B-NP	O
was	be	VBD	B-VP	O
dose	dose	NN	B-NP	O
and	and	CC	I-NP	O
time	time	NN	I-NP	O
dependent	dependent	JJ	B-ADJP	O
,	,	,	O	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
Fas	Fas	NN	B-NP	B-protein
,	,	,	O	O
TNF	TNF	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
or	or	CC	O	O
the	the	DT	B-NP	O
aromatic	aromatic	JJ	I-NP	B-protein
hydrocarbon	hydrocarbon	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
involved	involve	VBN	B-VP	O
disruption	disruption	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mitochondrial	mitochondrial	JJ	I-NP	O
transmembrane	transmembrane	JJ	I-NP	O
potential	potential	NN	I-NP	O
and	and	CC	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
caspase-9	caspase-9	NN	B-NP	B-protein
.	.	.	O	O

ZVAD-FMK	ZVAD-FMK	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
broad-spectrum	broad-spectrum	JJ	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
of	of	IN	B-PP	O
caspases	caspas	NNS	B-NP	B-protein
,	,	,	O	O
blocked	block	VBD	B-VP	O
DMA-2	DMA-2	NN	B-NP	B-protein
,	,	,	O	O
4-D-induced	4-D-induced	JJ	B-NP	O
apoptosis	apoptosis	NN	I-NP	O
completely	completely	RB	B-ADVP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
an	an	DT	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
of	of	IN	B-PP	O
caspase-9	caspase-9	NN	B-NP	B-protein
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
caspase-9	caspase-9	NN	B-NP	B-protein
and	and	CC	I-NP	O
caspase-3	caspase-3	NN	I-NP	O
inhibitors	inhibitor	NNS	I-NP	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
,	,	,	O	O
strongly	strongly	RB	B-VP	O
blocked	block	VBD	I-VP	O
DMA-2	DMA-2	NN	B-NP	B-protein
,	,	,	O	O
4-D-induced	4-D-induced	JJ	B-NP	O
apoptosis	apoptosis	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
of	of	IN	B-PP	O
caspase-3	caspase-3	NN	B-NP	B-protein
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
moderate	moderate	JJ	I-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

Unlike	Unlike	IN	B-PP	O
Fas	Fas	NN	B-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
apoptosis	apoptosis	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
initiator	initiator	NN	I-NP	O
caspase	caspase	NN	I-NP	O
,	,	,	O	O
caspase-8	caspase-8	NN	B-NP	B-protein
,	,	,	O	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
DMA-2	DMA-2	NN	B-NP	B-protein
,	,	,	O	O
4-D-induced	4-D-induced	JJ	B-NP	O
apoptosis	apoptosis	NN	I-NP	O
.	.	.	O	O

Transfection	Transfection	NN	B-NP	O
of	of	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
with	with	IN	B-PP	O
Bcl-2	Bcl-2	NN	B-NP	B-protein
prevented	prevent	VBD	B-VP	O
DMA-2	DMA-2	NN	B-NP	B-protein
,	,	,	O	O
4-D-induced	4-D-induced	JJ	B-NP	O
disruption	disruption	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mitochondrial	mitochondrial	JJ	I-NP	O
transmembrane	transmembrane	JJ	I-NP	O
potential	potential	NN	I-NP	O
and	and	CC	O	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
complete	complete	JJ	I-NP	O
blockage	blockage	NN	I-NP	O
of	of	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
DMA-2	DMA-2	NN	B-NP	B-protein
,	,	,	O	O
4-D	4-D	NN	B-NP	O
kills	kill	VBZ	B-VP	O
human	human	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
initiating	initiate	VBG	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
via	via	IN	B-PP	O
a	a	DT	B-NP	O
direct	direct	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
mitochondria	mitochondrion	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
caspases	caspas	NNS	B-NP	B-protein
occurs	occur	VBZ	B-VP	O
downstream	downstream	RB	B-ADVP	O
of	of	IN	B-PP	O
mitochondrial	mitochondrial	JJ	B-NP	O
damage	damage	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
of	of	IN	B-PP	O
mitochondria	mitochondrion	NNS	B-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
sufficient	sufficient	JJ	B-ADJP	O
for	for	IN	B-PP	O
triggering	trigger	VBG	B-VP	O
all	all	DT	B-NP	O
downstream	downstream	JJ	I-NP	O
events	event	NNS	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
Th1	Th1	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
by	by	IN	B-PP	O
IL-6	IL-6	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
SOCS1	SOCS1	NN	B-NP	B-protein
.	.	.	O	O

Interleukin	Interleukin	NN	B-NP	B-protein
6	6	CD	I-NP	I-protein
(	(	(	O	O
IL-6	IL-6	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
cytokine	cytokine	NN	I-NP	B-protein
produced	produce	VBN	B-VP	O
by	by	IN	B-PP	O
immune	immune	JJ	B-NP	O
and	and	CC	I-NP	O
nonimmune	nonimmune	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
exhibits	exhibit	VBZ	B-VP	O
functional	functional	JJ	B-NP	O
pleiotropy	pleiotropy	NN	I-NP	O
and	and	CC	I-NP	O
redundancy	redundancy	NN	I-NP	O
.	.	.	O	O

IL-6	IL-6	NN	B-NP	B-protein
plays	play	VBZ	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
differentiation	differentiation	NN	I-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
describe	describe	VBP	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
IL-6	IL-6	NN	B-NP	B-protein
:	:	:	O	O
the	the	DT	B-NP	O
negative	negative	JJ	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
CD4	CD4	NN	B-NP	B-protein
+	+	SYM	B-NP	O
Th1	Th1	NN	I-NP	O
cell	cell	NN	I-NP	O
differentiation	differentiation	NN	I-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
IL-6	IL-6	NN	B-NP	B-protein
-directed	-directed	JJ	I-NP	O
CD4	CD4	NN	I-NP	B-protein
+	+	SYM	B-NP	O
Th2	Th2	NN	I-NP	O
differentiation	differentiation	NN	I-NP	O
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
IL-4	IL-4	NN	B-NP	B-protein
,	,	,	O	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
Th1	Th1	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
by	by	IN	B-PP	O
IL-6	IL-6	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
IL-4	IL-4	NN	B-NP	B-protein
.	.	.	O	O

IL-6	IL-6	NN	B-NP	B-protein
upregulates	upregulate	VBZ	B-VP	O
suppressor	suppressor	NN	B-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-protein
signaling	signaling	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
SOCS1	SOCS1	NN	B-NP	B-protein
)	)	)	O	O
expression	expression	NN	B-NP	O
in	in	IN	B-PP	O
activated	activate	VBN	B-NP	B-cell_type
CD4+	CD4+	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
thereby	thereby	RB	B-VP	O
interfering	interfere	VBG	I-VP	O
with	with	IN	B-PP	O
signal	signal	NN	B-NP	B-protein
transducer	transducer	NN	I-NP	I-protein
and	and	CC	I-NP	I-protein
activator	activator	NN	I-NP	I-protein
of	of	IN	B-PP	I-protein
transcription	transcription	NN	B-NP	I-protein
1	1	CD	I-NP	I-protein
(	(	(	O	O
STAT1	STAT1	NN	B-NP	B-protein
)	)	)	O	O
phosphorylation	phosphorylation	NN	B-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
interferon	interferon	NN	B-NP	B-protein
gamma	gamma	NN	I-NP	I-protein
(	(	(	O	O
IFNgamma	IFNgamma	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
IFNgamma	IFNgamma	NN	B-NP	B-protein
receptor-mediated	receptor-mediated	JJ	I-NP	O
signals	signal	NNS	I-NP	O
by	by	IN	B-PP	O
IL-6	IL-6	NN	B-NP	B-protein
prevents	prevent	VBZ	B-VP	O
autoregulation	autoregulation	NN	B-NP	O
of	of	IN	B-PP	O
IFNgamma	IFNgamma	NN	B-NP	B-protein
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
by	by	IN	B-PP	O
IFNgamma	IFNgamma	NN	B-NP	B-protein
during	during	IN	B-PP	O
CD4+	CD4+	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
,	,	,	O	O
thereby	thereby	RB	B-VP	O
preventing	prevent	VBG	I-VP	O
Th1	Th1	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
IL-6	IL-6	NN	B-NP	B-protein
promotes	promote	VBZ	B-VP	O
CD4	CD4	NN	B-NP	B-protein
+	+	SYM	I-NP	O
Th2	Th2	NN	I-NP	O
differentiation	differentiation	NN	I-NP	O
and	and	CC	O	O
inhibits	inhibit	VBZ	B-VP	O
Th1	Th1	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
by	by	IN	B-PP	O
two	two	CD	B-NP	O
independent	independent	JJ	I-NP	O
molecular	molecular	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
.	.	.	O	O

Interaction	Interaction	NN	B-NP	O
between	between	IN	B-PP	O
CCAAT/enhancer	CCAAT/enhancer	NN	B-NP	B-protein
binding	binding	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
and	and	CC	O	O
cyclic	cyclic	JJ	B-NP	B-protein
AMP	AMP	NN	I-NP	I-protein
response	response	NN	I-NP	I-protein
element	element	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
regulates	regulate	VBZ	B-VP	O
human	human	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
transcription	transcription	NN	I-NP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
monocyte/macrophage	monocyte/macrophage	NN	I-NP	B-cell_type
lineage	lineage	NN	I-NP	I-cell_type
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
observations	observation	NNS	I-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
two	two	CD	B-NP	O
CCAAT/enhancer	CCAAT/enhancer	NN	I-NP	B-protein
binding	binding	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	O
C/EBP	C/EBP	NN	B-NP	O
)	)	)	O	O
binding	bind	VBG	B-NP	O
sites	site	NNS	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
critically	critically	RB	B-ADJP	O
important	important	JJ	I-ADJP	O
for	for	IN	B-PP	O
efficient	efficient	JJ	B-NP	O
human	human	JJ	I-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
HIV-1	HIV-1	NN	B-NP	O
)	)	)	O	O
replication	replication	NN	B-NP	O
within	within	IN	B-PP	O
cells	cell	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
monocyte/macrophage	monocyte/macrophage	NN	I-NP	B-cell_type
lineage	lineage	NN	I-NP	I-cell_type
,	,	,	O	O
a	a	DT	B-NP	O
cell	cell	NN	I-NP	O
type	type	NN	I-NP	O
likely	likely	RB	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
transport	transport	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
virus	virus	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
sequence	sequence	NN	B-NP	O
variation	variation	NN	I-NP	O
at	at	IN	B-PP	O
C/EBP	C/EBP	NN	B-NP	B-DNA
site	site	NN	I-NP	I-DNA
I	I	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
lies	lie	VBZ	B-VP	O
immediately	immediately	RB	B-ADVP	O
upstream	upstream	JJ	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	B-DNA
nuclear	nuclear	JJ	I-NP	I-DNA
factor	factor	NN	I-NP	I-DNA
kappa	kappa	NN	I-NP	I-DNA
B	B	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
and	and	CC	O	O
immediately	immediately	RB	B-ADJP	O
downstream	downstream	JJ	I-ADJP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
binding	bind	VBG	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
for	for	IN	B-PP	O
activating	activate	VBG	B-VP	O
transcription	transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
ATF	ATF	NN	B-NP	B-protein
)	)	)	O	O
/	/	SYM	B-NP	O
cyclic	cyclic	JJ	I-NP	B-protein
AMP	AMP	NN	I-NP	I-protein
response	response	NN	I-NP	I-protein
element	element	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	O
CREB	CREB	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
affect	affect	VB	I-VP	O
HIV-1	HIV-1	NN	B-NP	B-DNA
long	long	JJ	I-NP	I-DNA
terminal	terminal	JJ	I-NP	I-DNA
repeat	repeat	NN	I-NP	I-DNA
(	(	(	O	O
LTR	LTR	NN	B-NP	B-DNA
)	)	)	O	O
activity	activity	NN	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
that	that	IN	B-SBAR	O
C/EBP	C/EBP	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
interact	interact	VB	I-VP	O
with	with	IN	B-PP	O
many	many	JJ	B-NP	O
other	other	JJ	I-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
including	include	VBG	B-PP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ATF/CREB	ATF/CREB	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
,	,	,	O	O
we	we	PRP	B-NP	O
proceeded	proceed	VBD	B-VP	O
to	to	TO	I-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
an	an	DT	B-NP	O
adjacent	adjacent	JJ	I-NP	B-DNA
ATF/CREB	ATF/CREB	NN	I-NP	I-DNA
binding	binding	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
could	could	MD	B-VP	O
affect	affect	VB	I-VP	O
C/EBP	C/EBP	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
C/EBP	C/EBP	NN	B-NP	B-DNA
site	site	NN	I-NP	I-DNA
I	I	CD	I-NP	O
.	.	.	O	O

Electrophoretic	Electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
analyses	analysis	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
selected	select	VBN	B-NP	O
ATF/CREB	ATF/CREB	NN	I-NP	O
site	site	NN	I-NP	O
variants	variant	NNS	I-NP	O
assisted	assist	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
recruitment	recruitment	NN	I-NP	O
of	of	IN	B-PP	O
C/EBP	C/EBP	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
to	to	TO	B-PP	O
an	an	DT	B-NP	O
adjacent	adjacent	JJ	I-NP	O
,	,	,	O	O
naturally	naturally	RB	B-VP	O
occurring	occur	VBG	I-VP	O
,	,	,	O	O
low-affinity	low-affinity	JJ	B-NP	O
C/EBP	C/EBP	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

This	This	DT	B-NP	O
biophysical	biophysical	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
occur	occur	VB	I-VP	O
via	via	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
two	two	CD	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
.	.	.	O	O

First	First	RB	B-ADVP	O
,	,	,	O	O
low	low	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
CREB-1	CREB-1	NN	B-NP	B-protein
and	and	CC	I-NP	O
C/EBP	C/EBP	NN	I-NP	B-protein
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
heterodimerize	heterodimerize	VB	I-VP	O
and	and	CC	O	O
bind	bind	VB	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
site	site	NN	I-NP	O
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
half	half	JJ	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
from	from	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
ATF/CREB	ATF/CREB	NN	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
C/EBP	C/EBP	NN	I-NP	I-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
CREB-1	CREB-1	NN	B-NP	B-protein
homodimers	homodimer	NNS	I-NP	I-protein
bind	bind	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ATF/CREB	ATF/CREB	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
and	and	CC	O	O
recruit	recruit	NN	B-NP	B-protein
C/EBP	C/EBP	NN	I-NP	I-protein
dimers	dimer	NNS	I-NP	I-protein
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
cognate	cognate	JJ	I-NP	B-DNA
weak	weak	JJ	I-NP	I-DNA
binding	bind	VBG	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
.	.	.	O	O

This	This	DT	B-NP	O
interaction	interaction	NN	I-NP	O
is	be	VBZ	B-VP	O
reciprocal	reciprocal	JJ	B-ADJP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
C/EBP	C/EBP	NN	B-NP	B-protein
dimer	dimer	NN	I-NP	I-protein
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
strong	strong	JJ	I-NP	O
C/EBP	C/EBP	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
enhanced	enhance	VBN	B-NP	O
CREB-1	CREB-1	NN	I-NP	B-protein
recruitment	recruitment	NN	I-NP	O
to	to	TO	B-PP	O
ATF/CREB	ATF/CREB	NN	B-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
weakly	weakly	RB	I-VP	O
bound	bind	VBN	I-VP	O
by	by	IN	B-PP	O
CREB	CREB	NN	B-NP	B-protein
.	.	.	O	O

Sequence	Sequence	NN	B-NP	O
variation	variation	NN	I-NP	O
at	at	IN	B-PP	O
both	both	CC	O	O
C/EBP	C/EBP	NN	B-NP	B-protein
and	and	CC	I-NP	O
ATF/CREB	ATF/CREB	NN	I-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
affects	affect	VBZ	B-VP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
interactions	interaction	NNS	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
mediating	mediate	VBG	B-VP	O
both	both	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
.	.	.	O	O

Most	Most	RBS	B-ADVP	O
importantly	importantly	RB	I-ADVP	O
,	,	,	O	O
sequence	sequence	NN	B-NP	O
variation	variation	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
ATF/CREB	ATF/CREB	NN	I-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
affected	affect	VBD	B-VP	O
basal	basal	JJ	B-NP	O
LTR	LTR	NN	I-NP	B-DNA
activity	activity	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
LTR	LTR	NN	B-NP	B-DNA
function	function	NN	I-NP	O
following	follow	VBG	B-PP	O
interleukin-6	interleukin-6	NN	B-NP	B-protein
stimulation	stimulation	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
treatment	treatment	NN	I-NP	O
that	that	WDT	B-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
increases	increase	NNS	B-NP	O
in	in	IN	B-PP	O
C/EBP	C/EBP	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
HIV-1	HIV-1	NN	B-NP	B-DNA
LTR	LTR	NN	I-NP	I-DNA
ATF/CREB	ATF/CREB	NN	I-NP	O
binding	binding	NN	I-NP	O
site	site	NN	I-NP	O
sequence	sequence	NN	I-NP	O
variation	variation	NN	I-NP	O
may	may	MD	B-VP	O
modulate	modulate	VB	I-VP	O
cellular	cellular	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
viral	viral	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
through	through	IN	B-PP	O
the	the	DT	B-NP	O
C/EBP	C/EBP	NN	I-NP	B-protein
pathway	pathway	NN	I-NP	O

Selective	Selective	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
interleukin-4	interleukin-4	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
studies	study	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
aspirin	aspirin	NN	B-NP	O
(	(	(	O	O
acetylsalicylic	acetylsalicylic	JJ	B-NP	O
acid	acid	NN	I-NP	O
[	[	(	O	O
ASA	ASA	NN	B-NP	O
]	]	)	O	O
)	)	)	O	O
can	can	MD	B-VP	O
have	have	VB	I-VP	O
profound	profound	JJ	B-NP	O
immunomodulatory	immunomodulatory	JJ	I-NP	O
effects	effect	NNS	I-NP	O
by	by	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
cytokine	cytokine	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
several	several	JJ	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
concentrations	concentration	NNS	B-NP	O
of	of	IN	B-PP	O
ASA	ASA	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
range	range	NN	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
significantly	significantly	RB	I-VP	O
reduce	reduce	VB	I-VP	O
interleukin	interleukin	NN	B-NP	B-protein
(	(	(	O	I-protein
IL	IL	NN	B-NP	I-protein
)	)	)	O	I-protein
-4	-4	CD	B-NP	I-protein
secretion	secretion	NN	I-NP	O
and	and	CC	O	O
RNA	RNA	NN	B-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
freshly	freshly	RB	B-NP	O
isolated	isolate	VBN	I-NP	O
and	and	CC	I-NP	O
mitogen-primed	mitogen-primed	JJ	I-NP	B-cell_line
human	human	JJ	I-NP	I-cell_line
CD4+	CD4+	JJ	I-NP	I-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
IL-13	IL-13	NN	B-NP	B-protein
,	,	,	O	O
interferon-gamma	interferon-gamma	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
IL-2	IL-2	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

ASA	ASA	NN	B-NP	O
inhibited	inhibit	VBD	B-VP	O
IL-4	IL-4	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
IL-2	IL-2	NN	B-NP	B-protein
,	,	,	O	O
promoter-driven	promoter-driven	JJ	B-NP	O
chloramphenicol	chloramphenicol	NN	I-NP	B-protein
acetyltransferase	acetyltransferase	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
transiently	transiently	RB	B-NP	B-cell_line
transfected	transfecte	VBN	I-NP	I-cell_line
Jurkat	Jurkat	NN	I-NP	I-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
structurally	structurally	RB	I-NP	O
unrelated	unrelated	JJ	I-NP	O
nonsteroidal	nonsteroidal	JJ	I-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	O
drugs	drug	NNS	I-NP	O
indomethacin	indomethacin	NN	I-NP	O
and	and	CC	I-NP	O
flurbiprofen	flurbiprofen	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
cytokine	cytokine	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
weak	weak	JJ	I-NP	O
cyclo-oxygenase	cyclo-oxygenase	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
salicylic	salicylic	JJ	I-NP	O
acid	acid	NN	I-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
as	as	RB	B-ADJP	O
effective	effective	JJ	I-ADJP	O
as	as	IN	B-PP	O
ASA	ASA	NN	B-NP	O
in	in	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
IL-4	IL-4	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
promoter	promoter	NN	B-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
ASA	ASA	NN	B-NP	O
on	on	IN	B-PP	O
IL-4	IL-4	NN	B-NP	B-protein
transcription	transcription	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
nuclear	nuclear	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
known	know	VBN	I-NP	O
salicylate	salicylate	NN	I-NP	B-protein
target	target	NN	I-NP	I-protein
nuclear	nuclear	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	I-protein
NF	NF	NN	B-NP	I-protein
)	)	)	O	I-protein
-kappaB	-kappaB	NN	B-NP	I-protein
and	and	CC	O	O
was	be	VBD	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
reduced	reduce	VBN	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
inducible	inducible	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
to	to	TO	B-PP	O
an	an	DT	B-NP	O
IL-4	IL-4	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
overlapping	overlap	VBG	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
NF	NF	NN	I-NP	B-protein
of	of	IN	B-PP	I-protein
activated	activate	VBN	B-NP	I-protein
T	T	NN	I-NP	I-protein
cells-	cells-	NNS	I-NP	I-protein
and	and	CC	O	O
NF-kappaB-binding	NF-kappaB-binding	JJ	B-NP	B-DNA
P1	P1	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
anti-inflammatory	anti-inflammatory	JJ	B-NP	O
salicylates	salicylate	NNS	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
means	mean	NNS	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
previously	previously	RB	I-NP	O
unrecognized	unrecognized	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
action	action	NN	B-NP	O
,	,	,	O	O
can	can	MD	B-VP	O
influence	influence	VB	I-VP	O
the	the	DT	B-NP	O
nature	nature	NN	I-NP	O
of	of	IN	B-PP	O
adaptive	adaptive	JJ	B-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
by	by	IN	B-PP	O
selectively	selectively	RB	B-VP	O
inhibiting	inhibit	VBG	I-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
IL-4	IL-4	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
effector	effector	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
responses	response	NNS	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
CD4+	CD4+	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Molecular	Molecular	JJ	B-NP	O
and	and	CC	I-NP	O
cellular	cellular	JJ	I-NP	O
mediators	mediator	NNS	I-NP	O
of	of	IN	B-PP	O
interleukin-1	interleukin-1	NN	B-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
acute	acute	JJ	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
arthritis	arthritis	NN	I-NP	O
.	.	.	O	O

OBJECTIVE	OBJECTIVE	NN	B-NP	O
:	:	:	O	O
To	To	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
and	and	CC	I-NP	O
cellular	cellular	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
monarticular	monarticular	JJ	I-NP	O
arthritis	arthritis	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
methylated	methylate	VBN	B-NP	O
bovine	bovine	JJ	I-NP	B-protein
serum	serum	NN	I-NP	I-protein
albumin	albumin	NN	I-NP	I-protein
(	(	(	O	O
mBSA	mBSA	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
interleukin-1	interleukin-1	NN	B-NP	B-protein
(	(	(	O	O
IL-1	IL-1	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
Mice	Mouse	NNS	B-NP	O
were	be	VBD	B-VP	O
injected	inject	VBN	I-VP	O
intraarticularly	intraarticularly	RB	B-ADVP	O
with	with	IN	B-PP	O
mBSA	mBSA	NN	B-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
0	0	CD	I-NP	O
and	and	CC	O	O
subcutaneously	subcutaneously	RB	B-ADVP	O
with	with	IN	B-PP	O
recombinant	recombinant	JJ	B-NP	B-protein
human	human	JJ	I-NP	I-protein
IL-1beta	IL-1beta	NN	I-NP	I-protein
on	on	IN	B-PP	O
days	day	NNS	B-NP	O
0-2	0-2	CD	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
day	day	NN	B-NP	O
7	7	CD	I-NP	O
,	,	,	O	O
knee	knee	NN	B-NP	O
joints	joint	NNS	I-NP	O
were	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
and	and	CC	O	O
assessed	assess	VBN	B-VP	O
histologically	histologically	RB	B-ADVP	O
.	.	.	O	O

Flow	Flow	NN	B-NP	O
cytometry	cytometry	NN	I-NP	O
and	and	CC	O	O
RNase	RNase	NN	B-NP	B-protein
protection	protection	NN	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
analyze	analyze	VB	I-VP	O
IL-1	IL-1	NN	B-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
events	event	NNS	I-NP	O
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
C57BL/6	C57BL/6	NN	B-NP	O
(	(	(	O	O
B6	B6	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
129/Sv	129/Sv	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
(	(	(	O	O
B6	B6	NN	B-NP	O
x	x	SYM	O	O
129/	129/	CD	B-NP	O
Sv	Sv	NN	I-NP	O
)	)	)	O	O
F1	F1	NN	B-NP	O
hybrid	hybrid	NN	I-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
all	all	DT	B-NP	O
H-2b	H-2b	NN	I-NP	O
strains	strain	NNS	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
susceptible	susceptible	JJ	B-ADJP	O
to	to	TO	B-PP	O
mBSA	mBSA	NN	B-NP	O
/IL-1-induced	/IL-1-induced	JJ	I-NP	O
arthritis	arthritis	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
C3H/HeJ	C3H/HeJ	NN	B-NP	B-protein
(	(	(	O	O
H-2k	H-2k	NN	B-NP	O
)	)	)	O	O
mice	mouse	NNS	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O
.	.	.	O	O

B6	B6	NN	B-NP	O
mice	mouse	NNS	I-NP	O
lacking	lack	VBG	B-VP	O
T	T	NN	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
RAG1-/-	RAG1-/-	JJ	B-ADJP	O
)	)	)	O	O
or	or	CC	O	O
major	major	JJ	B-NP	B-protein
histocompatibility	histocompatibility	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
(	(	(	O	I-protein
MHC	MHC	NN	B-NP	I-protein
)	)	)	O	I-protein
class	class	NN	B-NP	I-protein
II	II	CD	B-NP	I-protein
antigens	antigen	NNS	I-NP	I-protein
(	(	(	O	O
MHCII-/-	MHCII-/-	JJ	B-ADVP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
B6	B6	NN	B-NP	O
mice	mouse	NNS	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
CD4+	CD4+	JJ	I-NP	B-protein
T	T	NN	I-NP	I-protein
cell-depleting	cell-depleting	JJ	I-NP	I-protein
monoclonal	monoclonal	JJ	I-NP	I-protein
antibody	antibody	NN	I-NP	I-protein
,	,	,	O	O
were	be	VBD	B-VP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
disease	disease	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
B	B	NN	B-NP	O
cell-deficient	cell-deficient	JJ	B-ADJP	O
(	(	(	O	O
muMT/	muMT/	NN	B-NP	O
muMT	muMT	NN	I-NP	O
)	)	)	O	O
mice	mouse	NNS	B-NP	O
developed	develop	VBD	B-VP	O
arthritis	arthritis	NN	B-NP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
incidence	incidence	NN	I-NP	O
and	and	CC	I-NP	O
severity	severity	NN	I-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
controls	control	NNS	B-NP	O
.	.	.	O	O

RelB-deficient	RelB-deficient	JJ	O	O
(	(	(	O	O
RelB-/-	RelB-/-	JJ	B-ADJP	O
)	)	)	O	O
bone	bone	NN	B-NP	O
marrow	marrow	NN	I-NP	O
chimeric	chimeric	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
had	have	VBD	B-VP	O
arthritis	arthritis	NN	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
in	in	IN	B-PP	O
incidence	incidence	NN	B-NP	O
and	and	CC	I-NP	O
severity	severity	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
B6	B6	NN	B-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
flow	flow	NN	B-NP	O
cytometry	cytometry	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
an	an	DT	B-NP	O
IL-1-dependent	IL-1-dependent	JJ	I-NP	O
leukocyte	leukocyte	NN	I-NP	O
infiltration	infiltration	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
synovial	synovial	JJ	I-NP	O
compartment	compartment	NN	I-NP	O
and	and	CC	I-NP	O
RNase	RNase	NN	I-NP	B-protein
protection	protection	NN	I-NP	O
assays	assay	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
messenger	messenger	NN	B-NP	B-RNA
RNA	RNA	NN	I-NP	I-RNA
(	(	(	O	O
mRNA	mRNA	NN	B-NP	B-RNA
)	)	)	O	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
chemokines	chemokine	NNS	I-NP	B-protein
monocyte	monocyte	NN	I-NP	B-protein
chemoattractant	chemoattractant	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
,	,	,	O	O
macrophage	macrophage	NN	B-NP	B-protein
inhibitory	inhibitory	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
(	(	(	O	O
MIP-2	MIP-2	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
RANTES	RANTES	NN	B-NP	B-protein
,	,	,	O	O
MIP-1alpha	MIP-1alpha	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
MIP-1beta	MIP-1beta	NN	B-NP	B-protein
,	,	,	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
Arthritis	Arthritis	NN	B-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
mBSA	mBSA	NN	B-NP	B-protein
/	/	SYM	B-NP	O
IL-1	IL-1	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
strain	strain	NN	B-NP	O
specific	specific	JJ	I-NP	O
and	and	CC	I-NP	O
dependent	dependent	JJ	I-NP	O
on	on	IN	B-PP	O
CD4+	CD4+	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
partially	partially	RB	B-ADVP	O
on	on	IN	B-PP	O
RelB	RelB	NN	B-NP	B-protein
,	,	,	B-PP	O
but	but	CC	I-PP	O
not	not	RB	B-PP	O
on	on	IN	I-PP	O
B	B	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
or	or	CC	O	O
antibody	antibody	NN	B-NP	O
.	.	.	O	O

IL-1	IL-1	NN	B-NP	B-protein
contributes	contribute	VBZ	B-VP	O
to	to	TO	I-VP	O
leukocyte	leukocyte	VB	I-VP	O
recruitment	recruitment	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
synovium	synovium	NN	I-NP	O
and	and	CC	O	O
directly	directly	RB	B-VP	O
induces	induce	VBZ	I-VP	O
chemokine	chemokine	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
production	production	NN	I-NP	O
by	by	IN	B-PP	O
synovial	synovial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

This	This	DT	B-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
monarticular	monarticular	JJ	I-NP	O
arthritis	arthritis	NN	I-NP	O
is	be	VBZ	B-VP	O
particularly	particularly	RB	B-ADJP	O
suitable	suitable	JJ	I-ADJP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
investigations	investigation	NNS	I-NP	O
into	into	IN	B-PP	O
cell-mediated	cell-mediated	JJ	B-NP	O
immunity	immunity	NN	I-NP	O
in	in	IN	B-PP	O
arthritis	arthritis	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
IL-1	IL-1	NN	B-NP	B-protein
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
and	and	CC	I-NP	O
negative	negative	JJ	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
granulopoiesis	granulopoiesis	NN	B-NP	O
by	by	IN	B-PP	O
endogenous	endogenous	JJ	B-NP	O
RARalpha	RARalpha	NN	I-NP	B-protein
.	.	.	O	O

Acute	Acute	JJ	B-NP	O
promyelocytic	promyelocytic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
APL	APL	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
always	always	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
chromosomal	chromosomal	JJ	B-NP	O
translocations	translocation	NNS	I-NP	O
that	that	WDT	B-NP	O
disrupt	disrupt	VBP	B-VP	O
the	the	DT	B-NP	O
retinoic	retinoic	JJ	I-NP	B-DNA
acid	acid	NN	I-NP	I-DNA
receptor	receptor	NN	I-NP	I-DNA
alpha	alpha	NN	I-NP	I-DNA
(	(	(	O	I-DNA
RARalpha	RARalpha	NN	B-NP	I-DNA
)	)	)	O	I-DNA
gene	gene	NN	B-NP	I-DNA
.	.	.	O	O

Whether	Whether	IN	B-SBAR	O
these	these	DT	B-NP	O
translocations	translocation	NNS	I-NP	O
relate	relate	VBP	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
endogenous	endogenous	JJ	B-NP	B-protein
RARalpha	RARalpha	NN	I-NP	I-protein
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
granulopoiesis	granulopoiesis	NN	I-NP	O
remains	remain	VBZ	B-VP	O
uncertain	uncertain	JJ	B-ADJP	O
because	because	IN	B-SBAR	O
most	most	JJS	B-NP	O
studies	study	NNS	I-NP	O
addressing	address	VBG	B-VP	O
this	this	DT	B-NP	O
question	question	NN	I-NP	O
have	have	VBP	B-VP	O
used	use	VBN	I-VP	O
non-physiological	non-physiological	JJ	B-NP	O
overexpression	overexpression	NN	I-NP	O
systems	system	NNS	I-NP	O
.	.	.	O	O

Granulocyte	Granulocyte	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
RARalpha-deficient	RARalpha-deficient	JJ	B-NP	O
(	(	(	O	O
RARalpha	RARalpha	NN	B-NP	B-protein
(	(	(	O	O
-/-	-/-	JJ	B-ADJP	O
)	)	)	O	O
)	)	)	O	O
mice	mouse	NNS	B-NP	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
and	and	CC	O	O
evaluated	evaluate	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
agonist-bound	agonist-bound	JJ	B-NP	O
and	and	CC	I-NP	O
ligand-free	ligand-free	JJ	I-NP	O
RARalpha	RARalpha	NN	I-NP	B-protein
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
RARalpha	RARalpha	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
dispensable	dispensable	JJ	B-ADJP	O
for	for	IN	B-PP	O
granulopoiesis	granulopoiesis	NN	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
RARalpha	RARalpha	NN	B-NP	B-protein
(	(	(	O	O
-/-	-/-	JJ	O	O
)	)	)	O	O
mice	mouse	NNS	B-NP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	B-cell_type
granulocyte	granulocyte	NN	I-NP	I-cell_type
population	population	NN	I-NP	I-cell_type
despite	despite	IN	B-PP	O
an	an	DT	B-NP	O
impaired	impaired	JJ	I-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
respond	respond	VB	I-VP	O
to	to	TO	B-PP	O
retinoids	retinoid	NNS	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
absolutely	absolutely	RB	B-VP	O
required	require	VBN	I-VP	O
,	,	,	O	O
RARalpha	RARalpha	NN	B-NP	B-protein
can	can	MD	B-VP	O
bidirectionally	bidirectionally	RB	I-VP	O
modulate	modulate	VB	I-VP	O
granulopoiesis	granulopoiesis	NN	B-NP	O
.	.	.	O	O

RARalpha	RARalpha	NN	B-NP	B-protein
stimulates	stimulate	VBZ	B-VP	O
differentiation	differentiation	NN	B-NP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
exogenous	exogenous	JJ	B-NP	O
retinoic	retinoic	JJ	I-NP	O
acid	acid	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
endogenous	endogenous	JJ	B-NP	O
retinoids	retinoid	NNS	I-NP	O
control	control	VBP	B-VP	O
granulopoiesis	granulopoiesis	NN	B-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
either	either	DT	B-NP	O
vitamin	vitamin	NN	I-NP	O
A-deficient	A-deficient	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
or	or	CC	I-NP	O
animals	animal	NNS	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
RAR	RAR	NN	I-NP	B-protein
antagonist	antagonist	NN	I-NP	O
accumulate	accumulate	VBP	B-VP	O
more	more	RBR	B-NP	O
immature	immature	JJ	I-NP	B-cell_type
granulocytes	granulocyte	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
bone	bone	NN	I-NP	O
marrow	marrow	NN	I-NP	O
.	.	.	O	O

Conversely	Conversely	RB	B-ADVP	O
,	,	,	O	O
RARalpha	RARalpha	NN	B-NP	B-protein
acts	act	VBZ	B-VP	O
to	to	TO	I-VP	O
limit	limit	VB	I-VP	O
differentiation	differentiation	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
ligand	ligand	NN	B-NP	O
because	because	IN	B-SBAR	O
granulocyte	granulocyte	NN	B-NP	B-cell_type
precursors	precursor	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
RARalpha	RARalpha	NN	B-NP	B-protein
(	(	(	O	O
-/-	-/-	JJ	O	O
)	)	)	O	O
mice	mouse	NNS	B-NP	O
differentiate	differentiate	VBP	B-VP	O
earlier	earlier	RBR	B-ADVP	O
in	in	IN	B-PP	O
culture	culture	NN	B-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
block	block	NN	I-NP	O
in	in	IN	B-PP	O
granulopoiesis	granulopoiesis	NN	B-NP	O
exerted	exert	VBN	B-VP	O
by	by	IN	B-PP	O
RARalpha	RARalpha	NN	B-NP	B-protein
fusion	fusion	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
expressed	express	VBN	B-VP	O
in	in	IN	B-PP	O
APL	APL	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
may	may	MD	B-VP	O
correspond	correspond	VB	I-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
amplification	amplification	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
unliganded	unliganded	JJ	B-NP	B-protein
RARalpha	RARalpha	NN	I-NP	I-protein
.	.	.	O	O

Expression	Expression	NN	B-NP	O
and	and	CC	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
stem	stem	NN	I-NP	O
cell	cell	NN	I-NP	O
promoter	promoter	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	B-DNA
CBFalpha2	CBFalpha2	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
:	:	:	O	O
distinct	distinct	JJ	B-NP	O
roles	role	NNS	I-NP	O
and	and	CC	O	O
regulation	regulation	NN	B-NP	O
in	in	IN	B-PP	O
natural	natural	JJ	B-NP	O
killer	killer	NN	I-NP	O
and	and	CC	O	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Runt	Runt	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
CBFalpha2	CBFalpha2	NN	I-NP	B-protein
(	(	(	O	O
AML1	AML1	NN	B-NP	B-protein
,	,	,	O	O
PEBP2alphaB	PEBP2alphaB	NN	B-NP	B-protein
,	,	,	O	O
or	or	CC	O	O
Runx1	Runx1	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
by	by	IN	B-PP	O
hematopoietic	hematopoietic	JJ	B-NP	B-cell_type
stem	stem	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
expressed	express	VBN	B-VP	O
at	at	IN	B-PP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
T-lineage	T-lineage	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
CBFalpha2	CBFalpha2	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
usually	usually	RB	I-VP	O
transcribed	transcribe	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
different	different	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
(	(	(	O	O
distal	distal	JJ	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
)	)	)	O	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
myeloid	myeloid	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
proximal	proximal	JJ	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
)	)	)	O	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
developmental	developmental	JJ	I-NP	O
and	and	CC	I-NP	O
functional	functional	JJ	I-NP	O
significance	significance	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
promoter	promoter	NN	I-NP	O
switch	switch	NN	I-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
known	know	VBN	I-VP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
that	that	IN	B-SBAR	O
both	both	CC	O	O
coding	cod	VBG	B-VP	O
and	and	CC	O	O
noncoding	noncoding	JJ	B-NP	O
sequences	sequence	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	B-DNA
5	5	CD	I-NP	I-DNA
'	'	SYM	I-NP	I-DNA
end	end	NN	I-NP	I-DNA
are	be	VBP	B-VP	O
highly	highly	RB	I-VP	O
conserved	conserve	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
overwhelming	overwhelming	JJ	I-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
CBFalpha2	CBFalpha2	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
murine	murine	JJ	B-NP	B-cell_line
hematopoietic	hematopoietic	JJ	I-NP	I-cell_line
stem	stem	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Distal	Distal	JJ	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
activity	activity	NN	I-NP	O
is	be	VBZ	B-VP	O
maintained	maintain	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
development	development	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
lower	low	JJR	B-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
development	development	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
downregulated	downregulate	VBD	B-VP	O
in	in	IN	B-PP	O
natural	natural	JJ	B-NP	O
killer	killer	NN	I-NP	O
cell	cell	NN	I-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
distal	distal	JJ	I-NP	B-protein
N-terminal	N-terminal	JJ	I-NP	I-protein
isoform	isoform	NN	I-NP	I-protein
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
functionally	functionally	RB	B-NP	O
important	important	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
sites	site	NNS	I-NP	O
from	from	IN	B-PP	O
known	know	VBN	B-NP	O
target	target	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
with	with	IN	B-PP	O
two-	two-	CD	B-NP	O
to	to	TO	B-PP	O
threefold	threefold	RB	B-NP	O
higher	high	JJR	I-NP	O
affinity	affinity	NN	I-NP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	B-protein
N-terminal	N-terminal	JJ	I-NP	I-protein
isoform	isoform	NN	I-NP	I-protein
.	.	.	O	O

Neither	Neither	CC	O	O
full-length	full-length	JJ	B-NP	B-protein
isoform	isoform	NN	I-NP	I-protein
alters	alter	VBZ	B-VP	O
growth	growth	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
myeloid	myeloid	JJ	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
under	under	IN	B-PP	O
nondifferentiating	nondifferentiating	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	B-protein
isoform	isoform	NN	I-NP	I-protein
selectively	selectively	RB	B-ADVP	O
delays	delay	VBZ	B-VP	O
mitotic	mitotic	JJ	B-NP	O
arrest	arrest	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
under	under	IN	B-PP	O
differentiating	differentiate	VBG	B-VP	O
conditions	condition	NNS	B-NP	O
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
generation	generation	NN	I-NP	O
of	of	IN	B-PP	O
greater	great	JJR	B-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
neutrophils	neutrophil	NNS	B-NP	B-cell_type
.	.	.	O	O

Constitutive	Constitutive	JJ	B-NP	O
PI3-K	PI3-K	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
proliferation	proliferation	NN	B-NP	O
,	,	,	B-NP	O
but	but	CC	I-NP	O
not	not	RB	I-NP	O
survival	survival	NN	B-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
Theileria	Theileria	NNP	B-NP	B-cell_type
parva-transformed	parva-transformed	JJ	I-NP	I-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Theileria	Theileria	NNP	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	O
parasite	parasite	NN	I-NP	O
that	that	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
lymphoproliferative	lymphoproliferative	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O
in	in	IN	B-PP	O
cattle	cattle	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
infection	infection	NN	B-NP	O
of	of	IN	B-PP	O
leucocytes	leucocyte	NNS	B-NP	B-cell_type
induces	induce	VBZ	B-VP	O
a	a	DT	B-NP	O
transformed	transform	VBN	I-NP	O
phenotype	phenotype	NN	I-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
tumour	tumour	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
parasite	parasite	NN	I-NP	O
induces	induce	VBZ	B-VP	O
this	this	DT	B-NP	O
phenotype	phenotype	NN	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
understood	understand	VBN	I-VP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
infected	infected	JJ	B-NP	O
B	B	NN	I-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
display	display	VBP	B-VP	O
constitutive	constitutive	JJ	B-NP	B-protein
phosphoinositide	phosphoinositide	NN	I-NP	I-protein
3-kinase	3-kinase	NN	I-NP	I-protein
(	(	(	O	O
PI3-K	PI3-K	NN	B-NP	B-protein
)	)	)	O	O
activity	activity	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
proliferation	proliferation	NN	B-NP	O
,	,	,	B-NP	O
but	but	CC	I-NP	O
not	not	RB	I-NP	O
survival	survival	NN	B-NP	O
.	.	.	O	O

Importantly	Importantly	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
one	one	CD	B-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
PI3-K	PI3-K	NN	B-NP	B-protein
mediates	mediate	VBZ	B-VP	O
the	the	DT	B-NP	O
proliferation	proliferation	NN	I-NP	O
of	of	IN	B-PP	O
infected	infected	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
granulocyte-monocyte	granulocyte-monocyte	JJ	I-NP	B-protein
colony-stimulating	colony-stimulating	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
GM-CSF	GM-CSF	NN	B-NP	B-protein
)	)	)	O	O
-dependent	-dependent	JJ	B-NP	O
autocrine	autocrine	JJ	I-NP	O
loop	loop	NN	I-NP	O
.	.	.	O	O

PI3-K	PI3-K	NN	B-NP	B-protein
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
GM-CSF	GM-CSF	NN	B-NP	B-protein
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
level	level	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
consistently	consistently	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
PI3-K	PI3-K	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
constitutive	constitutive	JJ	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-protein
and	and	CC	I-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
characterizes	characterize	VBZ	B-VP	O
Theileria-infected	Theileria-infected	JJ	B-NP	B-cell_type
leucocytes	leucocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Taken	Take	VBN	B-VP	O
together	together	RB	B-ADVP	O
,	,	,	O	O
our	our	PRP$	B-NP	O
results	result	NNS	I-NP	O
highlight	highlight	VBP	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
strategy	strategy	NN	I-NP	O
exploited	exploit	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	O
parasite	parasite	NN	I-NP	O
Theileria	Theileria	NN	I-NP	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
continued	continued	JJ	B-NP	O
proliferation	proliferation	NN	I-NP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
host	host	NN	I-NP	O
leucocyte	leucocyte	NN	I-NP	O
.	.	.	O	O

Lymphokine	Lymphokine	NN	B-NP	B-protein
dependence	dependence	NN	I-NP	O
of	of	IN	B-PP	O
STAT3	STAT3	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
produced	produce	VBN	B-VP	O
by	by	IN	B-PP	O
surface	surface	NN	B-NP	B-protein
immunoglobulin	immunoglobulin	NN	I-NP	I-protein
cross-linking	cross-linking	NN	I-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
phorbol	phorbol	NN	B-NP	O
ester	ester	NN	I-NP	O
plus	plus	CC	O	O
calcium	calcium	NN	B-NP	O
ionophore	ionophore	NN	I-NP	O
treatment	treatment	NN	I-NP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Stimulation	Stimulation	NN	B-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
surface	surface	NN	B-NP	B-protein
immunoglobulin	immunoglobulin	NN	I-NP	I-protein
(	(	(	O	O
sIg	sIg	NN	B-NP	O
)	)	)	O	O
triggering	triggering	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
mitogenic	mitogenic	JJ	I-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
phorbol	phorbol	NN	B-NP	O
ester	ester	NN	I-NP	O
and	and	CC	O	O
calcium	calcium	NN	B-NP	O
ionophore	ionophore	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
STAT	STAT	NN	B-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
delayed	delay	VBN	I-NP	O
nuclear	nuclear	JJ	I-NP	O
accumulation	accumulation	NN	I-NP	O
of	of	IN	B-PP	O
phosphorylated	phosphorylate	VBN	B-NP	O
STAT3	STAT3	NN	I-NP	B-protein
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
in	in	IN	B-PP	O
detail	detail	NN	B-NP	O
,	,	,	O	O
focusing	focus	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	B-protein
cell-derived	cell-derived	JJ	I-NP	I-protein
lymphokines	lymphokine	NNS	I-NP	I-protein
.	.	.	O	O

sIg	sIg	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
STAT3	STAT3	NN	B-NP	B-protein
was	be	VBD	B-VP	O
partially	partially	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
IL-6-	IL-6-	NN	B-NP	O
or	or	CC	O	O
IL-10-deficient	IL-10-deficient	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
partially	partially	RB	I-VP	O
blocked	block	VBN	I-VP	O
by	by	IN	B-PP	O
neutralizing	neutralize	VBG	B-VP	B-protein
antibodies	antibody	NNS	B-NP	I-protein
directed	direct	VBN	B-VP	O
against	against	IN	B-PP	O
either	either	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
lymphokines	lymphokine	NNS	I-NP	B-protein
.	.	.	O	O

sIg	sIg	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
STAT3	STAT3	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
was	be	VBD	B-VP	O
completely	completely	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
combining	combine	VBG	B-VP	O
IL-6-	IL-6-	NN	B-NP	B-protein
and	and	CC	O	O
IL-10-specific	IL-10-specific	JJ	B-NP	B-protein
neutralizing	neutralize	VBG	I-NP	I-protein
antibodies	antibody	NNS	I-NP	I-protein
,	,	,	O	O
or	or	CC	O	O
by	by	IN	B-PP	O
adding	add	VBG	B-VP	O
individual	individual	JJ	B-NP	O
neutralizing	neutralize	VBG	I-NP	O
antibodies	antibody	NNS	I-NP	B-protein
to	to	TO	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
lymphokine-deficient	lymphokine-deficient	JJ	B-NP	O
animals	animal	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
IL-10	IL-10	NN	B-NP	B-protein
alone	alone	RB	B-ADVP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
account	account	VB	I-VP	O
for	for	IN	B-PP	O
STAT3	STAT3	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
resulting	result	VBG	B-VP	O
from	from	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
stimulation	stimulation	NN	I-NP	O
with	with	IN	B-PP	O
phorbol	phorbol	NN	B-NP	O
ester	ester	NN	I-NP	O
and	and	CC	O	O
calcium	calcium	NN	B-NP	O
ionophore	ionophore	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
keeping	keep	VBG	B-NP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
,	,	,	O	O
soluble	soluble	JJ	B-NP	O
IL-6	IL-6	NN	I-NP	B-protein
and	and	CC	I-NP	O
IL-10	IL-10	NN	I-NP	B-protein
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
supernatant	supernatant	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
stimulated	stimulate	VBN	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

This	This	DT	B-NP	O
work	work	NN	I-NP	O
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
lymphokine	lymphokine	NN	I-NP	B-protein
pathway	pathway	NN	I-NP	O
is	be	VBZ	B-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
STAT3	STAT3	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
that	that	WDT	B-NP	O
occurs	occur	VBZ	B-VP	O
late	late	RB	B-ADVP	O
after	after	IN	B-PP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
stimulation	stimulation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
points	point	VBZ	B-VP	O
out	out	RP	B-PRT	O
differences	difference	NNS	B-NP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
that	that	WDT	B-NP	O
result	result	VBP	B-VP	O
from	from	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
antigen	antigen	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
and	and	CC	B-PP	O
through	through	IN	B-PP	O
pharmacological	pharmacological	JJ	B-NP	O
mimicry	mimicry	NN	I-NP	O
of	of	IN	B-PP	O
signaling	signaling	NN	B-NP	B-protein
mediators	mediator	NNS	I-NP	I-protein
.	.	.	O	O

Transcription	Transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
AP-4	AP-4	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
ligand	ligand	NN	I-NP	O
for	for	IN	B-PP	O
immunoglobulin-kappa	immunoglobulin-kappa	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
E-box	E-box	NN	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
.	.	.	O	O

Immunoglobulin	Immunoglobulin	NN	B-NP	B-DNA
(	(	(	O	I-DNA
Ig	Ig	NN	B-NP	I-DNA
)	)	)	O	I-DNA
-kappa	-kappa	NN	B-NP	I-DNA
promoters	promoter	NNS	I-NP	I-DNA
from	from	IN	B-PP	O
humans	human	NNS	B-NP	O
and	and	CC	I-NP	O
mice	mouse	NNS	I-NP	O
share	share	VBP	B-VP	O
conserved	conserve	VBN	B-NP	O
sequences	sequence	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
octamer	octamer	NN	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
common	common	JJ	B-ADJP	O
to	to	TO	B-PP	O
all	all	DT	B-NP	O
Ig	Ig	NN	I-NP	B-DNA
promoters	promoter	NNS	I-NP	I-DNA
and	and	CC	O	O
pivotal	pivotal	JJ	B-ADJP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
other	other	JJ	B-NP	O
conserved	conserve	VBN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
motifs	motif	NNS	I-NP	I-DNA
,	,	,	O	O
that	that	WDT	B-NP	O
differ	differ	VBP	B-VP	O
between	between	IN	B-PP	O
Ig	Ig	NN	B-NP	B-protein
variable	variable	JJ	I-NP	O
gene	gene	NN	I-NP	O
families	family	NNS	I-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
normal	normal	JJ	B-NP	O
promoter	promoter	NN	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
conserved	conserve	VBN	I-NP	B-DNA
motifs	motif	NNS	I-NP	I-DNA
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
stimulate	stimulate	VB	I-VP	O
transcription	transcription	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
octamer	octamer	NN	I-NP	B-DNA
.	.	.	O	O

One	One	CD	B-NP	O
example	example	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
E-box	E-box	NN	I-NP	B-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
E47/E12	E47/E12	NN	I-NP	O
type	type	NN	I-NP	O
(	(	(	O	O
5'-CAGCTG-3	5'-CAGCTG-3	NN	B-NP	B-DNA
'	'	''	O	I-DNA
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
promoters	promoter	NNS	I-NP	B-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
murine	murine	JJ	I-NP	I-DNA
Ig-kappa	Ig-kappa	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
subgroups/families	subgroups/family	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
exception	exception	NN	I-NP	O
of	of	IN	B-PP	O
subgroups	subgroup	NNS	B-NP	O
II	II	CD	B-NP	O
and	and	CC	I-NP	O
VI	VI	CD	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
related	relate	VBN	I-NP	O
murine	murine	JJ	I-NP	B-protein
families	family	NNS	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
ubiquitously	ubiquitously	RB	I-NP	O
expressed	express	VBN	I-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
AP-4	AP-4	NN	I-NP	B-protein
,	,	,	B-NP	O
and	and	CC	I-NP	O
not	not	RB	I-NP	O
E47	E47	NN	B-NP	B-protein
,	,	,	O	O
interacts	interact	VBZ	B-VP	O
specifically	specifically	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
kappa	kappa	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
E-boxes	E-box	NNS	I-NP	I-DNA
when	when	WRB	B-ADVP	O
tested	test	VBN	B-VP	O
in	in	IN	B-PP	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility-shift	mobility-shift	JJ	I-NP	O
assays	assay	NNS	I-NP	O
using	use	VBG	B-VP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
and	and	CC	I-NP	I-cell_line
murine	murine	JJ	I-NP	I-cell_line
B-cell	B-cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
AP-4	AP-4	NN	B-NP	B-protein
,	,	,	O	O
unlike	unlike	IN	B-PP	O
E47	E47	NN	B-NP	B-protein
,	,	,	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
act	act	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
transactivator	transactivator	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
agreement	agreement	NN	B-NP	O
with	with	IN	B-PP	O
previous	previous	JJ	B-NP	O
studies	study	NNS	I-NP	O
on	on	IN	B-PP	O
intact	intact	JJ	B-NP	O
kappa	kappa	NN	I-NP	B-DNA
promoters	promoter	NNS	I-NP	I-DNA
,	,	,	O	O
showing	show	VBG	B-VP	O
that	that	IN	B-SBAR	O
transcription	transcription	NN	B-NP	O
is	be	VBZ	B-VP	O
absent	absent	JJ	B-ADJP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
octamer	octamer	NN	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
mutated	mutate	VBN	I-VP	O
.	.	.	O	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
these	these	DT	B-NP	O
data	datum	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
conservation	conservation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
5'-CAGCTG-3	5'-CAGCTG-3	NN	I-NP	B-DNA
'	'	POS	B-NP	I-DNA
motif	motif	NN	I-NP	I-DNA
among	among	IN	B-PP	O
human	human	JJ	B-NP	B-DNA
and	and	CC	I-NP	I-DNA
murine	murine	JJ	I-NP	I-DNA
kappa	kappa	NN	I-NP	I-DNA
promoters	promoter	NNS	I-NP	I-DNA
,	,	,	O	O
we	we	PRP	B-NP	O
propose	propose	VBP	B-VP	O
that	that	IN	B-SBAR	O
AP-4	AP-4	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
ligand	ligand	NN	I-NP	O
for	for	IN	B-PP	O
Ig-kappa	Ig-kappa	NN	B-NP	B-protein
promoter	promoter	NN	I-NP	I-protein
E-boxes	E-box	NNS	I-NP	I-protein
.	.	.	O	O

A	A	DT	B-NP	O
16-mer	16-mer	NN	I-NP	O
peptide	peptide	NN	I-NP	O
(	(	(	O	O
RQIKIWFQNRRMKWKK	RQIKIWFQNRRMKWKK	NN	B-NP	B-protein
)	)	)	O	O
from	from	IN	B-PP	O
antennapedia	antennapedia	NNS	B-NP	O
preferentially	preferentially	RB	B-ADVP	O
targets	target	VBZ	B-VP	O
the	the	DT	B-NP	O
Class	Class	NN	I-NP	O
I	I	CD	I-NP	O
pathway	pathway	NN	I-NP	O
.	.	.	O	O

Translocation	Translocation	NN	B-NP	O
of	of	IN	B-PP	O
antigenic	antigenic	JJ	B-NP	O
peptides	peptide	NNS	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
cytosol	cytosol	NN	I-NP	O
of	of	IN	B-PP	O
antigen	antigen	NN	B-NP	B-cell_type
presenting	presenting	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
facilitates	facilitate	VBZ	B-VP	O
proteosomal	proteosomal	JJ	B-NP	O
processing	processing	NN	I-NP	O
and	and	CC	I-NP	O
loading	loading	NN	I-NP	O
into	into	IN	B-PP	O
Class	Class	NN	B-NP	B-protein
I	I	CD	B-NP	I-protein
molecules	molecule	NNS	I-NP	I-protein
for	for	IN	B-PP	O
MHC	MHC	NN	B-NP	B-protein
presentation	presentation	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
surface	surface	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
DNA	DNA	NN	I-NP	B-protein
binding	binding	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Drosophila	Drosophila	FW	I-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
Antennapedia	Antennapedia	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
60	60	CD	I-NP	B-protein
amino	amino	NN	I-NP	I-protein
acid	acid	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
,	,	,	O	O
is	be	VBZ	B-VP	O
rapidly	rapidly	RB	I-VP	O
taken	take	VBN	I-VP	O
up	up	RP	B-PRT	O
by	by	IN	B-PP	O
cells	cell	NNS	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
fused	fuse	VBN	I-VP	O
to	to	TO	B-PP	O
selected	select	VBN	B-NP	O
antigens	antigen	NNS	I-NP	O
to	to	TO	B-VP	O
enhance	enhance	VB	I-VP	O
their	their	PRP$	B-NP	O
immunogenicity	immunogenicity	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
now	now	RB	B-ADVP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
16	16	CD	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
peptide	peptide	NN	I-NP	O
from	from	IN	B-PP	O
antennapedia	antennapedia	NNS	B-NP	O
can	can	MD	B-VP	O
facilitate	facilitate	VB	I-VP	O
the	the	DT	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	O
uptake	uptake	NN	I-NP	O
of	of	IN	B-PP	O
CTL	CTL	NN	B-NP	O
epitope	epitope	NN	I-NP	O
9-mer	9-mer	NN	I-NP	O
peptides	peptide	NNS	I-NP	O
.	.	.	O	O

Synthetic	Synthetic	JJ	B-NP	O
peptides	peptide	NNS	I-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
16-mer	16-mer	NN	I-NP	O
antennapedia	antennapedia	NN	I-NP	O
peptide	peptide	NN	I-NP	O
linked	link	VBN	B-VP	O
in	in	IN	B-PP	O
tandem	tandem	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ovalbumin	ovalbumin	NN	I-NP	O
SIINFEKL	SIINFEKL	NN	I-NP	O
CTL	CTL	NN	I-NP	O
peptide	peptide	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
peptide	peptide	NN	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
rapidly	rapidly	RB	I-VP	O
internalise	internalise	VB	I-VP	O
into	into	IN	B-PP	O
APCs	APC	NNS	B-NP	B-cell_type
by	by	IN	B-PP	O
confocal	confocal	JJ	B-NP	O
microscopy	microscopy	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
peptide	peptide	NN	I-NP	O
induced	induce	VBD	B-VP	O
CTL	CTL	NN	B-NP	B-cell_type
in	in	IN	B-PP	O
C57BL/6	C57BL/6	NN	B-NP	O
mice	mouse	NNS	I-NP	O
and	and	CC	O	O
protected	protect	VBD	B-VP	O
them	them	PRP	B-NP	O
against	against	IN	B-PP	O
growth	growth	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
ovalbumin	ovalbumin	NN	I-NP	B-cell_line
expressing	express	VBG	B-VP	I-cell_line
tumour	tumour	NN	B-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
(	(	(	O	O
E.G7-OVA	E.G7-OVA	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hybrid	hybrid	NN	I-NP	O
peptide	peptide	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
processed	process	VBN	I-VP	O
and	and	CC	I-VP	O
presented	present	VBN	I-VP	O
by	by	IN	B-PP	O
APCs	APC	NNS	B-NP	B-cell_type
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
,	,	,	O	O
whether	whether	IN	B-SBAR	O
the	the	DT	B-NP	O
SIINFEKL	SIINFEKL	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
appended	append	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
C-terminus	C-terminus	NN	I-NP	B-protein
or	or	CC	I-NP	O
N-terminus	N-terminus	NN	I-NP	B-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Antennapedia	Antennapedia	NNP	I-NP	O
peptide	peptide	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
synthetic	synthetic	JJ	B-NP	O
peptides	peptide	NNS	I-NP	O
containing	contain	VBG	B-VP	O
other	other	JJ	B-NP	O
CTL	CTL	NN	I-NP	B-protein
peptide	peptide	NN	I-NP	I-protein
epitopes	epitope	NNS	I-NP	I-protein
may	may	MD	B-VP	O
be	be	VB	I-VP	O
useful	useful	JJ	B-ADJP	O
for	for	IN	B-PP	O
priming	prim	VBG	B-VP	O
CTLs	CTL	NNS	B-NP	B-cell_type
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O

Bone	Bone	NN	B-NP	B-cell_type
marrow	marrow	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
promote	promote	VBP	B-VP	O
TH2	TH2	NN	B-NP	O
polarization	polarization	NN	I-NP	O
and	and	CC	O	O
inhibit	inhibit	VBP	B-VP	O
virus-specific	virus-specific	JJ	B-NP	O
CTL	CTL	NN	I-NP	O
generation	generation	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
laboratory	laboratory	NN	I-NP	O
recently	recently	RB	B-ADVP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
human	human	JJ	B-NP	B-cell_type
bone	bone	NN	I-NP	I-cell_type
marrow	marrow	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
BMC	BMC	NN	B-NP	B-cell_type
)	)	)	O	O
inhibit	inhibit	VBP	B-VP	O
the	the	DT	B-NP	O
generation	generation	NN	I-NP	O
of	of	IN	B-PP	O
virus-specific	virus-specific	JJ	B-NP	B-cell_type
CTL	CTL	NN	I-NP	I-cell_type
in	in	IN	B-PP	O
culture	culture	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
culture	culture	NN	I-NP	O
supernatants	supernatant	NNS	I-NP	O
contained	contain	VBD	B-VP	O
increased	increase	VBN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
prostaglandin	prostaglandin	NN	B-NP	O
E	E	NN	I-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
(	(	(	O	O
PGE	PGE	NN	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
)	)	)	O	O
(	(	(	O	O
shown	show	VBN	B-VP	O
to	to	TO	I-VP	O
favor	favor	VB	I-VP	O
TH2	TH2	NN	B-NP	O
cell	cell	NN	I-NP	O
development	development	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
inhibited	inhibit	VBD	B-VP	O
EBV-CTL	EBV-CTL	NN	B-NP	O
effector	effector	NN	I-NP	O
cell	cell	NN	I-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
obtained	obtain	VBD	B-VP	O
PBL	PBL	NN	B-NP	B-cell_type
from	from	IN	B-PP	O
Epstein-Barr	Epstein-Barr	JJ	B-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
EBV	EBV	NN	B-NP	O
)	)	)	O	O
IgG	IgG	NN	B-NP	O
antibody	antibody	NN	I-NP	O
positive	positive	JJ	I-NP	O
kidney	kidney	NN	I-NP	O
transplant	transplant	NN	I-NP	O
recipients	recipient	NNS	I-NP	O
(	(	(	O	O
R	R	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
living-related	living-related	JJ	I-NP	O
donors	donor	NNS	I-NP	O
(	(	(	O	O
LRD	LRD	NN	B-NP	O
)	)	)	O	O
one	one	CD	B-NP	O
year	year	NN	I-NP	O
after	after	IN	B-PP	O
renal	renal	JJ	B-NP	O
transplantation	transplantation	NN	I-NP	O
.	.	.	O	O

EBV-specific	EBV-specific	JJ	B-NP	B-cell_type
CTL	CTL	NN	I-NP	I-cell_type
were	be	VBD	B-VP	O
then	then	RB	I-VP	O
generated	generate	VBN	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
by	by	IN	B-PP	O
stimulating	stimulate	VBG	B-VP	O
PBL	PBL	NN	B-NP	B-cell_type
with	with	IN	B-PP	O
autologous	autologous	JJ	B-NP	B-cell_line
EBV-transformed	EBV-transformed	JJ	I-NP	I-cell_line
B	B	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
(	(	(	O	O
EBV-B	EBV-B	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
or	or	CC	I-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
autologous	autologous	JJ	B-NP	B-cell_type
BMC	BMC	NN	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
BMC	BMC	NN	B-NP	B-cell_type
to	to	TO	B-PP	O
the	the	DT	B-NP	O
EBV-CTL	EBV-CTL	NN	I-NP	B-cell_line
generation	generation	NN	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
increased	increase	VBD	B-VP	O
the	the	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
CD3+	CD3+	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
IL-4	IL-4	NN	B-NP	B-protein
,	,	,	O	O
-5	-5	CD	B-NP	O
,	,	,	I-NP	O
-6	-6	CD	I-NP	O
,	,	,	I-NP	O
-10	-10	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
-13	-13	CD	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
CD3+	CD3+	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
also	also	RB	B-ADVP	O
expressed	express	VBD	B-VP	O
increased	increase	VBN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TH2	TH2	NN	I-NP	B-protein
associated	associated	JJ	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
CCR3	CCR3	NN	I-NP	B-protein
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
was	be	VBD	B-VP	O
even	even	RB	I-VP	O
observed	observe	VBN	I-VP	O
by	by	IN	B-PP	O
preparing	prepare	VBG	B-VP	O
EBV-CTL	EBV-CTL	NN	B-NP	B-cell_line
generating	generate	VBG	B-VP	I-cell_line
cultures	culture	NNS	B-NP	I-cell_line
in	in	IN	B-PP	O
trans-wells	trans-well	NNS	B-NP	O
that	that	WDT	B-NP	O
separated	separate	VBD	B-VP	O
the	the	DT	B-NP	O
autologous	autologous	JJ	I-NP	O
BMC	BMC	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
PBL	PBL	NN	I-NP	B-cell_type
+	+	SYM	B-NP	O
EBV-B	EBV-B	NN	I-NP	B-protein
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
observed	observe	VBN	I-VP	O
that	that	IN	B-SBAR	O
CD3+	CD3+	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
obtained	obtain	VBN	B-VP	O
after	after	IN	B-PP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
culture	culture	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
autologous	autologous	JJ	B-NP	O
BMC	BMC	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
inhibitors	inhibitor	NNS	B-NP	O
of	of	IN	B-PP	O
EBV-CTL	EBV-CTL	NN	B-NP	O
generation	generation	NN	I-NP	O
.	.	.	O	O

Protein	Protein	NN	B-NP	B-protein
Kinase	Kinase	NN	I-NP	I-protein
A	A	NN	I-NP	I-protein
(	(	(	O	O
PKA	PKA	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
cAMP	cAMP	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upregulation	upregulation	NN	I-NP	O
of	of	IN	B-PP	O
TH2	TH2	NN	B-NP	B-protein
cytokine	cytokine	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
EBV-CTL	EBV-CTL	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
by	by	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
BMC	BMC	NN	B-NP	B-cell_type
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
IL-4-mediated	IL-4-mediated	JJ	B-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
and	and	CC	O	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
(	(	(	O	O
STAT-6	STAT-6	NN	B-NP	B-protein
)	)	)	O	O
phosphorylation	phosphorylation	NN	B-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	I-VP	O
increased	increase	VBN	I-VP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
BMC	BMC	NN	I-NP	O
inhibition	inhibition	NN	I-NP	O
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
soluble	soluble	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
(	(	(	O	O
cytokines	cytokine	NNS	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
cell-cell	cell-cell	JJ	B-NP	O
contact	contact	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
autologous	autologous	JJ	I-NP	O
system	system	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
required	require	VBN	I-VP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
that	that	IN	I-SBAR	O
BMC	BMC	NN	B-NP	B-cell_type
(	(	(	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
partially	partially	RB	B-ADVP	O
,	,	,	O	O
via	via	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-protein
production	production	NN	I-NP	O
)	)	)	O	O
promote	promote	VBP	B-VP	O
TH2	TH2	NN	B-NP	O
polarization	polarization	NN	I-NP	O
in	in	IN	B-PP	O
culture	culture	NN	B-NP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
TH2	TH2	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
culturing	culture	VBG	B-VP	O
with	with	IN	B-PP	O
autologous	autologous	JJ	B-NP	O
BMC	BMC	NN	I-NP	O
directly	directly	RB	B-VP	O
inhibit	inhibit	VBP	I-VP	O
EBV-CTL	EBV-CTL	NN	B-NP	O
generation	generation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
TH2	TH2	NN	B-NP	B-cell_line
associated	associate	VBN	B-VP	O
PKA	PKA	NN	B-NP	B-protein
,	,	,	O	O
CCR3	CCR3	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
STAT-6	STAT-6	NN	B-NP	B-protein
phosphorylation	phosphorylation	NN	I-NP	O
are	be	VBP	B-VP	O
enhanced	enhance	VBN	I-VP	O
by	by	IN	B-PP	O
BMC	BMC	NN	B-NP	B-cell_type
.	.	.	O	O

Reduction	Reduction	NN	B-NP	O
in	in	IN	B-PP	O
DNA	DNA	NN	B-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
Pax-5a	Pax-5a	NN	I-NP	B-protein
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
aged	aged	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

Aging	Aging	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
intrinsic	intrinsic	JJ	B-NP	O
changes	change	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
humoral	humoral	JJ	I-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
occurrence	occurrence	NN	I-NP	O
of	of	IN	B-PP	O
autoimmune	autoimmune	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O
and	and	CC	O	O
pathogenic	pathogenic	JJ	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
Pax-5	Pax-5	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
key	key	JJ	I-NP	O
regulator	regulator	NN	I-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

Pax-5a/B	Pax-5a/B	NN	B-NP	B-protein
cell-specific	cell-specific	JJ	I-NP	I-protein
activator	activator	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
and	and	CC	O	O
an	an	DT	B-NP	O
alternatively	alternatively	RB	I-NP	O
spliced	splice	VBN	I-NP	O
isoform	isoform	NN	I-NP	O
,	,	,	O	O
Pax-5d	Pax-5d	NN	B-NP	B-protein
,	,	,	O	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
opposing	oppose	VBG	I-VP	O
functions	function	NNS	B-NP	O
in	in	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
transactivation	transactivation	NN	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
in	in	IN	B-PP	O
Pax-5d	Pax-5d	NN	B-NP	B-protein
.	.	.	O	O

To	To	TO	B-VP	O
study	study	VB	I-VP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
-specific	-specific	JJ	I-NP	O
changes	change	NNS	I-NP	O
that	that	WDT	B-NP	O
occur	occur	VBP	B-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
aging	aging	NN	I-NP	O
process	process	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
expression	expression	NN	B-NP	O
patterns	pattern	NNS	I-NP	O
of	of	IN	B-PP	O
Pax-5a	Pax-5a	NN	B-NP	B-protein
and	and	CC	I-NP	O
5d	5d	NN	I-NP	O
in	in	IN	B-PP	O
mature	mature	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
young	young	JJ	B-NP	O
and	and	CC	I-NP	O
aged	aged	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

RNase	RNase	NN	B-NP	B-protein
protection	protection	NN	I-NP	O
assays	assay	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
for	for	IN	B-PP	O
both	both	DT	B-NP	O
age	age	NN	I-NP	O
groups	group	NNS	I-NP	O
that	that	WDT	B-NP	O
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
aging	aging	NN	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
affect	affect	NN	I-NP	O
on	on	IN	B-PP	O
transcription	transcription	NN	B-NP	O
initiation	initiation	NN	I-NP	O
or	or	CC	O	O
alternative	alternative	JJ	B-NP	O
splicing	splicing	NN	I-NP	O
for	for	IN	B-PP	O
either	either	DT	B-NP	O
isoform	isoform	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
Pax-5a	Pax-5a	NN	B-NP	B-protein
but	but	CC	B-NP	O
not	not	RB	I-NP	O
Pax-5d	Pax-5d	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
aged	aged	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
Western	Western	JJ	B-NP	O
blot	blot	NN	I-NP	O
analyses	analysis	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
similar	similar	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
Pax-5a	Pax-5a	NN	B-NP	B-protein
and	and	CC	I-NP	O
5d	5d	NN	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
both	both	CC	O	O
age	age	NN	B-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
observed	observe	VBN	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
Pax-5a	Pax-5a	NN	B-NP	B-protein
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
Pax-5	Pax-5	NN	I-NP	B-DNA
target	target	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
aged	aged	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ig	Ig	NN	I-NP	B-protein
J	J	NN	I-NP	I-protein
chain	chain	NN	I-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
secreted	secrete	VBN	I-NP	B-RNA
form	form	NN	I-NP	I-RNA
of	of	IN	B-PP	O
Ig	Ig	NN	B-NP	B-protein
mu	mu	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
both	both	DT	O	O
known	know	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
suppressed	suppress	VBN	I-VP	O
by	by	IN	B-PP	O
Pax-5a	Pax-5a	NN	B-NP	B-protein
in	in	IN	B-PP	O
mature	mature	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
were	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
aged	aged	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

Together	Together	RB	B-ADVP	O
,	,	,	O	O
our	our	PRP$	B-NP	O
studies	study	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
changes	change	NNS	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
aging	aging	NN	I-NP	O
phenotype	phenotype	NN	I-NP	O
cause	cause	VBP	B-VP	O
posttranslational	posttranslational	JJ	B-NP	O
modification	modification	NN	I-NP	O
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
Pax-5a	Pax-5a	NN	B-NP	B-protein
but	but	CC	B-NP	O
not	not	RB	I-NP	O
Pax-5d	Pax-5d	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
abnormal	abnormal	JJ	I-NP	O
B	B	NN	I-NP	O
cell	cell	NN	I-NP	O
phenotype	phenotype	NN	I-NP	O
in	in	IN	B-PP	O
aged	aged	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
elevated	elevate	VBN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
J	J	NN	B-NP	B-protein
chain	chain	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
secretion	secretion	NN	B-NP	O
of	of	IN	B-PP	O
IgM	IgM	NN	B-NP	B-protein

NF-kappa	NF-kappa	NN	B-NP	B-protein
B/Rel	B/Rel	NN	I-NP	I-protein
participation	participation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lymphokine-dependent	lymphokine-dependent	JJ	I-NP	O
proliferation	proliferation	NN	I-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
lymphoid	lymphoid	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Proliferative	Proliferative	JJ	B-NP	O
responses	response	NNS	I-NP	O
of	of	IN	B-PP	O
lymphoid	lymphoid	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-4	IL-4	NN	I-NP	B-protein
depend	depend	VBP	B-VP	O
on	on	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
activation	activation	NN	B-NP	O
enhances	enhance	VBZ	B-VP	O
cellular	cellular	JJ	B-NP	O
competence	competence	NN	I-NP	O
to	to	TO	B-VP	O
respond	respond	VB	I-VP	O
to	to	TO	B-PP	O
cytokines	cytokine	NNS	B-NP	B-protein
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
fully	fully	RB	I-VP	O
understood	understand	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
NF-kappaB/Rel	NF-kappaB/Rel	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
represents	represent	VBZ	B-VP	O
one	one	CD	B-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
pathway	pathway	NN	I-NP	O
induced	induce	VBN	B-VP	O
during	during	IN	B-PP	O
such	such	JJ	B-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
that	that	IN	B-SBAR	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
through	through	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
IkappaBalpha	IkappaBalpha	NN	I-NP	B-protein
(	(	(	O	O
inhibitory	inhibitory	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
that	that	WDT	B-NP	O
dissociates	dissociate	VBZ	B-VP	O
from	from	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
)	)	)	O	O
mutant	mutant	NN	B-NP	O
refractory	refractory	JJ	B-ADJP	O
to	to	TO	B-PP	O
signal-induced	signal-induced	JJ	B-NP	O
degradation	degradation	NN	I-NP	O
(	(	(	O	O
IkappaBalpha	IkappaBalpha	NN	B-NP	B-protein
(	(	(	O	O
DeltaN	DeltaN	NN	B-NP	O
)	)	)	O	O
)	)	)	O	O
interfered	interfere	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
acquisition	acquisition	NN	I-NP	O
of	of	IN	B-PP	O
competence	competence	NN	B-NP	O
to	to	TO	B-VP	O
proliferate	proliferate	VB	I-VP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
IL-4	IL-4	NN	B-NP	B-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
IL-2	IL-2	NN	B-NP	B-protein
.	.	.	O	O

Thymocytes	Thymocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	B-NP	I-cell_type
from	from	IN	B-PP	O
IkappaBalpha	IkappaBalpha	NN	B-NP	B-protein
(	(	(	O	O
DeltaN	DeltaN	NN	B-NP	O
)	)	)	O	O
transgenic	transgenic	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
expressed	express	VBD	B-VP	O
normal	normal	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
IL-2R	IL-2R	NN	B-NP	B-protein
subunits	subunit	NNS	I-NP	I-protein
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
transgenic	transgenic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
exhibited	exhibit	VBD	B-VP	O
a	a	DT	B-NP	O
dramatic	dramatic	JJ	I-NP	O
defect	defect	NN	I-NP	O
in	in	IN	B-PP	O
Stat5A	Stat5A	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
defect	defect	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
for	for	IN	B-PP	O
IL-4	IL-4	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
Stat5	Stat5	NN	I-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
T	T	NN	B-NP	B-cell_type
lymphoid	lymphoid	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
receptor	receptor	NN	I-NP	O
substrate-2	substrate-2	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
and	and	CC	O	O
only	only	RB	B-NP	O
a	a	DT	I-NP	O
modest	modest	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
Stat6	Stat6	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
and	and	CC	O	O
insulin	insulin	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
substrate-1	substrate-1	NN	I-NP	I-protein
phosphorylation	phosphorylation	NN	I-NP	O
after	after	IN	B-PP	O
IL-4	IL-4	NN	B-NP	B-protein
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
NF-kappaB/Rel/IkappaBalpha	NF-kappaB/Rel/IkappaBalpha	NN	I-NP	B-protein
system	system	NN	I-NP	O
can	can	MD	B-VP	O
regulate	regulate	VB	I-VP	O
cytokine	cytokine	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
capacitation	capacitation	NN	I-NP	O
through	through	IN	B-PP	O
effects	effect	NNS	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
downstream	downstream	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Stat	Stat	NN	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
family	family	NN	I-NP	I-protein
.	.	.	O	O

BMS-189453	BMS-189453	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
retinoid	retinoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
antagonist	antagonist	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
testicular	testicular	JJ	I-NP	O
toxin	toxin	NN	I-NP	O
.	.	.	O	O

BMS-189453	BMS-189453	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
synthetic	synthetic	JJ	I-NP	O
retinoid	retinoid	NN	I-NP	O
that	that	WDT	B-NP	O
acts	act	VBZ	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
antagonist	antagonist	NN	I-NP	O
at	at	IN	B-PP	O
retinoic	retinoic	JJ	B-NP	B-protein
acid	acid	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
,	,	,	O	O
beta	beta	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
gamma	gamma	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
Sprague	Sprague	NNP	B-NP	O
Dawley	Dawley	NNP	I-NP	O
rats	rat	NNS	I-NP	O
at	at	IN	B-PP	O
daily	daily	JJ	B-NP	O
oral	oral	JJ	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
,	,	,	I-NP	O
60	60	CD	I-NP	O
,	,	,	O	O
or	or	CC	O	O
240	240	CD	B-NP	O
mg/kg	mg/kg	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
month	month	NN	I-NP	O
,	,	,	O	O
BMS-189453	BMS-189453	NN	B-NP	O
produced	produce	VBD	B-VP	O
increases	increase	NNS	B-NP	O
in	in	IN	B-PP	O
leukocyte	leukocyte	NN	B-NP	O
counts	count	NNS	I-NP	O
,	,	,	O	O
alkaline	alkaline	NN	B-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
and	and	CC	I-NP	O
alanine	alanine	NN	I-NP	O
aminotransferase	aminotransferase	NN	I-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
marked	mark	VBD	B-VP	O
testicular	testicular	JJ	B-NP	O
degeneration	degeneration	NN	I-NP	O
and	and	CC	I-NP	O
atrophy	atrophy	NN	I-NP	O
at	at	IN	B-PP	O
all	all	DT	B-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

Significant	Significant	JJ	B-NP	O
overt	overt	JJ	I-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
toxicity	toxicity	NN	B-NP	O
and	and	CC	I-NP	O
deaths	death	NNS	I-NP	O
occurred	occur	VBD	B-VP	O
at	at	IN	B-PP	O
240	240	CD	B-NP	O
mg/kg	mg/kg	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
body-weight	body-weight	NN	B-NP	O
and	and	CC	I-NP	O
food-consumption	food-consumption	NN	I-NP	O
decreases	decrease	NNS	I-NP	O
occurred	occur	VBD	B-VP	O
at	at	IN	B-PP	O
60	60	CD	B-NP	O
and	and	CC	I-NP	O
240	240	CD	I-NP	O
mg/kg	mg/kg	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
BMS-189453	BMS-189453	NN	B-NP	O
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
to	to	TO	B-PP	O
male	male	JJ	B-NP	O
rats	rat	NNS	I-NP	O
at	at	IN	B-PP	O
daily	daily	JJ	B-NP	O
doses	dose	NNS	I-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
12.5	12.5	CD	B-NP	O
to	to	TO	I-NP	O
100	100	CD	I-NP	O
mg/kg	mg/kg	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
only	only	RB	B-NP	O
minimal	minimal	JJ	I-NP	O
testicular	testicular	JJ	I-NP	O
changes	change	NNS	I-NP	O
occurred	occur	VBD	B-VP	O
at	at	IN	B-PP	O
all	all	DT	B-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
shortly	shortly	RB	B-ADVP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
dosing	dosing	NN	I-NP	O
period	period	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
1-month	1-month	JJ	I-NP	O
drug-free	drug-free	JJ	I-NP	O
observation	observation	NN	I-NP	O
period	period	NN	I-NP	O
,	,	,	O	O
marked	marked	JJ	B-NP	O
testicular	testicular	JJ	I-NP	O
atrophy	atrophy	NN	I-NP	O
was	be	VBD	B-VP	O
evident	evident	JJ	B-ADJP	O
at	at	IN	B-PP	O
all	all	DT	B-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

BMS-189453	BMS-189453	NN	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
administered	administer	VBN	I-VP	O
at	at	IN	B-PP	O
doses	dose	NNS	B-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
,	,	,	I-NP	O
10	10	CD	I-NP	O
,	,	,	O	O
or	or	CC	O	O
50	50	CD	B-NP	O
mg/kg	mg/kg	NN	I-NP	O
to	to	TO	B-PP	O
male	male	JJ	B-NP	O
rats	rat	NNS	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
or	or	CC	O	O
7	7	CD	B-NP	O
consecutive	consecutive	JJ	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Dose-	Dose-	JJ	B-NP	O
and	and	CC	I-NP	O
duration-dependent	duration-dependent	JJ	I-NP	O
testicular	testicular	JJ	I-NP	O
toxicity	toxicity	NN	I-NP	O
that	that	WDT	B-NP	O
occurred	occur	VBD	B-VP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
1-month	1-month	JJ	I-NP	O
observation	observation	NN	I-NP	O
period	period	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
recover	recover	VB	I-VP	O
,	,	,	O	O
and	and	CC	O	O
,	,	,	O	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
cases	case	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
severe	severe	JJ	I-ADJP	O
4	4	CD	B-NP	O
months	month	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
rabbits	rabbit	NNS	B-NP	O
administered	administer	VBN	B-VP	O
BMS-189453	BMS-189453	NN	B-NP	O
at	at	IN	B-PP	O
oral	oral	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
,	,	,	I-NP	O
10	10	CD	I-NP	O
,	,	,	O	O
or	or	CC	O	O
50	50	CD	B-NP	O
mg/kg	mg/kg	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
testicular	testicular	JJ	B-NP	O
degeneration	degeneration	NN	I-NP	O
and	and	CC	I-NP	O
atrophy	atrophy	NN	I-NP	O
were	be	VBD	B-VP	O
evident	evident	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high-dose	high-dose	JJ	I-NP	O
group	group	NN	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
month	month	NN	I-NP	O
following	follow	VBG	B-PP	O
treatment	treatment	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
studies	study	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
retinoid	retinoid	JJ	B-NP	O
antagonists	antagonist	NNS	I-NP	O
can	can	MD	B-VP	O
selectively	selectively	RB	I-VP	O
produce	produce	VB	I-VP	O
progressive	progressive	JJ	B-NP	O
and	and	CC	I-NP	O
prolonged	prolonged	JJ	I-NP	O
testicular	testicular	JJ	I-NP	O
toxicity	toxicity	NN	I-NP	O
after	after	IN	B-PP	O
single	single	JJ	B-NP	O
or	or	CC	I-NP	O
repeated	repeat	VBN	I-NP	O
oral	oral	JJ	I-NP	O
doses	dose	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
otherwise	otherwise	RB	I-VP	O
well	well	RB	I-VP	O
tolerated	tolerate	VBN	I-VP	O
.	.	.	O	O

Sequential	Sequential	JJ	B-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
NFAT	NFAT	NN	B-NP	B-protein
and	and	CC	I-NP	O
Egr	Egr	NN	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
FasL	FasL	NN	B-NP	B-protein
regulation	regulation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
critical	critical	JJ	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
NFAT	NFAT	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
in	in	IN	B-PP	O
maintaining	maintain	VBG	B-VP	O
lymphoid	lymphoid	JJ	B-NP	O
homeostasis	homeostasis	NN	I-NP	O
was	be	VBD	B-VP	O
revealed	reveal	VBN	I-VP	O
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
lacking	lack	VBG	B-VP	O
both	both	CC	O	O
NFATp	NFATp	NN	B-NP	B-protein
and	and	CC	O	O
NFAT4	NFAT4	NN	B-NP	B-protein
(	(	(	O	O
DKO	DKO	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

DKO	DKO	NN	B-NP	O
mice	mouse	NNS	I-NP	O
exhibit	exhibit	VBP	B-VP	O
increased	increase	VBN	B-NP	O
lymphoproliferation	lymphoproliferation	NN	I-NP	O
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
activation-induced	activation-induced	JJ	B-NP	O
cell	cell	NN	I-NP	O
death	death	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
impaired	impaired	JJ	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
FasL	FasL	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
Egr2	Egr2	NN	B-NP	B-protein
and	and	CC	I-NP	O
Egr3	Egr3	NN	I-NP	B-protein
are	be	VBP	B-VP	O
potent	potent	JJ	B-NP	O
activators	activator	NNS	I-NP	O
of	of	IN	B-PP	O
FasL	FasL	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
find	find	VBP	B-VP	O
that	that	IN	B-SBAR	O
Egr2	Egr2	NN	B-NP	B-protein
and	and	CC	I-NP	O
Egr3	Egr3	NN	I-NP	B-protein
are	be	VBP	B-VP	O
NFAT	NFAT	NN	B-NP	B-DNA
target	target	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
FasL	FasL	NN	B-NP	B-protein
occurs	occur	VBZ	B-VP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
NFAT	NFAT	NN	I-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
Egr3	Egr3	NN	B-NP	B-protein
,	,	,	O	O
as	as	IN	B-SBAR	O
demonstrated	demonstrate	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
exogenously	exogenously	RB	B-NP	O
provided	provide	VBN	I-NP	O
NFATp	NFATp	NN	I-NP	B-protein
to	to	TO	B-VP	O
restore	restore	VB	I-VP	O
Egr	Egr	NN	B-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
FasL	FasL	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
DKO	DKO	NN	B-NP	B-cell_type
lymph	lymph	NN	I-NP	I-cell_type
node	node	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Further	Further	RB	B-ADVP	O
,	,	,	O	O
Egr3	Egr3	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
enriched	enrich	VBN	I-VP	O
in	in	IN	B-PP	O
Th1	Th1	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
a	a	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
known	known	JJ	I-NP	O
preferential	preferential	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
FasL	FasL	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Th1	Th1	NN	I-NP	B-cell_type
versus	versus	IN	B-PP	I-cell_type
Th2	Th2	NN	B-NP	I-cell_type
subset	subset	NN	I-NP	I-cell_type
.	.	.	O	O

Mechanisms	Mechanism	NNS	B-NP	O
and	and	CC	O	O
clinical	clinical	JJ	B-NP	O
relevance	relevance	NN	I-NP	O
of	of	IN	B-PP	O
nongenomic	nongenomic	JJ	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
actions	action	NNS	I-NP	O
.	.	.	O	O

Glucocorticoids	Glucocorticoid	NNS	B-NP	O
have	have	VBP	B-VP	O
profound	profound	JJ	B-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	O
and	and	CC	I-NP	O
immunosuppressive	immunosuppressive	JJ	I-NP	O
actions	action	NNS	I-NP	O
when	when	WRB	B-ADVP	O
used	use	VBN	B-VP	O
therapeutically	therapeutically	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
dose	dose	NN	I-NP	O
is	be	VBZ	B-VP	O
quite	quite	RB	B-ADJP	O
variable	variable	JJ	I-ADJP	O
and	and	CC	O	O
depends	depend	VBZ	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
ranges	range	VBZ	B-VP	O
from	from	IN	B-PP	O
very	very	RB	B-NP	O
low	low	JJ	I-NP	O
to	to	TO	B-PP	O
extremely	extremely	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
rationale	rationale	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
various	various	JJ	B-NP	O
dosage	dosage	NN	I-NP	O
regimens	regimen	NNS	I-NP	O
for	for	IN	B-PP	O
specific	specific	JJ	B-NP	O
clinical	clinical	JJ	I-NP	O
indications	indication	NNS	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
distinct	distinct	JJ	I-NP	O
,	,	,	I-NP	O
therapeutically	therapeutically	RB	I-NP	O
relevant	relevant	JJ	I-NP	O
effects	effect	NNS	I-NP	O
:	:	:	O	O
genomic	genomic	JJ	B-NP	O
,	,	,	I-NP	O
specific	specific	JJ	I-NP	O
nongenomic	nongenomic	JJ	I-NP	O
and	and	CC	I-NP	O
unspecific	unspecific	JJ	I-NP	O
nongenomic	nongenomic	JJ	I-NP	O
.	.	.	O	O

Genomic	Genomic	JJ	B-NP	O
effects	effect	NNS	I-NP	O
are	be	VBP	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
cytosolic	cytosolic	JJ	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
alter	alter	VBP	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
specific	specific	JJ	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

Specific	Specific	JJ	B-NP	O
nongenomic	nongenomic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
occur	occur	VBP	B-VP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
steroid-selective	steroid-selective	JJ	B-NP	B-protein
membrane	membrane	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
.	.	.	O	O

Unspecific	Unspecific	JJ	B-NP	O
nongenomic	nongenomic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
occur	occur	VBP	B-VP	O
within	within	IN	B-PP	O
seconds	second	NNS	B-NP	O
,	,	,	O	O
but	but	CC	O	O
only	only	RB	B-ADVP	O
at	at	IN	B-PP	O
high	high	JJ	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
dosages	dosage	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
seem	seem	VBP	B-VP	O
to	to	TO	I-VP	O
result	result	VB	I-VP	O
from	from	IN	B-PP	O
direct	direct	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
with	with	IN	B-PP	O
biological	biological	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
unspecific	unspecific	JJ	B-NP	O
nongenomic	nongenomic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
,	,	,	O	O
methylprednisolone	methylprednisolone	NN	B-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
glucocorticoids	glucocorticoid	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
inhibit	inhibit	VB	I-VP	O
cation	cation	NN	B-NP	O
cycling	cycling	NN	I-NP	O
across	across	IN	B-PP	O
the	the	DT	B-NP	O
plasma	plasma	NN	I-NP	O
membrane	membrane	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
little	little	JJ	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
protein	protein	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
could	could	MD	B-VP	O
diminish	diminish	VB	I-VP	O
or	or	CC	I-VP	O
prevent	prevent	VB	I-VP	O
the	the	DT	B-NP	O
acute	acute	JJ	I-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
by	by	IN	B-PP	O
interfering	interfere	VBG	B-VP	O
with	with	IN	B-PP	O
processes	process	NNS	B-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
the	the	DT	B-NP	O
rise	rise	NN	I-NP	O
in	in	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
Ca2+	Ca2+	NN	I-NP	O
concentration	concentration	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
proposed	propose	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
additional	additional	JJ	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
benefit	benefit	NN	I-NP	O
of	of	IN	B-PP	O
higher	high	JJR	B-NP	O
doses	dose	NNS	I-NP	O
is	be	VBZ	B-VP	O
obtained	obtain	VBN	I-VP	O
via	via	IN	B-PP	O
these	these	DT	B-NP	O
nongenomic	nongenomic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
.	.	.	O	O

High	High	JJ	B-NP	O
glucose-induced	glucose-induced	JJ	I-NP	O
intercellular	intercellular	JJ	I-NP	B-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
(	(	(	O	O
ICAM-1	ICAM-1	NN	B-NP	B-protein
)	)	)	O	O
expression	expression	NN	B-NP	O
through	through	IN	B-PP	O
an	an	DT	B-NP	O
osmotic	osmotic	JJ	I-NP	O
effect	effect	NN	I-NP	O
in	in	IN	B-PP	O
rat	rat	NN	B-NP	B-cell_type
mesangial	mesangial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
PKC-NF-kappa	PKC-NF-kappa	NN	B-NP	O
B-dependent	B-dependent	JJ	B-ADJP	O
.	.	.	O	O

AIMS/HYPOTHESIS	AIMS/HYPOTHESIS	NNS	B-NP	O
:	:	:	O	O
Infiltration	Infiltration	NN	B-NP	O
of	of	IN	B-PP	O
mononuclear	mononuclear	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
glomerular	glomerular	JJ	B-NP	O
enlargement	enlargement	NN	I-NP	O
accompanied	accompany	VBN	B-VP	O
by	by	IN	B-PP	O
glomerular	glomerular	JJ	B-NP	O
cell	cell	NN	I-NP	O
proliferation	proliferation	NN	I-NP	O
are	be	VBP	B-VP	O
very	very	RB	B-NP	O
early	early	JJ	I-NP	O
characteristics	characteristic	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pathophysiology	pathophysiology	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabete	NNS	B-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
clarify	clarify	VB	I-VP	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
early	early	JJ	B-NP	O
diabetic	diabetic	JJ	I-NP	O
nephropathy	nephropathy	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
measured	measure	VBD	B-VP	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
-thymidine	-thymidine	JJ	I-NP	O
incorporation	incorporation	NN	I-NP	O
and	and	CC	I-NP	O
cell	cell	NN	I-NP	O
numbers	number	NNS	I-NP	O
to	to	TO	B-VP	O
show	show	VB	I-VP	O
the	the	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
ambient	ambient	JJ	I-NP	O
glucose	glucose	NN	I-NP	O
concentration	concentration	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
osmotic	osmotic	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
rat	rat	NN	B-NP	B-cell_type
mesangial	mesangial	JJ	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
proliferation	proliferation	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
measured	measure	VBD	B-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
high	high	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
intercellular	intercellular	JJ	B-NP	B-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
and	and	CC	O	O
vascular	vascular	JJ	B-NP	B-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
by	by	IN	B-PP	O
flow	flow	NN	B-NP	O
cytometry	cytometry	NN	I-NP	O
and	and	CC	O	O
semiquantitative	semiquantitative	JJ	B-NP	O
RT-PCR	RT-PCR	NN	I-NP	O
in	in	IN	B-PP	O
mesangial	mesangial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
the	the	DT	B-NP	O
adhesion	adhesion	NN	I-NP	O
of	of	IN	B-PP	O
leukocytes	leukocyte	NNS	B-NP	B-cell_type
to	to	TO	B-PP	O
mesangial	mesangial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

METHODS/RESULTS	METHODS/RESULTS	NNS	B-NP	O
:	:	:	O	O
Cells	Cell	NNS	B-NP	O
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
high	high	JJ	B-NP	O
D-glucose	D-glucose	NN	I-NP	O
(	(	(	O	O
30	30	CD	B-NP	O
mmol/l	mmol/l	NN	I-NP	O
)	)	)	O	O
caused	cause	VBD	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
-thymidine	-thymidine	JJ	I-NP	O
incorporation	incorporation	NN	I-NP	O
and	and	CC	I-NP	O
cell	cell	NN	I-NP	O
numbers	number	NNS	I-NP	O
at	at	IN	B-PP	O
24	24	CD	B-NP	O
and	and	CC	I-NP	O
48	48	CD	I-NP	O
h	h	NN	I-NP	O
and	and	CC	O	O
normalized	normalize	VBD	B-VP	O
at	at	IN	B-PP	O
72	72	CD	B-NP	O
h	h	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
whereas	whereas	IN	O	O
these	these	DT	B-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
high	high	JJ	B-NP	O
mannitol	mannitol	NN	I-NP	O
(	(	(	O	O
30	30	CD	B-NP	O
mmol/l	mmol/l	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
IL-1	IL-1	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
,	,	,	O	O
or	or	CC	O	O
TNF	TNF	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
-stimulated	-stimulated	JJ	I-NP	O
mesangial	mesangial	JJ	I-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

Cells	Cell	NNS	B-NP	O
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
high-glucose	high-glucose	JJ	B-NP	O
(	(	(	O	O
15	15	CD	B-NP	O
,	,	,	I-NP	O
30	30	CD	I-NP	O
,	,	,	O	O
or	or	CC	O	O
60	60	CD	B-NP	O
mmol/l	mmol/l	NN	I-NP	O
)	)	)	O	O
or	or	CC	O	O
osmotic	osmotic	JJ	B-NP	O
agents	agent	NNS	I-NP	O
(	(	(	O	O
L-glucose	L-glucose	NN	B-NP	O
,	,	,	O	O
raffinose	raffinose	NN	B-NP	O
and	and	CC	O	O
mannitol	mannitol	NN	B-NP	O
)	)	)	O	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
intercellular	intercellular	JJ	B-NP	B-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
after	after	IN	B-PP	O
24	24	CD	B-NP	O
h	h	NN	I-NP	O
,	,	,	O	O
reached	reach	VBD	B-VP	O
its	its	PRP$	B-NP	O
maximum	maximum	NN	I-NP	O
at	at	IN	B-PP	O
24	24	CD	B-NP	O
and	and	CC	I-NP	O
48	48	CD	I-NP	O
h	h	NN	I-NP	O
and	and	CC	O	O
gradually	gradually	RB	B-VP	O
decreased	decrease	VBD	I-VP	O
afterwards	afterwards	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
stimulatory	stimulatory	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
high	high	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
and	and	CC	O	O
high	high	JJ	B-NP	O
mannitol	mannitol	NN	I-NP	O
on	on	IN	B-PP	O
mRNA	mRNA	NN	B-NP	B-RNA
expression	expression	NN	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
as	as	RB	B-ADVP	O
early	early	RB	I-ADVP	O
as	as	IN	B-PP	O
6	6	CD	B-NP	O
h	h	NN	I-NP	O
and	and	CC	O	O
reached	reach	VBD	B-VP	O
its	its	PRP$	B-NP	O
maximum	maximum	NN	I-NP	O
at	at	IN	B-PP	O
12	12	CD	B-NP	O
h	h	NN	I-NP	O
.	.	.	O	O

Up-regulation	Up-regulation	NN	B-NP	O
of	of	IN	B-PP	O
ICAM-1	ICAM-1	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
and	and	CC	O	O
mRNA	mRNA	NN	B-NP	B-RNA
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
IL-1-beta	IL-1-beta	NN	B-NP	B-protein
and	and	CC	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
-stimulated	-stimulated	JJ	I-NP	O
mesangial	mesangial	JJ	I-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

Neither	Neither	CC	O	O
vascular	vascular	JJ	B-NP	B-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
nor	nor	CC	O	O
mRNA	mRNA	NN	B-NP	O
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
affected	affect	VBN	B-VP	O
by	by	IN	B-PP	O
high	high	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
and	and	CC	O	O
high	high	JJ	B-NP	O
mannitol	mannitol	NN	I-NP	O
.	.	.	O	O

Notably	Notably	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
C	C	NN	I-NP	I-protein
inhibitors	inhibitor	NNS	I-NP	O
calphostin	calphostin	NN	I-NP	O
C	C	NN	I-NP	O
and	and	CC	O	O
staurosporine	staurosporine	NN	B-NP	O
reduced	reduce	VBD	B-VP	O
high	high	JJ	B-NP	O
glucose-	glucose-	NN	I-NP	O
or	or	CC	O	O
high	high	JJ	B-NP	O
mannitol-induced	mannitol-induced	JJ	I-NP	O
intercellular	intercellular	JJ	I-NP	O
adhesion	adhesion	NN	I-NP	O
molecule-1	molecule-1	NN	I-NP	O
mRNA	mRNA	NN	I-NP	O
expression	expression	NN	I-NP	O
and	and	CC	O	O
high	high	JJ	B-NP	O
glucose-induced	glucose-induced	JJ	I-NP	O
proliferation	proliferation	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	O
N-tosyl-L-phenylalanine	N-tosyl-L-phenylalanine	NN	I-NP	O
chloromethyl	chloromethyl	NN	I-NP	O
ketone	ketone	NN	I-NP	O
reduced	reduce	VBD	B-VP	O
high	high	JJ	B-NP	O
glucose-	glucose-	NN	I-NP	O
or	or	CC	O	O
high	high	JJ	B-NP	O
mannitol-induced	mannitol-induced	JJ	I-NP	O
intercellular	intercellular	JJ	I-NP	O
adhesion	adhesion	NN	I-NP	O
molecule-1	molecule-1	NN	I-NP	O
mRNA	mRNA	NN	I-NP	O
expression	expression	NN	I-NP	O
and	and	CC	O	O
high	high	JJ	B-NP	O
glucose-induced	glucose-induced	JJ	I-NP	O
proliferation	proliferation	NN	I-NP	O
.	.	.	O	O

Results	Result	NNS	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
high	high	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
(	(	(	O	O
15	15	CD	B-NP	O
,	,	,	O	O
30	30	CD	B-NP	O
mmol/l	mmol/l	NN	I-NP	O
)	)	)	O	O
or	or	CC	O	O
high	high	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
osmotic	osmotic	JJ	B-NP	O
agents	agent	NNS	I-NP	O
remarkably	remarkably	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
adherent	adherent	JJ	B-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
mesangial	mesangial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.01	0.01	CD	B-NP	O
)	)	)	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
control	control	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
5	5	CD	B-NP	O
mmol/l	mmol/l	NN	I-NP	O
D-glucose	D-glucose	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Functional	Functional	JJ	B-NP	O
blocking	blocking	NN	I-NP	O
of	of	IN	B-PP	O
intercellular	intercellular	JJ	B-NP	B-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
on	on	IN	B-PP	O
mesangial	mesangial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
rat	rat	NN	B-NP	B-protein
intercellular	intercellular	JJ	I-NP	I-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
monoclonal	monoclonal	JJ	I-NP	I-protein
antibody	antibody	NN	I-NP	I-protein
,	,	,	O	O
calphostin	calphostin	NN	B-NP	O
C	C	NN	I-NP	O
,	,	,	O	O
staurosporine	staurosporine	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
N-tosyl-L-phenylalanine	N-tosyl-L-phenylalanine	NN	B-NP	O
chloromethyl	chloromethyl	NN	I-NP	O
ketone	ketone	NN	I-NP	O
significantly	significantly	RB	B-ADVP	O
inhibited	inhibit	VBD	B-VP	O
high	high	JJ	B-NP	O
glucose-	glucose-	NN	I-NP	O
or	or	CC	O	O
high	high	JJ	B-NP	O
mannitol-induced	mannitol-induced	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
leukocyte	leukocyte	NN	B-NP	O
adhesion	adhesion	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

CONCLUSION/INTERPRETATION	CONCLUSION/INTERPRETATION	NN	B-NP	O
:	:	:	O	O
These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
high	high	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
can	can	MD	B-VP	O
upregulate	upregulate	VB	I-VP	O
intercellular	intercellular	JJ	B-NP	B-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
and	and	CC	O	O
mRNA	mRNA	NN	B-NP	B-RNA
expression	expression	NN	I-NP	O
but	but	CC	B-PP	O
not	not	RB	B-NP	O
vascular	vascular	JJ	I-NP	B-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
mesangial	mesangial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
promote	promote	VB	B-VP	O
leukocyte	leukocyte	NN	B-NP	O
adhesion	adhesion	NN	I-NP	O
through	through	IN	B-PP	O
up-regulation	up-regulation	NN	B-NP	O
of	of	IN	B-PP	O
intercellular	intercellular	JJ	B-NP	B-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
through	through	IN	B-PP	O
osmotic	osmotic	JJ	B-NP	O
effect	effect	NN	I-NP	O
,	,	,	O	O
possibly	possibly	RB	B-ADVP	O
depending	depend	VBG	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
C	C	NN	I-NP	I-protein
nuclear	nuclear	JJ	I-NP	O
factor-kappa	factor-kappa	NN	I-NP	O
B	B	NN	I-NP	O
(	(	(	O	O
PKC	PKC	NN	B-NP	B-protein
-	-	HYPH	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
)	)	)	O	O
pathway	pathway	NN	B-NP	O
.	.	.	O	O

High	High	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
itself	itself	PRP	B-NP	O
can	can	MD	B-VP	O
also	also	RB	I-VP	O
promote	promote	VB	I-VP	O
mesangial	mesangial	JJ	B-NP	O
cell	cell	NN	I-NP	O
proliferation	proliferation	NN	I-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
PKC-NF-kappa	PKC-NF-kappa	NN	I-NP	O
B	B	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
hyperglycaemia	hyperglycaemia	NN	B-NP	O
in	in	IN	B-PP	O
itself	itself	PRP	B-NP	O
seems	seem	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
factor	factor	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
early	early	JJ	B-NP	O
diabetic	diabetic	JJ	I-NP	O
nephropathy	nephropathy	NN	I-NP	O
.	.	.	O	O

Combined	Combine	VBN	B-NP	O
corticosteroid/	corticosteroid/	NN	I-NP	O
granulocyte	granulocyte	NN	I-NP	O
colony-stimulating	colony-stimulating	JJ	I-NP	O
factor	factor	NN	I-NP	O
(	(	(	O	O
G-CSF	G-CSF	NN	B-NP	B-protein
)	)	)	O	O
therapy	therapy	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
congenital	congenital	JJ	I-NP	O
neutropenia	neutropenia	NN	I-NP	O
unresponsive	unresponsive	JJ	B-ADJP	O
to	to	TO	B-PP	O
G-CSF	G-CSF	NN	B-NP	B-protein
:	:	:	O	O
Activated	Activate	VBN	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
synergize	synergize	VBP	B-VP	O
with	with	IN	B-PP	O
G-CSF	G-CSF	NN	B-NP	B-protein
signals	signal	NNS	I-NP	O
.	.	.	O	O

More	More	JJR	B-NP	O
than	than	IN	I-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
congenital	congenital	JJ	I-NP	O
neutropenia	neutropenia	NN	I-NP	O
(	(	(	O	O
SCN	SCN	NN	B-NP	B-protein
)	)	)	O	O
respond	respond	VBP	B-VP	O
to	to	TO	I-VP	O
granulocyte	granulocyte	VB	I-VP	O
colony-stimulating	colony-stimulating	JJ	B-NP	O
factor	factor	NN	I-NP	O
(	(	(	O	O
G-CSF	G-CSF	NN	B-NP	B-protein
)	)	)	O	O
therapy	therapy	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
refractory	refractory	JJ	I-NP	O
state	state	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
remaining	remain	VBG	I-NP	O
patients	patient	NNS	I-NP	O
is	be	VBZ	B-VP	O
unknown	unknown	JJ	B-ADJP	O
.	.	.	O	O

To	To	TO	B-VP	O
address	address	VB	I-VP	O
this	this	DT	B-NP	O
issue	issue	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
studied	study	VBD	B-VP	O
a	a	DT	B-NP	O
child	child	NN	I-NP	O
with	with	IN	B-PP	O
SCN	SCN	NN	B-NP	B-protein
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
totally	totally	RB	B-ADJP	O
unresponsive	unresponsive	JJ	I-ADJP	O
to	to	TO	B-PP	O
G-CSF	G-CSF	NN	B-NP	B-protein
and	and	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
point	point	NN	I-NP	O
mutation	mutation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
extracellular	extracellular	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
G-CSF	G-CSF	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
GCSF-R	GCSF-R	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Marrow	Marrow	JJ	B-NP	O
stromal	stromal	JJ	I-NP	O
support	support	NN	I-NP	O
of	of	IN	B-PP	O
granulopoiesis	granulopoiesis	NN	B-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
plating	plat	VBG	B-VP	O
CD34	CD34	NN	B-NP	B-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
cells	cell	NNS	B-NP	I-cell_type
on	on	IN	B-PP	O
preformed	preformed	JJ	B-NP	O
stromal	stromal	JJ	I-NP	O
layers	layer	NNS	I-NP	O
.	.	.	O	O

Nonadherent	Nonadherent	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
harvested	harvest	VBN	I-VP	O
and	and	CC	O	O
assayed	assay	VBN	B-VP	O
in	in	IN	B-PP	O
clonogenic	clonogenic	JJ	B-NP	O
assays	assay	NNS	I-NP	O
for	for	IN	B-PP	O
granulocytic	granulocytic	JJ	B-NP	O
colony	colony	NN	I-NP	O
production	production	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
G-CSF	G-CSF	NN	B-NP	B-protein
and	and	CC	I-NP	O
corticosteroids	corticosteroid	NNS	I-NP	O
on	on	IN	B-PP	O
granulopoiesis	granulopoiesis	NN	B-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
in	in	IN	B-PP	O
clonogenic	clonogenic	JJ	B-NP	O
assays	assay	NNS	I-NP	O
of	of	IN	B-PP	O
marrow	marrow	NN	B-NP	B-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
by	by	IN	B-PP	O
proliferation	proliferation	NN	B-NP	O
studies	study	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	B-cell_line
myeloid	myeloid	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
32D	32D	NN	I-NP	O
expressing	express	VBG	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
mutated	mutate	VBN	I-NP	O
G-CSFR	G-CSFR	NN	I-NP	B-protein
,	,	,	B-PP	O
and	and	CC	I-PP	O
by	by	IN	B-PP	O
measuring	measure	VBG	B-VP	O
STAT5	STAT5	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
from	from	IN	B-PP	O
stimulated	stimulate	VBN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Patient	Patient	NN	B-NP	O
's	's	POS	B-NP	O
stroma	stroma	NN	I-NP	O
supported	support	VBD	B-VP	O
granulopoiesis	granulopoiesis	NN	B-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
control	control	NN	B-NP	B-cell_line
marrow	marrow	NN	I-NP	I-cell_line
CD34	CD34	NN	I-NP	I-cell_line
(	(	(	O	I-cell_line
+	+	SYM	O	I-cell_line
)	)	)	O	I-cell_line
cells	cell	NNS	B-NP	I-cell_line
in	in	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
manner	manner	NN	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
stroma	stroma	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
induce	induce	VB	I-VP	O
granulopoiesis	granulopoiesis	NN	B-NP	O
from	from	IN	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
CD34	CD34	NN	I-NP	B-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
cells	cell	NNS	B-NP	I-cell_type
.	.	.	O	O

Clonogenic	Clonogenic	JJ	B-NP	O
assays	assay	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
marrow	marrow	NN	I-NP	B-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
incorporating	incorporate	VBG	B-VP	O
either	either	CC	O	O
G-CSF	G-CSF	NN	B-NP	B-protein
or	or	CC	I-NP	O
hydrocortisone	hydrocortisone	NN	I-NP	O
produced	produce	VBD	B-VP	O
little	little	JJ	B-NP	O
neutrophil	neutrophil	NN	I-NP	O
growth	growth	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
inclusion	inclusion	NN	B-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
G-CSF	G-CSF	NN	B-NP	B-protein
and	and	CC	I-NP	O
hydrocortisone	hydrocortisone	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cytokine	cytokine	NN	I-NP	B-protein
``	``	``	I-NP	O
cocktail	cocktail	NN	I-NP	O
''	''	''	O	O
markedly	markedly	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
the	the	DT	B-NP	O
neutrophil	neutrophil	NN	I-NP	B-cell_type
numbers	number	NNS	I-NP	O
.	.	.	O	O

Proliferation	Proliferation	NN	B-NP	O
of	of	IN	B-PP	O
32D	32D	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
expressing	express	VBG	B-VP	O
the	the	DT	B-NP	O
mutated	mutate	VBN	I-NP	O
receptor	receptor	NN	I-NP	O
and	and	CC	I-NP	O
STAT5	STAT5	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
were	be	VBD	B-VP	O
improved	improve	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
G-CSF	G-CSF	NN	B-NP	B-protein
and	and	CC	I-NP	O
dexamethasone	dexamethasone	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
small	small	JJ	B-NP	O
daily	daily	JJ	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
prednisone	prednisone	NN	I-NP	O
were	be	VBD	B-VP	O
then	then	RB	I-VP	O
administered	administer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
conventional	conventional	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
subcutaneous	subcutaneous	JJ	B-NP	O
G-CSF	G-CSF	NN	I-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
responded	respond	VBD	B-VP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
neutrophil	neutrophil	NN	I-NP	O
numbers	number	NNS	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
complete	complete	JJ	I-NP	O
reversal	reversal	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
infectious	infectious	JJ	I-NP	O
problems	problem	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
provide	provide	VBP	B-VP	O
insight	insight	NN	B-NP	O
into	into	IN	B-PP	O
SCN	SCN	NN	B-NP	O
unresponsive	unresponsive	JJ	B-ADJP	O
to	to	TO	B-PP	O
standard	standard	JJ	B-NP	O
G-CSF	G-CSF	NN	I-NP	B-protein
treatment	treatment	NN	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
potential	potential	JJ	I-NP	O
corrective	corrective	JJ	I-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
combined	combined	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
G-CSF	G-CSF	NN	B-NP	B-protein
and	and	CC	I-NP	O
corticosteroids	corticosteroid	NNS	I-NP	O
through	through	IN	B-PP	O
synergistic	synergistic	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
STAT5	STAT5	NN	B-NP	B-protein
.	.	.	O	O

Human	Human	JJ	B-NP	B-cell_type
renal	renal	JJ	I-NP	I-cell_type
mesangial	mesangial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
a	a	DT	B-NP	O
target	target	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
9-cis	9-cis	JJ	B-NP	O
retinoic	retinoic	JJ	I-NP	O
acid	acid	NN	I-NP	O
.	.	.	O	O

Mesangial	Mesangial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
play	play	VBP	B-VP	O
an	an	DT	B-NP	O
active	active	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
glomerular	glomerular	JJ	B-NP	O
injury	injury	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
cultured	culture	VBN	B-NP	B-cell_line
human	human	JJ	I-NP	I-cell_line
mesangial	mesangial	JJ	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
(	(	(	O	O
CHMC	CHMC	NN	B-NP	B-cell_type
)	)	)	O	O
several	several	JJ	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
9-cis	9-cis	JJ	B-NP	O
retinoic	retinoic	JJ	I-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
9-cRA	9-cRA	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
an	an	DT	B-NP	O
activator	activator	NN	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
retinoic	retinoic	JJ	B-NP	B-protein
acid	acid	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
(	(	(	O	O
RARs	RAR	NNS	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
retinoid	retinoid	NN	B-NP	B-protein
X	X	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
(	(	(	O	O
RXRs	RXR	NNS	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

9-cRA	9-cRA	NN	B-NP	O
inhibited	inhibit	VBD	B-VP	O
foetal	foetal	JJ	B-NP	O
calf	calf	NN	I-NP	O
serum-induced	serum-induced	JJ	I-NP	O
CHMC	CHMC	NN	I-NP	O
proliferation	proliferation	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
also	also	RB	B-ADVP	O
prevented	prevent	VBD	B-VP	O
CHMC	CHMC	NN	B-NP	O
death	death	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
mediator	mediator	NN	I-NP	O
H	H	NN	I-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
O	O	NN	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

This	This	DT	B-NP	O
preventive	preventive	JJ	I-NP	O
effect	effect	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
any	any	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
H	H	NN	B-NP	B-protein
(	(	(	O	I-protein
2	2	CD	B-NP	I-protein
)	)	)	O	I-protein
O	O	NN	B-NP	I-protein
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
catabolism	catabolism	NN	B-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
persisted	persist	VBD	B-VP	O
even	even	RB	B-ADVP	O
when	when	WRB	I-ADVP	O
both	both	CC	O	O
catalase	catalase	NN	B-NP	B-protein
and	and	CC	O	O
glutathione	glutathione	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
were	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
9-cRA	9-cRA	NN	B-NP	O
diminished	diminish	VBD	B-VP	O
monocyte	monocyte	NN	B-NP	O
adhesion	adhesion	NN	I-NP	O
to	to	TO	B-PP	O
FCS-stimulated	FCS-stimulated	JJ	B-NP	B-cell_type
CHMC	CHMC	NN	I-NP	I-cell_type
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
retinoid	retinoid	NN	I-NP	O
also	also	RB	B-ADVP	O
inhibited	inhibit	VBD	B-VP	O
in	in	IN	B-PP	O
FCS-stimulated	FCS-stimulated	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
the	the	DT	B-NP	O
protein	protein	NN	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
mesangial	mesangial	JJ	I-NP	B-protein
adhesion	adhesion	NN	I-NP	I-protein
molecules	molecule	NNS	I-NP	I-protein
,	,	,	O	O
fibronectin	fibronectin	NN	B-NP	B-protein
and	and	CC	I-NP	O
osteopontin	osteopontin	NN	I-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
it	it	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
modify	modify	VB	I-VP	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
intercellular	intercellular	JJ	B-NP	B-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
and	and	CC	O	O
vascular	vascular	JJ	B-NP	B-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
.	.	.	O	O

All	All	DT	B-NP	O
major	major	JJ	I-NP	O
RARs	RAR	NNS	I-NP	B-protein
and	and	CC	I-NP	O
RXRs	RXR	NNS	I-NP	B-protein
isotypes	isotype	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
CHMC	CHMC	NN	B-NP	B-cell_type
regardless	regardless	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
or	or	CC	I-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
9-cRA	9-cRA	NN	B-NP	O
.	.	.	O	O

Transcripts	Transcript	NNS	B-NP	O
to	to	TO	B-PP	O
RAR-alpha	RAR-alpha	NN	B-NP	B-protein
,	,	,	I-NP	O
RAR-beta	RAR-beta	NN	I-NP	B-protein
and	and	CC	I-NP	O
RXR-alpha	RXR-alpha	NN	I-NP	B-protein
increased	increase	VBD	B-VP	O
after	after	IN	B-PP	O
incubation	incubation	NN	B-NP	O
with	with	IN	B-PP	O
9-cRA	9-cRA	NN	B-NP	O
whereas	whereas	IN	B-PP	O
RXR-gamma	RXR-gamma	NN	B-NP	B-protein
was	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
RARs	RAR	NNS	B-NP	B-protein
and	and	CC	I-NP	O
RXRs	RXR	NNS	I-NP	B-protein
in	in	IN	B-PP	O
9-cRA-anti-inflammatory	9-cRA-anti-inflammatory	JJ	B-NP	O
effects	effect	NNS	I-NP	O
.	.	.	O	O

9-cRA	9-cRA	NN	B-NP	O
was	be	VBD	B-VP	O
toxic	toxic	JJ	B-ADJP	O
only	only	RB	B-ADVP	O
at	at	IN	B-PP	O
50	50	CD	B-NP	O
microM	microM	NN	I-NP	O
(	(	(	O	O
a	a	DT	B-NP	O
concentration	concentration	NN	I-NP	O
50	50	CD	I-NP	O
-	-	HYPH	I-NP	O
5000	5000	CD	I-NP	O
times	time	NNS	I-ADJP	O
higher	high	JJR	I-ADJP	O
than	than	IN	B-PP	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
above	above	IN	B-PP	O
)	)	)	O	O
.	.	.	O	O

Cell	Cell	NN	B-NP	O
death	death	NN	I-NP	O
occurred	occur	VBD	B-VP	O
by	by	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
,	,	,	O	O
whose	whose	WP$	B-NP	O
onset	onset	NN	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
pronounced	pronounced	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
catalase	catalase	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
and	and	CC	O	O
reduced	reduce	VBN	B-NP	O
glutathione	glutathione	NN	I-NP	O
content	content	NN	I-NP	O
,	,	,	O	O
being	be	VBG	B-VP	O
more	more	RBR	I-VP	O
effectively	effectively	RB	I-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
all-trans	all-trans	JJ	B-NP	O
retinoic	retinoic	JJ	I-NP	O
acid	acid	NN	I-NP	O
.	.	.	O	O

Modulation	Modulation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oxidant/antioxidant	oxidant/antioxidant	JJ	I-NP	O
balance	balance	NN	I-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
inhibit	inhibit	VB	I-VP	O
apoptosis	apoptosis	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
mesangial	mesangial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
might	might	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
target	target	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	O
glomerulopathies	glomerulopathy	NNS	I-NP	O
with	with	IN	B-PP	O
9-cRA	9-cRA	NN	B-NP	O
.	.	.	O	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
mammalian	mammalian	JJ	B-NP	B-DNA
defensin	defensin	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

Antimicrobial	Antimicrobial	JJ	B-NP	O
peptides	peptide	NNS	I-NP	O
are	be	VBP	B-VP	O
a	a	DT	B-NP	O
prevalent	prevalent	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
host	host	NN	B-NP	O
defense	defense	NN	I-NP	O
found	find	VBN	B-VP	O
throughout	throughout	IN	B-PP	O
nature	nature	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
mammals	mammal	NNS	B-NP	O
,	,	,	O	O
defensins	defensin	NNS	B-NP	B-protein
are	be	VBP	B-VP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
abundant	abundant	JJ	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
broad-spectrum	broad-spectrum	JJ	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
are	be	VBP	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
epithelial	epithelial	JJ	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
hematopoietic	hematopoietic	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
defensin	defensin	NN	I-NP	O
peptides	peptide	NNS	I-NP	O
are	be	VBP	B-VP	O
especially	especially	RB	B-ADJP	O
abundant	abundant	JJ	I-ADJP	O
in	in	IN	B-PP	O
neutrophils	neutrophil	NNS	B-NP	B-cell_type
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
limited	limit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
promyelocyte	promyelocyte	JJ	I-NP	B-cell_type
stage	stage	NN	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
epithelial	epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
defensin	defensin	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
are	be	VBP	B-VP	O
found	find	VBN	I-VP	O
as	as	IN	B-PP	O
both	both	DT	B-NP	O
constitutively	constitutively	RB	I-NP	O
expressed	express	VBN	I-NP	O
and	and	CC	I-NP	O
inducible	inducible	JJ	I-NP	O
.	.	.	O	O

Induction	Induction	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
observed	observe	VBN	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
by	by	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
with	with	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
lipopolysaccharide	lipopolysaccharide	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
inflammatory	inflammatory	JJ	B-NP	B-protein
mediators	mediator	NNS	I-NP	I-protein
.	.	.	O	O

In	In	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
,	,	,	O	O
up-regulation	up-regulation	NN	B-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
defensin	defensin	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
occurs	occur	VBZ	B-VP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
infectious	infectious	JJ	I-NP	O
and	and	CC	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
states	state	NNS	I-NP	O
.	.	.	O	O

Gene	Gene	NN	B-NP	O
regulation	regulation	NN	I-NP	O
occurs	occur	VBZ	B-VP	O
via	via	IN	B-PP	O
signal	signal	NN	B-NP	O
transduction	transduction	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
common	common	JJ	B-ADJP	O
to	to	TO	B-PP	O
other	other	JJ	B-NP	O
innate	innate	JJ	I-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
,	,	,	O	O
utilizing	utilize	VBG	B-VP	O
transcription	transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	I-protein
NF	NF	NN	B-NP	I-protein
)	)	)	O	I-protein
-kappaB	-kappaB	NN	B-NP	I-protein
and	and	CC	O	O
NF	NF	NN	B-NP	B-protein
interleukin-6	interleukin-6	NN	I-NP	I-protein
.	.	.	O	O

Together	Together	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
a	a	DT	B-NP	O
broad-based	broad-based	JJ	I-NP	O
innate	innate	JJ	I-NP	O
host	host	NN	I-NP	O
defense	defense	NN	I-NP	O
whereby	whereby	WRB	B-ADVP	O
potent	potent	JJ	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
peptides	peptide	NNS	I-NP	O
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
to	to	TO	B-VP	O
prevent	prevent	VB	I-VP	O
initial	initial	JJ	B-NP	O
colonization	colonization	NN	I-NP	O
by	by	IN	B-PP	O
pathogenic	pathogenic	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
recognition	recognition	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
coupled	couple	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
nascent	nascent	JJ	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
response	response	NN	I-NP	O
can	can	MD	B-VP	O
bolster	bolster	VB	I-VP	O
this	this	DT	B-NP	O
defense	defense	NN	I-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
coordinated	coordinate	VBN	I-NP	O
up-regulation	up-regulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
peptides	peptide	NNS	I-NP	O
.	.	.	O	O

Multiple	Multiple	JJ	B-NP	O
signals	signal	NNS	I-NP	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
cyclic	cyclic	JJ	B-NP	B-protein
AMP-responsive	AMP-responsive	JJ	I-NP	I-protein
element	element	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	O
CREB	CREB	NN	B-NP	B-protein
)	)	)	O	O
binding	binding	NN	B-NP	O
protein	protein	NN	I-NP	O
interaction	interaction	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
CD3/CD28	CD3/CD28	NN	B-NP	B-protein
costimulation	costimulation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
optimal	optimal	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
cAMP-responsive	cAMP-responsive	JJ	B-NP	B-protein
element	element	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	O
CREB	CREB	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
full	full	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
requires	require	VBZ	B-VP	O
the	the	DT	B-NP	O
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
CD3	CD3	NN	B-NP	B-protein
and	and	CC	I-NP	O
CD28	CD28	NN	I-NP	B-protein
.	.	.	O	O

Using	Use	VBG	B-VP	O
a	a	DT	B-NP	O
reporter	reporter	NN	I-NP	O
system	system	NN	I-NP	O
to	to	TO	B-VP	O
detect	detect	VB	I-VP	O
interaction	interaction	NN	B-NP	O
of	of	IN	B-PP	O
CREB	CREB	NN	B-NP	B-protein
and	and	CC	O	O
CREB-binding	CREB-binding	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	O
CBP	CBP	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
CREB	CREB	NN	B-NP	B-protein
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
CBP	CBP	NN	B-NP	B-protein
only	only	RB	B-ADVP	O
by	by	IN	B-PP	O
engagement	engagement	NN	B-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
CD3	CD3	NN	B-NP	B-protein
and	and	CC	I-NP	O
CD28	CD28	NN	I-NP	B-protein
.	.	.	O	O

CD3/CD28	CD3/CD28	NN	B-NP	B-protein
-promoted	-promote	VBD	B-VP	O
CREB	CREB	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
CBP	CBP	NN	I-NP	B-protein
interaction	interaction	NN	I-NP	O
was	be	VBD	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
p38	p38	NN	B-NP	B-protein
mitogen-activated	mitogen-activated	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
MAPK	MAPK	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
calcium/calmodulin-dependent	calcium/calmodulin-dependent	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
CaMK	CaMK	NN	B-NP	B-protein
)	)	)	O	O
IV	IV	CD	B-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
identified	identify	VBN	I-NP	O
extracellular	extracellular	JJ	I-NP	B-protein
signal-regulated	signal-regulated	JJ	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
pathway	pathway	NN	I-NP	O
.	.	.	O	O

Extracellular	Extracellular	JJ	B-NP	B-protein
signal-regulated	signal-regulated	JJ	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
,	,	,	O	O
CaMKIV	CaMKIV	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
p38	p38	NN	B-NP	B-protein
MAPK	MAPK	NN	I-NP	I-protein
were	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
the	the	DT	B-NP	O
kinases	kinase	NNS	I-NP	B-protein
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
CREB	CREB	NN	B-NP	B-protein
Ser	Ser	NN	I-NP	O
(	(	(	O	O
133	133	CD	B-NP	O
)	)	)	O	O
phosphorylation	phosphorylation	NN	B-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
CD3/CD28	CD3/CD28	NN	B-NP	B-protein
.	.	.	O	O

A	A	DT	B-NP	O
reconstitution	reconstitution	NN	I-NP	O
experiment	experiment	NN	I-NP	O
illustrated	illustrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
optimum	optimum	JJ	B-NP	O
CREB	CREB	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
CBP	CBP	NN	I-NP	B-protein
interaction	interaction	NN	I-NP	O
and	and	CC	I-NP	O
CREB	CREB	NN	I-NP	B-protein
trans-activation	trans-activation	NN	I-NP	O
were	be	VBD	B-VP	O
attained	attain	VBN	I-VP	O
when	when	WRB	B-ADVP	O
these	these	DT	B-NP	O
three	three	CD	I-NP	O
kinase	kinase	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
were	be	VBD	B-VP	O
simultaneously	simultaneously	RB	I-VP	O
activated	activate	VBN	I-VP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
coordinated	coordinate	VBN	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
kinases	kinase	NNS	I-NP	B-protein
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
full	full	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
CREB	CREB	NN	B-NP	B-protein
.	.	.	O	O

Notably	Notably	RB	B-ADVP	O
,	,	,	O	O
CD28	CD28	NN	B-NP	B-protein
ligation	ligation	NN	I-NP	O
activated	activate	VBD	B-VP	O
p38	p38	NN	B-NP	B-protein
MAPK	MAPK	NN	I-NP	I-protein
and	and	CC	I-NP	O
CaMKIV	CaMKIV	NN	I-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
kinases	kinase	NNS	I-NP	B-protein
stimulated	stimulate	VBN	B-VP	O
by	by	IN	B-PP	O
CD3	CD3	NN	B-NP	B-protein
engagement	engagement	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
CD28	CD28	NN	B-NP	B-protein
acts	act	VBZ	B-VP	O
by	by	IN	B-PP	O
increasing	increase	VBG	B-VP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
extent	extent	NN	I-NP	O
of	of	IN	B-PP	O
p38	p38	NN	B-NP	B-protein
MAPK	MAPK	NN	I-NP	I-protein
and	and	CC	I-NP	O
CaMKIV	CaMKIV	NN	I-NP	B-protein
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
support	support	VBP	B-VP	O
the	the	DT	B-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
minimum	minimum	JJ	I-NP	O
activation	activation	NN	I-NP	O
threshold	threshold	NN	I-NP	O
for	for	IN	B-PP	O
CREB	CREB	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
CBP	CBP	NN	I-NP	B-protein
interaction	interaction	NN	I-NP	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
reached	reach	VBN	I-VP	O
only	only	RB	B-ADVP	O
when	when	WRB	I-ADVP	O
both	both	CC	O	O
CD3	CD3	NN	B-NP	B-protein
and	and	CC	I-NP	O
CD28	CD28	NN	I-NP	B-protein
are	be	VBP	B-VP	O
stimulated	stimulate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
murine	murine	JJ	I-NP	B-DNA
IL-2	IL-2	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
contains	contain	VBZ	B-VP	O
distal	distal	JJ	B-NP	B-DNA
regulatory	regulatory	JJ	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
responsive	responsive	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Ah	Ah	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
,	,	,	O	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
evolutionarily	evolutionarily	RB	I-NP	B-protein
conserved	conserve	VBN	I-NP	I-protein
bHLH-PAS	bHLH-PAS	JJ	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
family	family	NN	I-NP	I-protein
.	.	.	O	O

Signaling	Signal	VBG	B-VP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
TCR	TCR	NN	I-NP	B-protein
and	and	CC	O	O
costimulatory	costimulatory	JJ	B-NP	O
signals	signal	NNS	I-NP	O
primarily	primarily	RB	B-ADVP	O
control	control	VBP	B-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
in	in	IN	B-PP	O
naive	naive	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
minimal	minimal	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
expression	expression	NN	I-NP	O
lies	lie	VBZ	B-VP	O
proximal	proximal	JJ	B-ADJP	O
,	,	,	O	O
between	between	IN	B-PP	O
-300	-300	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-DNA
start	start	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
had	have	VBD	B-VP	O
previously	previously	RB	I-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
arylhydrocarbon	arylhydrocarbon	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
AHR	AHR	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bHLH-PAS	bHLH-PAS	JJ	I-NP	B-protein
family	family	NN	I-NP	I-protein
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
,	,	,	O	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
increased	increase	VBN	B-NP	O
mRNA	mRNA	NN	I-NP	B-RNA
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
in	in	IN	B-PP	O
murine	murine	JJ	B-NP	B-cell_type
fetal	fetal	JJ	I-NP	I-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
AHR	AHR	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
abundant	abundant	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
thymus	thymus	NN	I-NP	O
and	and	CC	O	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
immune	immune	JJ	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
its	its	PRP$	B-NP	O
overactivation	overactivation	NN	I-NP	O
by	by	IN	B-PP	O
chemicals	chemical	NNS	B-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
dioxins	dioxin	NNS	B-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
immunosuppression	immunosuppression	NN	B-NP	O
and	and	CC	O	O
thymic	thymic	JJ	B-NP	O
involution	involution	NN	I-NP	O
.	.	.	O	O

Binding	Binding	NN	B-NP	B-DNA
motifs	motif	NNS	I-NP	I-DNA
for	for	IN	B-PP	O
the	the	DT	B-NP	O
liganded	liganded	JJ	I-NP	O
AHR	AHR	NN	I-NP	B-protein
can	can	MD	B-VP	O
be	be	VB	I-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
region	region	NN	I-NP	O
-1300	-1300	CD	I-NP	O
to	to	TO	B-PP	O
-800	-800	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	B-DNA
IL-2	IL-2	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
here	here	RB	B-ADVP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
DNA	DNA	NN	I-NP	B-DNA
motifs	motif	NNS	I-NP	I-DNA
,	,	,	O	O
the	the	DT	B-NP	O
so-called	so-called	JJ	I-NP	O
dioxin	dioxin	NN	I-NP	B-DNA
response	response	NN	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
,	,	,	O	O
after	after	IN	B-PP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
liganded	liganded	JJ	I-NP	O
AHR	AHR	NN	I-NP	B-protein
are	be	VBP	B-VP	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
transactivate	transactivate	VB	I-VP	O
luciferase	luciferase	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
reporter	reporter	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
system	system	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
can	can	MD	B-VP	O
be	be	VB	I-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
AHR	AHR	NN	I-NP	B-protein
also	also	RB	B-ADVP	O
in	in	IN	B-PP	O
thymocytes	thymocyte	NNS	B-NP	B-cell_type
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
after	after	IN	B-PP	O
injection	injection	NN	B-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
,	,	,	I-NP	O
3	3	CD	I-NP	O
,	,	,	I-NP	O
7	7	CD	I-NP	O
,	,	,	O	O
8-tetrachlorodibenzo-p-dioxin	8-tetrachlorodibenzo-p-dioxin	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
ligand	ligand	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
AHR	AHR	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
AHR	AHR	NN	I-NP	B-protein
mediates	mediate	VBZ	B-VP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-protein
induction	induction	NN	I-NP	O
as	as	IN	B-SBAR	O
shown	show	VBN	B-VP	O
with	with	IN	B-PP	O
AHR	AHR	NN	B-NP	B-protein
-deficient	-deficient	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
spleen	spleen	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
costimulation	costimulation	NN	I-NP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
TCR	TCR	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
optimal	optimal	JJ	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
induction	induction	NN	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
contains	contain	VBZ	B-VP	O
novel	novel	JJ	B-NP	O
distal	distal	JJ	I-NP	B-DNA
regulatory	regulatory	JJ	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
addressed	address	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
AHR	AHR	NN	I-NP	B-protein
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
IL-2	IL-2	NN	B-NP	B-protein
and	and	CC	O	O
can	can	MD	B-VP	O
cooperate	cooperate	VB	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA

Visualization	Visualization	NN	B-NP	O
of	of	IN	B-PP	O
Syk-antigen	Syk-antigen	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
interactions	interaction	NNS	I-NP	O
using	use	VBG	B-VP	O
green	green	JJ	B-NP	B-protein
fluorescent	fluorescent	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
:	:	:	O	O
differential	differential	JJ	B-NP	O
roles	role	NNS	I-NP	O
for	for	IN	B-PP	O
Syk	Syk	NN	B-NP	B-protein
and	and	CC	I-NP	O
Lyn	Lyn	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
receptor	receptor	NN	B-NP	O
capping	capping	NN	I-NP	O
and	and	CC	I-NP	O
internalization	internalization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cross-linking	cross-linking	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
B	B	NN	I-NP	B-protein
cell	cell	NN	I-NP	I-protein
Ag	Ag	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
BCR	BCR	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
coupled	couple	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
intracellular	intracellular	JJ	I-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
cascades	cascade	NNS	I-NP	O
via	via	IN	B-PP	O
receptor-associated	receptor-associated	JJ	B-NP	O
,	,	,	I-NP	O
protein	protein	NN	I-NP	B-protein
tyrosine	tyrosine	NN	I-NP	I-protein
kinases	kinase	NNS	I-NP	I-protein
of	of	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
Src	Src	NN	I-NP	B-protein
and	and	CC	I-NP	O
Syk	Syk	NN	I-NP	B-protein
families	family	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
monitor	monitor	VB	I-VP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
subcellular	subcellular	JJ	I-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
Syk	Syk	NN	B-NP	B-protein
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
responding	respond	VBG	B-VP	O
to	to	TO	B-PP	O
BCR	BCR	NN	B-NP	B-protein
cross-linking	cross-linking	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
expressed	express	VBD	B-VP	O
in	in	IN	B-PP	O
Syk	Syk	NN	B-NP	B-cell_line
-deficient	-deficient	JJ	I-NP	I-cell_line
DT40	DT40	NN	I-NP	I-cell_line
B	B	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
a	a	DT	B-NP	O
fusion	fusion	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
Syk	Syk	NN	B-NP	B-protein
coupled	couple	VBN	B-VP	O
to	to	TO	B-PP	O
green	green	JJ	B-NP	B-protein
fluorescent	fluorescent	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
with	with	IN	B-PP	O
anti-IgM	anti-IgM	JJ	B-NP	B-protein
Abs	Ab	NNS	I-NP	I-protein
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
recruitment	recruitment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
kinase	kinase	NN	I-NP	B-protein
from	from	IN	B-PP	O
cytoplasmic	cytoplasmic	JJ	B-NP	O
and	and	CC	I-NP	O
nuclear	nuclear	JJ	I-NP	O
compartments	compartment	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cross-linked	cross-linked	JJ	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
at	at	IN	B-PP	O
the	the	DT	B-NP	O
plasma	plasma	NN	I-NP	O
membrane	membrane	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Syk-receptor	Syk-receptor	NN	I-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
aggregate	aggregate	VBP	B-VP	O
into	into	IN	B-PP	O
membrane	membrane	NN	B-NP	O
patches	patch	NNS	I-NP	O
that	that	WDT	B-NP	O
redistribute	redistribute	VBP	B-VP	O
to	to	TO	I-VP	O
form	form	VB	I-VP	O
a	a	DT	B-NP	O
cap	cap	NN	I-NP	B-protein
at	at	IN	B-PP	O
one	one	CD	B-NP	O
pole	pole	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
.	.	.	O	O

Syk	Syk	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
demonstrably	demonstrably	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
internalized	internalize	VBN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

Catalytically	Catalytically	RB	B-NP	O
active	active	JJ	I-NP	O
Syk	Syk	NN	I-NP	B-protein
promotes	promote	VBZ	B-VP	O
and	and	CC	I-VP	O
stabilizes	stabilize	VBZ	I-VP	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
tightly	tightly	RB	B-NP	O
capped	cap	VBN	I-NP	O
BCR	BCR	NN	I-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
at	at	IN	B-PP	O
the	the	DT	B-NP	O
plasma	plasma	NN	I-NP	O
membrane	membrane	NN	I-NP	O
.	.	.	O	O

Lyn	Lyn	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
recruitment	recruitment	NN	I-NP	O
of	of	IN	B-PP	O
Syk	Syk	NN	B-NP	B-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cross-linked	cross-linked	JJ	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
,	,	,	O	O
but	but	CC	O	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
internalization	internalization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
clustered	cluster	VBN	I-NP	O
BCR	BCR	NN	I-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
Lyn	Lyn	NN	B-NP	B-protein
,	,	,	O	O
receptor-Syk	receptor-Syk	NN	B-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
at	at	IN	B-PP	O
the	the	DT	B-NP	O
plasma	plasma	NN	I-NP	O
membrane	membrane	NN	I-NP	O
are	be	VBP	B-VP	O
long	long	JJ	B-ADJP	O
lived	live	VBN	B-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
receptor-mediated	receptor-mediated	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NF-AT	NF-AT	NN	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
enhanced	enhance	VBN	I-VP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
Lyn	Lyn	NN	B-NP	B-protein
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
function	function	VB	I-VP	O
to	to	TO	B-VP	O
negatively	negatively	RB	I-VP	O
regulate	regulate	VB	I-VP	O
aspects	aspect	NNS	B-NP	O
of	of	IN	B-PP	O
BCR	BCR	NN	B-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
signaling	signaling	NN	I-NP	O
by	by	IN	B-PP	O
stimulating	stimulate	VBG	B-VP	O
receptor	receptor	NN	B-NP	O
internalization	internalization	NN	I-NP	O
and	and	CC	I-NP	O
down-regulation	down-regulation	NN	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
interstitial	interstitial	JJ	I-NP	O
fibrosis	fibrosis	NN	I-NP	O
is	be	VBZ	B-VP	O
reduced	reduce	VBN	I-VP	O
in	in	IN	B-PP	O
angiotensin	angiotensin	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
type	type	NN	I-NP	I-protein
1a	1a	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
-deficient	-deficient	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

Unilateral	Unilateral	JJ	B-NP	O
ureteral	ureteral	JJ	I-NP	O
obstruction	obstruction	NN	I-NP	O
(	(	(	O	O
UUO	UUO	NN	B-NP	O
)	)	)	O	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
tubulointerstitial	tubulointerstitial	JJ	B-NP	O
fibrosis	fibrosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
affected	affect	VBN	I-NP	O
kidney	kidney	NN	I-NP	O
by	by	IN	B-PP	O
stimulating	stimulate	VBG	B-VP	O
the	the	DT	B-NP	O
renin-angiotensin	renin-angiotensin	NN	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
established	establish	VBD	B-VP	O
a	a	DT	B-NP	O
UUO	UUO	NNP	I-NP	O
model	model	NN	I-NP	O
in	in	IN	B-PP	O
angiotensin	angiotensin	NN	B-NP	B-protein
type	type	NN	I-NP	I-protein
1a	1a	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
AT1a	AT1a	NN	B-NP	O
)	)	)	O	O
deficient	deficient	JJ	O	O
(	(	(	O	O
mutant	mutant	JJ	B-ADJP	O
)	)	)	O	O
mice	mouse	NNS	B-NP	O
to	to	TO	B-VP	O
elucidate	elucidate	VB	I-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
angiotensin	angiotensin	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
through	through	IN	B-PP	O
AT1a	AT1a	NN	B-NP	B-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
fibrosis	fibrosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
obstructed	obstruct	VBN	I-NP	O
kidney	kidney	NN	I-NP	O
(	(	(	O	O
OBK	OBK	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
relative	relative	JJ	I-NP	O
volume	volume	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tubulointerstitium	tubulointerstitium	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
image	image	NN	I-NP	O
analyzer	analyzer	NN	I-NP	O
;	;	:	O	O
deposition	deposition	NN	B-NP	O
of	of	IN	B-PP	O
collagen	collagen	NN	B-NP	B-protein
types	type	NNS	I-NP	I-protein
III	III	CD	B-NP	I-protein
and	and	CC	I-NP	O
IV	IV	CD	I-NP	O
and	and	CC	O	O
monocyte	monocyte	NN	B-NP	B-cell_type
/	/	SYM	O	O
macrophage	macrophage	NN	B-NP	O
infiltration	infiltration	NN	I-NP	O
were	be	VBD	B-VP	O
histologically	histologically	RB	I-VP	O
examined	examine	VBN	I-VP	O
using	use	VBG	B-VP	O
specific	specific	JJ	B-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
.	.	.	O	O

Also	Also	RB	B-VP	O
determined	determine	VBN	I-VP	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
mRNA	mRNA	NN	I-NP	B-RNA
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
transforming	transform	VBG	B-NP	B-protein
growth	growth	NN	I-NP	I-protein
factor-beta	factor-beta	NN	I-NP	I-protein
by	by	IN	B-PP	O
Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O

Nuclear	Nuclear	JJ	B-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
by	by	IN	B-PP	O
gel	gel	NN	B-NP	O
shift	shift	NN	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

UUO	UUO	NN	B-NP	O
in	in	IN	B-PP	O
wild	wild	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
marked	marked	JJ	I-NP	O
expansion	expansion	NN	I-NP	O
of	of	IN	B-PP	O
relative	relative	JJ	B-NP	O
volume	volume	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tubulointerstitium	tubulointerstitium	NN	I-NP	O
,	,	,	O	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
deposition	deposition	NN	I-NP	O
of	of	IN	B-PP	O
collagen	collagen	NN	B-NP	B-protein
types	type	NNS	I-NP	I-protein
III	III	CD	B-NP	I-protein
and	and	CC	I-NP	O
IV	IV	CD	I-NP	O
and	and	CC	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
infiltrated	infiltrate	VBN	B-NP	O
monocytes	monocyte	NNS	I-NP	B-cell_type
/	/	SYM	B-VP	B-cell_type
macrophages	macrophage	NNS	B-NP	I-cell_type
in	in	IN	B-PP	O
the	the	DT	B-NP	O
interstitium	interstitium	NN	I-NP	O
,	,	,	O	O
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
sham-operated	sham-operated	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
comparison	comparison	NN	B-NP	O
,	,	,	O	O
these	these	DT	B-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
in	in	IN	B-PP	O
mutant	mutant	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
with	with	IN	B-PP	O
UUO	UUO	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
mRNA	mRNA	NN	I-NP	B-RNA
level	level	NN	I-NP	O
of	of	IN	B-PP	O
transforming	transform	VBG	B-NP	B-protein
growth	growth	NN	I-NP	I-protein
factor-beta	factor-beta	NN	I-NP	I-protein
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
OBK	OBK	NN	I-NP	B-protein
of	of	IN	B-PP	O
wild	wild	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
with	with	IN	B-PP	O
UUO	UUO	NN	B-NP	B-protein
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
sham-operated	sham-operated	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
mRNA	mRNA	NN	B-NP	B-RNA
level	level	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
OBK	OBK	NN	I-NP	B-protein
of	of	IN	B-PP	O
mutant	mutant	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
less	less	JJR	I-ADJP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
wild	wild	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
UUO	UUO	NN	B-NP	B-protein
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
in	in	IN	B-PP	O
wild	wild	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
OBK	OBK	NN	I-NP	B-protein
of	of	IN	B-PP	O
mutant	mutant	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
provide	provide	VBP	B-VP	O
direct	direct	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
that	that	IN	B-SBAR	O
angiotensin	angiotensin	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
acting	act	VBG	B-VP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
AT1a	AT1a	NN	I-NP	O
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
pivotal	pivotal	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
tubulointerstitial	tubulointerstitial	JJ	B-NP	O
fibrosis	fibrosis	NN	I-NP	O
in	in	IN	B-PP	O
UUO	UUO	NN	B-NP	B-protein
.	.	.	O	O

HLA-DQ	HLA-DQ	NN	B-NP	B-protein
tetramers	tetramer	NNS	I-NP	I-protein
identify	identify	VBP	B-VP	O
epitope-specific	epitope-specific	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
blood	blood	NN	I-NP	O
of	of	IN	B-PP	O
herpes	herpes	NN	B-NP	O
simplex	simplex	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
2-infected	2-infected	JJ	I-NP	O
individuals	individual	NNS	I-NP	O
:	:	:	O	O
direct	direct	JJ	B-NP	O
detection	detection	NN	I-NP	O
of	of	IN	B-PP	O
immunodominant	immunodominant	JJ	B-NP	B-cell_type
antigen-responsive	antigen-responsive	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Ag-specific	Ag-specific	JJ	B-NP	B-cell_type
CD4+	CD4+	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
blood	blood	NN	I-NP	O
in	in	IN	B-PP	O
low	low	JJ	B-NP	O
frequency	frequency	NN	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
they	they	PRP	B-NP	O
undergo	undergo	VBP	B-VP	O
recruitment	recruitment	NN	B-NP	O
and	and	CC	I-NP	O
expansion	expansion	NN	I-NP	O
during	during	IN	B-PP	O
immune	immune	JJ	B-NP	O
responses	response	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
numerous	numerous	JJ	B-NP	O
autoimmune	autoimmune	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

MHC	MHC	NN	B-NP	B-protein
tetramers	tetramer	NNS	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
constitute	constitute	VBP	B-VP	O
a	a	DT	B-NP	O
labeled	label	VBN	I-NP	O
MHC-peptide	MHC-peptide	NN	I-NP	O
ligand	ligand	NN	I-NP	O
suitable	suitable	JJ	B-ADJP	O
for	for	IN	B-PP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Ag-specific	Ag-specific	JJ	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
on	on	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
provide	provide	VBP	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
approach	approach	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
detection	detection	NN	I-NP	O
and	and	CC	I-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
such	such	JJ	B-NP	O
rare	rare	JJ	I-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
utilized	utilize	VBD	B-VP	O
this	this	DT	B-NP	O
technology	technology	NN	I-NP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
HLA	HLA	NN	B-NP	B-protein
DQ	DQ	NN	I-NP	I-protein
-restricted	-restricted	JJ	I-NP	O
Ag-specific	Ag-specific	JJ	I-NP	O
T	T	NN	I-NP	O
cells	cell	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
peripheral	peripheral	JJ	I-NP	O
blood	blood	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
immunodominant	immunodominant	JJ	B-NP	B-protein
epitopes	epitope	NNS	I-NP	I-protein
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
viral	viral	JJ	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Peptides	Peptide	NNS	B-NP	O
representing	represent	VBG	B-VP	O
potential	potential	JJ	B-NP	O
epitope	epitope	NN	I-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
VP16	VP16	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
from	from	IN	B-PP	O
HSV-2	HSV-2	NN	B-NP	O
were	be	VBD	B-VP	O
loaded	load	VBN	I-VP	O
onto	onto	IN	B-PP	O
recombinant	recombinant	JJ	B-NP	B-protein
DQ0602	DQ0602	NN	I-NP	I-protein
molecules	molecule	NNS	I-NP	I-protein
to	to	TO	B-VP	O
generate	generate	VB	I-VP	O
a	a	DT	B-NP	O
panel	panel	NN	I-NP	O
of	of	IN	B-PP	O
Ag-specific	Ag-specific	JJ	B-NP	O
DQ0602	DQ0602	NN	I-NP	O
tetramers	tetramer	NNS	I-NP	O
.	.	.	O	O

VP16	VP16	NN	B-NP	B-protein
Ag	Ag	NN	I-NP	I-protein
-specific	-specific	JJ	I-NP	O
DQ-restricted	DQ-restricted	JJ	I-NP	O
T	T	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
and	and	CC	O	O
expanded	expand	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
peripheral	peripheral	JJ	I-NP	O
blood	blood	NN	I-NP	O
of	of	IN	B-PP	O
HSV-2-infected	HSV-2-infected	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
,	,	,	O	O
representing	represent	VBG	B-VP	O
two	two	CD	B-NP	O
predominant	predominant	JJ	I-NP	O
epitope	epitope	NN	I-NP	O
specificities	specificity	NNS	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
VP16	VP16	NN	I-NP	O
369-380	369-380	CD	I-NP	O
peptide	peptide	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
lower	low	JJR	I-NP	O
binding	binding	NN	I-NP	O
affinity	affinity	NN	I-NP	O
for	for	IN	B-PP	O
DQ0602	DQ0602	NN	B-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
than	than	IN	B-PP	O
the	the	DT	B-NP	O
VP16	VP16	NN	I-NP	O
33-52	33-52	CD	I-NP	O
peptide	peptide	NN	I-NP	O
,	,	,	O	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
that	that	WDT	B-NP	O
recognized	recognize	VBD	B-VP	O
the	the	DT	B-NP	O
VP16	VP16	NN	I-NP	O
369-380	369-380	CD	I-NP	O
peptide	peptide	NN	I-NP	O
occurred	occur	VBD	B-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
much	much	RB	I-NP	O
higher	high	JJR	I-NP	O
frequency	frequency	NN	I-NP	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
specific	specific	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
VP16	VP16	NN	I-NP	O
33-52	33-52	CD	I-NP	O
peptide	peptide	NN	I-NP	O
.	.	.	O	O

Down-regulation	Down-regulation	NN	B-NP	O
of	of	IN	B-PP	O
BOB.1/OBF.1	BOB.1/OBF.1	NN	B-NP	B-protein
and	and	CC	I-NP	O
Oct2	Oct2	NN	I-NP	B-protein
in	in	IN	B-PP	O
classical	classical	JJ	B-NP	O
Hodgkin	Hodgkin	NN	I-NP	O
disease	disease	NN	I-NP	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
lymphocyte	lymphocyte	NN	B-NP	B-cell_type
predominant	predominant	JJ	I-NP	O
Hodgkin	Hodgkin	NN	I-NP	O
disease	disease	NN	I-NP	O
correlates	correlate	VBZ	B-VP	O
with	with	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-protein
transcription	transcription	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
tumor	tumor	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
L	L	NN	B-NP	B-cell_type
&	&	CC	I-NP	I-cell_type
H	H	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
)	)	)	O	O
of	of	IN	B-PP	O
lymphocyte	lymphocyte	NN	B-NP	O
predominant	predominant	JJ	I-NP	O
Hodgkin	Hodgkin	NN	I-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
LPHD	LPHD	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
Hodgkin	Hodgkin	NN	B-NP	B-cell_line
and	and	CC	O	I-cell_line
Reed-Sternberg	Reed-Sternberg	NN	B-NP	I-cell_line
(	(	(	O	I-cell_line
HRS	HRS	NN	B-NP	I-cell_line
)	)	)	O	I-cell_line
cells	cell	NNS	B-NP	I-cell_line
of	of	IN	B-PP	O
classical	classical	JJ	B-NP	O
Hodgkin	Hodgkin	NN	I-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
cHD	cHD	NN	B-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
transcribe	transcribe	VB	I-VP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-protein
,	,	,	O	O
despite	despite	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
rearranged	rearrange	VBN	B-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

Although	Although	IN	B-SBAR	O
initial	initial	JJ	B-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
suggested	suggest	VBN	I-VP	O
crippling	cripple	VBG	I-VP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
mutations	mutation	NNS	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
absent	absent	JJ	B-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
cHD	cHD	NN	B-NP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
work	work	NN	I-NP	O
of	of	IN	B-PP	O
our	our	PRP$	B-NP	O
group	group	NN	I-NP	O
has	have	VBZ	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
an	an	DT	B-NP	O
impaired	impaired	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
as	as	IN	B-PP	O
a	a	DT	B-NP	O
superior	superior	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
immunoglobulin	immunoglobulin	NN	B-NP	B-protein
transcription	transcription	NN	I-NP	O
is	be	VBZ	B-VP	O
mainly	mainly	RB	I-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
B-cell	B-cell	NN	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
Oct2	Oct2	NN	B-NP	B-protein
and	and	CC	I-NP	O
BOB.1/OBF.1	BOB.1/OBF.1	NN	I-NP	B-protein
,	,	,	O	O
we	we	PRP	B-NP	O
analyzed	analyze	VBD	B-VP	O
35	35	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
LPHD	LPHD	NN	B-NP	O
,	,	,	O	O
32	32	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
cHD	cHD	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
2	2	CD	B-NP	O
Hodgkin	Hodgkin	NN	I-NP	B-cell_line
disease	disease	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
for	for	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
and	and	CC	O	O
also	also	RB	B-ADVP	O
in	in	IN	B-PP	O
parallel	parallel	NN	B-NP	O
for	for	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
an	an	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
Oct2	Oct2	NN	B-NP	B-protein
and/or	and/or	CC	I-NP	O
BOB.1/OBF.1	BOB.1/OBF.1	NN	I-NP	B-protein
in	in	IN	B-PP	O
cHD	cHD	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
striking	striking	JJ	I-NP	O
overexpression	overexpression	NN	I-NP	O
of	of	IN	B-PP	O
Oct2	Oct2	NN	B-NP	B-protein
in	in	IN	B-PP	O
LPHD	LPHD	NN	B-NP	O
.	.	.	O	O

Immunoglobulin	Immunoglobulin	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
lacking	lack	VBG	I-VP	O
in	in	IN	B-PP	O
cHD	cHD	NN	B-NP	O
but	but	CC	O	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
LPHD	LPHD	NN	B-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
reintroduction	reintroduction	NN	I-NP	O
of	of	IN	B-PP	O
BOB.1/OBF.1	BOB.1/OBF.1	NN	B-NP	B-protein
and	and	CC	I-NP	O
Oct2	Oct2	NN	I-NP	B-protein
into	into	IN	B-PP	O
cultured	culture	VBN	B-NP	B-cell_line
HRS	HRS	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
restored	restore	VBD	B-VP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
cotransduced	cotransduce	VBN	B-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
constructs	construct	NNS	I-NP	I-DNA
.	.	.	O	O

Our	Our	PRP$	B-NP	O
findings	finding	NNS	I-NP	O
dismiss	dismiss	VBP	B-VP	O
the	the	DT	B-NP	O
concept	concept	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
cHD	cHD	NN	B-NP	O
and	and	CC	I-NP	O
LPHD	LPHD	NN	I-NP	O
is	be	VBZ	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
disrupting	disrupt	VBG	B-VP	O
mutations	mutation	NNS	B-NP	O
of	of	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-DNA
V	V	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
cHD	cHD	NN	B-NP	O
but	but	CC	O	O
is	be	VBZ	B-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
down-regulation	down-regulation	NN	I-NP	O
of	of	IN	B-PP	O
Oct2	Oct2	NN	B-NP	B-protein
and/or	and/or	CC	I-NP	O
BOB.1/OBF.1	BOB.1/OBF.1	NN	I-NP	B-protein
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
further	further	RBR	B-ADVP	O
revealed	reveal	VBD	B-VP	O
Oct2	Oct2	NN	B-NP	B-protein
as	as	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
and	and	CC	I-NP	O
valuable	valuable	JJ	I-NP	O
marker	marker	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
identification	identification	NN	I-NP	O
of	of	IN	B-PP	O
L	L	NN	B-NP	B-cell_type
&	&	CC	I-NP	I-cell_type
H	H	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
their	their	PRP$	B-NP	O
distinction	distinction	NN	I-NP	O
from	from	IN	B-PP	O
HRS	HRS	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
impairment	impairment	NN	I-NP	O
of	of	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	O
transcription	transcription	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
down-regulated	down-regulated	JJ	I-NP	O
synthesis	synthesis	NN	I-NP	O
of	of	IN	B-PP	O
Oct2	Oct2	NN	B-NP	B-protein
and	and	CC	I-NP	O
BOB.1/OBF.1	BOB.1/OBF.1	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
established	establish	VBN	I-NP	O
general	general	JJ	I-NP	O
recurrent	recurrent	JJ	I-NP	O
defect	defect	NN	I-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
HRS	HRS	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Constitutive	Constitutive	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
characteristic	characteristic	JJ	I-NP	O
feature	feature	NN	I-NP	O
of	of	IN	B-PP	O
mycosis	mycosis	NN	B-NP	O
fungoides	fungoide	NNS	I-NP	O
:	:	:	O	O
implications	implication	NNS	B-NP	O
for	for	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
resistance	resistance	NN	I-NP	O
and	and	CC	I-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
family	family	NN	I-NP	I-protein
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
regulator	regulator	NN	I-NP	O
of	of	IN	B-PP	O
genes	gene	NNS	B-NP	B-DNA
expressed	express	VBN	B-VP	O
during	during	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	O
responses	response	NNS	I-NP	O
,	,	,	O	O
immunoglobulin	immunoglobulin	NN	B-NP	B-protein
(	(	(	O	O
Ig	Ig	NN	B-NP	O
)	)	)	O	O
class	class	NN	B-NP	O
switching	switching	NN	I-NP	O
,	,	,	O	O
cellular	cellular	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
apoptosis	apoptosis	NN	B-NP	O
.	.	.	O	O

Recently	Recently	RB	B-ADVP	O
,	,	,	O	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
,	,	,	O	O
including	include	VBG	B-PP	O
p65	p65	NN	B-NP	B-protein
(	(	(	O	O
Rel	Rel	NN	B-NP	B-protein
A	A	NN	I-NP	I-protein
)	)	)	O	O
,	,	,	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
promoting	promote	VBG	B-VP	O
survival	survival	NN	B-NP	O
of	of	IN	B-PP	O
various	various	JJ	B-NP	O
hematopoeitic	hematopoeitic	JJ	I-NP	B-cell_type
neoplasms	neoplasm	NNS	I-NP	I-cell_type
,	,	,	O	O
including	include	VBG	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
malignancies	malignancy	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
adult	adult	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
leukemia-lymphoma	leukemia-lymphoma	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
active	active	JJ	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
p65	p65	NN	I-NP	O
(	(	(	O	O
Rel	Rel	NN	B-NP	B-protein
A	A	NN	I-NP	I-protein
)	)	)	O	O
in	in	IN	B-PP	O
cases	case	NNS	B-NP	O
of	of	IN	B-PP	O
mycosis	mycosis	NN	B-NP	O
fungoides	fungoide	NNS	I-NP	O
(	(	(	O	O
MF	MF	NNS	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
chemical	chemical	JJ	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
on	on	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
in	in	IN	B-PP	O
cutaneous	cutaneous	JJ	B-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lymphoma	lymphoma	NN	I-NP	I-cell_line
(	(	(	O	I-cell_line
CTCL	CTCL	NN	B-NP	I-cell_line
)	)	)	O	I-cell_line
cell	cell	NN	B-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
.	.	.	O	O

Paraffin-embedded	Paraffin-embedded	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
from	from	IN	B-PP	O
23	23	CD	B-NP	O
cutaneous	cutaneous	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
lymph	lymph	NN	I-NP	O
node	node	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
diagnosed	diagnose	VBN	B-VP	O
with	with	IN	B-PP	O
MF	MF	NN	B-NP	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
for	for	IN	B-PP	O
p65	p65	NN	B-NP	B-protein
(	(	(	O	O
Rel	Rel	NN	B-NP	B-protein
A	A	NN	I-NP	I-protein
)	)	)	O	O
expression	expression	NN	B-NP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
monoclonal	monoclonal	JJ	I-NP	B-protein
mouse	mouse	NN	I-NP	I-protein
antibody	antibody	NN	I-NP	I-protein
that	that	WDT	B-NP	O
detects	detect	VBZ	B-VP	O
the	the	DT	B-NP	O
activated	activated	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
p65	p65	NN	B-NP	B-protein
(	(	(	O	O
Rel	Rel	NN	B-NP	B-protein
A	A	NN	I-NP	I-protein
)	)	)	O	O
.	.	.	O	O

Apoptosis	Apoptosis	NN	B-NP	O
after	after	IN	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
inhibitors	inhibitor	NNS	I-NP	O
gliotoxin	gliotoxin	NN	I-NP	O
,	,	,	O	O
MG132	MG132	NN	B-NP	O
,	,	,	O	O
BAY	BAY	NN	B-NP	O
11-7082	11-7082	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
BAY	BAY	NN	B-NP	O
11-7085	11-7085	CD	I-NP	O
was	be	VBD	B-VP	O
quantitatively	quantitatively	RB	I-VP	O
measured	measure	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CTCL	CTCL	NN	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
HuT-78	HuT-78	NN	B-NP	B-cell_line
and	and	CC	O	O
HH	HH	NN	B-NP	O
by	by	IN	B-PP	O
propidium	propidium	NN	B-NP	O
iodide	iodide	NN	I-NP	O
(	(	(	O	O
PI	PI	NN	B-NP	O
)	)	)	O	O
/cell	/cell	VBP	B-VP	O
cycle	cycle	NN	B-NP	O
analysis	analysis	NN	I-NP	O
for	for	IN	B-PP	O
detection	detection	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
hypodiploid	hypodiploid	JJ	I-NP	O
(	(	(	O	O
sub-G	sub-G	NN	B-NP	O
(	(	(	O	O
0	0	CD	B-NP	O
)	)	)	O	O
)	)	)	O	O
population	population	NN	B-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
determination	determination	NN	B-NP	O
of	of	IN	B-PP	O
increased	increase	VBN	B-NP	O
Annexin	Annexin	NN	I-NP	O
V/7-amino-actinomycin	V/7-amino-actinomycin	NN	I-NP	O
D	D	NN	I-NP	O
(	(	(	O	O
7-AAD	7-AAD	NN	B-NP	O
)	)	)	O	O
expression	expression	NN	B-NP	O
.	.	.	O	O

Nuclear	Nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
from	from	IN	B-PP	O
CTCL	CTCL	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
before	before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
chemical	chemical	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
for	for	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
nuclear	nuclear	JJ	I-NP	O
DNA-binding	DNA-binding	JJ	I-NP	O
activity	activity	NN	I-NP	O
by	by	IN	B-PP	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assay	assay	NN	I-NP	O
(	(	(	O	O
EMSA	EMSA	NN	B-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
quantitative	quantitative	JJ	B-NP	O
densitometry	densitometry	NN	I-NP	O
.	.	.	O	O

Nuclear	Nuclear	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
p65	p65	NN	B-NP	O
(	(	(	O	O
Rel	Rel	NN	B-NP	B-protein
A	A	NN	I-NP	I-protein
)	)	)	O	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
various	various	JJ	I-NP	O
inhibitory	inhibitory	JJ	I-NP	O
compounds	compound	NNS	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
by	by	IN	B-PP	O
immunofluorescence	immunofluorescence	NN	B-NP	O
staining	staining	NN	I-NP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
CTCL	CTCL	NN	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

Neoplastic	Neoplastic	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
22	22	CD	B-NP	O
of	of	IN	B-PP	O
24	24	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
MF	MF	NN	B-NP	O
showed	show	VBD	B-VP	O
strong	strong	JJ	B-NP	O
nuclear	nuclear	JJ	I-NP	O
and	and	CC	I-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
active	active	JJ	B-NP	O
p65	p65	NN	I-NP	O
(	(	(	O	O
Rel	Rel	NN	B-NP	B-protein
A	A	NN	I-NP	I-protein
)	)	)	O	O
.	.	.	O	O

Compared	Compare	VBN	B-PP	O
with	with	IN	B-PP	O
untreated	untreated	JJ	B-NP	B-cell_type
control	control	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
a	a	DT	B-NP	O
marked	marked	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
DNA-binding	DNA-binding	JJ	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
marked	marked	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
p65	p65	NN	I-NP	O
(	(	(	O	O
Rel	Rel	NN	B-NP	B-protein
A	A	NN	I-NP	I-protein
)	)	)	O	O
expression	expression	NN	B-NP	O
were	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
from	from	IN	B-PP	O
both	both	CC	O	O
CTCL	CTCL	NN	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
after	after	IN	B-PP	O
chemical	chemical	JJ	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
inhibition	inhibition	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
active	active	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
p65	p65	NN	I-NP	I-protein
(	(	(	O	O
Rel	Rel	NN	B-NP	B-protein
A	A	NN	I-NP	I-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
commonly	commonly	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
neoplastic	neoplastic	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
MF	MF	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
CTCL	CTCL	NN	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
the	the	DT	B-NP	O
significant	significant	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
marked	marked	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
spontaneous	spontaneous	JJ	B-NP	O
apoptosis	apoptosis	NN	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
chemical	chemical	JJ	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
inhibition	inhibition	NN	I-NP	O
suggest	suggest	VBP	B-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
and	and	CC	I-NP	O
tumor	tumor	NN	I-NP	O
cell	cell	NN	I-NP	O
maintenance	maintenance	NN	I-NP	O
of	of	IN	B-PP	O
CTCLs	CTCLs	NN	B-NP	B-protein
.	.	.	O	O

HUM	HUM	NN	B-NP	O
PATHOL	PATHOL	NN	I-NP	O
31	31	CD	I-NP	O
:	:	:	O	O
1482-1490	1482-1490	CD	B-NP	O
.	.	.	O	O

Human	Human	JJ	B-NP	B-protein
T-cell	T-cell	NN	I-NP	I-protein
leukemia	leukemia	NN	I-NP	I-protein
virus	virus	NN	I-NP	I-protein
type	type	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
tax	tax	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
activates	activate	VBZ	B-VP	O
transcription	transcription	NN	B-NP	O
through	through	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-DNA
site	site	NN	I-NP	I-DNA
by	by	IN	B-PP	O
inducing	induce	VBG	B-VP	O
DNA	DNA	NN	B-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Human	Human	JJ	B-NP	B-protein
T-cell	T-cell	NN	I-NP	I-protein
leukemia	leukemia	NN	I-NP	I-protein
virus	virus	NN	I-NP	I-protein
type	type	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
(	(	(	O	I-protein
HTLV-1	HTLV-1	NN	B-NP	I-protein
)	)	)	O	I-protein
Tax	Tax	NN	B-NP	I-protein
protein	protein	NN	I-NP	I-protein
induces	induce	VBZ	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
various	various	JJ	B-NP	O
family	family	NN	I-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
AP-1	AP-1	NN	I-NP	B-protein
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
c-Jun	c-Jun	NN	B-NP	B-protein
,	,	,	O	O
JunD	JunD	NN	B-NP	B-protein
,	,	,	O	O
c-Fos	c-Fos	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
Fra-1	Fra-1	NN	B-NP	B-protein
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
RNA	RNA	NN	B-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
Tax	Tax	NN	B-NP	B-protein
in	in	IN	B-PP	O
transcription	transcription	NN	B-NP	O
through	through	IN	B-PP	O
AP-1-binding	AP-1-binding	JJ	B-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
(	(	(	O	O
AP-1	AP-1	NN	B-NP	B-DNA
site	site	NN	I-NP	I-DNA
)	)	)	O	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Transient	Transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
studies	study	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
Tax	Tax	NN	B-NP	B-protein
activated	activate	VBD	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
luciferase	luciferase	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
regulated	regulate	VBN	B-VP	O
by	by	IN	B-PP	O
two	two	CD	B-NP	O
copies	copy	NNS	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
AP-1	AP-1	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-cell_line
Jurkat	Jurkat	NN	I-NP	I-cell_line
T-cell	T-cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

Tax	Tax	NN	B-NP	B-protein
activates	activate	VBZ	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
viral	viral	JJ	B-NP	B-DNA
and	and	CC	I-NP	I-DNA
cellular	cellular	JJ	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
through	through	IN	B-PP	O
two	two	CD	B-NP	O
different	different	JJ	I-NP	O
enhancers	enhancer	NNS	I-NP	B-DNA
:	:	:	O	O
a	a	DT	O	O
cAMP-responsive	cAMP-responsive	JJ	O	B-DNA
(	(	(	O	I-DNA
CRE	CRE	NN	B-NP	I-DNA
)	)	)	O	I-DNA
-like	-like	JJ	B-NP	I-DNA
element	element	NN	I-NP	I-DNA
and	and	CC	O	O
a	a	DT	B-NP	O
kappaB	kappaB	NN	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
.	.	.	O	O

Two	Two	CD	B-NP	O
Tax	Tax	NN	I-NP	B-protein
mutants	mutant	NNS	I-NP	I-protein
differentially	differentially	RB	B-ADVP	O
activated	activate	VBD	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
elements	element	NNS	I-NP	O
.	.	.	O	O

Tax703	Tax703	NN	B-NP	B-protein
preferentially	preferentially	RB	B-ADVP	O
activated	activate	VBD	B-VP	O
the	the	DT	B-NP	O
kappaB	kappaB	NN	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
but	but	CC	B-NP	O
not	not	RB	I-NP	O
the	the	DT	B-NP	O
CRE-like	CRE-like	JJ	I-NP	O
one	one	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
TaxM22	TaxM22	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
reverse	reverse	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
Tax703	Tax703	NN	B-NP	B-protein
and	and	CC	I-NP	O
Tax	Tax	NN	I-NP	B-protein
,	,	,	B-NP	O
but	but	CC	I-NP	O
not	not	RB	I-NP	O
TaxM22	TaxM22	NN	B-NP	B-protein
,	,	,	O	O
converted	convert	VBD	B-VP	O
cell	cell	NN	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
mouse	mouse	NN	I-NP	B-cell_line
T-cell	T-cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
from	from	IN	B-PP	O
being	be	VBG	B-VP	O
interleukin	interleukin	NN	B-NP	O
(	(	(	O	O
IL	IL	NN	B-NP	O
)	)	)	O	O
-2-dependent	-2-dependent	JJ	B-ADJP	O
to	to	TO	B-PP	O
being	be	VBG	B-VP	O
IL-2-independent	IL-2-independent	JJ	B-ADJP	O
.	.	.	O	O

Unlike	Unlike	IN	B-PP	O
the	the	DT	B-NP	O
wild-type	wild-type	JJ	I-NP	B-protein
Tax	Tax	NN	I-NP	I-protein
,	,	,	I-NP	O
Tax703	Tax703	NN	I-NP	B-protein
and	and	CC	I-NP	O
TaxM22	TaxM22	NN	I-NP	B-protein
only	only	RB	B-ADVP	O
weakly	weakly	RB	I-ADVP	O
activated	activate	VBD	B-VP	O
the	the	DT	B-NP	O
AP-1	AP-1	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
T-cell	T-cell	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
Tax	Tax	NN	B-NP	B-protein
seems	seem	VBZ	B-VP	O
to	to	TO	I-VP	O
activate	activate	VB	I-VP	O
the	the	DT	B-NP	O
AP-1	AP-1	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
via	via	IN	B-PP	O
mechanisms	mechanism	NNS	B-NP	O
distinct	distinct	JJ	B-ADJP	O
from	from	IN	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
kappaB	kappaB	NN	B-NP	B-protein
or	or	CC	O	O
CRE-like	CRE-like	JJ	B-NP	B-DNA
elements	element	NNS	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
AP-1	AP-1	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
dispensable	dispensable	JJ	B-ADJP	O
for	for	IN	B-PP	O
IL-2-independent	IL-2-independent	JJ	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
CTLL-2	CTLL-2	NN	B-NP	B-protein
.	.	.	O	O

Electrophoretic	Electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
Tax	Tax	NN	B-NP	B-protein
induced	induce	VBD	B-VP	O
strong	strong	JJ	B-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
AP-1	AP-1	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
in	in	IN	B-PP	O
CTLL-2	CTLL-2	NN	B-NP	B-cell_line
,	,	,	O	O
whereas	whereas	IN	O	O
Tax703	Tax703	NN	B-NP	B-protein
did	do	VBD	B-VP	O
not	not	RB	O	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
binding	binding	NN	B-NP	O
activity	activity	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
AP-1	AP-1	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
Tax	Tax	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
binding	binding	NN	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
Tax	Tax	NN	B-NP	B-protein
in	in	IN	B-PP	O
CTLL-2	CTLL-2	NN	B-NP	B-cell_line
contained	contain	VBD	B-VP	O
JunD	JunD	NN	B-NP	B-protein
and	and	CC	I-NP	O
Fra-2	Fra-2	NN	I-NP	B-protein
.	.	.	O	O

Other	Other	JJ	B-NP	O
AP-1	AP-1	NN	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
undetectable	undetectable	JJ	B-ADJP	O
.	.	.	O	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
AP-1	AP-1	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
in	in	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
by	by	IN	B-PP	O
JunD	JunD	NN	B-NP	B-protein
and/or	and/or	CC	O	O
Fra-2	Fra-2	NN	B-NP	B-protein
was	be	VBD	B-VP	O
weak	weak	JJ	B-ADJP	O
.	.	.	O	O

c-Jun	c-Jun	NN	B-NP	B-protein
,	,	,	O	O
JunB	JunB	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
c-Fos	c-Fos	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
was	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
still	still	RB	B-ADJP	O
less	less	JJR	I-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
with	with	IN	B-PP	O
Tax	Tax	NN	B-NP	B-protein
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
by	by	IN	B-PP	O
Tax	Tax	NN	B-NP	B-protein
may	may	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
sufficient	sufficient	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
complete	complete	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-DNA
site	site	NN	I-NP	I-DNA
by	by	IN	B-PP	O
Tax	Tax	NN	B-NP	B-protein
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
Tax	Tax	NN	B-NP	B-protein
activates	activate	VBZ	B-VP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
cellular	cellular	JJ	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
with	with	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
by	by	IN	B-PP	O
inducing	induce	VBG	B-VP	O
the	the	DT	B-NP	O
DNA-binding	DNA-binding	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
a	a	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
distinct	distinct	JJ	B-ADJP	O
from	from	IN	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
CRE-like	CRE-like	JJ	B-NP	O
and	and	CC	I-NP	O
kappaB	kappaB	NN	I-NP	B-DNA
elements	element	NNS	I-NP	I-DNA
.	.	.	O	O

Copyright	Copyright	NN	B-NP	O
2001	2001	CD	I-NP	O
Academic	Academic	NNP	I-NP	O
Press	Press	NNP	I-NP	O
.	.	.	O	O

Strict	Strict	JJ	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
replication	replication	NN	I-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
genetic	genetic	JJ	I-NP	O
switch	switch	NN	I-NP	O
:	:	:	O	O
Tet	Tet	NN	B-NP	O
for	for	IN	B-PP	O
Tat	Tat	NN	B-NP	B-protein
.	.	.	O	O

Live-attenuated	Live-attenuated	JJ	B-NP	O
human	human	JJ	I-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
HIV-1	HIV-1	NN	B-NP	O
)	)	)	O	O
variants	variant	NNS	B-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
great	great	JJ	B-NP	O
promise	promise	NN	I-NP	O
as	as	IN	B-PP	O
AIDS	AIDS	NN	B-NP	O
vaccines	vaccine	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
continued	continue	VBD	B-VP	O
replication	replication	NN	B-NP	O
can	can	MD	B-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
selection	selection	NN	I-NP	O
of	of	IN	B-PP	O
faster-replicating	faster-replicating	JJ	B-NP	B-protein
variants	variant	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
pathogenic	pathogenic	JJ	B-ADJP	O
.	.	.	O	O

We	We	PRP	B-NP	O
therefore	therefore	RB	B-ADVP	O
designed	design	VBD	B-VP	O
HIV-1	HIV-1	NN	B-NP	B-DNA
genomes	genome	NNS	I-NP	I-DNA
that	that	WDT	B-NP	O
replicate	replicate	VBP	B-VP	O
exclusively	exclusively	RB	B-ADVP	O
upon	upon	IN	B-PP	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nontoxic	nontoxic	JJ	I-NP	O
effector	effector	NN	I-NP	O
doxycycline	doxycycline	NN	I-NP	O
(	(	(	O	O
dox	dox	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
achieved	achieve	VBN	I-VP	O
by	by	IN	B-PP	O
replacement	replacement	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
viral	viral	JJ	I-NP	O
TAR-Tat	TAR-Tat	NN	I-NP	O
system	system	NN	I-NP	O
for	for	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Escherichia	Escherichia	NNP	I-NP	O
coli-derived	coli-derived	JJ	I-NP	O
Tet	Tet	NN	I-NP	O
system	system	NN	I-NP	O
for	for	IN	B-PP	O
inducible	inducible	JJ	B-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
designer	designer	NN	I-NP	O
``	``	``	I-NP	O
HIV-rtTA	HIV-rtTA	NN	I-NP	O
''	''	''	I-NP	O
viruses	virus	NNS	I-NP	O
replicate	replicate	VBP	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
strictly	strictly	RB	I-NP	O
dox-dependent	dox-dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
both	both	CC	B-PP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
T-cell	T-cell	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
and	and	CC	B-PP	O
in	in	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
replication	replication	NN	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
fine-tuned	fine-tune	VBN	I-VP	O
by	by	IN	B-PP	O
simple	simple	JJ	B-NP	O
variation	variation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
dox	dox	NN	I-NP	O
concentration	concentration	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
HIV-rtTA	HIV-rtTA	NN	I-NP	O
viruses	virus	NNS	I-NP	O
provide	provide	VBP	B-VP	O
a	a	DT	B-NP	O
tool	tool	NN	I-NP	O
to	to	TO	B-VP	O
perform	perform	VB	I-VP	O
genetics	genetic	NNS	B-NP	O
,	,	,	O	O
e.g.	e.g.	FW	B-NP	O
,	,	,	I-NP	O
selection	selection	NN	I-NP	O
and	and	CC	I-NP	O
optimization	optimization	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
E.	E.	NNP	I-NP	O
coli-derived	coli-derived	JJ	I-NP	O
Tet	Tet	NN	I-NP	O
reagents	reagent	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
eukaryotic	eukaryotic	JJ	I-NP	O
background	background	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
such	such	JJ	B-NP	O
viruses	virus	NNS	I-NP	O
may	may	MD	B-VP	O
represent	represent	VB	I-VP	O
improved	improved	JJ	B-NP	O
vaccine	vaccine	NN	I-NP	O
candidates	candidate	NNS	I-NP	O
because	because	IN	B-SBAR	O
their	their	PRP$	B-NP	O
replication	replication	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
turned	turn	VBN	I-VP	O
on	on	RP	B-PRT	O
and	and	CC	O	O
off	off	RP	B-PRT	O
at	at	IN	B-PP	O
will	will	NN	B-NP	O
.	.	.	O	O

Synovial	Synovial	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
induced	induce	VBD	B-VP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
monocytic	monocytic	JJ	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

OBJECTIVE	OBJECTIVE	NN	B-NP	O
:	:	:	O	O
To	To	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
synovial	synovial	JJ	B-NP	O
fluids	fluid	NNS	I-NP	O
(	(	(	O	O
SF	SF	NN	B-NP	B-protein
)	)	)	O	O
on	on	IN	B-PP	O
DNA	DNA	NN	B-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
nuclear	nuclear	JJ	I-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
(	(	(	O	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Mono	Mono	NN	I-NP	B-cell_line
Mac	Mac	NN	I-NP	I-cell_line
6	6	CD	I-NP	I-cell_line
monocytic/macrophage	monocytic/macrophage	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
as	as	IN	B-PP	O
a	a	DT	B-NP	O
model	model	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
interaction	interaction	NN	I-NP	O
between	between	IN	B-PP	O
SF	SF	NN	B-NP	B-protein
and	and	CC	O	O
synovial	synovial	JJ	B-NP	B-cell_type
tissue	tissue	NN	I-NP	I-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
arthritis	arthritis	NN	B-NP	O
.	.	.	O	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
Mono	Mono	NN	B-NP	B-cell_line
Mac	Mac	NN	I-NP	I-cell_line
6	6	CD	B-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
incubated	incubate	VBN	I-VP	O
with	with	IN	B-PP	O
SF	SF	NN	B-NP	B-protein
from	from	IN	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
joints	joint	NNS	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
with	with	IN	B-PP	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
(	(	(	O	O
RA	RA	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
undifferentiated	undifferentiated	JJ	B-NP	O
seronegative	seronegative	JJ	I-NP	O
oligoarthritis	oligoarthritis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
osteoarthritis	osteoarthritis	NN	B-NP	O
(	(	(	O	O
OA	OA	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Nuclear	Nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
prepared	prepare	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Mono	Mono	NN	I-NP	B-cell_line
Mac	Mac	NN	I-NP	I-cell_line
6	6	CD	B-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
and	and	CC	O	O
RA	RA	NN	B-NP	O
synovial	synovial	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
by	by	IN	B-PP	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
analysis	analysis	NN	I-NP	O
(	(	(	O	O
EMSA	EMSA	NN	B-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
DNA	DNA	NN	I-NP	B-protein
binding	binding	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Induction	Induction	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
p65	p65	NN	I-NP	B-protein
(	(	(	O	I-protein
RelA	RelA	NN	B-NP	I-protein
)	)	)	O	I-protein
/p50	/p50	CD	B-NP	I-protein
heterodimer	heterodimer	NN	I-NP	I-protein
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
incubation	incubation	NN	B-NP	O
of	of	IN	B-PP	O
Mono	Mono	NN	B-NP	B-cell_line
Mac	Mac	NN	I-NP	I-cell_line
6	6	CD	B-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
with	with	IN	B-PP	O
SF	SF	NN	B-NP	B-protein
(	(	(	O	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
culture	culture	NN	B-NP	O
medium	medium	NN	I-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
5	5	CD	B-NP	O
of	of	IN	B-PP	O
8	8	CD	B-NP	O
subjects	subject	NNS	I-NP	O
with	with	IN	B-PP	O
RA	RA	NN	B-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
with	with	IN	B-PP	O
OA	OA	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
none	none	NN	B-NP	O
of	of	IN	B-PP	O
3	3	CD	B-NP	O
with	with	IN	B-PP	O
undifferentiated	undifferentiated	JJ	B-NP	O
seronegative	seronegative	JJ	I-NP	O
oligoarthritis	oligoarthritis	NN	I-NP	O
.	.	.	O	O

Incubation	Incubation	NN	B-NP	O
of	of	IN	B-PP	O
SF	SF	NN	B-NP	B-protein
with	with	IN	B-PP	O
neutralizing	neutralize	VBG	B-VP	B-protein
antibodies	antibody	NNS	B-NP	I-protein
against	against	IN	B-PP	O
tumor	tumor	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor-alpha	factor-alpha	NN	I-NP	I-protein
(	(	(	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
antibodies	antibody	NNS	B-NP	B-protein
against	against	IN	B-PP	O
interleukin	interleukin	NN	B-NP	B-protein
6	6	CD	I-NP	I-protein
(	(	(	O	O
IL-6	IL-6	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
significantly	significantly	RB	B-VP	O
reduced	reduce	VBD	I-VP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
p65/p50	p65/p50	NN	B-NP	B-protein
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
SF	SF	NN	B-NP	B-protein
from	from	IN	B-PP	O
subjects	subject	NNS	B-NP	O
with	with	IN	B-PP	O
RA	RA	NN	B-NP	B-protein
and	and	CC	I-NP	O
OA	OA	NN	I-NP	O
.	.	.	O	O

Unexpectedly	Unexpectedly	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
slowly	slowly	RB	I-NP	O
migrating	migrate	VBG	I-NP	O
SF	SF	NN	I-NP	B-protein
inducible	inducible	JJ	I-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
-binding	-binding	JJ	I-NP	O
complex	complex	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
EMSA	EMSA	NN	B-NP	O
of	of	IN	B-PP	O
Mono	Mono	NN	B-NP	B-cell_line
Mac	Mac	NN	I-NP	I-cell_line
6	6	CD	B-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
after	after	IN	B-PP	O
incubation	incubation	NN	B-NP	O
with	with	IN	B-PP	O
SF	SF	NN	B-NP	B-protein
from	from	IN	B-PP	O
5	5	CD	B-NP	O
of	of	IN	B-PP	O
8	8	CD	B-NP	O
RA	RA	NN	I-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
OA	OA	NN	I-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
complex	complex	NN	I-NP	O
by	by	IN	B-PP	O
SF	SF	NN	B-NP	B-protein
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
neutralization	neutralization	NN	B-NP	O
of	of	IN	B-PP	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
or	or	CC	I-NP	O
IL-6	IL-6	NN	I-NP	B-protein
in	in	IN	B-PP	O
SF	SF	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
complex	complex	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
inducible	inducible	JJ	B-ADJP	O
by	by	IN	B-PP	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
,	,	,	O	O
IL-1beta	IL-1beta	NN	B-NP	B-protein
,	,	,	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
/	/	SYM	I-NP	O
IL-1beta	IL-1beta	NN	I-NP	B-protein
,	,	,	O	O
IL-6	IL-6	NN	B-NP	B-protein
,	,	,	O	O
platelet	platelet	NN	B-NP	B-protein
derived	derive	VBN	I-NP	I-protein
growth	growth	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
lipopolysaccharide	lipopolysaccharide	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
tetradecanoyl	tetradecanoyl	NN	B-NP	O
phorbol	phorbol	NN	I-NP	O
acetate	acetate	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
slowly	slowly	RB	I-NP	B-protein
migrating	migrating	JJ	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
supershifted	supershifte	VBN	I-VP	O
with	with	IN	B-PP	O
antibodies	antibody	NNS	B-NP	B-protein
against	against	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
,	,	,	O	O
Jun	Jun	NN	B-NP	B-protein
,	,	,	O	O
or	or	CC	O	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	B-protein
coactivators	coactivator	NNS	I-NP	I-protein
p300	p300	NN	I-NP	B-protein
or	or	CC	I-NP	O
CBP	CBP	NN	I-NP	B-protein
.	.	.	O	O

A	A	DT	B-NP	O
NF-kappaB-binding	NF-kappaB-binding	JJ	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
with	with	IN	B-PP	O
similar	similar	JJ	B-NP	O
slow	slow	JJ	I-NP	O
mobility	mobility	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
prepared	prepare	VBN	B-VP	O
from	from	IN	B-PP	O
fresh	fresh	JJ	B-NP	O
human	human	JJ	I-NP	O
RA	RA	NN	I-NP	O
synovial	synovial	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
.	.	.	O	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
Biological	Biological	JJ	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
in	in	IN	B-PP	O
SF	SF	NN	B-NP	B-protein
from	from	IN	B-PP	O
RA	RA	NN	B-NP	O
and	and	CC	I-NP	O
OA	OA	NN	I-NP	O
subjects	subject	NNS	I-NP	O
is	be	VBZ	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
inducing	induce	VBG	B-VP	O
p65/p50	p65/p50	NN	B-NP	B-protein
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
macrophages	macrophage	NNS	B-NP	B-cell_type
.	.	.	O	O

A	A	DT	B-NP	O
property	property	NN	I-NP	O
of	of	IN	B-PP	O
SF	SF	NN	B-NP	B-protein
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
and	and	CC	O	O
other	other	JJ	B-NP	O
cytokines	cytokine	NNS	I-NP	B-protein
is	be	VBZ	B-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
slowly	slowly	RB	B-VP	O
migrating	migrate	VBG	I-VP	O
NF-kappaB-binding	NF-kappaB-binding	JJ	B-NP	B-protein
complex	complex	NN	I-NP	I-protein
.	.	.	O	O

Soluble	Soluble	JJ	B-NP	O
mediators	mediator	NNS	I-NP	O
in	in	IN	B-PP	O
SF	SF	NN	B-NP	O
of	of	IN	B-PP	O
subjects	subject	NNS	B-NP	O
with	with	IN	B-PP	O
RA	RA	NN	B-NP	B-protein
and	and	CC	I-NP	O
OA	OA	NN	I-NP	B-protein
can	can	MD	B-VP	O
therefore	therefore	RB	I-VP	O
modulate	modulate	VB	I-VP	O
binding	binding	NN	B-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
in	in	IN	B-PP	O
macrophages	macrophage	NNS	B-NP	B-cell_type
and	and	CC	O	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
arthritis	arthritis	NN	B-NP	O
.	.	.	O	O

Peroxisome	Peroxisome	NN	B-NP	B-protein
proliferator	proliferator	NN	I-NP	I-protein
activator	activator	NN	I-NP	I-protein
receptor-gamma	receptor-gamma	NN	I-NP	I-protein
agonists	agonist	NNS	I-NP	O
and	and	CC	O	O
15-deoxy-Delta	15-deoxy-Delta	NN	B-NP	O
(	(	(	O	O
12	12	CD	B-NP	O
,	,	,	I-NP	O
14	14	CD	I-NP	O
)	)	)	O	O
(	(	(	O	O
12	12	CD	B-NP	O
,	,	,	O	O
14	14	CD	B-NP	O
)	)	)	O	O
-PGJ	-PGJ	NN	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
induce	induce	VBP	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
malignant	malignant	JJ	I-NP	I-cell_type
B-lineage	B-lineage	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
research	research	NN	I-NP	O
described	describe	VBN	B-VP	O
herein	herein	RB	B-ADVP	O
evaluates	evaluate	VBZ	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
and	and	CC	O	O
functional	functional	JJ	B-NP	O
significance	significance	NN	I-NP	O
of	of	IN	B-PP	O
peroxisome	peroxisome	NN	B-NP	B-protein
proliferator	proliferator	NN	I-NP	I-protein
activator	activator	NN	I-NP	I-protein
receptor-gamma	receptor-gamma	NN	I-NP	I-protein
(	(	(	O	O
PPAR-gamma	PPAR-gamma	NN	B-NP	B-protein
)	)	)	O	O
on	on	IN	B-PP	O
B-lineage	B-lineage	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
mouse	mouse	NN	I-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
cells	cell	NNS	I-NP	O
reflective	reflective	JJ	B-ADJP	O
of	of	IN	B-PP	O
stages	stage	NNS	B-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
differentiation	differentiation	NN	I-NP	O
(	(	(	O	O
e.g.	e.g.	FW	B-NP	O
,	,	,	O	O
70Z/3	70Z/3	NN	B-NP	B-protein
,	,	,	O	O
CH31	CH31	NN	B-NP	B-protein
,	,	,	O	O
WEHI-231	WEHI-231	NN	B-NP	B-cell_line
,	,	,	O	O
CH12	CH12	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
J558	J558	NN	B-NP	B-protein
)	)	)	O	O
express	express	VBP	B-VP	O
PPAR-gamma	PPAR-gamma	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
and	and	CC	O	O
,	,	,	O	O
by	by	IN	B-PP	O
Western	Western	JJ	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
67-kDa	67-kDa	JJ	I-NP	B-protein
PPAR-gamma	PPAR-gamma	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

15-Deoxy-Delta	15-Deoxy-Delta	NN	B-NP	O
(	(	(	O	O
12	12	CD	B-NP	O
,	,	,	O	O
14	14	CD	B-NP	O
)	)	)	O	O
-PGJ	-PGJ	NN	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
(	(	(	O	O
15d-PGJ	15d-PGJ	NN	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
PPAR-gamma	PPAR-gamma	NN	I-NP	B-protein
agonist	agonist	NN	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
dose-dependent	dose-dependent	JJ	I-NP	O
antiproliferative	antiproliferative	JJ	I-NP	O
and	and	CC	I-NP	O
cytotoxic	cytotoxic	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
normal	normal	JJ	B-NP	O
and	and	CC	I-NP	O
malignant	malignant	JJ	I-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
as	as	IN	B-SBAR	O
shown	show	VBN	B-VP	O
by	by	IN	B-PP	O
[	[	(	O	O
(	(	(	O	O
3	3	CD	O	O
)	)	)	O	O
H	H	NN	B-NP	O
]	]	)	O	O
thymidine	thymidine	NN	B-NP	O
and	and	CC	O	O
3-	3-	CD	B-NP	O
[	[	(	O	O
4	4	CD	B-NP	O
,	,	,	O	O
5-dimethylthiazol-2-yl	5-dimethylthiazol-2-yl	NN	B-NP	O
]	]	)	O	O
-2	-2	CD	B-NP	O
,	,	,	O	O
5-diphenyltetrazolium	5-diphenyltetrazolium	NN	B-NP	O
bromide	bromide	NN	I-NP	O
assays	assay	NNS	I-NP	O
.	.	.	O	O

Only	Only	RB	B-NP	O
PPAR-gamma	PPAR-gamma	NN	I-NP	B-protein
agonists	agonist	NNS	I-NP	O
(	(	(	O	O
thiazolidinediones	thiazolidinedione	NNS	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
not	not	RB	O	O
PPAR-alpha	PPAR-alpha	NN	B-NP	B-protein
agonists	agonist	NNS	I-NP	O
,	,	,	O	O
mimicked	mimic	VBD	B-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
15d-PGJ	15d-PGJ	NN	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
B-lineage	B-lineage	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
15d-PGJ	15d-PGJ	NN	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
negatively	negatively	RB	B-ADVP	O
affects	affect	VBZ	B-VP	O
B-lineage	B-lineage	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
involves	involve	VBZ	B-VP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
PPAR-gamma	PPAR-gamma	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
PPAR-gamma	PPAR-gamma	NN	B-NP	B-protein
agonists	agonist	NNS	I-NP	O
induce	induce	VBP	B-VP	O
cytotoxicity	cytotoxicity	NN	B-NP	O
is	be	VBZ	B-VP	O
via	via	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
shown	show	VBN	B-VP	O
by	by	IN	B-PP	O
annexin	annexin	NN	B-NP	O
V	V	NN	I-NP	O
staining	staining	NN	I-NP	O
and	and	CC	O	O
as	as	IN	B-SBAR	O
confirmed	confirm	VBN	B-VP	O
by	by	IN	B-PP	O
DNA	DNA	NN	B-NP	O
fragmentation	fragmentation	NN	I-NP	O
detected	detect	VBN	B-VP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
TUNEL	TUNEL	NN	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
PGF	PGF	NN	B-NP	B-protein
(	(	(	O	O
2alpha	2alpha	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
affect	affect	VB	I-VP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
dramatically	dramatically	RB	B-VP	O
attenuated	attenuate	VBD	I-VP	O
the	the	DT	B-NP	O
deleterious	deleterious	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
PPAR-gamma	PPAR-gamma	NN	B-NP	B-protein
agonists	agonist	NNS	I-NP	O
on	on	IN	B-PP	O
B	B	NN	B-NP	O
lymphomas	lymphoma	NNS	I-NP	O
.	.	.	O	O

Surprisingly	Surprisingly	RB	B-ADVP	O
,	,	,	O	O
15d-PGJ	15d-PGJ	NN	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
induced	induce	VBD	B-VP	O
a	a	DT	B-NP	O
massive	massive	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
mitogen-activated	mitogen-activated	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
pretreatment	pretreatment	NN	B-NP	O
with	with	IN	B-PP	O
PGF	PGF	NN	B-NP	B-protein
(	(	(	O	O
2alpha	2alpha	NN	B-NP	O
)	)	)	O	O
blunted	blunt	VBD	B-VP	O
the	the	DT	B-NP	O
mitogen-activated	mitogen-activated	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
study	study	NN	I-NP	O
evaluating	evaluate	VBG	B-VP	O
PPAR-gamma	PPAR-gamma	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
significance	significance	NN	I-NP	O
on	on	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

PPAR-gamma	PPAR-gamma	NN	B-NP	B-protein
agonists	agonist	NNS	I-NP	O
may	may	MD	B-VP	O
serve	serve	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
counterbalance	counterbalance	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
stimulating	stimulate	VBG	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
PGs	PG	NNS	I-NP	B-protein
,	,	,	O	O
namely	namely	RB	B-NP	O
PGE	PGE	NN	I-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
promotes	promote	VBZ	B-VP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
differentiation	differentiation	NN	I-NP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
PGs	PG	NNS	B-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
15d-PGJ	15d-PGJ	NN	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
synthetic	synthetic	JJ	B-NP	O
PPAR-gamma	PPAR-gamma	NN	I-NP	O
agonists	agonist	NNS	I-NP	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
apoptosis	apoptosis	NN	B-NP	O
in	in	IN	B-PP	O
B-lineage	B-lineage	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
may	may	MD	B-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
novel	novel	JJ	B-NP	O
therapies	therapy	NNS	I-NP	O
for	for	IN	B-PP	O
fatal	fatal	JJ	B-NP	O
B	B	NN	I-NP	O
lymphomas	lymphoma	NNS	I-NP	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
STAT3	STAT3	NN	B-NP	B-protein
signaling	signaling	NN	I-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
of	of	IN	B-PP	O
leukemic	leukemic	JJ	B-NP	B-cell_type
large	large	JJ	I-NP	I-cell_type
granular	granular	JJ	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
decreased	decrease	VBN	B-NP	O
Mcl-1	Mcl-1	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

Large	Large	JJ	B-NP	B-cell_type
granular	granular	JJ	I-NP	I-cell_type
lymphocyte	lymphocyte	NN	I-NP	I-cell_type
(	(	(	O	O
LGL	LGL	NN	B-NP	B-cell_type
)	)	)	O	O
leukemia	leukemia	NN	B-NP	O
is	be	VBZ	B-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
expansion	expansion	NN	I-NP	O
of	of	IN	B-PP	O
antigen-activated	antigen-activated	JJ	B-NP	B-cell_type
cytotoxic	cytotoxic	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

These	These	DT	B-NP	O
leukemic	leukemic	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
Fas-mediated	Fas-mediated	JJ	B-NP	O
apoptosis	apoptosis	NN	I-NP	O
despite	despite	IN	B-PP	O
expressing	express	VBG	B-VP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
Fas	Fas	NN	B-NP	B-protein
.	.	.	O	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
leukemic	leukemic	JJ	B-NP	O
LGL	LGL	NN	I-NP	O
from	from	IN	B-PP	O
19	19	CD	B-NP	O
patients	patient	NNS	I-NP	O
displayed	display	VBD	B-VP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
activated	activate	VBN	B-NP	O
STAT3	STAT3	NN	I-NP	B-protein
.	.	.	O	O

Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
leukemic	leukemic	JJ	B-NP	O
LGL	LGL	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
JAK-selective	JAK-selective	JJ	I-NP	B-protein
tyrosine	tyrosine	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	O
AG-490	AG-490	NN	I-NP	O
induced	induce	VBD	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
corresponding	corresponding	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
STAT	STAT	NN	B-NP	B-protein
-DNA	-DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
using	use	VBG	B-VP	O
an	an	DT	B-NP	O
antisense	antisense	JJ	I-NP	O
oligonucleotide	oligonucleotide	NN	I-NP	O
approach	approach	NN	I-NP	O
to	to	TO	B-VP	O
diminish	diminish	VB	I-VP	O
STAT3	STAT3	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
Fas	Fas	NN	B-NP	B-protein
sensitivity	sensitivity	NN	I-NP	O
was	be	VBD	B-VP	O
restored	restore	VBN	I-VP	O
in	in	IN	B-PP	O
leukemic	leukemic	JJ	B-NP	B-cell_type
LGL	LGL	NN	I-NP	I-cell_type
.	.	.	O	O

AG-490-induced	AG-490-induced	JJ	B-NP	O
apoptosis	apoptosis	NN	I-NP	O
in	in	IN	B-PP	O
leukemic	leukemic	JJ	B-NP	B-cell_type
LGL	LGL	NN	I-NP	I-cell_type
was	be	VBD	B-VP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
Bcl-xL	Bcl-xL	NN	B-NP	B-protein
or	or	CC	I-NP	O
Bcl-2	Bcl-2	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
Bcl-2-family	Bcl-2-family	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
Mcl-1	Mcl-1	NN	I-NP	B-protein
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
by	by	IN	B-PP	O
AG-490	AG-490	NN	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

Activated	Activate	VBN	B-NP	O
STAT3	STAT3	NN	I-NP	B-protein
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
bind	bind	VB	I-VP	O
an	an	DT	B-NP	O
SIE-related	SIE-related	JJ	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	B-DNA
mcl-1	mcl-1	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

Using	Use	VBG	B-VP	O
a	a	DT	B-NP	O
luciferase	luciferase	NN	I-NP	O
reporter	reporter	NN	I-NP	O
assay	assay	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
v-src	v-src	JJ	B-NP	O
overexpression	overexpression	NN	I-NP	O
in	in	IN	B-PP	O
NIH3T3	NIH3T3	NN	B-NP	B-protein
induced	induce	VBD	B-VP	O
STAT3	STAT3	NN	B-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
mcl-1	mcl-1	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
and	and	CC	O	O
increased	increase	VBD	B-VP	O
endogenous	endogenous	JJ	B-NP	O
Mcl-1	Mcl-1	NN	I-NP	O
protein	protein	NN	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
STAT3	STAT3	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
contributed	contribute	VBD	B-VP	O
to	to	TO	B-PP	O
accumulation	accumulation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
leukemic	leukemic	JJ	I-NP	B-cell_line
LGL	LGL	NN	I-NP	I-cell_line
clones	clone	NNS	I-NP	I-cell_line
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
investigation	investigation	NN	B-NP	O
should	should	MD	B-VP	O
focus	focus	VB	I-VP	O
on	on	IN	B-PP	O
novel	novel	JJ	B-NP	O
strategies	strategy	NNS	I-NP	O
targeting	target	VBG	B-VP	O
STAT3	STAT3	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
LGL	LGL	NN	B-NP	O
leukemia	leukemia	NN	I-NP	O
.	.	.	O	O

Decreased	Decrease	VBN	B-NP	O
immediate	immediate	JJ	I-NP	B-DNA
inflammatory	inflammatory	JJ	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
induction	induction	NN	I-NP	O
in	in	IN	B-PP	O
activating	activate	VBG	B-VP	O
transcription	transcription	NN	B-NP	O
factor-2	factor-2	NN	I-NP	O
mutant	mutant	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

Transcription	Transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
activating	activate	VBG	B-VP	O
transcription	transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
ATF	ATF	NN	B-NP	O
)	)	)	O	O
-2	-2	CD	B-NP	O
is	be	VBZ	B-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	O
signals	signal	NNS	I-NP	O
transduced	transduce	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
JNK	JNK	NN	I-NP	B-protein
and	and	CC	I-NP	O
p38	p38	NN	I-NP	B-protein
MAP	MAP	NN	I-NP	O
kinase	kinase	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
better	well	RBR	I-VP	O
define	define	VB	I-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
ATF-2	ATF-2	NN	B-NP	B-protein
in	in	IN	B-PP	O
inflammation	inflammation	NN	B-NP	O
,	,	,	O	O
adult	adult	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
expressing	express	VBG	B-VP	O
small	small	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
mutant	mutant	JJ	I-NP	B-protein
ATF-2	ATF-2	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
were	be	VBD	B-VP	O
challenged	challenge	VBN	I-VP	O
with	with	IN	B-PP	O
lipopolysaccharide	lipopolysaccharide	NN	B-NP	O
(	(	(	O	O
LPS	LPS	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
anti-CD3	anti-CD3	JJ	B-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
or	or	CC	I-NP	O
virus	virus	NN	I-NP	O
.	.	.	O	O

Within	Within	IN	B-PP	O
3	3	CD	B-NP	O
h	h	NN	I-NP	O
of	of	IN	B-PP	O
challenge	challenge	NN	B-NP	O
by	by	IN	B-PP	O
LPS	LPS	NN	B-NP	O
,	,	,	O	O
ATF-2	ATF-2	NN	B-NP	B-protein
mutant	mutant	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
had	have	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
adhesion	adhesion	NN	I-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
E-selectin	E-selectin	NN	I-NP	B-protein
,	,	,	I-NP	O
P-selectin	P-selectin	NN	I-NP	B-protein
and	and	CC	I-NP	O
VCAM-1	VCAM-1	NN	I-NP	B-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
cytokines	cytokine	NNS	I-NP	B-protein
tumor	tumor	NN	I-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor-alpha	factor-alpha	NN	I-NP	I-protein
,	,	,	O	O
IL-1beta	IL-1beta	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-6	IL-6	NN	I-NP	B-protein
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
control	control	NN	B-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

Stimulation	Stimulation	NN	B-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
anti-CD3	anti-CD3	JJ	B-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
less	less	JJR	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
IL-1	IL-1	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-6	IL-6	NN	I-NP	B-protein
in	in	IN	B-PP	O
ATF-2	ATF-2	NN	B-NP	B-protein
mutant	mutant	JJ	I-NP	O
tissues	tissue	NNS	I-NP	O
.	.	.	O	O

ATF-2	ATF-2	NN	B-NP	B-protein
mutant	mutant	JJ	I-NP	O
thymocytes	thymocyte	NNS	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
anti-CD3	anti-CD3	JJ	B-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
demonstrated	demonstrate	VBD	B-VP	O
reduced	reduce	VBN	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
c-Jun	c-Jun	NN	B-NP	B-protein
,	,	,	O	O
JunB	JunB	NN	B-NP	B-protein
,	,	,	O	O
JunD	JunD	NN	B-NP	B-protein
and	and	CC	I-NP	O
Fra-2	Fra-2	NN	I-NP	B-protein
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
what	what	WP	B-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
after	after	IN	B-PP	O
p38	p38	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
inhibition	inhibition	NN	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
relative	relative	JJ	B-NP	O
ATF-2	ATF-2	NN	I-NP	B-protein
deficiency	deficiency	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
prevent	prevent	VB	I-VP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
mononuclear	mononuclear	JJ	I-NP	O
cell	cell	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
following	follow	VBG	B-PP	O
an	an	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
stimulus	stimulus	NN	I-NP	O
.	.	.	O	O

ATF-2	ATF-2	NN	B-NP	B-protein
mutant	mutant	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
proved	prove	VBD	B-VP	O
more	more	RBR	B-ADJP	O
susceptible	susceptible	JJ	I-ADJP	O
to	to	TO	B-PP	O
death	death	NN	B-NP	O
than	than	IN	B-PP	O
control	control	NN	B-NP	O
mice	mouse	NNS	I-NP	O
from	from	IN	B-PP	O
LPS	LPS	NN	B-NP	O
plus	plus	CC	I-NP	O
D-galactosamine	D-galactosamine	NN	B-NP	O
injection	injection	NN	I-NP	O
or	or	CC	O	O
Coxsackievirus	Coxsackievirus	NN	B-NP	O
B3	B3	NN	I-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
mononuclear	mononuclear	JJ	B-NP	B-cell_type
pulmonary	pulmonary	JJ	I-NP	I-cell_type
infiltrates	infiltrate	NNS	I-NP	I-cell_type
after	after	IN	B-PP	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-PP	O
Herpes	Herpes	NNP	B-NP	O
simplex	simplex	NN	I-NP	O
virus-1	virus-1	NN	I-NP	O
.	.	.	O	O

ATF-2	ATF-2	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
maximal	maximal	JJ	B-NP	O
immediate	immediate	JJ	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
adhesion	adhesion	NN	B-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
and	and	CC	O	O
cytokine	cytokine	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
,	,	,	O	O
but	but	CC	O	O
at	at	IN	B-PP	O
later	late	JJR	B-NP	O
time	time	NN	I-NP	O
points	point	NNS	I-NP	O
may	may	MD	B-VP	O
even	even	RB	I-VP	O
protect	protect	VB	I-VP	O
against	against	IN	B-PP	O
overactive	overactive	JJ	B-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
.	.	.	O	O

LIGHT	LIGHT	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
TNF-like	TNF-like	JJ	I-NP	B-protein
molecule	molecule	NN	I-NP	I-protein
,	,	,	O	O
costimulates	costimulate	VBZ	B-VP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
proliferation	proliferation	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
dendritic	dendritic	JJ	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
-mediated	-mediated	JJ	I-NP	O
allogeneic	allogeneic	JJ	I-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

LIGHT	LIGHT	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
recently	recently	RB	I-NP	O
identified	identify	VBN	I-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TNF	TNF	NN	I-NP	B-protein
superfamily	superfamily	NN	I-NP	I-protein
and	and	CC	O	O
its	its	PRP$	B-NP	O
receptors	receptor	NNS	I-NP	O
,	,	,	O	O
herpesvirus	herpesvirus	NN	B-NP	B-protein
entry	entry	NN	I-NP	I-protein
mediator	mediator	NN	I-NP	I-protein
and	and	CC	O	O
lymphotoxin	lymphotoxin	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
,	,	,	O	O
are	be	VBP	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
stromal	stromal	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
LIGHT	LIGHT	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
selectively	selectively	RB	I-VP	O
expressed	express	VBN	I-VP	O
on	on	IN	B-PP	O
immature	immature	JJ	B-NP	B-cell_type
dendritic	dendritic	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
DCs	DC	NNS	B-NP	B-cell_type
)	)	)	O	O
generated	generate	VBN	B-VP	O
from	from	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
PBMCs	PBMC	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
LIGHT	LIGHT	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
not	not	RB	O	O
detectable	detectable	JJ	B-ADJP	O
in	in	IN	B-PP	O
DCs	DC	NNS	B-NP	B-cell_type
either	either	CC	O	O
freshly	freshly	RB	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
PBMCs	PBMC	NNS	B-NP	B-cell_type
or	or	CC	O	O
rendered	render	VBN	B-VP	O
mature	mature	JJ	B-ADJP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
by	by	IN	B-PP	O
LPS	LPS	NN	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

Blockade	Blockade	NN	B-NP	O
of	of	IN	B-PP	O
LIGHT	LIGHT	NN	B-NP	B-protein
by	by	IN	B-PP	O
its	its	PRP$	B-NP	O
soluble	soluble	JJ	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
,	,	,	O	O
lymphotoxin	lymphotoxin	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
receptor-Ig	receptor-Ig	NN	I-NP	I-protein
or	or	CC	I-NP	O
HVEM-Ig	HVEM-Ig	NN	I-NP	B-protein
,	,	,	O	O
inhibits	inhibit	VBZ	B-VP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
DC	DC	NN	B-NP	B-cell_type
-mediated	-mediated	JJ	I-NP	O
primary	primary	JJ	I-NP	O
allogeneic	allogeneic	JJ	I-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
engagement	engagement	NN	B-NP	O
of	of	IN	B-PP	O
LIGHT	LIGHT	NN	B-NP	O
costimulates	costimulate	VBZ	B-VP	O
human	human	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
proliferation	proliferation	NN	I-NP	O
,	,	,	O	O
amplifies	amplify	VBZ	B-VP	O
the	the	DT	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
signaling	signaling	NN	I-NP	O
pathway	pathway	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
preferentially	preferentially	RB	B-VP	O
induces	induce	VBZ	I-VP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
,	,	,	B-NP	O
but	but	CC	I-NP	O
not	not	RB	I-NP	O
IL-4	IL-4	NN	B-NP	B-protein
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
antigenic	antigenic	JJ	I-NP	O
signal	signal	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
LIGHT	LIGHT	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
costimulatory	costimulatory	JJ	I-NP	B-protein
molecule	molecule	NN	I-NP	I-protein
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
DC	DC	NN	B-NP	B-cell_type
-mediated	-mediated	JJ	I-NP	O
cellular	cellular	JJ	I-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
.	.	.	O	O

Suppression	Suppression	NN	B-NP	O
of	of	IN	B-PP	O
HIV	HIV	NN	B-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
replication	replication	NN	I-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
dominant-negative	dominant-negative	JJ	I-NP	B-protein
Ets-1	Ets-1	NN	I-NP	I-protein
mutant	mutant	NN	I-NP	I-protein
.	.	.	O	O

Activity	Activity	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
immunodeficiency	immunodeficiency	NN	I-NP	I-DNA
virus	virus	NN	I-NP	I-DNA
(	(	(	O	I-DNA
HIV-1	HIV-1	NN	B-NP	I-DNA
)	)	)	O	I-DNA
long	long	JJ	B-NP	I-DNA
terminal	terminal	JJ	I-NP	I-DNA
repeat	repeat	NN	I-NP	I-DNA
(	(	(	O	O
LTR	LTR	NN	B-NP	B-DNA
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
binding	bind	VBG	B-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
for	for	IN	B-PP	O
the	the	DT	B-NP	O
Ets-1	Ets-1	NN	I-NP	B-protein
and	and	CC	I-NP	O
USF-1	USF-1	NN	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
,	,	,	O	O
is	be	VBZ	B-VP	O
integral	integral	JJ	B-ADJP	O
for	for	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	O
replication	replication	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Ets-1	Ets-1	NN	I-NP	B-protein
and	and	CC	I-NP	O
USF-1	USF-1	NN	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
play	play	VBP	B-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HIV-1	HIV-1	NN	I-NP	B-DNA
LTR	LTR	NN	I-NP	I-DNA
distal	distal	JJ	I-NP	O
enhancer	enhancer	NN	I-NP	O
region	region	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
indicated	indicate	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
potent	potent	JJ	I-NP	O
dominant	dominant	JJ	I-NP	O
negative	negative	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
mutant	mutant	JJ	I-NP	O
Ets-1	Ets-1	NN	I-NP	B-protein
lacking	lack	VBG	B-VP	O
trans-activation	trans-activation	NN	B-NP	B-protein
domains	domain	NNS	I-NP	I-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
LTR	LTR	NN	I-NP	B-DNA
.	.	.	O	O

To	To	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
biological	biological	JJ	I-NP	O
relevance	relevance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ets-1	Ets-1	NN	I-NP	B-protein
and	and	CC	I-NP	O
USF-1	USF-1	NN	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
in	in	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	O
replication	replication	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
dominant-negative	dominant-negative	JJ	I-NP	B-protein
mutant	mutant	NN	I-NP	I-protein
of	of	IN	B-PP	O
Ets-1	Ets-1	NN	B-NP	B-protein
(	(	(	O	O
dnEts-1	dnEts-1	NN	B-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	O
infection	infection	NN	I-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
dnEts	dnEt	NNS	B-NP	O
markedly	markedly	RB	B-ADVP	O
suppressed	suppress	VBD	B-VP	O
HIV-1	HIV-1	NN	B-NP	O
infection	infection	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
T	T	NN	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

This	This	DT	B-NP	O
finding	finding	NN	I-NP	O
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
formation	formation	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
transcriptionaly	transcriptionaly	RB	I-NP	O
active	active	JJ	I-NP	O
USF-1/Ets-1	USF-1/Ets-1	NN	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
productive	productive	JJ	I-NP	O
infection	infection	NN	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
by	by	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
interaction	interaction	NN	I-NP	O
between	between	IN	B-PP	O
USF-1	USF-1	NN	B-NP	B-protein
and	and	CC	I-NP	O
Ets-1	Ets-1	NN	I-NP	B-protein
with	with	IN	B-PP	O
the	the	DT	B-NP	O
HIV-1	HIV-1	NN	I-NP	B-DNA
LTR	LTR	NN	I-NP	I-DNA
may	may	MD	B-VP	O
provide	provide	VB	I-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
target	target	NN	I-NP	O
for	for	IN	B-PP	O
anti-HIV-1	anti-HIV-1	NN	B-NP	O
gene	gene	NN	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

Human	Human	JJ	B-NP	B-cell_type
eosinophils	eosinophil	NNS	I-NP	I-cell_type
constitutively	constitutively	RB	B-ADVP	O
express	express	VBP	B-VP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
of	of	IN	B-PP	I-protein
activated	activate	VBN	B-NP	I-protein
T	T	NN	I-NP	I-protein
cells	cell	NNS	I-NP	I-protein
p	p	NN	I-NP	O
and	and	CC	I-NP	O
c	c	NN	I-NP	O
.	.	.	O	O

BACKGROUND	BACKGROUND	NN	B-NP	O
:	:	:	O	O
Eosinophils	Eosinophil	NNS	B-NP	B-cell_type
are	be	VBP	B-VP	O
now	now	RB	I-VP	O
known	know	VBN	I-VP	O
to	to	TO	B-VP	O
produce	produce	VB	I-VP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
proinflammatory	proinflammatory	JJ	B-NP	B-protein
cytokines	cytokine	NNS	I-NP	I-protein
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
regulate	regulate	VBP	B-VP	O
their	their	PRP$	B-NP	O
production	production	NN	I-NP	O
are	be	VBP	B-VP	O
poorly	poorly	RB	I-VP	O
understood	understand	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
almost	almost	RB	B-NP	O
all	all	DT	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cytokines	cytokine	NNS	I-NP	B-protein
produced	produce	VBN	B-VP	O
by	by	IN	B-PP	O
eosinophils	eosinophil	NNS	B-NP	B-cell_type
,	,	,	O	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
proallergic	proallergic	JJ	I-NP	O
cytokine	cytokine	NN	I-NP	B-protein
IL-4	IL-4	NN	I-NP	B-protein
,	,	,	O	O
is	be	VBZ	B-VP	O
now	now	RB	I-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
regulated	regulate	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
by	by	IN	B-PP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
of	of	IN	B-PP	I-protein
activated	activate	VBN	B-NP	I-protein
T	T	NN	I-NP	I-protein
cells	cell	NNS	I-NP	I-protein
(	(	(	O	O
NFAT	NFAT	NN	B-NP	B-protein
)	)	)	O	O
family	family	NN	B-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

OBJECTIVE	OBJECTIVE	NN	B-NP	O
:	:	:	O	O
We	We	PRP	B-NP	O
sought	seek	VBD	B-VP	O
to	to	TO	I-VP	O
characterize	characterize	VB	I-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
NFAT	NFAT	NN	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
in	in	IN	B-PP	O
resting	rest	VBG	B-NP	O
and	and	CC	I-NP	O
activated	activate	VBN	I-NP	B-cell_type
eosinophils	eosinophil	NNS	I-NP	I-cell_type
.	.	.	O	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
Nuclear	Nuclear	JJ	B-NP	O
and	and	CC	I-NP	O
whole	whole	JJ	I-NP	O
cell	cell	NN	I-NP	O
extracts	extract	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
both	both	CC	B-NP	O
peripheral	peripheral	JJ	I-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
eosinophils	eosinophil	NNS	I-NP	I-cell_type
and	and	CC	O	O
those	those	DT	B-NP	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
bronchoalveolar	bronchoalveolar	JJ	B-NP	O
lavage	lavage	NN	I-NP	O
fluid	fluid	NN	I-NP	O
of	of	IN	B-PP	O
asthmatic	asthmatic	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
after	after	IN	B-PP	O
endobronchial	endobronchial	JJ	B-NP	O
allergen	allergen	NN	I-NP	O
challenge	challenge	NN	I-NP	O
.	.	.	O	O

NFAT	NFAT	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
immunoprecipitation	immunoprecipitation	NN	B-NP	O
and	and	CC	I-NP	O
Western	Western	NN	I-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
DNA-binding	DNA-binding	JJ	B-NP	O
assays	assay	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
RT-PCR	RT-PCR	NN	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
eosinophil	eosinophil	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Both	Both	CC	O	O
peripheral	peripheral	JJ	B-NP	O
blood	blood	NN	I-NP	O
and	and	CC	O	O
bronchoalveolar	bronchoalveolar	JJ	B-NP	B-cell_type
lavage	lavage	NN	I-NP	I-cell_type
fluid	fluid	NN	I-NP	I-cell_type
eosinophils	eosinophil	NNS	I-NP	I-cell_type
expressed	express	VBD	B-VP	O
NFATp	NFATp	NN	B-NP	B-protein
and	and	CC	I-NP	O
NFATc	NFATc	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

Unlike	Unlike	IN	B-PP	O
activated	activate	VBN	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
which	which	WDT	B-NP	O
express	express	VBP	B-VP	O
multiple	multiple	JJ	B-NP	O
NFATc	NFATc	NN	I-NP	B-protein
isoforms	isoform	NNS	I-NP	I-protein
,	,	,	O	O
eosinophils	eosinophil	NNS	B-NP	B-cell_type
preferentially	preferentially	RB	B-ADVP	O
express	express	VBP	B-VP	O
the	the	DT	B-NP	O
approximately	approximately	RB	I-NP	O
85-kd	85-kd	JJ	I-NP	B-protein
isoform	isoform	NN	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
eosinophils	eosinophil	NNS	B-NP	B-cell_type
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
constitutively	constitutively	RB	I-VP	O
express	express	VB	I-VP	O
NFATc	NFATc	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
.	.	.	O	O

A	A	DT	B-NP	O
brief	brief	JJ	I-NP	O
incubation	incubation	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-protein
(	(	(	O	I-protein
H	H	NN	B-NP	I-protein
)	)	)	O	I-protein
2	2	CD	B-NP	I-protein
cytokines	cytokine	NNS	I-NP	I-protein
IL-4	IL-4	NN	I-NP	B-protein
and	and	CC	I-NP	O
IL-5	IL-5	NN	I-NP	B-protein
was	be	VBD	B-VP	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
translocation	translocation	NN	I-NP	O
of	of	IN	B-PP	O
NFATc	NFATc	NN	B-NP	B-protein
.	.	.	O	O

Eosinophil	Eosinophil	NN	B-NP	O
nuclear	nuclear	JJ	I-NP	O
extracts	extract	NNS	I-NP	O
contain	contain	VBP	B-VP	O
multiple	multiple	JJ	B-NP	O
factors	factor	NNS	I-NP	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
specifically	specifically	RB	I-VP	O
recognize	recognize	VB	I-VP	O
the	the	DT	B-NP	O
IL-4	IL-4	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
P1	P1	NN	I-NP	I-DNA
NFAT	NFAT	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
in	in	IN	B-PP	O
DNA-binding	DNA-binding	JJ	B-NP	O
assays	assay	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
NFATp	NFATp	NN	B-NP	B-protein
.	.	.	O	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
NFATp	NFATp	NN	B-NP	B-protein
and	and	CC	I-NP	O
NFATc	NFATc	NN	I-NP	B-protein
can	can	MD	B-VP	O
regulate	regulate	VB	I-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
cytokines	cytokine	NNS	B-NP	B-protein
and	and	CC	O	O
other	other	JJ	B-NP	O
genes	gene	NNS	I-NP	O
in	in	IN	B-PP	O
eosinophils	eosinophil	NNS	B-NP	B-cell_type
but	but	CC	O	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
mechanism	mechanism	NN	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

BLyS	BLyS	NN	B-NP	O
BINDS	BINDS	NNS	I-NP	O
TO	TO	TO	B-PP	O
B	B	NN	B-NP	O
CELLS	CELLS	NN	I-NP	O
WITH	WITH	NN	I-NP	O
HIGH	HIGH	NN	I-NP	O
AFFINITY	AFFINITY	NN	I-NP	O
AND	AND	CC	O	O
INDUCES	INDUCES	VBZ	B-VP	O
ACTIVATION	ACTIVATION	NN	B-NP	O
OF	OF	IN	B-PP	O
THE	THE	DT	B-NP	O
TRANSCRIPTION	TRANSCRIPTION	NN	I-NP	B-protein
FACTORS	FACTORS	NN	I-NP	I-protein
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
AND	AND	NN	I-NP	O
ELF-1	ELF-1	NN	I-NP	B-protein
.	.	.	O	O

B	B	NN	B-NP	B-cell_type
lymphocyte	lymphocyte	NN	I-NP	I-cell_type
stimulator	stimulator	NN	I-NP	O
(	(	(	O	O
BLyS	BLyS	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TNF	TNF	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
of	of	IN	B-PP	O
proteins	protein	NNS	B-NP	O
expressed	express	VBN	B-VP	O
by	by	IN	B-PP	O
myeloid	myeloid	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
as	as	IN	B-PP	O
membrane-bound	membrane-bound	JJ	B-NP	B-protein
and	and	CC	I-NP	I-protein
soluble	soluble	JJ	I-NP	I-protein
forms	form	NNS	I-NP	I-protein
.	.	.	O	O

BLyS	BLyS	NN	B-NP	O
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
act	act	VB	I-VP	O
specifically	specifically	RB	B-ADVP	O
on	on	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
inducing	induce	VBG	B-VP	O
proliferation	proliferation	NN	B-NP	O
and	and	CC	O	O
immunoglobulin	immunoglobulin	NN	B-NP	B-protein
production	production	NN	I-NP	O
both	both	CC	O	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
undertaken	undertake	VBN	I-VP	O
to	to	TO	I-VP	O
characterize	characterize	VB	I-VP	O
binding	binding	NN	B-NP	O
of	of	IN	B-PP	O
radiolabeled	radiolabele	VBN	B-NP	O
BLyS	BLyS	NN	I-NP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
cognate	cognate	JJ	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
on	on	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
examine	examine	VB	B-VP	O
intracellular	intracellular	JJ	B-NP	O
events	event	NNS	I-NP	O
initiated	initiate	VBN	B-VP	O
by	by	IN	B-PP	O
BLyS	BLyS	NN	B-NP	O
binding	binding	NN	I-NP	O
.	.	.	O	O

Similar	Similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
other	other	JJ	B-NP	O
TNF	TNF	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
members	member	NNS	I-NP	I-protein
,	,	,	O	O
BLyS	BLyS	NN	B-NP	O
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
solution	solution	NN	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
homotrimer	homotrimer	NN	I-NP	O
as	as	IN	B-SBAR	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
gel	gel	NN	B-NP	O
filtration	filtration	NN	I-NP	O
chromatography	chromatography	NN	I-NP	O
and	and	CC	O	O
light	light	NN	B-NP	O
scattering	scattering	NN	I-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O

BLyS	BLyS	NN	B-NP	O
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
specific	specific	JJ	B-ADJP	O
as	as	IN	B-SBAR	O
other	other	JJ	B-NP	O
TNF	TNF	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
members	member	NNS	I-NP	I-protein
tested	test	VBN	B-VP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
compete	compete	VB	I-VP	O
for	for	IN	B-PP	O
(	(	(	O	O
125	125	CD	B-NP	O
)	)	)	O	O
I-	I-	NN	B-NP	O
BLyS	BLyS	NN	I-NP	O
binding	binding	NN	I-NP	O
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
equilibrium	equilibrium	NN	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
(	(	(	O	O
125	125	CD	B-NP	O
)	)	)	O	O
I-labeled	I-labeled	JJ	B-NP	O
BLyS	BLyS	NN	I-NP	O
to	to	TO	B-PP	O
purified	purify	VBN	B-NP	O
human	human	JJ	I-NP	B-cell_type
tonsillar	tonsillar	JJ	I-NP	I-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
demonstrated	demonstrate	VBD	B-VP	O
saturable	saturable	JJ	B-NP	O
binding	binding	NN	I-NP	O
.	.	.	O	O

Scatchard	Scatchard	NN	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
binding	bind	VBG	I-NP	O
data	datum	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
class	class	NN	I-NP	O
of	of	IN	B-PP	O
high-affinity	high-affinity	JJ	B-NP	O
binding	binding	NN	I-NP	O
on	on	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
approximately	approximately	RB	B-NP	O
2600	2600	CD	I-NP	B-DNA
binding	bind	VBG	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
per	per	IN	B-PP	O
cell	cell	NN	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
dissociation	dissociation	NN	I-NP	O
constant	constant	NN	I-NP	O
(	(	(	O	O
K	K	NN	B-NP	O
(	(	(	O	O
D	D	NN	B-NP	O
)	)	)	O	O
)	)	)	O	O
of	of	IN	B-PP	O
about	about	RB	B-NP	O
0.1	0.1	CD	I-NP	O
nM	nM	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
that	that	IN	B-SBAR	O
BLyS	BLyS	NN	B-NP	O
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
and	and	CC	O	O
the	the	DT	B-NP	O
Ets	Ets	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
ELF-1	ELF-1	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
mRNA	mRNA	NN	B-NP	B-RNA
for	for	IN	B-PP	O
Polo-like	Polo-like	JJ	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
PLK	PLK	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Copyright	Copyright	NN	B-NP	O
2001	2001	CD	I-NP	O
Academic	Academic	NNP	I-NP	O
Press	Press	NNP	I-NP	O
.	.	.	O	O

Design	Design	NN	B-NP	O
and	and	CC	I-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
inducibly	inducibly	RB	I-NP	O
activated	activate	VBN	I-NP	O
human	human	JJ	I-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
Nef	Nef	NN	I-NP	B-protein
to	to	TO	B-VP	O
study	study	VB	I-VP	O
immune	immune	JJ	B-NP	O
modulation	modulation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Nef	Nef	NN	I-NP	B-protein
protein	protein	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
HIV-1	HIV-1	NN	B-NP	O
)	)	)	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
enhance	enhance	VB	I-VP	O
the	the	DT	B-NP	O
infectivity	infectivity	NN	I-NP	O
of	of	IN	B-PP	O
virus	virus	NN	B-NP	O
particles	particle	NNS	I-NP	O
,	,	,	O	O
downmodulate	downmodulate	VBP	B-VP	O
cell	cell	NN	B-NP	B-protein
surface	surface	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
associate	associate	VBP	B-VP	O
with	with	IN	B-PP	O
many	many	JJ	B-NP	B-protein
intracellular	intracellular	JJ	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
facilitate	facilitate	VB	I-VP	O
HIV	HIV	NN	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
challenges	challenge	NNS	I-NP	O
in	in	IN	B-PP	O
defining	define	VBG	B-VP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
events	event	NNS	I-NP	O
regulated	regulate	VBN	B-VP	O
by	by	IN	B-PP	O
Nef	Nef	NN	B-NP	B-protein
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
obtaining	obtain	VBG	I-VP	O
good	good	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
Nef	Nef	NN	B-NP	B-protein
protein	protein	NN	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

This	This	DT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	B-PP	O
effects	effect	NNS	B-NP	O
of	of	IN	B-PP	O
Nef	Nef	NN	B-NP	B-protein
on	on	IN	B-PP	O
cell	cell	NN	B-NP	O
proliferation	proliferation	NN	I-NP	O
and	and	CC	I-NP	O
apoptosis	apoptosis	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
designed	design	VBN	I-VP	O
a	a	DT	B-NP	O
Nef	Nef	NN	I-NP	B-protein
protein	protein	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
readily	readily	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
T-cell	T-cell	NN	B-NP	B-cell_line
lines	line	NNS	I-NP	I-cell_line
and	and	CC	O	O
whose	whose	WP$	B-NP	O
function	function	NN	I-NP	O
is	be	VBZ	B-VP	O
inducibly	inducibly	RB	I-VP	O
activated	activate	VBN	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
composed	compose	VBN	I-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
fusion	fusion	NN	I-NP	O
between	between	IN	B-PP	O
full-length	full-length	JJ	B-NP	O
Nef	Nef	NN	I-NP	B-protein
and	and	CC	O	O
the	the	DT	B-NP	O
estrogen	estrogen	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
hormone-binding	hormone-binding	JJ	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
(	(	(	O	O
Nef-ER	Nef-ER	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
Nef-ER	Nef-ER	NN	I-NP	O
is	be	VBZ	B-VP	O
kept	keep	VBN	I-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
inactive	inactive	JJ	I-NP	O
state	state	NN	I-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
steric	steric	JJ	B-NP	O
hindrance	hindrance	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
membrane-permeable	membrane-permeable	JJ	I-NP	O
drug	drug	NN	I-NP	O
4-hydroxytamoxifen	4-hydroxytamoxifen	NN	I-NP	O
(	(	(	O	O
4-HT	4-HT	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ER	ER	NN	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
,	,	,	O	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
inducible	inducible	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
Nef-ER	Nef-ER	NN	B-NP	B-cell_line
within	within	IN	B-PP	I-cell_line
cells	cell	NNS	B-NP	I-cell_line
.	.	.	O	O

We	We	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
Nef-ER	Nef-ER	NN	B-NP	B-protein
inducibly	inducibly	RB	B-ADVP	O
associates	associate	VBZ	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
62-kDa	62-kDa	JJ	I-NP	B-protein
Ser/Thr	Ser/Thr	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
and	and	CC	O	O
is	be	VBZ	B-VP	O
localized	localized	JJ	B-ADJP	O
to	to	TO	B-PP	O
specific	specific	JJ	B-NP	O
membrane	membrane	NN	I-NP	B-protein
microdomains	microdomain	NNS	I-NP	I-protein
(	(	(	O	O
lipid	lipid	NN	B-NP	O
rafts	raft	NNS	I-NP	O
)	)	)	O	O
only	only	RB	B-PP	O
after	after	IN	I-PP	O
activation	activation	NN	B-NP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
this	this	DT	B-NP	O
inducible	inducible	JJ	I-NP	O
Nef	Nef	NN	I-NP	B-protein
,	,	,	O	O
we	we	PRP	B-NP	O
also	also	RB	B-ADVP	O
compared	compare	VBD	B-VP	O
the	the	DT	B-NP	O
specific	specific	JJ	I-NP	O
requirements	requirement	NNS	I-NP	O
for	for	IN	B-PP	O
CD4	CD4	NN	B-NP	B-protein
and	and	CC	I-NP	O
HLA-A2	HLA-A2	NN	I-NP	B-protein
downmodulation	downmodulation	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
SupT1	SupT1	NN	I-NP	B-cell_line
T-cell	T-cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

Half-maximal	Half-maximal	JJ	B-NP	O
downmodulation	downmodulation	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	B-protein
surface	surface	NN	I-NP	I-protein
CD4	CD4	NN	I-NP	I-protein
required	require	VBD	B-VP	O
very	very	RB	B-NP	O
little	little	JJ	I-NP	O
active	active	JJ	I-NP	O
Nef-ER	Nef-ER	NN	I-NP	O
and	and	CC	O	O
occurred	occur	VBD	B-VP	O
as	as	RB	B-ADVP	O
early	early	RB	I-ADVP	O
as	as	IN	B-PP	O
4	4	CD	B-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
4-HT	4-HT	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
downmodulation	downmodulation	NN	I-NP	O
of	of	IN	B-PP	O
HLA-A2	HLA-A2	NN	B-NP	B-protein
by	by	IN	B-PP	O
Nef	Nef	NN	B-NP	B-protein
required	require	VBD	B-VP	O
16	16	CD	B-NP	O
to	to	TO	B-PP	O
24	24	CD	B-NP	O
h	h	NN	I-NP	O
and	and	CC	O	O
about	about	RB	B-NP	O
50-	50-	CD	I-NP	O
to	to	TO	B-PP	O
100-fold-greater	100-fold-greater	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
4-HT	4-HT	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
HLA-A2	HLA-A2	NN	B-NP	B-protein
downmodulation	downmodulation	NN	I-NP	O
may	may	MD	B-VP	O
require	require	VB	I-VP	O
certain	certain	JJ	B-NP	O
threshold	threshold	NN	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
active	active	JJ	B-NP	O
Nef	Nef	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
differential	differential	JJ	I-NP	O
timing	timing	NN	I-NP	O
of	of	IN	B-PP	O
CD4	CD4	NN	B-NP	B-protein
and	and	CC	I-NP	O
HLA-A2	HLA-A2	NN	I-NP	B-protein
downmodulation	downmodulation	NN	I-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
implications	implication	NNS	B-NP	O
for	for	IN	B-PP	O
HIV	HIV	NN	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
and	and	CC	O	O
immune	immune	JJ	B-NP	O
evasion	evasion	NN	I-NP	O
.	.	.	O	O

Regulation	Regulation	NN	B-NP	O
of	of	IN	B-PP	O
chemokine	chemokine	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
rat	rat	NN	I-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
vanadium-induced	vanadium-induced	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
inflammation	inflammation	NN	I-NP	O
.	.	.	O	O

Environmental	Environmental	JJ	B-NP	O
and	and	CC	I-NP	O
occupational	occupational	JJ	I-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-PP	O
vanadium	vanadium	NN	B-NP	O
dusts	dust	NNS	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
toxic	toxic	JJ	B-NP	O
effects	effect	NNS	I-NP	O
mainly	mainly	RB	B-ADVP	O
confined	confine	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
respiratory	respiratory	JJ	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
a	a	DT	B-NP	O
rat	rat	NN	I-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
lung	lung	NN	I-NP	O
inflammation	inflammation	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
intratracheal	intratracheal	JJ	B-NP	O
instillation	instillation	NN	I-NP	O
of	of	IN	B-PP	O
sodium	sodium	NN	B-NP	O
metavanadate	metavanadate	NN	I-NP	O
(	(	(	O	O
NaVO3	NaVO3	NN	B-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
200	200	CD	B-NP	O
microg	microg	NN	I-NP	O
V/kg	V/kg	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
cytologic	cytologic	JJ	I-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
inflammation	inflammation	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
chemokine	chemokine	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
.	.	.	O	O

Significant	Significant	JJ	B-NP	O
polymorphonuclear	polymorphonuclear	JJ	I-NP	O
leukocyte	leukocyte	NN	I-NP	O
(	(	(	O	O
PMN	PMN	NN	B-NP	B-cell_type
)	)	)	O	O
influx	influx	NN	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
0.01	0.01	CD	I-NP	O
)	)	)	O	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
4	4	CD	B-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
NaVO3	NaVO3	NN	B-NP	O
instillation	instillation	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
alveolar	alveolar	JJ	B-NP	B-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
(	(	(	O	O
AMs	AM	NNS	B-NP	B-cell_type
)	)	)	O	O
in	in	IN	B-PP	O
bronchoalveolar	bronchoalveolar	JJ	B-NP	B-cell_type
lavage	lavage	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
BAL	BAL	NN	B-NP	I-cell_type
)	)	)	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
decrease	decrease	VB	I-VP	O
significantly	significantly	RB	B-ADVP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
neither	neither	CC	O	O
PMNs	PMN	NNS	B-NP	B-cell_type
nor	nor	CC	I-NP	O
AMs	AM	NNS	I-NP	B-cell_type
changed	change	VBD	B-VP	O
substantially	substantially	RB	B-NP	O
1	1	CD	I-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
NaVO3	NaVO3	NN	B-NP	O
instillation	instillation	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
Northern	Northern	NN	B-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
macrophage	macrophage	NN	B-NP	B-protein
inflammatory	inflammatory	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	O
MIP	MIP	NN	B-NP	O
)	)	)	O	O
-2	-2	CD	B-NP	O
mRNA	mRNA	NN	I-NP	O
in	in	IN	B-PP	O
BAL	BAL	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
increased	increase	VBD	B-VP	O
markedly	markedly	RB	B-NP	O
1	1	CD	I-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
NaVO3	NaVO3	NN	B-NP	O
instillation	instillation	NN	I-NP	O
and	and	CC	O	O
reduced	reduce	VBD	B-VP	O
a	a	DT	B-NP	O
little	little	JJ	I-NP	O
bit	bit	NN	I-NP	O
at	at	IN	B-PP	O
4	4	CD	B-NP	O
h	h	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
MIP-1alpha	MIP-1alpha	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
in	in	IN	B-PP	O
BAL	BAL	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
was	be	VBD	B-VP	O
expressed	express	VBN	I-VP	O
relatively	relatively	RB	B-NP	O
high	high	JJ	I-NP	O
1	1	CD	I-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
NaVO3	NaVO3	NN	B-NP	O
instillation	instillation	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
a	a	DT	B-NP	O
basal	basal	JJ	I-NP	O
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
control	control	NN	B-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
returned	return	VBD	B-VP	O
rapidly	rapidly	RB	B-ADVP	O
nearly	nearly	RB	B-ADVP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
level	level	NN	B-NP	O
at	at	IN	B-PP	O
4	4	CD	B-NP	O
h	h	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
MIP-2	MIP-2	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
PMN	PMN	NN	I-NP	B-protein
chemoattractant	chemoattractant	NN	I-NP	I-protein
and	and	CC	I-NP	O
MIP-1alpha	MIP-1alpha	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
macrophage/monocyte	macrophage/monocyte	NN	I-NP	B-protein
chemoattractant	chemoattractant	NN	I-NP	I-protein
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
well	well	RB	I-VP	O
known	know	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
facts	fact	NNS	I-NP	O
that	that	IN	B-SBAR	O
PMN	PMN	NN	B-NP	B-cell_type
influx	influx	NN	I-NP	O
was	be	VBD	B-VP	O
preceded	precede	VBN	I-VP	O
by	by	IN	B-PP	O
increased	increase	VBN	B-NP	O
MIP-2	MIP-2	NN	I-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
expression	expression	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
MIP-2	MIP-2	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
NaVO3-induced	NaVO3-induced	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
inflammation	inflammation	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
increased	increase	VBN	B-NP	O
MIP-1alpha	MIP-1alpha	NN	I-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
AMs	AM	NNS	I-NP	B-protein
in	in	IN	B-PP	O
BAL	BAL	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
AMs	AM	NNS	B-NP	B-protein
might	might	MD	B-VP	O
be	be	VB	I-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
MIP-1alpha	MIP-1alpha	NN	B-NP	B-protein
,	,	,	O	O
adherent	adherent	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
lining	lining	JJ	I-NP	O
surface	surface	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
airways	airway	NNS	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADJP	O
resistant	resistant	JJ	I-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
washed	wash	VBN	I-VP	O
out	out	RP	B-PRT	O
.	.	.	O	O

To	To	TO	B-VP	O
delineate	delineate	VB	I-VP	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
of	of	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
recently	recently	RB	B-ADVP	O
cloned	clone	VBD	B-VP	O
the	the	DT	B-NP	O
5'-flanking	5'-flanking	JJ	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MIP-2	MIP-2	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
promotor	promotor	NN	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
contains	contain	VBZ	B-VP	O
consensus	consensus	NN	B-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
for	for	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
kappaB	kappaB	NN	I-NP	I-protein
(	(	(	O	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
activator	activator	NN	B-NP	B-protein
protein-1	protein-1	NN	I-NP	I-protein
(	(	(	O	O
AP-1	AP-1	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assay	assay	NN	I-NP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
nuclear	nuclear	JJ	I-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
,	,	,	B-NP	O
not	not	RB	I-NP	O
AP-1	AP-1	NN	B-NP	B-protein
,	,	,	O	O
binding	binding	NN	B-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
NaVO3	NaVO3	NN	B-NP	O
instillation	instillation	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
MIP-2	MIP-2	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
.	.	.	O	O

p65	p65	NN	B-NP	O
(	(	(	O	O
Rel	Rel	NN	B-NP	B-protein
A	A	NN	I-NP	I-protein
)	)	)	O	O
and	and	CC	O	O
p50	p50	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
MIP-2	MIP-2	NN	B-NP	B-protein
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
binding	binding	NN	I-NP	O
.	.	.	O	O

Taken	Take	VBN	B-VP	O
together	together	RB	B-ADVP	O
,	,	,	O	O
our	our	PRP$	B-NP	O
studies	study	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
MIP-2	MIP-2	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
mediator	mediator	NN	I-NP	O
of	of	IN	B-PP	O
NaVO3-induced	NaVO3-induced	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
inflammation	inflammation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O
model	model	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
elevated	elevated	JJ	B-NP	O
MIP-2	MIP-2	NN	I-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
levels	level	NNS	I-NP	O
are	be	VBP	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
increased	increase	VBN	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
BAL	BAL	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
possible	possible	JJ	B-NP	O
MIP-2	MIP-2	NN	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
regulation	regulation	NN	I-NP	O
through	through	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
.	.	.	O	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
signal	signal	NN	B-NP	O
transduction	transduction	NN	I-NP	O
and	and	CC	I-NP	O
apoptosis	apoptosis	NN	I-NP	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	B-cell_type
lymphomonocytes	lymphomonocyte	NNS	I-NP	I-cell_type
exposed	expose	VBN	B-VP	O
to	to	TO	B-VP	O
bystander	bystander	VB	I-VP	O
HIV-1-infected	HIV-1-infected	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Persistent	Persistent	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
immune	immune	JJ	I-NP	O
system	system	NN	I-NP	O
is	be	VBZ	B-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hallmarks	hallmark	NNS	I-NP	O
of	of	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
we	we	PRP	B-NP	O
analysed	analyse	VBD	B-VP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
factors	factor	NNS	B-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-protein
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
STAT	STAT	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
and	and	CC	O	O
IRF-1	IRF-1	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
,	,	,	O	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
PBMC	PBMC	NN	B-NP	B-cell_type
)	)	)	O	O
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
HIV-infected	HIV-infected	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
.	.	.	O	O

Western	Western	JJ	B-NP	O
blot	blot	NN	I-NP	O
analyses	analysis	NNS	I-NP	O
and	and	CC	O	O
reverse	reverse	JJ	B-NP	O
transcriptase-polymerase	transcriptase-polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
both	both	DT	B-NP	O
cells	cell	NNS	I-NP	O
infected	infect	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
X4	X4	NN	I-NP	O
strain	strain	NN	I-NP	O
and	and	CC	O	O
cells	cell	NNS	B-NP	O
infected	infect	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
R5	R5	NN	I-NP	O
strain	strain	NN	I-NP	O
are	be	VBP	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
increase	increase	VB	I-VP	O
intracellular	intracellular	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
STAT	STAT	NN	B-NP	B-protein
1alpha	1alpha	NN	I-NP	I-protein
and	and	CC	O	O
beta	beta	NN	B-NP	O
proteins	protein	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
IRF-1	IRF-1	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
.	.	.	O	O

This	This	DT	B-NP	O
effect	effect	NN	I-NP	O
was	be	VBD	B-VP	O
prevented	prevent	VBN	I-VP	O
by	by	IN	B-PP	O
neutralizing	neutralize	VBG	B-VP	B-protein
antibodies	antibody	NNS	B-NP	I-protein
against	against	IN	B-PP	O
interferon-alpha	interferon-alpha	NN	B-NP	B-protein
(	(	(	O	O
IFN-alpha	IFN-alpha	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

HIV-1-infected	HIV-1-infected	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
dose-dependently	dose-dependently	RB	B-ADVP	O
induced	induce	VBD	B-VP	O
apoptotic	apoptotic	JJ	B-NP	O
commitment	commitment	NN	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
PBMC	PBMC	NN	I-NP	B-cell_type
,	,	,	O	O
as	as	IN	B-SBAR	O
revealed	reveal	VBN	B-VP	O
by	by	IN	B-PP	O
DNA	DNA	NN	B-NP	O
fragmentation	fragmentation	NN	I-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
caspase-3	caspase-3	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
,	,	,	O	O
even	even	RB	B-SBAR	O
if	if	IN	I-SBAR	O
a	a	DT	B-NP	O
slight	slight	JJ	I-NP	O
up-regulation	up-regulation	NN	I-NP	O
of	of	IN	B-PP	O
IL-1beta-converting	IL-1beta-converting	JJ	B-NP	B-RNA
enzyme	enzyme	NN	I-NP	I-RNA
mRNA	mRNA	NN	I-NP	I-RNA
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
.	.	.	O	O

Apoptosis	Apoptosis	NN	B-NP	O
induction	induction	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
abrogated	abrogate	VBN	I-VP	O
mainly	mainly	RB	B-ADVP	O
by	by	IN	B-PP	O
antibodies	antibody	NNS	B-NP	B-protein
against	against	IN	B-PP	O
tumour	tumour	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor-alpha	factor-alpha	NN	I-NP	I-protein
(	(	(	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
,	,	,	O	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
lesser	less	JJR	I-NP	O
extent	extent	NN	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
antibodies	antibody	NNS	B-NP	B-protein
against	against	IN	B-PP	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
.	.	.	O	O

All	All	PDT	B-NP	O
these	these	DT	I-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
uninfected	uninfected	JJ	B-NP	O
PBMC	PBMC	NN	I-NP	B-cell_type
can	can	MD	B-VP	O
undergo	undergo	VB	I-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
signal	signal	NN	B-NP	O
transduction	transduction	NN	I-NP	O
and	and	CC	I-NP	O
apoptosis	apoptosis	NN	I-NP	O
after	after	IN	B-PP	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-VP	O
bystander	bystander	VB	I-VP	O
HIV-infected	HIV-infected	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
subsequent	subsequent	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
cytokines	cytokine	NNS	B-NP	B-protein
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
IFNs	IFN	NNS	B-NP	B-protein
and	and	CC	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
physical	physical	JJ	I-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
C	C	NN	I-NP	I-protein
theta	theta	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
lipid	lipid	NN	I-NP	O
raft-associated	raft-associated	JJ	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
of	of	IN	B-PP	O
kappa	kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
IKK	IKK	NN	B-NP	B-protein
)	)	)	O	O
complex	complex	NN	B-NP	O
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
cascade	cascade	NN	I-NP	O
by	by	IN	B-PP	O
TCR	TCR	NN	B-NP	B-protein
and	and	CC	I-NP	O
CD28	CD28	NN	I-NP	B-protein
.	.	.	O	O

We	We	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
C	C	NN	I-NP	I-protein
theta	theta	NN	I-NP	O
(	(	(	O	O
PKCtheta	PKCtheta	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
cascade	cascade	NN	I-NP	O
in	in	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
CD4	CD4	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
lymphocytes	lymphocyte	NNS	B-NP	I-cell_type
.	.	.	O	O

Among	Among	IN	B-PP	O
six	six	CD	B-NP	O
or	or	CC	I-NP	O
so	so	RB	I-NP	O
PKC	PKC	NN	I-NP	B-protein
isoforms	isoform	NNS	I-NP	I-protein
expressed	express	VBN	B-VP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
only	only	RB	B-NP	O
PKCtheta	PKCtheta	NN	I-NP	B-protein
participates	participate	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
assembly	assembly	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
supramolecular	supramolecular	JJ	I-NP	O
activation	activation	NN	I-NP	O
clusters	cluster	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
contact	contact	NN	I-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TCR	TCR	NN	I-NP	B-protein
with	with	IN	B-PP	O
Ag	Ag	NN	B-NP	B-protein
.	.	.	O	O

Signaling	Signal	VBG	B-VP	O
via	via	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
TCR	TCR	NN	I-NP	B-protein
and	and	CC	I-NP	O
CD28	CD28	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
optimal	optimal	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
multisubunit	multisubunit	JJ	I-NP	B-protein
IkappaB	IkappaB	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	I-protein
IKK	IKK	NN	B-NP	I-protein
)	)	)	O	I-protein
complex	complex	NN	B-NP	I-protein
in	in	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
;	;	:	O	O
this	this	DT	B-NP	O
activation	activation	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
Ca	Ca	NN	I-NP	O
(	(	(	O	O
2+	2+	JJ	B-ADJP	O
)	)	)	O	O
-independent	-independent	JJ	B-NP	O
PKC	PKC	NN	I-NP	B-protein
isoform	isoform	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
rottlerin	rottlerin	NN	B-NP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
endogenous	endogenous	JJ	B-NP	O
PKCtheta	PKCtheta	NN	I-NP	B-protein
physically	physically	RB	B-ADVP	O
associates	associate	VBZ	B-VP	O
with	with	IN	B-PP	O
activated	activate	VBN	B-NP	O
IKK	IKK	NN	I-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
in	in	IN	B-PP	O
CD3/CD28-costimulated	CD3/CD28-costimulated	JJ	B-NP	B-cell_type
primary	primary	JJ	I-NP	I-cell_type
CD4	CD4	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
T	T	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
same	same	JJ	I-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
stimuli	stimulus	NNS	B-NP	O
also	also	RB	B-ADVP	O
induced	induce	VBD	B-VP	O
relocation	relocation	NN	B-NP	O
of	of	IN	B-PP	O
endogenous	endogenous	JJ	B-NP	O
PKCtheta	PKCtheta	NN	I-NP	B-protein
and	and	CC	I-NP	O
IKKs	IKK	NNS	I-NP	B-protein
to	to	TO	B-PP	O
a	a	DT	B-NP	O
GM1	GM1	NN	I-NP	B-DNA
ganglioside-enriched	ganglioside-enriched	JJ	I-NP	O
,	,	,	I-NP	O
detergent-insoluble	detergent-insoluble	JJ	I-NP	O
membrane	membrane	NN	I-NP	O
compartment	compartment	NN	I-NP	O
in	in	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

IKKs	IKK	NNS	B-NP	B-protein
recruited	recruit	VBN	B-VP	O
to	to	TO	B-PP	O
these	these	DT	B-NP	O
lipid	lipid	NN	I-NP	O
rafts	raft	NNS	I-NP	O
were	be	VBD	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
phosphorylating	phosphorylate	VBG	B-VP	O
a	a	DT	B-NP	O
recombinant	recombinant	JJ	I-NP	O
IkappaBalpha	IkappaBalpha	NN	I-NP	B-protein
sustrate	sustrate	NN	I-NP	O
.	.	.	O	O

Confocal	Confocal	JJ	B-NP	O
microscopy	microscopy	NN	I-NP	O
further	further	RBR	B-ADVP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
exogenously	exogenously	RB	B-NP	O
expressed	express	VBN	I-NP	O
PKCtheta	PKCtheta	NN	I-NP	B-protein
and	and	CC	I-NP	O
IKKss	IKKss	NN	I-NP	O
colocalize	colocalize	VBP	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
membrane	membrane	NN	I-NP	O
of	of	IN	B-PP	O
CD3/CD28-costimulated	CD3/CD28-costimulated	JJ	B-NP	B-cell_line
Jurkat	Jurkat	NN	I-NP	I-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Constitutively	Constitutively	RB	B-ADJP	O
active	active	JJ	I-ADJP	O
but	but	CC	B-CONJP	O
not	not	RB	I-CONJP	O
kinase-inactive	kinase-inactive	JJ	B-NP	O
PKCtheta	PKCtheta	NN	I-NP	B-protein
activated	activate	VBD	B-VP	O
IKKbeta	IKKbeta	NN	B-NP	B-protein
in	in	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
dominant-active	dominant-active	JJ	B-NP	O
PKCtheta	PKCtheta	NN	I-NP	B-protein
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
stimulatory	stimulatory	JJ	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
CD28	CD28	NN	I-NP	B-DNA
response	response	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

Taken	Take	VBN	B-VP	O
together	together	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
data	datum	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
PKCtheta	PKCtheta	NN	B-NP	B-protein
by	by	IN	B-PP	O
the	the	DT	B-NP	O
TCR	TCR	NN	I-NP	B-protein
and	and	CC	I-NP	O
CD28	CD28	NN	I-NP	B-protein
plays	play	VBZ	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
assembly	assembly	NN	I-NP	O
and	and	CC	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
IKK	IKK	NN	B-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
membrane	membrane	NN	I-NP	O

T-cell	T-cell	NN	B-NP	O
-mediated	-mediated	JJ	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
osteoclastogenesis	osteoclastogenesis	NN	B-NP	O
by	by	IN	B-PP	O
signalling	signalling	NN	B-NP	O
cross-talk	cross-talk	NN	I-NP	O
between	between	IN	B-PP	O
RANKL	RANKL	NN	B-NP	B-protein
and	and	CC	I-NP	O
IFN-gamma	IFN-gamma	NN	I-NP	B-protein
.	.	.	O	O

Bone	Bone	NN	B-NP	O
resorption	resorption	NN	I-NP	O
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
immune	immune	JJ	I-NP	O
system	system	NN	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
T-cell	T-cell	NN	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
RANKL	RANKL	NN	B-NP	B-protein
(	(	(	O	O
receptor	receptor	NN	B-NP	O
activator	activator	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	I-protein
NF	NF	NN	B-NP	I-protein
)	)	)	O	I-protein
-kappaB	-kappaB	NN	B-NP	I-protein
ligand	ligand	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tumour-necrosis	tumour-necrosis	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
family	family	NN	I-NP	I-protein
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
osteoclastogenesis	osteoclastogenesis	NN	B-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
pathological	pathological	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
autoimmune	autoimmune	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
whether	whether	IN	B-SBAR	O
activated	activate	VBN	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
maintain	maintain	VBP	B-VP	O
bone	bone	NN	B-NP	O
homeostasis	homeostasis	NN	I-NP	O
by	by	IN	B-PP	O
counterbalancing	counterbalance	VBG	B-VP	O
the	the	DT	B-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
RANKL	RANKL	NN	B-NP	B-protein
remains	remain	VBZ	B-VP	O
unknown	unknown	JJ	B-ADJP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
T-cell	T-cell	NN	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
interferon	interferon	NN	B-NP	B-protein
(	(	(	O	I-protein
IFN	IFN	NN	B-NP	I-protein
)	)	)	O	I-protein
-gamma	-gamma	NN	B-NP	I-protein
strongly	strongly	RB	B-ADVP	O
suppresses	suppress	VBZ	B-VP	O
osteoclastogenesis	osteoclastogenesis	NN	B-NP	O
by	by	IN	B-PP	O
interfering	interfere	VBG	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
RANKL	RANKL	NN	I-NP	B-protein
-RANK	-RANK	NN	I-NP	I-protein
signalling	signalling	NN	I-NP	O
pathway	pathway	NN	I-NP	O
.	.	.	O	O

IFN-gamma	IFN-gamma	NN	B-NP	B-protein
induces	induce	VBZ	B-VP	O
rapid	rapid	JJ	B-NP	O
degradation	degradation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
RANK	RANK	NN	I-NP	B-protein
adapter	adapter	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
,	,	,	O	O
TRAF6	TRAF6	NN	B-NP	B-protein
(	(	(	O	O
tumour	tumour	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
receptor-associated	receptor-associated	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
strong	strong	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
RANKL	RANKL	NN	I-NP	B-protein
-induced	-induced	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
and	and	CC	I-NP	O
JNK	JNK	NN	I-NP	B-protein
.	.	.	O	O

This	This	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
osteoclastogenesis	osteoclastogenesis	NN	B-NP	O
is	be	VBZ	B-VP	O
rescued	rescue	VBN	I-VP	O
by	by	IN	B-PP	O
overexpressing	overexpresse	VBG	B-VP	O
TRAF6	TRAF6	NN	B-NP	B-protein
in	in	IN	B-PP	O
precursor	precursor	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
which	which	WDT	B-NP	O
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
TRAF6	TRAF6	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
target	target	NN	I-NP	O
critical	critical	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
IFN-gamma	IFN-gamma	NN	I-NP	B-protein
action	action	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
provide	provide	VBP	B-VP	O
evidence	evidence	NN	B-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
accelerated	accelerate	VBN	I-NP	O
degradation	degradation	NN	I-NP	O
of	of	IN	B-PP	O
TRAF6	TRAF6	NN	B-NP	B-protein
requires	require	VBZ	B-VP	O
both	both	CC	O	O
its	its	PRP$	B-NP	O
ubiquitination	ubiquitination	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
initiated	initiate	VBN	I-VP	O
by	by	IN	B-PP	O
RANKL	RANKL	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ubiquitin-proteasome	ubiquitin-proteasome	JJ	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
study	study	NN	I-NP	O
shows	show	VBZ	B-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
cross-talk	cross-talk	NN	B-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
tumour	tumour	NN	I-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
and	and	CC	I-NP	O
IFN	IFN	NN	I-NP	B-protein
families	family	NNS	I-NP	I-protein
of	of	IN	B-PP	O
cytokines	cytokine	NNS	B-NP	B-protein
,	,	,	O	O
through	through	IN	B-PP	O
which	which	WDT	B-NP	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
provides	provide	VBZ	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
link	link	NN	I-NP	O
between	between	IN	B-PP	O
T-cell	T-cell	NN	B-NP	O
activation	activation	NN	I-NP	O
and	and	CC	O	O
bone	bone	NN	B-NP	O
resorption	resorption	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
may	may	MD	B-VP	O
offer	offer	VB	I-VP	O
a	a	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
approach	approach	NN	I-NP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
the	the	DT	B-NP	O
inflammation-induced	inflammation-induced	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
breakdown	breakdown	NN	I-NP	O
.	.	.	O	O

Stromal-derived	Stromal-derived	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
and	and	CC	O	O
thrombopoietin	thrombopoietin	NN	B-NP	B-protein
regulate	regulate	VBP	B-VP	O
distinct	distinct	JJ	B-NP	O
aspects	aspect	NNS	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
megakaryopoiesis	megakaryopoiesis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chemokine	chemokine	NN	I-NP	B-protein
binding	binding	NN	I-NP	I-protein
stromal-derived	stromal-derived	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
(	(	(	O	O
SDF-1	SDF-1	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
human	human	JJ	I-NP	O
megakaryopoiesis	megakaryopoiesis	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
and	and	CC	I-NP	O
molecular	molecular	JJ	I-NP	O
levels	level	NNS	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
comparison	comparison	NN	I-NP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
thrombopoietin	thrombopoietin	NN	B-NP	B-protein
(	(	(	O	O
TPO	TPO	NN	B-NP	B-protein
)	)	)	O	O
have	have	VBP	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
determined	determine	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
SDF-1	SDF-1	NN	B-NP	B-protein
,	,	,	O	O
unlike	unlike	IN	B-PP	O
TPO	TPO	NN	B-NP	B-protein
,	,	,	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
stimulate	stimulate	VB	I-VP	O
alpha	alpha	NN	B-NP	O
(	(	(	O	O
IIb	IIb	NN	B-NP	O
)	)	)	O	O
beta	beta	NN	B-NP	O
(	(	(	O	O
3	3	CD	B-NP	O
)	)	)	O	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
cell	cell	NN	B-NP	O
proliferation	proliferation	NN	I-NP	O
or	or	CC	O	O
differentiation	differentiation	NN	B-NP	O
or	or	CC	O	O
have	have	VB	B-VP	O
an	an	DT	B-NP	O
antiapoptotic	antiapoptotic	JJ	I-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
does	do	VBZ	B-VP	O
induce	induce	VB	I-VP	O
chemotaxis	chemotaxis	NN	B-NP	O
,	,	,	O	O
trans-Matrigel	trans-Matrigel	NN	B-NP	O
migration	migration	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
secretion	secretion	NN	B-NP	O
of	of	IN	B-PP	O
matrix	matrix	NN	B-NP	B-protein
metalloproteinase	metalloproteinase	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
(	(	(	O	O
MMP-9	MMP-9	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
vascular	vascular	JJ	B-NP	B-protein
endothelial	endothelial	JJ	I-NP	I-protein
growth	growth	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
VEGF	VEGF	NN	B-NP	B-protein
)	)	)	O	O
by	by	IN	B-PP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
both	both	CC	O	O
SDF-1	SDF-1	NN	B-NP	B-protein
and	and	CC	I-NP	O
TPO	TPO	NN	I-NP	B-protein
increase	increase	VBP	B-VP	O
the	the	DT	B-NP	O
adhesion	adhesion	NN	I-NP	O
of	of	IN	B-PP	O
alpha	alpha	NN	B-NP	B-cell_type
(	(	(	O	I-cell_type
IIb	IIb	NN	B-NP	I-cell_type
)	)	)	O	I-cell_type
beta	beta	NN	B-NP	I-cell_type
(	(	(	O	I-cell_type
3	3	CD	B-NP	I-cell_type
)	)	)	O	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
cells	cell	NNS	B-NP	I-cell_type
to	to	TO	B-PP	O
fibrinogen	fibrinogen	NN	B-NP	B-protein
and	and	CC	I-NP	O
vitronectin	vitronectin	NN	I-NP	B-protein
.	.	.	O	O

Investigating	Investigate	VBG	B-VP	O
the	the	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	O
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
SDF-1	SDF-1	NN	B-NP	B-protein
and	and	CC	I-NP	O
TPO	TPO	NN	I-NP	B-protein
revealed	reveal	VBD	B-VP	O
some	some	DT	B-NP	O
overlapping	overlap	VBG	I-NP	O
patterns	pattern	NNS	I-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
phosphorylation/activation	phosphorylation/activation	NN	I-NP	O
(	(	(	O	O
mitogen-activated	mitogen-activated	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
[	[	(	O	O
MAPK	MAPK	NN	B-NP	B-protein
]	]	)	O	O
p42/44	p42/44	NN	B-NP	B-protein
,	,	,	O	O
MAPK	MAPK	NN	B-NP	B-protein
p38	p38	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
AKT	AKT	NN	B-NP	B-protein
[	[	(	I-NP	O
protein	protein	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
]	]	)	O	O
)	)	)	O	O
and	and	CC	O	O
some	some	DT	B-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
distinct	distinct	JJ	B-ADJP	O
for	for	IN	B-PP	O
TPO	TPO	NN	B-NP	B-protein
(	(	(	O	O
eg	eg	FW	B-NP	O
,	,	,	I-NP	O
JAK-STAT	JAK-STAT	NN	I-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
for	for	IN	B-PP	O
SDF-1	SDF-1	NN	B-NP	B-protein
(	(	(	O	O
eg	eg	FW	B-NP	O
,	,	,	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
)	)	)	O	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
though	though	IN	B-SBAR	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
phosphatidyl-inositol	phosphatidyl-inositol	NN	B-NP	B-protein
3-kinase	3-kinase	NN	I-NP	I-protein
(	(	(	O	O
PI-3K	PI-3K	NN	B-NP	B-protein
)	)	)	O	O
by	by	IN	B-PP	O
LY294002	LY294002	NN	B-NP	O
in	in	IN	B-PP	O
alpha	alpha	NN	B-NP	B-cell_line
(	(	(	O	I-cell_line
IIb	IIb	NN	B-NP	I-cell_line
)	)	)	O	I-cell_line
beta	beta	NN	B-NP	I-cell_line
(	(	(	O	I-cell_line
3	3	CD	B-NP	I-cell_line
)	)	)	O	I-cell_line
(	(	(	O	I-cell_line
+	+	SYM	O	I-cell_line
)	)	)	O	I-cell_line
cells	cell	NNS	B-NP	I-cell_line
induced	induce	VBD	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
and	and	CC	O	O
inhibited	inhibit	VBD	B-VP	O
chemotaxis	chemotaxis	NN	B-NP	O
adhesion	adhesion	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
secretion	secretion	NN	I-NP	O
of	of	IN	B-PP	O
MMP-9	MMP-9	NN	B-NP	B-protein
and	and	CC	I-NP	O
VEGF	VEGF	NN	I-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
MAPK	MAPK	NN	B-NP	B-protein
p42/44	p42/44	NN	I-NP	O
(	(	(	O	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
MEK	MEK	NN	I-NP	B-protein
inhibitor	inhibitor	NN	I-NP	O
U0126	U0126	NN	I-NP	O
)	)	)	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
survival	survival	NN	I-NP	O
,	,	,	O	O
proliferation	proliferation	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
migration	migration	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

Hence	Hence	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
suggested	suggest	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
proliferative	proliferative	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
TPO	TPO	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
more	more	RBR	B-ADJP	O
related	related	JJ	I-ADJP	O
to	to	TO	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
JAK-STAT	JAK-STAT	NN	I-NP	O
pathway	pathway	NN	I-NP	O
(	(	(	O	O
unique	unique	JJ	B-ADJP	O
to	to	TO	B-PP	O
TPO	TPO	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
PI-3K-AKT	PI-3K-AKT	NN	I-NP	O
axis	axis	NN	I-NP	O
is	be	VBZ	B-VP	O
differentially	differentially	RB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
TPO-	TPO-	NN	B-NP	B-protein
and	and	CC	O	O
SDF-1-dependent	SDF-1-dependent	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
.	.	.	O	O

Accordingly	Accordingly	RB	B-ADVP	O
,	,	,	O	O
PI-3K	PI-3K	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
TPO	TPO	NN	B-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
,	,	,	O	O
TPO-	TPO-	NN	B-NP	B-protein
and	and	CC	O	O
SDF-1-regulated	SDF-1-regulated	JJ	B-NP	O
adhesion	adhesion	NN	I-NP	O
to	to	TO	B-PP	O
fibrinogen	fibrinogen	NN	B-NP	B-protein
and	and	CC	I-NP	O
vitronectin	vitronectin	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
SDF-1	SDF-1	NN	B-NP	B-protein
-mediated	-mediated	JJ	I-NP	O
migration	migration	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
expands	expand	VBZ	B-VP	O
the	the	DT	B-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
SDF-1	SDF-1	NN	B-NP	B-protein
and	and	CC	I-NP	O
TPO	TPO	NN	I-NP	B-protein
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
human	human	JJ	I-NP	O
megakaryopoiesis	megakaryopoiesis	NN	I-NP	O
and	and	CC	O	O
indicates	indicate	VBZ	B-VP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
observed	observe	VBN	I-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
responses	response	NNS	I-NP	O
.	.	.	O	O

(	(	(	O	O
Blood.	Blood.	NNP	B-NP	O
2000	2000	CD	I-NP	O
;	;	:	O	O
96	96	CD	B-NP	O
:	:	:	O	O
4142-4151	4142-4151	CD	B-NP	O
)	)	)	O	O

Adhesion	Adhesion	NN	B-NP	O
of	of	IN	B-PP	O
immature	immature	JJ	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
mature	mature	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
induces	induce	VBZ	B-VP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
thymic	thymic	JJ	I-NP	I-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
TEC	TEC	NNS	B-NP	B-cell_type
)	)	)	O	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
IL-6	IL-6	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
trascription	trascription	NN	I-NP	O
factors	factor	NNS	I-NP	O
(	(	(	O	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
and	and	CC	O	O
NF-IL6	NF-IL6	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
IL-6	IL-6	NN	B-NP	B-protein
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
:	:	:	O	O
role	role	NN	B-NP	O
of	of	IN	B-PP	O
alpha3beta1	alpha3beta1	NN	B-NP	B-protein
and	and	CC	I-NP	O
alpha6beta4	alpha6beta4	NN	I-NP	B-protein
integrins	integrin	NNS	I-NP	I-protein
.	.	.	O	O

T	T	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
precursors	precursor	NNS	I-NP	I-cell_type
homed	home	VBN	B-VP	O
to	to	TO	B-PP	O
thymus	thymus	NN	B-NP	O
develop	develop	NN	I-NP	O
in	in	IN	B-PP	O
close	close	JJ	B-NP	O
contact	contact	NN	I-NP	O
with	with	IN	B-PP	O
stromal	stromal	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Among	Among	IN	B-PP	O
them	them	PRP	B-NP	O
,	,	,	O	O
thymic	thymic	JJ	B-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
TEC	TEC	NNS	B-NP	B-cell_type
)	)	)	O	O
are	be	VBP	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
exert	exert	VB	I-VP	O
dominant	dominant	JJ	B-NP	O
roles	role	NNS	I-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
survival	survival	NN	I-NP	O
and	and	CC	I-NP	O
functional	functional	JJ	I-NP	O
shaping	shaping	NN	I-NP	O
.	.	.	O	O

Key	Key	NN	B-NP	O
molecules	molecule	NNS	I-NP	O
mediating	mediate	VBG	B-VP	O
TEC	TEC	NN	B-NP	B-cell_type
/	/	SYM	I-NP	O
thymocytes	thymocyte	NNS	I-NP	B-cell_type
interactions	interaction	NNS	I-NP	O
include	include	VBP	B-VP	O
cytokines	cytokine	NNS	B-NP	B-protein
and	and	CC	O	O
growth	growth	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
secreted	secrete	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
and	and	CC	O	O
adhesion	adhesion	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
mediating	mediate	VBG	B-VP	O
cell	cell	NN	B-NP	O
contact	contact	NN	I-NP	O
.	.	.	O	O

Signaling	Signaling	NN	B-NP	O
events	event	NNS	I-NP	O
triggered	trigger	VBN	B-VP	O
in	in	IN	B-PP	O
thymocytes	thymocyte	NNS	B-NP	B-cell_type
by	by	IN	B-PP	O
adhesion	adhesion	NN	B-NP	O
to	to	TO	B-PP	O
epithelial	epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
extensively	extensively	RB	I-VP	O
investigated	investigate	VBN	I-VP	O
,	,	,	O	O
whereas	whereas	IN	O	O
little	little	JJ	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
opposite	opposite	JJ	I-NP	O
phenomenon	phenomenon	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
previously	previously	RB	I-VP	O
investigated	investigate	VBN	I-VP	O
this	this	DT	B-NP	O
issue	issue	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
co-culture	co-culture	NN	I-NP	O
system	system	NN	I-NP	O
composed	compose	VBN	B-VP	O
of	of	IN	B-PP	O
TEC	TEC	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
human	human	JJ	B-NP	O
normal	normal	JJ	I-NP	O
thymus	thymus	NN	I-NP	O
and	and	CC	O	O
heterologous	heterologous	JJ	B-NP	B-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
thymocytes	thymocyte	NNS	B-NP	B-cell_type
adhere	adhere	VBP	B-VP	O
to	to	TO	B-PP	O
TEC	TEC	NN	B-NP	B-cell_type
involving	involve	VBG	B-VP	O
beta1	beta1	NN	B-NP	B-protein
and	and	CC	I-NP	I-protein
beta4	beta4	NN	I-NP	I-protein
integrins	integrin	NNS	I-NP	I-protein
and	and	CC	O	O
induce	induce	VB	B-VP	O
the	the	DT	B-NP	O
clustering	clustering	NN	I-NP	O
of	of	IN	B-PP	O
alpha3beta1	alpha3beta1	NN	B-NP	B-protein
and	and	CC	I-NP	O
alpha6beta4	alpha6beta4	NN	I-NP	B-protein
heterodimers	heterodimer	NNS	I-NP	I-protein
at	at	IN	B-PP	O
the	the	DT	B-NP	O
TEC	TEC	NN	I-NP	B-cell_type
surface	surface	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
thymocyte	thymocyte	NN	I-NP	O
adhesion	adhesion	NN	I-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
and	and	CC	I-NP	O
NF-IL6	NF-IL6	NN	I-NP	B-protein
gene	gene	NN	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
and	and	CC	O	O
enhanced	enhance	VBN	B-VP	O
IL-6	IL-6	NN	B-NP	B-protein
production	production	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
two	two	CD	I-NP	O
latter	latter	JJ	I-NP	O
phenomena	phenomenon	NNS	I-NP	O
were	be	VBD	B-VP	O
reproduced	reproduce	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
cross-linking	cross-linking	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
alpha3	alpha3	NN	I-NP	B-protein
,	,	,	I-NP	O
alpha6	alpha6	NN	I-NP	B-protein
,	,	,	I-NP	O
beta1	beta1	NN	I-NP	B-protein
and	and	CC	I-NP	O
beta4	beta4	NN	I-NP	B-protein
integrins	integrin	NNS	I-NP	I-protein
,	,	,	O	O
thus	thus	RB	B-ADVP	O
implying	imply	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
alpha3beta1	alpha3beta1	NN	I-NP	B-protein
and	and	CC	I-NP	O
alpha6beta4	alpha6beta4	NN	I-NP	B-protein
heterodimers	heterodimer	NNS	I-NP	I-protein
can	can	MD	B-VP	O
signal	signal	VB	I-VP	O
during	during	IN	B-PP	O
thymocyte	thymocyte	NN	B-NP	O
adhesion	adhesion	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
extended	extend	VBN	I-VP	O
our	our	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
work	work	NN	I-NP	O
investigating	investigate	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
experimental	experimental	JJ	I-NP	O
setting	set	VBG	B-VP	O
the	the	DT	B-NP	O
inducing	induce	VBG	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
non	non	NN	B-NP	O
stimulated	stimulate	VBN	B-VP	O
or	or	CC	I-VP	O
activated	activate	VBN	I-VP	O
policlonal	policlonal	JJ	B-NP	O
or	or	CC	I-NP	O
clonal	clonal	JJ	I-NP	O
mature	mature	JJ	I-NP	O
T	T	NN	I-NP	O
cells	cell	NNS	I-NP	O
as	as	IN	B-PP	O
representative	representative	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
more	more	RBR	I-NP	O
mature	mature	JJ	I-NP	B-cell_type
thymocyte	thymocyte	NN	I-NP	I-cell_type
subset	subset	NN	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
adhesion	adhesion	NN	B-NP	O
of	of	IN	B-PP	O
unstimulated	unstimulated	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
i	i	NN	I-NP	O
)	)	)	O	O
involved	involve	VBD	B-VP	O
beta1	beta1	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
beta4	beta4	NN	B-NP	B-protein
integrin	integrin	NN	I-NP	I-protein
functions	function	VBZ	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
surface	surface	NN	I-NP	O
ii	ii	NN	I-NP	O
)	)	)	O	O
induced	induce	VBD	B-VP	O
the	the	DT	B-NP	O
clustering	clustering	NN	I-NP	O
of	of	IN	B-PP	O
alpha3beta1	alpha3beta1	NN	B-NP	B-protein
,	,	,	B-NP	O
but	but	CC	I-NP	O
not	not	RB	I-NP	O
alpha2beta1	alpha2beta1	NN	B-NP	B-protein
heterodimers	heterodimer	NNS	I-NP	I-protein
at	at	IN	B-PP	O
the	the	DT	B-NP	O
TEC	TEC	NN	I-NP	B-cell_type
surface	surface	NN	I-NP	O
and	and	CC	O	O
iii	iii	NN	B-NP	O
)	)	)	O	O
up-regulated	up-regulate	VBD	B-VP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
IL-6	IL-6	NN	I-NP	B-protein
secretion	secretion	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
propose	propose	VBP	B-VP	O
that	that	IN	B-SBAR	O
alpha3beta1	alpha3beta1	NN	B-NP	B-protein
and	and	CC	I-NP	O
alpha6beta4	alpha6beta4	NN	I-NP	B-protein
heterodimers	heterodimer	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
induced	induce	VBN	I-VP	O
to	to	TO	I-VP	O
cluster	cluster	VB	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
TEC	TEC	NN	I-NP	B-protein
surface	surface	NN	I-NP	I-protein
recognizing	recognize	VBG	B-VP	I-protein
yet	yet	RB	B-NP	I-protein
unknown	unknown	JJ	I-NP	I-protein
cellular	cellular	JJ	I-NP	I-protein
ligands	ligand	NNS	I-NP	I-protein
differentially	differentially	RB	B-VP	O
expressed	express	VBN	I-VP	O
during	during	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

Identification	Identification	NN	B-NP	O
and	and	CC	I-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
SKAT-2	SKAT-2	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	B-DNA
Th2-specific	Th2-specific	JJ	I-NP	I-DNA
zinc	zinc	NN	I-NP	I-DNA
finger	finger	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
identified	identify	VBN	I-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	B-DNA
Kruppel-type	Kruppel-type	JJ	I-NP	I-DNA
zinc	zinc	NN	I-NP	I-DNA
finger	finger	NN	I-NP	I-DNA
(	(	(	O	I-DNA
ZF	ZF	NN	B-NP	I-DNA
)	)	)	O	I-DNA
gene	gene	NN	B-NP	I-DNA
,	,	,	O	O
SKAT-2	SKAT-2	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
selectively	selectively	RB	I-VP	O
expressed	express	VBN	I-VP	O
by	by	IN	B-PP	O
murine	murine	JJ	B-NP	B-cell_line
Th2	Th2	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
protein	protein	NN	I-NP	O
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
this	this	DT	B-NP	O
gene	gene	NN	I-NP	O
has	have	VBZ	B-VP	O
14	14	CD	B-NP	O
C2H2-type	C2H2-type	JJ	I-NP	O
ZF	ZF	NN	I-NP	O
tandemly	tandemly	RB	B-ADVP	O
arrayed	array	VBD	B-VP	O
at	at	IN	B-PP	O
its	its	PRP$	B-NP	O
C	C	NN	I-NP	B-protein
terminus	terminus	NN	I-NP	I-protein
and	and	CC	O	O
N-terminal	N-terminal	JJ	B-NP	B-protein
SCAN	SCAN	NN	I-NP	I-protein
box	box	NN	I-NP	I-protein
and	and	CC	O	O
KRAB	KRAB	NN	B-NP	B-protein
domains	domain	NNS	I-NP	I-protein
.	.	.	O	O

SKAT-2	SKAT-2	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
tissue	tissue	NN	B-NP	O
restricted	restrict	VBN	B-VP	O
in	in	IN	B-PP	O
expression	expression	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
RNA	RNA	NN	I-NP	O
level	level	NN	I-NP	O
,	,	,	O	O
detectable	detectable	JJ	B-ADJP	O
only	only	RB	B-PP	O
in	in	IN	I-PP	O
brain	brain	NN	B-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
low	low	JJ	B-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
kidney	kidney	NN	B-NP	O
and	and	CC	O	O
spleen	spleen	NN	B-NP	O
and	and	CC	O	O
few	few	JJ	B-NP	O
hematopoietic	hematopoietic	JJ	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
.	.	.	O	O

By	By	IN	B-PP	O
in	in	FW	B-NP	O
situ	situ	FW	I-NP	O
hybridization	hybridization	NN	I-NP	O
,	,	,	O	O
SKAT-2	SKAT-2	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
peak	peak	VB	I-VP	O
in	in	IN	B-PP	O
antigen-stimulated	antigen-stimulated	JJ	B-NP	B-cell_type
CD4	CD4	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
T	T	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
after	after	IN	B-PP	O
2-3	2-3	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
culture	culture	NN	B-NP	O
under	under	IN	B-PP	O
Th2	Th2	NN	B-NP	B-cell_type
but	but	CC	B-NP	O
not	not	RB	I-NP	O
Th1	Th1	NN	B-NP	O
biasing	biasing	NN	I-NP	O
conditions	condition	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
closely	closely	RB	B-ADVP	O
mirrored	mirror	VBD	B-VP	O
that	that	IN	B-SBAR	O
of	of	IN	B-PP	O
GATA-3	GATA-3	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
transient	transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
in	in	IN	B-PP	O
phorbol	phorbol	NN	B-NP	B-cell_line
12-myristate	12-myristate	NN	I-NP	I-cell_line
13-acetate/ionomycin-stimulated	13-acetate/ionomycin-stimulated	JJ	I-NP	I-cell_line
EL4	EL4	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
SKAT-2	SKAT-2	NN	B-NP	B-protein
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
up-regulate	up-regulate	VB	I-VP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-4	IL-4	NN	I-NP	B-protein
but	but	CC	B-NP	O
not	not	RB	I-NP	O
the	the	DT	B-NP	O
IL-5	IL-5	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
,	,	,	O	O
contrasting	contrast	VBG	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
GATA-3	GATA-3	NN	B-NP	B-protein
to	to	TO	B-VP	O
activate	activate	VB	I-VP	O
both	both	DT	B-NP	O
promoters	promoter	NNS	I-NP	B-DNA
.	.	.	O	O

This	This	DT	B-NP	O
result	result	NN	I-NP	O
was	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
using	use	VBG	B-VP	O
clones	clone	NNS	B-NP	O
of	of	IN	B-PP	O
EL4	EL4	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
stably	stably	RB	B-VP	O
expressing	express	VBG	I-VP	O
an	an	DT	B-NP	O
inducible	inducible	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
SKAT-2	SKAT-2	NN	B-NP	B-protein
,	,	,	O	O
thus	thus	RB	B-ADVP	O
SKAT-2	SKAT-2	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	B-DNA
Th2-specific	Th2-specific	JJ	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
selective	selective	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

hsp70	hsp70	NN	B-NP	B-protein
interacting	interact	VBG	B-VP	O
protein	protein	NN	B-NP	O
Hip	Hip	NN	I-NP	B-protein
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
folding	folding	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
hsp90-based	hsp90-based	JJ	I-NP	O
chaperone	chaperone	NN	I-NP	O
machinery	machinery	NN	I-NP	O
except	except	IN	B-SBAR	O
to	to	TO	B-VP	O
oppose	oppose	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
BAG-1	BAG-1	NN	B-NP	B-protein
.	.	.	O	O

Reticulocyte	Reticulocyte	NN	B-NP	O
lysate	lysate	NN	I-NP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
chaperone	chaperone	NN	I-NP	O
system	system	NN	I-NP	O
that	that	WDT	B-NP	O
assembles	assemble	VBZ	B-VP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
GR	GR	NN	B-NP	B-protein
)	)	)	O	O
.hsp90	.hsp90	CD	B-NP	O
heterocomplexes	heterocomplex	NNS	I-NP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
purified	purify	VBN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
prepared	prepare	VBN	I-VP	O
a	a	DT	B-NP	O
five-protein	five-protein	JJ	I-NP	O
heterocomplex	heterocomplex	NN	I-NP	O
assembly	assembly	NN	I-NP	O
system	system	NN	I-NP	O
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
proteins	protein	NNS	I-NP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
heterocomplex	heterocomplex	JJ	B-NP	B-protein
assembly-	assembly-	NN	I-NP	I-protein
hsp90	hsp90	NN	I-NP	I-protein
and	and	CC	I-NP	O
hsp70	hsp70	NN	I-NP	B-protein
-and	-and	SYM	B-NP	O
three	three	CD	B-NP	O
proteins	protein	NNS	I-NP	O
that	that	WDT	B-NP	O
act	act	VBP	B-VP	O
as	as	IN	B-SBAR	O
co-chaperones	co-chaperone	NNS	B-NP	O
to	to	TO	B-VP	O
enhance	enhance	VB	I-VP	O
assembly-	assembly-	RP	B-PRT	O
Hop	Hop	NNP	B-NP	O
,	,	,	O	O
hsp40	hsp40	NN	B-NP	B-protein
,	,	,	O	O
p23	p23	NN	B-NP	B-protein
[	[	(	O	O
Morishima	Morishima	NNP	B-NP	O
,	,	,	O	O
Y.	Y.	NNP	B-NP	O
,	,	,	O	O
Kanelakis	Kanelakis	NNP	B-NP	O
,	,	,	O	O
K.	K.	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
Silverstein	Silverstein	NNP	B-NP	O
,	,	,	O	O
A.	A.	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
Dittmar	Dittmar	NNP	B-NP	O
,	,	,	O	O
K.	K.	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
Estrada	Estrada	NNP	B-NP	O
,	,	,	O	O
L.	L.	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Pratt	Pratt	NNP	B-NP	O
,	,	,	O	O
W.	W.	NNP	B-NP	O
B.	B.	NNP	I-NP	O
(	(	(	O	O
2000	2000	CD	B-NP	O
)	)	)	O	O
J.	J.	NNP	B-NP	O
Biol.	Biol.	NNP	I-NP	O
Chem.	Chem.	NNP	I-NP	O
275	275	CD	I-NP	O
,	,	,	I-NP	O
6894-6900	6894-6900	CD	I-NP	O
]	]	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
hsp70	hsp70	NN	I-NP	B-protein
co-chaperone	co-chaperone	NN	I-NP	O
Hip	Hip	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
recovered	recover	VBN	I-VP	O
in	in	IN	B-PP	O
receptor.hsp90	receptor.hsp90	NN	B-NP	O
heterocomplexes	heterocomplex	NNS	I-NP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
intermediate	intermediate	JJ	I-NP	O
stage	stage	NN	I-NP	O
of	of	IN	B-PP	O
assembly	assembly	NN	B-NP	O
in	in	IN	B-PP	O
reticulocyte	reticulocyte	NN	B-NP	O
lysate	lysate	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Hip	Hip	NNP	B-NP	B-protein
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
intrinsic	intrinsic	JJ	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
assembly	assembly	NN	I-NP	O
machinery	machinery	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
immunodepletion	immunodepletion	NN	B-NP	O
of	of	IN	B-PP	O
Hip	Hip	NN	B-NP	B-protein
from	from	IN	B-PP	O
reticulocyte	reticulocyte	NN	B-NP	O
lysate	lysate	NN	I-NP	O
or	or	CC	I-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
Hip	Hip	NNP	B-NP	B-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
purified	purify	VBN	I-NP	O
five-protein	five-protein	JJ	I-NP	O
system	system	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
GR.hsp90	GR.hsp90	NN	B-NP	B-protein
heterocomplex	heterocomplex	NN	I-NP	O
assembly	assembly	NN	I-NP	O
or	or	CC	O	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
steroid	steroid	NN	B-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
that	that	WDT	B-NP	O
occurs	occur	VBZ	B-VP	O
with	with	IN	B-PP	O
assembly	assembly	NN	B-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
Hip	Hip	NN	B-NP	B-protein
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
assembly	assembly	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
recovered	recover	VBN	I-VP	O
in	in	IN	B-PP	O
GR.hsp90	GR.hsp90	NN	B-NP	B-protein
heterocomplexes	heterocomplex	NNS	I-NP	I-protein
assembled	assemble	VBN	B-VP	O
by	by	IN	B-PP	O
both	both	DT	B-NP	O
systems	system	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
five-protein	five-protein	JJ	I-NP	O
system	system	NN	I-NP	O
,	,	,	O	O
Hip	Hip	NN	B-NP	B-protein
prevents	prevent	VBZ	B-VP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
assembly	assembly	NN	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
hsp70	hsp70	NN	I-NP	B-protein
co-chaperone	co-chaperone	NN	I-NP	O
BAG-1	BAG-1	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
cotransfection	cotransfection	NN	B-NP	O
of	of	IN	B-PP	O
Hip	Hip	NN	B-NP	B-protein
with	with	IN	B-PP	O
BAG-1	BAG-1	NN	B-NP	B-protein
opposes	oppose	VBZ	B-VP	O
BAG-1	BAG-1	NN	B-NP	B-protein
reduction	reduction	NN	I-NP	O
of	of	IN	B-PP	O
steroid	steroid	NN	B-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
COS	COS	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
Hip	Hip	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
not	not	RB	O	O
a	a	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
assembly	assembly	NN	I-NP	O
machinery	machinery	NN	I-NP	O
but	but	CC	O	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
could	could	MD	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
opposition	opposition	NN	B-NP	O
to	to	TO	B-PP	O
BAG-1	BAG-1	NN	B-NP	B-protein
.	.	.	O	O

Cutting	Cutting	JJ	B-NP	O
edge	edge	NN	I-NP	O
:	:	:	O	O
STAT6-deficient	STAT6-deficient	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
have	have	VBP	B-VP	O
enhanced	enhance	VBN	I-VP	O
tumor	tumor	NN	B-NP	O
immunity	immunity	NN	I-NP	O
to	to	TO	B-PP	O
primary	primary	JJ	B-NP	O
and	and	CC	I-NP	O
metastatic	metastatic	JJ	I-NP	O
mammary	mammary	JJ	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
.	.	.	O	O

STAT4	STAT4	NN	B-NP	B-protein
and	and	CC	I-NP	O
STAT6	STAT6	NN	I-NP	B-protein
are	be	VBP	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
CD4	CD4	NN	B-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
Th1	Th1	NN	B-NP	O
and	and	CC	I-NP	O
Th2	Th2	NN	I-NP	O
development	development	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

Tumor	Tumor	NN	B-NP	O
immunologists	immunologist	NNS	I-NP	O
have	have	VBP	B-VP	O
hypothesized	hypothesize	VBN	I-VP	O
that	that	IN	B-SBAR	O
Th1	Th1	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
critical	critical	JJ	B-ADJP	O
in	in	IN	B-PP	O
tumor	tumor	NN	B-NP	O
immunity	immunity	NN	I-NP	O
because	because	IN	B-SBAR	O
they	they	PRP	B-NP	O
facilitate	facilitate	VBP	B-VP	O
differentiation	differentiation	NN	B-NP	O
of	of	IN	B-PP	O
CD8	CD8	NN	B-NP	B-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
T	T	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
potent	potent	JJ	B-NP	O
anti-tumor	anti-tumor	JJ	I-NP	O
effectors	effector	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
used	use	VBN	I-VP	O
STAT4	STAT4	NN	B-NP	B-protein
(	(	(	O	O
-/-	-/-	JJ	B-ADJP	O
)	)	)	O	O
and	and	CC	O	O
STAT6	STAT6	NN	B-NP	B-protein
(	(	(	O	O
-/-	-/-	JJ	O	O
)	)	)	O	O
mice	mouse	NNS	B-NP	O
to	to	TO	B-VP	O
test	test	VB	I-VP	O
this	this	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
.	.	.	O	O

BALB/c	BALB/c	NN	B-NP	O
and	and	CC	I-NP	O
knockout	knockout	NN	I-NP	O
mice	mouse	NNS	I-NP	O
were	be	VBD	B-VP	O
challenged	challenge	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mammary	mammary	JJ	I-NP	O
gland	gland	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
highly	highly	RB	I-NP	O
malignant	malignant	JJ	I-NP	O
and	and	CC	I-NP	O
spontaneously	spontaneously	RB	I-NP	O
metastatic	metastatic	JJ	I-NP	O
BALB/c-derived	BALB/c-derived	JJ	I-NP	O
4T1	4T1	NN	I-NP	O
mammary	mammary	JJ	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
.	.	.	O	O

Primary	Primary	JJ	B-NP	O
tumor	tumor	NN	I-NP	O
growth	growth	NN	I-NP	O
and	and	CC	O	O
metastatic	metastatic	JJ	B-NP	O
disease	disease	NN	I-NP	O
are	be	VBP	B-VP	O
reduced	reduce	VBN	I-VP	O
in	in	IN	B-PP	O
STAT6	STAT6	NN	B-NP	B-protein
(	(	(	O	O
-/-	-/-	JJ	O	O
)	)	)	O	O
mice	mouse	NNS	B-NP	O
relative	relative	JJ	B-ADJP	O
to	to	TO	B-PP	O
BALB/c	BALB/c	NN	B-NP	B-cell_type
and	and	CC	I-NP	O
STAT4	STAT4	NN	I-NP	B-protein
(	(	(	O	O
-/-	-/-	JJ	O	O
)	)	)	O	O
mice	mouse	NNS	B-NP	O
.	.	.	O	O

Ab	Ab	NN	B-NP	O
depletions	depletion	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
CD8	CD8	NN	B-NP	B-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
T	T	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
immunized	immunize	VBN	B-NP	O
STAT6	STAT6	NN	I-NP	B-protein
(	(	(	O	O
-/-	-/-	JJ	O	O
)	)	)	O	O
mice	mouse	NNS	B-NP	O
have	have	VBP	B-VP	O
higher	high	JJR	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
4T1-specific	4T1-specific	JJ	B-NP	B-cell_type
CTL	CTL	NN	I-NP	I-cell_type
than	than	IN	B-PP	O
BALB/c	BALB/c	NN	B-NP	B-protein
or	or	CC	I-NP	O
STAT4	STAT4	NN	I-NP	B-protein
(	(	(	O	O
-/-	-/-	JJ	O	O
)	)	)	O	O
mice	mouse	NNS	B-NP	O
.	.	.	O	O

Surprisingly	Surprisingly	RB	B-ADVP	O
,	,	,	O	O
Th1	Th1	NN	B-NP	B-cell_line
or	or	CC	I-NP	O
Th2	Th2	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
involved	involve	VBN	I-VP	O
,	,	,	O	O
because	because	IN	B-SBAR	O
CD4	CD4	NN	B-NP	B-protein
depletion	depletion	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
diminish	diminish	VB	I-VP	O
the	the	DT	B-NP	O
anti-tumor	anti-tumor	JJ	I-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
deletion	deletion	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
STAT6	STAT6	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
facilitates	facilitate	VBZ	B-VP	O
development	development	NN	B-NP	O
of	of	IN	B-PP	O
potent	potent	JJ	B-NP	O
anti-tumor	anti-tumor	JJ	I-NP	O
immunity	immunity	NN	I-NP	O
via	via	IN	B-PP	O
a	a	DT	B-NP	O
CD4	CD4	NN	I-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
-independent	-independent	JJ	B-NP	O
pathway	pathway	NN	I-NP	O
.	.	.	O	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
oncogenic	oncogenic	JJ	B-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
AP-1	AP-1	NN	I-NP	B-protein
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
infected	infect	VBN	B-VP	O
with	with	IN	B-PP	O
human	human	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
leukemia	leukemia	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

Human	Human	JJ	B-NP	B-protein
T	T	NN	I-NP	I-protein
cell	cell	NN	I-NP	I-protein
leukemia	leukemia	NN	I-NP	I-protein
virus	virus	NN	I-NP	I-protein
type	type	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
(	(	(	O	I-protein
HTLV-1	HTLV-1	NN	B-NP	I-protein
)	)	)	O	I-protein
Tax	Tax	NN	B-NP	I-protein
protein	protein	NN	I-NP	I-protein
transforms	transform	VBZ	B-VP	O
primary	primary	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

We	We	PRP	B-NP	O
previously	previously	RB	B-ADVP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
Tax	Tax	NN	B-NP	B-protein
induces	induce	VBZ	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
various	various	JJ	B-NP	O
family	family	NN	I-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
AP-1	AP-1	NN	I-NP	B-protein
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
c-Jun	c-Jun	NN	B-NP	B-protein
,	,	,	O	O
JunD	JunD	NN	B-NP	B-protein
,	,	,	O	O
c-Fos	c-Fos	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
Fra-1	Fra-1	NN	B-NP	B-protein
at	at	IN	B-PP	O
the	the	DT	B-NP	O
mRNA	mRNA	NN	I-NP	B-RNA
level	level	NN	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
examined	examine	VBN	I-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
Tax	Tax	NN	B-NP	B-protein
to	to	TO	B-VP	O
activate	activate	VB	I-VP	O
transcription	transcription	NN	B-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
AP-1-binding	AP-1-binding	JJ	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
(	(	(	O	O
AP-1	AP-1	NN	B-NP	B-DNA
site	site	NN	I-NP	I-DNA
)	)	)	O	O
.	.	.	O	O

A	A	DT	B-NP	O
transient	transient	JJ	I-NP	O
transfection	transfection	NN	I-NP	O
study	study	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
Tax	Tax	NN	B-NP	B-protein
can	can	MD	B-VP	O
activate	activate	VB	I-VP	O
transcription	transcription	NN	B-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
AP-1-binding	AP-1-binding	JJ	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
in	in	IN	B-PP	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
,	,	,	O	O
whereas	whereas	IN	O	O
any	any	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
did	do	VBD	B-VP	O
so	so	RB	B-ADJP	O
much	much	RB	I-ADJP	O
less	less	JJR	I-ADJP	O
than	than	IN	B-PP	O
Tax	Tax	NN	B-NP	B-protein
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
AP-1	AP-1	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
by	by	IN	B-PP	O
Tax	Tax	NN	B-NP	B-protein
may	may	MD	B-VP	O
require	require	VB	I-VP	O
a	a	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
other	other	JJ	B-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
.	.	.	O	O

Fresh	Fresh	JJ	B-NP	O
peripheral	peripheral	JJ	I-NP	O
blood	blood	NN	I-NP	O
leukemia	leukemia	NN	I-NP	O
cells	cell	NNS	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
surveyed	survey	VBN	I-NP	O
ATL	ATL	NN	I-NP	O
patients	patient	NNS	I-NP	O
displayed	display	VBD	B-VP	O
constitutive	constitutive	JJ	B-NP	O
AP-1	AP-1	NN	I-NP	B-protein
DNA-binding	DNA-binding	JJ	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
no	no	DT	B-NP	O
normal	normal	JJ	I-NP	O
individuals	individual	NNS	I-NP	O
did	do	VBD	B-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
HTLV-1	HTLV-1	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
,	,	,	O	O
including	include	VBG	B-PP	O
tax	tax	NN	B-NP	B-protein
,	,	,	O	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
significantly	significantly	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
fresh	fresh	JJ	B-NP	O
leukemia	leukemia	NN	I-NP	O
cells	cell	NNS	I-NP	O
from	from	IN	B-PP	O
ATL	ATL	NN	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
present	present	JJ	I-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-protein
occurs	occur	VBZ	B-VP	O
through	through	IN	B-PP	O
Tax-dependent	Tax-dependent	JJ	B-NP	O
and	and	CC	I-NP	O
-independent	-independent	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
in	in	IN	B-PP	O
HTLV-1-infected	HTLV-1-infected	JJ	B-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
some	some	DT	B-NP	O
roles	role	NNS	I-NP	O
in	in	IN	B-PP	O
dysregulated	dysregulate	VBN	B-NP	O
phenotypes	phenotype	NNS	I-NP	O
of	of	IN	B-PP	O
HTLV-1-infected	HTLV-1-infected	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

2	2	CD	B-NP	O
,	,	,	I-NP	O
2	2	CD	I-NP	O
'	'	SYM	I-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
,	,	,	I-NP	O
6	6	CD	I-NP	O
,	,	,	O	O
6'-pentachlorobiphenyl	6'-pentachlorobiphenyl	NN	B-NP	O
induces	induce	VBZ	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
monocytic	monocytic	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Polychlorinatedbiphenyls	Polychlorinatedbiphenyl	NNS	B-NP	O
(	(	(	O	O
PCBs	PCB	NNS	B-NP	B-protein
)	)	)	O	O
are	be	VBP	B-VP	O
a	a	DT	B-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
persistent	persistent	JJ	O	O
and	and	CC	O	O
widely	widely	RB	B-VP	O
dispersed	disperse	VBD	I-VP	O
environmental	environmental	JJ	B-NP	O
pollutants	pollutant	NNS	I-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
immunotoxic	immunotoxic	JJ	B-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
PCBs	PCB	NNS	B-NP	B-protein
on	on	IN	B-PP	O
immune	immune	JJ	B-NP	O
system	system	NN	I-NP	O
by	by	IN	B-PP	O
assessing	assess	VBG	B-VP	O
apoptotic	apoptotic	JJ	B-NP	O
cell	cell	NN	I-NP	O
death	death	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
monocytic	monocytic	JJ	I-NP	I-cell_line
U937	U937	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Among	Among	IN	B-PP	O
the	the	DT	B-NP	O
various	various	JJ	I-NP	O
congeners	congener	NNS	I-NP	O
tested	test	VBN	B-VP	O
,	,	,	O	O
2	2	CD	B-NP	O
,	,	,	I-NP	O
2	2	CD	I-NP	O
'	'	SYM	I-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
,	,	,	I-NP	O
6	6	CD	I-NP	O
,	,	,	O	O
6'-pentachlorobiphenyl	6'-pentachlorobiphenyl	NN	B-NP	O
(	(	(	O	O
PeCB	PeCB	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	O
ortho-substituted	ortho-substituted	JJ	I-NP	O
congener	congener	NN	I-NP	O
,	,	,	O	O
specifically	specifically	RB	B-ADVP	O
induced	induce	VBD	B-VP	O
DNA	DNA	NN	B-NP	O
fragmentation	fragmentation	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
hallmark	hallmark	NN	I-NP	O
of	of	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
examined	examine	VBN	I-NP	O
di-	di-	NN	I-NP	O
,	,	,	O	O
tri-	tri-	NN	B-NP	O
,	,	,	O	O
tetra-	tetra-	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
pentachlorobiphenyls	pentachlorobiphenyl	NNS	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	O	O
.	.	.	O	O

To	To	TO	B-VP	O
further	further	RB	I-VP	O
study	study	VB	I-VP	O
the	the	DT	B-NP	O
2	2	CD	I-NP	O
,	,	,	I-NP	O
2	2	CD	I-NP	O
'	'	SYM	I-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
,	,	,	I-NP	O
6	6	CD	I-NP	O
,	,	,	I-NP	O
6'-PeCB-induced	6'-PeCB-induced	JJ	I-NP	O
cell	cell	NN	I-NP	O
death	death	NN	I-NP	O
,	,	,	O	O
various	various	JJ	B-NP	O
features	feature	NNS	I-NP	O
of	of	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
.	.	.	O	O

2	2	CD	B-NP	O
,	,	,	I-NP	O
2	2	CD	I-NP	O
'	'	SYM	I-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
,	,	,	I-NP	O
6	6	CD	I-NP	O
,	,	,	I-NP	O
6'-PeCB	6'-PeCB	NN	I-NP	O
caused	cause	VBD	B-VP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
cell	cell	NN	B-NP	O
viability	viability	NN	I-NP	O
and	and	CC	O	O
induced	induce	VBD	B-VP	O
cellular	cellular	JJ	B-NP	O
morphologic	morphologic	JJ	I-NP	O
features	feature	NNS	I-NP	O
characteristic	characteristic	JJ	B-ADJP	O
of	of	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
chromatin	chromatin	NN	B-NP	B-DNA
aggregation	aggregation	NN	I-NP	O
and	and	CC	O	O
apoptotic	apoptotic	JJ	B-NP	O
bodies	body	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
caspase-3	caspase-3	NN	B-NP	B-protein
,	,	,	O	O
an	an	DT	B-NP	O
executioner	executioner	NN	I-NP	O
of	of	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
activated	activate	VBN	I-VP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
substrate	substrate	NN	I-NP	O
,	,	,	O	O
poly	poly	NN	B-NP	B-protein
(	(	(	O	I-protein
ADP-ribose	ADP-ribose	NN	B-NP	I-protein
)	)	)	O	I-protein
polymerase	polymerase	NN	B-NP	I-protein
(	(	(	O	O
PARP	PARP	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
was	be	VBD	B-VP	O
cleaved	cleave	VBN	I-VP	O
during	during	IN	B-PP	O
2	2	CD	B-NP	O
,	,	,	I-NP	O
2	2	CD	I-NP	O
'	'	SYM	I-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
,	,	,	I-NP	O
6	6	CD	I-NP	O
,	,	,	I-NP	O
6'-PeCB-induced	6'-PeCB-induced	JJ	I-NP	O
apoptosis	apoptosis	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
,	,	,	I-NP	O
3	3	CD	I-NP	O
'	'	SYM	I-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
,	,	,	I-NP	O
4	4	CD	I-NP	O
'	'	SYM	I-NP	O
,	,	,	O	O
5-PeCB	5-PeCB	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
congener	congener	NN	I-NP	O
of	of	IN	B-PP	O
coplanar	coplanar	JJ	B-NP	O
structure	structure	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-NP	O
well	well	RB	I-NP	O
as	as	IN	I-NP	O
2	2	CD	I-NP	O
,	,	,	I-NP	O
3	3	CD	I-NP	O
,	,	,	I-NP	O
7	7	CD	I-NP	O
,	,	,	O	O
8-TCDD	8-TCDD	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
induce	induce	VB	I-VP	O
apoptosis	apoptosis	NN	B-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
human	human	JJ	I-NP	B-cell_type
monocytic	monocytic	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
although	although	IN	B-SBAR	O
they	they	PRP	B-NP	O
potently	potently	RB	B-ADVP	O
induced	induce	VBD	B-VP	O
CYP	CYP	NN	B-NP	B-protein
1A1	1A1	NN	I-NP	I-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
hepatoma	hepatoma	NN	I-NP	I-cell_line
Hep	Hep	NN	I-NP	I-cell_line
G2	G2	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Taken	Take	VBN	B-VP	O
together	together	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
2	2	CD	B-NP	O
,	,	,	I-NP	O
2	2	CD	I-NP	O
'	'	SYM	B-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
,	,	,	I-NP	O
6	6	CD	I-NP	O
,	,	,	O	O
6'-PeCB	6'-PeCB	NN	B-NP	B-protein
induces	induce	VBZ	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
monocytic	monocytic	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
through	through	IN	B-PP	O
a	a	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
arylhydrocarbon	arylhydrocarbon	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

This	This	DT	B-NP	O
suggests	suggest	VBZ	B-VP	O
a	a	DT	B-NP	O
possibly	possibly	RB	I-NP	O
separate	separate	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
PCBs	PCB	NNS	B-NP	B-protein
cause	cause	VBP	B-VP	O
immunosuppression	immunosuppression	NN	B-NP	O
.	.	.	O	O

Effects	Effect	NNS	B-NP	O
of	of	IN	B-PP	O
deregulated	deregulate	VBN	B-NP	O
Raf	Raf	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
on	on	IN	B-PP	O
integrin	integrin	NN	B-NP	B-protein
,	,	,	O	O
cytokine-receptor	cytokine-receptor	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
in	in	IN	B-PP	O
hematopoietic	hematopoietic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
deregulated	deregulate	VBN	B-NP	O
Raf	Raf	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
and	and	CC	I-NP	O
differentiation	differentiation	NN	I-NP	O
of	of	IN	B-PP	O
hematopoietic	hematopoietic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
cytokine-dependent	cytokine-dependent	JJ	I-NP	B-cell_line
murine	murine	JJ	I-NP	I-cell_line
myeloid	myeloid	JJ	I-NP	I-cell_line
FDC-P1	FDC-P1	NN	I-NP	I-cell_line
and	and	CC	O	I-cell_line
human	human	JJ	B-NP	I-cell_line
erythroleukemic	erythroleukemic	JJ	I-NP	I-cell_line
TF-1	TF-1	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
transformed	transform	VBN	I-VP	O
to	to	TO	I-VP	O
grow	grow	VB	I-VP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
deregulated	deregulate	VBN	B-NP	O
Raf	Raf	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
exogenous	exogenous	JJ	B-NP	B-protein
cytokines	cytokine	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
conditionally	conditionally	RB	I-NP	O
active	active	JJ	I-NP	O
Raf	Raf	NN	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
beta-estradiol	beta-estradiol	NN	B-NP	O
as	as	IN	B-PP	O
cDNAs	cDNA	NNS	B-NP	B-DNA
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
Raf	Raf	NN	I-NP	B-protein
catalytic	catalytic	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
lacking	lack	VBG	B-VP	O
negative-regulatory	negative-regulatory	JJ	B-NP	B-DNA
domains	domain	NNS	I-NP	I-DNA
,	,	,	O	O
were	be	VBD	B-VP	O
ligated	ligate	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hormone	hormone	NN	I-NP	B-protein
binding	binding	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
estrogen	estrogen	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
deltaRaf	deltaRaf	NN	B-NP	O
:	:	:	O	O
ER	ER	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Continuous	Continuous	JJ	B-NP	O
deltaRaf	deltaRaf	NN	I-NP	O
expression	expression	NN	I-NP	O
prevented	prevent	VBD	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
exogenous	exogenous	JJ	B-NP	B-protein
cytokines	cytokine	NNS	I-NP	I-protein
and	and	CC	O	O
altered	alter	VBD	B-VP	O
the	the	DT	B-NP	O
morphology	morphology	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
FD/deltaRaf	FD/deltaRaf	NNP	I-NP	O
:	:	:	O	O
ER	ER	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
as	as	IN	B-SBAR	O
they	they	PRP	B-NP	O
grew	grow	VBD	B-VP	O
in	in	IN	B-PP	O
large	large	JJ	B-NP	O
aggregated	aggregated	JJ	I-NP	O
masses	mass	NNS	I-NP	O
(	(	(	O	O
>	>	SYM	B-NP	B-cell_line
100	100	CD	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
)	)	)	O	O
whereas	whereas	IN	B-PP	O
the	the	DT	B-NP	O
parental	parental	JJ	I-NP	B-cell_line
cytokine-dependent	cytokine-dependent	JJ	I-NP	I-cell_line
FDC-P1	FDC-P1	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
grew	grow	VBD	B-VP	O
in	in	IN	B-PP	O
smaller	small	JJR	B-NP	O
grape-like	grape-like	JJ	I-NP	O
clusters	cluster	NNS	I-NP	O
(	(	(	O	O
<	<	SYM	B-NP	O
10	10	CD	I-NP	O
cells	cell	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

FD/deltaRaf-1	FD/deltaRaf-1	NN	B-NP	O
:	:	:	O	O
ER	ER	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
growing	grow	VBG	B-VP	O
in	in	IN	B-PP	O
response	response	NN	B-PP	O
to	to	TO	I-PP	O
Raf	Raf	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
displayed	display	VBD	B-VP	O
decreased	decrease	VBN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Mac-2	Mac-2	NN	I-NP	B-protein
and	and	CC	I-NP	O
Mac-3	Mac-3	NN	I-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
on	on	IN	B-PP	O
their	their	PRP$	B-NP	O
cell	cell	NN	I-NP	O
surface	surface	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
were	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
in	in	IN	B-PP	O
IL-3	IL-3	NN	B-NP	B-protein
,	,	,	O	O
higher	high	JJR	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
adhesion	adhesion	NN	I-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
.	.	.	O	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
activated	activate	VBN	B-NP	O
Raf	Raf	NN	I-NP	B-protein
oncoproteins	oncoprotein	NNS	I-NP	I-protein
also	also	RB	B-ADVP	O
abrogated	abrogate	VBD	B-VP	O
cytokine	cytokine	NN	B-NP	B-protein
dependency	dependency	NN	I-NP	O
and	and	CC	O	O
prevented	prevent	VBD	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
of	of	IN	B-PP	O
TF-1	TF-1	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
differentiation	differentiation	NN	I-NP	O
status	status	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
Raf-responsive	Raf-responsive	JJ	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
immature	immature	JJ	I-ADJP	O
upon	upon	IN	B-PP	O
Raf	Raf	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
as	as	IN	B-PP	O
culture	culture	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
differentiation-inducing	differentiation-inducing	JJ	I-NP	O
agent	agent	NN	I-NP	O
phorbol	phorbol	NN	I-NP	O
12	12	CD	I-NP	O
myristate	myristate	NN	I-NP	O
13-acetate	13-acetate	NN	I-NP	O
(	(	(	O	O
PMA	PMA	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
beta-estradiol	beta-estradiol	NN	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CD11b	CD11b	NN	I-NP	B-protein
and	and	CC	I-NP	O
CD18	CD18	NN	I-NP	B-protein
integrin	integrin	NN	I-NP	I-protein
molecules	molecule	NNS	I-NP	I-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
surface	surface	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
Raf-responsive	Raf-responsive	JJ	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
induced	induce	VBN	I-VP	O
to	to	TO	B-VP	O
differentiate	differentiate	VB	I-VP	O
with	with	IN	B-PP	O
PMA	PMA	NN	B-NP	O
and	and	CC	I-NP	O
GM-CSF	GM-CSF	NN	I-NP	B-protein
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
deltaRaf	deltaRaf	NN	B-NP	B-protein
:	:	:	O	O
ER	ER	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CD11b	CD11b	NN	I-NP	B-protein
and	and	CC	I-NP	O
CD18	CD18	NN	I-NP	B-protein
molecules	molecule	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
.	.	.	O	O

Retinoic	Retinoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
RA	RA	NN	B-NP	O
)	)	)	O	O
inhibited	inhibit	VBD	B-VP	O
3H-thymidine	3H-thymidine	NN	B-NP	O
incorporation	incorporation	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
GM-CSF	GM-CSF	NN	B-NP	B-protein
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
Raf	Raf	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
counterbalanced	counterbalance	VBD	B-VP	O
the	the	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
RA	RA	NN	B-NP	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
PMA	PMA	NN	B-NP	O
.	.	.	O	O

Thus	Thus	RB	B-NP	O
deregulated	deregulate	VBN	I-NP	O
Raf	Raf	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
can	can	MD	B-VP	O
alter	alter	VB	I-VP	O
cytokine	cytokine	NN	B-NP	B-protein
dependency	dependency	NN	I-NP	O
,	,	,	O	O
integrin	integrin	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
stage	stage	NN	I-NP	O
of	of	IN	B-PP	O
differentiation	differentiation	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
Raf-responsive	Raf-responsive	JJ	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
will	will	MD	B-VP	O
be	be	VB	I-VP	O
useful	useful	JJ	B-ADJP	O
in	in	IN	B-PP	O
elucidating	elucidate	VBG	B-VP	O
the	the	DT	B-NP	O
roles	role	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MAP	MAP	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
cascade	cascade	NN	I-NP	O
on	on	IN	B-PP	O
hematopoietic	hematopoietic	JJ	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
differentiation	differentiation	NN	I-NP	O
and	and	CC	O	O
malignant	malignant	JJ	B-NP	O
transformation	transformation	NN	I-NP	O

Cyclic	Cyclic	JJ	B-NP	O
AMP	AMP	NN	I-NP	O
activates	activate	VBZ	B-VP	O
p38	p38	NN	B-NP	B-protein
mitogen-activated	mitogen-activated	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
in	in	IN	B-PP	O
Th2	Th2	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
:	:	:	O	O
phosphorylation	phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
GATA-3	GATA-3	NN	B-NP	B-protein
and	and	CC	I-NP	O
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
Th2	Th2	NN	B-NP	B-DNA
cytokine	cytokine	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
.	.	.	O	O

cAMP	cAMP	NN	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
second	second	JJ	I-NP	O
messenger	messenger	NN	I-NP	O
with	with	IN	B-PP	O
immunomodulatory	immunomodulatory	JJ	B-NP	O
properties	property	NNS	I-NP	O
.	.	.	O	O

Elevation	Elevation	NN	B-NP	O
of	of	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
cAMP	cAMP	NN	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
agents	agent	NNS	B-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
IL-1alpha	IL-1alpha	NN	B-NP	B-protein
or	or	CC	I-NP	O
PGs	PG	NNS	I-NP	B-protein
,	,	,	O	O
inhibits	inhibit	VBZ	B-VP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
effector	effector	NN	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
cAMP	cAMP	NN	I-NP	O
inhibits	inhibit	VBZ	B-VP	O
cytokine	cytokine	NN	B-NP	B-protein
production	production	NN	I-NP	O
in	in	IN	B-PP	O
Th1	Th1	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
but	but	CC	O	O
stimulates	stimulate	VBZ	B-VP	O
cytokine	cytokine	NN	B-NP	B-protein
production	production	NN	I-NP	O
in	in	IN	B-PP	O
Th2	Th2	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
that	that	IN	B-SBAR	O
cAMP-induced	cAMP-induced	JJ	B-NP	O
effects	effect	NNS	I-NP	O
in	in	IN	B-PP	O
Th2	Th2	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
occur	occur	VBP	B-VP	O
independently	independently	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
A	A	NN	I-NP	I-protein
pathway	pathway	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
mediator	mediator	NN	I-NP	O
of	of	IN	B-PP	O
cAMP-induced	cAMP-induced	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
events	event	NNS	I-NP	O
in	in	IN	B-PP	O
most	most	JJS	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
.	.	.	O	O

Instead	Instead	RB	B-ADVP	O
,	,	,	O	O
cAMP	cAMP	NN	B-NP	O
stimulates	stimulate	VBZ	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
p38	p38	NN	B-NP	B-protein
mitogen-activated	mitogen-activated	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
in	in	IN	B-PP	O
Th2	Th2	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

This	This	DT	B-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
Th2	Th2	NN	I-NP	O
-selective	-selective	JJ	I-NP	O
event	event	NN	I-NP	O
because	because	IN	B-SBAR	O
cAMP	cAMP	NN	B-NP	O
barely	barely	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
p38	p38	NN	B-NP	B-protein
phosphorylation	phosphorylation	NN	I-NP	O
in	in	IN	B-PP	O
Th1	Th1	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
Th2	Th2	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
cAMP	cAMP	NN	B-NP	O
promotes	promote	VBZ	B-VP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
IL-5	IL-5	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-13	IL-13	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
play	play	VBP	B-VP	O
distinct	distinct	JJ	B-NP	O
but	but	CC	I-NP	O
critical	critical	JJ	I-NP	O
roles	role	NNS	I-NP	O
in	in	IN	B-PP	O
asthma	asthma	NN	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
data	datum	NNS	I-NP	O
also	also	RB	B-ADVP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
cAMP	cAMP	NN	B-NP	O
causes	cause	VBZ	B-VP	O
increased	increase	VBN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
GATA-3	GATA-3	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
regulator	regulator	NN	I-NP	O
of	of	IN	B-PP	O
Th2	Th2	NN	B-NP	B-DNA
cytokine	cytokine	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
in	in	IN	B-PP	O
turn	turn	NN	B-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
airway	airway	NN	B-NP	O
inflammation	inflammation	NN	I-NP	O
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
Th2	Th2	NN	B-NP	O
-specific	-specific	JJ	I-NP	O
GATA-3	GATA-3	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
p38	p38	NN	B-NP	B-protein
mitogen-activated	mitogen-activated	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
together	together	RB	B-ADVP	O
provide	provide	VBP	B-VP	O
a	a	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
differential	differential	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
cAMP	cAMP	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
T	T	NN	I-NP	B-cell_type
helper	helper	NN	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
subsets	subset	NNS	I-NP	I-cell_type
.	.	.	O	O

Characterization	Characterization	NN	B-NP	O
of	of	IN	B-PP	O
IL-4	IL-4	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-13	IL-13	NN	I-NP	B-protein
signals	signal	NNS	I-NP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
IL-13	IL-13	NN	I-NP	O
receptor	receptor	NN	I-NP	O
alpha	alpha	NN	I-NP	O
chain	chain	NN	I-NP	O
1	1	CD	I-NP	O
:	:	:	O	O
redundancy	redundancy	NN	B-NP	O
of	of	IN	B-PP	O
requirement	requirement	NN	B-NP	O
of	of	IN	B-PP	O
tyrosine	tyrosine	NN	B-NP	O
residue	residue	NN	I-NP	O
for	for	IN	B-PP	O
STAT3	STAT3	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

IL-4	IL-4	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-13	IL-13	NN	I-NP	B-protein
are	be	VBP	B-VP	O
pleiotropic	pleiotropic	JJ	B-NP	B-protein
cytokines	cytokine	NNS	I-NP	I-protein
whose	whose	WP$	B-NP	O
biological	biological	JJ	I-NP	O
activities	activity	NNS	I-NP	O
overlap	overlap	VBP	B-VP	O
with	with	IN	B-PP	O
each	each	DT	B-NP	O
other	other	JJ	I-NP	O
.	.	.	O	O

IL-13	IL-13	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
chain	chain	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
(	(	(	O	O
IL-13R	IL-13R	NN	B-NP	B-protein
alpha	alpha	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
IL-13	IL-13	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
heterodimer	heterodimer	NN	I-NP	B-protein
composed	compose	VBN	B-VP	O
of	of	IN	B-PP	O
IL-13R	IL-13R	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
and	and	CC	I-NP	O
IL-4R	IL-4R	NN	I-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
chain	chain	NN	I-NP	I-protein
transduces	transduce	VBZ	B-VP	O
IL-13	IL-13	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-4	IL-4	NN	I-NP	B-protein
signals	signal	NNS	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	O
mapping	mapping	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
IL-13R	IL-13R	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
is	be	VBZ	B-VP	O
not	not	RB	O	O
fully	fully	RB	B-ADJP	O
understood	understand	VBN	I-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
constructed	construct	VBD	B-VP	O
wild	wild	JJ	B-NP	O
and	and	CC	I-NP	O
mutated	mutate	VBN	I-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-protein
IL-13R	IL-13R	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
analyzed	analyze	VBD	B-VP	O
IL-4	IL-4	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-13	IL-13	NN	I-NP	B-protein
signals	signal	NNS	I-NP	O
using	use	VBG	B-VP	O
an	an	DT	B-NP	O
IL-13R	IL-13R	NN	I-NP	B-cell_line
alpha	alpha	NN	I-NP	I-cell_line
1	1	CD	I-NP	I-cell_line
-transfected	-transfected	JJ	I-NP	I-cell_line
human	human	JJ	I-NP	I-cell_line
B	B	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
IL-13R	IL-13R	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
evoked	evoke	VBD	B-VP	O
STAT3	STAT3	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
IL-4	IL-4	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-13	IL-13	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
stimulated	stimulate	VBN	B-NP	B-cell_line
human	human	JJ	I-NP	I-cell_line
B	B	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
on	on	IN	B-PP	O
which	which	WDT	B-NP	O
IL-13R	IL-13R	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
was	be	VBD	B-VP	O
highly	highly	RB	I-VP	O
expressed	express	VBN	I-VP	O
,	,	,	O	O
IL-4	IL-4	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-13	IL-13	NN	I-NP	B-protein
induced	induce	VBD	B-VP	O
STAT3	STAT3	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

Replacement	Replacement	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
tyrosine	tyrosine	NN	I-NP	O
residues	residue	NNS	I-NP	O
completely	completely	RB	B-ADVP	O
abolished	abolish	VBD	B-VP	O
STAT3	STAT3	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
replacing	replace	VBG	B-VP	O
either	either	CC	B-NP	O
tyrosine	tyrosine	NN	I-NP	O
residue	residue	NN	I-NP	O
alone	alone	RB	B-ADVP	O
retained	retain	VBD	B-VP	O
it	it	PRP	B-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
Box1	Box1	NN	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
and	and	CC	O	O
the	the	DT	B-NP	O
C-terminal	C-terminal	JJ	I-NP	B-protein
tail	tail	NN	I-NP	I-protein
of	of	IN	B-PP	O
IL-13R	IL-13R	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
were	be	VBD	B-VP	O
critical	critical	JJ	B-ADJP	O
for	for	IN	B-PP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
Tyk2	Tyk2	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
Jak1	Jak1	NN	B-NP	B-protein
,	,	,	O	O
Tyk2	Tyk2	NN	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
insulin	insulin	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
substrate-1	substrate-1	NN	I-NP	I-protein
and	and	CC	I-NP	O
STAT6	STAT6	NN	I-NP	B-protein
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
STAT3	STAT3	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
with	with	IN	B-PP	O
IL-4	IL-4	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-13	IL-13	NN	I-NP	B-protein
signals	signal	NNS	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
along	along	IN	B-PP	O
with	with	IN	I-PP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
STAT6	STAT6	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
unique	unique	JJ	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
in	in	IN	B-PP	O
IL-13R	IL-13R	NN	B-NP	B-protein
alpha	alpha	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
to	to	TO	B-VP	O
activate	activate	VB	I-VP	O
STAT3	STAT3	NN	B-NP	B-protein
.	.	.	O	O

Functional	Functional	JJ	B-NP	O
uncoupling	uncoupling	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Janus	Janus	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
3-Stat5	3-Stat5	NN	I-NP	O
pathway	pathway	NN	I-NP	O
in	in	IN	B-PP	O
malignant	malignant	JJ	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
leukemia	leukemia	NN	I-NP	I-cell_type
virus	virus	NN	I-NP	I-cell_type
type	type	NN	I-NP	I-cell_type
1-transformed	1-transformed	JJ	I-NP	I-cell_type
human	human	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Human	Human	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
leukemia	leukemia	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
HTLV-1	HTLV-1	NN	B-NP	O
)	)	)	O	O
transforms	transform	VBZ	B-VP	O
cytokine	cytokine	NN	B-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
T	T	NN	I-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O
and	and	CC	O	O
causes	cause	VBZ	B-VP	O
adult	adult	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
leukemia	leukemia	NN	I-NP	O
.	.	.	O	O

Janus	Janus	NN	B-NP	B-protein
tyrosine	tyrosine	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
Jak	Jak	NN	B-NP	B-protein
)	)	)	O	O
3	3	CD	B-NP	O
and	and	CC	O	O
transcription	transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
Stat5a	Stat5a	NN	B-NP	B-protein
and	and	CC	I-NP	O
Stat5b	Stat5b	NN	I-NP	B-protein
are	be	VBP	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
proliferation	proliferation	NN	I-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
are	be	VBP	B-VP	O
constitutively	constitutively	RB	I-VP	O
hyperactivated	hyperactivate	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
HTLV-1-transformed	HTLV-1-transformed	JJ	I-NP	B-cell_line
human	human	JJ	I-NP	I-cell_line
T	T	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
and	and	CC	O	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
HTLV-1-infected	HTLV-1-infected	JJ	B-NP	O
patients	patient	NNS	I-NP	O
;	;	:	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
Jak3-Stat5	Jak3-Stat5	NN	I-NP	B-protein
pathway	pathway	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
progression	progression	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
disease	disease	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
postulated	postulate	VBN	I-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
recently	recently	RB	B-ADVP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
tyrphostin	tyrphostin	NN	B-NP	O
AG-490	AG-490	NN	I-NP	O
selectively	selectively	RB	B-ADVP	O
blocked	block	VBD	B-VP	O
IL-2	IL-2	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
Jak3/Stat5	Jak3/Stat5	NN	B-NP	O
and	and	CC	I-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
murine	murine	JJ	B-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
disruption	disruption	NN	B-NP	O
of	of	IN	B-PP	O
Jak3/Stat5a/b	Jak3/Stat5a/b	NN	B-NP	O
signaling	signaling	NN	I-NP	O
with	with	IN	B-PP	O
AG-490	AG-490	NN	B-NP	O
(	(	(	O	O
50	50	CD	B-NP	O
&	&	CC	I-NP	O
mgr	mgr	NN	I-NP	O
;	;	:	O	O
M	M	NN	B-NP	O
)	)	)	O	O
blocked	block	VBD	B-VP	O
the	the	DT	B-NP	O
proliferation	proliferation	NN	I-NP	O
of	of	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
but	but	CC	O	O
paradoxically	paradoxically	RB	B-VP	O
failed	fail	VBD	I-VP	O
to	to	TO	I-VP	O
inhibit	inhibit	VB	I-VP	O
the	the	DT	B-NP	O
proliferation	proliferation	NN	I-NP	O
of	of	IN	B-PP	O
HTLV-1-transformed	HTLV-1-transformed	JJ	B-NP	B-cell_line
human	human	JJ	I-NP	I-cell_line
T	T	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
HuT-102	HuT-102	NN	B-NP	B-cell_line
and	and	CC	I-NP	O
MT-2	MT-2	NN	I-NP	B-cell_line
.	.	.	O	O

Structural	Structural	JJ	B-NP	O
homologues	homologue	NNS	I-NP	O
of	of	IN	B-PP	O
AG-490	AG-490	NN	B-NP	O
also	also	RB	B-ADVP	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
proliferation	proliferation	NN	I-NP	O
of	of	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
HTLV-1-infected	HTLV-1-infected	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Disruption	Disruption	NN	B-NP	O
of	of	IN	B-PP	O
constitutive	constitutive	JJ	B-NP	O
Jak3/Stat5	Jak3/Stat5	NN	I-NP	O
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
AG-490	AG-490	NN	B-NP	O
was	be	VBD	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
by	by	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
tyrosine	tyrosine	NN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
Jak3	Jak3	NN	B-NP	B-protein
,	,	,	O	O
Stat5a	Stat5a	NN	B-NP	B-protein
(	(	(	O	O
Tyr	Tyr	NN	B-NP	B-protein
(	(	(	O	O
694	694	CD	B-NP	O
)	)	)	O	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
Stat5b	Stat5b	NN	B-NP	B-protein
(	(	(	O	O
Tyr	Tyr	NN	B-NP	B-protein
(	(	(	O	O
699	699	CD	B-NP	O
)	)	)	O	O
)	)	)	O	O
;	;	:	O	O
2	2	LS	B-LST	O
)	)	)	O	O
serine	serine	NN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
Stat5a	Stat5a	NN	B-NP	B-protein
(	(	(	O	O
Ser	Ser	NN	B-NP	O
(	(	(	O	O
726	726	CD	B-NP	O
)	)	)	O	O
)	)	)	O	O
as	as	IN	B-SBAR	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
phosphospecific	phosphospecific	JJ	I-NP	B-protein
Ab	Ab	NN	I-NP	I-protein
;	;	:	O	O
and	and	CC	O	O
3	3	LS	B-LST	O
)	)	)	O	O
Stat5a/b	Stat5a/b	NN	B-NP	O
DNA	DNA	NN	I-NP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Stat5-responsive	Stat5-responsive	JJ	I-NP	B-DNA
beta-casein	beta-casein	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
AG-490	AG-490	NN	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
DNA	DNA	NN	B-NP	O
binding	binding	NN	I-NP	O
by	by	IN	B-PP	O
p50/p65	p50/p65	NN	B-NP	B-protein
components	component	NNS	I-NP	I-protein
of	of	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
activated	activate	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
HTLV-1-encoded	HTLV-1-encoded	JJ	I-NP	B-protein
phosphoprotein	phosphoprotein	NN	I-NP	I-protein
,	,	,	O	O
Tax	Tax	NN	B-NP	B-protein
.	.	.	O	O

Collectively	Collectively	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
Jak3-Stat5	Jak3-Stat5	NN	I-NP	B-protein
pathway	pathway	NN	I-NP	O
in	in	IN	B-PP	O
HTLV-1-transformed	HTLV-1-transformed	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
has	have	VBZ	B-VP	O
become	become	VBN	I-VP	O
functionally	functionally	RB	B-ADJP	O
redundant	redundant	JJ	I-ADJP	O
for	for	IN	B-PP	O
proliferation	proliferation	NN	B-NP	O
.	.	.	O	O

Reversal	Reversal	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
functional	functional	JJ	I-NP	O
uncoupling	uncoupling	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
required	require	VBN	I-VP	O
before	before	IN	B-PP	O
Jak3/Stat5	Jak3/Stat5	NN	B-NP	B-protein
inhibitors	inhibitor	NNS	I-NP	I-protein
will	will	MD	B-VP	O
be	be	VB	I-VP	O
useful	useful	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
malignancy	malignancy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Epstein-Barr	Epstein-Barr	JJ	I-NP	B-DNA
virus	virus	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
initiating	initiate	VBG	B-VP	O
B-cell	B-cell	NN	B-NP	O
transformation	transformation	NN	I-NP	O
is	be	VBZ	B-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
RFX	RFX	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
B-cell-specific	B-cell-specific	JJ	I-NP	B-protein
activator	activator	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
BSAP/Pax5	BSAP/Pax5	NN	I-NP	O
.	.	.	O	O

Epstein-Barr	Epstein-Barr	JJ	B-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
EBV	EBV	NN	B-NP	O
)	)	)	O	O
-induced	-induced	JJ	B-NP	O
B-cell	B-cell	NN	I-NP	O
growth	growth	NN	I-NP	O
transformation	transformation	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
central	central	JJ	I-NP	O
feature	feature	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
virus	virus	NN	I-NP	O
'	'	POS	B-NP	O
strategy	strategy	NN	I-NP	O
for	for	IN	B-PP	O
colonizing	colonize	VBG	B-VP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
B-cell	B-cell	NN	I-NP	O
system	system	NN	I-NP	O
,	,	,	O	O
requires	require	VBZ	B-VP	O
full	full	JJ	B-NP	O
virus	virus	NN	I-NP	O
latent	latent	JJ	I-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
initiated	initiate	VBN	I-VP	O
by	by	IN	B-PP	O
transcription	transcription	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
viral	viral	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
Wp	Wp	NN	I-NP	O
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
EBV	EBV	NN	B-NP	O
accesses	access	VBZ	B-VP	O
other	other	JJ	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
growth-transforming	growth-transforming	JJ	I-NP	O
program	program	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
activated	activate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
work	work	NN	I-NP	O
focuses	focus	VBZ	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
Wp	Wp	NN	B-NP	B-DNA
which	which	WDT	B-NP	O
in	in	IN	B-PP	O
reporter	reporter	NN	B-NP	O
assays	assay	NNS	I-NP	O
confers	confer	VBZ	B-VP	O
B-cell	B-cell	NN	B-NP	B-cell_type
-specific	-specific	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

Bandshift	Bandshift	NN	B-NP	O
studies	study	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
contains	contain	VBZ	B-VP	O
three	three	CD	B-NP	O
factor	factor	NN	I-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
,	,	,	O	O
termed	term	VBN	B-NP	O
sites	site	NNS	I-NP	B-DNA
B	B	NN	I-NP	I-DNA
,	,	,	O	O
C	C	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
D	D	NNP	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
previously	previously	RB	I-NP	O
characterized	characterize	VBN	I-NP	O
CREB	CREB	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
site	site	NN	B-NP	B-DNA
C	C	NN	I-NP	I-DNA
binds	bind	VBZ	B-VP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ubiquitously	ubiquitously	RB	I-NP	B-protein
expressed	express	VBN	I-NP	I-protein
RFX	RFX	NN	I-NP	I-protein
family	family	NN	I-NP	I-protein
of	of	IN	B-PP	O
proteins	protein	NNS	B-NP	O
,	,	,	O	O
notably	notably	RB	B-ADVP	O
RFX1	RFX1	NN	B-NP	B-protein
,	,	,	O	O
RFX3	RFX3	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
associated	associate	VBN	I-NP	O
factor	factor	NN	I-NP	O
MIBP1	MIBP1	NN	I-NP	B-protein
,	,	,	O	O
whereas	whereas	IN	O	O
sites	site	NNS	B-NP	B-DNA
B	B	NN	B-NP	I-DNA
and	and	CC	O	O
D	D	NN	B-NP	O
both	both	DT	B-NP	O
bind	bind	VBP	B-VP	O
the	the	DT	B-NP	O
B-cell-specific	B-cell-specific	JJ	I-NP	B-protein
activator	activator	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
BSAP/Pax5	BSAP/Pax5	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
reporter	reporter	NN	B-NP	O
assays	assay	NNS	I-NP	O
with	with	IN	B-PP	O
mutant	mutant	JJ	B-NP	B-DNA
Wp	Wp	NN	I-NP	I-DNA
constructs	construct	NNS	I-NP	I-DNA
,	,	,	O	O
the	the	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
factor	factor	NN	B-NP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
any	any	DT	B-NP	O
one	one	CD	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
sites	site	NNS	I-NP	O
severely	severely	RB	B-ADVP	O
impaired	impair	VBD	B-VP	O
promoter	promoter	NN	B-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
wild-type	wild-type	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
could	could	MD	B-VP	O
be	be	VB	I-VP	O
activated	activate	VBN	I-VP	O
in	in	IN	B-PP	O
non-B	non-B	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
ectopic	ectopic	JJ	B-NP	O
BSAP	BSAP	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
Wp	Wp	NN	B-NP	O
regulation	regulation	NN	I-NP	O
by	by	IN	B-PP	O
BSAP	BSAP	NN	B-NP	B-protein
helps	help	VBZ	B-VP	O
to	to	TO	I-VP	O
ensure	ensure	VB	I-VP	O
the	the	DT	B-NP	O
B-cell	B-cell	NN	I-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
EBV	EBV	NN	B-NP	O
's	's	POS	B-NP	O
growth-transforming	growth-transforming	JJ	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Lck	Lck	NN	I-NP	B-protein
tyrosine	tyrosine	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Herpesvirus	Herpesvirus	NN	I-NP	B-protein
saimiri	saimiri	NN	I-NP	I-protein
tip	tip	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
involves	involve	VBZ	B-VP	O
two	two	CD	B-NP	O
binding	bind	VBG	I-NP	O
interactions	interaction	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Tip	Tip	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
of	of	IN	B-PP	O
Herpesvirus	Herpesvirus	NN	B-NP	B-protein
saimiri	saimiri	NN	I-NP	I-protein
strain	strain	NN	I-NP	I-protein
484C	484C	NN	I-NP	I-protein
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
and	and	CC	O	O
activates	activate	VBZ	B-VP	O
the	the	DT	B-NP	O
Lck	Lck	NN	I-NP	B-protein
tyrosine	tyrosine	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
.	.	.	O	O

Two	Two	CD	B-NP	O
sequences	sequence	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Tip	Tip	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
were	be	VBD	B-VP	O
previously	previously	RB	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
binding	binding	NN	B-NP	O
to	to	TO	B-PP	O
Lck	Lck	NN	B-NP	B-protein
.	.	.	O	O

A	A	DT	B-NP	O
proline-rich	proline-rich	JJ	I-NP	B-protein
region	region	NN	I-NP	I-protein
,	,	,	O	O
residues	residue	NNS	B-NP	O
132-141	132-141	CD	B-NP	O
,	,	,	O	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
SH3	SH3	NN	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Lck	Lck	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
here	here	RB	B-ADVP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
Lck-binding	Lck-binding	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
,	,	,	O	O
residues	residue	NNS	B-NP	O
104-113	104-113	CD	B-NP	O
,	,	,	O	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
carboxyl-terminal	carboxyl-terminal	JJ	I-NP	B-protein
half	half	NN	I-NP	I-protein
of	of	IN	B-PP	O
Lck	Lck	NN	B-NP	B-protein
and	and	CC	O	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
binding	binding	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
the	the	DT	B-NP	O
Lck	Lck	NN	I-NP	B-protein
SH3	SH3	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
.	.	.	O	O

Mutated	Mutate	VBN	B-NP	O
Tip	Tip	NN	I-NP	B-protein
containing	contain	VBG	B-VP	O
only	only	RB	B-NP	O
one	one	CD	I-NP	O
functional	functional	JJ	I-NP	O
Lck-binding	Lck-binding	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
can	can	MD	B-VP	O
bind	bind	VB	I-VP	O
stably	stably	RB	B-ADVP	O
to	to	TO	B-PP	O
Lck	Lck	NN	B-NP	B-protein
,	,	,	O	O
although	although	IN	B-SBAR	O
not	not	RB	O	O
as	as	RB	B-ADVP	O
strongly	strongly	RB	I-ADVP	O
as	as	IN	B-PP	O
wild-type	wild-type	JJ	B-NP	B-protein
Tip	Tip	NN	I-NP	I-protein
.	.	.	O	O

Interaction	Interaction	NN	B-NP	O
of	of	IN	B-PP	O
Tip	Tip	NN	B-NP	B-protein
with	with	IN	B-PP	O
Lck	Lck	NN	B-NP	B-protein
through	through	IN	B-PP	O
either	either	CC	B-NP	O
Lck-binding	Lck-binding	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
increases	increase	VBZ	B-VP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
Lck	Lck	NN	B-NP	B-protein
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

Simultaneous	Simultaneous	JJ	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
domains	domain	NNS	I-NP	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
maximal	maximal	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
Lck	Lck	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
transient	transient	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
Tip	Tip	NN	B-NP	B-protein
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
stimulate	stimulate	VB	I-VP	O
both	both	CC	O	O
Stat3	Stat3	NN	B-ADJP	B-protein
-dependent	-dependent	JJ	I-ADJP	O
and	and	CC	O	O
NF-AT	NF-AT	NN	B-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
.	.	.	O	O

Mutant	Mutant	JJ	B-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
Tip	Tip	NN	B-NP	B-protein
lacking	lack	VBG	B-VP	O
one	one	CD	B-NP	O
or	or	CC	O	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
Lck-binding	Lck-binding	JJ	I-NP	B-protein
domains	domain	NNS	I-NP	I-protein
retained	retain	VBD	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
stimulate	stimulate	VB	I-VP	O
Stat3	Stat3	NN	B-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
.	.	.	O	O

Tip	Tip	NN	B-NP	B-protein
lacking	lack	VBG	B-VP	O
the	the	DT	B-NP	O
proline-rich	proline-rich	JJ	I-NP	B-protein
Lck-binding	Lck-binding	JJ	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
exhibited	exhibit	VBD	B-VP	O
almost	almost	RB	B-NP	O
wild-type	wild-type	JJ	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
ablation	ablation	NN	B-NP	O
of	of	IN	B-PP	O
either	either	CC	B-NP	O
Lck-binding	Lck-binding	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
abolished	abolish	VBD	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
Tip	Tip	NN	B-NP	B-protein
to	to	TO	B-VP	O
stimulate	stimulate	VB	I-VP	O
NF-AT	NF-AT	NN	B-NP	B-protein
-dependent	-dependent	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
.	.	.	O	O

Full	Full	JJ	B-NP	O
biological	biological	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
Tip	Tip	NN	B-NP	B-protein
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
require	require	VB	I-VP	O
both	both	DT	B-NP	O
Lck-binding	Lck-binding	JJ	I-NP	B-protein
domains	domain	NNS	I-NP	I-protein
.	.	.	O	O

Accumulation	Accumulation	NN	B-NP	O
of	of	IN	B-PP	O
RXR	RXR	NN	B-NP	B-protein
alpha	alpha	SYM	B-NP	I-protein
during	during	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
cycling	cycle	VBG	B-VP	O
human	human	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
:	:	:	O	O
modulation	modulation	NN	B-NP	O
of	of	IN	B-PP	O
RXRE	RXRE	NN	B-NP	O
transactivation	transactivation	NN	I-NP	O
function	function	NN	I-NP	O
by	by	IN	B-PP	O
mitogen-activated	mitogen-activated	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
pathways	pathway	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
previously	previously	RB	I-VP	O
reported	report	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
resting	rest	VBG	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
immature	immature	JJ	I-NP	I-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
(	(	(	O	I-cell_type
PBT	PBT	NN	B-NP	I-cell_type
)	)	)	O	I-cell_type
lymphocytes	lymphocyte	NNS	B-NP	I-cell_type
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
retinoid	retinoid	NN	B-NP	B-protein
X	X	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
(	(	(	O	O
RXRalpha	RXRalpha	NN	B-NP	B-protein
)	)	)	O	O
expression	expression	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
unlike	unlike	IN	B-PP	O
resting	rest	VBG	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
cycling	cycle	VBG	B-VP	B-cell_type
human	human	JJ	B-NP	I-cell_type
mature	mature	JJ	I-NP	I-cell_type
PBT	PBT	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
T	T	NN	B-NP	B-cell_line
lymphocyte	lymphocyte	NN	I-NP	I-cell_line
leukemia	leukemia	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
is	be	VBZ	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
accumulation	accumulation	NN	I-NP	O
of	of	IN	B-PP	O
RXRalpha	RXRalpha	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
and	and	CC	I-NP	O
protein	protein	NN	I-NP	O
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
cyclosporin	cyclosporin	NN	B-NP	O
A	A	NN	I-NP	O
further	further	RBR	B-ADVP	O
augmented	augment	VBD	B-VP	O
RXRalpha	RXRalpha	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
the	the	DT	B-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
calcineurin	calcineurin	NN	B-NP	B-protein
pathways	pathway	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

9-cis	9-cis	JJ	B-NP	O
retinoic	retinoic	JJ	I-NP	O
acid	acid	NN	I-NP	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
accumulation	accumulation	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
retinoids	retinoid	NNS	B-NP	O
can	can	MD	B-VP	O
regulate	regulate	VB	I-VP	O
the	the	DT	B-NP	O
synthesis	synthesis	NN	I-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
own	own	JJ	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
during	during	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

Transfection	Transfection	NN	B-NP	O
analysis	analysis	NN	I-NP	O
in	in	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
using	use	VBG	B-VP	O
RXRE-dependent	RXRE-dependent	JJ	B-NP	O
reporter	reporter	NN	I-NP	O
assays	assay	NNS	I-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
RXRalpha	RXRalpha	NN	B-NP	B-protein
accumulated	accumulate	VBN	B-VP	O
during	during	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
was	be	VBD	B-VP	O
transcriptionally	transcriptionally	RB	B-ADJP	O
inactive	inactive	JJ	I-ADJP	O
.	.	.	O	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
such	such	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
mitogen-activated	mitogen-activated	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
pathways	pathway	NNS	I-NP	O
,	,	,	O	O
c-Jun	c-Jun	NN	B-NP	B-protein
N-terminal	N-terminal	JJ	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
JNK	JNK	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
extracellular	extracellular	JJ	B-NP	B-protein
signal-regulated	signal-regulated	JJ	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
ERK	ERK	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
in	in	IN	B-PP	O
modulating	modulate	VBG	B-VP	O
RXRE-dependent	RXRE-dependent	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
explored	explore	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
constitutively	constitutively	RB	B-NP	B-protein
active	active	JJ	I-NP	I-protein
MAP/ERK	MAP/ERK	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
(	(	(	O	O
MEKK1	MEKK1	NN	B-NP	B-protein
)	)	)	O	O
inhibited	inhibit	VBD	B-VP	O
RXRE-dependent	RXRE-dependent	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
dominant	dominant	JJ	B-NP	B-protein
negative	negative	JJ	I-NP	I-protein
MEKK1	MEKK1	NN	I-NP	I-protein
increased	increase	VBD	B-VP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
the	the	DT	B-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
JNK	JNK	NN	B-NP	B-protein
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
constitutively	constitutively	RB	B-NP	O
active	active	JJ	I-NP	O
MEK1	MEK1	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
activates	activate	VBZ	B-VP	O
ERK	ERK	NN	B-NP	B-protein
pathway	pathway	NN	I-NP	O
,	,	,	O	O
enhanced	enhance	VBD	B-VP	O
RXRE-dependent	RXRE-dependent	JJ	B-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
both	both	DT	B-NP	O
were	be	VBD	B-VP	O
activated	activate	VBN	I-VP	O
simultaneously	simultaneously	RB	B-ADVP	O
,	,	,	O	O
JNK	JNK	NN	B-NP	B-protein
pathway	pathway	NN	I-NP	O
was	be	VBD	B-VP	O
dominant	dominant	JJ	B-ADJP	O
over	over	IN	B-PP	O
ERK	ERK	NN	B-NP	B-protein
pathway	pathway	NN	I-NP	O
and	and	CC	O	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
RXRE-mediated	RXRE-mediated	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
a	a	DT	B-NP	O
dual	dual	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
RXRalpha	RXRalpha	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
resting	rest	VBG	B-VP	O
and	and	CC	I-VP	O
cycling	cycle	VBG	I-VP	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
indicate	indicate	VBP	B-VP	O
a	a	DT	B-NP	O
dynamic	dynamic	JJ	I-NP	O
balance	balance	NN	I-NP	O
between	between	IN	B-PP	O
JNK	JNK	NN	B-NP	B-protein
and	and	CC	I-NP	O
ERK	ERK	NN	I-NP	B-protein
pathways	pathway	NNS	I-NP	O
in	in	IN	B-PP	O
modulating	modulate	VBG	B-VP	O
RXRE-mediated	RXRE-mediated	JJ	B-NP	O
transactivation	transactivation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
proteasome	proteasome	NN	I-NP	B-protein
regulates	regulate	VBZ	B-VP	O
receptor-mediated	receptor-mediated	JJ	B-NP	O
endocytosis	endocytosis	NN	I-NP	O
of	of	IN	B-PP	O
interleukin-2	interleukin-2	NN	B-NP	B-protein
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
increasingly	increasingly	RB	I-VP	O
implicated	implicate	VBN	I-VP	O
the	the	DT	B-NP	O
proteasome	proteasome	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	B-protein
surface	surface	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proteasome	proteasome	NN	I-NP	B-protein
for	for	IN	B-PP	O
ligand-dependent	ligand-dependent	JJ	B-NP	O
endocytosis	endocytosis	NN	I-NP	O
and	and	CC	I-NP	O
degradation	degradation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
interleukin-2	interleukin-2	NN	I-NP	B-protein
(	(	(	O	O
IL-2	IL-2	NN	B-NP	B-protein
)	)	)	O	O
-interleukin-2	-interleukin-2	CD	B-NP	O
receptor	receptor	NN	I-NP	O
(	(	(	O	O
IL-2R	IL-2R	NN	B-NP	B-protein
)	)	)	O	O
complex	complex	NN	B-NP	O
.	.	.	O	O

Proteasome	Proteasome	NN	B-NP	B-protein
inhibitors	inhibitor	NNS	I-NP	O
impaired	impair	VBD	B-VP	O
internalization	internalization	NN	B-NP	O
of	of	IN	B-PP	O
IL-2.IL-2R	IL-2.IL-2R	NN	B-NP	B-protein
and	and	CC	O	O
prevented	prevent	VBD	B-VP	O
the	the	DT	B-NP	O
lysosomal	lysosomal	JJ	I-NP	O
degradation	degradation	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
cytokine	cytokine	NN	I-NP	B-protein
.	.	.	O	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
time-course	time-course	JJ	B-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
proteasome	proteasome	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
is	be	VBZ	B-VP	O
primarily	primarily	RB	I-VP	O
required	require	VBN	I-VP	O
after	after	IN	B-PP	O
initial	initial	JJ	B-NP	O
endocytosis	endocytosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-2.IL-2R	IL-2.IL-2R	NN	I-NP	B-protein
.	.	.	O	O

Proteasome	Proteasome	NN	B-NP	B-protein
function	function	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
lysosomal	lysosomal	JJ	I-NP	O
degradation	degradation	NN	I-NP	O
of	of	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
internalized	internalize	VBN	B-VP	O
by	by	IN	B-PP	O
IL-2R	IL-2R	NN	B-NP	B-protein
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
comprised	comprise	VBN	I-VP	O
of	of	IN	B-PP	O
cytoplasmic	cytoplasmic	JJ	B-NP	B-protein
tailless	tailless	JJ	I-NP	I-protein
beta-	beta-	NN	I-NP	I-protein
or	or	CC	I-NP	O
gamma	gamma	NN	I-NP	B-protein
c-subunits	c-subunit	NNS	I-NP	I-protein
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
target	target	NN	I-NP	O
protein	protein	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
proteasome	proteasome	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
either	either	CC	O	O
the	the	DT	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	B-protein
tail	tail	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-2R	IL-2R	NN	I-NP	B-protein
beta-	beta-	NN	I-NP	I-protein
or	or	CC	I-NP	O
gamma	gamma	NN	I-NP	B-protein
c-subunits	c-subunit	NNS	I-NP	I-protein
and	and	CC	O	O
their	their	PRP$	B-NP	O
associated	associate	VBN	I-NP	O
signaling	signaling	NN	I-NP	O
components	component	NNS	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
proteasome	proteasome	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
optimal	optimal	JJ	B-NP	O
endocytosis	endocytosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL-2R/ligand	IL-2R/ligand	NN	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
and	and	CC	O	O
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
subsequent	subsequent	JJ	I-NP	O
lysosomal	lysosomal	JJ	I-NP	O
degradation	degradation	NN	I-NP	O
of	of	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
,	,	,	O	O
possibly	possibly	RB	B-ADVP	O
by	by	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
trafficking	trafficking	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
lysosome	lysosome	NN	I-NP	O
.	.	.	O	O

Functional	Functional	JJ	B-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
alternative	alternative	JJ	I-NP	B-DNA
promoters	promoter	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-DNA
p45	p45	NN	I-NP	I-DNA
NF-E2	NF-E2	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

OBJECTIVE	OBJECTIVE	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
NF-E2	NF-E2	NN	I-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
heterodimeric	heterodimeric	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
composed	compose	VBN	B-VP	O
of	of	IN	B-PP	O
p45	p45	NN	B-NP	B-protein
and	and	CC	O	O
small	small	JJ	B-NP	B-protein
Maf	Maf	NN	I-NP	I-protein
family	family	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
,	,	,	O	O
is	be	VBZ	B-VP	O
considered	consider	VBN	I-VP	O
crucial	crucial	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
proper	proper	JJ	I-NP	O
differentiation	differentiation	NN	I-NP	O
of	of	IN	B-PP	O
erythrocytes	erythrocyte	NNS	B-NP	B-cell_type
and	and	CC	I-NP	O
megakaryocytes	megakaryocyte	NNS	I-NP	B-cell_type
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
studies	study	NNS	B-NP	O
aimed	aim	VBN	B-VP	O
at	at	IN	B-PP	O
understanding	understand	VBG	B-VP	O
the	the	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
controlling	control	VBG	B-VP	O
p45	p45	NN	B-NP	B-protein
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
erythroid	erythroid	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

MATERIALS	MATERIALS	NNS	B-NP	O
AND	AND	CC	I-NP	O
METHODS	METHODS	NNS	I-NP	O
:	:	:	O	O
Human	Human	JJ	B-NP	B-RNA
p45	p45	NN	I-NP	I-RNA
mRNAs	mRNA	NNS	I-NP	I-RNA
have	have	VBP	B-VP	O
two	two	CD	B-NP	O
alternative	alternative	JJ	I-NP	O
isoforms	isoform	NNS	I-NP	O
,	,	,	O	O
aNF-E2	aNF-E2	NN	B-NP	O
and	and	CC	I-NP	O
fNF-E2	fNF-E2	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
these	these	DT	B-NP	O
isoforms	isoform	NNS	I-NP	B-protein
are	be	VBP	B-VP	O
transcribed	transcribe	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
alternative	alternative	JJ	I-NP	B-DNA
promoters	promoter	NNS	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
lineage-specific	lineage-specific	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
isomers	isomer	NNS	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
erythroid	erythroid	JJ	I-NP	I-cell_type
and	and	CC	I-NP	I-cell_type
megakaryocytic	megakaryocytic	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
reverse	reverse	JJ	B-NP	B-protein
transcriptase	transcriptase	NN	I-NP	I-protein
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
or	or	CC	O	O
Northern	Northern	JJ	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
functional	functional	JJ	B-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
promoters	promoter	NNS	I-NP	B-DNA
,	,	,	O	O
plasmids	plasmid	NNS	B-NP	B-DNA
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
reporter	reporter	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
truncated	truncate	VBN	B-NP	O
or	or	CC	I-NP	O
mutated	mutate	VBN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
fragments	fragment	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
transfected	transfecte	VBN	I-VP	O
to	to	TO	B-PP	O
human	human	JJ	B-NP	B-cell_line
hematopoietic	hematopoietic	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
When	When	WRB	B-ADVP	O
CD34	CD34	NN	B-NP	B-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
cells	cell	NNS	B-NP	I-cell_type
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
human	human	JJ	B-NP	O
cord	cord	NN	I-NP	O
blood	blood	NN	I-NP	O
were	be	VBD	B-VP	O
induced	induce	VBN	I-VP	O
to	to	TO	B-PP	O
unilineage	unilineage	JJ	B-NP	O
erythroid	erythroid	JJ	I-NP	O
or	or	CC	I-NP	O
megakaryocytic	megakaryocytic	JJ	I-NP	O
differentiation	differentiation	NN	I-NP	O
in	in	IN	B-PP	O
liquid	liquid	JJ	B-NP	B-cell_line
suspension	suspension	NN	I-NP	I-cell_line
culture	culture	NN	I-NP	I-cell_line
,	,	,	O	O
both	both	DT	B-NP	O
transcripts	transcript	NNS	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
barely	barely	RB	B-VP	O
detected	detect	VBN	I-VP	O
at	at	IN	B-PP	O
day	day	NN	B-NP	O
0	0	CD	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
induced	induce	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
erythroid	erythroid	JJ	I-NP	O
and	and	CC	I-NP	O
megakaryocytic	megakaryocytic	JJ	I-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
.	.	.	O	O

fNF-E2	fNF-E2	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
more	more	RBR	B-ADJP	O
abundant	abundant	JJ	I-ADJP	O
in	in	IN	B-PP	O
erythroid	erythroid	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
than	than	IN	B-PP	O
megakaryocytic	megakaryocytic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
at	at	IN	B-PP	O
day	day	NN	B-NP	O
7	7	CD	I-NP	O
of	of	IN	B-PP	O
culture	culture	NN	B-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
both	both	DT	B-NP	O
isomers	isomer	NNS	I-NP	O
were	be	VBD	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
erythroid-megakaryocytic	erythroid-megakaryocytic	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
megakaryocytic	megakaryocytic	JJ	B-NP	O
maturation	maturation	NN	I-NP	O
with	with	IN	B-PP	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
erythroid	erythroid	JJ	B-NP	B-cell_type
phenotype	phenotype	NN	I-NP	I-cell_type
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
phorbol	phorbol	NN	B-NP	O
12-myristate	12-myristate	NN	I-NP	O
13-acetate	13-acetate	NN	I-NP	O
(	(	(	O	O
PMA	PMA	NN	B-NP	O
)	)	)	O	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
exclusive	exclusive	JJ	B-NP	O
downregulation	downregulation	NN	I-NP	O
of	of	IN	B-PP	O
fNF-E2	fNF-E2	NN	B-NP	B-protein
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
fNF-E2	fNF-E2	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
more	more	RBR	B-ADJP	O
erythroid	erythroid	JJ	I-ADJP	O
specific	specific	JJ	B-ADJP	O
.	.	.	O	O

Functional	Functional	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
fNF-E2	fNF-E2	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	B-DNA
is	be	VBZ	B-VP	O
active	active	JJ	B-ADJP	O
only	only	RB	B-PP	O
in	in	IN	I-PP	O
erythroid-megakaryocytic	erythroid-megakaryocytic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
double	double	JJ	I-NP	O
GATA	GATA	NN	I-NP	B-DNA
sit	sit	NN	I-NP	I-DNA
e	e	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
its	its	PRP$	B-NP	O
efficient	efficient	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
GATA	GATA	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
govern	govern	VBP	B-VP	O
the	the	DT	B-NP	O
differentiation	differentiation	NN	I-NP	O
of	of	IN	B-PP	O
erythroid	erythroid	JJ	B-NP	B-cell_type
lineage	lineage	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
are	be	VBP	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
full	full	JJ	B-NP	O
promoter	promoter	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
p45	p45	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

Transcriptional	Transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
heme	heme	NN	B-NP	B-protein
oxygenase-1	oxygenase-1	NN	I-NP	I-protein
and	and	CC	O	O
its	its	PRP$	B-NP	O
functional	functional	JJ	I-NP	O
significance	significance	NN	I-NP	O
in	in	IN	B-PP	O
acetaminophen-induced	acetaminophen-induced	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
and	and	CC	O	O
hepatocellular	hepatocellular	JJ	B-NP	O
injury	injury	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O
.	.	.	O	O

BACKGROUND/AIM	BACKGROUND/AIM	NN	B-NP	O
:	:	:	O	O
Glutathione	Glutathione	NN	B-NP	O
depletion	depletion	NN	I-NP	O
contributes	contribute	VBZ	B-VP	O
to	to	TO	I-VP	O
acetaminophen	acetaminophen	VB	I-VP	O
hepatotoxicity	hepatotoxicity	NN	B-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
induce	induce	VB	I-VP	O
the	the	DT	B-NP	O
oxidative	oxidative	JJ	I-NP	B-protein
stress	stress	NN	I-NP	I-protein
reactant	reactant	NN	I-NP	I-protein
heme	heme	NN	I-NP	I-protein
oxygenase-1	oxygenase-1	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
metabolites	metabolite	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
heme	heme	NN	I-NP	B-protein
oxygenase	oxygenase	NN	I-NP	I-protein
pathway	pathway	NN	I-NP	O
,	,	,	O	O
biliverdin	biliverdin	NN	B-NP	O
,	,	,	O	O
carbon	carbon	NN	B-NP	O
monoxide	monoxide	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
iron	iron	NN	B-NP	O
may	may	MD	B-VP	O
modulate	modulate	VB	I-VP	O
acetaminophen	acetaminophen	NN	B-NP	O
toxicity	toxicity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
cell-type	cell-type	JJ	B-NP	O
specific	specific	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
heme	heme	NN	B-NP	B-protein
oxygenase-1	oxygenase-1	NN	I-NP	I-protein
and	and	CC	O	O
its	its	PRP$	B-NP	O
impact	impact	NN	I-NP	O
on	on	IN	B-PP	O
liver	liver	NN	B-NP	O
injury	injury	NN	I-NP	O
and	and	CC	O	O
microcirculatory	microcirculatory	JJ	B-NP	O
disturbances	disturbance	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
acetaminophen-induced	acetaminophen-induced	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
.	.	.	O	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
Gene	Gene	NN	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
heme	heme	NN	B-NP	B-protein
oxygenase-1	oxygenase-1	NN	I-NP	I-protein
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
by	by	IN	B-PP	O
Northern-	Northern-	NN	B-NP	O
and	and	CC	O	O
Western	Western	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
immunohistochemistry	immunohistochemistry	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
time	time	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
heme	heme	NN	B-NP	B-protein
oxygenase-1	oxygenase-1	NN	I-NP	I-protein
and	and	CC	O	I-protein
-2	-2	CD	B-NP	I-protein
,	,	,	O	O
cytokine-induced	cytokine-induced	JJ	B-NP	O
neutrophil	neutrophil	NN	I-NP	O
chemoattractant-1	chemoattractant-1	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
intercellular	intercellular	JJ	B-NP	B-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
by	by	IN	B-PP	O
Northern	Northern	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O

DNA-binding	DNA-binding	JJ	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

Sinusoidal	Sinusoidal	JJ	B-NP	O
perfusion	perfusion	NN	I-NP	O
and	and	CC	O	O
leukocyte-endothelial	leukocyte-endothelial	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
were	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
by	by	IN	B-PP	O
intravital	intravital	JJ	B-NP	O
microscopy	microscopy	NN	I-NP	O
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Acetaminophen	Acetaminophen	NN	B-NP	O
caused	cause	VBD	B-VP	O
a	a	DT	B-NP	O
moderate	moderate	JJ	I-NP	O
sinusoidal	sinusoidal	JJ	I-NP	O
perfusion	perfusion	NN	I-NP	O
failure	failure	NN	I-NP	O
(	(	(	O	O
-15	-15	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
infiltration	infiltration	NN	B-NP	O
of	of	IN	B-PP	O
neutrophils	neutrophil	NNS	B-NP	B-cell_type
along	along	IN	B-PP	O
with	with	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
and	and	CC	O	O
intercellular	intercellular	JJ	B-NP	B-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
and	and	CC	O	O
cytokine-induced	cytokine-induced	JJ	B-NP	B-RNA
neutrophil	neutrophil	NN	I-NP	I-RNA
chemoattractant-1	chemoattractant-1	NN	I-NP	I-RNA
mRNAs	mRNA	NNS	I-NP	I-RNA
.	.	.	O	O

Induction	Induction	NN	B-NP	O
of	of	IN	B-PP	O
heme	heme	NN	B-NP	B-RNA
oxygenase-1	oxygenase-1	NN	I-NP	I-RNA
mRNA	mRNA	NN	I-NP	I-RNA
and	and	CC	O	O
protein	protein	NN	B-NP	O
(	(	(	O	O
approximately	approximately	RB	B-ADVP	O
30-fold	30-fold	RB	I-ADVP	O
)	)	)	O	O
in	in	IN	B-PP	O
hepatocytes	hepatocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
non-parenchymal	non-parenchymal	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
paralleled	parallel	VBD	B-VP	O
the	the	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Blockade	Blockade	NN	B-NP	O
of	of	IN	B-PP	O
heme	heme	NN	B-NP	B-protein
oxygenase	oxygenase	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
with	with	IN	B-PP	O
tin-protoporphyrin-IX	tin-protoporphyrin-IX	NN	B-NP	O
abrogated	abrogate	VBD	B-VP	O
acetaminophen-induced	acetaminophen-induced	JJ	B-NP	O
hepatic	hepatic	JJ	I-NP	O
neutrophil	neutrophil	NN	I-NP	O
accumulation	accumulation	NN	I-NP	O
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
affect	affect	VB	I-VP	O
sinusoidal	sinusoidal	JJ	B-NP	O
perfusion	perfusion	NN	I-NP	O
and	and	CC	I-NP	O
liver	liver	NN	I-NP	O
injury	injury	NN	I-NP	O
.	.	.	O	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
response	response	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
acetaminophen	acetaminophen	NN	B-NP	O
hepatotoxicity	hepatotoxicity	NN	I-NP	O
is	be	VBZ	B-VP	O
modulated	modulate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
parallel	parallel	JJ	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
heme	heme	NN	I-NP	B-DNA
oxygenase-1	oxygenase-1	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
heme	heme	NN	B-NP	B-protein
oxygenase-1	oxygenase-1	NN	I-NP	I-protein
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
permissive	permissive	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
sinusoidal	sinusoidal	JJ	B-NP	O
perfusion	perfusion	NN	I-NP	O
and	and	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
liver	liver	NN	B-NP	O
injury	injury	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
model	model	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
argue	argue	VBP	B-VP	O
against	against	IN	B-PP	O
a	a	DT	B-NP	O
central	central	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
and	and	CC	O	O
neutrophil	neutrophil	NN	B-NP	O
infiltration	infiltration	NN	I-NP	O
as	as	IN	B-PP	O
perpetuating	perpetuate	VBG	B-VP	B-protein
factors	factor	NNS	B-NP	I-protein
of	of	IN	B-PP	O
liver	liver	NN	B-NP	O
injury	injury	NN	I-NP	O
in	in	IN	B-PP	O
acetaminophen	acetaminophen	NN	B-NP	O
toxicity	toxicity	NN	I-NP	O
.	.	.	O	O

Tumor	Tumor	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor-alpha	factor-alpha	NN	I-NP	I-protein
-induced	-induced	JJ	I-NP	O
proliferation	proliferation	NN	I-NP	O
requires	require	VBZ	B-VP	O
synthesis	synthesis	NN	B-NP	O
of	of	IN	B-PP	O
granulocyte-macrophage	granulocyte-macrophage	JJ	B-NP	B-protein
colony-stimulating	colony-stimulating	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
.	.	.	O	O

OBJECTIVE	OBJECTIVE	NN	B-NP	O
:	:	:	O	O
Tumor	Tumor	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor-	factor-	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
(	(	(	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
)	)	)	O	O
induces	induce	VBZ	B-VP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
responses	response	NNS	I-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
them	them	PRP	B-NP	O
being	be	VBG	B-VP	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
seemingly	seemingly	RB	B-ADJP	O
contradictory	contradictory	JJ	I-ADJP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
set	set	VBD	B-VP	O
out	out	RP	B-PRT	O
to	to	TO	B-VP	O
find	find	VB	I-VP	O
differences	difference	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
modes	mode	NNS	I-NP	O
of	of	IN	B-PP	O
proliferative	proliferative	JJ	B-NP	O
and	and	CC	I-NP	O
apoptotic	apoptotic	JJ	I-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
TNF-	TNF-	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
.	.	.	O	O

MATERIALS	MATERIALS	NNS	B-NP	O
AND	AND	CC	I-NP	O
METHODS	METHODS	NNS	I-NP	O
:	:	:	O	O
We	We	PRP	B-NP	O
screened	screen	VBD	B-VP	O
a	a	DT	B-NP	O
panel	panel	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	B-cell_line
myeloid	myeloid	JJ	I-NP	I-cell_line
leukemia-derived	leukemia-derived	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
for	for	IN	B-PP	O
TNF-	TNF-	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
-responsiveness	-responsiveness	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
two	two	CD	B-NP	O
lines	line	NNS	I-NP	O
(	(	(	O	O
OCI-AML-1	OCI-AML-1	NN	B-NP	B-protein
,	,	,	I-NP	O
OCI-AML-11	OCI-AML-11	NN	I-NP	B-protein
)	)	)	O	O
,	,	,	O	O
TNF-	TNF-	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
acted	act	VBD	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
apoptotic	apoptotic	JJ	I-NP	O
agent	agent	NN	I-NP	O
;	;	:	O	O
in	in	IN	B-PP	O
others	other	NNS	B-NP	O
(	(	(	O	O
HU-3	HU-3	NN	B-NP	B-protein
,	,	,	O	O
M-07e	M-07e	NN	B-NP	O
,	,	,	O	O
TF-1	TF-1	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
it	it	PRP	B-NP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
opposite	opposite	JJ	I-NP	O
effect	effect	NN	I-NP	O
,	,	,	O	O
preventing	prevent	VBG	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
and	and	CC	O	O
inducing	induce	VBG	B-VP	O
proliferation	proliferation	NN	B-NP	O
.	.	.	O	O

Direct	Direct	JJ	B-NP	O
and	and	CC	I-NP	O
indirect	indirect	JJ	I-NP	O
signaling	signaling	NN	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
and	and	CC	O	O
cytokine	cytokine	NN	B-NP	B-protein
synthesis	synthesis	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
All	All	DT	B-NP	O
cell	cell	NN	I-NP	B-cell_line
lines	line	NNS	I-NP	I-cell_line
tested	test	VBN	B-VP	O
expressed	express	VBD	B-VP	O
TNF-	TNF-	NN	B-NP	O
alpha	alpha	SYM	B-NP	O
receptors	receptor	NNS	I-NP	O
I	I	CD	B-NP	O
and	and	CC	I-NP	O
II	II	CD	I-NP	O
and	and	CC	O	O
responded	respond	VBD	B-VP	O
to	to	TO	B-PP	O
TNF-	TNF-	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
by	by	IN	B-PP	O
upregulation	upregulation	NN	B-NP	O
of	of	IN	B-PP	O
intercellular	intercellular	JJ	B-NP	B-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
granulocyte-macrophage	granulocyte-macrophage	JJ	B-NP	B-protein
colony-stimulating	colony-stimulating	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
GM-CSF	GM-CSF	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
TNF-	TNF-	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
activate	activate	VB	I-VP	O
the	the	DT	B-NP	O
MAP	MAP	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
and	and	CC	O	O
p70S6	p70S6	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
pathways	pathway	NNS	I-NP	O
.	.	.	O	O

Nevertheless	Nevertheless	RB	B-ADVP	O
,	,	,	O	O
inhibitors	inhibitor	NNS	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
pathways	pathway	NNS	I-NP	O
clearly	clearly	RB	B-ADVP	O
reduced	reduce	VBD	B-VP	O
the	the	DT	B-NP	O
TNF-alpha	TNF-alpha	NN	I-NP	B-protein
-induced	-induced	JJ	I-NP	O
cell	cell	NN	I-NP	O
growth	growth	NN	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
TNF-	TNF-	NN	B-NP	B-cell_line
alpha-proliferative	alpha-proliferative	JJ	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
produced	produce	VBD	B-VP	O
a	a	DT	B-NP	O
growth	growth	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
that	that	WDT	B-NP	O
induced	induce	VBD	B-VP	O
proliferation	proliferation	NN	B-NP	O
upon	upon	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
above	above	JJ	I-NP	O
pathways	pathway	NNS	I-NP	O
.	.	.	O	O

Anti-GM-CSF	Anti-GM-CSF	JJ	B-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
TNF-alpha	TNF-alpha	NN	I-NP	B-protein
-induced	-induced	JJ	I-NP	O
growth	growth	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
autocrine	autocrine	JJ	I-NP	O
loop	loop	NN	I-NP	O
for	for	IN	B-PP	O
cell	cell	NN	B-NP	O
proliferation	proliferation	NN	I-NP	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
GM-CSF	GM-CSF	NN	B-NP	B-protein
.	.	.	O	O

Supporting	Support	VBG	B-VP	O
this	this	DT	B-NP	O
notion	notion	NN	I-NP	O
,	,	,	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
upregulation	upregulation	NN	I-NP	O
of	of	IN	B-PP	O
GM-CSF	GM-CSF	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
levels	level	NNS	I-NP	O
and	and	CC	O	O
protein	protein	NN	B-NP	O
secretion	secretion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
TNF-alpha	TNF-alpha	NN	I-NP	B-protein
-proliferative	-proliferative	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
the	the	DT	B-NP	O
TNF-alpha-apoptotic	TNF-alpha-apoptotic	JJ	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
.	.	.	O	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
identify	identify	VBP	B-VP	O
GM-CSF	GM-CSF	NN	B-NP	B-protein
synthesis	synthesis	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
early	early	JJ	I-NP	O
and	and	CC	I-NP	O
essential	essential	JJ	I-NP	O
step	step	NN	I-NP	O
in	in	IN	B-PP	O
TNF-	TNF-	NN	B-NP	O
alpha-induced	alpha-induced	JJ	I-NP	O
proliferation	proliferation	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
time	time	NN	I-NP	O
that	that	IN	B-ADVP	O
TNF-alpha-treated	TNF-alpha-treated	JJ	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
producing	produce	VBG	B-VP	O
no	no	RB	B-ADVP	O
or	or	CC	I-ADVP	O
only	only	RB	B-NP	O
minimal	minimal	JJ	I-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
GM-CSF	GM-CSF	NN	B-NP	B-protein
demonstrate	demonstrate	VBP	B-VP	O
an	an	DT	B-NP	O
apoptotic	apoptotic	JJ	I-NP	B-cell_line
phenotype	phenotype	NN	I-NP	I-cell_line
,	,	,	O	I-cell_line
while	while	IN	B-SBAR	I-cell_line
cell	cell	NN	B-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
GM-CSF	GM-CSF	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
rates	rate	NNS	I-NP	O
can	can	MD	B-VP	O
escape	escape	VB	I-VP	O
from	from	IN	B-PP	O
growth	growth	NN	B-NP	O
arrest	arrest	NN	I-NP	O
or	or	CC	B-NP	O
even	even	RB	I-NP	O
apoptosis	apoptosis	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
context	context	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
discuss	discuss	VBP	B-VP	O
arguments	argument	NNS	B-NP	O
pointing	point	VBG	B-VP	O
at	at	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
as	as	IN	B-PP	O
regulator	regulator	NN	B-NP	O
of	of	IN	B-PP	O
GM-CSF	GM-CSF	NN	B-NP	B-protein
synthesis	synthesis	NN	I-NP	O
and	and	CC	O	O
thus	thus	RB	B-ADVP	O
indirectly	indirectly	RB	B-ADVP	O
as	as	IN	B-PP	O
regulator	regulator	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
escape	escape	NN	I-NP	O
of	of	IN	B-PP	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
-induced	-induced	JJ	I-NP	O
apoptosis	apoptosis	NN	I-NP	O

Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
content	content	NN	I-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
:	:	:	O	O
evidence	evidence	NN	B-NP	O
for	for	IN	B-PP	O
heterogeneity	heterogeneity	NN	B-NP	O
.	.	.	O	O

Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
blood	blood	NN	I-NP	O
by	by	IN	B-PP	O
either	either	CC	O	O
nylon	nylon	NN	B-NP	O
wool	wool	NN	I-NP	O
filtration	filtration	NN	I-NP	O
or	or	CC	O	O
E-rosette	E-rosette	NN	B-NP	O
sedimentation	sedimentation	NN	I-NP	O
.	.	.	O	O

T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
isolated	isolate	VBN	B-VP	O
by	by	IN	B-PP	O
nylon	nylon	NN	B-NP	O
wool	wool	NN	I-NP	O
filtration	filtration	NN	I-NP	O
specifically	specifically	RB	B-ADVP	O
bind	bind	VBP	B-VP	O
6.7	6.7	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
0.2	0.2	CD	I-NP	O
fmol	fmol	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	B-cell_line
per	per	IN	B-PP	I-cell_line
million	million	CD	B-NP	I-cell_line
cells	cell	NNS	B-NP	I-cell_line
(	(	(	O	O
equivalent	equivalent	JJ	B-ADJP	O
to	to	TO	B-PP	O
4000	4000	CD	B-NP	O
+/-	+/-	CC	I-NP	O
200	200	CD	I-NP	O
receptors	receptor	NNS	I-NP	O
per	per	IN	B-PP	O
cell	cell	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
whereas	whereas	IN	O	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
isolated	isolate	VBN	B-VP	O
by	by	IN	B-PP	O
E-rosette	E-rosette	NN	B-NP	O
sedimentation	sedimentation	NN	I-NP	O
bind	bind	VBP	B-VP	O
12.0	12.0	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
0.7	0.7	CD	I-NP	O
fmol	fmol	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	B-cell_line
per	per	IN	B-PP	I-cell_line
million	million	CD	B-NP	I-cell_line
cells	cell	NNS	B-NP	I-cell_line
(	(	(	O	O
equivalent	equivalent	JJ	B-ADJP	O
to	to	TO	B-PP	O
7200	7200	CD	B-NP	O
+/-	+/-	CC	I-NP	O
400	400	CD	I-NP	O
receptors	receptor	NNS	I-NP	O
per	per	IN	B-PP	O
cell	cell	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

This	This	DT	B-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
bound	bind	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
preparations	preparation	NNS	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
(	(	(	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
.001	.001	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
immediately	immediately	RB	B-ADVP	O
after	after	IN	B-PP	O
cell	cell	NN	B-NP	O
isolation	isolation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
binding	binding	NN	I-NP	O
affinities	affinity	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
preparations	preparation	NNS	I-NP	O
for	for	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
were	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
.	.	.	O	O

T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
isolated	isolate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
nylon	nylon	NN	B-NP	O
wool	wool	NN	I-NP	O
filtration	filtration	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
E-rosette	E-rosette	NN	B-NP	O
sedimentation	sedimentation	NN	I-NP	O
bind	bind	VBP	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
as	as	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
isolated	isolate	VBN	B-VP	O
by	by	IN	B-PP	O
nylon	nylon	NN	B-NP	O
wool	wool	NN	I-NP	O
filtration	filtration	NN	I-NP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
isolated	isolate	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
E-rosette	E-rosette	NN	B-NP	O
sedimentation	sedimentation	NN	I-NP	O
following	follow	VBG	B-PP	O
by	by	IN	B-PP	O
nylon	nylon	NN	B-NP	O
wool	wool	NN	I-NP	O
filtration	filtration	NN	I-NP	O
bind	bind	VBP	B-VP	O
less	less	JJR	B-NP	O
dexamethasone	dexamethasone	NN	I-NP	O
than	than	IN	B-SBAR	O
do	do	VBP	O	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
isolated	isolate	VBN	B-VP	O
by	by	IN	B-PP	O
E-rosette	E-rosette	NN	B-NP	O
sedimentation	sedimentation	NN	I-NP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
heterogeneous	heterogeneous	JJ	B-ADJP	O
with	with	IN	B-PP	O
respect	respect	NN	B-NP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
quantity	quantity	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
.	.	.	O	O

Isolation	Isolation	NN	B-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
E-rosette	E-rosette	NN	B-NP	O
sedimentation	sedimentation	NN	I-NP	O
enriches	enrich	VBZ	B-VP	O
for	for	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
that	that	WDT	B-NP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
greater	great	JJR	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
isolation	isolation	NN	B-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
nylon	nylon	NN	B-NP	O
wool	wool	NN	I-NP	O
filtration	filtration	NN	I-NP	O
enriches	enrich	VBZ	B-VP	O
for	for	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
that	that	WDT	B-NP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
lesser	less	JJR	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
.	.	.	O	O

Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
and	and	CC	O	O
glucocorticoid	glucocorticoid	NN	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
leukemic	leukemic	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
established	establish	VBN	I-VP	O
optimal	optimal	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
measurement	measurement	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
(	(	(	O	O
GR	GR	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
white	white	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
whole-cell	whole-cell	JJ	I-NP	O
binding	binding	NN	I-NP	O
assay	assay	NN	I-NP	O
with	with	IN	B-PP	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
dexamethasone	dexamethasone	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
ligand	ligand	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
subsequent	subsequent	JJ	I-NP	O
determination	determination	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
GR	GR	NN	I-NP	B-protein
content	content	NN	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
and	and	CC	B-PP	O
in	in	IN	B-PP	O
leukemic	leukemic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
various	various	JJ	B-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
and	and	CC	I-NP	O
chronic	chronic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
leukemia	leukemia	NN	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
in	in	IN	B-PP	O
continuous	continuous	JJ	B-NP	B-cell_line
culture	culture	NN	I-NP	I-cell_line
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
subjected	subject	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
GR	GR	NN	I-NP	B-protein
assay	assay	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
were	be	VBD	B-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
cell	cell	NN	I-NP	B-cell_line
lines	line	NNS	I-NP	I-cell_line
to	to	TO	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
steroids	steroid	NNS	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
GR	GR	NN	I-NP	B-protein
content	content	NN	I-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
amounted	amounte	VBD	B-VP	O
to	to	TO	B-PP	O
4	4	CD	B-NP	O
,	,	,	I-NP	O
850	850	CD	I-NP	O
+/-	+/-	SYM	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
340	340	CD	I-NP	O
(	(	(	O	O
mean	mean	NN	B-NP	O
+/-	+/-	SYM	O	O
SD	SD	NN	B-NP	O
)	)	)	O	O
receptors/cell	receptors/cell	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mean	mean	JJ	I-NP	O
equilibrium	equilibrium	NN	I-NP	O
dissociation	dissociation	NN	I-NP	O
constant	constant	NN	I-NP	O
(	(	(	O	O
KD	KD	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	O	O
dexamethasone	dexamethasone	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
GR	GR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
1.2	1.2	CD	B-NP	O
x	x	SYM	O	O
10	10	CD	B-NP	O
(	(	(	O	O
-8	-8	CD	B-NP	O
)	)	)	O	O
M	M	NN	B-NP	O
.	.	.	O	O

Steroidal	Steroidal	JJ	B-NP	O
compounds	compound	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
known	know	VBN	I-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
potency	potency	NN	I-NP	O
effectively	effectively	RB	B-ADVP	O
competed	compete	VBD	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
steroids	steroid	NNS	B-NP	O
devoid	devoid	JJ	B-ADJP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
activity	activity	NN	I-NP	O
(	(	(	O	O
e.g.	e.g.	FW	B-PP	O
estradiol-17	estradiol-17	NN	B-NP	O
beta	beta	NN	I-NP	O
and	and	CC	O	O
testosterone	testosterone	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
ineffective	ineffective	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
GR	GR	NN	I-NP	B-protein
content	content	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
blast	blast	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
eight	eight	CD	B-NP	O
patients	patient	NNS	I-NP	O
suffering	suffer	VBG	B-VP	O
from	from	IN	B-PP	O
acute	acute	JJ	B-NP	O
leukemia	leukemia	NN	I-NP	O
and	and	CC	O	O
four	four	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
blast	blast	NN	I-NP	O
crisis	crisis	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
myelocytic	myelocytic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
highly	highly	RB	B-ADJP	O
variable	variable	JJ	I-ADJP	O
(	(	(	O	O
3	3	CD	B-NP	O
,	,	,	I-NP	O
230-29	230-29	CD	I-NP	O
,	,	,	I-NP	O
900	900	CD	I-NP	O
receptors/cell	receptors/cell	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	B-cell_type
of	of	IN	B-PP	O
six	six	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
lymphatic	lymphatic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
contained	contain	VBD	B-VP	O
a	a	DT	B-NP	O
rather	rather	RB	I-NP	O
stable	stable	JJ	I-NP	O
GR	GR	NN	I-NP	B-protein
content	content	NN	I-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
,	,	,	I-NP	O
930-5	930-5	CD	I-NP	O
,	,	,	I-NP	O
120	120	CD	I-NP	O
receptors/cell	receptors/cell	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
comparable	comparable	JJ	B-ADJP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

GR	GR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
12	12	CD	I-NP	B-cell_line
malignant	malignant	JJ	I-NP	I-cell_line
continuous	continuous	JJ	I-NP	I-cell_line
white	white	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
studied	study	VBN	B-VP	O
.	.	.	O	O

Large	Large	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
contained	contain	VBD	B-VP	O
more	more	JJR	B-NP	O
GR	GR	NN	I-NP	B-protein
than	than	IN	B-PP	O
the	the	DT	B-NP	O
smaller	small	JJR	I-NP	O
ones	one	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
GR	GR	NN	I-NP	B-protein
concentration	concentration	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
in	in	FW	B-PP	O
vitro	vitro	FW	B-NP	O
to	to	TO	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
as	as	IN	B-SBAR	O
judged	judge	VBN	B-VP	O
by	by	IN	B-PP	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
thymidine	thymidine	NN	I-NP	O
incorporation	incorporation	NN	I-NP	O
studies	study	NNS	I-NP	O
.	.	.	O	O

Distribution	Distribution	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
surface	surface	NN	I-NP	B-protein
markers	marker	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
leukemic	leukemic	JJ	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
relate	relate	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
GR	GR	NN	I-NP	B-protein
concentration	concentration	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
probably	probably	RB	B-ADVP	O
a	a	DT	B-NP	O
universal	universal	JJ	I-NP	O
feature	feature	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
leukemic	leukemic	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
,	,	,	O	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
probably	probably	RB	B-ADVP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
alone	alone	RB	I-VP	O
imply	imply	VB	I-VP	O
steroid	steroid	NN	B-NP	O
responsiveness	responsiveness	NN	I-NP	O
.	.	.	O	O

Evidence	Evidence	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
steroid	steroid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
in	in	IN	B-PP	O
rheumatoid	rheumatoid	JJ	B-NP	B-cell_type
synovial	synovial	JJ	I-NP	I-cell_type
tissue	tissue	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

One	One	CD	B-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
could	could	MD	B-VP	O
exert	exert	VB	I-VP	O
their	their	PRP$	B-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	O
action	action	NN	I-NP	O
is	be	VBZ	B-VP	O
via	via	IN	B-PP	O
rapidly	rapidly	RB	B-NP	O
saturable	saturable	JJ	I-NP	O
,	,	,	I-NP	O
stereo-specific	stereo-specific	JJ	I-NP	B-protein
cytoplasmic	cytoplasmic	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
.	.	.	O	O

This	This	DT	B-NP	O
report	report	NN	I-NP	O
is	be	VBZ	B-VP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
investigation	investigation	NN	I-NP	O
into	into	IN	B-PP	O
such	such	JJ	B-NP	O
a	a	DT	I-NP	O
possibility	possibility	NN	I-NP	O
in	in	IN	B-PP	O
synovial	synovial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Synovium	Synovium	NN	B-NP	O
,	,	,	O	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
knee	knee	NN	B-NP	O
joints	joint	NNS	I-NP	O
of	of	IN	B-PP	O
rheumatoid	rheumatoid	JJ	B-NP	O
patients	patient	NNS	I-NP	O
undergoing	undergo	VBG	B-VP	O
surgery	surgery	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
incubated	incubate	VBN	I-VP	O
with	with	IN	B-PP	O
clostridiopeptidase	clostridiopeptidase	NN	B-NP	O
A	A	NN	I-NP	O
and	and	CC	O	O
trypsin-EDTA	trypsin-EDTA	NN	B-NP	B-protein
to	to	TO	B-VP	O
obtain	obtain	VB	I-VP	O
cell	cell	NN	B-NP	O
suspensions	suspension	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
,	,	,	O	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
cells	cell	NNS	B-NP	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
synovial	synovial	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
aspirated	aspirate	VBN	B-VP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
electron	electron	NN	B-NP	O
microscopy	microscopy	NN	I-NP	O
.	.	.	O	O

Duplicate	Duplicate	JJ	B-NP	O
samples	sample	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
cell	cell	NN	I-NP	O
suspensions	suspension	NNS	I-NP	O
were	be	VBD	B-VP	O
incubated	incubate	VBN	I-VP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
H3Dexamethasone	H3Dexamethasone	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
x	x	NN	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
-10	-10	CD	B-NP	O
)	)	)	O	O
M-1	M-1	NN	B-NP	O
x	x	SYM	O	O
10	10	CD	B-NP	O
(	(	(	O	O
-9	-9	CD	B-NP	O
)	)	)	O	O
M	M	NN	B-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
30	30	CD	B-NP	O
minutes	minute	NNS	I-NP	O
at	at	IN	B-PP	O
37	37	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
steroid	steroid	NN	B-NP	O
bound	bind	VBD	B-VP	O
to	to	TO	B-PP	O
whole	whole	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
showed	show	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
for	for	IN	B-PP	O
specific	specific	JJ	B-NP	O
,	,	,	O	O
rapidly	rapidly	RB	B-ADJP	O
saturable	saturable	JJ	I-ADJP	O
,	,	,	O	O
receptors	receptor	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
synovial	synovial	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
synovial	synovial	JJ	B-NP	B-cell_type
fluid	fluid	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Electron	Electron	NN	B-NP	O
micrographs	micrograph	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
cells	cell	NNS	B-NP	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
synovial	synovial	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
synovial	synovial	JJ	B-NP	B-cell_type
fibroblast	fibroblast	NN	I-NP	I-cell_type
-	-	HYPH	B-ADJP	O
and	and	CC	O	O
macrophage-types	macrophage-type	NNS	B-NP	O
,	,	,	O	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
monocytes	monocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
macrophages	macrophage	NNS	B-NP	B-cell_type
.	.	.	O	O

Polymorphonuclear	Polymorphonuclear	JJ	B-NP	B-cell_type
leucocytes	leucocyte	NNS	I-NP	I-cell_type
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
absent	absent	JJ	B-ADJP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
synovial	synovial	JJ	B-NP	B-cell_type
fluid	fluid	NN	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
type	type	NN	I-NP	I-cell_type
polymorphonuclear	polymorphonuclear	JJ	I-NP	I-cell_type
leucocytes	leucocyte	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
predominant	predominant	JJ	I-NP	O
cell	cell	NN	I-NP	O
type	type	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
concluded	conclude	VBD	B-VP	O
from	from	IN	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
that	that	IN	B-SBAR	O
one	one	CD	B-NP	O
or	or	CC	I-NP	O
more	more	JJR	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
synovial	synovial	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
contain	contain	VBP	B-VP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
steroid	steroid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
,	,	,	O	O
but	but	CC	O	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
lacking	lack	VBG	I-VP	O
in	in	IN	B-PP	O
synovial	synovial	JJ	B-NP	B-cell_type
fluid	fluid	NN	I-NP	I-cell_type
polymorphonuclear	polymorphonuclear	JJ	I-NP	I-cell_type
leucocytes	leucocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Clinical	Clinical	JJ	B-NP	O
implications	implication	NNS	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
leukemia	leukemia	NN	I-NP	O
.	.	.	O	O

Glucorticoid	Glucorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
various	various	JJ	B-NP	O
populations	population	NNS	I-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
leukemic	leukemic	JJ	B-NP	B-cell_type
lymphoblasts	lymphoblast	NNS	I-NP	I-cell_type
.	.	.	O	O

Normal	Normal	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
contain	contain	VBP	B-VP	O
low	low	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
approximately	approximately	RB	B-NP	O
2	2	CD	I-NP	O
,	,	,	I-NP	O
500	500	CD	I-NP	O
sites/cell	sites/cell	NNS	I-NP	O
)	)	)	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
identical	identical	JJ	B-ADJP	O
in	in	IN	B-PP	O
T-	T-	NN	B-NP	O
and	and	CC	I-NP	O
non-T-fractions	non-T-fraction	NNS	I-NP	O
.	.	.	O	O

Phytohemagglutinin	Phytohemagglutinin	NN	B-NP	B-protein
treatment	treatment	NN	I-NP	O
increases	increase	VBZ	B-VP	O
levels	level	NNS	B-NP	O
about	about	IN	B-PP	O
3-fold	3-fold	RB	B-NP	O
.	.	.	O	O

Leukemic	Leukemic	JJ	B-NP	B-cell_type
lymphoblasts	lymphoblast	NNS	I-NP	I-cell_type
contain	contain	VBP	B-VP	O
larger	large	JJR	B-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
receptor	receptor	NN	B-NP	O
sites	site	NNS	I-NP	O
.	.	.	O	O

Presence	Presence	NN	B-NP	O
of	of	IN	B-PP	O
receptor	receptor	NN	B-NP	O
is	be	VBZ	B-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
sensitivitiy	sensitivitiy	NN	I-NP	O
to	to	TO	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
and	and	CC	O	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
therapy	therapy	NN	B-NP	O
.	.	.	O	O

Quantity	Quantity	NN	B-NP	O
of	of	IN	B-PP	O
receptor	receptor	NN	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
complete	complete	JJ	B-NP	O
remission	remission	NN	I-NP	O
duration	duration	NN	I-NP	O
independently	independently	RB	B-ADVP	O
of	of	IN	B-PP	O
leukemic	leukemic	JJ	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
type	type	NN	I-NP	I-cell_type
(	(	(	O	O
T	T	NN	B-NP	O
or	or	CC	O	O
null	null	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
initial	initial	JJ	B-NP	O
WBC	WBC	NNP	I-NP	O
,	,	,	O	O
or	or	CC	O	O
age	age	NN	B-NP	O
of	of	IN	B-PP	O
patient	patient	NN	B-NP	O
.	.	.	O	O

Quantitative	Quantitative	JJ	B-NP	O
determination	determination	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
lymphoblastic	lymphoblastic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
of	of	IN	B-PP	O
value	value	NN	B-NP	O
both	both	CC	B-PP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
independent	independent	JJ	I-NP	O
prognostic	prognostic	JJ	I-NP	O
variable	variable	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
suggesting	suggest	VBG	B-VP	O
which	which	WDT	B-NP	O
patients	patient	NNS	B-NP	O
should	should	MD	B-VP	O
receive	receive	VB	I-VP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

Functional	Functional	JJ	B-NP	O
and	and	CC	I-NP	O
physical	physical	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
protein-tyrosine	protein-tyrosine	JJ	B-NP	B-protein
kinases	kinase	NNS	I-NP	I-protein
Fyn	Fyn	NN	I-NP	B-protein
and	and	CC	I-NP	O
Csk	Csk	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
T-cell	T-cell	NN	I-NP	O
signaling	signaling	NN	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Src-like	Src-like	JJ	I-NP	B-protein
protein-tyrosine	protein-tyrosine	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
Fyn	Fyn	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
T-cell	T-cell	NN	B-NP	B-protein
antigen	antigen	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

Transient	Transient	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
actively	actively	RB	B-NP	O
mutated	mutate	VBN	I-NP	O
Fyn	Fyn	NN	I-NP	B-protein
,	,	,	O	O
having	have	VBG	B-VP	O
Phe-528	Phe-528	NN	B-NP	O
instead	instead	RB	B-CONJP	O
of	of	IN	I-CONJP	O
Tyr-528	Tyr-528	NN	B-NP	O
or	or	CC	I-NP	O
Thr-338	Thr-338	NN	I-NP	B-protein
instead	instead	RB	B-PP	O
of	of	IN	I-PP	O
Ile-338	Ile-338	NN	B-NP	B-protein
,	,	,	O	O
in	in	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
T-cells	T-cell	NNS	I-NP	I-cell_line
stimulated	stimulate	VBD	B-VP	O
the	the	DT	B-NP	O
serum	serum	NN	I-NP	B-DNA
response	response	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
(	(	(	O	O
SRE	SRE	NN	B-NP	B-DNA
)	)	)	O	O
,	,	,	O	O
12-O-tetradecanoyl-phorbol-13-acetate	12-O-tetradecanoyl-phorbol-13-acetate	NN	B-NP	B-DNA
response	response	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
,	,	,	O	O
cyclic	cyclic	JJ	B-NP	B-DNA
AMP	AMP	NN	I-NP	I-DNA
response	response	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
c-fos	c-fos	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
SRE	SRE	NN	B-NP	B-DNA
was	be	VBD	B-VP	O
particularly	particularly	RB	B-ADJP	O
prominent	prominent	JJ	I-ADJP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
with	with	IN	B-PP	O
active	active	JJ	B-NP	O
Fyn	Fyn	NN	I-NP	B-protein
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-ADJP	O
(	(	(	O	O
wild-type	wild-type	JJ	O	O
)	)	)	O	O
Fyn	Fyn	NN	B-NP	B-protein
.	.	.	O	O

SRE	SRE	NN	B-NP	B-DNA
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
stimulated	stimulate	VBN	I-VP	O
by	by	IN	B-PP	O
both	both	CC	B-NP	O
normal	normal	JJ	I-NP	O
and	and	CC	I-NP	O
active	active	JJ	I-NP	O
Lck	Lck	NN	I-NP	B-protein
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
and	and	CC	I-NP	O
active	active	JJ	I-NP	O
Fyn	Fyn	NN	I-NP	B-protein
stimulated	stimulate	VBD	B-VP	O
transcription	transcription	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
when	when	WRB	B-ADVP	O
transfected	transfecte	VBN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
stimulated	stimulate	VBN	I-VP	O
by	by	IN	B-PP	O
concanavalin	concanavalin	NN	B-NP	O
A	A	NN	I-NP	O
plus	plus	CC	O	O
12-O-tetradecanoylphorbol-13-acetate	12-O-tetradecanoylphorbol-13-acetate	NN	B-NP	O
.	.	.	O	O

Under	Under	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
,	,	,	O	O
Lck	Lck	NN	B-NP	B-protein
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
stimulate	stimulate	VB	I-VP	O
IL-2	IL-2	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
mutation	mutation	NN	B-NP	O
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
mutant	mutant	JJ	I-NP	O
Fyn	Fyn	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
deletions	deletion	NNS	B-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
SH2	SH2	NN	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
and	and	CC	O	O
so	so	RB	B-ADVP	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
transform	transform	VB	I-VP	O
chicken	chicken	NN	B-NP	B-cell_type
embryo	embryo	NN	I-NP	I-cell_type
fibroblasts	fibroblast	NNS	I-NP	I-cell_type
,	,	,	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
stimulate	stimulate	VB	I-VP	O
either	either	CC	O	O
the	the	DT	B-NP	O
c-fos	c-fos	NN	I-NP	B-DNA
or	or	CC	I-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
in	in	IN	B-PP	O
T-cell	T-cell	NN	B-NP	O
signaling	signaling	NN	I-NP	O
.	.	.	O	O

Csk	Csk	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
phosphorylates	phosphorylate	VBZ	B-VP	O
tyrosine	tyrosine	NN	B-NP	O
residues	residue	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
negative	negative	JJ	I-NP	B-DNA
regulatory	regulatory	JJ	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
Src	Src	NN	B-NP	B-protein
family	family	NN	I-NP	I-protein
kinases	kinase	NNS	I-NP	I-protein
,	,	,	O	O
down-regulated	down-regulate	VBN	B-NP	O
Fyn-	Fyn-	NN	I-NP	O
and	and	CC	O	O
Lck-mediated	Lck-mediated	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
serum	serum	NN	I-NP	B-DNA
response	response	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
and	and	CC	O	O
Fyn-mediated	Fyn-mediated	JJ	B-NP	O
enhancement	enhancement	NN	I-NP	O
of	of	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
activity	activity	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
Fyn	Fyn	NN	B-NP	B-protein
and	and	CC	I-NP	O
Lck	Lck	NN	I-NP	B-protein
,	,	,	O	O
whose	whose	WP$	B-NP	O
activities	activity	NNS	I-NP	O
are	be	VBP	B-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
Csk	Csk	NN	B-NP	B-protein
,	,	,	O	O
are	be	VBP	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
different	different	JJ	B-NP	O
phases	phase	NNS	I-NP	O
of	of	IN	B-PP	O
T-cell	T-cell	NN	B-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
novel	novel	JJ	I-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
containing	contain	VBG	B-VP	O
p65	p65	NN	B-NP	B-protein
homodimers	homodimer	NNS	I-NP	I-protein
:	:	:	O	O
implications	implication	NNS	B-NP	O
for	for	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
control	control	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
subunit	subunit	NN	B-NP	O
dimerization	dimerization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
predominant	predominant	JJ	I-NP	O
inducible	inducible	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
heteromeric	heteromeric	JJ	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
containing	contain	VBG	B-VP	O
two	two	CD	B-NP	O
Rel-related	Rel-related	JJ	I-NP	B-protein
DNA-binding	DNA-binding	JJ	I-NP	I-protein
subunits	subunit	NNS	I-NP	I-protein
,	,	,	O	O
termed	term	VBN	B-NP	O
p65	p65	NN	I-NP	B-protein
and	and	CC	I-NP	O
p50	p50	NN	I-NP	B-protein
.	.	.	O	O

Prior	Prior	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
when	when	WRB	B-ADVP	O
these	these	DT	B-NP	O
p65	p65	NN	I-NP	B-protein
and	and	CC	I-NP	O
p50	p50	NN	I-NP	B-protein
subunits	subunit	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
expressed	express	VBN	I-VP	O
independently	independently	RB	B-ADVP	O
as	as	IN	B-PP	O
stable	stable	JJ	B-NP	O
homodimers	homodimer	NNS	I-NP	B-protein
,	,	,	O	O
p65	p65	NN	B-NP	B-protein
stimulates	stimulate	VBZ	B-VP	O
kappa	kappa	NN	B-NP	O
B-directed	B-directed	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
p50	p50	NN	B-NP	B-protein
functions	function	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
kappa	kappa	NN	I-NP	B-protein
B-specific	B-specific	JJ	I-NP	I-protein
repressor	repressor	NN	I-NP	I-protein
.	.	.	O	O

While	While	IN	B-SBAR	O
authentic	authentic	JJ	B-NP	B-protein
p50	p50	NN	I-NP	I-protein
homodimers	homodimer	NNS	I-NP	I-protein
(	(	(	O	O
previously	previously	RB	B-NP	O
termed	term	VBN	I-NP	O
KBF1	KBF1	NN	I-NP	B-protein
)	)	)	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
from	from	IN	B-PP	O
nontransfected	nontransfected	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
experimental	experimental	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
supporting	support	VBG	B-VP	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
p65	p65	NN	B-NP	B-protein
homodimers	homodimer	NNS	I-NP	I-protein
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
was	be	VBD	B-VP	O
lacking	lack	VBG	I-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
now	now	RB	B-ADVP	O
provide	provide	VBP	B-VP	O
direct	direct	JJ	B-NP	O
biochemical	biochemical	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
endogenous	endogenous	JJ	I-NP	O
pool	pool	NN	I-NP	O
of	of	IN	B-PP	O
inducible	inducible	JJ	B-NP	O
p65	p65	NN	I-NP	B-protein
homodimers	homodimer	NNS	I-NP	I-protein
in	in	IN	B-PP	O
intact	intact	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

As	As	IN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
prototypical	prototypical	JJ	I-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
p50-p65	p50-p65	NN	I-NP	B-protein
heterodimer	heterodimer	NN	I-NP	I-protein
,	,	,	O	O
this	this	DT	B-NP	O
novel	novel	JJ	I-NP	O
p65	p65	NN	I-NP	B-protein
homodimeric	homodimeric	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
functionally	functionally	RB	I-VP	O
sequestered	sequester	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cytoplasm	cytoplasm	NN	I-NP	O
but	but	CC	O	O
rapidly	rapidly	RB	B-VP	O
appears	appear	VBZ	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
compartment	compartment	NN	I-NP	O
following	follow	VBG	B-PP	O
cellular	cellular	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

Site-directed	Site-directed	JJ	B-NP	O
mutagenesis	mutagenesis	NN	I-NP	O
studies	study	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
homodimerization	homodimerization	NN	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
p65	p65	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
dependent	dependent	JJ	B-ADJP	O
upon	upon	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
cysteine	cysteine	NN	B-NP	O
216	216	CD	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
conserved	conserve	VBN	I-NP	B-DNA
recognition	recognition	NN	I-NP	I-DNA
motif	motif	NN	I-NP	I-DNA
for	for	IN	B-PP	O
protein	protein	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
A	A	NN	I-NP	I-protein
(	(	(	O	O
RRPS	RRPS	NN	B-NP	B-protein
;	;	:	O	O
amino	amino	NN	B-NP	B-protein
acids	acid	NNS	I-NP	I-protein
273	273	CD	B-NP	I-protein
to	to	TO	B-PP	I-protein
276	276	CD	B-NP	I-protein
)	)	)	O	O
,	,	,	O	O
both	both	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
reside	reside	VBP	B-VP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
91-amino-acid	91-amino-acid	JJ	I-NP	B-protein
segment	segment	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Rel	Rel	NN	I-NP	B-protein
homology	homology	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
that	that	WDT	B-NP	O
mediates	mediate	VBZ	B-VP	O
self-association	self-association	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
mutations	mutation	NNS	B-NP	O
at	at	IN	B-PP	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
sites	site	NNS	I-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
heterodimerization	heterodimerization	NN	B-NP	O
of	of	IN	B-PP	O
p65	p65	NN	B-NP	B-protein
with	with	IN	B-PP	O
p50	p50	NN	B-NP	B-protein
or	or	CC	O	O
its	its	PRP$	B-NP	O
functional	functional	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
.	.	.	O	O

These	These	DT	B-NP	O
later	later	JJ	I-NP	O
findings	finding	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
neither	neither	CC	B-NP	O
homo-	homo-	JJ	I-NP	O
nor	nor	CC	I-NP	O
heterodimer	heterodimer	NN	I-NP	O
formation	formation	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
absolute	absolute	JJ	I-NP	O
prerequisite	prerequisite	NN	I-NP	O
for	for	IN	B-PP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
recognition	recognition	NN	I-NP	O
of	of	IN	B-PP	O
p65	p65	NN	B-NP	B-protein
.	.	.	O	O

Taken	Take	VBN	B-VP	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
prior	prior	JJ	B-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
transcription	transcription	NN	I-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
biological	biological	JJ	I-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
p65	p65	NN	B-NP	B-protein
and	and	CC	I-NP	O
p50	p50	NN	I-NP	B-protein
homodimers	homodimer	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
independently	independently	RB	I-VP	O
regulated	regulate	VBN	I-VP	O
,	,	,	O	O
thereby	thereby	RB	B-VP	O
providing	provide	VBG	I-VP	O
an	an	DT	B-NP	O
integrated	integrated	JJ	I-NP	O
and	and	CC	I-NP	O
flexible	flexible	JJ	I-NP	O
control	control	NN	I-NP	O
mechanism	mechanism	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
activation	activation	NN	I-NP	O
and	and	CC	O	O
repression	repression	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
/	/	SYM	B-NP	O
Rel	Rel	NN	I-NP	B-protein
-directed	-directed	JJ	I-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O

Carrier	Carri	JJR	B-NP	O
determination	determination	NN	I-NP	O
for	for	IN	B-PP	O
X-linked	X-linked	JJ	B-NP	O
agammaglobulinemia	agammaglobulinemia	NN	I-NP	O
using	use	VBG	B-VP	O
X	X	NN	B-NP	O
inactivation	inactivation	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
purified	purify	VBN	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
relatively	relatively	RB	I-NP	O
quick	quick	JJ	I-NP	O
and	and	CC	I-NP	O
simple	simple	JJ	I-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
assessment	assessment	NN	I-NP	O
of	of	IN	B-PP	O
X	X	NN	B-NP	O
inactivation	inactivation	NN	I-NP	O
status	status	NN	I-NP	O
for	for	IN	B-PP	O
carrier	carrier	NN	B-NP	O
determination	determination	NN	I-NP	O
in	in	IN	B-PP	O
families	family	NNS	B-NP	O
affected	affect	VBN	B-VP	O
by	by	IN	B-PP	O
X-linked	X-linked	JJ	B-NP	O
agammaglobulinemia	agammaglobulinemia	NN	I-NP	O
(	(	(	O	O
XLA	XLA	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

This	This	DT	B-NP	O
method	method	NN	I-NP	O
utilises	utilise	VBZ	B-VP	O
an	an	DT	B-NP	O
immunomagnetic	immunomagnetic	JJ	I-NP	O
separation	separation	NN	I-NP	O
technique	technique	NN	I-NP	O
for	for	IN	B-PP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
purification	purification	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
(	(	(	O	O
PCR	PCR	NN	B-NP	O
)	)	)	O	O
based	based	JJ	B-NP	O
assay	assay	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
determination	determination	NN	I-NP	O
of	of	IN	B-PP	O
methylation	methylation	NN	B-NP	O
status	status	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
androgen	androgen	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
AR	AR	NN	B-NP	O
)	)	)	O	O
gene	gene	NN	B-NP	O
locus	locus	NN	I-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
whether	whether	IN	B-SBAR	O
X	X	NN	B-NP	O
inactivation	inactivation	NN	I-NP	O
is	be	VBZ	B-VP	O
random	random	JJ	B-ADJP	O
or	or	CC	I-ADJP	O
non-random	non-random	JJ	I-ADJP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
locus	locus	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
obtained	obtain	VBN	I-VP	O
using	use	VBG	I-VP	O
this	this	DT	B-NP	O
assay	assay	NN	I-NP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
females	female	NNS	B-NP	O
known	know	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
carriers	carrier	NNS	B-NP	O
of	of	IN	B-PP	O
various	various	JJ	B-NP	O
X-linked	X-linked	JJ	I-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
disorders	disorder	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
four	four	CD	B-NP	O
females	female	NNS	I-NP	O
from	from	IN	B-PP	O
different	different	JJ	B-NP	O
families	family	NNS	I-NP	O
affected	affect	VBN	B-VP	O
by	by	IN	B-PP	O
XLA	XLA	NN	B-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
of	of	IN	B-PP	O
whom	whom	WP	B-NP	O
were	be	VBD	B-VP	O
of	of	IN	B-PP	O
unknown	unknown	JJ	B-NP	O
carrier	carrier	NN	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
we	we	PRP	B-NP	O
discuss	discuss	VBP	B-VP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
X-inactivation	X-inactivation	NN	I-NP	O
assays	assay	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
similar	similar	JJ	I-NP	O
assay	assay	NN	I-NP	O
has	have	VBZ	B-VP	O
recently	recently	RB	I-VP	O
been	be	VBN	I-VP	O
described	describe	VBN	I-VP	O
by	by	IN	B-PP	O
Allen	Allen	NNP	B-NP	O
et	et	FW	I-NP	O
al.	al.	FW	I-NP	O
(	(	(	O	O
1992	1992	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
applied	apply	VBN	B-VP	O
to	to	TO	B-PP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
one	one	CD	B-NP	O
family	family	NN	I-NP	O
affected	affect	VBN	B-VP	O
by	by	IN	B-PP	O
XLA	XLA	NN	B-NP	B-protein
.	.	.	O	O

Effects	Effect	NNS	B-NP	O
of	of	IN	B-PP	O
IL-4	IL-4	NN	B-NP	B-protein
and	and	CC	I-NP	O
Fc	Fc	NN	I-NP	B-protein
gamma	gamma	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
II	II	CD	I-NP	I-protein
engagement	engagement	NN	I-NP	O
on	on	IN	B-PP	O
Egr-1	Egr-1	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
during	during	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
membrane	membrane	NN	B-NP	B-protein
immunoglobulin	immunoglobulin	NN	I-NP	I-protein
crosslinking	crosslinking	NN	I-NP	O
.	.	.	O	O

Egr-1	Egr-1	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
immediate	immediate	JJ	I-NP	B-DNA
early	early	JJ	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
rapidly	rapidly	RB	I-VP	O
upregulated	upregulate	VBN	I-VP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
mitogenic	mitogenic	JJ	B-NP	O
signals	signal	NNS	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
antigen	antigen	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
crosslinking	crosslinking	NN	I-NP	O
on	on	IN	B-PP	O
murine	murine	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

It	It	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
Egr-1	Egr-1	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
are	be	VBP	B-VP	O
closely	closely	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
proliferation	proliferation	NN	I-NP	O
in	in	IN	B-PP	O
several	several	JJ	B-NP	O
models	model	NNS	I-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
and	and	CC	O	O
tolerance	tolerance	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
compared	compare	VBD	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
Egr-1	Egr-1	NN	B-NP	B-protein
during	during	IN	B-PP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
stimulation	stimulation	NN	I-NP	O
with	with	IN	B-PP	O
Fab'2	Fab'2	NN	B-NP	B-protein
and	and	CC	I-NP	O
IgG	IgG	NN	I-NP	B-protein
anti-immunoglobulin	anti-immunoglobulin	JJ	B-ADJP	O
(	(	(	O	O
anti-Ig	anti-Ig	JJ	B-ADJP	B-protein
)	)	)	O	O
,	,	,	O	O
since	since	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
that	that	IN	B-SBAR	O
Fab'2	Fab'2	NN	B-NP	B-protein
anti-Ig	anti-Ig	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
mitogenic	mitogenic	JJ	B-ADJP	O
while	while	IN	B-SBAR	O
IgG	IgG	NN	B-NP	B-protein
anti-Ig	anti-Ig	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
not	not	RB	O	O
,	,	,	O	O
owing	owe	VBG	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
crosslinking	crosslinke	VBG	B-VP	O
the	the	DT	B-NP	O
B	B	NN	I-NP	O
cell	cell	NN	I-NP	O
Fc	Fc	NN	I-NP	B-protein
gamma	gamma	NN	I-NP	I-protein
RII	RII	NN	I-NP	I-protein
to	to	TO	B-PP	O
membrane	membrane	NN	B-NP	O
Ig	Ig	NN	I-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
mitogenic	mitogenic	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Fab'2	Fab'2	NN	B-NP	O
anti-Ig	anti-Ig	NN	I-NP	B-protein
induce	induce	VBP	B-VP	O
large	large	JJ	B-NP	O
and	and	CC	I-NP	O
rapid	rapid	JJ	I-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
Egr-1	Egr-1	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
,	,	,	O	O
IgG	IgG	NN	B-NP	B-protein
anti-Ig	anti-Ig	NN	I-NP	I-protein
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
smaller	small	JJR	B-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
Egr-1	Egr-1	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
,	,	,	O	O
comparable	comparable	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
seen	see	VBN	B-VP	O
with	with	IN	B-PP	O
submitogenic	submitogenic	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
Fab'2	Fab'2	NN	B-NP	O
anti-Ig	anti-Ig	NN	I-NP	B-protein
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
Egr-1	Egr-1	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
proliferation	proliferation	NN	I-NP	O
breaks	break	NNS	I-NP	O
down	down	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
IL-4	IL-4	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
added	add	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
co-mitogen	co-mitogen	NN	I-NP	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
proliferation	proliferation	NN	I-NP	O
with	with	IN	B-PP	O
IgG	IgG	NN	B-NP	B-protein
anti-Ig	anti-Ig	JJ	I-NP	O
or	or	CC	I-NP	O
submitogenic	submitogenic	JJ	I-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
Fab'2	Fab'2	NN	B-NP	O
anti-Ig	anti-Ig	NN	I-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
corresponding	correspond	VBG	I-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
Egr-1	Egr-1	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
levels	level	NNS	I-NP	O
are	be	VBP	B-VP	O
observed	observe	VBN	I-VP	O
when	when	WRB	B-ADVP	O
IL-4	IL-4	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
added	add	VBN	I-VP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
IL-4	IL-4	NN	B-NP	B-protein
overcomes	overcome	VBZ	B-VP	O
Fc	Fc	NN	B-NP	O
receptor-mediated	receptor-mediated	JJ	I-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
proliferation	proliferation	NN	I-NP	O
without	without	IN	B-PP	O
affecting	affect	VBG	B-VP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
Egr-1	Egr-1	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
induction	induction	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
demonstrated	demonstrate	VBN	B-VP	O
earlier	earlier	RBR	B-ADVP	O
for	for	IN	B-PP	O
c-myc	c-myc	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
in	in	IN	B-PP	O
this	this	DT	B-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

Identification	Identification	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
cyclosporin-sensitive	cyclosporin-sensitive	JJ	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
tumor	tumor	NN	I-NP	I-DNA
necrosis	necrosis	NN	I-NP	I-DNA
factor	factor	NN	I-NP	I-DNA
alpha	alpha	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

Tumor	Tumor	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
(	(	(	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
cytokine	cytokine	NN	I-NP	B-protein
with	with	IN	B-PP	O
pleiotropic	pleiotropic	JJ	B-NP	O
biological	biological	JJ	I-NP	O
effects	effect	NNS	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
produced	produce	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
types	type	NNS	I-NP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
induction	induction	NN	B-NP	O
by	by	IN	B-PP	O
diverse	diverse	JJ	B-NP	O
stimuli	stimulus	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
paper	paper	NN	I-NP	O
,	,	,	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
is	be	VBZ	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
highly	highly	RB	I-VP	O
induced	induce	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
murine	murine	JJ	I-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
clone	clone	NN	I-NP	I-cell_line
by	by	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
with	with	IN	B-PP	O
T	T	NN	B-NP	B-protein
cell	cell	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
TCR	TCR	NN	B-NP	B-protein
)	)	)	O	O
ligands	ligand	NNS	B-NP	O
or	or	CC	B-PP	O
by	by	IN	B-PP	O
calcium	calcium	NN	B-NP	O
ionophores	ionophore	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

Induction	Induction	NN	B-NP	O
is	be	VBZ	B-VP	O
rapid	rapid	JJ	B-ADJP	O
,	,	,	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
de	de	FW	B-NP	O
novo	novo	FW	I-NP	O
protein	protein	NN	I-NP	O
synthesis	synthesis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
completely	completely	RB	I-VP	O
blocked	block	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
immunosuppressant	immunosuppressant	JJ	I-NP	O
cyclosporin	cyclosporin	NN	I-NP	O
A	A	NN	I-NP	O
(	(	(	O	O
CsA	CsA	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
identified	identify	VBN	I-VP	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
TNF-alpha	TNF-alpha	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
,	,	,	O	O
kappa	kappa	NN	B-NP	B-DNA
3	3	CD	I-NP	I-DNA
,	,	,	O	O
which	which	WDT	B-NP	O
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
key	key	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
calcium-mediated	calcium-mediated	JJ	I-NP	O
inducibility	inducibility	NN	I-NP	O
and	and	CC	I-NP	O
CsA	CsA	NN	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
oligonucleotide	oligonucleotide	NN	I-NP	O
containing	contain	VBG	B-VP	O
kappa	kappa	NN	B-NP	B-DNA
3	3	CD	I-NP	I-DNA
forms	form	VBZ	B-VP	O
two	two	CD	B-NP	O
DNA	DNA	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
with	with	IN	B-PP	O
proteins	protein	NNS	B-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
extracts	extract	NNS	B-NP	O
from	from	IN	B-PP	O
unstimulated	unstimulated	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

These	These	DT	B-NP	O
complexes	complex	NNS	I-NP	O
appear	appear	VBP	B-VP	O
in	in	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
only	only	RB	B-ADVP	O
after	after	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

Induction	Induction	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inducible	inducible	JJ	I-NP	B-protein
nuclear	nuclear	JJ	I-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
is	be	VBZ	B-VP	O
rapid	rapid	JJ	B-ADJP	O
,	,	,	O	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
blocked	block	VBN	B-VP	O
by	by	IN	B-PP	O
CsA	CsA	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
thus	thus	RB	O	O
,	,	,	O	O
exactly	exactly	RB	B-ADVP	O
parallels	parallel	VBZ	B-VP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
TNF-alpha	TNF-alpha	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
by	by	IN	B-PP	O
TCR	TCR	NN	B-NP	B-protein
ligands	ligand	NNS	I-NP	O
or	or	CC	B-PP	O
by	by	IN	B-PP	O
calcium	calcium	NN	B-NP	O
ionophore	ionophore	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
studies	study	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
kappa	kappa	NN	I-NP	B-protein
3	3	CD	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
resembles	resemble	VBZ	B-VP	O
the	the	DT	B-NP	O
preexisting	preexist	VBG	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
of	of	IN	B-PP	I-protein
activated	activate	VBN	B-NP	I-protein
T	T	NN	I-NP	I-protein
cells	cell	NNS	I-NP	I-protein
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
TNF-alpha	TNF-alpha	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
immediate	immediate	JJ	I-NP	B-DNA
early	early	JJ	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
in	in	IN	B-PP	O
activated	activate	VBN	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
provides	provide	VBZ	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
model	model	NN	I-NP	O
system	system	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
to	to	TO	B-VP	O
study	study	VB	I-VP	O
CsA-sensitive	CsA-sensitive	JJ	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
induction	induction	NN	I-NP	O
in	in	IN	B-PP	O
activated	activate	VBN	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Differences	Difference	NNS	B-NP	O
in	in	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
AP-1	AP-1	NN	I-NP	I-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
promyelocytic	promyelocytic	JJ	I-NP	I-cell_line
HL-60	HL-60	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
during	during	IN	B-PP	O
differentiation	differentiation	NN	B-NP	O
towards	towards	IN	B-PP	O
macrophages	macrophage	NNS	B-NP	B-cell_type
versus	versus	IN	B-PP	O
granulocytes	granulocyte	NNS	B-NP	B-cell_type
.	.	.	O	O

Commitment	Commitment	NN	B-NP	O
of	of	IN	B-PP	O
HL-60	HL-60	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
to	to	TO	B-PP	O
macrophage	macrophage	NN	B-NP	B-cell_type
or	or	CC	O	O
granulocytic	granulocytic	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
was	be	VBD	B-VP	O
achieved	achieve	VBN	I-VP	O
by	by	IN	B-PP	O
incubation	incubation	NN	B-NP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
beta-phorbol	beta-phorbol	NN	I-NP	O
12-myristate	12-myristate	NN	I-NP	O
13-acetate	13-acetate	NN	I-NP	O
(	(	(	O	O
PMA	PMA	NN	B-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
30-60	30-60	CD	B-NP	O
min	min	NN	I-NP	O
or	or	CC	B-PP	O
with	with	IN	B-PP	O
dimethyl	dimethyl	NN	B-NP	O
sulphoxide	sulphoxide	NN	I-NP	O
(	(	(	O	O
DMSO	DMSO	NN	B-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
24	24	CD	B-NP	O
h	h	NN	I-NP	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O
